PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Walker, J				Walker, John			Frederick Sanger (1918-2013) OBITUARY	NATURE			English	Biographical-Item												walker@mrc-mbu.cam.ac.uk							0	7	9	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					27	27		10.1038/505027a	http://dx.doi.org/10.1038/505027a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24409476	Bronze			2022-12-28	WOS:000329163300013
J	Elder, CJ; Bishop, NJ				Elder, Charlotte Jane; Bishop, Nicholas J.			Rickets	LANCET			English	Article							VITAMIN-D DEFICIENCY; TANDEM MASS-SPECTROMETRY; NUTRITIONAL RICKETS; 25-HYDROXYVITAMIN D-3; D SUPPLEMENTATION; CIRCULATING 25-HYDROXYVITAMIN-D; CALCIUM-ABSORPTION; GLOBAL PERSPECTIVE; FUTURE-DIRECTIONS; PRETERM INFANTS	Rickets, historically referred to as "the English disease", is common worldwide. Absence of phosphate at the growth plate and mineralising bone surfaces due to inadequate vitamin D supply either from sunlight exposure or diet is the main cause. Inherited disorders causing hypophosphataemia have shown the intricacies of phosphate metabolism. Present advice about the provision of vitamin D to young infants needs to be clarified; the existing guidance is fragmentary and contradictory, and will not help to eradicate the disease.	[Elder, Charlotte Jane; Bishop, Nicholas J.] Univ Sheffield, Sheffield Childrens Hosp, Acad Unit Child Hlth, Sheffield S10 2TH, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield	Bishop, NJ (corresponding author), Univ Sheffield, Sheffield Childrens Hosp, Acad Unit Child Hlth, Western Bank, Sheffield S10 2TH, S Yorkshire, England.	N.J.Bishop@sheffield.ac.uk		smithuis, frank/0000-0002-4704-9915				Abrams SA, 2009, J CLIN ENDOCR METAB, V94, P2421, DOI 10.1210/jc.2008-2587; Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Aggarwal V, 2012, J CLIN ENDOCR METAB, V97, P3461, DOI 10.1210/jc.2011-3120; Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2813; Ahmed SF, 2011, ARCH DIS CHILD, V96, P694, DOI 10.1136/adc.2009.173195; Aloia JF, 2011, J CLIN ENDOCR METAB, V96, P2987, DOI 10.1210/jc.2011-0090; Amukele TK, 2013, ARCH DIS CHILD, V98, P180, DOI 10.1136/archdischild-2012-302377; [Anonymous], 2010, CONS VIT D POS STAT; Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]; Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; Arundel P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8182; Ashraf S, 2002, ARCH DIS CHILD, V87, P263, DOI 10.1136/adc.87.3.263-a; Beck-Nielsen SS, 2009, EUR J ENDOCRINOL, V160, P491, DOI 10.1530/EJE-08-0818; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; BISHOP N, 1989, ARCH DIS CHILD, V64, P1403, DOI 10.1136/adc.64.10_Spec_No.1403; Bishop N, 2007, ARCH DIS CHILD, V92, P251, DOI 10.1136/adc.2006.106120; Callaghan AL, 2006, ARCH DIS CHILD, V91, P606, DOI 10.1136/adc.2006.095075; Calvo MS, 2004, AM J CLIN NUTR, V80, p1710S, DOI 10.1093/ajcn/80.6.1710S; Carpenter TO, 2011, J BONE MINER RES, V26, P1381, DOI 10.1002/jbmr.340; Chapman T, 2010, PEDIATR RADIOL, V40, P1184, DOI 10.1007/s00247-009-1470-8; Chen H, 2003, P NATL ACAD SCI USA, V100, P6109, DOI 10.1073/pnas.1031395100; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Christakos S, 2010, J STEROID BIOCHEM, V121, P183, DOI 10.1016/j.jsbmb.2010.03.005; Craviari T, 2008, J HEALTH POPUL NUTR, V26, P112; Daniels AL, 1929, AM J DIS CHILD, V37, P1177; Darling AL, 2013, OSTEOPOROSIS INT, V24, P477, DOI 10.1007/s00198-012-1973-2; Davies JH, 2011, ARCH DIS CHILD, V96, P614, DOI 10.1136/adc.2010.191627; De-Regil Luz M, 2012, COCHRANE DB SYST REV, V2; DeLucia MC, 2003, J CLIN ENDOCR METAB, V88, P3539, DOI 10.1210/jc.2002-021935; Demay MB, 2013, CALCIFIED TISSUE INT, V92, P99, DOI 10.1007/s00223-012-9633-2; DUNNIGAN MG, 1985, BMJ-BRIT MED J, V291, P239, DOI 10.1136/bmj.291.6490.239; Farrar MD, 2013, AM J CLIN NUTR, V97, P1210, DOI 10.3945/ajcn.112.052639; Farrar MD, 2011, AM J CLIN NUTR, V94, P1219, DOI 10.3945/ajcn.111.019976; Fraser WD, 2013, CALCIFIED TISSUE INT, V92, P118, DOI 10.1007/s00223-012-9693-3; Gallo S, 2013, J NUTR, V143, P148, DOI 10.3945/jn.112.167858; GLORIEUX FH, 1990, METABOLISM, V39, P10, DOI 10.1016/0026-0495(90)90264-D; Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583; Gordon CM, 2008, J CLIN ENDOCR METAB, V93, P2716, DOI 10.1210/jc.2007-2790; Greer FR, 2008, AM J CLIN NUTR, V88, p529S, DOI 10.1093/ajcn/88.2.529S; HARRELL RM, 1985, J CLIN INVEST, V75, P1858, DOI 10.1172/JCI111900; Hess AF, 1917, J AMER MED ASSOC, V69, P1583; Hess AF, 1921, J AMER MED ASSOC, V77, P39; HOLICK MF, 1991, NESTLE NUTR WORKS SE, V21, P1; Holick MF, 2008, J CLIN ENDOCR METAB, V93, P677, DOI 10.1210/jc.2007-2308; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hollis BW, 2004, AM J CLIN NUTR, V79, P717; HOPPE B, 1992, SCHWEIZ MED WSCHR, V122, P257; Hypponen E, 2011, J NUTR, V141, P843, DOI 10.3945/jn.110.133009; Institute of Medicine, 2010, DIETARY REFERENCE IN; Jeans PC, 1938, J PEDIATR-US, V13, P730, DOI 10.1016/S0022-3476(38)80162-1; Jeans PC, 1934, P SOC EXP BIOL MED, V31, P1159; Kaseda R, 2011, THER APHER DIAL, V15, P14, DOI 10.1111/j.1744-9987.2011.00920.x; Lanham-New S A, 2011, Br J Nutr, V105, P144, DOI 10.1017/S0007114510002576; Lensmeyer G, 2012, J CLIN ENDOCR METAB, V97, P163, DOI 10.1210/jc.2011-0584; LO CW, 1986, AM J CLIN NUTR, V44, P683, DOI 10.1093/ajcn/44.5.683; LOUDON I, 1986, MED HIST, V30, P1; Lucas-Herald A, 2012, PEDIATRICS, V130, P1116, DOI 10.1542/peds.2012-0462; Maiya S, 2008, HEART, V94, P581, DOI 10.1136/hrt.2007.119792; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Masuyama H, 1997, MOL ENDOCRINOL, V11, P1507, DOI 10.1210/me.11.10.1507; Matsuo K, 2009, PEDIATR INT, V51, P559, DOI 10.1111/j.1442-200X.2009.02834.x; Mazhar SB, 2012, VITAMIN D SUPPLEMENT; MELLANBY MA, 1989, NUTRITION, V5, P81; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Molnar F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018124; Moy RJ, 2012, ARCH DIS CHILD, V97, P952, DOI 10.1136/archdischild-2012-302287; Munns CF, 2012, MED J AUSTRALIA, V196, P466, DOI 10.5694/mja11.10662; Need AG, 2008, J BONE MINER RES, V23, P1859, DOI 10.1359/JBMR.080607; Office for National Statistics, 2011, CENS KEY STAT LOC AU; Ozkan B, 2009, EUR J PEDIATR, V168, P95, DOI 10.1007/s00431-008-0821-z; Paediatric Formulary Committee, 2013, BRIT NAT FORM CHILDR; Palm T., 1890, PRACTITIONER, V45, P270; Paterson D, 1926, Arch Dis Child, V1, P36; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Pettifor J. M., 2003, PEDIAT BONE BIOL DIS, P541; Pettifor JM, 2004, AM J CLIN NUTR, V80, p1725S, DOI 10.1093/ajcn/80.6.1725S; Pettifor JM, 2008, INDIAN J MED RES, V127, P245; Phinney KW, 2012, ANAL CHEM, V84, P956, DOI 10.1021/ac202047n; PIETREK J, 1976, LANCET, V1, P1145; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Prentice A, 2013, J STEROID BIOCHEM, V136, P201, DOI 10.1016/j.jsbmb.2012.11.018; Prideaux M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036786; REEVE LE, 1982, AM J CLIN NUTR, V36, P122, DOI 10.1093/ajcn/36.1.122; Robinson PD, 2006, ARCH DIS CHILD, V91, P564, DOI 10.1136/adc.2004.069575; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Rowe PSN, 2012, CELL BIOCHEM FUNCT, V30, P355, DOI 10.1002/cbf.2841; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Shaw NJ, 2013, ARCH DIS CHILD, V98, P368, DOI 10.1136/archdischild-2012-302585; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Stepman HCM, 2011, CLIN CHEM, V57, P441, DOI 10.1373/clinchem.2010.152553; Tai SSC, 2010, ANAL CHEM, V82, P1942, DOI 10.1021/ac9026862; Taylor SN, 2008, J AM COLL NUTR, V27, P690, DOI 10.1080/07315724.2008.10719746; Thacher TD, 2006, ANN TROP PAEDIATR, V26, P1, DOI 10.1179/146532806X90556; Thacher TD, 1999, NEW ENGL J MED, V341, P563, DOI 10.1056/NEJM199908193410803; Thacher TD, 2006, ACTA PAEDIATR, V95, P826, DOI 10.1080/08035250500452613; Tiosano D, 2012, CURR OPIN ENDOCRINOL, V19, P452, DOI 10.1097/MED.0b013e32835a3415; Trousseau A., 1872, LECT CLIN MED HOT DI; Valcour A, 2012, J CLIN ENDOCR METAB, V97, P3989, DOI 10.1210/jc.2012-2276; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Wharton B, 2003, LANCET, V362, P1389, DOI 10.1016/S0140-6736(03)14636-3; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173	107	91	92	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1665	1676		10.1016/S0140-6736(13)61650-5	http://dx.doi.org/10.1016/S0140-6736(13)61650-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG8LV	24412049				2022-12-28	WOS:000335670800029
J	Volberding, P				Volberding, Paul			HIV Cure: The Target Is Clearer but Not Yet Close	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY; INFECTION		[Volberding, Paul] Univ Calif San Francisco, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Volberding, P (corresponding author), Univ Calif San Francisco, AIDS Res Inst, 50 Beale St,Suite 1300, San Francisco, CA 94105 USA.							Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Henrich T, 2013, 6 INT WORKSH HIV PER; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; LIFSON AR, 1991, J INFECT DIS, V163, P959, DOI 10.1093/infdis/163.5.959; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103	9	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					505	+		10.7326/M13-2893	http://dx.doi.org/10.7326/M13-2893			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24424733				2022-12-28	WOS:000334093800009
J	Liu, ZK; Zhou, B; Zhang, Y; Wang, ZJ; Weng, HM; Prabhakaran, D; Mo, SK; Shen, ZX; Fang, Z; Dai, X; Hussain, Z; Chen, YL				Liu, Z. K.; Zhou, B.; Zhang, Y.; Wang, Z. J.; Weng, H. M.; Prabhakaran, D.; Mo, S-K; Shen, Z. X.; Fang, Z.; Dai, X.; Hussain, Z.; Chen, Y. L.			Discovery of a Three-Dimensional Topological Dirac Semimetal, Na3Bi	SCIENCE			English	Article							INSULATORS; GRAPHENE; PHASE	Three-dimensional (3D) topological Dirac semimetals (TDSs) represent an unusual state of quantum matter that can be viewed as "3D graphene." In contrast to 2D Dirac fermions in graphene or on the surface of 3D topological insulators, TDSs possess 3D Dirac fermions in the bulk. By investigating the electronic structure of Na3Bi with angle-resolved photoemission spectroscopy, we detected 3D Dirac fermions with linear dispersions along all momentum directions. Furthermore, we demonstrated the robustness of 3D Dirac fermions in Na3Bi against in situ surface doping. Our results establish Na3Bi as a model system for 3D TDSs, which can serve as an ideal platform for the systematic study of quantum phase transitions between rich topological quantum states.	[Liu, Z. K.; Shen, Z. X.] Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Zhou, B.; Prabhakaran, D.; Chen, Y. L.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Zhou, B.; Zhang, Y.; Mo, S-K; Hussain, Z.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Wang, Z. J.; Weng, H. M.; Fang, Z.; Dai, X.] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Wang, Z. J.; Weng, H. M.; Fang, Z.; Dai, X.] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Weng, H. M.; Fang, Z.; Dai, X.] Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China; [Chen, Y. L.] Diamond Light Source, Didcot, Oxon, England; [Chen, Y. L.] Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Oxford; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Chen, YL (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	yulin.chen@physics.ox.ac.uk	Hussain, Zahid/HGU-8912-2022; Dai, Xi/HCG-9886-2022; Weng, Hongming/F-2948-2011; Fang, Zhong/D-4132-2009; Dai, Xi/C-4236-2008; Chen, Yulin/C-1918-2012; Zhang, Yi/J-9025-2013; Wang, Zhijun/O-8015-2014; Mo, Sung-Kwan/F-3489-2013	Hussain, Zahid/0000-0003-4989-6496; Weng, Hongming/0000-0001-8021-9413; Dai, Xi/0000-0002-2396-0966; Zhang, Yi/0000-0003-1204-8717; Wang, Zhijun/0000-0003-2169-8068; Mo, Sung-Kwan/0000-0003-0711-8514	Engineering and Physical Sciences Research Council (UK) [EP/K04074X/1]; Defense Advanced Research Projects Agency (USA) MESO project [N66001-11-1-4105]; U.S. Department of Energy, Office of Science, Materials Sciences and Engineering Division; NSF of China; National Basic Research Program of China; International Science and Technology Cooperation Program of China; Engineering and Physical Sciences Research Council [EP/K04074X/1] Funding Source: researchfish; EPSRC [EP/K04074X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Defense Advanced Research Projects Agency (USA) MESO project(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Department of Energy, Office of Science, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); NSF of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International Science and Technology Cooperation Program of China; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank X. L. Qi and Z. Wang for insightful discussions, S. Clarke and J. Wright for help in sample synthesis, and P. Han and R. Yang for help with data analysis. Y.L.C. and B. Z. acknowledge support from the Engineering and Physical Sciences Research Council (UK) grant EP/K04074X/1 and a Defense Advanced Research Projects Agency (USA) MESO project (no. N66001-11-1-4105). Z. K. L. and Z. X. S. acknowledge support by the U.S. Department of Energy, Office of Science, Materials Sciences and Engineering Division. Z. F., X. D., and H. M. W. acknowledge support by the NSF of China, the National Basic Research Program of China, and the International Science and Technology Cooperation Program of China. The experiments were performed, and data were collected, at Beamline 10.0.1 of the Advanced Light Source, Lawrence Berkeley National Laboratory, USA.	Abrikosov AA, 1998, PHYS REV B, V58, P2788, DOI 10.1103/PhysRevB.58.2788; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chen Y, 2012, FRONT PHYS-BEIJING, V7, P175, DOI 10.1007/s11467-011-0197-9; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Goswami P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.196803; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Herring C, 1937, PHYS REV, V52, P0365, DOI 10.1103/PhysRev.52.365; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Klinkhamer FR, 2005, INT J MOD PHYS A, V20, P2795, DOI 10.1142/S0217751X05020902; Koshino M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195431; Liu CX, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041307; Liu Q, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156603; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; ROBER E, 1979, PHYS STATUS SOLIDI B, V93, pK99, DOI 10.1002/pssb.2220930244; Volovik GE, 2007, LECT NOTES PHYS, V718, P31, DOI [10.1007/3-540-70859-6_4, 10.1007/3-540-70859-6̲4]; Volovik G.E., 2003, UNIVERSE HELIUM DROP; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Xu G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186806; Yang KY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075129; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405; Zhang W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156808	28	1657	1673	30	902	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					864	867		10.1126/science.1245085	http://dx.doi.org/10.1126/science.1245085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24436183	Green Submitted			2022-12-28	WOS:000331552600040
J	Sacks, LV; Shamsuddin, HH; Yasinskaya, YI; Bouri, K; Lanthier, ML; Sherman, RE				Sacks, Leonard V.; Shamsuddin, Hala H.; Yasinskaya, Yuliya I.; Bouri, Khaled; Lanthier, Michael L.; Sherman, Rachel E.			Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURROGATE END-POINTS; CLINICAL-TRIALS; PHASE-III; DISEASE; CANCER; RATES	IMPORTANCE Some new drug applications fail because of inadequate drug performance and others are not approved because the information submitted to the US Food and Drug Administration (FDA) is unsatisfactory to make that determination. Resubmission of failed applications is costly, delaying marketing approval and the availability of new drugs to patients. OBJECTIVE To identify the reasons that FDA marketing approval for new drugs was delayed or denied. DESIGN, SETTING, AND PARTICIPANTS A retrospective review of FDA documents and extraction of data were performed. We examined all drug applications first submitted to the FDA between 2000 and 2012 for new molecular entities (NMEs), which are active ingredients never before marketed in the United States in any form. Using FDA correspondence and reviews, we investigated the reasons NMEs failed to obtain FDA approval. MAIN OUTCOMES AND MEASURES Reasons for delayed FDA approval or nonapproval of NME applications. RESULTS Of the 302 identified NME applications, 151 (50%) were approved when first submitted and 222 (73.5%) were ultimately approved. Seventy-one applications required 1 or more resubmissions before approval, with a median delay to approval of 435 days following the first unsuccessful submission. Of the unsuccessful first-time applications, 24 (15.9%) included uncertainties related to dose selection, 20 (13.2%) choice of study end points that failed to adequately reflect a clinically meaningful effect, 20 (13.2%) inconsistent results when different end points were tested, 17 (11.3%) inconsistent results when different trials or study sites were compared, and 20 (13.2%) poor efficacy when compared with the standard of care. The frequency of safety deficiencies was similar among never-approved drugs compared with those with delayed approval (43 of 80 never approved [53.8%] vs 37 of 71 eventually approved [52.1%]; difference, 1.7% [95% CI, -14.86% to 18.05%]; P = .87). However, efficacy deficiencies were significantly more frequent among the never-approved drugs than among those with delayed approvals (61 of 80 never approved [76.3%] vs 28 of 71 eventually approved [39.4%]; difference, 36.9% [95% CI, 20.25% to 50.86%]; P < .001). CONCLUSIONS AND RELEVANCE Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable study end points, accounted for significant delays in the approval of new drugs. Understanding the reasons for previous failures is helpful to improve the efficiency of clinical development for new drugs.	[Sacks, Leonard V.; Sherman, Rachel E.] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Shamsuddin, Hala H.; Yasinskaya, Yuliya I.] US FDA, Off Antimicrobial Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Bouri, Khaled] US FDA, Off Crit Path Programs, Off Commissioner, Silver Spring, MD 20993 USA; [Lanthier, Michael L.] US FDA, Off Commissioner, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Sacks, LV (corresponding author), US FDA, Off Med Policy, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,Bldg 51,Room 6342, Silver Spring, MD 20993 USA.	leonard.sacks@fda.hhs.gov						Amiri-Kordestani L, 2012, J NATL CANCER I, V104, P568, DOI 10.1093/jnci/djs180; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Bretz F, 2006, BIOMETRICAL J, V48, P623, DOI 10.1002/bimj.200510232; Coley N, 2009, ANN NY ACAD SCI, V1180, P119, DOI 10.1111/j.1749-6632.2009.04947.x; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gan HK, 2012, J NATL CANCER I, V104, P590, DOI 10.1093/jnci/djs141; Goffin J, 2005, CLIN CANCER RES, V11, P5928, DOI 10.1158/1078-0432.CCR-05-0130; Greene JA, 2012, NEW ENGL J MED, V367, P1481, DOI 10.1056/NEJMp1210007; International Conference on Harmonization Working Group, ICH HARM TRIP GUID E; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Pariser AR, 2012, DRUG DISCOV TODAY, V17, P898, DOI 10.1016/j.drudis.2012.04.011; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Rich S, 2012, J AM COLL CARDIOL, V60, P1202, DOI 10.1016/j.jacc.2012.03.080; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; US Food and Drug Administration, GUID IND NO IN PRESS; US Food and Drug Administration, 2005, BEXTR VALD; US Food and Drug Administration, DRUGS FDA; US Food and Drug Administration Center for Drug Evaluation and Research, MAN POL PROC REV CLA; Zia MI, 2005, J CLIN ONCOL, V23, P6982, DOI 10.1200/JCO.2005.06.679	25	117	123	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					378	384		10.1001/jama.2013.282542	http://dx.doi.org/10.1001/jama.2013.282542			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449316	Bronze			2022-12-28	WOS:000329939300023
J	Kirshner, HS				Kirshner, Howard S.			Dual-antiplatelet therapy does not reduce recurrent stroke but can increase ICH	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLOPIDOGREL; ASPIRIN		Vanderbilt Univ, Med Ctr, Nashville, TN 37203 USA	Vanderbilt University	Kirshner, HS (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37203 USA.							Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Yusuf S, 2001, NEW ENGL J MED, V345, P494	4	1	1	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC5	10.7326/0003-4819-160-2-201401210-02005	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445715				2022-12-28	WOS:000330275600004
J	Stewart, AK				Stewart, A. Keith			How Thalidomide Works Against Cancer	SCIENCE			English	Editorial Material							MULTIPLE-MYELOMA; CEREBLON EXPRESSION; LENALIDOMIDE; IKAROS; POMALIDOMIDE; AIOLOS; IRF4		Mayo Clin, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Stewart, AK (corresponding author), Mayo Clin, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	stewart.keith@mayo.edu			NCI NIH HHS [R01 CA183968] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA183968] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Ludwig H, 2012, BLOOD, V119, P3003, DOI 10.1182/blood-2011-11-374249; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Schuster SR, 2014, LEUKEMIA RES, V38, P23, DOI 10.1016/j.leukres.2013.08.015; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Stewart AK, 2009, BLOOD, V114, P5436, DOI 10.1182/blood-2009-07-204651; Zhang LH, 2013, BRIT J HAEMATOL, V160, P487, DOI 10.1111/bjh.12172; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	15	69	72	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					256	257		10.1126/science.1249543	http://dx.doi.org/10.1126/science.1249543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436409	Green Accepted			2022-12-28	WOS:000329718600022
J	Parry, BR; Surovtsev, IV; Cabeen, MT; O'Hem, CS; Dufresne, ER; Jacobs-Wagner, C				Parry, Bradley R.; Surovtsev, Ivan V.; Cabeen, Matthew T.; O'Hem, Corey S.; Dufresne, Eric R.; Jacobs-Wagner, Christine			The Bacterial Cytoplasm Has Glass-like Properties and Is Fluidized by Metabolic Activity	CELL			English	Article							CELL CURVATURE; PROTEIN; DYNAMICS; DIFFUSION; MOBILITY; HETEROGENEITIES; BIOSYNTHESIS; CYTOSKELETON; TRANSITION; CHROMATIN	The physical nature of the bacterial cytoplasm is poorly understood even though it determines cytoplasmic dynamics and hence cellular physiology and behavior. Through single-particle tracking of protein filaments, plasmids, storage granules, and foreign particles of different sizes, we find that the bacterial cytoplasm displays properties that are characteristic of glass-forming liquids and changes from liquid-like to solid-like in a component size-dependent fashion. As a result, the motion of cytoplasmic components becomes disproportionally constrained with increasing size. Remarkably, cellular metabolism fluidizes the cytoplasm, allowing larger components to escape their local environment and explore larger regions of the cytoplasm. Consequently, cytoplasmic fluidity and dynamics dramatically change as cells shift between metabolically active and dormant states in response to fluctuating environments. Our findings provide insight into bacterial dormancy and have broad implications to our understanding of bacterial physiology, as the glassy behavior of the cytoplasm impacts all intracellular processes involving large components.	[Parry, Bradley R.; Surovtsev, Ivan V.; Cabeen, Matthew T.; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Surovtsev, Ivan V.; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [O'Hem, Corey S.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [O'Hem, Corey S.; Dufresne, Eric R.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [O'Hem, Corey S.; Dufresne, Eric R.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA; [Dufresne, Eric R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA; [Dufresne, Eric R.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu	O'Hern, Corey S/I-3459-2014; Dufresne, Eric R/A-7760-2009	O'Hern, Corey S/0000-0002-8272-5640; Jacobs-Wagner, Christine/0000-0003-0980-5334; Dufresne, Eric Robert/0000-0002-3091-5039	National Institutes of Health [T32HG 003198, GM065835]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Jason Hocking for the construction of strains CJW4617 and CJW4619. We thank Dr. Anuradha Janakiraman, Dr. Max Nibert, and Dr. Cammie Lesser for providing the template for the construction of the IPTG-inducible allele that encodes GFP-mu NS. We also thank Dr. Joe Pogliano for providing JP924 strain and Dr. Manuel Campos for sharing the information about nucleoid expansion in response to DNP treatment. We also thank all members of the Jacobs-Wagner lab for critical reading of the manuscript and for fruitful discussions. B. R. P. was, in part, supported by the National Institutes of Health (T32HG 003198). This work was supported by the National Institutes of Health (GM065835 to C.J.-W.). C.J.-W. is a Howard Hughes Medical Institute investigator.	Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bakshi S, 2011, BIOPHYS J, V101, P2535, DOI 10.1016/j.bpj.2011.10.013; Brangwynne CP, 2009, TRENDS CELL BIOL, V19, P423, DOI 10.1016/j.tcb.2009.04.004; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Cabeen MT, 2010, J BACTERIOL, V192, P3368, DOI 10.1128/JB.01371-09; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cipelletti L, 2005, J PHYS-CONDENS MAT, V17, pR253, DOI 10.1088/0953-8984/17/6/R01; Coates A. R. M., 2003, DORMANCY LOW GROWTH; Coquel AS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003038; Dawson KA, 2002, CURR OPIN COLLOID IN, V7, P218, DOI 10.1016/S1359-0294(02)00052-3; Derman AI, 2008, MOL MICROBIOL, V67, P935, DOI 10.1111/j.1365-2958.2007.06066.x; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Doliwa B, 1998, PHYS REV LETT, V80, P4915, DOI 10.1103/PhysRevLett.80.4915; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; FEHR T, 1995, PHYS REV E, V52, P4016, DOI 10.1103/PhysRevE.52.4016; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Jun S, 2010, NAT REV MICROBIOL, V8, P600, DOI 10.1038/nrmicro2391; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Levi V, 2005, BIOPHYS J, V89, P4275, DOI 10.1529/biophysj.105.066670; Llopis PM, 2012, BIOPHYS J, V103, P1848, DOI 10.1016/j.bpj.2012.09.035; Maehara A, 2002, J BACTERIOL, V184, P3992, DOI 10.1128/JB.184.14.3992-4002.2002; Marcus AH, 1999, PHYS REV E, V60, P5725, DOI 10.1103/PhysRevE.60.5725; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Petekidis G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051402; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Qi QS, 2001, MICROBIOL-SGM, V147, P3353, DOI 10.1099/00221287-147-12-3353; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Spitzer J, 2011, MICROBIOL MOL BIOL R, V75, P491, DOI 10.1128/MMBR.00010-11; Spitzer J, 2009, MICROBIOL MOL BIOL R, V73, P371, DOI 10.1128/MMBR.00010-09; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Weeks ER, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.095704; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Zaccarelli E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.268301; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	47	436	437	4	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					183	194		10.1016/j.cell.2013.11.028	http://dx.doi.org/10.1016/j.cell.2013.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24361104	Green Accepted, Bronze			2022-12-28	WOS:000329912200020
J	McCartney, M; Goldacre, B; Chalmers, I; Reynolds, C; Mendel, J; Smith, S; Bewley, S; Gordon, P; Carroll, D; Dean, BJF; Greenhalgh, T; Heath, I; McKee, M; Pollock, A; Gordon, S				McCartney, Margaret; Goldacre, Ben; Chalmers, Iain; Reynolds, Carl; Mendel, Jonathan; Smith, Sam; Bewley, Susan; Gordon, Peter; Carroll, David; Dean, Ben J. F.; Greenhalgh, Trish; Heath, Iona; McKee, Martin; Pollock, Allyson; Gordon, Sian			Why the GMC should set up a central registry of doctors' competing interests	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHARMACEUTICAL-INDUSTRY; PHYSICIANS; GIFT		[Reynolds, Carl] Imperial Coll London, London, England; [Bewley, Susan] Kings Coll London, London WC2R 2LS, England; [Carroll, David] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Dean, Ben J. F.] Univ Oxford, Oxford OX1 2JD, England; [Greenhalgh, Trish] Barts & London Queen Marys Sch Med & Dent, London, England; [Heath, Iona; McKee, Martin] London Sch Hyg & Trop Med, London, England; [Pollock, Allyson] Queen Mary Univ London, London, England	Imperial College London; University of London; King's College London; Queens University Belfast; University of Oxford; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London		margaret@margaretmccartney.com	Mckee, Martin/E-6673-2018; Greenhalgh, Trisha/B-1825-2015; Dean, Benjamin/H-8437-2014; McKee, Marc D/E-2187-2011; mccartney, margaret/AAR-4727-2020	Mckee, Martin/0000-0002-0121-9683; Greenhalgh, Trisha/0000-0003-2369-8088; McKee, Marc D/0000-0001-8349-965X; McCartney, Margaret/0000-0002-7238-6358; pollock, allyson/0000-0002-7388-3110; bewley, susan/0000-0001-8064-652X; Goldacre, Ben/0000-0002-5127-4728				[Anonymous], 2013, GUARDIAN; GMC, FIN COMM ARR CONFL I; Gordon P., NHS SCOTLAND REGISTE; Green MJ, 2012, FAM MED, V44, P325; Horton R, 2004, LANCET, V363, P820, DOI 10.1016/S0140-6736(04)15699-7; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Mori Ipsos, TRUST PROF POLL 2013; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	8	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2014	348								g236	10.1136/bmj.g236	http://dx.doi.org/10.1136/bmj.g236			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MO	24429932	Green Published			2022-12-28	WOS:000329976000017
J	Chalmers, I; Bracken, MB; Djulbegovic, B; Garattini, S; Grant, J; Gulmezoglu, AM; Howells, DW; Ioannidis, JPA; Oliver, S				Chalmers, Iain; Bracken, Michael B.; Djulbegovic, Ben; Garattini, Silvio; Grant, Jonathan; Guelmezoglu, A. Metin; Howells, David W.; Ioannidis, John P. A.; Oliver, Sandy			How to increase value and reduce waste when research priorities are set	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; SCIENTIFIC BASIS; CLINICAL-TRIALS; HEALTH-CARE; METAANALYSES; CANCER; PATIENT; AGENDA; UNCERTAINTIES	The increase in annual global investment in biomedical research-reaching US$240 billion in 2010-has resulted in important health dividends for patients and the public. However, much research does not lead to worthwhile achievements, partly because some studies are done to improve understanding of basic mechanisms that might not have relevance for human health. Additionally, good research ideas often do not yield the anticipated results. As long as the way in which these ideas are prioritised for research is transparent and warranted, these disappointments should not be deemed wasteful; they are simply an inevitable feature of the way science works. However, some sources of waste cannot be justified. In this report, we discuss how avoidable waste can be considered when research priorities are set. We have four recommendations. First, ways to improve the yield from basic research should be investigated. Second, the transparency of processes by which funders prioritise important uncertainties should be increased, making clear how they take account of the needs of potential users of research. Third, investment in additional research should always be preceded by systematic assessment of existing evidence. Fourth, sources of information about research that is in progress should be strengthened and developed and used by researchers. Research funders have primary responsibility for reductions in waste resulting from decisions about what research to do.	[Chalmers, Iain] James Lind Initiat, Oxford OX2 7LG, England; [Bracken, Michael B.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Med, New Haven, CT USA; [Djulbegovic, Ben] Univ S Florida, Div Internal Med, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL USA; [Djulbegovic, Ben] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL 33612 USA; [Djulbegovic, Ben] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL 33612 USA; [Garattini, Silvio] Ist Ric Farmacol Mario Negri, IRCCS, Milan, Italy; [Grant, Jonathan] RAND Europe, Cambridge, England; [Guelmezoglu, A. Metin] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, CH-1211 Geneva, Switzerland; [Howells, David W.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Oliver, Sandy] Univ London, Inst Educ, London WC1N 1AZ, England	Yale University; Yale University; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; RAND Corporation; RAND Europe; The World Bank; United Nations Population Fund; World Health Organization; Florey Institute of Neuroscience & Mental Health; Stanford University; Stanford University; Stanford University; Stanford University; University of London; University College London; UCL Institute of Education	Chalmers, I (corresponding author), James Lind Initiat, Oxford OX2 7LG, England.	ichalmers@jameslind.net	Djulbegovic, Benjamin/I-3661-2012; Garattini, Silvio/AAA-6390-2020; Ioannidis, John P. A./G-9836-2011; Grant, Jonathan C/K-4282-2012	Djulbegovic, Benjamin/0000-0003-0671-1447; Garattini, Silvio/0000-0003-0647-9297; Grant, Jonathan C/0000-0002-1646-3486; Oliver, Sandy/0000-0001-9571-269X; Howells, David/0000-0002-2512-7724	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Al-Shahi Salman R, 2014, LANCET; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; [Anonymous], 2013, NAT IMMUNOL, V14, P415, DOI 10.1038/ni.2603; [Anonymous], UK HLTH RES AN 2009; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; BAUSELL RB, 1993, EVAL HEALTH PROF, V16, P3, DOI 10.1177/016327879301600101; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Boote JD, 2014, HEALTH EXPECT, V17, P440, DOI 10.1111/j.1369-7625.2012.00771.x; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Boudreau KJ, 2013, NOVELTY PARADOX BIAS; Bracken M, 2013, RISK CHANCE CAUSATIO; Bracken MB, 2011, EPIDEMIOLOGY, V22, P135, DOI 10.1097/EDE.0b013e318207fc7c; Broerse JE, 2012, BURNS, V36, P217; Caron-Flinterman JF, 2006, SCI PUBL POLICY, V33, P291, DOI DOI 10.3152/147154306781778993; Cartwright J., 2011, PATIENT PUBLIC INVOL; Chalmers I, 2003, BRIT MED J, V327, P1017, DOI 10.1136/bmj.327.7422.1017; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Chalmers I., 2007, TREATING INDIVIDUALS, P37; Chalmers I., 2001, SYSTEMATIC REV HLTH, P429, DOI DOI 10.1002/9780470693926.CH24; Chalmers I, 2013, J ROY SOC MED, V106, P482, DOI 10.1177/0141076813493063; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan A-W, 2014, LANCET; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; Clark O, 2001, LANCET, V358, P1648, DOI 10.1016/S0140-6736(01)06686-7; Clark T, 2013, BMJ-BRIT MED J, V346, pf1136; Clarke M., 2013, Journal of the Bahrain Medical Society, V24, P145; Collins FS, 2012, SCIENCE, V337, P503, DOI 10.1126/science.1227820; COMROE JH, 1976, SCIENCE, V192, P105, DOI 10.1126/science.769161; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Cooksey D., 2006, REV UK HLTH RES FUND; Cooper NJ, 2005, CLIN TRIALS, V2, P260, DOI 10.1191/1740774505cn090oa; Corner J, 2007, BRIT J CANCER, V96, P875, DOI 10.1038/sj.bjc.6603662; *DEP HLTH, 2001, RES GOV FRAM HLTH SO; Djulbegovic B, 2013, NATURE, V500, P395, DOI 10.1038/500395a; Djulbegovic B, 2011, J CLIN EPIDEMIOL, V64, P583, DOI 10.1016/j.jclinepi.2010.09.007; Elwyn G, 2010, J EVAL CLIN PRACT, V16, P627, DOI 10.1111/j.1365-2753.2009.01262.x; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Garattini S, 2009, J HEPATOL, V51, P792, DOI 10.1016/j.jhep.2009.07.005; Gilbert R, 2005, INT J EPIDEMIOL, V34, P874, DOI 10.1093/ije/dyi088; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Goudie AC, 2010, J CLIN EPIDEMIOL, V63, P983, DOI 10.1016/j.jclinepi.2010.01.022; Grant J, 2003, RES EVALUAT, V12, P217, DOI 10.3152/147154403781776618; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000010.pub3; Horn J, 2001, STROKE, V32, P2433, DOI 10.1161/hs1001.096009; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1438, DOI 10.1001/jama.263.10.1438; Institute of Medicine, 2007, LEARN WHAT WORKS INF; Ioannidis J.P., 2014, LANCET; Ioannidis JPA, 2011, NATURE, V477, P529, DOI 10.1038/477529a; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Ioannidis JPA, 2010, J CLIN EPIDEMIOL, V63, P945, DOI 10.1016/j.jclinepi.2010.04.002; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Jones AP, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-50; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Lee DS, 2003, J CARD FAIL, V9, P368, DOI 10.1054/S1071-9164(03)00125-8; Liberati A, 2011, LANCET, V378, P1777, DOI 10.1016/S0140-6736(11)61772-8; Liberati A, 2010, EUR J CLIN INVEST, V40, P69, DOI 10.1111/j.1365-2362.2009.02226.x; Lloyd K, 2011, NATURE, V474, P277, DOI 10.1038/474277a; Lophatananon A, 2011, BJU INT, V108, P1040, DOI 10.1111/j.1464-410X.2011.10609.x; Macleod R, 2014, LANCET; Marburger JH, 2005, SCIENCE, V308, P1087, DOI 10.1126/science.1114801; McKevitt C, 2004, STROKE, V35, P1499, DOI 10.1161/01.STR.0000127532.64840.36; Mervis J, 2012, SCIENCE, V338, P1274, DOI 10.1126/science.338.6112.1274; Mestre-Ferrandiz J, 2012, R D COST NEW MED; Milne R, 2012, BURDEN DIS RES FUNDI; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Nasser M, 2013, J CLIN EPIDEMIOL, V66, P469, DOI 10.1016/j.jclinepi.2012.08.006; National Institute for Health Research, 2012, IMPR MEM TRAUM BRAIN; Nicholson JM, 2012, NATURE, V492, P34, DOI 10.1038/492034a; Oliver S, 1999, CRITICAL ISSUES SOCI, P139; Oliver S, 1997, NONRANDOM REFLECTION, P272; Oliver S, 2009, PATIENT, V2, P179, DOI 10.2165/11314860-000000000-00000; Osherovich L, 2011, HEDGING ACAD RISK; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Poliakoff E, 2007, SCI COMMUN, V29, P242, DOI 10.1177/1075547007308009; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Rothwell PM, 2006, LANCET, V368, P262, DOI 10.1016/S0140-6736(06)69010-7; Rothwell Peter M., 2007, TREATING INDIVIDUALS; Rothwell PM, 1997, LANCET, V350, P1181, DOI 10.1016/S0140-6736(05)63832-9; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Russell JF, 2013, NATURE, V496, P7, DOI 10.1038/496007a; Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116; SINCLAIR JC, 1995, AM J OBSTET GYNECOL, V173, P335, DOI 10.1016/0002-9378(95)90223-6; Smith GD, 1997, LANCET, V350, P1182, DOI 10.1016/S0140-6736(05)63833-0; SMITH R, 1987, BRIT MED J, V295, P1404, DOI 10.1136/bmj.295.6610.1404; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Staley K., 2009, EXPLORING IMPACT PUB; Staley K, SCOPING RES PRIORITY; Stewart RJ, 2011, HEALTH EXPECT, V14, P439, DOI 10.1111/j.1369-7625.2010.00648.x; Stilgoe D, 2007, NANODIALOGUES EXPT P; Stokes D. E., 1997, PASTEURS QUADRANT BA; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; Taylor R, 2001, AUST NZ J PUBL HEAL, V25, P203, DOI 10.1111/j.1467-842X.2001.tb00564.x; Tsafnat G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f139; Vandenbroucke JP, 2010, LANCET, V375, P982, DOI 10.1016/S0140-6736(10)60437-0; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Wooding H, 2011, PROJECT RETROSIGHT U; Wooding S, 2004, RETURNS ARTHRITIS RE, V1; Wooding S., 2013, MENTAL HLTH RETROSIG	111	769	782	3	111	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					156	165		10.1016/S0140-6736(13)62229-1	http://dx.doi.org/10.1016/S0140-6736(13)62229-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	24411644				2022-12-28	WOS:000329579600031
J	Dyer, O				Dyer, Owen			America's first single payer system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												owen_dyer@hotmail.com						[Anonymous], EV VERM HLTH CAR REF; [Anonymous], VERM HLTH REF FIN PL	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2014	348								g102	10.1136/bmj.g102	http://dx.doi.org/10.1136/bmj.g102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KR	24415734				2022-12-28	WOS:000329611300004
J	Miguel, E; Camerer, C; Casey, K; Cohen, J; Esterling, KM; Gerber, A; Glennerster, R; Green, DP; Humphreys, M; Imbens, G; Laitin, D; Madon, T; Nelson, L; Nosek, BA; Petersen, M; Sedlmayr, R; Simmons, JP; Simonsohn, U; Van der Laan, M				Miguel, E.; Camerer, C.; Casey, K.; Cohen, J.; Esterling, K. M.; Gerber, A.; Glennerster, R.; Green, D. P.; Humphreys, M.; Imbens, G.; Laitin, D.; Madon, T.; Nelson, L.; Nosek, B. A.; Petersen, M.; Sedlmayr, R.; Simmons, J. P.; Simonsohn, U.; Van der Laan, M.			Promoting Transparency in Social Science Research	SCIENCE			English	Editorial Material							TRIALS; DESIGN; FALSE; BIAS		[Miguel, E.; Madon, T.; Nelson, L.; Petersen, M.; Van der Laan, M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Camerer, C.] CALTECH, Pasadena, CA 91125 USA; [Casey, K.; Cohen, J.; Imbens, G.; Laitin, D.] Stanford Univ, Stanford, CA 94305 USA; [Esterling, K. M.] Univ Calif Riverside, Riverside, CA 92521 USA; [Gerber, A.] Yale Univ, New Haven, CT USA; [Glennerster, R.] MIT, Cambridge, MA 02139 USA; [Green, D. P.; Humphreys, M.] Columbia Univ, New York, NY USA; [Nosek, B. A.] Univ Virginia, Charlottesville, VA USA; [Nosek, B. A.] Ctr Open Sci, Charlottesville, VA USA; [Sedlmayr, R.] Wellspring Advisors, New York, NY USA; [Simmons, J. P.; Simonsohn, U.] Univ Penn, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; California Institute of Technology; Stanford University; University of California System; University of California Riverside; Yale University; Massachusetts Institute of Technology (MIT); Columbia University; University of Virginia; University of Pennsylvania	Miguel, E (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	emiguel@berkeley.edu	Green, Donald P./E-4565-2010; imbens, guido/P-2333-2019; Simonsohn, Uri/ABF-2344-2020	Green, Donald P./0000-0002-8850-438X; Simonsohn, Uri/0000-0002-8601-7211; Nelson, Lewis/0000-0001-9551-3922; Esterling, Kevin/0000-0002-5529-6422; Nosek, Brian/0000-0001-6797-5476; Miguel, Edward/0000-0001-6927-709X; Madon, Temina/0000-0003-2427-3655	NIA NIH HHS [R24 AG048124] Funding Source: Medline; NICHD NIH HHS [P01 HD061315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD061315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG048124] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander A, 2012, PERSPECT PSYCHOL SCI, V7, P657, DOI 10.1177/1745691612462588; Casey K, 2012, Q J ECON, V127, P1755, DOI 10.1093/qje/qje027; Castro M. F., 2009, WORKING PAPER; Gerber A, 2008, Q J POLIT SCI, V3, P313, DOI 10.1561/100.00008024; GERBER AS, 2001, POLIT ANAL, V0009; Humphreys M, 2013, POLIT ANAL, V21, P1, DOI 10.1093/pan/mps021; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; LANE DM, 1978, BRIT J MATH STAT PSY, V31, P107, DOI 10.1111/j.2044-8317.1978.tb00578.x; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Neumark D, 2001, IND RELAT, V40, P121, DOI 10.1111/0019-8676.00199; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Office of Management and Budget, 2012, M1214 OFF PRES; Rosenblum M, 2011, BIOMETRIKA, V98, P845, DOI 10.1093/biomet/asr055; Rubin DB, 2008, ANN APPL STAT, V2, P808, DOI 10.1214/08-AOAS187; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Stroebe W, 2012, PERSPECT PSYCHOL SCI, V7, P670, DOI 10.1177/1745691612460687; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	18	228	232	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					30	31		10.1126/science.1245317	http://dx.doi.org/10.1126/science.1245317			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282HR	24385620	Green Accepted			2022-12-28	WOS:000329162000036
J	Goodman, R; Dellaripa, PF; Miller, AL; Loscalzo, J				Goodman, Russell; Dellaripa, Paul F.; Miller, Amy Leigh; Loscalzo, Joseph			An Unusual Case of Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM FOLLOW-UP; POLYARTERITIS-NODOSA; MICROSCOPIC POLYANGIITIS; NECROTIZING VASCULITIS; CLINICAL-FEATURES; PROGNOSIS; SPECTRUM; THERAPY		Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021					COHEN RD, 1980, MAYO CLIN PROC, V55, P146; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; FAUCI AS, 1979, NEW ENGL J MED, V301, P235, DOI 10.1056/NEJM197908023010503; FROHNERT PP, 1967, AM J MED, V43, P8, DOI 10.1016/0002-9343(67)90144-1; Gayraud M, 2001, ARTHRITIS RHEUM, V44, P666, DOI 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A; Guillevin L, 2011, MEDICINE, V90, P19, DOI 10.1097/MD.0b013e318205a4c6; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; LEIB ES, 1979, AM J MED, V67, P941, DOI 10.1016/0002-9343(79)90634-X; MANDELL BF, 1994, RHEUM DIS CLIN N AM, V20, P409; Pagnoux C, 2010, ARTHRITIS RHEUM-US, V62, P616, DOI 10.1002/art.27240; Ribi C, 2010, ARTHRITIS RHEUM-US, V62, P1186, DOI 10.1002/art.27340; Stanson AW, 2001, RADIOGRAPHICS, V21, P151, DOI 10.1148/radiographics.21.1.g01ja16151; STOCKIGT JR, 1979, NEW ENGL J MED, V300, P1218	13	1	1	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					70	75		10.1056/NEJMcps1215559	http://dx.doi.org/10.1056/NEJMcps1215559			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284XA	24382068				2022-12-28	WOS:000329354100013
J	Kreidberg, L; Bean, JL; Desert, JM; Benneke, B; Deming, D; Stevenson, KB; Seager, S; Berta-Thompson, Z; Seifahrt, A; Homeier, D				Kreidberg, Laura; Bean, Jacob L.; Desert, Jean-Michel; Benneke, Bjoern; Deming, Drake; Stevenson, Kevin B.; Seager, Sara; Berta-Thompson, Zachory; Seifahrt, Andreas; Homeier, Derek			Clouds in the atmosphere of the super-Earth exoplanet GJ 1214b	NATURE			English	Article							TRANSMISSION SPECTRUM; PLANET; RICH; DISTINGUISH; GJ1214B	Recent surveys have revealed that planets intermediate in size between Earth and Neptune ('super-Earths') are among the most common planets in the Galaxy(1-3). Atmospheric studies are the next step towards developing a comprehensive understanding of this new class of object(4-6). Much effort has been focused on using transmission spectroscopy to characterize the atmosphere of the super-Earth archetype GJ 1214b (refs 7-17), but previous observations did not have sufficient precision to distinguish between two interpretations for the atmosphere. The planet's atmosphere could be dominated by relatively heavy molecules, such as water (for example, a 100 per cent water vapour composition), or it could contain high-altitude clouds that obscure its lower layers. Here we report a measurement of the transmission spectrum of GJ 1214b at near-infrared wavelengths that definitively resolves this ambiguity. The data, obtained with the Hubble Space Telescope, are sufficiently precise to detect absorption features from a high mean-molecular-mass atmosphere. The observed spectrum, however, is featureless. We rule out cloud-free atmospheric models with compositions dominated by water, methane, carbon monoxide, nitrogen or carbon dioxide at greater than 5 sigma confidence. The planet's atmosphere must contain clouds to be consistent with the data.	[Kreidberg, Laura; Bean, Jacob L.; Stevenson, Kevin B.; Seifahrt, Andreas] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Desert, Jean-Michel] Univ Colorado, Dept Astrophys & Planetary Sci, CASA, Boulder, CO 80309 USA; [Desert, Jean-Michel] CALTECH, Dept Astron, Pasadena, CA 91101 USA; [Benneke, Bjoern; Seager, Sara] MIT, Dept Phys, Cambridge, MA 02139 USA; [Deming, Drake] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Berta-Thompson, Zachory] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA; [Berta-Thompson, Zachory] MIT, MIT Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Homeier, Derek] Ctr Rech Astrophys Lyon, F-69364 Lyon, France	University of Chicago; University of Colorado System; University of Colorado Boulder; California Institute of Technology; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park; Harvard University; Massachusetts Institute of Technology (MIT)	Kreidberg, L (corresponding author), Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA.	laura.kreidberg@uchicago.edu	Stevenson, Kevin/AAC-8222-2019	Stevenson, Kevin/0000-0002-7352-7941; Bean, Jacob/0000-0003-4733-6532; Homeier, Derek/0000-0002-8546-9128; Berta-Thompson, Zachory/0000-0002-3321-4924; Seifahrt, Andreas/0000-0003-4526-3747	NASA [NAS 5-26555]; NASA through Space Telescope Science Institute; National Science Foundation through a Graduate Research Fellowship; Alfred P. Sloan Foundation through a Sloan Research Fellowship; NASA through a Sagan Fellowship; European Research Council under the European Community [247060];  [GO-13021]	NASA(National Aeronautics & Space Administration (NASA)); NASA through Space Telescope Science Institute(Space Telescope Science Institute); National Science Foundation through a Graduate Research Fellowship; Alfred P. Sloan Foundation through a Sloan Research Fellowship; NASA through a Sagan Fellowship; European Research Council under the European Community(European Research Council (ERC)); 	This work is based on observations made with the NASA/ESA Hubble Space Telescope that were obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract number NAS 5-26555. These observations are associated with program GO-13021. Support for this work was provided by NASA through a grant from the Space Telescope Science Institute, the National Science Foundation through a Graduate Research Fellowship (to L. K.), the Alfred P. Sloan Foundation through a Sloan Research Fellowship (to J.L.B.), NASA through a Sagan Fellowship (to J.-M.D.), and the European Research Council (for D. H. under the European Community's Seventh Framework Programme, FP7/2007-2013 Grant Agreement number 247060).	Adams ER, 2008, ASTROPHYS J, V673, P1160, DOI 10.1086/524925; Anglada-Escude G, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201219250; Bean JL, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/92; Bean JL, 2010, NATURE, V468, P669, DOI 10.1038/nature09596; Benneke B, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/153; Benneke B, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/100; Berta ZK, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/35; Cassan A, 2012, NATURE, V481, P167, DOI 10.1038/nature10684; Deming D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/95; Desert JM, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/2/L40; Fortney JJ, 2005, MON NOT R ASTRON SOC, V364, P649, DOI 10.1111/j.1365-2966.2005.09587.x; Fortney JJ, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/80; Fraine JD, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/127; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Howe AR, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/176; Kempton EMR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/3; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Miller-Ricci E, 2010, ASTROPHYS J LETT, V716, pL74, DOI 10.1088/2041-8205/716/1/L74; Miller-Ricci E, 2009, ASTROPHYS J, V690, P1056, DOI 10.1088/0004-637X/690/2/1056; Morley CV, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/33; Nettelmann N, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/2; Petigura EA, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/69; Pont F, 2008, MON NOT R ASTRON SOC, V385, P109, DOI 10.1111/j.1365-2966.2008.12852.x; Rogers LA, 2010, ASTROPHYS J, V716, P1208, DOI 10.1088/0004-637X/716/2/1208; Stevenson K. B., 2013, TRANSMISSION SPECTRO; Swain M, 2013, ICARUS, V225, P432, DOI 10.1016/j.icarus.2013.04.003	26	553	556	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					69	+		10.1038/nature12888	http://dx.doi.org/10.1038/nature12888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24380954	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000329163300025
J	Brunecky, R; Alahuhta, M; Xu, Q; Donohoe, BS; Crowley, MF; Kataeva, IA; Yang, SJ; Resch, MG; Adams, MWW; Lunin, VV; Himmel, ME; Bomble, YJ				Brunecky, Roman; Alahuhta, Markus; Xu, Qi; Donohoe, Bryon S.; Crowley, Michael F.; Kataeva, Irina A.; Yang, Sung-Jae; Resch, Michael G.; Adams, Michael W. W.; Lunin, Vladimir V.; Himmel, Michael E.; Bomble, Yannick J.			Revealing Nature's Cellulase Diversity: The Digestion Mechanism of Caldicellulosiruptor bescii CelA	SCIENCE			English	Article							ANAEROCELLUM-THERMOPHILUM; CELLOBIOHYDROLASE-I; PRETREATMENT; CELLULOSOMES; DEGRADATION; SEQUENCE; BIOMASS; FAMILY	Most fungi and bacteria degrade plant cell walls by secreting free, complementary enzymes that hydrolyze cellulose; however, some bacteria use large enzymatic assemblies called cellulosomes, which recruit complementary enzymes to protein scaffolds. The thermophilic bacterium Caldicellulosiruptor bescii uses an intermediate strategy, secreting many free cellulases that contain multiple catalytic domains. One of these, CelA, comprises a glycoside hydrolase family 9 and a family 48 catalytic domain, as well as three type III cellulose-binding modules. In the saccharification of a common cellulose standard, Avicel, CelA outperforms mixtures of commercially relevant exo- and endoglucanases. From transmission electron microscopy studies of cellulose after incubation with CelA, we report morphological features that suggest that CelA not only exploits the common surface ablation mechanism driven by general cellulase processivity, but also excavates extensive cavities into the surface of the substrate. These results suggest that nature's repertoire of cellulose digestion paradigms remain only partially discovered and understood.	[Brunecky, Roman; Alahuhta, Markus; Xu, Qi; Donohoe, Bryon S.; Crowley, Michael F.; Resch, Michael G.; Lunin, Vladimir V.; Himmel, Michael E.; Bomble, Yannick J.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Kataeva, Irina A.; Yang, Sung-Jae; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University System of Georgia; University of Georgia	Bomble, YJ (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, 15013 Denver West Pkwy, Golden, CO 80401 USA.	yannick.bomble@nrel.gov	; crowley, michael/A-4852-2013	Brunecky, Roman/0000-0002-8352-4234; crowley, michael/0000-0001-5163-9398; Bomble, Yannick/0000-0001-7624-8000; Adams, Michael/0000-0002-9796-5014	BioEnergy Science Center (BESC); Office of Biological and Environmental Research in the U.S. DOE Office of Science	BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the U.S. DOE Office of Science(United States Department of Energy (DOE))	This work was supported by the BioEnergy Science Center (BESC). BESC is a U.S. Department of Energy (DOE) Bioenergy Research Center supported by the Office of Biological and Environmental Research in the U.S. DOE Office of Science. We acknowledge colleagues at the Biomass Conversion Research Laboratory at Michigan State University for providing the AFEX-pretreated materials. Structures have been deposited in the Protein Data Bank with PDB codes 4DOD (GH9), 4DOE (GH9-CB), and 4EL8 (GH48).	Alizadeh H, 2005, APPL BIOCHEM BIOTECH, V121, P1133, DOI 10.1385/ABAB:124:1-3:1133; Baker JO, 1998, APPL BIOCHEM BIOTECH, V70-2, P395, DOI 10.1007/BF02920154; BAKER JO, 1994, APPL BIOCHEM BIOTECH, V45-6, P245, DOI 10.1007/BF02941803; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Brunecky R, 2009, BIOTECHNOL BIOENG, V102, P1537, DOI 10.1002/bit.22211; Chundawat SPS, 2011, ENERG ENVIRON SCI, V4, P973, DOI 10.1039/c0ee00574f; Chundawat SPS, 2010, BIORESOURCE TECHNOL, V101, P8429, DOI 10.1016/j.biortech.2010.06.027; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; LIEBL W, 1994, MOL GEN GENET, V242, P111, DOI 10.1007/BF00277355; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; PATEL MM, 1992, J CHEM TECHNOL BIOT, V53, P253; PLAYNE MJ, 1984, BIOTECHNOL BIOENG, V26, P426, DOI 10.1002/bit.260260505; Resch MG, 2013, ENERG ENVIRON SCI, V6, P1858, DOI 10.1039/c3ee00019b; SHOEMAKER S, 1983, BIO-TECHNOL, V1, P691, DOI 10.1038/nbt1083-691; Textor LC, 2013, FEBS J, V280, P56, DOI 10.1111/febs.12049; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; WALKER LP, 1993, BIOTECHNOL BIOENG, V42, P1019, DOI 10.1002/bit.260420902; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P2026, DOI 10.1016/j.biortech.2005.01.018; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	24	214	226	1	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1513	1516		10.1126/science.1244273	http://dx.doi.org/10.1126/science.1244273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357319				2022-12-28	WOS:000328644300059
J	Barreca, M; Shalhoub, J				Barreca, Marco; Shalhoub, Joseph			Acute gastric band slippage	LANCET			English	Editorial Material									[Barreca, Marco; Shalhoub, Joseph] Luton & Dunstable Univ Hosp, Dept Surg, Luton LU4 0DZ, Beds, England		Barreca, M (corresponding author), Luton & Dunstable Univ Hosp, Lewsey Rd, Luton LU4 0DZ, Beds, England.	marco.barreca@ldh.nhs.uk	Shalhoub, Joseph/P-2171-2014	Shalhoub, Joseph/0000-0003-1011-7440					0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					782	782		10.1016/S0140-6736(13)60998-8	http://dx.doi.org/10.1016/S0140-6736(13)60998-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	24388763				2022-12-28	WOS:000341361500038
J	Shikuma, NJ; Pilhofer, M; Weiss, GL; Hadfield, MG; Jensen, GJ; Newman, DK				Shikuma, Nicholas J.; Pilhofer, Martin; Weiss, Gregor L.; Hadfield, Michael G.; Jensen, Grant J.; Newman, Dianne K.			Marine Tubeworm Metamorphosis Induced by Arrays of Bacterial Phage Tail-Like Structures	SCIENCE			English	Article							LARVAL SETTLEMENT; BIOFILMS; PROPHAGE; PRODUCE; SURFACE; GENES	Many benthic marine animal populations are established and maintained by free-swimming larvae that recognize cues from surface-bound bacteria to settle and metamorphose. Larvae of the tubeworm Hydroides elegans, an important biofouling agent, require contact with surface-bound bacteria to undergo metamorphosis; however, the mechanisms that underpin this microbially mediated developmental transition have been enigmatic. Here, we show that a marine bacterium, Pseudoalteromonas luteoviolacea, produces arrays of phage tail-like structures that trigger metamorphosis of H. elegans. These arrays comprise about 100 contractile structures with outward-facing baseplates, linked by tail fibers and a dynamic hexagonal net. Not only do these arrays suggest a novel form of bacterium-animal interaction, they provide an entry point to understanding how marine biofilms can trigger animal development.	[Shikuma, Nicholas J.; Pilhofer, Martin; Weiss, Gregor L.; Jensen, Grant J.; Newman, Dianne K.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Pilhofer, Martin; Jensen, Grant J.; Newman, Dianne K.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Hadfield, Michael G.] Univ Hawaii Manoa, Kewalo Marine Lab, Honolulu, HI 96813 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Hawaii System; University of Hawaii Manoa	Hadfield, MG (corresponding author), Univ Hawaii Manoa, Kewalo Marine Lab, Honolulu, HI 96813 USA.	hadfield@hawaii.edu; jensen@caltech.edu; dkn@caltech.edu		Hadfield, Michael/0000-0002-8808-5197; Shikuma, Nicholas/0000-0001-5518-5020	California Institute of Technology (Caltech) Division of Biology Postdoctoral Fellowship; Caltech Center for Environmental Microbiology Interactions; Howard Hughes Medical Institute; Office of Naval Research [N00014-08-1-0413, N00014-05-1-0579]; NIH [GM094800B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094800] Funding Source: NIH RePORTER	California Institute of Technology (Caltech) Division of Biology Postdoctoral Fellowship; Caltech Center for Environmental Microbiology Interactions; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Naval Research(Office of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Pernet for help with locating and identifying tubeworms and for giving us the algal strain used in this work; A. McDowall for help with EM; Y. Huang, who created the Str<SUP>R</SUP>-strain (7); A. Asahina and S. Wilbur for laboratory assistance; J. Levine for help with time-lapse microscopy; J. Ricci for help with phylogenetic analyses; and members of the Newman group for discussions and comments on the manuscript. The Howard Hughes Medical Institute, Z. Yu, and J. de la Cruz are acknowledged for providing access to the FEI Titan Krios at Janelia Farm and support in data collection. N.J.S. was supported by a California Institute of Technology (Caltech) Division of Biology Postdoctoral Fellowship. This collaboration was supported by the Caltech Center for Environmental Microbiology Interactions, the Howard Hughes Medical Institute (D.K.N. and G. J. J.), Office of Naval Research grants N00014-08-1-0413 and N00014-05-1-0579 (M. G. H.), NIH grant GM094800B (G. J. J.), and a gift from the Gordon and Betty Moore Foundation (Caltech). D.K.N. and G. J. J. are Investigators of the Howard Hughes Medical Institute. Strains obtained from the American Type Culture Collection listed in table S2 (ATCC 33492, ATCC 14393, ATCC 15057). DNA sequences encoding for mac, T6SS, and bacteriocin-2 genes are deposited under GenBank accession numbers KF724687, KF724688, and KF724689, respectively. Subtomogram averages were deposited in the Electron Microscopy Data Bank (accession numbers EMD-2543, EMD-2544, and EMD-2545). Author contributions: All authors designed research. N.J.S., M. P. and G. L. W. performed research. All authors wrote the paper.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Tran C, 2011, MAR ECOL PROG SER, V433, P85, DOI 10.3354/meps09192; Cerritelli ME, 1996, J MOL BIOL, V260, P767, DOI 10.1006/jmbi.1996.0436; Gebhart D, 2012, J BACTERIOL, V194, P6240, DOI 10.1128/JB.01272-12; Hadfield MG, 2001, CRC MAR SCI, P431; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; Huang Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00228; Huggett MJ, 2006, OECOLOGIA, V149, P604, DOI 10.1007/s00442-006-0470-8; Hurst MRH, 2004, J BACTERIOL, V186, P5116, DOI 10.1128/jb.186.15.5116-5128.2004; IMO, 2016, GUID DEV SHIP EN EFF; Kohler T, 2010, J BACTERIOL, V192, P1921, DOI 10.1128/JB.01459-09; Lau SCK, 2002, MAR ECOL PROG SER, V226, P301, DOI 10.3354/meps226301; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Nedved BT, 2009, SPRINGER SER BIOFILM, V4, P203, DOI 10.1007/7142_2008_15; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Penz T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003012; Penz T, 2010, VIRULENCE, V1, P541, DOI 10.4161/viru.1.6.13800; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pilhofer M, 2010, METHOD CELL BIOL, V96, P21, DOI 10.1016/S0091-679X(10)96002-0; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809; Unabia CRC, 1999, MAR BIOL, V133, P55, DOI 10.1007/s002270050442; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006	29	157	159	5	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					529	533		10.1126/science.1246794	http://dx.doi.org/10.1126/science.1246794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24407482	Green Accepted			2022-12-28	WOS:000330343700044
J	Ransom, SM; Stairs, IH; Archibald, AM; Hessels, JWT; Kaplan, DL; van Kerkwijk, MH; Boyles, J; Deller, AT; Chatterjee, S; Schechtman-Rook, A; Berndsen, A; Lynch, RS; Lorimer, DR; Karako-Argaman, C; Kaspi, VM; Kondratiev, VI; McLaughlin, MA; van Leeuwen, J; Rosen, R; Roberts, MSE; Stovall, K				Ransom, S. M.; Stairs, I. H.; Archibald, A. M.; Hessels, J. W. T.; Kaplan, D. L.; van Kerkwijk, M. H.; Boyles, J.; Deller, A. T.; Chatterjee, S.; Schechtman-Rook, A.; Berndsen, A.; Lynch, R. S.; Lorimer, D. R.; Karako-Argaman, C.; Kaspi, V. M.; Kondratiev, V. I.; McLaughlin, M. A.; van Leeuwen, J.; Rosen, R.; Roberts, M. S. E.; Stovall, K.			A millisecond pulsar in a stellar triple system	NATURE			English	Article							PLANETARY SYSTEM; BINARY EVOLUTION; DATA RELEASE; DISCOVERY; B1620-26	Gravitationally bound three-body systems have been studied for hundreds of years(1,2) and are common in our Galaxy(3,4). They show complex orbital interactions, which can constrain the compositions, masses and interior structures of the bodies(5) and test theories of gravity(6), if sufficiently precise measurements are available. A triple system containing a radio pulsar could provide such measurements, but the only previously known such system, PSR B1620-26 (refs 7, 8; with a millisecond pulsar, a white dwarf, and a planetary-mass object in an orbit of several decades), shows only weak interactions. Here we report precision timing and multiwavelength observations of PSR J0337+1715, a millisecond pulsar in a hierarchical triple system with two other stars. Strong gravitational interactions are apparent and provide the masses of the pulsar (1.4378(13)M-circle dot, where M-circle dot is the solar mass and the parentheses contain the uncertainty in the final decimal places) and the two white dwarf companions (0.19751(15)M-circle dot and 0.4101(3)M-circle dot), as well as the inclinations of the orbits (both about 39.2 degrees). The unexpectedly coplanar and nearly circular orbits indicate a complex and exotic evolutionary past that differs from those of known stellar systems. The gravitational field of the outer white dwarf strongly accelerates the inner binary containing the neutron star, and the system will thus provide an ideal laboratory in which to test the strong equivalence principle of general relativity.	[Ransom, S. M.; Rosen, R.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Stairs, I. H.; Berndsen, A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Archibald, A. M.; Hessels, J. W. T.; Deller, A. T.; Kondratiev, V. I.; van Leeuwen, J.] Netherlands Inst Radio Astron ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Archibald, A. M.; Lynch, R. S.; Karako-Argaman, C.; Kaspi, V. M.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Hessels, J. W. T.; van Leeuwen, J.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Kaplan, D. L.] Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA; [Kaplan, D. L.; Schechtman-Rook, A.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [van Kerkwijk, M. H.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Boyles, J.; Lorimer, D. R.; McLaughlin, M. A.; Rosen, R.] W Virginia Univ, Dept Phys & Astron, Morgantown, WV 26506 USA; [Boyles, J.] Western Kentucky Univ, Dept Phys & Astron, Bowling Green, KY 42101 USA; [Chatterjee, S.] Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; [Kondratiev, V. I.] PN Lebedev Phys Inst, Ctr Astro Space, Moscow 119991, Russia; [Roberts, M. S. E.] Eureka Sci Inc, Oakland, CA 94602 USA; [Roberts, M. S. E.] New York Univ Abu Dhabi, Dept Phys, Abu Dhabi, U Arab Emirates; [Stovall, K.] Univ Texas Brownsville, Dept Phys & Astron, Brownsville, TX 78520 USA; [Stovall, K.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	National Radio Astronomy Observatory (NRAO); University of British Columbia; McGill University; University of Amsterdam; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Madison; University of Toronto; West Virginia University; Western Kentucky University; Cornell University; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Eureka Scientific; University of Texas System; University of Texas Rio Grande Valley; University of New Mexico	Ransom, SM (corresponding author), Natl Radio Astron Observ, 520 Edgemont Rd, Charlottesville, VA 22903 USA.	sransom@nrao.edu	Kondratiev, Vladislav I./N-1105-2015; Chatterjee, Shami/AAE-8374-2022; Lorimer, Duncan/ABH-7909-2020; Hessels, Jason/GTO-3261-2022; Stovall, Kevin/D-9844-2014	Kondratiev, Vladislav I./0000-0001-8864-7471; Hessels, Jason/0000-0003-2317-1446; Stovall, Kevin/0000-0002-7261-594X; Chatterjee, Shami/0000-0002-2878-1502; McLaughlin, Maura/0000-0001-7697-7422; Roberts, Mallory/0000-0002-9396-9720; Kaplan, David/0000-0001-6295-2881; Deller, Adam/0000-0001-9434-3837; Ransom, Scott/0000-0001-5799-9714; Archibald, Anne/0000-0003-0638-3340; van Leeuwen, Joeri/0000-0001-8503-6958	NASA; NSERC; NWO; WV EPSCoR; CRAQ/FQRNT; CIFAR; Canada Research Chairs Program; Lorne Trottier Chair; Office Of The Director [0968296] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NWO(Netherlands Organization for Scientific Research (NWO)); WV EPSCoR; CRAQ/FQRNT; CIFAR(Canadian Institute for Advanced Research (CIFAR)); Canada Research Chairs Program(Canada Research Chairs); Lorne Trottier Chair; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank D. Levitan and R. Simcoe for providing optical and infrared observations; J. Deneva for early Arecibo telescope observations; P. Bergeron for use of his white dwarf photometry models; K. O'Neil and F. Camilo for approving discretionary time observations on the GBT and the Arecibo telescope, respectively; J. Heyl, E. Algol, and P. Freire for discussions; and G. Kuper, J. Sluman, Y. Tang, G. Jozsa, and R. Smits for their help supporting the WSRT observations. The GBT and VLBA are operated by the National Radio Astronomy Observatory, a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The Arecibo Observatory is operated by SRI International in alliance with Ana G. Mendez-Universidad Metropolitana and the Universities Space Research Association, under a cooperative agreement with the National Science Foundation. The WSRT is operated by the Netherlands Institute for Radio Astronomy (ASTRON). This paper made use of data from the WIYN Observatory at Kitt Peak National Observatory, National Optical Astronomy Observatory, which is operated by the Association of Universities for Research in Astronomy under cooperative agreement with the National Science Foundation. This work is also based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. I.H.S., V.M.K., M.H.v.K. and A.B. acknowledge support from NSERC. A.M.A. and J.W.T.H. acknowledge support from a Vrije Competitie grant from NWO. J.B., D.R.L, V.I.K. and M.A.M. were supported by a WV EPSCoR Research Challenge Grant. V.M.K. acknowledges support from CRAQ/FQRNT, CIFAR, the Canada Research Chairs Program and the Lorne Trottier Chair.	Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; BACKER DC, 1986, ANNU REV ASTRON ASTR, V24, P537, DOI 10.1146/annurev.aa.24.090186.002541; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Boyles J, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/80; BULIRSCH R, 1966, NUMER MATH, V8, P93, DOI 10.1007/BF02163179; Champion DJ, 2008, SCIENCE, V320, P1309, DOI 10.1126/science.1157580; Chatterjee S, 2009, ASTROPHYS J, V698, P250, DOI 10.1088/0004-637X/698/1/250; Condon JJ, 1998, ASTRON J, V115, P1693, DOI 10.1086/300337; Cordes J. M., 2001, NE2001 I NEW MODEL G; Cox A. N., 2000, ALLENS ASTROPHYSICAL, P381; Deller AT, 2011, PUBL ASTRON SOC PAC, V123, P275, DOI 10.1086/658907; DuPlain R, 2008, SPIE C SER, V7019; Fabrycky D., 2011, EXOPLANETS, P217; Ford EB, 2000, ASTROPHYS J, V535, P385, DOI 10.1086/308815; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Freire PCC, 2011, MON NOT R ASTRON SOC, V412, P2763, DOI 10.1111/j.1365-2966.2010.18109.x; Freire PCC, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/18/184007; Gonzalez ME, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/102; Gutzwiller MC, 1998, REV MOD PHYS, V70, P589, DOI 10.1103/RevModPhys.70.589; Hankins T. H., 1975, METHODS COMPUTATIONA, V14, P55; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; Karuppusamy R, 2008, PUBL ASTRON SOC PAC, V120, P191, DOI 10.1086/528699; Kopeikin S, 2004, PHYS REP, V400, P209, DOI 10.1016/j.physrep.2004.08.004; Kurucz R. L., 1993, ATLAS9 STELLAR ATMOS; Larwood JD, 1997, MON NOT R ASTRON SOC, V285, P288, DOI 10.1093/mnras/285.2.288; Lattimer JM, 2012, ANNU REV NUCL PART S, V62, P485, DOI 10.1146/annurev-nucl-102711-095018; Lynch RS, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/81; Mardling RA, 2013, MON NOT R ASTRON SOC, V435, P2187, DOI 10.1093/mnras/stt1438; Meixner M, 2010, PUBL ASTRON SOC PAC, V122, P451, DOI 10.1086/651710; Morrissey P, 2007, ASTROPHYS J SUPPL S, V173, P682, DOI 10.1086/520512; Newton I, 1687, PHILOS NATURALIS PRI; Ozel F, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/55; PEALE SJ, 1993, ASTRON J, V105, P1562, DOI 10.1086/116536; Portegies Zwart S, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/55; Rappaport S, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/33; Sigurdsson S, 2003, SCIENCE, V301, P193, DOI 10.1126/science.1086326; Stairs IH, 2005, ASTROPHYS J, V632, P1060, DOI 10.1086/432526; Tauris TM, 1999, ASTRON ASTROPHYS, V350, P928; TAYLOR JH, 1992, PHILOS T ROY SOC A, V341, P117, DOI 10.1098/rsta.1992.0088; Thorsett SE, 1999, ASTROPHYS J, V523, P763, DOI 10.1086/307771; Tokovinin A, 2006, ASTRON ASTROPHYS, V450, P681, DOI 10.1051/0004-6361:20054427; Tremblay PE, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/128; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3; WOLSZCZAN A, 1994, SCIENCE, V264, P538, DOI 10.1126/science.264.5158.538; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0	46	147	150	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					520	+		10.1038/nature12917	http://dx.doi.org/10.1038/nature12917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24390352	Green Submitted			2022-12-28	WOS:000329995000033
J	Thoma, A				Thoma, Achilleas			Methylprednisolone injections reduced carpal tunnel syndrome symptoms at 10 weeks and surgery at 1 year	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Thoma, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Flondell, Magnus/AAB-9565-2020; Ranstam, Jonas/A-4386-2009; Thoma, Achilles/AAQ-1767-2021	Flondell, Magnus/0000-0003-4215-4561; Ranstam, Jonas/0000-0002-8287-7273; Thoma, Achilles/0000-0002-8348-2863				Armstrong T, 2004, MUSCLE NERVE, V29, P82, DOI 10.1002/mus.10512; Dammers JWHH, 1999, BRIT MED J, V319, P884, DOI 10.1136/bmj.319.7214.884	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC11	10.7326/0003-4819-160-2-201401210-02011	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445709				2022-12-28	WOS:000330275600010
J	Caldecott, KW				Caldecott, Keith W.			Ribose-An Internal Threat to DNA	SCIENCE			English	Editorial Material							RIBONUCLEOTIDE INCORPORATION; REPAIR; REMOVAL; SIGNALS		Univ Sussex, Genome Damage & Stabil Ctr, Falmer, England	University of Sussex	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Falmer, England.	k.w.caldecott@sussex.ac.uk	Caldecott, Keith/S-4245-2019	Caldecott, Keith/0000-0003-4255-9016	Medical Research Council [MR/J006750/1] Funding Source: Medline; MRC [MR/J006750/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Dalgaard JZ, 2012, TRENDS GENET, V28, P592, DOI 10.1016/j.tig.2012.07.008; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Goksenin AY, 2012, J BIOL CHEM, V287, P42675, DOI 10.1074/jbc.M112.422733; Gosavi RA, 2012, NUCLEIC ACIDS RES, V40, P7518, DOI 10.1093/nar/gks413; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Tumbale P, 2014, NATURE, V506, P111, DOI 10.1038/nature12824; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021	14	48	48	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					260	261		10.1126/science.1248234	http://dx.doi.org/10.1126/science.1248234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436412				2022-12-28	WOS:000329718600025
J	Luterbacher, JS; Rand, JM; Alonso, DM; Han, J; Youngquist, JT; Maravelias, CT; Pfleger, BF; Dumesic, JA				Luterbacher, Jeremy S.; Rand, Jacqueline M.; Alonso, David Martin; Han, Jeehoon; Youngquist, J. Tyler; Maravelias, Christos T.; Pfleger, Brian F.; Dumesic, James A.			Nonenzymatic Sugar Production from Biomass Using Biomass-Derived gamma-Valerolactone	SCIENCE			English	Article							ENZYMATIC-HYDROLYSIS; ETHANOL-PRODUCTION; CORN STOVER; ACID; TECHNOLOGIES; PRETREATMENT; CONVERSION; CELLULOSE	Widespread production of biomass-derived fuels and chemicals will require cost-effective processes for breaking down cellulose and hemicellulose into their constituent sugars. Here, we report laboratory-scale production of soluble carbohydrates from corn stover, hardwood, and softwood at high yields (70 to 90%) in a solvent mixture of biomass-derived g-valerolactone (GVL), water, and dilute acid (0.05 weight percent H2SO4). GVL promotes thermocatalytic saccharification through complete solubilization of the biomass, including the lignin fraction. The carbohydrates can be recovered and concentrated (up to 127 grams per liter) by extraction from GVL into an aqueous phase by addition of NaCl or liquid CO2. This strategy is well suited for catalytic upgrading to furans or fermentative upgrading to ethanol at high titers and near theoretical yield. We estimate through preliminary techno-economic modeling that the overall process could be cost-competitive for ethanol production, with biomass pretreatment followed by enzymatic hydrolysis.	[Luterbacher, Jeremy S.; Rand, Jacqueline M.; Alonso, David Martin; Han, Jeehoon; Youngquist, J. Tyler; Maravelias, Christos T.; Pfleger, Brian F.; Dumesic, James A.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Luterbacher, Jeremy S./O-1800-2019; Pfleger, Brian Frederick/AAA-2559-2022; Maravelias, Christos/B-1376-2009; Luterbacher, Jeremy/A-5626-2013; Han, Jeehoon/AAI-8414-2020; Alonso, David Martin/AAC-3364-2019	Luterbacher, Jeremy S./0000-0002-0967-0583; Pfleger, Brian Frederick/0000-0002-9232-9959; Maravelias, Christos/0000-0002-4929-1748; Luterbacher, Jeremy/0000-0002-0967-0583; Han, Jeehoon/0000-0001-5268-2128; Alonso, David Martin/0000-0002-8937-7407	Great Lakes Bioenergy Research Center; U.S. Department of Energy [DE-FC02-07ER64494]; Board of Regents of the University of Wisconsin System [DE-FC02-07ER64494]; Swiss National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1149678] Funding Source: National Science Foundation	Great Lakes Bioenergy Research Center; U.S. Department of Energy(United States Department of Energy (DOE)); Board of Regents of the University of Wisconsin System; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Great Lakes Bioenergy Research Center (www.glbrc.org), supported by the U.S. Department of Energy, through Cooperative Agreement DE-FC02-07ER64494 between the Board of Regents of the University of Wisconsin System and the U.S. Department of Energy and the National Science Foundation (CBET-1149678). J.S.L. acknowledges support from the Swiss National Science Foundation. The authors thank S. Ralph (Forests Products Laboratory) for providing loblolly pine. Patents have been filed by the Wisconsin Alumni Research Foundation (WARF) involving the use of GVL as a solvent for biomass processing (application nos. 13/736550 and 13/918097), and D. M. A. and J.A.D. are involved with a start-up company (Glucan Biorenewables) that is working in this area.	Alonso D.M., 2012, ENERG ENVIRON SCI, V6, P76; Anbarasan P, 2012, NATURE, V491, P235, DOI 10.1038/nature11594; Binder JB, 2010, P NATL ACAD SCI USA, V107, P4516, DOI 10.1073/pnas.0912073107; Dodds DR, 2007, SCIENCE, V318, P1250, DOI 10.1126/science.1146356; Gurbuz EI, 2013, ANGEW CHEM INT EDIT, V52, P1270, DOI 10.1002/anie.201207334; Hodge DB, 2008, BIORESOURCE TECHNOL, V99, P8940, DOI 10.1016/j.biortech.2008.05.015; Humbird D, 2011, TP510047764 NAT REN; Kazi FK, 2010, FUEL, V89, pS20, DOI 10.1016/j.fuel.2010.01.001; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Lau MW, 2009, P NATL ACAD SCI USA, V106, P1368, DOI 10.1073/pnas.0812364106; LEE YY, 1999, ADV BIOCHEM ENG BIOT, V65, P93, DOI DOI 10.1007/3-540-49194-5_5; Luterbacher JS, 2012, ENERG ENVIRON SCI, V5, P6990, DOI 10.1039/c2ee02913h; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Pagan-Torres YJ, 2012, ACS CATAL, V2, P930, DOI 10.1021/cs300192z; Peterson AA, 2008, ENERG ENVIRON SCI, V1, P32, DOI 10.1039/b810100k; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; Selig MJ, 2007, BIOTECHNOL PROGR, V23, P1333, DOI 10.1021/bp0702018; Shill K, 2011, BIOTECHNOL BIOENG, V108, P511, DOI 10.1002/bit.23014; VONSIVERS M, 1995, BIORESOURCE TECHNOL, V51, P43, DOI 10.1016/0960-8524(94)00094-H; Wettstein SG, 2012, ENERG ENVIRON SCI, V5, P8199, DOI 10.1039/c2ee22111j; Youngquist JT, 2013, APPL MICROBIOL BIOT, V97, P5149, DOI 10.1007/s00253-013-4911-0	22	514	528	37	798	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					277	280		10.1126/science.1246748	http://dx.doi.org/10.1126/science.1246748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436415				2022-12-28	WOS:000329718600030
J	Kong, MF; Glibert, G; Baleanu, F; Karmali, R				Kong, Marie-France; Glibert, Gerald; Baleanu, Felicia; Karmali, Rafik			Progressive cerebellar ataxia and new-onset diabetes	LANCET			English	Editorial Material							ACID DECARBOXYLASE ANTIBODIES		[Kong, Marie-France; Glibert, Gerald; Baleanu, Felicia; Karmali, Rafik] Ctr Hosp Univ Brugmann, Brussels, Belgium; [Kong, Marie-France] Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Kong, MF (corresponding author), Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Dept Endocrinol & Diabet, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	marie-france.kong@uhl-tr.nhs.uk						Honnorat J, 2001, ARCH NEUROL-CHICAGO, V58, P225, DOI 10.1001/archneur.58.2.225; Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123; Pittock SJ, 2006, MAYO CLIN PROC, V81, P1207, DOI 10.4065/81.9.1207; Saiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183; Stenstrom G, 2005, DIABETES, V54, pS68, DOI 10.2337/diabetes.54.suppl_2.S68	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					186	186		10.1016/S0140-6736(13)62409-5	http://dx.doi.org/10.1016/S0140-6736(13)62409-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	24411971				2022-12-28	WOS:000329579600034
J	Ahmed, F				Ahmed, Faheem			The sideline or frontline: where should the UK medical profession stand in times of armed conflict overseas?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYRIA		Guys Kings & St Thomas Med Sch, Kings Coll London, London, England	University of London; King's College London	Ahmed, F (corresponding author), Guys Kings & St Thomas Med Sch, Kings Coll London, London, England.	faheem.ahmed@kcl.ac.uk						Ahmed F, 2013, LANCET, V382, P1619, DOI 10.1016/S0140-6736(13)62248-5; Amnesty International, CLIM FEAR SYR HOSP P; Arie S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7647; Committee for Disease Control, 2013, POL SYR; Dobri CS, 2009, VOJNOSANIT PREGL, V66, P63; Godlee F., 2001, BMJ-BRIT MED J, V343, pd6417; International Committee of the Red Cross, 1949, CONV 4 REL PROT CIV; International Committee of the Red Cross, 1977, PROT ADD GEN CONV 12; Medecins sans Frontieres, SYR URG NEED CROSS B; NHS Protect, 2011 12 FIG REL PHYS; Physicians for Human Rights, DUAL ASS SYR CIV UNL; Pitts-Tucker T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5410; UN Office of the High Commissioner for Human Rights, 2013, IND INT COMM INQ SYR; World Health Organization, 2013, SYR AR REP PUT POL R; World Health Organization (WHO), 2013, DON UPD SYR AR REP; World Medical Association, WMA REG TIM ARM CONF; World Medical Association, 2013, WMA DECL GEN	17	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2014	348								g83	10.1136/bmj.g83	http://dx.doi.org/10.1136/bmj.g83			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KR	24415635				2022-12-28	WOS:000329611300022
J	Le Cook, B; Wayne, GF; Kafali, EN; Liu, ZM; Shu, C; Flores, M				Le Cook, Benjamin; Wayne, Geoff Ferris; Kafali, E. Nilay; Liu, Zimin; Shu, Chang; Flores, Michael			Trends in Smoking Among Adults With Mental Illness and Association Between Mental Health Treatment and Smoking Cessation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOBACCO CESSATION; CIGARETTE-SMOKING; UNITED-STATES; NICOTINE DEPENDENCE; NATIONAL-SURVEY; SUBSTANCE USE; DRUG-USE; DISORDERS; OUTPATIENTS; DEPRESSION	IMPORTANCE Significant progress has been made in reducing the prevalence of tobacco use in the United States. However, tobacco cessation efforts have focused on the general population rather than individuals with mental illness, who demonstrate greater rates of tobacco use and nicotine dependence. OBJECTIVES To assess whether declines in tobacco use have been realized among individuals with mental illness and examine the association between mental health treatment and smoking cessation. DESIGN, SETTING, AND PARTICIPANTS Use of nationally representative surveys of noninstitutionalized US residents to compare trends in smoking rates between adults with and without mental illness and across multiple disorders (2004-2011 Medical Expenditure Panel Survey [MEPS]) and to compare rates of smoking cessation among adults with mental illness who did and did not receive mental health treatment (2009-2011 National Survey of Drug Use and Health [NSDUH]). The MEPS sample included 32 156 respondents with mental illness (operationalized as reporting severe psychological distress, probable depression, or receiving treatment for mental illness) and 133 113 without mental illness. The NSDUH sample included 14 057 lifetime smokers with mental illness. MAIN OUTCOMES AND MEASURES Current smoking status (primary analysis; MEPS sample) and smoking cessation, operationalized as a lifetime smoker who did not smoke in the last 30 days (secondary analysis; NSDUH sample). RESULTS Adjusted smoking rates declined significantly among individuals without mental illness (19.2%[95% CI, 18.7-19.7%] to 16.5%[95% CI, 16.0%-17.0%]; P < .001) but changed only slightly among those with mental illness (25.3%[95% CI, 24.2%-26.3%] to 24.9%[95% CI, 23.8%-26.0%]; P = .50), a significant difference in difference of 2.3%(95% CI, 0.7%-3.9%) (P = .005). Individuals with mental illness who received mental health treatment within the previous year were more likely to have quit smoking (37.2%[95% CI, 35.1%-39.4%]) than those not receiving treatment (33.1%[95% CI, 31.5%-34.7%]) (P = .005). CONCLUSIONS AND RELEVANCE Between 2004 and 2011, the decline in smoking among individuals with mental illness was significantly less than among those without mental illness, although quit rates were greater among those receiving mental health treatment. This suggests that tobacco control policies and cessation interventions targeting the general population have not worked as effectively for persons with mental illness.	[Le Cook, Benjamin; Wayne, Geoff Ferris; Kafali, E. Nilay] Harvard Univ, Sch Med, Dept Psychiat, Cambridge Hlth Alliance, Cambridge, MA 02138 USA; [Liu, Zimin] Southwest Univ, Coll Econ & Management, Chongqing, Peoples R China; [Shu, Chang] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Flores, Michael] Brown Univ, Providence, RI 02912 USA	Harvard University; Cambridge Health Alliance; Southwest University - China; Harvard University; Harvard T.H. Chan School of Public Health; Brown University	Le Cook, B (corresponding author), Ctr Multicultural Mental Hlth, 120 Beacon St,4th Floor, Somerville, MA 02143 USA.	bcook@cha.harvard.edu	Cook, Benjamin/AAA-3543-2022	Shu, Chang/0000-0002-3730-5102	National Institute of Mental Health (NIMH) [R01MH 091042]; William F. Milton Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023482] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); William F. Milton Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute of Mental Health (NIMH) grant R01MH 091042 (Dr Cook, principal investigator) and the William F. Milton Fund.	Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Aldworth J, 2010, INT J METH PSYCH RES, V19, P61, DOI 10.1002/mpr.312; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Aubin HJ, 2012, NEUROSCI BIOBEHAV R, V36, P271, DOI 10.1016/j.neubiorev.2011.06.007; Campion J., 2008, ADV PSYCHIAT TREAT, V14, P217, DOI [DOI 10.1192/APT.BP.108.005710, 10.1192/apt.bp.108.005710]; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fiore MC, 2008, JAMA-J AM MED ASSOC, V299, P2083, DOI 10.1001/jama.299.17.2083; Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hagman BT, 2008, ADDICT BEHAV, V33, P582, DOI 10.1016/j.addbeh.2007.11.007; Hall SM, 2006, AM J PUBLIC HEALTH, V96, P1808, DOI 10.2105/AJPH.2005.080382; Hitsman B, 2009, CAN J PSYCHIAT, V54, P368, DOI 10.1177/070674370905400604; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kalman D, 1998, SUBST USE MISUSE, V33, P2021, DOI 10.3109/10826089809069815; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawn S, 2005, AUST NZ J PSYCHIAT, V39, P866, DOI 10.1080/j.1440-1614.2005.01697.x; Lawrence D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-256; Le Cook B, 2013, SOC SCI MED, V84, P102, DOI 10.1016/j.socscimed.2013.02.006; Little R.J.A., 2002, STAT ANAL MISSING DA; McClave AK, 2010, AM J PUBLIC HEALTH, V100, P2464, DOI 10.2105/AJPH.2009.188136; McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769; McGovern MP, 2009, ADDICT BEHAV, V34, P892, DOI 10.1016/j.addbeh.2009.03.009; Munoz RF, 2009, NICOTINE TOB RES, V11, P1025, DOI 10.1093/ntr/ntp090; National Institute on Drug Abuse, 2009, TOB ADD WHAT AR EXT; Phillips KM, 2004, PROF PSYCHOL-RES PR, V35, P281, DOI 10.1037/0735-7028.35.3.281; Pregibon D., 1980, APPLIED STATISTICS, V29, P15, DOI [DOI 10.2307/2346405, 10.2307/2346405]; Prochaska J, 2004, PSYCHIAT SERV, V55, P1265, DOI 10.1176/appi.ps.55.11.1265; Prochaska JJ, 2008, AM J PUBLIC HEALTH, V98, P446, DOI 10.2105/AJPH.2006.101147; Prochaska JJ, 2010, DRUG ALCOHOL DEPEN, V110, P177, DOI 10.1016/j.drugalcdep.2010.03.002; Rubin DB, 1998, MULTIPLE IMPUTATION; Schroeder SA, 2010, ANNU REV PUBL HEALTH, V31, P297, DOI 10.1146/annurev.publhealth.012809.103701; Siru R, 2009, ADDICTION, V104, P719, DOI 10.1111/j.1360-0443.2009.02545.x; Spring B, 2003, AM J PSYCHIAT, V160, P316, DOI 10.1176/appi.ajp.160.2.316; StataCorp, 2011, STAT COMP PROGR REL; Thota AB, 2012, AM J PREV MED, V42, P525, DOI 10.1016/j.amepre.2012.01.019; Trosclair A, 2010, ADDICT BEHAV, V35, P438, DOI 10.1016/j.addbeh.2009.12.011; Vanable PA, 2003, PSYCHOL ADDICT BEHAV, V17, P259, DOI 10.1037/0893-164X.17.4.259; Warner KE, 2010, NICOTINE TOB RES, V12, P876, DOI 10.1093/ntr/ntq125; ZIEDONIS DM, 1994, HOSP COMMUNITY PSYCH, V45, P204; Zuvekas SH, 2001, HEALTH AFFAIR, V20, P214, DOI 10.1377/hlthaff.20.2.214	46	327	332	3	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					172	182		10.1001/jama.2013.284985	http://dx.doi.org/10.1001/jama.2013.284985			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SA	24399556	Bronze, Green Accepted			2022-12-28	WOS:000329339400023
J	Turkmen, YE; Aggarwal, VK				Tuerkmen, Yunus E.; Aggarwal, Varinder K.			A Simpler Route for Making Nitrogen-Alkene Rings	SCIENCE			English	Editorial Material							AZIRIDINES		[Tuerkmen, Yunus E.; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Turkmen, YE (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	v.aggarwal@bristol.ac.uk	Aggarwal, Varinder/AAG-8504-2019	Turkmen, Yunus/0000-0002-9797-2820; Aggarwal, Varinder/0000-0003-0344-6430	Engineering and Physical Sciences Research Council [EP/I038071/1, EP/K03927X/1] Funding Source: researchfish; EPSRC [EP/K03927X/1, EP/I038071/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aggarwal V.K., 2006, AZIRIDINES EPOXIDES, P1; ANDREAE S, 1991, SYNTHESIS-STUTTGART, P327; Grabowski K, 2007, CURR CHEM BIOL, V1, P115, DOI DOI 10.2174/187231307779814066; Ho CM, 1999, J CHEM SOC DALTON, P2411, DOI 10.1039/a903605i; Ismail FMD, 2009, EUR J MED CHEM, V44, P3373, DOI 10.1016/j.ejmech.2009.05.013; Jat JL, 2014, SCIENCE, V343, P61, DOI 10.1126/science.1245727; Muller P, 2003, CHEM REV, V103, P2905, DOI 10.1021/cr020043t; Pellissier H, 2010, TETRAHEDRON, V66, P1509, DOI 10.1016/j.tet.2009.11.089; Varszegi C, 2008, ANGEW CHEM INT EDIT, V47, P1477, DOI 10.1002/anie.200704772	9	3	3	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					33	34		10.1126/science.1248166	http://dx.doi.org/10.1126/science.1248166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385622	Green Submitted			2022-12-28	WOS:000329162000038
J	Arie, S				Arie, Sophie			Twin dilemma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						Braude P, 2013, REPROD BIOMED ONLINE, V27, P644, DOI 10.1016/j.rbmo.2013.08.009; Expert Group on Multiple Births after IVF, ON CHILD TIM; HFEA, 2011, IMPR OUTC FERT PAT M; HFEA, 2013, ASS REPR GYN CTR DAT; HFEA, ON TIM HFEA POL MULT; HFEA, 2006, MULT BIRTHS BACKGR S; Office For National Statistics, 2012, STAT B BIRTHS ENGL W	7	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2014	348								f7603	10.1136/bmj.f7603	http://dx.doi.org/10.1136/bmj.f7603			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285QD	24384464				2022-12-28	WOS:000329407800002
J	Sihvonen, R; Paavola, M; Malmivaara, A; Itala, A; Joukainen, A; Nurmi, H; Kalske, J; Jarvinen, TLN				Sihvonen, Raine; Paavola, Mika; Malmivaara, Antti; Itala, Ari; Joukainen, Antti; Nurmi, Heikki; Kalske, Juha; Jarvinen, Teppo L. N.			Arthroscopic Partial Meniscectomy versus Sham Surgery for a Degenerative Meniscal Tear	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; RADIOGRAPHIC OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; VERTEBROPLASTY; QUALITY; LIFE	BackgroundArthroscopic partial meniscectomy is one of the most common orthopedic procedures, yet rigorous evidence of its efficacy is lacking. MethodsWe conducted a multicenter, randomized, double-blind, sham-controlled trial in 146 patients 35 to 65 years of age who had knee symptoms consistent with a degenerative medial meniscus tear and no knee osteoarthritis. Patients were randomly assigned to arthroscopic partial meniscectomy or sham surgery. The primary outcomes were changes in the Lysholm and Western Ontario Meniscal Evaluation Tool (WOMET) scores (each ranging from 0 to 100, with lower scores indicating more severe symptoms) and in knee pain after exercise (rated on a scale from 0 to 10, with 0 denoting no pain) at 12 months after the procedure. ResultsIn the intention-to-treat analysis, there were no significant between-group differences in the change from baseline to 12 months in any primary outcome. The mean changes (improvements) in the primary outcome measures were as follows: Lysholm score, 21.7 points in the partial-meniscectomy group as compared with 23.3 points in the sham-surgery group (between-group difference, -1.6 points; 95% confidence interval [CI], -7.2 to 4.0); WOMET score, 24.6 and 27.1 points, respectively (between-group difference, -2.5 points; 95% CI, -9.2 to 4.1); and score for knee pain after exercise, 3.1 and 3.3 points, respectively (between-group difference, -0.1; 95% CI, -0.9 to 0.7). There were no significant differences between groups in the number of patients who required subsequent knee surgery (two in the partial-meniscectomy group and five in the sham-surgery group) or serious adverse events (one and zero, respectively). ConclusionsIn this trial involving patients without knee osteoarthritis but with symptoms of a degenerative medial meniscus tear, the outcomes after arthroscopic partial meniscectomy were no better than those after a sham surgical procedure. (Funded by the Sigrid Juselius Foundation and others; ClinicalTrials.gov number, NCT00549172.)	[Sihvonen, Raine] Hatanpaa City Hosp, Dept Orthoped & Traumatol, Tampere, Finland; [Paavola, Mika; Kalske, Juha; Jarvinen, Teppo L. N.] Univ Helsinki, Dept Orthoped & Traumatol, Cent Hosp, Helsinki 00029, Finland; [Paavola, Mika; Kalske, Juha; Jarvinen, Teppo L. N.] Univ Helsinki, Helsinki 00029, Finland; [Malmivaara, Antti] Natl Inst Hlth & Welf, Ctr Hlth & Social Econ, Helsinki, Finland; [Itala, Ari] Univ Turku, Dept Orthoped & Traumatol, Turku, Finland; [Joukainen, Antti] Kuopio Univ Hosp, Dept Orthoped Traumatol & Hand Surg, SF-70210 Kuopio, Finland; [Nurmi, Heikki] Cent Finland Cent Hosp, Dept Orthopedi & Traumatol, Jyvaskyla, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; University of Turku; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital	Jarvinen, TLN (corresponding author), Univ Helsinki, Dept Orthoped & Traumatol, Cent Hosp, Toolo Hosp, Topeliuksenkatu 5,POB 266, Helsinki 00029, Finland.	teppo.jarvinen@helsinki.fi	Joukainen, Antti/GLU-8888-2022; Paavola, Mika/S-1065-2018; Järvinen, Teppo/B-8189-2013	Paavola, Mika/0000-0002-2506-2115; Järvinen, Teppo/0000-0003-3713-956X; Jarvinen, Tero/0000-0002-4027-1759; Sihvonen, Raine/0000-0002-8744-3810; Joukainen, Antti/0000-0002-1428-5700	Sigrid Juselius Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Funded by the Sigrid Juselius Foundation and others	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; Briggs KK, 2006, J BONE JOINT SURG AM, V88A, P698, DOI 10.2106/JBJS.E.00339; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008; Buchbinder R, 2013, NEW ENGL J MED, V368, P1740, DOI 10.1056/NEJMe1302696; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Chatain F, 2003, ARTHROSCOPY, V19, P842, DOI 10.1016/S0749-8063(03)00735-7; COOPER DE, 1991, CLIN SPORT MED, V10, P529; Cullen Karen A, 2009, Natl Health Stat Report, P1; Ding CH, 2007, J RHEUMATOL, V34, P776; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2009, ARTHRITIS RHEUM-US, V60, P831, DOI 10.1002/art.24383; Fabricant PD, 2008, ARTHROSCOPY, V24, P769, DOI 10.1016/j.arthro.2008.02.015; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Hare KB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-71; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; HEDE A, 1992, J BONE JOINT SURG BR, V74, P118, DOI 10.1302/0301-620X.74B1.1732238; Herrlin SV, 2013, KNEE SURG SPORT TR A, V21, P358, DOI 10.1007/s00167-012-1960-3; Holmes R, 2013, AM J SPORT MED, V41, P1039, DOI 10.1177/0363546513479771; Jarvinen TLN, J CLIN EPID IN PRESS; Kallmes DF, 2012, NEW ENGL J MED, V366, P970; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Katz JN, 2009, ARTHRITIS RHEUM, V60, P633, DOI 10.1002/art.24363; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Kirkley A, 2007, CLIN J SPORT MED, V17, P349, DOI 10.1097/JSM.0b013e31814c3e15; Lyman S, 2012, ARTHROSCOPY, V28, P492, DOI 10.1016/j.arthro.2011.09.004; Metcalf MH, 2004, AM J SPORT MED, V32, P675, DOI 10.1177/0095399703258743; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Roos EM, 2001, OSTEOARTHR CARTILAGE, V9, P316, DOI 10.1053/joca.2000.0391; Sihvonen Raine, 2012, J Bone Joint Surg Am, V94, pe65, DOI 10.2106/JBJS.K.00804; Sihvonen R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002510; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Yim JH, 2013, AM J SPORT MED, V41, P1565, DOI 10.1177/0363546513488518	39	504	513	3	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2515	2524		10.1056/NEJMoa1305189	http://dx.doi.org/10.1056/NEJMoa1305189			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24369076	Green Published			2022-12-28	WOS:000328863700009
J	Tsai, CL; Tainer, JA				Tsai, Chi-Lin; Tainer, John A.			Probing DNA by 2-OG-Dependent Dioxygenase	CELL			English	Editorial Material							REPAIR; PROTEIN; DEMETHYLATION; ENZYMES; DAMAGE; TET2	TET-mediated 5-methyl cytosine (5mC) oxidation acts in epigenetic regulation, stem cell development, and cancer. Hu et al. now determine the crystal structure of the TET2 catalytic domain bound to DNA, shedding light on 5mC-DNA substrate recognition and the catalytic mechanism of 5mC oxidation.	[Tsai, Chi-Lin; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute	Tainer, JA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	jat@scripps.edu	Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020	Tainer, John/0000-0003-1659-2429; Tsai, Chi-Lin/0000-0002-0365-2405	NCI NIH HHS [P01 CA092584, R01 CA097209] Funding Source: Medline; NIGMS NIH HHS [R01 GM046312] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA097209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046312] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Wilkinson OJ, 2012, P NATL ACAD SCI USA, V109, P18755, DOI 10.1073/pnas.1209451109; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yi CQ, 2012, NAT STRUCT MOL BIOL, V19, P671, DOI 10.1038/nsmb.2320	9	3	3	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1448	1450		10.1016/j.cell.2013.12.002	http://dx.doi.org/10.1016/j.cell.2013.12.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360270	Green Accepted, Bronze			2022-12-28	WOS:000328693300003
J	Kingsdale, J				Kingsdale, Jon			After the False Start - What Can We Expect from the New Health Insurance Marketplaces?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Despite their troubled rollout, the health insurance exchanges should eventually promote enrollment and rational consumer choice, reduce the cost of distributing insurance, enhance competition, and improve cost and quality by helping to transform care delivery. Health insurance reform was conceived as a way of improving consumer choice, and under the Affordable Care Act (ACA), the year 2014 should have provided a test of how best to do so. Instead, the flawed launch of the exchanges in most of the country will test the memory of voters and determine the electoral costs of having made it harder for Americans to buy (or keep) coverage. The first lesson from the rollout was thus entirely unintended: implementation counts. Once the initial problems are corrected, the exchanges may still fulfill their promise, and it's worth remembering what that is. ...	Wakely Consulting Grp, Boston, MA 02129 USA		Kingsdale, J (corresponding author), Wakely Consulting Grp, Boston, MA 02129 USA.							Abaluck J, 2011, AM ECON REV, V101, P1180, DOI 10.1257/aer.101.4.1180; Collins S. R., 2009, HLTH CARE REFORM CAN; Jan T., 2013, BOSTON GLOBE; Johnson EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081521; Thibodeau P., 2013, HEALTHCARE GOV WEBSI	5	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					393	396		10.1056/NEJMp1315956	http://dx.doi.org/10.1056/NEJMp1315956			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303AA	24428426				2022-12-28	WOS:000330645400002
J	Yaqub, F				Yaqub, Farhat			Huda Zurayk: advancing health and research in the Arab world	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					299	299		10.1016/S0140-6736(13)62412-5	http://dx.doi.org/10.1016/S0140-6736(13)62412-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452041				2022-12-28	WOS:000330212600015
J	Korn, BS; Kikkawa, DO				Korn, Bobby S.; Kikkawa, Don O.			Ocular Manifestation of Electrical Burn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 42-year-old male electrician presented to the eye clinic with decreasing vision 4 weeks after an electrical burn of 14,000 V to the left shoulder. His vision in both eyes was limited to perception of hand motions, with an intraocular pressure of 14 mm Hg in each eye. A 42-year-old male electrician presented to the eye clinic with decreasing vision 4 weeks after an electrical burn of 14,000 V to the left shoulder. His vision in both eyes was limited to perception of hand motions, with an intraocular pressure of 14 mm Hg in each eye. Slit-lamp examination showed bilateral stellate anterior subcapsular opacities of the lens (top panels, right and left). Dilated funduscopic examination showed scattered cotton-wool spots and bilateral optic-nerve pallor, which was greatest in the left eye (bottom panels, right and left). Four months after the injury, the patient underwent cataract extraction and implantation of ...	[Korn, Bobby S.; Kikkawa, Don O.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Korn, BS (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	bkorn@ucsd.edu							0	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4							e6	10.1056/NEJMicm1213581	http://dx.doi.org/10.1056/NEJMicm1213581			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450916				2022-12-28	WOS:000330036200001
J	Baruch, M; Belotserkovsky, I; Hertzog, BB; Ravins, M; Dov, E; McIver, KS; Le Breton, YS; Zhou, YT; Chen, CY; Hanski, E				Baruch, Moshe; Belotserkovsky, Ilia; Hertzog, Baruch B.; Ravins, Miriam; Dov, Eran; McIver, Kevin S.; Le Breton, Yoann S.; Zhou, Yiting; Chen, Catherine Youting; Hanski, Emanuel			An Extracellular Bacterial Pathogen Modulates Host Metabolism to Regulate Its Own Sensing and Proliferation	CELL			English	Article							GROUP-A STREPTOCOCCUS; UNFOLDED PROTEIN RESPONSE; SOFT-TISSUE INFECTIONS; ASPARAGINE SYNTHETASE GENE; STREPTOLYSIN-S; MOLECULAR-MECHANISMS; STRUCTURE PREDICTION; GLOBAL BURDEN; CELL-DEATH; TNF-ALPHA	Successful infection depends on the ability of the pathogen to gain nutrients from the host. The extracellular pathogenic bacterium group A Streptococcus (GAS) causes a vast array of human diseases. By using the quorum-sensing sil system as a reporter, we found that, during adherence to host cells, GAS delivers streptolysin toxins, creating endoplasmic reticulum stress. This, in turn, increases asparagine (ASN) synthetase expression and the production of ASN. The released ASN is sensed by the bacteria, altering the expression of similar to 17% of GAS genes of which about one-third are dependent on the two-component system TrxSR. The expression of the streptolysin toxins is strongly upregulated, whereas genes linked to proliferation are downregulated in ASN absence. Asparaginase, a widely used chemotherapeutic agent, arrests GAS growth in human blood and blocks GAS proliferation in a mouse model of human bacteremia. These results delineate a pathogenic pathway and propose a therapeutic strategy against GAS infections.	[Baruch, Moshe; Belotserkovsky, Ilia; Hertzog, Baruch B.; Ravins, Miriam; Dov, Eran; Hanski, Emanuel] Hebrew Univ Jerusalem, Fac Med, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [McIver, Kevin S.; Le Breton, Yoann S.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [McIver, Kevin S.; Le Breton, Yoann S.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Zhou, Yiting; Chen, Catherine Youting; Hanski, Emanuel] Natl Univ Singapore, Ctr Res Excellence & Technol Enterprise CREATE, Mechanism Inflammat Program, Singapore 138602, Singapore; [Zhou, Yiting; Chen, Catherine Youting; Hanski, Emanuel] Hebrew Univ Jerusalem HUJI, Singapore 138602, Singapore	Hebrew University of Jerusalem; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National University of Singapore	Hanski, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel.	emanuelh@ekmd.huji.ac.il	McIver, Kevin/K-9657-2016; hanski, emanuel/M-2696-2018	McIver, Kevin/0000-0002-4769-4463; hanski, emanuel/0000-0001-5054-0628; Zhou, Yi-Ting/0000-0003-4543-3099	Israeli Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047928] Funding Source: NIH RePORTER	Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from: The Israeli Science Foundation administered by the Israel Academy of Science and Humanities, the German-Israeli Foundation for Scientific Research and Development, and the National Research Foundation of the Republic of Singapore (EH) and the U. S. National Institutes of Health Institute of Allergy & Infectious Diseases (AI47928, KSM). The FACS machine used in this study was donated by Ms. Nilly Yaffa Sikorsky. We thank Prof. Norman B. Grover from the Faculty of Medicine for performing the statistical analyses described in (Table 4S), Dr. Dinorah Barasch for performing the chromatography-tandem mass spectrometry analysis, and Dr. Florent Villiers for performing the clustering analysis of RNA-seq data.	Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; Belotserkovsky I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000651; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Christensen ST, 1998, CELL BIOL INT, V22, P591, DOI 10.1006/cbir.1998.0320; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Gjymishka A, 2009, BIOCHEM J, V417, P695, DOI 10.1042/BJ20081706; Glekas GD, 2010, J BIOL CHEM, V285, P1870, DOI 10.1074/jbc.M109.072108; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2002, MOL MICROBIOL, V46, P87, DOI 10.1046/j.1365-2958.2002.03127.x; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Jackson SJ, 2011, TROP MED INT HEALTH, V16, P2, DOI 10.1111/j.1365-3156.2010.02670.x; Kietzman CC, 2011, INFECT IMMUN, V79, P812, DOI 10.1128/IAI.01026-10; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Leday TV, 2008, INFECT IMMUN, V76, P4659, DOI 10.1128/IAI.00597-08; Lepoutre A, 2011, J CLIN MICROBIOL, V49, P4094, DOI 10.1128/JCM.00070-11; Lin JN, 2011, J CLIN MICROBIOL, V49, P3632, DOI 10.1128/JCM.00531-11; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; Medina E, 2001, J INFECT DIS, V184, P846, DOI 10.1086/323292; Miyoshi-Akiyama T, 2005, J INFECT DIS, V192, P107, DOI 10.1086/430617; Molloy EM, 2011, NAT REV MICROBIOL, V9, P670, DOI 10.1038/nrmicro2624; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Norrby-Teglund A, 2005, SCAND J INFECT DIS, V37, P166, DOI 10.1080/00365540410020866; OFEK I, 1990, INFECT IMMUN, V58, P3737, DOI 10.1128/IAI.58.11.3737-3742.1990; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Palmer M, 2001, TOXICON, V39, P1681, DOI 10.1016/S0041-0101(01)00155-6; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Short DM, 2007, PROTEOMICS, V7, P3085, DOI 10.1002/pmic.200600964; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; White CE, 2007, PHILOS T R SOC B, V362, P1135, DOI 10.1098/rstb.2007.2040; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	50	57	58	0	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					97	108		10.1016/j.cell.2013.12.007	http://dx.doi.org/10.1016/j.cell.2013.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439371	Green Accepted, Bronze			2022-12-28	WOS:000329912200013
J	Finnegan, NJ; Schumer, R; Finnegan, S				Finnegan, Noah J.; Schumer, Rina; Finnegan, Seth			A signature of transience in bedrock river incision rates over timescales of 10(4)-10(7) years	NATURE			English	Article							COSMOGENIC AL-26; TIBETAN-PLATEAU; STRATH TERRACES; STREAM INCISION; CLIMATE-CHANGE; YELLOW-RIVER; FORE-ARC; EROSION; CANYON; UPLIFT	Measured rates of river incision into bedrock are commonly interpreted as proxies for rates of rock uplift (see refs 1 and 2, for example) and indices of the strength of climatic forcing of erosion over time (see refs 3 and 4, for example). This approach implicitly assumes that river incision rates are in equilibrium with external forcings over a wide range of timescales. Here we directly test this assumption by examining the temporal scaling of bedrock river incision from 155 independent measurements of river incision compiled from 14 sites. Of these sites, 11 exhibit a negative power-law dependence of bedrock river incision rate on measurement interval, a relationship that is apparent over timescales of 10(4)-10(7) years and is independent of tectonic and geomorphic setting. Thus, like rates of sediment accumulation(5), rates of river incision into bedrock exhibit non-steady-state behaviour even over very long measurement intervals. Non-steady-state behaviour can be explained by episodic hiatuses in river incision triggered by alluvial deposition, if such hiatuses have a heavy-tailed length distribution(6). Regardless of its cause, the dependence of incision rate on measurement interval complicates efforts to infer tectonic or climatic forcing from changes in rates of river incision over time or from comparison of rates computed over different timescales.	[Finnegan, Noah J.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Schumer, Rina] Desert Res Inst, Div Hydrol Sci, Reno, NV 89512 USA; [Finnegan, Seth] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Santa Cruz; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of California System; University of California Berkeley	Finnegan, NJ (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	nfinnega@ucsc.edu	Schumer, Rina/H-1179-2011	Schumer, Rina/0000-0001-6094-5637	National Science Foundation [EAR-1049889]; Division Of Earth Sciences [1049889, 1242458] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported in part by the National Science Foundation (EAR-1049889). We thank J. Kirchner, B. Crosby and K. Ferrier for discussion and comments that improved the manuscript.	Anthony DM, 2004, J CAVE KARST STUD, V66, P46; BENDA L, 1990, EARTH SURF PROCESSES, V15, P457, DOI 10.1002/esp.3290150508; Blothe JH, 2013, EARTH PLANET SC LETT, V382, P38, DOI 10.1016/j.epsl.2013.08.044; Bull W.B., 1987, GEOMORPHOLOGY, V1, P15, DOI [10.1016/0169-555X(87)90004-3, DOI 10.1016/0169-555X(87)90004-3]; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Cheng SP, 2002, TERRA NOVA, V14, P215, DOI 10.1046/j.1365-3121.2002.00350.x; Cook KL, 2009, EARTH SURF PROC LAND, V34, P994, DOI 10.1002/esp.1790; DING MZ, 1995, PHYS REV E, V52, P207, DOI 10.1103/PhysRevE.52.207; Gani N., 2007, GSA TODAY, V17, P4, DOI DOI 10.1130/GSAT01709A.1; GARDNER TW, 1987, GEOLOGY, V15, P259, DOI 10.1130/0091-7613(1987)15<259:GATPRE>2.0.CO;2; Granger DE, 2001, GEOL SOC AM BULL, V113, P825, DOI 10.1130/0016-7606(2001)113<0825:PPIOTG>2.0.CO;2; Hancock GS, 2002, GEOL SOC AM BULL, V114, P1131; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; Jerolmack DJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044638; Jerolmack DJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000555; Karlstrom KE, 2007, GEOL SOC AM BULL, V119, P1283, DOI 10.1130/0016-7606(2007)119[1283:AAFSOQ]2.0.CO;2; Kirchner JW, 2001, GEOLOGY, V29, P591, DOI 10.1130/0091-7613(2001)029<0591:MEOYKY>2.0.CO;2; Lague D, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2008JF001210; Lamb MP, 2010, NAT GEOSCI, V3, P477, DOI 10.1038/NGEO894; Leland J, 1998, EARTH PLANET SC LETT, V154, P93, DOI 10.1016/S0012-821X(97)00171-4; Li JJ, 1997, J GEOPHYS RES-SOL EA, V102, P10121, DOI 10.1029/97JB00275; Mills HH, 2000, GEOLOGY, V28, P955, DOI 10.1130/0091-7613(2000)028<0955:AIROSI>2.3.CO;2; MOLNAR P, 1994, J GEOL, V102, P583, DOI 10.1086/629700; Ouimet WB, 2007, GEOL SOC AM BULL, V119, P1462, DOI 10.1130/B26136.1; Pazzaglia FJ, 2001, AM J SCI, V301, P385, DOI 10.2475/ajs.301.4-5.385; PERSONIUS SF, 1995, J GEOPHYS RES-SOL EA, V100, P20193, DOI 10.1029/95JB01684; Redner S., 2007, GUIDE 1 PASSAGE PROC; Roering JJ, 2005, GEOLOGY, V33, P349, DOI 10.1130/G21260.1; Sadler P., GEOLOGICAL IN PRESS; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Schaller M, 2005, EARTH SURF PROC LAND, V30, P955, DOI 10.1002/esp.1256; Schumer R, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2009JF001266; Stock GM, 2005, EARTH SURF PROC LAND, V30, P985, DOI 10.1002/esp.1258; Turowski JM, 2008, GEOMORPHOLOGY, V99, P26, DOI 10.1016/j.geomorph.2007.10.001; Wegmann KW, 2009, QUATERNARY SCI REV, V28, P137, DOI 10.1016/j.quascirev.2008.10.006; Wegmann KW, 2002, GEOL SOC AM BULL, V114, P731, DOI 10.1130/0016-7606(2002)114<0731:HSTCCA>2.0.CO;2; Whipple KX, 2004, ANNU REV EARTH PL SC, V32, P151, DOI 10.1146/annurev.earth.32.101802.120356; Whittaker AC, 2007, GEOLOGY, V35, P103, DOI 10.1130/G23106A.1; Yanites BJ, 2010, GEOLOGY, V38, P639, DOI 10.1130/G30883.1	39	109	112	0	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					391	+		10.1038/nature12913	http://dx.doi.org/10.1038/nature12913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429636				2022-12-28	WOS:000329621800040
J	Jackrel, ME; DeSantis, ME; Martinez, BA; Castellano, LM; Stewart, RM; Caldwell, KA; Caldwell, GA; Shorter, J				Jackrel, Meredith E.; DeSantis, Morgan E.; Martinez, Bryan A.; Castellano, Laura M.; Stewart, Rachel M.; Caldwell, Kim A.; Caldwell, Guy A.; Shorter, James			Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AGGREGATION; PROTEIN; CHAPERONE; TOXICITY; MODEL; DISAGGREGATION; DISORDERS; MUTATIONS; NEURONS	There are no therapies that reverse the proteotoxic misfolding events that underpin fatal neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD). Hsp104, a conserved hexameric AAA+ protein from yeast, solubilizes disordered aggregates and amyloid but has no metazoan homolog and only limited activity against human neurodegenerative disease proteins. Here, we reprogram Hsp104 to rescue TDP-43, FUS, and alpha-synuclein proteotoxicity by mutating single residues in helix 1, 2, or 3 of the middle domain or the small domain of nucleotide-binding domain 1. Potentiated Hsp104 variants enhance aggregate dissolution, restore proper protein localization, suppress proteotoxicity, and in a C. elegans PD model attenuate dopaminergic neurodegeneration. Potentiating mutations reconfigure how Hsp104 subunits collaborate, desensitize Hsp104 to inhibition, obviate any requirement for Hsp70, and enhance ATPase, translocation, and unfoldase activity. Our work establishes that disease-associated aggregates and amyloid are tractable targets and that enhanced disaggregases can restore proteostasis and mitigate neurodegeneration.	[Jackrel, Meredith E.; DeSantis, Morgan E.; Castellano, Laura M.; Stewart, Rachel M.; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [DeSantis, Morgan E.; Shorter, James] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Castellano, Laura M.; Shorter, James] Univ Penn, Perelman Sch Med, Pharmacol Grad Grp, Philadelphia, PA 19104 USA; [Martinez, Bryan A.; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Tuscaloosa	Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Stewart, Rachel/0000-0001-5864-3277; Stong, Laura/0000-0001-7964-0761; Jackrel, Meredith/0000-0003-4406-9504; Martinez, Bryan/0000-0002-0133-0306; Caldwell, Guy/0000-0002-8283-9090; Caldwell, Kim/0000-0003-1580-6122	American Heart Association postdoctoral fellowship; NIH training grant [T32GM071339]; NRSA predoctoral fellowship [F31NS079009]; SF graduate research fellowship [DGE-0822]; NSF CAREER Award [0845020]; NIH [R15NS075684, R21NS067354, R21HD074510, R01GM099836]; NIH Director's New Innovator Award [DP2OD002177]; Muscular Dystrophy Association Research Award [MDA277268]; Packard Center for ALS Research at Johns Hopkins University; Target ALS; Ellison Medical Foundation New Scholar in Aging Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD074510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, T32GM071339, R01GM099836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067354, R15NS075684, F31NS079009] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0845020] Funding Source: National Science Foundation	American Heart Association postdoctoral fellowship(American Heart Association); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SF graduate research fellowship; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Research Award(Muscular Dystrophy Association); Packard Center for ALS Research at Johns Hopkins University(Johns Hopkins University); Target ALS; Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Sue Lindquist, Johannes Buchner, Walid Houry, Aaron Gitler, Martin Duennwald, and Brad Johnson for kindly sharing reagents; Beatrice Razzo, Liz Sweeny, and Nabeel Akhtar for help in library construction and screening; and Mark Lemmon, Mariana Torrente, and Liz Sweeny for critiques. Our studies were supported by an American Heart Association postdoctoral fellowship (M.E.J); NIH training grant (T32GM071339) and NRSA predoctoral fellowship F31NS079009 (M.E.D.); NSF graduate research fellowship DGE-0822 (L.M.C.); NSF CAREER Award 0845020 (K.A.C.); NIH grant R15NS075684 (G.A.C); NIH Director's New Innovator Award DP2OD002177, NIH grants R21NS067354, R21HD074510, and R01GM099836, a Muscular Dystrophy Association Research Award (MDA277268), Packard Center for ALS Research at Johns Hopkins University, Target ALS, and an Ellison Medical Foundation New Scholar in Aging Award (J.S.).	Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Cushman-Nick M., 2013, PLOS GENET, V9; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481	26	154	156	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					170	182		10.1016/j.cell.2013.11.047	http://dx.doi.org/10.1016/j.cell.2013.11.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439375	Green Accepted, Bronze			2022-12-28	WOS:000329912200019
J	Zwar, NA; Mendelsohn, CP; Richmond, RL				Zwar, Nicholas A.; Mendelsohn, Colin P.; Richmond, Robyn L.			Supporting smoking cessation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							WITHDRAWAL SYMPTOMS; BEHAVIOR; QUIT; DEPENDENCE; MORTALITY; NICOTINE; CRAVINGS; BENEFITS; SMOKERS		[Zwar, Nicholas A.; Richmond, Robyn L.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [Mendelsohn, Colin P.] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia	University of New South Wales Sydney; University of Sydney	Zwar, NA (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.	n.zwar@unsw.edu.au	Richmond, Robyn L/K-8464-2014	Richmond, Robyn L/0000-0003-2897-4109; Zwar, Nicholas/0000-0001-6462-9121				Aveyard P, 2007, BMJ-BRIT MED J, V335, P37, DOI 10.1136/bmj.39252.591806.47; Barnes J, 2010, COCHRANE DB SYST REV, V10; Brewer JA, 2013, PSYCHOL ADDICT BEHAV, V27, P366, DOI 10.1037/a0028490; Brewer JA, 2011, DRUG ALCOHOL DEPEN, V119, P72, DOI 10.1016/j.drugalcdep.2011.05.027; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Cahill K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub6; Caponnetto P, 2013, Monaldi Arch Chest Dis, V79, P12; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Coleman T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078; Cooper J, 2011, AUST NZ J PUBL HEAL, V35, P368, DOI 10.1111/j.1753-6405.2011.00733.x; Cropley M, 2007, ADDICTION, V102, P989, DOI 10.1111/j.1360-0443.2007.01832.x; Davis James M, 2007, BMC Complement Altern Med, V7, P2, DOI 10.1186/1472-6882-7-2; Dempsey DA, 2001, DRUG SAFETY, V24, P277, DOI 10.2165/00002018-200124040-00005; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fagerstrom K, 2003, Monaldi Arch Chest Dis, V59, P91; Fiore MC, 2008, TREATING TOBACCO USE; Foulds J, 2010, INT J CLIN PRACT, V64, P142, DOI 10.1111/j.1742-1241.2009.02243.x; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Hajek P, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003999.pub3, 10.1002/14651858.CD003999.pub4]; Ho MK, 2010, CLIN PHARMACOL THER, V88, P779, DOI 10.1038/clpt.2010.175; Hughes JR, 2011, DRUG ALCOHOL DEPEN, V117, P111, DOI 10.1016/j.drugalcdep.2011.02.009; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Hughes JR, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000031.PUB3; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Lai DT, 2010, COCHRANE DB SYST REV, V1; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Lindson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub2; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; NICE, 2013, TOB HARM RED APPR SM; Pepper JK, 2014, TOB CONTROL, V23, P375, DOI 10.1136/tobaccocontrol-2013-051122; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Prochaska JJ, 2008, AM J PUBLIC HEALTH, V98, P446, DOI 10.2105/AJPH.2006.101147; RICHMOND RL, 1993, ADDICT BEHAV, V18, P187, DOI 10.1016/0306-4603(93)90049-F; Roberts V, 2012, PSYCHOPHARMACOLOGY, V222, P1, DOI 10.1007/s00213-012-2731-z; Schaffer SD, 2009, J CLIN NURS, V18, P1533, DOI 10.1111/j.1365-2702.2008.02724.x; Siru R, 2009, ADDICTION, V104, P719, DOI 10.1111/j.1360-0443.2009.02545.x; Stanton A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003289.pub5; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009670.pub4, 10.1002/14651858.CD002850.pub3]; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Ussher MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub4; White AR, 2011, COCHRANE DB SYST REV, V1; Whittaker R, 2012, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858; WHO, 2013, TOB FACT SHEET 339; Zwar N, 2011, SUPPORTING SMOKING C	48	41	41	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2014	348								f7535	10.1136/bmj.f7535	http://dx.doi.org/10.1136/bmj.f7535			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	293MN	24423971	Green Published			2022-12-28	WOS:000329975900005
J	Roberts, RG				Roberts, Richard G.			A Pardon for the Dingo	SCIENCE			English	Editorial Material							AUSTRALIA; DYNAMICS		Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia	University of Wollongong	Roberts, RG (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	rgrob@uow.edu.au	Roberts, Richard Graham/B-8245-2013	Roberts, Richard Graham/0000-0002-0128-4119				Donaldson M, 2012, KIMBERLEY ROCK ART; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2011, P ROY SOC B-BIOL SCI, V278, P3748, DOI 10.1098/rspb.2011.0343; Oskarsson MCR, 2012, P ROY SOC B-BIOL SCI, V279, P967, DOI 10.1098/rspb.2011.1395; Prideaux GJ, 2010, P NATL ACAD SCI USA, V107, P22157, DOI 10.1073/pnas.1011073107; Prowse TAA, 2014, ECOLOGY, V95, P693, DOI 10.1890/13-0746.1; Reeves JM, 2013, QUATERNARY SCI REV, V74, P21, DOI 10.1016/j.quascirev.2013.01.001; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roberts RG, 2010, SCIENCE, V327, P420, DOI 10.1126/science.1185517; Rule S, 2012, SCIENCE, V335, P1483, DOI 10.1126/science.1214261; Williams AN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0486	12	5	5	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					142	143		10.1126/science.1248646	http://dx.doi.org/10.1126/science.1248646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408422				2022-12-28	WOS:000329440800026
J	Gornall, J				Gornall, Jonathan			ALCOHOL AND PUBLIC HEALTH Under the influence: 1. False dawn for minimum unit pricing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						[Anonymous], 2011, EARLY DAY MOTION; [Anonymous], 2012, BBC; Boseley S., 2008, GUARDIAN; Chapman J., 2012, DAILY MAIL; Department for Transport, 2013, REPORTED ROAD CASUAL; Department of Health, 2011, PUBLIC HEALTH RESPON; Gilmore I, 2011, DAILY TELEGRAPH; Health of Commons Health Committee, 2009, ALCOHOL FIRST REPORT; Hennessy P, 2012, TELEGRAPH; HM Government, 2012, GOVERNMENTS ALCOHOL; HM Government, 2010, HEALTHY LIVES HEALTH; HM Treasury, 2010, REVIEW OF ALCOHOL TA; HM Treasury, 2011, OVERVIEW OF TAX LEGI; Home Office, 2012, CONS DEL GOV POL CUT; Kirkup. J, 2008, TELEGRAPH; Laurance Jeremy, 2010, INDEPENDENT; Maddox D, 2012, SCOTSMAN; Mason R., 2011, DAILY TELEGRAPH; Merrick R, 2010, DAILY POST; Nathanson V, 2002, BMA RESPONSE TO ALCO; National Institute for Health and Clinical Excellence, 2010, ALCOHOL USE DISORDER; NHS Confederation, 2010, TOO MUCH OF THE HARD; Office for National Statistics, 2013, STAT BULL; Oxford Economics, 2009, THE ECONOMIC OUTLOOK; Prime Minister's Strategy Unit, 2003, ALCOHOL HARM REDUCTI; Prime Minister's Strategy Unit, 2004, ALCOHOL HARM REDUCTI; Public Health Commission, 2009, WERE ALL IN THIS TOG; Public Health Committee, 2011, 12TH REPORT; ScHARR University of Sheffield, 2013, MODELLED INCOME GROU; Secretary of State for Health, 2010, GOVERNMENT RESPONSE; Smith S., 2010, DRINKS INDUSTRY TOAS; Triggle N., 2011, BBC NEWS; University of Sheffield, 2008, INDEPENDENT REVIEW O; WARD M, 2001, BBC NEWS; Watt H., 2011, TELEGRAPH; Watt Holly, 2010, DAILY TELEGRAPH; Wine and Spirit Trade Association, GENERAL FACTS AND FI	37	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								f7435	10.1136/bmj.f7435	http://dx.doi.org/10.1136/bmj.f7435			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KI	24401284				2022-12-28	WOS:000329610300001
J	Stern, M; Umansky, V; Bar-Joseph, I				Stern, Michael; Umansky, Vladimir; Bar-Joseph, Israel			Exciton Liquid in Coupled Quantum Wells	SCIENCE			English	Article							CONDENSATION	Excitons in semiconductors may form correlated phases at low temperatures. We report the observation of an exciton liquid in gallium arsenide/aluminum gallium arsenide-coupled quantum wells. Above a critical density and below a critical temperature, the photogenerated electrons and holes separate into two phases: an electron-hole plasma and an exciton liquid, with a clear sharp boundary between them. The two phases are characterized by distinct photoluminescence spectra and by different electrical conductance. The liquid phase is formed by the repulsive interaction between the dipolar excitons and exhibits a short-range order, which is manifested in the photoluminescence line shape.	[Stern, Michael; Umansky, Vladimir; Bar-Joseph, Israel] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Stern, M (corresponding author), CEA Saclay, DSM, IRAMIS, Quantron Grp,SPEC, F-91191 Gif Sur Yvette, France.	michael.stern@cea.fr	Umansky, Vladimir/P-1334-2019	Umansky, Vladimir/0000-0001-5727-2064	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	We thank R. Suris, B. Laikhtman, M. and R. Combescot, and V. Steinberg for fruitful discussions and M. Brook for the magnetic field measurements. This work was supported by the Israeli Science Foundation.	ALEXANDROU A, 1990, PHYS REV B, V42, P9225, DOI 10.1103/PhysRevB.42.9225; Combescot M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.176403; Gorbunov AV, 2012, JETP LETT+, V96, P138, DOI 10.1134/S0021364012140056; High AA, 2012, NATURE, V483, P584, DOI 10.1038/nature10903; KELDYSH LV, 1968, SOV PHYS JETP-USSR, V27, P521; Laikhtman B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195313; Lozovik YE, 1996, JETP LETT+, V64, P573, DOI 10.1134/1.567264; MASSELINK WT, 1985, PHYS REV B, V32, P8027, DOI 10.1103/PhysRevB.32.8027; Schinner GJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.127403; Shilo Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3335; Stern M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.256402; Suris R., 2007, LOW DIM STRUCT C GEN; Voros Z, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.016403; ZHU XJ, 1995, PHYS REV LETT, V74, P1633, DOI 10.1103/PhysRevLett.74.1633	14	52	53	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					55	57		10.1126/science.1243409	http://dx.doi.org/10.1126/science.1243409			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385625	Green Submitted			2022-12-28	WOS:000329162000045
J	Chakma, J; Sun, GH; Steinberg, JD; Sammut, SM; Jagsi, R				Chakma, Justin; Sun, Gordon H.; Steinberg, Jeffrey D.; Sammut, Stephen M.; Jagsi, Reshma			Asia's Ascent - Global Trends in Biomedical R&D Expenditures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chakma, Justin] Thomas McNerney & Partners, La Jolla, CA USA; [Sun, Gordon H.; Jagsi, Reshma] Univ Michigan Hlth Syst, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI USA; [Sun, Gordon H.] Univ Michigan Hlth Syst, Ctr Clin Management Res, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Jagsi, Reshma] Univ Michigan Hlth Syst, Ctr Bioeth & Social Sci Med, Ann Arbor, MI USA; [Sun, Gordon H.] Univ Michigan Hlth Syst, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI USA; [Jagsi, Reshma] Univ Michigan Hlth Syst, Dept Radiat Oncol, Ann Arbor, MI USA; [Steinberg, Jeffrey D.] Singapore Bioimaging Consortium, Agcy Sci Technol & Res, Singapore, Singapore; [Sammut, Stephen M.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); University of Pennsylvania	Chakma, J (corresponding author), Thomas McNerney & Partners, La Jolla, CA USA.		Steinberg, Jeffrey D/H-3540-2013	Steinberg, Jeffrey D/0000-0003-4110-3586; Jagsi, Reshma/0000-0001-6562-1228				Collins FS., 2013, FISCAL YEAR 2014 BUD; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Sampat BN, 2011, HEALTH AFFAIR, V30, P332, DOI 10.1377/hlthaff.2009.0917; Sun GH, 2012, NEW ENGL J MED, V367, P687, DOI 10.1056/NEJMp1206643	5	79	81	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					3	6		10.1056/NEJMp1311068	http://dx.doi.org/10.1056/NEJMp1311068			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284XA	24382062				2022-12-28	WOS:000329354100003
J	Hollis, A; Ahmed, Z				Hollis, Aidan; Ahmed, Ziana			Preserving Antibiotics, Rationally	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								With 51 tons of antibiotics consumed daily in the United States, the selective pressure in favor of antibiotic-resistant pathogens is strong. Given the critical public health threat, an economically rational solution is to impose a user fee on nonhuman antibiotic use. Antimicrobial resistance is a critical threat to public health. The value of antibiotics for human health is immeasurable, but were one to try to measure, a plausible estimate of the increase in life expectancy attributable to antibiotics might be 2 to 10 years.(1) If we multiply this increase by 300 million Americans and a dollar value of, say, $100,000 per life-year, we arrive at an estimate for the worth of the current stock of antibiotics of $60 trillion to $300 trillion in the United States alone. Unfortunately, this stock is being gradually depleted owing to genetic mutations in bacteria and ...	[Hollis, Aidan] Univ Calgary, Dept Econ, Calgary, AB T2N 1N4, Canada; [Hollis, Aidan] Incent Global Hlth, Washington, DC USA; [Ahmed, Ziana] Univ Toronto, Dept Econ, Toronto, ON M5S 1A1, Canada	University of Calgary; University of Toronto	Hollis, A (corresponding author), Univ Calgary, Dept Econ, Calgary, AB T2N 1N4, Canada.			Hollis, Aidan/0000-0001-5125-2193				Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; MCDERMOTT W, 1982, JOHNS HOPKINS MED J, V151, P302; Outterson Kevin, 2013, GLOBALIZATION HLTH C, P318; Research Council N., 1999, USE DRUGS FOOD ANIMA, DOI DOI 10.17226/5137	5	99	101	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2474	2476		10.1056/NEJMp1311479	http://dx.doi.org/10.1056/NEJMp1311479			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	278BT	24369073				2022-12-28	WOS:000328863700004
J	Scholl, HPN; Sahel, JA				Scholl, Hendrik P. N.; Sahel, Jose A.			Gene therapy arrives at the macula	LANCET			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; RETINAL DEGENERATION; VISUAL FUNCTION; VISION		[Scholl, Hendrik P. N.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Sahel, Jose A.] Inst Vis, INSERM, U968, Paris, France; [Sahel, Jose A.] Univ Paris 06, Univ Sorbonne, Inst Vis, UMR S968, Paris, France; [Sahel, Jose A.] Inst Vis, CNRS, UMR 7210, Paris, France; [Sahel, Jose A.] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose A.] Ctr Hosp Natl Ophtalmol Quinze Vingts, CIC 1423, Paris, France; [Sahel, Jose A.] UCL, Inst Ophthalmol, London, England	Johns Hopkins University; Johns Hopkins Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Fondation Adolphe de Rothschild; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Scholl, HPN (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.	hscholl1@jhmi.edu	Sahel, Jose-Alain/F-3172-2017	Sahel, Jose-Alain/0000-0002-4831-1153				Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Finger RP, 2008, QUAL LIFE RES, V17, P559, DOI 10.1007/s11136-008-9327-4; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Issa PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012864; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Sahel JA, 2013, ANNU REV NEUROSCI, V36, P467, DOI 10.1146/annurev-neuro-062012-170304; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Singh MS, 2013, P NATL ACAD SCI USA, V110, P1101, DOI 10.1073/pnas.1119416110	16	11	11	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1105	1107		10.1016/S0140-6736(14)60033-7	http://dx.doi.org/10.1016/S0140-6736(14)60033-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24439295				2022-12-28	WOS:000333956000007
J	Yates, T; Ner, SMH; Schulte, PJ; Thomas, L; Huffman, KM; Bales, CW; Califf, RM; Holman, RR; McMurray, JJV; Bethel, MA; Tuomilehto, J; Davies, MJ; Kraus, WE				Yates, Thomas; Ner, Steven M. Haff; Schulte, Phillip J.; Thomas, Laine; Huffman, Kim M.; Bales, Connie W.; Califf, Robert M.; Holman, Rury R.; McMurray, John J. V.; Bethel, M. Angelyn; Tuomilehto, Jaakko; Davies, Melanie J.; Kraus, William E.			Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis	LANCET			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; LIFE-STYLE; CARDIORESPIRATORY FITNESS; COST-EFFECTIVENESS; PREVENTION; METAANALYSIS; DISEASE; ADULTS; RISK	Background The extent to which change in physical activity can modify the risk of cardiovascular disease in individuals at high cardiovascular risk is uncertain. We investigated whether baseline and change in objectively-assessed ambulatory activity is associated with the risk of a cardiovascular event in individuals at high cardiovascular risk with impaired glucose tolerance. Methods We assessed prospective data from the NAVIGATOR trial involving 9306 individuals with impaired glucose tolerance who were recruited in 40 countries between January, 2002, and January, 2004. Participants also either had existing cardiovascular disease (if age >= 50 years) or at least one additional cardiovascular risk factor (if age >= 55 years). Participants were followed-up for cardiovascular events (defined as cardiovascular mortality, non-fatal stroke, or myocardial infarction) for 6 years on average and had ambulatory activity assessed by pedometer at baseline and 12 months. Adjusted Cox proportional hazard models quantified the association of baseline and change in ambulatory activity (from baseline to 12 months) with the risk of a subsequent cardiovascular event, after adjustment for each other and potential confounding variables. This study is registered with ClinicalTrials.gov NCT00097786. Findings During 45 211 person-years follow-up, 531 cardiovascular events occurred. Baseline ambulatory activity (hazard ratio [HR] per 2000 steps per day 0.90, 95% CI 0.84-0.96) and change in ambulatory activity (0.92, 0.86-0.99) were inversely associated with the risk of a cardiovascular event. Results for change in ambulatory activity were unaffected when also adjusted for changes in body-mass index and other potential confounding variables at 12 months. Interpretation In individuals at high cardiovascular risk with impaired glucose tolerance, both baseline levels of daily ambulatory activity and change in ambulatory activity display a graded inverse association with the subsequent risk of a cardiovascular event.	[Yates, Thomas; Davies, Melanie J.] NIHR Leicester Loughborough Diet Lifestyle & Phys, Leicester, Leics, England; [Yates, Thomas; Davies, Melanie J.] Univ Leicester, Ctr Diabet, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Schulte, Phillip J.; Thomas, Laine; Huffman, Kim M.; Bales, Connie W.; Califf, Robert M.; Kraus, William E.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Bales, Connie W.] Durham VA Med Ctr, Durham, NC USA; [Holman, Rury R.; Bethel, M. Angelyn] Univ Oxford, Diabet Trials Unit, Oxford, England; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	University of Leicester; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of Oxford; University of Glasgow; Danube University Krems; King Abdulaziz University	Yates, T (corresponding author), Leicester Gen Hosp, Leicester Diabet Ctr, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	ty20@le.ac.uk	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975; Yates, Thomas/0000-0002-5724-5178; Davies, Melanie/0000-0002-9987-9371	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	Novartis Pharmaceuticals.	Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042; Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Califf RM, 2008, AM HEART J, V156, P623, DOI 10.1016/j.ahj.2008.05.017; Crespo CJ, 1996, ARCH INTERN MED, V156, P93, DOI 10.1001/archinte.156.1.93; Dwyer T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7249; Ekelund U, 2007, DIABETES CARE, V30, P2101, DOI 10.2337/dc07-0719; Fretts AM, 2012, DIABETES CARE, V35, P1743, DOI 10.2337/dc11-2321; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Laukkanen JA, 2007, J INTERN MED, V262, P263, DOI 10.1111/j.1365-2796.2007.01807.x; Laukkanen JA, 2009, AM J CARDIOL, V103, P1598, DOI 10.1016/j.amjcard.2009.01.371; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; NHS Information Centre, HLTH SURV ENGL 2008; Preiss D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001925; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; SCHWARZ PE, 2012, NAT REV ENDOCRINOL, V8, P363, DOI [DOI 10.1038/NRENDO.2011.232, DOI 10.1038/nrendo.2011.232]; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Yates T, 2009, DIABETES CARE, V32, P1404, DOI 10.2337/dc09-0130	30	132	134	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1059	1066		10.1016/S0140-6736(13)62061-9	http://dx.doi.org/10.1016/S0140-6736(13)62061-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24361242				2022-12-28	WOS:000333521200031
J	Yih, WK; Lieu, TA; Kulldorff, M; Martin, D; McMahill-Walraven, CN; Platt, R; Selvam, N; Selvan, M; Lee, GM; Nguyen, M				Yih, W. Katherine; Lieu, Tracy A.; Kulldorff, Martin; Martin, David; McMahill-Walraven, Cheryl N.; Platt, Richard; Selvam, Nandini; Selvan, Mano; Lee, Grace M.; Nguyen, Michael			Intussusception Risk after Rotavirus Vaccination in US Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; LESS-THAN-5 YEARS; SAFETY; CHILDREN; HOSPITALIZATIONS; SURVEILLANCE; IMMUNIZATION; PENTAVALENT; REDUCTION; BENEFITS	BackgroundInternational postlicensure studies have identified an increased risk of intussusception after vaccination with the second-generation rotavirus vaccines RotaTeq (RV5, a pentavalent vaccine) and Rotarix (RV1, a monovalent vaccine). We studied this association among infants in the United States. MethodsThe study included data from infants 5.0 to 36.9 weeks of age who were enrolled in three U.S. health plans that participate in the Mini-Sentinel program sponsored by the Food and Drug Administration. Potential cases of intussusception and vaccine exposures from 2004 through mid-2011 were identified through procedural and diagnostic codes. Medical records were reviewed to confirm the occurrence of intussusception and the status with respect to rotavirus vaccination. The primary analysis used a self-controlled risk-interval design that included only vaccinated children. The secondary analysis used a cohort design that included exposed and unexposed person-time. ResultsThe analyses included 507,874 first doses and 1,277,556 total doses of RV5 and 53,638 first doses and 103,098 total doses of RV1. The statistical power for the analysis of RV1 was lower than that for the analysis of RV5. The number of excess cases of intussusception per 100,000 recipients of the first dose of RV5 was significantly elevated, both in the primary analysis (attributable risk, 1.1 [95% confidence interval, 0.3 to 2.7] for the 7-day risk window and 1.5 [95% CI, 0.2 to 3.2] for the 21-day risk window) and in the secondary analysis (attributable risk, 1.2 [95% CI, 0.2 to 3.2] for the 21-day risk window). No significant increase in risk was seen after dose 2 or 3. The results with respect to the primary analysis of RV1 were not significant, but the secondary analysis showed a significant risk after dose 2. ConclusionsRV5 was associated with approximately 1.5 (95% CI, 0.2 to 3.2) excess cases of intussusception per 100,000 recipients of the first dose. The secondary analysis of RV1 suggested a potential risk, although the study of RV1 was underpowered. These risks must be considered in light of the demonstrated benefits of rotavirus vaccination. (Funded by the Food and Drug Administration.) Rotavirus vaccination has been associated with a decline in rotavirus-associated illness, but intussusception remains a concern. In this study, the pentavalent rotavirus vaccine was associated with a slight increase in intussusception, as compared with the monovalent vaccine. In 1999, a tetravalent rhesus-human reassortant rotavirus vaccine (RotaShield, Wyeth Lederle) was voluntarily withdrawn from the U.S. market within a year after licensure owing to an association with intussusception. The excess risk of intussusception was estimated at approximately 1 to 2 cases per 10,000 recipients of the vaccine.(1) In 2006 and 2008, respectively, a pentavalent bovine-human reassortant rotavirus vaccine (RV5; RotaTeq, Merck) and a monovalent human rotavirus vaccine (RV1; Rotarix, GlaxoSmithKline) were licensed after evaluation in clinical trials involving more than 60,000 infants, which provided enough statistical power to allow detection of an intussusception risk of a magnitude similar to ...	[Yih, W. Katherine; Lieu, Tracy A.; Kulldorff, Martin; Platt, Richard; Lee, Grace M.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02215 USA; [Yih, W. Katherine; Lieu, Tracy A.; Kulldorff, Martin; Platt, Richard; Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Lee, Grace M.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Lee, Grace M.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Lieu, Tracy A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Martin, David; Nguyen, Michael] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [McMahill-Walraven, Cheryl N.] Aetna, Blue Bell, PA USA; [Selvam, Nandini] HealthCore, Govt & Acad Res, Alexandria, VA USA; [Selvan, Mano] Humana, Comprehens Hlth Insights, Louisville, KY USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Kaiser Permanente; US Food & Drug Administration (FDA); Humana Inc.	Yih, WK (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Fl, Boston, MA 02215 USA.	katherine_yih@harvardpilgrim.org		Kulldorff, Martin/0000-0002-5284-2993	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	Funded by the Food and Drug Administration.	[Anonymous], SATSCAN V7 0 SOFTW S; Belongia EA, 2010, PEDIATR INFECT DIS J, V29, P1, DOI 10.1097/INF.0b013e3181af8605; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, P916; Carlin JB, 2013, CLIN INFECT DIS, V57, P1427, DOI 10.1093/cid/cit520; Curtis LH, 2012, PHARMACOEPIDEM DR S, V21, P23, DOI 10.1002/pds.2336; Desai R, 2013, PEDIATR INFECT DIS J, V32, P1, DOI 10.1097/INF.0b013e318270362c; Gastanaduy PA, 2013, PEDIATRICS, V131, pE1115, DOI 10.1542/peds.2012-2797; Glanz JM, 2006, J CLIN EPIDEMIOL, V59, P808, DOI 10.1016/j.jclinepi.2005.11.012; Haber P, 2008, PEDIATRICS, V121, P1206, DOI 10.1542/peds.2007-3793; Haber P, 2013, PEDIATRICS, V131, P1042, DOI 10.1542/peds.2012-2554; Klein NP, 2010, PEDIATR INFECT DIS J, V29, P613, DOI 10.1097/INF.0b013e3181d581f9; Kramarz P, 2000, ARCH FAM MED, V9, P617, DOI 10.1001/archfami.9.7.617; Krishnamoorthy K, 2013, J STAT COMPUT SIM, V83, P2232, DOI 10.1080/00949655.2012.686616; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Loughlin J, 2012, PEDIATR INFECT DIS J, V31, P292, DOI 10.1097/INF.0b013e3182421390; Maro JC, 2009, ANN INTERN MED, V151, P341, DOI 10.7326/0003-4819-151-5-200909010-00139; McClure DL, 2008, VACCINE, V26, P3341, DOI 10.1016/j.vaccine.2008.03.074; Nguyen M, 2012, PHARMACOEPIDEM DR S, V21, P291, DOI 10.1002/pds.2323; Molto Y, 2011, PEDIATR INFECT DIS J, V30, pS16, DOI 10.1097/INF.0b013e3181fefc68; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343; Quintanar-Solares M, 2011, PEDIATR INFECT DIS J, V30, pS11, DOI 10.1097/INF.0b013e3181fefb32; Velazquez FR, 2012, PEDIATR INFECT DIS J, V31, P736, DOI 10.1097/INF.0b013e318253add3; Shui IM, 2012, JAMA-J AM MED ASSOC, V307, P598, DOI 10.1001/jama.2012.97; Tate JE, 2008, PEDIATRICS, V121, pE1125, DOI 10.1542/peds.2007-1590; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Weintraub E, 2013, ROTAVIRUS VACCINES I; Yen C, 2011, PEDIATR INFECT DIS J, V30, pS6, DOI 10.1097/INF.0b013e3181fefa05	33	207	210	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					503	512		10.1056/NEJMoa1303164	http://dx.doi.org/10.1056/NEJMoa1303164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24422676				2022-12-28	WOS:000331073500006
J	Nomura, R; Hirose, K; Uesugi, K; Ohishi, Y; Tsuchiyama, A; Miyake, A; Ueno, Y				Nomura, Ryuichi; Hirose, Kei; Uesugi, Kentaro; Ohishi, Yasuo; Tsuchiyama, Akira; Miyake, Akira; Ueno, Yuichiro			Low Core-Mantle Boundary Temperature Inferred from the Solidus of Pyrolite	SCIENCE			English	Article							EARTHS DEEP MANTLE; LATTICE THERMAL-CONDUCTIVITY; POST-PEROVSKITE; HEAT-FLUX; OUTER CORE; IRON; PERIDOTITE; PRESSURES; LIQUIDUS; ALLOY	The melting temperature of Earth's mantle provides key constraints on the thermal structures of both the mantle and the core. Through high-pressure experiments and three-dimensional x-ray microtomographic imaging, we showed that the solidus temperature of a primitive (pyrolitic) mantle is as low as 3570 +/- 200 kelvin at pressures expected near the boundary between the mantle and the outer core. Because the lowermost mantle is not globally molten, this provides an upper bound of the temperature at the core-mantle boundary (T-CMB). Such remarkably low T-CMB implies that the post-perovskite phase is present in wide areas of the lowermost mantle. The low T-CMB also requires that the melting temperature of the outer core is depressed largely by impurities such as hydrogen.	[Nomura, Ryuichi; Hirose, Kei; Ueno, Yuichiro] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Hirose, Kei; Ueno, Yuichiro] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan; [Hirose, Kei] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Uesugi, Kentaro; Ohishi, Yasuo] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Tsuchiyama, Akira; Miyake, Akira] Kyoto Univ, Div Earth & Planetary Sci, Kyoto 6068502, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Synchrotron Radiation Research Institute; Kyoto University	Nomura, R (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	nomura.r.ab@m.titech.ac.jp; kei@elsi.jp	Nomura, Ryuichi/B-9625-2015; Hirose, Kei/C-2165-2009; Yamaichi, Takeshi/A-5595-2010; Ueno, Yuichiro/A-9959-2014	Nomura, Ryuichi/0000-0003-4808-3709; Hirose, Kei/0000-0003-4366-7721; Ueno, Yuichiro/0000-0002-9095-4742; Uesugi, Kentaro/0000-0003-2579-513X	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24654175] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Ishikawa, Y. Kudo, and T. Tomomasa for their assistance in the experiments at BL10XU and BL47XU, SPring-8 (proposals no. 2012B0087 and 2012B1706). Discussions with E. Takahashi and Y. Nakajima were helpful. T. Kawamoto and F. Tomiyasu supported the Fourier transform infrared and thermal conversion elemental analyzer measurements, respectively. R.N. was supported by a Japan Society for the Promotion of Science Fellowship for Young Scientists. Data are available in the supplementary materials.	Alfe D, 2007, CONTEMP PHYS, V48, P63, DOI 10.1080/00107510701529653; Andrault D, 2012, NATURE, V487, P354, DOI 10.1038/nature11294; Andrault D, 2011, EARTH PLANET SC LETT, V304, P251, DOI 10.1016/j.epsl.2011.02.006; Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; Boehler R, 1996, ANNU REV EARTH PL SC, V24, P15, DOI 10.1146/annurev.earth.24.1.15; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Dixon JE, 2002, NATURE, V420, P385, DOI 10.1038/nature01215; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Fischer RA, 2013, EARTH PLANET SC LETT, V373, P54, DOI 10.1016/j.epsl.2013.04.035; Hernlund JW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028961; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Huang HJ, 2011, NATURE, V479, P513, DOI 10.1038/nature10621; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; Li J, 2003, TREATISE GEOCHEMISTR, V2, P521; Manthilake GM, 2011, P NATL ACAD SCI USA, V108, P17901, DOI 10.1073/pnas.1110594108; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; McNamara AK, 2010, EARTH PLANET SC LETT, V299, P1, DOI 10.1016/j.epsl.2010.07.042; Morard G, 2011, PHYS CHEM MINER, V38, P767, DOI 10.1007/s00269-011-0449-9; Nomura R, 2011, NATURE, V473, P199, DOI 10.1038/nature09940; Ohta K, 2012, EARTH PLANET SC LETT, V349, P109, DOI 10.1016/j.epsl.2012.06.043; Okuchi T, 1997, SCIENCE, V278, P1781, DOI 10.1126/science.278.5344.1781; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Sakamaki K, 2009, PHYS EARTH PLANET IN, V174, P192, DOI 10.1016/j.pepi.2008.05.017; Shahar A, 2009, EARTH PLANET SC LETT, V288, P228, DOI 10.1016/j.epsl.2009.09.025; Terasaki H, 2011, EARTH PLANET SC LETT, V304, P559, DOI 10.1016/j.epsl.2011.02.041; Terasaki H, 2012, PHYS EARTH PLANET IN, V194, P18, DOI 10.1016/j.pepi.2012.01.002; Tronnes RG, 2002, EARTH PLANET SC LETT, V197, P117, DOI 10.1016/S0012-821X(02)00466-1; Zerr A, 1998, SCIENCE, V281, P243, DOI 10.1126/science.281.5374.243; ZHANG JZ, 1994, J GEOPHYS RES-SOL EA, V99, P17729, DOI 10.1029/94JB01406	30	173	174	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					522	525		10.1126/science.1248186	http://dx.doi.org/10.1126/science.1248186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24436185				2022-12-28	WOS:000330343700042
J	Hafidi, Z; Daoudi, R				Hafidi, Zouheir; Daoudi, Rajae			Chorioretinal Toxoplasmosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 30-year-old man was found on funduscopic examination to have pigmented and sharply demarcated choroidal lesions involving the macular region. The lesions measured 5 mm in the right eye and less than 1 mm in the left eye. A 30-year-old man was incidentally found on funduscopic examination to have pigmented and sharply demarcated choroidal lesions involving the macular region. The lesions measured 5 mm in the right eye and less than 1 mm in the left eye (white arrows). There was no evidence of associated vitritis. This finding was consistent with scarring caused by inactive chorioretinal toxoplasmosis. The rest of the ophthalmologic examination was notable for low visual acuity in the right eye, at 6/150, associated with nystagmus; the best corrected visual acuity in the left eye was 6/24. The patient reported that he had always had poor ...	[Hafidi, Zouheir; Daoudi, Rajae] Univ Mohammed V Souissi, Rabat, Morocco	Mohammed V University in Rabat	Hafidi, Z (corresponding author), Univ Mohammed V Souissi, Rabat, Morocco.	zouheirhafidi@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					361	361		10.1056/NEJMicm1306819	http://dx.doi.org/10.1056/NEJMicm1306819			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450894				2022-12-28	WOS:000330036200011
J	Winickoff, JP; Gottlieb, M; Mello, MM				Winickoff, Jonathan P.; Gottlieb, Mark; Mello, Michelle M.			Tobacco 21-An Idea Whose Time Has Come	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Starting in May 2014, it will be illegal in New York City to sell tobacco products and e-cigarettes to persons younger than 21 years of age. Further dissemination of Tobacco 21 laws represents a critical opportunity for public health law to reduce a major health risk. On November 19, 2013, New York City Mayor Michael Bloomberg signed into law the Tobacco 21 bill, imposing the strictest age restriction on tobacco sales of any major U.S. city.(1) Beginning in May 2014, it will be illegal to sell tobacco products and electronic cigarettes to persons younger than 21 years of age. The law stops short of making possession of tobacco products by persons under 21 a crime, placing the responsibility on retailers under penalty of civil fines. Regulations issued by the Food and Drug Administration (FDA) set the national minimum tobacco-sales age at 18 but allow states and ...	[Winickoff, Jonathan P.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Winickoff, Jonathan P.] Mass Gen Hosp Children, Boston, MA USA; [Gottlieb, Mark] Northeastern Univ, Publ Hlth Advocacy Inst, Sch Law, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Northeastern University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Winickoff, JP (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.		Gottlieb, Mark A./ABI-1826-2020	Gottlieb, Mark A./0000-0001-8679-307X; Mello, Michelle/0000-0003-2877-4270					0	28	28	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					295	297		10.1056/NEJMp1314626	http://dx.doi.org/10.1056/NEJMp1314626			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294HP	24401021				2022-12-28	WOS:000330036200003
J	Mckee, M				Mckee, Martin			JAMES BOND'S ALCOHOL INDUCED TREMOR Time to revisit product placement in films and on television to promote health damaging products	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									London Sch Hyg & Trop Med, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Mckee, M (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				Bradwell P, 2013, INTELLIGENCE SECURIT; Charlesworth A, 2005, PEDIATRICS, V116, P1516, DOI 10.1542/peds.2005-0141; Frost C., 2012, MOVIFONE; Johnson G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7255; Mekemson C, 2002, TOB CONTROL, V11, pI81, DOI 10.1136/tc.11.suppl_1.i81	5	1	1	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2014	348								g324	10.1136/bmj.g324	http://dx.doi.org/10.1136/bmj.g324			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AS	24448463	Green Published			2022-12-28	WOS:000330296900014
J	Fisman, DN; Leung, GM; Lipsitch, M				Fisman, David N.; Leung, Gabriel M.; Lipsitch, Marc			Nuanced risk assessment for emerging infectious diseases	LANCET			English	Editorial Material							DYNAMICS		[Fisman, David N.] Univ Toronto, Dalla Lana Fac Publ Hlth, Toronto, ON M5T 3M7, Canada; [Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Toronto; University of Hong Kong; Harvard University; Harvard T.H. Chan School of Public Health	Fisman, DN (corresponding author), Univ Toronto, Dalla Lana Fac Publ Hlth, Toronto, ON M5T 3M7, Canada.	david.fisman@utoronto.ca		Leung, Gabriel/0000-0002-2503-6283; Lipsitch, Marc/0000-0003-1504-9213	NIGMS NIH HHS [U54GM088558, U54 GM088558] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Cauchemez S, 2013, Euro Surveill, V18; Fisman DM, 2013, PROMED MAIL; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Greer AL, 2010, EPIDEMIOL INFECT, V138, P1542, DOI 10.1017/S0950268810000579; LEAVITT JW, 1996, TYPHOID MARY CAPTIVE; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mailles A, 2013, Euro Surveill, V18; Mostaco-Guidolin LC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001614	12	15	16	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					189	190		10.1016/S0140-6736(13)62123-6	http://dx.doi.org/10.1016/S0140-6736(13)62123-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24439726	Bronze, Green Published			2022-12-28	WOS:000330027500004
J	Powell, JT; Sweeting, MJ; Thompson, MM; Ashleigh, R; Bell, R; Gomes, M; Greenhalgh, RM; Grieve, R; Heatley, F; Hinchliffe, RJ; Thompson, SG; Ulug, P				Powell, Janet T.; Sweeting, Michael J.; Thompson, Matthew M.; Ashleigh, Ray; Bell, Rachel; Gomes, Manuel; Greenhalgh, Roger M.; Grieve, Richard; Heatley, Francine; Hinchliffe, Robert J.; Thompson, Simon G.; Ulug, Pinar		IMPROVE Trial Investigators	Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; METAANALYSIS	Objective To assess whether a strategy of endovascular repair (if aortic morphology is suitable, open repair if not) versus open repair reduces early mortality for patients with suspected ruptured abdominal aortic aneurysm. Design Randomised controlled trial. Setting 30 vascular centres (29 UK, 1 Canadian), 2009-13. Participants 613 eligible patients (480 men) with a clinical diagnosis of ruptured aneurysm. Interventions 316 patients were randomised to the endovascular strategy (275 confirmed ruptures, 174 anatomically suitable for endovascular repair) and 297 to open repair (261 confirmed ruptures). Main outcome measures 30 day mortality, with 24 hour and in-hospital mortality, costs, and time and place of discharge as secondary outcomes. Results 30 day mortality was 35.4% (112/316) in the endovascular strategy group and 37.4% (111/297) in the open repair group: odds ratio 0.92 (95% confidence interval 0.66 to 1.28; P=0.62); odds ratio after adjustment for age, sex, and Hardman index 0.94 (0.67 to 1.33). Women may benefit more than men (interaction test P=0.02) from the endovascular strategy: odds ratio 0.44 (0.22 to 0.91) versus 1.18 (0.80 to 1.75). 30 day mortality for patients with confirmed rupture was 36.4% (100/275) in the endovascular strategy group and 40.6% (106/261) in the open repair group (P=0.31). More patients in the endovascular strategy than in the open repair group were discharged directly to home (189/201 (94%) v 141/183 (77%); P<0.001). Average 30 day costs were similar between the randomised groups, with an incremental cost saving for the endovascular strategy versus open repair of 1186 pound ((sic)1420; $1939) (95% confidence interval -625 pound to 2997) pound. Conclusions A strategy of endovascular repair was not associated with significant reduction in either 30 day mortality or cost. Longer term cost effectiveness evaluations are needed to assess the full effects of the endovascular strategy in both men and women.	[Powell, Janet T.] Univ London Imperial Coll Sci Technol & Med, London W6 8RP, England; [Sweeting, Michael J.; Thompson, Simon G.] Univ Cambridge, Cambridge, England; [Thompson, Matthew M.; Hinchliffe, Robert J.] Univ London St Georges Hosp, London, England; [Ashleigh, Ray] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England; [Bell, Rachel] Guys & St Thomas Hosp, London SE1 9RT, England; [Gomes, Manuel; Grieve, Richard] London Sch Hyg & Trop Med, London WC1, England; [Greenhalgh, Roger M.; Heatley, Francine; Ulug, Pinar] Univ London Imperial Coll Sci Technol & Med, London W6 8RP, England	Imperial College London; University of Cambridge; St Georges University London; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Powell, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Vasc Surg Res Grp, London W6 8RP, England.	j.powell@imperial.ac.uk	Powell, Janet/AAW-8669-2021; Sweeting, Michael John/U-3917-2019; Bown, Matthew/P-1957-2016	Powell, Janet/0000-0002-3905-1468; Sweeting, Michael John/0000-0003-0980-8965; Rowlands, Timothy/0000-0002-0245-7448; ULUG, PINAR/0000-0001-9719-1090; Grieve, Richard/0000-0001-8899-1301; Metcalfe, David/0000-0003-1008-3105; Howell, Simon/0000-0001-8467-1466; Halliday, Alison/0000-0001-9828-3579; Wallace, Tom/0000-0003-1630-7739; Bown, Matthew/0000-0002-6180-3611; chetter, ian/0000-0002-2566-6859; Gomes, Manuel/0000-0002-1428-1232	UK Health Technology Assessment award [07/37/64]; National Institute for Health Research [07/37/64, PDA/03/07/026] Funding Source: researchfish	UK Health Technology Assessment award; National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was supported by UK Health Technology Assessment award 07/37/64. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the National Institute of Health Research, the National Health Service, or the Department of Health. Neither the funder nor the sponsor had any role in study design, data collection and analysis, or interpretation of the findings.	Acosta S, 2006, J VASC SURG, V44, P949, DOI 10.1016/j.jvs.2006.07.041; Anjum A, 2012, BRIT J SURG, V99, P637, DOI 10.1002/bjs.8698; Bown MJ, 2002, BRIT J SURG, V89, P714, DOI 10.1046/j.1365-2168.2002.02122.x; Brattheim BJ, 2012, EUR J VASC ENDOVASC, V44, P267, DOI 10.1016/j.ejvs.2012.04.029; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; De Rango P, 2013, J VASC SURG, V57, P1684, DOI 10.1016/j.jvs.2013.03.040; Dick F, 2012, BRIT J SURG, V99, P940, DOI 10.1002/bjs.8780; Egorova N, 2008, J VASC SURG, V48, P1092, DOI 10.1016/j.jvs.2008.06.036; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Hardman DTA, 1996, J VASC SURG, V23, P123, DOI 10.1016/S0741-5214(05)80042-4; Hinchliffe RJ, 2006, EUR J VASC ENDOVASC, V32, P506, DOI 10.1016/j.ejvs.2006.05.016; Holt PJE, 2010, BRIT J SURG, V97, P496, DOI 10.1002/bjs.6911; Hoornweg LL, 2007, EUR J VASC ENDOVASC, V33, P679, DOI 10.1016/j.ejvs.2006.12.011; IMPROVE trial investigators, BR J SURG IN PRESS; Karkos CD, 2011, EUR J VASC ENDOVASC, V42, P775, DOI 10.1016/j.ejvs.2011.07.028; Lindholt Jes S, 2012, Clin Epidemiol, V4, P111, DOI 10.2147/CLEP.S31098; Mastracci TM, 2008, J VASC SURG, V47, P214, DOI 10.1016/j.jvs.2007.07.052; Mayer D, 2012, ANN SURG, V256, P688, DOI 10.1097/SLA.0b013e318271cebd; Mayer D, 2009, ANN SURG, V249, P510, DOI 10.1097/SLA.0b013e31819a8b65; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Mehta M, 2013, J VASC SURG, V57, P368, DOI 10.1016/j.jvs.2012.09.003; Mell MW, 2012, J VASC SURG, V56, P651, DOI 10.1016/j.jvs.2012.02.025; National Institute for Health and Clinical Excellence, 2009, END STENT GRAFTS TRE; Reimerink JJ, 2013, ANN SURG, V258, P248, DOI 10.1097/SLA.0b013e31828d4b76; Schermerhorn ML, 2012, ANN SURG, V256, P651, DOI 10.1097/SLA.0b013e31826b4f91; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	27	272	277	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2014	348								f7661	10.1136/bmj.f7661	http://dx.doi.org/10.1136/bmj.f7661			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MK	24418950	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000329975600003
J	Krauser, JS; Ebling, U; Flaschner, N; Heinze, J; Sengstock, K; Lewenstein, M; Eckardt, A; Becker, C				Krauser, J. S.; Ebling, U.; Flaeschner, N.; Heinze, J.; Sengstock, K.; Lewenstein, M.; Eckardt, A.; Becker, C.			Giant Spin Oscillations in an Ultracold Fermi Sea	SCIENCE			English	Article							MOTT INSULATOR; GAS; MAGNETISM; DYNAMICS	Collective behavior in many-body systems is the origin of many fascinating phenomena in nature, ranging from the formation of clouds to magnetic properties of solids. We report on the observation of collective spin dynamics in an ultracold Fermi sea with large spin. As a key result, we observed long-lived and large-amplitude coherent spin oscillations driven by local spin interactions. At ultralow temperatures, Pauli blocking stabilizes the collective behavior, and the Fermi sea behaves as a single entity in spin space. With increasing temperature, we observed a stronger damping associated with particle-hole excitations. Unexpectedly, we found a high-density regime where excited spin configurations are collisionally stabilized. Our results reveal the intriguing interplay between microscopic processes either stimulating or suppressing collective effects in a fermionic many-body system.	[Krauser, J. S.; Flaeschner, N.; Heinze, J.; Sengstock, K.; Becker, C.] Univ Hamburg, ILP Inst Laserphys, D-22761 Hamburg, Germany; [Ebling, U.] ICFO Inst Ciencies Foton, Castelldefels 08860, Spain; [Sengstock, K.; Becker, C.] Univ Hamburg, ZOQ, D-22761 Hamburg, Germany; [Lewenstein, M.] ICREA, Barcelona 08010, Spain; [Eckardt, A.] MPI PKS Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	University of Hamburg; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Hamburg; ICREA	Sengstock, K (corresponding author), Univ Hamburg, ILP Inst Laserphys, Luruper Chaussee 149, D-22761 Hamburg, Germany.	klaus.sengstock@physnet.uni-hamburg.de	Lewenstein, Maciej/I-1337-2014; Becker, Christoph/E-5304-2017; Eckardt, André/C-9895-2009	Lewenstein, Maciej/0000-0002-0210-7800; Eckardt, André/0000-0002-5542-3516; Ebling, Ulrich/0000-0003-3964-0331; Flaschner, Nick/0000-0002-6882-1337	Deutsche Forschungsgemeinschaft (DFG) [FOR 801]; DFG excellence cluster The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics, and Control of Matter on the Atomic Scale; European Research Council AdG QUAGATUA; Spanish Ministerio de Ciencia e Innovacion [FIS2008-00784]; European Union; ICREA Funding Source: Custom	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG excellence cluster The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics, and Control of Matter on the Atomic Scale; European Research Council AdG QUAGATUA; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission); ICREA(ICREA)	We acknowledge stimulating discussions with N. Cooper, W. Hofstetter, L. Mathey, and L. Santos. This work has been funded by Deutsche Forschungsgemeinschaft (DFG) grant FOR 801, DFG excellence cluster The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics, and Control of Matter on the Atomic Scale, European Research Council AdG QUAGATUA, Spanish Ministerio de Ciencia e Innovacion [grant TOQATA (FIS2008-00784) and Formacion de Personal Investigador fellowship], and European Union Integrated Project Simulators and Interfaces with Quantum Systems.	Cazalilla MA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103033; Dong Y, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.043610; Du X, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.150401; Ebling U, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063607; Gerving CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2179; Gorshkov AV, 2010, NAT PHYS, V6, P289, DOI 10.1038/NPHYS1535; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Heinze J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.250402; Ho TL, 1999, PHYS REV LETT, V82, P247, DOI 10.1103/PhysRevLett.82.247; Jo GB, 2009, SCIENCE, V325, P1521, DOI 10.1126/science.1177112; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Kawaguchi Y, 2012, PHYS REP, V520, P253, DOI 10.1016/j.physrep.2012.07.005; Koschorreck M, 2013, NAT PHYS, V9, P405, DOI 10.1038/nphys2637; Krauser JS, 2012, NAT PHYS, V8, P813, DOI [10.1038/nphys2409, 10.1038/NPHYS2409]; Lecheminant P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.240402; LHUILLIER C, 1985, PHYS REV LETT, V54, P1207, DOI 10.1103/PhysRevLett.54.1207; Lompe T, 2010, SCIENCE, V330, P940, DOI 10.1126/science.1193148; Martin MJ, 2013, SCIENCE, V341, P632, DOI 10.1126/science.1236929; Navon N, 2010, SCIENCE, V328, P729, DOI 10.1126/science.1187582; Nikuni T, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043411; Pechkis HK, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.025301; Rapp A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160405; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Rodriguez K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.050402; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; Stamper-Kurn DM, 2013, REV MOD PHYS, V85, P1191, DOI 10.1103/RevModPhys.85.1191; Taie S, 2012, NAT PHYS, V8, P825, DOI [10.1038/NPHYS2430, 10.1038/nphys2430]; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	32	41	41	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					157	160		10.1126/science.1244059	http://dx.doi.org/10.1126/science.1244059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408429	Green Submitted			2022-12-28	WOS:000329440800035
J	Turney, C				Turney, Chris			This was no Antarctic pleasure cruise	NATURE			English	Editorial Material									Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Turney, C (corresponding author), Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia.	c.turney@unsw.edu.au	Turney, Chris S M/P-8701-2018	Turney, Chris S M/0000-0001-6733-0993					0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					133	133		10.1038/505133a	http://dx.doi.org/10.1038/505133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286CG	24402248	Bronze			2022-12-28	WOS:000329441500004
J	Kasper, RS; Nobbe, S				Kasper, Romano Silvio; Nobbe, Stephan			Papillomatosis Cutis Lymphostatica	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An 88-year-old man presented with a 7-year history of asymptomatic, enlarging papules on his feet and toes. He had a 30-year history of chronic venous insufficiency and chronic leg edema. An 88-year-old man presented with a 7-year history of asymptomatic, enlarging papules on his feet and toes. He had a 30-year history of chronic venous insufficiency and chronic leg edema. Skin examination showed multiple skin-colored, confluent, partly hyperkeratotic, verrucous papules on both forefeet, as well as extensive pitting edema of the feet and legs (Panel A). The patient's history and clinical findings were consistent with papillomatosis cutis lymphostatica. This condition is a rare manifestation of primary (inherited) lymphedema or, more often, secondary lymphedema that can result from any disease or condition associated with damage to the lymphatic vessels, including chronic ...	[Kasper, Romano Silvio; Nobbe, Stephan] Univ Zurich Hosp, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Kasper, RS (corresponding author), Univ Zurich Hosp, CH-8091 Zurich, Switzerland.	stephan.nobbe@usz.ch							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					69	69		10.1056/NEJMicm1307463	http://dx.doi.org/10.1056/NEJMicm1307463			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284XA	24382067	Green Accepted			2022-12-28	WOS:000329354100012
J	Yoo, HG; Yoo, WH				Yoo, Han-Gyul; Yoo, Wan-Hee			Acupuncture with Gold Thread for Osteoarthritis of the Knee	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yoo, Han-Gyul] Univ Rhode Isl, Kingston, RI 02881 USA; [Yoo, Wan-Hee] Chonbuk Natl Univ, Jeonju, South Korea	University of Rhode Island; Jeonbuk National University	Yoo, HG (corresponding author), Univ Rhode Isl, Kingston, RI 02881 USA.	ywhim@jbnu.ac.kr							0	10	11	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					E37	E37		10.1056/NEJMicm1202540	http://dx.doi.org/10.1056/NEJMicm1202540			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24369089				2022-12-28	WOS:000328863700001
J	Cole, TB				Cole, Thomas B.			Adoration of the Wise Men Romare Bearden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2594	2595		10.1001/jama.2013.5483	http://dx.doi.org/10.1001/jama.2013.5483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368442				2022-12-28	WOS:000328818000001
J	Parkman, HP; Van Natta, ML; Abell, TL; McCallum, RW; Sarosiek, I; Nguyen, L; Snape, WJ; Koch, KL; Hasler, WL; Farrugia, G; Lee, L; Unalp-Arida, A; Tonascia, J; Hamilton, F; Pasricha, PJ				Parkman, Henry P.; Van Natta, Mark L.; Abell, Thomas L.; McCallum, Richard W.; Sarosiek, Irene; Nguyen, Linda; Snape, William J.; Koch, Kenneth L.; Hasler, William L.; Farrugia, Gianrico; Lee, Linda; Unalp-Arida, Aynur; Tonascia, James; Hamilton, Frank; Pasricha, Pankaj J.			Effect of Nortriptyline on Symptoms of Idiopathic Gastroparesis The NORIG Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; GASTROINTESTINAL SYMPTOMS; TRICYCLIC ANTIDEPRESSANTS; MOTILIN AGONIST; SEVERITY; MULTICENTER; VALIDATION; DYSPEPSIA; SATIATION; VALIDITY	IMPORTANCE Gastroparesis remains a challenging syndrome to manage, with few effective treatments and a lack of rigorously controlled trials. Tricyclic antidepressants are often used to treat refractory symptoms of nausea, vomiting, and abdominal pain. Evidence from well-designed studies for this use is lacking. OBJECTIVE To determine whether treatment with nortriptyline results in symptomatic improvement in patients with idiopathic gastroparesis. DESIGN, SETTING, AND PARTICIPANTS The NORIG (Nortriptyline for Idiopathic Gastroparesis) trial, a 15-week multicenter, parallel-group, placebo-controlled, double-masked, randomized clinical trial from the National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium (GpCRC), comparing nortriptyline with placebo for symptomatic relief in idiopathic gastroparesis. One hundred thirty patients with idiopathic gastroparesis were enrolled between March 2009 and June 2012 at 7 US academic medical centers. Patient follow-up was completed in October 2012. Inclusion criteria included delayed gastric emptying and moderate to severe symptom scores using the Gastroparesis Cardinal Symptom Index (GCSI). INTERVENTIONS Nortriptyline vs placebo. Study drug dose was increased at 3-week intervals (10, 25, 50, 75 mg) up to 75 mg at 12 weeks. MAIN OUTCOMES AND MEASURES The primary outcome measure of symptomatic improvement was a decrease from the patient's baseline GCSI score of at least 50% on 2 consecutive 3-week GCSI assessments during 15 weeks of treatment. RESULTS The primary symptomatic improvement outcome did not differ between 65 patients randomized to nortriptyline vs 65 patients randomized to placebo: 15 (23% [95% CI, 14%-35%]) in the nortriptyline group vs 14 (21% [95% CI, 12%-34%]) in the placebo group (P = .86). Treatment was stopped more often in the nortriptyline group (19 [29% {95% CI, 19%-42%}]) than in the placebo group (6 [9%] {95% CI, 3%-19%}]) (P = .007), but numbers of adverse events were not different (27 [95% CI, 18-39] vs 28 [95% CI, 19-40]) (P = .89). CONCLUSIONS AND RELEVANCE Among patients with idiopathic gastroparesis, the use of nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms. These findings do not support the use of nortriptyline for idiopathic gastroparesis.	[Parkman, Henry P.] Temple Univ, Philadelphia, PA 19140 USA; [Van Natta, Mark L.; Lee, Linda; Unalp-Arida, Aynur; Tonascia, James] Johns Hopkins Univ, Baltimore, MD USA; [Abell, Thomas L.] Univ Louisville, Louisville, KY 40292 USA; [McCallum, Richard W.; Sarosiek, Irene] Texas Tech Univ, El Paso, TX USA; [Nguyen, Linda] Stanford Univ, Palo Alto, CA 94304 USA; [Snape, William J.] Calif Pacific Med Ctr, San Francisco, CA USA; [Koch, Kenneth L.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Hasler, William L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Farrugia, Gianrico] Mayo Clin, Rochester, MN USA; [Hamilton, Frank] NIDDK, Bethesda, MD 20892 USA; [Pasricha, Pankaj J.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; University of Louisville; Texas Tech University System; Texas Tech University; Stanford University; California Pacific Medical Center; Wake Forest University; University of Michigan System; University of Michigan; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine	Parkman, HP (corresponding author), Temple Univ, Sch Med, Gastroenterol Sect, Parkinson Pavil,8th Floor,3401 N Broad St, Philadelphia, PA 19140 USA.	henry.parkman@temple.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK073983, U01DK073975, U01DK073985, U01DK074007, U01DK073974, U01DK074008]; NATIONAL EYE INSTITUTE [U10EY008057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK073974, U01DK074008, U01DK073985, U01DK073975, U01DK073983, U01DK074007, U01DK074035] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Gastroparesis Clinical Research Consortium (GpCRC) is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants U01DK073983, U01DK073975, U01DK073985, U01DK074007, U01DK073974, and U01DK074008.	Abell TL, 2008, AM J GASTROENTEROL, V103, P753, DOI 10.1111/j.1572-0241.2007.01636.x; Braak B, 2011, ALIMENT PHARM THER, V34, P638, DOI 10.1111/j.1365-2036.2011.04775.x; Camilleri M, 2013, AM J GASTROENTEROL, V108, P18, DOI 10.1038/ajg.2012.373; Choung RS, 2008, NEUROGASTROENT MOTIL, V20, P220, DOI 10.1111/j.1365-2982.2007.01029.x; CLOUSE RE, 1994, DIGEST DIS SCI, V39, P2352, DOI 10.1007/BF02087651; Delgado-Aros S, 2004, GASTROENTEROLOGY, V126, P432, DOI 10.1053/j.gastro.2003.11.007; Irvine EJ, 2006, GASTROENTEROLOGY, V130, P1538, DOI 10.1053/j.gastro.2005.11.058; Jones MP, 2002, AM J GASTROENTEROL, V97, P2184; Koch KL, 2000, J CLIN GASTROENTEROL, V31, P125, DOI 10.1097/00004836-200009000-00007; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; LOLDRUP D, 1989, PSYCHOPHARMACOLOGY, V99, P1, DOI 10.1007/BF00634443; Maranki JL, 2008, DIGEST DIS SCI, V53, P2072, DOI 10.1007/s10620-007-0124-7; McCallum RW, 2007, ALIMENT PHARM THER, V26, P1121, DOI 10.1111/j.1365-2036.2007.03461.x; Mertz H, 1998, AM J GASTROENTEROL, V93, P160, DOI 10.1111/j.1572-0241.1998.00160.x; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Parkman HP, 2011, CLIN GASTROENTEROL H, V9, P1056, DOI 10.1016/j.cgh.2011.08.013; Pasricha PJ, 2011, CLIN GASTROENTEROL H, V9, P567, DOI 10.1016/j.cgh.2011.03.003; Prakash C, 1998, DIGEST DIS SCI, V43, P1951, DOI 10.1023/A:1018878324327; Rentz AM, 2004, QUAL LIFE RES, V13, P1737, DOI 10.1007/s11136-004-9567-x; Revicki DA, 2003, ALIMENT PHARM THER, V18, P141, DOI 10.1046/j.1365-2036.2003.01612.x; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Sawhney MS, 2007, DIGEST DIS SCI, V52, P418, DOI 10.1007/s10620-006-9378-8; Silvers D, 1998, CLIN THER, V20, P438, DOI 10.1016/S0149-2918(98)80054-4; SNAPE WJ, 1982, ANN INTERN MED, V96, P444, DOI 10.7326/0003-4819-96-4-444; Spielberger CD, 1970, MANUAL STATE TRAIT A; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Tougas G, 2000, AM J GASTROENTEROL, V95, P1456, DOI 10.1111/j.1572-0241.2000.02076.x; Viramontes BE, 2001, NEUROGASTROENT MOTIL, V13, P567, DOI 10.1046/j.1365-2982.2001.00288.x; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; WEBER FH, 1993, AM J GASTROENTEROL, V88, P485	30	89	92	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2640	2649		10.1001/jama.2013.282833	http://dx.doi.org/10.1001/jama.2013.282833			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368464	Green Accepted, Bronze			2022-12-28	WOS:000328818000016
J	Palfi, S; Gurruchaga, JM; Ralph, GS; Lepetit, H; Lavisse, S; Buttery, PC; Watts, C; Miskin, J; Kelleher, M; Deeley, S; Iwamuro, H; Lefaucheur, JP; Thiriez, C; Fenelon, G; Lucas, C; Brugieres, P; Gabriel, I; Abhay, K; Drouot, X; Tani, N; Kas, A; Ghaleh, B; Le Corvoisier, P; Dolphin, P; Breen, DP; Mason, S; Guzman, NV; Mazarakis, ND; Radcliffe, PA; Harrop, R; Kingsman, SM; Rascol, O; Naylor, S; Barker, RA; Hantraye, P; Remy, P; Cesaro, P; Mitrophanous, KA				Palfi, Stephane; Gurruchaga, Jean Marc; Ralph, G. Scott; Lepetit, Helene; Lavisse, Sonia; Buttery, Philip C.; Watts, Colin; Miskin, James; Kelleher, Michelle; Deeley, Sarah; Iwamuro, Hirokazu; Lefaucheur, Jean Pascal; Thiriez, Claire; Fenelon, Gilles; Lucas, Cherry; Brugieres, Pierre; Gabriel, Inanna; Abhay, Kou; Drouot, Xavier; Tani, Naoki; Kas, Aurelie; Ghaleh, Bijan; Le Corvoisier, Philippe; Dolphin, Patrice; Breen, David P.; Mason, Sarah; Guzman, Natalie Valle; Mazarakis, Nicholas D.; Radcliffe, Pippa A.; Harrop, Richard; Kingsman, Susan M.; Rascol, Olivier; Naylor, Stuart; Barker, Roger A.; Hantraye, Philippe; Remy, Philippe; Cesaro, Pierre; Mitrophanous, Kyriacos A.			Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial	LANCET			English	Article							AMINO-ACID DECARBOXYLASE; GTP CYCLOHYDROLASE-I; TYROSINE-HYDROXYLASE; DOUBLE-BLIND; L-DOPA; NERVOUS-SYSTEM; DELIVERY; TRANSPLANTATION	Background Parkinson's disease is typically treated with oral dopamine replacement therapies; however, long-term treatment leads to motor complications and, occasionally, impulse control disorders caused by intermittent stimulation of dopamine receptors and off-target effects, respectively. We aimed to assess the safety, tolerability, and efficacy of bilateral, intrastriatal delivery of ProSavin, a lentiviral vector-based gene therapy aimed at restoring local and continuous dopamine production in patients with advanced Parkinson's disease. Methods We undertook a phase 1/2 open-label trial with 12-month follow-up at two study sites (France and UK) to assess the safety and efficacy of ProSavin after bilateral injection into the putamen of patients with Parkinson's disease. All patients were then enrolled in a separate open-label follow-up study of long-term safety. Three doses were assessed in separate cohorts: low dose (1.9 x 10(7) transducing units [TU]); mid dose (4.0 x 10(7) TU); and high dose (1 x 10(8) TU). Inclusion criteria were age 48-65 years, disease duration 5 years or longer, motor fluctuations, and 50% or higher motor response to oral dopaminergic therapy. The primary endpoints of the phase 1/2 study were the number and severity of adverse events associated with ProSavin and motor responses as assessed with Unified Parkinson's Disease Rating Scale (UPDRS) part III (off medication) scores, at 6 months after vector administration. Both trials are registered at ClinicalTrials.gov, NCT00627588 and NCT01856439. Findings 15 patients received ProSavin and were followed up (three at low dose, six mid dose, six high dose). During the first 12 months of follow-up, 54 drug-related adverse events were reported (51 mild, three moderate). Most common were increased on-medication dyskinesias (20 events, 11 patients) and on-off phenomena (12 events, nine patients). No serious adverse events related to the study drug or surgical procedure were reported. A significant improvement in mean UPDRS part III motor scores off medication was recorded in all patients at 6 months (mean score 38 [SD 9] vs 26 [8], n=15, p=0.0001) and 12 months (38 vs 27 [8]; n=15, p=0.0001) compared with baseline. Interpretation ProSavin was safe and well tolerated in patients with advanced Parkinson's disease. Improvement in motor behaviour was observed in all patients.	[Palfi, Stephane; Gurruchaga, Jean Marc; Lepetit, Helene; Iwamuro, Hirokazu; Lefaucheur, Jean Pascal; Thiriez, Claire; Fenelon, Gilles; Brugieres, Pierre; Gabriel, Inanna; Abhay, Kou; Drouot, Xavier; Tani, Naoki; Ghaleh, Bijan; Le Corvoisier, Philippe; Dolphin, Patrice; Remy, Philippe; Cesaro, Pierre] UF Neurochirurg, Grp Hosp Henri Mondor, AP HP, DHU PePsy,Ctr Invest Clin 006, Creteil, France; [Palfi, Stephane; Gurruchaga, Jean Marc; Lepetit, Helene; Iwamuro, Hirokazu; Lefaucheur, Jean Pascal; Thiriez, Claire; Fenelon, Gilles; Brugieres, Pierre; Gabriel, Inanna; Abhay, Kou; Drouot, Xavier; Tani, Naoki; Ghaleh, Bijan; Le Corvoisier, Philippe; Dolphin, Patrice; Remy, Philippe; Cesaro, Pierre] Univ Paris 12, Fac Med, Creteil, France; [Fenelon, Gilles; Cesaro, Pierre] Inst Rech Biomed, INSERM, U955, E01, Creteil, France; [Lavisse, Sonia; Kas, Aurelie; Hantraye, Philippe; Remy, Philippe] MIRCen, DSV I2BM, CEA, Fontenay Aux Roses, France; [Lavisse, Sonia; Kas, Aurelie; Hantraye, Philippe; Remy, Philippe] CNRS URA2210, Fontenay Aux Roses, France; [Ralph, G. Scott; Miskin, James; Kelleher, Michelle; Deeley, Sarah; Lucas, Cherry; Radcliffe, Pippa A.; Harrop, Richard; Kingsman, Susan M.; Naylor, Stuart; Mitrophanous, Kyriacos A.] Oxford BioMed, Oxford, England; [Buttery, Philip C.; Watts, Colin; Breen, David P.; Mason, Sarah; Guzman, Natalie Valle; Barker, Roger A.] John von Geest Ctr Brain Repair, Cambridge, England; [Buttery, Philip C.; Watts, Colin; Breen, David P.; Mason, Sarah; Guzman, Natalie Valle; Barker, Roger A.] Addenbrookes Hosp, Cambridge, England; [Mazarakis, Nicholas D.] Hammersmith Hosp Campus, Fac Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London, England; [Rascol, Olivier] Univ Hosp, CIC9302, Toulouse, France; [Rascol, Olivier] Univ Hosp, INSERM, UMR 825, Toulouse, France; [Rascol, Olivier] Univ Hosp, Dept Pharmacol & Neurosci, Toulouse, France; [Rascol, Olivier] Univ Toulouse 3, F-31062 Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Palfi, S (corresponding author), Grp Henri Mondor Albert Chenevier, AP HP, F-94010 Creteil, France.	stephane.palfi@hmn.aphp.fr	Fenelon, Gilles/R-3361-2018; le corvoisier, philippe/AAO-2862-2020	Drouot, Xavier/0000-0002-3940-4825; Barker, Roger Alistair/0000-0001-8843-7730; Thiriez, claire/0000-0002-4878-6298; Remy, Philippe/0000-0003-2150-2563; Ghaleh, Bijan/0000-0003-0061-5462; Le Corvoisier, Philippe/0000-0003-0402-9591	Oxford BioMedica; Medical Research Council [G108/507] Funding Source: researchfish; MRC [G108/507] Funding Source: UKRI	Oxford BioMedica; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding Oxford BioMedica.	Azzouz M, 2002, J NEUROSCI, V22, P10302; Bienemann AS, 2003, MOL THER, V7, P588, DOI 10.1016/S1525-0016(03)00069-8; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; COTZIAS GC, 1969, NEW ENGL J MED, V281, P272; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; GOETZ CG, 1994, MOVEMENT DISORD, V9, P390, DOI 10.1002/mds.870090403; Hadjiconstantinou M, 2008, CNS NEUROSCI THER, V14, P340, DOI 10.1111/j.1755-5949.2008.00058.x; Jarraya B, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000130; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kordower JH, 1999, EXP NEUROL, V160, P1, DOI 10.1006/exnr.1999.7178; Lane EL, 2010, PROG BRAIN RES, V184, P295, DOI 10.1016/S0079-6123(10)84015-4; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; LIMOUSIN P, 1995, CLIN NEUROPHARMACOL, V18, P258, DOI 10.1097/00002826-199506000-00006; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135; Olanow CW, 2006, LANCET NEUROL, V5, P677, DOI 10.1016/S1474-4422(06)70521-X; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Pavese N, 2006, NEUROLOGY, V67, P1612, DOI 10.1212/01.wnl.0000242888.30755.5d; Prashanth LK, 2011, INT REV NEUROBIOL, V98, P31, DOI 10.1016/B978-0-12-381328-2.00002-X; Schapira AHV, 2009, NEUROL CLIN, V27, P583, DOI 10.1016/j.ncl.2009.04.004; Shen Y, 2000, HUM GENE THER, V11, P1509, DOI 10.1089/10430340050083243; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Wu K, 2009, POSTGRAD MED J, V85, P590, DOI 10.1136/pgmj.2008.075820	33	284	304	4	108	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1138	1146		10.1016/S0140-6736(13)61939-X	http://dx.doi.org/10.1016/S0140-6736(13)61939-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24412048				2022-12-28	WOS:000333956000033
J	Scafidi, J; Hammond, TR; Scafidi, S; Ritter, J; Jablonska, B; Roncal, M; Szigeti-Buck, K; Coman, D; Huang, YG; McCarter, RJ; Hyder, F; Horvath, TL; Gallo, V				Scafidi, Joseph; Hammond, Timothy R.; Scafidi, Susanna; Ritter, Jonathan; Jablonska, Beata; Roncal, Maria; Szigeti-Buck, Klara; Coman, Daniel; Huang, Yuegao; McCarter, Robert J., Jr.; Hyder, Fahmeed; Horvath, Tamas L.; Gallo, Vittorio			Intranasal epidermal growth factor treatment rescues neonatal brain injury	NATURE			English	Article							WHITE-MATTER ABNORMALITIES; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PROGENITORS; MOUSE MODEL; FACTOR-I; CELLS; EGFR; MYELINATION; DELIVERY; PRETERM	There are no clinically relevant treatments available that improve function in the growing population of very preterm infants (less than 32 weeks' gestation) with neonatal brain injury. Diffuse white matter injury (DWMI) is a common finding in these children and results in chronic neurodevelopmental impairments(1,2). As shown recently, failure in oligodendrocyte progenitor cell maturation contributes to DWMI3. We demonstrated previously that the epidermal growth factor receptor (EGFR) has an important role in oligodendrocyte development(4). Here we examine whether enhanced EGFR signalling stimulates the endogenous response of EGFR-expressing progenitor cells during a critical period after brain injury, and promotes cellular and behavioural recovery in the developing brain. Using an established mouse model of very preterm brain injury, we demonstrate that selective overexpression of human EGFR in oligodendrocyte lineage cells or the administration of intranasal heparin-binding EGF immediately after injury decreases oligodendroglia death, enhances generation of new oligodendrocytes from progenitor cells and promotes functional recovery. Furthermore, these interventions diminish ultrastructural abnormalities and alleviate behavioural deficits on white-matter-specific paradigms. Inhibition of EGFR signalling with a molecularly targeted agent used for cancer therapy demonstrates that EGFR activation is an important contributor to oligodendrocyte regeneration and functional recovery after DWMI. Thus, our study provides direct evidence that targeting EGFR in oligodendrocyte progenitor cells at a specific time after injury is clinically feasible and potentially applicable to the treatment of premature children with white matter injury.	[Scafidi, Joseph; Hammond, Timothy R.; Ritter, Jonathan; Jablonska, Beata; Roncal, Maria; Gallo, Vittorio] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Scafidi, Joseph] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Hammond, Timothy R.] George Washington Univ, Inst Biomed Sci, Washington, DC 20052 USA; [Scafidi, Susanna] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Szigeti-Buck, Klara] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Coman, Daniel; Huang, Yuegao; Hyder, Fahmeed] Yale Univ, Dept Diagnost Radiol, MRRC, New Haven, CT 06520 USA; [McCarter, Robert J., Jr.] Childrens Natl Med Ctr, Ctr Translat Sci, Washington, DC 20010 USA	Children's National Health System; Children's National Health System; George Washington University; Johns Hopkins University; Yale University; Yale University; Children's National Health System	Gallo, V (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA.	vgallo@childrensnational.org	Hyder, Fahmeed/A-2644-2015	Hyder, Fahmeed/0000-0001-7822-4002; Scafidi, Joseph/0000-0003-2379-1370; Scafidi, Susanna/0000-0002-1229-8778	National Institutes of Health [K08NS073793, NSADA K12NS052159, K08NS069815, P01 NS062686, R01NS045702, R01NS056427, P30HD040677, R01MH067528, P30 NS05219, DP1 OD006850]; Childhood Brain Tumor Foundation; National Brain Tumor Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686, R01NS056427, K08NS073793, R01NS045702, K12NS052159, K08NS069815, P30NS052519] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Childhood Brain Tumor Foundation; National Brain Tumor Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Dupree for advice on electron microscopy analysis. We thank L.-J. Chew, J. Corbin and J. Liu for comments on the manuscript. We thank M. McKenna for discussion on metabolic studies. We thank D. Bergles for providing the PDGF alpha R-CreER mice and D. W. Threadgill for the EGFR<SUP>fl/fl</SUP> mice. We thank R. Packer for his support. This work was supported by National Institutes of Health grants: K08NS073793 (J. S.); NSADA K12NS052159 (J. S.); K08NS069815 (S. S.); P01 NS062686 (V. G., T. L. H.); R01NS045702 (V. G.); R01NS056427 (V. G.); P30HD040677 (V. G.); R01MH067528 (F. H.); P30 NS05219 (F. H.); R01MH067528 (F. H.); and the Pioneer Award DP1 OD006850 (T. L. H.). The Childhood Brain Tumor Foundation (J. S.) and the National Brain Tumor Society (J. S.) also provided support.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Anjari M, 2009, PEDIATRICS, V124, P268, DOI 10.1542/peds.2008-1294; Back SA, 2001, J NEUROSCI, V21, P1302; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Cantarella C, 2008, DEV NEUROBIOL, V68, P223, DOI 10.1002/dneu.20588; Carter R.J., 2001, CURRENT PROTOCOLS NE; Chahboune H, 2009, CEREB CORTEX, V19, P2891, DOI 10.1093/cercor/bhp068; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Duque A, 2012, BRAIN STRUCT FUNCT, V217, P459, DOI 10.1007/s00429-011-0350-9; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Furusho M, 2012, J NEUROSCI, V32, P6631, DOI 10.1523/JNEUROSCI.6005-11.2012; Heimberger AB, 2002, CLIN CANCER RES, V8, P3496; Hibbits N, 2009, ASN NEURO, V1, DOI 10.1042/AN20090032; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Ishibashi N, 2012, CIRCULATION, V125, P859, DOI 10.1161/CIRCULATIONAHA.111.048215; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Jablonska B, 2012, J NEUROSCI, V32, P14775, DOI 10.1523/JNEUROSCI.2060-12.2012; Jin KL, 2003, ANN NEUROL, V53, P405, DOI 10.1002/ana.10506; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Liebetanz D, 2006, EXP NEUROL, V202, P217, DOI 10.1016/j.expneurol.2006.05.032; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Ment LR, 2009, PEDIATRICS, V123, P503, DOI 10.1542/peds.2008-0025; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Raymond M, 2011, J NEUROSCI, V31, P17864, DOI 10.1523/JNEUROSCI.3179-11.2011; Ritter J, 2013, J NEUROSCI, V33, P8990, DOI 10.1523/JNEUROSCI.5528-12.2013; Ross TM, 2004, J NEUROIMMUNOL, V151, P66, DOI 10.1016/j.jneuroim.2004.02.011; Scafidi J, 2009, INT J DEV NEUROSCI, V27, P863, DOI 10.1016/j.ijdevneu.2009.05.009; Scafidi S, 2010, J NEUROCHEM, V114, P820, DOI 10.1111/j.1471-4159.2010.06807.x; Schalomon PM, 2002, BRAIN RES BULL, V57, P27, DOI 10.1016/S0361-9230(01)00633-5; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106; Zhou YX, 2012, NEUROBIOL DIS, V45, P196, DOI 10.1016/j.nbd.2011.08.004	48	164	170	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					230	+		10.1038/nature12880	http://dx.doi.org/10.1038/nature12880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24390343	Green Accepted			2022-12-28	WOS:000331107700040
J	Rahim, HFA; Sibai, A; Khader, Y; Hwalla, N; Fadhil, I; Alsiyabi, H; Mataria, A; Mendis, S; Mokdad, AH; Husseini, A				Rahim, Hanan F. Abdul; Sibai, Abla; Khader, Yousef; Hwalla, Nahla; Fadhil, Ibtihal; Alsiyabi, Huda; Mataria, Awad; Mendis, Shanthi; Mokdad, Ali H.; Husseini, Abdullatif			Non-communicable diseases in the Arab world	LANCET			English	Article							SOCIAL DETERMINANTS; PHYSICAL-ACTIVITY; PUBLIC-HEALTH; OBESITY; OVERWEIGHT; COUNTRIES; INCOME; INTERVENTIONS; PERCEPTIONS; PREVALENCE	According to the results of the Global Burden of Disease Study 2010, the burden of non-communicable diseases (cardiovascular disease, cancer, chronic lung diseases, and diabetes) in the Arab world has increased, with variations between countries of different income levels. Behavioural risk factors, including tobacco use, unhealthy diets, and physical inactivity are prevalent, and obesity in adults and children has reached an alarming level. Despite epidemiological evidence, the policy response to non-communicable diseases has been weak. So far, Arab governments have not placed a sufficiently high priority on addressing the high prevalence of non-communicable diseases, with variations in policies between countries and overall weak implementation. Cost-effective and evidence-based prevention and treatment interventions have already been identified. The implementation of these interventions, beginning with immediate action on salt reduction and stricter implementation of tobacco control measures, will address the rise in major risk factors. Implementation of an effective response to the non-communicable-disease crisis will need political commitment, multisectoral action, strengthened health systems, and continuous monitoring and assessment of progress. Arab governments should be held accountable for their UN commitments to address the crisis. Engagement in the global monitoring framework for non-communicable diseases should promote accountability for effective action. The human and economic burden leaves no room for inaction.	[Rahim, Hanan F. Abdul; Husseini, Abdullatif] Qatar Univ, Dept Hlth Sci, Coll Arts & Sci, Doha, Qatar; [Sibai, Abla] Amer Univ Beirut, Fac Hlth Sci, Dept Epidemiol & Populat Hlth, Beirut, Lebanon; [Hwalla, Nahla] Amer Univ Beirut, Dept Nutr & Food Sci, Fac Agr & Food Sci, Beirut, Lebanon; [Khader, Yousef] Jordan Univ Sci & Technol, Fac Med, Dept Community Med Publ Hlth & Family Med, Irbid, Jordan; [Fadhil, Ibtihal; Mataria, Awad] WHO, Reg Off Eastern Mediterranean, Cairo, Egypt; [Alsiyabi, Huda] Minist Hlth, Community Based Initiat Dept, Muscat, Oman; [Mendis, Shanthi] WHO, Dept Management Noncommunicable Dis, CH-1211 Geneva, Switzerland; [Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Mokdad, Ali H.] Birzeit Univ, Inst Community & Publ Hlth, Ramallah, Palestine	Qatar University; American University of Beirut; American University of Beirut; Jordan University of Science & Technology; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; World Health Organization; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Birzeit University	Rahim, HFA (corresponding author), Qatar Univ, Dept Hlth Sci, Coll Arts & Sci, Doha, Qatar.	hanan.arahim@qu.edu.qa	Rahim, Hanan Abdul/S-5987-2019; Mokdad, Ali H./AAD-1232-2022; Husseini, Abdullatif/E-8377-2015; Khader, Yousef/AAE-9620-2019; Mendis, Shanthi/GLT-0465-2022; Fadhil, Ibtihal/AAF-4123-2021	Rahim, Hanan Abdul/0000-0002-3719-5142; Mokdad, Ali H./0000-0002-4994-3339; Husseini, Abdullatif/0000-0001-8767-5956; Khader, Yousef/0000-0002-7830-6857; mendis, shanthi/0000-0002-8959-5738; Sibai, Abla/0000-0002-1851-5606	Qatar University; American University of Beirut	Qatar University(Qatar National Research Fund (QNRF)); American University of Beirut	We thank Qatar University and the American University of Beirut, which funded travel of HFAR to attend workshops related to the series. AH and AM were partly supported by the American University of Beirut.	Abu-Rmeileh NME, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001061; Al Riyami A A, 2004, East Mediterr Health J, V10, P600; Al-Hazzaa HM, 2011, DIABET METAB SYND OB, V4, P417, DOI 10.2147/DMSO.S26676; Al-Qaoud N, 2009, MED PRIN PRACT, V18, P111, DOI 10.1159/000189808; Al-Raees GY, 2009, INT J PEDIATR OBES, V4, P414, DOI 10.3109/17477160902763325; Al-Thani A, 2013, QATAR STEPWISE REPOR; Alasfoor D., 2009, Eastern Mediterranean Health Journal, V15, P890; Alwan A, 2012, PUBLIC HEALTH IN THE ARABWORLD, P149; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Anderson GF, 2009, HEALTH AFFAIR, V28, P202, DOI 10.1377/hlthaff.28.1.202; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Awaisu A, 2013, NICOTINE TOB RES, V15, P1765, DOI 10.1093/ntr/ntt059; Aziz Muna I Abdel, 2014, LANCET; Barouki Robert, 2012, Environ Health, V11, P42, DOI 10.1186/1476-069X-11-42; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Ben Romdhane H, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-9; BhanKhanna S., 2007, JK SCI, V9, P206, DOI [10.1016/j.cppeds.2011.01.001, DOI 10.1016/J.CPPEDS.2011.01.001]; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; bin Zaal AA, 2009, NUTR HOSP, V24, P437; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Bull F, 2013, BRIT J SPORT MED, V47, P600, DOI 10.1136/bjsports-2012-092109; Bump JB, 2013, HEALTH POLICY PLANN, V28, P123, DOI 10.1093/heapol/czs049; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dewachi O, 2014, LANCET; El Taguri A., 2009, Eastern Mediterranean Health Journal, V15, P549; El-Hazmi MAF, 2002, ANN SAUDI MED, V22, P303, DOI 10.5144/0256-4947.2002.303; El-Jardali F, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-200; Gaziano TA, 2013, ANNU REV PUBL HEALTH, V34, P317, DOI 10.1146/annurev-publhealth-031912-114402; Ham C, 2010, HEALTH ECON POLICY L, V5, P71, DOI 10.1017/S1744133109990120; Hawari FI, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-414; Herrera BM, 2011, MATURITAS, V69, P41, DOI 10.1016/j.maturitas.2011.02.018; Karnik S, 2012, INT J PREVENTIVE MED, V3, P1; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Lamotte C, 2011, EUR J PEDIATR, V170, P719, DOI 10.1007/s00431-010-1328-y; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mabry RM, 2010, OBES REV, V11, P457, DOI 10.1111/j.1467-789X.2009.00655.x; Mahfouz AA, 2008, J TROP PEDIATRICS, V54, P120, DOI 10.1093/tropej/fmm089; Martorell R, 2000, INT J OBESITY, V24, P959, DOI 10.1038/sj.ijo.0801264; Mashal R, 2012, RIV ITAL SOSTANZE GR, V89, P193; Maziak W, 2014, HEALTH POLICY PLANN, V29, P784, DOI 10.1093/heapol/czt055; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Meiro-Lorenzo MVT, 2011, EFFECTIVE RESPONSES; Mendis S, 2010, BRIT MED BULL, V96, P23, DOI 10.1093/bmb/ldq037; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Musaiger AO, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7122; MYNTTI C, 1993, SOC SCI MED, V37, P233, DOI 10.1016/0277-9536(93)90457-F; Naja F, 2013, EUR J NUTR, V52, P97, DOI 10.1007/s00394-011-0291-3; Naja F, 2011, PUBLIC HEALTH NUTR, V14, P1570, DOI 10.1017/S136898001100070X; Nasreddine L, 2012, NUTR METAB CARDIOVAS, V22, P793, DOI 10.1016/j.numecd.2012.05.010; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Nissinen A, 2001, B WORLD HEALTH ORGAN, V79, P963; Organization WH, 2009, GLOB HLTH RISKS MORT; Orsi CM, 2011, CURR OPIN ENDOCRINOL, V18, P14, DOI 10.1097/MED.0b013e3283423de1; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rocco L, 2011, CHRONIC DIS LABOR MA; Sibai AM, 2012, PUBLIC HEALTH IN THE ARABWORLD, P264; Sibai AM, 2011, ANN NUTR METAB, V57, P193, DOI 10.1159/000321527; Singh GK, 2008, ANN EPIDEMIOL, V18, P682, DOI 10.1016/j.annepidem.2008.05.001; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; The World Bank Human Development Department of the Middle East and North Africa Region, 2010, M CHALL HLTH TRANS M; The World Bank Human Development Network, 2011, GROW DANG NONC DIS A; The World Bank UN Food and Agriculture Organization International Bank for Reconstruction and Development, 2009, IMPR FOOD SEC AR COU; UN General Assembly, 2011, US GEN ASS 66 SESS S; UNICEF, 2009, TRACK PROGR CHILD MA; UNICEF, 2012, STAT WORLDS CHILDR 2; WHO, 2011, GLOBAL STATUS REPORT; WHO, GLOB HLTH EXP DAT; WHO Framework Convention on Tobacco Control, PART WHO FRAM CONV T; WHO media centre, 2012, WHO MEMB STAT MAK PR; WHO Regional Office for the Eastern Mediterranean, 2011, PLAN ACT PREV CONTR; WHO Regional Office for the Eastern Mediterranean, NONC DIS STEPWISE SU; WHO Regional Office for the Eastern Mediterranean, 2011, REG STRAT NUTR 2010; WHO Regional Office for the Eastern Mediterranean, 2013, REP CONS DEV STRAT D; WHO Regional Office for the Eastern Mediterranean, 2013, DEM SOC HLTH IND COU; WHO Regional Office for the Mediterranean Region, 2012, HLTH SYST STRENGTH C; WHO Regional Office of the Eastern Mediterranean, PAL STEPS SURV 2010; WHO World Economic Forum, 2011, BURD BEST BUYS RED E; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	84	214	216	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					356	367		10.1016/S0140-6736(13)62383-1	http://dx.doi.org/10.1016/S0140-6736(13)62383-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452044				2022-12-28	WOS:000330212600035
J	Downing, NS; Aminawung, JA; Shah, ND; Krumholz, HM; Ross, JS				Downing, Nicholas S.; Aminawung, Jenerius A.; Shah, Nilay D.; Krumholz, Harlan M.; Ross, Joseph S.			Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EFFICACY; CANCER; DRUGS	IMPORTANCE Many patients and physicians assume that the safety and effectiveness of newly approved therapeutic agents is well understood; however, the strength of the clinical trial evidence supporting approval decisions by the US Food and Drug Administration (FDA) has not been evaluated. OBJECTIVES To characterize pivotal efficacy trials (clinical trials that serve as the basis of FDA approval) for newly approved novel therapeutic agents. DESIGN AND SETTING Cross-sectional analysis using publicly available FDA documents for all novel therapeutic agents approved between 2005 and 2012. MAIN OUTCOMES AND MEASURES Pivotal efficacy trials were classified according to the following design features: randomization, blinding, comparator, and trial end point. Surrogate outcomes were defined as any end point using a biomarker expected to predict clinical benefit. The number of patients, trial duration, and trial completion rates were also determined. RESULTS Between 2005 and 2012, the FDA approved 188 novel therapeutic agents for 206 indications on the basis of 448 pivotal efficacy trials. The median number of pivotal trials per indication was 2 (interquartile range, 1-2.5), although 74 indications (36.8%) were approved on the basis of a single pivotal trial. Nearly all trials were randomized (89.3% [95% CI, 86.4%-92.2%]), double-blinded (79.5% [95% CI, 75.7%-83.2%]), and used either an active or placebo comparator (87.1% [95% CI, 83.9%-90.2%]). The median number of patients enrolled per indication among all pivotal trials was 760 (interquartile range, 270-1550). At least 1 pivotal trial with a duration of 6 months or greater supported the approval of 68 indications (33.8% [95% CI, 27.2%-40.4%]). Pivotal trials using surrogate end points as their primary outcome formed the exclusive basis of approval for 91 indications (45.3% [95% CI, 38.3%-52.2%]), clinical outcomes for 67 (33.3% [95% CI, 26.8%-39.9%]), and clinical scales for 36 (17.9% [95% CI, 12.6%-23.3%]). Trial features differed by therapeutic and indication characteristics, such as therapeutic area, expected length of treatment, orphan status, and accelerated approval. CONCLUSIONS AND RELEVANCE The quality of clinical trial evidence used by the FDA as the basis for recent approvals of novel therapeutic agents varied widely across indications. This variation has important implications for patients and physicians as they make decisions about the use of newly approved therapeutic agents.	[Downing, Nicholas S.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Aminawung, Jenerius A.; Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, Dept Internal Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Mayo Clinic	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	Pew Charitable Trusts; National Heart, Lung, and Blood Institute [1U01HL105270-02]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL CANCER INSTITUTE [U01CA152758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Pew Charitable Trusts; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this study was provided in part by The Pew Charitable Trusts. Dr Krumholz is supported by a National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center Award (1U01HL105270-02). Dr Ross is supported by the National Institute on Aging (K08 AG032886) and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program.	Anderson GM, 2008, JAMA-J AM MED ASSOC, V299, P1598, DOI 10.1001/jama.299.13.1598; [Anonymous], 2013, DRUGS FDA FDA APPR D; Booz Allen Hamilton Inc, IND EV FDAS 1 CYCL R; Chen DT, 2009, PHARMACOEPIDEM DR S, V18, P1094, DOI 10.1002/pds.1825; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539; Hamburg MA, 2010, NEW ENGL J MED, V363, P2228, DOI 10.1056/NEJMsa1007467; Healy D., 2012, PHARMAGEDDON; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Mitka M, 2012, JAMA-J AM MED ASSOC, V307, P2576, DOI 10.1001/jama.2012.6684; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; Schwartz LM, 2011, ARCH INTERN MED, V171, P1463, DOI 10.1001/archinternmed.2011.396; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; US Food and Drug Administration, 2012, FY 2012 INN DRUG APP; US Food and Drug Administration, GUID IND ENR STRAT C; US Food and Drug Administration (FDA), GUID IND PROV CLIN E; US Food and Drug Administration (FDA), INN DRUG APPR 2011 R; US Food and Drug Administration (FDA), 2013, GUID IND NONINF CLIN; US Food and Drug Administration (FDA), 2010, GUID IND AD DES CLIN; Zhang J, 2011, CONTEMP CLIN TRIALS, V32, P649, DOI 10.1016/j.cct.2011.04.015	28	268	286	2	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					368	377		10.1001/jama.2013.282034	http://dx.doi.org/10.1001/jama.2013.282034			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449315	Bronze, Green Accepted			2022-12-28	WOS:000329939300022
J	Portugal, SJ; Hubel, TY; Fritz, J; Heese, S; Trobe, D; Voelkl, B; Hailes, S; Wilson, AM; Usherwood, JR				Portugal, Steven J.; Hubel, Tatjana Y.; Fritz, Johannes; Heese, Stefanie; Trobe, Daniela; Voelkl, Bernhard; Hailes, Stephen; Wilson, Alan M.; Usherwood, James R.			Upwash exploitation and downwash avoidance by flap phasing in ibis formation flight	NATURE			English	Article							ENERGY SAVINGS; BIRDS; DYNAMICS; GEESE; KINEMATICS; LEADERSHIP; EFFICIENCY; BEHAVIOR; PAIRS; BAT	Many species travel in highly organized groups(1-3). The most quoted function of these configurations is to reduce energy expenditure and enhance locomotor performance of individuals in the assemblage(4-11). The distinctive V formation of bird flocks has long intrigued researchers and continues to attract both scientific and popular attention(4,7,9-14). The well-held belief is that such aggregations give an energetic benefit for those birds that are flying behind and to one side of another bird through using the regions of upwash generated by the wings of the preceding bird(4,7,9-11), although a definitive account of the aerodynamic implications of these formations has remained elusive. Here we show that individuals of northern bald ibises (Geronticus eremita) flying in a V flock position themselves in aerodynamically optimum positions, in that they agree with theoretical aerodynamic predictions. Furthermore, we demonstrate that birds show wingtip path coherence when flying in V positions, flapping spatially in phase and thus enabling upwash capture to be maximized throughout the entire flap cycle. In contrast, when birds fly immediately behind another bird-in a streamwise position-there is no wingtip path coherence; the wing-beats are in spatial anti-phase. This could potentially reduce the adverse effects of downwash for the following bird. These aerodynamic accomplishments were previously not thought possible for birds because of the complex flight dynamics and sensory feedback that would be required to perform such a feat(12,14). We conclude that the intricate mechanisms involved in V formation flight indicate awareness of the spatial wake structures of nearby flock-mates, and remarkable ability either to sense or predict it. We suggest that birds in V formation have phasing strategies to cope with the dynamic wakes produced by flapping wings.	[Portugal, Steven J.; Hubel, Tatjana Y.; Hailes, Stephen; Wilson, Alan M.; Usherwood, James R.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Fritz, Johannes; Heese, Stefanie; Trobe, Daniela; Voelkl, Bernhard] Waldrappteam, A-6162 Mutters, Austria; [Voelkl, Bernhard] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Hailes, Stephen] UCL, Dept Comp Sci, London WC1E 6BT, England	University of London; University of London Royal Veterinary College; Humboldt University of Berlin; University of London; University College London	Portugal, SJ (corresponding author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	SPortugal@rvc.ac.uk	Voelkl, Bernhard/D-1390-2009	Voelkl, Bernhard/0000-0001-5454-2508; Wilson, Alan/0000-0001-9914-3455; Portugal, Steven/0000-0002-2438-2352; Fritz, Johannes/0000-0003-4691-2892; Hubel, Tatjana/0000-0002-6749-6747	Engineering and Physical Sciences Research Council [EP/H013016/1]; Biotechnology and Biological Sciences Research Council [BB/J018007/1]; Wellcome Trust [095061/Z/10/Z]; BBSRC [BB/J018007/1] Funding Source: UKRI; EPSRC [EP/H013016/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Waldrappteam assisted with data collection and provided logistical support (J.F., B.V.). We thank members of the Structure & Motion Laboratory for discussions and assistance, particularly J. Lowe, K. Roskilly, A. Spence and S. Amos, and C. White and R. Bomphrey for reading an earlier draft of the paper. Funding was provided by an Engineering and Physical Sciences Research Council grant to A.M.W., J.R.U. and S.Ha. (EP/H013016/1), a Biotechnology and Biological Sciences Research Council grant to A.M.W. (BB/J018007/1) and a Wellcome Trust Fellowship (095061/Z/10/Z) to J.R.U.	Andersson M, 2004, BEHAV ECOL, V15, P158, DOI 10.1093/beheco/arg109; BADGEROW JP, 1981, J THEOR BIOL, V93, P41, DOI 10.1016/0022-5193(81)90055-2; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Batschelet E., 1981, CIRCULAR STAT BIOL, P15; BILL RG, 1976, SCIENCE, V193, P1146, DOI 10.1126/science.193.4258.1146; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; CAMHI JM, 1995, J EXP BIOL, V198, P1051; Chatard JC, 2003, MED SCI SPORT EXER, V35, P1176, DOI 10.1249/01.MSS.0000074564.06106.1F; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; CUTTS CJ, 1994, J EXP BIOL, V189, P251; Delextrat A, 2003, MED SCI SPORT EXER, V35, P1612, DOI 10.1249/01.MSS.0000084422.49491.2C; FISH FE, 1995, J EXP ZOOL, V273, P1, DOI 10.1002/jez.1402730102; Fisher NI, 1993, STAT ANAL CIRCULAR D, P59; Griffiths D. J., 1998, INTRO ELECTRODYNAMIC, P215; HAINSWORTH FR, 1987, J EXP BIOL, V128, P445; Holland RA, 2009, J EXP BIOL, V212, P4065, DOI 10.1242/jeb.034504; Hubel TY, 2012, J R SOC INTERFACE, V9, P1120, DOI 10.1098/rsif.2011.0838; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; HUMMEL D, 1983, J THEOR BIOL, V104, P321, DOI 10.1016/0022-5193(83)90110-8; Kaplan E., 2005, UNDERSTANDING GPS PR, P304, DOI [10.1016/s1364-6826(97)83337-8, DOI 10.1016/S1364-6826(97)83337-8]; King AJ, 2012, CURR BIOL, V22, pR561, DOI 10.1016/j.cub.2012.05.008; Kroner E., 1955, P PHYS SOC A, V68, P53; KUTSCH W, 1994, J COMP PHYSIOL A, V174, P643, DOI 10.1007/BF00217385; Liao JC, 2003, SCIENCE, V302, P1566, DOI 10.1126/science.1088295; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; Maeng JS, 2013, J THEOR BIOL, V320, P76, DOI 10.1016/j.jtbi.2012.11.032; Mardia K., 1999, DIRECTIONAL STAT, P94; MAY RM, 1979, NATURE, V282, P778, DOI 10.1038/282778a0; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Norberg U. M., 2011, VERTEBRATE FLIGHT ME, P118; Pennycuick C. J., 1989, BIRD FLIGHT PERFORMA, P37; PETIT DR, 1986, AUK, V103, P244; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Spence AJ, 2012, BIOL LETTERS, V8, P678, DOI 10.1098/rsbl.2011.1120; Sprent P., 2007, APPL NONPARAMETRIC S, P83; Usherwood JR, 2008, J R SOC INTERFACE, V5, P1303, DOI 10.1098/rsif.2008.0124; Usherwood JR, 2011, NATURE, V474, P494, DOI 10.1038/nature10164; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; White CR, 2013, J EXP BIOL, V216, P537, DOI 10.1242/jeb.076554; Willis D. J., 2007, P 25 AM I AER ASTR A; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958	42	187	197	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					399	+		10.1038/nature12939	http://dx.doi.org/10.1038/nature12939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429637	Green Accepted			2022-12-28	WOS:000329621800042
J	Chen, F; Krasnow, MA				Chen, Feng; Krasnow, Mark A.			Progenitor Outgrowth from the Niche in Drosophila Trachea Is Guided by FGF from Decaying Branches	SCIENCE			English	Article							RECEPTOR HOMOLOG; CELL-MIGRATION; STEM-CELL; SYSTEM; METAMORPHOSIS; MORPHOGENESIS; BREATHLESS; ENCODES; BRAIN	Although there has been progress identifying adult stem and progenitor cells and the signals that control their proliferation and differentiation, little is known about the substrates and signals that guide them out of their niche. By examining Drosophila tracheal outgrowth during metamorphosis, we show that progenitors follow a stereotyped path out of the niche, tracking along a subset of tracheal branches destined for destruction. The embryonic tracheal inducer branchless FGF (fibroblast growth factor) is expressed dynamically just ahead of progenitor outgrowth in decaying branches. Knockdown of branchless abrogates progenitor outgrowth, whereas misexpression redirects it. Thus, reactivation of an embryonic tracheal inducer in decaying branches directs outgrowth of progenitors that replace them. This explains how the structure of a newly generated tissue is coordinated with that of the old.	[Chen, Feng; Krasnow, Mark A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Chen, Feng] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Chen, Feng; Krasnow, Mark A.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	krasnow@stanford.edu			Genentech Graduate Fellowship; Ruth L. Kirschstein NIH training grant; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	Genentech Graduate Fellowship; Ruth L. Kirschstein NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Weaver, M. Metzstein, and other lab members for advice and reagents. This work was supported by a Genentech Graduate Fellowship and a Ruth L. Kirschstein NIH training grant (F. C.) and the Howard Hughes Medical Institute.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arias A.M., 1993, DEV DROSOPHILA, P609; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105; Guillemin K, 1996, DEVELOPMENT, V122, P1353; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; MATSUNO T, 1990, JPN J APPL ENTOMOL Z, V34, P165, DOI 10.1303/jjaez.34.165; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Pitsouli C, 2010, DEVELOPMENT, V137, P3615, DOI 10.1242/dev.056408; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712	23	22	22	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					186	189		10.1126/science.1241442	http://dx.doi.org/10.1126/science.1241442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408434	Green Accepted			2022-12-28	WOS:000329440800043
J	Teng, MWL; Smyth, MJ				Teng, Michele W. L.; Smyth, Mark J.			Can Cancer Trigger Autoimmunity?	SCIENCE			English	Editorial Material							SCLERODERMA		[Teng, Michele W. L.; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Canc Immunoregulat & Immunotherapy & Immunol Canc, Herston, Qld 4006, Australia; [Teng, Michele W. L.; Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Teng, MWL (corresponding author), QIMR Berghofer Med Res Inst, Canc Immunoregulat & Immunotherapy & Immunol Canc, 300 Herston Rd, Herston, Qld 4006, Australia.	mark.smyth@qimrberghofer.edu.au	Smyth, Mark J/H-8709-2014; Teng, Michele WL/S-5055-2016	Smyth, Mark J/0000-0001-7098-7240; Teng, Michele WL/0000-0003-1886-9145				Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Naschitz JE, 2001, CURR OPIN RHEUMATOL, V13, P62, DOI 10.1097/00002281-200101000-00010; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549	8	9	9	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					147	148		10.1126/science.1249486	http://dx.doi.org/10.1126/science.1249486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408426				2022-12-28	WOS:000329440800030
J	Smith, AK; Lo, B; Aronson, L				Smith, Alexander K.; Lo, Bernard; Aronson, Louise			Elder Self-Neglect - How Can a Physician Help?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ABUSE; RISK	Clinicians often expend considerable effort caring for elderly patients who neglect their own needs. But there are some practical approaches to the clinical care of self-neglecting patients. Mr. L. is a 96-year-old widower with critical aortic stenosis and mild cognitive impairment who had become increasingly short of breath and exhausted over the course of several weeks and needed 3 hours to get dressed on the day of admission. A concerned neighbor brought him to the hospital. He is not a candidate for aortic-valve replacement owing to poor functional status and coexisting conditions, and after several days of gentle diuresis, he can barely walk across the room. At the request of the primary care physician, Mr. L.'s son flies in for a family meeting to discuss discharge options. ...	[Smith, Alexander K.; Aronson, Louise] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA; [Smith, Alexander K.] San Francisco VA Med Ctr, San Francisco, CA USA; [Lo, Bernard] Greenwall Fdn Bioeth, New York, NY USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Smith, AK (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA.				NIA NIH HHS [P30 AG044281, K23 AG040772] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG040772, P30AG044281] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Dong XQ, 2013, JAMA INTERN MED, V173, P911, DOI 10.1001/jamainternmed.2013.238; Dong XQ, 2012, GERONTOLOGY, V58, P258, DOI 10.1159/000334256; Dong XQ, 2009, JAMA-J AM MED ASSOC, V302, P517, DOI 10.1001/jama.2009.1109; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Lachs MS, 2002, GERONTOLOGIST, V42, P734, DOI 10.1093/geront/42.6.734; MCDERMOTT W, 1982, JOHNS HOPKINS MED J, V151, P302; Outterson Kevin, 2013, GLOBALIZATION HLTH C, P318; Research Council N., 1999, USE DRUGS FOOD ANIMA, DOI DOI 10.17226/5137; Robine JM, 2007, BRIT MED J, V334, P570, DOI 10.1136/bmj.39129.397373.BE	10	8	8	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2476	2479		10.1056/NEJMp1310684	http://dx.doi.org/10.1056/NEJMp1310684			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	278BT	24369074	Green Accepted			2022-12-28	WOS:000328863700005
J	Berk, JL; Suhr, OB; Obici, L; Sekijima, Y; Zeldenrust, SR; Yamashita, T; Heneghan, MA; Gorevic, PD; Litchy, WJ; Wiesman, JF; Nordh, E; Corato, M; Lozza, A; Cortese, A; Robinson-Papp, J; Colton, T; Rybin, DV; Bisbee, AB; Ando, Y; Ikeda, S; Seldin, DC; Merlini, G; Skinner, M; Kelly, JW; Dyck, PJ				Berk, John L.; Suhr, Ole B.; Obici, Laura; Sekijima, Yoshiki; Zeldenrust, Steven R.; Yamashita, Taro; Heneghan, Michael A.; Gorevic, Peter D.; Litchy, William J.; Wiesman, Janice F.; Nordh, Erik; Corato, Manuel; Lozza, Alessandro; Cortese, Andrea; Robinson-Papp, Jessica; Colton, Theodore; Rybin, Denis V.; Bisbee, Alice B.; Ando, Yukio; Ikeda, Shu-ichi; Seldin, David C.; Merlini, Giampaolo; Skinner, Martha; Kelly, Jeffery W.; Dyck, Peter J.		Diflunisal Trial Consortium	Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; ROCHESTER DIABETIC-NEUROPATHY; LIVER-TRANSPLANTATION; SWEDISH PATIENTS; PLASMA-EXCHANGE; FOLLOW-UP; TRANSTHYRETIN; PROTEIN; DISEASE; AMYLOIDOGENESIS	IMPORTANCE Familial amyloid polyneuropathy, a lethal genetic disease caused by aggregation of variant transthyretin, induces progressive peripheral nerve deficits and disability. Diflunisal, a nonsteroidal anti-inflammatory agent, stabilizes transthyretin tetramers and prevents amyloid fibril formation in vitro. OBJECTIVE To determine the effect of diflunisal on polyneuropathy progression in patients with familial amyloid polyneuropathy. DESIGN, SETTING, AND PARTICIPANTS International randomized, double-blind, placebo-controlled study conducted among 130 patients with familial amyloid polyneuropathy exhibiting clinically detectable peripheral or autonomic neuropathy at amyloid centers in Sweden (Umea), Italy (Pavia), Japan (Matsumoto and Kumamoto), England (London), and the United States (Boston, Massachusetts; New York, New York; and Rochester, Minnesota) from 2006 through 2012. INTERVENTION Participants were randomly assigned to receive diflunisal, 250 mg (n=64), or placebo (n=66) twice daily for 2 years. MAIN OUTCOMES AND MEASURES The primary end point, the difference in polyneuropathy progression between treatments, was measured by the Neuropathy Impairment Score plus 7 nerve tests (NIS+7) which ranges from 0 (no neurological deficits) to 270 points (no detectable peripheral nerve function). Secondary outcomes included a quality-of-life questionnaire (36-Item Short-Form Health Survey [SF-36]) and modified body mass index. Because of attrition, we used likelihood-based modeling and multiple imputation analysis of baseline to 2-year data. RESULTS By multiple imputation, the NIS+7 score increased by 25.0 (95% CI, 18.4-31.6) points in the placebo group and by 8.7 (95% CI, 3.3-14.1) points in the diflunisal group, a difference of 16.3 points (95% CI, 8.1-24.5 points; P < .001). Mean SF-36 physical scores decreased by 4.9 (95% CI, -7.6 to -2.2) points in the placebo group and increased by 1.5 (95% CI, -0.8 to 3.7) points in the diflunisal group (P < .001). Mean SF-36 mental scores declined by 1.1 (95% CI, -4.3 to 2.0) points in the placebo group while increasing by 3.7 (95% CI, 1.0-6.4) points in the diflunisal group (P = .02). By responder analysis, 29.7% of the diflunisal group and 9.4% of the placebo group exhibited neurological stability at 2 years (<2-point increase in NIS+7 score; P = .007). CONCLUSIONS AND RELEVANCE Among patients with familial amyloid polyneuropathy, the use of diflunisal compared with placebo for 2 years reduced the rate of progression of neurological impairment and preserved quality of life. Although longer-term follow-up studies are needed, these findings suggest benefit of this treatment for familial amyloid polyneuropathy.	[Berk, John L.; Wiesman, Janice F.; Seldin, David C.; Skinner, Martha] Boston Univ, Sch Med, Dept Med, Amyloidosis Ctr, Boston, MA 02118 USA; [Berk, John L.; Wiesman, Janice F.; Seldin, David C.; Skinner, Martha] Boston Univ, Sch Med, Dept Neurol, Amyloidosis Ctr, Boston, MA 02118 USA; [Suhr, Ole B.; Nordh, Erik] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Obici, Laura; Merlini, Giampaolo] Univ Pavia, Fdn IRCCS Policlin San Matteo, Amyloidosis Res & Treatment Ctr, I-27100 Pavia, Italy; [Obici, Laura; Merlini, Giampaolo] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Sekijima, Yoshiki; Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan; [Zeldenrust, Steven R.; Litchy, William J.; Dyck, Peter J.] Mayo Clin, Dept Med, Rochester, MN USA; [Zeldenrust, Steven R.; Litchy, William J.; Dyck, Peter J.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Yamashita, Taro; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Heneghan, Michael A.] Kings Coll Hosp Fdn Trust, Inst Liver Studies, London, England; [Corato, Manuel] Ist Clin Humanitas, Rozzano, Italy; [Lozza, Alessandro; Cortese, Andrea] Fdn IRCCS, C Mondino Natl Inst Neurol, Pavia, Italy; [Gorevic, Peter D.; Robinson-Papp, Jessica] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Gorevic, Peter D.; Robinson-Papp, Jessica] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Colton, Theodore] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rybin, Denis V.; Bisbee, Alice B.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Boston University; Boston University; Umea University; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; Shinshu University; Mayo Clinic; Mayo Clinic; Kumamoto University; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; IRCCS Humanitas Research Hospital; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Boston University; Boston University; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Berk, JL (corresponding author), Amyloidosis Ctr, 72 E Concord St,K504, Boston, MA 02118 USA.	jberk@bu.edu	Cortese, Andrea/V-4371-2019; Robinson-Papp, Jessica/AAX-5802-2020; Cortese, Andrea/D-3611-2016; Cortese, Andrea/M-9377-2014; Merlini, Giampaolo/A-3817-2008; Obici, Laura/AAC-3060-2019; Perlini, Stefano/E-2670-2012	Cortese, Andrea/0000-0002-2208-5311; Robinson-Papp, Jessica/0000-0001-9397-8873; Merlini, Giampaolo/0000-0001-7680-3254; Obici, Laura/0000-0001-7468-700X; Perlini, Stefano/0000-0002-0320-8574; Ando, Yukio/0000-0001-7115-9105; Lozza, Alessandro/0000-0001-5622-2647; CORATO, MANUEL/0000-0002-3812-1874; Seldin, David C/0000-0003-0168-2333; Suhr, Ole/0000-0002-1175-2369	National Institute of Neurological Diseases and Stroke [R01-NS051306]; Orphan Products Division of the US Food and Drug Administration [FD-R-002532]; Young Family Amyloid Research Fund; National Center for Advancing Translational Sciences, National Institutes of Health [UL1-TR000157]; FOOD AND DRUG ADMINISTRATION [R01FD002532] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051306] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23500430] Funding Source: KAKEN	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Orphan Products Division of the US Food and Drug Administration; Young Family Amyloid Research Fund; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the National Institute of Neurological Diseases and Stroke (grant R01-NS051306), the Orphan Products Division of the US Food and Drug Administration (grant FD-R-002532), the Young Family Amyloid Research Fund, and the National Center for Advancing Translational Sciences, National Institutes of Health (grant UL1-TR000157). Merck Sharp and Dohme Inc supplied study drug (diflunisal).	Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; ANDRADE C, 1952, BRAIN, V75, P408, DOI 10.1093/brain/75.3.408; [Anonymous], 1995, ANN NEUROL, V38, P478; Apfel SC, 2000, JAMA-J AM MED ASSOC, V284, P2215, DOI 10.1001/jama.284.17.2215; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Coehlo T., 1996, NEUROMUSCUL DISORD, V6, P27; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Committee on National Statistics, 2010, PREV TREATM MISS DAT; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dyck PJ, 2012, ARCH NEUROL-CHICAGO, V69, P1609, DOI 10.1001/archneurol.2012.1481; Dyck PJ, 1997, NEUROLOGY, V49, P229, DOI 10.1212/WNL.49.1.229; DYCK PJ, 1995, NEUROLOGY, V45, P1115, DOI 10.1212/WNL.45.6.1115; DYCK PJ, 1987, DIABETES CARE, V10, P432, DOI 10.2337/diacare.10.4.432; DYCK PJ, 1991, NEW ENGL J MED, V325, P1482, DOI 10.1056/NEJM199111213252105; DYCK PJ, 1994, ANN NEUROL, V36, P838, DOI 10.1002/ana.410360607; DYCK PJ, 1986, NEW ENGL J MED, V314, P461, DOI 10.1056/NEJM198602203140801; Ferlini A, 1988, Adv Neurol, V48, P201; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; HOLMGREN G, 1991, CLIN GENET, V40, P242; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Liepnieks JJ, 2010, NEUROLOGY, V75, P324, DOI 10.1212/WNL.0b013e3181ea15d4; McDougall AJ, 1996, J NEUROL SCI, V138, P1, DOI 10.1016/0022-510X(95)00356-7; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817; Olofsson BO, 2002, TRANSPLANTATION, V73, P745, DOI 10.1097/00007890-200203150-00015; Plante-Bordeneuve V, 1998, NEUROLOGY, V51, P708, DOI 10.1212/WNL.51.3.708; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Seldin DC, 2004, BLOOD, V104, P1888, DOI 10.1182/blood-2004-01-0089; SERVICE FJ, 1983, MAYO CLIN PROC, V58, P283; SUHR O, 1994, J INTERN MED, V235, P479, DOI 10.1111/j.1365-2796.1994.tb01106.x; SUHR OB, 1995, TRANSPLANTATION, V60, P933, DOI 10.1097/00007890-199511150-00009; Tashima K, 1999, J NEUROL SCI, V171, P19, DOI 10.1016/S0022-510X(99)00231-2; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216	39	429	440	2	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2658	2667		10.1001/jama.2013.283815	http://dx.doi.org/10.1001/jama.2013.283815			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368466	Green Accepted			2022-12-28	WOS:000328818000018
J	Gomes, AP; Price, NL; Ling, AJY; Moslehi, JJ; Montgomery, MK; Rajman, L; White, JP; Teodoro, JS; Wrann, CD; Hubbard, BP; Mercken, EM; Palmeira, CM; de Cabo, R; Rolo, AP; Turner, N; Bell, EL; Sinclair, DA				Gomes, Ana P.; Price, Nathan L.; Ling, Alvin J. Y.; Moslehi, Javid J.; Montgomery, Magdalene K.; Rajman, Luis; White, James P.; Teodoro, Joao S.; Wrann, Christiane D.; Hubbard, Basil P.; Mercken, Evi M.; Palmeira, Carlos M.; de Cabo, Rafael; Rolo, Anabela P.; Turner, Nigel; Bell, Eric L.; Sinclair, David A.			Declining NAD(+) Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging	CELL			English	Article							CANCER-CELL METABOLISM; FATTY-ACID OXIDATION; GLUCOSE-HOMEOSTASIS; LIFE-SPAN; C-MYC; NICOTINAMIDE MONONUCLEOTIDE; CALORIE RESTRICTION; ENERGY-EXPENDITURE; DNA MUTATIONS; HYPOXIA	Ever since eukaryotes subsumed the bacterial ancestor of mitochondria, the nuclear and mitochondrial genomes have had to closely coordinate their activities, as each encode different subunits of the oxidative phosphorylation (OXPHOS) system. Mitochondrial dysfunction is a hallmark of aging, but its causes are debated. We show that, during aging, there is a specific loss of mitochondrial, but not nuclear, encoded OXPHOS subunits. We trace the cause to an alternate PGC-1 alpha/beta-independent pathway of nuclear-mitochondrial communication that is induced by a decline in nuclear NAD(+) and the accumulation of HIF-1 alpha under normoxic conditions, with parallels to Warburg reprogramming. Deleting SIRT1 accelerates this process, whereas raising NAD(+) levels in old mice restores mitochondrial function to that of a young mouse in a SIRT1-dependent manner. Thus, a pseudohypoxic state that disrupts PGC-1 alpha/beta-independent nuclear-mitochondrial communication contributes to the decline in mitochondrial function with age, a process that is apparently reversible.	[Gomes, Ana P.; Price, Nathan L.; Ling, Alvin J. Y.; Rajman, Luis; Hubbard, Basil P.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; [Gomes, Ana P.; Teodoro, Joao S.; Palmeira, Carlos M.; Rolo, Anabela P.] Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Gomes, Ana P.; Teodoro, Joao S.; Palmeira, Carlos M.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3004517 Coimbra, Portugal; [Moslehi, Javid J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med Oncol, Boston, MA 02115 USA; [Moslehi, Javid J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Moslehi, Javid J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA; [Montgomery, Magdalene K.; Turner, Nigel; Sinclair, David A.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [White, James P.; Wrann, Christiane D.] Harvard Univ, Sch Med, Dept Cell Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Mercken, Evi M.; de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Rolo, Anabela P.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Bell, Eric L.] MIT, Dept Biol, Paul F Glenn Lab Sci Aging, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Universidade de Coimbra; Universidade de Coimbra; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of New South Wales Sydney; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade de Aveiro; Massachusetts Institute of Technology (MIT)	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Glenn Labs Biol Mech Aging, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Palmeira, Carlos M/L-3390-2014; de Cabo, Rafael Carlos/J-5230-2016; Teodoro, João Soeiro/F-5432-2011; Rolo, Anabela/AAU-6567-2020; Turner, Nigel/H-7176-2013; de Cabo, Rafael/E-7996-2010; Rolo, Anabela/D-6062-2011; de Cabo, Rafael/J-5230-2016	Palmeira, Carlos M/0000-0002-2639-7697; de Cabo, Rafael Carlos/0000-0003-2830-5693; Teodoro, João Soeiro/0000-0002-1244-275X; Rolo, Anabela/0000-0003-3535-9630; Turner, Nigel/0000-0002-0119-9328; de Cabo, Rafael/0000-0003-2830-5693; Rolo, Anabela/0000-0003-3535-9630; Sinclair, David/0000-0002-9936-436X; Price, Nathan/0000-0002-2821-9608; Montgomery, Magdalene/0000-0003-2551-4174; Hubbard, Basil/0000-0003-4353-9674; de Cabo, Rafael/0000-0002-3354-2442	NIH/NIA; Glenn Foundation for Medical Research; United Mitochondrial Disease Foundation; Juvenile Diabetes Research Foundation; Portuguese Foundation for Science and Technology [SFRH/BD/44674/2008]; NSERC PGS-D fellowship; Australian Research Council Future Fellowship; NATIONAL INSTITUTE ON AGING [R37AG028730, ZIAAG000363, ZIAAG000362, R01AG028730] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation for Medical Research; United Mitochondrial Disease Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council Future Fellowship(Australian Research Council); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Sinclair lab is supported by the NIH/NIA, the Glenn Foundation for Medical Research, the United Mitochondrial Disease Foundation, the Juvenile Diabetes Research Foundation, and a gift from the Schulak family. A. P. G. was supported by the Portuguese Foundation for Science and Technology (SFRH/BD/44674/2008) and B. P. H. by an NSERC PGS-D fellowship. N.T. is supported by an Australian Research Council Future Fellowship. We are grateful to Michael Bonkowski, Carlos Daniel de Magalhaes Filho, Meghan Rego, Nikolina Dioufa, and David Zhang for technical advice and experimental assistance; William Kaelin Jr. for kindly providing the EglN1 KO mice; Daniel Kelly, John Rumsay, and Teresa Leone for unpublished PGC-1 alpha/beta KO myoblasts and advice; Bruce Spiegelman for PGC-1 alpha null myoblasts and advice; and Pere Puigserver and Zachary Gerhart-Hines for a SIRT1 adenovirus. D. A. S. is a consultant to Cohbar, OvaScience, HorizonScience, Segterra, MetroBiotech, and GlaxoSmithKline. Cohbar, MetroBiotech, and GlaxoSmithKline work on mitochondrially derived peptides, NAD<SUP>+</SUP>, and sirtuin modulation, respectively.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carabelli J, 2011, J CELL MOL MED, V15, P1329, DOI 10.1111/j.1582-4934.2010.01128.x; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gomes AP, 2012, BBA-MOL BASIS DIS, V1822, P185, DOI 10.1016/j.bbadis.2011.10.008; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Ido Y, 1997, INVEST OPHTH VIS SCI, V38, P1467; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Leiser SF, 2010, BIOL CHEM, V391, P1131, DOI 10.1515/BC.2010.123; Li FR, 2005, POWER ENGINEER, V19, P25, DOI 10.1049/pe:20050104; Libert S, 2013, ANNU REV PHYSIOL, V75, P669, DOI 10.1146/annurev-physiol-030212-183800; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ptitsyn A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-318; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanders E, 2012, BIOMED RES-INDIA, V23, P109; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Williams PD, 2003, EVOLUTION, V57, P1478; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	55	871	906	14	198	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1624	1638		10.1016/j.cell.2013.11.037	http://dx.doi.org/10.1016/j.cell.2013.11.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360282	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000328693300017
J	Parkhurst, CN; Yang, G; Ninan, I; Savas, JN; Yates, JR; Lafaille, JJ; Hempstead, BL; Littman, DR; Gan, WB				Parkhurst, Christopher N.; Yang, Guang; Ninan, Ipe; Savas, Jeffrey N.; Yates, John R., III; Lafaille, Juan J.; Hempstead, Barbara L.; Littman, Dan R.; Gan, Wen-Biao			Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor	CELL			English	Article							FLUORESCENT PROTEIN; RECEPTOR; RELEASE; BDNF; REVEALS; MICE; TRANSMISSION; MAINTENANCE; DEFICIENCY; DELETION	Microglia are the resident macrophages of the CNS, and their functions have been extensively studied in various brain pathologies. The physiological roles of microglia in brain plasticity and function, however, remain unclear. To address this question, we generated CX3CR1 CreER mice expressing tamoxifen-inducible Cre recombinase that allow for specific manipulation of gene function in microglia. Using CX3CR1 CreER to drive diphtheria toxin receptor expression in microglia, we found that microglia could be specifically depleted from the brain upon diphtheria toxin administration. Mice depleted of microglia showed deficits in multiple learning tasks and a significant reduction in motor-learning-dependent synapse formation. Furthermore, Cre-dependent removal of brain-derived neurotrophic factor (BDNF) from microglia largely recapitulated the effects of microglia depletion. Microglial BDNF increases neuronal tropomyosin-related kinase receptor B phosphorylation, a key mediator of synaptic plasticity. Together, our findings reveal thatmicroglia serve important physiological functions in learning and memory by promoting learning-related synapse formation through BDNF signaling.	[Parkhurst, Christopher N.; Gan, Wen-Biao] NYU, Sch Med, Mol Neurobiol Program, Kimmel Ctr Biol & Med,Skirball Inst,Dept Neurosci, New York, NY 10016 USA; [Yang, Guang] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Ninan, Ipe] NYU, Dept Psychiat, Sch Med, New York, NY 10016 USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Lafaille, Juan J.; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst,Dept Pathol, New York, NY 10016 USA; [Hempstead, Barbara L.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; New York University; Scripps Research Institute; New York University; Cornell University; Howard Hughes Medical Institute; New York University	Gan, WB (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Kimmel Ctr Biol & Med,Skirball Inst,Dept Neurosci, New York, NY 10016 USA.	wenbiao.gan@nyumc.org		Yang, Guang/0000-0002-5739-9126; Ninan, Ipe/0000-0001-9774-6455	NIH [R01 NS047325, P01 NS074972, RO1 MH96899, P41 GM103533, P01 AG031097, R01 MH067880, NS030687, F30 MH096370]; McKnight Memory Disorder Award; Whitehall Foundation; Alzheimer's Association [NIRG-11-205362]; National Institute of Aging Fellowship [F32 AG039127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH096370, R56MH096899, R01MH067880, R01MH096899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087198, R01NS030687, R01NS047325, P01NS074972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127, P01AG031097] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Memory Disorder Award; Whitehall Foundation; Alzheimer's Association(Alzheimer's Association); National Institute of Aging Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Takeshi Egawa for assistance in construction of the CX<INF>3</INF>CR1<SUP>CreER</SUP> mouse line, members of the Fishell laboratory for reagents and advice, Hernandez M. Silva for assistance with the microglial proliferation assay, members of the Chao lab for assistance with generation of neuronal cultures, and members of the Gan lab for critical readings of the manuscript. All raw MS data in this paper are available at http://fields.scripps.edu/published/MG_deletion upon publication. This work was supported by grants from the NIH (R01 NS047325 and P01 NS074972 to W. B. G.; RO1 MH96899 to I.N.; P41 GM103533, P01 AG031097, and R01 MH067880 to J.R.Y.; and NS030687 to B. L. H.), a McKnight Memory Disorder Award to W. B. G., NIH fellowship F30 MH096370 to C.N.P., the Whitehall Foundation (to G.Y.), the Alzheimer's Association (NIRG-11-205362 to G.Y.), and National Institute of Aging Fellowship F32 AG039127 (to J.N.S.). D. R. L. is a Howard Hughes Medical Institute Investigator.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chakravarthy S, 2006, P NATL ACAD SCI USA, V103, P1071, DOI 10.1073/pnas.0506305103; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GRAY EG, 1962, J ANAT, V96, P79; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HERZOG KH, 1994, DEVELOPMENT, V120, P1643; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Melo CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053793; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pattwell SS, 2012, J NEUROSCI, V32, P2410, DOI 10.1523/JNEUROSCI.5205-11.2012; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Spencer-Segal JL, 2011, J NEUROSCI, V31, P6780, DOI 10.1523/JNEUROSCI.0910-11.2011; Swinnen N, 2013, GLIA, V61, P150, DOI 10.1002/glia.22421; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zheng K, 2011, P NATL ACAD SCI USA, V108, P17201, DOI 10.1073/pnas.1114241108	51	1430	1463	13	177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1596	1609		10.1016/j.cell.2013.11.030	http://dx.doi.org/10.1016/j.cell.2013.11.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360280	Green Accepted, Bronze			2022-12-28	WOS:000328693300015
J	Dias, AS; de Almeida, I; Belmonte, JM; Glazier, JA; Stern, CD				Dias, Ana S.; de Almeida, Irene; Belmonte, Julio M.; Glazier, James A.; Stern, Claudio D.			Somites Without a Clock	SCIENCE			English	Article							SEGMENTATION CLOCK; CHICK-EMBRYO; VERTEBRATE SEGMENTATION; GENE-EXPRESSION; NODE REGRESSION; SOMITOGENESIS; OSCILLATIONS; ELONGATION; ACTIVATION; EVOLUTION	The formation of body segments (somites) in vertebrate embryos is accompanied by molecular oscillations (segmentation clock). Interaction of this oscillator with a wave traveling along the body axis (the clock-and-wavefront model) is generally believed to control somite number, size, and axial identity. Here we show that a clock-and-wavefront mechanism is unnecessary for somite formation. Non-somite mesoderm treated with Noggin generates many somites that form simultaneously, without cyclic expression of Notch-pathway genes, yet have normal size, shape, and fate. These somites have axial identity: The Hox code is fixed independently of somite fate. However, these somites are not subdivided into rostral and caudal halves, which is necessary for neural segmentation. We propose that somites are self-organizing structures whose size and shape is controlled by local cell-cell interactions.	[Dias, Ana S.; de Almeida, Irene; Stern, Claudio D.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Belmonte, Julio M.; Glazier, James A.] Indiana Univ, Dept Phys, Biocomplex Inst, Bloomington, IN 47405 USA	University of London; University College London; Indiana University System; Indiana University Bloomington	Stern, CD (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	c.stern@ucl.ac.uk	Belmonte, Julio M/AAB-6434-2020; Stern, Claudio/AAZ-7381-2021; Stern, Claudio D/C-6265-2008; Belmonte, Julio/J-8696-2013	Belmonte, Julio M/0000-0002-4315-9631; Stern, Claudio/0000-0002-9907-889X; Stern, Claudio D/0000-0002-9907-889X; Belmonte, Julio/0000-0002-4315-9631; De-Almeida, Irene/0000-0002-9209-1071; Glazier, James Alexander/0000-0003-3634-190X	Medical Research Council [G0700095]; NIH (National Institute of General Medical Sciences) [R01GM076692, R01GM077138]; MRC [G0700095] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Medical Research Council (grant G0700095) and the NIH (National Institute of General Medical Sciences grants R01GM076692 and R01GM077138). N. De-Oliveira helped with cloning, C. Thrasivoulou with confocal microscopy, and A. Norris with vibratome sectioning. S. Evans, J. Sharpe, A. Streit, and S. Thorsteinsdottir provided information and constructive comments.	BEDDINGTON RSP, 1989, MOL BIOL MED, V6, P263; BURKE AC, 1995, DEVELOPMENT, V121, P333; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; GAUNT SJ, 1994, INT J DEV BIOL, V38, P549; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harima Y, 2013, CELL REP, V3, P1, DOI 10.1016/j.celrep.2012.11.012; Hester SD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002155; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Jouve C, 2002, DEVELOPMENT, V129, P1107; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; LIM TM, 1987, DEVELOPMENT, V100, P525; Martins GG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007429; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Munoz-Sanjuan I., 2004, GASTRULATION, P475; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Rodrigues S, 2006, GENE EXPR PATTERNS, V6, P673, DOI 10.1016/j.modgep.2006.01.004; Schroter C, 2010, CURR BIOL, V20, P1254, DOI 10.1016/j.cub.2010.05.071; STERN CD, 1984, J EMBRYOL EXP MORPH, V81, P75; STERN CD, 1988, DEVELOPMENT, V104, P231; Streit A, 1999, MECH DEVELOP, V85, P85, DOI 10.1016/S0925-4773(99)00085-4; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Takahashi Y, 2003, DEVELOPMENT, V130, P4259, DOI 10.1242/dev.00629; Tonegawa A, 1997, DEVELOPMENT, V124, P1975; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011	28	82	83	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					791	795		10.1126/science.1247575	http://dx.doi.org/10.1126/science.1247575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24407478	Green Accepted			2022-12-28	WOS:000331557800045
J	McDonough, JE; Adashi, EY				McDonough, John E.; Adashi, Eli Y.			Realizing the Promise of the Affordable Care Act-January 1, 2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McDonough, John E.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Harvard University; Harvard T.H. Chan School of Public Health; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Obstet & Gynecol, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						Congressional Budget Office, CBOS MAY 2013 EST EF; Gostin LO, 2012, JAMA-J AM MED ASSOC, V308, P571, DOI 10.1001/jama.2012.9061; Jennings CC, 2010, NEW ENGL J MED, V362, P2244, DOI 10.1056/NEJMp1004761; The Advisory Board Co, 2013, WHER STAT STAND MED; The White House, 2013, 24 STAT ARE REF EXP	5	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					569	570		10.1001/jama.2013.286067	http://dx.doi.org/10.1001/jama.2013.286067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24384745				2022-12-28	WOS:000330941000008
J	Fletcher, RH				Fletcher, Robert H.			Annual or biennial FOBT screening reduced colorectal cancer mortality, but not all-cause mortality, at 30 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC2	10.7326/0003-4819-160-2-201401210-02002	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445712				2022-12-28	WOS:000330275600001
J	Feigin, VL; Forouzanfar, MH; Krishnamurthi, R; Mensah, GA; Connor, M; Bennett, DA; Moran, AE; Sacco, RL; Anderson, L; Truelsen, T; O'Donnell, M; Venketasubramanian, N; Barker-Collo, S; Lawes, CMM; Wang, WZ; Shinohara, Y; Witt, E; Ezzati, M; Naghavi, M; Murray, C				Feigin, Valery L.; Forouzanfar, Mohammad H.; Krishnamurthi, Rita; Mensah, George A.; Connor, Myles; Bennett, Derrick A.; Moran, Andrew E.; Sacco, Ralph L.; Anderson, Laurie; Truelsen, Thomas; O'Donnell, Martin; Venketasubramanian, Narayanaswamy; Barker-Collo, Suzanne; Lawes, Carlene M. M.; Wang, Wenzhi; Shinohara, Yukito; Witt, Emma; Ezzati, Majid; Naghavi, Mohsen; Murray, Christopher		Global Burden Dis Injuries Risk Fa; GBD Stroke Experts Grp	Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010	LANCET			English	Article							SYSTEMATIC ANALYSIS; ISCHEMIC-STROKE; CASE-FATALITY; HEART-DISEASE; 187 COUNTRIES; YOUNG-ADULTS; RISK-FACTORS; MORTALITY; TRENDS; COMMUNITY	Background Although stroke is the second leading cause of death worldwide, no comprehensive and comparable assessment of incidence, prevalence, mortality, disability, and epidemiological trends has been estimated for most regions. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the global and regional burden of stroke during 1990-2010. Methods We searched Medline, Embase, LILACS, Scopus, PubMed, Science Direct, Global Health Database, the WHO library, and WHO regional databases from 1990 to 2012 to identify relevant studies published between 1990 and 2010. We applied the GBD 2010 analytical technique (DisMod-MR), based on disease-specific, pre-specified associations between incidence, prevalence, and mortality, to calculate regional and country-specific estimates of stroke incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) lost by age group (<75 years, >= 75 years, and in total) and country income level (high-income, and low-income and middle-income) for 1990, 2005, and 2010. Findings We included 119 studies (58 from high-income countries and 61 from low-income and middle-income countries). From 1990 to 2010, the age-standardised incidence of stroke significantly decreased by 12% (95% CI 6-17) in high-income countries, and increased by 12% (-3 to 22) in low-income and middle-income countries, albeit nonsignificantly. Mortality rates decreased significantly in both high income (37%, 31-41) and low-income and middle-income countries (20%, 15-30). In 2010, the absolute numbers of people with first stroke (16.9 million), stroke survivors (33 million), stroke-related deaths (5.9 million), and DALYs lost (102 million) were high and had significantly increased since 1990 (68%, 84%, 26%, and 12% increase, respectively), with most of the burden (68.6% incident strokes, 52.2% prevalent strokes, 70.9% stroke deaths, and 77.7% DALYs lost) in low-income and middle-income countries. In 2010, 5.2 million (31%) strokes were in children (aged <20 years old) and young and middle-aged adults (20-64 years), to which children and young and middle-aged adults from low-income and middle-income countries contributed almost 74 000 (89%) and 4.0 million (78%), respectively, of the burden. Additionally, we noted significant geographical differences of between three and ten times in stroke burden between GBD regions and countries. More than 62% of new strokes, 69.8% of prevalent strokes, 45.5% of deaths from stroke, and 71.7% of DALYs lost because of stroke were in people younger than 75 years. Interpretation Although age-standardised rates of stroke mortality have decreased worldwide in the past two decades, the absolute number of people who have a stroke every year, stroke survivors, related deaths, and the overall global burden of stroke (DALYs lost) are great and increasing. Further study is needed to improve understanding of stroke determinants and burden worldwide, and to establish causes of disparities and changes in trends in stroke burden between countries of different income levels.	[Feigin, Valery L.; Krishnamurthi, Rita; Witt, Emma] Auckland Uwnivers Technol, Fac Hlth & Environm Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Forouzanfar, Mohammad H.; Naghavi, Mohsen; Murray, Christopher] Univ Washington, Dept Global Hlth, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Mensah, George A.] NIH, Heart Lung & Blood Inst, Bethesda, MD 20892 USA; [Connor, Myles] Univ Edinburgh, Div Clin Neurosci, Edinburgh EH8 9YL, Midlothian, Scotland; [Connor, Myles] Univ St Andrews, Bute Med Sch, St Andrews KY16 9AJ, Fife, Scotland; [Connor, Myles] Univ Witwatersrand, Sch Publ Hlth, ZA-2050 Johannesburg, South Africa; [Bennett, Derrick A.] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick A.] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Moran, Andrew E.] Columbia Univ, Med Ctr, Div Gen Med, New York, NY 10027 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Anderson, Laurie] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Anderson, Laurie] Washington State Inst Publ Policy, Olympia, WA USA; [Truelsen, Thomas] Univ Copenhagen, Herlev Hosp, Dept Neurol, DK-2730 Herlev, Denmark; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [O'Donnell, Martin] Natl Univ Ireland, Galway, Ireland; [Venketasubramanian, Narayanaswamy] Natl Univ Singapore, Yong Loo Lin Sch Med, Univ Med Cluster, Div Neurol, Singapore 117548, Singapore; [Venketasubramanian, Narayanaswamy] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Lawes, Carlene M. M.] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Shinohara, Yukito] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tachikawa, Tokyo, Japan	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; University of Edinburgh; University of St Andrews; University of Witwatersrand; University of Oxford; University of Oxford; Columbia University; University of Miami; University of Washington; University of Washington Seattle; University of Copenhagen; Herlev & Gentofte Hospital; Imperial College London; Ollscoil na Gaillimhe-University of Galway; National University of Singapore; National University of Singapore; University of Auckland; University of Auckland; Beijing Neurosurgical Institute; Capital Medical University	Feigin, VL (corresponding author), Auckland Univ Technol Univ, Fac Hlth & Environm Studies, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci,Sch Rehabil & Oc, Auckland 1142, New Zealand.	valery.feigin@aut.ac.nz	Bennett, Derrick/AAH-1220-2022; Krishnamurthi, Rita/AAU-7841-2021; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Truelsen, Thomas/AAY-1549-2020; O'Donnell, Martin/ABE-7459-2020; , Bennett/O-7998-2019; Feigin, Valery/AAF-2313-2019; Bennett, Derrick/AFL-9254-2022; Sacco, Ralph/Y-9278-2019	Bennett, Derrick/0000-0002-9170-8447; Krishnamurthi, Rita/0000-0003-0869-2083; O'Donnell, Martin/0000-0002-7347-7761; Bennett, Derrick/0000-0002-9170-8447; Feigin, Valery L./0000-0002-6372-1740; Pandian, Jeyaraj/0000-0003-0028-1968	Bill & Melinda Gates Foundation; Medical Research Council [G0801056] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; MRC [G0801056] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Bill & Melinda Gates Foundation.	Ahmad OB, 2013, AGE STANDARDIZATION; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Alzamora MT, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-5; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Andre C, 2006, STROKE, V37, P2784, DOI 10.1161/01.STR.0000244768.46566.73; [Anonymous], 2012, LANCET NEUROL, V11, P1013, DOI 10.1016/S1474-4422(12)70274-0; [Anonymous], 2011, LANCET, V377, P527, DOI 10.1016/S0140-6736(11)60182-7; Bennett DA, 2012, NEUROEPIDEMIOLOGY, V38, P30, DOI 10.1159/000334744; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Cairncross F, 2007, NATURE, V448, P875, DOI 10.1038/448875a; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de los Rios F, 2012, STROKE, V43, P3179, DOI 10.1161/STROKEAHA.112.667808; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Feigin V, 2004, LANCET, V363, P1920, DOI 10.1016/S0140-6736(04)16436-2; Feigin VL, 2011, STROKE, V42, P3655, DOI 10.1161/STROKEAHA.110.596858; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Gillum RF, 2011, STROKE, V42, P3294, DOI 10.1161/STROKEAHA.111.625343; HERMAN B, 1982, STROKE, V13, P629, DOI 10.1161/01.STR.13.5.629; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kunst AE, 2011, STROKE, V42, P2126, DOI 10.1161/STROKEAHA.110.599712; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Medin J, 2004, STROKE, V35, P1047, DOI 10.1161/01.STR.0000125866.78674.96; Mendis S., 2011, GLOB ATL CARD DIS PR; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Norrving B, 2013, NEUROLOGY, V80, pS5, DOI 10.1212/WNL.0b013e3182762397; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Putaala J, 2012, STROKE, V43, P2624, DOI 10.1161/STROKEAHA.112.662866; RANKIN J, 1957, Scott Med J, V2, P200; Redon J, 2011, EUR HEART J, V32, P1424, DOI 10.1093/eurheartj/ehr045; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sarti C, 2003, STROKE, V34, P1833, DOI 10.1161/01.STR.0000081224.15480.52; Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588; Sidney S, 2013, CIRCULATION, V127, P21, DOI 10.1161/CIRCULATIONAHA.112.155911; Stringhini S, 2012, STROKE, V43, P2283, DOI 10.1161/STROKEAHA.112.658468; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Thrift AG, 2000, STROKE, V31, P2087, DOI 10.1161/01.STR.31.9.2087; Truelsen T, 2003, STROKE, V34, P1346, DOI 10.1161/01.STR.0000069724.36173.4D; Vaartjes I, 2013, STROKE, V44, P591, DOI 10.1161/STROKEAHA.112.677724; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	50	2431	2577	16	305	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					245	255		10.1016/S0140-6736(13)61953-4	http://dx.doi.org/10.1016/S0140-6736(13)61953-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24449944	Green Accepted			2022-12-28	WOS:000330027500033
J	Hwang, TJ; Carpenter, D; Kesselheim, AS				Hwang, Thomas J.; Carpenter, Daniel; Kesselheim, Aaron S.			Assessment of US pathway for approving medical devices for rare conditions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSTHETIC TITANIUM RIB; PREMARKET APPROVAL; EXEMPTION; EUROPE; INSERTION; FAILINGS		[Hwang, Thomas J.] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02120 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Carpenter, Daniel] Harvard Univ, Fac Arts & Sci, Ctr Amer Polit Studies, Cambridge, MA 02138 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Hwang, Thomas/0000-0003-0717-1497	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; AHRQ HHS [K08HS18465-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Basu S, 2012, NEW ENGL J MED, V367, P485, DOI 10.1056/NEJMp1204170; Bernad DM, 2009, EXPERT REV MED DEVIC, V6, P137, DOI 10.1586/17434440.6.2.137; Campbell B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2782; Campbell RM, 2013, EUR SPINE J, V22, pS106, DOI 10.1007/s00586-013-2671-2; Center for Thoracic Insufficiency Syndrome Children's Hospital of Philadelphia, FREQ ASK QUEST VERT; Chen CE, 2012, JAMA-J AM MED ASSOC, V308, P1740, DOI 10.1001/jama.2012.14491; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Cohen D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6204; Cohen D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7090; Cohen D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7163; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Eikermann M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2771; Emans JB, 2005, SPINE, V30, pS58, DOI 10.1097/01.brs.0000175194.31986.2f; Eydelman MB, 2011, HEALTH AFFAIR, V30, P1210, DOI 10.1377/hlthaff.2011.0550; Fins JJ, 2011, HEALTH AFFAIR, V30, P302, DOI 10.1377/hlthaff.2010.0157; Food and Drug Administration, 2002, SUMM SAF PROB BEN AS; Food and Drug Administration, 2000, SUMM SAF PROB BEN CA; Food and Drug Administration, 1999, SUMM SAF PROB BEN VO; Food and Drug Administration, 2003, SUMM SAF PROB BEN ME; Food and Drug Administration, 1997, SUMM SAF PROB BEN KI; Gadepalli SK, 2011, J PEDIATR SURG, V46, P77, DOI 10.1016/j.jpedsurg.2010.09.070; Garber AM, 2010, NEW ENGL J MED, V362, P1161, DOI 10.1056/NEJMp1000447; Groenefeld B, 2013, SPINE, V38, pE819, DOI 10.1097/BRS.0b013e318292aafa; Heneghan C, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e306; Kaplan AV, 2004, CIRCULATION, V109, P3068, DOI 10.1161/01.CIR.0000134695.65733.64; Kramer DB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001519; Kramer DB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001276; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Normand SLT, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6848; PricewaterhouseCoopers, 2011, MED TECHN INN SCOR R MED TECHN INN SCOR R; Storz-Pfennig P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1646; Thompson M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2973; *US FDA, 2006, INF PHYS PAT WITHDR; US Food and Drug Administration, 2012, STRENGTH NAT SYST PO; US Food and Drug Administration, HUM DEV EX OV; US Food and Drug Administration, 2011, SUMM SAF PROB BEN EX; US Food and Drug Administration, LIST CDRH HUM DEV EX; US Food and Drug Administration, 2012, STRYK WINGSP STENT S	38	12	12	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2014	348								g217	10.1136/bmj.g217	http://dx.doi.org/10.1136/bmj.g217			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MR	24443478				2022-12-28	WOS:000329976300006
J	Baker, L				Baker, Lorraine			Sexual harassment by patients forces doctors to alter their practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lorretb56@gmail.com						Bratuskins PA, 2013, MED J AUSTRALIA, V199, P454, DOI 10.5694/mja12.11855	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2014	348								g118	10.1136/bmj.g118	http://dx.doi.org/10.1136/bmj.g118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MO	24429919				2022-12-28	WOS:000329976000002
J	Liu, L; Park, J; Siegel, DA; McCarty, KF; Clark, KW; Deng, W; Basile, L; Idrobo, JC; Li, AP; Gu, G				Liu, Lei; Park, Jewook; Siegel, David A.; McCarty, Kevin F.; Clark, Kendal W.; Deng, Wan; Basile, Leonardo; Idrobo, Juan Carlos; Li, An-Ping; Gu, Gong			Heteroepitaxial Growth of Two-Dimensional Hexagonal Boron Nitride Templated by Graphene Edges	SCIENCE			English	Article							GRAIN-BOUNDARIES; HETEROSTRUCTURES; FILMS	By adapting the concept of epitaxy to two-dimensional space, we show the growth of a single-atomic-layer, in-plane heterostructure of a prototypical material system-graphene and hexagonal boron nitride (h-BN). Monolayer crystalline h-BN grew from fresh edges of monolayer graphene with atomic lattice coherence, forming an abrupt one-dimensional interface, or boundary. More important, the h-BN lattice orientation is solely determined by the graphene, forgoing configurations favored by the supporting copper substrate.	[Liu, Lei; Deng, Wan; Gu, Gong] Univ Tennessee, Knoxville, TN 37996 USA; [Park, Jewook; Clark, Kendal W.; Basile, Leonardo; Idrobo, Juan Carlos; Li, An-Ping] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Siegel, David A.; McCarty, Kevin F.] Sandia Natl Labs, Livermore, CA 94550 USA; [Basile, Leonardo] Escuela Politec Nacl, Dept Fis, Quito, Ecuador	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; United States Department of Energy (DOE); Sandia National Laboratories; Escuela Politecnica Nacional Ecuador	Li, AP (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.	apli@ornl.gov; ggu1@utk.edu	Park, Jewook/N-2856-2015; Liu, Lei/E-6267-2014; Park, Jewook/AAK-9999-2020; Li, An-Ping/B-3191-2012; Gu, Gong/L-5919-2015; Idrobo, Juan Carlos/H-4896-2015; Basile, Leonardo/E-4862-2015	Park, Jewook/0000-0003-3683-1933; Li, An-Ping/0000-0003-4400-7493; Gu, Gong/0000-0002-3888-1427; Idrobo, Juan Carlos/0000-0001-7483-9034; Basile, Leonardo/0000-0001-7301-097X; Liu, Lei/0000-0002-7226-8423	NSF [ECCS-1231808]; Defense Advanced Research Projects Agency; National Secretariat of Higher Education, Science, Technology and Innovation of Ecuador (SENESCYT); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy; Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. Department of Energy [DE-AC04-94AL85000]	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Secretariat of Higher Education, Science, Technology and Innovation of Ecuador (SENESCYT); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	This work was partially supported by NSF (ECCS-1231808), the Defense Advanced Research Projects Agency (approved for public release; distribution is unlimited), and the National Secretariat of Higher Education, Science, Technology and Innovation of Ecuador (SENESCYT). A portion of this research was conducted at the Center for Nanophase Materials Sciences (CNMS), which is sponsored at Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy. Work at Sandia was supported by the Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. Department of Energy, under contract DE-AC04-94AL85000. We thank R. M. Feenstra for discussions on LEEM. Authors declare no conflicts of interest.	Bhowrnick S, 2011, J PHYS CHEM C, V115, P9889, DOI 10.1021/jp200671p; Choubak S, 2013, J PHYS CHEM LETT, V4, P1100, DOI 10.1021/jz400400u; Gao YB, 2013, NANO LETT, V13, P3439, DOI 10.1021/nl4021123; Joshi S, 2012, NANO LETT, V12, P5821, DOI 10.1021/nl303170m; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Kim SM, 2013, NANO LETT, V13, P933, DOI 10.1021/nl303760m; KROEMER H, 1987, J CRYST GROWTH, V81, P193, DOI 10.1016/0022-0248(87)90391-5; Levendorf MP, 2012, NATURE, V488, P627, DOI 10.1038/nature11408; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liu Z, 2013, NAT NANOTECHNOL, V8, P119, DOI [10.1038/nnano.2012.256, 10.1038/NNANO.2012.256]; Najmaei S, 2013, NAT MATER, V12, P754, DOI [10.1038/NMAT3673, 10.1038/nmat3673]; Ohring M, 1991, MAT SCI THIN FILMS; Oshima C, 1997, J PHYS-CONDENS MAT, V9, P1, DOI 10.1088/0953-8984/9/1/004; Plummer J. D., 2000, SILICON VLSI TECHNOL; Pruneda JM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161409; Sutter P, 2012, NANO LETT, V12, P4869, DOI 10.1021/nl302398m; Tian JF, 2012, NANO LETT, V12, P3893, DOI 10.1021/nl3002974; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Vlassiouk I, 2011, ACS NANO, V5, P6069, DOI 10.1021/nn201978y; Wintterlin J, 2009, SURF SCI, V603, P1841, DOI 10.1016/j.susc.2008.08.037; Wofford JM, 2010, NANO LETT, V10, P4890, DOI 10.1021/nl102788f; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/NMAT3010, 10.1038/nmat3010]; Zhang Y, 2012, ACS NANO, V6, P126, DOI 10.1021/nn202996r; Zhang YB, 2008, NAT PHYS, V4, P627, DOI 10.1038/nphys1022	24	429	431	31	830	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					163	167		10.1126/science.1246137	http://dx.doi.org/10.1126/science.1246137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408431				2022-12-28	WOS:000329440800037
J	Blanchard, MS; Romero, JM; Hoang, MP				Blanchard, Melvin S.; Romero, Javier M.; Hoang, Mai P.			Case 1-2014: A 32-Year-Old Man with Loss of Vision and a Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VITAMIN-A-DEFICIENCY; XEROPHTHALMIA; SCURVY; KERATOMALACIA		[Blanchard, Melvin S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Romero, Javier M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hoang, Mai P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Romero, Javier M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hoang, Mai P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blanchard, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA.			Romero, Javier/0000-0001-5749-3000	Lundbeck; Synark	Lundbeck(Lundbeck Corporation); Synark	Dr. Romero reports receiving payment for board membership at Lundbeck and consulting fees from Lundbeck and Synark. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1979, ARCH DERMATOL, V115, P73; BAISYA DC, 1971, BRIT J OPHTHALMOL, V55, P700, DOI 10.1136/bjo.55.10.700; Baron JH, 2009, NUTR REV, V67, P315, DOI 10.1111/j.1753-4887.2009.00205.x; Collins CE, 2010, CORNEA, V29, P828, DOI 10.1097/ICO.0b013e3181bd9ed5; Cooney TM, 2007, CORNEA, V26, P995, DOI 10.1097/ICO.0b013e3180959a5d; ELLIS CN, 1984, ARCH DERMATOL, V120, P1212, DOI 10.1001/archderm.120.9.1212; Galor A, 2007, RHEUM DIS CLIN N AM, V33, P835, DOI 10.1016/j.rdc.2007.08.002; Ghosheh FR, 2007, CORNEA, V26, P966, DOI 10.1097/ICO.0b013e3180cfe716; Graves JS, 2012, NEUROL CLIN, V30, P75, DOI 10.1016/j.ncl.2011.09.012; Leger D, 2008, CAN FAM PHYSICIAN, V54, P1403; LOGAN WS, 1972, ARCH DERMATOL, V105, P748, DOI 10.1001/archderm.105.5.748; Ohashi Y, 2006, CLIN CHIM ACTA, V369, P17, DOI 10.1016/j.cca.2005.12.035; SOMMER A, 1982, ARCH OPHTHALMOL-CHIC, V100, P953; SOMMER A, 1982, ARCH OPHTHALMOL-CHIC, V100, P399; Souza PMF, 2003, OPHTHALMOLOGY, V110, P493, DOI 10.1016/S0161-6420(02)01772-4; VALENTON MJ, 1975, AM J OPHTHALMOL, V80, P673, DOI 10.1016/0002-9394(75)90399-2; Walters RW, 2006, ARCH DERMATOL, V142, P658, DOI 10.1001/archderm.142.5.658	17	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					159	166		10.1056/NEJMcpc1214217	http://dx.doi.org/10.1056/NEJMcpc1214217			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401054				2022-12-28	WOS:000336119800012
J	Cole, TB				Cole, Thomas B.			Portrait of the Journalist Sylvia von Harden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					120	123		10.1001/jama.2013.279264	http://dx.doi.org/10.1001/jama.2013.279264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399533				2022-12-28	WOS:000329339400001
J	Vallee, M; Vitiello, S; Bellocchio, L; Hebert-Chatelain, E; Monlezun, S; Martin-Garcia, E; Kasanetz, F; Baillie, GL; Panin, F; Cathala, A; Roullot-Lacarriere, V; Fabre, S; Hurst, DP; Lynch, DL; Shore, DM; Deroche-Gamonet, V; Spampinato, U; Revest, JM; Maldonado, R; Reggio, PH; Ross, RA; Marsicano, G; Piazza, PV				Vallee, Monique; Vitiello, Sergio; Bellocchio, Luigi; Hebert-Chatelain, Etienne; Monlezun, Stephanie; Martin-Garcia, Elena; Kasanetz, Fernando; Baillie, Gemma L.; Panin, Francesca; Cathala, Adeline; Roullot-Lacarriere, Valerie; Fabre, Sandy; Hurst, Dow P.; Lynch, Diane L.; Shore, Derek M.; Deroche-Gamonet, Veronique; Spampinato, Umberto; Revest, Jean-Michel; Maldonado, Rafael; Reggio, Patricia H.; Ross, Ruth A.; Marsicano, Giovanni; Piazza, Pier Vincenzo			Pregnenolone Can Protect the Brain from Cannabis Intoxication	SCIENCE			English	Article							CB1 RECEPTORS; STRESS; ENDOCANNABINOIDS; NEUROSTEROIDS; ALLOSTERISM; AGONIST; SYSTEM; MEMORY; REWARD	Pregnenolone is considered the inactive precursor of all steroid hormones, and its potential functional effects have been largely uninvestigated. The administration of the main active principle of Cannabis sativa (marijuana), Delta(9)-tetrahydrocannabinol (THC), substantially increases the synthesis of pregnenolone in the brain via activation of the type-1 cannabinoid (CB1) receptor. Pregnenolone then, acting as a signaling-specific inhibitor of the CB1 receptor, reduces several effects of THC. This negative feedback mediated by pregnenolone reveals a previously unknown paracrine/autocrine loop protecting the brain from CB1 receptor overactivation that could open an unforeseen approach for the treatment of cannabis intoxication and addiction.	[Vallee, Monique; Vitiello, Sergio; Bellocchio, Luigi; Hebert-Chatelain, Etienne; Kasanetz, Fernando; Panin, Francesca; Cathala, Adeline; Roullot-Lacarriere, Valerie; Deroche-Gamonet, Veronique; Spampinato, Umberto; Revest, Jean-Michel; Marsicano, Giovanni; Piazza, Pier Vincenzo] INSERM, Neuroctr Magendie, U862, F-33000 Bordeaux, France; [Vallee, Monique; Vitiello, Sergio; Bellocchio, Luigi; Hebert-Chatelain, Etienne; Kasanetz, Fernando; Panin, Francesca; Cathala, Adeline; Roullot-Lacarriere, Valerie; Deroche-Gamonet, Veronique; Spampinato, Umberto; Revest, Jean-Michel; Marsicano, Giovanni; Piazza, Pier Vincenzo] Univ Bordeaux, Neuroctr Magendie, U862, F-33000 Bordeaux, France; [Monlezun, Stephanie; Fabre, Sandy] Alienor Farma Parc Sci Unitec1, F-33600 Pessac, France; [Martin-Garcia, Elena; Maldonado, Rafael] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Neuropharmacol, Barcelona 08003, Spain; [Baillie, Gemma L.; Ross, Ruth A.] Univ Aberdeen, Inst Med Sci, Kosterlitz Ctr Therapeut, Aberdeen AB25 2ZD, Scotland; [Hurst, Dow P.; Lynch, Diane L.; Shore, Derek M.; Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Pompeu Fabra University; University of Aberdeen; University of North Carolina; University of North Carolina Greensboro	Piazza, PV (corresponding author), INSERM, Neuroctr Magendie, U862, F-33000 Bordeaux, France.	pier-vincenzo.piazza@inserm.fr	Ross, R./AAG-7468-2019; Martín-García, Elena/H-5406-2013; Martín-García, Elena/GLN-3219-2022; Deroche-Gamonet, Véronique/E-5728-2010; Maldonado, Rafael/F-5657-2014; Marsicano, Giovanni/I-9603-2016	Martín-García, Elena/0000-0002-4487-3028; Martín-García, Elena/0000-0002-4487-3028; Maldonado, Rafael/0000-0002-4359-8773; Marsicano, Giovanni/0000-0003-3804-1951; Kasanetz, Fernando/0000-0003-4585-2314; Panin, Francesca/0000-0002-1949-4333; VALLEE, Monique/0000-0002-3642-4257; Deroche-Gamonet, Veronique/0000-0002-9704-6624	INSERM; University Victor Segalen-Bordeaux2; Structure Federative de Recherche Neurosciences (SFRn) de l'Universite de Bordeaux; Region Aquitaine funds; EU-FP7 (REPROBESITY) [HEALTH-F2-2008-223713]; European Research Council (ENDOFOOD) [ERC-2010-StG-260515]; Fondation pour la Recherche Medicale; Agence Nationale pour la Recherche; U.S. National Institutes of Health (NIH) [DA-03672, DA-003934, DA-09789, RO1 DA003934, KO5 DA021358]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003934, R01DA003672, K05DA021358, R37DA003672, P01DA009789] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Victor Segalen-Bordeaux2; Structure Federative de Recherche Neurosciences (SFRn) de l'Universite de Bordeaux; Region Aquitaine funds; EU-FP7 (REPROBESITY); European Research Council (ENDOFOOD)(European Research Council (ERC)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to A. Grel, A. Le Roux, and C. Dupuy for technical help. Supported by INSERM, the University Victor Segalen-Bordeaux2, the Structure Federative de Recherche Neurosciences (SFRn) de l'Universite de Bordeaux and Region Aquitaine funds (M. V., S. V., L. B., F. P., A. C., V. D.-G., J.-M.R., U. S., G. M., and P. V. P.) and INSERM (G. M.), EU-FP7 (REPROBESITY, HEALTH-F2-2008-223713, G. M.), the European Research Council (ENDOFOOD, ERC-2010-StG-260515, G. M.), the Fondation pour la Recherche Medicale (G. M.), the Agence Nationale pour la Recherche (contracts HICOMET and TIMMS, P. V. P.), the U.S. National Institutes of Health (NIH) (grants DA-03672, DA-003934, and DA-09789, R. A. R. and G. L. B., and RO1 DA003934 and KO5 DA021358, P. H. R. A patent on "Antagonists of CB1 receptor" is pending (no. WO/2012/160006).	Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Baillie GL, 2013, MOL PHARMACOL, V83, P322, DOI 10.1124/mol.112.080879; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Clark M, 2006, J CHEM INF MODEL, V46, P231, DOI 10.1021/ci050268f; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; FOSTER AB, 1983, J MED CHEM, V26, P50, DOI 10.1021/jm00355a011; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GREENBERG I, 1976, PSYCHOPHARMACOLOGY, V49, P79; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kirkham TC, 2005, BEHAV PHARMACOL, V16, P297, DOI 10.1097/00008877-200509000-00004; Krone N, 2010, J STEROID BIOCHEM, V121, P496, DOI 10.1016/j.jsbmb.2010.04.010; Lundqvist T, 2005, PHARMACOL BIOCHEM BE, V81, P319, DOI 10.1016/j.pbb.2005.02.017; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Marsicano G, 2006, J Endocrinol Invest, V29, P27; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Pamplona FA, 2012, P NATL ACAD SCI USA, V109, P21134, DOI 10.1073/pnas.1202906109; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porcu P, 2009, STEROIDS, V74, P463, DOI 10.1016/j.steroids.2008.12.015; Puighermanal E, 2013, NEUROPSYCHOPHARMACOL, V38, P1334, DOI 10.1038/npp.2013.31; Ross RA, 2007, TRENDS PHARMACOL SCI, V28, P567, DOI 10.1016/j.tips.2007.10.006; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Vallee M, 2001, INT REV NEUROBIOL, V46, P273; Williams CM, 1998, PHYSIOL BEHAV, V65, P343, DOI 10.1016/S0031-9384(98)00170-X	35	188	195	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					94	98		10.1126/science.1243985	http://dx.doi.org/10.1126/science.1243985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385629	Green Accepted			2022-12-28	WOS:000329162000056
J	Klauer, SG; Guo, F; Simons-Morton, BG; Ouimet, MC; Lee, SE; Dingus, TA				Klauer, Sheila G.; Guo, Feng; Simons-Morton, Bruce G.; Ouimet, Marie Claude; Lee, Suzanne E.; Dingus, Thomas A.			Distracted Driving and Risk of Road Crashes among Novice and Experienced Drivers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERFORMANCE; PHONES	BackgroundDistracted driving attributable to the performance of secondary tasks is a major cause of motor vehicle crashes both among teenagers who are novice drivers and among adults who are experienced drivers. MethodsWe conducted two studies on the relationship between the performance of secondary tasks, including cell-phone use, and the risk of crashes and near-crashes. To facilitate objective assessment, accelerometers, cameras, global positioning systems, and other sensors were installed in the vehicles of 42 newly licensed drivers (16.3 to 17.0 years of age) and 109 adults with more driving experience. ResultsDuring the study periods, 167 crashes and near-crashes among novice drivers and 518 crashes and near-crashes among experienced drivers were identified. The risk of a crash or near-crash among novice drivers increased significantly if they were dialing a cell phone (odds ratio, 8.32; 95% confidence interval [CI], 2.83 to 24.42), reaching for a cell phone (odds ratio, 7.05; 95% CI, 2.64 to 18.83), sending or receiving text messages (odds ratio, 3.87; 95% CI, 1.62 to 9.25), reaching for an object other than a cell phone (odds ratio, 8.00; 95% CI, 3.67 to 17.50), looking at a roadside object (odds ratio, 3.90; 95% CI, 1.72 to 8.81), or eating (odds ratio, 2.99; 95% CI, 1.30 to 6.91). Among experienced drivers, dialing a cell phone was associated with a significantly increased risk of a crash or near-crash (odds ratio, 2.49; 95% CI, 1.38 to 4.54); the risk associated with texting or accessing the Internet was not assessed in this population. The prevalence of high-risk attention to secondary tasks increased over time among novice drivers but not among experienced drivers. ConclusionsThe risk of a crash or near-crash among novice drivers increased with the performance of many secondary tasks, including texting and dialing cell phones. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Highway Traffic Safety Administration.)	[Klauer, Sheila G.; Guo, Feng; Lee, Suzanne E.; Dingus, Thomas A.] Virginia Tech, Transportat Inst, Blacksburg, VA 24061 USA; [Guo, Feng] Virginia Polytech Inst & State Univ, Dept Stat, Blacksburg, VA 24061 USA; Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Ouimet, Marie Claude] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Sherbrooke	Klauer, SG (corresponding author), Virginia Tech, Transportat Inst, 3500 Transportat Res Plaza, Blacksburg, VA 24061 USA.	cklauer@vtti.vt.edu		Klauer, Sheila/0000-0002-4653-2753; Simons-Morton, Bruce/0000-0003-1099-6617	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Highway Traffic Safety Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001707] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Highway Traffic Safety Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Highway Traffic Safety Administration.	[Anonymous], 2010, 811517 DOT HS NAT HI; Caird JK, 2008, ACCIDENT ANAL PREV, V40, P1282, DOI 10.1016/j.aap.2008.01.009; Engstrom J, 2005, TRANSPORT RES F-TRAF, V8, P97, DOI 10.1016/j.trf.2005.04.012; Guo F, 2009, 09UT006 NAT SURF TRA; Guo F, 2010, TRANSP RES RECORD, P66, DOI 10.3141/2147-09; Hancock PA, 2003, ACCIDENT ANAL PREV, V35, P501, DOI 10.1016/S0001-4575(02)00028-3; Harbluk JL, 2007, ACCIDENT ANAL PREV, V39, P372, DOI 10.1016/j.aap.2006.08.013; Horrey WJ, 2008, ACCIDENT ANAL PREV, V40, P675, DOI 10.1016/j.aap.2007.09.004; Hosking SG, 2006, 246 NAT ROADS MOT AS; Klauer S.G, 2006, IMPACT DRIVER INATTE; Lee SE, 2011, ACCIDENT ANAL PREV, V43, P1472, DOI 10.1016/j.aap.2011.02.026; Lee SE, 2008, TRANSPORT RES REC, P26, DOI 10.3141/2078-04; McEvoy SP, 2005, BRIT MED J, V331, P428, DOI 10.1136/bmj.38537.397512.55; National Highway Traffic Safety Administration, 2012, 811622 DOT HS NAT HI; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Simons-Morton BG, 2011, AM J PUBLIC HEALTH, V101, P2362, DOI 10.2105/AJPH.2011.300248; Victor T., 2005, THESIS UPPSALA U UPP; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0	18	472	478	4	188	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					54	59		10.1056/NEJMsa1204142	http://dx.doi.org/10.1056/NEJMsa1204142			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284XA	24382065	Green Submitted, Green Accepted			2022-12-28	WOS:000329354100010
J	Tumbale, P; Williams, JS; Schellenberg, MJ; Kunkel, TA; Williams, RS				Tumbale, Percy; Williams, Jessica S.; Schellenberg, Matthew J.; Kunkel, Thomas A.; Williams, R. Scott			Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity	NATURE			English	Article							RIBONUCLEOTIDE INCORPORATION; POLYMERASE; REMOVAL; SUPERFAMILY; MUTATIONS; ATAXIA	Faithful maintenance and propagation of eukaryotic genomes is ensured by three-step DNA ligation reactions used by ATP-dependent DNA ligases(1,2). Paradoxically, when DNA ligases encounter nicked DNA structures with abnormal DNA termini, DNA ligase catalytic activity can generate and/or exacerbate DNA damage through abortive ligation that produces chemically adducted, toxic 5'-adenylated (5'-AMP) DNA lesions(3-6). Aprataxin (APTX) reverses DNA adenylation but the context for deadenylation repair is unclear. Here we examine the importance of APTX to RNase-H2-dependent excision repair (RER) of a lesion that is very frequently introduced into DNA, a ribonucleotide. We show that ligases generate adenylated 5' ends containing a ribose characteristic of RNase H2 incision. APTX efficiently repairs adenylated RNA-DNA, and acting in an RNA-DNA damage response (RDDR), promotes cellular survival and prevents S-phase checkpoint activation in budding yeast undergoing RER. Structure-function studies of human APTX-RNA-DNA-AMP-Zn complexes define a mechanism for detecting and reversing adenylation at RNA-DNA junctions. This involves A-form RNA binding, proper protein folding and conformational changes, all of which are affected by heritable APTX mutations in ataxia with oculomotor apraxia 1. Together, these results indicate that accumulation of adenylated RNA-DNA may contribute to neurological disease.	[Tumbale, Percy; Williams, Jessica S.; Schellenberg, Matthew J.; Kunkel, Thomas A.; Williams, R. Scott] NIEHS, Struct Biol Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA; [Williams, Jessica S.; Kunkel, Thomas A.] NIEHS, Mol Genet Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Williams, RS (corresponding author), NIEHS, Struct Biol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.	williamsrs@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; Williams, R Scott/A-6059-2015	Kunkel, Thomas A./0000-0002-9900-1788; Williams, R Scott/0000-0002-4610-8397	US National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) [1Z01ES102765, Z01ES065070]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070, ZIAES065070, ZIAES102765] Funding Source: NIH RePORTER	US National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the intramural research program of the US National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) projects 1Z01ES102765 to R.S.W. and Z01ES065070 to T.A.K. X-ray diffraction data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID (or 22-BM) beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract number W-31-109-Eng-38. We thank L. Pedersen of the NIEHS collaborative crystallography group, and the Advanced Photon Source (APS) Southeast Regional Collaborative Access Team (SER-CAT) staff for assistance with crystallographic data collection. We thank L. Pedersen and B. Wallace for critical reading of the manuscript, J. Krahn for assistance with movies, and T. Ellenberger and P. O'Brien for DNA ligase expression vectors.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Daley JM, 2010, DNA REPAIR, V9, P690, DOI 10.1016/j.dnarep.2010.03.006; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003030; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pavlov YI, 2001, GENETICS, V159, P47; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Rass U, 2008, J BIOL CHEM, V283, P33994, DOI 10.1074/jbc.M807124200; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tranchant C, 2003, NEUROLOGY, V60, P868, DOI 10.1212/01.WNL.0000048562.88536.A4; Tumbale P, 2011, NAT STRUCT MOL BIOL, V18, P1189, DOI 10.1038/nsmb.2146; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9	38	73	76	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					111	+		10.1038/nature12824	http://dx.doi.org/10.1038/nature12824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24362567	Green Accepted			2022-12-28	WOS:000330648100042
J	Morey-Vargas, OL; Montori, VM				Morey-Vargas, Oscar L.; Montori, Victor M.			In type 2 diabetes, dipeptidyl peptidase-4 inhibitors do not increase pancreatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THERAPIES		[Morey-Vargas, Oscar L.; Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Morey-Vargas, OL (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Monami M, 2013, DIABETES OBES METAB, V15, P112, DOI 10.1111/dom.12000; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC8	10.7326/0003-4819-160-2-201401210-02008	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445718				2022-12-28	WOS:000330275600007
J	Mukherjee, D				Mukherjee, Debabrata			Antiplatelet therapies are more effective in smokers than nonsmokers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Texas Tech Univ, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Mukherjee, D (corresponding author), Texas Tech Univ, El Paso, TX 79905 USA.		Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Berger JS, 2009, CIRCULATION, V120, P2337, DOI 10.1161/CIRCULATIONAHA.109.866533; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V307, P2495, DOI 10.1001/jama.2012.5930; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC6	10.7326/0003-4819-160-2-201401210-02006	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445716				2022-12-28	WOS:000330275600005
J	Lane, R				Lane, Richard			Paul Glasziou: surfing the wave of evidence-based medicine	LANCET			English	Biographical-Item													Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				GLASZIOU P, PUBLICATION LIST	1	0	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					209	209		10.1016/S0140-6736(13)62386-7	http://dx.doi.org/10.1016/S0140-6736(13)62386-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24411648	Bronze			2022-12-28	WOS:000330027500014
J	Fisman, R				Fisman, Raymond			Straining Emergency Rooms by Expanding Health Insurance	SCIENCE			English	Editorial Material							DEPARTMENTS		Columbia Univ, New York, NY 10027 USA	Columbia University	Fisman, R (corresponding author), Columbia Univ, New York, NY 10027 USA.	rf250@columbia.edu						Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Billings J, 2013, HEALTH AFFAIR, V32, P2099, DOI 10.1377/hlthaff.2012.1276; Bishop TF, 2011, ARCH INTERN MED, V171, P1117, DOI 10.1001/archinternmed.2011.251; Chen C, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1109273; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Gonzalez Morganti K, 2013, EVOLVING ROLE EMERGE; Newton MF, 2008, JAMA-J AM MED ASSOC, V300, P1914, DOI 10.1001/jama.300.16.1914; Schuur JD, 2012, NEW ENGL J MED, V367, P391, DOI 10.1056/NEJMp1204431; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183	9	3	3	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					252	253		10.1126/science.1249341	http://dx.doi.org/10.1126/science.1249341			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	289YN	24385605				2022-12-28	WOS:000329718600019
J	Van Oystaeyen, A; Oliveira, RC; Holman, L; van Zweden, JS; Romero, C; Oi, CA; d'Ettorre, P; Khalesi, M; Billen, J; Wackers, F; Millar, JG; Wenseleers, T				Van Oystaeyen, Annette; Oliveira, Ricardo Caliari; Holman, Luke; van Zweden, Jelle S.; Romero, Carmen; Oi, Cintia A.; d'Ettorre, Patrizia; Khalesi, Mohammadreza; Billen, Johan; Waeckers, Felix; Millar, Jocelyn G.; Wenseleers, Tom			Conserved Class of Queen Pheromones Stops Social Insect Workers from Reproducing	SCIENCE			English	Article							IDENTIFICATION; HYDROCARBONS	A major evolutionary transition to eusociality with reproductive division of labor between queens and workers has arisen independently at least 10 times in the ants, bees, and wasps. Pheromones produced by queens are thought to play a key role in regulating this complex social system, but their evolutionary history remains unknown. Here, we identify the first sterility-inducing queen pheromones in a wasp, bumblebee, and desert ant and synthesize existing data on compounds that characterize female fecundity in 64 species of social insects. Our results show that queen pheromones are strikingly conserved across at least three independent origins of eusociality, with wasps, ants, and some bees all appearing to use nonvolatile, saturated hydrocarbons to advertise fecundity and/or suppress worker reproduction. These results suggest that queen pheromones evolved from conserved signals of solitary ancestors.	[Van Oystaeyen, Annette; Oliveira, Ricardo Caliari; van Zweden, Jelle S.; Oi, Cintia A.; Billen, Johan; Wenseleers, Tom] Katholieke Univ Leuven, Inst Zool, Lab Socioecol & Social Evolut, B-3000 Louvain, Belgium; [Holman, Luke] Australian Natl Univ, Res Sch Biol, Div Ecol Evolut & Genet, Canberra, ACT 0200, Australia; [Romero, Carmen; Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Romero, Carmen; Millar, Jocelyn G.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [d'Ettorre, Patrizia] Univ Paris 13, Lab Expt & Comparat Ethol LEEC, Sorbonne Paris Cite, F-93430 Villetaneuse, France; [Khalesi, Mohammadreza] Katholieke Univ Leuven, Dept Microbial & Mol Syst MS, Ctr Food & Microbial Technol, B-3001 Heverlee, Belgium; [Waeckers, Felix] Lancaster Environm Ctr, Lancaster LA1 4YQ, England	KU Leuven; Australian National University; University of California System; University of California Riverside; University of California System; University of California Riverside; Universite Paris 13; KU Leuven; Lancaster University	Van Oystaeyen, A (corresponding author), Katholieke Univ Leuven, Inst Zool, Lab Socioecol & Social Evolut, Naamsestr 59 Box 2466, B-3000 Louvain, Belgium.	annette.vanoystaeyen@bio.kuleuven.be; tom.wenseleers@bio.kuleuven.be	Holman, Luke/L-4392-2014; Van Oystaeyen, Annette/AEG-9300-2022; Oliveira, Ricardo/AAQ-1394-2021; van Zweden, Jelle S./AAD-7858-2020; Wenseleers, Tom/J-3960-2013; Oliveira, Ricardo Caliari/P-4260-2016	Oliveira, Ricardo/0000-0002-8996-1291; van Zweden, Jelle S./0000-0001-5283-5470; Wenseleers, Tom/0000-0002-1434-861X; Oliveira, Ricardo Caliari/0000-0002-8996-1291; Billen, Johan/0000-0002-2392-7293; Oi, Cintia Akemi/0000-0002-3682-8219; Millar, Jocelyn/0000-0001-7639-9001; Khalesi, Mohammadreza/0000-0001-6575-1401	Research Foundation Flanders (FWO); KU Leuven Centre of Excellence [PF/2010/007]; Erasmus Mundus Master in Evolutionary Biology (MEME); European Union [FP7-MC-ERG-2009-256524]; CNPq-Brazil [201959/2012-7, 238127/2012-5]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Research Foundation Flanders (FWO)(FWO); KU Leuven Centre of Excellence; Erasmus Mundus Master in Evolutionary Biology (MEME); European Union(European Commission); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Research Foundation Flanders (FWO), KU Leuven Centre of Excellence PF/2010/007 and the Erasmus Mundus Master in Evolutionary Biology (MEME) for funding, X. Cerda and A. Lenoir for help with collecting the Cataglyphis ants, and M. Ayasse and R. Gadagkar for comments. P.d.E. was supported by a European Union Grant (FP7-MC-ERG-2009-256524) and C.A.O. and R.C.O. by scholarships from CNPq-Brazil (201959/2012-7 and 238127/2012-5). We are also grateful to G. Derdelinckx and K. Vestrepen for allowing access to their Shimadzu gas chromatograph- mass spectrometer. Our data are available from the Dryad Repository: http://dx.doi.org/10.5061/dryad.cg4qp.	Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Fischman BJ, 2011, P NATL ACAD SCI USA, V108, P10847, DOI 10.1073/pnas.1100301108; Holman L, 2013, J EVOLUTION BIOL, V26, P1549, DOI 10.1111/jeb.12162; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P3793, DOI 10.1098/rspb.2010.0984; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Hunt JH, 2005, SCIENCE, V308, P264, DOI 10.1126/science.1109724; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Liebig J, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P254, DOI 10.1017/CBO9780511711909.014; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Mohammedi A, 1998, NATURWISSENSCHAFTEN, V85, P455, DOI 10.1007/s001140050531; Monnin T, 2006, ANN ZOOL FENN, V43, P515; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Smith AA, 2012, BEHAV ECOL SOCIOBIOL, V66, P1267, DOI 10.1007/s00265-012-1380-x; Smith AA, 2009, CURR BIOL, V19, P78, DOI 10.1016/j.cub.2008.11.059; Wilson JS, 2013, EVOL BIOL, V40, P101, DOI 10.1007/s11692-012-9189-0	18	228	230	11	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					287	290		10.1126/science.1244899	http://dx.doi.org/10.1126/science.1244899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436417				2022-12-28	WOS:000329718600033
J	Laguette, N; Bregnard, C; Hue, P; Basbous, J; Yatim, A; Larroque, M; Kirchhoff, F; Constantinou, A; Sobhian, B; Benkirane, M				Laguette, Nadine; Bregnard, Christelle; Hue, Pauline; Basbous, Jihane; Yatim, Ahmad; Larroque, Marion; Kirchhoff, Frank; Constantinou, Angelos; Sobhian, Bijan; Benkirane, Monsef			Premature Activation of the SLX4 Complex by Vpr Promotes G2/M Arrest and Escape from Innate Immune Sensing	CELL			English	Article							VIRUS TYPE-1 VPR; HOLLIDAY JUNCTION RESOLVASE; CELL-CYCLE ARREST; HIV-1 ACCESSORY PROTEINS; UBIQUITIN LIGASE; G(2); MUS81; GENE; RECOMBINATION; CHECKPOINT	The HIV auxiliary protein Vpr potently blocks the cell cycle at the G2/M transition. Here, we show that G2/M arrest results from untimely activation of the structure-specific endonuclease (SSE) regulator SLX4 complex (SLX4com) by Vpr, a process that requires VPRBP-DDB1-CUL4 E3-ligase complex. Direct interaction of Vpr with SLX4 induced the recruitment of VPRBP and kinase-active PLK1, enhancing the cleavage of DNA by SLX4-associated MUS81-EME1 endonucleases. G2/M arrest-deficient Vpr alleles failed to interact with SLX4 or to induce recruitment of MUS81 and PLK1. Furthermore, knockdown of SLX4, MUS81, or EME1 inhibited Vpr-induced G2/M arrest. In addition, we show that the SLX4com is involved in suppressing spontaneous and HIV-1-mediated induction of type 1 interferon and establishment of antiviral responses. Thus, our work not only reveals the identity of the cellular factors required for Vpr-mediated G2/M arrest but also identifies the SLX4com as a regulator of innate immunity.	[Laguette, Nadine; Bregnard, Christelle; Hue, Pauline; Yatim, Ahmad; Sobhian, Bijan; Benkirane, Monsef] Inst Genet Humaine, Mol Virol Lab, F-34000 Montpellier, France; [Basbous, Jihane; Larroque, Marion; Constantinou, Angelos] CNRS, UPR1142, Lab Instabilite Genome & Canc, F-34000 Montpellier, France; [Kirchhoff, Frank] Univ Ulm, Med Ctr, Inst Mol Virol, D-81089 Ulm, Germany	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ulm University	Laguette, N (corresponding author), Inst Genet Humaine, Mol Virol Lab, F-34000 Montpellier, France.	nadine.laguette@igh.cnrs.fr; monsef.benkirane@igh.cnrs.fr	Kirchhoff, Frank/O-8367-2018; Basbous, Jihane/AAQ-2040-2021; Constantinou, Angelos/E-5337-2013; Laguette, Nadine/A-2764-2019	Kirchhoff, Frank/0000-0002-7052-2360; Basbous, Jihane/0000-0002-3943-627X; Constantinou, Angelos/0000-0002-2994-8140; Laguette, Nadine/0000-0001-8072-5607; Sobhian, Bijan/0000-0001-7255-6006	ERC [250333]; SIDACTION (Fonds de dotation PIERRE BERGE); ANRS; European FP7 "HIT HIDDEN HIV" [305762]; la Fondation ARC pour la Recherche sur le Cancer [8604XA1020T]; SIDACTION; FRM	ERC(European Research Council (ERC)European Commission); SIDACTION (Fonds de dotation PIERRE BERGE); ANRS(ANRSFrench National Research Agency (ANR)); European FP7 "HIT HIDDEN HIV"; la Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); SIDACTION; FRM(Fondation pour la Recherche Medicale)	We thank members of the Molecular Virology lab for critical reading of the manuscript, K.J. Patel for MEF<SUP>SLX4-/-</SUP> cells, A. Smogorzewska for RA3331<SUP>SLX4-/-</SUP> and RA3331<SUP>SLX4+/+</SUP> cells, R. Hakem for MEF<SUP>MUS81-/-</SUP> cells, W. Harper for HIS<INF>6</INF>-tagged proteins and FLAG-tagged SLX4, and I. Poser for the BAC modification cassette and HeLa Kyoto cells. We are grateful to Montpellier RIO Imaging for help with the microscopy analyses. This work was supported by ERC (250333), SIDACTION (Fonds de dotation PIERRE BERGE), ANRS, and European FP7 "HIT HIDDEN HIV" (305762). Work in the laboratory of A.C. was supported by "la Fondation ARC pour la Recherche sur le Cancer" (8604XA1020T). P.H. and A.Y. were supported by SIDACTION and FRM, respectively.	Beck H, 2012, MOL CELL BIOL, V32, P4226, DOI 10.1128/MCB.00412-12; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Blais V, 2004, MOL BIOL CELL, V15, P552, DOI 10.1091/mbc.E03-08-0580; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Dehe PM, 2013, NAT STRUCT MOL BIOL, V20, P598, DOI 10.1038/nsmb.2550; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Fagerlie SR, 2004, J IMMUNOL, V173, P3863, DOI 10.4049/jimmunol.173.6.3863; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fugger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2395; Gallo-Fernandez M, 2012, NUCLEIC ACIDS RES, V40, P8325, DOI 10.1093/nar/gks599; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kim Y, 2013, BLOOD, V121, P54, DOI 10.1182/blood-2012-07-441212; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Matos J, 2013, CELL REP, V4, P76, DOI 10.1016/j.celrep.2013.05.039; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Poon B, 1997, J VIROL, V71, P3961, DOI 10.1128/JVI.71.5.3961-3971.1997; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Saugar I, 2013, NUCLEIC ACIDS RES, V41, P8943, DOI 10.1093/nar/gkt645; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sengerova B, 2011, CELL CYCLE, V10, P3999, DOI 10.4161/cc.10.23.18385; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Svendsen JM, 2010, GENE DEV, V24, P521, DOI 10.1101/gad.1903510; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tachiwana H, 2006, CANCER RES, V66, P627, DOI 10.1158/0008-5472.CAN-05-3144; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	56	153	154	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					134	145		10.1016/j.cell.2013.12.011	http://dx.doi.org/10.1016/j.cell.2013.12.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24412650	Bronze			2022-12-28	WOS:000329912200016
J	Muijres, FT; Dickinson, MH				Muijres, Florian T.; Dickinson, Michael H.			BIRD FLIGHT Fly with a little flap from your friends	NATURE			English	Editorial Material							ENERGY SAVINGS		[Muijres, Florian T.; Dickinson, Michael H.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Muijres, FT (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	flyman@uw.edu	Muijres, Florian Titus/N-6483-2015	Muijres, Florian Titus/0000-0002-5668-0653				BADGEROW JP, 1981, J THEOR BIOL, V93, P41, DOI 10.1016/0022-5193(81)90055-2; HUMMEL D, 1983, J THEOR BIOL, V104, P321, DOI 10.1016/0022-5193(83)90110-8; Lissaman P. B. S., 1968, J AIRCRAFT, V5, P17; Maeng JS, 2013, J THEOR BIOL, V320, P76, DOI 10.1016/j.jtbi.2012.11.032; Ning S.A., 2011, THESIS STANFORD U; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; Vachon M. J., 2002, AIAA ATM FLIGHT MECH; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; Willis D. J., 2007, 25 AIAA APPL AER C	9	8	9	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					295	296		10.1038/505295a	http://dx.doi.org/10.1038/505295a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429623				2022-12-28	WOS:000329621800023
J	Smith, R; Gotzsche, PC; Groves, T				Smith, Richard; Gotzsche, Peter C.; Groves, Trish			Should journals stop publishing research funded by the drug industry?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS; AUTHORSHIP		[Smith, Richard] Patients Know Best, London SW4 0LD, England; [Gotzsche, Peter C.] Nord Cochrane Ctr, Copenhagen, Denmark; [Groves, Trish] BMJ, London WC1H 9JR, England		Smith, R (corresponding author), Patients Know Best, London SW4 0LD, England.	richardswsmith@yahoo.co.uk; tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				AllTrials, 2013, ALL RESULTS REPORTED; Bruntland GH, 1999, DIRECTOR GENERALS AD; Buchkowsky SS, 2004, ANN PHARMACOTHER, V38, P579, DOI 10.1345/aph.1D267; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; Dickersin K., 2008, REPORTING AND OTHER; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Garattini S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1025; Godlee F, 2012, BMJ-BRIT MED J, V345, pe7888; Godlee F, 2013, BMJ; Godlee F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5193; Goldacre Ben, 2012, BAD PHARMA; Gotzsche PC, 2013, DEADLY MEDICINES AND; Handel AE, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4212; Healy David, 2004, LET THEM EAT PROZAC; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Proctor CJ, 2013, BMJ; Sackett DL, 2003, BRIT MED J, V327, P1442, DOI 10.1136/bmj.327.7429.1442; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Serebruany VL, 2012, THROMB HAEMOSTASIS, V108, P412, DOI 10.1160/TH12-04-0251; Smith R., 2006, THE TROUBLE WITH MED; Smith R., 2013, BMJ-BRIT MED J; Smith R, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010006; Smith Richard, 2012, BMJ; Stern S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001070; van Luijn JCF, 2010, EUR J CLIN PHARMACOL, V66, P445, DOI 10.1007/s00228-010-0808-3; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128	28	13	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2014	348								g171	10.1136/bmj.g171	http://dx.doi.org/10.1136/bmj.g171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MN	24423895				2022-12-28	WOS:000329975900008
J	Huskinson, B; Marshak, MP; Suh, C; Er, S; Gerhardt, MR; Galvin, CJ; Chen, XD; Aspuru-Guzik, A; Gordon, RG; Aziz, MJ				Huskinson, Brian; Marshak, Michael P.; Suh, Changwon; Er, Sueleyman; Gerhardt, Michael R.; Galvin, Cooper J.; Chen, Xudong; Aspuru-Guzik, Alan; Gordon, Roy G.; Aziz, Michael J.			A metal-free organic-inorganic aqueous flow battery	NATURE			English	Article							REDOX; ANTHRAQUINONE; REDUCTION; ENERGIES; PROGRESS; DENSITY; FIELD	As the fraction of electricity generation from intermittent renewable sources-such as solar or wind-grows, the ability to store large amounts of electrical energy is of increasing importance. Solid-electrode batteries maintain discharge at peak power for far too short a time to fully regulate wind or solar power output(1,2). In contrast, flow batteries can independently scale the power (electrode area) and energy (arbitrarily large storage volume) components of the system by maintaining all of the electro-active species in fluid form(3-5). Wide-scale utilization of flow batteries is, however, limited by the abundance and cost of these materials, particularly those using redox-active metals and precious-metal electrocatalysts(6,7). Here we describe a class of energy storage materials that exploits the favourable chemical and electro-chemical properties of a family of molecules known as quinones. The example we demonstrate is ametal-free flow battery based on the redox chemistry of 9,10-anthraquinone-2,7-disulphonic acid (AQDS). AQDS undergoes extremely rapid and reversible two-electron two-proton reduction on a glassy carbon electrode in sulphuric acid. An aqueous flow battery with inexpensive carbon electrodes, combining the quinone/hydroquinone couple with the Br-2/Br- redox couple, yields a peak galvanic power density exceeding 0.6 W cm(-2) at 1.3 A cm(-2). Cycling of this quinone-bromide flow battery showed >99 per cent storage capacity retention per cycle. The organic anthraquinone species can be synthesized from inexpensive commodity chemicals(8). This organic approach permits tuning of important properties such as the reduction potential and solubility by adding functional groups: for example, we demonstrate that the addition of two hydroxy groups to AQDS increases the open circuit potential of the cell by 11% and we describe a pathway for further increases in cell voltage. The use of p-aromatic redox-active organic molecules instead of redox-active metals represents a new and promising direction for realizing massive electrical energy storage at greatly reduced cost.	[Huskinson, Brian; Marshak, Michael P.; Gerhardt, Michael R.; Gordon, Roy G.; Aziz, Michael J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Marshak, Michael P.; Suh, Changwon; Er, Sueleyman; Galvin, Cooper J.; Chen, Xudong; Aspuru-Guzik, Alan; Gordon, Roy G.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Er, Sueleyman] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands	Harvard University; Harvard University; Eindhoven University of Technology	Aziz, MJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St, Cambridge, MA 02138 USA.	maziz@harvard.edu	Chen, Xudong/H-1520-2011; Gerhardt, Michael R./AAG-2371-2019; Marshak, Michael P/N-3213-2013; Suh, Changwon/N-1297-2014; Er, Süleyman/G-4145-2011; Aziz, Michael/AAK-4866-2020	Gerhardt, Michael R./0000-0002-1272-3607; Marshak, Michael P/0000-0002-8027-2705; Er, Süleyman/0000-0002-5005-3894; Aziz, Michael/0000-0001-9657-9456	US Department of Energy ARPA-E Award [DE-AR0000348]; Harvard School of Engineering and Applied Sciences; Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation [OCI-1053575]; NSF; Foundation for Fundamental Research on Matter (FOM); Netherlands Organization for Scientific Research (NWO)	US Department of Energy ARPA-E Award(United States Department of Energy (DOE)); Harvard School of Engineering and Applied Sciences; Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was partially funded through US Department of Energy ARPA-E Award DE-AR0000348 and partially funded through the Harvard School of Engineering and Applied Sciences. Theoretical work was funded in part through the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575. B. H. was supported by an NSF Graduate Research Fellowship. S. E. performed work aspart of the Fellowships for Young Energy Scientists programme of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organization for Scientific Research (NWO). We thank T. Betley, L. Hartle, R. Burton and R. Duncan for discussions.	BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Conant JB, 1922, J AM CHEM SOC, V44, P1382, DOI 10.1021/ja01427a020; Crossley ML, 1915, J AM CHEM SOC, V37, P2178, DOI 10.1021/ja02174a028; DEWAR MJS, 1969, TETRAHEDRON, V25, P4529, DOI 10.1016/S0040-4020(01)82995-1; Forster RJ, 2001, J ELECTROANAL CHEM, V498, P127, DOI 10.1016/S0022-0728(00)00331-4; Gordon O. W., 1997, US, Patent No. [5,595,628, 5595628]; Guin PS, 2011, INT J ELECTROCHEM, V2011, DOI 10.4061/2011/816202; Haase J., 1973, Czechoslovakian patent, Patent No. [148,977, 148977]; Hongo K, 2010, J PHYS CHEM LETT, V1, P1789, DOI 10.1021/jz100418p; Huskinson B, 2012, ENERG ENVIRON SCI, V5, P8690, DOI 10.1039/c2ee22274d; Kazacos G. C., 2008, MATER FORUM, V32, P72; KELSALL GH, 1993, J APPL ELECTROCHEM, V23, P296, DOI 10.1007/BF00296684; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Leung P, 2012, RSC ADV, V2, P10125, DOI 10.1039/c2ra21342g; Marten B, 1996, J PHYS CHEM-US, V100, P11775, DOI 10.1021/jp953087x; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Nguyen T, 2010, ELECTROCHEM SOC INTE, V19, P54, DOI 10.1149/2.F06103if; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pullman B., 1963, QUANTUM BIOCHEMISTRY, P475; Qu RJ, 2012, J CHEM ENG DATA, V57, P2442, DOI 10.1021/je300407g; Rugolo J, 2012, ENERG ENVIRON SCI, V5, P7151, DOI 10.1039/c2ee02542f; Skyllas-Kazacos M, 2011, J ELECTROCHEM SOC, V158, pR55, DOI 10.1149/1.3599565; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; US Geological Survey, 2010, 2010 MIN YB BROM; US Geological Survey, 2013, VAN MIN COMM SUMM; Wang JM, 2011, COMB CHEM HIGH T SCR, V14, P328, DOI 10.2174/138620711795508331; Wang W, 2012, CHEM COMMUN, V48, P6669, DOI 10.1039/c2cc32466k; Wass JRTJ, 2006, J PHYS CHEM A, V110, P2005, DOI 10.1021/jp055414z; Weber AZ, 2011, J APPL ELECTROCHEM, V41, P1137, DOI 10.1007/s10800-011-0348-2; Xu YC, 2009, INSIDE THE WORLD BANK: EXPLODING THE MYTH OF THE MONOLITHIC BANK, P1, DOI 10.1002/cta.587; Yang ZG, 2011, CHEM REV, V111, P3577, DOI 10.1021/cr100290v; Yao M, 2010, J POWER SOURCES, V195, P8336, DOI 10.1016/j.jpowsour.2010.06.069; YEO RS, 1979, J ELECTROCHEM SOC, V126, P1682, DOI 10.1149/1.2128776	36	989	1017	58	1255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					195	+		10.1038/nature12909	http://dx.doi.org/10.1038/nature12909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24402280	Green Submitted			2022-12-28	WOS:000329441500034
J	Lamas, D				Lamas, Daniela			Chronic Critical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROLONGED MECHANICAL VENTILATION; OUTCOMES		[Lamas, Daniela] Brigham & Womens Hosp, Beth Israel Deaconess Med Ctr, Dept Pulm, Boston, MA 02115 USA; [Lamas, Daniela] Brigham & Womens Hosp, Beth Israel Deaconess Med Ctr, Dept Crit Care Med, Boston, MA 02115 USA; [Lamas, Daniela] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Lamas, D (corresponding author), Brigham & Womens Hosp, Beth Israel Deaconess Med Ctr, Dept Pulm, 75 Francis St, Boston, MA 02115 USA.							Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Kahn JM, 2013, JAMA-J AM MED ASSOC, V309, P719, DOI 10.1001/jama.2013.848; Nelson JE, 2005, J CRIT CARE, V20, P79, DOI 10.1016/j.jcrc.2004.11.003; Nelson JE, 2007, ARCH INTERN MED, V167, P2509, DOI 10.1001/archinte.167.22.2509; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Teno JM, 2000, J AM GERIATR SOC, V48, pS70, DOI 10.1111/j.1532-5415.2000.tb03144.x	7	44	52	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					175	177		10.1056/NEJMms1310675	http://dx.doi.org/10.1056/NEJMms1310675			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401058				2022-12-28	WOS:000336119800016
J	Cole, HM; Fiore, MC				Cole, Helene M.; Fiore, Michael C.			The War Against Tobacco 50 Years and Counting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING; CARCINOMA		[Cole, Helene M.] JAMA, Chicago, IL 60611 USA; [Fiore, Michael C.] Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cole, HM (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	helene.cole@jamanetwork.org			NATIONAL CANCER INSTITUTE [P01CA180945, R35CA197573] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA019706] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA180945] Funding Source: Medline; NHLBI NIH HHS [R01 HL109031] Funding Source: Medline; NIDA NIH HHS [P50 DA019706] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 2012, PREVENTING TOBACCO U; [Anonymous], 1988, THE HEALTH CONSEQUEN; Brandt Allan M., 2007, THE CIGARETTE CENTUR; Centers for Disease Control and Prevention, NATIONAL HEALTH INTE; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; SNEGIREFF LS, 1954, NEW ENGL J MED, V250, P1042, DOI 10.1056/NEJM195406172502408; US Department of Health and Human Services, 1986, THE HEALTH CONSEQUEN; *US DHEW, 1964, PHS PUBLICATION, V1103; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001	10	25	29	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					131	132		10.1001/jama.2013.280767	http://dx.doi.org/10.1001/jama.2013.280767			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399546	Green Accepted			2022-12-28	WOS:000329339400013
J	Fynbo, JPU				Fynbo, Johan P. U.			An Exceptionally Bright Gamma-Ray Burst	SCIENCE			English	Editorial Material									Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Fynbo, JPU (corresponding author), Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, Juliane Maries Vej 30, DK-2100 Copenhagen, Denmark.	jfynbo@dark-cosmology.dk	Fynbo, Johan/L-8496-2014	Fynbo, Johan/0000-0002-8149-8298				Ackermann M, 2014, SCIENCE, V343, P42, DOI 10.1126/science.1242353; Brahe T., 1573, STELLA NOVA; Cucchiara A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/7; Gehrels N, 2009, ANNU REV ASTRON ASTR, V47, P567, DOI 10.1146/annurev.astro.46.060407.145147; Grieco V, 2012, MON NOT R ASTRON SOC, V423, P3049, DOI 10.1111/j.1365-2966.2012.21052.x; KLEBESADEL RW, 1973, ASTROPHYS J, V182, pL85, DOI 10.1086/181225; Levan A. J., 2013, ARXIV13075338; Maselli A, 2014, SCIENCE, V343, P48, DOI 10.1126/science.1242279; Preece R, 2014, SCIENCE, V343, P51, DOI 10.1126/science.1242302; Vestrand WT, 2014, SCIENCE, V343, P38, DOI 10.1126/science.1242316; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Xu D, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/98	12	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					34	35		10.1126/science.1248522	http://dx.doi.org/10.1126/science.1248522			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385623				2022-12-28	WOS:000329162000039
J	Wilkins, BJ; Rall, NA; Ostwal, Y; Kruitwagen, T; Hiragami-Hamada, K; Winkler, M; Barral, Y; Fischle, W; Neumann, H				Wilkins, Bryan J.; Rall, Nils A.; Ostwal, Yogesh; Kruitwagen, Tom; Hiragami-Hamada, Kyoko; Winkler, Marco; Barral, Yves; Fischle, Wolfgang; Neumann, Heinz			A Cascade of Histone Modifications Induces Chromatin Condensation in Mitosis	SCIENCE			English	Article							GENETIC-CODE EXPANSION; CHROMOSOME COMPACTION; H4-K16 ACETYLATION; AURORA B; H3; PHOSPHORYLATION; CENTROMERE; KINASE; YEAST; ANAPHASE	Metaphase chromosomes are visible hallmarks of mitosis, yet our understanding of their structure and of the forces shaping them is rudimentary. Phosphorylation of histone H3 serine 10 (H3 S10) by Aurora B kinase is a signature event of mitosis, but its function in chromatin condensation is unclear. Using genetically encoded ultraviolet light-inducible cross-linkers, we monitored protein-protein interactions with spatiotemporal resolution in living yeast to identify the molecular details of the pathway downstream of H3 S10 phosphorylation. This modification leads to the recruitment of the histone deacetylase Hst2p that subsequently removes an acetyl group from histone H4 lysine 16, freeing the H4 tail to interact with the surface of neighboring nucleosomes and promoting fiber condensation. This cascade of events provides a condensin-independent driving force of chromatin hypercondensation during mitosis.	[Wilkins, Bryan J.; Rall, Nils A.; Winkler, Marco; Neumann, Heinz] Univ Gottingen, Inst Microbiol & Genet, Free Floater Jr Res Grp Appl Synthet Biol, D-37077 Gottingen, Germany; [Ostwal, Yogesh; Hiragami-Hamada, Kyoko; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Kruitwagen, Tom; Barral, Yves] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	University of Gottingen; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Neumann, H (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Free Floater Jr Res Grp Appl Synthet Biol, D-37077 Gottingen, Germany.	hneumann@uni-goettingen.de	Neumann, Heinz/ABC-7323-2021; Neumann, Heinz/F-7875-2014	Neumann, Heinz/0000-0001-9657-1913; Barral, Yves/0000-0002-0989-3373	Alexander von Humboldt Foundation; German Research Foundation; University of Gottingen; Max Planck Society; Marie Curie Intra-European Fellowship for Career Development (IEF, FP7); European Research Council	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG)); University of Gottingen; Max Planck Society(Max Planck SocietyFoundation CELLEX); Marie Curie Intra-European Fellowship for Career Development (IEF, FP7); European Research Council(European Research Council (ERC)European Commission)	We thank J. W. Chin for materials. B. J. W. is supported by a postdoctoral fellowship of the Alexander von Humboldt Foundation. Research in the laboratory of H.N. is funded by the German Research Foundation (Emmy-Noether Programme) and the Freefloater Programme of the University of Gottingen. Work in the laboratory of W. F. is supported by the Max Planck Society. K. H.-H. is supported by a Marie Curie Intra-European Fellowship for Career Development (IEF, FP7). T. K. and Y.B. are supported by a grant from the European Research Council to Y.B.	Adhvaryu KK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002423; Campbell CS, 2013, NATURE, V497, P118, DOI 10.1038/nature12057; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Fry CJ, 2004, COLD SPRING HARB SYM, V69, P219, DOI 10.1101/sqb.2004.69.219; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Neumann H, 2012, FEBS LETT, V586, P2057, DOI 10.1016/j.febslet.2012.02.002; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498	26	155	159	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					77	80		10.1126/science.1244508	http://dx.doi.org/10.1126/science.1244508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385627	Green Published			2022-12-28	WOS:000329162000051
J	Meretoja, TJ; Leidenius, MHK; Tasmuth, T; Sipila, R; Kalso, E				Meretoja, Tuomo J.; Leidenius, Marjut H. K.; Tasmuth, Tiina; Sipila, Reetta; Kalso, Eija			Pain at 12 Months After Surgery for Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PERSISTENT PAIN		[Meretoja, Tuomo J.; Leidenius, Marjut H. K.] Univ Helsinki, Cent Hosp, Breast Surg Unit, FI-00029 Helsinki, Finland; [Tasmuth, Tiina] Univ Helsinki, Cent Hosp, Dept Oncol, FI-00029 Helsinki, Finland; [Sipila, Reetta; Kalso, Eija] Univ Helsinki, Cent Hosp, Dept Anaesthesia Intens Care Med Emergency Med &, FI-00029 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Meretoja, TJ (corresponding author), Univ Helsinki, Cent Hosp, POB 140, FI-00029 Helsinki, Finland.	tuomo.meretoja@fimnet.fi		Meretoja, Tuomo/0000-0002-2691-0710; Kalso, Eija/0000-0002-4899-605X				BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Sipila R, 2012, BRIT J CANCER, V107, P1459, DOI 10.1038/bjc.2012.445; Spielberger CD, 1983, MANUAL FOR THE STATE	6	80	82	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					90	92		10.1001/jama.2013.278795	http://dx.doi.org/10.1001/jama.2013.278795			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24381969				2022-12-28	WOS:000329161400022
J	Anyaegbunam, JA; Sotsky, J; Salib, C; Kissler, MJ; Jiao, JM; Charon, R				Anyaegbunam, Jennifer A.; Sotsky, Jennifer; Salib, Christopher; Kissler, Mark J.; Jiao, Jocelyn M.; Charon, Rita			Five Voices, One Story	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Anyaegbunam, Jennifer A.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Sotsky, Jennifer; Charon, Rita] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Salib, Christopher] Meharry Med Coll, Nashville, TN 37208 USA; [Kissler, Mark J.] Baylor Coll Med, Houston, TX 77030 USA; [Jiao, Jocelyn M.] Icahn Sch Med Mt Sinai, New York, NY USA	University of Virginia; Columbia University; Meharry Medical College; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai	Anyaegbunam, JA (corresponding author), Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.	jadaeze@gmail.com		Kissler, Mark/0000-0001-6969-6243	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL108014] Funding Source: NIH RePORTER; NHLBI NIH HHS [R25 HL108014] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bauby J.-D, 1998, DIVING BELL BUTTERFL; Irvine CA, 2005, LIT MED, V24, P8, DOI 10.1353/lm.2005.0027; Williams William Carlos, 1984, THE DOCTOR STORIES, P56	3	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2615	2616		10.1001/jama.2013.283712	http://dx.doi.org/10.1001/jama.2013.283712			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368459				2022-12-28	WOS:000328818000010
J	Bundred, N; Dixon, JM				Bundred, Nigel; Dixon, J. Michael			Carcinoma in situ	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL ADJUVANT BREAST; WOMEN								Breast Cancer Now [EDN-DIXON] Funding Source: researchfish	Breast Cancer Now		Abe O., 2010, Journal of the National Cancer Institute Monographs, P162, DOI 10.1093/jncimonographs/lgq039; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P197, DOI 10.1002/1097-0142(19860115)57:2<197::AID-CNCR2820570203>3.0.CO;2-N; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; Page D.L., 2004, BREAST, V1, P3; Sauven P, 2004, EUR J CANCER, V40, P653, DOI 10.1016/j.ejca.2003.10.028; Wolmark N, 1998, BREAST CANC RES TREA, V50, P227	9	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2013	347								f3289	10.1136/bmj.f3289	http://dx.doi.org/10.1136/bmj.f3289			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HH	24365752				2022-12-28	WOS:000329160600001
J	Llanos-Cuentas, A; Lacerda, MV; Rueangweerayut, R; Krudsood, S; Gupta, SK; Kochar, SK; Arthur, P; Chuenchom, N; Mohrle, JJ; Duparc, S; Ugwuegbulam, C; Kleim, JP; Carter, N; Green, JA; Kellam, L				Llanos-Cuentas, Alejandro; Lacerda, Marcus V.; Rueangweerayut, Ronnatrai; Krudsood, Srivicha; Gupta, Sandeep K.; Kochar, Sanjay K.; Arthur, Preetam; Chuenchom, Nuttagarn; Moehrle, Joerg J.; Duparc, Stephan; Ugwuegbulam, Cletus; Kleim, Joerg-Peter; Carter, Nick; Green, Justin A.; Kellam, Lynda			Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study	LANCET			English	Article							WR 238605; SAFETY; PRIMAQUINE; EFFICACY; REGIMENS	Background Clinical effectiveness of previous regimens to treat Plasmodium vivax infection have been hampered by compliance. We aimed to assess the dose-response, safety, and tolerability of single-dose tafenoquine plus 3-day chloroquine for P vivax malaria radical cure. Methods In this double-blind, randomised, dose-ranging phase 2b study, men and women (aged >= 16 years) with microscopically confirmed P vivax monoinfection (parasite density >100 to <100 000 per mu L blood) were enrolled from community health centres and hospitals across seven sites in Brazil, Peru, India, and Thailand. Patients with glucose-6-phosphate dehydrogenase enzyme activity of less than 70% were excluded. Eligible patients received chloroquine (days 1-3) and were randomly assigned (1:1:1:1:1:1) by a computer-generated randomisation schedule to receive single-dose tafenoquine 50 mg, 100 mg, 300 mg, or 600 mg, primaquine 15 mg for 14 days, or chloroquine alone. Randomisation was stratified by baseline parasite count (<= 7500 and >7500 per mu L blood). The primary efficacy endpoint was relapse-free efficacy at 6 months from initial dose (ie, clearance of initial infection without subsequent microscopically confirmed infection), analysed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01376167. Findings Between Sept 19, 2011, and March 25, 2013, 329 patients were randomly assigned to a treatment group (chloroquine plus tafenoquine 50 mg [n=55], 100 mg [n=57], 300 mg [n=57], 600 mg [n=56]; or to chloroquine plus primaquine [n=50]; or chloroquine alone [n=54]). Relapse-free efficacy at 6 months was 57.7% (95% CI 43-70) with tafenoquine 50 mg, 54.1% (40-66) with tafenoquine 100 mg, 89.2% (77-95) with tafenoquine 300 mg, 91.9% (80-97) with tafenoquine 600 mg, 77.3% (63-87) with primaquine, and 37.5% (23-52) with chloroquine alone. Tafenoquine 300 mg and 600 mg had better efficacy than chloroquine alone (treatment differences 51.7% [95% CI 35-69], p<0.0001, with tafenoquine 300 mg and 54.5% [38-71], p<0.0001, with tafenoquine 600 mg), as did primaquine (treatment difference 39.9% [21-59], p=0.0004). Adverse events were similar between treatments. 29 serious adverse events occurred in 26 (8%) of 329 patients; QT prolongation was the most common serious adverse event (11 [3%] of 329), occurring in five (2%) of 225 patients receiving tafenoquine, four (8%) of 50 patients receiving primaquine, and two (4%) of 54 patients receiving chloroquine alone, with no evidence of an additional effect on QT of chloroquine plus tafenoquine coadministration. Interpretation Single-dose tafenoquine 300 mg coadministered with chloroquine for P vivax malaria relapse prevention was more efficacious than chloroquine alone, with a similar safety profile. As a result, it has been selected for further clinical assessment in phase 3.	[Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop, Lima, Peru; [Lacerda, Marcus V.] Fundacao Med Trop Doutor Heitor Vieira Doura, Manaus, Amazonas, Brazil; [Rueangweerayut, Ronnatrai; Chuenchom, Nuttagarn] Mae Sot Hosp, Mae Sot, Tak Province, Thailand; [Krudsood, Srivicha] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Gupta, Sandeep K.] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India; [Kochar, Sanjay K.] Sardar Patel Med Coll, Bikaner, Rajasthan, India; [Arthur, Preetam] Sri Ramchandra Med Coll & Res Inst, Dept Med, Madras, Tamil Nadu, India; [Moehrle, Joerg J.; Duparc, Stephan] Med Malaria Venture, Geneva, Switzerland; [Ugwuegbulam, Cletus; Kleim, Joerg-Peter; Carter, Nick; Green, Justin A.; Kellam, Lynda] GlaxoSmithKline, Uxbridge UB11 1BT, Middx, England	Universidad Peruana Cayetano Heredia; Mahidol University; Sardar Patel Medical College, Bikaner; Sri Ramachandra Institute of Higher Education & Research; GlaxoSmithKline	Kellam, L (corresponding author), GlaxoSmithKline, Stockley Pk West, Uxbridge UB11 1BT, Middx, England.	lynda.m.kellam@gsk.com	Duparc, Stephan/AAH-8758-2020	Duparc, Stephan/0000-0002-9649-4847; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Arthur, Preetam/0000-0002-4757-1391	GlaxoSmithKline, Medicines for Malaria Venture	GlaxoSmithKline, Medicines for Malaria Venture	GlaxoSmithKline, Medicines for Malaria Venture.	Aguas Ricardo, 2012, Journal of Parasitology Research, P921715, DOI 10.1155/2012/921715; Battle KE, 2012, ADV PARASIT, V80, P1, DOI 10.1016/B978-0-12-397900-1.00001-3; Betuela I, 2012, J INFECT DIS, V206, P1771, DOI 10.1093/infdis/jis580; Brueckner RP, 1998, AM J TROP MED HYG, V58, P645, DOI 10.4269/ajtmh.1998.58.645; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Douglas NM, 2013, J INFECT DIS, V208, P801, DOI 10.1093/infdis/jit261; Douglas NM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-135; Dow GS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-212; Green J, 2013, 62 ANN M AM SOC TROP; Green J, 2012, 61 ANN M AM SOC TROP; John GK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-280; Luxemburger C, 1999, T ROY SOC TROP MED H, V93, P433, DOI 10.1016/S0035-9203(99)90149-9; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Miller AK, 2013, BRIT J CLIN PHARMACO, V76, P858, DOI 10.1111/bcp.12160; Nasveld PE, 2010, ANTIMICROB AGENTS CH, V54, P792, DOI 10.1128/AAC.00354-09; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Roy M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001979; Rueangweerayut R, 2012, 61 ANN M AM SOC TROP; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Walsh DS, 1999, J INFECT DIS, V180, P1282, DOI 10.1086/315034; Walsh DS, 2004, CLIN INFECT DIS, V39, P1095, DOI 10.1086/424508; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2010, GUID TREATM MAL, V2nd	24	179	186	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1049	1058		10.1016/S0140-6736(13)62568-4	http://dx.doi.org/10.1016/S0140-6736(13)62568-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24360369				2022-12-28	WOS:000333521200030
J	Gostin, LO; Altevogt, BM; Pope, AM				Gostin, Lawrence O.; Altevogt, Bruce M.; Pope, Andrew M.			Future Oversight of Recombinant DNA Research Recommendations of an Institute of Medicine Committee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENE-THERAPY		[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Altevogt, Bruce M.; Pope, Andrew M.] Natl Acad Sci, Inst Med, Board Hlth Sci Policy, Washington, DC 20418 USA	Georgetown University; National Academies of Sciences, Engineering & Medicine	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu			PHS HHS [HHSN263201200074I] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2013, OVERSIGHT REV CLIN G; Breakefield XO, 2012, NAT MED, V18, P1007, DOI 10.1038/nm0712-1007; Corrigan-Curay J., 2013, NIH REC DNA ADV COMM; Deakin CT, 2010, CURR OPIN MOL THER, V12, P578; Deakin CT, 2009, MOL THER, V17, P1842, DOI 10.1038/mt.2009.223; National Institute of Health, 2013, NIH GUID RES INV REC; Rainsbury JM, 2000, FOOD DRUG LAW J, V55, P575	7	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					671	672		10.1001/jama.2013.286312	http://dx.doi.org/10.1001/jama.2013.286312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24435443				2022-12-28	WOS:000331383700014
J	Moore, CW; Obrist, D; Steffen, A; Staebler, RM; Douglas, TA; Richter, A; Nghiem, SV				Moore, Christopher W.; Obrist, Daniel; Steffen, Alexandra; Staebler, Ralf M.; Douglas, Thomas A.; Richter, Andreas; Nghiem, Son V.			Convective forcing of mercury and ozone in the Arctic boundary layer induced by leads in sea ice	NATURE			English	Article							ATMOSPHERIC MERCURY; GASEOUS MERCURY; ELEMENTAL MERCURY; HEAT-TRANSFER; TROPOSPHERE; WINTER; OCEAN	The ongoing regime shift of Arctic sea ice from perennial to seasonal ice is associated with more dynamic patterns of opening and closing sea-ice leads (large transient channels of open water in the ice)(1-3), which may affect atmospheric and biogeochemical cycles in the Arctic(4). Mercury and ozone are rapidly removed from the atmospheric boundary layer during depletion events in the Arctic(5-7), caused by destruction of ozone along with oxidation of gaseous elemental mercury (Hg(0)) to oxidized mercury (Hg(II)) in the atmosphere and its subsequent deposition to snow and ice(5). Ozone depletion events can change the oxidative capacity of the air by affecting atmospheric hydroxyl radical chemistry(8), whereas atmospheric mercury depletion events can increase the deposition of mercury to the Arctic(6,9-11), some of which can enter ecosystems during snowmelt(12). Here we present near-surface measurements of atmospheric mercury and ozone from two Arctic field campaigns near Barrow, Alaska. We find that coastal depletion events are directly linked to sea-ice dynamics. A consolidated ice cover facilitates the depletion of Hg(0) and ozone, but these immediately recover to near-background concentrations in the upwind presence of open sea-ice leads. We attribute the rapid recoveries of Hg(0) and ozone to lead-initiated shallow convection in the stable Arctic boundary layer, which mixes Hg(0) and ozone from undepleted air masses aloft. This convective forcing provides additional Hg(0) to the surface layer at a time of active depletion chemistry, where it is subject to renewed oxidation. Future work will need to establish the degree to which large-scale changes in sea-ice dynamics across the Arctic alter ozone chemistry and mercury deposition in fragile Arctic ecosystems.	[Moore, Christopher W.; Obrist, Daniel] Desert Res Inst, Div Atmospher Sci, Reno, NV 89523 USA; [Steffen, Alexandra; Staebler, Ralf M.] Environm Canada, Air Qual Proc Res Sect, Toronto, ON M3H 5T4, Canada; [Douglas, Thomas A.] US Army Cold Reg Res & Engn Lab, Ft Wainwright, AK 99703 USA; [Richter, Andreas] Univ Bremen, Inst Environm Phys, D-28359 Bremen, Germany; [Nghiem, Son V.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Environment & Climate Change Canada; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); University of Bremen; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Moore, CW (corresponding author), Desert Res Inst, Div Atmospher Sci, Reno, NV 89523 USA.	chris.moore@dri.edu	Moore, Christopher/E-8448-2012; Richter, Andreas/C-4971-2008	Moore, Christopher/0000-0002-6042-5583; Richter, Andreas/0000-0003-3339-212X; Staebler, Ralf/0000-0002-6372-0414	National Aeronautics and Space Administration (NASA); Desert Research Institute; Science and Technology Branch of Environment Canada; Canadian International Polar Year government programme; NASA CSP; Directorate For Geosciences [1304305] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1739567] Funding Source: National Science Foundation	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Desert Research Institute; Science and Technology Branch of Environment Canada; Canadian International Polar Year government programme; NASA CSP; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported in part by the National Aeronautics and Space Administration (NASA) Cryospheric Sciences Program (CSP) and by the Desert Research Institute. The Science and Technology Branch of Environment Canada helped fund Hg measurements in 2012 along with the Canadian International Polar Year government programme in 2009. The research at the Jet Propulsion Laboratory, California Institute of Technology, was supported by NASA CSP. We thank Umiaq for field logistic assistance, the Barrow whaling community for beneficial interactions, and the National Oceanic and Atmosphere Administration (NOAA), Global Monitoring Division for the Barrow Observatory data. We gratefully acknowledge the NOAA Air Resources Laboratory (ARL) for provision of the HYSPLIT transport and dispersion model and READY Website (http://www.ready.noaa.gov) used in this publication. We thank K. Pratt and R. Kreidberg for feedback on the manuscript, B. Hatchett and T. Malamakal for help with radiosonde and WRF data, D. Hall and J. Schmaltz for MODIS imagery support, and J. Deary for outstanding field technical support.	Andersson ME, 2008, MAR CHEM, V110, P190, DOI 10.1016/j.marchem.2008.04.002; Andreas EL, 1999, J GEOPHYS RES-OCEANS, V104, P25721, DOI 10.1029/1999JC900241; Ariya PA, 2004, TELLUS B, V56, P397, DOI 10.1111/j.1600-0889.2004.00118.x; Aspmo K, 2006, ENVIRON SCI TECHNOL, V40, P4083, DOI 10.1021/es052117z; Banic CM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002116; Begoin M, 2010, ATMOS CHEM PHYS, V10, P6515, DOI 10.5194/acp-10-6515-2010; Bottenheim JW, 2002, ATMOS ENVIRON, V36, P2535, DOI 10.1016/S1352-2310(02)00121-8; Brooks SB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025525; Dommergue A, 2003, ENVIRON SCI TECHNOL, V37, P3289, DOI 10.1021/es026242b; Drevnick PE, 2012, ATMOS ENVIRON, V59, P509, DOI 10.1016/j.atmosenv.2012.05.048; Durnford D, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014809; Hutchings JK, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007182; Lehnherr I, 2011, NAT GEOSCI, V4, P298, DOI [10.1038/ngeo1134, 10.1038/NGEO1134]; Lindberg SE, 2002, ENVIRON SCI TECHNOL, V36, P1245, DOI 10.1021/es0111941; Marcq S, 2012, CRYOSPHERE, V6, P143, DOI 10.5194/tc-6-143-2012; National Atmospheric Deposition Program, 2011, ATM MERC NETW SIT OP; Nghiem S., 2013, EOS T AM GEOPHYS UN, V94, P289, DOI [10.1038/NGEO1779, DOI 10.1038/NGEO1779, DOI 10.1002/2013EO330002]; Nghiem SV, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016268; Perovich DK, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL031138, 10.1029/2007GL031480]; Pratt KA, 2013, NAT GEOSCI, V6, P351, DOI [10.1038/NGEO1779, 10.1038/ngeo1779]; Seabrook JA, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016335; SERREZE MC, 1992, J GEOPHYS RES-OCEANS, V97, P9411, DOI 10.1029/92JC00688; Shaw PM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042831; Simpson WR, 2007, ATMOS CHEM PHYS, V7, P4375, DOI 10.5194/acp-7-4375-2007; Skov H, 2004, ENVIRON SCI TECHNOL, V38, P2373, DOI 10.1021/es030080h; Steffen A, 2008, ATMOS CHEM PHYS, V8, P1445, DOI 10.5194/acp-8-1445-2008; Steffen A, 2013, ATMOS CHEM PHYS, V13, P7007, DOI 10.5194/acp-13-7007-2013; Steffen A, 2012, J ENVIRON MONITOR, V14, P752, DOI 10.1039/c2em10735j; Stephens CR, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016649; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Ubl S, 2012, ATMOS ENVIRON, V62, P391, DOI 10.1016/j.atmosenv.2012.07.061; Zheng JC, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002897	32	67	67	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					81	+		10.1038/nature12924	http://dx.doi.org/10.1038/nature12924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24429521				2022-12-28	WOS:000330648100035
J	McClung, MR; Grauer, A; Boonen, S; Bolognese, MA; Brown, JP; Diez-Perez, A; Langdahl, BL; Reginster, JY; Zanchetta, JR; Wasserman, SM; Katz, L; Maddox, J; Yang, YC; Libanati, C; Bone, HG				McClung, Michael R.; Grauer, Andreas; Boonen, Steven; Bolognese, Michael A.; Brown, Jacques P.; Diez-Perez, Adolfo; Langdahl, Bente L.; Reginster, Jean-Yves; Zanchetta, Jose R.; Wasserman, Scott M.; Katz, Leonid; Maddox, Judy; Yang, Yu-Ching; Libanati, Cesar; Bone, Henry G.			Romosozumab in Postmenopausal Women with Low Bone Mineral Density	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCLEROSTIN ANTIBODY; STRENGTH; DISEASE; WNT; OSTEOPOROSIS; DELETION; CARRIERS; PROTEIN; GENE	BackgroundSclerostin is an osteocyte-derived inhibitor of osteoblast activity. The monoclonal antibody romosozumab binds to sclerostin and increases bone formation. MethodsIn a phase 2, multicenter, international, randomized, placebo-controlled, parallel-group, eight-group study, we evaluated the efficacy and safety of romosozumab over a 12-month period in 419 postmenopausal women, 55 to 85 years of age, who had low bone mineral density (a T score of -2.0 or less at the lumbar spine, total hip, or femoral neck and -3.5 or more at each of the three sites). Participants were randomly assigned to receive subcutaneous romosozumab monthly (at a dose of 70 mg, 140 mg, or 210 mg) or every 3 months (140 mg or 210 mg), subcutaneous placebo, or an open-label active comparator oral alendronate (70 mg weekly) or subcutaneous teriparatide (20 g daily). The primary end point was the percentage change from baseline in bone mineral density at the lumbar spine at 12 months. Secondary end points included percentage changes in bone mineral density at other sites and in markers of bone turnover. ResultsAll dose levels of romosozumab were associated with significant increases in bone mineral density at the lumbar spine, including an increase of 11.3% with the 210-mg monthly dose, as compared with a decrease of 0.1% with placebo and increases of 4.1% with alendronate and 7.1% with teriparatide. Romosozumab was also associated with large increases in bone mineral density at the total hip and femoral neck, as well as transitory increases in bone-formation markers and sustained decreases in a bone-resorption marker. Except for mild, generally nonrecurring injection-site reactions with romosozumab, adverse events were similar among groups. ConclusionsIn postmenopausal women with low bone mass, romosozumab was associated with increased bone mineral density and bone formation and with decreased bone resorption. (Funded by Amgen and UCB Pharma; ClinicalTrials.gov number, NCT00896532.)	[McClung, Michael R.] Oregon Osteoporosis Ctr, Portland, OR 97213 USA; [Grauer, Andreas; Wasserman, Scott M.; Katz, Leonid; Maddox, Judy; Yang, Yu-Ching; Libanati, Cesar] Amgen Inc, Thousand Oaks, CA USA; [Boonen, Steven] Leuven Univ, Louvain, Belgium; [Reginster, Jean-Yves] Univ Liege, Liege, Belgium; [Bolognese, Michael A.] Bethesda Hlth Res Ctr, Bethesda, MD USA; [Brown, Jacques P.] Univ Laval, Quebec City, PQ, Canada; [Brown, Jacques P.] Ctr Hosp Univ Quebec Res Ctr, Quebec City, PQ, Canada; [Diez-Perez, Adolfo] Autonomous Univ Barcelona, Hosp Del Mar Red Temat Investigac Cooperativa Env, Barcelona, Spain; [Langdahl, Bente L.] Aarhus Univ, Aarhus, Denmark; [Zanchetta, Jose R.] Inst Investigac Metabol, Buenos Aires, DF, Argentina; [Bone, Henry G.] Michigan Bone & Mineral Clin, Detroit, MI USA	Oregon Osteoporosis Center; Amgen; KU Leuven; University of Liege; Laval University; Laval University; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Aarhus University	McClung, MR (corresponding author), Oregon Osteoporosis Ctr, 5050 NE Hoyt St,Suite 626, Portland, OR 97213 USA.	mmcclung@orost.com	McClung, Michael/ABA-4100-2021	McClung, Michael/0000-0002-7827-0778; Diez-Perez, Adolfo/0000-0001-8162-0209; Brown, Jacques/0000-0003-1910-788X	Amgen; UCB Pharma	Amgen(Amgen); UCB Pharma(UCB Pharma SA)	Supported by Amgen and UCB Pharma.	Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Gardner JC, 2005, J CLIN ENDOCR METAB, V90, P6392, DOI 10.1210/jc.2005-1235; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; van Lierop AH, 2011, J BONE MINER RES, V26, P2804, DOI 10.1002/jbmr.474; 2001, JAMA, V285, P785	16	716	760	5	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					412	420		10.1056/NEJMoa1305224	http://dx.doi.org/10.1056/NEJMoa1305224			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24382002	Bronze			2022-12-28	WOS:000330645400006
J	Devault, AM; Golding, GB; Waglechner, N; Enk, JM; Kuch, M; Tien, JH; Shi, M; Fisman, DN; Dhody, AN; Forrest, S; Bos, KI; Earn, DJD; Holmes, EC; Poinar, HN				Devault, Alison M.; Golding, G. Brian; Waglechner, Nicholas; Enk, Jacob M.; Kuch, Melanie; Tien, Joseph H.; Shi, Mang; Fisman, David N.; Dhody, Anna N.; Forrest, Stephen; Bos, Kirsten I.; Earn, David J. D.; Holmes, Edward C.; Poinar, Hendrik N.			Second-Pandemic Strain of Vibrio cholerae from the Philadelphia Cholera Outbreak of 1849	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME; PHYLOGENIES; PATTERNS; REVEALS; DAMAGE	In the 19th century, there were several major cholera pandemics in the Indian subcontinent, Europe, and North America. The causes of these outbreaks and the genomic strain identities remain a mystery. We used targeted high-throughput sequencing to reconstruct the Vibrio cholerae genome from the preserved intestine of a victim of the 1849 cholera outbreak in Philadelphia, part of the second cholera pandemic. This O1 biotype strain has 95 to 97% similarity with the classical O395 genome, differing by 203 single-nucleotide polymorphisms (SNPs), lacking three genomic islands, and probably having one or more tandem cholera toxin prophage (CTX) arrays, which potentially affected its virulence. This result highlights archived medical remains as a potential resource for investigations into the genomic origins of past pandemics.	[Devault, Alison M.; Enk, Jacob M.; Kuch, Melanie; Forrest, Stephen; Bos, Kirsten I.; Poinar, Hendrik N.] McMaster Univ, McMaster Ancient DNA Ctr, Hamilton, ON L8S 4L9, Canada; [Devault, Alison M.; Kuch, Melanie; Bos, Kirsten I.; Poinar, Hendrik N.] McMaster Univ, Dept Anthropol, Hamilton, ON L8S 4L9, Canada; [Golding, G. Brian; Enk, Jacob M.; Poinar, Hendrik N.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4L9, Canada; [Earn, David J. D.] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4L9, Canada; [Waglechner, Nicholas; Earn, David J. D.; Poinar, Hendrik N.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4L9, Canada; [Fisman, David N.] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Tien, Joseph H.] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Shi, Mang; Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis, Sydney, NSW 2006, Australia; [Shi, Mang; Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Biosecur Inst, Sydney, NSW 2006, Australia; [Shi, Mang; Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Dhody, Anna N.] Coll Phys Philadelphia, Mutter Museum, Philadelphia, PA USA	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto; University System of Ohio; Ohio State University; University of Sydney; University of Sydney; University of Sydney	Poinar, HN (corresponding author), McMaster Univ, Dept Anthropol, 1280 Main St W, Hamilton, ON L8S 4L9, Canada.	poinarh@mcmaster.ca; poinarh@mcmaster.ca	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019	Holmes, Edward/0000-0001-9596-3552; Shi, Mang/0000-0002-6154-4437; Earn, David/0000-0002-7562-1341; Bos, Kirsten/0000-0003-2937-3006				Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Armelagos GJ, 2005, SOC SCI MED, V61, P755, DOI 10.1016/j.socscimed.2004.08.066; Barbieri C, 2012, MOL BIOL EVOL, V29, P1213, DOI 10.1093/molbev/msr291; Barua Dhiman, 1992, P1; Bos KI, 2011, NATURE, V480, P278, DOI 10.1038/nature10675; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davis BM, 2000, P NATL ACAD SCI USA, V97, P8572, DOI 10.1073/pnas.140109997; Davis BM, 2000, J BACTERIOL, V182, P6992, DOI 10.1128/JB.182.24.6992-6998.2000; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faruque SM, 2007, P NATL ACAD SCI USA, V104, P5151, DOI 10.1073/pnas.0700365104; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrington J.M., 1995, GRAVE REFLECTIONS PO, P153; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P316; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Rosenberg CE., 1987, CHOLERA YEARS US 183; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	30	94	96	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					334	340		10.1056/NEJMoa1308663	http://dx.doi.org/10.1056/NEJMoa1308663			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24401020	Green Published			2022-12-28	WOS:000330036200008
J	Jaiswal, G; Gandhi, GY				Jaiswal, Gayatri; Gandhi, Gunjan Y.			Sodium-glucose cotransporter 2 inhibitors reduce HbA(1c) and weight but increase infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jaiswal, Gayatri; Gandhi, Gunjan Y.] Mayo Clin, Jacksonville, FL 32224 USA	Mayo Clinic	Jaiswal, G (corresponding author), Mayo Clin, Jacksonville, FL 32224 USA.		Tsapas, Apostolos/P-5593-2019	Tsapas, Apostolos/0000-0003-0221-4072				Cefalu WT, 2013, ANN INTERN MED, V382, P941; Kasichayanula S, 2013, BRIT J CLIN PHARMACO, V76, P432, DOI 10.1111/bcp.12056	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC10	10.7326/0003-4819-160-2-201401210-02010	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445708				2022-12-28	WOS:000330275600009
J	Chou, YC; Hillerich, K; Tersoff, J; Reuter, MC; Dick, KA; Ross, FM				Chou, Y. -C.; Hillerich, K.; Tersoff, J.; Reuter, M. C.; Dick, K. A.; Ross, F. M.			Atomic-Scale Variability and Control of III-V Nanowire Growth Kinetics	SCIENCE			English	Article							SUPERLATTICES; MORPHOLOGY; GAAS	In the growth of nanoscale device structures, the ultimate goal is atomic-level precision. By growing III-V nanowires in a transmission electron microscope, we measured the local kinetics in situ as each atomic plane was added at the catalyst-nanowire growth interface by the vapor-liquid-solid process. During growth of gallium phosphide nanowires at typical V/III ratios, we found surprising fluctuations in growth rate, even under steady growth conditions. We correlated these fluctuations with the formation of twin defects in the nanowire, and found that these variations can be suppressed by switching to growth conditions with a low V/III ratio. We derive a growth model showing that this unexpected variation in local growth kinetics reflects the very different supply pathways of the V and III species. The model explains under which conditions the growth rate can be controlled precisely at the atomic level.	[Chou, Y. -C.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Chou, Y. -C.] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 300, Taiwan; [Hillerich, K.; Dick, K. A.] Lund Univ, S-22100 Lund, Sweden; [Tersoff, J.; Reuter, M. C.; Ross, F. M.] IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; National Yang Ming Chiao Tung University; Lund University; International Business Machines (IBM)	Ross, FM (corresponding author), IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	fmross@us.ibm.com	Dick, Kimberly A/A-8579-2008	Dick, Kimberly A/0000-0003-4125-2039; /0000-0002-7775-2927	Center for Functional Nanomaterials, Brookhaven National Laboratory; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NSF [DMR-0907483]; Nanometer Structure Consortium at Lund University; Swedish Research Council; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation	Center for Functional Nanomaterials, Brookhaven National Laboratory; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Nanometer Structure Consortium at Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Supported by the Center for Functional Nanomaterials, Brookhaven National Laboratory, which is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-98CH10886 (Y.-C.C.); NSF grant DMR-0907483; and the Nanometer Structure Consortium at Lund University, the Swedish Research Council, the Swedish Foundation for Strategic Research, and the Knut and Alice Wallenberg Foundation. Y.-C.C. and K. H. performed experiments and data analysis, J.T. developed the growth model, M. C. R. developed the experimental techniques, and K. A. D. and F. M. R. designed the experiments and coordinated the analysis.	Algra RE, 2008, NATURE, V456, P369, DOI 10.1038/nature07570; Algra RE, 2010, NANO LETT, V10, P2349, DOI 10.1021/nl1000136; Bjork MT, 2002, NANO LETT, V2, P87, DOI 10.1021/nl010099n; Boulanger JP, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/3/035002; Boulanger J. P., 2013, THESIS; Boulanger JP, 2011, J CRYST GROWTH, V332, P21, DOI 10.1016/j.jcrysgro.2011.07.021; Caroff P, 2009, NAT NANOTECHNOL, V4, P50, DOI [10.1038/nnano.2008.359, 10.1038/NNANO.2008.359]; Caroff P, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495606; Colombo C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155326; Diaz RE, 2012, J CRYST GROWTH, V341, P1, DOI 10.1016/j.jcrysgro.2011.09.028; Dick KA, 2004, J CRYST GROWTH, V272, P131, DOI 10.1016/j.jcrysgro.2004.09.004; Dick KA, 2007, NANO LETT, V7, P1817, DOI 10.1021/nl0705900; Dubrovskii VG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205316; Glas F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.135501; Hofmann S, 2008, NAT MATER, V7, P372, DOI 10.1038/nmat2140; Jabeen F, 2011, J CRYST GROWTH, V323, P293, DOI 10.1016/j.jcrysgro.2010.12.007; Johansson J, 2006, NAT MATER, V5, P574, DOI 10.1038/nmat1677; Johansson J, 2005, J PHYS CHEM B, V109, P13567, DOI 10.1021/jp051702j; Johansson J, 2012, ACS NANO, V6, P6142, DOI 10.1021/nn301477x; Joyce HJ, 2010, NANO LETT, V10, P908, DOI 10.1021/nl903688v; Krogstrup P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/31/313001; Lehmann S, 2013, NANO LETT, V13, P4099, DOI 10.1021/nl401554w; Ross FM, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/11/114501; Schwarz KW, 2011, NANO LETT, V11, P316, DOI 10.1021/nl1027815; Verheijen MA, 2006, J AM CHEM SOC, V128, P1353, DOI 10.1021/ja057157h; Wen CY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.025503; Wen CY, 2009, SCIENCE, V326, P1247, DOI 10.1126/science.1178606; Zhang G, 2008, J APPL PHYS, V103, DOI 10.1063/1.2828165	28	74	76	0	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					281	284		10.1126/science.1244623	http://dx.doi.org/10.1126/science.1244623			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436416				2022-12-28	WOS:000329718600031
J	Silverman, E				Silverman, Ed			Biosimilars: what's in a name?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pharmalot@gmail.com							0	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2014	348								g272	10.1136/bmj.g272	http://dx.doi.org/10.1136/bmj.g272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MR	24443479				2022-12-28	WOS:000329976300007
J	Spence, D				Spence, Des			Bad medicine: the rise of duloxetine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL COMPARING DULOXETINE; DOUBLE-BLIND; PLACEBO; FIBROMYALGIA; MANAGEMENT; PAIN					destwo@yahoo.co.uk						[Anonymous], 2010, LILL PURS OK CYMB CH; Arnold LM, 2005, PAIN, V119, P5, DOI 10.1016/j.pain.2005.06.031; Arnold LM, 2004, ARTHRITIS RHEUM, V50, P2974, DOI 10.1002/art.20485; Bernardy K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009796.pub2; Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; Busch AJ, 2007, COCHRANE DB SYST REV, V4; Cymbalta sales data, 2013, TOP 100 STAT; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Health and Social Care Information Centre, 2013, PRESCR COST AN ENG 2; Kalso E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7339; Lunn MPT, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007115.pub3; Raskin J, 2005, PAIN MED, V6, P346, DOI 10.1111/j.1526-4637.2005.00061.x; Russell IJ, 2008, PAIN, V136, P432, DOI 10.1016/j.pain.2008.02.024; Skljarevski V, 2010, J PAIN, V11, P1282, DOI 10.1016/j.jpain.2010.03.002; US Food and Drug Administration, 2010, EL LILL COR PRES CYM; US Food and Drug Administration, 2009, CYMB DUL DISC SYNDR; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3	18	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2014	348								g139	10.1136/bmj.g139	http://dx.doi.org/10.1136/bmj.g139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MR	24443477				2022-12-28	WOS:000329976300001
J	Osborn, RR				Osborn, Rachel R.			The Mask	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Osborn, Rachel R.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Osborn, Rachel R.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Yale University; Yale University	Osborn, RR (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	rachel.osborn@yale.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					245	246		10.1001/jama.2013.284778	http://dx.doi.org/10.1001/jama.2013.284778			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24430317				2022-12-28	WOS:000329566400014
J	Joseph, J				Joseph, Jaimon			Rural postings: controversy in Indian specialists' training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jaithemon@gmail.com						Medical Council of India, 2011, VIS 2015, P10; Ministry of Health and Family Welfare, 2012, RUR HLTH STAT IND 20, P59	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2014	348								g54	10.1136/bmj.g54	http://dx.doi.org/10.1136/bmj.g54			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KR	24415736				2022-12-28	WOS:000329611300021
J	Malim, MH				Malim, Michael H.			HIV Ringside views	NATURE			English	Editorial Material							RESTRICTION FACTOR SAMHD1; CBF-BETA; INFECTION; DEGRADE		Kings Coll London, Dept Infect Dis, London SE1 9RT, England	University of London; King's College London	Malim, MH (corresponding author), Kings Coll London, Dept Infect Dis, London SE1 9RT, England.	michael.malim@kcl.ac.uk		Malim, Michael/0000-0002-7699-2064	MRC [G1001081, G1000196] Funding Source: UKRI; Medical Research Council [G1000196, G1001081] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Schwefel D, 2014, NATURE, V505, P234, DOI 10.1038/nature12815; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	9	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					167	168		10.1038/505167a	http://dx.doi.org/10.1038/505167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286CG	24402277				2022-12-28	WOS:000329441500027
J	Ryan, AM				Ryan, Andrew M.			Will Value-Based Purchasing Increase Disparities in Care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOSPITALS; PROGRAM	U.S. hospitals caring for more disadvantaged patients fared worse in the first year of Medicare's Hospital Value-Based Purchasing program. Over time, such resource reductions may cause the quality of care to deteriorate in hospitals serving more disadvantaged patients. Financial incentives for improving quality and efficiency have gone mainstream in U.S. health care. After years of small-scale pilot projects, demonstrations, and experiments, the Affordable Care Act mandated that Medicare payment to hospitals and physicians must depend, in part, on metrics of quality and efficiency. The first program to do so is Hospital Value-Based Purchasing (HVBP), which began affecting Medicare payments to acute care hospitals in October 2012. In the first year of HVBP, hospitals received incentives for performance on clinical-process and patient-experience measures. In subsequent years, hospitals will also receive incentives for performance on outcome-based measures, such as 30-day ...	Weill Cornell Med, Div Outcomes & Effectiveness Res, Dept Publ Hlth, New York, NY USA	Cornell University	Ryan, AM (corresponding author), Weill Cornell Med, Div Outcomes & Effectiveness Res, Dept Publ Hlth, New York, NY USA.							Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Gaskin DJ, 2008, HEALTH AFFAIR, V27, P518, DOI 10.1377/hlthaff.27.2.518; Jha AK, 2010, ANN INTERN MED, V153, P299, DOI 10.7326/0003-4819-153-5-201009070-00004; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Werner RM, 2012, HEALTH AFFAIR, V31, P1932, DOI 10.1377/hlthaff.2011.0990	5	70	70	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2472	2474		10.1056/NEJMp1312654	http://dx.doi.org/10.1056/NEJMp1312654			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	278BT	24369072				2022-12-28	WOS:000328863700003
J	Mehtani, N				Mehtani, Nicky			The measuring cup	LANCET			English	Editorial Material									[Mehtani, Nicky] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Mehtani, N (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21224 USA.	nicky.mehtani@jhmi.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2112	2113		10.1016/S0140-6736(13)62549-0	http://dx.doi.org/10.1016/S0140-6736(13)62549-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275OX	24360388				2022-12-28	WOS:000328687800033
J	Pugliese, G; Balducci, S				Pugliese, Giuseppe; Balducci, Stefano			NAVIGATOR: physical activity for cardiovascular health?	LANCET			English	Editorial Material							TYPE-2 DIABETES-MELLITUS; MORTALITY; EXERCISE; RISK; FITNESS; MEN		[Pugliese, Giuseppe] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00189 Rome, Italy; St Andrea Hosp, Diabet Unit, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Pugliese, G (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, I-00189 Rome, Italy.	giuseppe.pugliese@uniroma1.it	Pugliese, Giuseppe/G-8776-2012	Pugliese, Giuseppe/0000-0003-1574-0397				Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Yates T, 2014, LANCET, V383, P1059, DOI 10.1016/S0140-6736(13)62061-9	12	0	0	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1022	1023		10.1016/S0140-6736(13)62551-9	http://dx.doi.org/10.1016/S0140-6736(13)62551-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24361241				2022-12-28	WOS:000333521200008
J	Goede, V; Fischer, K; Busch, R; Engelke, A; Eichhorst, B; Wendtner, CM; Chagorova, T; de la Serna, J; Dilhuydy, MS; Illmer, T; Opat, S; Owen, CJ; Samoylova, O; Kreuzer, KA; Stilgenbauer, S; Dohner, H; Langerak, AW; Ritgen, M; Kneba, M; Asikanius, E; Humphrey, K; Wenger, M; Hallek, M				Goede, Valentin; Fischer, Kirsten; Busch, Raymonde; Engelke, Anja; Eichhorst, Barbara; Wendtner, Clemens M.; Chagorova, Tatiana; de la Serna, Javier; Dilhuydy, Marie-Sarah; Illmer, Thomas; Opat, Stephen; Owen, Carolyn J.; Samoylova, Olga; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Doehner, Hartmut; Langerak, Anton W.; Ritgen, Matthias; Kneba, Michael; Asikanius, Elina; Humphrey, Kathryn; Wenger, Michael; Hallek, Michael			Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ILLNESS RATING-SCALE; GENOMIC ABERRATIONS; ANTI-CD20 ANTIBODY; 1ST-LINE THERAPY; PROGRESSION-FREE; INITIAL THERAPY; IN-VITRO; RITUXIMAB; FLUDARABINE	Background The monoclonal anti-CD20 antibody rituximab, combined with chemotherapeutic agents, has been shown to prolong overall survival in physically fit patients with previously untreated chronic lymphocytic leukemia (CLL) but not in those with coexisting conditions. We investigated the benefit of the type 2, glycoengineered antibody obinutuzumab (also known as GA101) as compared with that of rituximab, each combined with chlorambucil, in patients with previously untreated CLL and coexisting conditions. Methods We randomly assigned 781 patients with previously untreated CLL and a score higher than 6 on the Cumulative Illness Rating Scale (CIRS) (range, 0 to 56, with higher scores indicating worse health status) or an estimated creatinine clearance of 30 to 69 ml per minute to receive chlorambucil, obinutuzumab plus chlorambucil, or rituximab plus chlorambucil. The primary end point was investigator-assessed progression-free survival. Results The patients had a median age of 73 years, creatinine clearance of 62 ml per minute, and CIRS score of 8 at baseline. Treatment with obinutuzumab-chlorambucil or rituximab-chlorambucil, as compared with chlorambucil monotherapy, increased response rates and prolonged progression-free survival (median progression-free survival, 26.7 months with obinutuzumab-chlorambucil vs. 11.1 months with chlorambucil alone; hazard ratio for progression or death, 0.18; 95% confidence interval [CI], 0.13 to 0.24; P<0.001; and 16.3 months with rituximab-chlorambucil vs. 11.1 months with chlorambucil alone; hazard ratio, 0.44; 95% CI, 0.34 to 0.57; P<0.001). Treatment with obinutuzumab-chlorambucil, as compared with chlorambucil alone, prolonged overall survival (hazard ratio for death, 0.41; 95% CI, 0.23 to 0.74; P = 0.002). Treatment with obinutuzumab-chlorambucil, as compared with rituximab-chlorambucil, resulted in prolongation of progression-free survival (hazard ratio, 0.39; 95% CI, 0.31 to 0.49; P<0.001) and higher rates of complete response (20.7% vs. 7.0%) and molecular response. Infusion-related reactions and neutropenia were more common with obinutuzumab-chlorambucil than with rituximab-chlorambucil, but the risk of infection was not increased. Conclusions Combining an anti-CD20 antibody with chemotherapy improved outcomes in patients with CLL and coexisting conditions. In this patient population, obinutuzumab was superior to rituximab when each was combined with chlorambucil.	[Goede, Valentin; Fischer, Kirsten; Engelke, Anja; Eichhorst, Barbara; Wendtner, Clemens M.; Kreuzer, Karl-Anton; Hallek, Michael] Univ Hosp Cologne, German CLL Study Grp, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med 1, Cologne, Germany; [Goede, Valentin] St Marien Hosp, Dept Geriatr Med & Res, Cologne, Germany; [Goede, Valentin] Univ Cologne, D-50924 Cologne, Germany; [Busch, Raymonde] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Wendtner, Clemens M.] Klinikum Schwabing, Munich, Germany; [Ritgen, Matthias; Kneba, Michael] Univ Schleswig Holstein, City Hosp Kiel, Dept Med 2, Kiel, Germany; [Stilgenbauer, Stephan; Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Hallek, Michael] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50924 Cologne, Germany; [Chagorova, Tatiana] Penza Reg Oncol Dispensary, Penza, Russia; [Samoylova, Olga] Reg Clin Hosp NA Semashko, Nizhnii Novgorod, Russia; [de la Serna, Javier] Hosp Univ 12 Octubre, Serv Hematol, Madrid, Spain; [Dilhuydy, Marie-Sarah] Hop Haut Leveque, Pessac, France; [Opat, Stephen] Monash Med Ctr, Dept Haematol, Clayton, Vic 3168, Australia; [Owen, Carolyn J.] Univ Calgary, Calgary, AB, Canada; [Langerak, Anton W.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Asikanius, Elina] F Hoffmann La Roche, Basel, Switzerland; [Humphrey, Kathryn] F Hoffmann La Roche, Welwyn Garden City, England; [Wenger, Michael] Genentech Inc, San Francisco, CA 94080 USA	University of Cologne; St. Marien Hospital; University of Cologne; Technical University of Munich; Munchen Klinik; University of Kiel; Schleswig Holstein University Hospital; Ulm University; University of Cologne; Hospital Universitario 12 de Octubre; CHU Bordeaux; Monash University; University of Calgary; Erasmus University Rotterdam; Erasmus MC; Roche Holding; Roche Holding; Roche Holding; Genentech	Hallek, M (corresponding author), Univ Cologne, German CLL Study Grp, D-50924 Cologne, Germany.	michael.hallek@uni-koeln.de	Döhner, Hartmut/C-8933-2016; Hallek, Michael/Y-3191-2019; DE LA SERNA, JAVIER/B-1735-2012; Opat, Stephen/AFR-0783-2022; Stilgenbauer, Stephan/ABE-6609-2020	Döhner, Hartmut/0000-0003-2116-5536; Hallek, Michael/0000-0002-7425-4455; DE LA SERNA, JAVIER/0000-0003-3904-1101; Opat, Stephen/0000-0002-0308-6458; Wendtner, Clemens-Martin/0000-0003-2866-2260	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	Funded by F. Hoffmann-La Roche; ClinicalTrials.gov number, NCT01010061.; Supported by F. Hoffmann-La Roche.	Alduaij W, 2011, BLOOD, V117, P4519, DOI 10.1182/blood-2010-07-296913; Bottcher S, 2009, LEUKEMIA, V23, P2007, DOI 10.1038/leu.2009.140; Bottcher S, 2012, J CLIN ONCOL, V30, P980, DOI 10.1200/JCO.2011.36.9348; Byrd JC, 2005, BLOOD, V105, P49, DOI 10.1182/blood-2004-03-0796; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dalle S, 2011, MOL CANCER THER, V10, P178, DOI 10.1158/1535-7163.MCT-10-0385; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Eichhorst BF, 2009, BLOOD, V114, P3382, DOI 10.1182/blood-2009-02-206185; Eichhorst BF, 2006, BLOOD, V107, P885, DOI 10.1182/blood-2005-06-2395; Flinn IW, 2007, J CLIN ONCOL, V25, P793, DOI 10.1200/JCO.2006.08.0762; Foa R, 2011, BLOOD, V118, P294; Goede V, 2013, LEUKEMIA, V27, P1172, DOI 10.1038/leu.2012.252; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; Hillmen P, 2010, ASH ANN M, V116, P697; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Howlader N, 2013, SEER CANC STAT REV; Knauf WU, 2009, J CLIN ONCOL, V27, P4378, DOI 10.1200/JCO.2008.20.8389; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; MARTI GE, 1992, ANN NY ACAD SCI, V651, P480; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Morschhauser F, 2011, HAEMATOLOGICA S2, V96, P935; Morschhauser F, 2009, BLOOD, V114, P884; O'Brien SM, 2001, J CLIN ONCOL, V19, P2165, DOI 10.1200/JCO.2001.19.8.2165; OBRIEN S, 2005, ASH ANN M, V106, P2117; Owen C, 2012, EXPERT OPIN BIOL TH, V12, P343, DOI 10.1517/14712598.2012.657622; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Patz M, 2011, BRIT J HAEMATOL, V152, P295, DOI 10.1111/j.1365-2141.2010.08428.x; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Rawstron AC, 2007, LEUKEMIA, V21, P956, DOI 10.1038/sj.leu.2404584; Ritgen M, 2008, LEUKEMIA, V22, P1377, DOI 10.1038/leu.2008.96; Robak T, 2013, FUTURE ONCOL, V9, P69, DOI [10.2217/fon.12.157, 10.2217/FON.12.157]; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Tam CS, 2008, BLOOD, V112, P975, DOI 10.1182/blood-2008-02-140582; Thurmes P, 2008, LEUKEMIA LYMPHOMA, V49, P49, DOI 10.1080/10428190701724785; Woyach JA, 2013, J CLIN ONCOL, V31, P440, DOI 10.1200/JCO.2011.41.5646	39	1056	1090	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1101	1110		10.1056/NEJMoa1313984	http://dx.doi.org/10.1056/NEJMoa1313984			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24401022				2022-12-28	WOS:000333054000006
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							BILATERAL PROPHYLACTIC MASTECTOMY; QUALITY-OF-LIFE; HEREDITARY BREAST-CANCER; SURGICAL ADJUVANT BREAST; OVARIAN-CANCER; FAMILY-HISTORY; FOLLOW-UP; MUTATION CARRIERS; SALPINGO-OOPHORECTOMY; SCORING SYSTEM	Description: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. Methods: The USPSTF reviewed the evidence on risk assessment, genetic counseling, and genetic testing for potentially harmful BRCA mutations in asymptomatic women with a family history of breast or ovarian cancer but no personal history of cancer or known potentially harmful BRCA mutations in the family. The USPSTF also reviewed interventions aimed at reducing the risk for BRCA-related cancer in women with potentially harmful BRCA mutations, including intensive cancer screening, medications, and risk-reducing surgery. Population: This recommendation applies to asymptomatic women who have not been diagnosed with BRCA-related cancer. Recommendation: The USPSTF recommends that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with 1 of several screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive, screening results should receive genetic counseling and, if indicated after counseling, BRCA testing. (B recommendation) The USPSTF recommends against routine genetic counseling or BRCA testing for women whose family history is not associated with an increased risk for potentially harmful mutations in the BRCA1 or BRCA2 genes. (D recommendation)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342				[Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, J MED GENET, V45, P425, DOI 10.1136/jmg.2007.056556; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; Ashton-Prolla P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-283; Balmana J, 2011, ANN ONCOL, V22, pvi31, DOI 10.1093/annonc/mdr373; Barcenas CH, 2006, J CLIN ONCOL, V24, P354, DOI 10.1200/JCO.2005.02.2368; Bellcross CA, 2009, GENET MED, V11, P783, DOI 10.1097/GIM.0b013e3181b9b04a; Bennett Paul, 2008, J Genet Couns, V17, P234, DOI 10.1007/s10897-007-9136-x; Bennett P, 2009, FAM CANCER, V8, P159, DOI 10.1007/s10689-008-9221-9; Berliner JL, 2013, J GENET COUNS, V22, P155, DOI 10.1007/s10897-012-9547-1; Bloom JR, 2006, PREV MED, V43, P379, DOI 10.1016/j.ypmed.2006.07.002; Bowen Deborah J, 2006, Cultur Divers Ethnic Minor Psychol, V12, P45, DOI 10.1037/1099-9809.12.1.45; Brain K, 2011, PSYCHO-ONCOLOGY, V20, P984, DOI 10.1002/pon.1807; Braithwaite D, 2005, CANCER DETECT PREV, V29, P433, DOI 10.1016/j.cdp.2005.06.001; Brandberg Y, 2012, EJSO-EUR J SURG ONC, V38, P38, DOI 10.1016/j.ejso.2011.10.010; Brandberg Y, 2008, J CLIN ONCOL, V26, P3943, DOI 10.1200/JCO.2007.13.9568; Centers for Disease Control and Prevention, 2013, BREAST CANC STAT; Centers for Disease Control and Prevention and National Cancer Institute, 2013, US CANC STAT 1999 20; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Contant CME, 2002, EUR J SURG ONCOL, V28, P627, DOI 10.1053/ejso.2002.1279; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138; Evans DG, 2009, J MED GENET, V46, P593, DOI 10.1136/jmg.2008.058248; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Finch A, 2011, GYNECOL ONCOL, V121, P163, DOI 10.1016/j.ygyno.2010.12.326; Finch A, 2013, PSYCHO-ONCOLOGY, V22, P212, DOI 10.1002/pon.2041; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Fry A, 2003, BRIT J CANCER, V89, P653, DOI 10.1038/sj.bjc.6601170; Gahm J, 2010, BREAST, V19, P462, DOI 10.1016/j.breast.2010.05.003; Gilpin CA, 2000, CLIN GENET, V58, P299, DOI 10.1034/j.1399-0004.2000.580408.x; Grady D, 2008, J NATL CANCER I, V100, P854, DOI 10.1093/jnci/djn153; Gronwald J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048462; Gurmankin AD, 2005, ARCH INTERN MED, V165, P523, DOI 10.1001/archinte.165.5.523; Hartge P, 1999, AM J HUM GENET, V64, P963, DOI 10.1086/302320; Helmes AW, 2006, PATIENT EDUC COUNS, V64, P96, DOI 10.1016/j.pec.2005.12.002; Hopwood P, 2004, BRIT J CANCER, V91, P884, DOI 10.1038/sj.bjc.6602081; Hoskins KF, 2006, CANCER-AM CANCER SOC, V107, P1769, DOI 10.1002/cncr.22202; Howlader N, 2013, SEER CANC STAT REV 1; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kelly KM, 2008, PATIENT EDUC COUNS, V70, P135, DOI 10.1016/j.pec.2007.09.007; Kriege M, 2006, CANCER-AM CANCER SOC, V106, P2318, DOI 10.1002/cncr.21863; Kurian AW, 2011, J CLIN ONCOL, V29, P4505, DOI 10.1200/JCO.2010.34.4440; Lancaster JM, 2007, GYNECOL ONCOL, V107, P159, DOI 10.1016/j.ygyno.2007.09.031; Le-Petross HT, 2011, CANCER-AM CANCER SOC, V117, P3900, DOI 10.1002/cncr.25971; Lindor Noralane M, 2008, J Natl Cancer Inst Monogr, P1, DOI 10.1093/jncimonographs/lgn001; Lippman ME, 2006, CLIN CANCER RES, V12, P5242, DOI 10.1158/1078-0432.CCR-06-0688; Malone KE, 2000, CANCER, V88, P1393, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P; Matloff ET, 2006, J WOMENS HEALTH, V15, P843, DOI 10.1089/jwh.2006.15.843; Metcalfe KA, 2004, PSYCHO-ONCOLOGY, V13, P14, DOI 10.1002/pon.726; Metcalfe KA, 2010, J CLIN ONCOL, V28, P387, DOI 10.1200/JCO.2009.25.0712; Mikkelsen EM, 2007, CANCER DETECT PREV, V31, P457, DOI 10.1016/j.cdp.2007.10.013; Mikkelsen EM, 2009, BREAST J, V15, P61, DOI 10.1111/j.1524-4741.2008.00672.x; National Cancer Institute, 2013, OV CANC; National Cancer Institute, 2013, BREAST CANC; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Nelson HD., 2013, RISK ASSESSMENT GENE; Nelson HD, 2009, COMP EFFECTIVENESS R; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Nelson HD, 2013, ANN INTERN MED, V158, P604, DOI 10.7326/0003-4819-158-8-201304160-00005; Oros KK, 2006, CLIN GENET, V70, P320, DOI 10.1111/j.1399-0004.2006.00673.x; Panchal SM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-116; Parmigiani G, 2007, ANN INTERN MED, V147, P441, DOI 10.7326/0003-4819-147-7-200710020-00002; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Pieterse AH, 2011, PATIENT EDUC COUNS, V85, P425, DOI 10.1016/j.pec.2011.01.017; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Robson ME, 2010, J CLIN ONCOL, V28, P893, DOI 10.1200/JCO.2009.27.0660; Roshanai AH, 2009, ACTA ONCOL, V48, P999, DOI 10.1080/02841860903104137; Rowan E, 2007, J MED GENET, V44; Skytte AB, 2011, CLIN GENET, V79, P431, DOI 10.1111/j.1399-0004.2010.01604.x; Smerecnik CMR, 2009, J GENET COUNS, V18, P217, DOI 10.1007/s10897-008-9210-z; Smith A, 2007, J MED GENET, V44, P10, DOI 10.1136/jmg.2006.043091; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vos JR, 2013, EUR J CANCER; Wasteson E, 2011, EUR J CANCER CARE, V20, P508, DOI 10.1111/j.1365-2354.2010.01204.x	83	278	286	1	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					271	281		10.7326/M13-2747	http://dx.doi.org/10.7326/M13-2747			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB3BO	24366376				2022-12-28	WOS:000331666500007
J	Li, XC; Holland, DM; Gerber, EP; Yoo, C				Li, Xichen; Holland, David M.; Gerber, Edwin P.; Yoo, Changhyun			Impacts of the north and tropical Atlantic Ocean on the Antarctic Peninsula and sea ice	NATURE			English	Article							SOUTHERN ANNULAR MODE; CLIMATE; CIRCULATION; OSCILLATION; TRENDS; VARIABILITY; DRIVEN; FLOW	In recent decades, Antarctica has experienced pronounced climate changes. The Antarctic Peninsula exhibited the strongest warming(1,2) of any region on the planet, causing rapid changes in land ice(3,4). Additionally, in contrast to the sea-ice decline over the Arctic, Antarctic sea ice has not declined, but has instead undergone a perplexing redistribution(5,6). Antarctic climate is influenced by, among other factors, changes in radiative forcing(7) and remote Pacific climate variability(8,9), but none explains the observed Antarctic Peninsula warming or the sea-ice redistribution in austral winter. However, in the north and tropical Atlantic Ocean, the Atlantic Multidecadal Oscillation(10,11) (a leading mode of sea surface temperature variability) has been overlooked in this context. Here we show that sea surface warming related to the Atlantic Multidecadal Oscillation reduces the surface pressure in the Amundsen Sea and contributes to the observed dipole-like sea-ice redistribution between the Ross and Amundsen-Bellingshausen-Weddell seas and to the Antarctic Peninsula warming. Support for these findings comes from analysis of observational and reanalysis data, and independently from both comprehensive and idealized atmospheric model simulations. We suggest that the north and tropical Atlantic is important for projections of future climate change in Antarctica, and has the potential to affect the global thermohaline circulation(6) and sea-level change(3,12).	[Li, Xichen; Holland, David M.; Gerber, Edwin P.; Yoo, Changhyun] NYU, Courant Inst Math Sci, New York, NY 10012 USA	New York University	Li, XC (corresponding author), NYU, Courant Inst Math Sci, 251 Mercer St, New York, NY 10012 USA.	xichen@cims.nyu.edu		Gerber, Edwin/0000-0002-6010-6638	NSF Office of Polar Programs [ANT-0732869]; NASA Polar Programs [NNX12AB69G]; New York University Abu Dhabi [G1204]; NSF Office of Atmospheric and Geospace Sciences [AGS-1264195]; National Science Foundation (NSF); Office of Science (BER) of the US Department of Energy (DOE); Directorate For Geosciences [1264195] Funding Source: National Science Foundation	NSF Office of Polar Programs(National Science Foundation (NSF)); NASA Polar Programs; New York University Abu Dhabi; NSF Office of Atmospheric and Geospace Sciences; National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Science (BER) of the US Department of Energy (DOE)(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	X.L., D.M.H. and C.Y. were supported by the NSF Office of Polar Programs (grant number ANT-0732869), the NASA Polar Programs (grant number NNX12AB69G), and New York University Abu Dhabi (grant number G1204). E.P.G. was supported by the NSF Office of Atmospheric and Geospace Sciences (grant number AGS-1264195). The HadISST SST and SIC data was provided by the British Met Office, Hadley Centre. The Antarctic weather station data was made available by the British Antarctic Survey. The MERRA atmospheric reanalysis data was provided by the Global Modeling and Assimilation Office (GMAO) at NASA Goddard Space Flight Center (GSFC) through the NASA Goddard Earth Sciences (GES) Data and Information Services Center (DISC) online archive (http://disc.sci.gsfc.nasa.gov/mdisc/data-holdings/merra/merra_products_nonjs.shtml). The ERA-Interim atmospheric reanalysis was provided by the ECMWF. The comprehensive atmospheric model (CAM4) was made available by the National Center for Atmospheric Research (NCAR), supported by the National Science Foundation (NSF) and the Office of Science (BER) of the US Department of Energy (DOE). The idealized atmospheric model (the GFDL dry dynamical core) was developed by the National Oceanic and Atmospheric Administration (NOAA) at the GFDL. Computing resources were provided by the National Energy Research Scientific Computing Center (NERSC) and High Performance Computing (HPC) at New York University (NYU).	Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Bracegirdle TJ, 2012, J CLIMATE, V25, P7138, DOI 10.1175/JCLI-D-11-00685.1; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; BRETHERTON CS, 1992, J CLIMATE, V5, P541, DOI 10.1175/1520-0442(1992)005<0541:AIOMFF>2.0.CO;2; Bromwich DH, 2013, NAT GEOSCI, V6, P139, DOI [10.1038/ngeo1671, 10.1038/NGEO1671]; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Fogt RL, 2011, CLIM DYNAM, V36, P1555, DOI 10.1007/s00382-010-0905-0; Franzke C, 2004, J ATMOS SCI, V61, P145, DOI 10.1175/1520-0469(2004)061<0145:ITNAOA>2.0.CO;2; Goosse H., 2013, CRYOSPHERE DISCUSS, V7, P4585; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Hakkinen S, 2011, SCIENCE, V334, P655, DOI 10.1126/science.1205683; HELD IM, 1994, B AM METEOROL SOC, V75, P1825, DOI 10.1175/1520-0477(1994)075<1825:APFTIO>2.0.CO;2; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; HOSKINS BJ, 1981, J ATMOS SCI, V38, P1179, DOI 10.1175/1520-0469(1981)038<1179:TSLROA>2.0.CO;2; JAMES PM, 1994, Q J ROY METEOR SOC, V120, P1045, DOI 10.1002/qj.49712051812; JIN FF, 1995, J ATMOS SCI, V52, P307, DOI 10.1175/1520-0469(1995)052<0307:TDRTTH>2.0.CO;2; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; KAROLY DJ, 1989, J CLIMATE, V2, P1239, DOI 10.1175/1520-0442(1989)002<1239:SHCFAW>2.0.CO;2; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Lefebvre W, 2005, OCEAN SCI DISCUSS, V2, P299, DOI DOI 10.5194/OSD-2-299-2005; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; O'Donnell R, 2011, J CLIMATE, V24, P2099, DOI 10.1175/2010JCLI3656.1; Okumura YM, 2012, J CLIMATE, V25, P7421, DOI 10.1175/JCLI-D-12-00050.1; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Ryu JH, 2008, J ATMOS SCI, V65, P1817, DOI 10.1175/2007JAS2466.1; SARDESHMUKH PD, 1988, J ATMOS SCI, V45, P1228, DOI 10.1175/1520-0469(1988)045<1228:TGOGRF>2.0.CO;2; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schneider DP, 2012, CLIM DYNAM, V38, P323, DOI 10.1007/s00382-010-0985-x; Seo KH, 2012, J ATMOS SCI, V69, P79, DOI 10.1175/2011JAS3686.1; Son SW, 2008, SCIENCE, V320, P1486, DOI 10.1126/science.1155939; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Yoo C, 2012, J ATMOS SCI, V69, P2379, DOI 10.1175/JAS-D-11-0261.1; Yuan XJ, 2001, GEOPHYS RES LETT, V28, P3609, DOI 10.1029/2001GL012969; Zhang R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037260	45	166	171	7	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					538	+		10.1038/nature12945	http://dx.doi.org/10.1038/nature12945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451542				2022-12-28	WOS:000329995000037
J	Yeo, A; Ramachandran, M				Yeo, Andrea; Ramachandran, Manoj			Acute haematogenous osteomyelitis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							C-REACTIVE PROTEIN; SICKLE-CELL-DISEASE; SEPTIC ARTHRITIS; STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; MUSCULOSKELETAL INFECTIONS; OSTEOARTICULAR INFECTIONS; PEDIATRIC OSTEOMYELITIS; ANTIBIOTIC-THERAPY; JOINT INFECTIONS		[Ramachandran, Manoj] Barts Hlth NHS Trust, Royal London Hosp, Ctr Orthopaed, London E1 1BB, England; Barts Hlth NHS Trust, Barts Childrens Hosp, Ctr Orthopaed, London E1 1BB, England; Barts Hlth NHS Trust, London Childrens Hosp, Ctr Orthopaed, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Barts Health NHS Trust	Ramachandran, M (corresponding author), Barts Hlth NHS Trust, Royal London Hosp, Ctr Orthopaed, London E1 1BB, England.	ramachandran@bartshealth.nhs.uk						Arnold JC, 2012, PEDIATRICS, V130, pE821, DOI 10.1542/peds.2012-0220; Bachur R, 2007, CLIN PEDIATR, V46, P30, DOI 10.1177/0009922806289081; Belthur MV, 2012, J BONE JOINT SURG AM, V94A, P34, DOI 10.2106/JBJS.J.01915; Berger E, 2009, ARCH PEDIAT ADOL MED, V163, P251, DOI 10.1001/archpediatrics.2008.545; British Orthopaedic Association and British Society for Children's Orthopaedic Surgery, 2013, MAN AC BON JOINT INF; Butbul-Aviel Y, 2005, PEDIATR EMERG CARE, V21, P828, DOI 10.1097/01.pec.0000190226.12610.24; Ceroni D, 2010, J PEDIATR ORTHOPED, V30, P301, DOI 10.1097/BPO.0b013e3181d4732f; Copley LAB, 2013, J BONE JOINT SURG AM, V95A, P686, DOI 10.2106/JBJS.L.00037; Dartnell J, 2012, J BONE JOINT SURG BR, V94B, P584, DOI 10.1302/0301-620X.94B5.28523; Dodwell ER, 2013, CURR OPIN PEDIATR, V25, P58, DOI 10.1097/MOP.0b013e32835c2b42; Frank G, 2005, PEDIATR CLIN N AM, V52, P1083, DOI 10.1016/j.pcl.2005.04.003; Gafur OA, 2008, J PEDIATR ORTHOPED, V28, P777, DOI 10.1097/BPO.0b013e318186eb4b; Goergens ED, 2005, J PAEDIATR CHILD H, V41, P59, DOI 10.1111/j.1440-1754.2005.00538.x; Gutierrez K, 2005, PEDIATR CLIN N AM, V52, P779, DOI 10.1016/j.pcl.2005.02.005; Harris JC, 2011, EMERG MED AUSTRALAS, V23, P317, DOI 10.1111/j.1742-6723.2011.01413.x; Hawkshead JJ, 2009, J PEDIATR ORTHOPED, V29, P85, DOI 10.1097/BPO.0b013e3181901c3a; Herigon JC, 2010, PEDIATRICS, V125, pE1294, DOI 10.1542/peds.2009-2867; Hernigou P, 2010, CLIN ORTHOP RELAT R, V468, P1676, DOI 10.1007/s11999-009-1149-3; Host B, 2000, EUR J CLIN MICROBIOL, V19, P608, DOI 10.1007/s100960000324; Howard-Jones AR, 2013, J PAEDIATR CHILD H, V49, P760, DOI 10.1111/jpc.12251; Inusa BPD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065001; Jacqueline C, 2010, J ANTIMICROB CHEMOTH, V65, P1749, DOI 10.1093/jac/dkq193; JARAMILLO D, 1995, AM J ROENTGENOL, V165, P399, DOI 10.2214/ajr.165.2.7618566; JONES DC, 1981, J BONE JOINT SURG BR, V63, P376, DOI 10.1302/0301-620X.63B3.7263748; Karmazyn B, 2010, SEMIN ULTRASOUND CT, V31, P100, DOI 10.1053/j.sult.2009.12.002; Marti-Carvajal AJ, 2012, COCHRANE DB SYST REV, V12; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; Montgomery CO, 2013, J PEDIATR ORTHOPED, V33, P464, DOI 10.1097/BPO.0b013e318278484f; Paakkonen M, 2010, CLIN ORTHOP RELAT R, V468, P861, DOI 10.1007/s11999-009-0936-1; Parsch K, 2010, CHILDRENS ORTHOPAEDICS AND FRACTURES, THIRD EDITION, P135, DOI 10.1007/978-1-84882-611-3_10; Peltola H, 2010, PEDIATR INFECT DIS J, V29, P1123, DOI 10.1097/INF.0b013e3181f55a89; Perlman MH, 2000, J PEDIATR ORTHOPED, V20, P40, DOI 10.1097/00004694-200001000-00009; Perry DC, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4250; PIEHL FC, 1993, J PEDIATR ORTHOPED, V13, P225; Pineda Carlos, 2009, Semin Plast Surg, V23, P80, DOI 10.1055/s-0029-1214160; Riise OR, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-45; ROINE I, 1995, PEDIATR INFECT DIS J, V14, P40, DOI 10.1097/00006454-199501000-00008; Sreenivas T, 2011, J CHILD ORTHOP, V5, P231, DOI 10.1007/s11832-011-0347-1; Streetly A, 2010, J CLIN PATHOL, V63, P626, DOI 10.1136/jcp.2010.077560; The Pediatric Orthopedic Society of North America (POSNA), 2013, AC OST; Thomsen Isaac, 2011, Curr Infect Dis Rep, V13, P451, DOI 10.1007/s11908-011-0202-z; TUSON CE, 1994, J BONE JOINT SURG BR, V76B, P306, DOI 10.1302/0301-620X.76B2.8113299; van Schuppen J, 2012, INSIGHTS IMAGING, V3, P519, DOI 10.1007/s13244-012-0186-8; Warmann SW, 2011, J PEDIATR SURG, V46, P1550, DOI 10.1016/j.jpedsurg.2010.11.037; WILLIAMSON JB, 1990, ARCH DIS CHILD-FETAL, V65, P1060, DOI 10.1136/adc.65.10_Spec_No.1060; Zaoutis T, 2009, PEDIATRICS, V123, P636, DOI 10.1542/peds.2008-0596	46	31	33	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2014	348								g66	10.1136/bmj.g66	http://dx.doi.org/10.1136/bmj.g66			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AH	24446020	Green Published			2022-12-28	WOS:000330295700012
J	Claussnitzer, M; Dankel, SN; Klocke, B; Grallert, H; Glunk, V; Berulava, T; Lee, H; Oskolkov, N; Fadista, J; Ehlers, K; Wahl, S; Hoffmann, C; Qian, K; Ronn, T; Riess, H; Muller-Nurasyid, M; Bretschneider, N; Schroeder, T; Skurk, T; Horsthemke, B; Spieler, D; Klingenspor, M; Seifert, M; Kern, MJ; Mejhert, N; Dahlman, I; Hansson, O; Hauck, SM; Bluher, M; Arner, P; Groop, L; Illig, T; Suhre, K; Hsu, YH; Mellgren, G; Hauner, H; Laumen, H				Claussnitzer, Melina; Dankel, Simon N.; Klocke, Bernward; Grallert, Harald; Glunk, Viktoria; Berulava, Tea; Lee, Heekyoung; Oskolkov, Nikolay; Fadista, Joao; Ehlers, Kerstin; Wahl, Simone; Hoffmann, Christoph; Qian, Kun; Ronn, Tina; Riess, Helene; Mueller-Nurasyid, Martina; Bretschneider, Nancy; Schroeder, Timm; Skurk, Thomas; Horsthemke, Bernhard; Spieler, Derek; Klingenspor, Martin; Seifert, Martin; Kern, Michael J.; Mejhert, Niklas; Dahlman, Ingrid; Hansson, Ola; Hauck, Stefanie M.; Blueher, Matthias; Arner, Peter; Groop, Leif; Illig, Thomas; Suhre, Karsten; Hsu, Yi-Hsiang; Mellgren, Gunnar; Hauner, Hans; Laumen, Helmut		DIAGRAM Consortium	Leveraging Cross- Species Transcription Factor Binding Site Patterns: From Diabetes Risk Loci to Disease Mechanisms	CELL			English	Article							GENOME-WIDE ASSOCIATION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; EPIGENOMIC ANALYSIS; ADIPOSE-TISSUE; LARGE-SCALE; PPAR-GAMMA; IN-VIVO; GENE; PPAR-GAMMA-2; VARIANT	Genome-wide association studies have revealed numerous risk loci associated with diverse diseases. However, identification of disease-causing variants within association loci remains a major challenge. Divergence in gene expression due to cis-regulatory variants in noncoding regions is central to disease susceptibility. We show that integrative computational analysis of phylogenetic conservation with a complexity assessment of co-occurring transcription factor binding sites (TFBS) can identify cis-regulatory variants and elucidate their mechanistic role in disease. Analysis of established type 2 diabetes risk loci revealed a striking clustering of distinct homeobox TFBS. We identified the PRRX1 homeobox factor as a repressor of PPARG2 expression in adipose cells and demonstrate its adverse effect on lipid metabolism and systemic insulin sensitivity, dependent on the rs4684847 risk allele that triggers PRRX1 binding. Thus, cross-species conservation analysis at the level of co-occurring TFBS provides a valuable contribution to the translation of genetic association signals to disease-related molecular mechanisms.	[Claussnitzer, Melina; Glunk, Viktoria; Lee, Heekyoung; Ehlers, Kerstin; Qian, Kun; Skurk, Thomas; Hauner, Hans; Laumen, Helmut] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, Chair Nutr Med, D-85350 Freising Weihenstephan, Germany; [Claussnitzer, Melina; Glunk, Viktoria; Lee, Heekyoung; Ehlers, Kerstin; Hoffmann, Christoph; Qian, Kun; Skurk, Thomas; Klingenspor, Martin; Hauner, Hans; Laumen, Helmut] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Nutr Med Unit, D-85350 Freising Weihenstephan, Germany; [Claussnitzer, Melina; Grallert, Harald; Glunk, Viktoria; Lee, Heekyoung; Ehlers, Kerstin; Wahl, Simone; Qian, Kun; Hauck, Stefanie M.; Hauner, Hans; Laumen, Helmut] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Claussnitzer, Melina; Glunk, Viktoria; Lee, Heekyoung; Ehlers, Kerstin; Qian, Kun; Hauner, Hans; Laumen, Helmut] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Nutrigenom & Type Diabet 2, D-85764 Neuherberg, Germany; [Claussnitzer, Melina; Glunk, Viktoria; Lee, Heekyoung; Ehlers, Kerstin; Qian, Kun; Hauner, Hans; Laumen, Helmut] Tech Univ Munich, D-85350 Freising Weihenstephan, Germany; [Claussnitzer, Melina; Hsu, Yi-Hsiang] Harvard Univ, Sch Med, Hebrew SeniorLife Inst Aging Res, Boston, MA 02131 USA; [Dankel, Simon N.; Mellgren, Gunnar] Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway; [Dankel, Simon N.; Mellgren, Gunnar] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, N-5021 Bergen, Norway; [Dankel, Simon N.; Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Klocke, Bernward; Bretschneider, Nancy; Seifert, Martin] Genomatix Software GmbH, D-80335 Munich, Germany; [Grallert, Harald; Wahl, Simone; Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Berulava, Tea; Horsthemke, Bernhard] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45147 Essen, Germany; [Oskolkov, Nikolay; Fadista, Joao; Ronn, Tina; Hansson, Ola; Groop, Leif] Lund Univ, Dept Clin Sci, Diabet & Endocrinol Res Unit, S-20502 Malmo, Sweden; [Hoffmann, Christoph; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, Chair Mol Nutr Med, D-85350 Freising Weihenstephan, Germany; [Riess, Helene] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89081 Ulm, Germany; [Riess, Helene] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Mueller-Nurasyid, Martina] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, D-81377 Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Schroeder, Timm] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Res Unit Stem Cell Dynam, D-85764 Neuherberg, Germany; [Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, CH-4058 Basel, Switzerland; [Spieler, Derek] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Spieler, Derek] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany; [Kern, Michael J.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Mejhert, Niklas; Dahlman, Ingrid; Arner, Peter] Karolinska Univ Hosp Huddinge, Ctr Endocrinol & Metab, Karolinska Inst, Dept Med, SE-14186 Stockholm, Sweden; [Hauck, Stefanie M.] Helmholtz Zentrum Munchen, Res Unit Prot Sci, D-85764 Neuherberg, Germany; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Illig, Thomas] Hannover Med Sch, Hanover Unified Biobank, D-30625 Hannover, Germany; [Suhre, Karsten] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Suhre, Karsten] Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Hsu, Yi-Hsiang] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Skurk, Thomas; Hauner, Hans] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Ctr Nutr Med, D-81675 Munich, Germany; [Laumen, Helmut] Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Neuherberg, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Harvard University; Harvard Medical School; Hebrew SeniorLife; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Duisburg Essen; Lund University; Technical University of Munich; Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Medical University of South Carolina; Karolinska Institutet; Karolinska University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Harvard T.H. Chan School of Public Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Claussnitzer, M (corresponding author), Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, Chair Nutr Med, D-85350 Freising Weihenstephan, Germany.	melinaclaussnitzer@hsl.harvard.edu; helmut.laumen@tum.de	Laumen, Helmut/M-5140-2013; Mellgren, Gunnar/AAG-6573-2020; Klingenspor, Martin/K-5033-2019; Oskolkov, Nikolay/AAH-2349-2019; Klingenspor, Martin/D-6930-2011; Langenberg, Claudia/ABG-9067-2021; Suhre, Karsten/AAF-1778-2020; Hide, Winston/R-3815-2019; Seifert, Martin/GSE-3648-2022; Meitinger, Thomas/O-1318-2015; Altshuler, David M/A-4476-2009; FROGUEL, Philippe/O-6799-2017; Rudan, Igor/I-1467-2012; Hide, Winston Hide/C-7217-2009; Benediktsson, Rafn/R-2457-2018; Müller-Nurasyid, Martina/I-8735-2018; Fadista, Joao/AAM-4870-2020; Thorand, Barbara/B-5349-2014; Hauck, Stefanie/B-3300-2013; Boehm, Bernhard Otto/F-8750-2015; Schroeder, Timm/F-8448-2010; Hansson, Ola/F-1793-2011; Palmer, Colin NA/C-7053-2008; Hide, Winston A/V-2727-2017; Wijmenga, Cisca/D-2173-2009; Aulchenko, Yurii/M-8270-2013	Laumen, Helmut/0000-0002-5885-5242; Mellgren, Gunnar/0000-0001-6282-4986; Klingenspor, Martin/0000-0002-4502-6664; Langenberg, Claudia/0000-0002-5017-7344; Suhre, Karsten/0000-0001-9638-3912; Hide, Winston/0000-0002-8621-3271; Altshuler, David M/0000-0002-7250-4107; FROGUEL, Philippe/0000-0003-2972-0784; Rudan, Igor/0000-0001-6993-6884; Hide, Winston Hide/0000-0002-8621-3271; Benediktsson, Rafn/0000-0002-2954-9801; Müller-Nurasyid, Martina/0000-0003-3793-5910; Fadista, Joao/0000-0003-2539-634X; Thorand, Barbara/0000-0002-8416-6440; Hauck, Stefanie/0000-0002-1630-6827; Schroeder, Timm/0000-0001-9320-0252; Hansson, Ola/0000-0002-7394-7639; Palmer, Colin NA/0000-0002-6415-6560; Hide, Winston A/0000-0002-8621-3271; Weedon, Michael/0000-0002-6174-6135; Pramstaller, Peter P/0000-0002-9831-8302; Ronn, Tina/0000-0001-7622-800X; Bergman, Richard/0000-0003-1539-4471; fadista, joao/0000-0001-7558-7043; Gloyn, Anna/0000-0003-1205-1844; Tuomi, Tiinamaija/0000-0002-8306-6202; Couper, David/0000-0002-4313-9235; Dahlman, Ingrid/0000-0003-3819-5977; Hattersley, Andrew/0000-0001-5620-473X; Van Duijn, Cornelia/0000-0002-2374-9204; Aulchenko, Yurii/0000-0002-7899-1575; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Arner, Peter/0000-0002-6208-6220; Mejhert, Niklas/0000-0003-1785-833X; Meitinger, Thomas/0000-0002-8838-8403; Dankel, Simon/0000-0001-6972-1824; Jorgensen, Torben/0000-0001-9453-2830; Lindgren, Cecilia/0000-0002-4903-9374; Skurk, Thomas/0000-0002-6875-1658; Dina, Christian/0000-0002-7722-7348; Zeggini, Eleftheria/0000-0003-4238-659X; Saxena, Richa/0000-0003-2233-1065	Else Kroner-Fresenius Foundation; Bad Homburg v. d. H, Germany; Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen; Helmholtz Graduate School for Environmental Health, HELENA; German Federal Ministry of Education and Research; Competence Network Obesity (German Obesity Biomaterial Bank) [FKZ 01GI1128]; University Duisburg-Essen [01KU1216E]; KG Jebsen Center for Diabetes Research, University of Bergen, Norway; Western Norway Regional Health Authority, Norway; Swedish Research Council [2009-1039, 3492006-237, 2011-3315, 521-20103490, GA 269045]; "Biomedical Research Program'' funds at Weill Cornell Medical College in Qatar; Qatar Foundation; MRC [MC_UU_12015/1, MC_U106179474, MC_UU_12015/4] Funding Source: UKRI; Medical Research Council [MC_UU_12015/4, MC_U106179471, MC_U106179474, MC_UU_12015/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016371] Funding Source: researchfish	Else Kroner-Fresenius Foundation; Bad Homburg v. d. H, Germany; Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen; Helmholtz Graduate School for Environmental Health, HELENA; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Competence Network Obesity (German Obesity Biomaterial Bank); University Duisburg-Essen; KG Jebsen Center for Diabetes Research, University of Bergen, Norway; Western Norway Regional Health Authority, Norway; Swedish Research Council(Swedish Research CouncilEuropean Commission); "Biomedical Research Program'' funds at Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by the Else Kroner-Fresenius Foundation, Bad Homburg v. d. H, Germany; the grant Virtual Institute "Molecular basis of glucose regulation and type 2 diabetes'' received from the Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; the grant Clinical Cooperation Group "Nutrigenomics and type 2 diabetes'' received from the Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany, and the Technische Universitat Munchen; the Helmholtz Graduate School for Environmental Health, HELENA; a grant from the German Federal Ministry of Education and Research to the German Centre for Diabetes Research (DZD e.V.); the Competence Network Obesity (German Obesity Biomaterial Bank; FKZ 01GI1128), and the University Duisburg-Essen (01KU1216E); the KG Jebsen Center for Diabetes Research, University of Bergen, Norway and the Western Norway Regional Health Authority, Norway; by grants from the Swedish Research Council, including strategic research area grant EXODIAB (2009-1039), Linnaeus grant (3492006-237), Collaborative Grant (2011-3315), and Project Grant (521-20103490) and by an ERC Advanced Researcher Grant GENETARGET-T2D (GA 269045); and by "Biomedical Research Program'' funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation. We thank Karl-Fredrik Eriksson and Targ Elgzyri for providing human fat biopsy material and Charlotte Ling for supporting generation of microarray data (Lund University). We are grateful to Andrea Califano (Columbia University, New York, NY) for critical review and constructive scientific comments on the manuscript. We further thank Bernd Baumann, Vidar M. Steen, and Jorn V. Sagen for expert advice, and Elisabeth Hofmair, Manuela Hubersberger, Margit Solsvik, Linn Jeanette Waagbo, Tone Nygaard Flolo, Jan-Inge Bjune, Zina Fandalyuk, Vivian Veum, and Christine Haugen for excellent technical assistance. We thank Ralf Kuhn (Helmholtz Zentrum Mu " nchen, Mu " nchen-Neuherberg) for providing CRISPR/ Cas vectors. We thank Christine Stansberg, Rita Holdhus, and Kjell Petersen at the Norwegian Microarray Consortium (NMC) (Bergen node, Norway), Douglas P. Kiel and David Karasik (Hebrew SeniorLife Institute for Aging Research, Harvard Medical School, Boston, MA), and Michael Molla (Joslin Diabetes Center, Harvard Medical School, Boston, MA) for expert assistance. Wethank surgeon Hans Jorgen Nielsen and colleagues (Voss Hospital, Norway), surgeons Barbara Auras Jaatun, Inge Glamb~k, and colleagues (Haraldsplass Deaconess Hospital, Bergen), surgeon Christian Busch (Klinikk Bergen, Nesttun), and all the patients for providing human adipose tissue. We thank Reiner Schroeer and Dorothy Dankel for critical reading of the manuscript. The authors have filed a patent related to this work.	Alberobello AT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-144; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnone MI, 1997, DEVELOPMENT, V124, P1851; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Cadoudal T, 2007, DIABETOLOGIA, V50, P666, DOI 10.1007/s00125-006-0560-5; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Du BW, 2013, J BIOL CHEM, V288, P3036, DOI 10.1074/jbc.M112.440370; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kang ES, 2005, CLIN PHARMACOL THER, V78, P202, DOI 10.1016/j.clpt.2005.04.013; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Ozaki K, 2006, NAT GENET, V38, P921, DOI 10.1038/ng1846; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	51	90	92	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					343	358		10.1016/j.cell.2013.10.058	http://dx.doi.org/10.1016/j.cell.2013.10.058			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439387	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000329912200032
J	Kowdley, KV; Lawitz, E; Poordad, F; Cohen, DE; Nelson, DR; Zeuzem, S; Everson, GT; Kwo, P; Foster, GR; Sulkowski, MS; Xie, WG; Pilot-Matias, T; Liossis, G; Larsen, L; Khatri, A; Podsadecki, T; Bernstein, B				Kowdley, Kris V.; Lawitz, Eric; Poordad, Fred; Cohen, Daniel E.; Nelson, David R.; Zeuzem, Stefan; Everson, Gregory T.; Kwo, Paul; Foster, Graham R.; Sulkowski, Mark S.; Xie, Wangang; Pilot-Matias, Tami; Liossis, George; Larsen, Lois; Khatri, Amit; Podsadecki, Thomas; Bernstein, Barry			Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLUS RIBAVIRIN; HCV INFECTION; BOCEPREVIR; INHIBITOR; ASSOCIATION; TELAPREVIR	BackgroundAn interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r), the nonnucleoside polymerase inhibitor ABT-333, and ribavirin showed efficacy against the hepatitis C virus (HCV) in a pilot study involving patients with HCV genotype 1 infection. The addition of another potent agent, the NS5A inhibitor ABT-267, may improve efficacy, especially in difficult-to-treat patients. This study was designed to evaluate multiple regimens of direct-acting antiviral agents and ribavirin in patients with HCV genotype 1 infection who had not received therapy previously or who had no response to prior therapy with pegylated interferon and ribavirin. MethodsIn this phase 2b, open-label study with 14 treatment subgroups, 571 patients without cirrhosis who had not received treatment previously or who had not had a response to prior therapy were randomly assigned to a regimen of ABT-450/r, combined with ABT-267 or ABT-333 or both, for 8, 12, or 24 weeks and received at least one dose of therapy. All the subgroups but 1 also received ribavirin (dose determined according to body weight). The primary end point was sustained virologic response at 24 weeks after the end of treatment. The primary efficacy analysis compared rates between previously untreated patients who received three direct-acting antiviral agents and ribavirin for 8 weeks and those who received the same therapy for 12 weeks. ResultsAmong previously untreated patients who received three direct-acting antiviral agents (with the ABT-450/r dose administered as 150 mg of ABT-450 and 100 mg of ritonavir) plus ribavirin, the rate of sustained virologic response at 24 weeks after treatment was 88% among those who received the therapy for 8 weeks and 95% among those who received the therapy for 12 weeks (difference, -7 percentage points; 95% confidence interval, -19 to 5; P=0.24). The rates of sustained virologic response across all treatment subgroups ranged from 83 to 100%. The most frequent adverse events were fatigue, headache, nausea, and insomnia. Eight patients (1%) discontinued treatment owing to adverse events. ConclusionsIn this phase 2b study, all-oral regimens of antiviral agents and ribavirin were effective both in patients with HCV genotype 1 infection who had not received therapy previously and in those who had not had a response to prior therapy. (Funded by AbbVie; ClinicalTrials.gov number, NCT01464827.) In this phase 2 study, peginterferon-free regimens were effective in patients with hepatitis C virus genotype 1 infection. Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, liver cancer, and end-stage liver disease.(1) The current standard of care for chronic HCV genotype 1 infection is pegylated interferon (peginterferon) and ribavirin, with a protease inhibitor (boceprevir or telaprevir).(2) Although the addition of a protease inhibitor has been associated with a significant increase in response rates, only approximately one third of patients who had not had a response to prior therapy with peginterferon and ribavirin had a sustained virologic response when re-treated with the addition of a protease inhibitor.(3),(4) Furthermore, these therapies are associated with adverse ...	[Kowdley, Kris V.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98111 USA; [Lawitz, Eric; Poordad, Fred] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Cohen, Daniel E.; Xie, Wangang; Pilot-Matias, Tami; Liossis, George; Larsen, Lois; Khatri, Amit; Podsadecki, Thomas; Bernstein, Barry] AbbVie, N Chicago, IL USA; [Nelson, David R.] Univ Florida, Coll Med, Gainesville, FL USA; [Zeuzem, Stefan] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Everson, Gregory T.] Univ Colorado Denver, Aurora, CO USA; [Kwo, Paul] Indiana Univ, Indianapolis, IN 46204 USA; [Foster, Graham R.] Univ London, Barts Hlth, London WC1E 7HU, England; [Sulkowski, Mark S.] Johns Hopkins Univ, Baltimore, MD USA	Virginia Mason Medical Center; University of Texas System; University of Texas Health San Antonio; AbbVie; State University System of Florida; University of Florida; Goethe University Frankfurt; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Barts Health NHS Trust; University of London; Johns Hopkins University	Kowdley, KV (corresponding author), Virginia Mason Med Ctr, Inst Digest Dis, Mailstop C3 GAS,1100 9th Ave, Seattle, WA 98111 USA.	kris.kowdley@vmmc.org	Kowdley, Kris/AAF-5202-2019; Zeuzem, Stefan/AAE-7435-2019	Foster, Graham/0000-0002-3704-386X	AbbVie; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA034621] Funding Source: NIH RePORTER	AbbVie(AbbVie); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by AbbVie.	[Anonymous], 2013, VICT BOC CAPS PRESCR; [Anonymous], 2013, INC TEL FILM COAT TA; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bacon BR, 2010, HEPATOLOGY, V52, p430A; Gane E, 2013, 20 C RETR OPP INF AT; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lawitz E, 2012, J HEPATOL, V56, pS469, DOI 10.1016/S0168-8278(12)61198-2; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Menon RM, 2009, GLOBAL ANTIVIRAL J, V5, P53; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Seeff LB, 2002, HEPATOLOGY, V36, pS1, DOI 10.1053/jhep.2002.36992; Sulkowski M, 2012, J HEPATOL S, V56, pS560; Zeuzem S, 2012, J HEPATOL, V56, pS1; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	22	213	219	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					222	232		10.1056/NEJMoa1306227	http://dx.doi.org/10.1056/NEJMoa1306227			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428468	Bronze			2022-12-28	WOS:000330035600008
J	Sulkowski, MS; Gardiner, DF; Rodriguez-Torres, M; Reddy, KR; Hassanein, T; Jacobson, I; Lawitz, E; Lok, AS; Hinestrosa, F; Thuluvath, PJ; Schwartz, H; Nelson, DR; Everson, GT; Eley, T; Wind-Rotolo, M; Huang, SP; Gao, M; Hernandez, D; McPhee, F; Sherman, D; Hindes, R; Symonds, W; Pasquinelli, C; Grasela, DM				Sulkowski, Mark S.; Gardiner, David F.; Rodriguez-Torres, Maribel; Reddy, K. Rajender; Hassanein, Tarek; Jacobson, Ira; Lawitz, Eric; Lok, Anna S.; Hinestrosa, Federico; Thuluvath, Paul J.; Schwartz, Howard; Nelson, David R.; Everson, Gregory T.; Eley, Timothy; Wind-Rotolo, Megan; Huang, Shu-Pang; Gao, Min; Hernandez, Dennis; McPhee, Fiona; Sherman, Diane; Hindes, Robert; Symonds, William; Pasquinelli, Claudio; Grasela, Dennis M.		AI444040 Study Grp	Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; REPLICATION COMPLEX INHIBITOR; PEGINTERFERON ALPHA-2A; VIRUS EPIDEMIOLOGY; HEALTH BURDEN; DOUBLE-BLIND; GENOTYPE 1; RIBAVIRIN; COMBINATION; TELAPREVIR	BackgroundAll-oral combination therapy is desirable for patients with chronic hepatitis C virus (HCV) infection. We evaluated daclatasvir (an HCV NS5A replication complex inhibitor) plus sofosbuvir (a nucleotide analogue HCV NS5B polymerase inhibitor) in patients infected with HCV genotype 1, 2, or 3. MethodsIn this open-label study, we initially randomly assigned 44 previously untreated patients with HCV genotype 1 infection and 44 patients infected with HCV genotype 2 or 3 to daclatasvir at a dose of 60 mg orally once daily plus sofosbuvir at a dose of 400 mg orally once daily, with or without ribavirin, for 24 weeks. The study was expanded to include 123 additional patients with genotype 1 infection who were randomly assigned to daclatasvir plus sofosbuvir, with or without ribavirin, for 12 weeks (82 previously untreated patients) or 24 weeks (41 patients who had previous virologic failure with telaprevir or boceprevir plus peginterferon alfa-ribavirin). The primary end point was a sustained virologic response (an HCV RNA level of <25 IU per milliliter) at week 12 after the end of therapy. ResultsOverall, 211 patients received treatment. Among patients with genotype 1 infection, 98% of 126 previously untreated patients and 98% of 41 patients who did not have a sustained virologic response with HCV protease inhibitors had a sustained virologic response at week 12 after the end of therapy. A total of 92% of 26 patients with genotype 2 infection and 89% of 18 patients with genotype 3 infection had a sustained virologic response at week 12. High rates of sustained virologic response at week 12 were observed among patients with HCV subtypes 1a and 1b (98% and 100%, respectively) and those with CC and non-CC IL28B genotypes (93% and 98%, respectively), as well as among patients who received ribavirin and those who did not (94% and 98%, respectively). The most common adverse events were fatigue, headache, and nausea. ConclusionsOnce-daily oral daclatasvir plus sofosbuvir was associated with high rates of sustained virologic response among patients infected with HCV genotype 1, 2, or 3, including patients with no response to prior therapy with telaprevir or boceprevir. (Funded by Bristol-Myers Squibb and Pharmasset (Gilead); A1444040 ClinicalTrials.gov number, NCT01359644.) In this study, once-daily treatment with oral daclatasvir plus sofosbuvir was associated with high rates of sustained virologic response among patients with genotype 1, 2, or 3 HCV infection, including those in whom previous therapy with telaprevir or boceprevir had failed. Chronic infection with hepatitis C virus (HCV) affects approximately 170 million people worldwide and is a major cause of cirrhosis and hepatocellular carcinoma.(1),(2) HCV-related morbidity and mortality are increasing; since 2007, HCV-related deaths in the United States have exceeded those from human immunodeficiency virus (HIV) infection.(3),(4) HCV is classified into six major genotypes.(5),(6) Genotypes 1, 2, and 3 are found worldwide, with subtype 1a predominating in the United States and subtype 1b predominating in Europe, Japan, and China.(5),(7),(8) Peginterferon alfa-ribavirin treatment for chronic HCV infection is associated with a sustained virologic response (undetectable HCV RNA ...	[Sulkowski, Mark S.] Johns Hopkins Univ, Baltimore, MD 21287 USA; [Thuluvath, Paul J.] Mercy Med Ctr, Baltimore, MD USA; [Gardiner, David F.; Eley, Timothy; Sherman, Diane; Pasquinelli, Claudio; Grasela, Dennis M.] Bristol Myers Squibb, Hopewell, NJ USA; [Wind-Rotolo, Megan; Huang, Shu-Pang] Bristol Myers Squibb Co, Princeton, NJ USA; [Rodriguez-Torres, Maribel] Fdn Invest, San Juan, PR USA; [Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA; [Jacobson, Ira] Weill Cornell Med Coll, New York, NY USA; [Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Lok, Anna S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hinestrosa, Federico] Orlando Immunol Ctr, Orlando, FL USA; [Nelson, David R.] Univ Florida, Gainesville, FL USA; [Everson, Gregory T.] Univ Colorado Denver, Aurora, CO USA; [Gao, Min; Hernandez, Dennis; McPhee, Fiona] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Symonds, William] Gilead Sci, Foster City, CA USA	Johns Hopkins University; Mercy Medical Center - Maryland; Bristol-Myers Squibb; Bristol-Myers Squibb; University of Pennsylvania; Cornell University; University of Texas System; University of Texas Health San Antonio; University of Michigan System; University of Michigan; Orlando Immunology Center; State University System of Florida; University of Florida; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Bristol-Myers Squibb; Gilead Sciences	Sulkowski, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 600 N Wolfe St,1830 Bldg,Rm 445, Baltimore, MD 21287 USA.	msulkowski@jhmi.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Bristol-Myers Squibb; Pharmasset (Gilead); NATIONAL INSTITUTE ON DRUG ABUSE [K24DA034621] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Pharmasset (Gilead); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by Bristol-Myers Squibb and Pharmasset (Gilead).	Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; Dore GJ, 2012, HEPATOLOGY, V56, p558A; Drenth JPH, 2013, NEW ENGL J MED, V368, P1931, DOI 10.1056/NEJMe1303818; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2012, HEPATOLOGY, V56, p553A; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kanwal F, 2011, GASTROENTEROLOGY, V140; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; McHutchison JG, 2009, NEW ENGL J MED, V361, P1027; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Negro F, 2011, LIVER INT, V31, P1, DOI 10.1111/j.1478-3231.2011.02537.x; Nettles RE, 2011, HEPATOLOGY, V54, P1956, DOI 10.1002/hep.24609; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pol S, 2012, LANCET INFECT DIS, V12, P671, DOI 10.1016/S1473-3099(12)70138-X; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Sulkowski M, 2012, J HEPATOL, V56, pS560; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; World Health Organization, 2012, GLOB AL RESP GAR HEP; Zeuzem S, 2012, HEPATOLOGY, V56, p308A; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	35	884	934	0	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					211	221		10.1056/NEJMoa1306218	http://dx.doi.org/10.1056/NEJMoa1306218			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428467	Bronze			2022-12-28	WOS:000330035600007
J	[Anonymous]				[Anonymous]			WHO response to BMJ queries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2014	348								f7271	10.1136/bmj.f7271	http://dx.doi.org/10.1136/bmj.f7271			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MN	24423892				2022-12-28	WOS:000329975900003
J	Milner, J; Shrubsole, C; Das, P; Jones, B; Ridley, I; Chalabi, Z; Hamilton, I; Armstrong, B; Davies, M; Wilkinson, P				Milner, James; Shrubsole, Clive; Das, Payel; Jones, Benjamin; Ridley, Ian; Chalabi, Zaid; Hamilton, Ian; Armstrong, Ben; Davies, Michael; Wilkinson, Paul			Home energy efficiency and radon related risk of lung cancer: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESIDENTIAL RADON; INDOOR RADON; COLLABORATIVE ANALYSIS; COST-EFFECTIVENESS; INDIVIDUAL DATA; VENTILATION; EXPOSURE; IMPACT; GAS	Objective To investigate the effect of reducing home ventilation as part of household energy efficiency measures on deaths from radon related lung cancer. Design Modelling study. Setting England. Intervention Home energy efficiency interventions, motivated in part by targets for reducing greenhouse gases, which entail reduction in uncontrolled ventilation in keeping with good practice guidance. Main outcome measures Modelled current and future distributions of indoor radon levels for the English housing stock and associated changes in life years due to lung cancer mortality, estimated using life tables. Results Increasing the air tightness of dwellings (without compensatory purpose-provided ventilation) increased mean indoor radon concentrations by an estimated 56.6%, from 21.2 becquerels per cubic metre (Bq/m(3)) to 33.2 Bq/m(3). After the lag in lung cancer onset, this would result in an additional annual burden of 4700 life years lost and (at peak) 278 deaths. The increases in radon levels for the millions of homes that would contribute most of the additional burden are below the threshold at which radon remediation measures are cost effective. Fitting extraction fans and trickle ventilators to restore ventilation will help offset the additional burden but only if the ventilation related energy efficiency gains are lost. Mechanical ventilation systems with heat recovery may lower radon levels and the risk of cancer while maintaining the advantage of energy efficiency for the most airtight dwellings but there is potential for a major adverse impact on health if such systems fail. Conclusion Unless specific remediation is used, reducing the ventilation of dwellings will improve energy efficiency only at the expense of population wide adverse impact on indoor exposure to radon and risk of lung cancer. The implications of this and other consequences of changes to ventilation need to be carefully evaluated to ensure that the desirable health and environmental benefits of home energy efficiency are not compromised by avoidable negative impacts on indoor air quality.	[Milner, James; Chalabi, Zaid; Armstrong, Ben; Wilkinson, Paul] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England; [Shrubsole, Clive; Das, Payel; Jones, Benjamin; Ridley, Ian; Davies, Michael] UCL, Bartlett Sch Grad Studies, London WC1E 6BT, England; [Jones, Benjamin] Univ Nottingham, Dept Architecture & Built Environm, Nottingham NG7 2RD, England; [Ridley, Ian] RMIT Univ, Melbourne, Vic 3001, Australia; [Hamilton, Ian] UCL, UCL Energy Inst, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Nottingham; Royal Melbourne Institute of Technology (RMIT); University of London; University College London	Wilkinson, P (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, 15-17 Tavistock Pl, London WC1H 9SH, England.	paul.wilkinson@lshtm.ac.uk	Shrubsole, Clive/L-7783-2018; Davies, Michael/GWV-2527-2022; Das, Payel/AAC-4783-2020; Das, Payel/GWQ-5753-2022; Hamilton, Ian/O-6234-2014; Hamilton, Ian/O-6756-2019	Shrubsole, Clive/0000-0003-1212-3668; Hamilton, Ian/0000-0003-2582-2361; Hamilton, Ian/0000-0003-2582-2361; Milner, James/0000-0003-0304-639X; Jones, Benjamin/0000-0002-1517-4711; RIDLEY, Ian Alexander/0000-0001-9240-5088; armstrong, benedict/0000-0003-4407-0409; Davies, Michael/0000-0003-2173-7063; Jones, Benjamin/0000-0002-5606-9379; Wilkinson, Paul/0000-0001-7456-259X; Das, Payel/0000-0002-3239-4222	European Union [265325]; EPSRC [EP/I02929X/1, EP/K011839/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K011839/1, EP/I02929X/1] Funding Source: researchfish	European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research leading to these results received funding from the European Union seventh framework programme FP7/2007-2013 under grant agreement No 265325 (Public health impacts in urban environments of greenhouse gas emissions reduction strategies, PURGE). The funders had no role in study design, in the collection, analysis, and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication. All researchers involved in the work were independent of the funder.	American Society of Heating Refrigeration and Air-Conditioning Engineers, 2009, FUNDAMENTALS; Arvela H., 2013, RADIAT PROT DOSIM, DOI 10.1093/rpd/nct278; Ashok GV, 2012, RADIAT PROT DOSIM, V148, P92, DOI 10.1093/rpd/ncq590; Bone A, 2010, PERSPECT PUBLIC HEAL, V130, P233, DOI 10.1177/1757913910369092; Briggs DJ, 2003, J ENVIRON MANAGE, V67, P107, DOI 10.1016/S0301-4797(02)00159-7; Committee on Climate Change, 2011, MEETING CARBON BUDGE; Committee on Climate Change, 2008, FIRST REPORT; Darby S, 2006, SCAND J WORK ENV HEA, V32, P1; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Darby S, 2001, ANN ONCOL, V12, P1341, DOI 10.1023/A:1012518223463; Das P, 2013, BUILD ENVIRON, V66, P72, DOI 10.1016/j.buildenv.2013.03.021; Davies M, 2012, ENERG BUILDINGS, V46, P80, DOI 10.1016/j.enbuild.2011.10.043; Denman AR, 2008, J RADIOL PROT, V28, P61, DOI 10.1088/0952-4746/28/1/003; Department for Communities and Local Government, 2010, HOUSEHOLD REPORT 200; Department of Energy and Climate Change, 2012, THE ENERGY EFFICIENC; Dimitroulopoulou S, 2005, CONTRACT NO BRE REPO; Emmerich SJ, 2001, ASHRAE T, V107, P619; Fang J.B., 1995, COMPUTER SIMULATIONS; Gallelli G, 1998, J ENVIRON RADIOACTIV, V39, P117, DOI 10.1016/S0265-931X(97)00056-8; Gray A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3110; Hamilton IG, 2011, BUILD SERV ENG RES T, V32, P85, DOI 10.1177/0143624410394532; Hanninen OO, 2005, INDOOR AIR, V15, P246, DOI 10.1111/j.1600-0668.2005.00365.x; Health Protection Agency, 2009, RADON AND PUBLIC HEA; HM Government, 2013, THE BUILDING REGULAT; HM Government, 2010, THE BUILDING REGULAT; Hunter N, 2009, RADIAT PROT DOSIM, V136, P17, DOI 10.1093/rpd/ncp148; Institute for Sustainability, 2011, RETROFIT GUIDE 6 IMP; Janssen MPM, 2003, INDOOR AIR, V13, P118, DOI 10.1034/j.1600-0668.2003.00157.x; Kennedy CA, 2002, J ENVIRON RADIOACTIV, V59, P19, DOI 10.1016/S0265-931X(01)00031-5; Kreider J, 1994, HEATING AND COOLING; Krewski D, 2006, J TOXICOL ENV HEAL A, V69, P533, DOI 10.1080/15287390500260945; Lugg A, 1997, APPL ENERG, V56, P93, DOI 10.1016/S0306-2619(97)00002-0; Manuel John, 2011, Environ Health Perspect, V119, pA76, DOI 10.1289/ehp.119-a76; Miles J, 2007, INDICATIVE ATLAS OF; Miller B.G., 2006, COMPARING ESTIMATED; Miller BG, 2003, J EPIDEMIOL COMMUN H, V57, P200, DOI 10.1136/jech.57.3.200; National Cancer Institute at the National Institutes of Health, 2013, RADON AND LUNG CANCE; Nazaroff WW, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015022; Nero A, 1980, RADON AND ITS DAUGHT; NHS Information Centre, 2011, STATISTICS ON SMOKIN; Oreszczyn T, 2006, ENERG BUILDINGS, V38, P245, DOI 10.1016/j.enbuild.2005.06.006; Palmer J, 2011, GREAT BRITAINS HOUSI; Pan W, 2010, BUILD ENVIRON, V45, P2387, DOI 10.1016/j.buildenv.2010.04.011; Parkin DM, 2011, BRIT J CANCER, V105, pS57, DOI 10.1038/bjc.2011.485; Pavia M, 2003, B WORLD HEALTH ORGAN, V81, P732; Rees D. M., 2011, HPACRCE015; Rericha V, 2006, ENVIRON HEALTH PERSP, V114, P818, DOI 10.1289/ehp.8476; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sinnott D, 2012, BUILD ENVIRON, V51, P269, DOI 10.1016/j.buildenv.2011.11.016; Stephen R, 2000, 100 IP BUILD RES EST; Swiss Federal Office for Public Health, 2013, ENERGY EFFICIENCY AN; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X	52	71	74	1	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2014	348								f7493	10.1136/bmj.f7493	http://dx.doi.org/10.1136/bmj.f7493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KR	24415631	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000329611300001
J	Fogel, EL; Sherman, S				Fogel, Evan L.; Sherman, Stuart			ERCP for Gallstone Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE BILIARY PANCREATITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; BILE-DUCT STONES; CONSERVATIVE MANAGEMENT; SELECTIVE USE; SPHINCTEROTOMY; CHOLECYSTECTOMY; METAANALYSIS; MORTALITY	A 74-year-old man is admitted to the hospital after an acute onset of epigastric pain, which has been unrelenting for 6 hours. He has tachycardia, at a rate of 114 beats per minute; his blood pressure is 140/90 mm Hg, respiratory rate 24 breaths per minute, temperature 37.6 degrees C, and oxygen saturation 92% while he is breathing ambient air. His serum amylase level is 1270 U per liter (normal range, 19 to 86), and his lipase level is 6430 U per liter (normal range, 7 to 59); these levels are consistent with a diagnosis of acute pancreatitis. Other laboratory results at admission include a hematocrit of 47%, white-cell count of 18,000 per cubic millimeter, calcium level of 7.8 mg per deciliter (2.0 mmol per liter), alanine aminotransferase level of 295 IU per liter, aspartate aminotransferase level of 221 IU per liter, alkaline phosphatase level of 217 IU per liter, bilirubin level of 0.9 mg per deciliter (15.4 mu mol per liter), glucose level of 240 mg per deciliter (13.3 mmol per liter), blood urea nitrogen level of 47 mg per deciliter (16.8 mmol per liter), and creatinine level of 1.3 mg per deciliter (114.9 mu mol per liter). Abdominal ultrasonography reveals gallbladder stones; the common bile duct is 6 mm in diameter, and no intraductal stones are identified. The pancreatitis, which is presumed to have a biliary cause, is predicted to be severe. The consulting gastroenterologist initially favors ongoing supportive therapy but will consider selective endoscopic retrograde cholangiopancreatography (ERCP), depending on the patient's clinical course.	[Fogel, Evan L.; Sherman, Stuart] Indiana Univ, Dept Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis	Fogel, EL (corresponding author), Indiana Univ Hlth, 550 N Univ Blvd,Suite 1602, Indianapolis, IN 46202 USA.	efogel@iu.edu			Olympus; Repligen; Cook; Boston Scientific	Olympus; Repligen; Cook; Boston Scientific(Boston Scientific)	Dr. Fogel reports receiving lecture fees from Olympus; and Dr. Sherman, consulting fees from Repligen and lecture fees from Cook, Olympus, and Boston Scientific. No other potential conflict of interest relevant to this article was reported.	ACOSTA JM, 1974, NEW ENGL J MED, V290, P484, DOI 10.1056/NEJM197402282900904; ACOSTA JM, 1980, SURGERY, V88, P118; ACOSTA JM, 1978, SURGERY, V83, P367; Ayub K, 2004, COCHRANE DB SYST REV, V4; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Barthel JS, 1998, SURG ENDOSC-ULTRAS, V12, P394, DOI 10.1007/s004649900689; Boerma D, 2002, LANCET, V360, P761, DOI 10.1016/S0140-6736(02)09896-3; Buter A, 2002, BRIT J SURG, V89, P298, DOI 10.1046/j.0007-1323.2001.02025.x; Chen P, 2010, PANCREAS, V39, P398, DOI 10.1097/MPA.0b013e3181bd6821; FAN ST, 1993, NEW ENGL J MED, V328, P228, DOI 10.1056/NEJM199301283280402; Folsch UR, 1997, NEW ENGL J MED, V336, P237, DOI 10.1056/NEJM199701233360401; Forsmark CE, 2007, GASTROENTEROLOGY, V132, P2022, DOI 10.1053/j.gastro.2007.03.065; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Howard TJ, 2007, J GASTROINTEST SURG, V11, P43, DOI 10.1007/s11605-007-0112-4; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; KELLY TR, 1980, SURGERY, V88, P345; Lehman GA, 2008, MED CLIN N AM, V92, P925, DOI 10.1016/j.mcna.2008.03.001; LERCH MM, 1993, GASTROENTEROLOGY, V104, P853, DOI 10.1016/0016-5085(93)91022-A; Lightner AM, 2001, FRONT BIOSCI-LANDMRK, V6, pE66, DOI 10.2741/Lightner; Mofidi R, 2008, PANCREATOLOGY, V8, P55, DOI 10.1159/000115667; Moretti A, 2008, DIGEST LIVER DIS, V40, P379, DOI 10.1016/j.dld.2007.12.001; Mounzer R, 2012, GASTROENTEROLOGY, V142, P1476, DOI 10.1053/j.gastro.2012.03.005; NEOPTOLEMOS JP, 1988, LANCET, V2, P979, DOI 10.1016/S0140-6736(88)90740-4; NOWAK A, 1995, GASTROENTEROLOGY, V108, pA380; Oria A, 2007, ANN SURG, V245, P10, DOI 10.1097/01.sla.0000232539.88254.80; Pasricha P, 1997, Gastroenterology, V113, P1040, DOI 10.1016/S0016-5085(97)70204-X; Petrov MS, 2008, ANN SURG, V247, P250, DOI 10.1097/SLA.0b013e31815edddd; Pitchumoni CS, 2005, J CLIN GASTROENTEROL, V39, P798, DOI 10.1097/01.mcg.0000177257.87939.00; Sharma VK, 1999, AM J GASTROENTEROL, V94, P3211, DOI 10.1111/j.1572-0241.1999.01520.x; SIEGEL JH, 1994, GASTROINTEST ENDOSC, V40, P573, DOI 10.1016/S0016-5107(94)70255-1; Srinivasa S, 2010, CAN J SURG, V53, P403; Stabuc B, 2008, EUR J GASTROEN HEPAT, V20, P1171, DOI 10.1097/MEG.0b013e32830a9a31; STONE HH, 1981, ANN SURG, V194, P305, DOI 10.1097/00000658-198109000-00008; SWISHER SG, 1994, AM SURGEON, V60, P759; [唐悦锋 Tang Yuefeng], 2010, [中国普通外科杂志, Chinese Journal of General Surgery], V19, P801; Telem DA, 2009, J GASTROINTEST SURG, V13, P2183, DOI 10.1007/s11605-009-1041-1; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tse F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009779.pub2; Uomo G, 1997, PANCREAS, V14, P28, DOI 10.1097/00006676-199701000-00005; Uy MC, 2009, J PANCREAS, V10, P299; Wall I, 2011, PANCREAS, V40, P547, DOI 10.1097/MPA.0b013e318215368d; Wang GJ, 2009, WORLD J GASTROENTERO, V15, P1427, DOI 10.3748/wjg.15.1427; WELBOURN CRB, 1995, GUT, V37, P119, DOI 10.1136/gut.37.1.119; WHITE TT, 1960, ANN SURG, V151, P245, DOI 10.1097/00000658-196002000-00014; Zhan XB, 2011, J GASTROEN HEPATOL, V26, P1500, DOI 10.1111/j.1440-1746.2011.06755.x; Zhou Ming-Qing, 2002, Hepatobiliary Pancreat Dis Int, V1, P608	46	23	32	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					150	157		10.1056/NEJMct1208450	http://dx.doi.org/10.1056/NEJMct1208450			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401052				2022-12-28	WOS:000336119800010
J	Jones, DS				Jones, David S.			HISTORY OF MEDICINE Doctors and the Dangers of Driving	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Automobiles have been the subject of more than a century's worth of varied public health warnings in the Journal. Doctors have remained ambivalent, however, about taking aggressive action to combat the dangers of driving. In 1925, the editors of the Journal warned that new technologies had introduced new causes of death and disability that had been absent from life under a more primitive state of affairs (1925b; see Historical Journal Articles Cited). What prompted their concern? The automobile. Doctors recognized the enjoyment that cars provided and the efficiencies they offered doctors who made house calls. But doctors also recognized driving's dire consequences. The editors wrote that the automobile toll of the streets is appalling. Nearly 30% of the deaths were of children a massacre of the innocent. Doctors have now worked for ...	[Jones, David S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02114 USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Jones, DS (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02114 USA.								0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					8	11		10.1056/NEJMp1311500	http://dx.doi.org/10.1056/NEJMp1311500			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284XA	24382063	Green Submitted			2022-12-28	WOS:000329354100005
J	Hayek, G; D'Assignies, G				Hayek, Georges; D'Assignies, Gaspard			An Unknowingly Swallowed Inedible Toy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 72-year-old woman presented to the emergency department with a 3-day history of periumbilical pain. She had had one episode of vomiting. She had no other notable medical history. A 72-year-old woman presented to the emergency department with a 3-day history of periumbilical pain. She had had one episode of vomiting. She had no other notable medical history. Physical examination showed a temperature of 38 degrees C and right abdominal tenderness without contracture. Laboratory tests showed a C-reactive protein level of 256 mg per liter and a white-cell count of 19,300 per cubic millimeter, with 90% neutrophils. A contrast-enhanced computed tomographic (CT) scan of the abdomen obtained during the portal venous phase shows infiltration of the root of the mesentery surrounding the superior mesenteric artery in association with pneumoretroperitoneum (Panel A, ...	[Hayek, Georges; D'Assignies, Gaspard] AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP)	Hayek, G (corresponding author), AP HP, Paris, France.	grghayek@gmail.com							0	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2535	2535		10.1056/NEJMicm1304625	http://dx.doi.org/10.1056/NEJMicm1304625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	278BT	24369078				2022-12-28	WOS:000328863700011
J	Bernstein, R				Bernstein, Rachel			Education Evolving: Teaching Biology Online	CELL			English	Editorial Material								The rise of massive open online courses (MOOCs) is shaking up education. For science professors, the Internet offers new opportunities and technological tools to develop new materials, rethink curricula, and teach more effectively, benefiting students both on campus and on the web.											0	7	7	2	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1443	1445		10.1016/j.cell.2013.11.038	http://dx.doi.org/10.1016/j.cell.2013.11.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360268	Bronze			2022-12-28	WOS:000328693300001
J	Herpertz-Dahlmann, B; Schwarte, R; Krei, M; Egberts, K; Warnke, A; Wewetzer, C; Pfeiffer, E; Fleischhaker, C; Scherag, A; Holtkamp, K; Hagenah, U; Buhren, K; Konrad, K; Schmidt, U; Schade-Brittinger, C; Timmesfeld, N; Dempfle, A				Herpertz-Dahlmann, Beate; Schwarte, Reinhild; Krei, Melanie; Egberts, Karin; Warnke, Andreas; Wewetzer, Christoph; Pfeiffer, Ernst; Fleischhaker, Christian; Scherag, Andre; Holtkamp, Kristian; Hagenah, Ulrich; Buehren, Katharina; Konrad, Kerstin; Schmidt, Ulrike; Schade-Brittinger, Carmen; Timmesfeld, Nina; Dempfle, Astrid			Day-patient treatment after short inpatient care versus continued inpatient treatment in adolescents with anorexia nervosa (ANDI): a multicentre, randomised, open-label, non-inferiority trial	LANCET			English	Article							EATING-DISORDER; WEIGHT; HOSPITALIZATION; PREDICTORS; PROGRAM; NEED	Background In-patient treatment (IP) is the treatment setting of choice for moderately-to-severely ill adolescents with anorexia nervosa, but it is costly, and the risks of relapse and readmissions are high. Day patient treatment (DP) is less expensive and might avoid problems of relapse and readmission by easing the transition from hospital to home. We investigated the safety and efficacy of DP after short inpatient care compared with continued IP. Methods For this multicentre, randomised, open-label, non-inferiority trial, we enrolled female patients (aged 11-18 years) with anorexia nervosa from six centres in Germany. Patients were eligible if they had a body-mass index (BMI) below the tenth percentile and it was their first admission to hospital for anorexia nervosa. We used a computer-generated randomisation sequence to randomly assign patients to continued IP or DP after 3 weeks of inpatient care (1:1; stratified for age and BMI at admission). The treatment programme and treatment intensity in both study groups were identical. The primary outcome was the increase in BMI between the time of admission and a 12-month follow-up adjusted for age and duration of illness (non-inferiority margin of 0.75 kg/m(2)). Analysis was done by modified intention to treat. This trial is registered with the International Standard Randomised Controlled Trial Number Register, number ISRCTN67783402, and the Deutsches Register Klinischer Studien, number DRKS00000101. Findings Between Feb 2, 2007, to April 27, 2010, we screened 660 patients for eligibility, 172 of whom we randomly allocated to treatment:85 to IP and 87 to DP. DP was non-inferior to IP with respect to the primary outcome, BMI at the 12-month follow-up (mean difference 0.46 kg/m(2) in favour of DP (95% CI, -0.11 to 1.02; p(non-inferiority) < 0.0001). The number of treatment-related serious adverse events was similar in both study groups (eight in the IP group, seven in the DP group). Three serious adverse events in the IP group and two in the DP group were related to suicidal ideation; one patient in the DP attempted suicide 3 months after she was discharged. Interpretation DP after short inpatient care in adolescent patients with non-chronic anorexia nervosa seems no less effective than IP for weight restoration and maintenance during the first year after admission. Thus, DP might be a safe and less costly alternative to IP. Our results justify the broad implementation of this approach.	[Herpertz-Dahlmann, Beate; Schwarte, Reinhild; Krei, Melanie; Hagenah, Ulrich; Buehren, Katharina] Rhein Westfal TH Aachen, Univ Hosp, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-52074 Aachen, Germany; [Egberts, Karin; Warnke, Andreas] Univ Hosp Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Wurzburg, Germany; [Wewetzer, Christoph] Kliniken Stadt Koln, Dept Child & Adolescent Psychiat & Psychotherapy, Cologne, Germany; [Pfeiffer, Ernst] Charite, Dept Child & Adolescent Psychiat Psychosomat & Ps, Berlin, Germany; [Fleischhaker, Christian] Univ Med Ctr, Dept Child & Adolescent Psychiat & Psychotherapy, Freiburg, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Holtkamp, Kristian] DRK Fachklin Bad Neuenahr, Dept Child & Adolescent Psychiat Psychosomat & Ps, Bad Neuenahr Ahrweiler, Germany; [Konrad, Kerstin] Rhein Westfal TH Aachen, Univ Hosp, Child Neuropsychol Sect, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-52074 Aachen, Germany; [Schmidt, Ulrike] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Schade-Brittinger, Carmen] Univ Marburg, Coordinating Ctr Clin Trials, Marburg, Germany; [Timmesfeld, Nina; Dempfle, Astrid] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; University of Duisburg Essen; RWTH Aachen University; RWTH Aachen University Hospital; University of London; King's College London; Philipps University Marburg; Philipps University Marburg	Herpertz-Dahlmann, B (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Child & Adolescent Psychiat Psychosomat & Ps, Neuenhofer Weg 21, D-52074 Aachen, Germany.	bherpertz-dahlmann@ukaachen.de	Dempfle, Astrid/ABB-8889-2020; Dempfle, Astrid/D-1513-2012; Egberts, Karin Maria/AAV-4042-2020; Konrad, Kerstin/H-7747-2013	Dempfle, Astrid/0000-0002-2618-3920; Egberts, Karin Maria/0000-0002-0270-0954; Konrad, Kerstin/0000-0001-9039-2615; Scherag, Andre/0000-0002-9406-4704	German Ministry for Education and Research	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Funding German Ministry for Education and Research.	Agras WS, 2004, INT J EAT DISORDER, V35, P509, DOI 10.1002/eat.10261; American Psychiatric Association, 2006, AM J PSYCHIAT S, V163, P4; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; Byford S, 2007, BRIT J PSYCHIAT, V191, P436, DOI 10.1192/bjp.bp.107.036806; Carter JC, 2004, PSYCHOL MED, V34, P671, DOI 10.1017/S0033291703001168; Castro J, 2004, INT J EAT DISORDER, V36, P22, DOI 10.1002/eat.20009; Catalan Agency for Health Technology Assessment and Research, 2009, CLIN PRACT GUID EAT; Dancyger I, 2003, Eat Weight Disord, V8, P242; DANZIGER Y, 1989, J ADOLESCENT HEALTH, V10, P328, DOI 10.1016/0197-0070(89)90067-3; Delmo C., 2000, KIDDIE SADS PRESENT, V3rd ed.; Fichter MM, 1998, INT J EAT DISORDER, V24, P227, DOI 10.1002/(SICI)1098-108X(199811)24:3<227::AID-EAT1>3.3.CO;2-O; Franke G.H., 2000, BSI BRIEF SYMPTOM IN; German Institute for Federal Statistics, DIAGN KRANK AB 2000; Godart NT, 2005, AM J PSYCHIAT, V162, P2398, DOI 10.1176/appi.ajp.162.12.2398; Goldstein M, 2011, INT J EAT DISORDER, V44, P29, DOI 10.1002/eat.20789; Gowers SG, 2007, BRIT J PSYCHIAT, V191, P427, DOI 10.1192/bjp.bp.107.036764; Guarda AS, 2007, AM J PSYCHIAT, V164, P108, DOI 10.1176/appi.ajp.164.1.108; Halmi Katherine A, 2009, Dialogues Clin Neurosci, V11, P100; Health and Social Care Information Centre, PROV MONTHL HOSP EP; Hebebrand J, 2000, AM J PSYCHIAT, V157, P1024, DOI 10.1176/appi.ajp.157.6.1024; Herpertz S., 2011, S3 LEITLINIE DIAGNOS; Herpertz-Dahlmann B, 2009, CHILD ADOL PSYCH CL, V18, P131, DOI 10.1016/j.chc.2008.07.010; Kaplan AS, 2009, PSYCHOL MED, V39, P1037, DOI 10.1017/S003329170800442X; Krug I, 2013, J HEALTH PSYCHOL, V18, P26, DOI 10.1177/1359105311435946; Lievers LS, 2009, EUR CHILD ADOLES PSY, V18, P75, DOI 10.1007/s00787-008-0706-8; Lock J, 2010, ARCH GEN PSYCHIAT, V67, P1025, DOI 10.1001/archgenpsychiatry.2010.128; Marshall M, 2011, COCHRANE DB SYST REV, V12; MORGAN HG, 1988, BRIT J PSYCHIAT, V152, P367, DOI 10.1192/bjp.152.3.367; NICE, 2004, EAT DIS COR INT TREA; Olmsted M. P., 2010, The treatment of eating disorders: a clinical handbook, P198; Ornstein RM, 2012, EAT WEIGHT DISORD-ST, V17, pE170, DOI 10.1007/BF03325344; Paul T., 2005, EATING DISORDER INVE; Pavlova B, 2010, SOC PSYCH PSYCH EPID, V45, P541, DOI 10.1007/s00127-009-0092-7; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pinheiro AP, 2010, INT J EAT DISORDER, V43, P123, DOI 10.1002/eat.20671; Rosenberger WF, 2002, RANDOMIZATION CLIN T; Royal College of Psychiatrists, 2012, EAT DIS UK SERV DIST; SIGNORINI DF, 1993, STAT MED, V12, P2343, DOI 10.1002/sim.4780122410; Steinhausen HC, 2009, INT J EAT DISORDER, V42, P19, DOI 10.1002/eat.20577; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Striegel-Moore RH, 2000, INT J EAT DISORDER, V27, P381; Strober M, 2012, INT J EAT DISORDER, V45, P155, DOI 10.1002/eat.22005; Treat TA, 2008, INT J EAT DISORDER, V41, P564, DOI 10.1002/eat.20571; van Elburg AA, 2012, INT J EAT DISORDER, V45, P193, DOI 10.1002/eat.20918; Wentz E, 2009, BRIT J PSYCHIAT, V194, P168, DOI 10.1192/bjp.bp.107.048686; Willer MG, 2005, AM J PSYCHIAT, V162, P2374, DOI 10.1176/appi.ajp.162.12.2374; Zipfel S, 2002, INT J EAT DISORDER, V31, P105, DOI 10.1002/eat.10009	47	148	149	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1222	1229		10.1016/S0140-6736(13)62411-3	http://dx.doi.org/10.1016/S0140-6736(13)62411-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24439238				2022-12-28	WOS:000334104600026
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE CT; DANTE TRIAL; MORTALITY; RISK	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lung cancer. Methods: The USPSTF reviewed the evidence on the efficacy of low-dose computed tomography, chest radiography, and sputum cytologic evaluation for lung cancer screening in asymptomatic persons who are at average or high risk for lung cancer (current or former smokers) and the benefits and harms of these screening tests and of surgical resection of early-stage non-small cell lung cancer. The USPSTF also commissioned modeling studies to provide information about the optimum age at which to begin and end screening, the optimum screening interval, and the relative benefits and harms of different screening strategies. Population: This recommendation applies to asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Recommendation: The USPSTF recommends annual screening for lung cancer with low-dose computed tomography in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. (B recommendation)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.		wang, edwin/G-5372-2010	Pignone, Michael/0000-0002-6657-7342				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; American Cancer Society, 2013, CANC FACTS FIG 2013; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; de Koning HJ, 2013, AHRQ PUBLICATION; Humphrey L, 2013, AHRQ PUBLICATION, V13-05188-EF-1; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Infante M, 2008, LUNG CANCER, V59, P355, DOI 10.1016/j.lungcan.2007.08.040; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; National Comprehensive Cancer Network Committee, 2014, NAT COMPR CANC NETW; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Pinsky PF, 2013, CANCER; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172	20	1763	1796	3	92	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					330	+		10.7326/M13-2771	http://dx.doi.org/10.7326/M13-2771			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24378917				2022-12-28	WOS:000332793900005
J	Albert, FW; Treusch, S; Shockley, AH; Bloom, JS; Kruglyak, L				Albert, Frank W.; Treusch, Sebastian; Shockley, Arthur H.; Bloom, Joshua S.; Kruglyak, Leonid			Genetics of single-cell protein abundance variation in large yeast populations	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; EXPRESSION; REVEALS; TRANSCRIPTION; CONSTRUCTION; ARCHITECTURE; DISSECTION; EVOLUTION; STRAINS	Variation among individuals arises in part from differences in DNA sequences, but the genetic basis for variation in most traits, including common diseases, remains only partly understood. Many DNA variants influence phenotypes by altering the expression level of one or several genes. The effects of such variants can be detected as expression quantitative trait loci (eQTL)(1). Traditional eQTL mapping requires large-scale genotype and gene expression data for each individual in the study sample, which limits sample sizes to hundreds of individuals in both humans and model organisms and reduces statistical power(2-6). Consequently, many eQTL are probably missed, especially those with smaller effects(7). Furthermore, most studies use messenger RNA rather than protein abundance as the measure of gene expression. Studies that have used mass-spectrometry proteomics(8-13) reported unexpected differences between eQTL and protein QTL (pQTL) for the same genes(9,10), but these studies have been even more limited in scope. Here we introduce a powerful method for identifying genetic loci that influence protein expression in the yeast Saccharomyces cerevisiae. We measure single-cell protein abundance through the use of green fluorescent protein tags in very large populations of genetically variable cells, and use pooled sequencing to compare allele frequencies across the genome in thousands of individuals with high versus low protein abundance. We applied this method to 160 genes and detected many more loci per gene than previous studies. We also observed closer correspondence between loci that influence protein abundance and loci that influence mRNA abundance of a given gene. Most loci that we detected were clustered in 'hotspots' that influence multiple proteins, and some hotspots were found to influence more than half of the proteins that we examined. The variants that underlie these hotspots have profound effects on the gene regulatory network and provide insights into genetic variation in cell physiology between yeast strains.	[Albert, Frank W.; Bloom, Joshua S.; Kruglyak, Leonid] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Albert, Frank W.; Treusch, Sebastian] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Shockley, Arthur H.] Synthet Genom, La Jolla, CA 92037 USA; [Bloom, Joshua S.; Kruglyak, Leonid] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Kruglyak, Leonid] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Princeton University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Albert, FW (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	falbert@mednet.ucla.edu; LKruglyak@mednet.ucla.edu		Albert, Frank/0000-0002-1380-8063	National Institutes of Health (NIH) [R01 GM102308]; James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute; German Science Foundation [AL 1525/1-1]; National Science Foundation; NIH [F32 GM101857-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM101857, R01GM102308] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. DeCoste at the Princeton Flow Cytometry Resource Facility for technical assistance and advice on the experiments. This work was supported by National Institutes of Health (NIH) grant R01 GM102308, a James S. McDonnell Centennial Fellowship, and the Howard Hughes Medical Institute (L. K.), German Science Foundation research fellowship AL 1525/1-1 (F. W. A.), a National Science Foundation fellowship (J.S.B.), and NIH postdoctoral fellowship F32 GM101857-02 (S.T.).	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butler G, 2013, ANNU REV MICROBIOL, V67, P291, DOI 10.1146/annurev-micro-092412-155658; Edwards MD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S8; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Howson R, 2005, COMP FUNCT GENOM, V6, P2, DOI 10.1002/cfg.449; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Khan Z, 2009, P NATL ACAD SCI USA, V106, P15544, DOI 10.1073/pnas.0904100106; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lewis JA, 2012, G3-GENES GENOM GENET, V2, P1607, DOI 10.1534/g3.112.004127; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litvin O, 2009, P NATL ACAD SCI USA, V106, P6441, DOI 10.1073/pnas.0810208106; Meyer M, 2010, COLD SPRING HARBOR P; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Spor A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-296; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	41	82	83	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					494	+		10.1038/nature12904	http://dx.doi.org/10.1038/nature12904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24402228	Green Submitted, Green Accepted			2022-12-28	WOS:000332165100039
J	Nelson, HD; Pappas, M; Zakher, B; Mitchell, JP; Okinaka-Hu, L; Fu, RW				Nelson, Heidi D.; Pappas, Miranda; Zakher, Bernadette; Mitchell, Jennifer Priest; Okinaka-Hu, Leila; Fu, Rongwei			Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							BILATERAL PROPHYLACTIC MASTECTOMY; QUALITY-OF-LIFE; HEREDITARY BREAST-CANCER; OVARIAN-CANCER; FAMILY-HISTORY; PSYCHOLOGICAL DISTRESS; MUTATION CARRIERS; FOLLOW-UP; CLINICAL CHARACTERISTICS; RACIAL-DIFFERENCES	Background: Mutations in breast cancer susceptibility genes (BRCA1 and BRCA2) are associated with increased risks for breast, ovarian, and other types of cancer. Purpose: To review new evidence on the benefits and harms of risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women. Data Sources: MEDLINE and PsycINFO between 2004 and 30 July 2013, the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews from 2004 through the second quarter of 2013, Health Technology Assessment during the fourth quarter of 2012, Scopus, and reference lists. Study Selection: English-language studies about accuracy of risk assessment and benefits and harms of genetic counseling, genetic testing, and interventions to reduce cancer incidence and mortality. Data Extraction: Individual investigators extracted data on participants, study design, analysis, follow-up, and results, and a second investigator confirmed key data. Investigators independently dual-rated study quality and applicability by using established criteria. Data Synthesis: Five referral models accurately estimated individual risk for BRCA mutations. Genetic counseling increased the accuracy of risk perception and decreases the intention for genetic testing among unlikely carriers and cancer-related worry, anxiety, and depression. No trials evaluated the effectiveness of intensive screening or risk-reducing medications in mutation carriers, although false-positive rates, unneeded imaging, and unneeded surgeries were higher with screening. Among high-risk women and mutation carriers, risk-reducing mastectomy decreased breast cancer by 85% to 100% and breast cancer mortality by 81% to 100% compared with women without surgery; risk-reducing salpingo-ciophorectomy decreased breast cancer incidence by 37% to 100%, ovarian cancer by 69% to 100%, and all-cause mortality by 55% to 100%. Limitation: The analysis included only English-language articles; efficacy trials in mutation carriers were lacking. Conclusion: Studies of risk assessment, genetic counseling, genetic testing, and interventions to reduce cancer and mortality indicate potential benefits and harms that vary according to risk.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA; Providence Canc Ctr, Portland, OR USA	Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu			Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	[Anonymous], 2013, GENETICS; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, J MED GENET, V45, P425, DOI 10.1136/jmg.2007.056556; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Arason A, 1998, J MED GENET, V35, P446, DOI 10.1136/jmg.35.6.446; Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; Arver Brita, 2004, Fam Cancer, V3, P109; Ashton-Prolla P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-283; Atkins D, 2011, J CLIN EPIDEMIOL, V64, P1198, DOI 10.1016/j.jclinepi.2010.11.021; Barcenas CH, 2006, J CLIN ONCOL, V24, P354, DOI 10.1200/JCO.2005.02.2368; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Bellcross C, 2010, GENET MED, V12, P240, DOI 10.1097/GIM.0b013e3181d4bc3a; Bellcross CA, 2009, GENET MED, V11, P783, DOI 10.1097/GIM.0b013e3181b9b04a; Bennett Paul, 2008, J Genet Couns, V17, P234, DOI 10.1007/s10897-007-9136-x; Bennett P, 2009, FAM CANCER, V8, P159, DOI 10.1007/s10689-008-9221-9; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Berry DA, 1997, J NATL CANCER I, V89, P227, DOI 10.1093/jnci/89.3.227; Bloom JR, 2006, PREV MED, V43, P379, DOI 10.1016/j.ypmed.2006.07.002; Bowen Deborah J, 2006, Cultur Divers Ethnic Minor Psychol, V12, P45, DOI 10.1037/1099-9809.12.1.45; Bowen DJ, 2004, PATIENT EDUC COUNS, V53, P79, DOI 10.1016/S0738-3991(03)00122-8; Bowen DJ, 2002, GENET MED, V4, P359, DOI 10.1097/00125817-200209000-00007; Brain K, 2011, PSYCHO-ONCOLOGY, V20, P984, DOI 10.1002/pon.1807; Brain K, 2002, BRIT J CANCER, V86, P233, DOI 10.1038/sj.bjc.6600051; Brain KE, 2012, GYNECOL ONCOL, V127, P556, DOI 10.1016/j.ygyno.2012.08.034; Braithwaite D, 2005, CANCER DETECT PREV, V29, P433, DOI 10.1016/j.cdp.2005.06.001; Brandberg Y, 2012, EJSO-EUR J SURG ONC, V38, P38, DOI 10.1016/j.ejso.2011.10.010; Brandberg Y, 2008, J CLIN ONCOL, V26, P3943, DOI 10.1200/JCO.2007.13.9568; Burke W, 2000, AM J MED GENET, V90, P361, DOI 10.1002/(SICI)1096-8628(20000228)90:5<361::AID-AJMG4>3.0.CO;2-8; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Cull A, 1998, BRIT J CANCER, V77, P830, DOI 10.1038/bjc.1998.135; Dagan E, 2009, PREV MED, V48, P193, DOI 10.1016/j.ypmed.2008.11.007; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Einbeigi Z, 2001, EUR J CANCER, V37, P1904, DOI 10.1016/S0959-8049(01)00223-4; Ertmanski S, 2009, GENET TEST MOL BIOMA, V13, P325, DOI 10.1089/gtmb.2008.0126; Evans DGR, 2009, J MED GENET, V46, P254, DOI 10.1136/jmg.2008.062232; Evans DGR, 2009, CANCER EPIDEM BIOMAR, V18, P2123, DOI 10.1158/1055-9965.EPI-09-0138; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Finch A, 2011, GYNECOL ONCOL, V121, P163, DOI 10.1016/j.ygyno.2010.12.326; Finch A, 2013, PSYCHO-ONCOLOGY, V22, P212, DOI 10.1002/pon.2041; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Foster C, 2007, BRIT J CANCER, V96, P718, DOI 10.1038/sj.bjc.6603610; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Fry A, 2003, BRIT J CANCER, V89, P653, DOI 10.1038/sj.bjc.6601170; Gahm J, 2010, BREAST, V19, P462, DOI 10.1016/j.breast.2010.05.003; Geirdal AO, 2005, FAM CANCER, V4, P121, DOI 10.1007/s10689-004-7995-y; Gilpin CA, 2000, CLIN GENET, V58, P299, DOI 10.1034/j.1399-0004.2000.580408.x; Graves KD, 2012, CANCER EPIDEM BIOMAR, V21, P445, DOI 10.1158/1055-9965.EPI-11-0991; Gurmankin AD, 2005, ARCH INTERN MED, V165, P523, DOI 10.1001/archinte.165.5.523; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Helmes AW, 2006, PATIENT EDUC COUNS, V64, P96, DOI 10.1016/j.pec.2005.12.002; Hermsen BBJ, 2007, BRIT J CANCER, V96, P1335, DOI 10.1038/sj.bjc.6603725; Hopwood P, 1998, PSYCHO-ONCOL, V7, P402, DOI 10.1002/(SICI)1099-1611(1998090)7:5<402::AID-PON317>3.3.CO;2-O; Hopwood P, 2004, BRIT J CANCER, V91, P884, DOI 10.1038/sj.bjc.6602081; Hoskins KF, 2006, CANCER-AM CANCER SOC, V107, P1769, DOI 10.1002/cncr.22202; Julian-Reynier C, 2011, EUR J HUM GENET, V19, P500, DOI 10.1038/ejhg.2010.241; Kelly KM, 2008, PATIENT EDUC COUNS, V70, P135, DOI 10.1016/j.pec.2007.09.007; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; Kinney AY, 2005, CANCER-AM CANCER SOC, V104, P2508, DOI 10.1002/cncr.21479; Kramer JL, 2005, J CLIN ONCOL, V23, P8629, DOI 10.1200/JCO.2005.02.9199; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kriege M, 2006, CANCER-AM CANCER SOC, V106, P2318, DOI 10.1002/cncr.21863; Le-Petross HT, 2011, CANCER-AM CANCER SOC, V117, P3900, DOI 10.1002/cncr.25971; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lerman C, 1996, HEALTH PSYCHOL, V15, P75; Lerman C, 1999, CANCER EPIDEM BIOMAR, V8, P361; Lindor Noralane M, 2008, J Natl Cancer Inst Monogr, P1, DOI 10.1093/jncimonographs/lgn001; Lobb EA, 2004, BRIT J CANCER, V90, P321, DOI 10.1038/sj.bjc.6601502; Low CA, 2008, ANN BEHAV MED, V35, P61, DOI 10.1007/s12160-007-9004-9; Madoff ET, 2006, J WOMENS HLTH LARCHM, V15, P843; Mai PL, 2011, JNCI-J NATL CANCER I, V103, P788, DOI 10.1093/jnci/djr114; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Mefford HC, 1999, AM J HUM GENET, V65, P575, DOI 10.1086/302511; Meiser B, 2002, EUR J CANCER, V38, P2025, DOI 10.1016/S0959-8049(02)00264-2; Metcalfe KA, 2004, PSYCHO-ONCOLOGY, V13, P14, DOI 10.1002/pon.726; Metcalfe KA, 2012, BREAST CANCER RES TR, V133, P735, DOI 10.1007/s10549-011-1941-0; Mikkelsen EM, 2007, CANCER DETECT PREV, V31, P457, DOI 10.1016/j.cdp.2007.10.013; Mikkelsen EM, 2009, BREAST J, V15, P61, DOI 10.1111/j.1524-4741.2008.00672.x; National Cancer Institute, 2013, GEN BREAST OV CANC P; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; National Comprehensive Cancer Network, 2013, GEN FAM HIGH RISK AS; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Nelson HD., 2013, RISK ASSESSMENT GENE; Nelson HD, 2005, GENETIC RISK ASSESSM; Nelson HD, 2009, COMP EFFECTIVENESS M; Nelson HD, 2013, ANN INTERN MED, V158, P604, DOI 10.7326/0003-4819-158-8-201304160-00005; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Olson JE, 2004, CANCER DETECT PREV, V28, P357, DOI 10.1016/j.cdp.2004.03.003; Panchal SM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-116; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Parmigiani G, 2007, ANN INTERN MED, V147, P441, DOI 10.7326/0003-4819-147-7-200710020-00002; Peelen T, 1997, AM J HUM GENET, V60, P1041; Pieterse AH, 2011, PATIENT EDUC COUNS, V85, P425, DOI 10.1016/j.pec.2011.01.017; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Reichelt JG, 2008, FAM CANCER, V7, P245, DOI 10.1007/s10689-008-9182-z; Reichelt Jon G, 2004, Fam Cancer, V3, P21; Rijnsburger AJ, 2004, BRIT J CANCER, V91, P69, DOI 10.1038/sj.bjc.6601912; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Roshanai AH, 2009, ACTA ONCOL, V48, P999, DOI 10.1080/02841860903104137; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Shochat T, 2010, J SLEEP RES, V19, P333, DOI 10.1111/j.1365-2869.2009.00805.x; Skytte AB, 2011, CLIN GENET, V79, P431, DOI 10.1111/j.1399-0004.2010.01604.x; Smerecnik CMR, 2009, J GENET COUNS, V18, P217, DOI 10.1007/s10897-008-9210-z; Spiegel TN, 2011, BREAST, V20, P424, DOI 10.1016/j.breast.2011.04.004; Srivastava A, 2001, ONCOLOGY-NY, V15, P889; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Tonin PN, 1998, AM J HUM GENET, V63, P1341, DOI 10.1086/302099; U.S. Preventive Services Task Force, 2008, PROC MAN; van Dijk S, 2006, J CLIN ONCOL, V24, P3672, DOI 10.1200/JCO.2005.03.7259; Wasteson E, 2011, EUR J CANCER CARE, V20, P508, DOI 10.1111/j.1365-2354.2010.01204.x; Watson M, 1999, BRIT J CANCER, V79, P868, DOI 10.1038/sj.bjc.6690139; Watson M, 1998, J MED GENET, V35, P731, DOI 10.1136/jmg.35.9.731; Weitzel JN, 2007, CANCER EPIDEM BIOMAR, V16, P1615, DOI 10.1158/1055-9965.EPI-07-0198; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Whittemore AS, 2004, CANCER EPIDEM BIOMAR, V13, P2078	123	166	172	0	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					255	266		10.7326/M13-1684	http://dx.doi.org/10.7326/M13-1684			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB3BO	24366442				2022-12-28	WOS:000331666500005
J	Zanne, AE; Tank, DC; Cornwell, WK; Eastman, JM; Smith, SA; FitzJohn, RG; McGlinn, DJ; O'Meara, BC; Moles, AT; Reich, PB; Royer, DL; Soltis, DE; Stevens, PF; Westoby, M; Wright, IJ; Aarssen, L; Bertin, RI; Calaminus, A; Govaerts, R; Hemmings, F; Leishman, MR; Oleksyn, J; Soltis, PS; Swenson, NG; Warman, L; Beaulieu, JM				Zanne, Amy E.; Tank, David C.; Cornwell, William K.; Eastman, Jonathan M.; Smith, Stephen A.; FitzJohn, Richard G.; McGlinn, Daniel J.; O'Meara, Brian C.; Moles, Angela T.; Reich, Peter B.; Royer, Dana L.; Soltis, Douglas E.; Stevens, Peter F.; Westoby, Mark; Wright, Ian J.; Aarssen, Lonnie; Bertin, Robert I.; Calaminus, Andre; Govaerts, Rafael; Hemmings, Frank; Leishman, Michelle R.; Oleksyn, Jacek; Soltis, Pamela S.; Swenson, Nathan G.; Warman, Laura; Beaulieu, Jeremy M.			Three keys to the radiation of angiosperms into freezing environments	NATURE			English	Article							EVOLUTION; CHARACTER; DIVERSIFICATION; ANATOMY; HEIGHT; ORIGIN; GENES; HABIT	Early flowering plants are thought to have been woody species restricted to warm habitats(1-3). This lineage has since radiated into almost every climate, with manifold growth forms(4). As angiosperms spread and climate changed, they evolved mechanisms to cope with episodic freezing. To explore the evolution of traits underpinning the ability to persist in freezing conditions, we assembled a large species-level database of growth habit (woody or herbaceous; 49,064 species), as well as leaf phenology (evergreen or deciduous), diameter of hydraulic conduits (that is, xylem vessels and tracheids) and climate occupancies (exposure to freezing). To model the evolution of species' traits and climate occupancies, we combined these data with an unparalleled dated molecular phylogeny (32,223 species) for land plants. Here we show that woody clades successfully moved into freezing-prone environments by either possessing transport networks of small safe conduits(5) and/or shutting down hydraulic function by dropping leaves during freezing. Herbaceous species largely avoided freezing periods by senescing cheaply constructed aboveground tissue. Growth habit has long been considered labile(6), but we find that growth habit was less labile than climate occupancy. Additionally, freezing environments were largely filled by lineages that had already become herbs or, when remaining woody, already had small conduits (that is, the trait evolved before the climate occupancy). By contrast, most deciduous woody lineages had an evolutionary shift to seasonally shedding their leaves only after exposure to freezing (that is, the climate occupancy evolved before the trait). For angiosperms to inhabit novel cold environments they had to gain new structural and functional trait solutions; our results suggest that many of these solutions were probably acquired before their foray into the cold.	[Zanne, Amy E.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Zanne, Amy E.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63121 USA; [Tank, David C.; Eastman, Jonathan M.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Tank, David C.; Eastman, Jonathan M.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA; [Cornwell, William K.] Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Cornwell, William K.; Moles, Angela T.; Hemmings, Frank; Warman, Laura] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Smith, Stephen A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [FitzJohn, Richard G.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [FitzJohn, Richard G.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [FitzJohn, Richard G.; Westoby, Mark; Wright, Ian J.; Leishman, Michelle R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [McGlinn, Daniel J.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [McGlinn, Daniel J.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [O'Meara, Brian C.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Reich, Peter B.; Oleksyn, Jacek] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Royer, Dana L.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; [Soltis, Douglas E.; Calaminus, Andre] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Stevens, Peter F.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Aarssen, Lonnie] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Bertin, Robert I.] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Govaerts, Rafael] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Oleksyn, Jacek] Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol & Ecol, E Lansing, MI 48824 USA; [Warman, Laura] US Forest Serv, Inst Pacific Isl Forestry, USDA, Hilo, HI 96720 USA; [Beaulieu, Jeremy M.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA	George Washington University; Missouri Botanical Gardens; Idaho; University of Idaho; Idaho; University of Idaho; Vrije Universiteit Amsterdam; University of New South Wales Sydney; University of Michigan System; University of Michigan; University of British Columbia; University of British Columbia; Macquarie University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Tennessee System; University of Tennessee Knoxville; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; Wesleyan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Saint Louis; Queens University - Canada; College of the Holy Cross; Royal Botanic Gardens, Kew; Polish Academy of Sciences; Michigan State University; United States Department of Agriculture (USDA); United States Forest Service; University of Tennessee System; University of Tennessee Knoxville	Zanne, AE (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	aezanne@gmail.com	Soltis, Douglas/L-5957-2015; McGlinn, D. J./AAB-2473-2021; Warman, Laura/C-6651-2011; Soltis, Pamela S/GNH-5557-2022; Oleksyn, Jacek/I-4539-2012; Oleksyn, Jacek/AAR-2351-2020; Smith, Stephen/AAE-8623-2019; Leishman, Michelle/AAU-4102-2020; Moles, Angela T/C-3083-2008; Leishman, Michelle M/G-9726-2012; Wright, Ian J/G-4979-2012; Soltis, Pamela S/L-5184-2015; Cornwell, William/I-4083-2019	McGlinn, D. J./0000-0003-2359-3526; Warman, Laura/0000-0001-7339-749X; Soltis, Pamela S/0000-0001-9310-8659; Smith, Stephen/0000-0003-2035-9531; Leishman, Michelle/0000-0003-4830-5797; Moles, Angela T/0000-0003-2041-7762; Leishman, Michelle M/0000-0003-4830-5797; Wright, Ian J/0000-0001-8338-9143; FitzJohn, Richard/0000-0001-8888-3837; Reich, Peter/0000-0003-4424-662X; Oleksyn, Jacek/0000-0002-6576-3258; Westoby, Mark/0000-0001-7690-4530; Royer, Dana/0000-0003-0976-953X; O'Meara, Brian/0000-0002-0337-5997; Hemmings, Frank/0000-0002-0355-0070; Cornwell, Will/0000-0003-4080-4073	National Evolutionary Synthesis Center (NESCent), National Science Foundation [EF- 0905606]; Macquarie University Genes to Geoscience Research Centre; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Evolutionary Synthesis Center (NESCent), National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Macquarie University Genes to Geoscience Research Centre; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank T. Robertson and A. Hahn at the Global Biodiversity Information Facility for providing species' georeference points, A. Ordonez for providing growth form data, and A. Miller and D. Ackerly for helpful comments on a draft of this manuscript. Support for this work was given to the working group "Tempo and Mode of Plant Trait Evolution: Synthesizing Data from Extant and Extinct Taxa" by the National Evolutionary Synthesis Center (NESCent), National Science Foundation grant #EF- 0905606 and Macquarie University Genes to Geoscience Research Centre.	Beaulieu JM, 2013, SYST BIOL, V62, P725, DOI 10.1093/sysbio/syt034; Botta A, 2000, GLOBAL CHANGE BIOL, V6, P709, DOI 10.1046/j.1365-2486.2000.00362.x; Cronquist A, 1968, EVOLUTION CLASSIFICA; Davis SD, 1999, AM J BOT, V86, P1367, DOI 10.2307/2656919; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Feild TS, 2012, INT J PLANT SCI, V173, P596, DOI 10.1086/666099; Feild TS, 2004, PALEOBIOLOGY, V30, P82, DOI 10.1666/0094-8373(2004)030<0082:DADANI>2.0.CO;2; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Jansson R, 2013, EVOLUTION, V67, P1741, DOI 10.1111/evo.12089; Judd WS, 1994, HARVARD PAPERS BOTAN, V1, P1; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Lens F, 2012, NEW PHYTOL, V193, P12, DOI 10.1111/j.1469-8137.2011.03888.x; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; Maddison WP, 2006, EVOLUTION, V60, P1743, DOI 10.1554/05-666.1; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Philippe Marc, 2008, Palaeoworld, V17, P142, DOI 10.1016/j.palwor.2008.06.001; Sinnott EW, 1915, J GEOL, V23, P289, DOI 10.1086/622242; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Soltis DE, 2013, AM J BOT, V100, P916, DOI 10.3732/ajb.1300044; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Spicer R, 2010, NEW PHYTOL, V186, P577, DOI 10.1111/j.1469-8137.2010.03236.x; STEBBINS G. LEDYARD, 1965, ANN MISSOURI BOT GARD, V52, P457, DOI 10.2307/2394810; TAYLOR DW, 1992, PLANT SYST EVOL, V180, P137, DOI 10.1007/BF00941148; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Tyree M. T., 2002, SPR S WOOD; Wheeler EA, 2007, IAWA J, V28, P229, DOI 10.1163/22941932-90001638; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379	29	939	990	30	583	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					89	+		10.1038/nature12872	http://dx.doi.org/10.1038/nature12872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24362564	Green Published			2022-12-28	WOS:000330648100037
J	Sun, X; Ioannidis, JPA; Agoritsas, T; Alba, AC; Guyatt, G				Sun, Xin; Ioannidis, John P. A.; Agoritsas, Thomas; Alba, Ana C.; Guyatt, Gordon			How to Use a Subgroup Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-TRIAL OUTCOMES; DOUBLE-BLIND; METAANALYSIS; THERAPY; SEPSIS; PREVENTION; SELECTION	Clinicians, when trying to apply trial results to patient care, need to individualize patient care and, potentially, manage patients based on results of subgroup analyses. Apparently compelling subgroup effects often prove spurious, and guidance is needed to differentiate credible from less credible subgroup claims. We therefore provide 5 criteria to use when assessing the validity of subgroup analyses: (1) Can chance explain the apparent subgroup effect; (2) Is the effect consistent across studies; (3) Was the subgroup hypothesis one of a small number of hypotheses developed a priori with direction specified; (4) Is there strong preexisting biological support; and (5) Is the evidence supporting the effect based on within- or between-study comparisons. The first 4 criteria are applicable to individual studies or systematic reviews, the last only to systematic reviews of multiple studies. These criteria will help clinicians deciding whether to use subgroup analyses to guide their patient care.	[Sun, Xin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610064, Sichuan, Peoples R China; [Sun, Xin; Agoritsas, Thomas; Guyatt, Gordon] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Alba, Ana C.] Univ Hlth Network, Toronto Gen Hosp, Heart Failure & Transplantat Program, Toronto, ON, Canada	Sichuan University; McMaster University; Stanford University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Guyatt, G (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, 1200 Main St W,Room 2C12, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Ioannidis, John P. A./G-9836-2011; Agoritsas, Thomas/F-4321-2014	Agoritsas, Thomas/0000-0002-6182-9969; Sun, Xin/0000-0002-6554-7088; Alba, Ana/0000-0003-2744-2696	Swiss National Science Foundation [PBGEP3-142251]; Sichuan University in China [2013SCU04A37]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sichuan University in China	Dr Agoritsas was financially supported by the Fellowship for Prospective Researchers grant PBGEP3-142251 from the Swiss National Science Foundation. Dr Sun is supported by Young Investigators Award 2013SCU04A37 from Sichuan University in China.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1994, BMJ, V308, P235; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; BUYSE ME, 1989, CONTROL CLIN TRIALS, V10, pS187; Canadian Cooperative Study Group, 1978, N Engl J Med, V299, P53; Contopoulos-Ioannidis DG, 2012, PEDIATRICS, V129, pS161, DOI 10.1542/peds.2012-0055J; COUNSELL CE, 1994, BMJ-BRIT MED J, V309, P1677, DOI 10.1136/bmj.309.6970.1677; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; DHAINAUT JFA, 1994, CRIT CARE MED, V22, P1720, DOI 10.1097/00003246-199422110-00005; Dhainaut JFA, 1998, CRIT CARE MED, V26, P1963, DOI 10.1097/00003246-199812000-00021; FURBERG CD, 1987, STAT MED, V6, P295, DOI 10.1002/sim.4780060316; Furukawa TA, 2002, INT J EPIDEMIOL, V31, P72, DOI 10.1093/ije/31.1.72; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Institute of Medicine, 2011, DIET REF INT VIT D C; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; KELTON JG, 1978, BLOOD, V52, P1073; Natanson C, 1998, CRIT CARE MED, V26, P1927, DOI 10.1097/00003246-199812000-00001; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; SCHNEIDER B, 1989, CONTROL CLIN TRIALS, V10, pS176; Sun X, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.e155, DOI 10.1136/BMJ.E155]; Sun X, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1569; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; van Oldenrijk J, 2008, BMC MUSCULOSKEL DIS, V9, DOI [10.1186/1471-2474-9-93, 10.1186/1471-2474-9-91]; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716	31	278	288	3	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					405	411		10.1001/jama.2013.285063	http://dx.doi.org/10.1001/jama.2013.285063			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449319				2022-12-28	WOS:000329939300026
J	Giroud, M; Jacquin, A; Bejot, Y				Giroud, Maurice; Jacquin, Agnes; Bejot, Yannick			The worldwide landscape of stroke in the 21st century	LANCET			English	Editorial Material							POPULATION; TRENDS		[Giroud, Maurice] Univ Hosp, Dijon Stroke Registry, Dept Neurol, F-21000 Dijon, France; Univ Burgundy, Med Sch Dijon, F-21000 Dijon, France	CHU Dijon Bourgogne; Universite de Bourgogne; Universite de Bourgogne	Giroud, M (corresponding author), Univ Hosp, Dijon Stroke Registry, Dept Neurol, F-21000 Dijon, France.	maurice.giroud@chu-dijon.fr	JACQUIN, Agnès/AFN-9891-2022; Béjot, Yannick/D-3942-2019	Béjot, Yannick/0000-0001-7848-7072				Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9; de los Rios F, 2012, STROKE, V43, P3179, DOI 10.1161/STROKEAHA.112.667808; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2013, LANCET; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lavados PM, 2007, LANCET NEUROL, V6, P362, DOI 10.1016/S1474-4422(07)70003-0; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; MALMGREN R, 1987, LANCET, V2, P1196; Medin J, 2004, STROKE, V35, P1047, DOI 10.1161/01.STR.0000125866.78674.96; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550	12	23	24	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					195	197		10.1016/S0140-6736(13)62077-2	http://dx.doi.org/10.1016/S0140-6736(13)62077-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24449941				2022-12-28	WOS:000330027500008
J	Fitzgerald, JE				Fitzgerald, J. Edward			A shared wave is a clinical test of health-and humanity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Surgeons England, Assoc Surg Training, London WC2A 3PE, England	Royal College of Surgeons of England	Fitzgerald, JE (corresponding author), Royal Coll Surgeons England, Assoc Surg Training, London WC2A 3PE, England.	edwardfitzgerald@doctors.org.uk	Fitzgerald, James/F-2565-2013	Fitzgerald, James/0000-0002-4453-5117				Corballis MC, 1999, AM SCI, V87, P138, DOI 10.1511/1999.2.138; Goldin-Meadow S, 2013, ANNU REV PSYCHOL, V64, P257, DOI 10.1146/annurev-psych-113011-143802; Mountza. Wikipedia, 2013, MOUNTZ; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2014	348									10.1136/bmj.g281	http://dx.doi.org/10.1136/bmj.g281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MR	24443480				2022-12-28	WOS:000329976300008
J	Akin, O; Zipursky, SL				Akin, Orkun; Zipursky, S. Lawrence			The Shape of Things to Come	CELL			English	Editorial Material							PROTEINS; SYG-1	Surface receptors can link binding of ligands to changes in the actin-based cell cytoskeleton. Chia et al. and Chen et al. provide evidence for direct binding between the cytoplasmic tails of receptors and the WAVE complex, a regulator of the actin nucleator Arp2/3 complex, which might help to explain how environmental signals are translated into changes in morphology and motility.	[Akin, Orkun; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu		Zipursky, Stephen/0000-0001-5630-7181				Chen BY, 2014, CELL, V156, P195, DOI 10.1016/j.cell.2013.11.048; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Chia PH, 2014, CELL, V156, P208, DOI 10.1016/j.cell.2013.12.009; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X	8	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					13	14		10.1016/j.cell.2013.12.037	http://dx.doi.org/10.1016/j.cell.2013.12.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439365	Bronze			2022-12-28	WOS:000329912200006
J	Chia, PH; Chen, BY; Li, PP; Rosen, MK; Shen, K				Chia, Poh Hui; Chen, Baoyu; Li, Pengpeng; Rosen, Michael K.; Shen, Kang			Local F-actin Network Links Synapse Formation and Axon Branching	CELL			English	Article							IN-VIVO; CAENORHABDITIS-ELEGANS; DENDRITIC SPINES; FAMILY PROTEINS; NERVOUS WRECK; WAVE COMPLEX; N-WASP; GROWTH; MECHANISMS; SYNAPTOGENESIS	Axonal branching and synapse formation are tightly linked developmental events during the establishment of synaptic circuits. Newly formed synapses promote branch initiation and stability. However, little is known about molecular mechanisms that link these two processes. Here, we show that local assembly of an F-actin cytoskeleton at nascent presynaptic sites initiates both synapse formation and axon branching. We further find that assembly of the F-actin network requires a direct interaction between the synaptic cell adhesion molecule SYG-1 and a key regulator of actin cytoskeleton, the WVE-1/WAVE regulatory complex (WRC). SYG-1 cytoplasmic tail binds to the WRC using a consensus WRC interacting receptor sequence (WIRS). WRC mutants or mutating the SYG-1 WIRS motif leads to loss of local F-actin, synaptic material, and axonal branches. Together, these data suggest that synaptic adhesion molecules, which serve as a necessary component for both synaptogenesis and axonal branch formation, directly regulate subcellular actin cytoskeletal organization.	[Chia, Poh Hui; Li, Pengpeng; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Chen, Baoyu; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biophys, Dallas, TX 75390 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu	Chen, Baoyu/A-7072-2011	Chen, Baoyu/0000-0002-6366-159X	Howard Hughes Medical Institute; National Institutes of Health [R01 NS048392]; Agency for Science, Technology, and Research in Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology, and Research in Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Howard Hughes Medical Institute and National Institutes of Health (grant R01 NS048392). P.H. Chia is supported by the Agency for Science, Technology, and Research in Singapore. We thank the International Caenorhabditis Genetic Center and the Japanese National Bio-resource Project for strains. We also thank C. Gao for technical assistance.	Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Bleckert A, 2012, J NEUROPHYSIOL, V107, P3479, DOI 10.1152/jn.00789.2011; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Dent E.W., 2011, COLD SPRING HARB PER, V3; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Doussau F, 2000, BIOCHIMIE, V82, P353, DOI 10.1016/S0300-9084(00)00217-0; Dwivedy A, 2007, DEVELOPMENT, V134, P2137, DOI 10.1242/dev.002345; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007; Ketschek A, 2010, J NEUROSCI, V30, P12185, DOI 10.1523/JNEUROSCI.1740-10.2010; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Manitt C, 2009, J NEUROSCI, V29, P11065, DOI 10.1523/JNEUROSCI.0947-09.2009; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nelson JC, 2013, J NEUROSCI, V33, P1366, DOI 10.1523/JNEUROSCI.3471-12.2012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pawson C, 2008, J NEUROSCI, V28, P11111, DOI 10.1523/JNEUROSCI.0833-08.2008; Pielage J, 2011, NEURON, V69, P1114, DOI 10.1016/j.neuron.2011.02.007; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Shakir MA, 2008, GENETICS, V179, P1957, DOI 10.1534/genetics.108.088963; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Spillane M, 2011, DEV NEUROBIOL, V71, P747, DOI 10.1002/dneu.20907; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tang HR, 2013, CURR BIOL, V23, P107, DOI 10.1016/j.cub.2012.11.059; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Waites CL, 2011, J NEUROSCI, V31, P14250, DOI 10.1523/JNEUROSCI.1835-11.2011; Xu K., 2012, ACTIN SPECTRIN ASS P; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhang YQ, 2010, J BIOL CHEM, V285, P23038, DOI 10.1074/jbc.M109.096164	52	93	94	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					208	220		10.1016/j.cell.2013.12.009	http://dx.doi.org/10.1016/j.cell.2013.12.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439377	Bronze, Green Accepted			2022-12-28	WOS:000329912200022
J	Linneweber, GA; Jacobson, J; Busch, KE; Hudry, B; Christov, CP; Dormann, D; Yuan, M; Otani, T; Knust, E; de Bono, M; Miguel-Aliaga, I				Linneweber, Gerit A.; Jacobson, Jake; Busch, Karl Emanuel; Hudry, Bruno; Christov, Christo P.; Dormann, Dirk; Yuan, Michaela; Otani, Tomoki; Knust, Elisabeth; de Bono, Mario; Miguel-Aliaga, Irene			Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; ARTERIAL DIFFERENTIATION; DROSOPHILA HOMOLOG; MIDGUT HOMEOSTASIS; TUMOR ANGIOGENESIS; REMOTE-CONTROL; CAROTID-BODY; FAT-CELLS; INSULIN; HYPOXIA	During adaptive angiogenesis, a key process in the etiology and treatment of cancer and obesity, the vasculature changes to meet the metabolic needs of its target tissues. Although the cues governing vascular remodeling are not fully understood, target-derived signals are generally believed to underlie this process. Here, we identify an alternative mechanism by characterizing the previously unrecognized nutrient-dependent plasticity of the Drosophila tracheal system: a network of oxygen-delivering tubules developmentally akin to mammalian blood vessels. We find that this plasticity, particularly prominent in the intestine, drives-rather than responds to-metabolic change. Mechanistically, it is regulated by distinct populations of nutrient- and oxygen-responsive neurons that, through delivery of both local and systemic insulin- and VIP-like neuropeptides, sculpt the growth of specific tracheal subsets. Thus, we describe a novel mechanism by which nutritional cues modulate neuronal activity to give rise to organ-specific, long-lasting changes in vascular architecture.	[Linneweber, Gerit A.; Jacobson, Jake; Hudry, Bruno; Dormann, Dirk; Miguel-Aliaga, Irene] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Gut Signalling & Metab Grp, London W12 0NN, England; [Busch, Karl Emanuel; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Christov, Christo P.; Otani, Tomoki] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Yuan, Michaela; Knust, Elisabeth] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Imperial College London; MRC Laboratory Molecular Biology; University of Cambridge; Max Planck Society	Miguel-Aliaga, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Gut Signalling & Metab Grp, Du Cane Rd, London W12 0NN, England.	i.miguel-aliaga@imperial.ac.uk	Linneweber, Gerit A/B-1797-2014; HUDRY, Bruno/S-4330-2018; Knust, Elisabeth/B-4338-2017	Linneweber, Gerit A/0000-0001-8393-6426; HUDRY, Bruno/0000-0003-1299-843X; Miguel-Aliaga, Irene/0000-0002-1082-5108; Busch, Karl Emanuel/0000-0001-7886-3226; de Bono, Mario/0000-0001-8347-0443	Wellcome Trust RCDF [WT083559MA]; Wellcome Trust PhD studentship [WT086807MA]; EMBO LTF; ERC Starting Grant; BBSRC project grant [BB/J007110/1]; EMBO Young Investigator Programme; MRC; BBSRC [BB/J007110/1] Funding Source: UKRI; MRC [MC_UP_1102/3, MC_U105178786] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J007110/1] Funding Source: researchfish; Medical Research Council [MC_UP_1102/3, MC_U105178786] Funding Source: researchfish	Wellcome Trust RCDF(Wellcome Trust); Wellcome Trust PhD studentship(Wellcome Trust); EMBO LTF(European Molecular Biology Organization (EMBO)); ERC Starting Grant(European Research Council (ERC)); BBSRC project grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Jordi Casanova, Jaya Krishnan, Stefan Luschnig, Helen Skaer, Pablo Wappner, and members of the lab (Bhavna Chanana, Paola Cognigni, Esmeralda Parra-Peralbo, and Clara Recasens-Zorzo) for discussions and/or critical reading of the manuscript. We also thank Zoltan Soltesz for the image analysis software used to analyse the GCaMP fluorescence. We are grateful to Li Liu and Yijin Wang for sharing results prior to publication and to Boris Adryan, Jordi Casanova, Louise Couton, Sebastian Groenke, Linda Partridge, Stefan Pulver, Orie Shafer, Maarten Zwart, the VDRC, and Bloomington Stock Center for providing fly stocks and antibodies. This work was funded by a Wellcome Trust RCDF to I.M.-A. (WT083559MA), a Wellcome Trust PhD studentship to G.A.L. (WT086807MA), an EMBO LTF to B.H., an ERC Starting Grant, a BBSRC project grant (BB/J007110/1) and the MRC. I.M-A. is also supported by the EMBO Young Investigator Programme.	Adolphe JL, 2010, BRIT J NUTR, V103, P929, DOI 10.1017/S0007114509992753; Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P3079, DOI 10.1210/jc.2012-1112; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Cheung U, 2006, J EXP BIOL, V209, P4429, DOI 10.1242/jeb.02553; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Davies AM, 2009, AUTON NEUROSCI-BASIC, V151, P39, DOI 10.1016/j.autneu.2009.07.011; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; FUJIWARA N, 1987, J PHYSIOL-LONDON, V384, P131, DOI 10.1113/jphysiol.1987.sp016447; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gervais L, 2011, DEVELOPMENT, V138, P1269, DOI 10.1242/dev.059188; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Holzer P, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P817; Jang YC, 2000, J SURG RES, V93, P144, DOI 10.1006/jsre.2000.5973; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Krnjevic K, 1999, CROAT MED J, V40, P375; Kumar M, 2013, NUTR REV, V71, P23, DOI 10.1111/j.1753-4887.2012.00542.x; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li ZH, 2013, DEV CELL, V24, P133, DOI 10.1016/j.devcel.2012.12.010; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miguel-Aliaga I, 2008, PLOS BIOL, V6, P538, DOI 10.1371/journal.pbio.0060058; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; O'Farrell F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001612; Ogasawara M, 1999, CLIN EXP METASTAS, V17, P283, DOI 10.1023/A:1006648402164; Pardal R, 2002, NAT NEUROSCI, V5, P197, DOI 10.1038/nn812; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Prabhakar NR, 2000, J APPL PHYSIOL, V88, P2287, DOI 10.1152/jappl.2000.88.6.2287; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Ribatti D, 2007, PHARMACOL REV, V59, P185, DOI 10.1124/pr.59.2.3; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rutland CS, 2007, PLACENTA, V28, P734, DOI 10.1016/j.placenta.2006.07.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Storkebaum E, 2011, NAT NEUROSCI, V14, P1390, DOI 10.1038/nn.2947; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010; Suska A, 2011, DEV BIOL, V353, P72, DOI 10.1016/j.ydbio.2011.02.015; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Talsma AD, 2012, P NATL ACAD SCI USA, V109, P12177, DOI 10.1073/pnas.1200247109; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Toda M, 2008, P NATL ACAD SCI USA, V105, P13550, DOI 10.1073/pnas.0800767105; Tonello C, 1999, FEBS LETT, V442, P167, DOI 10.1016/S0014-5793(98)01627-5; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Vesalius Andreas, 1543, HUMANI CORPORIFABR; Willecke M, 2011, ONCOGENE, V30, P4067, DOI 10.1038/onc.2011.125; ZWAAN BJ, 1991, HEREDITY, V66, P29, DOI 10.1038/hdy.1991.4	63	51	51	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					69	83		10.1016/j.cell.2013.12.008	http://dx.doi.org/10.1016/j.cell.2013.12.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439370	Green Published, hybrid			2022-12-28	WOS:000329912200011
J	Crooks, RM				Crooks, Richard M.			THERAPEUTICS Detective work on drug dosage	NATURE			English	Editorial Material							APTAMER-BASED SENSOR; BLOOD-SERUM		Univ Texas Austin, Dept Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Crooks, RM (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.	crooks@cm.utexas.edu						Ferguson BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007095; Lubin AA, 2010, ACCOUNTS CHEM RES, V43, P496, DOI 10.1021/ar900165x; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Swensen JS, 2009, J AM CHEM SOC, V131, P4262, DOI 10.1021/ja806531z; UEDA Y, 1989, CHEM PHARM BULL, V37, P1639; Xiao Y, 2005, ANGEW CHEM INT EDIT, V44, P5456, DOI 10.1002/anie.200500989	6	2	2	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					165	166		10.1038/505165a	http://dx.doi.org/10.1038/505165a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24402276				2022-12-28	WOS:000329441500025
J	Macrae, D; Grieve, R; Allen, E; Sadique, Z; Morris, K; Pappachan, J; Parslow, R; Tasker, RC; Elbourne, D				Macrae, Duncan; Grieve, Richard; Allen, Elizabeth; Sadique, Zia; Morris, Kevin; Pappachan, John; Parslow, Roger; Tasker, Robert C.; Elbourne, Diana		CHiP Investigators	A Randomized Trial of Hyperglycemic Control in Pediatric Intensive Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN THERAPY; STRESS HYPERGLYCEMIA; CRITICAL ILLNESS; GLYCEMIC CONTROL; GLUCOSE CONTROL; MORTALITY; RISK	BACKGROUND Whether an insulin infusion should be used for tight control of hyperglycemia in critically ill children remains unclear. METHODS We randomly assigned children (<= 16 years of age) who were admitted to the pediatric intensive care unit (ICU) and were expected to require mechanical ventilation and vasoactive drugs for at least 12 hours to either tight glycemic control, with a target blood glucose range of 72 to 126 mg per deciliter (4.0 to 7.0 mmol per liter), or conventional glycemic control, with a target level below 216 mg per deciliter (12.0 mmol per liter). The primary outcome was the number of days alive and free from mechanical ventilation at 30 days after randomization. The main prespecified subgroup analysis compared children who had undergone cardiac surgery with those who had not. We also assessed costs of hospital and community health services. RESULTS A total of 1369 patients at 13 centers in England underwent randomization: 694 to tight glycemic control and 675 to conventional glycemic control; 60% had undergone cardiac surgery. The mean between-group difference in the number of days alive and free from mechanical ventilation at 30 days was 0.36 days (95% confidence interval [CI], -0.42 to 1.14); the effects did not differ according to subgroup. Severe hypoglycemia (blood glucose, <36 mg per deciliter [12.0 mmol per liter]) occurred in a higher proportion of children in the tight-glycemic-control group than in the conventional-glycemic-control group (7.3% vs. 1.5%, P<0.001). Overall, the mean 12-month costs were lower in the tight-glycemic-control group than in the conventional-glycemic-control group. The mean 12-month costs were similar in the two groups in the cardiac-surgery subgroup, but in the subgroup that had not undergone cardiac surgery, the mean cost was significantly lower in the tight-glycemic-control group than in the conventional-glycemic-control group: -$13,120 (95% CI, -$24,682 to -$1,559). CONCLUSIONS This multicenter, randomized trial showed that tight glycemic control in critically ill children had no significant effect on major clinical outcomes, although the incidence of hypoglycemia was higher with tight glucose control than with conventional glucose control. (Funded by the National Institute for Health Research, Health Technology Assessment Program, U.K. National Health Service; CHiP Current Controlled Trials number, ISRCTN61735247.)	[Macrae, Duncan] Royal Brompton & Harefield NHS Fdn Trust, London SW3 6NP, England; [Grieve, Richard; Sadique, Zia] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Allen, Elizabeth; Elbourne, Diana] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Allen, Elizabeth; Elbourne, Diana] London Sch Hyg & Trop Med, Clin Trials Unit, London WC1, England; [Morris, Kevin] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Pappachan, John] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Parslow, Roger] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet & Therapeut, Div Epidemiol, Leeds, W Yorkshire, England; [Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol & Anesthesia, Boston, MA USA; [Tasker, Robert C.] Harvard Univ, Sch Med, Boston, MA USA	Royal Brompton & Harefield NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Birmingham; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Leeds; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Macrae, D (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Sydney St, London SW3 6NP, England.	d.macrae@rbht.nhs.uk	Macrae, Duncan/AAC-9564-2020; Tasker, Robert C/R-5837-2019; Peters, Mark/AAD-7518-2019; Parslow, Roger/AAV-1477-2020	Peters, Mark/0000-0003-3653-4808; Sadique, Zia/0000-0001-5814-0258; Tasker, Robert/0000-0003-3647-8113; Parslow, Roger/0000-0002-3945-5294; Macrae, Duncan/0000-0002-7158-6585; Brierley, Joe/0000-0003-0919-6882; Mok, Quen/0000-0003-4807-9275; Grieve, Richard/0000-0001-8899-1301; Inwald, David/0000-0001-9518-7821; Dunger, Professor David/0000-0002-2566-9304; Pathan, Nazima/0000-0001-7656-9453	NIHR-HTA, a research institute of the U.K. National Health Service; National Institute for Health Research [NF-SI-0513-10012, PDA/03/07/026, NF-SI-0508-10274] Funding Source: researchfish	NIHR-HTA, a research institute of the U.K. National Health Service; National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant from the NIHR-HTA, a research institute of the U.K. National Health Service.	Agus MSD, 2012, NEW ENGL J MED, V367, P1208, DOI 10.1056/NEJMoa1206044; Branco Ricardo G, 2005, Pediatr Crit Care Med, V6, P470, DOI 10.1097/01.PCC.0000161284.96739.3A; Branco RG, 2011, PEDIATR CRIT CARE ME, V12, P265, DOI 10.1097/PCC.0b013e3181f52847; Branco RG, 2010, PEDIATR CRIT CARE ME, V11, P755, DOI 10.1097/PCC.0b013e3181f4d606; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Draper E, 2007, PAEDIAT INTENSIVE CA; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Lacroix Jacques, 2005, Pediatr Crit Care Med, V6, pS126, DOI 10.1097/01.PCC.0000161287.61028.D4; Leteurtre S, 1999, MED DECIS MAKING, V19, P399, DOI 10.1177/0272989X9901900408; Macrae D, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-5; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tasker RC, 2012, JAMA-J AM MED ASSOC, V308, P1687, DOI 10.1001/jama.2012.14151; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Wiener RS, 2009, JAMA-J AM MED ASSOC, V301, P936; Yates AR, 2006, PEDIATR CRIT CARE ME, V7, P351, DOI 10.1097/01.PCC.0000227755.96700.98; Yung M, 2008, PEDIATR CRIT CARE ME, V9, P147, DOI 10.1097/PCC.0b013e3181668c22	30	137	143	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					107	118		10.1056/NEJMoa1302564	http://dx.doi.org/10.1056/NEJMoa1302564			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401049	Green Accepted			2022-12-28	WOS:000336119800006
J	Ebbert, JO; Hatsukami, DK; Croghan, IT; Schroeder, DR; Allen, SS; Hays, JT; Hurt, RD				Ebbert, Jon O.; Hatsukami, Dorothy K.; Croghan, Ivana T.; Schroeder, Darrell R.; Allen, Sharon S.; Hays, J. Taylor; Hurt, Richard D.			Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; SMOKING-CESSATION; WEIGHT CONCERNS; ABSTINENCE; PLACEBO	IMPORTANCE Combining pharmacotherapies for tobacco-dependence treatment may increase smoking abstinence. OBJECTIVE To determine efficacy and safety of varenicline and bupropion sustained-release (SR; combination therapy) compared with varenicline (monotherapy) in cigarette smokers. DESIGN, SETTING, AND PARTICIPANTS Randomized, blinded, placebo-controlled multicenter clinical trial with a 12-week treatment period and follow-up through week 52 conducted between October 2009 and April 2013 at 3 midwestern clinical research sites. Five hundred six adult (>= 18 years) cigarette smokers were randomly assigned and 315 (62%) completed the study. INTERVENTIONS Twelve weeks of varenicline and bupropion SR or varenicline and placebo. MAIN OUTCOMES AND MEASURES Primary outcomewas abstinence rates atweek 12, defined as prolonged (no smoking from 2 weeks after the target quit date) abstinence and 7-day point-prevalence (no smoking past 7 days) abstinence. Secondary outcomes were prolonged and point-prevalence smoking abstinence rates at weeks 26 and 52. Outcomes were biochemically confirmed. RESULTS At 12 weeks, 53.0% of the combination therapy group achieved prolonged smoking abstinence and 56.2% achieved 7-day point-prevalence smoking abstinence compared with 43.2% and 48.6% in varenicline monotherapy (odds ratio [OR], 1.49; 95% CI, 1.05-2.12; P = .03 and OR, 1.36; 95% CI, 0.95-1.93; P = .09, respectively). At 26 weeks, 36.6% of the combination therapy group achieved prolonged and 38.2% achieved 7-day point-prevalence smoking abstinence compared with 27.6% and 31.9% in varenicline monotherapy (OR, 1.52; 95% CI, 1.04-2.22; P = .03 and OR, 1.32; 95% CI, 0.91-1.91; P = .14, respectively). At 52 weeks, 30.9% of the combination therapy group achieved prolonged and 36.6% achieved 7-day point-prevalence smoking abstinence compared with 24.5% and 29.2% in varenicline monotherapy (OR, 1.39; 95% CI, 0.93-2.07; P = .11 and OR, 1.40; 95% CI, 0.96-2.05; P = .08, respectively). Participants receiving combination therapy reported more anxiety (7.2% vs 3.1%; P = .04) and depressive symptoms (3.6% vs 0.8%; P = .03). CONCLUSIONS AND RELEVANCE Among cigarette smokers, combined use of varenicline and bupropion, compared with varenicline alone, increased prolonged abstinence but not 7-day point prevalence at 12 and 26 weeks. Neither outcome was significantly different at 52 weeks. Further research is required to determine the role of combination therapy in smoking cessation.	[Ebbert, Jon O.; Croghan, Ivana T.; Schroeder, Darrell R.; Hays, J. Taylor; Hurt, Richard D.] Mayo Clin, Nicotine Dependence Ctr, Rochester, MN 55905 USA; [Hatsukami, Dorothy K.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Allen, Sharon S.] Univ Minnesota, Minneapolis, MN USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ebbert, JO (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	ebbert.jon@mayo.edu		Hays, J Taylor/0000-0002-6110-3121; Allen, Sharon/0000-0003-2797-8001	National Institutes of Health (NIH) [CA 138417]; NATIONAL CANCER INSTITUTE [R01CA138417] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The clinical trial was supported by National Institutes of Health (NIH) grant CA 138417 (primary investigator, Dr Ebbert). Medication (varenicline) was provided by Pfizer.	ASCHER JA, 1995, J CLIN PSYCHIAT, V56, P395; Aubin HJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4439; Beck AT, 1996, PSYCHOL ASSESS; Clark MM, 2006, ADDICT BEHAV, V31, P1144, DOI 10.1016/j.addbeh.2005.08.011; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Copeland AL, 2006, ADDICT BEHAV, V31, P115, DOI 10.1016/j.addbeh.2005.04.020; Croghan IT, 2012, CONTEMP CLIN TRIALS, V33, P576, DOI 10.1016/j.cct.2012.02.014; Damaj MI, 2004, MOL PHARMACOL, V66, P675, DOI 10.1124/mol.104.001313; Ebbert JO, 2009, NICOTINE TOB RES, V11, P234, DOI 10.1093/ntr/ntn031; Farley AC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006219.pub3; Foulds J, 1993, Arch Fam Med, V2, P417, DOI 10.1001/archfami.2.4.417; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hays JT, 2010, DRUGS, V70, P2357, DOI 10.2165/11538190-000000000-00000; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hughes JR, 2007, NICOTINE TOB RES, V9, P329, DOI 10.1080/14622200701188927; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Hughes JR, MINNESOTA NICOTINE W; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Meyers AW, 1997, J CONSULT CLIN PSYCH, V65, P448, DOI 10.1037/0022-006X.65.3.448; National Institute of Health, NIH POL REP RAC ETHN; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; Pomerleau C S, 2001, Nicotine Tob Res, V3, P51, DOI 10.1080/14622200020032105; Posner K, SUICIDALITY ISSUES C; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581	26	96	99	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					155	163		10.1001/jama.2013.283185	http://dx.doi.org/10.1001/jama.2013.283185			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SA	24399554	Green Accepted			2022-12-28	WOS:000329339400021
J	Sherwood, SC; Bony, S; Dufresne, JL				Sherwood, Steven C.; Bony, Sandrine; Dufresne, Jean-Louis			Spread in model climate sensitivity traced to atmospheric convective mixing	NATURE			English	Article							GENERAL-CIRCULATION; HYDROLOGICAL CYCLE; RELATIVE-HUMIDITY; FEEDBACKS; FUTURE; CLOUDS; SIMULATIONS; CMIP5	Equilibrium climate sensitivity refers to the ultimate change in global mean temperature in response to a change in external forcing. Despite decades of research attempting to narrow uncertainties, equilibrium climate sensitivity estimates from climate models still span roughly 1.5 to 5 degrees Celsius for a doubling of atmospheric carbon dioxide concentration, precluding accurate projections of future climate. The spread arises largely from differences in the feedback from low clouds, for reasons not yet understood. Here we show that differences in the simulated strength of convective mixing between the lower and middle tropical troposphere explain about half of the variance in climate sensitivity estimated by 43 climate models. The apparent mechanism is that such mixing dehydrates the low-cloud layer at a rate that increases as the climate warms, and this rate of increase depends on the initial mixing strength, linking the mixing to cloud feedback. The mixing inferred from observations appears to be sufficiently strong to imply a climate sensitivity of more than 3 degrees for a doubling of carbon dioxide. This is significantly higher than the currently accepted lower bound of 1.5 degrees, thereby constraining model projections towards relatively severe future warming.	[Sherwood, Steven C.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Sherwood, Steven C.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Bony, Sandrine; Dufresne, Jean-Louis] Univ Paris 06, CNRS, Meteorol Dynam Lab, F-75252 Paris, France; [Bony, Sandrine; Dufresne, Jean-Louis] Univ Paris 06, CNRS, Inst Pierre Simon Laplace LMD IPSL, F-75252 Paris, France	University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Ecole des Ponts ParisTech; UDICE-French Research Universities; Sorbonne Universite	Sherwood, SC (corresponding author), Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia.	s.sherwood@unsw.edu.au	Dufresne, Jean-Louis/I-5616-2015; Sherwood, Steven/B-5673-2008; Bony, Sandrine/AAG-5804-2019	Dufresne, Jean-Louis/0000-0003-4764-9600; Sherwood, Steven/0000-0001-7420-8216; Bony, Sandrine/0000-0002-4791-4438	FP7-ENV-2009-1 European project EUCLIPSE [244067]	FP7-ENV-2009-1 European project EUCLIPSE	This work was supported by the FP7-ENV-2009-1 European project EUCLIPSE (number 244067). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output, especially the participants contributing additional CFMIP2 experiments and diagnostics crucial to our study. The US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support for CMIP and led the development of software infrastructure in partnership with the Global Organisation for Earth System Science Portals. We also thank the National Center for Atmospheric Research and the Earth System Grid Federation for providing access to PCM output, the Australian National Computational Infrastructure, and the IPSL Prodiguer-Ciclad facility for providing a convenient archive of CMIP data. Finally, we thank B. Stevens, C. Bretherton and G. Schmidt for comments on early versions of the manuscript.	Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Brient F, 2013, CLIM DYNAM, V40, P2415, DOI 10.1007/s00382-011-1279-7; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Fasullo JT, 2012, SCIENCE, V338, P792, DOI 10.1126/science.1227465; Forster PM, 2013, J GEOPHYS RES-ATMOS, V118, P1139, DOI 10.1002/jgrd.50174; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018747; HARTMANN DL, 1980, J ATMOS SCI, V37, P1233, DOI 10.1175/1520-0469(1980)037<1233:OTUOER>2.0.CO;2; Hegerl G. C., 2007, WORKING GROUP 1 PHYS, P663; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Klein SA, 2013, J GEOPHYS RES-ATMOS, V118, P1329, DOI 10.1002/jgrd.50141; Nolan DS, 2010, J ATMOS SCI, V67, P4028, DOI 10.1175/2010JAS3417.1; Randall D. A., 2007, WORKING GROUP 1 PHYS, P589; Rieck M, 2012, J ATMOS SCI, V69, P2538, DOI 10.1175/JAS-D-11-0203.1; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rio C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036779; Sherwood SC, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000301; Sherwood SC, 2006, J CLIMATE, V19, P6278, DOI 10.1175/JCLI3979.1; Sherwood SC, 2008, J CLIMATE, V21, P5336, DOI 10.1175/2008JCL12320.1; Soden BJ, 2008, J CLIMATE, V21, P3504, DOI 10.1175/2007JCLI2110.1; Soden BJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047632; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Stevens B, 2007, J ATMOS SCI, V64, P2916, DOI 10.1175/JAS3983.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vial J, 2013, CLIM DYNAM, V41, P3339, DOI 10.1007/s00382-013-1725-9; Volodin EM, 2008, IZV ATMOS OCEAN PHY+, V44, P288, DOI 10.1134/S0001433808030043; Webb MJ, 2013, CLIM DYNAM, V41, P1923, DOI 10.1007/s00382-012-1608-5; Webb MJ, 2013, CLIM DYNAM, V40, P677, DOI 10.1007/s00382-012-1336-x; YANO J, 1991, J ATMOS SCI, V48, P377, DOI 10.1175/1520-0469(1991)048<0377:AIMOTE>2.0.CO;2; Zahn M, 2013, J CLIMATE, V26, P562, DOI 10.1175/JCLI-D-12-00222.1; Zelinka MD, 2012, J CLIMATE, V25, P3715, DOI 10.1175/JCLI-D-11-00248.1; Zhang CD, 2008, J CLIMATE, V21, P3453, DOI 10.1175/2007JCLI1870.1	35	461	465	5	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					37	+		10.1038/nature12829	http://dx.doi.org/10.1038/nature12829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24380952				2022-12-28	WOS:000329163300019
J	Foa, EB; McLean, CP; Capaldi, S; Rosenfield, D				Foa, Edna B.; McLean, Carmen P.; Capaldi, Sandra; Rosenfield, David			Prolonged Exposure vs Supportive Counseling for Sexual Abuse-Related PTSD in Adolescent Girls A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDRENS DEPRESSION; SYMPTOM SCALE; INVENTORY; THERAPY; HEALTH; YOUTH	IMPORTANCE Evidence-based treatments for posttraumatic stress disorder (PTSD) have not been established for adolescents despite high prevalence of PTSD in this population. OBJECTIVE To examine the effects of counselor-delivered prolonged exposure therapy compared with supportive counseling for adolescents with PTSD. DESIGN, SETTING, AND PARTICIPANTS A single-blind, randomized clinical trial of 61 adolescent girls with PTSD using a permuted block design. Counselors previously naive to prolonged exposure therapy provided the treatments in a community mental health clinic. Data collection lasted from February 2006 through March 2012. INTERVENTIONS Participants received fourteen 60- to 90-minute sessions of prolonged exposure therapy (n = 31) or supportive counseling (n = 30). MAIN OUTCOMES AND MEASURES All outcomes were assessed before treatment, at mid-treatment, and after treatment and at 3-, 6-, and 12-month follow-up. The primary outcome, PTSD symptom severity, was assessed by the Child PTSD Symptom Scale-Interview (range, 0-51; higher scores indicate greater severity). Secondary outcomes were presence or absence of PTSD diagnosis assessed by the DSM-IV Schedule for Affective Disorders and Schizophrenia for School-Age Children and functioning assessed by the Children's Global Assessment Scale (range, 1-100; higher scores indicate better functioning). Additional secondary measures, PTSD severity assessed by the Child PTSD Symptom Scale-Self-Report (range, 0-51; higher scores indicate greater severity) and depression severity assessed by the Children's Depression Inventory (range, 0-54; higher scores indicate greater severity), were also assessed weekly during treatment. RESULTS Data were analyzed as intent to treat. During treatment, participants receiving prolonged exposure demonstrated greater improvement on the PTSD symptom severity scale (difference between treatments in improvement, 7.5; 95% CI, 2.5-12.5; P < .001) and on all secondary outcomes (loss of PTSD diagnosis: difference, 29.3%, 95% CI, 20.2%-41.2%; P = .01; self-reported PTSD severity: difference, 6.2; 95% CI, 1.2-11.2; P = .02; depression: difference, 4.9; 95% CI, 1.6-8.2; P = .008; global functioning: difference, 10.1; 95% CI, 3.4-16.8; P = .008). These treatment differences were maintained through the 12-month follow-up: for interviewer-assessed PTSD (difference, 6.0; 95% CI, 1.6-10.4; P = .02), loss of PTSD diagnosis (difference, 31.1; 95% CI, 14.7-34.8; P = .01), self-reported PTSD (difference, 9.3; 95% CI, 1.2-16.5; P = .02), depression (difference, 7.2; 95% CI, 1.4-13.0; P = .02), and global functioning (difference, 11.2; 95% CI, 4.5-17.9; P = .01). CONCLUSION AND RELEVANCE Adolescents girls with sexual abuse-related PTSD experienced greater benefit from prolonged exposure therapy than from supportive counseling even when delivered by counselors who typically provide supportive counseling.	[Foa, Edna B.; McLean, Carmen P.; Capaldi, Sandra] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Rosenfield, David] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA	University of Pennsylvania; Southern Methodist University	Foa, EB (corresponding author), Univ Penn, Dept Psychiat, 3535 Market St,6th Floor, Philadelphia, PA 19104 USA.	foa@mail.med.upenn.edu		McLean, Carmen/0000-0003-4322-9318	National Institute of Mental Health [R01 MH074505]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074505] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was conducted with support from the National Institute of Mental Health (R01 MH074505) awarded to Dr Foa.	[Anonymous], 2013, VA DOD CLIN PRACT GU; Benjamini Y, 2001, ANN STAT, V29, P1165; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P81; Briere J, 2013, INTEGRATIVE TR UNPUB; Chrestman K., 2008, PROLONGED EXPOSURE M; Cohen JA, 2004, J AM ACAD CHILD PSY, V43, P393, DOI 10.1097/00004583-200404000-00005; Cohen JA, 1996, CLIENT CTR THE UNPUB; Cohen JA, 2012, CHILD ABUSE NEGLECT, V36, P528, DOI 10.1016/j.chiabu.2012.03.007; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; FINKELHOR D, 1985, AM J ORTHOPSYCHIAT, V55, P530, DOI 10.1111/j.1939-0025.1985.tb02703.x; Foa E.B., 2019, PROLONGED EXPOSURE T, V2, DOI [10.1093/med-psych/9780190926939.001.0001/med-9780190926939, DOI 10.1093/MED-PSYCH/9780190926939.001.0001/MED-9780190926939]; Foa E. B., 2001, INT ENCY SOCIAL BEHA, P12363, DOI DOI 10.1016/B0-08-043076-7/01338-3; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; GIACONIA RM, 1995, J AM ACAD CHILD PSY, V34, P1369, DOI 10.1097/00004583-199510000-00023; Gilboa-Schechtman E, 2010, J AM ACAD CHILD PSY, V49, P1034, DOI 10.1016/j.jaac.2010.07.014; Gillihan SJ, 2013, PSYCHOL ASSESSMENT, V25, P23, DOI 10.1037/a0029553; Hanson RF, 2008, AM J ORTHOPSYCHIAT, V78, P313, DOI 10.1037/a0014056; Hedeker D., 2006, LONGITUDINAL DATA AN; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kaufman J, 1996, SCHEDULE AFFECTIVE D; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ERN.11.94, 10.1586/ern.11.94]; MCLEER SV, 1994, J AM ACAD CHILD PSY, V33, P313, DOI 10.1097/00004583-199403000-00003; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Rogers CR., 1951, CLIENT CENT THER; Roodman AA, 2001, CLIN PSYCHOL REV, V21, P183, DOI 10.1016/S0272-7358(99)00045-8; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; SMUCKER MR, 1986, J ABNORM CHILD PSYCH, V14, P25, DOI 10.1007/BF00917219; SNIJDERS TAB, 1993, J EDUC STAT, V18, P237, DOI 10.3102/10769986018003237; Timbremont B, 2004, J CLIN CHILD ADOLESC, V33, P149, DOI 10.1207/S15374424JCCP3301_14	31	98	100	0	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2650	2657		10.1001/jama.2013.282829	http://dx.doi.org/10.1001/jama.2013.282829			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	277KN	24368465	Bronze			2022-12-28	WOS:000328818000017
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Screening propaganda: the television shows that gave harms second billing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BBC, 2013, BBC ONES LONG LIV BR; General Medical Council, DUT DOCT; ITV, 2013, EXP; NHS Cancer Screening Programmes, BOW CANC SCREEN FACT; NHS Cancer Screening Programmes, NHS BREAST SCREEN HE; NHS Cancer Screening Programmes, CERV CANC SCREEN FAC; O'Connor GT, 2012, JAMA-J AM MED ASSOC, V307, P2434, DOI 10.1001/jama.2012.6096; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; US Preventative Task Force, 2012, SCREEN PROST CANC CU	9	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2013	347								f7643	10.1136/bmj.f7643	http://dx.doi.org/10.1136/bmj.f7643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MZ	24361856				2022-12-28	WOS:000328825000007
J	Wang, T; Chen, J; Yang, TG; Xiao, CL; Sun, ZG; Huang, L; Dai, DX; Yang, XM; Zhang, DH				Wang, Tao; Chen, Jun; Yang, Tiangang; Xiao, Chunlei; Sun, Zhigang; Huang, Long; Dai, Dongxu; Yang, Xueming; Zhang, Dong H.			Dynamical Resonances Accessible Only by Reagent Vibrational Excitation in the F plus HD -> HF plus D Reaction	SCIENCE			English	Article							CHEMICAL-REACTIONS; TRANSITION-STATE; MOLECULAR-BEAM; ATOM REACTION; CHD3; A+BC; CH4	Experimental limitations in vibrational excitation efficiency have previously hindered investigation of how vibrational energy might mediate the role of dynamical resonances in bimolecular reactions. Here, we report on a high-resolution crossed-molecular-beam experiment on the vibrationally excited HD(v = 1) + F -> HF + D reaction, in which two broad peaks for backward-scattered HF(v' = 2 and 3) products clearly emerge at collision energies of 0.21 kilocalories per mole (kcal/mol) and 0.62 kcal/mol from differential cross sections measured over a range of energies. We attribute these features to excited Feshbach resonances trapped in the peculiar HF(v' = 4)-D vibrationally adiabatic potential in the postbarrier region. Quantum dynamics calculations on a highly accurate potential energy surface show that these resonance states correlate to the HD(v' = 1) state in the entrance channel and therefore can only be accessed by the vibrationally excited HD reagent.	[Wang, Tao; Chen, Jun; Yang, Tiangang; Xiao, Chunlei; Sun, Zhigang; Huang, Long; Dai, Dongxu; Yang, Xueming; Zhang, Dong H.] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China; [Yang, Xueming; Zhang, Dong H.] Univ Sci & Technol China, Ctr Adv Chem Phys, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xiao, CL (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China.	chunleixiao@dicp.ac.cn; zsun@dicp.ac.cn; xmyang@dicp.ac.cn; zhangdh@dicp.ac.cn	Yang, Tiangang/A-3962-2015; Yang, Xueming/C-8764-2013; Sun, Zhigang/B-5757-2011; xiao, chunlei/D-1019-2014; Yang, Tiangang/C-8788-2013; CHEN, Jun/A-6437-2014	xiao, chunlei/0000-0002-1549-5945; Yang, Tiangang/0000-0002-8940-8875; CHEN, Jun/0000-0002-8021-7458	National Natural Science Foundation of China; Ministry of Science and Technology of China; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China, the Ministry of Science and Technology of China, and the Chinese Academy of Sciences.	BRONIKOWSKI MJ, 1991, J CHEM PHYS, V95, P8647, DOI 10.1063/1.461243; Camden JP, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2034507; Crim FF, 1999, ACCOUNTS CHEM RES, V32, P877, DOI 10.1021/ar950046a; Czako G, 2011, SCIENCE, V334, P343, DOI 10.1126/science.1208514; Czako G, 2009, J AM CHEM SOC, V131, P17534, DOI 10.1021/ja906886z; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Fernandez-Alonso F, 2002, ANNU REV PHYS CHEM, V53, P67, DOI 10.1146/annurev.physchem.53.091001.094554; Liu KP, 2012, ADV CHEM PHYS, V149, P1; Liu KP, 2001, ANNU REV PHYS CHEM, V52, P139, DOI 10.1146/annurev.physchem.52.1.139; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Mukherjee N, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790402; Mukherjee N, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3599711; NEUHAUSER D, 1992, SCIENCE, V257, P519, DOI 10.1126/science.257.5069.519; NEUMARK DM, 1985, J CHEM PHYS, V82, P3045, DOI 10.1063/1.448254; NEUMARK DM, 1985, J CHEM PHYS, V82, P3067, DOI 10.1063/1.448255; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Ren ZF, 2008, P NATL ACAD SCI USA, V105, P12662, DOI 10.1073/pnas.0709974105; SCHATZ GC, 1984, J PHYS CHEM-US, V88, P2971, DOI 10.1021/j150658a011; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; SCHATZ GC, 1973, J CHEM PHYS, V58, P4023, DOI 10.1063/1.1679760; SIMPSON WR, 1995, J CHEM PHYS, V103, P7313, DOI 10.1063/1.470305; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; SKODJE RT, 1994, J CHEM PHYS, V101, P1725, DOI 10.1063/1.467728; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Vitanov NV, 2001, ADV ATOM MOL OPT PHY, V46, P55, DOI 10.1016/S1049-250X(01)80063-X; Wang FY, 2011, SCIENCE, V331, P900, DOI 10.1126/science.1199771; Wang T, 2013, J PHYS CHEM LETT, V4, P368, DOI 10.1021/jz302103u; WU SF, 1973, MOL PHYS, V25, P839, DOI 10.1080/00268977300100731; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Yang XM, 2008, ACCOUNTS CHEM RES, V41, P981, DOI 10.1021/ar700258g; Yoon S, 2002, J CHEM PHYS, V116, P10744, DOI 10.1063/1.1476318; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875; Zhang WQ, 2009, SCIENCE, V325, P303, DOI 10.1126/science.1175018; Zhang ZJ, 2012, J PHYS CHEM LETT, V3, P3416, DOI 10.1021/jz301649w	35	94	100	5	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1499	1502		10.1126/science.1246546	http://dx.doi.org/10.1126/science.1246546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357315				2022-12-28	WOS:000328644300055
J	Rudge, SA; Wakelam, MJO				Rudge, Simon A.; Wakelam, Michael J. O.			SnapShot: Lipid Kinases and Phosphatases	CELL			English	Editorial Material									[Rudge, Simon A.; Wakelam, Michael J. O.] Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Rudge, SA (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England.			Wakelam, Michael/0000-0003-4059-9276	BBSRC [BBS/E/B/0000M243, BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/0000M243] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Kielkowska A., 2013, ADV BIOL REGUL; Kok BPC, 2012, CHEM REV, V112, P5121, DOI 10.1021/cr200433m; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Stephens L, 2011, ADV ENZYME REGUL, V51, P27, DOI 10.1016/j.advenzreg.2010.09.007; Wakelam MJO, 2011, BBA-MOL CELL BIOL L, V1811, P758, DOI 10.1016/j.bbalip.2011.09.004	7	6	6	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7								10.1016/j.cell.2013.12.005	http://dx.doi.org/10.1016/j.cell.2013.12.005			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360283	Bronze			2022-12-28	WOS:000328693300020
J	Kerry, VB; Mullan, F				Kerry, Vanessa B.; Mullan, Fitzhugh			Global Health Service Partnership: building health professional leadership	LANCET			English	Editorial Material							MIGRATION; EDUCATION		[Kerry, Vanessa B.; Mullan, Fitzhugh] Seed Global Hlth, Boston, MA 02114 USA; [Kerry, Vanessa B.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kerry, Vanessa B.] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care, Boston, MA 02114 USA; [Kerry, Vanessa B.] Harvard Univ, Sch Med, Boston, MA USA; [Mullan, Fitzhugh] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Mullan, Fitzhugh] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; George Washington University; George Washington University	Kerry, VB (corresponding author), Seed Global Hlth, Boston, MA 02114 USA.	vkerry@seedglobalhealth.org						Achiek M, 2010, S SUDAN MED J, V3; ADETUYIBI A, 1977, MED EDUC, V11, P355, DOI 10.1111/j.1365-2923.1977.tb00628.x; Awases M, 2003, MIGRATION HLTH PROES; Bezuidenhout MM, 2009, S AFR FAM PRACT, V51, P211, DOI 10.1080/20786204.2009.10873850; Bundred PE, 2000, LANCET, V356, P245, DOI 10.1016/S0140-6736(00)02492-2; Celletti F, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001108; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Kerry V, 2013, CONS U GLOB HLTH NN; Kerry VB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001118; Malawi Health Equity Network, 2010 2011 HLTH SECT; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; Muula AS, 2005, CROAT MED J, V46, P21; Pallangyo K, 2012, J PUBLIC HEALTH POL, V33, pS13, DOI 10.1057/jphp.2012.40; PEPFAR, U ED MONDL UCSD MED; PEPFAR, 2013, HLTH SYST STRENGTH; Third World Academy of Sciences, 2011, BUILD SCI CAP TWAS P; Wellcome Trust, 2013, GLOB HLTH RES; World Health Organisation report, 2006, 2006 WHO	20	14	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1688	1691		10.1016/S0140-6736(13)61683-9	http://dx.doi.org/10.1016/S0140-6736(13)61683-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24360618				2022-12-28	WOS:000335670800031
J	Young, AF; Sanchez-Yamagishi, JD; Hunt, B; Choi, SH; Watanabe, K; Taniguchi, T; Ashoori, RC; Jarillo-Herrero, P				Young, A. F.; Sanchez-Yamagishi, J. D.; Hunt, B.; Choi, S. H.; Watanabe, K.; Taniguchi, T.; Ashoori, R. C.; Jarillo-Herrero, P.			Tunable symmetry breaking and helical edge transport in a graphene quantum spin Hall state	NATURE			English	Article							TOPOLOGICAL INSULATORS	Low-dimensional electronic systems have traditionally been obtained by electrostatically confining electrons, either in heterostructures or in intrinsically nanoscale materials such as single molecules, nanowires and graphene. Recently, a new method has emerged with the recognition that symmetry-protected topological (SPT) phases(1,2), which occur in systems with an energy gap to quasiparticle excitations (such as insulators or superconductors), can host robust surface states that remain gapless as long as the relevant global symmetry remains unbroken. The nature of the charge carriers in SPT surface states is intimately tied to the symmetry of the bulk, resulting in one- and two-dimensional electronic systems with novel properties. For example, time reversal symmetry endows the massless charge carriers on the surface of a three-dimensional topological insulator with helicity, fixing the orientation of their spin relative to their momentum(3,4). Weakly breaking this symmetry generates a gap on the surface(5), resulting in charge carriers with finite effective mass and exotic spin textures(6). Analogous manipulations have yet to be demonstrated in two-dimensional topological insulators, where the primary example of a SPT phase is the quantum spin Hall state(7,8). Here we demonstrate experimentally that charge-neutral monolayer graphene has a quantum spin Hall state(9,10) when it is subjected to a very large magnetic field angled with respect to the graphene plane. In contrast to time-reversal-symmetric systems(7), this state is protected by a symmetry of planar spin rotations that emerges as electron spins in a half-filled Landau level are polarized by the large magnetic field. The properties of the resulting helical edge states can be modulated by balancing the applied field against an intrinsic antiferromagnetic instability(11-13), which tends to spontaneously break the spin-rotation symmetry. In the resulting canted antiferromagnetic state, we observe transport signatures of gapped edge states, which constitute a new kind of one- dimensional electronic system with a tunable bandgap and an associated spin texture(14).	[Young, A. F.; Sanchez-Yamagishi, J. D.; Hunt, B.; Choi, S. H.; Ashoori, R. C.; Jarillo-Herrero, P.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan	Massachusetts Institute of Technology (MIT); National Institute for Materials Science	Young, AF (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	afy@mit.edu; jdsy@mit.edu; benhunt@mit.edu	WATANABE, Kenji/H-2825-2011; TANIGUCHI, Takashi/H-2718-2011; Hunt, Benjamin/C-3395-2017; Young, Andrea F/H-9697-2012; Jarillo-Herrero, Pablo/E-3755-2013	WATANABE, Kenji/0000-0003-3701-8119; Hunt, Benjamin/0000-0002-5008-8042; Young, Andrea F/0000-0001-5954-8028; /0000-0001-5031-1673; Sanchez-Yamagishi, Javier/0000-0001-9703-6525; Jarillo-Herrero, Pablo/0000-0001-8217-8213	BES Program of the Office of Science of the US DOE [FG02-08ER46514]; Gordon and Betty Moore Foundation [GBMF2931]; US DOE, BES Office, Division of Materials Sciences and Engineering [DE-SC0001819]; NSF [DMR-0845287, DMR-0819762, ECS-0335765, DMR-0654118]; ONR GATE MURI; Pappalardo Fellowship in Physics	BES Program of the Office of Science of the US DOE; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US DOE, BES Office, Division of Materials Sciences and Engineering; NSF(National Science Foundation (NSF)); ONR GATE MURI; Pappalardo Fellowship in Physics	We acknowledge discussions with D. Abanin, A. Akhmerov, C. Beenakker, L. Brey, L. Fu, M. Kharitonov, L. Levitov, P. Lee and J. Sau. B.H. and R.C.A. were funded by the BES Program of the Office of Science of the US DOE, contract no. FG02-08ER46514, and the Gordon and Betty Moore Foundation, through grant GBMF2931. J.D.S.-Y, and P.J.-H. were primarily supported by the US DOE, BES Office, Division of Materials Sciences and Engineering, under award DE-SC0001819. Early fabrication feasibility studies were supported by NSF Career Award no. DMR-0845287 and the ONR GATE MURI. This work made use of the MRSEC Shared Experimental Facilities supported by the NSF under award no. DMR-0819762 and of Harvard's CNS, supported by the NSF under grant no. ECS-0335765. Some measurements were performed at the National High Magnetic Field Laboratory, which is supported by NSF Cooperative Agreement DMR-0654118, the State of Florida and the DOE. A.F.Y. acknowledges the support of the Pappalardo Fellowship in Physics.	Abanin DA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.176803; Abanin DA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035416; Alicea J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075422; ASHOORI RC, 1992, PHYS REV LETT, V68, P3088, DOI 10.1103/PhysRevLett.68.3088; Buttner B, 2011, NAT PHYS, V7, P418, DOI 10.1038/NPHYS1914; Checkelsky JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206801; Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Du L., 2013, OBSERVATION QUANTUM; Fertig HA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116805; GOODALL RK, 1985, PHYS REV B, V31, P6597, DOI 10.1103/PhysRevB.31.6597; Goossens AM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685504; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Herbut IF, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.165411; Hsieh TH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1969; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Jalilian R, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295705; Jung J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235417; Kharitonov M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075450; Kindermann M., 2013, TOPOLOGICAL CRYSTALL; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Marchenko D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2227; Mazo V., 2013, SUPERFLUID INSULATOR; Min H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165310; Nomura K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.216801; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Roth A, 2009, SCIENCE, V325, P294, DOI 10.1126/science.1174736; Ryu S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065010; SEMENOFF GW, 1984, PHYS REV LETT, V53, P2449, DOI 10.1103/PhysRevLett.53.2449; Shitade A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256403; Xu SY, 2012, NAT PHYS, V8, P616, DOI [10.1038/nphys2351, 10.1038/NPHYS2351]; Yang K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075423	36	198	198	5	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					528	+		10.1038/nature12800	http://dx.doi.org/10.1038/nature12800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24362569	Green Submitted			2022-12-28	WOS:000329995000035
J	Thome, S				Thome, Stephan			Edoxaban was noninferior to warfarin for preventing recurrent venous thromboembolism, with less bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mayo Clin, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Thome, S (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.							Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC4	10.7326/0003-4819-160-2-201401210-02004	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445714				2022-12-28	WOS:000330275600003
J	Tirschwell, D				Tirschwell, David			In 85-year-old adults, MMSE predicted 5-year risk for first stroke better than Framingham score	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS; DISEASE		Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Tirschwell, D (corresponding author), Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA.			Tirschwell, David/0000-0002-8059-2901				Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Briasoulis A, 2013, HEART; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Moreno G, 2013, J AM GERIATR SOC, V61, P2027, DOI 10.1111/jgs.12513; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441	6	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC13	10.7326/0003-4819-160-2-201401210-02013	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445711				2022-12-28	WOS:000330275600012
J	Charo, RA				Charo, R. Alta			Physicians and the (Woman's) Body Politic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Alicia Beltran's Kafka-esque pregnancy experience is part of an ongoing struggle in which pregnant women and their physicians are marked for intense attention by legislators and judges acting as arbiters of medical knowledge despite a lack of expertise or detachment.The only amendment that didn't get offered today . . . was that a legislator be in the room. Some places, some decisions do not belong to you. You can't have them. You just can't. Representative Sondy Pope (D-Cross Plains) speaking in opposition to Wisconsin Senate Bill 206 requiring even medically unnecessary ultrasound before abortion (June 13, 2013). Alicia Beltran is famous for her recent Kafka-esque pregnancy experience. She had stopped using painkillers and weaned herself off the antiaddiction medication. She provided full information to her health care provider. But instead of receiving prenatal care, she was ordered by ...	[Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Charo, R. Alta] Univ Wisconsin, Dept Med Hist & Bioeth, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				American Institute of Ultrasound in Medicine, PRACT GUID; Kessler RC, 2009, J PSYCHIATR RES, V43, P770; Kessler RC, 2011, J PSYCHIATR RES, V45, P1133; Kessler RC, 2011, SOC SCI MED, V72, P72; Kessler RC, 2012, J PSYCHIATR RES, V46, P410, DOI 10.1016/j.jpsychires.2012.01.021; Lee SJ, 2005, JAMA-J AM MED ASSOC, V294, P947, DOI 10.1001/jama.294.8.947; Weinberger SE, 2012, NEW ENGL J MED, V367, P1557, DOI 10.1056/NEJMsb1209858	7	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					193	195		10.1056/NEJMp1313499	http://dx.doi.org/10.1056/NEJMp1313499			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294HK	24382001				2022-12-28	WOS:000330035600003
J	Pan, YF; Baker, BS				Pan, Yufeng; Baker, Bruce S.			Genetic Identification and Separation of Innate and Experience-Dependent Courtship Behaviors in Drosophila	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; FRUITLESS GENE; SEX-DETERMINATION; DOUBLESEX GENE; NEURAL CIRCUITRY; FEMALE DROSOPHILA; MELANOGASTER; EXPRESSION; NEURONS; DIFFERENTIATION	Wild-type D. melanogaster males innately possess the ability to perform a multistep courtship ritual to conspecific females. The potential for this behavior is specified by the male-specific products of the fruitless (fru(M)) gene; males without fru(M) do not court females when held in isolation. We show that such fru(M) null males acquire the potential for courtship when grouped with other flies; they apparently learn to court flies with which they were grouped, irrespective of sex or species and retain this behavior for at least a week. The male-specific product of the doublesex gene (dsx(M)) is necessary and sufficient for the acquisition of the potential for such experience-dependent courtship. These results reveal a process that builds, via dsx(M) and social experience, the potential for a more flexible sexual behavior, which could be evolutionarily conserved as dsx-related genes that function in sexual development are found throughout the animal kingdom.	[Pan, Yufeng; Baker, Bruce S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Pan, YF (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	pyfapyf@gmail.com; bakerb@janelia.hhmi.org	Pan, Yufeng/V-2376-2017	Pan, Yufeng/0000-0002-1535-9716	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the Fly Light project team in Janelia Farm for generating the expression pattern images shown in Figures S2A and S2B; G. Rubin, K. Scott, Y. Ben-Shahar, C. Pikielny, L. Vosshall, and B. Dickson for fly stocks; G. Card for sharing high-speed cameras; V. Jayaraman, M. Reiser, J. Simpson, J. Truman, L. Riddiford, Y. Aso, T. Shirangi, and members of the B. Baker lab for discussions. We also thank A. Howard for administrative support; members of the fly facility in Janelia Farm for technical support. This work was supported by the Howard Hughes Medical Institute.	Anand A, 2001, GENETICS, V158, P1569; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BAKER BS, 1980, GENETICS, V94, P383; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Carney GE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-288; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Farine JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040396; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lu BK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002587; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Mellert DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051489; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; Pan YF, 2012, P NATL ACAD SCI USA, V109, P10065, DOI 10.1073/pnas.1207107109; Pan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021144; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Shirangi TR, 2006, NAT GENET, V38, P1435, DOI 10.1038/ng1908; Song HJ, 2002, GENETICS, V162, P1703; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; TIERNEY AJ, 1986, ANIM LEARN BEHAV, V14, P339, DOI 10.3758/BF03200077; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Villella A, 1996, GENETICS, V143, P331; Villella A, 1997, GENETICS, V147, P1107; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	57	57	58	2	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					236	248		10.1016/j.cell.2013.11.041	http://dx.doi.org/10.1016/j.cell.2013.11.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439379	Green Accepted, Bronze			2022-12-28	WOS:000329912200024
J	Steele, AM; Shields, BM; Wensley, KJ; Colclough, K; Ellard, S; Hattersley, AT				Steele, Anna M.; Shields, Beverley M.; Wensley, Kirsty J.; Colclough, Kevin; Ellard, Sian; Hattersley, Andrew T.			Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild Hyperglycemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MICROVASCULAR COMPLICATIONS; NONDIABETIC SUBJECTS; GLYCATED HEMOGLOBIN; GLUCOSE; DISEASE; MICROALBUMINURIA; ASSOCIATION; POPULATION; MODY3	IMPORTANCE Glycemic targets in diabetes have been developed to minimize complication risk. Patients with heterozygous, inactivating glucokinase (GCK) mutations have mild fasting hyperglycemia from birth, resulting in an elevated glycated hemoglobin (HbA(1c)) level that mimics recommended levels for type 1 and type 2 diabetes. OBJECTIVE To assess the association between chronic, mild hyperglycemia and complication prevalence and severity in patients with GCK mutations. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study in the United Kingdom between August 2008 and December 2010. Assessment of microvascular and macrovascular complications in participants 35 years or older was conducted in 99 GCK mutation carriers (median age, 48.6 years), 91 nondiabetic, familial, nonmutation carriers (control) (median age, 52.2 years), and 83 individuals with young-onset type 2 diabetes (YT2D), diagnosed at age 45 years or younger (median age, 54.7 years). MAIN OUTCOMES AND MEASURES Prevalence and severity of nephropathy, retinopathy, peripheral neuropathy, peripheral vascular disease, and cardiovascular disease. RESULTS Median HbA1c was 6.9% in patients with the GCK mutation, 5.8% in controls, and 7.8% in patients with YT2D. Patients with GCK had a low prevalence of clinically significant microvascular complications (1% [95% CI, 0%-5%]) that was not significantly different from controls (2% [95% CI, 0.3%-8%], P=.52) and lower than in patients with YT2D (36% [95% CI, 25%-47%], P<.001). Thirty percent of patients with GCK had retinopathy (95% CI, 21%-41%) compared with 14% of controls (95% CI, 7%-23%, P=.007) and 63% of patients with YT2D (95% CI, 51%-73%, P<.001). Neither patients with GCK nor controls required laser therapy for retinopathy compared with 28% (95% CI, 18%-39%) of patients with YT2D (P<.001). Neither patients with GCK patients nor controls had proteinuria and microalbuminuria was rare (GCK, 1% [95% CI, 0.2%-6%]; controls, 2% [95% CI, 0.2%-8%]), whereas 10% (95% CI, 4%-19%) of YT2D patients had proteinuria (P<.001 vs GCK) and 21% (95% CI, 13%-32%) had microalbuminuria (P<.001). Neuropathy was rare in patients with GCK (2% [95% CI, 0.3%-8%]) and controls (95% CI, 0% [0%-4%]) but present in 29% (95% CI, 20%-50%) of YT2D patients (P<.001). Patients with GCK had a low prevalence of clinically significant macrovascular complications (4% [95% CI, 1%-10%]) that was not significantly different from controls (11% [95% CI, 5%-19%]; P=.09), and lower in prevalence than patients with YT2D (30% [95% CI, 21%-41%], P<.001). CONCLUSIONS AND RELEVANCE Despite a median duration of 48.6 years of hyperglycemia, patients with a GCK mutation had low prevalence of microvascular and macrovascular complications. These findings may provide insights into the risks associated with isolated, mild hyperglycemia.	[Steele, Anna M.; Shields, Beverley M.; Wensley, Kirsty J.; Ellard, Sian; Hattersley, Andrew T.] Univ Exeter, Exeter Med Sch, Exeter Clin Res Facil, Natl Inst Hlth Res, Exeter, Devon, England; [Colclough, Kevin; Ellard, Sian] Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Dept Mol Genet, Exeter, Devon, England	University of Exeter	Hattersley, AT (corresponding author), Exeter Med Sch, Exeter Clin Res Facil, Natl Inst Hlth Res, Barrack Rd, Exeter EX2 5DW, Devon, England.	a.t.hattersley@exeter.ac.uk		Hattersley, Andrew/0000-0001-5620-473X; Ellard, Sian/0000-0002-7620-5526	Diabetes UK [BDA:RD07/0003473]; National Institute of Health Research (NIHR); European Community [CEED3 223211]; Diabetes UK [07/0003473] Funding Source: researchfish; National Institute for Health Research [RDA/03/07/073, NF-SI-0611-10219] Funding Source: researchfish	Diabetes UK(Diabetes UK); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); European Community(European Commission); Diabetes UK(Diabetes UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by grant BDA:RD07/0003473 from Diabetes UK and the National Institute of Health Research (NIHR) (Dr Steele). Drs Steele, Shields, Hattersly, and Ellard and Ms Wensley are employed as core members of staff within the NIHR-funded Exeter Clinical Research Facility, and Dr Hattersly is an NIHR Senior Investigator. Drs Hattersly and Ellard are Wellcome Trust Senior Investigators. The research leading to these results has also received funding under grant agreement CEED3 223211, from the European Community's Seventh Framework Programme (FP7/2007-2013).	[Anonymous], 1995, DIABETES, V44, P968; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Byrne MM, 1996, DIABETES, V45, P1503, DOI 10.2337/diabetes.45.11.1503; Criqui M H, 1996, Vasc Med, V1, P65; Gregg EW, 2007, DIABETES RES CLIN PR, V77, P485, DOI 10.1016/j.diabres.2007.01.005; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.1591; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Horn PS, 2001, CLIN CHEM, V47, P2137; Khaw KT, 2006, CURR OPIN LIPIDOL, V17, P637, DOI 10.1097/MOL.0b013e3280106b95; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Klein Ronald, 2006, Trans Am Ophthalmol Soc, V104, P98; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; Physicians RCo, CHRONIC KIDNEY DISEA; Prineas RJ, 1982, THE MINNESOTA CODE M; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sagen JV, 2008, PEDIATR DIABETES, V9, P442, DOI 10.1111/j.1399-5448.2008.00399.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steele AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065326; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; Stride A, 2013, DIABETOLOGIA, P4; Townsend N.W., 2012, CORONARY HEART DISEA; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK National Screening Committee, ESSENTIAL ELEMENTS I; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Velho G, 1996, DIABETES CARE, V19, P915, DOI 10.2337/diacare.19.9.915; WU MS, 1990, DIABETES CARE, V13, P1, DOI 10.2337/diacare.13.1.1; YUDKIN JS, 1988, LANCET, V2, P530	32	181	199	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					279	286		10.1001/jama.2013.283980	http://dx.doi.org/10.1001/jama.2013.283980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24430320	Green Submitted, Bronze			2022-12-28	WOS:000329566400020
J	Gornall, J				Gornall, Jonathan			ALCOHOL AND PUBLIC HEALTH Under the influence: 4. Election prospects triumph over public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						Australian National Preventive Health Agency, EXPL PUBL INT CAS MI; Distilled Spirits Industry Council of Australia, MIN PRIC; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7435; Green M., 2013, OFF LICENCE NEWS; Hawkins B, 2013, CRIT POLICY STUD, V7, P53, DOI 10.1080/19460171.2013.766023; Helm Toby, 2013, OBSERVER; Home Office, 2013, NEXT STEPS FOLL CONS; Johnston Philip, 2013, TELEGRAPH; Kirkup. J, 2008, TELEGRAPH; Kirkup J, 2013, TELEGRAPH; Liberal Democrats, 2010, OUR MAN; Mason R., 2013, TELEGRAPH; Meng Y, 2013, MODELLED INCOME GROU; NGOs pull out of Government's alcohol network of the responsibility deal, 2013, NGO PULL OUT GOVER E; NSW Government, REG LOBB; Sheffield Alcohol Research Group, 2013, ADD EX IMP BAN BE; Thomas N., 2013, SUNDAY TELEGRAP 0303; Wintour P, 2013, GUARDIAN	18	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								f7610	10.1136/bmj.f7610	http://dx.doi.org/10.1136/bmj.f7610			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KI	24403569				2022-12-28	WOS:000329610300005
J	Zorzela, L; Golder, S; Liu, YL; Pilkington, K; Hartling, L; Joffe, A; Loke, Y; Vohra, S				Zorzela, Liliane; Golder, Su; Liu, Yali; Pilkington, Karen; Hartling, Lisa; Joffe, Ari; Loke, Yoon; Vohra, Sunita			Quality of reporting in systematic reviews of adverse events: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED-TRIALS; MYOCARDIAL-INFARCTION; SAFETY; EXTENSION; METAANALYSES; HARMS; ROSIGLITAZONE; INTERVENTIONS; CHALLENGES; APPARENT	Objectives To examine the quality of reporting of harms in systematic reviews, and to determine the need for a reporting guideline specific for reviews of harms. Design Systematic review. Data sources Cochrane Database of Systematic Reviews (CDSR) and Database of Abstracts of Reviews of Effects (DARE). Review methods Databases were searched for systematic reviews having an adverse event as the main outcome, published from January 2008 to April 2011. Adverse events included an adverse reaction, harms, or complications associated with any healthcare intervention. Articles with a primary aim to investigate the complete safety profile of an intervention were also included. We developed a list of 37 items to measure the quality of reporting on harms in each review; data were collected as dichotomous outcomes ("yes" or "no" for each item). Results Of 4644 reviews identified, 309 were systematic reviews or meta-analyses primarily assessing harms (13 from CDSR; 296 from DARE). Despite a short time interval, the comparison between the years of 2008 and 2010-11 showed no difference on the quality of reporting over time (P=0.079). Titles in fewer than half the reviews (proportion of reviews 0.46 (95% confidence interval 0.40 to 0.52)) did not mention any harm related terms. Almost one third of DARE reviews (0.26 (0.22 to 0.31)) did not clearly define the adverse events reviewed, nor did they specify the study designs selected for inclusion in their methods section. Almost half of reviews (n=170) did not consider patient risk factors or length of follow-up when reviewing harms of an intervention. Of 67 reviews of complications related to surgery or other procedures, only four (0.05 (0.01 to 0.14)) reported professional qualifications of the individuals involved. The overall, unweighted, proportion of reviews with good reporting was 0.56 (0.55 to 0.57); corresponding proportions were 0.55 (0.53 to 0.57) in 2008, 0.55 (0.54 to 0.57) in 2009, and 0.57 (0.55 to 0.58) in 2010-11. Conclusion Systematic reviews compound the poor reporting of harms data in primary studies by failing to report on harms or doing so inadequately. Improving reporting of adverse events in systematic reviews is an important step towards a balanced assessment of an intervention.	[Zorzela, Liliane] Univ Alberta, Dept Pediat, Edmonton Clin Hlth Acad 4 548, Edmonton, AB, Canada; [Golder, Su] Univ York, Ctr Reviews & Disseminat, MRC, York YO10 5DD, N Yorkshire, England; [Liu, Yali] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China; [Pilkington, Karen] Univ Westminster, Sch Life Sci, London W1R 8AL, England; [Hartling, Lisa] Univ Alberta, Edmonton Clin Hlth Acad 4 472, Dept Pediat, Edmonton, AB T6G 2M7, Canada; [Joffe, Ari] Univ Alberta, Dept Pediat, Stollery Childrens Hosp, Edmonton, AB, Canada; [Loke, Yoon] Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Vohra, Sunita] Univ Alberta, Dept Pediat, Edmonton, AB T5K 0L4, Canada	University of Alberta; University of York - UK; Lanzhou University; University of Westminster; University of Alberta; Stollery Children's Hospital; University of Alberta; University of East Anglia; University of Alberta	Vohra, S (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB T5K 0L4, Canada.	svohra@ualberta.ca	Vohra, Sunita/F-5755-2016	Vohra, Sunita/0000-0002-6210-7933; Liu, Yali/0000-0003-0037-6326; golder, su/0000-0002-8987-5211				Aronson JK, 2002, FUND CLIN PHARMACOL, V16, P49, DOI 10.1046/j.1472-8206.2002.00066.x; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Cornelius VR, 2009, PHARMACOEPIDEM DR S, V18, P1223, DOI 10.1002/pds.1844; Derry S, 2001, BMC Med Res Methodol, V1, P7, DOI 10.1186/1471-2288-1-7; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Ernst E, 2001, BRIT MED J, V323, P546, DOI 10.1136/bmj.323.7312.546; Ernst E, 2001, ARCH INTERN MED, V161, P125, DOI 10.1001/archinte.161.1.125-a; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Golder S, 2008, J CLIN EPIDEMIOL, V61, P440, DOI 10.1016/j.jclinepi.2007.06.005; Golder Su, 2006, BMC Med Res Methodol, V6, P22, DOI 10.1186/1471-2288-6-22; Golder Su, 2006, BMC Med Res Methodol, V6, P3, DOI 10.1186/1471-2288-6-3; Golder S, 2013, J CLIN EPIDEMIOL, V66, P253, DOI 10.1016/j.jclinepi.2012.09.013; Golder S, 2008, BRIT J CLIN PHARMACO, V66, P767, DOI 10.1111/j.1365-2125.2008.03272.x; Hammad TA, 2013, CLIN TRIALS, V10, P389, DOI 10.1177/1740774513479467; Hernandez AV, 2008, AM HEART J, V156, P23, DOI 10.1016/j.ahj.2008.03.002; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Loke Y K, 2001, BMC Clin Pharmacol, V1, P3, DOI 10.1186/1472-6904-1-3; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Loke YK, 2011, THER ADV DRUG SAF, V2, P59, DOI 10.1177/2042098611401129; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MacPherson Hugh, 2010, J Evid Based Med, V3, P140, DOI 10.1111/j.1756-5391.2010.01086.x; McIntosh Heather M, 2004, BMC Med Res Methodol, V4, P19, DOI 10.1186/1471-2288-4-19; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pilkington K, 2012, COMPLEMENT THER MED, V20, P73, DOI 10.1016/j.ctim.2011.10.002; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Shuster JJ, 2007, STAT MED, V26, P4375, DOI 10.1002/sim.3060; Singh S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-138; Vandermeer B, 2009, STAT METHODS MED RES, V18, P421, DOI 10.1177/0962280208092559; Warren FC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-64; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yazici Y, 2008, BULL HOSP JT DIS, V66, P143; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	45	115	116	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								f7668	10.1136/bmj.f7668	http://dx.doi.org/10.1136/bmj.f7668			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KI	24401468	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000329610300007
J	Smith, JM				Smith, Jeanette M.			Boogie Woogie Paul Chidlaw	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		CHIDLAW MMP, 1989, CINCINNATI MAGAZINE, V22, P80; 2008, JAMA            1224	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					12	13		10.1001/jama.2013.279250	http://dx.doi.org/10.1001/jama.2013.279250			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24381953				2022-12-28	WOS:000329161400001
J	Parashar, UD; Nelson, EAS; Kang, G				Parashar, Umesh D.; Nelson, E. Anthony S.; Kang, Gagandeep			Diagnosis, management, and prevention of rotavirus gastroenteritis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL SEVERITY; SEVERE DIARRHEA; RISK-FACTORS; INTUSSUSCEPTION; INFECTION; VACCINE; HOSPITALIZATION; INFANTS; SURVEILLANCE; GUIDELINES		[Parashar, Umesh D.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Nelson, E. Anthony S.] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Kang, Gagandeep] Christian Med Coll & Hosp, Div Gastrointestinal Sci, Vellore 632004, Tamil Nadu, India	Centers for Disease Control & Prevention - USA; Chinese University of Hong Kong; Christian Medical College & Hospital (CMCH) Vellore	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	uap2@cdc.gov	Nelson, E Anthony S/ABF-4238-2020	Nelson, E Anthony S/0000-0002-2521-3403	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Alberta Health Service, 2011, ALB HLTH SERV AC CHI; Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Armon K, 2001, ARCH DIS CHILD, V85, P132, DOI 10.1136/adc.85.2.132; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Carlin JB, 2013, CLIN INFECT DIS; *CDCP, 1999, MORB MORTAL WKLY REP, V48; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P577; CLEMENS J, 1993, PEDIATRICS, V92, P680; Cortese M., 2013, ESTIMATES BENEFITS P; Dalby-Payne J, 2011, CLIN EVID, V07, P314; Dennehy PH, 2006, PEDIATR INFECT DIS J, V25, P1123, DOI 10.1097/01.inf.0000243777.01375.5b; Dickey M, 2009, PEDIATR INFECT DIS J, V28, P318, DOI 10.1097/INF.0b013e31818ddbe9; Fedorowicz Z, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005506.pub5; Food and Drug Administration, 2013, FIN STUD RES MIN POS; Freedman SB, 2010, PEDIATRICS, V125, pE1278, DOI 10.1542/peds.2009-3270; Gastanaduy PA, 2013, JAMA-J AM MED ASSOC, V310, P851, DOI 10.1001/jama.2013.170800; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Goldman RD, 2008, PEDIATRICS, V122, P545, DOI 10.1542/peds.2007-3141; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Gregorio GV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007296.pub2; Gregorio GV, 2009, COCHRANE DB SYST REV, V2; Guideline Development Group, 2009, DIARRH VOM CAUS GAST; Haber P, 2013, PEDIATRICS, V131, P1042, DOI 10.1542/peds.2012-2554; Hahn S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002847; Harting L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004390.pub2; HERRING AJ, 1982, J CLIN MICROBIOL, V16, P473, DOI 10.1128/JCM.16.3.473-477.1982; do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Kang G, 2004, J MED VIROL, V73, P118, DOI 10.1002/jmv.20053; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lawson AL, 2012, ESSENTIAL EVIDENCE 2; Lazzerini M, 2013, COCHRANE DB SYST REV, V1; Le Saux N, 2010, PEDIATR INFECT DIS J, V29, P879, DOI 10.1097/INF.0b013e3181e20c94; Lewis KDC, 2012, VACCINE, V30, pA159, DOI 10.1016/j.vaccine.2011.07.126; Lo Vecchio A, 2011, J PEDIATR GASTR NUTR, V52, P183, DOI 10.1097/MPG.0b013e3181e233ac; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Murphy MS, 1998, ARCH DIS CHILD, V79, P279, DOI 10.1136/adc.79.3.279; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; NELSON EA, 2003, HONG KONG J PAEDIATR, V8, P203; Newman RD, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.1.e3; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Patel MM, 2013, PEDIATR INFECT DIS J, V32, pE134, DOI 10.1097/INF.0b013e31827d3b68; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Pringle K, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-58; Velazquez FR, 2012, PEDIATR INFECT DIS J, V31, P736, DOI 10.1097/INF.0b013e318253add3; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rossignol JF, 2006, LANCET, V368, P124, DOI 10.1016/S0140-6736(06)68852-1; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Sarker SA, 2001, J PEDIATR GASTR NUTR, V32, P19, DOI 10.1097/00005176-200101000-00009; Sarker SA, 2013, GASTROENTEROLOGY, V145, P740, DOI 10.1053/j.gastro.2013.06.053; Shui IM, 2012, JAMA-J AM MED ASSOC, V307, P598, DOI 10.1001/jama.2012.97; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; THOMAS EE, 1988, J CLIN MICROBIOL, V26, P1189, DOI 10.1128/JCM.26.6.1189-1193.1988; van den Berg J, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-134; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; WARD RL, 1986, J INFECT DIS, V154, P871, DOI 10.1093/infdis/154.5.871; World Health Organization, 2009, Weekly Epidemiological Record, V84, P517; World Health Organization, 2005, TREATM DIARRH MAN PH; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zlamy M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-112	69	75	81	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2013	347								f7204	10.1136/bmj.f7204	http://dx.doi.org/10.1136/bmj.f7204			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285PM	24379214	Green Accepted			2022-12-28	WOS:000329406100001
J	Kieffer-Kwon, KR; Tang, ZH; Mathe, E; Qian, JS; Sung, MH; Li, GL; Resch, W; Baek, S; Pruett, N; Grontved, L; Vian, L; Nelson, S; Zare, H; Hakim, O; Reyon, D; Yamane, A; Nakahashi, H; Kovalchuk, AL; Zou, JZ; Joung, JK; Sartorelli, V; Wei, CL; Ruan, XA; Hager, GL; Ruan, YJ; Casellas, R				Kieffer-Kwon, Kyong-Rim; Tang, Zhonghui; Mathe, Ewy; Qian, Jason; Sung, Myong-Hee; Li, Guoliang; Resch, Wolfgang; Baek, Songjoon; Pruett, Nathanael; Grontved, Lars; Vian, Laura; Nelson, Steevenson; Zare, Hossein; Hakim, Ofir; Reyon, Deepak; Yamane, Arito; Nakahashi, Hirotaka; Kovalchuk, Alexander L.; Zou, Jizhong; Joung, J. Keith; Sartorelli, Vittorio; Wei, Chia-Lin; Ruan, Xiaoan; Hager, Gordon L.; Ruan, Yijun; Casellas, Rafael			Interactome Maps of Mouse Gene Regulatory Domains Reveal Basic Principles of Transcriptional Regulation	CELL			English	Article							AID EXPRESSION; ACTIVATION; ENHANCERS; RECOMBINATION; PLURIPOTENCY; INTEGRATION; DOWNSTREAM; LANDSCAPE; DEAMINASE; RECEPTOR	A key finding of the ENCODE project is that the enhancer landscape of mammalian cells undergoes marked alterations during ontogeny. However, the nature and extent of these changes are unclear. As part of the NIH Mouse Regulome Project, we here combined DNaseI hypersensitivity, ChIP-seq, and ChIA-PET technologies to map the promoter-enhancer interactomes of pluripotent ES cells and differentiated B lymphocytes. We confirm that enhancer usage varies widely across tissues. Unexpectedly, we find that this feature extends to broadly transcribed genes, including Myc and Pim1 cell-cycle regulators, which associate with an entirely different set of enhancers in ES and B cells. By means of high-resolution CpG methylomes, genome editing, and digital footprinting, we show that these enhancers recruit lineage-determining factors. Furthermore, we demonstrate that the turning on and off of enhancers during development correlates with promoter activity. We propose that organisms rely on a dynamic enhancer landscape to control basic cellular functions in a tissue-specific manner.	[Kieffer-Kwon, Kyong-Rim; Mathe, Ewy; Qian, Jason; Resch, Wolfgang; Pruett, Nathanael; Vian, Laura; Nelson, Steevenson; Yamane, Arito; Nakahashi, Hirotaka; Casellas, Rafael] NIAMS, NIH, Bethesda, MD 20892 USA; [Tang, Zhonghui; Li, Guoliang; Ruan, Xiaoan; Ruan, Yijun] Univ Connecticut, Jackson Lab Genom Med, Farmington, CT 06030 USA; [Tang, Zhonghui; Li, Guoliang; Ruan, Xiaoan; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Sung, Myong-Hee; Baek, Songjoon; Grontved, Lars; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Zare, Hossein; Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Hakim, Ofir] Bar Ilan Univ, IL-5290002 Ramat Gan, Israel; [Reyon, Deepak; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Mol Pathol Unit, Charlestown, MA 02129 USA; [Reyon, Deepak; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Reyon, Deepak; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kovalchuk, Alexander L.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Zou, Jizhong] NIAMS, Lab Stem Cell Biol, NIH, Bethesda, MD 20892 USA; [Wei, Chia-Lin] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Jackson Laboratory; University of Connecticut; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Bar Ilan University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Energy (DOE); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Casellas, R (corresponding author), NIAMS, NIH, Bethesda, MD 20892 USA.	rafael.casellas@nih.gov	Sung, Myong-Hee/AAC-7316-2020; Reyon, Deepak/HCH-3183-2022; Mathe, Ewy/L-1616-2019; Li, Guoliang/D-8014-2012; zare, hossein/ABB-5871-2021	Sung, Myong-Hee/0000-0002-9739-8558; Li, Guoliang/0000-0003-1601-6640; Hakim, Ofir/0000-0003-0063-2721; Kovalchuk, Alexander/0000-0003-2761-0442; Sartorelli, Vittorio/0000-0002-9284-3675; Tang, Zhonghui/0000-0003-2907-3986; Resch, Wolfgang/0000-0001-7594-5963; Zou, Jizhong/0000-0003-1021-0549; Qian, Jason/0000-0002-1144-2547; Grontved, Lars/0000-0002-6735-8483; Mathe, Ewy/0000-0003-4491-8107	Intramural Research Program of NIAMS; NCI; internal Jackson Laboratory fund [JAX19020120]; NIH [DP1 GM105378, P50 HG005550]; Defense Advanced Research Projects Agency [W911NF-11-2-0056]; Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; NIH UGSP program; NATIONAL CANCER INSTITUTE [ZIABC010027] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041164, ZIAAR041148, Z01AR041149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); internal Jackson Laboratory fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; NIH UGSP program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kefei Yu for CH12 cells and protocols; J. Simone and J. Lay for cell sorting; G. Gutierrez for technical assistance with Illumina analyzer. This work was supported by the Intramural Research Program of NIAMS and NCI, and internal Jackson Laboratory fund JAX19020120 to Y.R. J.K.J. was supported by NIH grants DP1 GM105378 and P50 HG005550, the Defense Advanced Research Projects Agency grant W911NF-11-2-0056 and The Jim and Ann Orr Massachusetts General Hospital Research Scholar Award. J. Q. was supported by the NIH UGSP program. All animal experiments were performed according to NIH guidelines. High-performance computation was performed using NIH Helix Systems (http://helix.nih.gov). J. K. J. has a financial interest in Transposagen Biopharmaceuticals. J.K.J.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.	Baek S, 2012, METHODS MOL BIOL, V833, P433, DOI 10.1007/978-1-61779-477-3_26; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Casellas R, 2009, IMMUNOLOGY, V126, P316, DOI 10.1111/j.1365-2567.2008.03050.x; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Davidson E. H., 2001, DEV EVOLUTION; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Huang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069056; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Liu ZM, 2002, J BIOL CHEM, V277, P32640, DOI 10.1074/jbc.M204065200; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Treiber N, 2010, GENE DEV, V24, P2270, DOI 10.1101/gad.1976610; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Xie W, 2013, SCIENCE, V341, P245, DOI 10.1126/science.1236254; Zhang JY, 2012, METHODS, V58, P289, DOI 10.1016/j.ymeth.2012.08.009; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	49	237	242	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1507	1520		10.1016/j.cell.2013.11.039	http://dx.doi.org/10.1016/j.cell.2013.11.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360274	Green Accepted, Bronze			2022-12-28	WOS:000328693300008
J	Liu, W; Ma, Q; Wong, K; Li, WB; Ohgi, K; Zhang, J; Aggarwal, AK; Rosenfeld, MG				Liu, Wen; Ma, Qi; Wong, Kaki; Li, Wenbo; Ohgi, Kenny; Zhang, Jie; Aggarwal, Aneel K.; Rosenfeld, Michael G.			Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release	CELL			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; GENE-EXPRESSION; PHOSPHATIDYLSERINE RECEPTOR; P-TEFB; DEPENDENT TRANSCRIPTION; SELECTIVE-INHIBITION; BET BROMODOMAINS; APOPTOTIC CELLS; C-MYC	Distal enhancers characterized by the H3K4me(1) mark play critical roles in developmental and transcriptional programs. However, potential roles of specific distal regulatory elements in regulating RNA polymerase II (Pol II) promoter-proximal pause release remain poorly investigated. Here, we report that a unique cohort of jumonji C-domain-containing protein 6 (JMJD6) and bromodomain-containing protein 4 (Brd4) cobound distal enhancers, termed antipause enhancers (A-PEs), regulate promoter-proximal pause release of a large subset of transcription units via long-range interactions. Brd4-dependent JMJD6 recruitment on A-PEs mediates erasure of H4R3me 2(s), which is directly read by 7SK snRNA, and decapping/demethylation of 7SK snRNA, ensuring the dismissal of the 7SK snRNA/HEXIM inhibitory complex. The interactions of both JMJD6 and Brd4 with the P-TEFb complex permit its activation and pause release of regulated coding genes. The functions of JMJD6/Brd4-associated dual histone and RNA demethylase activity on anti-pause enhancers have intriguing implications for these proteins in development, homeostasis, and disease.	[Liu, Wen; Ma, Qi; Wong, Kaki; Li, Wenbo; Ohgi, Kenny; Zhang, Jie; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Liu, Wen] Xiamen Univ, Sch Pharmaceut Sci, Xiamen 361102, Fujian, Peoples R China; [Ma, Qi] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Xiamen University; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Liu, W (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	w2liu@xmu.edu.cn; mrosenfeld@ucsd.edu	li, wenbo/GZM-8930-2022; Ma, Qi/C-9716-2015	Ma, Qi/0000-0002-8705-4460; Liu, Wen/0000-0003-3434-4162	NIH [NS34934, DK39949, DK18477, CA173903, HL065445, DK097748]; Susan Komen for the Cure Postdoctoral Fellowship [PDF12229881]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA173903] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097748, R01DK018477, R01DK039949, R37DK039949, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Komen for the Cure Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Thomas M. Vondriska at UCLA for mass spectrometry analysis to identify JMJD6-associated proteins. We thank Janet Hightower for assistance with figure preparation. M. G. R. is an Investigator with the Howard Hughes Medical Institute. This work was supported by NIH grants (NS34934, DK39949, DK18477, CA173903, HL065445, and DK097748) to M. G. R. W. L. is the recipient of a Susan Komen for the Cure Postdoctoral Fellowship (PDF12229881).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; SHUMYATSKY GP, 1990, NUCLEIC ACIDS RES, V18, P6347, DOI 10.1093/nar/18.21.6347; Tibrewal N, 2007, MOL CELL BIOCHEM, V304, P119, DOI 10.1007/s11010-007-9492-8; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	251	257	3	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1581	1595		10.1016/j.cell.2013.10.056	http://dx.doi.org/10.1016/j.cell.2013.10.056			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360279	Green Accepted, Bronze			2022-12-28	WOS:000328693300014
J	Lisowski, L; Dane, AP; Chu, K; Zhang, Y; Cunningham, SC; Wilson, EM; Nygaard, S; Grompe, M; Alexander, IE; Kay, MA				Lisowski, Leszek; Dane, Allison P.; Chu, Kirk; Zhang, Yue; Cunningham, Sharon C.; Wilson, Elizabeth M.; Nygaard, Sean; Grompe, Markus; Alexander, Ian E.; Kay, Mark A.			Selection and evaluation of clinically relevant AAV variants in a xenograft liver model	NATURE			English	Article							ENHANCED GENE DELIVERY; ADENOASSOCIATED VIRUS; EFFICIENT TRANSDUCTION; FACTOR-IX; DIRECTED EVOLUTION; VIRAL VECTORS; IN-VITRO; HEMOPHILIA; EXPRESSION; THERAPY	Recombinant adeno-associated viral (rAAV) vectors have shown early promise in clinical trials(1-3). The therapeutic transgene cassette can be packaged in different AAV capsid pseudotypes, each having a unique transduction profile. At present, rAAV capsid serotype selection for a specific clinical trial is based on effectiveness in animal models. However, preclinical animal studies are not always predictive of human outcome(4-8). Here, in an attempt to further our understanding of these discrepancies, we used a chimaeric human-murine liver model to compare directly the relative efficiency of rAAV transduction in human versus mouse hepatocytes in vivo. As predicted from preclinical and clinical studies(4,5,8), rAAV2 vectors functionally transduced mouse and human hepatocytes at equivalent but relatively low levels. However, rAAV8 vectors, which are very effective in many animal models, transduced human hepatocytes rather poorly-approximately 20 times less efficiently than mouse hepatocytes. In light of the limitations of the rAAV vectors currently used in clinical studies, we used the same murine chimaeric liver model to perform serial selection using a human-specific replication-competent viral library composed of DNA-shuffled AAV capsids. One chimaeric capsid composed of five different parental AAV capsids was found to transduce human primary hepatocytes at high efficiency in vitro and in vivo, and provided species-selected transduction in primary liver, cultured cells and a hepatocellular carcinoma xenograft model. This vector is an ideal clinical candidate and a reagent for gene modification of human xenotransplants in mouse models of human diseases. More importantly, our results suggest that humanized murine models may represent a more precise approach for both selecting and evaluating clinically relevant rAAV serotypes for gene therapeutic applications.	[Lisowski, Leszek; Chu, Kirk; Zhang, Yue; Kay, Mark A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Lisowski, Leszek; Chu, Kirk; Zhang, Yue; Kay, Mark A.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Dane, Allison P.; Cunningham, Sharon C.; Alexander, Ian E.] Childrens Hosp Westmead, Gene Therapy Res Unit, Westmead, NSW 2145, Australia; [Dane, Allison P.; Cunningham, Sharon C.; Alexander, Ian E.] Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Wilson, Elizabeth M.] Yecuris Corp, Portland, OR 97062 USA; [Nygaard, Sean; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; [Alexander, Ian E.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2145, Australia	Stanford University; Stanford University; University of Sydney; Children's Medical Research Institute - Australia; Oregon Health & Science University; University of Sydney	Kay, MA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, 269 Campus Dr, Stanford, CA 94305 USA.	markay@stanford.edu	Lisowski, Leszek/AAU-2228-2020	Lisowski, Leszek/0000-0002-4772-8651; Grompe, Markus/0000-0002-6616-4345; Alexander, Ian E/0000-0002-6213-5627; Kay, Mark/0000-0002-2799-2615	National Institutes of Health [HL092096, HL064274, DK048252]; Berry Fellowship Foundation; Australian National Health and Medical Research Council (NHMRC) [1008021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064274, R01HL092096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Berry Fellowship Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants HL092096 and HL064274 to M. A. K. and DK048252 to M. G.; L. L. was supported in part by the Berry Fellowship Foundation; I. E. A. by Australian National Health and Medical Research Council (NHMRC) grant 1008021.	Arbetman AE, 2005, J VIROL, V79, P15238, DOI 10.1128/JVI.79.24.15238-15245.2005; Asuri P, 2012, MOL THER, V20, P329, DOI 10.1038/mt.2011.255; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Cunningham SC, 2008, MOL THER, V16, P1081, DOI 10.1038/mt.2008.72; Davidoff AM, 2005, MOL THER, V11, P875, DOI 10.1016/j.ymthe.2004.12.022; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Grompe M., 2013, GASTROENTEROLOGY; Hazari S, 2011, WORLD J GASTROENTERO, V17, P300, DOI 10.3748/wjg.v17.i3.300; Jiang HY, 2006, BLOOD, V108, P3321, DOI 10.1182/blood-2006-04-017913; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; LIEBER A, 1995, HUM GENE THER, V6, P1029, DOI 10.1089/hum.1995.6.8-1029; Ling C, 2010, HUM GENE THER, V21, P1741, DOI 10.1089/hum.2010.075; Lisowski L, 2012, MOL THER, V20, P1912, DOI 10.1038/mt.2012.164; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nakai H, 2002, J VIROL, V76, P11343, DOI 10.1128/JVI.76.22.11343-11349.2002; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2007, BLOOD, V109, P1414, DOI 10.1182/blood-2006-03-010181; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nietupski JB, 2011, MOL THER, V19, P1999, DOI 10.1038/mt.2011.119; Nonnenmacher M, 2012, GENE THER, V19, P649, DOI 10.1038/gt.2012.6; Perabo L, 2003, MOL THER, V8, P151, DOI 10.1016/S1525-0016(03)00123-0; Petek LM, 2010, MOL THER, V18, P1624, DOI 10.1038/mt.2010.102; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Rutledge EA, 1998, J VIROL, V72, P309, DOI 10.1128/JVI.72.1.309-319.1998; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106	35	283	309	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					382	+		10.1038/nature12875	http://dx.doi.org/10.1038/nature12875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24390344	Green Accepted			2022-12-28	WOS:000331477800044
J	Mokdad, AH; Jaber, S; Aziz, MIA; AlBuhairan, F; AlGhaithi, A; AlHamad, NM; Al-Hooti, SN; Al-Jasari, A; AlMazroa, MA; AlQasmi, AM; Alsowaidi, S; Asad, M; Atkinson, C; Badawi, A; Bakfalouni, T; Barkia, A; Biryukov, S; El Bcheraoui, C; Daoud, F; Forouzanfar, MH; Gonzalez-Medina, D; Hamadeh, RR; Hsairi, M; Hussein, SS; Karam, N; Khalifa, SEAH; Khoja, TAM; Lami, F; Leach-Kemon, K; Memish, ZA; Mokdad, AA; Naghavi, M; Nasher, J; Qasem, MBH; Shuaib, M; Al Thani, AAM; Al Thani, MH; Zamakhshary, M; Lopez, AD; Murray, CJL				Mokdad, Ali H.; Jaber, Sara; Aziz, Muna I. Abdel; AlBuhairan, Fadia; AlGhaithi, Abduljabbar; AlHamad, Nawal M.; Al-Hooti, Suad N.; Al-Jasari, Adel; AlMazroa, Mohammad A.; AlQasmi, Ahmed Mohamed; Alsowaidi, Shirina; Asad, Majed; Atkinson, Charles; Badawi, Alaa; Bakfalouni, Talal; Barkia, AbdelAziz; Biryukov, Stan; El Bcheraoui, Charbel; Daoud, Farah; Forouzanfar, Mohammad Hossein; Gonzalez-Medina, Diego; Hamadeh, Randah R.; Hsairi, Mohamed; Hussein, Seifeddin Saleh; Karam, Nadim; Khalifa, Shams Eldin Ali Hassan; Khoja, Tawfik A. M.; Lami, Faris; Leach-Kemon, Katherine; Memish, Ziad A.; Mokdad, Ali A.; Naghavi, Mohsen; Nasher, Jamal; Qasem, M. Bassam Hijawi; Shuaib, Mohammad; Al Thani, Al Anoud M.; Al Thani, Mohamed H.; Zamakhshary, Mohammed; Lopez, Alan D.; Murray, Christopher J. L.			The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors	LANCET			English	Article							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; 187 COUNTRIES; 21 REGIONS; DISABILITY; MORTALITY; EPIDEMIOLOGY; UTILITY; JORDAN; EGYPT	Background The Arab world has a set of historical, geopolitical, social, cultural, and economic characteristics and has been involved in several wars that have affected the burden of disease. Moreover, financial and human resources vary widely across the region. We aimed to examine the burden of diseases and injuries in the Arab world for 1990, 2005, and 2010 using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010). Methods We divided the 22 countries of the Arab League into three categories according to their gross national income: low-income countries (LICs; Comoros, Djibouti, Mauritania, Yemen, and Somalia), middle-income countries (MICs; Algeria, Egypt, Iraq, Jordan, Lebanon, Libya, Morocco, occupied Palestinian territory, Sudan, Syria, and Tunisia), and high-income countries (HICs; Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates). For the whole Arab world, each income group, and each individual country, we estimated causes of death, disability-adjusted life years (DALYs), DALY-attributable risk factors, years of life lived with disability (YLDs), years of life lost due to premature mortality (YLLs), and life expectancy by age and sex for 1990, 2005, and 2010. Findings Ischaemic heart disease was the top cause of death in the Arab world in 2010 (contributing to 14.3% of deaths), replacing lower respiratory infections, which were the leading cause of death in 1990 (11.0%). Lower respiratory infections contributed to the highest proportion of DALYs overall (6.0%), and in female indivduals (6.1%), but ischaemic heart disease was the leading cause of DALYs in male individuals (6.0%). DALYs from non-communicable diseases-especially ischaemic heart disease, mental disorders such as depression and anxiety, musculoskeletal disorders including low back pain and neck pain, diabetes, and cirrhosis-increased since 1990. Major depressive disorder was ranked first as a cause of YLDs in 1990, 2005, and 2010, and lower respiratory infections remained the leading cause of YLLs in 2010 (9.2%). The burden from HIV/AIDS also increased substantially, specifically in LICs and MICs, and road injuries continued to rank highly as a cause of death and DALYs, especially in HICs. Deaths due to suboptimal breastfeeding declined from sixth place in 1990 to tenth place in 2010, and childhood underweight declined from fifth to 11th place. Interpretation Since 1990, premature death and disability caused by communicable, newborn, nutritional, and maternal disorders (with the exception of HIV/AIDS) has decreased in the Arab world-although these disorders do still persist in LICs-whereas the burden of non-communicable diseases and injuries has increased. The changes in the burden of disease will challenge already stretched human and financial resources because many Arab countries are now dealing with both non-communicable and infectious diseases. A road map for health in the Arab world is urgently needed.	[Mokdad, Ali H.; Jaber, Sara; Atkinson, Charles; Biryukov, Stan; El Bcheraoui, Charbel; Daoud, Farah; Forouzanfar, Mohammad Hossein; Gonzalez-Medina, Diego; Leach-Kemon, Katherine; Mokdad, Ali A.; Naghavi, Mohsen; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Aziz, Muna I. Abdel] Inst Publ Hlth, Khartoum, Sudan; [AlBuhairan, Fadia] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [AlGhaithi, Abduljabbar; Al-Jasari, Adel; Nasher, Jamal] Minist Publ Hlth & Populat, Sanaa, Yemen; [AlHamad, Nawal M.] Minist Hlth, Kuwait, Kuwait; [Al-Hooti, Suad N.] Kuwait Inst Sci Res, Kuwait, Kuwait; [AlMazroa, Mohammad A.; Memish, Ziad A.; Zamakhshary, Mohammed] Minist Hlth, Riyadh, Saudi Arabia; [AlQasmi, Ahmed Mohamed] Minist Hlth, Muscat, Oman; [Alsowaidi, Shirina] United Arab Emirates Univ, Al Ain, U Arab Emirates; [Asad, Majed; Hussein, Seifeddin Saleh; Qasem, M. Bassam Hijawi] Minist Hlth, Amman, Jordan; [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Bakfalouni, Talal] Minist Hlth, Damascus, Syria; [Barkia, AbdelAziz] Minist Hlth, Rabat, Morocco; [Hamadeh, Randah R.] Arabian Gulf Univ, Al Manamah, Bahrain; [Hsairi, Mohamed] Natl Inst Publ Hlth, Tunis, Tunisia; [Khalifa, Shams Eldin Ali Hassan; Al Thani, Al Anoud M.; Al Thani, Mohamed H.] Supreme Council Hlth, Doha, Qatar; [Karam, Nadim] Univ Balamand, Balamand, Lebanon; [Khoja, Tawfik A. M.] Hlth Ministers Council Cooperat Council States, Riyadh, Saudi Arabia; [Lami, Faris] Baghdad Coll Med, Baghdad, Iraq; [Shuaib, Mohammad] Minist Hlth, Baghdad, Iraq; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; King Saud Bin Abdulaziz University for Health Sciences; Kuwait Institute for Scientific Research; Ministry of Health - Saudi Arabia; United Arab Emirates University; Public Health Agency of Canada; Arabian Gulf University; University Balamand; Ministry of Health Iraq; University of Melbourne	Mokdad, AH (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	mokdaa@uw.edu	Memish, Ziad Ahmed/AEJ-9424-2022; Hamadeh, Randah R./AAE-9720-2020; Lopez, Alan D/F-1487-2010; Lami, Faris/AAW-7666-2021; Lopez, Alan/AAA-2734-2022; Badawi, Alaa/ABC-1300-2021	Memish, Ziad Ahmed/0000-0002-5099-0714; Hamadeh, Randah R./0000-0002-4205-1354; Lopez, Alan D/0000-0001-5818-6512; Lami, Faris/0000-0002-3673-3818; Zamakhshary, Mohammed/0000-0001-8870-8684	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill & Melinda Gates Foundation provided funding for this study.	Abdul Rahim HF, 2014, LANCET; Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; Al-Nsour M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130030; Alhamad L., 2008, POLITICAL PARTICIPAT; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Ansari S, 2000, PUBLIC HEALTH, V114, P37, DOI 10.1016/S0033-3506(00)00306-1; Barss P, 2009, OCCUP MED-OXFORD, V59, P493, DOI 10.1093/occmed/kqp101; Batniji R, 2014, LANCET; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Boutayeb Abdesslam, 2006, Int J Health Geogr, V5, P61, DOI 10.1186/1476-072X-5-61; Clark J, 2004, COMP POLIT STUD, V37, P941, DOI 10.1177/0010414004267982; DeJong J, 2005, REPROD HEALTH MATTER, V13, P49, DOI 10.1016/S0968-8080(05)25181-9; El-Khoby T, 2000, AM J TROP MED HYG, V62, P88, DOI 10.4269/ajtmh.2000.62.88; El-Zein A, 2014, LANCET; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Guetat I., 2006, J EC FINANCE, V30, P208, DOI DOI 10.1007/BF02761487; Heydemann S, 2004, NETWORKS OF PRIVILEGE IN THE MIDDLE EAST, P1; Jabbour S, 2003, BRIT MED J, V326, P1141, DOI 10.1136/bmj.326.7399.1141; Jamal A, 2013, MIDDLE E, P246; Karam EG, 2008, PLOS MED, V5, P579, DOI 10.1371/journal.pmed.0050061; Khatib O, 2004, East Mediterr Health J, V10, P778; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kronfol N. M., 2012, Eastern Mediterranean Health Journal, V18, P1151; League of Arab States, MEMB STAT; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mabry RM, 2010, OBES REV, V11, P457, DOI 10.1111/j.1467-789X.2009.00655.x; Mahmood Saba, 2012, POLITICS PIETY ISLAM; Makhoul J, 2006, BMJ-BRIT MED J, V333, P859, DOI 10.1136/bmj.333.7573.859; Mandil A, 2009, INT J PUBLIC HEALTH, V54, P361, DOI 10.1007/s00038-009-0065-3; Masoud T, 2010, LOGIC ISLAMIST ELECT; Maziak W, 2014, HEALTH POLICY PLANN, V29, P784, DOI 10.1093/heapol/czt055; Mokdad AH, 2007, INT J PUBLIC HEALTH, V52, P263, DOI 10.1007/s00038-007-0221-6; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Okasha A, 1998, ACTA PSYCHIAT SCAND, V98, P406, DOI 10.1111/j.1600-0447.1998.tb10106.x; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Sadik AT, 2001, WORLD DEV, V29, P2111, DOI 10.1016/S0305-750X(01)00083-3; Saleh SS, 2014, LANCET; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sibai AM, 2011, ANN NUTR METAB, V57, P193, DOI 10.1159/000321527; The World Bank, LITTL GREEN DAT BOOK; UN Sustainable Development and Productivity Division Economic and Social Commission for Western Asia, 2003, GOV SUST DEV AR REG; United Nation Development Programme, 2009, AR HUM DEV REP 2009; Usmanova G, 2013, INT J PUBLIC HEALTH, V58, P217, DOI 10.1007/s00038-012-0433-2; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO, 2011, COUNTR HLTH INF SYST; WHO Regional Office for the Eastern Mediterranean, 2012, INT C HLTH LIF NONC; WHO Regional Office for the Eastern Mediterranean, 2011, DEM SOC HLTH IND COU; WHO Regional Office for the Eastern Mediterranean, 2004, HLTH SYST PRIOR E ME; World Health Organization, 2001, NAT BURD DIS STUD PR; World Health Organization, METR DIS ADJ LIF YEA; Zogby J., 2005, ATTITUDES ARABS IN D	60	197	200	1	89	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					309	320		10.1016/S0140-6736(13)62189-3	http://dx.doi.org/10.1016/S0140-6736(13)62189-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452042				2022-12-28	WOS:000330212600030
J	Feld, ED				Feld, Ellen D.			Time to Get Over It	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ATTITUDES; DONATION		Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA	Drexel University	Feld, ED (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA.	edf26@drexel.edu						Gallup Organization, 2005, NATIONAL SURVEY OF O; Hobeika MJ, 2009, J TRAUMA, V67, P372, DOI 10.1097/TA.0b013e3181986ae6; RIKER RR, 1995, TRANSPLANTATION, V59, P880; Thornton JD, 2010, J NATL MED ASSOC, V102, P52	4	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					359	360		10.1001/jama.2013.285398	http://dx.doi.org/10.1001/jama.2013.285398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449312				2022-12-28	WOS:000329939300018
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			How should medical science change?	LANCET			English	Editorial Material									[Kleinert, Sabine; Horton, Richard] The Lancet, London NW1 7BY, England		Kleinert, S (corresponding author), The Lancet, London NW1 7BY, England.							Aitkenhead Decca, 2013, GUARDIAN 1206; Al-Shahi Salman R, 2014, LANCET; Chalmers I, 2014, LANCET; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan A-W, 2014, LANCET; Glasziou P, 2014, LANCET; Ioannidis J.P., 2014, LANCET; Macleod MR, 2014, LANCET; Schekman Randy, 2013, GUARDIAN 1209	9	43	44	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					197	198		10.1016/S0140-6736(13)62678-1	http://dx.doi.org/10.1016/S0140-6736(13)62678-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24411649				2022-12-28	WOS:000330027500009
J	Schramek, D; Sendoel, A; Segal, JP; Beronja, S; Heller, E; Oristian, D; Reva, B; Fuchs, E				Schramek, Daniel; Sendoel, Ataman; Segal, Jeremy P.; Beronja, Slobodan; Heller, Evan; Oristian, Daniel; Reva, Boris; Fuchs, Elaine			Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas	SCIENCE			English	Article							TGF-BETA; HEAD; MUTATIONS; MICE	Mining modern genomics for cancer therapies is predicated on weeding out "bystander" alterations (nonconsequential mutations) and identifying "driver" mutations responsible for tumorigenesis and/or metastasis. We used a direct in vivo RNA interference (RNAi) strategy to screen for genes that upon repression predispose mice to squamous cell carcinomas (SCCs). Seven of our top hits-including Myh9, which encodes nonmuscle myosin IIa-have not been linked to tumor development, yet tissue-specific Myh9 RNAi and Myh9 knockout trigger invasive SCC formation on tumor-susceptible backgrounds. In human and mouse keratinocytes, myosin IIa's function is manifested not only in conventional actin-related processes but also in regulating posttranscriptional p53 stabilization. Myosin IIa is diminished in human SCCs with poor survival, which suggests that in vivo RNAi technology might be useful for identifying potent but low-penetrance tumor suppressors.	[Schramek, Daniel; Sendoel, Ataman; Segal, Jeremy P.; Beronja, Slobodan; Heller, Evan; Oristian, Daniel; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Reva, Boris] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA	Howard Hughes Medical Institute; Rockefeller University; Icahn School of Medicine at Mount Sinai	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Schramek, Daniel/AAL-1470-2020; Fuchs, Elaine/G-1565-2016; Schramek, Daniel/J-5792-2014; Reva, Boris/AAB-8932-2022	Schramek, Daniel/0000-0001-9977-2104; Beronja, Slobodan/0000-0002-6769-9261; Sendoel, Ataman/0000-0002-0381-9965	American Association for Cancer Research; Austrian Program for Advanced Research and Technology of the Austrian Academy of Sciences; NIH [R37-AR27883]; Emerald Foundation Inc.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883] Funding Source: NIH RePORTER	American Association for Cancer Research; Austrian Program for Advanced Research and Technology of the Austrian Academy of Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation Inc.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the Fuchs laboratory for helpful discussions, especially C. Luxenburg for helpful experimental suggestions and S. Dewell for deep sequencing; S. Karlsson for T beta RII<SUP>fl/fl</SUP> mice; and T. Golub for sharing HNSCC data with us prior to publication. Special thanks go to the TCGA patients, the TCGA Program, and the cBIO Portal for Cancer Genomics. D. S. is an Emerald Foundation Young Investigator. D. S. was supported by the American Association for Cancer Research and the Austrian Program for Advanced Research and Technology of the Austrian Academy of Sciences. D. S. and A. S. are fellows of the Human Frontier Science Program Organization. E. F. is an Investigator of the Howard Hughes Medical Institute. Supported by NIH grant R37-AR27883 (E. F.) and Emerald Foundation Inc. The Rockefeller University has applied for a patent regarding the use of nuclear export inhibitors for the treatment of human squamous cell carcinomas, with D. S. and E. F. as inventors.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Berton TR, 2003, ONCOGENE, V22, P5415, DOI 10.1038/sj.onc.1206825; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Fritsch A, 2010, NAT PHYS, V6, P730, DOI 10.1038/nphys1800; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Murphy CT, 2001, NAT CELL BIOL, V3, P311, DOI 10.1038/35060110; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130	16	183	192	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					309	313		10.1126/science.1248627	http://dx.doi.org/10.1126/science.1248627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436421	Green Accepted			2022-12-28	WOS:000329718600039
J	De Vadder, F; Kovatcheva-Datchary, P; Goncalves, D; Vinera, J; Zitoun, C; Duchampt, A; Backhed, F; Mithieux, G				De Vadder, Filipe; Kovatcheva-Datchary, Petia; Goncalves, Daisy; Vinera, Jennifer; Zitoun, Carine; Duchampt, Adeline; Backhed, Fredrik; Mithieux, Gilles			Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits	CELL			English	Article							CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; RAT SMALL-INTESTINE; GLUCOSE-6-PHOSPHATASE GENE; GLUCOSE-PRODUCTION; GASTRIC BYPASS; DIETARY FIBER; FOOD-INTAKE; GLUCONEOGENESIS; MICE	Soluble dietary fibers promote metabolic benefits on body weight and glucose control, but underlying mechanisms are poorly understood. Recent evidence indicates that intestinal gluconeogenesis (IGN) has beneficial effects on glucose and energy homeostasis. Here, we show that the short-chain fatty acids (SCFAs) propionate and butyrate, which are generated by fermentation of soluble fiber by the gut microbiota, activate IGN via complementary mechanisms. Butyrate activates IGN gene expression through a cAMP-dependent mechanism, while propionate, itself a substrate of IGN, activates IGN gene expression via a gut-brain neural circuit involving the fatty acid receptor FFAR3. The metabolic benefits on body weight and glucose control induced by SCFAs or dietary fiber in normal mice are absent in mice deficient for IGN, despite similar modifications in gut microbiota composition. Thus, the regulation of IGN is necessary for the metabolic benefits associated with SCFAs and soluble fiber.	[De Vadder, Filipe; Goncalves, Daisy; Vinera, Jennifer; Zitoun, Carine; Duchampt, Adeline; Mithieux, Gilles] INSERM, U855, F-69372 Lyon, France; [De Vadder, Filipe; Goncalves, Daisy; Vinera, Jennifer; Zitoun, Carine; Duchampt, Adeline; Mithieux, Gilles] Univ Lyon, F-69008 Lyon, France; [De Vadder, Filipe; Goncalves, Daisy; Vinera, Jennifer; Zitoun, Carine; Duchampt, Adeline; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, S-41345 Gothenburg, Sweden; [Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Gothenburg; University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen	Mithieux, G (corresponding author), INSERM, U855, F-69372 Lyon, France.	gilles.mithieux@inserm.fr	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818; De Vadder, Filipe/0000-0001-9195-5344; Gilles, Mithieux/0000-0003-3579-8529				ANDERSON JW, 1984, P SOC EXP BIOL MED, V177, P372; Battezzati A, 2004, AM J PHYSIOL-ENDOC M, V286, pE129, DOI 10.1152/ajpendo.00486.2002; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969; Croset M, 2001, DIABETES, V50, P740, DOI 10.2337/diabetes.50.4.740; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Delaere F, 2013, MOL METAB, V2, P47, DOI 10.1016/j.molmet.2012.11.003; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Duraffourd C, 2012, CELL, V150, P377, DOI 10.1016/j.cell.2012.05.039; El Aidy S, 2013, GUT, V62, P1306, DOI 10.1136/gutjnl-2011-301955; El Aidy S, 2013, ISME J, V7, P743, DOI 10.1038/ismej.2012.142; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gautier-Stein A, 2006, J BIOL CHEM, V281, P31268, DOI 10.1074/jbc.M603258200; Hayes MT, 2011, OBES SURG, V21, P759, DOI 10.1007/s11695-011-0380-7; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MENDELOFF AI, 1977, NEW ENGL J MED, V297, P811, DOI 10.1056/NEJM197710132971506; Mithieux G, 2004, AM J PHYSIOL-ENDOC M, V286, pE370, DOI 10.1152/ajpendo.00299.2003; Mithieux G, 2004, J BIOL CHEM, V279, P44231, DOI 10.1074/jbc.R400011200; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Mithieux G, 2013, TRENDS ENDOCRIN MET, V24, P378, DOI 10.1016/j.tem.2013.04.005; Mithieux G, 2012, OBES SURG, V22, P1920, DOI 10.1007/s11695-012-0755-4; Mutel E, 2011, DIABETES, V60, P3121, DOI 10.2337/db11-0571; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Penhoat A, 2011, PHYSIOL BEHAV, V105, P89, DOI 10.1016/j.physbeh.2011.03.012; Pillot B, 2009, ENDOCRINOLOGY, V150, P616, DOI 10.1210/en.2008-0601; Rajas F, 1999, GASTROENTEROLOGY, V117, P132, DOI 10.1016/S0016-5085(99)70559-7; RAY TK, 1983, AM J CLIN NUTR, V37, P376, DOI 10.1093/ajcn/37.3.376; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang AH, 2012, J NUTR, V142, P1, DOI 10.3945/jn.111.148155	52	1172	1202	37	351	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					84	96		10.1016/j.cell.2013.12.016	http://dx.doi.org/10.1016/j.cell.2013.12.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24412651	Bronze, Green Submitted			2022-12-28	WOS:000329912200012
J	Marx, V				Marx, Vivien			LIFE IN THE DANGER ZONE	NATURE			English	Editorial Material																		Munster VJ, 2013, NEW ENGL J MED, V368, P1560, DOI 10.1056/NEJMc1215691	1	1	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					437	440		10.1038/505437a	http://dx.doi.org/10.1038/505437a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	288OR	24429638	Green Published, Bronze			2022-12-28	WOS:000329621800052
J	McDougal, WS; Lee, RJ; Efstathiou, JA; Harisinghani, M; Wu, CL				McDougal, W. Scott; Lee, Richard J.; Efstathiou, Jason A.; Harisinghani, Mukesh; Wu, Chin-Lee			Case 2-2014-A 44-Year-Old Man with a Lesion on the Penis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER; LYMPHADENECTOMY; SURGERY; CHEMOTHERAPY; RADIOTHERAPY; EXPERIENCE; MANAGEMENT; CISPLATIN; SKIN	A 44-year-old man was seen in the urology clinic because of a penile lesion that had been enlarging for 6 months. Examination and imaging revealed an ulcerated mass and enlarged inguinal lymph nodes. A diagnostic procedure was performed, and management decisions were made. Presentation of Case A 44-year-old man was seen in the urology clinic at this hospital because of a lesion on the penis. The patient had been in good health until 6 months earlier when, while visiting another country, a sports-related injury to his groin occurred, after which he noted a small, dark area on the distal penis and slight hematuria. The next day, he saw a physician at a local hospital who made a diagnosis of hematoma. The lesion persisted, and 2 months later, a small, firm nodule developed at the site. During the next 2.5 months, the nodule enlarged, ...	[McDougal, W. Scott] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Lee, Richard J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Efstathiou, Jason A.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Harisinghani, Mukesh] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Wu, Chin-Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [McDougal, W. Scott] Harvard Univ, Sch Med, Dept Urol, Boston, MA USA; [Lee, Richard J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Efstathiou, Jason A.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Harisinghani, Mukesh] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Wu, Chin-Lee] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	McDougal, WS (corresponding author), Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA.		Harisinghani, Mukesh/D-7590-2011					Bermejo C, 2007, J UROLOGY, V177, P1335, DOI 10.1016/j.juro.2006.11.038; Broders AC, 1921, ANN SURG, V73, P141, DOI 10.1097/00000658-192102000-00001; Chen MF, 2004, WORLD J UROL, V22, P60, DOI 10.1007/s00345-003-0383-7; Crook JM, 2005, INT J RADIAT ONCOL, V62, P460, DOI 10.1016/j.ijrobp.2004.10.016; Crook J, 2009, WORLD J UROL, V27, P189, DOI 10.1007/s00345-008-0309-5; de Crevoisier R, 2009, INT J RADIAT ONCOL, V74, P1150, DOI 10.1016/j.ijrobp.2008.09.054; Feldman AS, 2011, J UROLOGY, V186, P1303, DOI 10.1016/j.juro.2011.05.084; Franks KN, 2011, J UROLOGY, V186, P524, DOI 10.1016/j.juro.2011.03.117; Gotsadze D, 2000, EUR UROL, V38, P306, DOI 10.1159/000020298; Graafland NM, 2010, J UROLOGY, V184, P1347, DOI 10.1016/j.juro.2010.06.016; Haas GP, 1999, J UROLOGY, V161, P1823, DOI 10.1016/S0022-5347(05)68815-5; LUCIA MS, 1992, UROL CLIN N AM, V19, P227; McDougal WS, 2005, J UROLOGY, V174, P2218, DOI 10.1097/01.ju.0000181225.31468.82; MCDOUGAL WS, 1986, J UROLOGY, V136, P38, DOI 10.1016/S0022-5347(17)44718-5; MCDOUGAL WS, 1995, J UROLOGY, V154, P1364, DOI 10.1016/S0022-5347(01)66863-0; Muneer A, 2012, TXB PENILE CANC; Ozsahin M, 2006, INT J RADIAT ONCOL, V66, P674, DOI 10.1016/j.ijrobp.2006.05.053; Pagliaro LC, 2010, J CLIN ONCOL, V28, P3851, DOI 10.1200/JCO.2010.29.5477; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tabatabaei S, 2005, J UROLOGY, V174, P923, DOI 10.1097/01.ju.0000170234.14519.19; Tabatabaei S, 2003, J UROLOGY, V169, P118, DOI 10.1016/S0022-5347(05)64049-9; Young RH, 2000, TUMORS PROSTATE SEMI	22	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					263	271		10.1056/NEJMcpc1310005	http://dx.doi.org/10.1056/NEJMcpc1310005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428472				2022-12-28	WOS:000330035600013
J	Rudge, SA; Wakelam, MJO				Rudge, Simon A.; Wakelam, Michael J. O.			SnapShot: Lipid Kinase and Phosphatase Reaction Pathways	CELL			English	Editorial Material									[Rudge, Simon A.; Wakelam, Michael J. O.] Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Rudge, SA (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England.			Wakelam, Michael/0000-0003-4059-9276	BBSRC [BBS/E/B/0000H213, BB/H024824/1, BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H024824/1, BBS/E/B/0000H213, BBS/E/B/000C0415] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))			0	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2								10.1016/j.cell.2014.01.003	http://dx.doi.org/10.1016/j.cell.2014.01.003			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3QV	24439389	Bronze			2022-12-28	WOS:000349544300001
J	Silva, A; Monticone, F; Castaldi, G; Galdi, V; Alu, A; Engheta, N				Silva, Alexandre; Monticone, Francesco; Castaldi, Giuseppe; Galdi, Vincenzo; Alu, Andrea; Engheta, Nader			Performing Mathematical Operations with Metamaterials	SCIENCE			English	Article								We introduce the concept of metamaterial analog computing, based on suitably designed metamaterial blocks that can perform mathematical operations (such as spatial differentiation, integration, or convolution) on the profile of an impinging wave as it propagates through these blocks. Two approaches are presented to achieve such functionality: (i) subwavelength structured metascreens combined with graded-index waveguides and (ii) multilayered slabs designed to achieve a desired spatial Green's function. Both techniques offer the possibility of miniaturized, potentially integrable, wave-based computing systems that are thinner than conventional lens-based optical signal and data processors by several orders of magnitude.	[Silva, Alexandre; Engheta, Nader] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Monticone, Francesco; Alu, Andrea] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Castaldi, Giuseppe; Galdi, Vincenzo] Univ Sannio, Dept Engn, Waves Grp, I-82100 Benevento, Italy	University of Pennsylvania; University of Texas System; University of Texas Austin; University of Sannio	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu	; Alu, Andrea/A-1328-2007; Galdi, Vincenzo/B-1670-2008	Monticone, Francesco/0000-0003-0457-1807; CASTALDI, Giuseppe/0000-0003-4400-9990; Alu, Andrea/0000-0002-4297-5274; Silva, Alexandre/0000-0001-8496-6504; Galdi, Vincenzo/0000-0002-4796-3600	U.S. Office of Naval Research Multidisciplinary University Research Initiative (MURI) [N00014-10-1-0942]	U.S. Office of Naval Research Multidisciplinary University Research Initiative (MURI)	Supported in part by U.S. Office of Naval Research Multidisciplinary University Research Initiative (MURI) grant N00014-10-1-0942.	Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Cai W, 2010, OPTICAL METAMATERIALS: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-1151-3; Caloz C, 2006, ELECTROMAGNETIC METAMATERIALS: TRANSMISSION LINE THEORY AND MICROWAVE APPLICATIONS: THE ENGINEERING APPROACH, P1; CASASENT D, 1977, P IEEE, V65, P143, DOI 10.1109/PROC.1977.10439; Castaldi G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.063902; CLYMER AB, 1993, IEEE ANN HIST COMPUT, V15, P19, DOI 10.1109/85.207741; Eleftheriades GV, 2005, NEGATIVE-REFRACTION METAMATERIALS: FUNDAMENTAL PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/0471744751; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Goodman J. W., 2005, INTRO FOURIER OPTICS; Kempe A.B., 1875, P LOND MATH SOC, VS1-7, P213, DOI [10.1112/plms/s1-7.1.213, DOI 10.1112/PLMS/S1-7.1.213]; Kuester EF, 2003, IEEE T ANTENN PROPAG, V51, P2641, DOI 10.1109/TAP.2003.817560; Lai Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.253902; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Milton GW, 2013, J MECH PHYS SOLIDS, V61, P1543, DOI 10.1016/j.jmps.2012.08.011; Monticone F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203903; Naik GV, 2011, OPT MATER EXPRESS, V1, P1090, DOI 10.1364/OME.1.001090; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; OZAKTAS HM, 1993, J OPT SOC AM A, V10, P2522, DOI 10.1364/JOSAA.10.002522; Pandey A, 2012, OPT LETT, V37, P5238, DOI 10.1364/OL.37.005238; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2003, J PHYS-CONDENS MAT, V15, P6345, DOI 10.1088/0953-8984/15/37/004; PRICE DD, 1984, IEEE MICRO, V4, P22, DOI 10.1109/MM.1984.291305; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1877	28	585	604	31	442	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					160	163		10.1126/science.1242818	http://dx.doi.org/10.1126/science.1242818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408430				2022-12-28	WOS:000329440800036
J	Alexandre, C; Baena-Lopez, A; Vincent, JP				Alexandre, Cyrille; Baena-Lopez, Alberto; Vincent, Jean-Paul			Patterning and growth control by membrane-tethered Wingless	NATURE			English	Article							LONG-RANGE ACTION; GENE-EXPRESSION; IMAGINAL DISCS; MORPHOGEN GRADIENT; SIGNALING PATHWAY; DROSOPHILA LEG; SENSELESS; MARGIN; CELLS; NOTCH	Wnts are evolutionarily conserved secreted signalling proteins that, in various developmental contexts, spread from their site of synthesis to form a gradient and activate target-gene expression at a distance. However, the requirement for Wnts to spread has never been directly tested. Here we used genome engineering to replace the endogenous wingless gene, which encodes the main Drosophila Wnt, with one that expresses a membrane-tethered form of the protein. Surprisingly, the resulting flies were viable and produced normally patterned appendages of nearly the right size, albeit with a delay. We show that, in the prospective wing, prolonged wingless transcription followed by memory of earlier signalling allows persistent expression of relevant target genes. We suggest therefore that the spread of Wingless is dispensable for patterning and growth even though it probably contributes to increasing cell proliferation.	[Alexandre, Cyrille; Baena-Lopez, Alberto; Vincent, Jean-Paul] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk	Baena, Luis Alberto/GLR-1590-2022	Baena, Luis Alberto/0000-0002-8663-3794	UK Medical Research Council [U117584268]; ERC grant (WNTEXPORT) from the European Union; Sir Henry Wellcome post-doctoral fellowship [082694/Z/07/Z]	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC grant (WNTEXPORT) from the European Union; Sir Henry Wellcome post-doctoral fellowship	This work was supported by the UK Medical Research Council (U117584268), an ERC grant (WNTEXPORT) from the European Union to JPV and a Sir Henry Wellcome post-doctoral fellowship to L. A. B-L. (082694/Z/07/Z). We are grateful to U.-M. Fiuza for discussion and A. Mitchell for help in generating the first wingless knockout allele. Discussions with G. Struhl have led to significant improvement of the manuscript. We thank colleagues listed in the Methods Summary, as well as the Developmental Studies Hybridoma Bank and the Bloomington Stock Center for providing antibodies and fly strains.	Alexandre C, 1999, DEVELOPMENT, V126, P5689; Arias AM, 2003, NAT REV MOL CELL BIO, V4, P321, DOI 10.1038/nrm1078; Artero R, 2003, DEVELOPMENT, V130, P6257, DOI 10.1242/dev.00843; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Baena-Lopez LA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000360; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Couso JP, 1995, CURR BIOL, V5, P1437, DOI 10.1016/S0960-9822(95)00281-8; COUSO JP, 1993, SCIENCE, V259, P484, DOI 10.1126/science.8424170; COUSO JP, 1994, DEVELOPMENT, V120, P621; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Garcia-Garcia MJ, 1999, DEVELOPMENT, V126, P3523; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Giorgianni MW, 2011, DEV CELL, V20, P455, DOI 10.1016/j.devcel.2011.03.017; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Jafar-Nejad H, 2006, DEVELOPMENT, V133, P1683, DOI 10.1242/dev.02338; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Perez L, 2011, DEVELOPMENT, V138, P3125, DOI 10.1242/dev.065599; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Sato A, 1999, DEVELOPMENT, V126, P4421; Sivasankaran R, 2000, MECH DEVELOP, V91, P427, DOI 10.1016/S0925-4773(99)00313-5; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Swarup S., 2012, COLD SPRING HARB PER, V4; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; WILDER EL, 1995, DEVELOPMENT, V121, P477; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386	39	202	205	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					180	+		10.1038/nature12879	http://dx.doi.org/10.1038/nature12879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24390349	Green Accepted			2022-12-28	WOS:000329441500031
J	Koven, S				Koven, Suzanne			Mom at Bedside, Appears Calm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koven, Suzanne] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Koven, Suzanne] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Koven, S (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					104	105		10.1056/NEJMp1312171	http://dx.doi.org/10.1056/NEJMp1312171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TA	24401048				2022-12-28	WOS:000336119800005
J	Sarna, L; Bialous, SA; Nandy, K; Antonio, ALM; Yang, Q				Sarna, Linda; Bialous, Stella Aguinaga; Nandy, Karabi; Antonio, Anna Liza Malazarte; Yang, Qing			Changes in Smoking Prevalences Among Health Care Professionals From 2003 to 2010-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sarna, Linda; Nandy, Karabi; Antonio, Anna Liza Malazarte] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA; [Bialous, Stella Aguinaga] Tobacco Policy Int, San Francisco, CA USA; [Yang, Qing] RTI Hlth Solut, Res Triangle Pk, NC USA	University of California System; University of California Los Angeles; Research Triangle Institute	Sarna, L (corresponding author), Univ Calif Los Angeles, Sch Nursing, 700 Tiverton Ave,POB 956918, Los Angeles, CA 90095 USA.	lsarna@sonnet.ucla.edu		Yang, Qing/0000-0003-4844-4690				Fiore MC, 2008, TREATING TOBACCO USE; Koh HK, 2012, AM J PREV MED, V43, pS264, DOI 10.1016/j.amepre.2012.08.008; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; SARNA L, 2006, CRIT CARE NURS CLIN, V18, pR13; Sarna L, 2010, NICOTINE TOB RES, V12, P1167, DOI 10.1093/ntr/ntq161; Sarna Linda, 2006, Crit Care Nurs Clin North Am, V18, P113, DOI 10.1016/j.ccell.2005.11.002; US Department of Commerce, TOBACCO USE SUPPLEME	7	30	33	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					197	199		10.1001/jama.2013.284871	http://dx.doi.org/10.1001/jama.2013.284871			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399560	Bronze			2022-12-28	WOS:000329339400027
J	Euser, SM; de Jong, S; Bruin, JP; Klapwijk, HP; Brandsema, PS; Reijnen, L; Den Boer, JW				Euser, Sjoerd M.; de Jong, Sandra; Bruin, Jacob P.; Klapwijk, Henk P.; Brandsema, Petra S.; Reijnen, Linda; Den Boer, Jeroen W.			Legionnaires' disease associated with a car wash installation	LANCET			English	Editorial Material							LEGIONELLA-PNEUMOPHILA SEROGROUP-1		[Euser, Sjoerd M.; Bruin, Jacob P.; Reijnen, Linda; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, NL-2035 RC Haarlem, Netherlands; [de Jong, Sandra; Klapwijk, Henk P.] Dienst Gezondheid & Jeugd ZHZ, Municipal Hlth Serv, Dordrecht, Netherlands; [Brandsema, Petra S.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Euser, SM (corresponding author), Reg Publ Hlth Lab Kennemerland, Boerhaavelaan 26, NL-2035 RC Haarlem, Netherlands.	s.euser@streeklabhaarlem.nl						Den Boer JW, 2007, INT J HYG ENVIR HEAL, V210, P1, DOI 10.1016/j.ijheh.2006.07.002; Euser SM, 2012, EUROSURVEILLANCE, V17, P15; Fry NK, 2002, EUR J CLIN MICROBIOL, V21, P722, DOI 10.1007/s10096-002-0790-5; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07	4	8	9	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2114	2114		10.1016/S0140-6736(13)62188-1	http://dx.doi.org/10.1016/S0140-6736(13)62188-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275OX	24360389				2022-12-28	WOS:000328687800034
J	Hou, Y; Fan, W; Yan, LY; Li, R; Lian, Y; Huang, J; Li, JS; Xu, LY; Tang, FC; Xie, XS; Qiao, J				Hou, Yu; Fan, Wei; Yan, Liying; Li, Rong; Lian, Ying; Huang, Jin; Li, Jinsen; Xu, Liya; Tang, Fuchou; Xie, X. Sunney; Qiao, Jie			Genome Analyses of Single Human Oocytes	CELL			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; MEIOTIC RECOMBINATION; MATERNAL AGE; CROSSOVER INTERFERENCE; CHROMATID INTERFERENCE; SPERM CELLS; ANEUPLOIDY; NONDISJUNCTION; RATES; RESOLUTION	Single-cell genome analyses of human oocytes are important for meiosis research and preimplantation genomic screening. However, the nonuniformity of single-cell whole-genome amplification hindered its use. Here, we demonstrate genome analyses of single human oocytes using multiple annealing and looping-based amplification cycle (MALBAC)-based sequencing technology. By sequencing the triads of the first and second polar bodies (PB1 and PB2) and the oocyte pronuclei from same female egg donors, we phase the genomes of these donors with detected SNPs and determine the crossover maps of their oocytes. Our data exhibit an expected crossover interference and indicate a weak chromatid interference. Further, the genome of the oocyte pronucleus, including information regarding aneuploidy and SNPs in disease-associated alleles, can be accurately deduced from the genomes of PB1 and PB2. The MALBAC-based preimplantation genomic screening in in vitro fertilization (IVF) enables accurate and cost-effective selection of normal fertilized eggs for embryo transfer.	[Hou, Yu; Fan, Wei; Yan, Liying; Li, Rong; Lian, Ying; Huang, Jin; Li, Jinsen; Xu, Liya; Tang, Fuchou; Xie, X. Sunney; Qiao, Jie] Peking Univ, Hosp 3, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Hou, Yu; Fan, Wei; Yan, Liying; Li, Rong; Lian, Ying; Huang, Jin; Li, Jinsen; Xu, Liya; Tang, Fuchou; Xie, X. Sunney; Qiao, Jie] Peking Univ, Hosp 3, Ctr Reprod Med, Beijing 100871, Peoples R China; [Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China; [Fan, Wei] Peking Tsinghua Ctr Life Sci, Beijing 100084, Peoples R China; [Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China	Peking University; Peking University; Harvard University	Tang, FC (corresponding author), Peking Univ, Hosp 3, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.	tangfuchou@pku.edu.cn; xie@chemistry.harvard.edu; jie.qiao@263.net	Xu, Liya/AAV-5387-2021	Fan, Wei/0000-0001-5036-8733; Hou, Yu/0000-0001-7875-7087; Qiao, Jie/0000-0003-2126-1376	National Basic Research Program of China [2011CB944500, 2012CB966704, 2011CB966303]; National Natural Science of China [31230047, 31322037, 31271543]; Beijing Municipal Science and Technology Commission [Z131100005213006]; Peking University; National Natural Science Foundation of China [81000275]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Peking University(Peking University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	J.Q. and F. T. were supported by grants from the National Basic Research Program of China (2011CB944500, 2012CB966704, and 2011CB966303) and grants from the National Natural Science of China (31230047, 31322037, and 31271543). X. S. X., F. T., and J.Q. were supported by a grant from the Beijing Municipal Science and Technology Commission (Z131100005213006) and a Peking University grant for translational research. L.Y. was supported by a grant from the National Natural Science Foundation of China (81000275). The authors would like to acknowledge the oocyte and sperm donor volunteers and the staff at the Peking University Third Hospital for recruiting donors and collecting samples. We acknowledge the staff of the BIOPIC sequencing facility at Peking University for assistance. We also thank A. R. Chapman, J. Zhang, C. Zong, S. Lu, and A. Surani for helpful discussions. We sincerely thank N. Kleckner for providing us with helpful advice on the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bugge M, 1998, HUM MOL GENET, V7, P661, DOI 10.1093/hmg/7.4.661; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cheng EY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000661; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Fonseka KGL, 2011, CYTOGENET GENOME RES, V133, P280, DOI 10.1159/000322816; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Hann MC, 2011, ASIAN J ANDROL, V13, P212, DOI 10.1038/aja.2011.1; Harper JC, 2012, HUM GENET, V131, P175, DOI 10.1007/s00439-011-1056-z; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kurahashi H, 2012, CONGENIT ANOM, V52, P8, DOI 10.1111/j.1741-4520.2011.00350.x; Li R, 2008, REPROD BIOMED ONLINE, V16, P627, DOI 10.1016/S1472-6483(10)60475-0; Liss J., 2011, OTOLARYNGOLOGY-POL, V65, P443; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Munne S, 2007, REPROD BIOMED ONLINE, V14, P628, DOI 10.1016/S1472-6483(10)61057-7; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pellestor F, 2002, HUM REPROD, V17, P2134, DOI 10.1093/humrep/17.8.2134; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Qiao J, 2014, MOL ASPECTS MED, V38, P54, DOI 10.1016/j.mam.2013.06.001; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; SPEED TP, 1992, P NATL ACAD SCI USA, V89, P3103, DOI 10.1073/pnas.89.7.3103; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Teuscher F, 2000, GENETICS, V156, P1449; Treff NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/j.fertnstert.2012.12.018; Van den Veyver IB, 2009, PRENATAL DIAG, V29, P29, DOI 10.1002/pd.2127; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; ZHAO HY, 1995, GENETICS, V139, P1057; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	47	225	260	2	174	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1492	1506		10.1016/j.cell.2013.11.040	http://dx.doi.org/10.1016/j.cell.2013.11.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360273	Bronze			2022-12-28	WOS:000328693300007
J	Wright, JT; Fine, LJ; Lackland, DT; Ogedegbe, G; Himmelfarb, CRD				Wright, Jackson T., Jr.; Fine, Lawrence J.; Lackland, Daniel T.; Ogedegbe, Gbenga; Himmelfarb, Cheryl R. Dennison			Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View	ANNALS OF INTERNAL MEDICINE			English	Article							HYPERTENSION; METAANALYSIS; STROKE; MANAGEMENT; REDUCTION; MORTALITY; ADULTS		Case Western Reserve Univ, Cleveland, OH 44106 USA; NHLBI, Bethesda, MD 20892 USA; Med Univ S Carolina, Charleston, SC 29425 USA; NYU, Sch Med, New York, NY USA; Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Medical University of South Carolina; New York University; Johns Hopkins University	Wright, JT (corresponding author), Univ Hosp Case Med Ctr, Bolwell Suite 2200,11100 Euclid Ave, Cleveland, OH 44106 USA.	Jackson.Wright@case.edu	Himmelfarb, Cheryl Dennison/V-5660-2019	Himmelfarb, Cheryl Dennison/0000-0003-1918-4316				[Anonymous], 1991, JAMA, V265, P3255; Aronow WS, 2011, J AM SOC HYPERTENS, V5, P259, DOI 10.1016/j.jash.2011.06.001; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Canadian Hypertension Education Program, 2013, 2013 CAN HYP ED PROG; Center for Disease Control and prevention, 2013, NHANES RESP RAT POP; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Czernichow S, 2011, J HYPERTENS, V29, P4, DOI 10.1097/HJH.0b013e32834000be; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; National Institute for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Sipahi I, 2012, STROKE, V43, P432, DOI 10.1161/STROKEAHA.111.636829; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Wright JD, 2001, MEAN SYSTOLIC DIASTO, P1	22	240	241	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					499	+		10.7326/M13-2981	http://dx.doi.org/10.7326/M13-2981			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24424788				2022-12-28	WOS:000334093800008
J	Patel, V; Saxena, S				Patel, Vikram; Saxena, Shekhar			Transforming Lives, Enhancing Communities - Innovations in Global Mental Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Mental disorders account for nearly a quarter of all years lost to disability globally. This burden has many ill effects, but arguably the most important reason for action is that many people with mental disorders are subject to severe human rights violations. Mr. K. spent nearly a year and a half bound to a log in his home village in northeastern Ghana. His crime? He had a psychotic disorder, and his family could not afford the $17 for antipsychotic medication that would have stabilized his condition. Instead, they consulted a traditional healer, who pinned Mr. K.'s right leg inside a hole in the log and warned his family not to free him lest the wrath of the gods be visited on them. At least 10% of the world's population is affected by one of a wide range of mental disorders; as many ...	[Patel, Vikram] London Sch Hyg & Trop Med, London, England; [Patel, Vikram] Publ Hlth Fdn India, New Delhi, India; [Patel, Vikram] Sangath Ctr, Salcette, Goa, India; [Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; World Health Organization	Patel, V (corresponding author), London Sch Hyg & Trop Med, London, England.			Patel, Vikram/0000-0003-1066-8584	Wellcome Trust [091834, 084674, 100714] Funding Source: Medline; World Health Organization [001] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization(World Health Organization)		Bloom DE, 2011, GLOBAL EC BURDEN NON; Patel Vikarm, 2012, MENTAL HLTH HUMAN RI, P362; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P631; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organization, 2016, MHGAP INT GUID MENT	5	77	79	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					498	501		10.1056/NEJMp1315214	http://dx.doi.org/10.1056/NEJMp1315214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA4NT	24428425	Green Accepted			2022-12-28	WOS:000331073500005
J	Weiss, RA				Weiss, Robin A.			Immunotherapy for HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Two recent studies show that a hybrid virus, the simian immunodeficiency virus bearing the envelope antigens of HIV-1, can be cleared from the blood of rhesus macaques by the infusion of monoclonal antibodies. The provision of immunotherapy through antibody infusion has a venerable and valuable record in the treatment of infectious disease. In 1901, the first Nobel Prize in Physiology or Medicine was awarded to Emil von Behring for serum therapy, especially its application against diphtheria, and more recently, postexposure prophylaxis against rabies has combined antibody treatment with active immunization. Although immunotherapy for chronic, persistent infections is more problematic, new studies by Barouch et al.(1) and Shingai et al.(2) on the treatment of rhesus macaques indicate that monoclonal antibodies show much promise in clearing infection with a hybrid form of the simian immunodeficiency ...	UCL, Div Infect & Immun, London WC1E 6BT, England	University of London; University College London	Weiss, RA (corresponding author), UCL, Div Infect & Immun, London WC1E 6BT, England.							Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Watkins JD, 2013, AIDS, V27, pF13, DOI 10.1097/QAD.0b013e328360eac6	5	5	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					379	380		10.1056/NEJMcibr1314577	http://dx.doi.org/10.1056/NEJMcibr1314577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450898				2022-12-28	WOS:000330036200015
J	Yang, WS; SriRamaratnam, R; Welsch, ME; Shimada, K; Skouta, R; Viswanathan, VS; Cheah, JH; Clemons, PA; Shamji, AF; Clish, CB; Brown, LM; Girotti, AW; Cornish, VW; Schreiber, SL; Stockwell, BR				Yang, Wan Seok; SriRamaratnam, Rohitha; Welsch, Matthew E.; Shimada, Kenichi; Skouta, Rachid; Viswanathan, Vasanthi S.; Cheah, Jaime H.; Clemons, Paul A.; Shamji, Alykhan F.; Clish, Clary B.; Brown, Lewis M.; Girotti, Albert W.; Cornish, Virginia W.; Schreiber, Stuart L.; Stockwell, Brent R.			Regulation of Ferroptotic Cancer Cell Death by GPX4	CELL			English	Article							GLUTATHIONE-PEROXIDASE 4; HUMAN TUMOR-CELLS; OXIDATIVE STRESS; RAS; IDENTIFICATION; GLUTATHIONE-PEROXIDASE-4; EXPRESSION; MECHANISM; APOPTOSIS; GROWTH	Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown. We sought a common mediator for the lethality of 12 ferroptosisinducing small molecules. We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compounds and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compounds. GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compounds with other lethal mechanisms. In addition, two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models. Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis. Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.	[Yang, Wan Seok; Shimada, Kenichi; Skouta, Rachid; Viswanathan, Vasanthi S.; Brown, Lewis M.; Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [SriRamaratnam, Rohitha; Welsch, Matthew E.; Cornish, Virginia W.; Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA; [Viswanathan, Vasanthi S.; Cheah, Jaime H.; Clemons, Paul A.; Shamji, Alykhan F.; Clish, Clary B.; Schreiber, Stuart L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Girotti, Albert W.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Brown, Lewis M.] Columbia Univ, Quantitat Prote Ctr, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Syst Biol, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical College of Wisconsin; Columbia University; Columbia University	Stockwell, BR (corresponding author), Columbia Univ, Dept Biol Sci, 1208 Northwest Corner Bldg,12th Floor,550 West 12, New York, NY 10027 USA.	bstockwell@columbia.edu	Skouta, Rachid/Q-7132-2016; Girotti, Albert/AAF-6910-2020; Skouta, Rachid/M-2690-2019; Clish, Clary B/ABB-9374-2021; Stockwell, Brent R/AAE-7200-2019; Clish, Clary/AAB-7124-2019; Shimada, Kenichi/AAD-7996-2021	Clish, Clary B/0000-0001-8259-9245; Stockwell, Brent R/0000-0002-3532-3868; Shimada, Kenichi/0000-0001-8540-9785; Viswanathan, Vasanthi/0000-0001-9878-3629; Skouta, Rachid/0000-0003-3324-4362	NCI's Cancer Target Discovery and Development Network [RC2-CA148399]; Howard Hughes Medical Institute; NIH [5R01-CA70823-15]; US National Institutes of Health [5R01CA097061, 5R01GM085081, R01CA161061]; Arnold and Mabel Beckman Foundation; NYSTAR; NATIONAL CANCER INSTITUTE [R01CA161061, RC2CA148399, R21CA177591, R01CA070823, R01CA097061] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081] Funding Source: NIH RePORTER	NCI's Cancer Target Discovery and Development Network; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NYSTAR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Broad Institute MLPCN team and GNF for assistance in screening compounds, Alan Epstein, Riccardo Dalla-Favera, Andrew Kung, James Doroshow, and the Columbia Genome Center for providing cell lines, Siu-hong Ho for help with flow cytometry, the Columbia NYSTEM Chemical Probe Synthesis Facility (NYSTEM contract No. C026715) for synthesis of RSL3 analogs, and Dr. John Decatur and the Columbia Chemistry NMR core facility (NSF grant CHE 0840451 and NIH grant 1S10RR025431-01A1). NCI60 cell line testing and some in vivo toxicity testing were carried out through NCI/ DTP. We thank Ulshulaa Dholakia and Beverly Shelton for assistance with the animal studies and Terumo Miyazawa for sharing an authentic PC-OOH standard. We thank Scott Geromanos, James Langridge, LeRoy Martin, Martha Stapels, and Johannes PC Vissers (Waters) for their support and advice on mass spectrometry data collection and analysis, and Ryan Colligan for technical assistance with mass spectrometry data processing. The cancer cell line profiling was supported by the NCI's Cancer Target Discovery and Development Network (RC2-CA148399, awarded to S. L. S.). S. L. S. is an investigator at the Howard Hughes Medical Institute. A. W. G. was supported by NIH grant 5R01-CA70823-15. This research was supported by grants to B. R. S. from the US National Institutes of Health (5R01CA097061, 5R01GM085081, and R01CA161061), the Arnold and Mabel Beckman Foundation, and NYSTAR. B. R. S. is an Early Career Scientist of the Howard Hughes Medical Institute.	Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fanelus I, 2008, BIOCHEM BIOPH RES CO, V371, P203, DOI 10.1016/j.bbrc.2008.04.009; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kakhlon O, 2002, BIOCHEM SOC T, V30, P777, DOI 10.1042/bst0300777; KANG YJ, 1992, AM J PHYSIOL, V262, pC122, DOI 10.1152/ajpcell.1992.262.1.C122; Kumagai T, 2004, J BIOL CHEM, V279, P48389, DOI 10.1074/jbc.M409935200; Mackinnon Andrew L, 2009, Curr Protoc Chem Biol, V1, P55; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; PARTHASARATHY S, 1985, P NATL ACAD SCI USA, V82, P3000, DOI 10.1073/pnas.82.9.3000; Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Root DE, 2003, CHEM BIOL, V10, P881, DOI 10.1016/j.chembiol.2003.08.009; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Sengupta A, 2013, J INVEST DERMATOL, V133, P1731, DOI 10.1038/jid.2013.52; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Weiwer M, 2012, BIOORG MED CHEM LETT, V22, P1822, DOI 10.1016/j.bmcl.2011.09.047; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2012, ACS MED CHEM LETT, V3, P35, DOI 10.1021/ml200195s; Yoo SE, 2012, FREE RADICAL BIO MED, V52, P1820, DOI 10.1016/j.freeradbiomed.2012.02.043	31	2454	2560	147	790	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					317	331		10.1016/j.cell.2013.12.010	http://dx.doi.org/10.1016/j.cell.2013.12.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439385	Green Accepted, Bronze			2022-12-28	WOS:000329912200030
J	Morris, AM; Regenbogen, SE; Hardiman, KM; Hendren, S				Morris, Arden M.; Regenbogen, Scott E.; Hardiman, Karin M.; Hendren, Samantha			Sigmoid Diverticulitis A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LEFT-COLONIC DIVERTICULITIS; ACUTE UNCOMPLICATED DIVERTICULITIS; COMPLICATED DIVERTICULITIS; YOUNGER PATIENTS; FOLLOW-UP; ANTIINFLAMMATORY DRUGS; PRACTICE PARAMETERS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; NATURAL-HISTORY	IMPORTANCE Diverticulitis is a common disease. Recent changes in understanding its natural history have substantially modified treatment paradigms. OBJECTIVE To review the etiology and natural history of diverticulitis and recent changes in treatment guidelines. EVIDENCE REVIEW We searched the MEDLINE and Cochrane databases for English-language articles pertaining to diagnosis and management of diverticulitis published between January 1, 2000, and March 31, 2013. Search terms applied to 4 thematic topics: pathophysiology, natural history, medical management, and indications for surgery. We excluded small case series and articles based on data accrued prior to 2000. We hand searched the bibliographies of included studies, yielding a total of 186 articles for full review. We graded the level of evidence and classified recommendations by size of treatment effect, according to the guidelines from the American Heart Association Task Force on Practice Guidelines. FINDINGS Eighty articles met criteria for analysis. The pathophysiology of diverticulitis is associated with altered gut motility, increased luminal pressure, and a disordered colonic microenvironment. Several studies examined histologic commonalities with inflammatory bowel disease and irritable bowel syndrome but were focused on associative rather than causal pathways. The natural history of uncomplicated diverticulitis is often benign. For example, in a cohort study of 2366 of 3165 patients hospitalized for acute diverticulitis and followed up for 8.9 years, only 13.3% of patients had a recurrence and 3.9%, a second recurrence. In contrast to what was previously thought, the risk of septic peritonitis is reduced and not increased with each recurrence. Patient-reported outcomes studies show 20% to 35% of patients managed nonoperatively progress to chronic abdominal pain compared with 5% to 25% of patients treated operatively. Randomized trials and cohort studies have shown that antibiotics and fiber were not as beneficial as previously thought and that mesalamine might be useful. Surgical therapy for chronic disease is not always warranted. CONCLUSIONS AND RELEVANCE Recent studies demonstrate a lesser role for aggressive antibiotic or surgical intervention for chronic or recurrent diverticulitis than was previously thought necessary.	[Morris, Arden M.; Regenbogen, Scott E.; Hardiman, Karin M.; Hendren, Samantha] Univ Michigan, Dept Surg, Div Colorectal Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Morris, AM (corresponding author), Univ Michigan, Dept Surg, Div Colorectal Surg, 1500 E Med Ctr Dr,TC 2124, Ann Arbor, MI 48109 USA.	ammsurg@med.umich.edu		Morris, Arden/0000-0001-5795-2940				Alonso S, 2010, COLORECTAL DIS, V12, pE278, DOI 10.1111/j.1463-1318.2009.02122.x; Altadill A, 2012, INFLAMM BOWEL DIS, V18, P120, DOI 10.1002/ibd.21682; Ambrosetti P, 2005, DIS COLON RECTUM, V48, P787, DOI 10.1007/s10350-004-0853-z; Ambrosetti P, 2002, EUR RADIOL, V12, P1145, DOI 10.1007/s00330-001-1143-y; Ambrosetti P, 2007, J GASTROINTEST SURG, V11, P767, DOI 10.1007/s11605-007-0138-7; Ambrosetti P, 2012, DIGEST DIS, V30, P51, DOI 10.1159/000335717; Anaya DA, 2005, ARCH SURG-CHICAGO, V140, P681, DOI 10.1001/archsurg.140.7.681; Andeweg C, 2008, WORLD J SURG, V32, P1501, DOI 10.1007/s00268-008-9530-z; Bar-Meir S, 2012, DIGEST DIS, V30, P60, DOI 10.1159/000335921; Bianchi M, 2011, ALIMENT PHARM THER, V33, P902, DOI 10.1111/j.1365-2036.2011.04606.x; Binda GA, 2012, BRIT J SURG, V99, P600, DOI 10.1002/bjs.8736; Binda GA, 2012, BRIT J SURG, V99, P276, DOI 10.1002/bjs.7723; Biondo S, 2002, BRIT J SURG, V89, P1137, DOI 10.1046/j.1365-2168.2002.02195.x; Bottner M, 2012, DIGEST DIS, V30, P19, DOI 10.1159/000335699; Brandimarte G, 2004, MED SCI MONITOR, V10, pPI70; Broderick-Villa G, 2005, ARCH SURG-CHICAGO, V140, P576, DOI 10.1001/archsurg.140.6.576; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Chapman J, 2005, ANN SURG, V242, P576, DOI 10.1097/01.sla.0000184843.89836.35; Chapman JR, 2006, ANN SURG, V243, P876, DOI 10.1097/01.sla.0000219682.98158.11; Comparato G, 2007, DIGEST DIS SCI, V52, P2934, DOI 10.1007/s10620-007-9766-8; Costedio MM, 2008, J GASTROINTEST SURG, V12, P1439, DOI 10.1007/s11605-008-0536-5; Costi R, 2012, SURG ENDOSC, V26, P2061, DOI 10.1007/s00464-012-2157-z; Crowe FL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4131; de Korte N, 2011, BRIT J SURG, V98, P761, DOI 10.1002/bjs.7376; Dharmarajan S, 2011, DIS COLON RECTUM, V54, P663, DOI 10.1007/DCR.0b013e31820ef759; Dobbins C, 2006, COLORECTAL DIS, V8, P37, DOI 10.1111/j.1463-1318.2005.00847.x; Dughera L, 2004, Minerva Gastroenterol Dietol, V50, P149; Egger B, 2008, DIS COLON RECTUM, V51, P1044, DOI 10.1007/s10350-008-9234-3; Eglinton T, 2010, BRIT J SURG, V97, P952, DOI 10.1002/bjs.7035; Etzioni DA, 2009, ANN SURG, V249, P210, DOI 10.1097/SLA.0b013e3181952888; Faria GR, 2011, WORLD J GASTROENTERO, V17, P207, DOI 10.3748/wjg.v17.i2.207; Forgione A, 2009, ANN SURG, V249, P218, DOI 10.1097/SLA.0b013e318195c5fc; Fozard JBJ, 2011, COLORECTAL DIS, V13, P1, DOI 10.1111/j.1463-1318.2010.02531.x; Gervaz P, 2012, COLORECTAL DIS, V14, P463, DOI 10.1111/j.1463-1318.2011.02642.x; Gibbons RJ, 2003, CIRCULATION, V107, P2979, DOI 10.1161/01.CIR.0000063682.20730.A5; Goh H, 2002, ANN ROY COLL SURG, V84, P93; Golder M, 2007, COLORECTAL DIS, V9, P218, DOI 10.1111/j.1463-1318.2006.01160.x; Goldstein NS, 2000, AM J SURG PATHOL, V24, P668, DOI 10.1097/00000478-200005000-00005; Guagnini F, 2006, GUT, V55, P946, DOI 10.1136/gut.2005.076372; Guzzo J, 2004, DIS COLON RECTUM, V47, P1187, DOI 10.1007/s10350-004-0546-7; Haboubi NY, 2012, DIGEST DIS, V30, P29, DOI 10.1159/000335704; Hall JF, 2011, DIS COLON RECTUM, V54, P283, DOI 10.1007/DCR.0b013e3182028576; Hjern F, 2008, BRIT J SURG, V95, P758, DOI 10.1002/bjs.6137; Hjern F, 2011, BRIT J SURG, V98, P997, DOI 10.1002/bjs.7477; Hjern F, 2007, SCAND J GASTROENTERO, V42, P41, DOI 10.1080/00365520600780650; Hjern F, 2012, AM J GASTROENTEROL, V107, P296, DOI 10.1038/ajg.2011.352; Humes DJ, 2008, BRIT J SURG, V95, P195, DOI 10.1002/bjs.5962; Humes DJ, 2012, GUT, V61, P95, DOI 10.1136/gut.2011.238808; Issa N, 2009, COLORECTAL DIS, V11, P198, DOI 10.1111/j.1463-1318.2008.01546.x; Iwase H, 2005, J CLIN GASTROENTEROL, V39, P674, DOI 10.1097/01.mcg.0000173856.84814.37; Janes S, 2005, BRIT J SURG, V92, P133, DOI 10.1002/bjs.4873; Kaser SA, 2012, COLORECTAL DIS, V14, pe111, DOI 10.1111/j.1463-1318.2011.02801.x; Kaiser AM, 2005, AM J GASTROENTEROL, V100, P910, DOI 10.1111/j.1572-0241.2005.41154.x; Klarenbeek BR, 2010, ANN SURG, V251, P670, DOI 10.1097/SLA.0b013e3181d3447d; Kotzampassakis N, 2010, DIS COLON RECTUM, V53, P333, DOI 10.1007/DCR.0b013e3181c3808c; Lahat A, 2008, WORLD J GASTROENTERO, V14, P2763, DOI 10.3748/wjg.14.2763; Lahat A, 2006, WORLD J GASTROENTERO, V12, P2932, DOI 10.3748/wjg.v12.i18.2932; Lam TJ, 2010, COLORECTAL DIS, V12, P1122, DOI 10.1111/j.1463-1318.2009.01992.x; Lau KC, 2011, DIS COLON RECTUM, V54, P1265, DOI 10.1097/DCR.0b013e31822899a2; Lidsky ME, 2012, SURGERY, V152, P465, DOI 10.1016/j.surg.2012.06.038; Lopez-Borao J, 2012, COLORECTAL DIS, V14, pE407, DOI 10.1111/j.1463-1318.2012.02976.x; Makela JT, 2009, HEPATO-GASTROENTEROL, V56, P1382; Maselli MA, 2004, DIGEST LIVER DIS, V36, P348, DOI 10.1016/j.dld.2004.01.014; Mizuki A, 2005, ALIMENT PHARM THER, V21, P889, DOI 10.1111/j.1365-2036.2005.02422.x; Morris CR, 2003, GUT, V52, P1734, DOI 10.1136/gut.52.12.1734; Morris CR, 2003, BRIT J SURG, V90, P1267, DOI 10.1002/bjs.4221; Moya P, 2012, TECH COLOPROCTOL, V16, P301, DOI 10.1007/s10151-012-0847-0; Nelson RS, 2006, DIS COLON RECTUM, V49, P1341, DOI 10.1007/s10350-006-0655-6; Nelson RS, 2008, AM J SURG, V196, P969, DOI 10.1016/j.amjsurg.2008.07.035; Oomen JLT, 2006, COLORECTAL DIS, V8, P112, DOI 10.1111/j.1463-1318.2005.00848.x; PARKS TG, 1969, BRIT MED J, V4, P639, DOI 10.1136/bmj.4.5684.639; Pasternak I, 2012, INT J COLORECTAL DIS, V27, P781, DOI 10.1007/s00384-011-1386-2; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Pessaux P, 2004, WORLD J SURG, V28, P92, DOI 10.1007/s00268-003-7146-x; Pittet O, 2009, WORLD J SURG, V33, P547, DOI 10.1007/s00268-008-9898-9; Poletti PA, 2004, AM J ROENTGENOL, V182, P1159, DOI 10.2214/ajr.182.5.1821159; Rafferty J, 2006, DIS COLON RECTUM, V49, P939, DOI 10.1007/s10350-006-0578-2; Regenbogen SE, 2014, JAMA SURG, V149, P292, DOI 10.1001/jamasurg.2013.5477; Ribas Y, 2010, INT J COLORECTAL DIS, V25, P1363, DOI 10.1007/s00384-010-0967-9; Ridgway PF, 2009, COLORECTAL DIS, V11, P941, DOI 10.1111/j.1463-1318.2008.01737.x; Ritz JP, 2011, J GASTROINTEST SURG, V15, P667, DOI 10.1007/s11605-011-1457-2; Ritz JP, 2011, SURGERY, V149, P606, DOI 10.1016/j.surg.2010.10.005; Rosemar A, 2008, DIS COLON RECTUM, V51, P450, DOI 10.1007/s10350-007-9172-5; Schmilovitz-Weiss H, 2012, J CLIN GASTROENTEROL, V46, P317, DOI 10.1097/MCG.0b013e31823a43a1; Schug-Pass C, 2010, INT J COLORECTAL DIS, V25, P751, DOI 10.1007/s00384-010-0899-4; Shabanzadeh DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009092.pub2; Shaikh S, 2007, BRIT J SURG, V94, P876, DOI 10.1002/bjs.5703; Society for Surgery of the Alimentary Tract, PAT CAR GUID; Strate LL, 2008, JAMA-J AM MED ASSOC, V300, P907, DOI 10.1001/jama.300.8.907; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; Strate LL, 2009, AM J GASTROENTEROL, V104, P1221, DOI 10.1038/ajg.2009.121; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tursi A, 2002, DIGEST LIVER DIS, V34, P510, DOI 10.1016/S1590-8658(02)80110-4; Tursi A, 2012, NEUROGASTROENTEROL M, V24; Tursi A, 2011, DIGEST DIS SCI, V56, P3112, DOI 10.1007/s10620-011-1731-x; Unlu C, 2012, INT J COLORECTAL DIS, V27, P419, DOI 10.1007/s00384-011-1308-3; von Rahden BHA, 2012, J GASTROINTEST SURG, V16, P173, DOI 10.1007/s11605-011-1702-8; von Rahden BHA, 2011, LANGENBECK ARCH SURG, V396, P759, DOI 10.1007/s00423-011-0797-4; Westwood DA, 2011, BRIT J SURG, V98, P1630, DOI 10.1002/bjs.7602; Williams PT, 2009, MED SCI SPORT EXER, V41, P1042, DOI 10.1249/MSS.0b013e318192d02d; Wong WD, 2000, DIS COLON RECTUM, V43, P290; World Gastroenterology Organisation, PRACT GUID DIV DIS; Yoo PS, 2008, AM J SURG, V196, P710, DOI 10.1016/j.amjsurg.2008.07.017	104	108	116	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					287	297		10.1001/jama.2013.282025	http://dx.doi.org/10.1001/jama.2013.282025			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24430321				2022-12-28	WOS:000329566400021
J	Mahony, C				Mahony, Chris			2013 was a horrible year for nursing-nurses are "burnt out," says chief	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2014	348								g126	10.1136/bmj.g126	http://dx.doi.org/10.1136/bmj.g126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MN	24423894	Bronze, Green Published			2022-12-28	WOS:000329975900007
J	Macleod, MR; Michie, S; Roberts, I; Dirnagl, U; Chalmers, I; Ioannidis, JPA; Salman, RA; Chan, AW; Glasziou, P				Macleod, Malcolm R.; Michie, Susan; Roberts, Ian; Dirnagl, Ulrich; Chalmers, Iain; Ioannidis, John P. A.; Salman, Rustam Al-Shahi; Chan, An-Wen; Glasziou, Paul			Biomedical research: increasing value, reducing waste	LANCET			English	Editorial Material							HEALTH; TRIAL		[Macleod, Malcolm R.; Salman, Rustam Al-Shahi] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland; [Michie, Susan] UCL, Div Psychol & Language Sci, London, England; [Roberts, Ian] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England; [Dirnagl, Ulrich] Charite, Ctr Stroke Res, D-13353 Berlin, Germany; [Chalmers, Iain] James Lind Initiat, Oxford, England; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Chan, An-Wen] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON, Canada; [Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia	University of Edinburgh; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stanford University; Stanford University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Bond University	Macleod, MR (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland.	malcolm.macleod@ed.ac.uk	Ioannidis, John P. A./G-9836-2011; Glasziou, Paul/A-7832-2008; Macleod, Malcolm Robert/B-2052-2010; Michie, Susan/A-1745-2010	Glasziou, Paul/0000-0001-7564-073X; Macleod, Malcolm Robert/0000-0001-9187-9839; Michie, Susan/0000-0003-0063-6378; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Dirnagl, Ulrich/0000-0003-0755-6119	MRC [G1002605] Funding Source: UKRI; Medical Research Council [G1002605] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10057] Funding Source: researchfish; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish; National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/L000970/1] Funding Source: Medline; Department of Health [NF-SI-0611-10057] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement; National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Department of Health		Al-Shahi Salman R, 2014, LANCET; Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Chalmers I, 2014, LANCET; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan A-W, 2014, LANCET; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Glasziou P, 2014, LANCET; Ioannidis J.P., 2014, LANCET; Jefferson T., 2003, PEER REV HLTH SCI; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; Krumholz SD, 2011, ARCH INTERN MED, V171, P1100, DOI 10.1001/archinternmed.2011.241; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Minnerup J, 2010, J CEREBR BLOOD F MET, V30, P1619, DOI 10.1038/jcbfm.2010.74; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Petit-Zeman S, 2010, LANCET, V376, P667, DOI 10.1016/S0140-6736(10)60712-X; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Shaw S, 2006, J ROY SOC MED, V99, P14, DOI 10.1258/jrsm.99.1.14; Stamatakis E, 2013, EUR J CLIN INVEST, V43, P469, DOI 10.1111/eci.12074; Sullivan FM, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13470; The Academy of Medical Sciences, NEW PATHW REG MED RE; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1	23	550	568	1	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					101	104		10.1016/S0140-6736(13)62329-6	http://dx.doi.org/10.1016/S0140-6736(13)62329-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	287YX	24411643				2022-12-28	WOS:000329579600006
J	Kaiser, D				Kaiser, David			Shut up and calculate!	NATURE			English	Editorial Material									MIT, Program Sci Technol & Soc, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kaiser, D (corresponding author), MIT, Program Sci Technol & Soc, Cambridge, MA 02139 USA.	dikaiser@mit.edu	Kaiser, David/C-7149-2014	Kaiser, David/0000-0002-5054-6744				Anderson Oscar E., 1962, HIST US ATOMIC ENERG, VI; FORMAN P, 1987, HIST STUD PHYS BIOL, V18, P149, DOI 10.2307/27757599; Galison P., 1997, IMAGE LOGIC MAT CULT; Guerlac Henry, 1987, RADAR WORLD WAR 2; Kaiser David, 2011, HIPPIES SAVED PHYS S; LESLIE S., 1993, COLD WAR AM SCI; Munns David D. P., 2013, SINGLE SKY INT COMMU; ROBERTS A, 1948, PHYS TODAY, V1, P17; Schweber S.S., 1994, QED MEN WHO MADE IT; Westwick Peter J., 2003, NATL LABS SCI AM SYS	10	11	11	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					153	155		10.1038/505153a	http://dx.doi.org/10.1038/505153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286CG	24409511	Bronze			2022-12-28	WOS:000329441500012
J	Lakdawalla, DN; Jena, AB; Doctor, JN				Lakdawalla, Darius N.; Jena, Anupam B.; Doctor, Jason N.			Careful Use of Science to Advance the Debate on the UK Cancer Drugs Fund	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFE; END		[Lakdawalla, Darius N.; Doctor, Jason N.] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	University of Southern California; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu	Lakdawalla, Darius/B-4409-2011	Lakdawalla, Darius/0000-0001-5934-8042	NIA NIH HHS [RC4 AG039036, P30 AG043073, RC4AG039036] Funding Source: Medline; NIH HHS [DP5 OD017897, 1DP5OD017897-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [RC4AG039036] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Lakdawalla DN, 2012, HEALTH AFFAIR, V31, P676, DOI 10.1377/hlthaff.2011.1300; Linley WG, 2013, HEALTH ECON, V22, P948, DOI 10.1002/hec.2872; Purushotham A., 2010, LANCET, V376, P389; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; VERHOEF LCG, 1994, MED DECIS MAKING, V14, P194, DOI 10.1177/0272989X9401400213	8	3	3	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					25	26		10.1001/jama.2013.282839	http://dx.doi.org/10.1001/jama.2013.282839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24381964	Green Accepted			2022-12-28	WOS:000329161400012
J	Pannicke, U; Baumann, B; Fuchs, S; Henneke, P; Rensing-Ehl, A; Rizzi, M; Janda, A; Hese, K; Schlesier, M; Holzmann, K; Borte, S; Laux, C; Rump, EM; Rosenberg, A; Zelinski, T; Schrezenmeier, H; Wirth, T; Ehl, S; Schroeder, ML; Schwarz, K				Pannicke, Ulrich; Baumann, Bernd; Fuchs, Sebastian; Henneke, Philipp; Rensing-Ehl, Anne; Rizzi, Marta; Janda, Ales; Hese, Katrin; Schlesier, Michael; Holzmann, Karlheinz; Borte, Stephan; Laux, Constanze; Rump, Eva-Maria; Rosenberg, Alan; Zelinski, Teresa; Schrezenmeier, Hubert; Wirth, Thomas; Ehl, Stephan; Schroeder, Marlis L.; Schwarz, Klaus			Deficiency of Innate and Acquired Immunity Caused by an IKBKB Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NF-KAPPA-B; T-CELLS; ECTODERMAL DYSPLASIA; LIVER DEGENERATION; SIGNALING PATHWAYS; ALPHA MUTATION; KINASE-BETA; IKK-BETA; ACTIVATION; TRANSCRIPTION	BackgroundSevere combined immunodeficiency (SCID) comprises a heterogeneous group of heritable deficiencies of humoral and cell-mediated immunity. Many patients with SCID have lymphocyte-activation defects that remain uncharacterized. MethodsWe performed genetic studies in four patients, from four families of Northern Cree ancestry, who had clinical characteristics of SCID, including early onset of severe viral, bacterial, and fungal infections despite normal B-cell and T-cell counts. Genomewide homozygosity mapping was used to identify a candidate region, which was found on chromosome 8; all genes within this interval were sequenced. Immune-cell populations, signal transduction on activation, and effector functions were studied. ResultsThe patients had hypogammaglobulinemia or agammaglobulinemia, and their peripheral-blood B cells and T cells were almost exclusively of naive phenotype. Regulatory T cells and T cells were absent. All patients carried a homozygous duplication c.1292dupG in exon 13 of IKBKB, which encodes IB kinase 2 (IKK2, also known as IKK) leading to loss of expression of IKK2, a component of the IKK-nuclear factor B (NF-B) pathway. Immune cells from the patients had impaired responses to stimulation through T-cell receptors, B-cell receptors, toll-like receptors, inflammatory cytokine receptors, and mitogens. ConclusionsA form of human SCID is characterized by normal lymphocyte development despite a loss of IKK2 function. IKK2 deficiency results in an impaired response to activation stimuli in a variety of immune cells, leading to clinically relevant impairment of adaptive and innate immunity. Although Ikk2 deficiency is lethal in mouse embryos, our observations suggest a more restricted, unique role of IKK2-NF-B signaling in humans. (Funded by the German Federal Ministry of Education and Research and others.)	[Pannicke, Ulrich; Laux, Constanze; Schrezenmeier, Hubert; Schwarz, Klaus] Univ Ulm, Univ Hosp Ulm, Inst Transfus Med, D-89069 Ulm, Germany; [Baumann, Bernd; Wirth, Thomas] Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany; [Holzmann, Karlheinz] Univ Ulm, Ctr Biomed Res, Genom Core Facil, D-89069 Ulm, Germany; [Rump, Eva-Maria; Schrezenmeier, Hubert; Schwarz, Klaus] German Red Cross Blood Serv Baden Wuerttemberg Ha, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany; [Fuchs, Sebastian; Henneke, Philipp; Rensing-Ehl, Anne; Rizzi, Marta; Janda, Ales; Hese, Katrin; Schlesier, Michael; Ehl, Stephan] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Fuchs, Sebastian] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Henneke, Philipp; Ehl, Stephan] Univ Hosp Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Schlesier, Michael] Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Borte, Stephan] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Borte, Stephan] Karolinska Univ, Huddinge Hosp, Div Clin Immunol & Transfus Med, Dept Lab Med,Karolinska Inst, Stockholm, Sweden; [Rosenberg, Alan] Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada; [Zelinski, Teresa] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Zelinski, Teresa; Schroeder, Marlis L.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada	Ulm University; Ulm University; Ulm University; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Leipzig University; Karolinska Institutet; Karolinska University Hospital; University of Saskatchewan; University of Manitoba; University of Manitoba	Schwarz, K (corresponding author), Univ Ulm, Univ Hosp Ulm, Inst Transfus Med, D-89069 Ulm, Germany.	klaus.schwarz@uni-ulm.de; klaus.schwarz@uni-ulm.de	Wirth, Thomas/X-7172-2019; Pannicke, Ulrich/D-7348-2014; Rizzi, Marta/ABE-7264-2020; Ehl, Stephan/AAM-6006-2020	Ehl, Stephan/0000-0002-9265-2721; Rizzi, Marta/0000-0002-5153-6089; Fuchs, Sebastian/0000-0001-9191-7970	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funded by the German Federal Ministry of Education and Research and others	Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Dvorak CC, 2013, J CLIN IMMUNOL; Gerondakis S, 2012, IMMUNOL REV, V246, P272, DOI 10.1111/j.1600-065X.2011.01090.x; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Granados EL, 2008, HUM MUTAT, V29, P861, DOI 10.1002/humu.20740; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jain G, 2012, NEOPLASIA, V14, P178, DOI 10.1593/neo.111444; Janssen R, 2004, J EXP MED, V200, P559, DOI 10.1084/jem.20040773; Lahtela J, 2010, NEW ENGL J MED, V363, P1631, DOI 10.1056/NEJMoa0911698; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Lupino E, 2012, J IMMUNOL, V188, P2545, DOI 10.4049/jimmunol.1102938; McDonald DR, 2007, J ALLERGY CLIN IMMUN, V120, P900, DOI 10.1016/j.jaci.2007.08.035; Mooster JL, 2010, J ALLERGY CLIN IMMUN, V126, P127, DOI 10.1016/j.jaci.2010.04.026; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Schmidt-Supprian M, 2004, J IMMUNOL, V173, P1612, DOI 10.4049/jimmunol.173.3.1612; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; van Gent R, 2010, CLIN IMMUNOL, V136, P307, DOI 10.1016/j.clim.2010.03.431; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	32	124	129	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2504	2514		10.1056/NEJMoa1309199	http://dx.doi.org/10.1056/NEJMoa1309199			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24369075				2022-12-28	WOS:000328863700008
J	Attia, E				Attia, Evelyn			Anorexia nervosa in adolescents: challenges remain	LANCET			English	Editorial Material									[Attia, Evelyn] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Attia, Evelyn] Weill Cornell Med Coll, New York, NY USA	Columbia University; Cornell University	Attia, E (corresponding author), Columbia Univ, Med Ctr, New York, NY 10032 USA.	ea12@columbia.edu						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Attia E, 2007, AM J PSYCHIAT, V164, P1805, DOI 10.1176/appi.ajp.2007.07071151; Attia E, 2009, NEW ENGL J MED, V360, P500, DOI 10.1056/NEJMct0805569; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; Herpertz-Dahlmann B, 2013, LANCET; Kaplan AS, 2009, PSYCHOL MED, V39, P1037, DOI 10.1017/S003329170800442X; Lock J, 2010, ARCH GEN PSYCHIAT, V67, P1025, DOI 10.1001/archgenpsychiatry.2010.128; Olmsted MP, 2013, PSYCHOTHER RES, V23, P277, DOI 10.1080/10503307.2012.721937; Striegel-Moore RH, 2000, INT J EAT DISORDER, V27, P381; Walsh BT, 2013, AM J PSYCHIAT, V170, P477, DOI 10.1176/appi.ajp.2012.12081074	10	9	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1191	1192		10.1016/S0140-6736(13)62550-7	http://dx.doi.org/10.1016/S0140-6736(13)62550-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24439239				2022-12-28	WOS:000334104600006
J	Furman, RR; Sharman, JP; Coutre, SE; Cheson, BD; Pagel, JM; Hillmen, P; Barrientos, JC; Zelenetz, AD; Kipps, TJ; Flinn, I; Ghia, P; Eradat, H; Ervin, T; Lamanna, N; Coiffier, B; Pettitt, AR; Ma, S; Stilgenbauer, S; Cramer, P; Aiello, M; Johnson, DM; Miller, LL; Li, D; Jahn, TM; Dansey, RD; Hallek, M; O'Brien, SM				Furman, Richard R.; Sharman, Jeff P.; Coutre, Steven E.; Cheson, Bruce D.; Pagel, John M.; Hillmen, Peter; Barrientos, Jacqueline C.; Zelenetz, Andrew D.; Kipps, Thomas J.; Flinn, Ian; Ghia, Paolo; Eradat, Herbert; Ervin, Thomas; Lamanna, Nicole; Coiffier, Bertrand; Pettitt, Andrew R.; Ma, Shuo; Stilgenbauer, Stephan; Cramer, Paula; Aiello, Maria; Johnson, Dave M.; Miller, Langdon L.; Li, Daniel; Jahn, Thomas M.; Dansey, Roger D.; Hallek, Michael; O'Brien, Susan M.			Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOMIC ABERRATIONS; SURVIVAL; INHIBITOR; EXPRESSION; CAL-101; MUTATION; DISEASE; PI3K	BackgroundPatients with relapsed chronic lymphocytic leukemia (CLL) who have clinically significant coexisting medical conditions are less able to undergo standard chemotherapy. Effective therapies with acceptable side-effect profiles are needed for this patient population. MethodsIn this multicenter, randomized, double-blind, placebo-controlled, phase 3 study, we assessed the efficacy and safety of idelalisib, an oral inhibitor of the delta isoform of phosphatidylinositol 3-kinase, in combination with rituximab versus rituximab plus placebo. We randomly assigned 220 patients with decreased renal function, previous therapy-induced myelosuppression, or major coexisting illnesses to receive rituximab and either idelalisib (at a dose of 150 mg) or placebo twice daily. The primary end point was progression-free survival. At the first prespecified interim analysis, the study was stopped early on the recommendation of the data and safety monitoring board owing to overwhelming efficacy. ResultsThe median progression-free survival was 5.5 months in the placebo group and was not reached in the idelalisib group (hazard ratio for progression or death in the idelalisib group, 0.15; P<0.001). Patients receiving idelalisib versus those receiving placebo had improved rates of overall response (81% vs. 13%; odds ratio, 29.92; P<0.001) and overall survival at 12 months (92% vs. 80%; hazard ratio for death, 0.28; P=0.02). Serious adverse events occurred in 40% of the patients receiving idelalisib and rituximab and in 35% of those receiving placebo and rituximab. ConclusionsThe combination of idelalisib and rituximab, as compared with placebo and rituximab, significantly improved progression-free survival, response rate, and overall survival among patients with relapsed CLL who were less able to undergo chemotherapy. (Funded by Gilead; ClinicalTrials.gov number, NCT01539512.) A placebo-controlled study of idelalisib in patients with relapsed chronic lymphocytic leukemia who were receiving rituximab was stopped early because of significant improvement in rates of response, progression-free survival, and overall survival with idelalisib. Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia among adults. Standard treatments include combinations of purine analogues, alkylating agents, and monoclonal antibodies. In younger patients without major coexisting illnesses, these regimens can provide high response rates of durable length but have substantial toxic effects. As a result, these treatments often have unacceptable side effects in older patients and those with coexisting illnesses.(1) Patients with relapsed CLL often have limited options because of the development of resistance to, or persisting toxic effects of, previous therapies. This is particularly true for elderly patients and those with coexisting illnesses.(2) For these patients, ...	[Furman, Richard R.] Weill Cornell Med Coll, New York, NY USA; [Zelenetz, Andrew D.] Columbia Univ, Mem Sloan Kettering Canc Ctr, Med Ctr, New York, NY USA; [Lamanna, Nicole] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Sharman, Jeff P.] US Oncol Res, Springfield, OR USA; [Coutre, Steven E.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Aiello, Maria; Johnson, Dave M.; Miller, Langdon L.; Li, Daniel; Jahn, Thomas M.; Dansey, Roger D.] Gilead Sci Inc, Foster City, CA 94404 USA; [Cheson, Bruce D.] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Pagel, John M.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Hillmen, Peter] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Pettitt, Andrew R.] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Barrientos, Jacqueline C.] Hofstra North Shore LIJ, Sch Med, New Hyde Pk, NY USA; [Kipps, Thomas J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Flinn, Ian] Sarah Cannon Res Inst, Nashville, TN USA; [Ghia, Paolo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Milan, Italy; [Eradat, Herbert] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ervin, Thomas] Florida Canc Specialists, Englewood, CO USA; [Coiffier, Bertrand] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France; [Ma, Shuo] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Stilgenbauer, Stephan] Univ Ulm, D-89069 Ulm, Germany; [Cramer, Paula; Hallek, Michael] Univ Cologne, D-50931 Cologne, Germany; [O'Brien, Susan M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Cornell University; Columbia University; Memorial Sloan Kettering Cancer Center; Columbia University; US Oncology Network; Stanford University; Gilead Sciences; Georgetown University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Saint James's University Hospital; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Hofstra University; University of California System; University of California San Diego; Sarah Cannon Research Institute; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CHU Lyon; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ulm University; University of Cologne; University of Texas System; UTMD Anderson Cancer Center	Furman, RR (corresponding author), Weill Cornell Med Coll, Div Hematol Oncol, 525 E 68th St, New York, NY 10065 USA.	rrfurman@med.cornell.edu	Ghia, Paolo/K-7138-2016; Barrientos, Jacqueline/AAE-6683-2022; Lamanna, Nicole/ABB-7835-2020; Stilgenbauer, Stephan/ABE-6609-2020; Hallek, Michael/Y-3191-2019	Ghia, Paolo/0000-0003-3750-7342; Lamanna, Nicole/0000-0003-3331-9491; Hallek, Michael/0000-0002-7425-4455; Coutre, Steven/0000-0001-8420-5748; Flinn, Ian/0000-0001-6724-290X; Barrientos, Jacqueline Claudia/0000-0001-6018-5535	Gilead; NATIONAL CANCER INSTITUTE [P01CA081534, P30CA060553, P30CA016672] Funding Source: NIH RePORTER	Gilead(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Gilead	Barrientos JC, 2013, J CLIN ONCOL, V31; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Brown JR, 2013, J CLIN ONCOL, V31; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Byrd JC, 2001, J CLIN ONCOL, V19, P2153, DOI 10.1200/JCO.2001.19.8.2153; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Cheson BD, 2012, J CLIN ONCOL, V30, P2820, DOI 10.1200/JCO.2012.43.3748; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Eichhorst B, 2009, LEUKEMIA LYMPHOMA, V50, P171, DOI 10.1080/10428190802688517; Extermann M, 1998, J CLIN ONCOL, V16, P1582, DOI 10.1200/JCO.1998.16.4.1582; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Gribben JG, 2011, J CLIN ONCOL, V29, P544, DOI 10.1200/JCO.2010.32.3865; Hallek M, 2012, BLOOD; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Huhn D, 2001, BLOOD, V98, P1326, DOI 10.1182/blood.V98.5.1326; Itala M, 2002, EUR J HAEMATOL, V69, P129, DOI 10.1034/j.1600-0609.2002.02786.x; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; O'Brien SM, 2001, J CLIN ONCOL, V19, P2165, DOI 10.1200/JCO.2001.19.8.2165; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Wierda, 2010, J CLIN ONCOL, V28, P3670, DOI 10.1200/JCO.2010.31.3544; Wierda WG, 2010, J CLIN ONCOL, V28, P1749, DOI 10.1200/JCO.2009.25.3187; Zenz T, 2010, J CLIN ONCOL, V28, P4473, DOI 10.1200/JCO.2009.27.8762	31	1262	1306	1	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					997	1007		10.1056/NEJMoa1315226	http://dx.doi.org/10.1056/NEJMoa1315226			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24450857	Green Accepted			2022-12-28	WOS:000332689100007
J	Nakada, D; Oguro, H; Levi, BP; Ryan, N; Kitano, A; Saitoh, Y; Takeichi, M; Wendt, GR; Morrison, SJ				Nakada, Daisuke; Oguro, Hideyuki; Levi, Boaz P.; Ryan, Nicole; Kitano, Ayumi; Saitoh, Yusuke; Takeichi, Makiko; Wendt, George R.; Morrison, Sean J.			Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy	NATURE			English	Article							RECEPTOR-ALPHA; BONE-MARROW; EXPRESSION; PROGENITORS; DIVISION; MICE	Sexually dimorphic mammalian tissues, including sexual organs and the brain, contain stem cells that are directly or indirectly regulated by sex hormones(1-6). An important question is whether stem cells also exhibit sex differences in physiological function and hormonal regulation in tissues that do not show sex-specific morphological differences. The terminal differentiation and function of some haematopoietic cells are regulated by sex hormones(7-10), but haematopoietic stem-cell function is thought to be similar in both sexes. Here we show that mouse haematopoietic stem cells exhibit sex differences in cell-cycle regulation by oestrogen. Haematopoietic stem cells in female mice divide significantly more frequently than in male mice. This difference depends on the ovaries but not the testes. Administration of oestradiol, a hormone produced mainly in the ovaries, increased haematopoietic stem-cell division in males and females. Oestrogen levels increased during pregnancy, increasing haematopoietic stem-cell division, haematopoietic stem-cell frequency, cellularity, and erythropoiesis in the spleen. Haematopoietic stem cells expressed high levels of oestrogen receptor-alpha (ER alpha). Conditional deletion of ER alpha from haematopoietic stem cells reduced haematopoietic stem-cell division in female, but not male, mice and attenuated the increases in haematopoietic stem-cell division, haematopoietic stem-cell frequency, and erythropoiesis during pregnancy. Oestrogen/ER alpha signalling promotes haematopoietic stem-cell self-renewal, expanding splenic haematopoietic stem cells and erythropoiesis during pregnancy.	[Nakada, Daisuke; Ryan, Nicole; Kitano, Ayumi; Saitoh, Yusuke; Takeichi, Makiko] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Nakada, Daisuke] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Nakada, Daisuke] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Oguro, Hideyuki; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pediat, Dallas, TX 75390 USA; [Oguro, Hideyuki; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Levi, Boaz P.; Wendt, George R.] Univ Michigan, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan	Nakada, D (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	nakada@bcm.edu; Sean.Morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021; Oguro, Hideyuki/Q-5478-2019	Oguro, Hideyuki/0000-0002-9070-4575; Wendt, George/0000-0002-8302-079X; Morrison, Sean/0000-0003-1587-8329; Nakada, Daisuke/0000-0001-6010-7094	Cancer Prevention and Research Institute of Texas; National Heart Lung and Blood Institute [HL097760]; Irvington Institute-Cancer Research Institute/Edmond J. Safra Memorial Fellowship; National Institutes of Health (NCRR) [S10RR024574, NIAID AI036211, NCI P30CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Irvington Institute-Cancer Research Institute/Edmond J. Safra Memorial Fellowship; National Institutes of Health (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.J.M. is a Howard Hughes Medical Institute Investigator and the Mary McDermott Cook Chair in Pediatric Genetics. This work was supported by the Cancer Prevention and Research Institute of Texas (awards to D.N. and S.J.M.) and the National Heart Lung and Blood Institute (HL097760 to S.J.M.). B.P.L. was supported by an Irvington Institute-Cancer Research Institute/Edmond J. Safra Memorial Fellowship. Flow-cytometry was partially supported by the National Institutes of Health (NCRR grant S10RR024574, NIAID AI036211 and NCI P30CA125123) for the BCM Cytometry and Cell Sorting Core. We also thank J. Richards, S. Mani and former members of the Nakada laboratory for discussions. This work was initiated in the Life Sciences Institute at the University of Michigan then completed at Baylor College of Medicine and Children's Research Institute at UT Southwestern. We thank the University of Virginia Center for Research in Reproduction for measuring serum hormone levels. This work is dedicated to Nicole Ryan who passed away during the study.	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; BLOBEL GA, 1995, MOL CELL BIOL, V15, P3147; Blobel GA, 1996, MOL CELL BIOL, V16, P1687, DOI 10.1128/mcb.16.4.1687; Carreras E, 2008, J IMMUNOL, V180, P727, DOI 10.4049/jimmunol.180.2.727; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Ghazeeri G, 2011, AM J REPROD IMMUNOL, V66, P163, DOI 10.1111/j.1600-0897.2011.01052.x; Gourdy P, 2005, BLOOD, V105, P2415, DOI 10.1182/blood-2004-07-2819; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Mahendroo MS, 1997, MOL ENDOCRINOL, V11, P917, DOI 10.1210/me.11.7.917; Maymon R, 2006, ULTRASOUND MED BIOL, V32, P1827, DOI 10.1016/j.ultrasmedbio.2006.06.017; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; SHEEHAN HL, 1948, BRIT MED J, V2, P1105, DOI 10.1136/bmj.2.4590.1105; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thurmond TS, 2000, ENDOCRINOLOGY, V141, P2309, DOI 10.1210/en.141.7.2309; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wit JM, 2012, NAT REV ENDOCRINOL, V8, P135, DOI 10.1038/nrendo.2011.161; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	38	228	239	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					555	+		10.1038/nature12932	http://dx.doi.org/10.1038/nature12932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451543	Green Accepted			2022-12-28	WOS:000329995000041
J	Ortega, R; Connor, C; Rodriguez, G; Spencer, C				Ortega, Rafael; Connor, Christopher; Rodriguez, Gerardo; Spencer, Caresse			Endotracheal Extubation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Endotracheal extubation the removal of an endotracheal tube from the trachea is frequently performed in operating rooms, postanesthesia care units, and intensive care units. This review focuses on extubation after general anesthesia and short-term intubation.	[Ortega, Rafael; Connor, Christopher; Rodriguez, Gerardo; Spencer, Caresse] Boston Med Ctr, Boston, MA USA	Boston Medical Center	Ortega, R (corresponding author), Boston Univ, Med Ctr, Dept Anesthesiol, 88 E Newton St, Boston, MA 02118 USA.	rafael.ortega@bmc.org							0	9	9	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3							e4	10.1056/NEJMvcm1300964	http://dx.doi.org/10.1056/NEJMvcm1300964			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428490				2022-12-28	WOS:000330035600001
J	Salman, RA; Beller, E; Kagan, J; Hemminki, E; Phillips, RS; Savulescu, J; Macleod, M; Wisely, J; Chalmers, I				Salman, Rustam Al-Shahi; Beller, Elaine; Kagan, Jonathan; Hemminki, Elina; Phillips, Robert S.; Savulescu, Julian; Macleod, Malcolm; Wisely, Janet; Chalmers, Iain			Increasing value and reducing waste in biomedical research regulation and management	LANCET			English	Article							RESEARCH ETHICS COMMITTEES; CLINICAL-TRIALS; RESEARCH GOVERNANCE; HEALTH-CARE; RANDOMIZED-TRIALS; CHILDHOOD-CANCER; INFORMED-CONSENT; DATA QUALITY; IMPACT; UK	After identification of an important research question and selection of an appropriate study design, waste can arise from the regulation, governance, and management of biomedical research. Obtaining regulatory and governance approval has become increasingly burdensome and disproportionate to the conceivable risks to research participants. Regulation and governance involve interventions that are assumed to be justified in the interests of patients and the public, but they can actually compromise these interests. Inefficient management of the procedural conduct of research is wasteful, especially if it results in poor recruitment and retention of participants in well designed studies addressing important questions. These sources of waste can be minimised if the following four recommendations are addressed. First, regulators should use their influence to reduce other causes of waste and inefficiency in research. Second, regulators and policy makers should work with researchers, patients, and health professionals to streamline and harmonise the laws, regulations, guidelines, and processes that govern whether and how research can be done, and ensure that they are proportionate to the plausible risks associated with the research. Third, researchers and research managers should increase the efficiency of recruitment, retention, data monitoring, and data sharing in research through use of research designs known to reduce inefficiencies, and further research should be done to learn how efficiency can be increased. Finally, everyone, particularly those responsible for health-care systems, should promote integration of research into everyday clinical practice. Regulators and researchers should monitor adherence to each of these recommendations and publish metrics.	[Salman, Rustam Al-Shahi; Macleod, Malcolm] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Beller, Elaine] Bond Univ, Ctr Res Evidence Based Practice, Robina, Qld, Australia; [Kagan, Jonathan] NIAID, Div Clin Res, Bethesda, MD 20892 USA; [Hemminki, Elina] Natl Inst Hlth & Welf, Helsinki, Finland; [Phillips, Robert S.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Savulescu, Julian] Univ Oxford, Oxford Ctr Neuroeth, Oxford, England; [Wisely, Janet] Hlth Res Author, London, England; [Chalmers, Iain] James Lind Initiat, Oxford, England	University of Edinburgh; Bond University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Finland National Institute for Health & Welfare; University of York - UK; University of Oxford	Salman, RA (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Bramwell Dott Bldg, Edinburgh EH4 2XU, Midlothian, Scotland.	rustam.al-shahi@ed.ac.uk	Macleod, Malcolm Robert/B-2052-2010; Beller, Elaine/E-1615-2013	Macleod, Malcolm Robert/0000-0001-9187-9839; Phillips, Bob/0000-0002-4938-9673; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Beller, Elaine/0000-0002-3241-2611	National Institute for Health Research (UK); Medical Research Council (UK); MRC [G1002605] Funding Source: UKRI; Medical Research Council [G1002605] Funding Source: researchfish	National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Sarah Thorning (Bond University, Robina, QLD, Australia) for her assistance with citation searching; Johan Sundstrom and Susanne Heller (Uppsala Clinical Research Centre, Uppsala University Hospital, Uppsala, Sweden) for their permission to use the case study in panel 1 and figure 1; and Nancy Lester (National Institute for Health Research's Clinical Research Network, Leeds, UK) for her comments about this manuscript and for panel 5 and figure 3. IC is funded by the National Institute for Health Research (UK), and RA-SS is funded by a Medical Research Council (UK) senior clinical fellowship.	Academy of Medical Sciences, 2011, NEW PATHW REG GOV HL; Al-Shahi R, 2005, J ROY SOC MED, V98, P444, DOI 10.1258/jrsm.98.10.444; [Anonymous], 1990, LANCET, V336, P846; [Anonymous], 2010, OFF J EUR UNION L, V273, P33; Baigent C, 2008, CLIN TRIALS, V5, P49, DOI 10.1177/1740774507087554; Bakobaki J, 2012, CLIN TRIALS, V9, P777, DOI 10.1177/1740774512458993; Bakobaki JM, 2012, CLIN TRIALS, V9, P257, DOI 10.1177/1740774511427325; Barrett G, 2006, BMJ-BRIT MED J, V332, P1068, DOI 10.1136/bmj.38805.473738.7C; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; Blunt J, 1998, BMJ-BRIT MED J, V316, P58, DOI 10.1136/bmj.316.7124.58; Bollyky TJ, 2010, CLIN TRIALS, V7, P719, DOI 10.1177/1740774510386390; Burnett J, 2007, BMJ-BRIT MED J, V334, P671; Califf RM, 2003, CONTROL CLIN TRIALS, V24, P256, DOI 10.1016/S0197-2456(03)00005-9; Califf RM, 2006, CLIN TRIALS, V3, P496, DOI 10.1177/1740774506073173; Campbell M K, 2007, Health Technol Assess, V11, pix; Chalmers I, 2000, LANCET, V356, P774, DOI 10.1016/S0140-6736(05)73681-3; CHALMERS I, 2007, INT J PHARM MED, V21, P395; Chalmers I, 2007, J ROY SOC MED, V100, P440, DOI 10.1258/jrsm.100.10.440; Chalmers I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5776; Chalmers I, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-102; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chalmers L, 2000, J ROY SOC MED, V93, P555, DOI 10.1177/014107680009301101; Christie DRH, 2007, INTERN MED J, V37, P680, DOI 10.1111/j.1445-5994.2007.01451.x; Clarke M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-16; Department of Health (Research and Development Directorate), 2006, BEST RES BEST HLTH N; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Edwards SJL, 1998, SOC SCI MED, V47, P1825, DOI 10.1016/S0277-9536(98)00235-4; Ennis L, 2013, BRIT J PSYCHIAT, V203, P381, DOI 10.1192/bjp.bp.112.119818; European Forum for Good Clinical Practice (EFGCP), 2009, IMP CLIN RES EUR LEG; Evans I, 2011, TESTING TREATMENTS B; Fern L, 2008, BRIT J CANCER, V99, P1967, DOI 10.1038/sj.bjc.6604751; Fletcher B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000496; Fonville AF, 2013, STROKE, V44, P2729, DOI 10.1161/STROKEAHA.113.001493; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Forsberg JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5647; Frewer LJ, 2011, BONE MARROW TRANSPL, V46, P443, DOI 10.1038/bmt.2010.139; Fudge N, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4625; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; GMC, 2006, GOOD MED PRACT; GMC, 2013, GOOD MED PRACT; Godlee F, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c725; Gotzsche PC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8522; Hansson MG, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2335; Hedgecoe A, 2006, J MED ETHICS, V32, P483, DOI 10.1136/jme.2005.013888; Institute for Laboratory Animal Research National Research Council, 1996, GUIDE CARE USE LAB A; Jester PM, 2006, CONTEMP CLIN TRIALS, V27, P254, DOI 10.1016/j.cct.2006.02.004; Journot V, 2011, CONTEMP CLIN TRIALS, V32, P16, DOI 10.1016/j.cct.2010.10.001; Junghans C, 2005, BMJ-BRIT MED J, V331, P940, DOI 10.1136/bmj.38583.625613.AE; Katz J, 1996, JAMA-J AM MED ASSOC, V276, P1662, DOI 10.1001/jama.276.20.1662; Kho ME, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b866; Kramer JM, 2012, CLIN PHARMACOL THER, V91, P535, DOI 10.1038/clpt.2011.341; Lambers Heerspink HJ, 2008, BRIT J CLIN PHARMACO, V66, P546, DOI 10.1111/j.1365-2125.2008.03246.x; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Macefield RC, 2013, CLIN TRIALS, V10, P104, DOI 10.1177/1740774512467405; Majumdar SR, 2008, ARCH INTERN MED, V168, P657, DOI 10.1001/archinternmed.2007.124; da Silva MEM, 2012, J MED ETHICS, V38, P639, DOI 10.1136/medethics-2011-100208; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; McJoynt TA, 2009, J CLIN ONCOL, V27, P3855, DOI 10.1200/JCO.2008.21.4338; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; Medicines and Healthcare Products Regulatory Agency, 2012, RISK AD APPR MAN CLI; Millum J, 2013, JAMA-J AM MED ASSOC, V310, P2143, DOI 10.1001/jama.2013.281632; Neaton JD, 2010, CLIN TRIALS, V7, P705, DOI 10.1177/1740774510376547; O'Leary M, 2008, SEMIN ONCOL, V35, P484, DOI 10.1053/j.seminoncol.2008.07.008; Papanikolaou PN, 2006, PLOS MED, V3, P1603, DOI 10.1371/journal.pmed.0030341; Pappworth M. H., 1962, 20 CENTURY, P66; Peddicord D, 2010, HEALTH AFFAIR, V29, P2082, DOI 10.1377/hlthaff.2010.0635; Prescott RJ, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/hta3200; Reith C, 2013, NEW ENGL J MED, V369, P1061, DOI 10.1056/NEJMsb1300760; Rendell JM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000021.pub3; Roberts I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3879; Roberts I, 2011, LANCET, V377, P1071, DOI 10.1016/S0140-6736(11)60317-6; Rogers CG, 1998, J PEDIATR-US, V132, P606, DOI 10.1016/S0022-3476(98)70347-6; Rothwell PM, 2006, LANCET, V368, P262, DOI 10.1016/S0140-6736(06)69010-7; Russell WMS., 1959, MED J AUSTRALIA; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Savulescu J, 2010, ROUTLEDGE COMPANION, P781; Shaw S, 2006, J ROY SOC MED, V99, P14, DOI 10.1258/jrsm.99.1.14; Shaw S, 2005, J ROY SOC MED, V98, P496, DOI 10.1258/jrsm.98.11.496; Slowther A, 2006, J ROY SOC MED, V99, P65, DOI 10.1258/jrsm.99.2.65; Smith CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051623; Smithells R., 1975, POSTGRAD MED J, V15, P39; Smyth RL, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6756; Stiller CA, 2012, ANN ONCOL, V23, P2464, DOI 10.1093/annonc/mds183; Stiller CA, 1999, ARCH DIS CHILD, V81, P202, DOI 10.1136/adc.81.3.202; Sully BGO, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-166; Tobias, 2001, INFORMED CONSENT MED, P266; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub5, 10.1002/14651858.MR000013.pub4]; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Tupasela A, 2010, SCAND J PUBLIC HEALT, V38, P46, DOI 10.1177/1403494809353824; Unguru Y, 2011, PEDIATR BLOOD CANCER, V56, P1019, DOI 10.1002/pbc.22976; van Staa TP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e55; Venet D, 2012, CLIN TRIALS, V9, P705, DOI 10.1177/1740774512447898; Vist GE, 2008, COCHRANE DB SYST REV, V16, DOI DOI 10.1002/14651858.MR000009.PUB4; Warlow C, 2006, LANCET, V367, P12, DOI 10.1016/S0140-6736(06)67902-6; Warlow C, 2005, CLIN MED, V5, P33, DOI 10.7861/clinmedicine.5-1-33; Watson Judith M, 2006, BMC Med Res Methodol, V6, P34, DOI 10.1186/1471-2288-6-34; Weisfeld V, 2011, PUBLIC ENGAGEMENT CL; Whitney SN, 2011, J INTERN MED, V269, P396, DOI 10.1111/j.1365-2796.2011.02351_2.x	100	256	260	2	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					176	185		10.1016/S0140-6736(13)62297-7	http://dx.doi.org/10.1016/S0140-6736(13)62297-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	287YX	24411646	Green Accepted			2022-12-28	WOS:000329579600033
J	Macilwain, C				Macilwain, Colin			Emerging powers need a more-inclusive science	NATURE			English	Editorial Material												cfmworldview@googlemail.com						Nature, 2011, NATURE, V472, P276	1	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					7	7		10.1038/505007a	http://dx.doi.org/10.1038/505007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282IB	24380933	Bronze			2022-12-28	WOS:000329163300002
J	Watson, K				Watson, Katie			Reframing Regret	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ABORTION		Northwestern Univ, Feinberg Sch Med, Med Humanities & Bioeth Program, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Watson, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Med Humanities & Bioeth Program, Chicago, IL 60611 USA.	k-watson@northwestern.edu						ADLER NE, 1992, AM PSYCHOL, V47, P1194, DOI 10.1037/0003-066X.47.10.1194; Appleton Susan Frelich, 2011, YALE J L FEMINISM, V23, P255; Guttmacher Institute, FACTS ON INDUCED ABO; Kimport K, 2012, SYMB INTERACT, V35, P105, DOI 10.1002/symb.11; Major B, 2009, AM PSYCHOL, V64, P863, DOI 10.1037/a0017497; Manian M, 2009, DUKE J GENDER L POLY, V16, P223; Parsons Craig, 2008, Aust Nurs J, V15, P28; PERSKE R, 1972, MENT RETARD, V10, P24; Raiten JM, 2012, NEW ENGL J MED, V367, P1779, DOI 10.1056/NEJMp1209698; Smith K, 2010, NURSING CARE FOR IND, P362; Weitz TA, 2008, CONTRACEPTION, V78, P87, DOI 10.1016/j.contraception.2008.04.116	11	15	15	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					27	28		10.1001/jama.2013.283739	http://dx.doi.org/10.1001/jama.2013.283739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	282HN	24381965				2022-12-28	WOS:000329161400013
J	Schumacher, DJ; Bria, C; Frohna, JG				Schumacher, Daniel J.; Bria, Corinne; Frohna, John G.			The Quest Toward Unsupervised Practice Promoting Autonomy, Not Independence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPETENCE		[Schumacher, Daniel J.] Boston Med Ctr, Boston, MA 02118 USA; [Bria, Corinne] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Frohna, John G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Frohna, John G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA	Boston Medical Center; Cincinnati Children's Hospital Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schumacher, DJ (corresponding author), Boston Med Ctr, 1 Boston Med Ctr Pl, Boston, MA 02118 USA.	daniel.schumacher@bmc.org						Carraccio C, 2002, ACAD MED, V77, P361, DOI 10.1097/00001888-200205000-00003; Hicks Patricia J, 2010, J Grad Med Educ, V2, P410, DOI 10.4300/JGME-D-10-00126.1; Kennedy TJT, 2007, J GEN INTERN MED, V22, P1080, DOI 10.1007/s11606-007-0179-3; Kennedy TJT, 2008, ACAD MED, V83, pS89, DOI 10.1097/ACM.0b013e318183c8b7; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; ten Cate O, 2007, ACAD MED, V82, P542, DOI 10.1097/ACM.0b013e31805559c7; Ten Cate O, 2010, MED TEACH, V32, P669, DOI 10.3109/0142159X.2010.500897	7	24	27	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2613	2614		10.1001/jama.2013.282324	http://dx.doi.org/10.1001/jama.2013.282324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368458				2022-12-28	WOS:000328818000009
J	Batniji, R; Khatib, L; Cammett, M; Sweet, J; Basu, S; Jamal, A; Wise, P; Giacaman, R				Batniji, Rajaie; Khatib, Lina; Cammett, Melani; Sweet, Jeffrey; Basu, Sanjay; Jamal, Amaney; Wise, Paul; Giacaman, Rita			Governance and health in the Arab world	LANCET			English	Article							INEQUALITY; DEMOCRACY; CARE	Since late 2010, the Arab world has entered a tumultuous period of change, with populations demanding more inclusive and accountable government. The region is characterised by weak political institutions, which exclude large proportions of their populations from political representation and government services. Building on work in political science and economics, we assess the extent to which the quality of governance, or the extent of electoral democracy, relates to adult, infant, and maternal mortality, and to the perceived accessibility and improvement of health services. We compiled a dataset from the World Bank, WHO, Institute for Health Metrics and Evaluation, Arab Barometer Survey, and other sources to measure changes in demographics, health status, and governance in the Arab World from 1980 to 2010. We suggest an association between more effective government and average reductions in mortality in this period; however, there does not seem to be any relation between the extent of democracy and mortality reductions. The movements for changing governance in the region threaten access to services in the short term, forcing migration and increasing the vulnerability of some populations. In view of the patterns observed in the available data, and the published literature, we suggest that efforts to improve government effectiveness and to reduce corruption are more plausibly linked to population health improvements than are efforts to democratise. However, these patterns are based on restricted mortality data, leaving out subjective health metrics, quality of life, and disease-specific data. To better guide efforts to transform political and economic institutions, more data are needed for health-care access, health-care quality, health status, and access to services of marginalised groups.	[Batniji, Rajaie; Basu, Sanjay] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Sweet, Jeffrey; Wise, Paul] Stanford Univ, Freeman Spogli Inst, Stanford, CA 94305 USA; [Khatib, Lina] Carnegie Middle East Ctr, Beirut, Lebanon; [Cammett, Melani] Brown Univ, Dept Polit Sci, Providence, RI 02912 USA; [Jamal, Amaney] Princeton Univ, Dept Polit Sci, Princeton, NJ 08544 USA; [Giacaman, Rita] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel	Stanford University; Stanford University; Brown University; Princeton University; Birzeit University	Batniji, R (corresponding author), Stanford Univ, Ctr Democracy Dev & Rule Law, Encina Hall, Stanford, CA 94305 USA.	rajaie.batniji@gmail.com	Sorenson, T/AAM-6778-2021		Freeman Spogli Institute For International Studies at the Global Underdevelopment Action Fund Stanford University (Stanford, CA, USA); American University of Beirut (Beirut, Lebanon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER	Freeman Spogli Institute For International Studies at the Global Underdevelopment Action Fund Stanford University (Stanford, CA, USA); American University of Beirut (Beirut, Lebanon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this research was provided by The Freeman Spogli Institute For International Studies at the Global Underdevelopment Action Fund Stanford University (Stanford, CA, USA). The American University of Beirut (Beirut, Lebanon) provided additional support.	Abdelfattah D., 2011, 201168 CARIM AS EUR; Abdul Rahim HF, 2014, LANCET; Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; Alesina A, 2003, J ECON GROWTH, V8, P155, DOI 10.1023/A:1024471506938; Alhamad L., 2008, POLITICAL PARTICIPAT; Ali HM, 2000, LANCET, V355, P1851, DOI 10.1016/S0140-6736(00)02289-3; Andrews M., 2013, GOING FORM BASED GOV; Anthonsen M, 2012, ECON GOV, V13, P145, DOI 10.1007/s10101-011-0105-3; Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; Cammett M, 2013, POLITICAL EC MIDDLE; Dewachi O, 2014, LANCET; Diaz-Cayeros A, 2003, POLITICS PUBLIC SP 2; Diaz-Cayeros A, 2013, WORLD DEV, V53, P80, DOI 10.1016/j.worlddev.2013.01.008; Dreze J., 1990, POLITICAL EC HUNGER; Durac V., 2013, CIVIL SOC ACTIVISM A; El-Zein A, 2014, LANCET; Elgazzar HA., 2011, RAISING RETURNS DIST; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Fukuyama Francis., 2004, STATE BUILDING GOVER; Gerring J, 2012, J POLIT, V74, P1, DOI 10.1017/S0022381611001113; Grant RW, 2005, AM POLIT SCI REV, V99, P29, DOI 10.1017/S0003055405051476; Guetat I., 2006, J EC FINANCE, V30, P208, DOI DOI 10.1007/BF02761487; Haddad B., 2012, BUSINESS NETWORKS SY; Hankir Zahra., 2020, OUR WOMEN GROUND ARA; Hausmann R., 2013, GLOBAL GENDER GAP RE; Heydemann S, 2004, NETWORKS OF PRIVILEGE IN THE MIDDLE EAST, P1; Holmberg S, 2011, HEALTH ECON POLICY L, V6, P529, DOI 10.1017/S174413311000023X; Horton R, 2009, LANCET, V373, P784, DOI 10.1016/S0140-6736(09)60100-8; Huber E., 2001, CONT SOCIOLOGY; Hundt GL, 2012, SOC SCI MED, V74, P36, DOI 10.1016/j.socscimed.2011.08.042; Jabbour S, 2012, PUBLIC HEALTH IN THE ARABWORLD, P1; Jamal A., 2007, ENCY WOMEN ISLAMIC C; Jamal A., 2012, STANF COMP POL WORKS; Jamal A, 2013, MIDDLE E; Kangas B, 2010, MED ANTHROPOL, V29, P344, DOI 10.1080/01459740.2010.501315; Kaufmann D, 5430 WORLD BANK; Kouzis AC, 1998, PSYCHOL MED, V28, P1301, DOI 10.1017/S0033291798007454; Kuhn R, 2012, POPUL DEV REV, V38, P649, DOI 10.1111/j.1728-4457.2012.00531.x; LEMARCHAND R, 1972, COMP POLIT, V4, P149, DOI 10.2307/421508; Loewe M., 2009, PENSION SCHEMES PENS; Mahoney James, 2010, COLONIALISM POSTCOLO; MANSFIELD ED, 1995, INT SECURITY, V20, P5, DOI 10.2307/2539213; McGuire JW, 2001, WORLD DEV, V29, P1673, DOI 10.1016/S0305-750X(01)00062-6; Medecins Sans Frontieres, 2012, SYR MED WEAP PERS; Nakkash R, 2014, LANCET; Norris P, 2012, MAKING DEMOCRATIC GOVERNANCE WORK: HOW REGIMES SHAPE PROSPERITY, WELFARE, AND PEACE, P1, DOI 10.1017/CBO9781139061902; Powell-Jackson T, 2011, SOC SCI MED, V73, P33, DOI 10.1016/j.socscimed.2011.04.013; Ross M, 2006, AM J POLIT SCI, V50, P860, DOI 10.1111/j.1540-5907.2006.00220.x; Saleh SS, 2014, LANCET; Secretariat of the Financial Inclusion for the Arab Region Initiative, 2020, APPROACH DIGITAL FIN; Sen K, 2012, SOC MED, V6, P171; Shehata D, 2011, FOREIGN AFF, V90, P26; Stork J., 2011, GUARDIAN; Tabutin D, 2012, PUBLIC HLTH ARAB WOR; Tartir A, 2012, PERSISTENT FAILURE W; Tell T., 2014, LANCET; Tsai LL, 2007, AM POLIT SCI REV, V101, P355, DOI 10.1017/S0003055407070153; UNDP (United Nations Development Program), 2010, HUM DEV REP 2010 REA; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Zogby J., 2005, ATTITUDES ARABS IN D	61	47	47	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					343	355		10.1016/S0140-6736(13)62185-6	http://dx.doi.org/10.1016/S0140-6736(13)62185-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452043	Green Accepted			2022-12-28	WOS:000330212600034
J	Bradford, MA				Bradford, Mark A.			ECOLOGY Good dirt with good friends	NATURE			English	Editorial Material							CARBON; COMMUNITY		Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Yale University	Bradford, MA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	mark.bradford@yale.edu	Bradford, Mark A/G-3850-2012	Bradford, Mark A/0000-0002-2022-8331				Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Bonan GB, 2013, GLOBAL CHANGE BIOL, V19, P957, DOI 10.1111/gcb.12031; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Denman K. L., 2007, CLIMATE CHANGE 2007; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Johnson NC, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12085; Orwin KH, 2011, ECOL LETT, V14, P493, DOI 10.1111/j.1461-0248.2011.01611.x; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]	10	13	13	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					486	487		10.1038/nature12849	http://dx.doi.org/10.1038/nature12849			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24402226				2022-12-28	WOS:000329995000023
J	Doody, RS; Thomas, RG; Farlow, M; Iwatsubo, T; Vellas, B; Joffe, S; Kieburtz, K; Raman, R; Sun, XY; Aisen, PS; Siemers, E; Liu-Seifert, H; Mohs, R				Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; Raman, Rema; Sun, Xiaoying; Aisen, Paul S.; Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard		Alzheimers Dis Cooperative Study; Solanezumab Study Grp	Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA MONOCLONAL-ANTIBODY; QUALITY-OF-LIFE; AMYLOID-BETA; CEREBROSPINAL-FLUID; A-BETA; CLINICAL-TRIALS; DEMENTIA; PLASMA; SCALE; IMMUNOTHERAPY	BackgroundAlzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss. Solanezumab, a humanized monoclonal antibody, preferentially binds soluble forms of amyloid and in preclinical studies promoted its clearance from the brain. MethodsIn two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, respectively, with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered intravenously at a dose of 400 mg) every 4 weeks for 18 months. The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning). After analysis of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease. ResultsNeither study showed significant improvement in the primary outcomes. The modeled difference between groups (solanezumab group minus placebo group) in the change from baseline was -0.8 points for the ADAS-cog11 score (95% confidence interval [CI], -2.1 to 0.5; P=0.24) and -0.4 points for the ADCS-ADL score (95% CI, -2.3 to 1.4; P=0.64) in EXPEDITION 1 and -1.3 points (95% CI, -2.5 to 0.3; P=0.06) and 1.6 points (95% CI, -0.2 to 3.3; P=0.08), respectively, in EXPEDITION 2. Between-group differences in the changes in the ADAS-cog14 score were -1.7 points in patients with mild Alzheimer's disease (95% CI, -3.5 to 0.1; P=0.06) and -1.5 in patients with moderate Alzheimer's disease (95% CI, -4.1 to 1.1; P=0.26). In the combined safety data set, the incidence of amyloid-related imaging abnormalities with edema or hemorrhage was 0.9% with solanezumab and 0.4% with placebo for edema (P=0.27) and 4.9% and 5.6%, respectively, for hemorrhage (P=0.49). ConclusionsSolanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.	[Doody, Rachelle S.] Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, Dept Neurol, Houston, TX 77030 USA; [Thomas, Ronald G.; Raman, Rema; Sun, Xiaoying] Univ Calif San Diego, Alzheimers Dis Cooperat Study, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Thomas, Ronald G.; Raman, Rema; Aisen, Paul S.; Mohs, Richard] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Farlow, Martin] Indiana Univ, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46204 USA; [Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Iwatsubo, Takeshi] Univ Tokyo, Sch Med, Dept Neuropathol, Tokyo 113, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Sch Pharmacol Sci, Dept Neuropathol & Neurosci, Tokyo, Japan; [Vellas, Bruno] Ctr Hosp Univ Toulouse, UMR 1027, Toulouse, France; [Joffe, Steven] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Kieburtz, Karl] Univ Rochester, Med Ctr, Ctr Human Expt Therapeut, Rochester, NY 14642 USA	Baylor College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; Indiana University System; Indiana University-Purdue University Indianapolis; Eli Lilly; University of Tokyo; University of Tokyo; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Pennsylvania; University of Rochester	Doody, RS (corresponding author), Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, Dept Neurol, 1977 Butler Blvd,Suite E 5-101, Houston, TX 77030 USA.	rdoody@bcm.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384	Eli Lilly	Eli Lilly(Eli Lilly)	Funded by Eli Lilly; EXPEDITION 1 and 2 ClinicalTrials.gov numbers, NCT00905372 and NCT00904683.	BERG L, 1992, ANN NEUROL, V31, P242, DOI 10.1002/ana.410310303; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Farlow M, 2012, ALZHEIMERS DEMENT, V8, P261, DOI 10.1016/j.jalz.2011.09.224; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Kind P., 1996, QUAL LIFE PHARMACOEC, V25, P3110, DOI [10.1097/00007632-200012150-00005, DOI 10.1097/00007632-200012150-00005]; Lachno DR, 2013, J ALZHEIMERS DIS, V34, P897, DOI 10.3233/JAD-122317; Lachno DR, 2011, J ALZHEIMERS DIS, V26, P531, DOI 10.3233/JAD-2011-110296; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Siemers ER, 2010, CLIN NEUROPHARMACOL, V33, P67, DOI 10.1097/WNF.0b013e3181cb577a; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; Wimo A., 1998, HLTH EC DEMENTIA, DOI DOI 10.1186/S12913-017-2422-X; Yamada K, 2009, J NEUROSCI, V29, P11393, DOI 10.1523/JNEUROSCI.2021-09.2009	27	1006	1066	4	188	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					311	321		10.1056/NEJMoa1312889	http://dx.doi.org/10.1056/NEJMoa1312889			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450890	Bronze			2022-12-28	WOS:000330036200006
J	Lawrence, MS; Stojanov, P; Mermel, CH; Robinson, JT; Garraway, LA; Golub, TR; Meyerson, M; Gabriel, SB; Lander, ES; Getz, G				Lawrence, Michael S.; Stojanov, Petar; Mermel, Craig H.; Robinson, James T.; Garraway, Levi A.; Golub, Todd R.; Meyerson, Matthew; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad			Discovery and saturation analysis of cancer genes across 21 tumour types	NATURE			English	Article							MUTATIONS	Although a few cancer genes are mutated in a high proportion of tumours of a given type (>20%), most are mutated at intermediate frequencies (2-20%). To explore the feasibility of creating a comprehensive catalogue of cancer genes, we analysed somatic point mutations in exome sequences from 4,742 human cancers and their matched normal-tissue samples across 21 cancer types. We found that large-scale genomic analysis can identify nearly all known cancer genes in these tumour types. Our analysis also identified 33 genes that were not previously known to be significantly mutated in cancer, including genes related to proliferation, apoptosis, genome stability, chromatin regulation, immune evasion, RNA processing and protein homeostasis. Down-sampling analysis indicates that larger sample sizes will reveal many more genes mutated at clinically important frequencies. We estimate that near-saturation may be achieved with 6005,000 samples per tumour type, depending on background mutation frequency. The results may help to guide the next stage of cancer genomics.	[Lawrence, Michael S.; Stojanov, Petar; Mermel, Craig H.; Robinson, James T.; Garraway, Levi A.; Golub, Todd R.; Meyerson, Matthew; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Stojanov, Petar; Garraway, Levi A.; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Boston, MA 02215 USA; [Mermel, Craig H.; Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Mermel, Craig H.; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Garraway, Levi A.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Lander, Eric S.] MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	lander@broadinstitute.org; gadgetz@broadinstitute.org	Lawrence, Michael/AAC-8202-2020; Mermel, Craig/AAZ-7322-2020; Stojanov, Petar/GQI-4462-2022	Mermel, Craig/0000-0002-0816-3395; Stojanov, Petar/0000-0001-7815-776X; Meyerson, Matthew/0000-0002-9133-8108	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA157304] Funding Source: Medline; NHGRI NIH HHS [U54 HG003067] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA157304] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	13	1979	2028	8	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					495	+		10.1038/nature12912	http://dx.doi.org/10.1038/nature12912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24390350	Green Accepted, Green Submitted			2022-12-28	WOS:000329995000029
J	Salloway, S; Sperling, R; Fox, NC; Blennow, K; Klunk, W; Raskind, M; Sabbagh, M; Honig, LS; Porsteinsson, AP; Ferris, S; Reichert, M; Ketter, N; Nejadnik, B; Guenzler, V; Miloslavsky, M; Wang, D; Lu, Y; Lull, J; Tudor, IC; Liu, EC; Grundman, M; Yuen, E; Black, R; Brashear, HR				Salloway, Stephen; Sperling, Reisa; Fox, Nick C.; Blennow, Kaj; Klunk, William; Raskind, Murray; Sabbagh, Marwan; Honig, Lawrence S.; Porsteinsson, Anton P.; Ferris, Steven; Reichert, Marcel; Ketter, Nzeera; Nejadnik, Bijan; Guenzler, Volkmar; Miloslavsky, Maja; Wang, Daniel; Lu, Yuan; Lull, Julia; Tudor, Iulia Cristina; Liu, Enchi; Grundman, Michael; Yuen, Eric; Black, Ronald; Brashear, H. Robert		Bapineuzumab 301 302 Clinical	Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMAGING ABNORMALITIES; MOUSE MODEL; ANTIBODIES; PEPTIDE; EPITOPE	BackgroundBapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clinical development for the treatment of Alzheimer's disease. MethodsWe conducted two double-blind, randomized, placebo-controlled, phase 3 trials involving patients with mild-to-moderate Alzheimer's disease one involving 1121 carriers of the apolipoprotein E (APOE) epsilon 4 allele and the other involving 1331 noncarriers. Bapineuzumab or placebo, with doses varying by study, was administered by intravenous infusion every 13 weeks for 78 weeks. The primary outcome measures were scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11, with scores ranging from 0 to 70 and higher scores indicating greater impairment) and the Disability Assessment for Dementia (DAD, with scores ranging from 0 to 100 and higher scores indicating less impairment). A total of 1090 carriers and 1114 noncarriers were included in the efficacy analysis. Secondary outcome measures included findings on positron-emission tomographic amyloid imaging with the use of Pittsburgh compound B (PIB-PET) and cerebrospinal fluid phosphorylated tau (phospho-tau) concentrations. ResultsThere were no significant between-group differences in the primary outcomes. At week 78, the between-group differences in the change from baseline in the ADAS-cog11 and DAD scores (bapineuzumab group minus placebo group) were -0.2 (P=0.80) and -1.2 (P=0.34), respectively, in the carrier study; the corresponding differences in the noncarrier study were -0.3 (P=0.64) and 2.8 (P=0.07) with the 0.5-mg-per-kilogram dose of bapineuzumab and 0.4 (P=0.62) and 0.9 (P=0.55) with the 1.0-mg-per-kilogram dose. The major safety finding was amyloid-related imaging abnormalities with edema among patients receiving bapineuzumab, which increased with bapineuzumab dose and APOE epsilon 4 allele number and which led to discontinuation of the 2.0-mg-per-kilogram dose. Between-group differences were observed with respect to PIB-PET and cerebrospinal fluid phospho-tau concentrations in APOE epsilon 4 allele carriers but not in noncarriers. ConclusionsBapineuzumab did not improve clinical outcomes in patients with Alzheimer's disease, despite treatment differences in biomarkers observed in APOE epsilon 4 carriers.	[Salloway, Stephen] Butler Hosp, Providence, RI 02906 USA; [Sperling, Reisa] Brigham & Womens Hosp, Boston, MA 02115 USA; [Fox, Nick C.] UCL, Inst Neurol, London WC1E 6BT, England; [Blennow, Kaj] Univ Gothenburg, Sahlgrenska Univ Hosp, Molndal, Sweden; [Klunk, William] Univ Pittsburgh, Pittsburgh, PA USA; [Raskind, Murray] Vet Affairs Med Ctr, Seattle, WA 98108 USA; [Sabbagh, Marwan] Sun Hlth Res Inst, Cleo Roberts Ctr Clin Res, Sun City, AZ USA; [Honig, Lawrence S.] Columbia Univ, New York, NY USA; [Ferris, Steven] NYU, Langone Med Ctr, New York, NY USA; [Porsteinsson, Anton P.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Reichert, Marcel; Ketter, Nzeera; Nejadnik, Bijan; Guenzler, Volkmar; Miloslavsky, Maja; Wang, Daniel; Lu, Yuan; Tudor, Iulia Cristina; Liu, Enchi; Yuen, Eric; Brashear, H. Robert] Janssen Alzheimer Immunotherapy Res & Dev, San Francisco, CA USA; [Lull, Julia] Janssen Res & Dev, Titusville, NJ USA; [Grundman, Michael] Global R&D Partners, San Diego, CA USA; [Grundman, Michael] Univ Calif San Diego, San Diego, CA 92103 USA; [Black, Ronald] Pfizer, Collegeville, PA USA	Butler Hospital Rhode Island; Harvard University; Brigham & Women's Hospital; University of London; University College London; Sahlgrenska University Hospital; University of Gothenburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Banner Research; Banner Health; Banner Sun Health Research Institute; Columbia University; New York University; NYU Langone Medical Center; University of Rochester; Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Janssen Pharmaceuticals; University of California System; University of California San Diego; Pfizer	Salloway, S (corresponding author), Brown Univ, Butler Hosp, Warren Alpert Med Sch, 345 Blackstone Blvd, Providence, RI 02906 USA.	ssalloway@butler.org	Fox, Nick C/B-1319-2009; Preda, Adrian/K-8889-2013; Noble, James McCallum/AAA-4218-2020; Burke, William/C-1203-2012; Tsuang, Debby/L-7234-2016; Fox, Nick C/AAE-1849-2021; Levey, Allan/F-2104-2011; Sadowski, Martin/N-8296-2015	Fox, Nick C/0000-0002-6660-657X; Preda, Adrian/0000-0003-3373-2438; Noble, James McCallum/0000-0003-0648-6702; Tsuang, Debby/0000-0002-4716-1894; Fox, Nick C/0000-0002-6660-657X; Levey, Allan/0000-0002-3153-502X; Barest, Glenn/0000-0002-5402-5372; Porsteinsson, Anton/0000-0002-0166-1738; Sadowski, Martin/0000-0002-3830-1779; Ferris, Steven/0000-0001-8641-6223; Klunk, William/0000-0001-5512-0251; Wiemerslage, Lyle/0000-0002-6857-0136; DeKosky, Steven/0000-0003-3743-2758; Kohlrus, Stephanie/0000-0002-3135-9572; Genius, Just/0000-0003-3270-3491; Peltsch, Alicia/0000-0002-5934-6183; Leverenz, James/0000-0002-0896-0749	Janssen Alzheimer Immunotherapy; Pfizer; EudraCT [2009-012748-17]; MRC [G0902227, MR/K013041/1] Funding Source: UKRI; Alzheimers Research UK [ARUK-Network2011-6-ICE, ARUK-PG2014-1] Funding Source: researchfish; Medical Research Council [MR/L010305/1, MR/L501517/1, MR/K013041/1, G0902227] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10134, NF-SI-0508-10123] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, P30AG008051, P50AG005136, P50AG008702] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001820] Funding Source: NIH RePORTER	Janssen Alzheimer Immunotherapy; Pfizer(Pfizer); EudraCT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	Funded by Janssen Alzheimer Immunotherapy and Pfizer; Bapineuzumab 301 and 302 ClinicalTrials.gov numbers, NCT00575055 and NCT00574132, and EudraCT number, 2009-012748-17.	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bard F, 2004, P NATL ACAD SCI USA, V101, P11526, DOI 10.1073/pnas.0403553101; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Gauthier S, 1997, Int Psychogeriatr, V9 Suppl 1, P163, DOI 10.1017/S1041610297004857; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison J, 2007, ARCH NEUROL-CHICAGO, V64, P1323, DOI 10.1001/archneur.64.9.1323; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Selkoe DJ, 2002, SCIENCE, V298, P963; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; STERN Y, 1994, J GERONTOL, V49, pM216, DOI 10.1093/geronj/49.5.M216; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Zago W, 2013, ALZHEIMERS DEMENT; Zago W, 2012, J NEUROSCI, V32, P2696, DOI 10.1523/JNEUROSCI.1676-11.2012	30	1177	1224	8	318	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					322	333		10.1056/NEJMoa1304839	http://dx.doi.org/10.1056/NEJMoa1304839			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450891	Bronze, Green Accepted			2022-12-28	WOS:000330036200007
J	Deisseroth, K				Deisseroth, Karl			Circuit dynamics of adaptive and maladaptive behaviour	NATURE			English	Review							DEEP BRAIN-STIMULATION; LATERAL HABENULA; DOPAMINERGIC-NEURONS; OPTOGENETIC CONTROL; ANIMAL-MODELS; GAMMA RHYTHM; REWARD; AMYGDALA; CONNECTIVITY; NETWORKS	The recent development of technologies for investigating specific components of intact biological systems has allowed elucidation of the neural circuitry underlying adaptive and maladaptive behaviours. Investigators are now able to observe and control, with high spatio-temporal resolution, structurally defined intact pathways along which electrical activity flows during and after the performance of complex behaviours. These investigations have revealed that control of projection-specific dynamics is well suited to modulating behavioural patterns that are relevant to a broad range of psychiatric diseases. Structural dynamics principles have emerged to provide diverse, unexpected and causal insights into the operation of intact and diseased nervous systems, linking form and function in the brain.	[Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu			Wiegers Family Fund; NARSAD; NIMH; NIDA; DARPA; Keck Foundation; McKnight Foundation; Yu Foundation; Snyder Foundation; Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R01MH075957, R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794, R37DA035377] Funding Source: NIH RePORTER	Wiegers Family Fund; NARSAD(NARSAD); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Yu Foundation; Snyder Foundation; Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	I am deeply indebted to my patients over the years for their insight, perseverance and strength in working to convey the most complex and nearly inarticulatable inner thought processes and feelings associated with severe psychiatric disease. I am also grateful to my entire laboratory for support, as well as to V. Sohal, A. Schatzberg, H. Mayberg, R. Malenka, A. Etkin, L. Grosenick, A. Kreitzer, T. Insel, M. Warden, M. Zelikowsky and E. Ferenczi for comments and discussions over the years. K.D. has been supported by the Wiegers Family Fund, NARSAD, NIMH, NIDA, DARPA, the Keck Foundation, the McKnight Foundation, the Yu, Snyder and Woo Foundations, and the Gatsby Charitable Foundation.	Abbott A, 2011, NATURE, V480, P161, DOI 10.1038/480161a; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Akam T, 2012, NAT NEUROSCI, V15, P763, DOI 10.1038/nn.3081; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; Antinone SE, 2010, J VIROL, V84, P1504, DOI 10.1128/JVI.02029-09; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Benabid AL, 2012, PARKINSONISM RELA S1, V18, P21; Bewernick BH, 2012, NEUROPSYCHOPHARMACOL, V37, P1975, DOI 10.1038/npp.2012.44; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Birdno MJ, 2008, NEUROTHERAPEUTICS, V5, P14, DOI 10.1016/j.nurt.2007.10.067; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Cabral J, 2012, PHARMACOPSYCHIATRY, V45, pS57, DOI 10.1055/s-0032-1309001; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Carter ME, 2011, TRENDS MOL MED, V17, P197, DOI 10.1016/j.molmed.2010.12.005; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Chan DTM, 2009, ASIAN J SURG, V32, P258, DOI 10.1016/S1015-9584(09)60404-8; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Deco G, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00068; Deisseroth K, 2012, BIOL PSYCHIAT, V71, P1030, DOI 10.1016/j.biopsych.2011.12.021; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Deisseroth K, 2010, SCI AM, V303, P48, DOI 10.1038/scientificamerican1110-48; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Farrell SM, 2012, BIOL PSYCHIAT, V71, P538, DOI 10.1016/j.biopsych.2011.12.023; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Foti D, 2012, PSYCHOPHYSIOLOGY, V49, P617, DOI 10.1111/j.1469-8986.2011.01343.x; Goodman WK, 2012, ANNU REV MED, V63, P511, DOI 10.1146/annurev-med-052209-100401; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grubert C, 2011, WORLD J BIOL PSYCHIA, V12, P516, DOI 10.3109/15622975.2011.583940; Gunaydin L., 2013, 2013 NEUR M PLANN; Gutierrez GJ, 2013, NEURON, V77, P845, DOI 10.1016/j.neuron.2013.01.016; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Holtzheimer PE, 2011, ANNU REV NEUROSCI, V34, P289, DOI 10.1146/annurev-neuro-061010-113638; IWATA J, 1988, BEHAV NEUROSCI, V102, P66, DOI 10.1037/0735-7044.102.1.66; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Jirsa VK, 2004, NEUROINFORMATICS, V2, P183, DOI 10.1385/NI:2:2:183; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Kuhn B, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00049; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li XB, 2011, PSYCHIAT RES-NEUROIM, V194, P141, DOI 10.1016/j.pscychresns.2011.04.012; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Maher BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034053; Maks CB, 2009, J NEUROL NEUROSUR PS, V80, P659, DOI 10.1136/jnnp.2007.126219; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Oluigbo Chima O, 2012, IEEE Rev Biomed Eng, V5, P88, DOI 10.1109/RBME.2012.2197745; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Osten P, 2013, NAT METHODS, V10, P515, DOI [10.1038/NMETH.2477, 10.1038/nmeth.2477]; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinotsis DA, 2013, NEUROIMAGE, V65, P127, DOI 10.1016/j.neuroimage.2012.10.016; RAUSCHNING W, 1986, UPSALA J MED SCI, V91, P251, DOI 10.3109/03009738609178662; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Rho YA, 2011, BRAIN CONNECT, V1, P73, DOI 10.1089/brain.2011.0009; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stefanik MT, 2013, ADDICT BIOL, V18, P50, DOI 10.1111/j.1369-1600.2012.00479.x; Stopper CM, 2014, CEREB CORTEX, V24, P154, DOI 10.1093/cercor/bhs297; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tiesinga PH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00196; TOGA AW, 1994, J NEUROSCI METH, V54, P239, DOI 10.1016/0165-0270(94)90196-1; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Voon V, 2011, BRAIN, V134, P1438, DOI 10.1093/brain/awr080; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Young JW, 2011, J PSYCHOPHARMACOL, V25, P934, DOI 10.1177/0269881111400646; Zalocusky K, 2013, OPTOGENETICS, V1, P1, DOI DOI 10.2478/0PT0G-2013-0001; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	127	119	121	1	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					309	317		10.1038/nature12982	http://dx.doi.org/10.1038/nature12982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429629	Green Accepted			2022-12-28	WOS:000329621800028
J	Wald, A; Corey, L; Timmler, B; Magaret, A; Warren, T; Tyring, S; Johnston, C; Kriesel, J; Fife, K; Galitz, L; Stoelben, S; Huang, ML; Selke, S; Stobernack, HP; Ruebsamen-Schaeff, H; Birkmann, A				Wald, Anna; Corey, Lawrence; Timmler, Burkhard; Magaret, Amalia; Warren, Terri; Tyring, Stephen; Johnston, Christine; Kriesel, John; Fife, Kenneth; Galitz, Lawrence; Stoelben, Susanne; Huang, Meei-Li; Selke, Stacy; Stobernack, Hans-Peter; Ruebsamen-Schaeff, Helga; Birkmann, Alexander			Helicase-Primase Inhibitor Pritelivir for HSV-2 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIMPLEX-VIRUS TYPE-2; GENITAL HERPES; ANTIVIRAL ACTIVITY; DNA; ACYCLOVIR; DISEASE; BAY-57-1293; SUPPRESSION; SUPERIOR	BackgroundPritelivir, an inhibitor of the viral helicase-primase complex, exhibits antiviral activity in vitro and in animal models of herpes simplex virus (HSV) infection. We tested the efficacy and safety of pritelivir in otherwise healthy persons with genital HSV-2 infection. MethodsWe randomly assigned 156 HSV-2-positive persons with a history of genital herpes to receive one of four doses of oral pritelivir (5, 25, or 75 mg daily, or 400 mg weekly) or placebo for 28 days. Participants obtained daily swabs from the genital area for HSV-2 testing, which was performed with a polymerase-chain-reaction assay. Participants also maintained a diary of genital signs and symptoms. The primary end point was the rate of genital HSV shedding. ResultsHSV shedding among placebo recipients was detected on 16.6% of days; shedding among pritelivir recipients was detected on 18.2% of days among those receiving 5 mg daily, 9.3% of days among those receiving 25 mg daily, 2.1% of days among those receiving 75 mg daily, and 5.3% of days among those receiving 400 mg weekly. The relative risk of viral shedding with pritelivir, as compared with placebo, was 1.11 (95% confidence interval [CI], 0.65 to 1.87) with the 5-mg daily dose, 0.57 (95% CI, 0.31 to 1.03) with the 25-mg daily dose, 0.13 (95% CI, 0.04 to 0.38) with the 75-mg daily dose, and 0.32 (95% CI, 0.17 to 0.59) with the 400-mg weekly dose. The percentage of days with genital lesions was also significantly reduced, from 9.0% in the placebo group to 1.2% in both the group receiving 75 mg of pritelivir daily (relative risk, 0.13; 95% CI, 0.02 to 0.70) and the group receiving 400 mg weekly (relative risk, 0.13; 95% CI, 0.03 to 0.52). The rate of adverse events was similar in all groups. ConclusionsPritelivir reduced the rates of genital HSV shedding and days with lesions in a dose-dependent manner in otherwise healthy men and women with genital herpes. (Funded by AiCuris; ClinicalTrials.gov number, NCT01047540.) New treatments are needed for herpes simplex virus infection. In this placebo-controlled, randomized, dose-ranging trial, pritelivir, an inhibitor of the viral helicase-primase complex, reduced genital HSV-2 shedding in a dose-dependent fashion. Treatment of genital infections with the herpes simplex virus (HSV) relies on nucleoside analogues that inhibit the HSV DNA polymerase after phosphorylation by the viral thymidine kinase.(1) These compounds, which were developed three decades ago and are in widespread use today, ameliorate clinical disease. However, they do not abrogate viral shedding and only partially reduce the risk of transmission to sexual partners.(2)-(4) In immunocompromised persons, resistance to nucleoside analogues develops occasionally, and treatment options for acyclovir-resistant HSV are limited.(5),(6) The thiazolylamide pritelivir (BAY 57-1293; AIC316) is the first in a new class of antiviral agents that inhibit HSV ...	[Wald, Anna; Corey, Lawrence; Magaret, Amalia; Johnston, Christine; Huang, Meei-Li; Selke, Stacy] Univ Washington, Seattle, WA 98104 USA; [Wald, Anna; Corey, Lawrence; Magaret, Amalia; Johnston, Christine; Huang, Meei-Li; Selke, Stacy] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Timmler, Burkhard; Stoelben, Susanne; Stobernack, Hans-Peter; Ruebsamen-Schaeff, Helga; Birkmann, Alexander] AiCuris, Wuppertal, Germany; [Warren, Terri] Westover Hts Clin, Portland, OR USA; [Tyring, Stephen] Univ Texas Houston, Houston, TX USA; [Kriesel, John] Univ Utah, Salt Lake City, UT USA; [Fife, Kenneth] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Galitz, Lawrence] Cetero Res, Miami, FL USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University Bloomington	Wald, A (corresponding author), Univ Washington, Virol Res Clin, Box 359928,325 9th Ave, Seattle, WA 98104 USA.	annawald@u.washington.edu	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020; Warren, Terri/AAJ-1650-2021	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Birkmann, Alexander/0000-0001-5670-4814; Johnston, Christine/0000-0002-3073-0843	AiCuris; Amgen; Agenus; Genentech; Genocea; Gilead; Vical; Immune Design	AiCuris; Amgen(Amgen); Agenus; Genentech(Roche HoldingGenentech); Genocea; Gilead(Gilead Sciences); Vical; Immune Design	Supported by AiCuris.; Dr. Wald reports receiving consulting fees from Amgen, travel support from Vical, and grant support through her institution from Agenus, Genentech, Genocea, Gilead, and Vical; Dr. Corey reports holding stock in Immune Design and being a co-inventor on several patents associated with the development of an HSV-2 vaccine; Drs. Timmler, Stoelben, Stobernack, Ruebsamen-Schaeff, and Birkmann are employees of AiCuris; Drs. Timmler, Ruebsamen-Schaeff, and Birkmann report holding stock options in AiCuris; Dr. Birkmann reports contributing to patents related to galenics and the synthesis of drug substances through AiCuris; Dr. Magaret reports receiving consulting fees from Immune Design; Dr. Warren reports receiving travel support from AiCuris and Vical and grant support through her institution from Agenus, Genocea, AiCuris, and Vical; Dr. Fife reports receiving travel support from Vical and grant support through his institution from Genocea, Vical, and AiCuris; Dr. Johnston reports receiving grant support through her institution from AiCuris; and Dr. Tyring reports receiving grant support through his institution from Agenus, Genocea, AiCuris, and Vical. No other potential conflict of interest relevant to this article was reported.	ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Baumeister Judith, 2007, Antiviral Chemistry & Chemotherapy, V18, P35; Betz UAK, 2002, ANTIMICROB AGENTS CH, V46, P1766, DOI 10.1128/AAC.46.6.1766-1772.2002; Birkmann A, 2011, 24 INT C ANT RES SOF; Biswas S, 2007, ANTIVIR RES, V75, P30, DOI 10.1016/j.antiviral.2006.11.006; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; CRUMPACKER CS, 1982, NEW ENGL J MED, V306, P343, DOI 10.1056/NEJM198202113060606; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; DOUGLAS JM, 1984, NEW ENGL J MED, V310, P1551, DOI 10.1056/NEJM198406143102402; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Field HJ, 2011, DRUG RESIST UPDATE, V14, P45, DOI 10.1016/j.drup.2010.11.002; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; Johnston C, 2012, LANCET, V379, P616; Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Magaret AS, 2009, SEX TRANSM INFECT, V85, P270, DOI 10.1136/sti.2008.034751; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Reyes M, 2003, ARCH INTERN MED, V163, P76, DOI 10.1001/archinte.163.1.76; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Schiffer JT, 2011, J INFECT DIS, V204, P554, DOI 10.1093/infdis/jir314; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043	22	89	94	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					201	210		10.1056/NEJMoa1301150	http://dx.doi.org/10.1056/NEJMoa1301150			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428466				2022-12-28	WOS:000330035600006
J	Wen, L				Wen, Leana			Patients can't trust doctors' advice if we hide our financial connections with drug companies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCENTIVES		George Washington Univ, Washington, DC USA	George Washington University	Wen, L (corresponding author), George Washington Univ, Washington, DC USA.	Wen.Leana@gmail.com						Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Centers for Medicare & Medicaid Services, OFF WEBS OP PAYM; Delbanco T, 2010, ANN INTERN MED, V153, P121, DOI 10.7326/0003-4819-153-2-201007200-00008; Fugh-Berman A, 2007, PLOS MED, V4, P621, DOI 10.1371/journal.pmed.0040150; Gawande A., 2009, COST CONUNDRUM NEW Y; Goff SL, 2008, J GEN INTERN MED, V23, P236, DOI 10.1007/s11606-007-0470-3; Hall MA, 2000, HEALTH AFFAIR, V19, P156, DOI 10.1377/hlthaff.19.4.156; Institute of Medicine, 2009, CONFL INT RES ED PRA; Institute of Medicine, 2012, BEST CAR LOW COST PA; Krupa C, 2010, AM MED NEWS; Pearson SD, 2006, ARCH INTERN MED, V166, P623, DOI 10.1001/archinte.166.6.623; Tattersall MHN, 2009, MED J AUSTRALIA, V190, P65, DOI 10.5694/j.1326-5377.2009.tb02277.x	12	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2014	348								g167	10.1136/bmj.g167	http://dx.doi.org/10.1136/bmj.g167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MO	24430529	Green Submitted			2022-12-28	WOS:000329976000009
J	Chen, CH; Lee, CS; Lee, MTM; Ouyang, WC; Chen, CC; Chong, MY; Wu, JY; Tan, HKL; Lee, YC; Chuo, LJ; Chiu, NY; Tsang, HY; Chang, TJ; Lung, FW; Chiu, CH; Chang, CH; Chen, YS; Hou, YM; Chen, CC; Lai, TJ; Tung, CL; Chen, CY; Lane, HY; Su, TP; Feng, J; Lin, JJ; Chang, CJ; Teng, PR; Liu, CY; Chen, CK; Liu, IC; Chen, JJ; Lu, T; Fan, CC; Wu, CK; Li, CF; Wang, KHT; Wu, LSH; Peng, HL; Chang, CP; Lu, LS; Chen, YT; Cheng, ATA				Chen, C. -H.; Lee, C. -S.; Lee, M. -T. M.; Ouyang, W. -C.; Chen, Chiao-Chicy; Chong, M. -Y.; Wu, J. -Y.; Tan, H. K. -L.; Lee, Y. -C.; Chuo, L. -J.; Chiu, N. -Y.; Tsang, H. -Y.; Chang, T. -J.; Lung, F. -W.; Chiu, C. -H.; Chang, C. -H.; Chen, Y. -S.; Hou, Y. -M.; Chen, Cheng-Chung; Lai, T. -J.; Tung, C. -L.; Chen, C. -Y.; Lane, H. -Y.; Su, T. -P.; Feng, J.; Lin, J. -J.; Chang, C. -J.; Teng, P. -R.; Liu, C. -Y.; Chen, C. -K.; Liu, I. -C.; Chen, J. -J.; Lu, T.; Fan, C. -C.; Wu, C. -K.; Li, C. -F.; Wang, K. H. -T.; Wu, L. S. -H.; Peng, H. -L.; Chang, C. -P.; Lu, L. -S.; Chen, Y. -T.; Cheng, A. T. -A.		Taiwan Bipolar Consortium	Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPHYLACTIC LITHIUM; ASSOCIATION; PREVENTION; PHARMACOGENETICS; SCHIZOPHRENIA; TRIAL	Background Lithium has been a first-line choice for maintenance treatment of bipolar disorders to prevent relapse of mania and depression, but many patients do not have a response to lithium treatment. Methods We selected subgroups from a sample of 1761 patients of Han Chinese descent with bipolar I disorder who were recruited by the Taiwan Bipolar Consortium. We assessed their response to lithium treatment using the Alda scale and performed a genomewide association study on samples from one subgroup of 294 patients with bipolar I disorder who were receiving lithium treatment. We then tested the single-nucleotide polymorphisms (SNPs) that showed the strongest association with a response to lithium for association in a replication sample of 100 patients and tested them further in a follow-up sample of 24 patients. We sequenced the exons, exon-intron boundaries, and part of the promoter of the gene encoding glutamate decarboxylase-like protein 1 (GADL1) in 94 patients who had a response to lithium and in 94 patients who did not have a response in the genomewide association sample. Results Two SNPs in high linkage disequilibrium, rs17026688 and rs17026651, that are located in the introns of GADL1 showed the strongest associations in the genomewide association study (P = 5.50x10(-37) and P = 2.52x10(-37), respectively) and in the replication sample of 100 patients (P = 9.19x10(-15) for each SNP). These two SNPs had a sensitivity of 93% for predicting a response to lithium and differentiated between patients with a good response and those with a poor response in the follow-up cohort. Resequencing of GADL1 revealed a novel variant, IVS8+48delG, which lies in intron 8 of the gene, is in complete linkage disequilibrium with rs17026688 and is predicted to affect splicing. Conclusions Genetic variations in GADL1 are associated with the response to lithium maintenance treatment for bipolar I disorder in patients of Han Chinese descent. (Funded by Academia Sinica and others.)	[Chen, C. -H.; Lee, M. -T. M.; Wu, J. -Y.; Lee, Y. -C.; Li, C. -F.; Wang, K. H. -T.; Wu, L. S. -H.; Peng, H. -L.; Chang, C. -P.; Lu, L. -S.; Chen, Y. -T.; Cheng, A. T. -A.] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chiu, C. -H.; Chen, Cheng-Chung; Lin, J. -J.] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Lung, F. -W.; Chiu, C. -H.; Fan, C. -C.] Taipei City Psychiat Ctr, Taipei, Taiwan; [Lee, C. -S.; Chen, Chiao-Chicy] Mackay Med Coll, Dept Psychiat, Taipei, Taiwan; [Lee, C. -S.; Chen, Chiao-Chicy] Mackay Mem Hosp, Taipei, Taiwan; [Chen, Y. -S.; Su, T. -P.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Feng, J.] Far Eastern Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Chang, C. -J.] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, I. -C.] Fu Jen Catholic Univ, Cardinal Tien Hosp, Sch Med, Dept Psychiat, Taipei, Taiwan; [Tan, H. K. -L.; Chen, J. -J.] Taoyuan Mental Hosp, Taoyaun, Taiwan; [Liu, C. -Y.] Chang Gung Univ, Dept Psychiat, Taoyaun, Taiwan; [Liu, C. -Y.] Chang Gung Med Ctr Linkou, Taoyaun, Taiwan; [Fan, C. -C.] Ju Shan Hosp, Taoyaun, Taiwan; [Chong, M. -Y.] Chang Gung Univ, Dept Psychiat, Kaohsiung, Taiwan; [Chong, M. -Y.] Chang Gung Med Ctr Kaohsiung, Kaohsiung, Taiwan; [Tsang, H. -Y.; Chen, Cheng-Chung] Kaohsiung Municipal Kai Syuan Psychiat Hosp, Kaohsiung, Taiwan; [Chen, C. -H.; Lu, T.] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Wu, C. -K.] Tsyr Huey Mental Hosp, Kaohsiung, Taiwan; [Lung, F. -W.] Kaohsiung Med Univ, Dept Psychiat, Kaohsiung, Taiwan; [Lung, F. -W.] Natl Def Med Ctr, Kaohsiung, Taiwan; [Lane, H. -Y.] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Chuo, L. -J.] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Lai, T. -J.] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Chen, C. -H.; Lee, M. -T. M.; Wu, J. -Y.; Chang, C. -H.] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Chiu, N. -Y.] Changhua Christian Hosp, Dept Psychiat, Changhua, Taiwan; [Teng, P. -R.] Show Chwan Mem Hosp, Dept Psychiat, Changhua, Taiwan; [Chang, T. -J.; Chen, C. -Y.] Tsaotun Psychiat Ctr, Nantou, Taiwan; [Hou, Y. -M.] Chia Yi Christian Hosp, Dept Psychiat, Chiayi, Taiwan; [Tung, C. -L.] Buddhist Tzu Chi Da Lin Gen Hosp, Dept Psychiat, Chiayi, Taiwan; [Ouyang, W. -C.] Jianan Mental Hosp, Tainan, Taiwan; [Lin, J. -J.] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Chen, C. -K.] Chang Gung Univ, Dept Psychiat, Keelung, Taiwan; [Chen, C. -K.] Chang Gung Med Ctr Keelung, Keelung, Taiwan; [Wu, L. S. -H.] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Lee, Y. -C.] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Chen, Y. -T.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Academia Sinica - Taiwan; Taipei Medical University; Mackay Medical College; Mackay Memorial Hospital; Taipei Veterans General Hospital; Far Eastern Memorial Hospital; Cathay General Hospital; Fu Jen Catholic University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Medical University; National Defense Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; Changhua Christian Hospital; Show Chwan Memorial Hospital; Buddhist Tzu Chi General Hospital; Chi Mei Hospital; Chang Gung University; Tzu Chi University; National Tsing Hua University; Duke University	Cheng, ATA (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	chen0010@ibms.sinica.edu.tw; bmandrew@gate.sinica.edu.tw	Cheng, Andrew/O-1159-2018; Lee, Yi-Ching/AAE-6900-2022; Chen, Chien Hsiun/Q-3826-2018; Wu, Jer-Yuarn/S-7010-2018; Etain, Bruno/L-6647-2017; Lee, Ming Ta Michael/N-5396-2015	Cheng, Andrew/0000-0002-2698-0516; Lee, Yi-Ching/0000-0002-7734-5619; Etain, Bruno/0000-0002-5377-1488; Pan, Chun-Hung/0000-0002-8542-558X; Lee, Ming Ta Michael/0000-0003-2510-8977	Academia Sinica, Taiwan [AS 23-23, 52102310023C]; Academia Sinica Genomic Medicine Multicenter Study [AS 40-05]; National Science Council, Taiwan (National Center for Genomic Medicine [NSC101-2319-B-001-001]; Translational Resource Center for Genomic Medicine [NSC101-2325-B-001-035]; National Research Program for Biopharmaceuticals [NSC100-2325-B-001-026, NSC101-2325-B-001-023]	Academia Sinica, Taiwan(Academia Sinica - Taiwan); Academia Sinica Genomic Medicine Multicenter Study(Academia Sinica - Taiwan); National Science Council, Taiwan (National Center for Genomic Medicine; Translational Resource Center for Genomic Medicine; National Research Program for Biopharmaceuticals	Supported by grants from Academia Sinica, Taiwan (AS 23-23, 52102310023C), and Academia Sinica Genomic Medicine Multicenter Study (AS 40-05); and the National Science Council, Taiwan (National Center for Genomic Medicine, NSC101-2319-B-001-001; Translational Resource Center for Genomic Medicine, NSC101-2325-B-001-035; and National Research Program for Biopharmaceuticals, NSC100-2325-B-001-026 and NSC101-2325-B-001-023).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baldessarini RJ, 2000, ARCH GEN PSYCHIAT, V57, P187, DOI 10.1001/archpsyc.57.2.187; Cheng ATA, 2001, BRIT J PSYCHIAT, V178, P567, DOI 10.1192/bjp.178.6.567; Cruceanu C, 2009, GENOME MED, V1, DOI 10.1186/gm79; Fountoulakis KN, 2012, EUR ARCH PSY CLIN N, V262, pS1, DOI 10.1007/s00406-012-0323-x; Frye MA, 2011, NEW ENGL J MED, V364, P51, DOI 10.1056/NEJMcp1000402; Garnham J, 2007, J AFFECT DISORDERS, V104, P185, DOI 10.1016/j.jad.2007.03.003; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Goudet C, 2009, BRAIN RES REV, V60, P43, DOI 10.1016/j.brainresrev.2008.12.007; Grof P, 2002, J CLIN PSYCHIAT, V63, P942, DOI 10.4088/JCP.v63n1013; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Kleindienst N, 2005, PSYCHOL MED, V35, P1685, DOI 10.1017/S0033291705004484; Kleindienst N, 2005, BIPOLAR DISORD, V7, P404, DOI 10.1111/j.1399-5618.2005.00244.x; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; LEE WH, 1988, J SURG ONCOL, V38, P173, DOI 10.1002/jso.2930380309; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Malhotra AK, 2012, MOL PSYCHIATR, V17, P760, DOI 10.1038/mp.2011.146; McCarthy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032091; McCarthy MJ, 2010, PHARMACOGENOMICS, V11, P1439, DOI [10.2217/pgs.10.127, 10.2217/PGS.10.127]; Muller-Oerlinghausen B, 2002, LANCET, V359, P241, DOI 10.1016/S0140-6736(02)07450-0; Paton C, 2010, J PSYCHOPHARMACOL, V24, P1739, DOI 10.1177/0269881110367728; Perlis RH, 2009, AM J PSYCHIAT, V166, P718, DOI 10.1176/appi.ajp.2009.08111633; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REGIER DA, 1994, AM J PSYCHIAT, V151, P1340; Rybakowski JK, 2011, WORLD J BIOL PSYCHIA, V12, P340, DOI 10.3109/15622975.2011.559274; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Wasserman D, 2012, EUR PSYCHIAT, V27, P129, DOI 10.1016/j.eurpsy.2011.06.003; Yang Y Y, 1991, J Formos Med Assoc, V90, P509; Yang YP, 2012, BIOMATERIALS, V33, P1462, DOI 10.1016/j.biomaterials.2011.10.071	29	114	117	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					119	128		10.1056/NEJMoa1212444	http://dx.doi.org/10.1056/NEJMoa1212444			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24369049	Bronze			2022-12-28	WOS:000336119800007
J	Morata, G				Morata, Gines			Non-essential spread	NATURE			English	Editorial Material									Univ Autonoma Madrid, Ctr Biol Mol, CSIC UAM, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Morata, G (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, CSIC UAM, E-28049 Madrid, Spain.	gmorata@cbm.uam.es		Morata, Gines/0000-0003-3274-5173					0	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					162	162		10.1038/nature12848	http://dx.doi.org/10.1038/nature12848			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24390347				2022-12-28	WOS:000329441500022
J	Outterson, K				Outterson, Kevin			The Drug Quality and Security Act - Mind the Gaps	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Law, Boston, MA 02215 USA; [Outterson, Kevin] Univ Iowa, Coll Law, Iowa City, IA 52242 USA	Boston University; University of Iowa	Outterson, K (corresponding author), Boston Univ, Sch Law, Boston, MA 02215 USA.			Outterson, Kevin/0000-0003-2513-3216				National Conference of State Legislatures, 2013, STAT REG COMP PHARM; Outterson K, 2012, NEW ENGL J MED, V367, P1969, DOI 10.1056/NEJMp1212667; Sanchez J., 2013, PHARM COMPOUND UPDAT; Special Commission on the Oversight of Compounding Pharmacies, 2013, REC OV COMP PHARM CO	4	12	29	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					97	99		10.1056/NEJMp1314691	http://dx.doi.org/10.1056/NEJMp1314691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TA	24369048	Green Published			2022-12-28	WOS:000336119800002
J	Graham, J; Kirkbride, P; Cann, K; Hasler, E; Prettyjohns, M				Graham, John; Kirkbride, Peter; Cann, Kimberley; Hasler, Elise; Prettyjohns, Matthew			GUIDELINES Prostate cancer: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Graham, John; Cann, Kimberley; Hasler, Elise; Prettyjohns, Matthew] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Kirkbride, Peter] Clatterbridge Canc Ctr NHS Fdn Trust, Wirral CH63 4JY, Merseyside, England		Graham, J (corresponding author), Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales.	john.graham@nhs.net		Graham, John/0000-0003-3381-9787				[Anonymous], LOCALISED PROSTATE C; Graham J, 2008, BRIT MED J, V336, P610, DOI 10.1136/bmj.39498.525706.AD; National Institute for Health and Care Excellence, 2012, TECHNOLOGY APPRAISAL, V259; National Institute for Health and Care Excellence, 2008, CLINICAL GUIDELINE 5, V58; National Institute for Health and Care Excellence, 2012, CLINICAL GUIDELINE 1, V146; National Institute for Health and Care Excellence, 2012, TECHNOLOGY APPRAISAL, V255; National Institute for Health and Care Excellence, 2014, CLINICAL GUIDELINE 1; Office for National Statistics, 2011, CANCER STATISTICS RE, V42	8	48	48	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								f7524	10.1136/bmj.f7524	http://dx.doi.org/10.1136/bmj.f7524			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KI	24401467				2022-12-28	WOS:000329610300002
J	Blumenthal, D; Stremikis, K; Cutler, D				Blumenthal, David; Stremikis, Kristof; Cutler, David			Health Care Spending - A Giant Slain or Sleeping?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; INSURANCE; PHYSICIAN; SLOWDOWN; PAYMENT; DEMAND; PRICES; GROWTH; COSTS		[Blumenthal, David; Stremikis, Kristof] Commonwealth Fund, New York, NY USA; [Cutler, David] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Cutler, David] NBER, Cambridge, MA 02138 USA	Commonwealth Fund; Harvard University; National Bureau of Economic Research	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY USA.			Cutler, David/0000-0002-4949-8917				Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; [Anonymous], 2013, MOR DOCT HOSP PARTN; [Anonymous], 2013, CMS ANN NEW IN IMPR; [Anonymous], 2013, STRENGTH AFF QUAL AM; [Anonymous], 2008, WAST IN US HLTH CAR; [Anonymous], 2010, MIRROR MIRROR WALL P; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Berenson RA, 2012, HEALTH AFFAIR, V31, P973, DOI 10.1377/hlthaff.2011.0920; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bipartisan Policy Center, 2013, BIP RX PAT CTR CAR S; Blumenthal D, 2012, NEW ENGL J MED, V366, P1953, DOI 10.1056/NEJMp1203427; Blumenthal David, 2010, HEART POWER HLTH POL; Brookings Institute, 2013, BEND CURV PERS CTR H; Center for Sustainable Health Spending, 2013, INS BUR LAB STAT BLS; Center for Sustainable Health SpenIdem, 2013, INS MONTHL PRIC IND; Chandra A, 2007, J POLIT ECON, V115, P103, DOI 10.1086/512249; Chernew M, 2005, HEALTH SERV RES, V40, P1021, DOI 10.1111/j.1475-6773.2005.00409.x; Chernew ME, 2010, NEW ENGL J MED, V362, P1166, DOI 10.1056/NEJMp1002873; Congressional Budget Office, 2013, BUDG EC OUTL FISC YE; Cuckler GA, 2013, HLTH AFF MILLWOOD, V32, P1820; Cutler D.M., 1995, TECHNOLOGY HLTH COST; Cutler D, 2012, NEW ENGL J MED, V367, P1875, DOI 10.1056/NEJMp1209711; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Cutler DM, 2013, HEALTH AFFAIR, V32, P841, DOI 10.1377/hlthaff.2012.0289; Davis K, 2011, ACHIEVING MEDICARE M; Davis K., 1981, RECENT TRENDS HOSP C; Davis K., 1975, NATL HLTH INSURANCE; DAVIS K, 1990, HLTH CARE COST CONTA; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P1057, DOI 10.1001/jama.299.9.1057; ERP, 2013, EC REPORT PRESIDENT; FELDSTEIN M, 1977, J PUBLIC ECON, V7, P155, DOI 10.1016/0047-2727(77)90044-5; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Fuchs VR, 2013, NEW ENGL J MED, V369, P107, DOI 10.1056/NEJMp1305298; Greene J, 2013, HEALTH AFFAIR, V32, P1299, DOI 10.1377/hlthaff.2012.1409; Guterman S, 2011, HIGH PERFORMANCE ACC; Herman B., 2012, BECKERS HOSP RE 0403; IMS Institute for Healthcare Informatics, 2012, GLOB US MED OUTL 201; Institute of Medicine, 2013, BETT CAR LOW COST PA; Kaiser Family Foundation, 2013, EMPL HLTH BEN 2013 A; Kaiser Family Foundation and Altarum Institute, 1992, J ECON PERSPECT, V6, P3; Larch Martin., 2020, NUMERICAL COMPLIANCE; Laugesen MJ, 2011, HEALTH AFFAIR, V30, P1647, DOI 10.1377/hlthaff.2010.0204; Lee DW, 2012, HEALTH AFFAIR, V31, P1876, DOI 10.1377/hlthaff.2011.1034; Lee DW, 2011, J AM COLL RADIOL, V8, P393, DOI 10.1016/j.jacr.2010.11.016; Levin DC, 2010, J AM COLL RADIOL, V7, P235, DOI 10.1016/j.jacr.2010.01.011; Levin DC, 2010, J AM COLL RADIOL, V7, P33, DOI 10.1016/j.jacr.2009.09.012; MANNING WG, 1987, AM ECON REV, V77, P251; National Coalition on Health Care, 2012, CURB COSTS IMPR CAR; Nisen M., 2012, BUSINESS INSIDE 0628; Petersen MMDGP, 2013, GROWTH DISPERSION AC; Pozen A, 2010, INQUIRY-J HEALTH CAR, V47, P124, DOI 10.5034/inquiryjrnl_47.02.124; Ricciardi L, 2013, HEALTH AFFAIR, V32, P376, DOI 10.1377/hlthaff.2012.1216; Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744; Robinson JC, 2006, HEALTH AFFAIR, V25, P1205, DOI 10.1377/hlthaff.25.5.1205; RUSSELL LB, 1989, NEW ENGL J MED, V320, P439, DOI 10.1056/NEJM198902163200706; Ryu AJ, 2013, HEALTH AFFAIR, V32, P835, DOI 10.1377/hlthaff.2012.1297; Smith SD, 2000, IMPACT TECHNOLOGICAL; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327; Strunk BC, 2002, AGING PLAYS LTD ROLE; Strunk BC, 2006, HEALTH AFFAIR, V25, pW141, DOI 10.1377/hlthaff.25.w141; The Commonwealth Fund Commission on a High Performance Health System, 2013, CONFR COSTS STAB US; Thorpe KE, 2004, HLTH AFF MILLWOOD S; Thorpe KE, 2005, HLTH AFF MILLWOOD S; Thorpe KE, 2010, HEALTH AFFAIR, V29, P718, DOI 10.1377/hlthaff.2009.0474; Wilson CT, 2007, HEALTH AFFAIR, V26, P162, DOI 10.1377/hlthaff.26.1.162	68	34	35	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2551	2557		10.1056/NEJMhpr1310415	http://dx.doi.org/10.1056/NEJMhpr1310415			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	278BT	24369080	Green Published			2022-12-28	WOS:000328863700015
J	Oudeman, EA; Frijns, CJM; Klijn, CJM				Oudeman, Eline A.; Frijns, Catharina J. M.; Klijn, Catharina J. M.			Multiple Cerebral Infarctions and Intracranial Vessel Abnormalities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							B-CELL LYMPHOMA; INTRAVASCULAR LYMPHOMA; MANAGEMENT		[Oudeman, Eline A.; Frijns, Catharina J. M.; Klijn, Catharina J. M.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Oudeman, EA (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, POB 85500, NL-3508 GA Utrecht, Netherlands.	e.a.oudeman@gmail.com	Klijn, C.J.M./E-1700-2016	Klijn, C.J.M./0000-0002-8495-4578				Ferreri AJM, 2004, BRIT J HAEMATOL, V127, P173, DOI 10.1111/j.1365-2141.2004.05177.x; Kadkhodayan Y, 2004, RADIOLOGY, V233, P878, DOI 10.1148/radiol.2333031621; Matsue K, 2011, ANN HEMATOL, V90, P417, DOI 10.1007/s00277-010-1101-3; Ponzoni M, 2007, J CLIN ONCOL, V25, P3168, DOI 10.1200/JCO.2006.08.2313; Shimada K, 2009, LANCET ONCOL, V10, P895, DOI 10.1016/S1470-2045(09)70140-8; Zuckerman D, 2006, ONCOLOGIST, V11, P496, DOI 10.1634/theoncologist.11-5-496	6	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2668	2669		10.1001/jama.2013.284467	http://dx.doi.org/10.1001/jama.2013.284467			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368467				2022-12-28	WOS:000328818000019
J	Remuzzi, G; Horton, R				Remuzzi, Giuseppe; Horton, Richard			Acute renal failure: an unacceptable death sentence globally	LANCET			English	Editorial Material							ACUTE KIDNEY INJURY		[Remuzzi, Giuseppe] Int Soc Nephrol, Brussels, Belgium; [Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Horton, Richard] The Lancet, London NW1 7BY, England	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII	Remuzzi, G (corresponding author), Int Soc Nephrol, Brussels, Belgium.	giuseppe.remuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Callegari JG, 2012, KIDNEY INT, V81, P331, DOI 10.1038/ki.2011.408; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Imani PD, 2013, PEDIATR NEPHROL, V28, P2199, DOI 10.1007/s00467-013-2544-2; International Society of Nephrology, SAV YOUNG LIV AS AFR; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; National Institute for Health and Care Excellence, AC KIDN INJ PREV DET; Okunola O, 2012, Afr J Med Med Sci, V41, P119; Okunola OO, 2012, SAUDI J KIDNEY DIS T, V23, P1315, DOI 10.4103/1319-2442.103587	8	41	45	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2041	2042		10.1016/S0140-6736(13)62193-5	http://dx.doi.org/10.1016/S0140-6736(13)62193-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24360375				2022-12-28	WOS:000328687800008
J	Murakawa, H; Bahramy, MS; Tokunaga, M; Kohama, Y; Bell, C; Kaneko, Y; Nagaosa, N; Hwang, HY; Tokura, Y				Murakawa, H.; Bahramy, M. S.; Tokunaga, M.; Kohama, Y.; Bell, C.; Kaneko, Y.; Nagaosa, N.; Hwang, H. Y.; Tokura, Y.			Detection of Berry's Phase in a Bulk Rashba Semiconductor	SCIENCE			English	Article							CONDUCTANCE; TRANSPORT; SURFACE	The motion of electrons in a solid has a profound effect on its topological properties and may result in a nonzero Berry's phase, a geometric quantum phase encoded in the system's electronic wave function. Despite its ubiquity, there are few experimental observations of Berry's phase of bulk states. Here, we report detection of a nontrivial pi Berry's phase in the bulk Rashba semiconductor BiTeI via analysis of the Shubnikov-de Haas (SdH) effect. The extremely large Rashba splitting in this material enables the separation of SdH oscillations, stemming from the spin-split inner and outer Fermi surfaces. For both Fermi surfaces, we observe a systematic pi-phase shift in SdH oscillations, consistent with the theoretically predicted nontrivial pi Berry's phase in Rashba systems.	[Murakawa, H.; Bahramy, M. S.; Kaneko, Y.; Nagaosa, N.; Hwang, H. Y.; Tokura, Y.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Bahramy, M. S.; Nagaosa, N.; Tokura, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Bahramy, M. S.; Nagaosa, N.; Tokura, Y.] Univ Tokyo, Quantum Phase Elect Ctr, Tokyo 1138656, Japan; [Tokunaga, M.; Kohama, Y.] Univ Tokyo, Inst Solid State Phys, Int MegaGauss Sci Lab, Kashiwa, Chiba 2778581, Japan; [Bell, C.; Hwang, H. Y.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA	RIKEN; University of Tokyo; University of Tokyo; University of Tokyo; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Murakawa, H (corresponding author), Osaka Univ, Dept Phys, Grad Sch Sci, Osaka, Japan.	murakawa-h@riken.jp	Bahramy, Mohammad Saeed/B-2865-2013; Tokura, Yoshinori/C-7352-2009; Ishida, Mari/AAU-3379-2020; Nagaosa, Naoto/G-7057-2012; Kohama, Yoshimitsu/AAF-3281-2020; Bell, Christopher/B-8785-2009; Kaneko, Yoshio/D-3905-2017; Tokunaga, Masashi/C-6821-2014; Hwang, Harold Y/I-6943-2012	Bahramy, Mohammad Saeed/0000-0001-9024-6335; Tokura, Yoshinori/0000-0002-2732-4983; Bell, Christopher/0000-0003-4732-0354; Kaneko, Yoshio/0000-0001-5209-1379; Tokunaga, Masashi/0000-0002-1401-9381; Kohama, Yoshimitsu/0000-0003-0149-704X	Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), Japan; U.S. Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]; Ministry of Education, Culture, Sports, Science and Technology, Japan [23340096, 24224009]	Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), Japan; U.S. Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank J. G. Checkelsky for fruitful discussions. This work was supported by the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), Japan, and the U.S. Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-76SF00515 (C. B. and H.Y.H). This research was partly supported by Grants-in-Aid for Scientific Research (B) (no. 23340096) and (S) (no. 24224009) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ADAMS EN, 1959, J PHYS CHEM SOLIDS, V10, P254, DOI 10.1016/0022-3697(59)90002-2; Analytis JG, 2010, NAT PHYS, V6, P960, DOI 10.1038/NPHYS1861; Bahramy MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1679; Bahramy MS, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.041202; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Buttner B, 2011, NAT PHYS, V7, P418, DOI 10.1038/NPHYS1914; Champel T, 2001, PHILOS MAG B, V81, P55, DOI 10.1080/13642810108216525; Chang MC, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.085315; Crepaldi A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.096803; DAS B, 1989, PHYS REV B, V39, P1411, DOI 10.1103/PhysRevB.39.1411; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Ishizaka K, 2011, NAT MATER, V10, P521, DOI [10.1038/NMAT3051, 10.1038/nmat3051]; Koga T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.046801; Landolt G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116403; Landwehr G., 1991, LANDAU LEVEL SPECTRO; Lee JS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.117401; Luk'yanchuk IA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166402; Luk'yanchuk IA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.256801; Mikitik GP, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235112; Mikitik GP, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.033301; Mikitik GP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.106403; Mikitik GP, 1999, PHYS REV LETT, V82, P2147, DOI 10.1103/PhysRevLett.82.2147; Morpurgo AF, 1998, PHYS REV LETT, V80, P1050, DOI 10.1103/PhysRevLett.80.1050; Nitta J, 1997, PHYS REV LETT, V78, P1335, DOI 10.1103/PhysRevLett.78.1335; NIU Q, 1984, J PHYS A-MATH GEN, V17, P2453, DOI 10.1088/0305-4470/17/12/016; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Park J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.126402; Ramanayaka AN, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165327; RASHBA EI, 1960, SOV PHYS-SOL STATE, V2, P1109; ROTH LM, 1966, SEMICONDUCT SEMIMET, V1, P159; Sacepe B, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1586; Schneider JM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.166403; Shen SQ, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.081311; Shoenberg D., 1984, MAGNETIC OSCILLATION; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Winkler R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155303; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Xiong J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045314; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhu ZW, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115137	41	214	217	13	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1490	1493		10.1126/science.1242247	http://dx.doi.org/10.1126/science.1242247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357313				2022-12-28	WOS:000328644300052
J	Chen, BH; Gilbert, LA; Cimini, BA; Schnitzbauer, J; Zhang, W; Li, GW; Park, J; Blackburn, EH; Weissman, JS; Qi, LS; Huang, B				Chen, Baohui; Gilbert, Luke A.; Cimini, Beth A.; Schnitzbauer, Joerg; Zhang, Wei; Li, Gene-Wei; Park, Jason; Blackburn, Elizabeth H.; Weissman, Jonathan S.; Qi, Lei S.; Huang, Bo			Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System	CELL			English	Article							SEQUENCE-SPECIFIC CONTROL; CHROMATIN DYNAMICS; GENE-EXPRESSION; RNA; ORGANIZATION; TELOMERES; CHROMOSOMES; VISUALIZATION; HYBRIDIZATION; TRANSCRIPTION	The spatiotemporal organization and dynamics of chromatin play critical roles in regulating genome function. However, visualizing specific, endogenous genomic loci remains challenging in living cells. Here, we demonstrate such an imaging technique by repurposing the bacterial CRISPR/Cas system. Using an EGFP-tagged endonuclease-deficient Cas9 protein and a structurally optimized small guide (sg) RNA, we show robust imaging of repetitive elements in telomeres and coding genes in living cells. Furthermore, an array of sgRNAs tiling along the target locus enables the visualization of nonrepetitive genomic sequences. Using this method, we have studied telomere dynamics during elongation or disruption, the subnuclear localization of the MUC4 loci, the cohesion of replicated MUC4 loci on sister chromatids, and their dynamic behaviors during mitosis. This CRISPR imaging tool has potential to significantly improve the capacity to study the conformation and dynamics of native chromosomes in living human cells.	[Chen, Baohui; Schnitzbauer, Joerg; Zhang, Wei; Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Li, Gene-Wei; Park, Jason; Weissman, Jonathan S.; Qi, Lei S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Cimini, Beth A.; Blackburn, Elizabeth H.; Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Cimini, Beth A.] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Park, Jason; Qi, Lei S.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Li, Gene-Wei; Weissman, Jonathan S.] Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Weissman, Jonathan S.; Qi, Lei S.; Huang, Bo] Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Qi, LS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	stanley.qi@ucsf.edu; bo.huang@ucsf.edu	Cimini, Beth/ABA-9337-2021; Gilbert, Luke/AAC-5300-2019; Qi, Lei S/AAC-5088-2019	Cimini, Beth/0000-0001-9640-9318; Chen, Baohui/0000-0002-8999-6531; Weissman, Jonathan/0000-0003-2445-670X; Li, Gene-Wei/0000-0001-7036-8511; Qi, Lei S/0000-0002-3965-3223; Gilbert, Luke/0000-0001-5854-0825	California Institute for Quantitative Biomedical Research [QB3]; UCSF Program for Breakthroughs in Biomedical Research; UCSF Center for Systems and Synthetic Biology; NIH Office of The Director (OD); National Institute of Dental & Craniofacial Research (NIDCR); Boehringer Ingelheim Fonds Ph.D. fellowship; NIH [GM081879, DA036858, GM102706, CA168370, CA096840]; NIH Director's Early Independence Award [OD017887]; Leukemia and Lymphoma Society; Helen Hay Whitney Foundation; NIH Pathway to Independence Award [GM105913]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U01CA168370, R01CA096840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM105913, T32GM007810, P50GM102706, T32GM007618, P50GM081879, K99GM105913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017887] Funding Source: NIH RePORTER	California Institute for Quantitative Biomedical Research; UCSF Program for Breakthroughs in Biomedical Research; UCSF Center for Systems and Synthetic Biology; NIH Office of The Director (OD); National Institute of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Boehringer Ingelheim Fonds Ph.D. fellowship(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Early Independence Award; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Helen Hay Whitney Foundation; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Cell Line Genetics for karyotype analysis. B. C., W.Z. and B. H. acknowledge support from the California Institute for Quantitative Biomedical Research (QB3) and the UCSF Program for Breakthroughs in Biomedical Research. L. S. Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology, NIH Office of The Director (OD), and National Institute of Dental & Craniofacial Research (NIDCR). J.S. acknowledges support from a Boehringer Ingelheim Fonds Ph.D. fellowship. This work was in part supported by NIH P50 (grant GM081879, L. S. Q.), NIH Director's Early Independence Award (grant OD017887, L. S. Q.), NIH R01 (grant DA036858, L. S. Q. and J.S.W.), NIH P50 (grant GM102706, J.S. W), NIH U01 (grant CA168370, J.S. W), NIH R01 (grant CA096840, E. H. B. and B. A. C.), the Leukemia and Lymphoma Society (L. A. G.), the Helen Hay Whitney Foundation (G. W. L.), NIH Pathway to Independence Award (GM105913, G. W. L.), and the Howard Hughes Medical Institute (L. A. G., G. L., J.P. and J.S.W).	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hellwig D, 2008, J BIOPHOTONICS, V1, P245, DOI 10.1002/jbio.200810014; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Levi V, 2005, BIOPHYS J, V89, P4275, DOI 10.1529/biophysj.105.066670; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2013, CELL, V152, P1209, DOI 10.1016/j.cell.2013.02.048; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Sinclair P, 2010, J CELL BIOL, V190, P761, DOI 10.1083/jcb.200912167; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wang XY, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-4; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005	46	1162	1309	22	352	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1479	1491		10.1016/j.cell.2013.12.001	http://dx.doi.org/10.1016/j.cell.2013.12.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360272	Green Accepted, Bronze			2022-12-28	WOS:000328693300006
J	Eckel-Mahan, KL; Patel, VR; de Mateo, S; Orozco-Solis, R; Ceglia, NJ; Sahar, S; Dilag-Penilla, SA; Dyar, KA; Baldi, P; Sassone-Corsi, P				Eckel-Mahan, Kristin L.; Patel, Vishal R.; de Mateo, Sara; Orozco-Solis, Ricardo; Ceglia, Nicholas J.; Sahar, Saurabh; Dilag-Penilla, Sherry A.; Dyar, Kenneth A.; Baldi, Pierre; Sassone-Corsi, Paolo			Reprogramming of the Circadian Clock by Nutritional Challenge	CELL			English	Article							PPAR-GAMMA; GENE-EXPRESSION; SHIFT WORK; PYRUVATE-CARBOXYLASE; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS; BODY-MASS; DIET; FAT; METABOLISM	Circadian rhythms and cellular metabolism are intimately linked. Here, we reveal that a high-fat diet (HFD) generates a profound reorganization of specific metabolic pathways, leading to widespread remodeling of the liver clock. Strikingly, in addition to disrupting the normal circadian cycle, HFD causes an unexpectedly large-scale genesis of de novo oscillating transcripts, resulting in reorganization of the coordinated oscillations between coherent transcripts and metabolites. The mechanisms underlying this reprogramming involve both the impairment of CLOCK: BMAL1 chromatin recruitment and a pronounced cyclic activation of surrogate pathways through the transcriptional regulator PPAR gamma. Finally, we demonstrate that it is specifically the nutritional challenge, and not the development of obesity, that causes the reprogramming of the clock and that the effects of the diet on the clock are reversible.	[Eckel-Mahan, Kristin L.; de Mateo, Sara; Orozco-Solis, Ricardo; Sahar, Saurabh; Dilag-Penilla, Sherry A.; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Patel, Vishal R.; Ceglia, Nicholas J.; Baldi, Pierre] Univ Calif Irvine, Sch Informat & Comp Sci, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Dyar, Kenneth A.] Venetian Inst Mol Med, I-35129 Padua, Italy	University of California System; University of California Irvine; University of California System; University of California Irvine; Veneto Institute Molecular Medicine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Irvine, CA 92697 USA.	psc@uci.edu	Dyar, Kenneth/K-4735-2014; Dyar, Kenneth/N-8399-2019; de Mateo Lopez, Sara/L-1870-2017	Dyar, Kenneth/0000-0002-9010-8757; de Mateo Lopez, Sara/0000-0003-4754-6599; Eckel-Mahan, Kristin/0000-0001-8201-1675	NIH/NRSA [F32 DK083881]; NIH [GM081634, AG033888, LM010235]; Merieux Research Grant; Sirtris Pharmaceuticals [SP-48984]; NSF [IIS-0513376]; NIH-NLM [T15 LM07443]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK083881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033888] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010235, T15LM007443] Funding Source: NIH RePORTER	NIH/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merieux Research Grant; Sirtris Pharmaceuticals; NSF(National Science Foundation (NSF)); NIH-NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank members of the Sassone-Corsi laboratory for constructive comments. We would also like to thank Melanie Oakes, Seung-Ah Chung, and Valentina Ciobanu at the UCI Genomics High-Throughput Facility at the University of California, Irvine. We are grateful to Janice Jones, Jeff Buckthal, Robert Eckel, Hong Wang, Selma Masri, and Jennifer Mondok for helpful comments regarding the data or for technical assistance. Monetary support includes NIH/NRSA F32 DK083881 (K. L. E.-M.), NIH grants GM081634 and AG033888 (P.S.-C.), Merieux Research Grant, and Sirtris Pharmaceuticals SP-48984 (P.S.-C.). The work of V. R. P., N.J.C., and P. B. is supported by NSF IIS-0513376, NIH LM010235, and NIH-NLM T15 LM07443 to P.B.	Antunes LD, 2010, ARQ BRAS ENDOCRINOL, V54, P652, DOI 10.1590/S0004-27302010000700010; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Bray MS, 2009, OBES REV, V10, P6, DOI 10.1111/j.1467-789X.2009.00684.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Das UN, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-35; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fajas L, 2001, NUTR METAB CARDIOVAS, V11, P64; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kumashiro N, 2013, DIABETES, V62, P2183, DOI 10.2337/db12-1311; Lee JHW, 2011, J HYDRO-ENVIRON RES, V5, P143, DOI 10.1016/j.jher.2011.07.001; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Masri S, 2013, P NATL ACAD SCI USA, V110, P3339, DOI 10.1073/pnas.1217632110; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Menet JS, 2011, CURR OPIN NEUROBIOL, V21, P849, DOI 10.1016/j.conb.2011.06.008; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; Perreault M, 2010, DIABETES OBES METAB, V12, P234, DOI 10.1111/j.1463-1326.2009.01157.x; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sharifian Akbar, 2005, J Circadian Rhythms, V3, P15, DOI 10.1186/1740-3391-3-15; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	72	411	426	8	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1464	1478		10.1016/j.cell.2013.11.034	http://dx.doi.org/10.1016/j.cell.2013.11.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360271	Green Accepted, Bronze			2022-12-28	WOS:000328693300005
J	O'Donnell, MR; Schluger, NW				O'Donnell, Max R.; Schluger, Neil W.			Long walk to treatment for XDR tuberculosis in South Africa	LANCET			English	Editorial Material							CASCADE; CARE		[O'Donnell, Max R.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [O'Donnell, Max R.] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [O'Donnell, Max R.] Ctr AIDS Programme Res South Africa, Durban, South Africa; [Schluger, Neil W.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Schluger, Neil W.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Schluger, Neil W.] World Lung Fdn, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University	O'Donnell, MR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	max.odonnell@einstein.yu.edu	Schluger, Neil/ABA-1793-2021		NIAID NIH HHS [K23 AI098479] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Battersby John D., 1988, NY TIMES; COLLIE A, 1989, S AFR MED J, V76, P676; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dooley KE, 2013, CURR OPIN HIV AIDS, V8, P579, DOI 10.1097/COH.0000000000000009; Ghosh R, 2009, CURR OPIN CRIT CARE, V15, P279, DOI 10.1097/MCC.0b013e32832faef2; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Pietersen E, 2014, LANCET; Treatment Action Group, 2013, 2013 REP TUB RES FUN; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, MULT EXT DRUG RES TU	12	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1193	1194		10.1016/S0140-6736(14)60043-X	http://dx.doi.org/10.1016/S0140-6736(14)60043-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LO	24439236				2022-12-28	WOS:000334104600007
J	Crowley, RA; Golden, W				Crowley, Ryan A.; Golden, William			Health Policy Basics: Medicaid Expansion	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIANS; STATE; CARE	Medicaid is the largest single source of health insurance coverage in the United States, providing insurance for more than 62 million persons and families in 2013. The Patient Protection and Affordable Care Act sought to expand Medicaid eligibility to nearly all low-income persons with incomes up to 138% of the federal poverty level. However, the U. S. Supreme Court ruled that states' expansion would be optional. Although more than half of the states and the District of Columbia have opted to expand Medicaid starting in 2014, many states continue to oppose increasing access to the program. This article will discuss the basic provisions of the expansion and the benefits and challenges patients and physicians may face as Medicaid grows.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Arkansas Div Med Serv, Little Rock, AR USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA	American College of Physicians; University of Arkansas System; University of Arkansas Medical Sciences	Crowley, RA (corresponding author), Amer Coll Physicians, Customer Serv, 190 N Independence Mall West, Philadelphia, PA 19106 USA.				American College of Physicians	American College of Physicians	Financial support for the development of this article came exclusively from the American College of Physicians operating budget.	Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Broaddus M., 2010, CHILDLESS ADULTS WHO; Cheung PT, 2012, ANN EMERG MED, V60, P4, DOI 10.1016/j.annemergmed.2012.01.035; Congressional Budget Office, 2013, CBOS MAY 2013 EST EF; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; Goin D., 2012, MUCH WILL MED PHYS F; Jindal Bobby, 2013, TIMES PICAYUNE  0723; Johnson SR., 2013, MODERN HEALTHCARE; Kaiser Commission on Medicaid and the Uninsured, 2010, EXP MED LOW INC CHIL; Kaiser Commission on Medicaid and the Uninsured, 2013, MED PRIM; Kaiser Family Foundation, 2013, STAT STAT ACT MED EX; Long SK, 2013, HEALTH AFFAIR, V32, P1560, DOI 10.1377/hlthaff.2012.1010; Long SK, 2013, NATL FINDINGS ACCESS; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; The Kaiser Commission on Medicaid and the Uninsured, 2013, COV GAP UN POOR AD S	15	14	14	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					423	+		10.7326/M13-2626	http://dx.doi.org/10.7326/M13-2626			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24366475				2022-12-28	WOS:000333521300020
J	de Koning, HJ; Meza, R; Plevritis, SK; ten Haaf, K; Munshi, VN; Jeon, J; Erdogan, SA; Kong, CY; Han, SS; van Rosmalen, J; Choi, SE; Pinsky, PF; de Gonzalez, AB; Berg, CD; Black, WC; Tammemagi, MC; Hazelton, WD; Feuer, EJ; McMahon, PM				de Koning, Harry J.; Meza, Rafael; Plevritis, Sylvia K.; ten Haaf, Kevin; Munshi, Vidit N.; Jeon, Jihyoun; Erdogan, Saadet Ayca; Kong, Chung Yin; Han, Summer S.; van Rosmalen, Joost; Choi, Sung Eun; Pinsky, Paul F.; de Gonzalez, Amy Berrington; Berg, Christine D.; Black, William C.; Tammemaegi, Martin C.; Hazelton, William D.; Feuer, Eric J.; McMahon, Pamela M.			Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							SELECTION CRITERIA; UNITED-STATES; SMOKING; CT; POPULATION; MORTALITY; PROSTATE; STAGE; IMPACT; AGE	Background: The optimum screening policy for lung cancer is unknown. Objective: To identify efficient computed tomography (CT) screening scenarios in which relatively more lung cancer deaths are averted for fewer CT screening examinations. Design: Comparative modeling study using 5 independent models. Data Sources: The National Lung Screening Trial; the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial; the Surveillance, Epidemiology, and End Results program; and the U.S. Smoking History Generator. Target Population: U.S. cohort born in 1950. Time Horizon: Cohort followed from ages 45 to 90 years. Perspective: Societal. Intervention: 576 scenarios with varying eligibility criteria (age, pack-years of smoking, years since quitting) and screening intervals. Outcome Measures: Benefits included lung cancer deaths averted or life-years gained. Harms included CT examinations, false-positive results (including those obtained from biopsy/surgery), overdiagnosed cases, and radiation-related deaths. Results of Best-Case Scenario: The most advantageous strategy was annual screening from ages 55 through 80 years for ever-smokers with a smoking history of at least 30 pack-years and ex-smokers with less than 15 years since quitting. It would lead to 50% (model ranges, 45% to 54%) of cases of cancer being detected at an early stage (stage I/II), 575 screening examinations per lung cancer death averted, a 14% (range, 8.2% to 23.5%) reduction in lung cancer mortality, 497 lung cancer deaths averted, and 5250 life-years gained per the 100 000-member cohort. Harms would include 67 550 false-positive test results, 910 biopsies or surgeries for benign lesions, and 190 overdiagnosed cases of cancer (3.7% of all cases of lung cancer [model ranges, 1.4% to 8.3%]). Results of Sensitivity Analysis: The number of cancer deaths averted for the scenario varied across models between 177 and 862; the number of overdiagnosed cases of cancer varied between 72 and 426. Limitations: Scenarios assumed 100% screening adherence. Data derived from trials with short duration were extrapolated to lifetime follow-up. Conclusion: Annual CT screening for lung cancer has a favorable benefit-harm ratio for individuals aged 55 through 80 years with 30 or more pack-years' exposure to smoking.	Erasmus MC, NL-3000 CA Rotterdam, Netherlands; Univ Michigan, Ann Arbor, MI 48109 USA; Stanford Univ, Stanford, CA 94305 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; NCI, Bethesda, MD 20892 USA; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; Brock Univ, St Catharines, ON L2S 3A1, Canada	Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; Stanford University; Harvard University; Massachusetts General Hospital; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Dartmouth College; Brock University	de Koning, HJ (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	h.dekoning@erasmusmc.nl	Haaf, Kevin ten/AAI-3998-2020; Peng, Bo/A-6920-2009; de gonzalez, amy berrington/L-7017-2017; Berg, Christine/K-1047-2014; de+Koning, Harry/AAF-9062-2019	Haaf, Kevin ten/0000-0001-5006-6938; Peng, Bo/0000-0001-8225-2284; de gonzalez, amy berrington/0000-0002-7332-8387; de+Koning, Harry/0000-0003-4682-3646; Tammemagi, Martin/0000-0002-4989-5058	National Cancer Institute; NATIONAL CANCER INSTITUTE [U01CA152956] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: National Cancer Institute.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Anderson CM, 2012, RISK ANAL, V32, pS14, DOI 10.1111/j.1539-6924.2011.01703.x; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Caldarella A, 2007, EJSO-EUR J SURG ONC, V33, P763, DOI 10.1016/j.ejso.2007.01.001; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; de Gelder R, 2008, INT J CANCER, V123, P680, DOI 10.1002/ijc.23540; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; de Gonzalez AB, 2008, J MED SCREEN, V15, P153, DOI 10.1258/jms.2008.008052; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Holford TR, 2013, AM J PREV M IN PRESS; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Horeweg N, 2013, AM J RESP CRIT CARE, V187, P848, DOI 10.1164/rccm.201209-1651OC; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Jeon J, 2012, RISK ANAL, V32, pS51, DOI 10.1111/j.1539-6924.2011.01775.x; Korfage IJ, 2006, EUR J CANCER, V42, P165, DOI 10.1016/j.ejca.2005.10.011; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Ma JM, 2013, CANCER-AM CANCER SOC, V119, P1381, DOI 10.1002/cncr.27813; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Peto J, 2012, BRIT J CANCER, V107, P406, DOI 10.1038/bjc.2012.97; Pinsky PF, 2013, CANCER; Radzikowska E, 2002, ANN ONCOL, V13, P1087, DOI 10.1093/annonc/mdf187; Ringer G, 2005, CLIN LUNG CANCER, V7, P180, DOI 10.3816/CLC.2005.n.033; Rosenberg MA, 2012, RISK ANAL, V32, pS25, DOI 10.1111/j.1539-6924.2011.01662.x; Sagerup CMT, 2011, THORAX, V66, P301, DOI 10.1136/thx.2010.151621; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Schwartz KL, 2003, CANCER CAUSE CONTROL, V14, P761, DOI 10.1023/A:1026321923883; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; van der Aalst CM, 2011, EUR RESPIR J, V37, P1466, DOI 10.1183/09031936.00035410; van der Aalst CM, 2010, BEST PRACT RES CL GA, V24, P465, DOI 10.1016/j.bpg.2010.06.001; van der Aalst CM, 2010, THORAX, V65, P600, DOI 10.1136/thx.2009.133751; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	42	344	349	1	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					311	+		10.7326/M13-2316	http://dx.doi.org/10.7326/M13-2316			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24379002	Green Accepted			2022-12-28	WOS:000332793900003
J	McClellan, M; Patel, K; Sanghavi, D				McClellan, Mark; Patel, Kavita; Sanghavi, Darshak			Medicare Physician Payment Reform Will 2014 Be the Fix for SGR?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McClellan, Mark; Patel, Kavita; Sanghavi, Darshak] Brookings Inst, Washington, DC 20036 USA	Brookings Institution	McClellan, M (corresponding author), Brookings Inst, 1775 Massachusetts Ave NW, Washington, DC 20036 USA.	mmcclellan@brookings.edu						[Anonymous], DESCRIPTION OF THE C; [Anonymous], MEDICARES PAYMENT TO; Congressional Budget Office, OPTIONS FOR REDUCING; Federman AD, 2011, HEALTH POLICY, V102, P229, DOI 10.1016/j.healthpol.2011.05.003; McClellan M, HEALTH AFFAIRS; Sanghavi DM, JAMA FORUM	6	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					669	670		10.1001/jama.2013.286100	http://dx.doi.org/10.1001/jama.2013.286100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA8ZO	24419744				2022-12-28	WOS:000331383700013
J	Horton, R				Horton, Richard			Health in the Arab world: a renewed opportunity	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Abdul Rahim HF, 2014, LANCET; Alwan A, 2014, LANCET; Aziz Muna I Abdel, 2014, LANCET; Batniji R, 2014, LANCET; Dewachi O, 2014, LANCET; El-Zein A, 2014, LANCET; Giacaman R, 2014, LANCET; Jabbour S, 2012, PUBLIC HEALTH IN THE; Jabbour S., 2014, LANCET; Nakkash R, 2014, LANCET; Rashad H, 2014, LANCET; Saleh SS, 2014, LANCET; Tell T., 2014, LANCET; Zurayk H, 2014, LANCET	14	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					283	284		10.1016/S0140-6736(13)62703-8	http://dx.doi.org/10.1016/S0140-6736(13)62703-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452038				2022-12-28	WOS:000330212600006
J	Chan, AW; Song, FJ; Vickers, A; Jefferson, T; Dickersin, K; Gotzsche, PC; Krumholz, HM; Ghersi, D; van der Worp, HB				Chan, An-Wen; Song, Fujian; Vickers, Andrew; Jefferson, Tom; Dickersin, Kay; Gotzsche, Peter C.; Krumholz, Harlan M.; Ghersi, Davina; van der Worp, H. Bart			Increasing value and reducing waste: addressing inaccessible research	LANCET			English	Article							OUTCOME REPORTING BIAS; RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; MEDICAL-RESEARCH; DRUG TRIALS; ELIGIBILITY CRITERIA; JOURNAL EDITORS; SPIRIT 2013; LEVEL DATA; RAW DATA	The methods and results of health research are documented in study protocols, full study reports (detailing all analyses), journal reports, and participant-level datasets. However, protocols, full study reports, and participant-level datasets are rarely available, and journal reports are available for only half of all studies and are plagued by selective reporting of methods and results. Furthermore, information provided in study protocols and reports varies in quality and is often incomplete. When full information about studies is inaccessible, billions of dollars in investment are wasted, bias is introduced, and research and care of patients are detrimentally affected. To help to improve this situation at a systemic level, three main actions are warranted. First, academic institutions and funders should reward investigators who fully disseminate their research protocols, reports, and participant-level datasets. Second, standards for the content of protocols and full study reports and for data sharing practices should be rigorously developed and adopted for all types of health research. Finally, journals, funders, sponsors, research ethics committees, regulators, and legislators should endorse and enforce policies supporting study registration and wide availability of journal reports, full study reports, and participant-level datasets.	[Chan, An-Wen] Univ Toronto, Womens Coll Hosp, Dept Med, Womens Coll Res Inst, Toronto, ON, Canada; [Song, Fujian] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Vickers, Andrew] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Jefferson, Tom] Cochrane Collaborat, Rome, Italy; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD USA; [Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Krumholz, Harlan M.] Yale Univ, Yale Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Yale Sch Med, Dept Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Ghersi, Davina] Natl Hlth & Med Res Council, Res Translat Branch, Canberra, ACT, Australia; [van der Worp, H. Bart] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of East Anglia; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rigshospitalet; University of Copenhagen; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University; Utrecht University; Utrecht University Medical Center	Chan, AW (corresponding author), 790 Bay St,Suite 735, Toronto, ON M5G 1N8, Canada.	anwen.chan@utoronto.ca	, Harlan/AAI-2875-2020; Song, Fujian/B-3516-2013	Vickers, Andrew/0000-0003-1525-6503	National Cancer Institute [P50-CA92629]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Heart, Lung, and Blood Institute; Dutch Heart Foundation [2010T075]; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA092629] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dutch Heart Foundation(Netherlands Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Sir Iain Chalmers and Paul Glasziou for helpful feedback on drafts of this report. No specific funding was provided for this report. AV's work on this project was partly supported by the National Cancer Institute (P50-CA92629), the Sidney Kimmel Center for Prostate and Urologic Cancers, and David H Koch through the Prostate Cancer Foundation. HMK is supported by a grant (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. HBvdW is supported by the Dutch Heart Foundation (grant 2010T075).	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; [Anonymous], 2013, GENE EXPRESSION OMNI; [Anonymous], 2012, HARV U SAYS IT CANT; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bjork Bo-Christer, 2010, PLoS One, V5, pe11273, DOI 10.1371/journal.pone.0011273; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; Boffetta P, 2008, JNCI-J NATL CANCER I, V100, P988, DOI 10.1093/jnci/djn191; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Bracken MB, 2009, ANN EPIDEMIOL, V19, P220, DOI 10.1016/j.annepidem.2008.11.006; Brice A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6170; CEO Roundtable on Cancer, 2013, PROJ DAT SPHER OV; Chalmers I, 1999, LANCET, V353, P490, DOI 10.1016/S0140-6736(98)07618-1; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5776; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, LANCET, V381, P91, DOI 10.1016/S0140-6736(12)62160-6; Chan AW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8013; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Chan AW, 2006, BMJ-BRIT MED J, V332, P1086, DOI 10.1136/bmj.332.7549.1086; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chan L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001016; Coombes KR, 2007, NAT MED, V13, P1276, DOI 10.1038/nm1107-1276b; De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; Doshi Peter, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002496; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Drazen JM, 2012, NEW ENGL J MED, V367, P863, DOI 10.1056/NEJMe1209433; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; Equator Network, 2012, REP GUID DEV; European Medicines Agency, 2013, PUBL ACC CLIN TRIAL; European Medicines Agency Heads of Medicines Agencies, 2012, HMA EMA GUID DOC ID; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Galsworthy MJ, 2012, LANCET, V380, P971, DOI 10.1016/S0140-6736(12)61528-1; Gandhi M, 2005, AIDS, V19, P1885, DOI 10.1097/01.aids.0000189866.67182.f7; Glasziou P, 2006, LANCET, V367, P2057, DOI 10.1016/S0140-6736(06)68919-8; GlaxoSmithKline, 2013, PUBL DISCL CLIN RES; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7888; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Hannink G, 2013, ANN SURG, V257, P818, DOI 10.1097/SLA.0b013e3182864fa3; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Hopewell S, 2007, Cochrane Database Syst Rev, pMR000011; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hothorn T, 2011, BRIEF BIOINFORM, V12, P288, DOI 10.1093/bib/bbq084; Hrynaszkiewicz Iain, 2010, BMJ, V340, pc181, DOI [10.1186/1745-6215-11-9, 10.1136/bmj.c181]; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Ioannidis J.P., 2014, LANCET; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Kirkham JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009810; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f819; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Krumholz HM, 2013, ANN INTERN MED, V158, P910, DOI 10.7326/0003-4819-158-12-201306180-00009; Lopes RD, 2013, AM HEART J, V166, P208, DOI 10.1016/j.ahj.2013.05.005; Mansi BA, 2012, MAYO CLIN PROC, V87, P424, DOI 10.1016/j.mayocp.2012.02.009; Mathieu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059910; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; McLellan F, 2004, LANCET, V363, P44, DOI 10.1016/S0140-6736(03)15248-8; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Moher D, 2004, CAN MED ASSOC J, V171, P750, DOI 10.1503/cmaj.1041299; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; National Academy of Sciences National Academy of Engineering & Institute of Medicine, 2009, ENS INT ACC STEW RES; National Institute for Health Research, FREQ ASK QUEST; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; nternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Expert Working Group, 1995, ICH HARM TRIP GUID S; Olson L, 2010, B WORLD HEALTH ORGAN, V88, P568, DOI 10.2471/BLT.10.030810; Peters J, 2008, EVAL HEALTH PROF, V31, P370, DOI 10.1177/0163278708324438; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P793, DOI 10.1001/jama.2010.1161; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Rathore SS, 2002, NEW ENGL J MED, V347, P1403, DOI 10.1056/NEJMoa021266; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; Reveiz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012484; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Scherer R, 2013, 21 COCHR C QUEB QC C, P53; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Simundic AM, 2009, BIOCHEM MEDICA, V19, P294; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Strech D, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-100; Suber P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5184; Sune P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054583; ter Riet G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043404; The Royal Society Science Policy Centre, 2012, SCI OP ENT; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Turner S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002521; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vandenbroucke JP, 2010, LANCET, V375, P982, DOI 10.1016/S0140-6736(10)60437-0; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Vickers A, 2012, EUR UROL, V62, P204, DOI 10.1016/j.eururo.2012.04.024; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-15; Vickers AJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2323; Vickers Andrew J, 2010, BMC Res Notes, V3, P234, DOI 10.1186/1756-0500-3-234; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141; Williams RJ, 2010, CAN MED ASSOC J, V182, P1638, DOI 10.1503/cmaj.092252; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; Zarin DA, 2013, NEW ENGL J MED, V369, P468, DOI 10.1056/NEJMe1307268; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	121	472	488	0	107	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					257	266		10.1016/S0140-6736(13)62296-5	http://dx.doi.org/10.1016/S0140-6736(13)62296-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24411650	Green Accepted			2022-12-28	WOS:000330027500035
J	Artsimovitch, I				Artsimovitch, Irina			MOLECULAR BIOLOGY The tug of DNA repair	NATURE			English	Editorial Material							MECHANISM; COLI		[Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Artsimovitch, Irina] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu	Artsimovitch, Irina/L-3467-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067153] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cohen SE, 2010, P NATL ACAD SCI USA, V107, P15517, DOI 10.1073/pnas.1005203107; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Ganesan A, 2012, PROG MOL BIOL TRANSL, V110, P25, DOI 10.1016/B978-0-12-387665-2.00002-X; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; OGAWA H, 1968, MOL GEN GENET, V101, P227, DOI 10.1007/BF00271625; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Yang W, 2010, ANNU REV BIOPHYS, V39, P367, DOI 10.1146/annurev.biophys.093008.131415	11	2	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					298	299		10.1038/nature12850	http://dx.doi.org/10.1038/nature12850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24402229				2022-12-28	WOS:000329621800025
J	Cohen, P; Levy, JD; Zhang, YY; Frontini, A; Kolodin, DP; Svensson, KJ; Lo, JC; Zeng, X; Ye, L; Khandekar, MJ; Wu, J; Gunawardana, SC; Banks, AS; Camporez, JPG; Jurczak, MJ; Kajimura, S; Piston, DW; Mathis, D; Cinti, S; Shulman, GI; Seale, P; Spiegelman, BM				Cohen, Paul; Levy, Julia D.; Zhang, Yingying; Frontini, Andrea; Kolodin, Dmitriy P.; Svensson, Katrin J.; Lo, James C.; Zeng, Xing; Ye, Li; Khandekar, Melin J.; Wu, Jun; Gunawardana, Subhadra C.; Banks, Alexander S.; Camporez, Joao Paulo G.; Jurczak, Michael J.; Kajimura, Shingo; Piston, David W.; Mathis, Diane; Cinti, Saverio; Shulman, Gerald I.; Seale, Patrick; Spiegelman, Bruce M.			Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch	CELL			English	Article							INSULIN-RESISTANCE; PPAR-GAMMA; TRANSCRIPTIONAL CONTROL; GLUCOSE-INTOLERANCE; MESSENGER-RNA; OBESITY; TISSUE; MICE; WHITE; INFLAMMATION	A clear relationship exists between visceral obesity and type 2 diabetes, whereas subcutaneous obesity is comparatively benign. Here, we show that adipocyte- specific deletion of the coregulatory protein PRDM16 caused minimal effects on classical brown fat but markedly inhibited beige adipocyte function in subcutaneous fat following cold exposure or beta 3-agonist treatment. These animals developed obesity on a high-fat diet, with severe insulin resistance and hepatic steatosis. They also showed altered fat distribution with markedly increased subcutaneous adiposity. Subcutaneous adipose tissue in mutant mice acquired many key properties of visceral fat, including decreased thermogenic and increased inflammatory gene expression and increased macrophage accumulation. Transplantation of subcutaneous fat into mice with diet-induced obesity showed a loss of metabolic benefit when tissues were derived from PRDM16 mutant animals. These findings indicate that PRDM16 and beige adipocytes are required for the "browning'' of white fat and the healthful effects of subcutaneous adipose tissue.	[Cohen, Paul; Levy, Julia D.; Zhang, Yingying; Svensson, Katrin J.; Lo, James C.; Zeng, Xing; Ye, Li; Khandekar, Melin J.; Wu, Jun; Banks, Alexander S.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Cohen, Paul; Levy, Julia D.; Zhang, Yingying; Svensson, Katrin J.; Lo, James C.; Zeng, Xing; Ye, Li; Khandekar, Melin J.; Wu, Jun; Banks, Alexander S.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Cohen, Paul; Lo, James C.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Frontini, Andrea; Cinti, Saverio] Univ Politecn Marche, Dept Expt & Clin Med, I-60020 Ancona, Italy; [Kolodin, Dmitriy P.; Mathis, Diane] Harvard Univ, Sch Med, Dept Microbiol & Immunolbiol, Div Immunol, Boston, MA 02115 USA; [Gunawardana, Subhadra C.; Piston, David W.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06519 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06519 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Kajimura, Shingo] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Seale, Patrick] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Marche Polytechnic University; Harvard University; Harvard Medical School; Vanderbilt University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA.	bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019; Lo, James/GYR-1149-2022; Frontini, A/AAB-8767-2021; Banks, Alexander/B-4832-2012; Svensson, Katrin J./AAA-4770-2021; Gunawardana, subhadra/I-8374-2019; Camporez, Joao Paulo G/B-9122-2015; Shulman, Gerald I./P-7176-2019	Kajimura, Shingo/0000-0003-0672-5910; Lo, James/0000-0003-0244-1670; Banks, Alexander/0000-0003-1787-6925; Svensson, Katrin J./0000-0001-5376-5128; Gunawardana, subhadra/0000-0003-4211-982X; Shulman, Gerald I./0000-0003-1529-5668; Camporez, Joao Paulo/0000-0003-3486-4301; CINTI, Saverio/0000-0003-0362-5017; Jurczak, Michael/0000-0002-6335-6915; Frontini, Andrea/0000-0002-7381-4107; Zhang, Yingying/0000-0002-3435-1330	American Heart Association grant [11FTF7510004]; National Science Foundation Graduate Research Fellowship; NIH [DK040936, DK045735, DK059635, DK092541, DK031405]; JPB foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092541, R01DK040936, P30DK045735, P30DK043351, U24DK059635, P30DK034989, K08DK097303, R01DK031405, R37DK031405] Funding Source: NIH RePORTER	American Heart Association grant(American Heart Association); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Evan Rosen (Beth Israel Deaconess Medical Center) for providing Adiponectin-Cre mice, Dr. Vicki Huff (MD Anderson) for providing Wt1<SUP>lox/lox</SUP> mice, and the Nikon Imaging Center at Harvard Medical School for use of microscopy equipment. We thank Dr. Vamsi Mootha (Massachusetts General Hospital) for guidance on data analysis and Drs. Rana Gupta, Pere Puigserver, Evan Rosen, and members of the Spiegelman lab for helpful discussions. P.C. was supported by the American Heart Association grant 11FTF7510004. D.P.K. was supported by a National Science Foundation Graduate Research Fellowship. This work was supported by NIH grants DK040936, DK045735, DK059635 (G.I.S.); NIH grant DK092541 (D.M.); and by NIH grant DK031405 and the JPB foundation (B.M.S.).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027; Frontini A, 2013, BBA-MOL CELL BIOL L, V1831, P950, DOI 10.1016/j.bbalip.2013.02.005; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Giordano A, 2013, J LIPID RES, V54, P2423, DOI 10.1194/jlr.M038638; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kalupahana NS, 2012, OBESITY, V20, P48, DOI 10.1038/oby.2011.299; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Pardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026989; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rahman S, 2013, ENDOCRINOLOGY, V154, P2687, DOI 10.1210/en.2012-2162; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sears DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007250; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Skopkova M, 2007, OBESITY, V15, P2396, DOI 10.1038/oby.2007.285; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; VAGUE J, 1947, PRESSE MED, V55, P339; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034	57	587	613	3	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					304	316		10.1016/j.cell.2013.12.021	http://dx.doi.org/10.1016/j.cell.2013.12.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439384	Green Accepted, Bronze			2022-12-28	WOS:000329912200029
J	Mundinger, GS				Mundinger, Gerhard S.			Halo Phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A healthy 14-year-old boy presented for evaluation of a congenital melanocytic nevus on the left shin that had been followed closely by the dermatology service since the boy was 3 years of age. The nevus, present since birth, had grown with the patient and had typical features. An otherwise healthy 14-year-old boy presented for evaluation of an 11.0-cm-by-4.5-cm congenital melanocytic nevus on the medial left shin that had been followed closely by the dermatology service since the boy was 3 years of age. The nevus, present since birth, had grown with the patient and had typical features, including variegated color, hypertrichosis, small scattered macules, and an irregularly scalloped border. In addition, a white halo surrounding its borders had gradually appeared during the past year. Halo nevi (also known as Sutton's nevi or leukoderma acquisitum centrifugum) are nevi that develop a border of depigmentation resembling a halo. The ...	Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Mundinger, GS (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.	gmundin1@jhmi.edu							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					262	262		10.1056/NEJMicm1306230	http://dx.doi.org/10.1056/NEJMicm1306230			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428471				2022-12-28	WOS:000330035600012
J	Strander, B; Hallgren, J; Sparen, P				Strander, Bjorn; Hallgren, Jonas; Sparen, Par			Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-SITU CARCINOMA; DEATH CERTIFICATES; INVASIVE CANCER; FOLLOW-UP; RISK; REGISTER; COMPLETENESS; SURVIVAL; EFFICACY; CYTOLOGY	Objective To determine factors influencing long term risks for acquiring or dying from invasive cervical or vaginal cancer in women previously treated for cervical intraepithelial neoplasia grade 3 (CIN3). Design Population based cohort study conducted in 1958-2008, followed up until 2009 in the Swedish Cancer Registry and Swedish Cause of Death Register, linked to the Swedish Population Register. Standardised incidence and mortality ratios were calculated for the risk of acquiring or dying from vaginal or cervical cancer, with the general female population in Sweden as reference. Relative risks in multivariable regression models were also calculated, adjusting for follow-up duration, treatment period, and age at CIN3 treatment or attained age. Setting Entire female population of Sweden. Participants 150 883 women in Sweden diagnosed and treated with CIN3 and followed up for invasive cervical or vaginal cancer, and related mortality. The cohort comprised 3 148 222 woman years. Main outcome measures Standardised incidence and mortality ratios, stratified by period for treatment. Relative standardised incidence ratios and standardised mortality ratios for age at acquiring or dying from cervical or vaginal cancer (attained age), adjusted for preset variables. Results Women previously diagnosed with CIN3 had an increased risk of dying from invasive cervical or vaginal cancer, compared with the general female population (standardised mortality ratio 2.35, 95% confidence interval 2.11 to 2.61). After age 60 years, these women had an accelerated increased risk of acquiring invasive cancer; a similar steep increase in mortality risk was seen after age 70. Regression analyses indicated that the increase in risk over time is highly attributable to ageing. Conclusions Women previously treated for CIN3 are at increased risk of developing and dying from cervical or vaginal cancer, compared with the general female population. The risk accelerates above age 60 years, suggesting a need for lifelong surveillance of these women.	[Strander, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynaecol, Gothenburg, Sweden; [Hallgren, Jonas; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Gothenburg; Karolinska Institutet	Strander, B (corresponding author), Sahlgrens Univ Hosp, Reg Canc Ctr, SE-41345 Gothenburg, Sweden.	bjorn.strander@rccvast.se	Strander, Björn/AAB-2609-2021	Strander, Björn/0000-0001-8369-7955; Sparen, Par/0000-0002-5184-8971	Halland County Scientific Board; Swedish Cancer Society	Halland County Scientific Board; Swedish Cancer Society(Swedish Cancer Society)	This study was supported by the Halland County Scientific Board and the Swedish Cancer Society. These sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Barken SS, 2011, INT J CANCER, V2011, P26248; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Cervix cancer prevention, 2010, CERV CANC PREV GUID, V63; Committee on Practice Bulletins-Gynecology, 2012, OBSTET GYNECOL, V120, P1222, DOI [DOI 10.1097/AOG.0B013E318277C92A, 10.1097/ AOG.0b013e318277c92a]; Cruickshank ME, 1997, BRIT J OBSTET GYNAEC, V104, P586, DOI 10.1111/j.1471-0528.1997.tb11537.x; Cruickshank ME, 2002, BJOG-INT J OBSTET GY, V109, P579, DOI 10.1111/j.1471-0528.2002.01554.x; Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; DeVeale B, 2004, AGING CELL, V3, P195, DOI 10.1111/j.1474-9728.2004.00106.x; Fall K, 2008, SCAND J UROL NEPHROL, V42, P352, DOI 10.1080/00365590802078583; Hakama M, 2004, INT J CANCER, V112, P1072, DOI 10.1002/ijc.20513; Jakobsson M, 2009, BJOG-INT J OBSTET GY, V116, P838, DOI 10.1111/j.1471-0528.2009.02115.x; Kalliala I, 2007, GYNECOL ONCOL, V105, P228, DOI 10.1016/j.ygyno.2006.12.028; Kalliala I, 2010, INT J CANCER, V126, P224, DOI 10.1002/ijc.24713; Kocken M, 2011, LANCET ONCOL, V12, P441, DOI 10.1016/S1470-2045(11)70078-X; Legood R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7086; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; MATTSSON B, 1985, ACTA RADIOL ONCOL, V24, P219, DOI 10.3109/02841868509134390; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; MITCHELL H, 1990, CANCER CAUSE CONTROL, V1, P143, DOI 10.1007/BF00053165; Naucler P, 2009, JNCI-J NATL CANCER I, V101, P88, DOI 10.1093/jnci/djn444; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; PETTERSSON F, 1989, RADIOTHER ONCOL, V16, P115, DOI 10.1016/0167-8140(89)90028-5; Rapiti E, 2012, EUR J CANCER, V48, P845, DOI 10.1016/j.ejca.2011.05.002; Ronco G, 2007, BRIT MED J, V335, P1053, DOI 10.1136/bmj.39364.439444.80; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; Silfverdal L, 2011, INT J CANCER, V129, P1450, DOI 10.1002/ijc.25749; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; Strander B., 2008, THESIS GOTHENBURG U; Strander B, 2007, BMJ-BRIT MED J, V335, P1077, DOI 10.1136/bmj.39363.471806.BE; VANWIJNGAARDEN WJ, 1993, BRIT MED J, V306, P967, DOI 10.1136/bmj.306.6883.967	35	61	62	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2014	348								f7361	10.1136/bmj.f7361	http://dx.doi.org/10.1136/bmj.f7361			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MN	24423603	Green Published, hybrid			2022-12-28	WOS:000329975900004
J	Spencer, JR				Spencer, John R.			Glimpsing Eruptions on Europa	SCIENCE			English	Editorial Material							MOON		SW Res Inst, Boulder, CO 80302 USA		Spencer, JR (corresponding author), SW Res Inst, 1050 Walnut St, Boulder, CO 80302 USA.	spencer@boulder.swri.edu						Anderson JD, 1998, SCIENCE, V281, P2019, DOI 10.1126/science.281.5385.2019; Chyba CF, 2000, NATURE, V403, P381, DOI 10.1038/35000281; HALL DT, 1995, NATURE, V373, P677, DOI 10.1038/373677a0; Hedman MM, 2013, NATURE, V500, P182, DOI 10.1038/nature12371; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; Pappalardo R., 2009, EUROPA; Roth L, 2014, SCIENCE, V343, P171, DOI 10.1126/science.1247051; Space Studies Board, 2011, VIS VOYAG PLAN SCI D; Space Studies Board, 2003, NEW FRONT SOL SYST I; Spencer JR, 2013, ANNU REV EARTH PL SC, V41, P693, DOI 10.1146/annurev-earth-050212-124025; Zahnle K, 2003, ICARUS, V163, P263, DOI 10.1016/S0019-1035(03)00048-4	12	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					148	149		10.1126/science.1248879	http://dx.doi.org/10.1126/science.1248879			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408427				2022-12-28	WOS:000329440800031
J	Holford, TR; Meza, R; Warner, KE; Meernik, C; Jeon, J; Moolgavkar, SH; Levy, DT				Holford, Theodore R.; Meza, Rafael; Warner, Kenneth E.; Meernik, Clare; Jeon, Jihyoun; Moolgavkar, Suresh H.; Levy, David T.			Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG-CANCER; US MIDDLE; MORTALITY; TRENDS; IMPACT	IMPORTANCE January 2014 marks the 50th anniversary of the first surgeon general's report on smoking and health. This seminal document inspired efforts by governments, nongovernmental organizations, and the private sector to reduce the toll of cigarette smoking through reduced initiation and increased cessation. OBJECTIVE To model reductions in smoking-related mortality associated with implementation of tobacco control since 1964. DESIGN, SETTING, AND PARTICIPANTS Smoking histories for individual birth cohorts that actually occurred and under likely scenarios had tobacco control never emerged were estimated. National mortality rates and mortality rate ratio estimates from analytical studies of the effect of smoking on mortality yielded death rates by smoking status. Actual smoking-related mortality from 1964 through 2012 was compared with estimated mortality under no tobacco control that included a likely scenario (primary counterfactual) and upper and lower bounds that would capture plausible alternatives. EXPOSURES National Health Interview Surveys yielded cigarette smoking histories for the US adult population in 1964-2012. MAIN OUTCOMES AND MEASURES Number of premature deaths avoided and years of life saved were primary outcomes. Change in life expectancy at age 40 years associated with change in cigarette smoking exposure constituted another measure of overall health outcomes. RESULTS In 1964-2012, an estimated 17.7 million deaths were related to smoking, an estimated 8.0 million (credible range [CR], 7.4-8.3 million, for the lower and upper tobacco control counterfactuals, respectively) fewer premature smoking-related deaths than what would have occurred under the alternatives and thus associated with tobacco control (5.3 million [CR, 4.8-5.5 million] men and 2.7 million [CR, 2.5-2.7 million] women). This resulted in an estimated 157 million years (CR, 139-165 million) of life saved, a mean of 19.6 years for each beneficiary (111 million [CR, 97-117 million] for men, 46 million [CR, 42-48 million] for women). During this time, estimated life expectancy at age 40 years increased 7.8 years for men and 5.4 years for women, of which tobacco control is associated with 2.3 years (CR, 1.8-2.5) (30% [CR, 23%-32%]) of the increase for men and 1.6 years (CR, 1.4-1.7) (29% [CR, 25%-32%]) for women. CONCLUSIONS AND RELEVANCE Tobacco control was estimated to be associated with avoidance of 8 million premature deaths and an estimated extended mean life span of 19 to 20 years. Although tobacco control represents an important public health achievement, efforts must continue to reduce the effect of smoking on the nation's death toll.	[Holford, Theodore R.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06511 USA; [Meza, Rafael; Meernik, Clare] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Warner, Kenneth E.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Jeon, Jihyoun; Moolgavkar, Suresh H.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA; [Levy, David T.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA	Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Georgetown University	Holford, TR (corresponding author), Yale Univ, Sch Publ Hlth, Dept Biostat, 60 Coll St, New Haven, CT 06511 USA.	theodore.holford@yale.edu	Levy, David/GPS-4945-2022; Meernik, Clare/O-2995-2016	Meernik, Clare/0000-0002-8564-1266; Warner, Kenneth/0000-0002-8214-1776	National Cancer Institute [R01-CA-152956]; NATIONAL CANCER INSTITUTE [U01CA152956, P30CA016359] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by the National Cancer Institute (R01-CA-152956).	Agaku IT, 2013, JAMA-J AM MED ASSOC, V309, P1992, DOI 10.1001/jama.2013.4412; Anderson CM, 2012, RISK ANAL, V32, pS14, DOI 10.1111/j.1539-6924.2011.01703.x; [Anonymous], CANCER PREVENTION ST; [Anonymous], NATIONAL ESTIMATES B; [Anonymous], CURRENT CANCER PREVE; [Anonymous], NHANES EPIDEMIOLOGIC; [Anonymous], SMOKING ATTRIBUTABLE; [Anonymous], 2013, ANNUAL ESTIMATES OF; [Anonymous], 1989, REDUCING THE HEALTH; Arias E., 2010, UNITED STATES LIFE T; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022; Holford TR, 2012, RISK ANAL, V32, pS39, DOI 10.1111/j.1539-6924.2011.01759.x; Jeon J, 2012, RISK ANAL, V32, pS51, DOI 10.1111/j.1539-6924.2011.01775.x; Levy DT, 2010, AM J PREV MED, V38, pS364, DOI 10.1016/j.amepre.2009.11.016; McCarthy M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5543; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Murphy SL, 2013, DEATHS FINAL DATA FO; Quinn VP, 2009, J GEN INTERN MED, V24, P149, DOI 10.1007/s11606-008-0865-9; Richardson A, 2013, NICOTINE TOB RES, V15, P1729, DOI 10.1093/ntr/ntt053; Rosenberg MA, 2012, RISK ANAL, V32, pS25, DOI 10.1111/j.1539-6924.2011.01662.x; Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service, 1964, SMOKING AND HEALTH R; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751; WARNER KE, 1989, AM J PUBLIC HEALTH, V79, P144, DOI 10.2105/AJPH.79.2.144; Warner KE, 2014, AM J PUBLIC HEALTH, V104, P83, DOI 10.2105/AJPH.2013.301591; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001	27	200	207	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					164	171		10.1001/jama.2013.285112	http://dx.doi.org/10.1001/jama.2013.285112			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399555	Green Accepted, Bronze			2022-12-28	WOS:000329339400022
J	Bwakura-Dangarembizi, M; Kendall, L; Bakeera-Kitaka, S; Nahirya-Ntege, P; Keishanyu, R; Nathoo, K; Spyer, MJ; Kekitiinwa, A; Lutaakome, J; Mhute, T; Kasirye, P; Munderi, P; Musiime, V; Gibb, DM; Walker, AS; Prendergast, AJ				Bwakura-Dangarembizi, Mutsawashe; Kendall, Lindsay; Bakeera-Kitaka, Sabrina; Nahirya-Ntege, Patricia; Keishanyu, Rosette; Nathoo, Kusum; Spyer, Moira J.; Kekitiinwa, Adeodata; Lutaakome, Joseph; Mhute, Tawanda; Kasirye, Philip; Munderi, Paula; Musiime, Victor; Gibb, Diana M.; Walker, A. Sarah; Prendergast, Andrew J.		Arrow Trial Team	A Randomized Trial of Prolonged Co-trimoxazole in HIV-Infected Children in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; HUMAN-IMMUNODEFICIENCY-VIRUS; INSECTICIDE-TREATED BEDNETS; ANTIRETROVIRAL THERAPY; COTE-DIVOIRE; OPPORTUNISTIC INFECTIONS; HIV-1-INFECTED ADULTS; UGANDAN CHILDREN; MORTALITY; MALARIA	BackgroundCo-trimoxazole (fixed-dose trimethoprim-sulfamethoxazole) prophylaxis administered before antiretroviral therapy (ART) reduces morbidity in children infected with the human immunodeficiency virus (HIV). We investigated whether children and adolescents receiving long-term ART in sub-Saharan Africa could discontinue co-trimoxazole. MethodsWe conducted a randomized, noninferiority trial of stopping versus continuing daily open-label co-trimoxazole in children and adolescents in Uganda and Zimbabwe. Eligible participants were older than 3 years of age, had been receiving ART for more than 96 weeks, were using insecticide-treated bed nets (in malaria-endemic areas), and had not had Pneumocystis jirovecii pneumonia. Coprimary end points were hospitalization or death and adverse events of grade 3 or 4. ResultsA total of 758 participants were randomly assigned to stop or continue co-trimoxazole (382 and 376 participants, respectively), after receiving ART for a median of 2.1 years (interquartile range, 1.8 to 2.3). The median age was 7.9 years (interquartile range, 4.6 to 11.1), and the median CD4 T-cell percentage was 33% (interquartile range, 26 to 39). Participants who stopped co-trimoxazole had higher rates of hospitalization or death than those who continued (72 participants [19%] vs. 48 [13%]; hazard ratio, 1.64; 95% confidence interval [CI], 1.14 to 2.37; P=0.007; noninferiority not shown). There was no evidence of variation across ages (P=0.93 for interaction). A total of 2 participants in the prophylaxis-stopped group (1%) died, as did 3 in the prophylaxis-continued group (1%). Most hospitalizations in the prophylaxis-stopped group were for malaria (49 events, vs. 21 in the prophylaxis-continued group) or infections other than malaria (53 vs. 25), particularly pneumonia, sepsis, and meningitis. Rates of adverse events of grade 3 or 4 were similar in the two groups (hazard ratio, 1.20; 95% CI, 0.83 to 1.72; P=0.33), but more grade 4 adverse events occurred in the prophylaxis-stopped group (hazard ratio, 2.04; 95% CI, 0.99 to 4.22; P=0.05), with anemia accounting for the largest number of events (12, vs. 2 with continued prophylaxis). ConclusionsContinuing co-trimoxazole prophylaxis after 96 weeks of ART was beneficial, as compared with stopping prophylaxis, with fewer hospitalizations for both malaria and infection not related to malaria. (Funded by the United Kingdom Medical Research Council and others; ARROW Current Controlled Trials number, ISRCTN24791884.)	[Bwakura-Dangarembizi, Mutsawashe; Nathoo, Kusum; Mhute, Tawanda] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Kendall, Lindsay; Spyer, Moira J.; Gibb, Diana M.; Walker, A. Sarah; Prendergast, Andrew J.] UCL, MRC, Clin Trials Unit, London WC2B 6NH, England; [Prendergast, Andrew J.] Univ London Queen Mary, Ctr Paediat, Blizard Inst, London, England; [Bakeera-Kitaka, Sabrina; Kekitiinwa, Adeodata; Musiime, Victor] Mulago Hosp, Paediat Infect Dis Clin Baylor Uganda, Kampala, Uganda; [Keishanyu, Rosette; Musiime, Victor] Joint Clin Res Ctr, Kampala, Uganda; [Nahirya-Ntege, Patricia; Lutaakome, Joseph; Munderi, Paula] Uganda Res Unit AIDS, Uganda Virus Res Inst, Entebbe, Uganda; [Nahirya-Ntege, Patricia; Lutaakome, Joseph; Munderi, Paula] Uganda Res Unit AIDS, MRC, Entebbe, Uganda	University of Zimbabwe; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; Queen Mary University London; Mulago National Referral Hospital; Joint Clinic Research Center - United Arab Emirates; Uganda Virus Research Institute	Prendergast, AJ (corresponding author), UCL, MRC, Clin Trials Unit, Aviat House,125 Kingsway, London WC2B 6NH, England.	a.prendergast@qmul.ac.uk	Walker, Sarah/HDM-8717-2022; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Kendall, Lindsay/0000-0003-2812-0154; Kasirye, Phillip/0000-0001-6620-483X; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177; Prendergast, Andrew/0000-0001-7904-7992; Musiime, Victor/0000-0001-7472-9054	U.K. Medical Research Council; U.K. Department for International Development; ViiV Healthcare; GlaxoSmithKline; MRC [MC_EX_G0300400, MC_U122886353] Funding Source: UKRI; Medical Research Council [MC_U122886353, MC_EX_G0300400] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.K. Department for International Development; ViiV Healthcare; GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the U.K. Medical Research Council and the U.K. Department for International Development. ViiV Healthcare and GlaxoSmithKline donated first-line drugs for the Antiretroviral Research for Watoto (ARROW) trial and provided funding for virologic assays.	Anglaret X, 2000, AIDS, V14, P2628, DOI 10.1097/00002030-200011100-00036; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; [Anonymous], 1994, INT C HARM TECHN REQ; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; Campbell JD, 2012, CLIN INFECT DIS, V54, P1204, DOI 10.1093/cid/cis013; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Date AA, 2010, B WORLD HEALTH ORGAN, V88, P253, DOI 10.2471/BLT.09.066522; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Gasasira AF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-177; Gibb DM, 2013, LANCET, V381, P1391, DOI 10.1016/S0140-6736(12)62198-9; Gibb DM, 2000, LANCET, V355, P1331, DOI 10.1016/S0140-6736(00)02117-6; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Gsponer T, 2012, PEDIATRICS, V130, pE966, DOI 10.1542/peds.2011-3020; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Hamer DH, 2008, AM J TROP MED HYG, V79, P299, DOI 10.4269/ajtmh.2008.79.299; Kamya MR, 2007, AIDS, V21, P2059, DOI 10.1097/QAD.0b013e3282ef6da1; Kreuzer KA, 1997, BRIT J HAEMATOL, V96, P235, DOI 10.1046/j.1365-2141.1997.d01-2031.x; Malamba SS, 2006, AM J TROP MED HYG, V75, P375, DOI 10.4269/ajtmh.2006.75.375; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mulenga V, 2007, AIDS, V21, P77, DOI 10.1097/QAD.0b013e3280114ed7; Nachman S, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1847; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Prendergast A, 2011, CLIN INFECT DIS, V52, P953, DOI 10.1093/cid/cir029; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sutcliffe CG, 2009, LANCET INFECT DIS, V9, P736; Suthar AB, 2012, B WORLD HEALTH ORGAN, V90, P128, DOI 10.2471/BLT.11.093260; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; Urschel S, 2005, AIDS, V19, P2103, DOI 10.1097/01.aids.0000194795.20928.2b; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; WHO, 2010, GUID TREATM MAL, V2nd; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2006, WHO CAS DEF HIV SURV; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization (WHO), 2006, GUID COTR PROPH HIV	40	79	79	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					41	53		10.1056/NEJMoa1214901	http://dx.doi.org/10.1056/NEJMoa1214901			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284XA	24382064	Green Accepted, Green Published			2022-12-28	WOS:000329354100009
J	Nord, AS; Blow, MJ; Attanasio, C; Akiyama, JA; Holt, A; Hosseini, R; Phouanenavong, S; Plajzer-Frick, I; Shoukry, M; Afzal, V; Rubenstein, JLR; Rubin, EM; Pennacchio, LA; Visel, A				Nord, Alex S.; Blow, Matthew J.; Attanasio, Catia; Akiyama, Jennifer A.; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubenstein, John L. R.; Rubin, Edward M.; Pennacchio, Len A.; Visel, Axel			Rapid and Pervasive Changes in Genome-wide Enhancer Usage during Mammalian Development	CELL			English	Article							TRANSCRIPTION FACTORS; CARDIAC DEVELOPMENT; GENE-EXPRESSION; ASSOCIATION; PROTEINS; INSULIN; SPECIFICATION; SIGNATURES; MUTATIONS; RECEPTORS	Enhancers are distal regulatory elements that can activate tissue-specific gene expression and are abundant throughout mammalian genomes. Although substantial progress has been made toward genome-wide annotation of mammalian enhancers, their temporal activity patterns and global contributions in the context of developmental in vivo processes remain poorly explored. Here we used epigenomic profiling for H3K27ac, a mark of active enhancers, coupled to transgenic mouse assays to examine the genome-wide utilization of enhancers in three different mouse tissues across seven developmental stages. The majority of the similar to 90,000 enhancers identified exhibited tightly temporally restricted predicted activity windows and were associated with stage-specific biological functions and regulatory pathways in individual tissues. Comparative genomic analysis revealed that evolutionary conservation of enhancers decreases following midgestation across all tissues examined. The dynamic enhancer activities uncovered in this study illuminate rapid and pervasive temporal in vivo changes in enhancer usage that underlie processes central to development and disease.	[Nord, Alex S.; Blow, Matthew J.; Attanasio, Catia; Akiyama, Jennifer A.; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.; Visel, Axel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.; Visel, Axel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California San Francisco; University of California System; University of California Merced	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	lapennacchio@lbl.gov; avisel@lbl.gov	Visel, Axel/A-9398-2009; attanasio, catia/D-5042-2017; Blow, Matthew/G-6369-2012	Visel, Axel/0000-0002-4130-7784; attanasio, catia/0000-0001-8077-5719; Blow, Matthew/0000-0002-8844-9149; Nord, Alexander/0000-0003-4259-7514; Pennacchio, Len/0000-0002-8748-3732	NIH/NIGMS NRSA [GM105202]; SNSF advanced researchers fellowship; NIH [R01NS062859A, R01HG003988, U01DE020060]; NIMH [R37MH049428]; Department of Energy, University of California [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE020060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH081880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099099, R01NS034661, R01NS062859] Funding Source: NIH RePORTER	NIH/NIGMS NRSA; SNSF advanced researchers fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	sThe authors thank Chia-lin Wei and Cindy Choi for help with chromatin immunoprecipitation from embryonic mouse tissue and Diane Dickel and Han Wu for guidance and advice regarding enhancer activity analysis. A.S.N. was supported by NIH/NIGMS NRSA F32 fellowship GM105202. C. A. was supported by a SNSF advanced researchers fellowship. A. V. and L. A. P. were supported by NIH grants R01NS062859A, R01HG003988, and U01DE020060. J.L.R.R. was supported by NIMH grant R37MH049428. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California.	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Albrieux M, 2004, J NEUROSCI, V24, P1719, DOI 10.1523/JNEUROSCI.3548-02.2004; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Clinton M., 2000, GENOME BIOL, V1; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Dickel DE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0359; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DONATH MY, 1994, P NATL ACAD SCI USA, V91, P1686, DOI 10.1073/pnas.91.5.1686; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendry IA, 2000, BRAIN RES, V870, P10, DOI 10.1016/S0006-8993(00)02387-8; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HINTON DR, 1990, J NEUROSCI, V10, P2763; Hoerder-Suabedissen A, 2013, P NATL ACAD SCI USA, V110, P3555, DOI 10.1073/pnas.1218510110; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Hu CL, 2009, AM J PHYSIOL-HEART C, V297, pH1776, DOI 10.1152/ajpheart.00050.2009; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raff R. A., 1996, SHAPE LIFE GENES DEV; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sidhu A, 1998, J NEUROCHEM, V70, P2459; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; WHITNEY JB, 1977, CELL, V12, P863, DOI 10.1016/0092-8674(77)90150-7; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Zorn A.M., 2008, LIVER DEV	66	236	238	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1521	1531		10.1016/j.cell.2013.11.033	http://dx.doi.org/10.1016/j.cell.2013.11.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360275	Bronze, Green Accepted			2022-12-28	WOS:000328693300009
J	Price, RN; Nosten, F				Price, Ric N.; Nosten, Francois			Single-dose radical cure of Plasmodium vivax: a step closer	LANCET			English	Editorial Material							MALARIA RELAPSE; PRIMAQUINE; TRIAL		[Price, Ric N.; Nosten, Francois] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Price, Ric N.] Charles Darwin Univ, Global Hlth Div, Menzies Sch Hlth Res, Darwin, NT 0811, Australia; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand	University of Oxford; Charles Darwin University; Menzies School of Health Research; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU)	Price, RN (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England.	rprice@menzies.edu.au	Nosten, Francois/AAC-5509-2019	Nosten, Francois/0000-0002-7951-0745; Price, Richard/0000-0003-2000-2874	Wellcome Trust [091625, 089275] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; John GK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-280; Llanos-Cuentas A, 2013, LANCET; PETERS W, 1993, ANN TROP MED PARASIT, V87, P547, DOI 10.1080/00034983.1993.11812809; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2012, TRENDS PARASITOL, V28, P522, DOI 10.1016/j.pt.2012.08.005; Sutanto I, 2013, ANTIMICROB AGENTS CH, V57, P1128, DOI 10.1128/AAC.01879-12; Walsh DS, 2004, CLIN INFECT DIS, V39, P1095, DOI 10.1086/424508; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	11	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1020	1021		10.1016/S0140-6736(13)62672-0	http://dx.doi.org/10.1016/S0140-6736(13)62672-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24360370	Green Accepted			2022-12-28	WOS:000333521200007
J	Prasad, V; Mailankody, S				Prasad, Vinay; Mailankody, Sham			The Accelerated Approval of Oncologic Drugs Lessons From Ponatinib	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHROMOSOME-POSITIVE LEUKEMIAS		[Prasad, Vinay; Mailankody, Sham] NCI, Med Oncol Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mailankody, S (corresponding author), NCI, Med Oncol Serv, NIH, 10 Ctr Dr,10-12N226, Bethesda, MD 20892 USA.	sham.mailankody@nih.gov		Prasad, Vinayak/0000-0002-6110-8221				[Anonymous], DRUG DETAILS PONATIN; [Anonymous], SUSPENSION OF MARKET; Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; U.S Food and Drug Administration, FDA DRUG SAFETY COMM; Wilson WH, 2013, CLIN CANCER RES, V19, P2804, DOI 10.1158/1078-0432.CCR-13-0315	7	42	43	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					353	354		10.1001/jama.2013.284531	http://dx.doi.org/10.1001/jama.2013.284531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449310				2022-12-28	WOS:000329939300015
J	Brenner, S				Brenner, Sydney			Frederick Sanger (1918-2013)	SCIENCE			English	Biographical-Item									Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Brenner, S (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	sydney.brenner@hotmail.com						SANGER F, PUBLICATION LIST	1	7	7	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					262	262		10.1126/science.1249912	http://dx.doi.org/10.1126/science.1249912			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436413				2022-12-28	WOS:000329718600026
J	Nguyen, C; Haushalter, RW; Lee, DJ; Markwick, PRL; Bruegger, J; Caldara-Festin, G; Finzel, K; Jackson, DR; Ishikawa, F; O'Dowd, B; McCammon, JA; Opella, SJ; Tsai, SC; Burkart, MD				Chi Nguyen; Haushalter, Robert W.; Lee, D. John; Markwick, Phineus R. L.; Bruegger, Joel; Caldara-Festin, Grace; Finzel, Kara; Jackson, David R.; Ishikawa, Fumihiro; O'Dowd, Bing; McCammon, J. Andrew; Opella, Stanley J.; Tsai, Shiou-Chuan; Burkart, Michael D.			Trapping the dynamic acyl carrier protein in fatty acid biosynthesis	NATURE			English	Article							ESCHERICHIA-COLI; STRUCTURAL INSIGHTS; SYNTHASE; COMPLEX; DEHYDRATASE; REVEAL; CRYSTALLIZATION; INHIBITION; BINDING; DOMAIN	Acyl carrier protein (ACP) transports the growing fatty acid chain between enzymatic domains of fatty acid synthase (FAS) during biosynthesis(1). Because FAS enzymes operate on ACP-bound acyl groups, ACP must stabilize and transport the growing lipid chain(2). ACPs have a central role in transporting starting materials and intermediates throughout the fatty acid biosynthetic pathway(3-5). The transient nature of ACP-enzyme interactions impose major obstacles to obtaining high-resolution structural information about fatty acid biosynthesis, and a new strategy is required to study protein-protein interactions effectively. Here we describe the application of a mechanism-based probe that allows active site-selective covalent crosslinking of AcpP to FabA, the Escherichia coli ACP and fatty acid 3-hydroxyacyl-ACP dehydratase, respectively. We report the 1.9 angstrom crystal structure of the crosslinked AcpP-FabA complex as a homodimer in which AcpP exhibits two different conformations, representing probable snapshots of ACP in action: the 4'-phosphopantetheine group of AcpP first binds an arginine-rich groove of FabA, then an AcpP helical conformational change locks AcpP and FabA in place. Residues at the interface of AcpP and FabA are identified and validated by solution nuclear magnetic resonance techniques, including chemical shift perturbations and residual dipolar coupling measurements. These not only support our interpretation of the crystal structures but also provide an animated view of ACP in action during fatty acid dehydration. These techniques, in combination with molecular dynamics simulations, show for the first time that FabA extrudes the sequestered acyl chain from the ACP binding pocket before dehydration by repositioning helix III. Extensive sequence conservation among carrier proteins suggests that the mechanistic insights gleaned from our studies may be broadly applicable to fatty acid, polyketide and non-ribosomal biosynthesis. Here the foundation is laid for defining the dynamic action of carrier-protein activity in primary and secondary metabolism, providing insight into pathways that can have major roles in the treatment of cancer, obesity and infectious disease.	[Chi Nguyen; Bruegger, Joel; Caldara-Festin, Grace; Jackson, David R.; Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Chi Nguyen; Bruegger, Joel; Caldara-Festin, Grace; Jackson, David R.; Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Chi Nguyen; Bruegger, Joel; Caldara-Festin, Grace; Jackson, David R.; Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Haushalter, Robert W.; Lee, D. John; Markwick, Phineus R. L.; Finzel, Kara; Ishikawa, Fumihiro; O'Dowd, Bing; McCammon, J. Andrew; Opella, Stanley J.; Burkart, Michael D.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Markwick, Phineus R. L.] San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Markwick, Phineus R. L.; McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Burkart, MD (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	sctsai@uci.edu; mburkart@ucsd.edu	Nguyen, Chi/GZG-5146-2022; Nguyen, Chi/GWR-1592-2022; McCammon, J. Andrew/AAG-1832-2021	McCammon, J. Andrew/0000-0003-3065-1456	Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; NSF; NIH; HHMI; Advanced Light Source; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231];  [GM100305];  [GM095970]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100305, R01GM066978, R01GM095970] Funding Source: NIH RePORTER	Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Advanced Light Source; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.D.B. and S.-C.T. are supported by GM100305 and GM095970. We thank J. J. LaClair for figure editing. We thank X. Huang for assistance with NMR facilities and experimental setup. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The Advanced Light Source is supported by the Office of Basic Energy Sciences of the US Department of Energy under contract no. DE-AC02-05CH11231. J.A.M. is supported by NSF, NIH and HHMI. Portions of the research are supported by the Advanced Light Source, supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231.	Agarwal V, 2012, P NATL ACAD SCI USA, V109, P17406, DOI 10.1073/pnas.1207028109; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; ANDERSON MS, 1985, J BIOL CHEM, V260, P5536; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Crosby J, 2012, NAT PROD REP, V29, P1111, DOI 10.1039/c2np20062g; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; ENDO K, 1970, J BIOL CHEM, V245, P4293; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Guy JE, 2011, P NATL ACAD SCI USA, V108, P16594, DOI 10.1073/pnas.1110221108; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Ishikawa F, 2012, J AM CHEM SOC, V134, P769, DOI 10.1021/ja2082334; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Joshi AK, 2005, BIOCHEMISTRY-US, V44, P4100, DOI 10.1021/bi047856r; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Markwick PRL, 2011, PHYS CHEM CHEM PHYS, V13, P20053, DOI 10.1039/c1cp22100k; Markwick PRL, 2009, J AM CHEM SOC, V131, P16968, DOI 10.1021/ja907476w; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Moynie L, 2013, J MOL BIOL, V425, P365, DOI 10.1016/j.jmb.2012.11.017; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Qiu XY, 2004, ACTA CRYSTALLOGR D, V60, P1545, DOI 10.1107/S0907444904015422; Rock C O, 1981, Methods Enzymol, V71 Pt C, P341; Roujeinikova A, 2002, ACTA CRYSTALLOGR D, V58, P330, DOI 10.1107/S0907444901020091; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Zhuang ZH, 2008, BIOCHEMISTRY-US, V47, P2789, DOI 10.1021/bi702334h	30	172	180	2	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					427	431		10.1038/nature12810	http://dx.doi.org/10.1038/nature12810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24362570	Green Accepted			2022-12-28	WOS:000329621800048
J	Friedman, JR; Nunnari, J				Friedman, Jonathan R.; Nunnari, Jodi			Mitochondrial form and function	NATURE			English	Review							ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; INNER MEMBRANE; NUCLEOID STRUCTURE; CALCIUM UNIPORTER; CRYSTAL-STRUCTURE; MTDNA STABILITY; DNA REPLICATION	Mitochondria are one of the major ancient endomembrane systems in eukaryotic cells. Owing to their ability to produce ATP through respiration, they became a driving force in evolution. As an essential step in the process of eukaryotic evolution, the size of the mitochondrial chromosome was drastically reduced, and the behaviour of mitochondria within eukaryotic cells radically changed. Recent advances have revealed how the organelle's behaviour has evolved to allow the accurate transmission of its genome and to become responsive to the needs of the cell and its own dysfunction.	[Friedman, Jonathan R.; Nunnari, Jodi] Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Nunnari, J (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu	Friedman, Jonathan/GWV-4047-2022	Friedman, Jonathan/0000-0001-8155-2429	NIH [R01GM062942, R01GM097432, R01GM106019]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942, R01GM097432, R01GM106019] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Nunnari lab for helpful discussions and comments. We also thank K. Osteryoung and S. Lewis for helpful discussions. J.N. is supported by NIH grants R01GM062942, R01GM097432 and R01GM106019. J.F. is supported by a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Faelber K, 2013, PROG MOL BIOL TRANSL, V117, P411, DOI 10.1016/B978-0-12-386931-9.00015-5; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Fung S, 2013, MOL BIOL CELL, V24, P184, DOI 10.1091/mbc.E12-09-0651; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; Gadir N, 2011, RNA, V17, P1551, DOI 10.1261/rna.2621111; Garcia M, 2007, MOL BIOL CELL, V18, P362, DOI 10.1091/mbc.E06-09-0827; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hanekamp T, 2002, GENETICS, V162, P1147; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Hedskog L, 2013, P NATL ACAD SCI USA, V110, P7916, DOI 10.1073/pnas.1300677110; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mbantenkhu M, 2011, J BIOL CHEM, V286, P42360, DOI 10.1074/jbc.M111.307512; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Messerschmitt M, 2003, J CELL BIOL, V160, P553, DOI 10.1083/jcb.200211113; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Namba T, 2013, CELL REP, V5, P331, DOI 10.1016/j.celrep.2013.09.020; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Nishida K, 2003, P NATL ACAD SCI USA, V100, P2146, DOI 10.1073/pnas.0436886100; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Swayne TC, 2011, CURR BIOL, V21, P1994, DOI 10.1016/j.cub.2011.10.019; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Voss C, 2012, J CELL SCI, V125, P4791, DOI 10.1242/jcs.105635; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	125	910	942	38	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					335	343		10.1038/nature12985	http://dx.doi.org/10.1038/nature12985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429632	Green Accepted			2022-12-28	WOS:000329621800031
J	Rosen, ED; Spiegelman, BM				Rosen, Evan D.; Spiegelman, Bruce M.			What We Talk About When We Talk About Fat	CELL			English	Review							BROWN ADIPOSE-TISSUE; ACTIVATED-RECEPTOR-GAMMA; DIET-INDUCED OBESITY; REGULATORY T-CELLS; MITOCHONDRIAL UNCOUPLING PROTEIN; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; PPAR-GAMMA; TRANSCRIPTIONAL CONTROL; GENE-EXPRESSION	There has been an upsurge of interest in the adipocyte coincident with the onset of the obesity epidemic and the realization that adipose tissue plays a major role in the regulation of metabolic function. The past few years, in particular, have seen significant changes in the way that we classify adipocytes and how we view adipose development and differentiation. We have new perspective on the roles played by adipocytes in a variety of homeostatic processes and on the mechanisms used by adipocytes to communicate with other tissues. Finally, there has been significant progress in understanding how these relationships are altered during metabolic disease and how they might be manipulated to restore metabolic health.	[Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Rosen, Evan D.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Rosen, Evan D.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Rosen, Evan D.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Rosen, ED (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA.	erosen@bidmc.harvard.edu; bruce_spiegelman@dfci.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087092, R01DK085171] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK087092, R01 DK085171] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Asilmaz E, 2004, J CLIN INVEST, V113, P414, DOI 10.1172/JCI200419511; Barnhart KF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002621; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; BATHIJA A, 1979, AM J HEMATOL, V6, P191, DOI 10.1002/ajh.2830060303; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; BJORNTORP P, 1975, AM J CLIN NUTR, V28, P445; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boustany-Kari CM, 2011, EUR J PHARMACOL, V658, P270, DOI 10.1016/j.ejphar.2011.02.021; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Campos-Sandoval JA, 2011, J MED CHEM, V54, P4378, DOI 10.1021/jm200256g; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Chechi K, 2013, TRENDS ENDOCRIN MET, V24, P408, DOI 10.1016/j.tem.2013.04.002; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Chen L, 2013, CELL BIOL INT, V37, P533, DOI 10.1002/cbin.10063; Cherian S, 2012, AM J PHYSIOL-ENDOC M, V303, pE937, DOI 10.1152/ajpendo.00061.2012; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Chou SH, 2011, P NATL ACAD SCI USA, V108, P6585, DOI 10.1073/pnas.1015674108; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; CINTI S, 1984, J SUBMICR CYTOL PATH, V16, P243; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; Considine R V, 2001, Rev Endocr Metab Disord, V2, P357, DOI 10.1023/A:1011896331159; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cristancho AG, 2011, P NATL ACAD SCI USA, V108, P16271, DOI 10.1073/pnas.1109409108; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dani C, 2013, INT J OBESITY, V37, P163, DOI 10.1038/ijo.2012.28; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Denis GV, 2013, MOL ASPECTS MED, V34, P59, DOI 10.1016/j.mam.2012.10.004; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; DOBSON DE, 1990, CELL, V61, P223, DOI 10.1016/0092-8674(90)90803-M; Drogemuller C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011258; Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elias I, 2013, ADIPOCYTE, V2, P109, DOI 10.4161/adip.22880; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; ENGLISH JT, 1973, RADIOLOGY, V107, P279, DOI 10.1148/107.2.279; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Garten A, 2012, ENDOCRIN METAB CLIN, V41, P283, DOI 10.1016/j.ecl.2012.04.011; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Griffith JF, 2009, BONE, V44, P1092, DOI 10.1016/j.bone.2009.02.022; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HAYWARD JS, 1992, CAN J ZOOL, V70, P171, DOI 10.1139/z92-025; HELLMAN B, 1963, ACTA PHYSIOL SCAND, V58, P255, DOI 10.1111/j.1748-1716.1963.tb02647.x; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hernandez TL, 2011, OBESITY, V19, P1388, DOI 10.1038/oby.2011.64; Hesslein DGT, 2009, BONE, V44, P537, DOI 10.1016/j.bone.2008.11.021; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Himms-Hagen J., 2000, AM J PHYSIOL-CELL PH, V279, pC670; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Iglesias P, 2012, EUR J ENDOCRINOL, V167, P301, DOI 10.1530/EJE-12-0357; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jiang CT, 2013, J BIOL CHEM, V288, P3844, DOI 10.1074/jbc.M112.426338; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Jun LS, 2011, AM J PHYSIOL-ENDOC M, V301, pE825, DOI 10.1152/ajpendo.00147.2011; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim DH, 2012, DIABETES, V61, P2299, DOI 10.2337/db11-1579; Kim DH, 2010, DIABETES, V59, P907, DOI 10.2337/db09-1141; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim YW, 2006, DIABETES, V55, P716, DOI 10.2337/diabetes.55.03.06.db05-0917; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Koh YJ, 2007, J CLIN INVEST, V117, P3684, DOI 10.1172/JCI32504; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Konige M, 2014, BBA-MOL BASIS DIS, V1842, P393, DOI 10.1016/j.bbadis.2013.05.007; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; KRAL JG, 1977, EUR J CLIN INVEST, V7, P413, DOI 10.1111/j.1365-2362.1977.tb01628.x; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lu YP, 2012, P NATL ACAD SCI USA, V109, P9065, DOI 10.1073/pnas.1205810109; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MacKellar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008197; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Mauer MM, 2001, NEUROSCI BIOBEHAV R, V25, P15, DOI 10.1016/S0149-7634(00)00047-6; Maymo JL, 2011, PLACENTA, V32, pS146, DOI 10.1016/j.placenta.2011.01.004; McCullough AW, 1944, J MORPHOL, V75, P193, DOI 10.1002/jmor.1050750203; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mittendorfer B, 2011, DIABETES, V60, P1474, DOI 10.2337/db10-1302; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moon HS, 2013, ENDOCR REV, V34, P377, DOI 10.1210/er.2012-1053; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Morroni M, 2004, P NATL ACAD SCI USA, V101, P16801, DOI 10.1073/pnas.0407647101; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Murphy KT, 2013, AM J PHYSIOL-ENDOC M, V304, pE1338, DOI 10.1152/ajpendo.00021.2013; Myers MG, 2012, CELL METAB, V15, P150, DOI 10.1016/j.cmet.2012.01.002; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Natarajan A, 2010, CELL CYCLE, V9, P2045, DOI 10.4161/cc.9.11.11854; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nawarskas J, 2001, Heart Dis, V3, P378; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oelkrug R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3140; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Ota T, 2013, DIABETES METAB J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Ottaviani E, 2011, GEN COMP ENDOCR, V174, P1, DOI 10.1016/j.ygcen.2011.06.018; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POISSONNET CM, 1983, EARLY HUM DEV, V8, P1, DOI 10.1016/0378-3782(83)90028-2; POISSONNET CM, 1984, EARLY HUM DEV, V10, P1, DOI 10.1016/0378-3782(84)90106-3; POND CM, 1992, P NUTR SOC, V51, P367, DOI 10.1079/PNS19920050; Pond CM, 2002, CYTOKINE, V17, P131, DOI 10.1006/cyto.2001.0999; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Ravussin E, 2009, OBESITY, V17, P1736, DOI 10.1038/oby.2009.184; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rockson SG, 2010, ANN NY ACAD SCI, V1207, pE2, DOI 10.1111/j.1749-6632.2010.05804.x; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; SALANS LB, 1971, J CLIN INVEST, V50, P1005, DOI 10.1172/JCI106570; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Shi HF, 2007, AM J PHYSIOL-ENDOC M, V293, pE1012, DOI 10.1152/ajpendo.00649.2006; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimizu M, 2006, MOL CELL BIOCHEM, V286, P33, DOI 10.1007/s11010-005-9052-z; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; Singleton A. J, 2008, CULTURAL ENCY BODY; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Symonds ME, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/305763; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trajkovski M, 2013, TRENDS ENDOCRIN MET, V24, P442, DOI 10.1016/j.tem.2013.05.002; Tran TT, 2010, NAT REV ENDOCRINOL, V6, P195, DOI 10.1038/nrendo.2010.20; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Turer AT, 2011, DIABETOLOGIA, V54, P2515, DOI 10.1007/s00125-011-2252-z; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Velders GJM, 2012, SCIENCE, V335, P922, DOI 10.1126/science.1216414; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; WASSERMANN F., 1965, HANDBOOK PHYSIOL, V5, P87; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Wrann CD, 2012, J CLIN INVEST, V122, P1010, DOI 10.1172/JCI58431; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018	302	1348	1392	18	307	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					20	44		10.1016/j.cell.2013.12.012	http://dx.doi.org/10.1016/j.cell.2013.12.012			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439368	Bronze, Green Accepted			2022-12-28	WOS:000329912200009
J	Scholefield, BR; Perkins, GD; Duncan, HP; Gao, F; Morris, KP				Scholefield, Barnaby R.; Perkins, Gavin D.; Duncan, Heather P.; Gao, Fang; Morris, Kevin P.			Should children who have a cardiac arrest be treated with therapeutic hypothermia?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							2010 INTERNATIONAL CONSENSUS; CARDIOVASCULAR CARE SCIENCE; CARDIOPULMONARY-RESUSCITATION; TREATMENT RECOMMENDATIONS; EPIDEMIOLOGY		[Scholefield, Barnaby R.; Duncan, Heather P.; Morris, Kevin P.] Birmingham Childrens Hosp, Intens Care Unit, Birmingham B4 6NH, W Midlands, England; [Scholefield, Barnaby R.; Gao, Fang] Univ Birmingham, Perioperat Anaesthesia & Crit Care Trials Grp, Birmingham B15 2TT, W Midlands, England; [Perkins, Gavin D.] Univ Warwick & Heart England NHS Fdn Trust, Coventry, W Midlands, England	University of Birmingham; University of Birmingham; Heart of England NHS Foundation Trust	Scholefield, BR (corresponding author), Birmingham Childrens Hosp, Intens Care Unit, Birmingham B4 6NH, W Midlands, England.	Barney.scholefield@bch.nhs.uk	Scholefield, Barney/ABG-7312-2021; Duncan, Heather/AAX-4143-2020; Perkins, Gavin/E-7613-2010; Smith, Fang G/H-8451-2018	Duncan, Heather/0000-0003-1771-8644; Smith, Fang G/0000-0002-8095-0609; Perkins, Gavin/0000-0003-3027-7548; Scholefield, Barney/0000-0002-6198-4985				Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; Bembea MM, 2010, PEDIATR CRIT CARE ME, V11, P723, DOI 10.1097/PCC.0b013e3181dde659; Buttram S, 2009, CRITICAL CARE MED S, V37, P480; de Caen AR, 2010, RESUSCITATION, V81, pE213, DOI 10.1016/j.resuscitation.2010.08.028; Deakin CD, 2010, RESUSCITATION, V81, pE93, DOI 10.1016/j.resuscitation.2010.08.027; Deasy C, 2010, RESUSCITATION, V81, P1095, DOI 10.1016/j.resuscitation.2010.04.029; Doherty DR, 2009, CIRCULATION, V119, P1492, DOI 10.1161/CIRCULATIONAHA.108.791384; Fink EL, 2010, PEDIATR CRIT CARE ME, V11, P66, DOI 10.1097/PCC.0b013e3181c58237; Haque IU, 2006, PEDIATR CRIT CARE ME, V7, P7, DOI 10.1097/01.PCC.0000192322.45123.80; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; Moler FW, 2011, CRIT CARE MED, V39, P141, DOI 10.1097/CCM.0b013e3181fa3c17; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Scholefield B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009442.pub2; Scholefield BR, 2010, ARCH DIS CHILD, V95, P796, DOI 10.1136/adc.2009.176735; Topjian A, 2011, PEDIATR CRIT CARE ME, V12, pE127, DOI 10.1097/PCC.0b013e3181e28717; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	20	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2014	348								f7672	10.1136/bmj.f7672	http://dx.doi.org/10.1136/bmj.f7672			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MP	24435412				2022-12-28	WOS:000329976100001
J	Tay, Y; Rinn, J; Pandolfi, PP				Tay, Yvonne; Rinn, John; Pandolfi, Pier Paolo			The multilayered complexity of ceRNA crosstalk and competition	NATURE			English	Review							RNA-BINDING PROTEIN; LONG-NONCODING-RNA; MICRORNA TARGET SITES; MESSENGER-RNA; HEPATOCELLULAR-CARCINOMA; TRANSLATIONAL REPRESSION; ENDOGENOUS MICRORNA; TUMOR-SUPPRESSOR; CIRCULAR RNAS; IN-VIVO	Recent reports have described an intricate interplay among diverse RNA species, including protein-coding messenger RNAs and non-coding RNAs such as long non-coding RNAs, pseudogenes and circular RNAs. These RNA transcripts act as competing endogenous RNAs (ceRNAs) or natural microRNA sponges - they communicate with and co-regulate each other by competing for binding to shared microRNAs, a family of small non-coding RNAs that are important post-transcriptional regulators of gene expression. Understanding this novel RNA crosstalk will lead to significant insight into gene regulatory networks and have implications in human development and disease.	[Tay, Yvonne; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Sch Med,Canc Res Inst,Dept Pathol & Med, Boston, MA 02215 USA; [Rinn, John] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Rinn, John] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rinn, John] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Sch Med,Canc Res Inst,Dept Pathol & Med, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu		Rinn, John/0000-0002-7231-7539; Pandolfi, Pier Paolo/0000-0002-5352-5295	Leukemia & Lymphoma Society; US National Institutes of Health [R01 CA-82328]; NATIONAL CANCER INSTITUTE [R01CA082328, R01CA170158] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. M. Tan, R. Taulli, F. Karreth and other members of the Pandolfi laboratory for helpful discussions and critical review of the manuscript. Y.T. received a Special Fellow Award from The Leukemia & Lymphoma Society. P.P.P. was supported by US National Institutes of Health grant R01 CA-82328.	Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Almeida MI, 2012, EXPERT OPIN BIOL TH, V12, P1153, DOI 10.1517/14712598.2012.693470; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Barker A, 2012, J BIOCHEM, V151, P423, DOI 10.1093/jb/mvs010; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Fan M, 2013, EXP THER MED, V5, P1143, DOI 10.3892/etm.2013.933; Fang L, 2013, FASEB J, V27, P907, DOI 10.1096/fj.12-220905; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Glorian V, 2011, CELL DEATH DIFFER, V18, P1692, DOI 10.1038/cdd.2011.35; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kluiver J, 2012, METHODS, V58, P113, DOI 10.1016/j.ymeth.2012.07.019; Kumar M. S., 2013, NATURE; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lembo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031129; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Libri V, 2012, P NATL ACAD SCI USA, V109, P279, DOI 10.1073/pnas.1114204109; Loinger A, 2012, BIOPHYS J, V102, P1712, DOI [10.1016/j.bpj.2012.01.058, 10.1016/j.bpj.2012.03.055]; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Maas S, 2012, ADV PROTEIN CHEM STR, V86, P193, DOI 10.1016/B978-0-12-386497-0.00006-2; Mallick B, 2011, RNA BIOL, V8, P665, DOI 10.4161/rna.8.4.15584; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Marques AC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r102; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mitrovich QM, 2005, CURR BIOL, V15, P963, DOI 10.1016/j.cub.2005.04.055; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Pal S, 2012, PHARMACOL THERAPEUT, V136, P283, DOI 10.1016/j.pharmthera.2012.08.005; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rutnam ZJ, 2012, J CELL SCI, V125, P2075, DOI 10.1242/jcs100818; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sanchez-Diaz Patricia, 2006, RNA Biol, V3, P101; Sarver AL, 2012, BIOINFORMATION, V8, P731, DOI 10.6026/97320630008731; Schug J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-264; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Srikantan S, 2011, MOL CELL BIOL, V31, P3790, DOI 10.1128/MCB.05639-11; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Taulli R, 2013, NAT STRUCT MOL BIOL, V20, P541, DOI 10.1038/nsmb.2580; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Tollervey D, 2006, NATURE, V440, P425, DOI 10.1038/440425a; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Yoo S, 2013, J NEUROCHEM, V126, P792, DOI 10.1111/jnc.12266; Yoon JH, 2012, METHODS, V58, P81, DOI 10.1016/j.ymeth.2012.07.004; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337	100	2535	2641	33	519	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					344	352		10.1038/nature12986	http://dx.doi.org/10.1038/nature12986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429633	Green Accepted			2022-12-28	WOS:000329621800032
J	Kiguli, S; Akech, SO; Mtove, G; Opoka, RO; Engoru, C; Olupot-Olupot, P; Nyeko, R; Evans, J; Crawley, J; Prevatt, N; Reyburn, H; Levin, M; George, EC; South, A; Babiker, AG; Gibb, DM; Maitland, K				Kiguli, Sarah; Akech, Samuel O.; Mtove, George; Opoka, Robert O.; Engoru, Charles; Olupot-Olupot, Peter; Nyeko, Richard; Evans, Jennifer; Crawley, Jane; Prevatt, Natalie; Reyburn, Hugh; Levin, Michael; George, Elizabeth C.; South, Annabelle; Babiker, Abdel G.; Gibb, Diana M.; Maitland, Kathryn			WHO guidelines on fluid resuscitation in children: missing the FEAST data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AFRICAN CHILDREN; SEPTIC SHOCK; BOLUS; MORTALITY; SUPPORT; SEPSIS		[Kiguli, Sarah; Opoka, Robert O.] Makerere Univ, Mulago Hosp, Dept Paediat, Kampala, Uganda; [Akech, Samuel O.] Kilifi Clin Trials Facil, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Mtove, George] Hosp Teule, Joint Malaria Programme, Dept Paediat, Muheza, Tanzania; [Engoru, Charles] Soroti Reg Referral Hosp, Dept Paediat, Soroti, Uganda; [Olupot-Olupot, Peter] Mbale Reg Referral Hosp, Dept Paediat, Mbale, Uganda; [Nyeko, Richard] St Marys Hosp, Dept Paediat, Lacor, Uganda; [Evans, Jennifer] Univ Wales Hosp, Dept Paediat, Cardiff CF4 4XW, S Glam, Wales; [Crawley, Jane] Univ Oxford, Nuffield Dept Med, Oxford, England; [Prevatt, Natalie; Levin, Michael; Maitland, Kathryn] Fac Med, Dept Paediat, Wellcome Trust Ctr Clin Trop Med, London W2 1PG, England; [Reyburn, Hugh] Joint Malaria Programme, Moshi, Tanzania; [George, Elizabeth C.; South, Annabelle; Babiker, Abdel G.; Gibb, Diana M.] UCL, Med Res Council, Clin Trials Unit, London, England	Makerere University; Mulago National Referral Hospital; Cardiff University; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Medical Research Council Clinical Trials Unit; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London	Maitland, K (corresponding author), Fac Med, Dept Paediat, Wellcome Trust Ctr Clin Trop Med, St Marys Campus, London W2 1PG, England.	k.maitland@imperial.ac.uk	George, Elizabeth/V-3381-2017	George, Elizabeth/0000-0002-2928-3580; Levin, Michael/0000-0003-2767-6919; Maitland, Kathryn/0000-0002-0007-0645; South, Annabelle/0000-0001-8912-2001; Mtove, George/0000-0001-5173-0829	MRC [G0601027, G0801439] Funding Source: UKRI; Medical Research Council [G0601027, G0801439] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Akech S, 2010, BMJ-BRIT MED J, V341, pc4416; [Anonymous], 2012, WHO TECH REP SER, V972, P1; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Duke T, 2011, LANCET, V378, P1685, DOI 10.1016/S0140-6736(11)60881-7; Ford N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043953; Hilton AK, 2012, CRIT CARE, V16, DOI 10.1186/cc11154; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V365, P1351; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Otieno H, 2004, ARCH DIS CHILD, V89, P977, DOI 10.1136/adc.2003.043901; Pamba A, 2004, ARCH DIS CHILD, V89, P950, DOI 10.1136/adc.2003.032516; Ralston ME, 2013, LANCET, V381, P256, DOI 10.1016/S0140-6736(12)61191-X; Sleight P., 2000, CURR CONTR TRIALS C, V1, P25; Southall DP, 2011, ARCH DIS CHILD, V96, P905, DOI 10.1136/archdischild-2011-300436; World Health Organization, 2005, EM TRIAG ASS TREATM; World Health Organization, 2013, GUIDELINES MANAGEMEN; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	21	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2014	348								f7003	10.1136/bmj.f7003	http://dx.doi.org/10.1136/bmj.f7003			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MN	24423891	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000329975900002
J	Spence, D				Spence, Des			Frequent attenders are getting poor care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL-PRACTICE					destwo@yahoo.co.uk	Smits, Frans T/N-3904-2018	Smits, Frans T/0000-0002-7753-4639				Heywood PL, 1998, FAM PRACT, V15, P198, DOI 10.1093/fampra/15.3.198; Neal RD, 1998, BRIT J GEN PRACT, V48, P895; NHS England, NHS ALL 2013 14; Paterson C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572689; Stewart P, 2002, BRIT J GEN PRACT, V52, P1000; Triggle N, 2014, BBC NEWS; Watt N., 2014, GUARDIAN	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2014	348								g208	10.1136/bmj.g208	http://dx.doi.org/10.1136/bmj.g208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MK	24421341				2022-12-28	WOS:000329975600015
J	Johnson-Arbor, K				Johnson-Arbor, Kelly			Digital Frostbite	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hartford Hosp, Hartford, CT 06115 USA	Hartford Hospital	Johnson-Arbor, K (corresponding author), Hartford Hosp, Hartford, CT 06115 USA.	kkja@me.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					E3	E3		10.1056/NEJMicm1310126	http://dx.doi.org/10.1056/NEJMicm1310126			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401075				2022-12-28	WOS:000336119800001
J	Reenan, R				Reenan, Robert			Correcting Mutations by RNA Repair	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brown Univ, Providence, RI 02912 USA	Brown University	Reenan, R (corresponding author), Brown Univ, Providence, RI 02912 USA.							Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252	3	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					172	174		10.1056/NEJMcibr1313514	http://dx.doi.org/10.1056/NEJMcibr1313514			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401057				2022-12-28	WOS:000336119800015
J	Abrams, DB				Abrams, David B.			Promise and Peril of e-Cigarettes CanDisruptiveTechnologyMake Cigarettes Obsolete?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Abrams, David B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Schroeder Inst Tobacco Res & Policy Studies Legac, Baltimore, MD USA; [Abrams, David B.] Georgetown Univ, Med Ctr, Dept Oncol Adjunct, Washington, DC 20007 USA; [Abrams, David B.] Lombardi Comprehens Canc Ctr, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Abrams, DB (corresponding author), Legacy Fdn, Schroeder Inst, Johns Hopkins Bloomberg Sch Publ Hlth, 1724 Massachusetts Ave NW, Washington, DC 20036 USA.	dabrams@legacyforhealth.org	Abrams, David B/AAY-7699-2020	Abrams, David B/0000-0002-0868-4350				Benowitz NL, 2013, JAMA-J AM MED ASSOC, V310, P685, DOI 10.1001/jama.2013.109501; Campaign for Tobacco Free Kids, TOLL OF TOBACCO AROU; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Department of Health, SMOKING IN ENGLAND; Fagerstrom KO, 2014, ADDICT BEHAV, V39, P507, DOI 10.1016/j.addbeh.2013.11.002; Henningfield JE, 2010, TOB CONTROL, V19, P89, DOI 10.1136/tc.2009.035279; Herzog B, EQUITY RESEARCH; Polosa R, 2013, LANCET ONCOL, V14, pE582, DOI 10.1016/S1470-2045(13)70495-9; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; Zeller M, 2009, TOB CONTROL, V18, P324, DOI 10.1136/tc.2008.027318	11	154	154	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					135	136		10.1001/jama.2013.285347	http://dx.doi.org/10.1001/jama.2013.285347			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399548				2022-12-28	WOS:000329339400015
J	Smith, AL; Chapman, S				Smith, Andrea L.; Chapman, Simon			Quitting Smoking Unassisted The 50-Year Research Neglect of a Major Public Health Phenomenon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CESSATION; IMPACT		[Smith, Andrea L.; Chapman, Simon] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Edward Ford Bldg A27, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009	Smith, Andrea Lynne Leslie/0000-0002-9194-4888				Chapman S, 2009, LANCET, V373, P701, DOI 10.1016/S0140-6736(09)60416-5; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Horn D., 1978, PROGRESS IN SMOKING; Krasnegor N A, 1979, NIDA Res Monogr, P186; LICHTENSTEIN E, 1992, J CONSULT CLIN PSYCH, V60, P518, DOI 10.1037/0022-006X.60.4.518; Newport F., 2013, MOST US SMOKERS WANT; Pierce JP, 2012, ANNU REV PUBL HEALTH, V33, P341, DOI 10.1146/annurev-publhealth-031811-124624; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Taubes G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1050; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Walsh RA, 2011, ADDICTION, V106, P451, DOI 10.1111/j.1360-0443.2010.03282.x; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001	12	16	16	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					137	138		10.1001/jama.2013.282618	http://dx.doi.org/10.1001/jama.2013.282618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SA	24399549				2022-12-28	WOS:000329339400016
J	Iacobucci, G				Iacobucci, Gareth			The battle for NHS 111: who should run it now?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Buckman L, 2012, NHS 111 CCG APPL IMP; Deloitte LLP, 2013, NHS DIR 111 GO LIV R; Gould M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5017; House of Commons Health Committee, EXP DAT TRANS NHS DI; Iacobucci G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6828; Iacobucci G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4717; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2394; Kmietowicz Zosia, 2013, BMJ, V347, pf6811, DOI 10.1136/bmj.f6811; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2729; Limb M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3382; Limb M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3065; NHS South West Commissioning Support Unit, INV TEND PRIM CAR OU; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4837; Turner, 2013, BMJ OPEN, V3; West Midlands NHS, 2013, 111 UPD CCG GOV BOD	15	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2014	348								f7659	10.1136/bmj.f7659	http://dx.doi.org/10.1136/bmj.f7659			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285QD	24385550				2022-12-28	WOS:000329407800004
J	Jha, P; Peto, R				Jha, Prabhat; Peto, Richard			Global Health: Global Effects of Smoking, of Quitting, and of Taxing Tobacco	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MORTALITY; IMPACT; CARCINOMA; CESSATION; BENEFITS; HAZARDS; DEATHS; POLICY; INDIA		[Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada; [Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Peto, Richard] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Oxford; University of Oxford	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada.	prabhat.jha@utoronto.ca			Medical Research Council [MC_U137686857] Funding Source: Medline; MRC [MC_U137686857] Funding Source: UKRI; Cancer Research UK [16896] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)		Abascal W, 2012, LANCET, V380, P1575, DOI 10.1016/S0140-6736(12)60826-5; Alam DS, 2013, B WORLD HEALTH ORGAN, V91, P757, DOI 10.2471/BLT.13.120196; [Anonymous], 2013, DRAFT ACTION PLAN FO; [Anonymous], 1962, SMOKING AND HEALTH S; [Anonymous], 2012, MARKET RESEARCH FOR; [Anonymous], 2013, DRAFT COMPREHENSIVE; [Anonymous], 1964, SMOKING AND HEALTH R; Bala MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub3; Barber S, 2008, TOBACCO ECONOMICS IN; Baumgardner JR, 2012, NEW ENGL J MED, V367, P2068, DOI 10.1056/NEJMp1210319; Blecher E, 2008, J HEALTH ECON, V27, P930, DOI 10.1016/j.jhealeco.2008.02.010; Blecher E, 2010, TOB CONTROL, V19, P325, DOI 10.1136/tc.2009.030155; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Cancer Research UK, THE ANSWER IS PLAIN; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P140; Chaloupka FJ., 2000, TOBACCO CONTROL DEV, P237; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eriksen M, 2012, THE TOBACCO ATLAS; Federal Trade Commission, 2013, CIGARETTE REPORT FOR; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Forey B, 2013, INTERNATIONAL SMOKIN; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Giovino GA, 2013, LANCET, V382, P128; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Giovino GA, 2012, LANCET, V380, P1908; Gu DF, 2010, NEW ENGL J MED, V363, P2273; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Hammond D, 2010, SALUD PUBLICA MEXICO, V52, pS226, DOI 10.1590/S0036-36342010000800018; Hartmann-Boyce J, 2013, ADDICTION, V108, P1711, DOI 10.1111/add.12291; Hill C., 2013, IMPACT DE LAUGMENTAT; Hu TW, 2008, TOBACCO TAXATION AND; International Agency for Research on Cancer, 2011, EFFECTIVENESS OF TAX, V14; Jamison DT, 2013, LANCET; Jha P., 2011, Economic and Political Weekly, V46, P44; Jha P, 2010, EVIDENCE BASED CARDI, P111, DOI [10.1002/9781444309768.ch9, DOI 10.1002/9781444309768.CH9]; Jha P, 1999, CURBING THE EPIDEMIC; Jha P, 2012, TOBACCO TAXES A WIN; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; Jha P, 2013, EUR J EPIDEMIOL, V28, P617, DOI 10.1007/s10654-013-9835-6; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Joossens L, 2009, HOW ELIMINATING THE; Kenkel Donald, 2000, THBACCO CONTROL DEVE, P177; Kostova D, 2012, TOB CONTROL, V21, P64, DOI 10.1136/tc.2010.038786corr1; Levy DT, 2007, HEALTH POLICY, V82, P167, DOI 10.1016/j.healthpol.2006.09.008; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Peto R, 2012, MORTALITY FROM SMOKI; Peto R., 2001, CRITICAL ISSUES GLOB, P154, DOI DOI 10.4314/NMP.V55I6.45441; Peto R, 2010, NEW ENGL J MED, V362, P855, DOI 10.1056/NEJMc1000079; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Saffer H., 2000, TOBACCO CONTROL POLI, P215; Sakata R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7093; Sitas F, 2013, LANCET, V382, P685, DOI 10.1016/S0140-6736(13)61610-4; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Van Walbeek C, 2006, S AFR J ECON, V74, P110, DOI 10.1111/j.1813-6982.2006.00051.x; Wakefield MA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003175; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; World Health Organization, 2013, WHO REPORT ON THE GL; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; Yurekli A, 2010, APPL ECON, V42, P545, DOI 10.1080/00036840701720721; Zatonski WA, 2010, TOBACCO SCIENCE POLI, P134	66	434	443	5	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					60	68		10.1056/NEJMra1308383	http://dx.doi.org/10.1056/NEJMra1308383			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284XA	24382066				2022-12-28	WOS:000329354100011
J	Wang, K; Lee, J				Wang, Krystle; Lee, Jason			Rumpel-Leede Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 47-year-old woman with a history of abdominal surgery presented with syncope and acute gastrointestinal bleeding. She went to the hospital, and while she was undergoing BP monitoring, a petechial rash was noted on each arm, near the sphygmomanometer cuff. A 47-year-old woman with a history of abdominal surgery presented with syncope and acute gastrointestinal bleeding. She went to the hospital, and while she was undergoing continuous blood-pressure monitoring, a petechial rash with a well-demarcated upper margin was noted on each arm distal to the sphygmomanometer cuff. Continuous blood-pressure monitoring was immediately stopped, and after a period of 6 days, the rashes had resolved. The formation of petechiae distal to a tourniquet or sphygmomanometer on release of pressure is known as the Rumpel-Leede sign. This sign was reported in 1909 by Theodor Rumpel, and again independently in 1911 by Carl ...	[Wang, Krystle; Lee, Jason] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Jefferson University	Wang, K (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.	krystle.wang@jefferson.edu							0	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					E1	E1		10.1056/NEJMicm1305270	http://dx.doi.org/10.1056/NEJMicm1305270			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284XA	24382085				2022-12-28	WOS:000329354100002
J	Lockyer, N				Lockyer, Nigel			Together to the next frontier	NATURE			English	Editorial Material									Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA	United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory	Lockyer, N (corresponding author), Fermilab Natl Accelerator Lab, POB 500, Batavia, IL 60510 USA.	lockyer@fnal.gov							0	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					367	368		10.1038/504367a	http://dx.doi.org/10.1038/504367a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24358507	Bronze			2022-12-28	WOS:000328575300028
J	Gopal, AK; Kahl, BS; de Vos, S; Wagner-Johnston, ND; Schuster, SJ; Jurczak, WJ; Flinn, IW; Flowers, CR; Martin, P; Viardot, A; Blum, KA; Goy, AH; Davies, AJ; Zinzani, PL; Dreyling, M; Johnson, D; Miller, LL; Holes, L; Li, D; Dansey, RD; Godfrey, WR; Salles, GA				Gopal, Ajay K.; Kahl, Brad S.; de Vos, Sven; Wagner-Johnston, Nina D.; Schuster, Stephen J.; Jurczak, Wojciech J.; Flinn, Ian W.; Flowers, Christopher R.; Martin, Peter; Viardot, Andreas; Blum, Kristie A.; Goy, Andre H.; Davies, Andrew J.; Zinzani, Pier Luigi; Dreyling, Martin; Johnson, Dave; Miller, Langdon L.; Holes, Leanne; Li, Daniel; Dansey, Roger D.; Godfrey, Wayne R.; Salles, Gilles A.			PI3K delta Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-HODGKIN-LYMPHOMA; IBRITUMOMAB TIUXETAN; CELL; PI3K; RADIOIMMUNOTHERAPY; BENDAMUSTINE; CAL-101; THERAPY	BackgroundPhosphatidylinositol-3-kinase delta (PI3K) mediates B-cell receptor signaling and microenvironmental support signals that promote the growth and survival of malignant B lymphocytes. In a phase 1 study, idelalisib, an orally active selective PI3K inhibitor, showed antitumor activity in patients with previously treated indolent non-Hodgkin's lymphomas. MethodsIn this single-group, open-label, phase 2 study, 125 patients with indolent non-Hodgkin's lymphomas who had not had a response to rituximab and an alkylating agent or had had a relapse within 6 months after receipt of those therapies were administered idelalisib, 150 mg twice daily, until the disease progressed or the patient withdrew from the study. The primary end point was the overall rate of response; secondary end points included the duration of response, progression-free survival, and safety. ResultsThe median age of the patients was 64 years (range, 33 to 87); patients had received a median of four prior therapies (range, 2 to 12). Subtypes of indolent non-Hodgkin's lymphoma included follicular lymphoma (72 patients), small lymphocytic lymphoma (28), marginal-zone lymphoma (15), and lymphoplasmacytic lymphoma with or without Waldenstrom's macroglobulinemia (10). The response rate was 57% (71 of 125 patients), with 6% meeting the criteria for a complete response. The median time to a response was 1.9 months, the median duration of response was 12.5 months, and the median progression-free survival was 11 months. Similar response rates were observed across all subtypes of indolent non-Hodgkin's lymphoma, though the numbers were small for some categories. The most common adverse events of grade 3 or higher were neutropenia (in 27% of the patients), elevations in aminotransferase levels (in 13%), diarrhea (in 13%), and pneumonia (in 7%). ConclusionsIn this single-group study, idelalisib showed antitumor activity with an acceptable safety profile in patients with indolent non-Hodgkin's lymphoma who had received extensive prior treatment. (Funded by Gilead Sciences and others; ClinicalTrials.gov number, NCT01282424.) Idelalisib, which inhibits PI3K isoform delta, produced antitumor responses in nearly 60% of pretreated patients with indolent non-Hodgkin's lymphomas. Responses lasted a median of 11 months. Grade 3 or higher toxic effects were seen in 13 to 27% of patients. Indolent non-Hodgkin's lymphomas constitute approximately one third of all cases of non-Hodgkin's lymphoma and include follicular lymphoma, small lymphocytic lymphoma, marginal-zone lymphoma, and lymphoplasmacytic lymphoma with or without Waldenstrom's macroglobulinemia.(1)-(3) It was estimated that approximately 20,000 people in the United States were diagnosed with indolent non-Hodgkin's lymphoma in 2012 and that approximately 7000 died of this disease.(4),(5) The mainstay of treatment for indolent non-Hodgkin's lymphoma is an anti-CD20 antibody (primarily rituximab) in combination with chemotherapy consisting of alkylating agents, anthracyclines, antimitotic agents, or purine analogues. Although the current treatments for indolent non-Hodgkin's lymphomas are initially effective in inducing ...	[Gopal, Ajay K.] Univ Washington, Sch Med, Div Med Oncol, Seattle, WA 98109 USA; [Gopal, Ajay K.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Johnson, Dave; Miller, Langdon L.; Holes, Leanne; Li, Daniel; Dansey, Roger D.; Godfrey, Wayne R.] Gilead Sci Inc, Seattle, WA USA; [Kahl, Brad S.] Univ Wisconsin, Carbone Canc Ctr, Hematol Clin, Madison, WI 53706 USA; [de Vos, Sven] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Wagner-Johnston, Nina D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Schuster, Stephen J.] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA; [Jurczak, Wojciech J.] Jagiellonian Univ, Dept Hematol, Krakow, Poland; [Flinn, Ian W.] Sarah Cannon Res Inst, Hematol Malignancies Res Program, Nashville, TN USA; [Flowers, Christopher R.] Emory Univ, Winship Canc Ctr, Dept Med Hematol Oncol, Atlanta, GA 30322 USA; [Martin, Peter] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA; [Viardot, Andreas] Univ Hosp Ulm, Dept Internal Med, Ulm, Germany; [Dreyling, Martin] Univ Hosp Grosshadern, Dept Internal Med, LMU, Munich, Germany; [Blum, Kristie A.] Ohio State Univ, Wexner Med Ctr, Div Hematol, Columbus, OH 43210 USA; [Goy, Andre H.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Div Lymphoma, Hackensack, NJ USA; [Davies, Andrew J.] Univ Southampton, Canc Sci Unit, Southampton, Hants, England; [Zinzani, Pier Luigi] Univ Bologna, Inst Hematol & Oncol, Bologna, Italy; [Salles, Gilles A.] Univ Lyon 1, Hosp Civils Lyon, Dept Hematol, Pierre Benite, France	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Gilead Sciences; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Jagiellonian University; Collegium Medicum Jagiellonian University; Sarah Cannon Research Institute; Emory University; Cornell University; Ulm University; University of Munich; University System of Ohio; Ohio State University; Hackensack University Medical Center; University of Southampton; University of Bologna; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gopal, AK (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Oncol,Seattle Canc Care Alliance, 825 Eastlake Ave E,G3-200, Seattle, WA 98109 USA.	agopal@u.washington.edu	Godfrey, Wayne/AAL-7219-2020; Jurczak, Wojciech/AAV-7973-2020; Jurczak, Wojciech/L-7645-2019; Jurczak, Wojciech/M-1625-2019; Zinzani, Pier Luigi/J-9182-2016; Flowers, Christopher R/F-1953-2010; Blum, Kristie/E-2768-2011; Goy, Andre/AHC-0473-2022; Jurczak, Wojciech/ABB-2136-2020; Salles, Gilles/Z-2336-2019; Goy, Andre/AAS-4464-2020	Jurczak, Wojciech/0000-0003-1879-8084; Zinzani, Pier Luigi/0000-0002-2112-2651; Flowers, Christopher R/0000-0002-9524-3990; Goy, Andre/0000-0001-5125-6522; Jurczak, Wojciech/0000-0003-1879-8084; Salles, Gilles/0000-0002-9541-8666; Goy, Andre/0000-0001-5125-6522; Gopal, Ajay/0000-0003-3023-6834; Flinn, Ian/0000-0001-6724-290X; Davies, Andrew/0000-0002-7517-6938	Gilead Sciences; NATIONAL CANCER INSTITUTE [P30CA016058, P30CA015704, P30CA014520] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Gilead Sciences and others	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Benson DM, 2013, J CLIN ONCOL S, V31, P8526; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Brown JR, 2013, J CLIN ONCOL, V31; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheson BD, 2009, J CLIN ONCOL, V27, P1492, DOI 10.1200/JCO.2008.18.7252; Di Bella N, 2010, BLOOD, V115, P475, DOI 10.1182/blood-2009-08-233155; Durand CA, 2009, J IMMUNOL, V183, P5673, DOI 10.4049/jimmunol.0900432; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Gribben JG, 2007, BLOOD, V109, P4617, DOI 10.1182/blood-2006-10-041863; Herman SEM, 2011, BLOOD, V117, P4323, DOI 10.1182/blood-2010-11-315705; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; HORNING SJ, 1993, SEMIN ONCOL, V20, P75; Horning SJ, 2005, J CLIN ONCOL, V23, P712, DOI 10.1200/JCO.2005.07.040; Johnston PB, 2006, EXPERT REV ANTICANC, V6, P861, DOI 10.1586/14737140.6.6.861; Kahl BS, 2010, CANCER-AM CANCER SOC, V116, P106, DOI 10.1002/cncr.24714; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Leonard John P, 2008, Clin Adv Hematol Oncol, V6, P437; Lunning MA, 2012, BLOOD REV, V26, P279, DOI 10.1016/j.blre.2012.09.004; National Cancer Institute, 2009, COMM TERM CRIT ADV E; National Cancer Institute, 2013, EST NEW CANC CAUS DE; National Comprehensive Cancer Network, 2013, TREATM GUID LYMPH; Owen RG, 2013, BRIT J HAEMATOL, V160, P171, DOI 10.1111/bjh.12102; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tomblyn M, 2012, CANCER CONTROL, V19, P196, DOI 10.1177/107327481201900304; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; William BM, 2010, EXPERT OPIN BIOL TH, V10, P1271, DOI 10.1517/14712598.2010.504707; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; Witzig TE, 2009, J CLIN ONCOL, V27, P5404, DOI 10.1200/JCO.2008.21.1169	34	777	798	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1008	1018		10.1056/NEJMoa1314583	http://dx.doi.org/10.1056/NEJMoa1314583			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24450858	Bronze, Green Accepted			2022-12-28	WOS:000332689100008
J	Okada, Y; Wu, D; Trynka, G; Raj, T; Terao, C; Ikari, K; Kochi, Y; Ohmura, K; Suzuki, A; Yoshida, S; Graham, RR; Manoharan, A; Ortmann, W; Bhangale, T; Denny, JC; Carroll, RJ; Eyler, AE; Greenberg, JD; Kremer, JM; Pappas, DA; Jiang, L; Yin, J; Ye, LY; Su, DF; Yang, J; Xie, G; Keystone, E; Westra, HJ; Esko, T; Metspalu, A; Zhou, XZ; Gupta, N; Mirel, D; Stahl, EA; Diogo, D; Cui, J; Liao, K; Guo, MH; Myouzen, K; Kawaguchi, T; Coenen, MJH; van Riel, PLCM; van de Laar, MAFJ; Guchelaar, HJ; Huizinga, TWJ; Dieude, P; Mariette, X; Bridges, SL; Zhernakova, A; Toes, REM; Tak, PP; Miceli-Richard, C; Bang, SY; Lee, HS; Martin, J; Gonzalez-Gay, MA; Rodriguez-Rodriguez, L; Rantapaa-Dahlqvist, S; Arlestig, L; Choi, HK; Kamatani, Y; Galan, P; Lathrop, M; Eyre, S; Bowes, J; Barton, A; de Vries, N; Moreland, LW; Criswell, LA; Karlson, EW; Taniguchi, A; Yamada, R; Kubo, M; Liu, JS; Bae, SC; Worthington, J; Padyukov, L; Klareskog, L; Gregersen, PK; Raychaudhuri, S; Stranger, BE; De Jager, PL; Franke, L; Visscher, PM; Brown, MA; Yamanaka, H; Mimori, T; Takahashi, A; Xu, HJ; Behrens, TW; Siminovitch, KA; Momohara, S; Matsuda, F; Yamamoto, K; Plenge, RM				Okada, Yukinori; Wu, Di; Trynka, Gosia; Raj, Towfique; Terao, Chikashi; Ikari, Katsunori; Kochi, Yuta; Ohmura, Koichiro; Suzuki, Akari; Yoshida, Shinji; Graham, Robert R.; Manoharan, Arun; Ortmann, Ward; Bhangale, Tushar; Denny, Joshua C.; Carroll, Robert J.; Eyler, Anne E.; Greenberg, Jeffrey D.; Kremer, Joel M.; Pappas, Dimitrios A.; Jiang, Lei; Yin, Jian; Ye, Lingying; Su, Ding-Feng; Yang, Jian; Xie, Gang; Keystone, Ed; Westra, Harm-Jan; Esko, Tonu; Metspalu, Andres; Zhou, Xuezhong; Gupta, Namrata; Mirel, Daniel; Stahl, Eli A.; Diogo, Dorothee; Cui, Jing; Liao, Katherine; Guo, Michael H.; Myouzen, Keiko; Kawaguchi, Takahisa; Coenen, Marieke J. H.; van Riel, Piet L. C. M.; van de laar, Mart A. F. J.; Guchelaar, Henk-Jan; Huizinga, Tom W. J.; Dieude, Philippe; Mariette, Xavier; Bridges, S. Louis, Jr.; Zhernakova, Alexandra; Toes, Rene E. M.; Tak, Paul P.; Miceli-Richard, Corinne; Bang, So-Young; Lee, Hye-Soon; Martin, Javier; Gonzalez-Gay, Miguel A.; Rodriguez-Rodriguez, Luis; Rantapaa-Dahlqvist, Solbritt; Arlestig, Lisbeth; Choi, Hyon K.; Kamatani, Yoichiro; Galan, Pilar; Lathrop, Mark; Eyre, Steve; Bowes, John; Barton, Anne; de Vries, Niek; Moreland, Larry W.; Criswell, Lindsey A.; Karlson, Elizabeth W.; Taniguchi, Atsuo; Yamada, Ryo; Kubo, Michiaki; Liu, Jun S.; Bae, Sang-Cheol; Worthington, Jane; Padyukov, Leonid; Klareskog, Lars; Gregersen, Peter K.; Raychaudhuri, Soumya; Stranger, Barbara E.; De Jager, Philip L.; Franke, Lude; Visscher, Peter M.; Brown, Matthew A.; Yamanaka, Hisashi; Mimori, Tsuneyo; Takahashi, Atsushi; Xu, Huji; Behrens, Timothy W.; Siminovitch, Katherine A.; Momohara, Shigeki; Matsuda, Fumihiko; Yamamoto, Kazuhiko; Plenge, Robert M.		RACI Consortium; GARNET Consortium	Genetics of rheumatoid arthritis contributes to biology and drug discovery	NATURE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR INHIBITION; LOCI; RISK; SUSCEPTIBILITY; IDENTIFICATION; RESOURCE	A major challenge in human genetics is to devise a systematic strategy to integrate disease-associated variants with diverse genomic and biological data sets to provide insight into disease pathogenesis and guide drug discovery for complex traits such as rheumatoid arthritis (RA)(1). Here we performed a genome-wide association study meta-analysis in a total of >100,000 subjects of European and Asian ancestries (29,880 RA cases and 73,758 controls), by evaluating similar to 10 million single-nucleotide polymorphisms. We discovered 42 novel RA risk loci at a genome-wide level of significance, bringing the total to 101 (refs 2-4). We devised an in silico pipeline using established bioinformatics methods based on functional annotation(5), cis-acting expression quantitative trait loci(6) and pathway analyses(7-9)-as well as novel methods based on genetic overlap with human primary immunodeficiency, haematological cancer somatic mutations and knockout mouse phenotypes-to identify 98 biological candidate genes at these 101 risk loci. We demonstrate that these genes are the targets of approved therapies for RA, and further suggest that drugs approved for other indications may be repurposed for the treatment of RA. Together, this comprehensive genetic study sheds light on fundamental genes, pathways and cell types that contribute to RA pathogenesis, and provides empirical evidence that the genetics of RA can provide important information for drug discovery.	[Okada, Yukinori; Wu, Di; Trynka, Gosia; Diogo, Dorothee; Cui, Jing; Liao, Katherine; Guo, Michael H.; Karlson, Elizabeth W.; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Okada, Yukinori; Wu, Di; Trynka, Gosia; Raj, Towfique; Diogo, Dorothee; Cui, Jing; Liao, Katherine; Raychaudhuri, Soumya; De Jager, Philip L.; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Okada, Yukinori; Wu, Di; Trynka, Gosia; Raj, Towfique; Esko, Tonu; Gupta, Namrata; Mirel, Daniel; Diogo, Dorothee; Cui, Jing; Liao, Katherine; Guo, Michael H.; Raychaudhuri, Soumya; De Jager, Philip L.; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Wu, Di; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Wu, Di] Monash Univ, Monash Inst Med Res, Ctr Canc Res, Clayton, Vic 3800, Australia; [Raj, Towfique; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Programin Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Terao, Chikashi; Kawaguchi, Takahisa; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan; [Terao, Chikashi; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin immunol, Kyoto 6068507, Japan; [Ikari, Katsunori; Yoshida, Shinji; Taniguchi, Atsuo; Yamanaka, Hisashi; Momohara, Shigeki] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1620054, Japan; [Kochi, Yuta; Suzuki, Akari; Myouzen, Keiko; Yamamoto, Kazuhiko] RIKEN, Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa 2300045, Japan; [Graham, Robert R.; Manoharan, Arun; Ortmann, Ward; Bhangale, Tushar; Behrens, Timothy W.] Genentech Inc, Immunol Biomarkers Grp, San Francisco, CA 94080 USA; [Denny, Joshua C.; Carroll, Robert J.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Denny, Joshua C.; Eyler, Anne E.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Greenberg, Jeffrey D.] NYU, Hosp Joint Dis, New York, NY 10003 USA; [Kremer, Joel M.] Albany Med Ctr, Dept Med, Albany, NY 12206 USA; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY 12206 USA; [Pappas, Dimitrios A.] Columbia Univ, Coll Phys & Surg, Presbyterian Hosp, Div Rheumatol,Dept Med, New York, NY 10032 USA; [Jiang, Lei; Yin, Jian; Ye, Lingying; Xu, Huji] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Rheumatol & Immunol, Shanghai 200003, Peoples R China; [Su, Ding-Feng] Second Mil Med Univ, Dept Pharmacol, Shanghai 200433, Peoples R China; [Yang, Jian; Visscher, Peter M.; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4072, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Xie, Gang; Siminovitch, Katherine A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON M5G 2M9, Canada; [Xie, Gang; Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON M5S 2J7, Canada; [Keystone, Ed] Mt Sinai Hosp, Dept Med, Toronto, ON M5S 2J7, Canada; [Keystone, Ed] Univ Toronto, Toronto, ON M5S 2J7, Canada; [Westra, Harm-Jan; Zhernakova, Alexandra; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Guo, Michael H.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Zhou, Xuezhong] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing 100044, Peoples R China; [Stahl, Eli A.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van Riel, Piet L. C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands; [van de laar, Mart A. F. J.] Univ Twente, Arthrit Ctr Twente, Dept Rheumatol & Clin Immunol, NL-7500 AE Enschede, Netherlands; [van de laar, Mart A. F. J.] Med Spectrum Twente, NL-7500 AE Enschede, Netherlands; [Guchelaar, Henk-Jan] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-2300 RC Leiden, Netherlands; [Huizinga, Tom W. J.; Zhernakova, Alexandra; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Dieude, Philippe] Hop Bichat Claude Bernard, AP HP, Serv Rhumatol, F-75018 Paris, France; [Dieude, Philippe] Hop Bichat Claude Bernard, AP HP, INSERM, U699, F-75018 Paris, France; [Dieude, Philippe] Univ Paris 07, F-75013 Paris, France; [Mariette, Xavier; Miceli-Richard, Corinne] Univ Paris 11, Hop Univ Paris Sud, AP HP, INSERM,U1012, F-94275 Le Kremlin Bicetre, France; [Bridges, S. Louis, Jr.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Tak, Paul P.] Univ Cambridge, Cambridge CB2 1TN, England; [Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133792, South Korea; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Gonzalez-Gay, Miguel A.] Hosp Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander 39008, Spain; [Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, Madrid 28040, Spain; [Rantapaa-Dahlqvist, Solbritt; Arlestig, Lisbeth] Umea Univ, Dept Publ Hlth & Clin Med, SE-90187 Umea, Sweden; [Rantapaa-Dahlqvist, Solbritt; Arlestig, Lisbeth] Umea Univ, Dept Rheumatol, SE-90187 Umea, Sweden; [Choi, Hyon K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Kamatani, Yoichiro] CEPH, F-75010 Paris, France; [Galan, Pilar] Univ Paris 13, UREN Nutr Epidemiol Res Unit, INSERM, U557,Inra,U1125,Cnam, F-93017 Bobigny, France; [Lathrop, Mark] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Eyre, Steve; Bowes, John; Barton, Anne; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Epidemiol Unit, Manchester M13 9NT, Lancs, England; [Eyre, Steve; Bowes, John; Worthington, Jane] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester Musculoskeletal Biomed Res Unit, Natl Inst Hlth Res, Manchester M13 9NT, Lancs, England; [de Vries, Niek] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Niek] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Moreland, Larry W.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94117 USA; [Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Unit Stat Genet, Kyoto 6068507, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Dept Med Solna, Rheumatol Unit, SE-17176 Stockholm, Sweden; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Raychaudhuri, Soumya] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Res Unit, NIHR Manchester Musculoskeletal Biomed, Manchester M13 9NT, Lancs, England; [Stranger, Barbara E.] Univ Chicago, Med Genet Sect, Chicago, IL 60637 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Takahashi, Atsushi] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Matsuda, Fumihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST Program, Kawaguchi, Saitama 3320012, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Unite U852, INSERM, Kyoto 6068507, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1130033, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Monash University; Harvard University; Brigham & Women's Hospital; Kyoto University; Kyoto University; Tokyo Women's Medical University; RIKEN; Roche Holding; Genentech; Vanderbilt University; Vanderbilt University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Albany Medical College; Columbia University; NewYork-Presbyterian Hospital; Naval Medical University; Naval Medical University; University of Queensland; University of Queensland; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Groningen; University of Tartu; Harvard University; Boston Children's Hospital; Beijing Jiaotong University; Icahn School of Medicine at Mount Sinai; Radboud University Nijmegen; Radboud University Nijmegen; University of Twente; Medical Spectrum Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Alabama System; University of Alabama Birmingham; University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline; University of Cambridge; Hanyang University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Clinico San Carlos; Umea University; Umea University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Boston University; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; McGill University; University of Manchester; University of Manchester; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; Kyoto University; RIKEN; Karolinska Institutet; Northwell Health; University of Manchester; University of Chicago; University of Chicago; RIKEN; Japan Science & Technology Agency (JST); Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; University of Tokyo	Plenge, RM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	yokada.brc@tmd.ac.jp; robert.plenge@merck.com	Raj, Towfique/ABD-7620-2021; guchelaar, henk-jan/AAP-1381-2021; Yang, Jian/A-5852-2010; Suzuki, Akari/N-5389-2015; Deloukas, Panos/B-2922-2013; Denny, Josh/AAL-3359-2021; Martin, Javier/B-8141-2008; Kochi, Yuta/P-4487-2018; Martín, María/HDL-9512-2022; Martín, Javier/AAV-5209-2021; Brown, Matthew A/E-5749-2010; Rodriguez-Rodriguez, Luis/H-5880-2013; Kubo, Michiaki/N-7947-2015; Zhou, Xuezhong/AAZ-5025-2021; eyre, stephen/K-3776-2017; Wu, Di/AAB-7566-2021; Franke, Lude/P-7036-2016; de Bakker, Paul IW/B-8730-2009; van Riel, P.L.C.M./H-8082-2014; Yamamoto, Kazuhiko/N-5096-2015; González-Gay, Miguel A./B-2306-2008; Wijmenga, Cisca/D-2173-2009; Zhernakova, Alexandra/ABA-9372-2020; Xu, Huji/AAB-2902-2021; Visscher, Peter/ABB-6151-2020; Coenen, Marieke/A-2159-2010; Kamatani, Yoichiro/N-5513-2015; ZHOU, XUE/F-6129-2013; Worthington, Jane/M-9770-2014; Siminovitch, Katherine/K-1475-2013; Bae, Sang-Cheol/P-2051-2015; Zhou, Xuezhong/I-4101-2014; Barton, Anne/N-2053-2014; de Vries, Niek/J-9348-2013; Padyukov, Leonid/A-4890-2009	Yang, Jian/0000-0003-2001-2474; Deloukas, Panos/0000-0001-9251-070X; Denny, Josh/0000-0002-3049-7332; Martin, Javier/0000-0002-2202-0622; Brown, Matthew A/0000-0003-0538-8211; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; eyre, stephen/0000-0002-1251-6974; Wu, Di/0000-0001-8331-2357; Franke, Lude/0000-0002-5159-8802; de Bakker, Paul IW/0000-0001-7735-7858; González-Gay, Miguel A./0000-0002-7924-7406; Xu, Huji/0000-0002-8588-118X; Visscher, Peter/0000-0002-2143-8760; Coenen, Marieke/0000-0001-8796-2031; Worthington, Jane/0000-0003-0544-042X; Moreland, Larry/0000-0003-4483-0359; Raychaudhuri, Soumya/0000-0002-1901-8265; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Zhou, Xuezhong/0000-0002-4713-3594; Toes, Rene/0000-0002-9618-6414; Takahashi, Meiko/0000-0002-8344-5472; Guchelaar, Henk-Jan/0000-0002-7085-1383; Stranger, Barbara/0000-0001-9021-7331; Dieude, Philippe/0000-0002-4814-0307; Alfredsson, Lars/0000-0003-1688-6697; Zhernakova, Alexandra/0000-0002-4574-0841; manoharan, arun prasad/0000-0002-7030-7353; Barton, Anne/0000-0003-3316-2527; Yamada, Ryo/0000-0002-1587-630X; Bae, Sang-Cheol/0000-0003-4658-1093; de Vries, Niek/0000-0002-6257-8604; DIOGO, DOROTHEE/0000-0003-2913-5913; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	National Institutes of Health (NIH) [R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; Burroughs Wellcome Fund; Japan Society of the Promotion of Science; Australian National Health and Medical Research Council [1036541]; Netherlands Organization for Scientific Research; Dutch Reumafonds [11-1-101]; Rosalind Franklin Fellowship, University of Groningen; Korea Healthcare technology R&D project, Ministry for Health and Welfare [A121983]; RETICS program; RIER; Instituto de Salud Carlos III, Health Ministry [RD12/0009]; Medical Biobank of Northern Sweden; NIH (NIAMS) [R01-AR056768, R01-AR056291, R01-AR065944, P60 AR047785, R21 AR056042]; European Research Council; NIH [R01AR063759-01A1, K08-KAR055688A]; National Health and Medical Research Foundation Senior Principal Research Fellowship; Queensland State Government Premier's Fellowship; China Ministry of Science and Technology [2011CB946100]; National Natural Science Foundation of China [30972339, 81020108029, 81273283]; Science and Technology Commission of Shanghai Municipality [08XD1400400, 11410701600, 10JC1418400]; Canada Research Chair; Sherman Family Chair in Genomics Medicine; Canadian Institutes for Health Research [79321]; Ontario Research Fund [05-075]; Health and Labour Sciences Research Grants; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; BE THE CURE (BTCure) project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056042, R01AR057108, R01AR059648, K08AR060257, R01AR065944, P60AR047785, R01AR063759, R01AR056291, K24AR052403, R01AR056768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007450] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23229007, 221S0001, 24390360, 22133008] Funding Source: KAKEN	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Reumafonds; Rosalind Franklin Fellowship, University of Groningen; Korea Healthcare technology R&D project, Ministry for Health and Welfare; RETICS program; RIER; Instituto de Salud Carlos III, Health Ministry; Medical Biobank of Northern Sweden; NIH (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Foundation Senior Principal Research Fellowship; Queensland State Government Premier's Fellowship; China Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Sherman Family Chair in Genomics Medicine; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BE THE CURE (BTCure) project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	R.M.P. is supported by National Institutes of Health (NIH) grants R01-AR057108, R01-AR056768, U01-GM092691 and R01-AR059648, and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. Y.O. is supported by a grant from the Japan Society of the Promotion of Science. D. W. is supported by a grant from the Australian National Health and Medical Research Council (1036541). G. T. is supported by the Rubicon grant from the Netherlands Organization for Scientific Research. A.Z. is supported by a grant from the Dutch Reumafonds (11-1-101) and from the Rosalind Franklin Fellowship, University of Groningen. S.-C. B., S.-Y.B. and H.-S.L. are supported by the Korea Healthcare technology R&D project, Ministry for Health and Welfare (A121983). J.M., M.A.G.-G. and L.R.-R. are funded by the RETICS program, RIER, RD12/0009 from the Instituto de Salud Carlos III, Health Ministry. S.R.-D. and L.A.'s work is supported by the Medical Biobank of Northern Sweden. H. K. C. is supported by NIH (NIAMS) grants R01-AR056291, R01-AR065944, R01-AR056768, P60 AR047785 and R21 AR056042. L. P. and L. K. are supported by a senior investigator grant from the European Research Council. S. R. is supported by NIH grants R01AR063759-01A1 and K08-KAR055688A. P. M. V. is a National Health and Medical Research Council Senior Principal Research Fellow. M. A. B. is funded by the National Health and Medical Research Foundation Senior Principal Research Fellowship, and a Queensland State Government Premier's Fellowship. H. X. is funded by the China Ministry of Science and Technology (973 program grant 2011CB946100), the National Natural Science Foundation of China (grants 30972339, 81020108029 and 81273283), and the Science and Technology Commission of Shanghai Municipality (grants 08XD1400400, 11410701600 and 10JC1418400). K. A. S. is supported by a Canada Research Chair, The Sherman Family Chair in Genomics Medicine, Canadian Institutes for Health Research grant 79321 and Ontario Research Fund grant 05-075. S. M. is supported by Health and Labour Sciences Research Grants. The BioBank Japan Project is supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. This study is supported by the BE THE CURE (BTCure) project. We thank K. Akari, K. Tokunaga and N. Nishida for supporting the study.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Parvaneh N, 2013, J ALLERGY CLIN IMMUN, V131, P314, DOI 10.1016/j.jaci.2012.11.051; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sekine C, 2008, J IMMUNOL, V180, P1954, DOI 10.4049/jimmunol.180.3.1954; Smolen JS, 2013, ANN RHEUM DIS, V72, P482, DOI 10.1136/annrheumdis-2012-202469; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	30	1371	1401	12	457	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					376	+		10.1038/nature12873	http://dx.doi.org/10.1038/nature12873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24390342	Green Accepted, Green Submitted			2022-12-28	WOS:000331477800043
J	Tobias, JA; Cornwallis, CK; Derryberry, EP; Claramunt, S; Brumfield, RT; Seddon, N				Tobias, Joseph A.; Cornwallis, Charlie K.; Derryberry, Elizabeth P.; Claramunt, Santiago; Brumfield, Robb T.; Seddon, Nathalie			Species coexistence and the dynamics of phenotypic evolution in adaptive radiation	NATURE			English	Article							CHARACTER DISPLACEMENT; CONTINENTAL RADIATION; CONVERGENT EVOLUTION; COMPETITION; DRIVE; SONG; RECOGNITION; COEVOLUTION; DIVERGENCE	Interactions between species can promote evolutionary divergence of ecological traits and social signals(1,2), a process widely assumed to generate species differences in adaptive radiation(3-5). However, an alternative view is that lineages typically interact when relatively old(6), by which time selection for divergence is weak(7,8) and potentially exceeded by convergent selection acting on traits mediating interspecific competition(9). Few studies have tested these contrasting predictions across large radiations, or by controlling for evolutionary time. Thus the role of species interactions in driving broad-scale patterns of trait divergence is unclear(10). Here we use phylogenetic estimates of divergence times to show that increased trait differences among coexisting lineages of ovenbirds (Furnariidae) are explained by their greater evolutionary age in relation to non-interacting lineages, and that-when these temporal biases are accounted for-the only significant effect of coexistence is convergence in a social signal (song). Our results conflict with the conventional view that coexistence promotes trait divergence among co-occurring organisms at macroevolutionary scales, and instead provide evidence that species interactions can drive phenotypic convergence across entire radiations, a pattern generally concealed by biases in age.	[Tobias, Joseph A.; Cornwallis, Charlie K.; Seddon, Nathalie] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Cornwallis, Charlie K.] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Derryberry, Elizabeth P.; Claramunt, Santiago; Brumfield, Robb T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Derryberry, Elizabeth P.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Claramunt, Santiago; Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Claramunt, Santiago] Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA	University of Oxford; Lund University; Louisiana State University System; Louisiana State University; Tulane University; Louisiana State University System; Louisiana State University; American Museum of Natural History (AMNH)	Tobias, JA (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	joseph.tobias@zoo.ox.ac.uk	Claramunt Tammaro, Santiago Javier/H-5483-2019; Brumfield, Robb T/K-6108-2015	Claramunt Tammaro, Santiago Javier/0000-0002-8926-5974; Brumfield, Robb T/0000-0003-2307-0688; Seddon, Nathalie/0000-0002-1880-6104; Tobias, Joseph/0000-0003-2429-6179; Derryberry, Elizabeth/0000-0002-8248-9748	John Fell Fund; Browne Fellowship, Queen's College, Oxford; Vetenskapsradet; National Science Foundation; Royal Society	John Fell Fund; Browne Fellowship, Queen's College, Oxford; Vetenskapsradet(Swedish Research Council); National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London)	We thank G. Grether, J. Hadfield, S. Nakagawa, A. Phillimore, A. Pigot, R. Ricklefs, G. Thomas and S. West for comments and discussion. We are also indebted to the many individuals who collected specimens, tissue samples and sound recordings, and to numerous institutions (particularly the Macaulay Library, Cornell University) for granting access to this material. Complete acknowledgements and data sets are provided in the Supplementary Information. This research was supported by the John Fell Fund (to J. A. T.), the Browne Fellowship, Queen's College, Oxford, and Vetenskapsradet (to C. K. C.), the National Science Foundation (to R. T. B.) and the Royal Society (to N.S.).	BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; CHESSER RT, 1994, EVOLUTION, V48, P490, DOI 10.1111/j.1558-5646.1994.tb01326.x; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Darwin C., 1877, ORIGIN SPECIES; Davies TJ, 2007, ECOL LETT, V10, P146, DOI 10.1111/j.1461-0248.2006.01005.x; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Derryberry EP, 2011, EVOLUTION, V65, P2973, DOI 10.1111/j.1558-5646.2011.01374.x; Derryberry EP, 2012, EVOLUTION, V66, P2784, DOI 10.1111/j.1558-5646.2012.01642.x; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Gilmour AR, 2009, ASREML USER GUIDE RE; Grant BR, 2010, P NATL ACAD SCI USA, V107, P20156, DOI 10.1073/pnas.1015115107; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grether GF, 2009, BIOL REV, V84, P617, DOI 10.1111/j.1469-185X.2009.00089.x; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Huntley JW, 2008, PALEOBIOLOGY, V34, P378, DOI 10.1666/07058.1; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Laiolo P, 2012, J ANIM ECOL, V81, P594, DOI 10.1111/j.1365-2656.2011.01946.x; Lynch J.D., 1989, P527; Monroe MJ, 2012, J EVOLUTION BIOL, V25, P2341, DOI 10.1111/j.1420-9101.2012.02609.x; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfennig DW, 2010, AM NAT, V176, pS26, DOI 10.1086/657056; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Pinheiro J., 2013, PACKAGE NLME LINEAR, V3, P1; Price TD, 2010, PHILOS T R SOC B, V365, P1749, DOI 10.1098/rstb.2009.0269; Reznick DN, 2009, NATURE, V457, P837, DOI 10.1038/nature07894; Ridgely R. S., 2005, DIGITAL DISTRIBUTION, V2.1; Rundell RJ, 2009, TRENDS ECOL EVOL, V24, P394, DOI 10.1016/j.tree.2009.02.007; Saetre GP, 1997, NATURE, V387, P589; SCHOENER TW, 1965, EVOLUTION, V19, P189, DOI 10.2307/2406374; Seddon N, 2005, EVOLUTION, V59, P200; Seddon N, 2010, P ROY SOC B-BIOL SCI, V277, P2475, DOI 10.1098/rspb.2010.0210; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Tobias JA, 2010, EVOLUTION, V64, P2820, DOI 10.1111/j.1558-5646.2010.01067.x; Tobias JA, 2009, EVOLUTION, V63, P3168, DOI 10.1111/j.1558-5646.2009.00795.x; Weir JT, 2012, EVOLUTION, V66, P2773, DOI 10.1111/j.1558-5646.2012.01635.x; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910	40	139	140	3	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					359	+		10.1038/nature12874	http://dx.doi.org/10.1038/nature12874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24362572	Green Published			2022-12-28	WOS:000331477800039
J	Weintraub, ES; Baggs, J; Duffy, J; Vellozzi, C; Belongia, EA; Irving, S; Klein, NP; Glanz, JM; Jacobsen, SJ; Naleway, A; Jackson, LA; DeStefano, F				Weintraub, Eric S.; Baggs, James; Duffy, Jonathan; Vellozzi, Claudia; Belongia, Edward A.; Irving, Stephanie; Klein, Nicola P.; Glanz, Jason M.; Jacobsen, Steven J.; Naleway, Allison; Jackson, Lisa A.; DeStefano, Frank			Risk of Intussusception after Monovalent Rotavirus Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE EVENTS; US CHILDREN; SAFETY; PENTAVALENT; SURVEILLANCE; VACCINES; IMMUNIZATION; DATALINK; BENEFITS; EFFICACY	BackgroundAlthough current rotavirus vaccines were not associated with an increased risk of intussusception in large trials before licensure, recent postlicensure data from international settings suggest the possibility of a small increase in risk of intussusception after monovalent rotavirus vaccination. We examined this risk in a population in the United States. MethodsParticipants were infants between the ages of 4 and 34 weeks who were enrolled in six integrated health care organizations in the Vaccine Safety Datalink (VSD) project. We reviewed medical records and visits for intussusception within 7 days after monovalent rotavirus vaccination from April 2008 through March 2013. Using sequential analyses, we then compared the risk of intussusception among children receiving monovalent rotavirus vaccine with historical background rates. We further compared the risk after monovalent rotavirus vaccination with the risk in a concurrent cohort of infants who received the pentavalent rotavirus vaccine. ResultsDuring the study period, 207,955 doses of monovalent rotavirus vaccine (including 115,908 first doses and 92,047 second doses) were administered in the VSD population. We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine. For the two doses combined, the expected number of intussusception cases was 0.72, resulting in a significant relative risk of 8.4. For the pentavalent rotavirus vaccine, 1,301,810 doses were administered during the study period, with 8 observed intussusception cases (7.11 expected), for a nonsignificant relative risk of 1.1. The relative risk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination, as compared with the risk after pentavalent rotavirus vaccination, was 9.4 (95% confidence interval, 1.4 to 103.8). The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 5.3 per 100,000 infants vaccinated. ConclusionsIn this prospective postlicensure study of more than 200,000 doses of monovalent rotavirus vaccine, we observed a significant increase in the rate of intussusception after vaccination, a risk that must be weighed against the benefits of preventing rotavirus-associated illness. (Funded by the Centers for Disease Control and Prevention.) Vaccination has been associated with a decline in rotavirus-associated illness, but concern about intussusception remains. In this CDC report, the monovalent rotavirus vaccine was associated with a slight increase in intussusception risk, as compared with the pentavalent vaccine. The first licensed rotavirus vaccine (RotaShield) was withdrawn from the U.S. market in 1999 because of an increased risk of intussusception.(1) Subsequently, two rotavirus vaccines have been licensed in the United States: RotaTeq (a pentavalent rotavirus vaccine) in 2006 and Rotarix (a monovalent rotavirus vaccine) in 2008.(2),(3) The two vaccines underwent prelicensure clinical trials involving 60,000 to 70,000 infants each, in which no increased risk of intussusception was identified.(4),(5) Postlicensure monitoring in the Vaccine Safety Datalink (VSD) project has not found an increase in the risk of intussusception after pentavalent rotavirus vaccination.(6),(7) At the time of the ...	[Weintraub, Eric S.; Baggs, James; Duffy, Jonathan; Vellozzi, Claudia; DeStefano, Frank] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA 30333 USA; [Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Irving, Stephanie; Naleway, Allison] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Klein, Nicola P.] Kaiser Permanente No Calif, Vaccine Study Ctr, Oakland, CA USA; [Glanz, Jason M.] Kaiser Permanente Colorado, Aurora, CO USA; [Jacobsen, Steven J.] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Jackson, Lisa A.] Grp Hlth Res Inst, Seattle, WA USA	Centers for Disease Control & Prevention - USA; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Weintraub, ES (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, 1600 Clifton Rd NE,MS D26, Atlanta, GA 30333 USA.	eiw8@cdc.gov		Baggs, James/0000-0003-0757-4683; Belongia, Edward/0000-0001-7478-0415; Jacobsen, Steven/0000-0002-8174-8533; Irving, Stephanie/0000-0001-7437-6797; Naleway, Allison/0000-0001-5747-4643	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the Centers for Disease Control and Prevention.	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], INTUSSUSCEPTION RISK; [Anonymous], ADV COMM IMM PRACT M; Baggs J, 2011, PEDIATRICS, V127, pS45, DOI 10.1542/peds.2010-1722H; Belongia EA, 2010, PEDIATR INFECT DIS J, V29, P1, DOI 10.1097/INF.0b013e3181af8605; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Bines JE, 2009, J INFECT DIS, V200, pS282, DOI 10.1086/605051; Carlin JB, 2013, CLIN INFECT DIS, V57, P1427, DOI 10.1093/cid/cit520; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P1007; Cortese MM, 2013, PEDIATRICS, V132, pE25, DOI 10.1542/peds.2012-3804; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Desai R, 2013, PEDIATR INFECT DIS J, V32, P1, DOI 10.1097/INF.0b013e318270362c; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Greene SK, 2011, PHARMACOEPIDEM DR S, V20, P583, DOI 10.1002/pds.2133; Haber P, 2013, PEDIATRICS, V131, P1042, DOI 10.1542/peds.2012-2554; Justice F, 2005, J PAEDIATR CHILD H, V41, P475, DOI 10.1111/j.1440-1754.2005.00686.x; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; Kulldorff M, 2011, SEQUENTIAL ANAL, V30, P58, DOI 10.1080/07474946.2011.539924; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Mullooly J, 1999, AM J EPIDEMIOL, V149, P186; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164; Velazquez FR, 2012, PEDIATR INFECT DIS J, V31, P736, DOI 10.1097/INF.0b013e318253add3; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Shui IM, 2012, JAMA-J AM MED ASSOC, V307, P598, DOI 10.1001/jama.2012.97; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Yih WK, 2011, PEDIATRICS, V127, pS54, DOI 10.1542/peds.2010-1722I	30	147	153	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					513	519		10.1056/NEJMoa1311738	http://dx.doi.org/10.1056/NEJMoa1311738			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24422678				2022-12-28	WOS:000331073500007
J	Otto, R; Ma, JY; Ray, AW; Daluz, JS; Li, J; Guo, H; Continetti, RE				Otto, Rico; Ma, Jianyi; Ray, Amelia W.; Daluz, Jennifer S.; Li, Jun; Guo, Hua; Continetti, Robert E.			Imaging Dynamics on the F + H2O -> HF plus OH Potential Energy Surfaces from Wells to Barriers	SCIENCE			English	Article							TRANSITION-STATE; SCATTERING CALCULATIONS; PHOTODETACHMENT; SPECTROSCOPY; RESONANCES; REACTIVITY; FLUORIDE; COMPLEX; ENERGY; F+H2O	The study of gas-phase reaction dynamics has advanced to a point where four-atom reactions are the proving ground for detailed comparisons between experiment and theory. Here, a combined experimental and theoretical study of the dissociation dynamics of the tetra-atomic FH2O system is presented, providing snapshots of the F + H2O -> HF + OH reaction. Photoelectron-photofragment coincidence measurements of the dissociative photodetachment (DPD) of the F-(H2O) anion revealed various dissociation pathways along different electronic states. A distinct photoelectron spectrum of stable FH-OH complexes was also measured and attributed to long-lived Feshbach resonances. Comparison to full-dimensional quantum calculations confirms the sensitivity of the DPD measurements to the subtle dynamics on the low-lying FH2O potential energy surfaces over a wide range of nuclear configurations and energies.	[Otto, Rico; Ray, Amelia W.; Daluz, Jennifer S.; Continetti, Robert E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ma, Jianyi] Sichuan Univ, Inst Atom & Mol Phys, Chengdu 610065, Sichuan, Peoples R China; [Ma, Jianyi; Li, Jun; Guo, Hua] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	University of California System; University of California San Diego; Sichuan University; University of New Mexico	Guo, H (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	hguo@unm.edu; rcontinetti@ucsd.edu	Guo, H./J-2685-2014; Li, Jun/H-4980-2013; Continetti, Robert E/L-4235-2013	Guo, H./0000-0001-9901-053X; Li, Jun/0000-0003-2392-8322; Continetti, Robert/0000-0002-0685-4459	U.S. Department of Energy [DE-FG03-98ER14879, DE-FG02-05ER15694]; German Academic Exchange Service (DAAD); National Natural Science Foundation of China [21303110]	U.S. Department of Energy(United States Department of Energy (DOE)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the U.S. Department of Energy (DE-FG03-98ER14879 to R. E. C. and DE-FG02-05ER15694 to H. G.). R.O. thanks the German Academic Exchange Service (DAAD) for a postdoctoral research fellowship. J.M. thanks the National Natural Science Foundation of China (21303110) for partial support.	Alagia M, 1996, CHEM PHYS, V207, P389, DOI 10.1016/0301-0104(95)00422-X; BLONDEL C, 1989, PHYS REV A, V40, P3698, DOI 10.1103/PhysRevA.40.3698; Brownsword RA, 1997, CHEM PHYS LETT, V275, P325, DOI 10.1016/S0009-2614(97)00719-7; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; CLARY DC, 1992, J CHEM PHYS, V96, P3656, DOI 10.1063/1.461919; Continetti RE, 2001, ANNU REV PHYS CHEM, V52, P165, DOI 10.1146/annurev.physchem.52.1.165; Deskevich MP, 2004, J CHEM PHYS, V120, P7281, DOI 10.1063/1.1667468; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Garand E, 2008, SCIENCE, V319, P72, DOI 10.1126/science.1150602; Harich SA, 2002, NATURE, V419, P281, DOI 10.1038/nature01068; Ishikawa Y, 2002, CHEM PHYS LETT, V363, P458, DOI 10.1016/S0009-2614(02)01207-1; Johnson CJ, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3641875; Li J, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4791640; Li J, 2013, CHEM SCI, V4, P629, DOI 10.1039/c2sc21457a; Li J, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4748857; Liu S, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3701266; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Neufeld DA, 1997, ASTROPHYS J, V488, pL141, DOI 10.1086/310942; Neumark DM, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2216709; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Ricaud P., 2006, ADV FLUORINE SCI, V1, P1; STEVENS PS, 1989, J PHYS CHEM-US, V93, P4068, DOI 10.1021/j100347a040; Wang XG, 2008, SCIENCE, V322, P573, DOI 10.1126/science.1163195; Weis P, 1999, J AM CHEM SOC, V121, P3531, DOI 10.1021/ja9842161; Xiao CL, 2011, SCIENCE, V333, P440, DOI 10.1126/science.1205770; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Yang X, 2001, J CHEM PHYS, V115, P2889, DOI 10.1063/1.1394758; Ziemkiewicz M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2098648; Ziemkiewicz M, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3194284; Zolot AM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2998524	30	81	82	4	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					396	399		10.1126/science.1247424	http://dx.doi.org/10.1126/science.1247424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24407479				2022-12-28	WOS:000330039300042
J	Schultz, NA; Dehlendorff, C; Jensen, BV; Bjerregaard, JK; Nielsen, KR; Bojesen, SE; Calatayud, D; Nielsen, SE; Yilmaz, M; Hollander, NH; Andersen, KK; Johansen, JS				Schultz, Nicolai A.; Dehlendorff, Christian; Jensen, Benny V.; Bjerregaard, Jon K.; Nielsen, Kaspar R.; Bojesen, Stig E.; Calatayud, Dan; Nielsen, Svend E.; Yilmaz, Mette; Hollander, Niels Henrik; Andersen, Klaus K.; Johansen, Julia S.			MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADENOCARCINOMA; DIAGNOSIS; GEMCITABINE; PROGNOSIS; APOPTOSIS; PROFILES; PATTERNS; MIR-34A; MARKER	IMPORTANCE Biomarkers for the early diagnosis of patients with pancreatic cancer are needed to improve prognosis. OBJECTIVES To describe differences in microRNA expression in whole blood between patients with pancreatic cancer, chronic pancreatitis, and healthy participants and to identify panels of microRNAs for use in diagnosis of pancreatic cancer compared with the cancer antigen 19-9 (CA19-9). DESIGN, SETTING, AND PARTICIPANTS A case-control study that included 409 patients with pancreatic cancer and 25 with chronic pancreatitis who had been included prospectively in the Danish BIOPAC (Biomarkers in Patients with Pancreatic Cancer) study (July 2008-October 2012) plus 312 blood donors as healthy participants. The microRNA expressions in pretreatment whole blood RNA samples were collected and analyzed in 3 randomly determined subcohorts: discovery cohort (143 patients with pancreatic cancer, 18 patients with chronic pancreatitis, and 69 healthy participants), training cohort (180 patients with pancreatic cancer, 1 patient with chronic pancreatitis, and 199 healthy participants), and validation cohort (86 patients with pancreatic cancer, 7 patients with chronic pancreatitis, and 44 healthy participants); 754 microRNAs were screened in the discovery cohort and 38 microRNAs in the training cohort and 13 microRNAs in the validation cohort. MAIN OUTCOMES AND MEASURES Identification of microRNA panels (classifiers) for diagnosing pancreatic cancer. RESULTS The discovery cohort demonstrated that 38 microRNAs in whole blood were significantly dysregulated in patients with pancreatic cancer compared with controls. These microRNAs were tested in the training cohort and 2 diagnostic panels were constructed comprising 4 microRNAs in index I (miR-145, miR-150, miR-223, miR-636) and 10 in index II (miR-26b, miR-34a, miR-122, miR-126*, miR-145, miR-150, miR-223, miR-505, miR-636, miR-885.5p). The test characteristics for the training cohort were index I area under the curve (AUC) of 0.86 (95% CI, 0.82-0.90), sensitivity of 0.85 (95% CI, 0.79-0.90), and specificity of 0.64 (95% CI, 0.57-0.71); index II AUC of 0.93 (95% CI, 0.90-0.96), sensitivity of 0.85 (95% CI, 0.79-0.90), and specificity of 0.85 (95% CI, 0.80-0.85); and CA19-9 AUC of 0.90 (95% CI, 0.87-0.94), sensitivity of 0.86 (95% CI, 0.80-0.90), and specificity of 0.99 (95% CI, 0.96-1.00). Performances were strengthened in the validation cohort by combining panels and CA19-9 (index I AUC of 0.94 [95% CI, 0.90-0.98] and index II AUC of 0.93 [95% CI, 0.89-0.97]). Compared with CA19-9 alone, the AUC for the combination of index I and CA19-9 was significantly higher (P = .01). The performance of the panels in patients with stage IA-IIB pancreatic cancer was index I AUC of 0.80 (95% CI, 0.73-0.87); index I and CA19-9 AUC of 0.83 (95% CI, 0.76-0.90); index II AUC of 0.91 (95% CI, 0.87-0.94); and index II and CA19-9 AUC of 0.91 (95% CI, 0.86-0.95). CONCLUSIONS AND RELEVANCE This study identified 2 diagnostic panels based on microRNA expression in whole blood with the potential to distinguish patients with pancreatic cancer from healthy controls. Further research is necessary to understand whether these have clinical implications for early detection of pancreatic cancer and how much this information adds to serum CA19-9.	[Schultz, Nicolai A.; Jensen, Benny V.; Johansen, Julia S.] Copenhagen Univ Hosp, Herlev Hosp, Dept Oncol, Copenhagen, Denmark; [Schultz, Nicolai A.; Johansen, Julia S.] Copenhagen Univ Hosp, Herlev Hosp, Dept Med, Copenhagen, Denmark; [Schultz, Nicolai A.] Copenhagen Univ Hosp, Herlev Hosp, Dept Gastroenterol, Copenhagen, Denmark; [Schultz, Nicolai A.; Calatayud, Dan] Copenhagen Univ Hosp, Rigshosp, Dept Surg Gastroenterol & Transplantat, Copenhagen, Denmark; [Dehlendorff, Christian; Andersen, Klaus K.] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Bjerregaard, Jon K.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Nielsen, Kaspar R.] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Nielsen, Svend E.] Cent Hosp Hillerod, Dept Oncol, Hillerod, Denmark; [Yilmaz, Mette] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark; [Hollander, Niels Henrik] Naestved Hosp, Dept Oncol, Naestved, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Danish Cancer Society; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; Aalborg University Hospital; Naestved Hospital	Johansen, JS (corresponding author), Herlev Hosp, Dept Oncol, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	julia.johansen@post3.tele.dk	Dehlendorff, Christian/AAG-9421-2019	Dehlendorff, Christian/0000-0001-6161-4565; Bojesen, Stig/0000-0002-4061-4133; Bjerregaard, Jon Kroll/0000-0003-1088-7242	Research Council at Herlev Hospital; Joint Proof-of-Concept Fund (Ministry of Science, Technology and Innovation, Denmark); Region Hovedstadens forsknings fond til Sundhedsforskning; Danish Cancer Society; Aase og Ejnar Danielsens Fond; Prosektor Axel Soeborg Ohlsen og Else Soeborg Ohlsen Mindelegat	Research Council at Herlev Hospital; Joint Proof-of-Concept Fund (Ministry of Science, Technology and Innovation, Denmark); Region Hovedstadens forsknings fond til Sundhedsforskning; Danish Cancer Society(Danish Cancer Society); Aase og Ejnar Danielsens Fond; Prosektor Axel Soeborg Ohlsen og Else Soeborg Ohlsen Mindelegat	The study was supported by grants from the Research Council at Herlev Hospital, the Joint Proof-of-Concept Fund (Ministry of Science, Technology and Innovation, Denmark), Region Hovedstadens forsknings fond til Sundhedsforskning, the Danish Cancer Society, Aase og Ejnar Danielsens Fond, and Prosektor Axel Soeborg Ohlsen og Else Soeborg Ohlsen Mindelegat.	Attia J, 2009, JAMA-J AM MED ASSOC, V301, P304, DOI 10.1001/jama.2008.993; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Bauer AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034151; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Eichelser C, 2013, CLIN CHEM, V59, P1489, DOI 10.1373/clinchem.2013.205161; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jang JY, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.1; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kong XY, 2010, WORLD J GASTROENTERO, V16, P4599, DOI 10.3748/wjg.v16.i36.4599; Liu JQ, 2012, INT J CANCER, V131, P683, DOI 10.1002/ijc.26422; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; McShane LM, 2012, J CLIN ONCOL, V30, P4223, DOI 10.1200/JCO.2012.42.6858; miRbase, MIRBASE MICRORNA DAT; Nugent M, 2012, J SURG ONCOL, V106, P947, DOI 10.1002/jso.23174; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Schultz NA, 2012, MODERN PATHOL, V25, P1609, DOI 10.1038/modpathol.2012.122; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Szafranska AE, 2008, CLIN CHEM, V54, P1716, DOI 10.1373/clinchem.2008.109603; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28	40	310	333	3	105	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					392	404		10.1001/jama.2013.284664	http://dx.doi.org/10.1001/jama.2013.284664			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449318				2022-12-28	WOS:000329939300025
J	Shirley, K; McNicholl, FP				Shirley, Kate; McNicholl, Feargal P.			Blurred vision and epistaxis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA		[Shirley, Kate] Belfast Hlth & Social Care Trust, Dept Ophthalmol, Belfast BT12 6BA, Antrim, North Ireland; [McNicholl, Feargal P.] Altnagelvin Hosp, Dept Haematol, Altnagelvin, Londonderry, North Ireland		Shirley, K (corresponding author), Belfast Hlth & Social Care Trust, Dept Ophthalmol, Belfast BT12 6BA, Antrim, North Ireland.	kshirley01@qub.ac.uk						Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Cancer Research UK, 2013, TRIAL LOOK IM DAS NE; McCormack PL, 2011, DRUGS, V71, P1771, DOI 10.2165/11207580-000000000-00000; OHKOSHI K, 1992, BRIT J OPHTHALMOL, V76, P651, DOI 10.1136/bjo.76.11.651; Reddy SC, 2003, OPHTHALMOLOGICA, V217, P441, DOI 10.1159/000073077; Stein B, 2010, CLIN THER, V32, P804, DOI 10.1016/j.clinthera.2010.05.003; Swerdlow SH, 2008, WHO CLASSIFICATION T; [No title captured]	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2014	348								g91	10.1136/bmj.g91	http://dx.doi.org/10.1136/bmj.g91			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AH	24445968				2022-12-28	WOS:000330295700013
J	Berndt, C; Feseker, T; Treude, T; Krastel, S; Liebetrau, V; Niemann, H; Bertics, VJ; Dumke, I; Dunnbier, K; Ferre, B; Graves, C; Gross, F; Hissmann, K; Huhnerbach, V; Krause, S; Lieser, K; Schauer, J; Steinle, L				Berndt, C.; Feseker, T.; Treude, T.; Krastel, S.; Liebetrau, V.; Niemann, H.; Bertics, V. J.; Dumke, I.; Duennbier, K.; Ferre, B.; Graves, C.; Gross, F.; Hissmann, K.; Huehnerbach, V.; Krause, S.; Lieser, K.; Schauer, J.; Steinle, L.			Temporal Constraints on Hydrate-Controlled Methane Seepage off Svalbard	SCIENCE			English	Article							CONTINENTAL-MARGIN; FRAM STRAIT; NW-SVALBARD; RELEASE; CLIMATE; SITES	Methane hydrate is an icelike substance that is stable at high pressure and low temperature in continental margin sediments. Since the discovery of a large number of gas flares at the landward termination of the gas hydrate stability zone off Svalbard, there has been concern that warming bottom waters have started to dissociate large amounts of gas hydrate and that the resulting methane release may possibly accelerate global warming. Here, we corroborate that hydrates play a role in the observed seepage of gas, but we present evidence that seepage off Svalbard has been ongoing for at least 3000 years and that seasonal fluctuations of 1 degrees to 2 degrees C in the bottom-water temperature cause periodic gas hydrate formation and dissociation, which focus seepage at the observed sites.	[Berndt, C.; Treude, T.; Krastel, S.; Liebetrau, V.; Bertics, V. J.; Dumke, I.; Duennbier, K.; Gross, F.; Hissmann, K.; Krause, S.; Lieser, K.; Schauer, J.] GEOMAR Helmholtz Ctr Ocean Res Kiel, D-24148 Kiel, Germany; [Feseker, T.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Feseker, T.] Univ Bremen, Fac Geosci, D-28359 Bremen, Germany; [Niemann, H.; Steinle, L.] Univ Basel, Dept Environm Sci, CH-4056 Basel, Switzerland; [Ferre, B.] Univ Tromso, Dept Geol, CAGE Ctr Arctic Gas Hydrate Environm & Climate, N-9037 Tromso, Norway; [Graves, C.; Huehnerbach, V.] Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Bremen; University of Bremen; University of Basel; UiT The Arctic University of Tromso; NERC National Oceanography Centre	Berndt, C (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, D-24148 Kiel, Germany.	cberndt@geomar.de	Treude, Tina/AAD-5817-2020; Liebetrau, Volker/AAF-9556-2021; Niemann, Helge/C-6630-2014; Berndt, Christian/GVS-3279-2022; Krastel, Sebastian/C-2001-2017	Niemann, Helge/0000-0002-3468-8304; Krastel, Sebastian/0000-0002-5899-9748; Treude, Tina/0000-0001-6366-286X; Graves, Carolyn/0000-0003-3050-7702; Gross, Felix/0000-0002-0749-829X; Berndt, Christian/0000-0001-5055-0180; Ferre, Benedicte/0000-0003-1646-9287	German Research Foundation (DFG); Swiss National Science Foundation; Cluster of Excellence "The Future Ocean"; ESONET project (European Seas Observatory NETwork); PERGAMON project (European Cooperation in Science and Technology); Alexander von Humboldt Foundation; NERC [noc010011, NE/D005825/1, NE/D005728/1, NE/D005779/1] Funding Source: UKRI; Natural Environment Research Council [noc010011, NE/D005779/1, NE/D005728/1, NE/D005825/1] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cluster of Excellence "The Future Ocean"; ESONET project (European Seas Observatory NETwork); PERGAMON project (European Cooperation in Science and Technology); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This manuscript is dedicated to the memory of our beloved colleague and friend Victoria Bertics. We are grateful to K. Bergmann and the officers and crew of R/V Maria S. Merian for their help at sea. The German Research Foundation (DFG), the Swiss National Science Foundation, and the Cluster of Excellence "The Future Ocean" supported the project financially. Further support came from the ESONET project (European Seas Observatory NETwork), the PERGAMON project (European Cooperation in Science and Technology), and the Alexander von Humboldt Foundation. Figure 1 was drafted by using Generic Mapping Tools (22). Supplementary data are available at http://dx.doi.org/10.1594/PANGAEA.824947.	Archer D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000854; Biastoch A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047222; Carcione JM, 2005, GEOPHYS PROSPECT, V53, P803, DOI 10.1111/j.1365-2478.2005.00502.x; Chabert A, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008211; Dickens GR, 2011, CLIM PAST, V7, P831, DOI 10.5194/cp-7-831-2011; EIKEN O, 1993, SEDIMENT GEOL, V82, P15, DOI 10.1016/0037-0738(93)90110-Q; Ferre B, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008300; Fisher RE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049319; Knies J, 2002, MAR PETROL GEOL, V19, P811, DOI 10.1016/S0264-8172(02)00090-9; Luff R, 2004, EARTH PLANET SC LETT, V221, P337, DOI 10.1016/S0012-821X(04)00107-4; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Rajan A, 2012, MAR PETROL GEOL, V32, P36, DOI 10.1016/j.marpetgeo.2011.12.008; Reagan MT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041332; Sarkar S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009126; Solheim A, 1996, GLOBAL PLANET CHANGE, V12, P135, DOI 10.1016/0921-8181(95)00016-X; Spielhagen RF, 2011, SCIENCE, V331, P450, DOI 10.1126/science.1197397; Thatcher KE, 2013, J GEOPHYS RES-SOL EA, V118, P22, DOI 10.1029/2012JB009605; VORREN TO, 1989, MAR GEOL, V85, P251, DOI 10.1016/0025-3227(89)90156-4; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Westbrook GK, 2008, MAR PETROL GEOL, V25, P744, DOI 10.1016/j.marpetgeo.2008.02.003; Westbrook GK, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039191; Whiteman G, 2013, NATURE, V499, P401, DOI 10.1038/499401a	22	186	193	19	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					284	287		10.1126/science.1246298	http://dx.doi.org/10.1126/science.1246298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24385604	Green Accepted, Green Submitted			2022-12-28	WOS:000329718600032
J	Bagnall, MW; McLean, DL				Bagnall, Martha W.; McLean, David L.			Modular Organization of Axial Microcircuits in Zebrafish	SCIENCE			English	Article							INTERNEURONS; RECRUITMENT; LOCOMOTION; EVOLUTION; NETWORKS; CIRCUITS; WALKING	Locomotion requires precise control of spinal networks. In tetrapods and bipeds, dynamic regulation of locomotion is simplified by the modular organization of spinal limb circuits, but it is not known whether their predecessors, fish axial circuits, are similarly organized. Here, we demonstrate that the larval zebrafish spinal cord contains distinct, parallel microcircuits for independent control of dorsal and ventral musculature on each side of the body. During normal swimming, dorsal and ventral microcircuits are equally active, but, during postural correction, fish differentially engage these microcircuits to generate torque for self-righting. These findings reveal greater complexity in the axial spinal networks responsible for swimming than previously recognized and suggest an early template of modular organization for more-complex locomotor circuits in later vertebrates.	[Bagnall, Martha W.; McLean, David L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	McLean, DL (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	david-mclean@northwestern.edu		Bagnall, Martha/0000-0003-2102-6165	NIH [K99 DC012536, R01 NS067299]; Esther A. and Joseph Klingenstein Fund; Searle Scholars Program; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Esther A. and Joseph Klingenstein Fund; Searle Scholars Program; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to E. Cadoff and S. Kishore for generating DNA constructs; E. Cadoff for behavioral experiments; and the McLean lab, E. B. Han, G. B. Edgerton, J. Fetcho, M. Scanziani, M. E. Hale, and M. A. MacIver for feedback on the manuscript. rock solo fish were a gift from T. Nicolson; the CatCh construct was a gift from E. Bamberg. Funding for these experiments came from NIH grants K99 DC012536 (M. W. B.) and R01 NS067299 (D. L. M.) Additional support was provided by the Esther A. and Joseph Klingenstein Fund, the Searle Scholars Program, and the Alfred P. Sloan Foundation (D. L. M.). The authors declare no competing financial interests.	Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Buschges A, 2012, CURR OPIN NEUROBIOL, V22, P602, DOI 10.1016/j.conb.2012.02.003; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Deliagina TG, 2012, CURR OPIN NEUROBIOL, V22, P646, DOI 10.1016/j.conb.2012.03.002; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GRILLNER S, 1975, PHYSIOL REV, V55, P247, DOI 10.1104/pp.55.2.247; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Hagglund M, 2013, P NATL ACAD SCI USA, V110, P11589, DOI 10.1073/pnas.1304365110; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; King HM, 2011, P NATL ACAD SCI USA, V108, P21146, DOI 10.1073/pnas.1118669109; Kohashi T, 2012, J NEUROSCI, V32, P5810, DOI 10.1523/JNEUROSCI.6169-11.2012; Kozlov A, 2009, P NATL ACAD SCI USA, V106, P20027, DOI 10.1073/pnas.0906722106; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Menelaou E, 2012, J NEUROSCI, V32, P10925, DOI 10.1523/JNEUROSCI.1809-12.2012; Miri A, 2013, NEURON, V80, P827, DOI 10.1016/j.neuron.2013.10.049; Mo W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-110; Riley BB, 2000, J NEUROBIOL, V43, P329, DOI 10.1002/1097-4695(20000615)43:4<329::AID-NEU2>3.3.CO;2-8; Roberts A, 2008, J COMP PHYSIOL A, V194, P185, DOI 10.1007/s00359-007-0273-3; Roberts A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00016; ROVAINEN CM, 1979, J NEUROPHYSIOL, V42, P745, DOI 10.1152/jn.1979.42.3.745; Schilling N, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-4; ULLEN F, 1995, J EXP BIOL, V198, P665; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zelenin PV, 2007, J NEUROSCI, V27, P1024, DOI 10.1523/JNEUROSCI.4925-06.2007	29	60	61	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					197	200		10.1126/science.1245629	http://dx.doi.org/10.1126/science.1245629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408436	Green Accepted			2022-12-28	WOS:000329440800046
J	Helaine, S; Cheverton, AM; Watson, KG; Faure, LM; Matthews, SA; Holden, DW				Helaine, Sophie; Cheverton, Angela M.; Watson, Kathryn G.; Faure, Laura M.; Matthews, Sophie A.; Holden, David W.			Internalization of Salmonella by Macrophages Induces Formation of Nonreplicating Persisters	SCIENCE			English	Article							BACTERIAL PERSISTENCE; REPLICATION; INDUCTION; TOLERANCE; MECHANISM	Many bacterial pathogens cause persistent infections despite repeated antibiotic exposure. Bacterial persisters are antibiotic-tolerant cells, but little is known about their growth status and the signals and pathways leading to their formation in infected tissues. We used fluorescent single-cell analysis to identify Salmonella persisters during infection. These were part of a nonreplicating population formed immediately after uptake by macrophages and were induced by vacuolar acidification and nutritional deprivation, conditions that also induce Salmonella virulence gene expression. The majority of 14 toxin-antitoxin modules contributed to intracellular persister formation. Some persisters resumed intracellular growth after phagocytosis by naive macrophages. Thus, the vacuolar environment induces phenotypic heterogeneity, leading to either bacterial replication or the formation of nonreplicating persisters that could provide a reservoir for relapsing infection.	[Helaine, Sophie; Cheverton, Angela M.; Watson, Kathryn G.; Faure, Laura M.; Matthews, Sophie A.; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London	Helaine, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC, Ctr Mol Bacteriol & Infect, Armstrong Rd, London SW7 2AZ, England.	s.helaine@imperial.ac.uk; d.holden@imperial.ac.uk		Helaine, Sophie/0000-0002-9877-4180; Faure, Laura/0000-0003-0862-0792	Imperial College London Junior Research Fellowship; Wellcome Trust; Medical Research Council (UK); Medical Research Council [MR/K027077/1] Funding Source: researchfish; MRC [MR/K027077/1] Funding Source: UKRI	Imperial College London Junior Research Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Holden laboratory for comments on the manuscript. We are grateful to A. Ryan and I. Glegola-Madejska for technical support. This research was supported by an Imperial College London Junior Research Fellowship to S. H. and grants to D. W. H. from the Wellcome Trust and Medical Research Council (UK). The data are included in the main and the supplementary figures.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Figueira R, 2013, MBIO, V4, DOI 10.1128/mBio.00065-13; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858	21	458	469	14	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					204	208		10.1126/science.1244705	http://dx.doi.org/10.1126/science.1244705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408438	Green Accepted			2022-12-28	WOS:000329440800048
J	Schroeder, SA; Koh, HK				Schroeder, Steven A.; Koh, Howard K.			Tobacco Control 50 Years After the 1964 Surgeon General's Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING		[Schroeder, Steven A.] Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Koh, Howard K.] US Dept Hlth & Human Serv, Washington, DC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schroeder, SA (corresponding author), Univ Calif San Francisco, Smoking Cessat Leadership Ctr, 3333 Calif St,Ste 430, San Francisco, CA 94143 USA.	schroeder@medicine.ucsf.edu						Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; Centers for Disease Control and Prevention, BEST PRACT COMPR TOB; Cole HM, 2014, JAMA-J AM MED ASSOC, V311, P131, DOI 10.1001/jama.2013.280767; Ebbert JO, 2014, JAMA-J AM MED ASSOC, V311, P155, DOI 10.1001/jama.2013.283185; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Fiore MC, 2008, TREATING TOBACCO USE; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P133, DOI 10.1001/jama.2013.284534; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Koh HK, 2012, JAMA-J AM MED ASSOC, V308, P767, DOI 10.1001/jama.2012.9741; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Prochaska JJ, 2011, NEW ENGL J MED, V365, P196, DOI 10.1056/NEJMp1105248; Schroeder SA, 2004, NEW ENGL J MED, V350, P293, DOI 10.1056/NEJMsr031421; Schroeder SA, 2012, JAMA-J AM MED ASSOC, V308, P1586, DOI 10.1001/jama.2012.13858; Schroeder SA, 2010, ANNU REV PUBL HEALTH, V31, P297, DOI 10.1146/annurev.publhealth.012809.103701; Smith AL, 2014, JAMA-J AM MED ASSOC, V311, P137, DOI 10.1001/jama.2013.282618; Williams JM, 2013, JAMA PSYCHIAT, V70, P1261, DOI 10.1001/jamapsychiatry.2013.2182	17	31	35	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					141	143		10.1001/jama.2013.285243	http://dx.doi.org/10.1001/jama.2013.285243			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399551				2022-12-28	WOS:000329339400018
J	Holmes, D				Holmes, David			Jotham Musinguzi: delivering for Africa	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					21	21		10.1016/S0140-6736(13)62721-X	http://dx.doi.org/10.1016/S0140-6736(13)62721-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24388299				2022-12-28	WOS:000329341200015
J	Jat, JL; Paudyal, MP; Gao, HY; Xu, QL; Yousufuddin, M; Devarajan, D; Ess, DH; Kurti, L; Falck, JR				Jat, Jawahar L.; Paudyal, Mahesh P.; Gao, Hongyin; Xu, Qing-Long; Yousufuddin, Muhammed; Devarajan, Deepa; Ess, Daniel H.; Kuerti, Laszlo; Falck, John R.			Direct Stereospecific Synthesis of Unprotected N-H and N-Me Aziridines from Olefins	SCIENCE			English	Article							MECHANISM; AMINATION; EPOXIDES; PROGRESS	Despite the prevalence of the N-H aziridine motif in bioactive natural products and the clear advantages of this unprotected parent structure over N-protected derivatives as a synthetic building block, no practical methods have emerged for direct synthesis of this compound class from unfunctionalized olefins. Here, we present a mild, versatile method for the direct stereospecific conversion of structurally diverse mono-, di-, tri-, and tetrasubstituted olefins to N-H aziridines using O-(2,4-dinitrophenyl)hydroxylamine (DPH) via homogeneous rhodium catalysis with no external oxidants. This method is operationally simple (i.e., one-pot), scalable, and fast at ambient temperature, furnishing N-H aziridines in good-to-excellent yields. Likewise, N-alkyl aziridines are prepared from N-alkylated DPH derivatives. Quantum-mechanical calculations suggest a plausible Rh-nitrene pathway.	[Jat, Jawahar L.; Paudyal, Mahesh P.; Gao, Hongyin; Xu, Qing-Long; Kuerti, Laszlo; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Div Chem, Dallas, TX 75390 USA; [Yousufuddin, Muhammed] Univ Texas Arlington, Ctr Nanostruct Mat, Arlington, TX 76019 USA; [Devarajan, Deepa; Ess, Daniel H.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Arlington; Brigham Young University	Ess, DH (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	dhe@chem.byu.edu; laszlo.kurti@utsouthwestern.edu; j.falck@utsouthwestern.edu	Jat, Jawahar/AAQ-2871-2020	Kurti, Laszlo/0000-0002-3412-5894; Jat, Jawahar Lal/0000-0003-4087-0353	NIH [GM31278, DK38226]; Robert A. Welch Foundation [GL625910, I-1764]; UT Southwestern Endowed Scholars in Biomedical Research Program (W. W. Caruth Jr. Endowed Scholarship in Biomedical Research); American Chemical Society-Petroleum Research Fund [51707-DNI1]; American Cancer Society and Simmons Cancer Center Institutional Research Grant (New Investigator Award in Cancer Research) [ACS-IRG 02-196]; UT Arlington; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); UT Southwestern Endowed Scholars in Biomedical Research Program (W. W. Caruth Jr. Endowed Scholarship in Biomedical Research); American Chemical Society-Petroleum Research Fund(American Chemical Society); American Cancer Society and Simmons Cancer Center Institutional Research Grant (New Investigator Award in Cancer Research); UT Arlington; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.R.F. thanks NIH (GM31278, DK38226) and the Robert A. Welch Foundation (grant GL625910) for funding. L. K. gratefully acknowledges the generous financial support of the UT Southwestern Endowed Scholars in Biomedical Research Program (W. W. Caruth Jr. Endowed Scholarship in Biomedical Research), the Robert A. Welch Foundation (grant I-1764), the American Chemical Society-Petroleum Research Fund (grant 51707-DNI1), and the American Cancer Society and Simmons Cancer Center Institutional Research Grant (New Investigator Award in Cancer Research, ACS-IRG 02-196). D. H. E. thanks Brigham Young University and the Fulton Supercomputing Lab. M.Y. acknowledges a grant from UT Arlington to support the upgrade of the x-ray facility. We also thank K. Schug, M. Kukula, and the Shimadzu Center for Advanced Analytical Chemistry (SCAAC, UT Arlington) for assistance in the full characterization of new compounds. The generous donation of 100 g of aminating agent 1a and 5 g of aminating agent 1b by Corvinus Chemicals, LLC (Dallas, TX), as well as 20 kg of 2,2,2-trifluoroethanol (TFE) by Joyant Pharmaceuticals, Inc. (Dallas, TX), is also gratefully acknowledged. We thank P. S. Baran, J. Du Bois, E. M. Carreira, A. J. Catino, M. P. Doyle, M. Krische, and R. Sarpong for helpful commentary. Metrical parameters for the structure of compound 10ss are available free of charge from the Cambridge Crystallographic Data Centre under reference no. CCDC-959664.	Aggarwal V.K., 2006, AZIRIDINES EPOXIDES, P1; ANDREAE S, 1991, SYNTHESIS-STUTTGART, P327; Beller M., 2004, TRANSITION METALS OR, V2nd, P389; BOTTARO JC, 1980, J CHEM SOC CHEM COMM, P560, DOI 10.1039/c39800000560; Botuha C, 2011, HETEROCYCLES IN NATURAL PRODUCT SYNTHESIS, P3; Cardillo G, 2009, ASYMMETRIC SYNTHESIS, P3; Chawla R, 2013, RSC ADV, V3, P11385, DOI 10.1039/c3ra00175j; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Espino CG, 2004, J AM CHEM SOC, V126, P15378, DOI 10.1021/ja0446294; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Ho CM, 1999, J CHEM SOC DALTON, P2411, DOI 10.1039/a903605i; Ismail FMD, 2009, EUR J MED CHEM, V44, P3373, DOI 10.1016/j.ejmech.2009.05.013; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V2, P607; Jenkins DM, 2012, SYNLETT, P1267, DOI 10.1055/s-0031-1290977; Karila D, 2011, CURR ORG CHEM, V15, P1507, DOI 10.2174/138527211795378128; Koohang A, 1999, TETRAHEDRON, V55, P9669, DOI 10.1016/S0040-4020(99)00522-0; Lebel H, 2005, J AM CHEM SOC, V127, P14198, DOI 10.1021/ja0552850; Lebel H., 2011, CATALYZED CARBON HET, P137; Lebel H, 2007, ORG LETT, V9, P4797, DOI 10.1021/ol702152e; Lin XF, 2007, CHEM-ASIAN J, V2, P1101, DOI 10.1002/asia.200700068; Lorpitthaya R, 2010, CHEM-EUR J, V16, P588, DOI 10.1002/chem.200901727; Lowden PA.S., 2006, AZIRIDINES EPOXIDES, P399, DOI DOI 10.1002/3527607862.CH11; Lu ZJ, 2007, J AM CHEM SOC, V129, P7185, DOI 10.1021/ja069371r; Maestre L, 2013, J AM CHEM SOC, V135, P1338, DOI 10.1021/ja307229e; McCoull W, 2000, SYNTHESIS-STUTTGART, P1347, DOI 10.1055/s-2000-7097; Muchalski H., 2011, SCI SYNTHESIS, V1, P155; Muller P, 2003, CHEM REV, V103, P2905, DOI 10.1021/cr020043t; Njardarson JT, 2013, SYNLETT, V24, P787, DOI 10.1055/s-0032-1318326; Ogawa C., 2012, SCI SYNTHESIS WATER, P579; Osborn HMI, 1997, TETRAHEDRON-ASYMMETR, V8, P1693, DOI 10.1016/S0957-4166(97)00177-8; Pellissier H, 2010, TETRAHEDRON, V66, P1509, DOI 10.1016/j.tet.2009.11.089; Rios R. A., 2012, COMPREHENSIVE CHIRAL, P399; Sweeney JB, 2002, CHEM SOC REV, V31, P247, DOI 10.1039/b006015l; Sweeney J, 2009, EUR J ORG CHEM, V2009, P4911, DOI 10.1002/ejoc.200900211; Thibodeaux CJ, 2012, CHEM REV, V112, P1681, DOI 10.1021/cr200073d; Varszegi C, 2008, ANGEW CHEM INT EDIT, V47, P1477, DOI 10.1002/anie.200704772; VEDEJS E, 1992, TETRAHEDRON LETT, V33, P3261, DOI 10.1016/S0040-4039(00)92062-8; Yamamoto H., 2012, COMPREHENSIVE CHIRAL, P168; Ye S., 2010, HDB CYCLIZATION REAC, V2, P687; Zalatan DN, 2010, TOP CURR CHEM, V292, P347, DOI 10.1007/128_2009_19; Zhu C, 2012, J AM CHEM SOC, V134, P18253, DOI 10.1021/ja309637r	41	194	197	10	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					61	65		10.1126/science.1245727	http://dx.doi.org/10.1126/science.1245727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385626	Green Accepted			2022-12-28	WOS:000329162000047
J	Okuyama, T; Yokoi, S; Abe, H; Isoe, Y; Suehiro, Y; Imada, H; Tanaka, M; Kawasaki, T; Yuba, S; Taniguchi, Y; Kamei, Y; Okubo, K; Shimada, A; Naruse, K; Takeda, H; Oka, Y; Kubo, T; Takeuchi, H				Okuyama, Teruhiro; Yokoi, Saori; Abe, Hideki; Isoe, Yasuko; Suehiro, Yuji; Imada, Haruka; Tanaka, Minoru; Kawasaki, Takashi; Yuba, Shunsuke; Taniguchi, Yoshihito; Kamei, Yasuhiro; Okubo, Kataaki; Shimada, Atsuko; Naruse, Kiyoshi; Takeda, Hiroyuki; Oka, Yoshitaka; Kubo, Takeo; Takeuchi, Hideaki			A Neural Mechanism Underlying Mating Preferences for Familiar Individuals in Medaka Fish	SCIENCE			English	Article							EXPRESSION; INSIGHTS; SYSTEM	Social familiarity affects mating preference among various vertebrates. Here, we show that visual contact of a potential mating partner before mating (visual familiarization) enhances female preference for the familiarized male, but not for an unfamiliarized male, in medaka fish. Terminal-nerve gonadotropin-releasing hormone 3 (TN-GnRH3) neurons, an extrahypothalamic neuromodulatory system, function as a gate for activating mating preferences based on familiarity. Basal levels of TN-GnRH3 neuronal activity suppress female receptivity for any male (default mode). Visual familiarization facilitates TN-GnRH3 neuron activity (preference mode), which correlates with female preference for the familiarized male. GnRH3 peptides, which are synthesized specifically in TN-GnRH3 neurons, are required for the mode-switching via self-facilitation. Our study demonstrates the central neural mechanisms underlying the regulation of medaka female mating preference based on visual social familiarity.	[Okuyama, Teruhiro; Yokoi, Saori; Abe, Hideki; Isoe, Yasuko; Suehiro, Yuji; Imada, Haruka; Shimada, Atsuko; Takeda, Hiroyuki; Oka, Yoshitaka; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Okuyama, Teruhiro; Tanaka, Minoru; Kamei, Yasuhiro; Naruse, Kiyoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Abe, Hideki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Suehiro, Yuji] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Kawasaki, Takashi; Yuba, Shunsuke] Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan; [Taniguchi, Yoshihito] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo 1608582, Japan; [Okubo, Kataaki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 1130033, Japan; [Naruse, Kiyoshi] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Tokyo Women's Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Keio University; University of Tokyo; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Takeuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	takeuchi@biol.s.u-tokyo.ac.jp	Oka, Yoshitaka/G-4952-2014; Takeuchi, Hideaki/W-6739-2018; Yokoi, Saori/GSM-8778-2022; Oka, Yoshitaka/C-9670-2010; Abe, Hideki/AAC-6085-2019; Kamei, Yasuhiro/AAD-9281-2019; Abe, Hideki/D-2791-2011; KUBO, TAKEO/G-4951-2014; TAKEUCHI, HIDEAKI/G-4969-2014	Oka, Yoshitaka/0000-0002-3482-3051; Takeuchi, Hideaki/0000-0001-6610-3895; Oka, Yoshitaka/0000-0002-3482-3051; Abe, Hideki/0000-0002-8931-5767; Kamei, Yasuhiro/0000-0001-6382-1365; Abe, Hideki/0000-0002-8931-5767; TANAKA, MINORU/0000-0001-9100-1487; Kubo, Takeo/0000-0002-5914-5269; Okuyama, Teruhiro/0000-0003-1566-0063; Naruse, Kiyoshi/0000-0001-9185-3495; Okubo, Kataaki/0000-0002-4178-3094	National Institute for Basic Biology Priority Collaborative Research Project [10-104]; Cell Science Research Foundation; Comprehensive Brain Science Network;  [23300115]; Grants-in-Aid for Scientific Research [23300115, 25251034] Funding Source: KAKEN	National Institute for Basic Biology Priority Collaborative Research Project; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Comprehensive Brain Science Network; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the National BioResource Project Medaka for supplying the medaka strains; Y. Wakamatu for the STIII strains; Solution Oriented Research for Science and Technology (SORST) Kondoh Research Team for cxcr4(kazura) and cxcr7(yanagi) mutant strains; Y. Nagahama for Tg(gnrh1:gfp), Tg(gnrh2:gfp), and Tg(gnrh3:gfp); T. Sasado, S. Nonaka, H. Otsuna, S. Kanda, T. Yamamoto, E. Yamamoto, T. Karigo, and I. Hara, for technical assistance; T. Hiraki for NPFF immunostaining; and S. Nakagawa, F. Loosli, S. Furutani-Seiki, H. Kondoh, and F. Gabbiani for discussion. This work was supported by National Institute for Basic Biology Priority Collaborative Research Project (10-104), Grant-in-Aid for Scientific Research (B) 23300115, Grant-in-Aid for a Japan Society for Promotion of Science (JSPS) postdoctoral SPD fellowship (to T. O.), the Cell Science Research Foundation (to T. O.), Comprehensive Brain Science Network (to T. O.), and Grant-in-Aid for JSPS fellows (to S. Yokoi, Y. S., H. I, and Y. I.). There are MTAs associated with cxcr4(kazura), cxcr7(yanagi), d-rR-Tg (olvas: GFP) medaka and ST-III medaka as provided by the National BioResource Project (NBRP).	Abe H, 2000, J NEUROPHYSIOL, V83, P3196, DOI 10.1152/jn.2000.83.5.3196; Abe H, 2011, J REPROD DEVELOP, V57, P665, DOI 10.1262/jrd.11-055E; Akazome Y, 2011, J NEUROENDOCRINOL, V23, P570, DOI 10.1111/j.1365-2826.2011.02142.x; Brown C., 2006, FISH COGNITION AND B; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KYLE AL, 1995, CELL TISSUE RES, V280, P605, DOI 10.1007/BF00318363; Okubo K, 2006, ENDOCRINOLOGY, V147, P1076, DOI 10.1210/en.2005-0468; Ono T., 1957, J FAC SCI HOKKAIDO 6, V13, P197; Palevitch O, 2010, GEN COMP ENDOCR, V165, P262, DOI 10.1016/j.ygcen.2009.07.001; Sasado T, 2008, DEV BIOL, V320, P328, DOI 10.1016/j.ydbio.2008.05.544; Sockman KW, 2009, DEV NEUROBIOL, V69, P339, DOI 10.1002/dneu.20707; Toba Y, 2008, DEV NEUROBIOL, V68, P487, DOI 10.1002/dneu.20594; Verzijden MN, 2012, TRENDS ECOL EVOL, V27, P511, DOI 10.1016/j.tree.2012.05.007; WALTER RO, 1970, ANIM BEHAV, V18, P125, DOI 10.1016/0003-3472(70)90079-5; Wilczynski W, 2010, CURR OPIN NEUROBIOL, V20, P754, DOI 10.1016/j.conb.2010.08.021; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	17	92	94	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					91	94		10.1126/science.1244724	http://dx.doi.org/10.1126/science.1244724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385628				2022-12-28	WOS:000329162000055
J	Jensen, MD; Ryan, DH				Jensen, Michael D.; Ryan, Donna H.			New Obesity Guidelines Promise and Potential	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jensen, Michael D.] Mayo Clin, Rochester, MN 55905 USA; [Ryan, Donna H.] Pennington Biomed Res Ctr, New Orleans, LA USA	Mayo Clinic; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Jensen, MD (corresponding author), Mayo Clin, Endocrine Res Unit, 5-194 Joseph, Rochester, MN 55905 USA.	jensen@mayo.edu		Ryan, Donna/0000-0001-8374-2277				Gibbons GH, 2013, CIRCULATION, V128, P1716, DOI 10.1161/CIRCULATIONAHA.113.005548; Institute of Medicine (IOM), 2011, FINDING WHAT WORKS I; IOM (Institute of Medicine), 2011, CLINICAL PRACTICE GU; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S	7	40	42	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					23	24		10.1001/jama.2013.282546	http://dx.doi.org/10.1001/jama.2013.282546			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24381963				2022-12-28	WOS:000329161400011
J	Wood, JN				Wood, John N.			Results in Analgesia - Darwin 1, Pharma 0	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAIN; CHANNELS; VENOM		UCL, London WC1E 6BT, England	University of London; University College London	Wood, JN (corresponding author), UCL, London WC1E 6BT, England.				BBSRC [BB/F000227/1] Funding Source: UKRI; Arthritis Research UK [20200] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: Medline; Versus Arthritis [20200] Funding Source: Medline; Wellcome Trust [101054] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110	5	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2558	2560		10.1056/NEJMcibr1313354	http://dx.doi.org/10.1056/NEJMcibr1313354			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24369081				2022-12-28	WOS:000328863700016
J	de Wit, J; Seager, S				de Wit, Julien; Seager, Sara			Constraining Exoplanet Mass from Transmission Spectroscopy	SCIENCE			English	Article							GJ 1214B; PLANET; TRANSITS; KEPLER	Determination of an exoplanet's mass is a key to understanding its basic properties, including its potential for supporting life. To date, mass constraints for exoplanets are predominantly based on radial velocity (RV) measurements, which are not suited for planets with low masses, large semimajor axes, or those orbiting faint or active stars. Here, we present a method to extract an exoplanet's mass solely from its transmission spectrum. We find good agreement between the mass retrieved for the hot Jupiter HD 189733b from transmission spectroscopy with that from RV measurements. Our method will be able to retrieve the masses of Earth-sized and super-Earth planets using data from future space telescopes that were initially designed for atmospheric characterization.	[de Wit, Julien; Seager, Sara] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Seager, Sara] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	de Wit, J (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jdewit@mit.edu		/0000-0003-2415-2191	Wallonie-Bruxelles International; Belgian American Educational Foundation; Grayce B. Kerr Fund; Belgian Senate; Duesberg-Baily Thil Lorrain Foundation	Wallonie-Bruxelles International; Belgian American Educational Foundation; Grayce B. Kerr Fund; Belgian Senate; Duesberg-Baily Thil Lorrain Foundation	We are grateful to A. Zsom and V. Stamenkovic for helpful discussions and careful reviews of the manuscript. We also thank S. Messenger, W. Bains, N. Lewis, B.-O. Demory, N. Madhusudhan, A. Triaud, M. Gillon, A. C. Cameron, R. Hu, and B. Benneke. We thank the anonymous referees who helped to improve the paper. J.d.W. thanks G. Cataldo and P. Ferruit for providing information on JWST's Near Infrared Spectrograph (NIRSpec) and A. Belu for further discussions on this matter. J.d.W. acknowledges support from the Wallonie-Bruxelles International, the Belgian American Educational Foundation, and the Grayce B. Kerr Fund in the form of fellowships, as well as from the Belgian Senate in the form of the Odissea Prize. J.d.W. is also particularly grateful to the Duesberg-Baily Thil Lorrain Foundation for its support when he conceived this study.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Barstow JK, 2013, MON NOT R ASTRON SOC, V434, P2616, DOI 10.1093/mnras/stt1204; Barstow JK, 2013, MON NOT R ASTRON SOC, V430, P1188, DOI 10.1093/mnras/sts686; Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Cameron AC, 2010, MON NOT R ASTRON SOC, V407, P507, DOI 10.1111/j.1365-2966.2010.16922.x; Demory BO, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L25; Euler L., 1740, COMMENTARII ACAD SCI, V7, P150; Fabrycky D., 2010, NONKEPLERIAN DYNAMIC, P217; Faigler S, 2011, MON NOT R ASTRON SOC, V415, P3921, DOI 10.1111/j.1365-2966.2011.19011.x; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howe AR, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/176; Kaltenegger L, 2009, ASTROPHYS J, V698, P519, DOI 10.1088/0004-637X/698/1/519; Lecavelier Des Etangs A., 2008, A A, V481, pL83; Madhusudhan N, 2009, ASTROPHYS J, V707, P24, DOI 10.1088/0004-637X/707/1/24; Mislis D, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201116711; Pont F, 2008, MON NOT R ASTRON SOC, V385, P109, DOI 10.1111/j.1365-2966.2008.12852.x; Rogers LA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/59; Schneider J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116713; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Seager S, 2010, PR S ASTROP, P1; Stamenkovic V, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/41; Steffen JH, 2013, MON NOT R ASTRON SOC, V428, P1077, DOI 10.1093/mnras/sts090; Wright JT, 2011, PUBL ASTRON SOC PAC, V123, P412, DOI 10.1086/659427	24	83	83	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1473	1477		10.1126/science.1245450	http://dx.doi.org/10.1126/science.1245450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357312	Green Submitted			2022-12-28	WOS:000328644300049
J	Eyre, O; Thapar, A				Eyre, Olga; Thapar, Anita			Common adolescent mental disorders: transition to adulthood	LANCET			English	Editorial Material							YOUNG ADULTHOOD; BIRTH COHORT; DEPRESSION; ANXIETY; HEALTH; TRAJECTORIES; PREVALENCE; CHILDHOOD; OUTCOMES		[Eyre, Olga; Thapar, Anita] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Child & Adolescent Psychiat Sect, Cardiff CF24 4HQ, S Glam, Wales	Cardiff University	Eyre, O (corresponding author), Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Child & Adolescent Psychiat Sect, Cardiff CF24 4HQ, S Glam, Wales.	eyreo2@cardiff.ac.uk	Thapar, Anita/AAH-5555-2020	Thapar, Anita/0000-0002-3689-737X; Eyre, Olga/0000-0003-1944-9679	Medical Research Council [MR/L010305/1] Funding Source: Medline; The Sir Jules Thorn Charitable Trust [06JTA] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Sir Jules Thorn Charitable Trust		Clark C, 2007, ARCH GEN PSYCHIAT, V64, P668, DOI 10.1001/archpsyc.64.6.668; Copeland W, 2011, J AM ACAD CHILD PSY, V50, P252, DOI 10.1016/j.jaac.2010.12.014; Costello EJ, 2011, J CHILD PSYCHOL PSYC, V52, P1015, DOI 10.1111/j.1469-7610.2011.02446.x; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Fergusson DM, 2007, BRIT J PSYCHIAT, V191, P335, DOI 10.1192/bjp.bp.107.036079; Fergusson DM, 2005, ARCH GEN PSYCHIAT, V62, P66, DOI 10.1001/archpsyc.62.1.66; Galambos NL, 2006, DEV PSYCHOL, V42, P350, DOI 10.1037/0012-1649.42.2.350; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Merikangas KR, 2003, ARCH GEN PSYCHIAT, V60, P993, DOI 10.1001/archpsyc.60.9.993; Newman DL, 1996, J CONSULT CLIN PSYCH, V64, P552, DOI 10.1037/0022-006X.64.3.552; Patton GC, 2014, LANCET; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Rohde P, 2005, J ABNORM PSYCHOL, V114, P409, DOI 10.1037/0021-843X.114.3.409; Steinhausen HC, 2006, J AFFECT DISORDERS, V96, P49, DOI 10.1016/j.jad.2006.05.019; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4	15	21	22	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1366	1368		10.1016/S0140-6736(13)62633-1	http://dx.doi.org/10.1016/S0140-6736(13)62633-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24439296				2022-12-28	WOS:000335318400007
J	Stoessl, AJ				Stoessl, A. Jon			Gene therapy for Parkinson's disease: a step closer?	LANCET			English	Editorial Material							DOUBLE-BLIND; DISORDERS; DOPAMINE; TRIAL; BRAIN		[Stoessl, A. Jon] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada; [Stoessl, A. Jon] Vancouver Coastal Hlth, Vancouver, BC V6T 2B5, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	Stoessl, AJ (corresponding author), Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada.	jstoessl@mail.ubc.ca	Stoessl, A Jon/J-9661-2015	Stoessl, A Jon/0000-0002-9778-7246				Abbruzzese G, 2012, FUNCT NEUROL, V27, P147; Ahlskog JE, 2007, NEUROLOGY, V69, P1701, DOI 10.1212/01.wnl.0000296942.14309.4a; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Fasano A, 2012, LANCET NEUROL, V11, P429, DOI 10.1016/S1474-4422(12)70049-2; Lang AE, 2004, LANCET NEUROL, V3, P309, DOI 10.1016/S1474-4422(04)00740-9; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; 2011, EUR NEUROPSYCHOPHARM, V21, P718	12	17	20	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1107	1109		10.1016/S0140-6736(13)62108-X	http://dx.doi.org/10.1016/S0140-6736(13)62108-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24412047				2022-12-28	WOS:000333956000008
J	Cogan, GB; Thesen, T; Carlson, C; Doyle, W; Devinsky, O; Pesaran, B				Cogan, Gregory B.; Thesen, Thomas; Carlson, Chad; Doyle, Werner; Devinsky, Orrin; Pesaran, Bijan			Sensory-motor transformations for speech occur bilaterally	NATURE			English	Article							BRAIN; INTEGRATION; PERCEPTION; LANGUAGE	Historically, the study of speech processing has emphasized a strong link between auditory perceptual input and motor production output(1-4). A kind of 'parity' is essential, as both perception-and production-based representations must form a unified interface to facilitate access to higher-order language processes such as syntax and semantics, believed to be computed in the dominant, typically left hemisphere(5,6). Although various theories have been proposed to unite perception and production(2,7), the underlying neural mechanisms are unclear. Early models of speech and language processing proposed that perceptual processing occurred in the left posterior superior temporal gyrus (Wernicke's area) and motor production processes occurred in the left inferior frontal gyrus (Broca's area)(8,9). Sensory activity was proposed to link to production activity through connecting fibre tracts, forming the left lateralized speech sensory-motor system(10). Although recent evidence indicates that speech perception occurs bilaterally(11-13), prevailing models maintain that the speech sensory-motor system is left lateralized(11,14-18) and facilitates the transformation from sensory-based auditory representations to motor-based production representations(11,15,16). However, evidence for the lateralized computation of sensory-motor speech transformations is indirect and primarily comes from stroke patients that have speech repetition deficits (conduction aphasia) and studies using covert speech and haemodynamic functional imaging(16,19). Whether the speech sensory-motor system is lateralized, like higher-order language processes, or bilateral, like speech perception, is controversial. Here we use direct neural recordings in subjects performing sensory-motor tasks involving overt speech production to show that sensory-motor transformations occur bilaterally. We demonstrate that electrodes over bilateral inferior frontal, inferior parietal, superior temporal, premotor and somatosensory cortices exhibit robust sensory-motor neural responses during both perception and production in an overt word-repetition task. Using a non-word transformation task, we show that bilateral sensory-motor responses can perform transformations between speech-perception-and speech-production-based representations. These results establish a bilateral sublexical speech sensory-motor system.	[Cogan, Gregory B.; Pesaran, Bijan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Thesen, Thomas; Carlson, Chad; Devinsky, Orrin] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Doyle, Werner; Devinsky, Orrin] NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA	New York University; New York University; New York University	Pesaran, B (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	bijan@nyu.edu		Carlson, Chad/0000-0001-6490-7814; Pesaran, Bijan/0000-0003-4116-0038; Devinsky, Orrin/0000-0003-0044-4632; Cogan, Gregory/0000-0003-1557-6507	NIDCD [R03-DC010475]; Burroughs Wellcome Fund; NYSTAR; McKnight Scholar Award; Sloan Research Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010475] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NYSTAR; McKnight Scholar Award; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank A. Weiss, J. MacArthur and L. Frank for developing the data acquisition hardware and software; O. Felsovalyi, E. Londen, P. Purushothaman, L. Melloni, C. Boomhaur and A. Trongnetrpunya for technical assistance; and D. Poeppel and C. Brody for comments on the manuscript. This work was supported, in part, by R03-DC010475 from the NIDCD, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (B. P.), a Watson Investigator Program Award from NYSTAR (B. P.), a McKnight Scholar Award (B. P.) and a Sloan Research Fellowship (B.P.).	Agnew ZK, 2013, NEUROIMAGE, V73, P191, DOI 10.1016/j.neuroimage.2012.08.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENSON DF, 1973, ARCH NEUROL-CHICAGO, V28, P339, DOI 10.1001/archneur.1973.00490230075011; Berwick RC, 2013, TRENDS COGN SCI, V17, P89, DOI 10.1016/j.tics.2012.12.002; CARAMAZZA A, 1981, BRAIN LANG, V14, P235, DOI 10.1016/0093-934X(81)90078-X; Chang EF, 2013, P NATL ACAD SCI USA, V110, P2653, DOI 10.1073/pnas.1216827110; CHOMSKY Noam, 1986, KNOWLEDGE LANGUAGE I; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DAMASIO H, 1980, BRAIN, V103, P337, DOI 10.1093/brain/103.2.337; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Goodglass H, 2000, ASSESSMENT APHASIA R; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; HALLE M, 1962, IRE T INFORM THEOR, V8, P155, DOI 10.1109/TIT.1962.1057686; Halle M, 1959, P SEMINAR SPEECH COM, VII; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hickok G, 2009, J NEUROPHYSIOL, V101, P2725, DOI 10.1152/jn.91099.2008; Jakobson Roman, 1972, CHILD LANGUAGE APHAS, P14; Kovalev D, 2005, AM J NEURORADIOL, V26, P1078; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lichtheim Ludwig, 1885, BRAIN, V7, P433, DOI DOI 10.1093/BRAIN/7.4.433; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Markowitz DA, 2011, J NEUROSCI, V31, P18412, DOI 10.1523/JNEUROSCI.4165-11.2011; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Murphy K, 1997, J APPL PHYSIOL, V83, P1438, DOI 10.1152/jappl.1997.83.5.1438; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; OLLER DK, 1988, CHILD DEV, V59, P441, DOI 10.1111/j.1467-8624.1988.tb01479.x; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Wernicke C., 1970, ARCH NEUROL-CHICAGO, V22, P280, DOI DOI 10.1001/ARCHNEUR.1970.00480210090013; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Yang AI, 2012, NEUROIMAGE, V63, P157, DOI 10.1016/j.neuroimage.2012.06.039; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097	36	140	141	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					94	+		10.1038/nature12935	http://dx.doi.org/10.1038/nature12935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24429520	Green Accepted, Green Submitted			2022-12-28	WOS:000332224400049
J	Kode, A; Manavalan, JS; Mosialou, I; Bhagat, G; Rathinam, CV; Luo, N; Khiabanian, H; Lee, A; Murty, VV; Friedman, R; Brum, A; Park, D; Galili, N; Mukherjee, S; Teruya-Feldstein, J; Raza, A; Rabadan, R; Berman, E; Kousteni, S				Kode, Aruna; Manavalan, John S.; Mosialou, Ioanna; Bhagat, Govind; Rathinam, Chozha V.; Luo, Na; Khiabanian, Hossein; Lee, Albert; Murty, Vundavalli V.; Friedman, Richard; Brum, Andrea; Park, David; Galili, Naomi; Mukherjee, Siddhartha; Teruya-Feldstein, Julie; Raza, Azra; Rabadan, Raul; Berman, Ellin; Kousteni, Stavroula			Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts	NATURE			English	Article							BONE-MARROW NICHE; STEM-CELL NICHE; PROGENITOR CELLS; NOTCH ACTIVATION; EXPRESSION; PATHWAY; IDENTIFICATION; RESISTANCE; PROMOTER; GENE	Cells of the osteoblast lineage affect the homing(1,2) and the number of long-term repopulating haematopoietic stem cells(3,4), haematopoietic stem cell mobilization and lineage determination and B cell lymphopoiesis(5-7). Osteoblasts were recently implicated in pre-leukaemic conditions in mice(8,9). However, a single genetic change in osteoblasts that can induce leukaemogenesis has not been shown. Here we show that an activating mutation of beta-catenin in mouse osteoblasts alters the differentiation potential of myeloid and lymphoid progenitors leading to development of acute myeloid leukaemia with common chromosomal aberrations and cell autonomous progression. Activated beta-catenin stimulates expression of the Notch ligand jagged 1 in osteoblasts. Subsequent activation of Notch signalling in haematopoietic stem cell progenitors induces the malignant changes. Genetic or pharmacological inhibition of Notch signalling ameliorates acute myeloid leukaemia and demonstrates the pathogenic role of the Notch pathway. In 38% of patients with myelodysplastic syndromes or acute myeloid leukaemia, increased beta-catenin signalling and nuclear accumulation was identified in osteoblasts and these patients showed increased Notch signalling in haematopoietic cells. These findings demonstrate that genetic alterations in osteoblasts can induce acute myeloid leukaemia, identify molecular signals leading to this transformation and suggest a potential novel pharmacotherapeutic approach to acute myeloid leukaemia.	[Kode, Aruna; Manavalan, John S.; Mosialou, Ioanna; Luo, Na; Brum, Andrea; Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY 10032 USA; [Bhagat, Govind] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Rathinam, Chozha V.] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Khiabanian, Hossein; Lee, Albert; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Khiabanian, Hossein; Lee, Albert; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Murty, Vundavalli V.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Murty, Vundavalli V.] Columbia Univ, Inst Canc Genet, Irving Canc Res Ctr, New York, NY 10032 USA; [Friedman, Richard] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Biomed Informat Shared Resource, New York, NY 10032 USA; [Friedman, Richard] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; [Brum, Andrea] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Park, David; Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Galili, Naomi; Raza, Azra] Columbia Univ, Myelodysplast Syndromes Ctr, New York, NY 10032 USA; [Mukherjee, Siddhartha] Columbia Univ, Dept Med Hematol, New York, NY 10032 USA; [Mukherjee, Siddhartha] Columbia Univ, Dept Oncol, New York, NY 10032 USA; [Berman, Ellin] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; Columbia University	Kousteni, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY 10032 USA.	sk2836@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Bhagat, Govind/AAE-9493-2021; Khiabanian, Hossein/N-7207-2019	Bhagat, Govind/0000-0001-6250-048X; Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255; Brum, Andrea/0000-0001-6881-1123	National Institutes of Health [R01 AR054447, P01 AG032959, R01 AR055931]; Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York; European Union [INTERBONE-FP7-PEOPLE-2011-IRSES-295181]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054447, R01AR055931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York; European Union(European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to M. Taketo for providing the Catnb<SUP>+/lox(ex3)</SUP> mice; R. Dalla-Favera and G. Karsenty for helpful discussions and critical reading of the manuscript; M. Van Den Brink for providing funding support; D. McMahon and C. A. Zhang for help with statistical analysis; and J. Sha, F. N. Emmons, I. Linkov and J. Pichard for technical assistance. The histology and metabolic unit facility of the Diabetes and Endocrinology Research Center (DERC, NIDDK DK063608-07), the Molecular Pathology facility of the Herbert Irving Cancer Center of Columbia University Medical Center provided help with histological analysis and W. Fantl and G. Nolan for provided flow cytometry conditions for the nuclear beta-catenin antibody. This work was supported by the National Institutes of Health (R01 AR054447, and P01 AG032959 and R01 AR055931 to S. K.) and by the Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York (to E. B.) and by a European Union Marie Curie Fellowship INTERBONE-FP7-PEOPLE-2011-IRSES-295181 (to A.B.).	Baia G, 2008, NEOPLASIA, V10, P604, DOI 10.1593/neo.08356; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Kannan S, 2013, J EXP MED, V210, P321, DOI 10.1084/jem.20121527; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Krebs LT, 2000, GENE DEV, V14, P1343; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Manavalan JS, 2012, J CLIN ENDOCR METAB, V97, P3240, DOI 10.1210/jc.2012-1546; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parfitt AM., 1983, BONE HISTOMORPHOMETR, V1983, P143; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Recker RR, 2011, BONE, V49, P955, DOI 10.1016/j.bone.2011.07.017; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Rubin MR, 2011, J CLIN ENDOCR METAB, V96, P176, DOI 10.1210/jc.2009-2682; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Simon R. M., 2003, DESIGN ANAL DNA MICR, P65; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S2; van de Loosdrecht AA, 2008, BLOOD, V111, P1067, DOI 10.1182/blood-2007-07-098764; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	51	353	365	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					240	+		10.1038/nature12883	http://dx.doi.org/10.1038/nature12883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24429522	Green Accepted			2022-12-28	WOS:000331107700042
J	Campins, H; Comfort, CM				Campins, Humberto; Comfort, Christine M.			SOLAR SYSTEM Evaporating asteroid	NATURE			English	Editorial Material							CERES; ORGANICS; PLANETS; SURFACE; ORIGIN; ICE		[Campins, Humberto; Comfort, Christine M.] Univ Cent Florida, Dept Phys & Astron, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Campins, H (corresponding author), Univ Cent Florida, Dept Phys & Astron, Orlando, FL 32816 USA.	campins@physics.ucf.edu						AHEARN MF, 1992, ICARUS, V98, P54, DOI 10.1016/0019-1035(92)90206-M; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; LEBOFSKY LA, 1978, MON NOT R ASTRON SOC, V182, P17; McCord TB, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002244; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Russell CT, 2011, SPACE SCI REV, V163, P3, DOI 10.1007/s11214-011-9836-2; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Walsh KJ, 2012, METEORIT PLANET SCI, V47, P1941, DOI 10.1111/j.1945-5100.2012.01418.x	13	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					487	488		10.1038/505487a	http://dx.doi.org/10.1038/505487a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451536				2022-12-28	WOS:000329995000024
J	Druker, BJ				Druker, Brian J.			Janet Rowley (1925-2013) OBITUARY	NATURE			English	Biographical-Item									Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University	Druker, BJ (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.	drukerb@ohsu.edu		Druker, Brian/0000-0001-8331-8206				ROWLEY JD, PUBLICATION LIST	1	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					484	484		10.1038/505484a	http://dx.doi.org/10.1038/505484a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451535	Bronze			2022-12-28	WOS:000329995000022
J	Greber, BJ; Boehringer, D; Leitner, A; Bieri, P; Voigts-Hoffmann, F; Erzberger, JP; Leibundgut, M; Aebersold, R; Ban, N				Greber, Basil J.; Boehringer, Daniel; Leitner, Alexander; Bieri, Philipp; Voigts-Hoffmann, Felix; Erzberger, Jan P.; Leibundgut, Marc; Aebersold, Ruedi; Ban, Nenad			Architecture of the large subunit of the mammalian mitochondrial ribosome	NATURE			English	Article							CROSS-LINKED PEPTIDES; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CRYO-EM; RNA; PROTEINS; VISUALIZATION; COMPONENT; SYSTEM	Mitochondrial ribosomes synthesize a number of highly hydrophobic proteins encoded on the genome of mitochondria, the organelles in eukaryotic cells that are responsible for energy conversion by oxidative phosphorylation. The ribosomes in mammalian mitochondria have undergone massive structural changes throughout their evolution, including ribosomal RNA shortening and acquisition of mitochondria-specific ribosomal proteins. Here we present the three-dimensional structure of the 39S large subunit of the porcine mitochondrial ribosome determined by cryo-electron microscopy at 4.9 angstrom resolution. The structure, combined with data from chemical crosslinking and mass spectrometry experiments, reveals the unique features of the 39S subunit at near-atomic resolution and provides detailed insight into the architecture of the polypeptide exit site. This region of the mitochondrial ribosome has been considerably remodelled compared to its bacterial counterpart, providing a specialized platform for the synthesis and membrane insertion of the highly hydrophobic protein components of the respiratory chain.	[Greber, Basil J.; Boehringer, Daniel; Bieri, Philipp; Voigts-Hoffmann, Felix; Erzberger, Jan P.; Leibundgut, Marc; Ban, Nenad] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Leitner, Alexander; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Ban, N (corresponding author), ETH, Dept Biol, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch; ban@mol.biol.ethz.ch	Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725; Bieri, Philipp/0000-0001-9031-2945; Greber, Basil/0000-0001-9379-7159	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF; European Research Council (ERC) under the European Community [250071]; Commission of the European Communities through the PROSPECTS consortium (EU) [201648, 233226]; European Research Council [ERC-2008-AdG 233226]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF; European Research Council (ERC) under the European Community(European Research Council (ERC)); Commission of the European Communities through the PROSPECTS consortium (EU)(European Commission); European Research Council(European Research Council (ERC)European Commission)	Cryo-EM data were collected at the electron microscopy facility of ETH Zurich (EMEZ) and at FEI Company Eindhoven. We thank P. Tittmann, F. de Haas and K. Sader for support. We acknowledge the use of computing infrastructure provided by the Central Information Technology Services of ETH Zurich. This work was supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF, European Research Council (ERC) grant 250071 under the European Community's Seventh Framework Programme (to N. B.), the Commission of the European Communities through the PROSPECTS consortium (EU FP7 projects 201648, 233226) (R. A.) and the European Research Council (ERC-2008-AdG 233226) (R.A.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; ATTARDI G, 1971, NATURE-NEW BIOL, V229, P133, DOI 10.1038/newbio229133a0; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cui WJ, 2011, PROTEIN PEPTIDE LETT, V18, P718, DOI 10.2174/092986611795445996; Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Handa Y, 2010, J MOL BIOL, V404, P260, DOI 10.1016/j.jmb.2010.09.033; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Josyula R, 2006, J MOL BIOL, V359, P798, DOI 10.1016/j.jmb.2006.04.020; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polikanov YS, 2012, SCIENCE, V336, P915, DOI 10.1126/science.1218538; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Spirina O, 2000, GENE, V261, P229, DOI 10.1016/S0378-1119(00)00504-7; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Weiss C, 1999, P NATL ACAD SCI USA, V96, P8890, DOI 10.1073/pnas.96.16.8890; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	54	162	164	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					515	+		10.1038/nature12890	http://dx.doi.org/10.1038/nature12890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24362565	Green Submitted			2022-12-28	WOS:000329995000032
J	Leeman, DS; Brunet, A				Leeman, Dena S.; Brunet, Anne			STEM CELLS Sex specificity in the blood	NATURE			English	Editorial Material							HEMATOPOIETIC STEM		[Leeman, Dena S.; Brunet, Anne] Stanford Univ, Dept Genet, Canc Biol Program, Stanford, CA 94305 USA; [Leeman, Dena S.; Brunet, Anne] Stanford Univ, Glenn Labs Biol Aging, Stanford, CA 94305 USA	Stanford University; Stanford University	Leeman, DS (corresponding author), Stanford Univ, Dept Genet, Canc Biol Program, Stanford, CA 94305 USA.	abrunet1@stanford.edu			NIA NIH HHS [P01 AG036695] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG036695] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baerlocher GM, 2009, BLOOD, V114, P219, DOI 10.1182/blood-2009-03-209833; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Illing A, 2012, HAEMATOL-HEMATOL J, V97, P1131, DOI 10.3324/haematol.2011.052456; Jain Arvind, 2013, BMC Hematol, V13, P10, DOI 10.1186/2052-1839-13-10; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647	13	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					488	490		10.1038/505488a	http://dx.doi.org/10.1038/505488a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451537				2022-12-28	WOS:000329995000025
J	Zhang, Q; Shalaby, NA; Buszczak, M				Zhang, Qiao; Shalaby, Nevine A.; Buszczak, Michael			Changes in rRNA Transcription Influence Proliferation and Cell Fate Within a Stem Cell Lineage	SCIENCE			English	Article							BAG-OF-MARBLES; POLYMERASE-I TRANSCRIPTION; DROSOPHILA FUSOME; FACTOR SL1; NICHE; DIFFERENTIATION; CENTROSOME; SUBUNITS; PROTEIN; GENE	Ribosome biogenesis drives cell growth and proliferation, but mechanisms that modulate this process within specific lineages remain poorly understood. Here, we identify a Drosophila RNA polymerase I (Pol I) regulatory complex composed of Under-developed (Udd), TAF1B, and a TAF1C-like factor. Disruption of udd or TAF1B results in reduced ovarian germline stem cell (GSC) proliferation. Female GSCs display high levels of ribosomal RNA (rRNA) transcription, and Udd becomes enriched in GSCs relative to their differentiating daughters. Increasing Pol I transcription delays differentiation, whereas reducing rRNA production induces both morphological changes that accompany multicellular cyst formation and specific decreased expression of the bone morphogenetic protein (BMP) pathway component Mad. These findings demonstrate that modulating rRNA synthesis fosters changes in the cell fate, growth, and proliferation of female Drosophila GSCs and their daughters.	[Zhang, Qiao; Shalaby, Nevine A.; Buszczak, Michael] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Buszczak, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	michael.buszczak@utsouthwestern.edu		Buszczak, Michael/0000-0001-6361-3654	NIH [R01GM086647, R01GM045820]; E.E. and Greer Garson Fogelson Endowment (University of Texas Southwestern Medical Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086647, R01GM045820] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); E.E. and Greer Garson Fogelson Endowment (University of Texas Southwestern Medical Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Raftery, Z. Chen, A. Spradling, J. Pradel, N. Perrimon, the Bloomington Stock Center, and the Iowa Developmental Studies Hybridoma Bank for providing reagents. J. Huynh and P. R. Hiesinger provided imaging advice. N. Conrad, J. Jiang, and P. R. Hiesinger provided comments. Supported by NIH (R01GM086647 and R01GM045820) and E.E. and Greer Garson Fogelson Endowment (University of Texas Southwestern Medical Center).	Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Naidu S, 2011, SCIENCE, V333, P1640, DOI 10.1126/science.1207656; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Perrin L, 1998, J CELL SCI, V111, P2753; SEIFARTH W, 1991, MOL GEN GENET, V228, P424, DOI 10.1007/BF00260636; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sutherland DJ, 2003, DEVELOPMENT, V130, P5705, DOI 10.1242/dev.00801; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	29	118	119	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					298	301		10.1126/science.1246384	http://dx.doi.org/10.1126/science.1246384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436420	Green Accepted			2022-12-28	WOS:000329718600036
J	Costanza, R; Kubiszewski, I; Giovannini, E; Lovins, H; McGlade, J; Pickett, KE; Ragnarsdottir, KV; Roberts, D; De Vogli, R; Wilkinson, R				Costanza, Robert; Kubiszewski, Ida; Giovannini, Enrico; Lovins, Hunter; McGlade, Jacqueline; Pickett, Kate E.; Ragnarsdottir, Kristin Vala; Roberts, Debra; De Vogli, Roberto; Wilkinson, Richard			Time to leave GDP behind	NATURE			English	Editorial Material									[Costanza, Robert; Kubiszewski, Ida] Australian Natl Univ, Crawford Sch Publ Policy, Canberra, ACT 0200, Australia; [Giovannini, Enrico] Univ Roma Tor Vergata, Dept Econ & Finance, Rome, Italy; [Lovins, Hunter] Nat Capital Solut, Longmont, CO USA; [McGlade, Jacqueline] Univ Coll London, Nairobi, Kenya; [McGlade, Jacqueline] United Nations Environm Program, Nairobi, Kenya; [Pickett, Kate E.] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Ragnarsdottir, Kristin Vala] Univ Iceland, Inst Earth Sci, Reykjavik, Iceland; [Ragnarsdottir, Kristin Vala] Univ Iceland, Inst Sustainable Dev Studies, Reykjavik, Iceland; [Roberts, Debra] Environm Planning & Climate Protect Dept, Durban, South Africa; [De Vogli, Roberto] Univ Calif Davis, Davis, CA 95616 USA; [Wilkinson, Richard] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	Australian National University; University of Rome Tor Vergata; University of York - UK; University of Iceland; University of Iceland; University of California System; University of California Davis; University of Nottingham	Costanza, R (corresponding author), Australian Natl Univ, Crawford Sch Publ Policy, GPO Box 4, Canberra, ACT 0200, Australia.	robert.costanza@anu.edu.au	Ragnarsdottir, Kristin Vala/L-5369-2016; Kubiszewski, Ida/A-5146-2012; Costanza, Robert/A-4912-2008; Costanza, Robert/AAJ-3546-2021; McGlade, Jacqueline/AAX-1847-2020	Ragnarsdottir, Kristin Vala/0000-0001-6958-0734; Kubiszewski, Ida/0000-0003-3264-7899; Costanza, Robert/0000-0001-6348-8734; McGlade, Jacqueline/0000-0002-8657-6734				[Anonymous], 2007, REDEFINING PROGR; Barford A, 2010, SOC SCI MED, V70, P496, DOI 10.1016/j.socscimed.2009.10.059; Costanza R., 2009, PARDEE PAPER; Costanza R, 2007, ECOL ECON, V61, P267, DOI 10.1016/j.ecolecon.2006.02.023; Diener E., 2003, WELL BEING FDN HEDON, P434; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Kubiszewski I, 2013, ECOL ECON, V93, P57, DOI 10.1016/j.ecolecon.2013.04.019; Layard R., 2005, PROSPECT, V108; Seligman M.E., 2012, FLOURISH VISIONARY N; Stiglitz J.E., 2009, REPORT COMMISSION ME, V12; van den Bergh JCJM, 2009, J ECON PSYCHOL, V30, P117, DOI 10.1016/j.joep.2008.12.001; Wilkinson R, 2009, SPIRIT LEVEL WHY GRE, V1	12	362	379	21	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					283	285		10.1038/505283a	http://dx.doi.org/10.1038/505283a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	288OR	24436983	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000329621800013
J	Kim, HK; Kim, RR; Oh, JH; Cho, H; Varshavsky, A; Hwang, CS				Kim, Heon-Ki; Kim, Ryu-Ryun; Oh, Jang-Hyun; Cho, Hanna; Varshavsky, Alexander; Hwang, Cheol-Sang			The N-Terminal Methionine of Cellular Proteins as a Degradation Signal	CELL			English	Article							END RULE PATHWAY; UBIQUITIN LIGASES; QUALITY-CONTROL; COTRANSLATIONAL UBIQUITINATION; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC PROTEASOME; MISFOLDED PROTEIN; GTPASE ARL3P; ACETYLATION; RECOGNITION	The Arg/N-end rule pathway targets for degradation proteins that bear specific unacetylated N-terminal residues while the Ac/N-end rule pathway targets proteins through their N-infinity-terminally acetylated (Nt-acetylated) residues. Here, we show that Ubr1, the ubiquitin ligase of the Arg/N-end rule pathway, recognizes unacetylated N-terminal methionine if it is followed by a hydrophobic residue. This capability of Ubr1 expands the range of substrates that can be targeted for degradation by the Arg/N-end rule pathway because virtually all nascent cellular proteins bear N-terminal methionine. We identified Msn4, Sry1, Arl3, and Pre5 as examples of normal or misfolded proteins that can be destroyed through the recognition of their unacetylated N-terminal methionine. Inasmuch as proteins bearing the Nt-acetylated N-terminal methionine residue are substrates of the Ac/N-end rule pathway, the resulting complementarity of the Arg/N-end rule and Ac/N-end rule pathways enables the elimination of protein substrates regardless of acetylation state of N-terminal methionine in these substrates.	[Kim, Heon-Ki; Kim, Ryu-Ryun; Cho, Hanna; Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Gyeongbuk, South Korea; [Oh, Jang-Hyun; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Pohang University of Science & Technology (POSTECH); California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu; cshwang@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; cho, Hanna/0000-0002-5339-2541	National Research Foundation (NRF) of the Korea government (MSIP) [NRF-2011-0021975, NRF-2012R1A4A1028200]; Korean Healthcare Technology R&D Project of the Ministry of Health Welfare [HI11C1279]; T.J. Park Science Fellowship of POSCO T.J. Park Foundation; U.S. National Institutes of Health [DK039520, GM031530]; Korean Government's NRF-2013-Global Ph.D. Fellowship Program [NRF-2013H1A2A1033225]; BK21 PLUS Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R56DK039520, R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Research Foundation (NRF) of the Korea government (MSIP); Korean Healthcare Technology R&D Project of the Ministry of Health Welfare; T.J. Park Science Fellowship of POSCO T.J. Park Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Government's NRF-2013-Global Ph.D. Fellowship Program; BK21 PLUS Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.-Y. Kim (Korea Research, Institute of Biosciences and Biotechnology) for calculating the relative content of encoded human Met-Phi proteins, and D. H. Wolf (University of Stuttgart, Germany) for providing pFE15. We also thank C. Brower, K. Piatkov, J. Raskatov and B. Wadas (California Institute of Technology), and I. Hwang (Pohang University of Science and Technology) for helpful comments on the manuscript. We are grateful to members of the Hwang and Varshavsky laboratories for their assistance and advice. This work was supported by grants to C.-S.H from the National Research Foundation (NRF) of the Korea government (MSIP) (NRF-2011-0021975 and NRF-2012R1A4A1028200), the Korean Healthcare Technology R&D Project of the Ministry of Health & Welfare (HI11C1279), and the T.J. Park Science Fellowship of POSCO T.J. Park Foundation, and also by grants to A.V. from the U.S. National Institutes of Health (DK039520 and GM031530). H.-K.K was supported by the Korean Government's NRF-2013-Global Ph.D. Fellowship Program (NRF-2013H1A2A1033225) and the BK21 PLUS Program.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fredrickson EK, 2012, SEMIN CELL DEV BIOL, V23, P530, DOI 10.1016/j.semcdb.2011.12.006; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; HEINEMEYER W, 1994, BIOCHEMISTRY-US, V33, P12229, DOI 10.1021/bi00206a028; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; Mischerikow N, 2011, PROTEOMICS, V11, P571, DOI 10.1002/pmic.201000397; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Takatsume Y, 2010, BIOCHEM J, V427, P275, DOI 10.1042/BJ20091334; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wada M, 2003, FEMS MICROBIOL LETT, V225, P189, DOI 10.1016/S0378-1097(03)00484-1; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247	36	116	119	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					158	169		10.1016/j.cell.2013.11.031	http://dx.doi.org/10.1016/j.cell.2013.11.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24361105	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000329912200018
J	Mc Donald, J; Krainc, D				Mc Donald, Jessica; Krainc, Dimitri			Alzheimer Gene APOE epsilon 4 Linked to Brain Development in Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REPLACEMENT MICE; APOLIPOPROTEIN-E; ABSENCE		[Mc Donald, Jessica; Krainc, Dimitri] Northwestern Univ, Feinberg Sch Med, Dept Neurol, 303 E Chicago Ave,Ward 12-140, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Krainc, D (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, 303 E Chicago Ave,Ward 12-140, Chicago, IL 60611 USA.	krainc@northwestern.edu						Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Knickmeyer RC, 2014, CEREB CORTEX, V24, P1230, DOI 10.1093/cercor/bhs401; Rogalski EJ, 2011, ALZ DIS ASSOC DIS, V25, P159, DOI 10.1097/WAD.0b013e318201f249; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Trommer BL, 2004, NEUROREPORT, V15, P2655, DOI 10.1097/00001756-200412030-00020; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013	9	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					298	+		10.1001/jama.2013.285400	http://dx.doi.org/10.1001/jama.2013.285400			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24430322				2022-12-28	WOS:000329566400022
J	Meehan, T; Nogueira, C				Meehan, Thomasina; Nogueira, Claudia			Tinnitus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Meehan, Thomasina; Nogueira, Claudia] Nottingham Univ Hosp, Queens Med Ctr Campus, Nottingham, England	Nottingham University Hospital NHS Trust; University of Nottingham								Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; Moller AR., 2010, TXB TINNITUS; Tyler R. S., 2000, TINNITUS HDB	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2014	348								g216	10.1136/bmj.g216	http://dx.doi.org/10.1136/bmj.g216			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MK	24421343				2022-12-28	WOS:000329975600017
J	Biller, SJ; Schubotz, F; Roggensack, SE; Thompson, AW; Summons, RE; Chisholm, SW				Biller, Steven J.; Schubotz, Florence; Roggensack, Sara E.; Thompson, Anne W.; Summons, Roger E.; Chisholm, Sallie W.			Bacterial Vesicles in Marine Ecosystems	SCIENCE			English	Article							OUTER-MEMBRANE VESICLES; RELEASE; PROTEIN; PROCHLOROCOCCUS; MECHANISM; GENES	Many heterotrophic bacteria are known to release extracellular vesicles, facilitating interactions between cells and their environment from a distance. Vesicle production has not been described in photoautotrophs, however, and the prevalence and characteristics of vesicles in natural ecosystems is unknown. Here, we report that cultures of Prochlorococcus, a numerically dominant marine cyanobacterium, continuously release lipid vesicles containing proteins, DNA, and RNA. We also show that vesicles carrying DNA from diverse bacteria are abundant in coastal and open-ocean seawater samples. Prochlorococcus vesicles can support the growth of heterotrophic bacterial cultures, which implicates these structures in marine carbon flux. The ability of vesicles to deliver diverse compounds in discrete packages adds another layer of complexity to the flow of information, energy, and biomolecules in marine microbial communities.	[Biller, Steven J.; Roggensack, Sara E.; Thompson, Anne W.; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Schubotz, Florence; Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Biller, SJ (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sbiller@mit.edu; chisholm@mit.edu	Summons, Roger Everett/AAL-3789-2020; Biller, Steven/CAI-9174-2022; Biller, Steven/CAG-2216-2022	Chisholm, Sallie/0000-0003-1480-2445	Gordon and Betty Moore Foundation; NSF Center for Microbial Oceanography: Research and Education (C-MORE); NSF-Biological Oceanography; MIT Energy Initiative Seed Grant program; NASA Astrobiology Institute [NNA13AA90A]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Center for Microbial Oceanography: Research and Education (C-MORE)(National Science Foundation (NSF)); NSF-Biological Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); MIT Energy Initiative Seed Grant program; NASA Astrobiology Institute	We thank the members of the Chisholm laboratory, D. McLaughlin, and W. Burkholder for helpful discussions and advice; J. Jones for advice on particle analysis and providing access to equipment; N. Watson for microscopy assistance; and the J. King laboratory, Massachusetts Institute of Technology (MIT) for equipment use. J. Roden, L. Kelly, and P. Berube provided helpful suggestions on the manuscript. We also thank the captain and crew of the R/V Atlantic Explorer, R. Johnson, S. Bell, R. Parsons, and the rest of the BATS team for assistance with field sampling and providing access to data. Sequence data are available from the National Center for Biotechnology Information Sequence Read Archive (Prochlorococcus MED4 vesicles: SRP031649; field vesicles: SRP031871). This work was supported by grants from the Gordon and Betty Moore Foundation, the NSF Center for Microbial Oceanography: Research and Education (C-MORE), NSF-Biological Oceanography, and the MIT Energy Initiative Seed Grant program to S. W. C. F. S. and R. E. S. were supported by an award (NNA13AA90A) from the NASA Astrobiology Institute.	Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; Bertilsson S, 2005, VIE MILIEU, V55, P225; Borch NH, 1999, AQUAT MICROB ECOL, V16, P265, DOI 10.3354/ame016265; Chiura HX, 2011, FEMS MICROBIOL ECOL, V76, P576, DOI 10.1111/j.1574-6941.2011.01077.x; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Gorby Y, 2008, GEOBIOLOGY, V6, P232, DOI 10.1111/j.1472-4669.2008.00158.x; Grzymski JJ, 2012, ISME J, V6, P71, DOI 10.1038/ismej.2011.72; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Klieve AV, 2005, APPL ENVIRON MICROB, V71, P4248, DOI 10.1128/AEM.71.8.4248-4253.2005; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; MacDonald IA, 2013, J BACTERIOL, V195, P2971, DOI 10.1128/JB.02267-12; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; MUGOPSTELTEN D, 1978, BIOCHIM BIOPHYS ACTA, V508, P287, DOI 10.1016/0005-2736(78)90331-0; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Roden JA, 2012, INFECT IMMUN, V80, P929, DOI 10.1128/IAI.05769-11; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Sher D, 2011, ISME J, V5, P1125, DOI 10.1038/ISMEJ.2011.1; Shibata A, 1997, MAR ECOL PROG SER, V155, P303, DOI 10.3354/meps155303; TANOUE E, 1995, GEOCHIM COSMOCHIM AC, V59, P2643, DOI 10.1016/0016-7037(95)00134-4; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; WELLS ML, 1991, NATURE, V353, P342, DOI 10.1038/353342a0; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197	29	285	295	5	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					183	186		10.1126/science.1243457	http://dx.doi.org/10.1126/science.1243457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408433	Green Submitted			2022-12-28	WOS:000329440800042
J	Deng, QL; Ramskold, D; Reinius, B; Sandberg, R				Deng, Qiaolin; Ramskold, Daniel; Reinius, Bjorn; Sandberg, Rickard			Single-Cell RNA-Seq Reveals Dynamic, Random Monoallelic Gene Expression in Mammalian Cells	SCIENCE			English	Article							X-CHROMOSOME INACTIVATION; EARLY MOUSE EMBRYOS; VARIABILITY; PENETRANCE; ALLELES	Expression from both alleles is generally observed in analyses of diploid cell populations, but studies addressing allelic expression patterns genome-wide in single cells are lacking. Here, we present global analyses of allelic expression across individual cells of mouse preimplantation embryos of mixed background (CAST/EiJ x C57BL/6J). We discovered abundant (12 to 24%) monoallelic expression of autosomal genes and that expression of the two alleles occurs independently. The monoallelic expression appeared random and dynamic because there was considerable variation among closely related embryonic cells. Similar patterns of monoallelic expression were observed in mature cells. Our allelic expression analysis also demonstrates the de novo inactivation of the paternal X chromosome. We conclude that independent and stochastic allelic transcription generates abundant random monoallelic expression in the mammalian cell.	[Deng, Qiaolin; Ramskold, Daniel; Reinius, Bjorn; Sandberg, Rickard] Ludwig Inst Canc Res, S-17177 Stockholm, Sweden; [Ramskold, Daniel; Reinius, Bjorn; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet	Sandberg, R (corresponding author), Ludwig Inst Canc Res, Box 240, S-17177 Stockholm, Sweden.	rickard.sandberg@ki.se	Deng, Qiaolin/AAD-6905-2020	Sandberg, Rickard/0000-0001-6473-1740; Deng, Qiaolin/0000-0001-5934-7816; Reinius, Bjorn/0000-0002-7021-5248; Ramskold, Daniel/0000-0003-2892-673X	Swedish Research Council [2011-965, 2008-4562]; European Research Council [243066]; Foundation for Strategic Research; Ake Wiberg Foundation [756194131]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Foundation for Strategic Research; Ake Wiberg Foundation	Q.D. designed and performed mouse work and generated RNA-seq libraries. D. R. designed and performed computational analyses and prepared figures and tables. B. R. analyzed X chromosome data, prepared figures, and generated RNA-seq libraries. R. S. coordinated and designed the study and wrote the manuscript with input from other authors. We are grateful to C. Burge, T. Perlmann, S. Linnarsson, G. Winberg, and other members of our laboratory for comments on the manuscript and A. Johnsson for managing sequencing. This work was supported by the Swedish Research Council grants 2011-965 (Q. D.) and 2008-4562 (R. S.), by the European Research Council Starting Grant 243066 (R. S.), by the Foundation for Strategic Research (R. S.), and Ake Wiberg Foundation grant 756194131 (R. S.). Sequence data have been deposited in National Center for Biotechnology Information Gene Expression Omnibus (GSE45719) and Sequence Read Archive (SRP020490).	Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Carey JC, 1999, AM J MED GENET, V89, P7, DOI 10.1002/(SICI)1096-8628(19990326)89:1<7::AID-AJMG4>3.0.CO;2-#; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; JANKU P, 1980, AM J MED GENET, V5, P117, DOI 10.1002/ajmg.1320050203; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; LEE J, 2011, MOD HEALTHCARE, V41, P12; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	27	717	729	10	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					193	196		10.1126/science.1245316	http://dx.doi.org/10.1126/science.1245316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408435				2022-12-28	WOS:000329440800045
J	Lane-Fall, M				Lane-Fall, Meghan			Accommodating Bigotry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lane-Fall, Meghan] Univ Penn, Dept Anesthesiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lane-Fall, Meghan] Univ Penn, Dept Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lane-Fall, M (corresponding author), Univ Penn, Dept Anesthesiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	meghan.lane-fall@uphs.upenn.edu	Lane-Fall, Meghan Brooks/L-9854-2013	Lane-Fall, Meghan Brooks/0000-0001-7050-0017				American Medical Association, 2012, OPINION 9 06 FREE CH; Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Foubister V., 2001, AM MED NEWS, V22, P8226; Karoub J., SOME PATIENTS WONT S; Kipnis K., 2006, BIOMEDICAL ETHICS; Legal Information Institute, 2010, BATT; Newsroom WNEM, NURSES TOLD NOT TO T; Norris M., FOR A BLACK DOCTOR B; Paul-Emile K, 2012, UCLA LAW REV, V60, P462	9	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					139	140		10.1001/jama.2013.283733	http://dx.doi.org/10.1001/jama.2013.283733			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399550				2022-12-28	WOS:000329339400017
J	Ng, M; Freeman, MK; Fleming, TD; Robinson, M; Dwyer-Lindgren, L; Thomson, B; Wollum, A; Sanman, E; Wulf, S; Lopez, AD; Murray, CJL; Gakidou, E				Marie Ng; Freeman, Michael K.; Fleming, Thomas D.; Robinson, Margaret; Dwyer-Lindgren, Laura; Thomson, Blake; Wollum, Alexandra; Sanman, Ella; Wulf, Sarah; Lopez, Alan D.; Murray, Christopher J. L.; Gakidou, Emmanuela			Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOBACCO CONTROL POLICIES; CORONARY-HEART-DISEASE; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; MORTALITY; CANCER; IMPACT; SNUS; CESSATION; HEALTH	IMPORTANCE Tobacco is a leading global disease risk factor. Understanding national trends in prevalence and consumption is critical for prioritizing action and evaluating tobacco control progress. OBJECTIVE To estimate the prevalence of daily smoking by age and sex and the number of cigarettes per smoker per day for 187 countries from 1980 to 2012. DESIGN Nationally representative sources that measured tobacco use (n = 2102 country-years of data) were systematically identified. Survey data that did not report daily tobacco smoking were adjusted using the average relationship between different definitions. Age-sex-country-year observations (n = 38 315) were synthesized using spatial-temporal gaussian process regression to model prevalence estimates by age, sex, country, and year. Data on consumption of cigarettes were used to generate estimates of cigarettes per smoker per day. MAIN OUTCOMES AND MEASURES Modeled age-standardized prevalence of daily tobacco smoking by age, sex, country, and year; cigarettes per smoker per day by country and year. RESULTS Global modeled age-standardized prevalence of daily tobacco smoking in the population older than 15 years decreased from 41.2%(95% uncertainty interval [UI], 40.0%-42.6%) in 1980 to 31.1%(95% UI, 30.2%-32.0%; P <.001) in 2012 for men and from 10.6%(95% UI, 10.2%-11.1%) to 6.2%(95% UI, 6.0%-6.4%; P <.001) for women. Global modeled prevalence declined at a faster rate from 1996 to 2006 (mean annualized rate of decline, 1.7%; 95% UI, 1.5%-1.9%) compared with the subsequent period (mean annualized rate of decline, 0.9%; 95% UI, 0.5%-1.3%; P =.003). Despite the decline in modeled prevalence, the number of daily smokers increased from 721 million (95% UI, 700 million-742 million) in 1980 to 967 million (95% UI, 944 million-989 million; P <.001) in 2012. Modeled prevalence rates exhibited substantial variation across age, sex, and countries, with rates below 5% for women in some African countries to more than 55% for men in Timor-Leste and Indonesia. The number of cigarettes per smoker per day also varied widely across countries and was not correlated with modeled prevalence. CONCLUSIONS AND RELEVANCE Since 1980, large reductions in the estimated prevalence of daily smoking were observed at the global level for both men and women, but because of population growth, the number of smokers increased significantly. As tobacco remains a threat to the health of the world's population, intensified efforts to control its use are needed.	[Marie Ng; Freeman, Michael K.; Fleming, Thomas D.; Robinson, Margaret; Dwyer-Lindgren, Laura; Thomson, Blake; Wollum, Alexandra; Sanman, Ella; Wulf, Sarah; Murray, Christopher J. L.; Gakidou, Emmanuela] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Melbourne	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; Dwyer-Lindgren, Laura/0000-0002-3872-6451; Thomson, Blake/0000-0002-6433-0338; Wollum, Alexandra/0000-0002-5737-0112	Bill & Melinda Gates Foundation; State of Washington	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); State of Washington	This research was conducted as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2.0. This study is supported by a grant from the Bill & Melinda Gates Foundation and the State of Washington.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Andalon M, 2013, ECON PAP, V32, P10, DOI 10.1111/1759-3441.12020; [Anonymous], 1964, SMOKING AND HEALTH R; [Anonymous], 1997, TOBACCO OR HEALTH A; Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; Centers for Disease Control and Prevention, REPRODUCTIVE HEALTH; Crosbie E, 2011, TOB CONTROL, V20, P64, DOI 10.1136/tc.2010.037010; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; Euromonitor International, TOBACCO INDUSTRY MAR; European Commission, EUROBAROMETER SURVEY; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Food and Agriculture Organization of the United Nations, PROJECTIONS OF TOBAC; Forey B, 2002, INTERNATIONAL SMOKIN; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Green LW, 2000, AM J PUBLIC HEALTH, V90, P337, DOI 10.2105/AJPH.90.3.337; Halkjelsvik T, 2013, HEALTH EDUC RES, V28, P888, DOI 10.1093/her/cyt064; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Institute for Health Metrics and Evaluation, GLOBAL BURDEN OF DIS; Institute for Health Metrics and Evaluation, GLOBAL HEALTH DATA E; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Jha P, 1999, CURBING THE EPIDEMIC; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kenfield SA, 2010, TOB CONTROL, V19, P248, DOI 10.1136/tc.2009.032839; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Luo J, 2007, LANCET, V369, P2015, DOI 10.1016/S0140-6736(07)60678-3; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; P. N. Lee Statistics and Computing, INTERNATIONAL MORTAL; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ramstrom LM, 2006, TOB CONTROL, V15, P210, DOI 10.1136/tc.2005.014969; ROSENGREN A, 1992, J INTERN MED, V231, P357, DOI 10.1111/j.1365-2796.1992.tb00944.x; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Shopland D., 1998, SMOKING AND TOBACCO, V9; Stephens T, 2001, TOB CONTROL, V10, P317, DOI 10.1136/tc.10.4.317; U.S. Department of Health and Human Services, 2010, ENDING THE TOBACCO E; United Nations Children's Fund, MULTIPLE INDICATOR C; US Agency for International Development, MEASURE DHS DEMOGRAP; US Department of Agriculture, TOBACCO YEARBOOK USD; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO, STEPWISE APPROACH TO; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; World Health Organization, GLOBAL ADULT TOBACCO; World Health Organization, 2006, TOBACCO DEADLY IN AN; World Health Organization, 2013, WHO REPORT ON THE GL; World Health Organization, WHO FRAMEWORK CONVEN; World Health Organization, WORLD HEALTH SURVEY; World Health Organization, WHO GLOBAL INFOBASE; World Health Organization, GLOBAL YOUTH TOBACCO; World Lung Foundation; American Cancer Society, THE TOBACCO ATLAS	55	1017	1052	1	109	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					183	192		10.1001/jama.2013.284692	http://dx.doi.org/10.1001/jama.2013.284692			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SA	24399557	Bronze			2022-12-28	WOS:000329339400024
J	Kumar, V; Kim, K; Joseph, C; Kourrich, S; Yoo, SH; Huang, HC; Vitaterna, MH; de Villena, FPM; Churchill, G; Bonci, A; Takahashi, JS				Kumar, Vivek; Kim, Kyungin; Joseph, Chryshanthi; Kourrich, Said; Yoo, Seung-Hee; Huang, Hung Chung; Vitaterna, Martha H.; de Villena, Fernando Pardo-Manuel; Churchill, Gary; Bonci, Antonello; Takahashi, Joseph S.			C57BL/6N Mutation in Cytoplasmic FMRP interacting protein 2 Regulates Cocaine Response	SCIENCE			English	Article							SYNAPTIC PLASTICITY; MOUSE; WAVE-1	The inbred mouse C57BL/6J is the reference strain for genome sequence and for most behavioral and physiological phenotypes. However, the International Knockout Mouse Consortium uses an embryonic stem cell line derived from a related C57BL/6N substrain. We found that C57BL/6N has a lower acute and sensitized response to cocaine and methamphetamine. We mapped a single causative locus and identified a nonsynonymous mutation of serine to phenylalanine (S968F) in Cytoplasmic FMRP interacting protein 2 (Cyfip2) as the causative variant. The S968F mutation destabilizes CYFIP2, and deletion of the C57BL/6N mutant allele leads to acute and sensitized cocaine-response phenotypes. We propose that CYFIP2 is a key regulator of cocaine response in mammals and present a framework to use mouse substrains to identify previously unknown genes and alleles regulating behavior.	[Kumar, Vivek; Kim, Kyungin; Joseph, Chryshanthi; Yoo, Seung-Hee; Huang, Hung Chung; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kumar, Vivek; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kourrich, Said; Bonci, Antonello] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Vitaterna, Martha H.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [de Villena, Fernando Pardo-Manuel] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Churchill, Gary] Jackson Lab, Bar Harbor, ME 04609 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Northwestern University; University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory	Takahashi, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Churchill, Gary/AAY-7496-2020; Kourrich, Said/M-3916-2014	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Churchill, Gary/0000-0001-9190-9284; 	National Research Service Award from NIDA [F32DA024556]; NIH [U01MH61915]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER	National Research Service Award from NIDA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Khan and W. Khan for genotyping help; A. M. Wissman, J. Gibson, and K. Huber for help with diolistics; C. Olker for behavioral testing; C. Cowan for advice on sensitization; M. Strobel for C57BL/6 substrain DNA; S. Padrick, B. Chen, and M. Rosen for WRC reagents and advice; T. Keane (Sanger Centre) for access to sequencing data; N. Kumar and I. Kornblum for technical help; and O. Hermanson and P. Lowrey for advice on manuscript. V. K. was funded through National Research Service Award F32DA024556 from NIDA. NIH grant U01MH61915 funded J. S. T. J. S. T. is an Investigator and S.H.Y. and V. K. were associates in the Howard Hughes Medical Institute.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Morse H. C., 1978, ORIGINS OF INBRED MI; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Qurashi A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-18; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	23	122	122	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1508	1512		10.1126/science.1245503	http://dx.doi.org/10.1126/science.1245503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357318	Green Submitted, Green Accepted			2022-12-28	WOS:000328644300058
J	MacLaren, RE; Groppe, M; Barnard, AR; Cottriall, CL; Tolmachova, T; Seymour, L; Clark, KR; During, MJ; Cremers, FPM; Black, GCM; Lotery, AJ; Downes, SM; Webster, AR; Seabra, MC				MacLaren, Robert E.; Groppe, Markus; Barnard, Alun R.; Cottriall, Charles L.; Tolmachova, Tanya; Seymour, Len; Clark, K. Reed; During, Matthew J.; Cremers, Frans P. M.; Black, Graeme C. M.; Lotery, Andrew J.; Downes, Susan M.; Webster, Andrew R.; Seabra, Miguel C.			Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial	LANCET			English	Article							LEBERS CONGENITAL AMAUROSIS; DEGENERATION; MUTATIONS; EXPRESSION; DISEASE; CLONING; MODELS; CHM	Background Choroideremia is an X-linked recessive disease that leads to blindness due to mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed the effects of retinal gene therapy with an adeno-associated viral (AAV) vector encoding REP1 (AAV. REP1) in patients with this disease. Methods In a multicentre clinical trial, six male patients (aged 35-63 years) with choroideremia were administered AAV. REP1 (0.6-1.0 x 10(10) genome particles, subfoveal injection). Visual function tests included best corrected visual acuity, microperimetry, and retinal sensitivity tests for comparison of baseline values with 6 months after surgery. This study is registered with ClinicalTrials.gov, number NCT01461213. Findings Despite undergoing retinal detachment, which normally reduces vision, two patients with advanced choroideremia who had low baseline best corrected visual acuity gained 21 letters and 11 letters (more than two and four lines of vision). Four other patients with near normal best corrected visual acuity at baseline recovered to within one to three letters. Mean gain in visual acuity overall was 3.8 letters (SE 4.1). Maximal sensitivity measured with dark-adapted microperimetry increased in the treated eyes from 23.0 dB (SE 1.1) at baseline to 25.3 dB (1.3) after treatment (increase 2.3 dB [95% CI 0.8-3.8]). In all patients, over the 6 months, the increase in retinal sensitivity in the treated eyes (mean 1.7 [SE 1.0]) was correlated with the vector dose administered per mm(2) of surviving retina (r=0.82, p=0.04). By contrast, small non-significant reductions (p>0.05) were noted in the control eyes in both maximal sensitivity (-0.8 dB [1.5]) and mean sensitivity (-1.6 dB [0.9]). One patient in whom the vector was not administered to the fovea re-established variable eccentric fixation that included the ectopic island of surviving retinal pigment epithelium that had been exposed to vector. Interpretation The initial results of this retinal gene therapy trial are consistent with improved rod and cone function that overcome any negative effects of retinal detachment. These findings lend support to further assessment of gene therapy in the treatment of choroideremia and other diseases, such as age-related macular degeneration, for which intervention should ideally be applied before the onset of retinal thinning.	[MacLaren, Robert E.; Groppe, Markus; Barnard, Alun R.; Downes, Susan M.] Univ Oxford, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [MacLaren, Robert E.; Groppe, Markus; Cottriall, Charles L.; Downes, Susan M.] Oxford Univ Hosp NHS Trust, Oxford Eye Hosp, Oxford, England; [MacLaren, Robert E.; Groppe, Markus; Cottriall, Charles L.; Downes, Susan M.] NIHR Biomed Res Ctr, Oxford, England; [MacLaren, Robert E.; Groppe, Markus; Webster, Andrew R.] Moorfields Eye Hosp NHS Fdn Trust, London, England; [MacLaren, Robert E.; Groppe, Markus; Webster, Andrew R.] NIHR Ophthalmol Biomed Res Ctr, London, England; [Tolmachova, Tanya; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Seymour, Len] Univ Oxford, Dept Oncol, Oxford OX3 9DU, England; [Clark, K. Reed] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [During, Matthew J.] Ohio State Univ, Med Ctr, Coll Med, Columbus, OH 43210 USA; [Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands; [Black, Graeme C. M.] St Marys Hosp, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester M13 0JH, Lancs, England; [Lotery, Andrew J.] Univ Southampton, Fac Med, Clin Neurosci Grp, Southampton SO9 5NH, Hants, England; [Webster, Andrew R.] UCL Inst Ophthalmol, London, England; [Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr, P-1200 Lisbon, Portugal	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Imperial College London; University of Oxford; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Radboud University Nijmegen; Radboud University Nijmegen; University of Manchester; University of Southampton; University of London; University College London; Universidade Nova de Lisboa	MacLaren, RE (corresponding author), Univ Oxford, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England.	enquiries@eye.ox.ac.uk	Seabra, Miguel/AAC-3099-2019; During, Matthew/AAC-1388-2020; Cremers, Frans/A-5625-2014; wei, wei/HHR-8613-2022; Seabra, Miguel C/M-3280-2013; Black, Graeme/K-7374-2015	Cremers, Frans/0000-0002-4954-5592; Seabra, Miguel C/0000-0002-6404-4892; Black, Graeme/0000-0001-8727-6592; Tolmachova, Tanya/0000-0002-8841-0797; Groppe, Markus/0000-0003-1963-3484; Lotery, Andrew/0000-0001-5541-4305; MacLaren, Robert/0000-0002-3096-4682; seymour, len/0000-0003-3825-0841	UK Department of Health; Wellcome Trust; Cancer Research UK [11339] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10185] Funding Source: researchfish; Fight for Sight [1801/02, 1936/38] Funding Source: researchfish	UK Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	Funding UK Department of Health and Wellcome Trust.	Arland V, 2003, VISION RES, V43, P919, DOI 10.1016/S0042-6989(02)00389-9; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86; Chen FK, 2009, INVEST OPHTH VIS SCI, V50, P3464, DOI 10.1167/iovs.08-2926; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; Endo K, 2000, ACTA OPHTHALMOL SCAN, V78, P483, DOI 10.1034/j.1600-0420.2000.078004483.x; Jacobson SG, 2006, INVEST OPHTH VIS SCI, V47, P4113, DOI 10.1167/iovs.06-0424; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; KLEIN R, 1983, OPHTHALMOLOGY, V90, P1357; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Loeb JE, 1999, HUM GENE THER, V10, P2295, DOI 10.1089/10430349950016942; MacLaren RE, 2009, CURR OPIN MOL THER, V11, P540; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mauthner L., 1872, BERL NATUR MED VER I, V2, P191; SANKILA EM, 1992, NAT GENET, V1, P109, DOI 10.1038/ng0592-109; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Syed R, 2013, INVEST OPHTH VIS SCI, V54, P950, DOI 10.1167/iovs.12-10707; Tolmachova T, 2013, J MOL MED, V91, P825, DOI 10.1007/s00109-013-1006-4; Tolmachova T, 2010, INVEST OPHTH VIS SCI, V51, P4913, DOI 10.1167/iovs.09-4892; VANBOKHOVEN H, 1994, HUM MOL GENET, V3, P1041, DOI 10.1093/hmg/3.7.1041; Vandenberghe L.H., 2011, SCI TRANSL MED, V3; vandenHurk JAJM, 1997, HUM MUTAT, V9, P110, DOI 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.3.CO;2-9	27	532	572	1	77	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1129	1137		10.1016/S0140-6736(13)62117-0	http://dx.doi.org/10.1016/S0140-6736(13)62117-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24439297	Green Accepted, Green Published			2022-12-28	WOS:000333956000032
J	Pauli, A; Norris, ML; Valen, E; Chew, GL; Gagnon, JA; Zimmerman, S; Mitchell, A; Ma, J; Dubrulle, J; Reyon, D; Tsai, SQ; Joung, JK; Saghatelian, A; Schier, AF				Pauli, Andrea; Norris, Megan L.; Valen, Eivind; Chew, Guo-Liang; Gagnon, James A.; Zimmerman, Steven; Mitchell, Andrew; Ma, Jiao; Dubrulle, Julien; Reyon, Deepak; Tsai, Shengdar Q.; Joung, J. Keith; Saghatelian, Alan; Schier, Alexander F.			Toddler: An Embryonic Signal That Promotes Cell Movement via Apelin Receptors	SCIENCE			English	Article							ZEBRAFISH GASTRULATION; CARDIOVASCULAR DEVELOPMENT; DROSOPHILA GASTRULATION; DEFICIENT MICE; BLOOD-VESSELS; APJ RECEPTOR; STEM-CELLS; IN-VIVO; MIGRATION; PROTEIN	It has been assumed that most, if not all, signals regulating early development have been identified. Contrary to this expectation, we identified 28 candidate signaling proteins expressed during zebrafish embryogenesis, including Toddler, a short, conserved, and secreted peptide. Both absence and overproduction of Toddler reduce the movement of mesendodermal cells during zebrafish gastrulation. Local and ubiquitous production of Toddler promote cell movement, suggesting that Toddler is neither an attractant nor a repellent but acts globally as a motogen. Toddler drives internalization of G protein-coupled APJ/Apelin receptors, and activation of APJ/Apelin signaling rescues toddler mutants. These results indicate that Toddler is an activator of APJ/Apelin receptor signaling, promotes gastrulation movements, and might be the first in a series of uncharacterized developmental signals.	[Pauli, Andrea; Norris, Megan L.; Valen, Eivind; Chew, Guo-Liang; Gagnon, James A.; Zimmerman, Steven; Dubrulle, Julien; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Mitchell, Andrew; Ma, Jiao; Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Joung, J. Keith; Schier, Alexander F.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Schier, Alexander F.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University	Pauli, A (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	pauli@fas.harvard.edu; schier@fas.harvard.edu	Tsai, Shengdar Q./G-4600-2012; Chew, Guo-Liang/R-9904-2019; Valen, Eivind/A-8617-2011; Reyon, Deepak/HCH-3183-2022	Tsai, Shengdar Q./0000-0001-9161-3993; Chew, Guo-Liang/0000-0003-4357-1404; Schier, Alexander Franz/0000-0001-7645-5325; Gagnon, James/0000-0003-3978-6058; Norris, Megan/0000-0003-0666-2665; Valen, Eivind/0000-0003-1840-6108	Editas Medicine; NIH; Human Frontier Science Program; Howard Hughes Medical Institute; American Cancer Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD076935] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102491, R01GM056211] Funding Source: NIH RePORTER	Editas Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Richardson and C. Kraft from the Harvard Center for Biological Imaging for technical support; F. Merkle for providing human and mouse embryonic stem cell RNA; M. Lin for the initial PhyloCSF analysis; L. Solnica-Krezel, E. Raz, C. Houart, members of the 2013 MBL Zebrafish Course, and the Schier laboratory for helpful discussions; and S. Mango, W. Talbot, R. Losick, J. Farrell, and K. Rogers for comments on the manuscript. Obtaining the TALEN plasmids will require the completion of a Uniform Biological Material Transfer Agreement with the Massachusetts General Hospital. The Massachusetts General Hospital has applied for a patent that covers the FLASH method used to make the TALENs and J. K. J. is an inventor on this patent. J. K. J. has financial interests in Editas Medicine and Transposagen Biopharmaceuticals. J. K. J. is a member of the Scientific Advisory Board of Transposagen Biopharmaceuticals and is a co-founder and paid consultant of Editas Medicine and holds equity in both companies. J.K.J.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. This research was supported by NIH (A. F. S., A. P., and A. S.), Human Frontier Science Program (A. P. and E. V.), Howard Hughes Medical Institute (G.-L. C.), and the American Cancer Society (J.A.G.).	Alberts B, 2007, MOLECULAR BIOLOGY OF; Barnes G, 2010, HEART, V96, P1011, DOI 10.1136/hrt.2009.191122; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; D'Aniello C, 2009, CIRC RES, V105, P231, DOI 10.1161/CIRCRESAHA.109.201186; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Giacobini P, 2007, J NEUROSCI, V27, P431, DOI 10.1523/JNEUROSCI.4979-06.2007; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Haskel-Ittah M, 2012, CELL, V150, P1016, DOI 10.1016/j.cell.2012.06.044; Hassan AS, 2010, GENE EXPR PATTERNS, V10, P127, DOI 10.1016/j.gep.2010.02.001; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Inui M, 2006, DEV BIOL, V298, P188, DOI 10.1016/j.ydbio.2006.06.028; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Kang YJ, 2013, CIRC RES, V113, P22, DOI 10.1161/CIRCRESAHA.113.301324; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Kirfel G, 2002, EUR J CELL BIOL, V81, P664, DOI 10.1078/0171-9335-00284; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2010, BIOCHEM BIOPH RES CO, V395, P185, DOI 10.1016/j.bbrc.2010.03.151; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Li X, 2013, DEVELOPMENT, V140, P3028, DOI 10.1242/dev.094839; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Nair S, 2008, SCIENCE, V322, P89, DOI 10.1126/science.1160038; Nornes Svanhild, 2009, BMC Res Notes, V2, P231, DOI 10.1186/1756-0500-2-231; Nowotschin S, 2010, CURR OPIN GENET DEV, V20, P420, DOI 10.1016/j.gde.2010.05.008; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Paskaradevan S, 2012, BIOL OPEN, V1, P275, DOI 10.1242/bio.2012380; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pezeron G, 2008, CURR BIOL, V18, P276, DOI 10.1016/j.cub.2008.01.028; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Roberts EM, 2009, J ENDOCRINOL, V202, P453, DOI 10.1677/JOE-09-0134; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Sheikh AY, 2008, AM J PHYSIOL-HEART C, V294, pH88, DOI 10.1152/ajpheart.00935.2007; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tempel D, 2012, CIRC RES, V111, P585, DOI 10.1161/CIRCRESAHA.111.262097; Tucker B, 2007, GENE EXPR PATTERNS, V7, P258, DOI 10.1016/j.modgep.2006.09.006; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang INE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038328; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zhou NM, 2003, VIROLOGY, V307, P22, DOI 10.1016/S0042-6822(02)00021-1	56	393	431	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					746	+	1248636	10.1126/science.1248636	http://dx.doi.org/10.1126/science.1248636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24407481	Green Accepted			2022-12-28	WOS:000331557800032
J	Fenalti, G; Giguere, PM; Katritch, V; Huang, XP; Thompson, AA; Cherezov, V; Roth, BL; Stevens, RC				Fenalti, Gustavo; Giguere, Patrick M.; Katritch, Vsevolod; Huang, Xi-Ping; Thompson, Aaron A.; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.			Molecular control of delta-opioid receptor signalling	NATURE			English	Article							CRYSTALLIZING MEMBRANE; ALLOSTERIC REGULATION; INVERSE AGONISTS; PROTEIN; SODIUM; BINDING; DESIGN; DISCOVERY; SELECTIVITY; ANTAGONISTS	Opioids represent widely prescribed and abused medications, although their signal transduction mechanisms are not well understood. Here we present the 1.8 angstrom high-resolution crystal structure of the human delta-opioid receptor (delta-OR), revealing the presence and fundamental role of a sodium ion in mediating allosteric control of receptor functional selectivity and constitutive activity. The distinctive delta-OR sodium ion site architecture is centrally located in a polar interaction network in the seven-transmembrane bundle core, with the sodium ion stabilizing a reduced agonist affinity state, and thereby modulating signal transduction. Site-directed mutagenesis and functional studies reveal that changing the allosteric sodium site residue Asn 131 to an alanine or a valine augments constitutive beta-arrestin-mediated signalling. Asp95Ala, Asn310Ala and Asn314Ala mutations transform classical delta-opioid antagonists such as naltrindole into potent beta-arrestin-biased agonists. The data establish the molecular basis for allosteric sodium ion control in opioid signalling, revealing that sodium-coordinating residues act as 'efficacy switches' at a prototypic G-protein-coupled receptor.	[Fenalti, Gustavo; Katritch, Vsevolod; Thompson, Aaron A.; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Giguere, Patrick M.; Huang, Xi-Ping; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC 27599 USA; [Giguere, Patrick M.; Huang, Xi-Ping; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Giguere, Patrick M.; Huang, Xi-Ping; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Stevens, RC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	bryan_roth@med.unc.edu; stevens@scripps.edu	Stevens, Raymond/K-7272-2015; Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Y-2721-2019; Katritch, Vsevolod/Q-8357-2016	Stevens, Raymond/0000-0002-4522-8725; Roth, Bryan/0000-0002-0561-6520; Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Huang, Xi-Ping/0000-0002-2585-653X; Thompson, Aaron/0000-0003-4314-4242	National Institutes of Health [P50 GM073197, U54 GM094618, R01 DA017204]; NIMH Psychoactive Drug Screening Program; Michael Hooker Chair for Protein Therapeutics and Translational Proteomics; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, P50GM073197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair for Protein Therapeutics and Translational Proteomics; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health Common Fund grant P50 GM073197 for technology development (V. C. and R. C. S.), PSI:Biology grant U54 GM094618 for biological studies and structure production (target GPCR-39) (V. K., V. C. and R. C. S.), R01 DA017204 and the NIMH Psychoactive Drug Screening Program (P. G., X.-P. H., B. L. R.) and the Michael Hooker Chair for Protein Therapeutics and Translational Proteomics to B. L. R. We thank J. Velasquez for help with molecular biology, T. Trinh and M. Chu for help with baculovirus expression, G. W. Han for help with structure analysis and quality control review, E. Abola for help with sodium site analysis, A. Walker for assistance with manuscript preparation and J. Smith, R. Fischetti and N. Sanishvili for assistance in development and use of the minibeam and beamtime at beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bonner G, 2000, EUR J PHARMACOL, V403, P37, DOI 10.1016/S0014-2999(00)00578-1; Burford NT, 2013, P NATL ACAD SCI USA, V110, P10830, DOI 10.1073/pnas.1300393110; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; CHILDERS SR, 1993, MOL PHARMACOL, V44, P827; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Chu R, 2002, J MOL BIOL, V323, P253, DOI 10.1016/S0022-2836(02)00884-7; COOPER DMF, 1982, J NEUROCHEM, V38, P1164, DOI 10.1111/j.1471-4159.1982.tb05365.x; COSTA T, 1990, MOL PHARMACOL, V37, P383; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filizola M, 2013, TRENDS PHARMACOL SCI, V34, P6, DOI 10.1016/j.tips.2012.10.002; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Liu JG, 2002, J PHARMACOL EXP THER, V302, P1070, DOI 10.1124/jpet.102.035964; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEVE KA, 1991, MOL PHARMACOL, V39, P570; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pasternak GW, 2014, NEUROPHARMACOLOGY, V76, P198, DOI 10.1016/j.neuropharm.2013.03.039; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; PORTOGHESE PS, 1988, J MED CHEM, V31, P281, DOI 10.1021/jm00397a001; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Selley DE, 2000, BRIT J PHARMACOL, V130, P987, DOI 10.1038/sj.bjp.0703382; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Szekeres PG, 1997, J PHARMACOL EXP THER, V283, P1276; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yabaluri N, 1997, J NEUROCHEM, V68, P1053	46	347	356	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					191	196		10.1038/nature12944	http://dx.doi.org/10.1038/nature12944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24413399	Green Accepted, Green Submitted			2022-12-28	WOS:000331107700031
J	Peltola, H; Paakkonen, M				Peltola, Heikki; Paakkonen, Markus			Acute Osteomyelitis in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE HEMATOGENOUS OSTEOMYELITIS; STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS; C-REACTIVE PROTEIN; METHICILLIN-RESISTANT; CLINDAMYCIN TREATMENT; SEPTIC ARTHRITIS; JOINT INFECTIONS; KINGELLA-KINGAE; BONE; THERAPY	Unless acute osteomyelitis in children is diagnosed promptly and treated appropriately, it can be a devastating or even fatal disease. This review summarizes the current approach to the treatment of acute osteomyelitis in children. Bacteria may reach bone through direct inoculation from traumatic wounds, by spreading from adjacent tissue affected by cellulitis or septic arthritis, or through hematogenous seeding. In children, an acute bone infection is most often hematogenous in origin.(1) In high-income countries, acute osteomyelitis occurs in about 8 of 100,000 children per year,(2) but it is considerably more common in low-income countries. Boys are affected twice as often as girls.(2),(3) Unless acute osteomyelitis is diagnosed promptly and treated appropriately,(4) it can be a devastating or even fatal disease with a high rate of sequelae, especially in resource-poor countries where patients present ...	[Peltola, Heikki] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Peltola, Heikki] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Paakkonen, Markus] Univ Turku, Div Dis Musculoskeletal Syst, Turku, Finland; [Paakkonen, Markus] Turku Univ Hosp, Turku 20521, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku	Paakkonen, M (corresponding author), Turku Univ Hosp, Kiinamyllynkatu 4-8,POB 52, Turku 20521, Finland.	markus.paakkonen@helsinki.fi						Arnold JC, 2012, PEDIATRICS, V130, pE821, DOI 10.1542/peds.2012-0220; Atkins BL, 1997, J INFECTION, V34, P133, DOI 10.1016/S0163-4453(97)92452-X; Belthur MV, 2012, J BONE JOINT SURG AM, V94A, P34, DOI 10.2106/JBJS.J.01915; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Bradley JS, 2011, PEDIATRICS, V128, pE1034, DOI 10.1542/peds.2011-1496; Bradley JS, 1998, PEDIATRICS, V102, P1376, DOI 10.1542/peds.102.6.1376; Butbul-Aviel Y, 2005, PEDIATR EMERG CARE, V21, P828, DOI 10.1097/01.pec.0000190226.12610.24; Ceroni D, 2003, REV CHIR ORTHOP, V89, P250; Chen CJ, 2007, PEDIATR INFECT DIS J, V26, P985, DOI 10.1097/INF.0b013e31812e62dc; COLE WG, 1982, J BONE JOINT SURG BR, V64, P218, DOI 10.1302/0301-620X.64B2.6802854; Connolly LP, 2002, J NUCL MED, V43, P1310; Connolly SA, 2007, AM J ROENTGENOL, V189, P867, DOI 10.2214/AJR.07.2416; Dartnell J, 2012, J BONE JOINT SURG BR, V94B, P584, DOI 10.1302/0301-620X.94B5.28523; DICH VQ, 1975, AM J DIS CHILD, V129, P1273, DOI 10.1001/archpedi.1975.02120480007004; Dubnov-Raz G, 2008, PEDIATRICS, V122, P1305, DOI 10.1542/peds.2007-3070; EBONG WW, 1986, ANN RHEUM DIS, V45, P911, DOI 10.1136/ard.45.11.911; FEIGIN RD, 1975, PEDIATRICS, V55, P213; GILLESPIE WJ, 1981, J BONE JOINT SURG BR, V63, P126, DOI 10.1302/0301-620X.63B1.7009619; Grammatico-Guillon L, 2013, ACTA PAEDIATR, V102, pe120, DOI 10.1111/apa.12115; GREEN JH, 1967, BMJ-BRIT MED J, V2, P414, DOI 10.1136/bmj.2.5549.414; HARRIS NH, 1960, J BONE JOINT SURG BR, V42, P535, DOI 10.1302/0301-620X.42B3.535; Have KLV, 2009, J PEDIATR ORTHOPED, V29, P927, DOI 10.1097/BPO.0b013e3181bd1e0c; Jaberi FM, 2002, J PEDIATR ORTHOPED, V22, P317; Jagodzinski NA, 2009, J PEDIATR ORTHOPED, V29, P518, DOI 10.1097/BPO.0b013e3181ab472d; Ju KL, 2011, J BONE JOINT SURG AM, V93A, P1693, DOI [10.2106/JBJSJ.01154, 10.2106/JBJS.J.01154]; Kaplan Sheldon L., 2003, Pediatric Infectious Disease Journal, V22, pS178, DOI 10.1097/01.inf.0000087020.75886.93; KAPLAN SL, 1982, SOUTHERN MED J, V75, P138, DOI 10.1097/00007611-198202000-00005; Kenney WE, 1944, SURGERY, V16, P477; Krogstad P, 2009, TXB PEDIAT INFECT DI, V6th, P725; Landersdorfer CB, 2009, CLIN PHARMACOKINET, V48, P89, DOI 10.2165/0003088-200948020-00002; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Mantadakis E, 2012, INT J INFECT DIS, V16, pE236, DOI 10.1016/j.ijid.2011.12.012; Marti-Carvajal AJ, 2012, COCHRANE DB SYST REV, V12; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; Meller I, 1989, Orthop Rev, V18, P824; Messina AF, 2011, PEDIATR INFECT DIS J, V30, P1019, DOI 10.1097/INF.0b013e31822db658; Paakkonen M, 2010, CLIN ORTHOP RELAT R, V468, P861, DOI 10.1007/s11999-009-0936-1; Peltola H, 2012, CLIN MICROBIOL INFEC, V18, P582, DOI 10.1111/j.1469-0691.2011.03643.x; Peltola H, 2010, PEDIATR INFECT DIS J, V29, P1123, DOI 10.1097/INF.0b013e3181f55a89; Penberthy GC, 1941, ANN SURG, V114, P129, DOI 10.1097/00000658-194107000-00014; Prado MA, 2008, REV CHIL INFECTOL, V25, P30, DOI /S0716-10182008000100007; Riise OR, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-45; SHERMAN JW, 1987, AM J MED, V83, P137, DOI 10.1016/0002-9343(87)90508-0; STEPHENS MM, 1988, CLIN ORTHOP RELAT R, P211; SUMMERSGILL JT, 1982, ANTIMICROB AGENTS CH, V21, P601, DOI 10.1128/AAC.21.4.601; SYROGIANNOPOULOS GA, 1988, LANCET, V1, P37; TETZLAFF TR, 1978, J PEDIATR-US, V92, P485, DOI 10.1016/S0022-3476(78)80455-7; TETZLAFF TR, 1978, J PEDIATR-US, V92, P135, DOI 10.1016/S0022-3476(78)80095-X; VAUGHAN PA, 1987, J PEDIATR ORTHOPED, V7, P652; Yagupsky P, 2011, PEDIATRICS, V127, P557, DOI 10.1542/peds.2010-1867	50	189	198	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					352	360		10.1056/NEJMra1213956	http://dx.doi.org/10.1056/NEJMra1213956			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450893				2022-12-28	WOS:000330036200010
J	Djulbegovic, B; Hozo, I; Ioannidis, JPA				Djulbegovic, Benjamin; Hozo, Iztok; Ioannidis, John P. A.			Improving the Drug Development Process More Not Less Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Djulbegovic, Benjamin] Univ S Florida, Dept Internal Med, H Lee Moffitt Canc Ctr & Res Inst, Div Evidence Based Med, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL USA; [Djulbegovic, Benjamin] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcome Behav, Tampa, FL USA; [Hozo, Iztok] Indiana Univ, Dept Math, Gary, IN USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities Sci, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Meta Res Innovat Ctr Stanford, Stanford, CA USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Indiana University System; Indiana University Northwest; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Djulbegovic, Benjamin/I-3661-2012; Ioannidis, John P. A./G-9836-2011; Hozo, ihozo@iun.edu/R-3498-2016	Djulbegovic, Benjamin/0000-0003-0671-1447; Hozo, ihozo@iun.edu/0000-0003-2349-5707	NATIONAL CANCER INSTITUTE [R01CA133594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052956, R01NS044417] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA133594-01] Funding Source: Medline; NINDS NIH HHS [1 R01 NS052956-01, 1R01NS044417-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bhattacharjee Y, 2012, SCIENCE, V338, P29, DOI 10.1126/science.338.6103.29; CHALMERS TC, 1975, MED CLIN N AM, V59, P1035, DOI 10.1016/S0025-7125(16)32001-6; Djulbegovic B, 2013, NATURE, V500, P395, DOI 10.1038/500395a; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pisano G., 2006, HARVARD BUS REV, P1; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609	10	24	23	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					355	356		10.1001/jama.2013.283742	http://dx.doi.org/10.1001/jama.2013.283742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449311				2022-12-28	WOS:000329939300016
J	Du, Z; Santella, A; He, F; Tiongson, M; Bao, ZR				Du, Zhuo; Santella, Anthony; He, Fei; Tiongson, Michael; Bao, Zhirong			De Novo Inference of Systems-Level Mechanistic Models of Development from Live-Imaging-Based Phenotype Analysis	CELL			English	Article							SINGLE-CELL RESOLUTION; C. ELEGANS EMBRYO; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; EMBRYOGENESIS; LINEAGE; PROTEIN	Elucidation of complex phenotypes for mechanistic insights presents a significant challenge in systems biology. We report a strategy to automatically infer mechanistic models of cell fate differentiation based on live-imaging data. We use cell lineage tracing and combinations of tissue-specific marker expression to assay progenitor cell fate and detect fate changes upon genetic perturbation. Based on the cellular phenotypes, we further construct a model for how fate differentiation progresses in progenitor cells and predict cell-specific gene modules and cell-to-cell signaling events that regulate the series of fate choices. We validate our approach in C. elegans embryogenesis by perturbing 20 genes in over 300 embryos. The result not only recapitulates current knowledge but also provides insights into gene function and regulated fate choice, including an unexpected self-renewal. Our study provides a powerful approach for automated and quantitative interpretation of complex in vivo information.	[Du, Zhuo; Santella, Anthony; He, Fei; Tiongson, Michael; Bao, Zhirong] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Bao, ZR (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	baoz@mskcc.org	Du, Zhuo/AAD-2263-2019; FEI, HE/C-5912-2015	Du, Zhuo/0000-0002-6322-4656; FEI, HE/0000-0002-1165-3248; Bao, Zhirong/0000-0002-2201-2745	NIH [HD075602, GM097576]; NIH Office of Research Infrastructure Programs [P40 OD010440]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD075602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097576] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Priess for critical discussions, J. Rothman, M. Maduro, J. Gaudet, J. Kimble, and B. Page for reagents; Q. Li and Y. Kamikawa for technical assistance; and I. Kovacevic and M. Pellegrino for critical reading of the manuscript. This work is partly supported by NIH grants (HD075602 and GM097576) to Z. B. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Arata Y, 2010, DEVELOPMENT, V137, P3337, DOI 10.1242/dev.054742; Bao ZR, 2008, DEV BIOL, V318, P65, DOI 10.1016/j.ydbio.2008.02.054; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; BOWERMAN B, 1993, CELL, V74, P443, DOI 10.1016/0092-8674(93)80046-H; Busch W, 2012, NAT METHODS, V9, P1101, DOI [10.1038/NMETH.2185, 10.1038/nmeth.2185]; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hench J, 2009, DEV BIOL, V333, P1, DOI 10.1016/j.ydbio.2009.06.014; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Mace DL, 2013, G3-GENES GENOM GENET, V3, P851, DOI 10.1534/g3.113.005918; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Moore JL, 2013, DEVELOPMENT, V140, P3266, DOI 10.1242/dev.096040; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Page BD, 2007, DEVELOPMENT, V134, P2303, DOI 10.1242/dev.02855; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schnabel R., 1997, C ELEGANS, P361; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4	24	56	56	3	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					359	372		10.1016/j.cell.2013.11.046	http://dx.doi.org/10.1016/j.cell.2013.11.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439388	Green Accepted, Bronze			2022-12-28	WOS:000329912200033
J	Fairclough, S				Fairclough, Stephen			Physiological data must remain confidential	NATURE			English	Editorial Material									Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England	Liverpool John Moores University	Fairclough, S (corresponding author), Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England.	s.fairclough@ljmu.ac.uk		Fairclough, Stephen/0000-0002-7850-5688					0	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					263	263		10.1038/505263a	http://dx.doi.org/10.1038/505263a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	288OR	24429594	Bronze			2022-12-28	WOS:000329621800004
J	Mott, R; Yuan, W; Kaisaki, P; Gan, XC; Cleak, J; Edwards, A; Baud, A; Flint, J				Mott, Richard; Yuan, Wei; Kaisaki, Pamela; Gan, Xiangchao; Cleak, James; Edwards, Andrew; Baud, Amelie; Flint, Jonathan			The Architecture of Parent-of-Origin Effects in Mice	CELL			English	Article							HETEROGENEOUS STOCK MICE; QUANTITATIVE TRAITS; COMPLEX DISEASES; EXPRESSION; GENE; ASSOCIATION; GROWTH; HERITABILITY; ALLELES	The number of imprinted genes in the mammalian genome is predicted to be small, yet we show here, in a survey of 97 traits measured in outbred mice, that most phenotypes display parent-of-origin effects that are partially confounded with family structure. To address this contradiction, using reciprocal F1 crosses, we investigated the effects of knocking out two nonimprinted candidate genes, Man1a2 and H2-ab1, that reside at nonimprinted loci but that show parent-of-origin effects. We show that expression of multiple genes becomes dysregulated in a sex-, tissue-, and parent-of-origin- dependent manner. We provide evidence that nonimprinted genes can generate parent-of-origin effects by interaction with imprinted loci and deduce that the importance of the number of imprinted genes is secondary to their interactions. We propose that this gene network effect may account for some of the missing heritability seen when comparing sibling-based to population-based studies of the phenotypic effects of genetic variants.	[Mott, Richard; Yuan, Wei; Kaisaki, Pamela; Gan, Xiangchao; Cleak, James; Edwards, Andrew; Baud, Amelie; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Mott, R (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	richard.mott@well.ox.ac.uk	Baud, Amelie/AAB-1606-2021	Baud, Amelie/0000-0003-2448-0283; Gan, Xiangchao/0000-0001-6398-5191; Mott, Richard/0000-0002-1022-9330; Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust [083573/Z/07/Z, 090532/Z/09/Z, 089269/Z/09/Z]; MRC Hub grant [G0900747 91070]	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust grants 083573/Z/07/Z, 090532/Z/09/Z, and 089269/Z/09/Z. We thank Binnaz Yalcin for technical assistance, Tim Aitman, Elizabeth M. Fisher, Julian Knight, Delia O'Rourke, and Emma Huang for comments. We thank the High-Throughput Genomics Group at the WTCHG (funded by Wellcome Trust grant 090532/Z/09/Z and MRC Hub grant G0900747 91070) for the generation of the sequencing data.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; BENOIST CO, 1983, CELL, V34, P169, DOI 10.1016/0092-8674(83)90147-2; Cabrera CP, 2012, G3-GENES GENOM GENET, V2, P1067, DOI 10.1534/g3.112.002618; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; KANBOURSHAKIR A, 1993, BIOL REPROD, V48, P977, DOI 10.1095/biolreprod48.5.977; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Nagano Y, 2001, NEUROSCI LETT, V316, P103, DOI 10.1016/S0304-3940(01)02330-8; Neugebauer N, 2010, ANIMAL, V4, P672, DOI 10.1017/S1751731109991625; Qin YM, 2002, J IMMUNOL, V169, P3536, DOI 10.4049/jimmunol.169.7.3536; Seoighe C, 2006, BIOINFORMATICS, V22, P3032, DOI 10.1093/bioinformatics/btl521; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Spencer HG, 2009, GENETICA, V136, P285, DOI 10.1007/s10709-008-9300-8; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tremblay LO, 2007, J BIOL CHEM, V282, P2558, DOI 10.1074/jbc.M608661200; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vento MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015636; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Whittaker JC, 2003, AM J HUM GENET, V72, P1035, DOI 10.1086/374382; Wolf JB, 2009, J EVOLUTION BIOL, V22, P2519, DOI 10.1111/j.1420-9101.2009.01874.x; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	41	56	56	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					332	342		10.1016/j.cell.2013.11.043	http://dx.doi.org/10.1016/j.cell.2013.11.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439386	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000329912200031
J	Platero-Luengo, A; Gonzalez-Granero, S; Duran, R; Diaz-Castro, B; Piruat, JI; Garcia-Verdugo, JM; Pardal, R; Lopez-Barneo, J				Platero-Luengo, Aida; Gonalez-Granero, Susana; Duran, Rocio; Diaz-Castro, Blanca; Piruat, Jose I.; Manuel Garcia-Verdugo, Jose; Pardal, Ricardo; Lopez-Barneo, Jose			An O-2-Sensitive Glomus Cell-Stem Cell Synapse Induces Carotid Body Growth in Chronic Hypoxia	CELL			English	Article							ENDOTHELIN RECEPTOR ANTAGONIST; PULMONARY-HYPERTENSION; ADULT NEUROGENESIS; GENE-EXPRESSION; RAT; OXYGEN; MICE; HYPERPLASIA; MECHANISMS; RESPONSES	Neural stem cells (NSCs) exist in germinal centers of the adult brain and in the carotid body (CB), an oxygen- sensing organ that grows under chronic hypoxemia. How stem cell lineage differentiation into mature glomus cells is coupled with changes in physiological demand is poorly understood. Here, we show that hypoxia does not affect CB NSC proliferation directly. Rather, mature glomus cells expressing endothelin-1, the O-2-sensing elements in the CB that secrete neurotransmitters in response to hypoxia, establish abundant synaptic-like contacts with stem cells, which express endothelin receptors, and instruct their growth. Inhibition of glomus cell transmitter release or their selective destruction markedly diminishes CB cell growth during hypoxia, showing that CB NSCs are under the direct "synaptic'' control of the mature O-2-sensitive cells. Thus, glomus cells not only acutely activate the respiratory center but also induce NSC-dependent CB hypertrophy necessary for acclimatization to chronic hypoxemia.	[Platero-Luengo, Aida; Duran, Rocio; Diaz-Castro, Blanca; Piruat, Jose I.; Pardal, Ricardo; Lopez-Barneo, Jose] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Dept Fisiol Med & Biofis,Inst Biomed Sevilla IBiS, Seville 41013, Spain; [Gonalez-Granero, Susana; Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolu, Valencia 46071, Spain; [Gonalez-Granero, Susana; Manuel Garcia-Verdugo, Jose; Lopez-Barneo, Jose] Ctr Invest Biomed Red Enfermedade Neurodegenerat, Madrid 28031, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Valencia; CIBERNED	Pardal, R (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen Rocio, Dept Fisiol Med & Biofis,Inst Biomed Sevilla IBiS, Seville 41013, Spain.	rpardal@us.es; lbarneo@us.es	Pardal, Ricardo/C-4370-2015; García-Verdugo, José Manuel/L-8421-2017; González-Granero, Susana/Q-3861-2018; Platero Luengo, Aida/GNW-5468-2022; IBIS, FISIOPATOLOGIA/O-9510-2015; Platero-Luengo, Aida/A-6352-2017; Luengo, Aida Platero/ABE-3282-2020; IBIS, NEUROBIOLOGIA/O-9922-2015	Pardal, Ricardo/0000-0003-1085-0714; García-Verdugo, José Manuel/0000-0001-9872-6499; González-Granero, Susana/0000-0003-1531-550X; Platero-Luengo, Aida/0000-0002-4693-7654; Luengo, Aida Platero/0000-0002-4693-7654; 	Botin Foundation; European Research Council; Spanish Ministries of Science and Innovation and Health (SAF program); Spanish Ministries of Science and Innovation and Health (TERCEL program)	Botin Foundation; European Research Council(European Research Council (ERC)European Commission); Spanish Ministries of Science and Innovation and Health (SAF program); Spanish Ministries of Science and Innovation and Health (TERCEL program)	Research was supported by the Botin Foundation (J.L.-B.), the European Research Council (Starting Grant; R. P.), and the Spanish Ministries of Science and Innovation and Health (SAF and TERCEL programs). A. P.-L. received a predoctoral fellowship of the FPU program. We are indebted to Patricia Ortega-Saenz, Paula Garcia-Flores, and Francisco M. Vega for help in the experiments. We thank Maria Jose Castro and Konstantin Levitsky for technical assistance and Martine Clozel (Actelion Pharmaceuticals) for the gift of bosentan.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; ARIASSTELLA J, 1976, HUM PATHOL, V7, P361, DOI 10.1016/S0046-8177(76)80052-4; Bishop T, 2013, J PHYSIOL-LONDON, V591, P3565, DOI 10.1113/jphysiol.2012.247254; Bonano M, 2008, DEV BIOL, V323, P114, DOI 10.1016/j.ydbio.2008.08.007; BONVALLET ST, 1994, AM J PHYSIOL, V266, pH1327, DOI 10.1152/ajpheart.1994.266.4.H1327; Chell JM, 2012, CELL STEM CELL, V11, P282, DOI 10.1016/j.stem.2012.08.009; Chen J, 2007, AM J PHYSIOL-LUNG C, V292, pL1257, DOI 10.1152/ajplung.00419.2006; Clouthier DE, 1998, DEVELOPMENT, V125, P813; CZYZYKKRZESKA MF, 1992, J NEUROCHEM, V58, P1538, DOI 10.1111/j.1471-4159.1992.tb11376.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Diaz-Castro B, 2012, MOL CELL BIOL, V32, P3347, DOI 10.1128/MCB.00128-12; EDDAHIBI S, 1995, AM J PHYSIOL-HEART C, V268, pH828, DOI 10.1152/ajpheart.1995.268.2.H828; ELTON TS, 1992, AM J PHYSIOL, V263, pR1260, DOI 10.1152/ajpregu.1992.263.6.R1260; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; HEATH D, 1982, J PATHOL, V138, P115, DOI 10.1002/path.1711380203; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Joseph V, 2009, CELL MOL LIFE SCI, V66, P3565, DOI 10.1007/s00018-009-0143-y; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kokovay E, 2007, CELL, V131, P234, DOI 10.1016/j.cell.2007.10.006; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; MCQUEEN DS, 1995, J AUTONOM NERV SYST, V53, P115, DOI 10.1016/0165-1838(94)00179-N; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2000, J NEUROSCI, V20, P7370; OPARIL S, 1995, AM J PHYSIOL-LUNG C, V268, pL95, DOI 10.1152/ajplung.1995.268.1.L95; Ortega-Saenz P, 2007, RESP PHYSIOL NEUROBI, V157, P140, DOI 10.1016/j.resp.2007.02.009; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Powell FL, 1998, RESP PHYSIOL, V112, P123, DOI 10.1016/S0034-5687(98)00026-7; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Shichiri M, 1998, MOL ENDOCRINOL, V12, P172, DOI 10.1210/me.12.2.172; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Stosic J, 2010, BIOMED ENVIRON SCI, V23, P293, DOI 10.1016/S0895-3988(10)60066-9; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Timmers HJLM, 2003, J PHYSIOL-LONDON, V553, P3, DOI 10.1113/jphysiol.2003.052415; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; WANG YZ, 1994, AM J PHYSIOL-CELL PH, V267, pC1130, DOI 10.1152/ajpcell.1994.267.4.C1130; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	48	72	74	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					291	303		10.1016/j.cell.2013.12.013	http://dx.doi.org/10.1016/j.cell.2013.12.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439383	Bronze			2022-12-28	WOS:000329912200028
J	Grigoriadis, S; VonderPorten, EH; Mamisashvili, L; Tomlinson, G; Dennis, CL; Koren, G; Steiner, M; Mousmanis, P; Cheung, A; Ross, LE				Grigoriadis, Sophie; VonderPorten, Emily H.; Mamisashvili, Lana; Tomlinson, George; Dennis, Cindy-Lee; Koren, Gideon; Steiner, Meir; Mousmanis, Patricia; Cheung, Amy; Ross, Lori E.			Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN-REUPTAKE INHIBITORS; MATERNAL USE; MEDICATION USE; PREGNANCY; RISK; DEPRESSION; DELIVERY; MORBIDITY; OUTCOMES; QUALITY	Objective To examine the risk for persistent pulmonary hypertension of the newborn associated with antenatal exposure to antidepressants. Design Systematic review and meta-analysis. Data sources Embase, Medline, PsycINFO, and CINAHL from inception to 30 December 2012. Eligibility English language studies reporting persistent pulmonary hypertension of the newborn associated with exposure to antidepressants. Two independent reviewers extracted data and assessed the quality of each article. Results Of the 3077 abstracts reviewed, 738 papers were retrieved and seven included. All seven studies were above our quality threshold. Quantitative analysis was only possible for selective serotonin reuptake inhibitors (SSRIs). Although exposure to SSRIs in early pregnancy was not associated with persistent pulmonary hypertension of the newborn (odds ratio 1.23, 95% confidence interval 0.58 to 2.60; P=0.58), exposure in late pregnancy was (2.50, 1.32 to 4.73; P=0.005). Effects were not significant for any of the moderator variables examined, including study design, congenital malformations, and meconium aspiration. It was not possible to assess for the effect of caesarean section, body mass index, or preterm delivery. The absolute risk difference for development of persistent pulmonary hypertension of the newborn after exposure to SSRIs in late pregnancy was 2.9 to 3.5 per 1000 infants; therefore an estimated 286 to 351 women would need to be treated with an SSRI in late pregnancy to result in an average of one additional case of persistent pulmonary hypertension of the newborn. Conclusions The risk of persistent pulmonary hypertension of the newborn seems to be increased for infants exposed to SSRIs in late pregnancy, independent of the potential moderator variables examined. A significant relation for exposure to SSRIs in early pregnancy was not evident. Although the statistical association was significant, clinically the absolute risk of persistent pulmonary hypertension of the newborn remained low even in the context of late exposure to SSRIs.	[Grigoriadis, Sophie; VonderPorten, Emily H.; Mamisashvili, Lana; Cheung, Amy] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; [Grigoriadis, Sophie; Cheung, Amy] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Grigoriadis, Sophie; Cheung, Amy] Sunnybrook Res Inst, Toronto, ON, Canada; [Tomlinson, George] Mt Sinai Hosp, Univ Hlth Network, Dept Med, Toronto, ON M5G 1X5, Canada; [Dennis, Cindy-Lee] Univ Toronto, Fac Nursing, Toronto, ON, Canada; [Dennis, Cindy-Lee] Univ Toronto, Fac Med, Toronto, ON, Canada; [Dennis, Cindy-Lee] Womens Coll Res Inst, Toronto, ON, Canada; [Koren, Gideon] Hosp Sick Children, Dept Pediat, Motherisk Program, Toronto, ON M5G 1X8, Canada; [Steiner, Meir] St Josephs Healthcare, Womens Hlth Concerns Clin, Hamilton, ON, Canada; [Mousmanis, Patricia] Ontario Coll Family Phys, Hlth Child Dev Program, Toronto, ON, Canada; [Ross, Lori E.] Ctr Addict & Mental Hlth, Hlth Syst & Hlth Equ Res Grp, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Grigoriadis, S (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Psychiat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	sophie.grigoriadis@sunnybrook.ca	Grigoriadis, Sophie/AAM-9372-2021; Dennis, Cindy-Lee/ABA-2860-2020; Koren, Gideon/AAG-7726-2019; Grigoriadis, Sophie/AAM-9355-2021; Steiner, Meir/B-2121-2016; Tomlinson, George A/L-5432-2016	Grigoriadis, Sophie/0000-0003-3461-6850; Dennis, Cindy-Lee/0000-0002-0135-7242; Koren, Gideon/0000-0002-9234-0875; Tomlinson, George A/0000-0002-9328-6399	Canadian Institutes of Health Research [KRS-83127]; Ontario Ministry of Health and Long-Term Care through the Drug Innovation Fund [2008-005]; Canadian Institutes of Health Research; Ontario Women's Health Council [NOW-88207, NOW-84656]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care through the Drug Innovation Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council	This study was funded by a research syntheses grant from the Canadian Institutes of Health Research (KRS-83127) and the Ontario Ministry of Health and Long-Term Care through the Drug Innovation Fund (grant No 2008-005). SG held a new investigator award in women's health research from Canadian Institutes of Health Research in partnership with the Ontario Women's Health Council (award NOW-88207). LER held a new investigator award from the Canadian Institutes of Health Research and the Ontario Women's Health Council (award NOW-84656). The funding sources had no role in the study design; collection, analysis, or interpretation of results; writing of the manuscript; or submission of the manuscript for publication. The researchers were independent from the funders. The views expressed here do not necessarily reflect those of the Ministry of Health and Long-Term Care.	Andrade SE, 2009, PHARMACOEPIDEM DR S, V18, P246, DOI 10.1002/pds.1710; Austin MP, 2007, MED J AUSTRALIA, V186, P364, DOI 10.5694/j.1326-5377.2007.tb00940.x; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chung TKH, 2001, PSYCHOSOM MED, V63, P830, DOI 10.1097/00006842-200109000-00017; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Friedman SH, 2005, J AM ACAD PSYCHIATRY, V33, P496; Friedman SH, 2007, WORLD PSYCHIATRY, V6, P137; Galbally M, 2012, CNS DRUGS, V26, P813, DOI 10.2165/11630310-000000000-00000; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE309, DOI 10.4088/JCP.12r07967; Grigoriadis S, 2011, ARCH WOMEN MENT HLTH, V14, P325, DOI 10.1007/s00737-011-0223-5; Groome LJ, 1995, J DEV BEHAV PEDIATR, V16, P391; Grzeskowiak LE, 2012, EUR J CLIN PHARMACOL, V68, P459, DOI 10.1007/s00228-011-1154-9; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Hernandez-Martinez C, 2011, WOMEN HEALTH, V51, P124, DOI 10.1080/03630242.2010.550991; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hildingsson I, 2002, BJOG-INT J OBSTET GY, V109, P618, DOI 10.1111/j.1471-0528.2002.01393.x; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Kallen B, 2008, PHARMACOEPIDEM DR S, V17, P801, DOI 10.1002/pds.1570; Kallen B, 2011, EUR J CLIN PHARMACOL, V67, P839, DOI 10.1007/s00228-011-1021-8; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Koren G, 2012, AM J OBSTET GYNECOL, V207, P157, DOI 10.1016/j.ajog.2012.02.009; Koren G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7642; Lim K, 2012, EARLY HUM DEV, V88, P609, DOI 10.1016/j.earlhumdev.2012.01.004; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Oates M, 2003, BRIT MED BULL, V67, P219, DOI 10.1093/bmb/ldg011; Occhiogrosso M, 2012, AM J PSYCHIAT, V169, P134, DOI 10.1176/appi.ajp.2011.11040553; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Ross LE, 2011, INT J METH PSYCH RES, V20, P224, DOI 10.1002/mpr.356; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Spinelli MG, 2004, AM J PSYCHIAT, V161, P1548, DOI 10.1176/appi.ajp.161.9.1548; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; 't Jong GW, 2012, REPROD TOXICOL, V34, P293, DOI 10.1016/j.reprotox.2012.04.015; The R Project for Statistical Computing, 2012, R LANG ENV STAT COMP; US Food and Drug Administration, 2012, PUBL HLTH ADV TREATM; US Food and Drug Administration, 2012, FDA DRUG SAF COMM SE; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walsh-Sukys MC, 2000, PEDIATRICS, V105, P14, DOI 10.1542/peds.105.1.14; Wells G.A., 2009, NEWCASTLE OTTAWA SCA; Wichman CL, 2009, MAYO CLIN PROC, V84, P23, DOI 10.4065/84.1.23; Wiklund I, 2007, ACTA OBSTET GYN SCAN, V86, P451, DOI 10.1080/00016340701217913; Wilson KL, 2011, AM J PERINAT, V28, P19, DOI 10.1055/s-0030-1262507; Winovitch KC, 2011, J MATERN-FETAL NEO M, V24, P1398, DOI 10.3109/14767058.2010.551681; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]	50	102	107	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2014	348								f6932	10.1136/bmj.f6932	http://dx.doi.org/10.1136/bmj.f6932			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MN	24429387	Green Published, hybrid			2022-12-28	WOS:000329975900001
J	Tozer, S; Morin, X				Tozer, Samuel; Morin, Xavier			Young Neurons Sever Ties to the Parental Niche	SCIENCE			English	Editorial Material							CELLS		[Tozer, Samuel] Ecole Normale Super, Inst Biol, F-75005 Paris, France; INSERM, U1024, F-75005 Paris, France; CNRS, UMR 8197, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Tozer, S (corresponding author), Ecole Normale Super, Inst Biol, F-75005 Paris, France.	xavier.morin@ens.fr	morin, xavier/AAI-3306-2020	Morin, Xavier/0000-0001-9999-0355				Cheng PL, 2012, ANNU REV NEUROSCI, V35, P181, DOI 10.1146/annurev-neuro-061010-113618; Das RM, 2014, SCIENCE, V343, P200, DOI 10.1126/science.1247521; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; Hatanaka Y, 2012, DEV GROWTH DIFFER, V54, P398, DOI 10.1111/j.1440-169X.2012.01344.x; Paridaen JTML, 2013, CELL, V155, P333, DOI 10.1016/j.cell.2013.08.060; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294	8	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					146	147		10.1126/science.1249497	http://dx.doi.org/10.1126/science.1249497			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408425				2022-12-28	WOS:000329440800029
J	Elkins, MH; Williams, HL; Shreve, AT; Neumark, DM				Elkins, Madeline H.; Williams, Holly L.; Shreve, Alexander T.; Neumark, Daniel M.			Relaxation Mechanism of the Hydrated Electron	SCIENCE			English	Article							RESOLVED PHOTOELECTRON-SPECTROSCOPY; WATER CLUSTER ANIONS; LOW KINETIC-ENERGY; SOLVATED ELECTRONS; AQUEOUS-SOLUTIONS; EXCESS ELECTRONS; LIQUID WATER; DYNAMICS; BULK; SPECTRA	The relaxation dynamics of the photoexcited hydrated electron have been subject to conflicting interpretations. Here, we report time-resolved photoelectron spectra of hydrated electrons in a liquid microjet with the aim of clarifying ambiguities from previous experiments. A sequence of three ultrashort laser pulses (similar to 100 femtosecond duration) successively created hydrated electrons by charge-transfer-to-solvent excitation of dissolved anions, electronically excited these electrons via the s -> p transition, and then ejected them into vacuum. Two distinct transient signals were observed. One was assigned to the initially excited p-state with a lifetime of similar to 75 femtoseconds, and the other, with a lifetime of similar to 400 femtoseconds, was attributed to s-state electrons just after internal conversion in a nonequilibrated solvent environment. These assignments support the nonadiabatic relaxation model.	[Elkins, Madeline H.; Williams, Holly L.; Neumark, Daniel M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Shreve, Alexander T.] Intel Corp, Hillsboro, OR 97124 USA; [Neumark, Daniel M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Intel Corporation; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Neumark, DM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dneumark@berkeley.edu	Neumark, Daniel M/B-9551-2009	Neumark, Daniel M/0000-0002-3762-9473	National Science Foundation (NSF) [CHE-1011819]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research is supported by the National Science Foundation (NSF) under grant CHE-1011819. The data presented in this paper are available upon request sent to dneumark@berkeley.edu.	Abel B, 2013, ANNU REV PHYS CHEM, V64, P533, DOI 10.1146/annurev-physchem-040412-110038; Alizadeh E, 2012, CHEM REV, V112, P5578, DOI 10.1021/cr300063r; Assel M, 2000, CHEM PHYS LETT, V317, P13, DOI 10.1016/S0009-2614(99)01369-X; Bragg AE, 2004, SCIENCE, V306, P669, DOI 10.1126/science.1103527; Buchner F, 2012, PHYS CHEM CHEM PHYS, V14, P5837, DOI 10.1039/c2cp23305c; COE JV, 1990, J CHEM PHYS, V92, P3980, DOI 10.1063/1.457805; Garrett BC, 2005, CHEM REV, V105, P355, DOI 10.1021/cr030453x; Griffin GB, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3263419; HART EJ, 1962, J AM CHEM SOC, V84, P4090, DOI 10.1021/ja00880a025; Horio T, 2012, CHEM PHYS LETT, V535, P12, DOI 10.1016/j.cplett.2012.03.051; Jacobson LD, 2011, J AM CHEM SOC, V133, P19889, DOI 10.1021/ja208024p; Kambhampati P, 2002, J PHYS CHEM A, V106, P2374, DOI 10.1021/jp014291p; Kloepfer JA, 2000, J CHEM PHYS, V113, P6288, DOI 10.1063/1.1309011; KRUIT P, 1983, J PHYS E SCI INSTRUM, V16, P313, DOI 10.1088/0022-3735/16/4/016; Lubcke A, 2010, PHYS CHEM CHEM PHYS, V12, P14629, DOI 10.1039/c0cp00847h; Ma L, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3245859; MIGUS A, 1987, PHYS REV LETT, V58, P1559, DOI 10.1103/PhysRevLett.58.1559; Neumark DM, 2008, MOL PHYS, V106, P2183, DOI 10.1080/00268970802279555; Paik DH, 2004, SCIENCE, V306, P672, DOI 10.1126/science.1102827; Pshenichnikov MS, 2004, CHEM PHYS LETT, V389, P171, DOI 10.1016/j.cplett.2004.03.107; ROSSKY PJ, 1988, J PHYS CHEM-US, V92, P4277, DOI 10.1021/j100326a009; SCHWARTZ BJ, 1994, J CHEM PHYS, V101, P6902, DOI 10.1063/1.468319; Shi XL, 1996, J PHYS CHEM-US, V100, P11903, DOI 10.1021/jp961261r; Shreve AT, 2013, CHEM SCI, V4, P1633, DOI 10.1039/c3sc22063j; Shreve AT, 2010, CHEM PHYS LETT, V493, P216, DOI 10.1016/j.cplett.2010.05.059; Siefermann KR, 2010, NAT CHEM, V2, P274, DOI [10.1038/NCHEM.580, 10.1038/nchem.580]; Tang Y, 2010, CHEM PHYS LETT, V494, P111, DOI 10.1016/j.cplett.2010.05.084; Tauber MJ, 2001, J PHYS CHEM A, V105, P10952, DOI 10.1021/jp012184p; Thaller A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2155481; Thurmer S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.173005; Turi L, 2012, CHEM REV, V112, P5641, DOI 10.1021/cr300144z; Wang CR, 2008, PHYS CHEM CHEM PHYS, V10, P4463, DOI 10.1039/b806287k; Weber JM, 2001, CHEM PHYS LETT, V339, P337, DOI 10.1016/S0009-2614(01)00295-0; Winter B, 2006, CHEM REV, V106, P1176, DOI 10.1021/cr040381p; Yokoyama K, 1998, J PHYS CHEM A, V102, P6957, DOI 10.1021/jp981809p; Young RM, 2012, CHEM REV, V112, P5553, DOI 10.1021/cr300042h; Zharikov AA, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2165198	39	98	98	4	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1496	1499		10.1126/science.1246291	http://dx.doi.org/10.1126/science.1246291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357314				2022-12-28	WOS:000328644300054
J	Liu, W; Wacker, D; Gati, C; Han, GW; James, D; Wang, DJ; Nelson, G; Weierstall, U; Katritch, V; Barty, A; Zatsepin, NA; Li, DF; Messerschmidt, M; Boutet, S; Williams, GJ; Koglin, JE; Seibert, MM; Wang, C; Shah, STA; Basu, S; Fromme, R; Kupitz, C; Rendek, KN; Grotjohann, I; Fromme, P; Kirian, RA; Beyerlein, KR; White, TA; Chapman, HN; Caffrey, M; Spence, JCH; Stevens, RC; Cherezov, V				Liu, Wei; Wacker, Daniel; Gati, Cornelius; Han, Gye Won; James, Daniel; Wang, Dingjie; Nelson, Garrett; Weierstall, Uwe; Katritch, Vsevolod; Barty, Anton; Zatsepin, Nadia A.; Li, Dianfan; Messerschmidt, Marc; Boutet, Sebastien; Williams, Garth J.; Koglin, Jason E.; Seibert, M. Marvin; Wang, Chong; Shah, Syed T. A.; Basu, Shibom; Fromme, Raimund; Kupitz, Christopher; Rendek, Kimberley N.; Grotjohann, Ingo; Fromme, Petra; Kirian, Richard A.; Beyerlein, Kenneth R.; White, Thomas A.; Chapman, Henry N.; Caffrey, Martin; Spence, John C. H.; Stevens, Raymond C.; Cherezov, Vadim			Serial Femtosecond Crystallography of G Protein-Coupled Receptors	SCIENCE			English	Article								X-ray crystallography of G protein-coupled receptors and other membrane proteins is hampered by difficulties associated with growing sufficiently large crystals that withstand radiation damage and yield high-resolution data at synchrotron sources. We used an x-ray free-electron laser (XFEL) with individual 50-femtosecond-duration x-ray pulses to minimize radiation damage and obtained a high-resolution room-temperature structure of a human serotonin receptor using sub-10-micrometer microcrystals grown in a membrane mimetic matrix known as lipidic cubic phase. Compared with the structure solved by using traditional microcrystallography from cryo-cooled crystals of about two orders of magnitude larger volume, the room-temperature XFEL structure displays a distinct distribution of thermal motions and conformations of residues that likely more accurately represent the receptor structure and dynamics in a cellular environment.	[Liu, Wei; Wacker, Daniel; Han, Gye Won; Katritch, Vsevolod; Wang, Chong; Stevens, Raymond C.; Cherezov, Vadim] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Gati, Cornelius; Barty, Anton; Kirian, Richard A.; Beyerlein, Kenneth R.; White, Thomas A.; Chapman, Henry N.] DESY, Ctr Free Elect Laser Sci, D-22607 Hamburg, Germany; [James, Daniel; Wang, Dingjie; Nelson, Garrett; Weierstall, Uwe; Zatsepin, Nadia A.; Kirian, Richard A.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Li, Dianfan; Shah, Syed T. A.; Caffrey, Martin] Trinity Coll Dublin, Sch Med, Dublin 2, Ireland; [Li, Dianfan; Shah, Syed T. A.; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Messerschmidt, Marc; Boutet, Sebastien; Williams, Garth J.; Koglin, Jason E.; Seibert, M. Marvin] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Seibert, M. Marvin] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Basu, Shibom; Fromme, Raimund; Kupitz, Christopher; Rendek, Kimberley N.; Grotjohann, Ingo; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Chapman, Henry N.] Univ Hamburg, Dept Phys, D-22761 Hamburg, Germany; [Chapman, Henry N.] Ctr Ultrafast Imaging, D-22607 Hamburg, Germany	Scripps Research Institute; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Arizona State University; Arizona State University-Tempe; Trinity College Dublin; Trinity College Dublin; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Uppsala University; Arizona State University; Arizona State University-Tempe; University of Hamburg	Cherezov, V (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	vcherezo@scripps.edu	Han, Gye Won/GLQ-8724-2022; Zatsepin, Nadia/AAF-2451-2019; Katritch, Vsevolod/Q-8357-2016; Fromme, Raimund/W-5838-2019; Fromme, Raimund/AAG-6578-2019; Beyerlein, Kenneth/ABB-9823-2020; Han, Gye Won/GLQ-8673-2022; Shah, Syed Tasadaque Ali/AAB-4890-2021; Basu, Shibom/GLU-3308-2022; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Y-2721-2019; FRS, Henry N Chapman/G-2153-2010; Han, Gye Won/GLT-1531-2022; Barty, Anton/K-5137-2014; Fromme, Raimund/C-8885-2012; Messerschmidt, Marc/F-3796-2010; Cherezov, Vadim/L-9812-2013; Messerschmidt, Marc/Y-8929-2019; soler, martha maricel m gomez/L-6025-2014; Li, Dianfan/AHC-2751-2022	Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Fromme, Raimund/0000-0003-4835-1080; Beyerlein, Kenneth/0000-0002-7701-4369; Basu, Shibom/0000-0001-6484-8236; Stevens, Raymond/0000-0002-4522-8725; FRS, Henry N Chapman/0000-0002-4655-1743; Barty, Anton/0000-0003-4751-2727; Fromme, Raimund/0000-0003-4835-1080; Messerschmidt, Marc/0000-0002-8641-3302; Cherezov, Vadim/0000-0002-5265-3914; Messerschmidt, Marc/0000-0002-8641-3302; soler, martha maricel m gomez/0000-0002-4412-8108; Li, Dianfan/0000-0003-4729-4678; Caffrey, Martin/0000-0002-2931-4551; James, Daniel/0000-0002-8348-6661; Zatsepin, Nadia/0000-0003-1757-0205; Kirian, Richard/0000-0001-7197-3086	National Institutes of Health Common Fund in Structural Biology [P50 GM073197, P50 GM073210, R01 GM095583]; National Institute of General Medical Sciences PSI: Biology [U54 GM094618, U54 GM094599]; NSF Science and Technology Center [1231306]; Helmholz Association; German Research Foundation; German Federal Ministry of Education and Research; Science Foundation Ireland [07/IN.1/B1836, 12/IA/1255]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210, U54GM094618, P50GM073197, R01GM095583, U54GM094599] Funding Source: NIH RePORTER	National Institutes of Health Common Fund in Structural Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences PSI: Biology; NSF Science and Technology Center(National Science Foundation (NSF)); Helmholz Association; German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Parts of this research were carried out at the LCLS, a National User Facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences and at the General Medicine and Cancer Institute Collaborative Access Team of the Argonne Photon Source, Argonne National Laboratory. This work was supported by the National Institutes of Health Common Fund in Structural Biology grants P50 GM073197 (V. C. and R. C. S.), P50 GM073210 (M. C.), and R01 GM095583 (P. F.); National Institute of General Medical Sciences PSI: Biology grants U54 GM094618 (V. C., V. K., and R. C. S.) and U54 GM094599 (P. F.); and NSF Science and Technology Center award 1231306 (J.C.H.S.). We further acknowledge support from the Helmholz Association, the German Research Foundation, the German Federal Ministry of Education and Research (H.N.C.), and Science Foundation Ireland (07/IN.1/B1836, 12/IA/1255) (M. C.). We give special thanks to G. M. Stewart, T. Anderson, SLAC Infomedia, and K. Kadyshevskaya from The Scripps Research Institute for preparing Fig. 1; T. Trinh and M. Chu for help with baculovirus expression; H. Liu and M. Klinker for help with data processing; A. Walker for assistance with manuscript preparation; and I. Wilson for reviewing the manuscript. Coordinates and the structure factors have been deposited in PDB under the accession code 4NC3. The diffraction patterns have been deposited in the Coherent X-ray Imaging Data Bank http://cxidb.org under the accession code ID-21. U. W. and J.C.H.S. are inventors on a patent application filed by Arizona State University titled "Apparatus and Methods for Lipidic Cubic Phase (LCP) Injection for Membrane Protein Investigations." W. L. developed protocols of producing high-density microcrystals in LCP; prepared samples; and helped with testing LCP injector, data collection, and writing the paper. Da.W. prepared 5-HT<INF>2B</INF> microcrystals in LCP and helped with data collection, structure refinement, analysis, and writing the paper. C. G. participated in data collection and processed and analyzed data. G. W. H. performed structure refinement. D.J., Di.W., and G.N. helped develop and operate the LCP injector. U. W. conceived, designed, and developed the LCP injector. V. K. analyzed the results and helped with writing the paper. A. B. participated in data collection, wrote data processing software, and helped with data processing and writing the paper. N.A.Z. and Sh.B. participated in data collection and helped with data processing. D. L. helped with data collection. Se. B., M. M., G.J.W., J.E.K., and M. M. S. set up the XFEL experiment, beamline, controls, and data acquisition; operated the CXI beamline; and performed the data collection. C. W. helped with sample preparation. S. T. A. S. synthesized and purified 7.9 MAG. R. F., C. K., K.N.R., and I. G. participated in data collection and contributed to sample characterization. P. F. was involved in the initiation and planning of the experiments, assisted with sample characterization and data collection, and contributed to writing the paper. R. A. K. developed the Monte Carlo integration method and contributed to data processing. K. R. B. contributed to software development and data processing. T. A. W. developed the Monte Carlo integration method, wrote data processing software, and contributed to data processing. H.N.C. supervised software development and data processing and helped with writing the paper. M. C. provided the 7.9 MAG and helped with data collection and with writing the paper. J.C.H.S.; helped develop the LCP injector and developed the Monte Carlo integration method with R. A. K. R. C. S. supervised GPCR production and contributed to writing the paper. V. C. conceived the project, designed the experiments, supervised data collection, performed structure refinement, analyzed the results, and wrote the paper.	Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Caffrey M, 2012, BIOCHEMISTRY-US, V51, P6266, DOI 10.1021/bi300010w; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Hart P, 2012, PROC SPIE, V8504, DOI 10.1117/12.930924; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Pan AC, 2013, DRUG DISCOV TODAY, V18, P667, DOI 10.1016/j.drudis.2013.02.007; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Smith JL, 2012, CURR OPIN STRUC BIOL, V22, P602, DOI 10.1016/j.sbi.2012.09.001; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; White TA, 2013, ACTA CRYSTALLOGR D, V69, P1231, DOI 10.1107/S0907444913013620; Willis B.T.M., 1975, THERMAL VIBRATIONS C	25	338	348	5	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1521	1524		10.1126/science.1244142	http://dx.doi.org/10.1126/science.1244142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357322	Green Accepted, Green Published			2022-12-28	WOS:000328644300062
J	Conine, CC; Moresco, JJ; Gu, WF; Shirayama, M; Conte, D; Yates, JR; Mello, CC				Conine, Colin C.; Moresco, James J.; Gu, Weifeng; Shirayama, Masaki; Conte, Darryl, Jr.; Yates, John R., III; Mello, Craig C.			Argonautes Promote Male Fertility and Provide a Paternal Memory of Germline Gene Expression in C. elegans	CELL			English	Article							FERTILIZATION-DEFECTIVE MUTANTS; MAJOR SPERM PROTEIN; CAENORHABDITIS-ELEGANS; SMALL RNAS; EPIGENETIC MEMORY; SPERMATOGENESIS; REVEALS; PIRNAS; TRANSCRIPTION; CHROMATIN	During each life cycle, germ cells preserve and pass on both genetic and epigenetic information. In C. elegans, the ALG-3/4 Argonaute proteins are expressed during male gametogenesis and promote male fertility. Here, we show that the CSR-1 Argonaute functions with ALG-3/4 to positively regulate target genes required for spermiogenesis. Our findings suggest that ALG-3/4 functions during spermatogenesis to amplify a small RNA signal that represents an epigenetic memory of male-specific gene expression. CSR-1, which is abundant in mature sperm, appears to transmit this memory to offspring. Surprisingly, in addition to small RNAs targeting male-specific genes, we show that males also harbor an extensive repertoire of CSR-1 small RNAs targeting oogenesis-specific mRNAs. Together, these findings suggest that C. elegans sperm transmit not only the genome but also epigenetic binary signals in the form of Argonaute/small RNA complexes that constitute a memory of gene expression in preceding generations.	[Conine, Colin C.; Gu, Weifeng; Shirayama, Masaki; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Conine, Colin C.; Gu, Weifeng; Shirayama, Masaki; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Shirayama, Masaki; Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Scripps Research Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.	craig.mello@umassmed.edu		Conine, Colin/0000-0001-7915-0463; Moresco, James/0000-0003-1178-1642	National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; National Institute on Aging [R01AG027463-04]; NIH [GM058800]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058800, R01GM058800, P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Mello laboratory for helpful discussions, E. Youngman and R. Sharma for experimental support, E. Kittler and the UMass Deep Sequencing Core for Illumina sequencing, P. Furcinitti and the UMass Light Microscopy Core for use of the confocal microscope, and the Caenorhabditis Genetics Center for providing strains. J.J.M. and J.R.Y. were supported by the National Center for Research Resources (5P41RR011823-17), National Institute of General Medical Sciences (8 P41 GM103533-17), and National Institute on Aging (R01AG027463-04). C. C. M. is a Howard Hughes Medical Institute Investigator and is supported by NIH grant GM058800.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; ARGON Y, 1980, GENETICS, V96, P413; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BRENNER S, 1974, GENETICS, V77, P71; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; BURKE DJ, 1983, J MOL BIOL, V171, P1, DOI 10.1016/S0022-2836(83)80312-X; Buttery SM, 2003, MOL BIOL CELL, V14, P5082, DOI 10.1091/mbc.E03-04-0246; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2010, P NATL ACAD SCI USA, V107, P3588, DOI 10.1073/pnas.0911685107; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gu WF, 2012, CELL, V151, P1488, DOI 10.1016/j.cell.2012.11.023; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; HIRSH D, 1976, DEV BIOL, V49, P220, DOI 10.1016/0012-1606(76)90268-2; Jannes P, 1998, HUM REPROD, V13, P372, DOI 10.1093/humrep/13.2.372; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Miller Michael A., 2006, V351, P193; Nishibu T, 2012, BIOSCI TRENDS, V6, P248, DOI 10.5582/bst.2012.v6.5.248; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SETCHELL BP, 1988, J REPROD FERTIL, V82, P567, DOI 10.1530/jrf.0.0820567; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shakes DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000611; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Wu JC, 2012, GENETICS, V190, P143, DOI 10.1534/genetics.111.135376; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	46	107	108	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1532	1544		10.1016/j.cell.2013.11.032	http://dx.doi.org/10.1016/j.cell.2013.11.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360276	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000328693300010
J	Bershteyn, M; Hayashi, Y; Desachy, G; Hsiao, EC; Sami, S; Tsang, KM; Weiss, LA; Kriegstein, AR; Yamanaka, S; Wynshaw-Boris, A				Bershteyn, Marina; Hayashi, Yohei; Desachy, Guillaume; Hsiao, Edward C.; Sami, Salma; Tsang, Kathryn M.; Weiss, Lauren A.; Kriegstein, Arnold R.; Yamanaka, Shinya; Wynshaw-Boris, Anthony			Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells	NATURE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; UNIPARENTAL DISOMY; MITOTIC BEHAVIOR; DIEKER-SYNDROME; SOMATIC-CELLS; HUMAN EMBRYOS; ASSOCIATION; INSTABILITY; MECHANISMS	Ring chromosomes are structural aberrations commonly associated with birth defects, mental disabilities and growth retardation(1,2). Rings form after fusion of the long and short arms of a chromosome, and are sometimes associated with large terminal deletions(2). Owing to the severity of these large aberrations that can affect multiple contiguous genes, no possible therapeutic strategies for ring chromosome disorders have been proposed. During cell division, ring chromosomes can exhibit unstable behaviour leading to continuous production of aneuploid progeny with low viability and high cellular death rate(3-9). The overall consequences of this chromosomal instability have been largely unexplored in experimental model systems. Here we generated human induced pluripotent stem cells (iPSCs)(10-12) from patient fibroblasts containing ring chromosomes with large deletions and found that reprogrammed cells lost the abnormal chromosome and duplicated the wild-type homologue through the compensatory uniparental disomy (UPD) mechanism. The karyotypically normal iPSCs with isodisomy for the corrected chromosome outgrew co-existing aneuploid populations, enabling rapid and efficient isolation of patient-derived iPSCs devoid of the original chromosomal aberration. Our results suggest a fundamentally different function for cellular reprogramming as a means of 'chromosome therapy'(13) to reverse combined loss-of-function across many genes in cells with large-scale aberrations involving ring structures. In addition, our work provides an experimentally tractable human cellular system for studying mechanisms of chromosomal number control, which is of critical relevance to human development and disease.	[Bershteyn, Marina; Wynshaw-Boris, Anthony] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Bershteyn, Marina; Wynshaw-Boris, Anthony] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Bershteyn, Marina; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Hayashi, Yohei; Sami, Salma; Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Hayashi, Yohei; Sami, Salma; Yamanaka, Shinya] Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA; [Desachy, Guillaume; Tsang, Kathryn M.; Weiss, Lauren A.] Univ Calif San Francisco, Inst Human Genet, Dept Psychiat, San Francisco, CA 94143 USA; [Hsiao, Edward C.] Univ Calif San Francisco, Div Endocrinol & Metab, San Francisco, CA 94143 USA; [Hsiao, Edward C.] Univ Calif San Francisco, Inst Human Genet, Dept Med, San Francisco, CA 94143 USA; [Yamanaka, Shinya] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Yamanaka, Shinya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Wynshaw-Boris, Anthony] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kyoto University; Case Western Reserve University	Wynshaw-Boris, A (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	syamanaka@gladstone.ucsf.edu; ajw168@case.edu	Hayashi, Yohei/AAF-6059-2020; Hayashi, Yohei/L-8190-2019	Hayashi, Yohei/0000-0001-5490-7052; 	NIH/NIGMS [GM007085-32]; California Institute for Regenerative Medicine [TG2-01153]; Uehara Memorial Foundation; USCF's Program for Breakthrough Biomedical Research; NIAMS/NIH [K08 AR056299]; UCSF Department of Medicine; NHLBI/NIH [UO1HL098179]; MEXT (Japan); JSPS (Japan); JSPS; NIBIO (Japan); L. K. Whittier Foundation; Roddenberry Foundation; National Center for Research Resources [RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007085] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Uehara Memorial Foundation(Uehara Memorial Foundation); USCF's Program for Breakthrough Biomedical Research; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UCSF Department of Medicine; NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MEXT (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIBIO (Japan)(National Institute of Biomedical Innovation); L. K. Whittier Foundation; Roddenberry Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank N. Larocque and S. Fisher for access to the University of California San Francisco (UCSF) Human Embryonic Stem Cell Shared Research and Training Facility. We thank P. Tesar and Z. Nevin for comments on the manuscript; D. Srivastava and B. Conklin for advice; H. Belinson, A. Pollen and T. Nowakowski for helpful discussions; S. Hirotsune for LIS1 antibody; K. Essex for administrative support; and the Gladstone Stem Cell, Histology and Microscopy, and Bioinformatics Cores for technical support. The research was made possible by support from a NIH/NIGMS postdoctoral training grant in medical genetics (grant number GM007085-32) and a postdoctoral training fellowship from the California Institute for Regenerative Medicine (grant number TG2-01153) to M. B.; from the Uehara Memorial Foundation and USCF's Program for Breakthrough Biomedical Research to Y.H.; from the NIAMS/NIH (K08 AR056299) and the UCSF Department of Medicine to E. C. H.; and from the NHLBI/NIH (UO1HL098179), the Leading Project of MEXT (Japan), the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the JSPS (Japan), Grants-in-Aid for Scientific Research of the JSPS and MEXT (Japan), the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (Japan), the L. K. Whittier Foundation, and the Roddenberry Foundation to S.Y. The Gladstone Institutes received support from a National Center for Research Resources Grant RR18928. S.Y. is a member without salary of the scientific advisory boards of iPierian, iPS Academia Japan, Megakaryon Corporation and HEALIOS K. K. Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of CIRM or any other agency of the State of California.	Azuhata T, 2001, J PEDIATR SURG, V36, P1785, DOI 10.1053/jpsu.2001.28839; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; BARTSCH O, 1994, J MED GENET, V31, P534, DOI 10.1136/jmg.31.7.534; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; COTE GB, 1981, ANN GENET-PARIS, V24, P231; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; DOBYNS WB, 1983, J PEDIATR-US, V102, P552, DOI 10.1016/S0022-3476(83)80183-8; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Hussein SMI, 2013, BIOESSAYS, V35, P152, DOI 10.1002/bies.201200114; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Jobanputra V, 2009, AM J MED GENET A, V149A, P1310, DOI 10.1002/ajmg.a.32680; KISTENMACHER ML, 1970, AM J HUM GENET, V22, P304; KOSZTOLANYI G, 1987, HUM GENET, V75, P174, DOI 10.1007/BF00591082; Mantzouratou A, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-3; Matsumoto Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-190; McClintock B, 1938, GENETICS, V23, P315; Meisner LF, 2008, METHODS, V45, P133, DOI 10.1016/j.ymeth.2008.03.005; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PETERSEN MB, 1992, GENOMICS, V13, P269, DOI 10.1016/0888-7543(92)90242-K; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Foundation for Statistical Computing V. Austria. . R Development Core Team, 2008, R LANG ENV STAT COMP; Robinson WP, 2000, BIOESSAYS, V22, P452; Sodre CP, 2010, GENET MOL RES, V9, P134, DOI 10.4238/vol9-1gmr707; Speevak MD, 2003, AM J MED GENET A, V121A, P141, DOI 10.1002/ajmg.a.20184; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TOMMERUP N, 1992, J MED GENET, V29, P879, DOI 10.1136/jmg.29.12.879; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wilton L, 2002, PRENATAL DIAG, V22, P512, DOI 10.1002/pd.388; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HZ, 2012, CYTOGENET GENOME RES, V136, P180, DOI 10.1159/000336978	38	60	65	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					99	+		10.1038/nature12923	http://dx.doi.org/10.1038/nature12923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24413397	Green Accepted, Green Submitted			2022-12-28	WOS:000332224400050
J	van Heerden, JH; Wortel, MT; Bruggeman, FJ; Heijnen, JJ; Bollen, YJM; Planque, R; Hulshof, J; O'Toole, TG; Wahl, SA; Teusink, B				van Heerden, Johan H.; Wortel, Meike T.; Bruggeman, Frank J.; Heijnen, Joseph J.; Bollen, Yves J. M.; Planque, Robert; Hulshof, Josephus; O'Toole, Tom G.; Wahl, S. Aljoscha; Teusink, Bas			Lost in Transition: Start-Up of Glycolysis Yields Subpopulations of Nongrowing Cells	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE REVEALS; GLYCEROL PRODUCTION; TREHALOSE SYNTHASE; GENE-EXPRESSION; TPS1 MUTANTS; YEAST; GLUCOSE; HEXOKINASE; METABOLISM; DEREGULATION	Cells need to adapt to dynamic environments. Yeast that fail to cope with dynamic changes in the abundance of glucose can undergo growth arrest. We show that this failure is caused by imbalanced reactions in glycolysis, the essential pathway in energy metabolism in most organisms. The imbalance arises largely from the fundamental design of glycolysis, making this state of glycolysis a generic risk. Cells with unbalanced glycolysis coexisted with vital cells. Spontaneous, nongenetic metabolic variability among individual cells determines which state is reached and, consequently, which cells survive. Transient ATP (adenosine 5'-triphosphate) hydrolysis through futile cycling reduces the probability of reaching the imbalanced state. Our results reveal dynamic behavior of glycolysis and indicate that cell fate can be determined by heterogeneity purely at the metabolic level.	[van Heerden, Johan H.; Wortel, Meike T.; Bruggeman, Frank J.; Teusink, Bas] Vrije Univ Amsterdam, Netherlands Inst Syst Biol, AIMMS, NL-1081 HV Amsterdam, Netherlands; [van Heerden, Johan H.; Wortel, Meike T.; Heijnen, Joseph J.; Wahl, S. Aljoscha; Teusink, Bas] Delft Univ Technol, NCSB, Kluyver Ctr Genom Ind Fermentat, NL-2628 BC Delft, Netherlands; [van Heerden, Johan H.; Wortel, Meike T.; Bruggeman, Frank J.; Bollen, Yves J. M.; Teusink, Bas] Vrije Univ Amsterdam, Dept Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands; [Heijnen, Joseph J.; Wahl, S. Aljoscha] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Bollen, Yves J. M.] Vrije Univ Amsterdam, LaserLaB Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Planque, Robert; Hulshof, Josephus] Vrije Univ Amsterdam, Dept Math, NL-1081 HV Amsterdam, Netherlands; [O'Toole, Tom G.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Delft University of Technology; Vrije Universiteit Amsterdam; Delft University of Technology; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Teusink, B (corresponding author), Vrije Univ Amsterdam, Netherlands Inst Syst Biol, AIMMS, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	b.teusink@vu.nl	Bruggeman, Frank/AAS-8371-2020; Bruggeman, Frank/C-4356-2015; Wortel, Meike/AAM-7589-2020; Wahl, Sebastian Aljoscha/B-1839-2013	Bruggeman, Frank/0000-0002-0255-4766; Bruggeman, Frank/0000-0002-0255-4766; Wortel, Meike/0000-0002-3191-2710; Teusink, Bas/0000-0003-3929-0423; Bollen, Yves/0000-0001-6251-3360; Planque, Robert/0000-0002-0489-5425; Wahl, Sebastian Aljoscha/0000-0003-2120-1859	AIMMS; FP7 UNICELLSYS; Kluyver Centre for Genomics of Industrial Fermentation; NCSB; Netherlands Genomics Initiatives	AIMMS; FP7 UNICELLSYS; Kluyver Centre for Genomics of Industrial Fermentation; NCSB; Netherlands Genomics Initiatives	This work was supported by funding from AIMMS, FP7 UNICELLSYS, and Kluyver Centre for Genomics of Industrial Fermentation and NCSB, funded by the Netherlands Genomics Initiatives.	Abate A, 2012, INT J ROBUST NONLIN, V22, P1120, DOI 10.1002/rnc.2798; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Blazquez MA, 1995, MOL GEN GENET, V249, P655, DOI 10.1007/BF00418035; Bonini BM, 2003, BBA-BIOENERGETICS, V1606, P83, DOI 10.1016/S0005-2728(03)00086-0; Canelas AB, 2011, METAB ENG, V13, P294, DOI 10.1016/j.ymben.2011.02.005; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Ernandes JR, 1998, YEAST, V14, P255, DOI 10.1002/(SICI)1097-0061(199802)14:3<255::AID-YEA228>3.0.CO;2-N; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Geertman JMA, 2006, FEMS YEAST RES, V6, P1193, DOI 10.1111/j.1567-1364.2006.00124.x; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; Hohmann S, 1996, MOL MICROBIOL, V20, P981, DOI 10.1111/j.1365-2958.1996.tb02539.x; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iynedjian PB, 1998, TRENDS BIOCHEM SCI, V23, P467, DOI 10.1016/S0968-0004(98)01317-6; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; LONDESBOROUGH J, 1993, EUR J BIOCHEM, V216, P841, DOI 10.1111/j.1432-1033.1993.tb18206.x; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Mashego MR, 2006, METAB ENG, V8, P370, DOI 10.1016/j.ymben.2006.02.002; NEVES MJ, 1995, CURR GENET, V27, P110, DOI 10.1007/BF00313424; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Overkamp KM, 2002, APPL ENVIRON MICROB, V68, P2814, DOI 10.1128/AEM.68.6.2814-2821.2002; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; Teusink B, 2010, WIRES SYST BIOL MED, V2, P518, DOI 10.1002/wsbm.74; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; VANAELST L, 1993, MOL MICROBIOL, V8, P927; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69	41	182	184	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					987	+	1245114	10.1126/science.1245114	http://dx.doi.org/10.1126/science.1245114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24436182				2022-12-28	WOS:000332309600035
J	Kim, TH; Li, FG; Ferreiro-Neira, I; Ho, LL; Luyten, A; Nalapareddy, K; Long, H; Verzi, M; Shivdasani, RA				Kim, Tae-Hee; Li, Fugen; Ferreiro-Neira, Isabel; Ho, Li-Lun; Luyten, Annouck; Nalapareddy, Kodandaramireddy; Long, Henry; Verzi, Michael; Shivdasani, Ramesh A.			Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity	NATURE			English	Article							ATONAL HOMOLOG 1; SECRETASE INHIBITORS; STEM-CELLS; DIFFERENTIATION; ENHANCERS; REVEALS; IDENTIFICATION; RECOMBINATION; REQUIREMENT; GENES	Cells differentiate when transcription factors bind accessible cis-regulatory elements to establish specific gene expression programs. In differentiating embryonic stem cells, chromatin at lineage-restricted genes becomes sequentially accessible(1-4), probably by means of 'pioneer' transcription factor activity(5), but tissues may use other strategies in vivo. Lateral inhibition is a pervasive process in which one cell forces a different identity on its neighbours(6), and it is unclear how chromatin in equipotent progenitors undergoing lateral inhibition quickly enables distinct, transiently reversible cell fates. Here we report the chromatin and transcriptional underpinnings of differentiation in mouse small intestine crypts, where notch signalling mediates lateral inhibition to assign progenitor cells into absorptive or secretory lineages(7-9). Transcript profiles in isolated LGR5(+) intestinal stem cells(10) and secretory and absorptive progenitors indicated that each cell population was distinct and the progenitors specified. Nevertheless, secretory and absorptive progenitors showed comparable levels of H3K4me2 and H3K27ac histone marks and DNase I hypersensitivity-signifying accessible, permissive chromatin-at most of the same cis-elements. Enhancers acting uniquely in progenitors were well demarcated in LGR5(+) intestinal stem cells, revealing early priming of chromatin for divergent transcriptional programs, and retained active marks well after lineages were specified. On this chromatin background, ATOH1, a secretory-specific transcription factor, controls lateral inhibition through delta-like notch ligand genes and also drives the expression of numerous secretory lineage genes. Depletion of ATOH1 from specified secretory cells converted them into functional enterocytes, indicating prolonged responsiveness of marked enhancers to the presence or absence of a key transcription factor. Thus, lateral inhibition and intestinal crypt lineage plasticity involve interaction of a lineage-restricted transcription factor with broadly permissive chromatin established in multipotent stem cells.	[Kim, Tae-Hee; Li, Fugen; Ferreiro-Neira, Isabel; Ho, Li-Lun; Luyten, Annouck; Nalapareddy, Kodandaramireddy; Long, Henry; Verzi, Michael; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kim, Tae-Hee; Li, Fugen; Ferreiro-Neira, Isabel; Ho, Li-Lun; Luyten, Annouck; Nalapareddy, Kodandaramireddy; Long, Henry; Verzi, Michael; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Kim, Tae-Hee; Ferreiro-Neira, Isabel; Ho, Li-Lun; Luyten, Annouck; Nalapareddy, Kodandaramireddy; Verzi, Michael; Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Kim, Tae-Hee; Ferreiro-Neira, Isabel; Ho, Li-Lun; Luyten, Annouck; Nalapareddy, Kodandaramireddy; Verzi, Michael; Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu		Nalapareddy, Kodandaramireddy/0000-0003-3290-5114	NIH [R01DK082889, R01DK081113, K99DK095983, K01DK088868, P50CA127003]; North American Neuroendocrine Tumor Society; Caring For Carcinoid Foundation; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK088868, R01DK082889, K99DK095983, R01DK081113] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Neuroendocrine Tumor Society; Caring For Carcinoid Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01DK082889 and R01DK081113 (R. A. S.), K99DK095983 (T.-H. K.), K01DK088868 (M. V.), and P50CA127003; a North American Neuroendocrine Tumor Society fellowship (T.-H. K.); and the Caring For Carcinoid Foundation (R. A. S.). We thank S. Robine for villin-Cre<SUP>ER-T2</SUP> mice; T. Honjo and S. Artavanis-Tsakonas for Rbpj<SUP>fl</SUP> mice; J. Johnson for ATOH1 antibody; D. Podolsky for TFF3 antibody; and M. Brown and P. Cejas for discussions.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaaij LTJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r50; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kim TH, 2011, J BIOL CHEM, V286, P11427, DOI 10.1074/jbc.M110.188797; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	157	160	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					511	+		10.1038/nature12903	http://dx.doi.org/10.1038/nature12903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24413398	Green Submitted, Green Accepted			2022-12-28	WOS:000332165100043
J	Averill, C; Turner, BL; Finzi, AC				Averill, Colin; Turner, Benjamin L.; Finzi, Adrien C.			Mycorrhiza-mediated competition between plants and decomposers drives soil carbon storage	NATURE			English	Article							ORGANIC-CARBON; MICROBIAL EFFICIENCY; NITROGEN LIMITATION; SENSITIVITY; ECOSYSTEMS; MATTER	Soil contains more carbon than the atmosphere and vegetation combined(1). Understanding the mechanisms controlling the accumulation and stability of soil carbon is critical to predicting the Earth's future climate(2,3). Recent studies suggest that decomposition of soil organic matter is often limited by nitrogen availability to microbes(4-6) and that plants, via their fungal symbionts, compete directly with free-living decomposers for nitrogen(6,7). Ectomycorrhizal and ericoid mycorrhizal (EEM) fungi produce nitrogen-degrading enzymes, allowing them greater access to organic nitrogen sources than arbuscular mycorrhizal (AM) fungi(8-10). This leads to the theoretical prediction that soil carbon storage is greater in ecosystems dominated by EEM fungi than in those dominated by AM fungi(11). Using global data sets, we show that soil in ecosystems dominated by EEM-associated plants contains 70% more carbon per unit nitrogen than soil in ecosystems dominated by AM-associated plants. The effect of mycorrhizal type on soil carbon is independent of, and of far larger consequence than, the effects of net primary production, temperature, precipitation and soil clay content. Hence the effect of mycorrhizal type on soil carbon content holds at the global scale. This finding links the functional traits of mycorrhizal fungi to carbon storage at ecosystem-to-global scales, suggesting that plant-decomposer competition for nutrients exerts a fundamental control over the terrestrial carbon cycle.	[Averill, Colin] Univ Texas Austin, Dept Integrat Biol, Grad Program Ecol Evolut & Behav, Austin, TX 78712 USA; [Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Finzi, Adrien C.] Boston Univ, Dept Biol, Boston, MA 02215 USA	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute; Boston University	Averill, C (corresponding author), Univ Texas Austin, Dept Integrat Biol, Grad Program Ecol Evolut & Behav, Austin, TX 78712 USA.	colin.averill@utexas.edu	Turner, Benjamin L/E-5940-2011; Finzi, Adrien/A-7017-2016	Turner, Benjamin L/0000-0002-6585-0722; Finzi, Adrien/0000-0003-2220-4533	Center for Tropical Forest Science (CTFS); Smithsonian Institution Geo-observatories (SIGEO); University of Texas at Austin; National Science Foundation [DGE-1110007]; NSF [DEB 07-43564]; DOE [10-DOE-1053, DE-SC0006916]	Center for Tropical Forest Science (CTFS); Smithsonian Institution Geo-observatories (SIGEO); University of Texas at Austin; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	We thank L. Nave and the International Soil Carbon Network for access to their database. C. Hawkes provided feedback during data collection and initial analyses of C storage. C. Iversen, J. Powers and M. Vadeboncouer provided unpublished data that contributed to this analysis. D. Jacquier provided the Australian soil database and E. Carlston helped to extract data from the Australian soil database. C. Shaw provided the Siltanen soil carbon database and the Forest Ecosystem Carbon Database of Canadian soils. T. Baisden provided scans of the California Soil-Vegetation Survey. E. Brzostek, N. Fowler, P. Groffman, E. Hobbie, B. Schlesinger and B. Waring provided feedback on earlier versions of this manuscript. The Center for Tropical Forest Science (CTFS) and Smithsonian Institution Geo-observatories (SIGEO) provided funding for the collection and analysis of soil profile data at large forest dynamics plots, and we thank the many collaborators, field assistants and laboratory technicians who assisted in the collection and analysis of soil profile data. This work benefited from extensive data contributions to the International Soil Carbon Network from both the USDA Natural Resources Conservation Service, National Cooperative Soil Survey, and the US Geological Survey. C.A. was supported by a fellowship from the University of Texas at Austin and by the National Science Foundation Graduate Research Fellowship Program (grant DGE-1110007). A.C.F. was supported by NSF grant number DEB 07-43564 and DOE grants 10-DOE-1053 and DE-SC0006916. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Aleksandra M., 2011, LMMFIT GOODNESS OF F; Allison SD, 2010, SOIL BIOL BIOCHEM, V42, P1157, DOI 10.1016/j.soilbio.2010.03.026; Averill C, 2011, ECOLOGY, V92, P883, DOI 10.1890/10-0746.1; CEBRIAN J, 1995, SCIENCE, V268, P1606, DOI 10.1126/science.268.5217.1606; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Fox J., 2019, R COMPANION APPL REG, V.; Frey SD, 2013, NAT CLIM CHANGE, V3, P395, DOI [10.1038/nclimate1796, 10.1038/NCLIMATE1796]; GADGIL RL, 1971, NATURE, V233, P133, DOI 10.1038/233133a0; Gallet-Budynek A, 2009, OECOLOGIA, V160, P129, DOI 10.1007/s00442-009-1284-2; Gee G.W., 2002, METHODS SOIL ANAL PA, V5, P255, DOI [DOI 10.2136/SSSABOOKSER5.4.C12, 10.2136/sssabookser5.4.c12]; Grossman R.B., 2002, METHODS SOIL ANAL 4, P201, DOI DOI 10.2136/SSSABOOKSER5.4.C9; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LINDAHL BD, 2005, FUNGAL COMMUNITY ITS, P331; Lindahl BD, 2010, ISME J, V4, P872, DOI 10.1038/ismej.2010.19; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Mayes MA, 2012, SOIL SCI SOC AM J, V76, P1027, DOI 10.2136/sssaj2011.0340; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Orwin KH, 2011, ECOL LETT, V14, P493, DOI 10.1111/j.1461-0248.2011.01611.x; Pinheiro J., 2013, R PACKAGE3, P1; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; RYGIEWICZ PT, 1994, NATURE, V369, P58, DOI 10.1038/369058a0; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Talbot JM, 2008, OECOLOGIA, V155, P583, DOI 10.1007/s00442-007-0940-7; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tofallis C, 2008, J MOD APPL STAT METH, V7, P526; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Whittaker R. H., 1975, COMMUNITIES ECOSYSTE, P111; Yee TW, 2010, J STAT SOFTW, V32, P1; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	40	522	548	113	1420	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					543	+		10.1038/nature12901	http://dx.doi.org/10.1038/nature12901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24402225				2022-12-28	WOS:000329995000038
J	King, J				King, John			CLIMATE SCIENCE A resolution of the Antarctic paradox	NATURE			English	Editorial Material							TRENDS; NORTH		British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	King, J (corresponding author), British Antarctic Survey, High Cross, Cambridge CB3 0ET, England.	jcki@bas.ac.uk			NERC [bas0100023] Funding Source: UKRI; Natural Environment Research Council [bas0100023] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Li XC, 2014, NATURE, V505, P538, DOI 10.1038/nature12945; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Turner J, 2004, INT J CLIMATOL, V24, P1, DOI 10.1002/joc.965; Turner J, 2013, J CLIMATE, V26, P1473, DOI 10.1175/JCLI-D-12-00068.1; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; Yuan XJ, 2001, GEOPHYS RES LETT, V28, P3609, DOI 10.1029/2001GL012969	8	23	25	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					491	492		10.1038/505491a	http://dx.doi.org/10.1038/505491a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451539				2022-12-28	WOS:000329995000027
J	Olin, JW; Kadian-Dodov, D				Olin, Jeffrey W.; Kadian-Dodov, Daniella			Exercise-Induced Leg Pain and High Blood Pressure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FIBROMUSCULAR DYSPLASIA; ASSOCIATION; MANAGEMENT		[Olin, Jeffrey W.] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Olin, Jeffrey W.] Icahn Sch Med Mt Sinai, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Olin, JW (corresponding author), Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, One Gustave L Levy Pl,POB 1033, New York, NY 10029 USA.	jeffrey.olin@mountsinai.org						Olin JW, 2012, CIRCULATION, V125, P3182, DOI 10.1161/CIRCULATIONAHA.112.091223; Olin JW, 2011, J VASC SURG, V53, P826, DOI 10.1016/j.jvs.2010.10.066; Persu A, 2012, EUR J CLIN INVEST, V42, P338, DOI 10.1111/j.1365-2362.2011.02577.x; Plouin PF, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-28; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Savard S, 2012, CIRCULATION, V126, P3062, DOI 10.1161/CIRCULATIONAHA.112.117499; Slovut DP, 2004, NEW ENGL J MED, V350, P1862, DOI 10.1056/NEJMra032393; Trinquart L, 2010, HYPERTENSION, V56, P525, DOI 10.1161/HYPERTENSIONAHA.110.152918	8	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					412	413		10.1001/jama.2013.284646	http://dx.doi.org/10.1001/jama.2013.284646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449320				2022-12-28	WOS:000329939300027
J	Cheskin, LJ; Kahan, S				Cheskin, Lawrence J.; Kahan, Scott			Bariatric surgery increases weight loss and diabetes remission more than nonsurgical treatment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Cheskin, Lawrence J.; Kahan, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cheskin, LJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.		Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030				Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	1	3	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC7	10.7326/0003-4819-160-2-201401210-02007	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445717				2022-12-28	WOS:000330275600006
J	Takada, T; Terada, K; Kajiwara, H; Ikusaka, M				Takada, Toshihiko; Terada, Kazuhiko; Kajiwara, Hideki; Ikusaka, Masatomi			Imaging-negative psoas abscess	LANCET			English	Editorial Material									[Takada, Toshihiko; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chiba 2608677, Japan; [Takada, Toshihiko; Terada, Kazuhiko; Kajiwara, Hideki] Kimitsu Chuo Hosp, Dept Gen Med, Kisarazu City, Chiba, Japan	Chiba University	Takada, T (corresponding author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	ttakada@water.ocn.ne.jp						Chern CH, 1997, AM J EMERG MED, V15, P83, DOI 10.1016/S0735-6757(97)90057-7; Dovas S, 2008, INT UROL NEPHROL, V40, P543, DOI 10.1007/s11255-008-9358-3; GRUENWALD I, 1992, J UROLOGY, V147, P1624, DOI 10.1016/S0022-5347(17)37650-4; Mallick IH, 2004, POSTGRAD MED J, V80, P459, DOI 10.1136/pgmj.2003.017665; Yin Hsin-Pei, 2004, J Chin Med Assoc, V67, P156	5	4	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					280	280		10.1016/S0140-6736(13)62408-3	http://dx.doi.org/10.1016/S0140-6736(13)62408-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24439738				2022-12-28	WOS:000330027500038
J	Taubman, SL; Allen, HL; Wright, BJ; Baicker, K; Finkelstein, AN				Taubman, Sarah L.; Allen, Heidi L.; Wright, Bill J.; Baicker, Katherine; Finkelstein, Amy N.			Medicaid Increases Emergency-Department Use: Evidence from Oregon's Health Insurance Experiment	SCIENCE			English	Article							CARE; VISITS; REFORM	In 2008, Oregon initiated a limited expansion of a Medicaid program for uninsured, low-income adults, drawing names from a waiting list by lottery. This lottery created a rare opportunity to study the effects of Medicaid coverage by using a randomized controlled design. By using the randomization provided by the lottery and emergency-department records from Portland-area hospitals, we studied the emergency department use of about 25,000 lottery participants over about 18 months after the lottery. We found that Medicaid coverage significantly increases overall emergency use by 0.41 visits per person, or 40% relative to an average of 1.02 visits per person in the control group. We found increases in emergency-department visits across a broad range of types of visits, conditions, and subgroups, including increases in visits for conditions that may be most readily treatable in primary care settings.	[Taubman, Sarah L.; Baicker, Katherine; Finkelstein, Amy N.] NBER, Cambridge, MA 02138 USA; [Allen, Heidi L.] Columbia Univ, Sch Social Work, New York, NY 10027 USA; [Wright, Bill J.] Providence Portland Med Ctr, Ctr Outcomes Res & Educ, Portland, OR 97213 USA; [Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Finkelstein, Amy N.] MIT, Dept Econ, Cambridge, MA 02142 USA	National Bureau of Economic Research; Columbia University; Providence Portland Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT)	Taubman, SL (corresponding author), NBER, Cambridge, MA 02138 USA.	staub@nber.org			U.S. Department of Health and Human Services; California HealthCare Foundation; John D. and Catherine T. MacArthur Foundation; National Institute on Aging [P30AG012810, RC2AGO36631, R01AG0345151]; Robert Wood Johnson Foundation; Alfred P. Sloan Foundation; Smith Richardson Foundation; U.S. Social Security Administration [5 RRC 08098400-03-00]; Centers for Medicare and Medicaid Services; NATIONAL INSTITUTE ON AGING [R01AG034151, RC2AG036631, P30AG012810] Funding Source: NIH RePORTER	U.S. Department of Health and Human Services; California HealthCare Foundation; John D. and Catherine T. MacArthur Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Smith Richardson Foundation; U.S. Social Security Administration; Centers for Medicare and Medicaid Services; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Chandra, J. Levin, R. Levin, B. Olken, J. Shapiro, and H. Williams for helpful comments and advice; to Mira Bernstein for immeasurable contribution to the study; to I. Colaiacovo, N. Subramanian, A. Zhou, A. Barnett, and J. Dennett for expert research assistance; to M. Callan for invaluable expertise in collecting and processing the data; to the Oregon Association of Hospital and Health Systems and the hospitals who provided emergency-department data; to numerous Oregon state employees for help acquiring the necessary data and for answering our many questions about the administration of state programs; and to our generous funders. The Oregon Health Insurance Experiment study was funded by the Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services, the California HealthCare Foundation, the John D. and Catherine T. MacArthur Foundation, the National Institute on Aging (grants P30AG012810, RC2AGO36631, and R01AG0345151), the Robert Wood Johnson Foundation, the Alfred P. Sloan Foundation, the Smith Richardson Foundation, the U.S. Social Security Administration (through grant 5 RRC 08098400-03-00 to NBER as part of the SSA Retirement Research Consortium), and the Centers for Medicare and Medicaid Services. The findings and conclusions expressed are solely those of the authors and do not represent the views of the funders. Replication code and a modified version of the data are available on the Oregon Health Insurance Experiment Web site (www.nber.org/oregon/data.html).	Allen H, 2010, HEALTH AFFAIR, V29, P1498, DOI 10.1377/hlthaff.2010.0191; Anderson M., REV ECON STAT, DOI 10.1162/REST_a_00378; Anderson M, 2012, AM ECON J-ECON POLIC, V4, P1, DOI 10.1257/pol.4.1.1; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; [Anonymous], HEALTHCARE COST AND; Baicker K., 2013, NBER WORKING PAPER N; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Billings JC, 2000, EMERGENCY ROOM USE T; Chen C, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1109273; Currie J, 1996, Q J ECON, V111, P431, DOI 10.2307/2946684; Dudiak Z., 2013, PITTSBURGH AREA LEGI; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Lowe RA, 2008, ACAD EMERG MED, V15, P506, DOI 10.1111/j.1553-2712.2008.00108.x; Miller S, 2012, J PUBLIC ECON, V96, P893, DOI 10.1016/j.jpubeco.2012.07.004; Newhouse J. P., 1993, FREE FOR ALL LESSONS; Palm-Houser S., 2013, GOVERNOR KASICH INCL; Raven MC, 2013, JAMA-J AM MED ASSOC, V309, P1145, DOI 10.1001/jama.2013.1948; Snyder R., 2013, FACTS ABOUT MEDICAID; Taubman S., 2013, THE OREGON HEALTH IN; U.S. Department of Health and Human Services, 2009, NEW DATA SAY UNINSUR	21	349	350	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					263	268		10.1126/science.1246183	http://dx.doi.org/10.1126/science.1246183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	289YN	24385603	Green Accepted, Green Submitted			2022-12-28	WOS:000329718600027
J	Chen, BY; Brinkmann, K; Chen, ZC; Pak, CW; Liao, YX; Shi, SY; Henry, L; Grishin, NV; Bogdan, S; Rosen, MK				Chen, Baoyu; Brinkmann, Klaus; Chen, Zhucheng; Pak, Chi W.; Liao, Yuxing; Shi, Shuoyong; Henry, Lisa; Grishin, Nick V.; Bogdan, Sven; Rosen, Michael K.			The WAVE Regulatory Complex Links Diverse Receptors to the Actin Cytoskeleton	CELL			English	Article							SIGNAL INTEGRATION; WASP; ACTIVATION; MEMBRANE; PROTEINS; POLYMERIZATION; PROTOCADHERIN; NUCLEATION; MUTATIONS; MECHANISM	The WAVE regulatory complex (WRC) controls actin cytoskeletal dynamics throughout the cell by stimulating the actin-nucleating activity of the Arp2/3 complex at distinct membrane sites. However, the factors that recruit the WRC to specific locations remain poorly understood. Here, we have identified a large family of potential WRC ligands, consisting of similar to 120 diverse membrane proteins, including proto-cadherins, ROBOs, netrin receptors, neuroligins, GPCRs, and channels. Structural, biochemical, and cellular studies reveal that a sequence motif that defines these ligands binds to a highly conserved interaction surface of the WRC formed by the Sra and Abi subunits. Mutating this binding surface in flies resulted in defects in actin cytoskeletal organization and egg morphology during oogenesis, leading to female sterility. Our findings directly link diverse membrane proteins to the WRC and actin cytoskeleton and have broad physiological and pathological ramifications in metazoans.	[Chen, Baoyu; Chen, Zhucheng; Pak, Chi W.; Liao, Yuxing; Shi, Shuoyong; Henry, Lisa; Grishin, Nick V.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Chen, Baoyu; Chen, Zhucheng; Pak, Chi W.; Liao, Yuxing; Shi, Shuoyong; Henry, Lisa; Grishin, Nick V.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Brinkmann, Klaus; Bogdan, Sven] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Munster	Bogdan, S (corresponding author), Univ Munster, Inst Neurobiol, D-48149 Munster, Germany.	sbogdan@uni-muenster.de; michael.rosen@utsouthwestern.edu	Liao, Yuxing/AAI-2582-2020; Chen, Baoyu/A-7072-2011	Chen, Baoyu/0000-0002-6366-159X; Liao, Yuxing/0000-0002-1238-2021	American Heart Association; Cancer Research Institute; National Institutes of Health (NIH) [1F32DK091074]; Deutsche Forschungsgemeinschaft (DFG); NIH [R01-GM056322, R01-GM094575]; Welch Foundation [I-1544, I-1550]; Howard Hughes Medical Institute; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, R01GM056322] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Cancer Research Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Roybal and C. Wuelfing for making MMLVs for generating stable Sra1-YPet cell lines; S. B. Padrick for help in fitting the anisotropy data; S. B. Padrick, K. Huber, and P. Li for discussion; B. T. Nixon, Y.M. Chook, S. B. Padrick, D. Jia, T. Zobel, J. Squarr, and M. Bechtold for reviewing the manuscript; and N. Brose, I. Bezprozvanny, T. C. Sudhof, K. Huber, K. W. Roche, J. R. Bamburg, and T. Pawson for sharing the vectors for hNeuroligin-4X, rCav1.3, hBAI3, rmGluR5, rGluR6, mCherry, and hCD16-hCD7, respectively. Research was supported by fellowships from the American Heart Association, the Cancer Research Institute, and the National Institutes of Health (NIH) (1F32DK091074) to B. C., Z.C., and C. W. P., respectively, grants to S. B. from the Deutsche Forschungsgemeinschaft (DFG), grants from the NIH and Welch Foundation to M. K. R. (R01-GM056322 and I-1544, respectively) and N. V. G. (R01-GM094575 and I-1550, respectively), and the Howard Hughes Medical Institute. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the U.S. Department of Energy under contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alegado RA, 2012, ELIFE, V1, DOI 10.7554/eLife.00013; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; Bilder D, 2012, DEV CELL, V22, P12, DOI 10.1016/j.devcel.2011.12.003; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Burkhardt P, 2011, P NATL ACAD SCI USA, V108, P15264, DOI 10.1073/pnas.1106189108; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Chia PH, 2014, CELL, V156, P208, DOI 10.1016/j.cell.2013.12.009; Depienne C, 2011, NEUROLOGY, V76, P260, DOI 10.1212/WNL.0b013e318207b1e0; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Dimova PS, 2012, PEDIATR NEUROL, V46, P397, DOI 10.1016/j.pediatrneurol.2012.03.004; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emond MR, 2009, DEV BIOL, V334, P72, DOI 10.1016/j.ydbio.2009.07.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GUTZEIT HO, 1991, J CELL SCI, V100, P781; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hudson AM, 2002, ANNU REV GENET, V36, P455, DOI 10.1146/annurev.genet.36.052802.114101; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Karpushev AV, 2011, HYPERTENSION, V57, P996, DOI 10.1161/HYPERTENSIONAHA.110.157784; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Oda H, 1996, CANCER RES, V56, P3320; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pathirana S, 2001, MECH DEVELOP, V109, P137, DOI 10.1016/S0925-4773(01)00557-3; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Stavoe AKH, 2012, GENE DEV, V26, P2206, DOI 10.1101/gad.193409.112; Stephan R, 2011, MOL BIOL CELL, V22, P4079, DOI 10.1091/mbc.E11-02-0121; Tai K, 2010, BRAIN RES, V1344, P13, DOI 10.1016/j.brainres.2010.04.065; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Viktorinova I, 2009, DEVELOPMENT, V136, P4123, DOI 10.1242/dev.039099; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zobel T, 2013, J MICROSC-OXFORD, V251, P224, DOI 10.1111/jmi.12020	58	173	175	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					195	207		10.1016/j.cell.2013.11.048	http://dx.doi.org/10.1016/j.cell.2013.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439376	Green Accepted, Bronze			2022-12-28	WOS:000329912200021
J	DiBiase, RA				DiBiase, Roman A.			EARTH SCIENCE River incision revisited	NATURE			English	Editorial Material							BE-10; RATES; AL-26		CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	DiBiase, RA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	rdibiase@caltech.edu						Anderson RS, 1996, GEOLOGY, V24, P47, DOI 10.1130/0091-7613(1996)024<0047:ETOIID>2.3.CO;2; Crosby BT, 2006, GEOMORPHOLOGY, V82, P16, DOI 10.1016/j.geomorph.2005.08.023; Finnegan NJ, 2014, NATURE, V505, P391, DOI 10.1038/nature12913; Granger DE, 1997, GEOLOGY, V25, P107, DOI 10.1130/0091-7613(1997)025<0107:QDROTN>2.3.CO;2; Herman F, 2013, NATURE, V504, P423, DOI 10.1038/nature12877; Korup O, 2010, P NATL ACAD SCI USA, V107, P5317, DOI 10.1073/pnas.0907531107; Leland J, 1998, EARTH PLANET SC LETT, V154, P93, DOI 10.1016/S0012-821X(97)00171-4; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Sadler P., 2013, GEOL SOC AM ABSTR, V45, P86; Sadler P. M., GEOL SOC LO IN PRESS; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Schumer R, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2009JF001266; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413	14	10	11	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					294	295		10.1038/505294a	http://dx.doi.org/10.1038/505294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429622	Green Accepted			2022-12-28	WOS:000329621800022
J	Elfstrom, KM; Smelov, V; Johansson, ALV; Eklund, C; Naucler, P; Arnheim-Dahlstrom, L; Dillner, J				Elfstrom, K. Miriam; Smelov, Vitaly; Johansson, Anna L. V.; Eklund, Carina; Naucler, Pontus; Arnheim-Dahlstrom, Lisen; Dillner, Joakim			Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; GLOBAL PROFICIENCY; RISK; DNA; CYTOLOGY; PERFORMANCE; NEOPLASIA; TESTS	Objectives To assess whether the increased sensitivity of screening for human papillomavirus (HPV) may represent overdiagnosis and to compare the long term duration of protective effect against cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in HPV based and cytology based screening. Design 13 year follow-up of the Swedescreen randomised controlled trial of primary HPV screening. Setting Organised cervical screening programme in Sweden. Participants 12 527 women aged 32-38 attending organised screening were enrolled and randomised to HPV and cytology double testing (intervention arm, n=6257) or to cytology only, with samples frozen for future HPV testing (control arm, n=6270). Main outcome measures Cumulative incidence of CIN2+ and CIN3+ (Kaplan Meier curves). Longitudinal test characteristics were calculated for cytology only, HPV testing only, and cytology and HPV testing combined, adjusting for censoring. Results The increased detection of CIN2+ in the intervention arm decreased over time. After six years, the cumulative incidence of CIN3+ was similar in both trial arms, and after 11 years the cumulative incidence of CIN2+ became similar in both arms. The longitudinal sensitivity of cytology for CIN2+ in the control arm at three years was similar to the sensitivity of HPV testing in the intervention arm at five years of follow-up: 85.94% (95% confidence interval 76.85% to 91.84%) v 86.40% (79.21% to 91.37%). The sensitivity of HPV screening for CIN3+ after five years was 89.34% (80.10% to 94.58%) and for cytology after three years was 92.02% (80.59% to 96.97%). Conclusions Over long term follow-up, the cumulative incidence of CIN2+ was the same for HPV screening and for cytology, implying that the increased sensitivity of HPV screening for CIN2+ reflects earlier detection rather than overdiagnosis. The low long term risks of CIN3+ among women who tested negative in HPV screening, support screening intervals of five years for such women.	[Elfstrom, K. Miriam; Johansson, Anna L. V.; Arnheim-Dahlstrom, Lisen; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Smelov, Vitaly; Eklund, Carina; Dillner, Joakim] Karolinska Inst, Dept Lab Med Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Naucler, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Naucler, Pontus] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Dillner, J (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	joakim.dillner@ki.se		Smelov, Vitaly/0000-0002-7353-1561; Johansson, Anna/0000-0002-1191-7231	EU; Swedish Cancer Society; Swedish Foundation for Strategic Research	EU(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This study was supported by the PREHDICT and CoheaHr projects (EU FP7 programmes), the Swedish Cancer Society, and the Swedish Foundation for Strategic Research. The funding sources had no role in the study design; the collection, analysis, and interpretation of data; and the writing of the article and the decision to submit it for publication.	Adriaensen WJ, 2013, J CLIN EPIDEMIOL, V66, P639, DOI 10.1016/j.jclinepi.2012.09.018; Antolini L, 2012, STAT MED, V31, P1113, DOI 10.1002/sim.4443; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bulkmans NWJ, 2005, BRIT J CANCER, V92, P1800, DOI 10.1038/sj.bjc.6602541; de Kok IMCM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e670; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Eklund C, 2012, J CLIN MICROBIOL, V50, P2289, DOI 10.1128/JCM.00840-12; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Forslund O, 2002, J MED VIROL, V66, P535, DOI 10.1002/jmv.2178; Jacobs MV, 1999, J CLIN PATHOL, V52, P498, DOI 10.1136/jcp.52.7.498; Kitchener HC, 2011, EUR J CANCER, V47, P864, DOI 10.1016/j.ejca.2011.01.008; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Leinonen MK, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7789; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Schiffman M, 2011, CANCER EPIDEM BIOMAR, V20, P1398, DOI 10.1158/1055-9965.EPI-11-0206; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Wahlstrom C, 2007, J MED VIROL, V79, P1169, DOI 10.1002/jmv.20898; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	27	76	82	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2014	348								g130	10.1136/bmj.g130	http://dx.doi.org/10.1136/bmj.g130			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MP	24435414	Green Published, hybrid			2022-12-28	WOS:000329976100003
J	Hensch, TK				Hensch, Takao K.			Bistable Parvalbumin Circuits Pivotal for Brain Plasticity	CELL			English	Editorial Material							INTERNEURONS; CORTEX	Experience shapes brain function throughout life to varying degrees. In a recent issue of Nature, Donato et al. identify reversible shifts in focal parvalbumin cell state during adult learning, placing it on a mechanistic continuum with developmental critical periods. A disinhibitory microcircuit controls the plasticity switch to modulate memory formation.	[Hensch, Takao K.] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Hensch, Takao K.] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School	Hensch, TK (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, 52 Oxford St, Cambridge, MA 02138 USA.	hensch@mcb.harvard.edu	Hensch, Takao/L-4182-2019		NICHD NIH HHS [P30 HD018655] Funding Source: Medline; NIMH NIH HHS [P50 MH094271, 1P50MH094271] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Canty AJ, 2009, J NEUROSCI, V29, P10695, DOI 10.1523/JNEUROSCI.2658-09.2009; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gu Y, 2013, NEURON, V79, P335, DOI 10.1016/j.neuron.2013.05.016; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Spatazza J, 2013, CELL REP, V3, P1815, DOI 10.1016/j.celrep.2013.05.014; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Tamura H, 2012, J NEUROSCI, V32, P12657, DOI 10.1523/JNEUROSCI.2542-12.2012	10	23	23	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					17	19		10.1016/j.cell.2013.12.034	http://dx.doi.org/10.1016/j.cell.2013.12.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439367	Bronze, Green Accepted			2022-12-28	WOS:000329912200008
J	Smith, JM				Smith, Jeanette M.			Flower Still Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					228	229		10.1001/jama.2013.279278	http://dx.doi.org/10.1001/jama.2013.279278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24430306				2022-12-28	WOS:000329566400001
J	Sihvola, A				Sihvola, Ari			Enabling Optical Analog Computing with Metamaterials	SCIENCE			English	Editorial Material									Aalto Univ, Sch Elect Engn, Dept Radio Sci & Engn, Espoo 02150, Finland	Aalto University	Sihvola, A (corresponding author), Aalto Univ, Sch Elect Engn, Dept Radio Sci & Engn, Otakaari 5A, Espoo 02150, Finland.	ari.sihvola@aalto.fi	Sihvola, Ari/K-8267-2013					Alu A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013026; [Anonymous], 1944, BAS FIR CONTR MECH; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Goodman J. W., 2005, INTRO FOURIER OPTICS; Kettunen H, 2008, J APPL PHYS, V103, DOI 10.1063/1.2917402; Lipworth G, 2013, J OPT SOC AM A, V30, P1603, DOI 10.1364/JOSAA.30.001603; Pendry JB, 2003, J PHYS-CONDENS MAT, V15, P6345, DOI 10.1088/0953-8984/15/37/004; PRICE DD, 1984, IEEE MICRO, V4, P22, DOI 10.1109/MM.1984.291305; Sihvola A., 2007, METAMATERIALS, V56, P2, DOI [10.1016/j.metmat.2007.02.003, DOI 10.1016/J.METMAT.2007.02.003]; Silva A, 2014, SCIENCE, V343, P160, DOI [10.1126/science.1242818, 10.1126/science.124405]	10	20	20	7	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					144	145		10.1126/science.1248659	http://dx.doi.org/10.1126/science.1248659			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408424				2022-12-28	WOS:000329440800028
J	Lewis, B				Lewis, Bradley			The art of medicine	LANCET			English	Editorial Material									NYU, Gallatin Sch Individualized Study, New York, NY 10012 USA	New York University	Lewis, B (corresponding author), NYU, Gallatin Sch Individualized Study, 550 1St Ave, New York, NY 10012 USA.	bradley.lewis@nyu.edu						Angel M., 2011, NEW YORK REVIEW OF B; Friedman RA., 2013, NEW YORK TIMES; Hamkins S., 2013, THE ART OF NARRATIVE; Insel T. R., 2013, DIRECTORS BLOG TRANS; Lewis B., 2011, NARRATIVE PSYCHIATRY	5	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					22	23		10.1016/S0140-6736(13)62722-1	http://dx.doi.org/10.1016/S0140-6736(13)62722-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SP	24400334				2022-12-28	WOS:000329341200016
J	Capel, B				Capel, Blanche			The Minimalist Y	SCIENCE			English	Editorial Material							MALE-MICE; LONG ARM; CHROMOSOME; TESTIS; SRY		Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Capel, B (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	blanche.capel@duke.edu			NICHD NIH HHS [R37 HD039963] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD039963] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Kleiman SE, 2007, HUM REPROD, V22, P151, DOI 10.1093/humrep/del341; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Qin YJ, 2005, HUM MOL GENET, V14, P1221, DOI 10.1093/hmg/ddi133; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Vernet N, 2012, REPRODUCTION, V144, P433, DOI 10.1530/REP-12-0158; Yamauchi Y, 2014, SCIENCE, V343, P69, DOI 10.1126/science.1242544; Yamauchi Y, 2009, BIOL REPROD, V81, P353, DOI 10.1095/biolreprod.109.076307	14	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					32	33		10.1126/science.1248486	http://dx.doi.org/10.1126/science.1248486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385621				2022-12-28	WOS:000329162000037
J	Powers, SW; Kashikar-Zuck, SM; Allen, JR; LeCates, SL; Slater, SK; Zafar, M; Kabbouche, MA; O'Brien, HL; Shenk, CE; Rausch, JR; Hershey, AD				Powers, Scott W.; Kashikar-Zuck, Susmita M.; Allen, Janelle R.; LeCates, Susan L.; Slater, Shalonda K.; Zafar, Marium; Kabbouche, Marielle A.; O'Brien, Hope L.; Shenk, Chad E.; Rausch, Joseph R.; Hershey, Andrew D.			Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine in Children and Adolescents A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC DAILY HEADACHE; QUALITY-OF-LIFE; PHARMACOLOGICAL-TREATMENT; DOUBLE-BLIND; PLACEBO; TOPIRAMATE; DISABILITY; MANAGEMENT; CHILDHOOD; EFFICACY	IMPORTANCE Early, safe, effective, and durable evidence-based interventions for children and adolescents with chronic migraine do not exist. OBJECTIVE To determine the benefits of cognitive behavioral therapy (CBT) when combined with amitriptyline vs headache education plus amitriptyline. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial of 135 youth (79% female) aged 10 to 17 years diagnosed with chronic migraine (>15 days with headache/month) and a Pediatric Migraine Disability Assessment Score (PedMIDAS) greater than 20 points were assigned to the CBT plus amitriptyline group (n = 64) or the headache education plus amitriptyline group (n = 71). The study was conducted in the Headache Center at Cincinnati Children's Hospital between October 2006 and September 2012; 129 completed 20-week follow-up and 124 completed 12-month follow-up. INTERVENTIONS Ten CBT vs 10 headache education sessions involving equivalent time and therapist attention. Each group received 1 mg/kg/d of amitriptyline and a 20-week end point visit. In addition, follow-up visits were conducted at 3, 6, 9, and 12 months. MAIN OUTCOMES AND MEASURES The primary end point was days with headache and the secondary end point was PedMIDAS (disability score range: 0-240 points; 0-10 for little to none, 11-30 for mild, 31-50 for moderate, >50 for severe); both end points were determined at 20 weeks. Durability was examined over the 12-month follow-up period. Clinical significance was measured by a 50% or greater reduction in days with headache and a disability score in the mild to none range (<20 points). RESULTS At baseline, there were a mean (SD) of 21 (5) days with headache per 28 days and the mean (SD) PedMIDAS was 68 (32) points. At the 20-week end point, days with headache were reduced by 11.5 for the CBT plus amitriptyline group vs 6.8 for the headache education plus amitriptyline group (difference, 4.7 [95% CI, 1.7-7.7] days; P = .002). The PedMIDAS decreased by 52.7 points for the CBT group vs 38.6 points for the headache education group (difference, 14.1 [95% CI, 3.3-24.9] points; P = .01). In the CBT group, 66% had a 50% or greater reduction in headache days vs 36% in the headache education group (odds ratio, 3.5 [95% CI, 1.7-7.2]; P < .001). At 12-month follow-up, 86% of the CBT group had a 50% or greater reduction in headache days vs 69% of the headache education group; 88% of the CBT group had a PedMIDAS of less than 20 points vs 76% of the headache education group. Measured treatment credibility and integrity was high for both groups. CONCLUSIONS AND RELEVANCE Among young persons with chronic migraine, the use of CBT plus amitriptyline resulted in greater reductions in days with headache and migraine-related disability compared with use of headache education plus amitriptyline. These findings support the efficacy of CBT in the treatment of chronic migraine in children and adolescents.	[Powers, Scott W.; Kashikar-Zuck, Susmita M.; Allen, Janelle R.; Slater, Shalonda K.; Zafar, Marium; Shenk, Chad E.; Rausch, Joseph R.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [LeCates, Susan L.; Kabbouche, Marielle A.; O'Brien, Hope L.; Hershey, Andrew D.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Powers, Scott W.; Allen, Janelle R.; LeCates, Susan L.; Slater, Shalonda K.; Kabbouche, Marielle A.; O'Brien, Hope L.; Hershey, Andrew D.] Cincinnati Childrens Hosp Med Ctr, Headache Ctr, Cincinnati, OH 45229 USA; [Powers, Scott W.; Kashikar-Zuck, Susmita M.; Slater, Shalonda K.; Kabbouche, Marielle A.; O'Brien, Hope L.; Shenk, Chad E.; Rausch, Joseph R.; Hershey, Andrew D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Powers, SW (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	scott.powers@cchmc.org	O'Brien, Hope Lorraine/AHB-9810-2022; O'Brien, Hope/AAZ-9717-2020; Rausch, Joseph R/E-8107-2018; Hershey, Andrew D./K-1245-2019	Hershey, Andrew D./0000-0002-1598-7536; Powers, Scott/0000-0002-5348-9650; Shenk, Chad/0000-0001-6700-5656	National Institute of Neurological Disorders and Stroke [R01NS05036]; National Center for Research Resources [8 UL1 TR000077]; National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases [T32DK063929]; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR056687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK063929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050536] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by grant R01NS05036 from the National Institute of Neurological Disorders and Stroke (Dr Powers), grant 8 UL1 TR000077 from the National Center for Research Resources and the National Center for Advancing Translational Sciences, and grant T32DK063929 from the National Institute of Diabetes and Digestive and Kidney Diseases for some of the postdoctoral fellows who contributed to the trial (Dr Powers, program director). Amitriptyline, which was provided without cost to participants, was purchased using National Institutes of Health grant funds and managed by the investigational pharmacy at Cincinnati Children's Hospital Medical Center. If prevention drug was clinically prescribed during the 12-month follow-up period, families had financial responsibility for the medications as with typical clinical practice.	Andrasik F, 2005, HEADACHE, V45, P520, DOI 10.1111/j.1526-4610.2005.05104.x; Arruda MA, 2013, JAMA PEDIATR, V167, P300, DOI 10.1001/jamapediatrics.2013.1105; Bigal ME, 2004, NEUROLOGY, V63, P843, DOI 10.1212/01.WNL.0000137039.08724.18; Bille B, 1997, CEPHALALGIA, V17, P488, DOI 10.1046/j.1468-2982.1997.1704488.x; Brasure M, 2013, PREVENTIVE PHARM TRE; Buse DC, 2012, HEADACHE, V52, P1456, DOI 10.1111/j.1526-4610.2012.02223.x; Connelly M, 2006, J PEDIATR PSYCHOL, V31, P737, DOI 10.1093/jpepsy/jsj003; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Eccleston C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003968.pub3; El-Chammas K, 2013, JAMA PEDIATR, V167, P250, DOI 10.1001/jamapediatrics.2013.508; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Hershey AD, 2004, CEPHALALGIA, V24, P844, DOI 10.1111/j.1468-2982.2004.00757.x; Hershey AD, 2000, HEADACHE, V40, P539, DOI 10.1046/j.1526-4610.2000.00085.x; Hershey AD, 2009, PEDIAT HEADACHES CLI; Hershey AD, 2013, HEADACHE, V53, P799, DOI 10.1111/head.12105; Hershey AD, 2010, PEDIATR ANN, V39, P416, DOI 10.3928/00904481-20100623-06; Hershey AD, 2010, LANCET NEUROL, V9, P190, DOI 10.1016/S1474-4422(09)70303-5; Holroyd KA, 2005, HEADACHE, V45, P487, DOI 10.1111/j.1526-4610.2005.05100.x; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Holroyd KA, 2010, BMJ-BRIT MED J, V341, P4871; Jackson JL, 2012, JAMA-J AM MED ASSOC, V307, P1736, DOI 10.1001/jama.2012.505; Jackson JL, 2010, BMJ-BRIT MED J, V341, pc5222; Kashikar-Zuck S, 2012, ARTHRITIS RHEUM-US, V64, P297, DOI 10.1002/art.30644; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Lewis D, 2004, NEUROLOGY, V63, P2215, DOI 10.1212/01.WNL.0000147332.41993.90; Lipton RB, 2011, HEADACHE, V51, P693, DOI 10.1111/j.1526-4610.2011.01885.x; Olesen J, 2006, CEPHALALGIA, V26, P742, DOI 10.1111/j.1468-2982.2006.01172.x; Palermo TM, 2009, PAIN, V146, P205, DOI 10.1016/j.pain.2009.07.034; Penzien DB, 2005, HEADACHE, V45, pS110, DOI 10.1111/j.1526-4610.2005.4502004.x; Powers SW, 2006, HEADACHE, V46, pS149, DOI 10.1111/j.1526-4610.2006.00568.x; Powers SW, 2003, PEDIATRICS, V112, pE1, DOI 10.1542/peds.112.1.e1; Rothrock JF, 2012, HEADACHE, V52, P1204, DOI 10.1111/j.1526-4610.2012.02193.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein S, 2009, HEADACHE, V49, P1153, DOI 10.1111/j.1526-4610.2009.01508.x; Silberstein SD, 2007, HEADACHE, V47, P170, DOI 10.1111/j.1526-4610.2006.00684.x; Slater SK, 2012, CEPHALALGIA, V32, P1116, DOI 10.1177/0333102412460776; Split W, 1999, HEADACHE, V39, P494, DOI 10.1046/j.1526-4610.1999.3907494.x; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; World Health Organization, 2011, ATLAS HEADACHE DISOR	40	154	157	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2622	2630		10.1001/jama.2013.282533	http://dx.doi.org/10.1001/jama.2013.282533			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368463	Bronze, Green Accepted			2022-12-28	WOS:000328818000014
J	Feeney, WE; Medina, I; Somveille, M; Heinsohn, R; Hall, ML; Mulder, RA; Stein, JA; Kilner, RM; Langmore, NE				Feeney, W. E.; Medina, I.; Somveille, M.; Heinsohn, R.; Hall, M. L.; Mulder, R. A.; Stein, J. A.; Kilner, R. M.; Langmore, N. E.			Brood Parasitism and the Evolution of Cooperative Breeding in Birds	SCIENCE			English	Article							CUCKOOS	The global distribution of cooperatively breeding birds is highly uneven, with hotspots in Australasia and sub-Saharan Africa. The ecological drivers of this distribution remain enigmatic yet could yield insights into the evolution and persistence of cooperative breeding. We report that the global distributions of avian obligate brood parasites and cooperatively breeding passerines are tightly correlated and that the uneven phylogenetic distribution of cooperative breeding is associated with the uneven targeting of hosts by brood parasites. With a long-term field study, we show that brood parasites can acquire superior care for their young by targeting cooperative breeders. Conversely, host defenses against brood parasites are strengthened by helpers at the nest. Reciprocally selected interactions between brood parasites and cooperative breeders may therefore explain the close association between these two breeding systems.	[Feeney, W. E.; Medina, I.; Langmore, N. E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Somveille, M.; Kilner, R. M.] Univ Cambridge, Dept Zool, Cambridge, England; [Heinsohn, R.; Stein, J. A.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Hall, M. L.; Mulder, R. A.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	Australian National University; University of Cambridge; Australian National University; University of Melbourne	Langmore, NE (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	naomi.langmore@anu.edu.au	Hall, Michelle L/A-1904-2010; Langmore, Naomi E/C-9302-2009; Kilner, Rebecca/B-2867-2012; Feeney, William E/D-3180-2013	Hall, Michelle L/0000-0002-1263-8314; Kilner, Rebecca/0000-0003-1159-0758; Feeney, William E/0000-0002-7475-4724; Somveille, Marius/0000-0002-6868-5080	Canberra Birds Conservation Fund; Australian Geographic; Australian Research Council (ARC) [DP110103120, DP110101966]	Canberra Birds Conservation Fund; Australian Geographic; Australian Research Council (ARC)(Australian Research Council)	We thank our field assistants, L. Joseph for assistance with specimens, and A. Cockburn for helpful discussions. W. E. F. was supported by the Canberra Birds Conservation Fund and Australian Geographic. R. A. M. and M. L. H. were supported by Australian Research Council (ARC) Discovery Grant DP110103120. N.E.L. was supported by ARC Discovery Grant DP110101966. Data are archived on Figshare. N.E.L. and W. E. F. conceived the study; macroecological analyses were done by M. S. and J.A.S.; comparative analyses were done by I. M.; field data were collected by N.E.L., R. M. K., R. H., M. L. H., and R. A. M.; model and playback experiments were done by W. E. F.; and N.E.L. and R. M. K. wrote the paper.	BROOKER MG, 1989, AUSTR ZOOLOGICAL REV, V2, P1; Brown M, 2007, IBIS, V149, P321, DOI 10.1111/j.1474-919X.2006.00633.x; Canestrari D, 2009, ANIM BEHAV, V77, P1337, DOI 10.1016/j.anbehav.2009.02.009; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cockburn A, 2011, CURR BIOL, V21, pR195, DOI 10.1016/j.cub.2011.01.044; Davies N. B., 2000, CUCKOOS COWBIRDS AND; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; Feeney WE, 2012, ANIM BEHAV, V84, P3, DOI 10.1016/j.anbehav.2012.04.011; Gonzalez JCT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1297; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Langmore NE, 2012, BEHAV ECOL, V23, P798, DOI 10.1093/beheco/ars033; Langmore NE, 2003, NATURE, V422, P157, DOI 10.1038/nature01460; Maree S., 2005, ROBERTSBIRDS SO AFRI; Monadjem A, 1996, S AFR J SCI, V92, P295; POIANI A, 1994, ANIM BEHAV, V47, P697, DOI 10.1006/anbe.1994.1094	15	79	80	3	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1506	1508		10.1126/science.1240039	http://dx.doi.org/10.1126/science.1240039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357317				2022-12-28	WOS:000328644300057
J	Konstantinides, N; Averof, M				Konstantinides, Nikolaos; Averof, Michalis			A Common Cellular Basis for Muscle Regeneration in Arthropods and Vertebrates	SCIENCE			English	Article							SATELLITE CELLS; STEM-CELLS; LINEAGE; RESTRICTION; EVOLUTION; HYDRA	Many animals are able to regenerate amputated or damaged body parts, but it is unclear whether different taxa rely on similar strategies. Planarians and vertebrates use different strategies, based on pluripotent versus committed progenitor cells, respectively, to replace missing tissues. In most animals, however, we lack the experimental tools needed to determine the origin of regenerated tissues. Here, we present a genetically tractable model for limb regeneration, the crustacean Parhyale hawaiensis. We demonstrate that regeneration in Parhyale involves lineage-committed progenitors, as in vertebrates. We discover Pax3/7-expressing muscle satellite cells, previously identified only in chordates, and show that these cells are a source of regenerating muscle in Parhyale. These similarities point to a common cellular basis of regeneration, dating back to the common ancestors of bilaterians.	[Konstantinides, Nikolaos; Averof, Michalis] Fdn Res & Technol Hellas FORTH, IMBB, Iraklion 70013, Crete, Greece; [Konstantinides, Nikolaos] Univ Crete, Grad Programme Mol Biol & Biomed, Iraklion, Greece; [Konstantinides, Nikolaos] Univ Crete, Sch Med, Iraklion, Greece; [Konstantinides, Nikolaos; Averof, Michalis] Ecole Normale Super Lyon, IGFL, F-69364 Lyon, France; [Averof, Michalis] CNRS, F-75700 Paris, France	University of Crete; University of Crete; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	Konstantinides, N (corresponding author), Fdn Res & Technol Hellas FORTH, IMBB, Iraklion 70013, Crete, Greece.	nikolaos.konstantinides@ens-lyon.fr; michalis.averof@ens-lyon.fr		Averof, Michalis/0000-0002-6803-7251	Heraklitos II program of the Ministry of Education (Greece); European Social Fund; Agence Nationale de la Recherche (France) [ANR-12-CHEX-0001-01]	Heraklitos II program of the Ministry of Education (Greece); European Social Fund(European Social Fund (ESF)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	We thank A. Pavlopoulos, Z. Kontarakis, E. Kabrani, N. Patel, and M. Grillo for sharing reagents and unpublished information and Z. Kontarakis, K. Echeverri, E. Houliston, M. Telford, V. Laudet, F. Alwes, and two anonymous referees for suggesting improvements. Our research was supported by the Heraklitos II program of the Ministry of Education (Greece) and the European Social Fund, and by grant ANR-12-CHEX-0001-01 of the Agence Nationale de la Recherche (France).	Bode HR, 1996, J CELL SCI, V109, P1155; Bosch TCG, 2009, BIOESSAYS, V31, P478, DOI 10.1002/bies.200800183; Davis GK, 2005, DEV BIOL, V285, P169, DOI 10.1016/j.ydbio.2005.06.014; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Gerberding M, 2002, DEVELOPMENT, V129, P5789, DOI 10.1242/dev.00155; Kontarakis Z, 2011, DEVELOPMENT, V138, P2625, DOI 10.1242/dev.066324; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Muller WA, 2004, DEV BIOL, V275, P215, DOI 10.1016/j.ydbio.2004.08.006; Pavlopoulos A, 2005, P NATL ACAD SCI USA, V102, P7888, DOI 10.1073/pnas.0501101102; Pavlopoulos A, 2009, P NATL ACAD SCI USA, V106, P13897, DOI 10.1073/pnas.0902804106; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Somorjai IML, 2012, P NATL ACAD SCI USA, V109, P517, DOI 10.1073/pnas.1100045109; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265	21	61	64	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					788	791		10.1126/science.1243529	http://dx.doi.org/10.1126/science.1243529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24385602				2022-12-28	WOS:000331557800044
J	Lesterlin, C; Ball, G; Schermelleh, L; Sherratt, DJ				Lesterlin, Christian; Ball, Graeme; Schermelleh, Lothar; Sherratt, David J.			RecA bundles mediate homology pairing between distant sisters during DNA break repair	NATURE			English	Article							ESCHERICHIA-COLI CHROMOSOME; DOUBLE-STRANDED DNA; IN-VIVO; STRUCTURED ILLUMINATION; SINGLE-MOLECULE; LIVE CELLS; PROTEIN; RECOMBINATION; SEGREGATION; ARCHITECTURE	DNA double-strand break (DSB) repair by homologous recombination has evolved to maintain genetic integrity in all organisms(1). Although many reactions that occur during homologous recombination are known(1-3), it is unclear where, when and how they occur in cells. Here, by using conventional and super-resolution microscopy, we describe the progression of DSB repair in live Escherichia coli. Specifically, we investigate whether homologous recombination can occur efficiently between distant sister loci that have segregated to opposite halves of an E. coli cell. We show that a site-specific DSB in one sister can be repaired efficiently using distant sister homology. After RecBCD processing of the DSB, RecA is recruited to the cut locus, where it nucleates into a bundle that contains many more RecA molecules than can associate with the two single-stranded DNA regions that format the DSB. Mature bundles extend along the long axis of the cell, in the space between the bulk nucleoid and the inner membrane. Bundle formation is followed by pairing, in which the two ends of the cut locus relocate at the periphery of the nucleoid and together move rapidly towards the homology of the uncut sister. After sister locus pairing, RecA bundles disassemble and proteins that act late in homologous recombination are recruited to give viable recombinants 1-2-generation-time equivalents after formation of the initial DSB. Mutated RecA proteins that do not form bundles are defective in sister pairing and in DSB-induced repair. This work reveals an unanticipated role of RecA bundles in channelling the movement of the DNA DSB ends, thereby facilitating the long-range homology search that occurs before the strand invasion and transfer reactions.	[Lesterlin, Christian; Ball, Graeme; Schermelleh, Lothar; Sherratt, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Sherratt, DJ (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	david.sherratt@bioch.ox.ac.uk	Schermelleh, Lothar/H-4588-2019	Schermelleh, Lothar/0000-0002-1612-9699; Sherratt, David/0000-0002-2104-5430; Lesterlin, Christian/0000-0002-9108-0848; Ball, Graeme/0000-0002-6526-2306	EMBO long-term fellowship [LTF-535-2009]; Wellcome Trust Programme Grant [WT083469MA]; Wellcome Trust Strategic Award [091911]	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust Strategic Award(Wellcome Trust)	This work was supported by an EMBO long-term fellowship to C. L. (LTF-535-2009); by a Wellcome Trust Programme Grant to D.J.S. (WT083469MA); and by a Wellcome Trust Strategic Award (091911) supporting advanced microscopy at Micron Oxford. We thank I. Dobbie for his support and advice on imaging. We thank D. Leach and S. Kowalczykowski for the gift of strains and plasmids, N. Dubarry for critical reading of the manuscript and M, Stouf for the gift of pMS11. We thank E. Birt and K. Prosser for preliminary experiments.	Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bakshi S, 2012, MOL MICROBIOL, V85, P21, DOI 10.1111/j.1365-2958.2012.08081.x; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; BRENNER SL, 1988, J MOL BIOL, V204, P959, DOI 10.1016/0022-2836(88)90055-1; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DICAPUA E, 1990, J MOL BIOL, V214, P557, DOI 10.1016/0022-2836(90)90198-U; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Feinstein E, 2011, NUCLEIC ACIDS RES, V39, P3781, DOI 10.1093/nar/gkr013; GARVEY N, 1985, J BACTERIOL, V163, P870, DOI 10.1128/JB.163.3.870-876.1985; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Handa N, 2009, J BIOL CHEM, V284, P18664, DOI 10.1074/jbc.M109.004895; Helmstetter C. E., 1996, ESCHERICHIA COLI SAL, V2, P1627; KARU AE, 1982, MOL GEN GENET, V185, P275, DOI 10.1007/BF00330798; Kidane D, 2005, J CELL BIOL, V170, P357, DOI 10.1083/jcb.200412090; Kuwada N. J., 2013, NUCL ACIDS RES; Lesterlin C, 2012, EMBO J, V31, P3468, DOI 10.1038/emboj.2012.194; Lesterlin C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000288; Levin-Zaidman S, 2000, P NATL ACAD SCI USA, V97, P6791, DOI 10.1073/pnas.090532397; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Meile JC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-28; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Renzette N, 2008, MOL MICROBIOL, V67, P1347, DOI 10.1111/j.1365-2958.2008.06130.x; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; SASSANFAR M, 1991, J BACTERIOL, V173, P5869, DOI 10.1128/jb.173.18.5869-5875.1991; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Wang XD, 2011, P NATL ACAD SCI USA, V108, pE243, DOI 10.1073/pnas.1100874108; White MA, 2008, NATURE, V455, P1248, DOI 10.1038/nature07282; Yu X, 2004, CURR PROTEIN PEPT SC, V5, P73, DOI 10.2174/1389203043486883	44	111	112	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					249	+		10.1038/nature12868	http://dx.doi.org/10.1038/nature12868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24362571	Green Submitted, Green Accepted			2022-12-28	WOS:000331107700044
J	Gooch, RA; Kahn, JM				Gooch, Rebecca A.; Kahn, Jeremy M.			ICU Bed Supply, Utilization, and Health Care Spending An Example of Demand Elasticity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Gooch, Rebecca A.; Kahn, Jeremy M.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15261 USA; [Kahn, Jeremy M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kahn, JM (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 3550 Terrace St,Scaife Hall,Room 602-B, Pittsburgh, PA 15261 USA.	kahnjm@upmc.edu		Kahn, Jeremy/0000-0001-9688-5576				Chen LM, 2012, ARCH INTERN MED, V172, P1220, DOI 10.1001/archinternmed.2012.2606; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Linde-Zwirble WT, 2008, CRIT CARE MED, V36, pA8; Noland RB, 2001, TRANSPORT RES A-POL, V35, P47, DOI 10.1016/S0965-8564(99)00047-6; Organisation for Economic Cooperation and Development, 2011, HLTH GAL OECD IND; RICE TH, 1989, J HEALTH POLIT POLIC, V14, P587, DOI 10.1215/03616878-14-3-587; Stelfox HT, 2012, ARCH INTERN MED, V172, P467, DOI 10.1001/archinternmed.2011.2315; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC	9	108	109	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					567	568		10.1001/jama.2013.283800	http://dx.doi.org/10.1001/jama.2013.283800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24408679				2022-12-28	WOS:000330941000007
J	Gokhberg, K; Kolorenc, P; Kuleff, AI; Cederbaum, LS				Gokhberg, Kirill; Kolorenc, Premysl; Kuleff, Alexander I.; Cederbaum, Lorenz S.			Site- and energy-selective slow-electron production through intermolecular Coulombic decay	NATURE			English	Article							CORRELATED MOLECULAR CALCULATIONS; RESONANT AUGER-SPECTRA; GAUSSIAN-BASIS SETS; CHARGE DEPENDENCE; STRAND BREAKS; CORE-LEVEL; ATOMS; WATER; DNA; SPECTROSCOPY	Irradiation of matter with light tends to electronically excite atoms and molecules, with subsequent relaxation processes determining where the photon energy is ultimately deposited and electrons and ions produced. In weakly bound systems, intermolecular Coulombic decay(1) (ICD) enables very efficient relaxation of electronic excitation through transfer of the excess energy to neighbouring atoms or molecules that then lose an electron and become ionized(2-9). Here we propose that the emission site and energy of the electrons released during this process can be controlled by coupling the ICD to a resonant core excitation. We illustrate this concept with ab initio many body calculations on the argon-krypton model system, where resonant photoabsorption produces an initial or 'parent' excitation of the argon atom, which then triggers a resonant-Auger-ICD cascade that ends with the emission of a slow electron from the krypton atom. Our calculations show that the energy of the emitted electrons depends sensitively on the initial excited state of the argon atom. The incident energy can thus be adjusted both to produce the initial excitation in a chosen atom and to realize an excitation that will result in the emission of ICD electrons with desired energies. These properties of the decay cascade might have consequences for fundamental and applied radiation biology and could be of interest in the development of new spectroscopic techniques.	[Gokhberg, Kirill; Kuleff, Alexander I.; Cederbaum, Lorenz S.] Heidelberg Univ, Inst Phys Chem, D-69120 Heidelberg, Germany; [Kolorenc, Premysl] Charles Univ Prague, Fac Math & Phys, Inst Theoret Phys, CR-18000 Prague, Czech Republic	Ruprecht Karls University Heidelberg; Charles University Prague	Gokhberg, K (corresponding author), Heidelberg Univ, Inst Phys Chem, Neuenheimer Feld 229, D-69120 Heidelberg, Germany.	kirill.gokhberg@pci.uni-heidelberg.de; alexander.kuleff@pci.uni-heidelberg.de	Kuleff, Alexander I./P-2916-2017; Kolorenc, Premysl/J-9097-2014	Kuleff, Alexander I./0000-0003-2583-4370; Kolorenc, Premysl/0000-0002-0747-4546	European Research Council under the European Community [227597]; Czech Science Foundation [P208/12/0521]	European Research Council under the European Community(European Research Council (ERC)); Czech Science Foundation(Grant Agency of the Czech Republic)	The research leading to these results received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Advanced Investigator Grant no. 227597. P.K. acknowledges the support from the Czech Science Foundation (grant no. P208/12/0521).	Adelstein SJ, 2003, CANCER BIOTHER RADIO, V18, P301, DOI 10.1089/108497803322285062; [Anonymous], 2012, NIST ATOMIC SPECTRA; Averbukh V, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2126976; Aziz EF, 2008, NATURE, V455, P89, DOI 10.1038/nature07252; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Carravetta V, 2002, CHEM PHYS LETT, V354, P100, DOI 10.1016/S0009-2614(02)00114-8; Cederbaum LS, 1997, PHYS REV LETT, V79, P4778, DOI 10.1103/PhysRevLett.79.4778; DEGOUW JA, 1995, J PHYS B-AT MOL OPT, V28, P2127, DOI 10.1088/0953-4075/28/11/012; Demekhin PV, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3211114; FAIRCHILD RG, 1982, INVEST RADIOL, V17, P407, DOI 10.1097/00004424-198207000-00020; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Feyer V, 2008, J PHYS CHEM A, V112, P7806, DOI 10.1021/jp803017y; FUGGLE JC, 1980, PHYS REV A, V22, P1615, DOI 10.1103/PhysRevA.22.1615; Gorczyca TW, 1999, PHYS REV A, V60, P1216, DOI 10.1103/PhysRevA.60.1216; Grieves GA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016104; Hasi A. U., 1979, ELECT MOL PHOTON MOL, P281; HAUSAMANN D, 1985, MOL PHYS, V54, P1085, DOI 10.1080/00268978500100871; Havermeier T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.133401; Hergenhahn U, 2003, CHEM PHYS, V289, P57, DOI 10.1016/S0301-0104(02)00795-4; Hergenhahn U, 2011, J ELECTRON SPECTROSC, V184, P78, DOI 10.1016/j.elspec.2010.12.020; Huels MA, 2003, J AM CHEM SOC, V125, P4467, DOI 10.1021/ja029527x; Jahnke T, 2010, NAT PHYS, V6, P139, DOI 10.1038/NPHYS1498; Kay A, 1998, SCIENCE, V281, P679, DOI 10.1126/science.281.5377.679; Kim HK, 2011, P NATL ACAD SCI USA, V108, P11821, DOI 10.1073/pnas.1104382108; Martin F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068101; MCCARTHY IE, 1991, REP PROG PHYS, V54, P789, DOI 10.1088/0034-4885/54/6/001; Milne-Brownlie DS, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032701; Morishita Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.243402; Mucke M, 2010, NAT PHYS, V6, P143, DOI 10.1038/NPHYS1500; Muller IB, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2357921; Ohrwall G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173401; Ohrwall G, 2010, J PHYS CHEM B, V114, P17057, DOI 10.1021/jp108956v; Ottosson N, 2012, CHEM PHYS LETT, V543, P1, DOI 10.1016/j.cplett.2012.05.051; Peterson KA, 2003, J CHEM PHYS, V119, P11113, DOI 10.1063/1.1622924; Pokapanich W, 2011, J AM CHEM SOC, V133, P13430, DOI 10.1021/ja203430s; POMPLUN E, 1991, INT J RADIAT BIOL, V59, P625, DOI 10.1080/09553009114550561; Santra R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.153401; Santra R, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.245104; Schirmer J, 1998, J CHEM PHYS, V109, P4734, DOI 10.1063/1.477085; Schwartz CP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.198102; Sisourat N, 2010, NAT PHYS, V6, P508, DOI 10.1038/NPHYS1685; Stoychev SD, 2011, J AM CHEM SOC, V133, P6817, DOI 10.1021/ja200963y; Stoychev SD, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3499317; Stoychev SD, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2960593; Surdutovich E, 2012, J PHYS CONF SER, V373, DOI 10.1088/1742-6596/373/1/012001; Trinter F, 2014, NATURE, V505, P664, DOI 10.1038/nature12927; Ueda K, 2006, SEIKAGAKU, V78, P75; von Sonntag C., 2006, FREE RADICAL INDUCED; Wilson AK, 1999, J CHEM PHYS, V110, P7667, DOI 10.1063/1.478678; WOON DE, 1993, J CHEM PHYS, V98, P1358, DOI 10.1063/1.464303; Yamazaki M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.043004	51	109	109	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					661	+		10.1038/nature12936	http://dx.doi.org/10.1038/nature12936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24362566	Green Submitted			2022-12-28	WOS:000330321000036
J	Trinter, F; Schoffler, MS; Kim, HK; Sturm, FP; Cole, K; Neumann, N; Vredenborg, A; Williams, J; Bocharova, I; Guillemin, R; Simon, M; Belkacem, A; Landers, AL; Weber, T; Schmidt-Bocking, H; Dorner, R; Jahnke, T				Trinter, F.; Schoeffler, M. S.; Kim, H-K; Sturm, F. P.; Cole, K.; Neumann, N.; Vredenborg, A.; Williams, J.; Bocharova, I.; Guillemin, R.; Simon, M.; Belkacem, A.; Landers, A. L.; Weber, Th.; Schmidt-Boecking, H.; Doerner, R.; Jahnke, T.			Resonant Auger decay driving intermolecular Coulombic decay in molecular dimers	NATURE			English	Article							POTENTIAL-ENERGY SURFACE; MOMENTUM SPECTROSCOPY; RECOIL-ION; AB-INITIO; EXCITATION; ELECTRONS; CLUSTERS	In 1997, it was predicted(1) that an electronically excited atom or molecule placed in a loosely bound chemical system (such as a hydrogen-bonded or van-der-Waals- bonded cluster) could efficiently decay by transferring its excess energy to a neighbouring species that would then emit a low-energy electron. This intermolecular Coulombic decay (ICD) process has since been shown to be a common phenomenon(2-12), raising questions about its role in DNA damage induced by ionizing radiation, in which low-energy electrons are known to play an important part(13,14). It was recently suggested(15) that ICD can be triggered efficiently and site-selectively by resonantly core-exciting a target atom, which then transforms through Auger decay into an ionic species with sufficiently high excitation energy to permit ICD to occur. Here we show experimentally that resonant Auger decay can indeed trigger ICD in dimers of both molecular nitrogen and carbon monoxide. By using ion and electron momentum spectroscopy to measure simultaneously the charged species created in the resonant-Auger-driven ICD cascade, we find that ICD occurs in less time than the 20 femtoseconds it would take for individual molecules to undergo dissociation. Our experimental confirmation of this process and its efficiency may trigger renewed efforts to develop resonant X-ray excitation schemes(16,17) for more localized and targeted cancer radiation therapy.	[Trinter, F.; Schoeffler, M. S.; Kim, H-K; Sturm, F. P.; Cole, K.; Neumann, N.; Vredenborg, A.; Schmidt-Boecking, H.; Doerner, R.; Jahnke, T.] Goethe Univ Frankfurt, Inst Kernphys, D-60438 Frankfurt, Germany; [Schoeffler, M. S.; Sturm, F. P.; Bocharova, I.; Belkacem, A.; Weber, Th.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Williams, J.; Landers, A. L.] Auburn Univ, Dept Phys, Auburn, AL 36849 USA; [Guillemin, R.; Simon, M.] UPMC, F-75005 Paris, France; [Guillemin, R.; Simon, M.] CNRS, UMR 7614, Lab Chim Phys Mat & Rayonnement, F-75005 Paris, France	Goethe University Frankfurt; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Auburn University System; Auburn University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite	Jahnke, T (corresponding author), Goethe Univ Frankfurt, Inst Kernphys, Max Von Laue Str 1, D-60438 Frankfurt, Germany.	trinter@atom.uni-frankfurt.de; jahnke@atom.uni-frankfurt.de	SIMON, Marc/ABH-1911-2021; Schoeffler, Markus S/B-6261-2008; Doerner, Reinhard/A-5340-2008; Jahnke, Till/AGE-4901-2022; Trinter, Florian/AAJ-1403-2020	SIMON, Marc/0000-0002-2525-5435; Schoeffler, Markus S/0000-0001-9214-6848; Doerner, Reinhard/0000-0002-3728-4268; Trinter, Florian/0000-0002-0891-9180	Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; Division of Chemical Sciences, Geosciences, and Biosciences of the US Department of Energy at the Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Alexander von Humboldt foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Division of Chemical Sciences, Geosciences, and Biosciences of the US Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft and the Deutscher Akademischer Austauschdienst. We thank the staff of the Advanced Light Source for excellent support during the beam time. This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, and by the Division of Chemical Sciences, Geosciences, and Biosciences of the US Department of Energy at the Lawrence Berkeley National Laboratory under contract number DE-AC02-05CH11231. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract number DE-AC02-05CH11231. We thank K. Gokhberg and L. Cederbaum for suggesting this experiment and for many discussions. M.S.S. thanks the Alexander von Humboldt foundation for financial support.	Aoto T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243401; Aquilanti V, 2002, J CHEM PHYS, V117, P615, DOI 10.1063/1.1482696; BALTZER P, 1994, J PHYS B-AT MOL OPT, V27, P4915, DOI 10.1088/0953-4075/27/20/011; Barth S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1937395; Botting SK, 1997, PHYS REV A, V56, P3666, DOI 10.1103/PhysRevA.56.3666; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Cederbaum LS, 1997, PHYS REV LETT, V79, P4778, DOI 10.1103/PhysRevLett.79.4778; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; Gokhberg K, 2014, NATURE, V505, P661, DOI 10.1038/nature12936; Grieves GA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016104; Hanel G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188104; HAVENITH M, 1994, J MOL SPECTROSC, V167, P248, DOI 10.1006/jmsp.1994.1232; Havermeier T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.153401; Howell RW, 2008, INT J RADIAT BIOL, V84, P959, DOI 10.1080/09553000802395527; Jahnke T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163401; Jahnke T, 2010, NAT PHYS, V6, P139, DOI 10.1038/NPHYS1498; Jahnke T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.153401; Kim HK, 2011, P NATL ACAD SCI USA, V108, P11821, DOI 10.1073/pnas.1104382108; Kimura M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.043414; Kimura M, 2013, J PHYS CHEM LETT, V4, P1838, DOI 10.1021/jz4006674; Marburger S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.203401; Meredith AW, 1998, J PHYS CHEM A, V102, P434, DOI 10.1021/jp972114b; Mucke M, 2010, NAT PHYS, V6, P143, DOI 10.1038/NPHYS1500; O'Keeffe P, 2013, J PHYS CHEM LETT, V4, P1797, DOI 10.1021/jz400671h; Ohrwall G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173401; Pradhan AK, 2009, J PHYS CHEM A, V113, P12356, DOI 10.1021/jp904977z; Schoffler MS, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095013; Ueda K, 2008, J ELECTRON SPECTROSC, V166, P3, DOI 10.1016/j.elspec.2008.03.002; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203	29	105	105	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					664	666		10.1038/nature12927	http://dx.doi.org/10.1038/nature12927			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24362568				2022-12-28	WOS:000330321000037
J	Alwan, A				Alwan, Ala			Responding to priority health challenges in the Arab world	LANCET			English	Editorial Material									WHO, Reg Off Eastern Mediterranean, Cairo 11371, Egypt	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	Alwan, A (corresponding author), WHO, Reg Off Eastern Mediterranean, Cairo 11371, Egypt.	alwana@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2012, RES AD GEN ASS POL D; [Anonymous], 2012, SHAP FUT HLTH WHO E; WHO Regional Committee for the Eastern Mediterranean, 2013, DUB DECL SAV LIV MOT; World Health Organization, 2013, GLOB ACT PLAN PREV C	4	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					284	286		10.1016/S0140-6736(13)62572-6	http://dx.doi.org/10.1016/S0140-6736(13)62572-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452039	Bronze, Green Published			2022-12-28	WOS:000330212600007
J	Cox, AL; Siliciano, RF				Cox, Andrea L.; Siliciano, Robert F.			HIV Not-so-innocent bystanders	NATURE			English	Editorial Material							T-CELL DEPLETION; SIV INFECTION; IMMUNODEFICIENCY; INFLAMMASOMES; INFLAMMATION; ACTIVATION		[Cox, Andrea L.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Cox, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA.	acox@jhmi.edu; rsiciliano@jhmi.edu		Cox, Andrea/0000-0002-9331-2462	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108403] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI108403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Iannello A, 2010, CURR HIV RES, V8, P147, DOI 10.2174/157016210790442713; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Monroe KM, 2013, SCIENCE; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Watanabe D, 2010, VIRAL IMMUNOL, V23, P619, DOI 10.1089/vim.2010.0065; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	15	14	15	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					492	493		10.1038/505492a	http://dx.doi.org/10.1038/505492a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451540	Green Accepted			2022-12-28	WOS:000329995000028
J	Wang, Y; Eldridge, N; Metersky, ML; Verzier, NR; Meehan, TP; Pandolfi, MM; Foody, JM; Ho, SY; Galusha, D; Kliman, RE; Sonnenfeld, N; Krumholz, HM; Battles, J				Wang, Yun; Eldridge, Noel; Metersky, Mark L.; Verzier, Nancy R.; Meehan, Thomas P.; Pandolfi, Michelle M.; Foody, JoAnne M.; Ho, Shih-Yieh; Galusha, Deron; Kliman, Rebecca E.; Sonnenfeld, Nancy; Krumholz, Harlan M.; Battles, James			National Trends in Patient Safety for Four Common Conditions, 2005-2011	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MEDICARE BENEFICIARIES; AMERICAN-COLLEGE; MORTALITY-RATES; OUTCOMES; QUALITY; ERRORS; CARE; INTERVENTION; DISPARITIES	BackgroundChanges in adverse-event rates among Medicare patients with common medical conditions and conditions requiring surgery remain largely unknown. MethodsWe used Medicare Patient Safety Monitoring System data abstracted from medical records on 21 adverse events in patients hospitalized in the United States between 2005 and 2011 for acute myocardial infarction, congestive heart failure, pneumonia, or conditions requiring surgery. We estimated trends in the rate of occurrence of adverse events for which patients were at risk, the proportion of patients with one or more adverse events, and the number of adverse events per 1000 hospitalizations. ResultsThe study included 61,523 patients hospitalized for acute myocardial infarction (19%), congestive heart failure (25%), pneumonia (30%), and conditions requiring surgery (27%). From 2005 through 2011, among patients with acute myocardial infarction, the rate of occurrence of adverse events declined from 5.0% to 3.7% (difference, 1.3 percentage points; 95% confidence interval [CI], 0.7 to 1.9), the proportion of patients with one or more adverse events declined from 26.0% to 19.4% (difference, 6.6 percentage points; 95% CI, 3.3 to 10.2), and the number of adverse events per 1000 hospitalizations declined from 401.9 to 262.2 (difference, 139.7; 95% CI, 90.6 to 189.0). Among patients with congestive heart failure, the rate of occurrence of adverse events declined from 3.7% to 2.7% (difference, 1.0 percentage points; 95% CI, 0.5 to 1.4), the proportion of patients with one or more adverse events declined from 17.5% to 14.2% (difference, 3.3 percentage points; 95% CI, 1.0 to 5.5), and the number of adverse events per 1000 hospitalizations declined from 235.2 to 166.9 (difference, 68.3; 95% CI, 39.9 to 96.7). Patients with pneumonia and those with conditions requiring surgery had no significant declines in adverse-event rates. ConclusionsFrom 2005 through 2011, adverse-event rates declined substantially among patients hospitalized for acute myocardial infarction or congestive heart failure but not among those hospitalized for pneumonia or conditions requiring surgery.	[Metersky, Mark L.] Univ Connecticut, Sch Med, Div Pulm & Crit Care Med, Farmington, CT USA; [Wang, Yun; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Meehan, Thomas P.; Galusha, Deron; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Wang, Yun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Foody, JoAnne M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Foody, JoAnne M.] Harvard Univ, Sch Med, Boston, MA USA; [Eldridge, Noel; Battles, James] Agcy Healthcare Res & Qual, Dept Hlth & Human Serv, Rockville, MD 20850 USA; [Kliman, Rebecca E.; Sonnenfeld, Nancy] Ctr Medicare Serv, Dept Hlth & Human Serv, Baltimore, MD USA; [Kliman, Rebecca E.; Sonnenfeld, Nancy] Ctr Medicaid Serv, Dept Hlth & Human Serv, Baltimore, MD USA	University of Connecticut; Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Agency for Healthcare Research & Quality; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Wang, Y (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, SPH2,Rm 437F,655 Huntington Ave, Boston, MA 02115 USA.	yunwang@hsph.harvard.edu; noel.eldridge@ahrq.hhs.gov	, Harlan/AAI-2875-2020; Pandolfi, Margareth/H-7616-2016		Agency for Healthcare Research and Quality; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Agency for Healthcare Research and Quality and others.	Agency for Healthcare Research and Quality, PAT SAF CHALL GRANTS; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bonow RO, 2005, CIRCULATION, V112, P1853, DOI 10.1161/CIRCULATIONAHA.105.170072; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Clinton HR, 2006, NEW ENGL J MED, V354, P2205, DOI 10.1056/NEJMp068100; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Dodson JA, 2012, CIRC-CARDIOVASC QUAL, V5, P298, DOI 10.1161/CIRCOUTCOMES.112.966077; Downey JR, 2012, HEALTH SERV RES, V47, P414, DOI 10.1111/j.1475-6773.2011.01361.x; Gallagher TH, 2007, NEW ENGL J MED, V356, P2713, DOI 10.1056/NEJMra070568; Greenberg MD, 2009, HEALTH SERV RES, V44, P739, DOI 10.1111/j.1475-6773.2008.00926.x; Huddleston JI, 2009, J ARTHROPLASTY, V24, P95, DOI 10.1016/j.arth.2009.05.001; Hunt DR, FUNDAMENTALS MEDICAR; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2002, JAMA-J AM MED ASSOC, V289, P2649; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Levinson DR, 2010, OEI060800221 DEP HLT; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Lyder CH, 2012, J AM GERIATR SOC, V60, P1603, DOI 10.1111/j.1532-5415.2012.04106.x; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McCannon CJ, 2007, JT COMM J QUAL PATIE, V33, P477, DOI 10.1016/S1553-7250(07)33051-1; Metersky ML, 2011, MED CARE, V49, P504, DOI 10.1097/MLR.0b013e31820fc218; Parry G, 2012, JAMA-J AM MED ASSOC, V307, P2155, DOI 10.1001/jama.2012.3649; Peterson ED, 2009, CIRC-CARDIOVASC QUAL, V2, P491, DOI 10.1161/CIRCOUTCOMES.108.847145; Russell TR, 2006, AM SURGEON, V72, P1005; Russell TR, 2006, AM SURGEON, V72, P1021; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Yeh RW, 2012, CIRC-CARDIOVASC QUAL, V5, P197, DOI 10.1161/CIRCOUTCOMES.111.962456; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	37	163	168	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					341	351		10.1056/NEJMsa1300991	http://dx.doi.org/10.1056/NEJMsa1300991			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450892	Green Accepted			2022-12-28	WOS:000330036200009
J	Abel, KM; Heuvelman, HP; Jorgensen, L; Magnusson, C; Wicks, S; Susser, E; Hallkvist, J; Dalman, C				Abel, K. M.; Heuvelman, H. P.; Joergensen, L.; Magnusson, C.; Wicks, S.; Susser, E.; Hallkvist, J.; Dalman, C.			Severe bereavement stress during the prenatal and childhood periods and risk of psychosis in later life: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTENATAL MATERNAL EXPOSURE; EARLY PARENTAL LOSS; BIPOLAR DISORDER; MAJOR DEPRESSION; MENTAL-HEALTH; SCHIZOPHRENIA; SUICIDE; EVENTS; DEATH; SEPARATION	Objective To examine the risk of psychosis associated with severe bereavement stress during the antenatal and postnatal period, between conception to adolescence, and with different causes of death. Design Population based cohort study. Setting Swedish national registers including births between 1973 and 1985 and followed-up to 2006. Participants In a cohort of 1 045 336 Swedish births (1973-85), offspring born to mothers exposed to severe maternal bereavement stress six months before conception or during pregnancy, or exposed to loss of a close family member subsequently from birth to 13 years of age were followed until 2006. Admissions were identified by linkage to national patient registers. Main outcome measures Crude and adjusted odds ratios for all psychosis, non-affective psychosis, and affective psychosis. Results Maternal bereavement stress occurring preconception or during the prenatal period was not associated with a significant excess risk of psychosis in offspring (adjusted odds ratio, preconception 1.24, 95% confidence interval 0.96 to 1.62; first trimester 0.95, 0.58 to1.56; second trimester 0.79, 0.46 to 1.33; third trimester 1.14, 0.78 to 1.66). Risks increased modestly after exposure to the loss of a close family member from birth to adolescence for all psychoses (adjusted odds ratio 1.17, 1.04 to 1.32). The pattern of risk was generally similar for non-affective and affective psychosis. Thus estimates were higher after death in the nuclear compared with extended family but remained non-significant for prenatal exposure; the earlier the exposure to death in the nuclear family occurred in childhood (all psychoses: adjusted odds ratio, birth to 2.9 years 1.84, 1.41 to 2.41; 3-6.9 years 1.47, 1.16 to 1.85; 7-12.9 years 1.32, 1.10 to 1.58) and after suicide. Following suicide, risks were especially higher for affective psychosis (birth to 2.9 years 3.33, 2.00 to 5.56; 6.9 years 1.84, 1.04 to 3.25; 7-12.9 years 2.68, 1.84 to 3.92). Adjustment for key confounders attenuated but did not explain associations with risk. Conclusions Postnatal but not prenatal bereavement stress in mothers is associated with an increased risk of psychosis in offspring. Risks are especially high for affective psychosis after suicide in the nuclear family, an effect that is not explained by family psychiatric history. Future studies are needed to understand possible sources of risk and resilience so that structures can be put in place to support vulnerable children and their families.	[Abel, K. M.; Heuvelman, H. P.] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester Acad Hlth Sci Ctr, Ctr Womens Mental Hlth, Manchester, Lancs, England; [Heuvelman, H. P.] Univ Manchester, Cathie Marsh Ctr Census & Survey Res, Manchester, Lancs, England; [Joergensen, L.; Magnusson, C.; Wicks, S.; Hallkvist, J.; Dalman, C.] Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden; [Susser, E.] Columbia Univ, Mailman Sch Publ Hlth, Imprints Ctr Genet & Environm Life Course Studies, Ny City, NY USA; [Susser, E.] Columbia Univ, New York State Psychiat Inst, Imprints Ctr Genet & Environm Life Course Studies, Ny City, NY USA; [Hallkvist, J.] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	University of Manchester; University of Manchester; Karolinska Institutet; New York State Psychiatry Institute; Uppsala University	Abel, KM (corresponding author), Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester Acad Hlth Sci Ctr, Ctr Womens Mental Hlth, Manchester, Lancs, England.	kathryn.abel@manchester.ac.uk		Dalman, Christina/0000-0002-3579-2357; Abel, Kathryn M/0000-0003-3538-8896; Magnusson, Cecilia/0000-0002-8567-6725; Heuvelman, Hendrik Pieter/0000-0002-4662-7533	National Institutes of Health; Swedish Research Council; Swedish Council for Working Life and Social Research [2003-0376]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	KMA and HH were supported by a National Institutes of Health Research Capacity Funding small grant for travel to Sweden, and this grant also supported some costs of the data linkage. Other data linkage and staff costs in Sweden were supported by grants from the Swedish Research Council (CD) and Swedish Council for Working Life and Social Research (2003-0376). ES acknowledges support received as Lisa Oehler, visiting professor, Department of Psychiatry, University of Gottingen, Germany.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Barker DJP, 1998, MOTHERS BABIES HLTH; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Buss C, 2012, P NATL ACAD SCI USA, V109, pE1312, DOI 10.1073/pnas.1201295109; Buss C, 2010, PSYCHONEUROENDOCRINO, V35, P141, DOI 10.1016/j.psyneuen.2009.07.010; Cantor-Graae E, 2007, CAN J PSYCHIAT, V52, P277, DOI 10.1177/070674370705200502; Class Q.A., 2013, PSYCHOL MED, V17, P1; Class QA, 2011, PSYCHOSOM MED, V73, P234, DOI 10.1097/PSY.0b013e31820a62ce; Conwell Y, 1996, AM J PSYCHIAT, V153, P1001; Crump C, 2013, BRIT J PSYCHIAT, V203, P297, DOI 10.1192/bjp.bp.112.123992; Del Giudice M, 2012, PSYCHONEUROENDOCRINO, V37, P1614, DOI 10.1016/j.psyneuen.2012.05.014; Fauth Becky., 2009, ASS CHILDHOOD BEREAV; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Furukawa TA, 1999, J AFFECT DISORDERS, V52, P85, DOI 10.1016/S0165-0327(98)00054-8; Garcia-Moreno C, 2009, LANCET, V373, P278, DOI 10.1016/S0140-6736(09)60079-9; Herman DB, 2006, SOC PSYCH PSYCH EPID, V41, P605, DOI 10.1007/s00127-006-0078-7; HUTTUNEN MO, 1978, ARCH GEN PSYCHIAT, V35, P429; Imamura Y, 1999, ACTA PSYCHIAT SCAND, V100, P344; Jorgensen L, 2010, ACTA PSYCHIAT SCAND, V121, P389, DOI 10.1111/j.1600-0447.2009.01500.x; Kessing LV, 2004, BIPOLAR DISORD, V6, P122, DOI 10.1111/j.1399-5618.2004.00102.x; Khashan AS, 2009, HUM REPROD, V24, P429, DOI 10.1093/humrep/den418; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Khashan AS, 2011, J PSYCHIATR RES, V45, P879, DOI 10.1016/j.jpsychires.2010.12.005; King S, 2005, STRESS, V8, P35, DOI 10.1080/10253890500108391; Kuramoto SJ, 2013, JAMA PSYCHIAT, V70, P149, DOI 10.1001/jamapsychiatry.2013.274; Lin KK, 2004, J CLIN CHILD ADOLESC, V33, P673, DOI 10.1207/s15374424jccp3304_3; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Maier EH, 2000, INT J BEHAV DEV, V24, P183, DOI 10.1080/016502500383304; MEIJER A, 1985, ACTA PSYCHIAT SCAND, V72, P505, DOI 10.1111/j.1600-0447.1985.tb02647.x; Morgan C, 2007, PSYCHOL MED, V37, P495, DOI 10.1017/S0033291706009330; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Myhrman A, 1996, BRIT J PSYCHIAT, V169, P637, DOI 10.1192/bjp.169.5.637; Parsons S., 2011, STUD IMP LONG TERM S; Rogers CH, 2008, J FAM PSYCHOL, V22, P203, DOI 10.1037/0893-3200.22.2.203; Selten JP, 2003, SCHIZOPHR RES, V63, P131, DOI 10.1016/S0920-9964(02)00375-4; Selten JP, 1999, SCHIZOPHR RES, V35, P243, DOI 10.1016/S0920-9964(98)00143-1; Susser E, 2012, SCHIZOPHRENIA BULL, V38, P672, DOI 10.1093/schbul/sbs074; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Tsuchiya KJ, 2005, J AFFECT DISORDERS, V86, P151, DOI 10.1016/j.jad.2005.01.006; van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Wicks S, 2005, AM J PSYCHIAT, V162, P1652, DOI 10.1176/appi.ajp.162.9.1652; Wilcox HC, 2010, J AM ACAD CHILD PSY, V49, P514, DOI 10.1016/j.jaac.2010.01.020	46	49	50	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2014	348								f7679	10.1136/bmj.f7679	http://dx.doi.org/10.1136/bmj.f7679			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298AS	24449616	Green Published			2022-12-28	WOS:000330296900003
J	Graff, J; Joseph, NF; Hom, ME; Samiei, A; Meng, J; Seo, J; Rei, D; Bero, AW; Phan, TX; Wagner, F; Holson, E; Xu, JB; Sun, J; Neve, RL; Mach, RH; Haggarty, SJ; Tsai, LH				Graeff, Johannes; Joseph, Nadine F.; Hom, Meryl E.; Samiei, Alireza; Meng, Jia; Seo, Jinsoo; Rei, Damien; Bero, Adam W.; Phan, Trongha X.; Wagner, Florence; Holson, Edward; Xu, Jinbin; Sun, Jianjun; Neve, Rachael L.; Mach, Robert H.; Haggarty, Stephen J.; Tsai, Li-Huei			Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories	CELL			English	Article							HISTONE DEACETYLASE INHIBITOR; CONTEXTUAL FEAR; SPONTANEOUS-RECOVERY; SYNAPTIC PLASTICITY; RETROGRADE-AMNESIA; PROTEIN-SYNTHESIS; CONDITIONED FEAR; EXTINCTION; RETRIEVAL; GENE	Traumatic events generate some of the most enduring forms of memories. Despite the elevated lifetime prevalence of anxiety disorders, effective strategies to attenuate long-term traumatic memories are scarce. The most efficacious treatments to diminish recent (i.e., day-old) traumata capitalize on memory updating mechanisms during reconsolidation that are initiated upon memory recall. Here, we show that, in mice, successful reconsolidation-updating paradigms for recent memories fail to attenuate remote (i.e., month-old) ones. We find that, whereas recent memory recall induces a limited period of hippocampal neuroplasticity mediated, in part, by S-nitrosylation of HDAC2 and histone acetylation, such plasticity is absent for remote memories. However, by using an HDAC2-targeting inhibitor (HDACi) during reconsolidation, even remote memories can be persistently attenuated. This intervention epigenetically primes the expression of neuroplasticity-related genes, which is accompanied by higher metabolic, synaptic, and structural plasticity. Thus, applying HDACis during memory reconsolidation might constitute a treatment option for remote traumata.	[Graeff, Johannes; Joseph, Nadine F.; Hom, Meryl E.; Samiei, Alireza; Meng, Jia; Seo, Jinsoo; Rei, Damien; Bero, Adam W.; Phan, Trongha X.; Neve, Rachael L.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Graeff, Johannes; Joseph, Nadine F.; Hom, Meryl E.; Meng, Jia; Seo, Jinsoo; Rei, Damien; Bero, Adam W.; Phan, Trongha X.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Graeff, Johannes; Joseph, Nadine F.; Wagner, Florence; Holson, Edward; Haggarty, Stephen J.; Tsai, Li-Huei] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA; [Xu, Jinbin; Sun, Jianjun; Mach, Robert H.] Washington Univ, Sch Med, Dept Radiol, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Ctr Human Genet Res, Boston, MA 02114 USA; [Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Xu, Jinbin/ABG-1280-2020; Seo, Jinsoo/AAD-4950-2019; Haggarty, Stephen J/M-9495-2016	Xu, Jinbin/0000-0002-2120-8287; Seo, Jinsoo/0000-0001-6432-6964; Haggarty, Stephen J/0000-0002-7872-168X; Mach, Robert/0000-0002-7645-2869; Graff, Johannes/0000-0002-3219-3578; Meng, Jia/0000-0003-3455-205X	NIH NINDS/NIA [NS078839]; NIH/NIDA [R01DA028301]; Picower Neurological Disorder Fund (PNDRF); Stanley Medical Foundation, HHMI, and a Bard Richmond fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090214, R01NS078839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301] Funding Source: NIH RePORTER	NIH NINDS/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Picower Neurological Disorder Fund (PNDRF); Stanley Medical Foundation, HHMI, and a Bard Richmond fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank MIT's BioMicroCenter for the RNA sequencing, Martin Kahn for help with the qRT-PCR and IHC experiments, and Theo Elfers for critical comments on the manuscript. This work was partially supported by NIH NINDS/NIA (NS078839) to L.-H.T. and NIH/NIDA (R01DA028301) to S.J.H., the Picower Neurological Disorder Fund (PNDRF), the Stanley Medical Foundation, HHMI, and a Bard Richmond fellowship to J.G.	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Costanzi M, 2011, LEARN MEMORY, V18, P508, DOI 10.1101/lm.2175811; Cukor J, 2010, ANN NY ACAD SCI, V1208, P82, DOI 10.1111/j.1749-6632.2010.05793.x; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Foa EB, 2000, J CLIN PSYCHIAT, V61, P43; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Fujita Y, 2012, J PSYCHIATR RES, V46, P635, DOI 10.1016/j.jpsychires.2012.01.026; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Graff J, 2013, J NEUROSCI, V33, P8951, DOI 10.1523/JNEUROSCI.5657-12.2013; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Harooni HE, 2009, BEHAV BRAIN RES, V201, P166, DOI 10.1016/j.bbr.2009.02.011; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Itzhak Y, 2012, NEUROBIOL LEARN MEM, V97, P409, DOI 10.1016/j.nlm.2012.03.005; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kaplan GB, 2011, PHARMACOL BIOCHEM BE, V99, P217, DOI 10.1016/j.pbb.2011.01.009; Kearns MC, 2012, DEPRESS ANXIETY, V29, P833, DOI 10.1002/da.21997; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Lattal KM, 2013, NAT NEUROSCI, V16, P124, DOI 10.1038/nn.3302; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Neve Rachael L, 2013, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0413s62; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Pavlov I., 1927, SCIENCE; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Sananbenesi F, 2007, NAT NEUROSCI, V10, P1012, DOI 10.1038/nn1943; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Stafford JM, 2012, BIOL PSYCHIAT, V72, P25, DOI 10.1016/j.biopsych.2011.12.012; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Urcelay GP, 2009, LEARN BEHAV, V37, P60, DOI 10.3758/LB.37.1.60; Wu CS, 2011, MOL CELL BIOL, V31, P4874, DOI 10.1128/MCB.05593-11; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070	70	242	252	0	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					261	276		10.1016/j.cell.2013.12.020	http://dx.doi.org/10.1016/j.cell.2013.12.020			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439381	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000329912200026
J	Mathias, J				Mathias, Jeph			Doctors and climate change: "you played at rapid sequence induction while my world burned"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Landour Community Hosp, Emmanuel Hosp Assoc EHA India, Mussoorie 248179, Uttarakhand, India		Mathias, J (corresponding author), Landour Community Hosp, Emmanuel Hosp Assoc EHA India, Mussoorie 248179, Uttarakhand, India.	jephmathias@gmail.com							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2014	348								g119	10.1136/bmj.g119	http://dx.doi.org/10.1136/bmj.g119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MP	24435413				2022-12-28	WOS:000329976100002
J	Bernal, W; Wendon, J				Bernal, William; Wendon, Julia			Acute Liver Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTRACRANIAL-PRESSURE; HEPATIC-ENCEPHALOPATHY; FULMINANT-HEPATITIS; BRAIN EDEMA; ACETAMINOPHEN; OUTCOMES; TRANSPLANTATION; MULTICENTER; HYPOTHERMIA; PROGNOSIS	Acute liver failure is a rare but life-threatening critical illness requiring intensive care. This article reviews common causes, diagnostic approaches, and therapeutic interventions. Acute liver failure is a rare but life-threatening critical illness that occurs most often in patients who do not have preexisting liver disease. With an incidence of fewer than 10 cases per million persons per year in the developed world, acute liver failure is seen most commonly in previously healthy adults in their 30s and presents unique challenges in clinical management. The clinical presentation usually includes hepatic dysfunction, abnormal liver biochemical values, and coagulopathy; encephalopathy may develop, with multiorgan failure and death occurring in up to half the cases (Figure 1).(1)-(3) The rarity of acute liver failure, along with ...	[Bernal, William; Wendon, Julia] Kings Coll London, Inst Liver Studies, Liver Intens Therapy Unit, London WC2R 2LS, England	University of London; King's College London	Bernal, W (corresponding author), Kings Coll Hosp London, Liver Intens Therapy Unit, Inst Liver Studies, Kings Coll London, Denmark Hill Campus,Denmark Hill, London SE5 9RS, England.	william.bernal@kcl.ac.uk			Pulsion; Excalenz; Fresenius; Asahi Kasei	Pulsion; Excalenz; Fresenius; Asahi Kasei(Asahi Kasei Corporation)	Dr. Wendon reports receiving fees for board membership from Pulsion and Excalenz and lecture fees from Fresenius and Asahi Kasei. No other potential conflict of interest relevant to this article was reported.	Acharya SK, 2009, GASTROENTEROLOGY, V136, P2159, DOI 10.1053/j.gastro.2009.02.050; Agarwal B, 2012, J HEPATOL, V57, P780, DOI 10.1016/j.jhep.2012.06.020; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bernal W, 2009, J HEPATOL, V50, P306, DOI 10.1016/j.jhep.2008.09.012; BERNUAU J, 1986, SEMIN LIVER DIS, V6, P97, DOI 10.1055/s-2008-1040593; Berry PA, 2010, LIVER INT, V30, P733, DOI 10.1111/j.1478-3231.2010.02219.x; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Bower WA, 2007, AM J GASTROENTEROL, V102, P2459, DOI 10.1111/j.1572-0241.2007.01388.x; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Craig DGN, 2012, BRIT J CLIN PHARMACO, V73, P285, DOI 10.1111/j.1365-2125.2011.04067.x; Davenport A, 2009, SEMIN DIALYSIS, V22, P169, DOI 10.1111/j.1525-139X.2008.00539.x; Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5; Desjardins P, 2012, NEUROCHEM INT, V60, P690, DOI 10.1016/j.neuint.2012.02.001; Eefsen M, 2007, J HEPATOL, V47, P381, DOI 10.1016/j.jhep.2007.04.015; Escorsell A, 2007, LIVER TRANSPLANT, V13, P1389, DOI 10.1002/lt.21119; Etogo-Asse FE, 2012, LIVER INT, V32, P523, DOI [10.1111/j.1478-3231.2012.02758.x, 10.1111/j.1478-3231.2011.02657.x]; Germani G, 2012, J HEPATOL, V57, P288, DOI 10.1016/j.jhep.2012.03.017; Heard KJ, 2008, NEW ENGL J MED, V359, P285, DOI 10.1056/NEJMct0708278; Henrion J, 2012, LIVER INT, V32, P1039, DOI 10.1111/j.1478-3231.2011.02655.x; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Hughes RD, 2012, TRANSPLANTATION, V93, P342, DOI 10.1097/TP.0b013e31823b72d6; Ichai P, 2008, LIVER TRANSPLANT, V14, pS67, DOI 10.1002/lt.21612; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Karvellas CJ, 2009, INTENS CARE MED, V35, P1390, DOI 10.1007/s00134-009-1472-x; Khandelwal N, 2011, HEPATOLOGY, V53, P567, DOI 10.1002/hep.24060; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P224, DOI 10.1046/j.1365-2893.2003.00415.x; Kitzberger R, 2009, CLIN GASTROENTEROL H, V7, P1000, DOI 10.1016/j.cgh.2009.05.019; Kumar R, 2012, CLIN GASTROENTEROL H, V10, P925, DOI 10.1016/j.cgh.2012.04.011; Kumar R, 2010, HEPATOLOGY, V51, P1665, DOI 10.1002/hep.23534; Larsen FS, 2011, J HEPATOL, V54, pS26, DOI 10.1016/S0168-8278(11)60058-5; Larsen FS, 2010, HEPATOLOGY, V52, p376A; Lee WM, 2012, HEPATOLOGY, V55, P965, DOI 10.1002/hep.25551; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Leithead JA, 2009, GUT, V58, P443, DOI 10.1136/gut.2008.154120; Lescot T, 2012, ANESTHESIOLOGY, V117, P898, DOI 10.1097/ALN.0b013e318266c6df; McPhail MJW, 2010, J HEPATOL, V53, P492, DOI 10.1016/j.jhep.2010.03.023; Mochida S, 2008, HEPATOL RES, V38, P970, DOI 10.1111/j.1872-034X.2008.00368.x; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Myers RP, 2008, CLIN GASTROENTEROL H, V6, P918, DOI 10.1016/j.cgh.2008.02.053; O'Riordan A, 2011, NEPHROL DIAL TRANSPL, V26, P3501, DOI 10.1093/ndt/gfr050; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937; Rezende G, 2003, HEPATOLOGY, V38, P613, DOI 10.1053/jhep.2003.50366; Saliba F, 2013, ANN INTERN MED, V159, P522, DOI 10.7326/0003-4819-159-8-201310150-00005; Simpson KJ, 2009, LIVER TRANSPLANT, V15, P600, DOI 10.1002/lt.21681; Stravitz RT, 2012, J HEPATOL, V56, P129, DOI 10.1016/j.jhep.2011.04.020; Stutchfield BM, 2011, BRIT J SURG, V98, P623, DOI 10.1002/bjs.7418; Torres HA, 2012, NAT REV CLIN ONCOL, V9, P156, DOI 10.1038/nrclinonc.2012.1; Trey C, 1970, Prog Liver Dis, V3, P282; Tritto G, 2012, SEMIN RESP CRIT CARE, V33, P70, DOI 10.1055/s-0032-1301736; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; Vaquero J, 2012, NEUROCHEM INT, V60, P723, DOI 10.1016/j.neuint.2011.09.006; Walsh TS, 2000, CRIT CARE MED, V28, P649, DOI 10.1097/00003246-200003000-00008; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; Wendon J, 2008, NEUROCRIT CARE, V9, P97, DOI 10.1007/s12028-008-9123-6; Wlodzimirow KA, 2012, ALIMENT PHARM THER, V35, P1245, DOI 10.1111/j.1365-2036.2012.05097.x	62	636	673	4	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2525	2534		10.1056/NEJMra1208937	http://dx.doi.org/10.1056/NEJMra1208937			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24369077	Bronze			2022-12-28	WOS:000328863700010
J	Gilbert, JA; Krajmalnik-Brown, R; Porazinska, DL; Weiss, SJ; Knight, R				Gilbert, Jack A.; Krajmalnik-Brown, Rosa; Porazinska, Dorota L.; Weiss, Sophie J.; Knight, Rob			Toward Effective Probiotics for Autism and Other Neurodevelopmental Disorders	CELL			English	Editorial Material							GUT MICROBIOTA	Hsaio and colleagues link gut microbes to autism spectrum disorders (ASD) in a mouse model. They show that ASD symptoms are triggered by compositional and structural shifts of microbes and associated metabolites, but symptoms are relieved by a Bacteroides fragilis probiotic. Thus probiotics may provide therapeutic strategies for neurodevelopmental disorders.	[Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Krajmalnik-Brown, Rosa] Arizona State Univ, Swette Ctr Environm Biotechnol, Biodesign Inst, Tempe, AZ 85287 USA; [Krajmalnik-Brown, Rosa] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA; [Porazinska, Dorota L.; Weiss, Sophie J.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Porazinska, Dorota L.; Weiss, Sophie J.; Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Knight, R (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Gilbert, Jack/AAF-3270-2019; Krajmalnik-Brown, Rosa/AAA-4803-2021; Knight, Rob/D-1299-2010	Knight, Rob/0000-0002-0975-9019; Krajmalnik-Brown, Rosa/0000-0001-6064-3524	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [P30 DK042086] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Knight JG, 2007, MOL PSYCHIATR, V12, P424, DOI 10.1038/sj.mp.4001959; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Persico AM, 2013, NEUROTOXICOL TERATOL, V36, P82, DOI 10.1016/j.ntt.2012.09.002; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721	10	66	75	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1446	1448		10.1016/j.cell.2013.11.035	http://dx.doi.org/10.1016/j.cell.2013.11.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360269	Green Accepted, Bronze			2022-12-28	WOS:000328693300002
J	Xie, MY; Li, MF; Vilborg, A; Lee, N; Shu, MD; Yartseva, V; Sestan, N; Steitz, JA				Xie, Mingyi; Li, Mingfeng; Vilborg, Anna; Lee, Nara; Shu, Mei-Di; Yartseva, Valeria; Sestan, Nenad; Steitz, Joan A.			Mammalian 5 '-Capped MicroRNA Precursors that Generate a SingleMicroRNA	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; NUCLEAR EXPORT; HERPESVIRUS USES; VIRAL MICRORNAS; MESSENGER-RNAS; IN-VIVO; BIOGENESIS; PATHWAY; EXPRESSION	MicroRNAs (miRNAs) are short RNA gene regulators typically produced from primary transcripts that are cleaved by the nuclear microprocessor complex, with the resulting precursor miRNA hairpins exported by exportin 5 and processed by cytoplasmic Dicer to yield two (5p and 3p) miRNAs. Here, we document microprocessor-independent 7-methylguanosine (m(7)G)-capped pre-miRNAs, whose 5' ends coincide with transcription start sites and 3' ends are most likely generated by transcription termination. By establishing a small RNA Cap-seq method that employs the cap-binding protein eIF4E, we identified a group of murine m(7)G-capped pre-miRNAs genome wide. The m(7)G-capped pre-miRNAs are exported via the PHAX-exportin 1 pathway. After Dicer cleavage, only the 3p-miRNA is efficiently loaded onto Argonaute to form a functional microRNP. This unusual miRNA biogenesis pathway, which differs in pre-miRNA synthesis, nuclear-cytoplasmic transport, and guide strand selection, enables the development of shRNA expression constructs that produce a single 3p-siRNA.	[Xie, Mingyi; Vilborg, Anna; Lee, Nara; Shu, Mei-Di; Steitz, Joan A.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Mol Biophys & Biochem,Howard Hughes Med Inst, New Haven, CT 06536 USA; [Li, Mingfeng; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Yartseva, Valeria] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Mol Biophys & Biochem,Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Vilborg, Anna/0000-0003-0917-9062	National Institutes of Health [CA16038, MH081896]; Leukemia and Lymphoma Society [5416-13]; Wenner-Gren Foundations; Swedish Society for Medical Research; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Wenner-Gren Foundations; Swedish Society for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Curt Hagedorn, Mary Anne Kidwell, Jennifer Doudna, Xinguo Chen, and Sandra Wolin for generous gifts of eIF4E, recombinant human Dicer and Deinococcus radiodurans PNPase, respectively. We are also grateful to Cecilia Canessa, Demian Cazalla, Sreeganga Chandra, Junhong Gui, Nikolay Kolev, Di Li, Tianbo Li, Zissimos Mourelatos, Huafang Shi, Christian Tschudi, Elisabetta Ullu, and Yongquan Zhang for other reagents and protocols, Xinguo Chen and Kazimierz Tycowski for critical discussion and Angela Miccinello for editorial assistance. This work was supported by grants from National Institutes of Health (CA16038 and MH081896). M. X. is a Fellow of the Leukemia and Lymphoma Society (grant 5416-13). A. V. is supported by the Wenner-Gren Foundations and Swedish Society for Medical Research. J.A.S is an Investigator at the Howard Hughes Medical Institute.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bogerd HP, 2010, MOL CELL, V37, P135, DOI 10.1016/j.molcel.2009.12.016; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Bussing I, 2010, EMBO J, V29, P1830, DOI 10.1038/emboj.2010.82; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Castanotto D, 2009, P NATL ACAD SCI USA, V106, P21655, DOI 10.1073/pnas.0912384106; Cazalla D, 2011, MOL CELL, V43, P982, DOI 10.1016/j.molcel.2011.07.025; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen XG, 2013, CELL, V153, P166, DOI 10.1016/j.cell.2013.02.037; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Denti MA, 2004, MOL THER, V10, P191, DOI 10.1016/j.ymthe.2004.04.008; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Gurtan AM, 2012, RNA, V18, P1116, DOI 10.1261/rna.032680.112; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Iwasaki YW, 2013, RNA, V19, P490, DOI 10.1261/rna.036608.112; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pan QW, 2012, TRENDS BIOTECHNOL, V30, P206, DOI 10.1016/j.tibtech.2012.01.002; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Wang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1770; Weiner AM, 2005, MOL CELL, V20, P168, DOI 10.1016/j.molcel.2005.10.009; White E, 2013, NUCLEIC ACIDS RES, V41, P1797, DOI 10.1093/nar/gks1335; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	58	138	142	2	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1568	1580		10.1016/j.cell.2013.11.027	http://dx.doi.org/10.1016/j.cell.2013.11.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360278	Bronze, Green Accepted			2022-12-28	WOS:000328693300013
J	Patton, GC; Coffey, C; Romaniuk, H; Mackinnon, A; Carlin, JB; Degenhardt, L; Olsson, CA; Moran, P				Patton, George C.; Coffey, Carolyn; Romaniuk, Helena; Mackinnon, Andrew; Carlin, John B.; Degenhardt, Louisa; Olsson, Craig A.; Moran, Paul			The prognosis of common mental disorders in adolescents: a 14-year prospective cohort study	LANCET			English	Article							PSYCHIATRIC-DISORDER; YOUNG ADULTHOOD; DEPRESSION; ANXIETY; HEALTH; AGE; COMORBIDITY; PREDICTORS; CHILDHOOD; COMMUNITY	Background Most adults with common mental disorders report their first symptoms before 24 years of age. Although adolescent anxiety and depression are frequent, little clarity exists about which syndromes persist into adulthood or resolve before then. In this report, we aim to describe the patterns and predictors of persistence into adulthood. Methods We recruited a stratified, random sample of 1943 adolescents from 44 secondary schools across the state of Victoria, Australia. Between August, 1992, and January, 2008, we assessed common mental disorder at five points in adolescence and three in young adulthood, commencing at a mean age of 15.5 years and ending at a mean age of 29.1 years. Adolescent disorders were defined on the Revised Clinical Interview Schedule (CIS-R) at five adolescent measurement points, with a primary cutoff score of 12 or higher representing a level at which a family doctor would be concerned. Secondary analyses addressed more severe disorders at a cutoff of 18 or higher. Findings 236 of 821 (29%; 95% CI 25-32) male participants and 498 of 929 (54%; 51-57) female participants reported high symptoms on the CIS-R (>= 12) at least once during adolescence. Almost 60% (434/734) went on to report a further episode as a young adult. However, for adolescents with one episode of less than 6 months duration, just over half had no further common mental health disorder as a young adult. Longer duration of mental health disorders in adolescence was the strongest predictor of clear-cut young adult disorder odds ratio [OR] for persistent young adult disorder vs none 3.16, 95% CI 1.86- 5.37). Girls (2.12, 1.29-3.48) and adolescents with a background of parental separation or divorce (1.62, 1.03-2.53) also had a greater likelihood of having ongoing disorder into young adulthood than did those without such a background. Rates of adolescent onset disorder dropped sharply by the late 20s (0.57, 0.45- 0.73), suggesting a further resolution for many patients whose symptoms had persisted into the early 20s. Interpretation Episodes of adolescent mental disorder often precede mental disorders in young adults. However, many such disorders, especially when brief in duration, are limited to the teenage years, with further symptom remission common in the late 20s. The resolution of many adolescent disorders gives reason for optimism that interventions that shorten the duration of episodes could prevent much morbidity later in life.	[Patton, George C.; Romaniuk, Helena; Carlin, John B.; Olsson, Craig A.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Mackinnon, Andrew] Univ Melbourne, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Carlin, John B.; Degenhardt, Louisa] Univ Melbourne, Sch Populat & Global Hlth, Parkville, Vic 3052, Australia; [Olsson, Craig A.] Univ Melbourne, Parkville, Vic 3052, Australia; [Patton, George C.; Coffey, Carolyn; Olsson, Craig A.] Royal Childrens Hosp, Ctr Adolescent Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Romaniuk, Helena; Carlin, John B.] Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Olsson, Craig A.] Deakin Univ, Sch Psychol, Geelong, Vic 3217, Australia; [Moran, Paul] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England	University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of New South Wales Sydney; Deakin University; University of London; King's College London	Patton, GC (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	george.patton@rch.org.au	Moran, Paul A/B-1740-2010; Patton, George C/B-5246-2013; Degenhardt, Louisa J/D-4515-2012; Olsson, Craig A/AAR-5057-2020; Carlin, John B/B-3492-2012; Ribeiro, Ana Cristina/HHN-7466-2022; Carlin, John/AAG-4332-2020	Moran, Paul A/0000-0002-9257-8699; Patton, George C/0000-0001-5039-8326; Degenhardt, Louisa J/0000-0002-8513-2218; Olsson, Craig A/0000-0002-5927-2014; Carlin, John B/0000-0002-2694-9463; Ribeiro, Ana Cristina/0000-0002-0493-8376; Carlin, John/0000-0002-2694-9463; Romaniuk, Helena/0000-0002-5801-2077; Mackinnon, Andrew/0000-0003-0831-9801	Australia's National Health and Medical Research Council	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Australia's National Health and Medical Research Council.	[Anonymous], 1997, COMP INT DIAGN INT C; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Clark C, 2007, ARCH GEN PSYCHIAT, V64, P668, DOI 10.1001/archpsyc.64.6.668; Colman I, 2007, BIOL PSYCHIAT, V62, P1265, DOI 10.1016/j.biopsych.2007.05.012; Copeland W, 2011, J AM ACAD CHILD PSY, V50, P252, DOI 10.1016/j.jaac.2010.12.014; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; FERDINAND RF, 1995, SOC PSYCH PSYCH EPID, V30, P60; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Finkelstein DM, 2007, J ADOLESCENT HEALTH, V40, P127, DOI 10.1016/j.jadohealth.2006.10.006; Fombonne E, 2001, BRIT J PSYCHIAT, V179, P218, DOI 10.1192/bjp.179.3.218; FREUD A, 1958, PSYCHOANAL STUD CHIL, V13, P255, DOI 10.1080/00797308.1958.11823182; Gibb SJ, 2010, BRIT J PSYCHIAT, V197, P122, DOI 10.1192/bjp.bp.109.076570; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; LEWINSOHN PM, 1994, J AM ACAD CHILD PSY, V33, P809, DOI 10.1097/00004583-199407000-00006; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MOFFITT TE, 1988, AUST NZ J CRIMINOL, V21, P227, DOI 10.1177/000486588802100405; Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; National Health and Medical Research Council, 1987, IS THER SAF LEV DAIL; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patton GC, 2008, BRIT J PSYCHIAT, V192, P294, DOI 10.1192/bjp.bp.106.031112; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; RUTTER M, 1976, J CHILD PSYCHOL PSYC, V17, P35, DOI 10.1111/j.1469-7610.1976.tb00372.x; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Singleton N., 2001, PSYCHIAT MORBIDITY A; Stanley Hall G., 1905, ADOLESCENCE ITS PSYC; Wells JE, 2004, PSYCHOL MED, V34, P1001, DOI 10.1017/S0033291703001843	35	280	287	2	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1404	1411		10.1016/s0140-6736(13)62116-9	http://dx.doi.org/10.1016/s0140-6736(13)62116-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24439298				2022-12-28	WOS:000335318400026
J	Hashimoto, H; Pais, JE; Zhang, X; Saleh, L; Fu, ZQ; Dai, N; Correa, IR; Zheng, Y; Cheng, XD				Hashimoto, Hideharu; Pais, June E.; Zhang, Xing; Saleh, Lana; Fu, Zheng-Qing; Dai, Nan; Correa, Ivan R., Jr.; Zheng, Yu; Cheng, Xiaodong			Structure of a Naegleria Tet-like dioxygenase in complex with 5-methylcytosine DNA	NATURE			English	Article							5-HYDROXYMETHYLCYTOSINE CONTENT; CRYSTAL-STRUCTURES; BASE; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; GLYCOSYLASE; PROTEINS; DEMETHYLATION; INTERMEDIATE; CONVERSION	Cytosine residues in mammalian DNA occur in five forms: cytosine (C), 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). The ten-eleven translocation (Tet) dioxygenases convert 5mC to 5hmC, 5fC and 5caC in three consecutive, Fe(II)- and alpha-ketoglutarate-dependent oxidation reactions(1-4). The Tet family of dioxygenases is widely distributed across the tree of life(5), including in the heterolobosean amoeboflagellate Naegleria gruberi. The genome of Naegleria(6) encodes homologues of mammalian DNA methyltransferase and Tet proteins(7). Here we study biochemically and structurally one of the Naegleria Tet-like proteins (NgTet1), which shares significant sequence conservation (approximately 14% identity or 39% similarity) with mammalian Tet1. Like mammalian Tet proteins, NgTet1 acts on 5mC and generates 5hmC, 5fC and 5caC. The crystal structure of NgTet1 in complex with DNA containing a 5mCpG site revealed that NgTet1 uses a base-flipping mechanism to access 5mC. The DNA is contacted from the minor groove and bent towards the major groove. The flipped 5mC is positioned in the active-site pocket with planar stacking contacts, Watson-Crick polar hydrogen bonds and van der Waals interactions specific for 5mC. The sequence conservation between NgTet1 and mammalian Tet1, including residues involved in structural integrity and functional significance, suggests structural conservation across phyla.	[Hashimoto, Hideharu; Zhang, Xing; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Pais, June E.; Saleh, Lana; Dai, Nan; Correa, Ivan R., Jr.; Zheng, Yu] New England Biolabs Inc, Ipswich, MA 01938 USA; [Fu, Zheng-Qing] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Fu, Zheng-Qing] Argonne Natl Lab, Adv Photon Source, Sect 22, Argonne, IL 60439 USA	Emory University; New England Biolabs; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Argonne National Laboratory	Cheng, XD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	zhengy@neb.com; xcheng@emory.edu	hashimoto, hal/C-2079-2012; Dai, Nan/I-5950-2013	hashimoto, hal/0000-0002-5674-5779; Correa, Ivan/0000-0002-3169-6878	National Institutes of Health [GM049245, GM095209, GM105132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM105132, R01GM049245, R44GM095209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. J. Roberts who initiated this collaborative work, and participated both in the work and the writing of the manuscript. We thank J. R. Horton for critical comments and B. Baker for synthesizing the oligonucleotides. Y.Z. thanks C. Fulton for helpful discussions on N. gruberi biology. The Department of Biochemistry of Emory University School of Medicine supported the use of SER-CAT beamlines. This work was supported by grants from the National Institutes of Health GM049245 to X. C. (who is a Georgia Research Alliance Eminent Scholar) and GM095209 and GM105132 to Y.Z.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Fu Y, 2012, CURR OPIN CHEM BIOL, V16, P516, DOI 10.1016/j.cbpa.2012.10.002; Fu ZQ, 2007, J APPL CRYSTALLOGR, V40, P387, DOI 10.1107/S0021889807003998; Fu ZQ, 2005, ACTA CRYSTALLOGR D, V61, P951, DOI 10.1107/S0907444905010541; Haffner MC, 2011, ONCOTARGET, V2, P627; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P10203, DOI 10.1093/nar/gks845; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Horton JR, 2004, NUCLEIC ACIDS RES, V32, P3877, DOI 10.1093/nar/gkh701; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Sun ZY, 2013, CELL REP, V3, P567, DOI 10.1016/j.celrep.2013.01.001; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Upadhyay AK, 2011, CURR OPIN STRUC BIOL, V21, P750, DOI 10.1016/j.sbi.2011.08.003; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang L, 2012, ACTA CHIM SINICA, V70, P2123, DOI 10.6023/A12090619	42	92	96	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					391	+		10.1038/nature12905	http://dx.doi.org/10.1038/nature12905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24390346	Green Accepted			2022-12-28	WOS:000331477800046
J	Cole, TB				Cole, Thomas B.			Portrait of H. H. Thyssen-Bornemisza (Man in a Chair) Lucian Freud	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					334	335		10.1001/jama.2013.279292	http://dx.doi.org/10.1001/jama.2013.279292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449295				2022-12-28	WOS:000329939300001
J	Chapuisat, M				Chapuisat, Michel			Smells Like Queen Since the Cretaceous	SCIENCE			English	Editorial Material							PHEROMONES; HYMENOPTERA; EVOLUTION		Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Chapuisat, M (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	michel.chapuisat@unil.ch	Chapuisat, Michel/T-8686-2017	Chapuisat, Michel/0000-0001-7207-199X				Amsalem E, 2009, P R SOC B, V276, P1295, DOI 10.1098/rspb.2008.1688; Boroczky K, 2009, J CHEM ECOL, V35, P1202, DOI 10.1007/s10886-009-9693-6; Darrouzet E, 2010, J CHEM ECOL, V36, P1092, DOI 10.1007/s10886-010-9845-8; HOLLDOBLER B, 1983, ANN ENTOMOL SOC AM, V76, P235, DOI 10.1093/aesa/76.2.235; Holman L, 2013, J EVOLUTION BIOL, V26, P1549, DOI 10.1111/jeb.12162; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Liebig J, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P254, DOI 10.1017/CBO9780511711909.014; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Niehuis O, 2013, NATURE, V494, P345, DOI 10.1038/nature11838; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899	12	8	8	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					254	255		10.1126/science.1249285	http://dx.doi.org/10.1126/science.1249285			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436408	Green Published			2022-12-28	WOS:000329718600020
J	Choi, J; Tanaka, K; Cao, YR; Qi, Y; Qiu, J; Liang, Y; Lee, SY; Stacey, G				Choi, Jeongmin; Tanaka, Kiwamu; Cao, Yangrong; Qi, Yue; Qiu, Jing; Liang, Yan; Lee, Sang Yeol; Stacey, Gary			Identification of a Plant Receptor for Extracellular ATP	SCIENCE			English	Article							POLLEN GERMINATION; SIGNALING ROLE; ARABIDOPSIS; PROTEIN; EXPRESSION; LECTINS; KINASES; CLONING; GROWTH; GENES	Extracellular adenosine 5'-triphosphate (ATP) is an essential signaling molecule that is perceived in mammals by plasma membrane P2-type purinoceptors. Similar ATP receptors do not exist in plants, although extracellular ATP has been shown to play critical roles in plant growth, development, and stress responses. Here, we identify an ATP-insensitive Arabidopsis mutant, dorn1 (Does not Respond to Nucleotides 1), defective in lectin receptor kinase I.9 (Arabidopsis Information Resource accession code At5g60300). DORN1 binds ATP with high affinity (dissociation constant of 45.7 +/- 3.1 nanomolar) and is required for ATP-induced calcium response, mitogen-activated protein kinase activation, and gene expression. Ectopic expression of DORN1 increased the plant response to physical wounding. We propose that DORN1 is essential for perception of extracellular ATP and likely plays a variety of roles in plant stress resistance.	[Choi, Jeongmin; Tanaka, Kiwamu; Cao, Yangrong; Liang, Yan; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr, Div Biochem, Columbia, MO 65211 USA; [Choi, Jeongmin; Tanaka, Kiwamu; Cao, Yangrong; Liang, Yan; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA; [Qi, Yue; Qiu, Jing] Univ Missouri, Dept Stat, Columbia, MO 65211 USA; [Lee, Sang Yeol] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Jinju 660701, Gyeongsangnam D, South Korea	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Gyeongsang National University	Stacey, G (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Div Biochem, Columbia, MO 65211 USA.	staceyg@missouri.edu	Tanaka, Kiwamu/E-9942-2013	Tanaka, Kiwamu/0000-0001-5045-560X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-08ER15309]; Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea [PJ009068]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea	We thank M. R. Knight (Durham University) for providing aequorin-expressing transgenic Arabidopsis; S. C. Peck and J. C. Anderson (University of Missouri) for technical advice on charge-coupled device camera imaging; G. A. Weisman (University of Missouri) for critical comments on the manuscript; and M. R. Dixon (University of Dallas), A. J. Witte (University of Missouri), and Y. Tanaka (Columbia, MO) for support during the mutant screening. This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-08ER15309 and the Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea (grant no. PJ009068) to G. S. The accession number of the microarray discussed in this manuscript is GSE52610 in Gene Expression Omnibus. J. C., K. T., and G. S. are co-inventors on a provisional patent application titled, "Novel extracellular ATP receptor, lectin receptor kinase I.9 and its application to develop plants more stress resistant to bacterial disease and wound damage." The authors declare that there are no competing financial interests.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; BARONDES SH, 1988, TRENDS BIOCHEM SCI, V13, P480, DOI 10.1016/0968-0004(88)90235-6; Bouwmeester K., 2013, PLANT BIOTECHNOL J; Bouwmeester K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001327; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Dark A, 2011, PLANT SIGNAL BEHAV, V6, P1855, DOI 10.4161/psb.6.11.17014; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Herve C, 1999, PLANT MOL BIOL, V39, P671, DOI 10.1023/A:1006136701595; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Lew RR, 2000, PLANT SCI, V153, P1, DOI 10.1016/S0168-9452(99)00242-3; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reichler SA, 2009, J EXP BOT, V60, P2129, DOI 10.1093/jxb/erp091; Roberts D D, 1983, Prog Clin Biol Res, V138, P131; ROBERTS DD, 1983, J BIOL CHEM, V258, P3820; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Steinebrunner I, 2003, PLANT PHYSIOL, V131, P1638, DOI 10.1104/pp.102.014308; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; Tanaka K, 2010, PLANT PHYSIOL, V154, P705, DOI 10.1104/pp.110.162503; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; Weerasinghe RR, 2009, FEBS LETT, V583, P2521, DOI 10.1016/j.febslet.2009.07.007; Wu SJ, 2008, PLANT CELL PHYSIOL, V49, P617, DOI 10.1093/pcp/pcn033	30	325	357	13	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					290	294		10.1126/science.343.6168.290	http://dx.doi.org/10.1126/science.343.6168.290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436418				2022-12-28	WOS:000329718600034
J	Tobias, DK; Pan, A; Jackson, CL; O'Reilly, EJ; Ding, EL; Willett, WC; Manson, JE; Hu, FB				Tobias, Deirdre K.; Pan, An; Jackson, Chandra L.; O'Reilly, Ellis J.; Ding, Eric L.; Willett, Walter C.; Manson, JoAnn E.; Hu, Frank B.			Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; OBESITY PARADOX; RISK; WEIGHT; DEATH; ASSOCIATION; OVERWEIGHT; MELLITUS; DISEASE	BackgroundThe relation between body weight and mortality among persons with type 2 diabetes remains unresolved, with some studies suggesting decreased mortality among overweight or obese persons as compared with normal-weight persons (an obesity paradox). MethodsWe studied participants with incident diabetes from the Nurses' Health Study (8970 participants) and Health Professionals Follow-up Study (2457 participants) who were free of cardiovascular disease and cancer at the time of a diagnosis of diabetes. Body weight shortly before diagnosis and height were used to calculate the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters). Multivariable Cox models were used to estimate the hazard ratios and 95% confidence intervals for mortality across BMI categories. ResultsThere were 3083 deaths during a mean period of 15.8 years of follow-up. A J-shaped association was observed across BMI categories (18.5 to 22.4, 22.5 to 24.9 [reference], 25.0 to 27.4, 27.5 to 29.9, 30.0 to 34.9, and 35.0) for all-cause mortality (hazard ratio, 1.29 [95% confidence interval {CI}, 1.05 to 1.59]; 1.00; 1.12 [95% CI, 0.98 to 1.29]; 1.09 [95% CI, 0.94 to 1.26]; 1.24 [95% CI, 1.08 to 1.42]; and 1.33 [95% CI, 1.14 to 1.55], respectively). This relationship was linear among participants who had never smoked (hazard ratios across BMI categories: 1.12, 1.00, 1.16, 1.21, 1.36, and 1.56, respectively) but was nonlinear among participants who had ever smoked (hazard ratios across BMI categories: 1.32, 1.00, 1.09, 1.04, 1.14, and 1.21) (P=0.04 for interaction). A direct linear trend was observed among participants younger than 65 years of age at the time of a diabetes diagnosis but not among those 65 years of age or older at the time of diagnosis (P<0.001 for interaction). ConclusionsWe observed a J-shaped association between BMI and mortality among all participants and among those who had ever smoked and a direct linear relationship among those who had never smoked. We found no evidence of lower mortality among patients with diabetes who were overweight or obese at diagnosis, as compared with their normal-weight counterparts, or of an obesity paradox. (Funded by the National Institutes of Health and the American Diabetes Association.) Some studies suggest lower mortality among patients with type 2 diabetes who were overweight or obese at diagnosis. In this study, there was a direct linear relation between BMI and mortality among participants who had never smoked but a nonlinear relation among those who had smoked. Excess adiposity is a well-established risk factor for premature death in the general population, including death due to cardiovascular disease or cancer.(1)-(4) However, a so-called obesity paradox (i.e., an association between obesity, as compared with normal weight, and reduced mortality) has been reported among patients with heart failure, end-stage renal disease, or hypertension, and, recently, among those with type 2 diabetes.(5)-(12) Most of these studies, however, have been limited by small samples and suboptimal control for smoking status and preexisting chronic conditions. Smoking is a concern in analyses of body weight and mortality because it is associated with ...	[Tobias, Deirdre K.; Pan, An; Jackson, Chandra L.; O'Reilly, Ellis J.; Ding, Eric L.; Willett, Walter C.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter C.; Manson, JoAnn E.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [O'Reilly, Ellis J.; Ding, Eric L.; Willett, Walter C.; Hu, Frank B.] Channing Div Network Med, Boston, MA USA; [Manson, JoAnn E.] Div Prevent Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Pan, An] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Pan, An] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Pan, An] Natl Univ Hlth Syst, Singapore, Singapore	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National University of Singapore; National University of Singapore; National University of Singapore	Tobias, DK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	dbanel@hsph.harvard.edu; ephanp@nus.edu.sg	Ding, Eric L./K-1118-2019; Pan, An/C-5572-2011; Jackson, Chandra L/A-6291-2017	Ding, Eric L./0000-0002-5881-8097; Pan, An/0000-0002-1089-7945; Jackson, Chandra L/0000-0002-0915-8272	National Institutes of Health [UM1 CA167552, UM1 CA176726, P01 CA87969, R01 HL034594, P01CA055075, DK58845, CA55075, CA87969, HL34594, P30 DK46200, 1U54CA155626-01]; American Diabetes Association [7-12-MN-34]; NATIONAL CANCER INSTITUTE [UM1CA176726, UM1CA167552, P01CA055075, U54CA155626, P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, P30DK046200, T32DK007703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (UM1 CA167552, UM1 CA176726, P01 CA87969, R01 HL034594, P01CA055075, DK58845, CA55075, CA87969, HL34594, P30 DK46200, and 1U54CA155626-01) and the American Diabetes Association (7-12-MN-34).	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P2085, DOI 10.1001/jama.2012.14669; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; CHATURVEDI N, 1995, DIABETES CARE, V18, P766, DOI 10.2337/diacare.18.6.766; Chen ZM, 2012, INT J EPIDEMIOL, V41, P472, DOI 10.1093/ije/dyr208; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI [10.1139/H06-092, 10.1139/h06-092]; De Gonzalez AB, 2011, NEW ENGL J MED, V365, P869; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Florez H, 2012, JAMA-J AM MED ASSOC, V308, P619, DOI 10.1001/jama.2012.9776; Gavin JR, 1997, DIABETES CARE, V20, P1183; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Khalangot M, 2009, HEART, V95, P454, DOI 10.1136/hrt.2008.150524; Lavie CJ, 2010, MAYO CLIN PROC, V85, P605, DOI 10.4065/mcp.2010.0333; Logue J, 2013, DIABETES CARE, V36, P887, DOI 10.2337/dc12-0944; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; McEwen LN, 2012, DIABETES CARE, V35, P1301, DOI 10.2337/dc11-2281; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2010, NEW ENGL J MED, V362, P2433; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ross C, 1997, DIABETES CARE, V20, P650, DOI 10.2337/diacare.20.4.650; Schmidt D, 2007, NUTR CLIN PRACT, V22, P11, DOI 10.1177/011542650702200111; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zoppini G, 2003, INT J OBESITY, V27, P281, DOI 10.1038/sj.ijo.802199	39	288	299	4	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					233	244		10.1056/NEJMoa1304501	http://dx.doi.org/10.1056/NEJMoa1304501			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428469	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000330035600009
J	Ioannidis, JPA; Greenland, S; Hlatky, MA; Khoury, MJ; Macleod, MR; Moher, D; Schulz, KF; Tibshirani, R				Ioannidis, John P. A.; Greenland, Sander; Hlatky, Mark A.; Khoury, Muin J.; Macleod, Malcolm R.; Moher, David; Schulz, Kenneth F.; Tibshirani, Robert			Increasing value and reducing waste in research design, conduct, and analysis	LANCET			English	Article							CONFLICTS-OF-INTEREST; PATIENT-IMPORTANT OUTCOMES; CLINICAL-TRIALS; REPRODUCIBLE RESEARCH; SYSTEMATIC REVIEWS; REPORTING GUIDELINES; VALIDATION PRACTICES; SAMPLE-SIZE; QUALITY; METAANALYSES	Correctable weaknesses in the design, conduct, and analysis of biomedical and public health research studies can produce misleading results and waste valuable resources. Small effects can be difficult to distinguish from bias introduced by study design and analyses. An absence of detailed written protocols and poor documentation of research is common. Information obtained might not be useful or important, and statistical precision or power is often too low or used in a misleading way. Insufficient consideration might be given to both previous and continuing studies. Arbitrary choice of analyses and an overemphasis on random extremes might affect the reported findings. Several problems relate to the research workforce, including failure to involve experienced statisticians and methodologists, failure to train clinical researchers and laboratory scientists in research methods and design, and the involvement of stakeholders with conflicts of interest. Inadequate emphasis is placed on recording of research decisions and on reproducibility of research. Finally, reward systems incentivise quantity more than quality, and novelty more than reliability. We propose potential solutions for these problems, including improvements in protocols and documentation, consideration of evidence from studies in progress, standardisation of research efforts, optimisation and training of an experienced and non-conflicted scientific workforce, and reconsideration of scientific reward systems.	[Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Hlatky, Mark A.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Div Epidemiol, Stanford, CA 94305 USA; [Hlatky, Mark A.] Stanford Univ, Div Hlth Serv Res, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.; Tibshirani, Robert] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Greenland, Sander] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Greenland, Sander] Univ Calif Los Angeles, Sch Publ Hlth, Dept Stat, Los Angeles, CA 90024 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA USA; [Khoury, Muin J.] NCI, Epidemiol & Genom Res Program, Rockville, MD USA; [Macleod, Malcolm R.] Univ Edinburgh, Sch Med, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Moher, David] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Schulz, Kenneth F.] FHI 360, Durham, NC USA; [Schulz, Kenneth F.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Edinburgh; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, Stanford, CA 94350 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Moher, David/I-3408-2019; Harding, Richard/G-9729-2012; Macleod, Malcolm Robert/B-2052-2010	Moher, David/0000-0003-2434-4206; Macleod, Malcolm Robert/0000-0001-9187-9839; Hlatky, Mark/0000-0003-4686-9441	National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	National Centre for the Replacement		Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2765, DOI 10.1001/jama.287.21.2765; Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; Bath PMW, 2009, INT J STROKE, V4, P471, DOI 10.1111/j.1747-4949.2009.00386.x; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Boffetta P, 2012, INT J EPIDEMIOL, V41, P686, DOI 10.1093/ije/dys010; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Bosch X, 2013, EUR J CLIN INVEST, V43, P660, DOI 10.1111/eci.12090; Bracken MB, 2009, ANN EPIDEMIOL, V19, P220, DOI 10.1016/j.annepidem.2008.11.006; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Castaldi PJ, 2011, BRIEF BIOINFORM, V12, P189, DOI 10.1093/bib/bbq073; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chan A-W, 2014, LANCET; Chavalarias D, 2010, J CLIN EPIDEMIOL, V63, P1205, DOI 10.1016/j.jclinepi.2009.12.011; Deverka PA, 2012, GENET MED, V14, P656, DOI 10.1038/gim.2012.3; Diggle PJ, 2010, BIOSTATISTICS, V11, P375, DOI 10.1093/biostatistics/kxq029; Dirnagl U, 2012, J CEREBR BLOOD F MET, V32, P933, DOI 10.1038/jcbfm.2012.51; Dwan Kerry, 2011, Cochrane Database Syst Rev, pMR000031, DOI 10.1002/14651858.MR000031.pub2; Evans I, 2010, TESTING TREATMENTS B; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Fortier I, 2010, INT J EPIDEMIOL, V39, P1383, DOI 10.1093/ije/dyq139; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Garcia-Berthou Emili, 2004, BMC Med Res Methodol, V4, P13, DOI 10.1186/1471-2288-4-13; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Greenberg Steven A, 2009, BMJ, V339, pb2680, DOI 10.1136/bmj.b2680; Greenland S, 2008, INT J EPIDEMIOL, V37, P430, DOI 10.1093/ije/dyn064; Greenland S, 2007, INT J EPIDEMIOL, V36, P944, DOI 10.1093/ije/dym174; Greenland S, 2012, J EPIDEMIOL COMMUN H, V66, P967, DOI 10.1136/jech-2011-200459; Greenland S, 2012, ANN EPIDEMIOL, V22, P364, DOI 10.1016/j.annepidem.2012.02.007; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Hothorn T, 2011, BRIEF BIOINFORM, V12, P288, DOI 10.1093/bib/bbq084; Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2008, SEMIN HEMATOL, V45, P160, DOI 10.1053/j.seminhematol.2008.04.010; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2012, NAT MED, V18, P1736, DOI 10.1038/nm.3020; Ioannidis JPA, 2012, EUR J CLIN INVEST, V42, P349, DOI 10.1111/j.1365-2362.2011.02617.x; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Ioannidis JPA, 2010, J CLIN EPIDEMIOL, V63, P945, DOI 10.1016/j.jclinepi.2010.04.002; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P2783, DOI 10.1002/cncr.24315; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kazi DS, 2012, CIRC-CARDIOVASC QUAL, V5, P249, DOI 10.1161/CIRCOUTCOMES.112.965764; Keen HI, 2005, J RHEUMATOL, V32, P2083; Keiding N, 2010, BIOSTATISTICS, V11, P376, DOI 10.1093/biostatistics/kxq033; Khoury MJ, 2011, GENET EPIDEMIOL, V35, P845, DOI 10.1002/gepi.20634; Khoury MJ, 2011, CANCER EPIDEM BIOMAR, V20, P2105, DOI 10.1158/1055-9965.EPI-11-0481; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Lash, 2008, MODERN EPIDEMIOLOGY, P345; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Little R. J. A., 2002, STAT ANAL MISSING DA; Mann H, JLL B COMMENTARIES H; Maxwell SE, 2004, PSYCHOL METHODS, V9, P147, DOI 10.1037/1082-989X.9.2.147; MCKINNEY WP, 1989, JAMA-J AM MED ASSOC, V261, P3430, DOI 10.1001/jama.261.23.3430; McNamee D, 2001, LANCET, V357, P1819, DOI 10.1016/S0140-6736(00)05011-X; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Montori VM, 2007, LANCET, V370, P1104, DOI 10.1016/S0140-6736(07)61489-5; Ocana A, 2011, JNCI-J NATL CANCER I, V103, P16, DOI 10.1093/jnci/djq463; Ommen G, 2012, EVOLUTION TRANSLATIO; Palepu Anita, 2011, Open Med, V5, pe65; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Peng RD, 2009, BIOSTATISTICS, V10, P405, DOI 10.1093/biostatistics/kxp014; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Pinto RZ, 2013, PHYS THER, V93, P299, DOI 10.2522/ptj.20120206; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Qaseem A, 2008, ANN INTERN MED, V148, P370, DOI 10.7326/0003-4819-148-5-200803040-00008; Rasmussen N, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-116; Richter SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016461; Richter S, 2010, CHLOE, V41, P7; Riechelmann RP, 2007, J CLIN ONCOL, V25, P4642, DOI 10.1200/JCO.2007.11.2482; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Scharfstein DO, 1999, J AM STAT ASSOC, V94, P1096, DOI 10.2307/2669923; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Senn S., 2007, STAT ISSUES DRUG DEV, V2nd; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Soares MO, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16070; Solove DJ, 2007, FUTURE REPUTATION; Stewart L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-7; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Tzoulaki I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6829; Veenstra DL, 2010, GENET MED, V12, P686, DOI 10.1097/GIM.0b013e3181eff533; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Witten DM, 2013, J AM MED INFORM ASSN, V20, P125, DOI 10.1136/amiajnl-2012-000972; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	101	815	831	1	162	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					166	175		10.1016/S0140-6736(13)62227-8	http://dx.doi.org/10.1016/S0140-6736(13)62227-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	24411645	Green Accepted			2022-12-28	WOS:000329579600032
J	Coley, PD; Kursar, TA				Coley, Phyllis D.; Kursar, Thomas A.			On Tropical Forests and Their Pests	SCIENCE			English	Editorial Material							SPECIES COEXISTENCE; EVOLUTION; TRAITS; TREES; INGA		[Coley, Phyllis D.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Smithsonian Trop Res Inst, Panama City, Panama	Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian Tropical Research Institute	Coley, PD (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	coley@biology.utah.edu						Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Becerra JX, 2009, P NATL ACAD SCI USA, V106, P18062, DOI 10.1073/pnas.0904456106; Fine PVA, 2013, ECOLOGY, V94, P1764, DOI 10.1890/12-1920.1; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; Leigh EG, 2004, BIOTROPICA, V36, P447, DOI 10.1111/j.1744-7429.2004.tb00342.x; Liu XJ, 2013, FUNCT ECOL, V27, P264, DOI 10.1111/1365-2435.12018; Palow DT, 2012, FUNCT ECOL, V26, P1144, DOI 10.1111/j.1365-2435.2012.02019.x; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Sedio B. E., 2013, THESIS U MICHIGAN; Sedio BE, 2012, J ECOL, V100, P1183, DOI 10.1111/j.1365-2745.2012.01993.x; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	14	76	77	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					35	36		10.1126/science.1248110	http://dx.doi.org/10.1126/science.1248110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24385624				2022-12-28	WOS:000329162000040
J	Knutson, HA; Benneke, B; Deming, D; Homeier, D				Knutson, Heather A.; Benneke, Bjoern; Deming, Drake; Homeier, Derek			A featureless transmission spectrum for the Neptune-mass exoplanet GJ 436b	NATURE			English	Article							TRANSITING HOT NEPTUNE; SUPER-EARTH; HD 189733B; ATMOSPHERE; HUBBLE; PLANETS; SPECTROSCOPY; METHANE; PARAMETERS; RADIATION	GJ 436b is a warm-approximately 800 kelvin-exoplanet that periodically eclipses its low-mass (half the mass of the Sun) host star, and is one of the few Neptune-mass planets that is amenable to detailed characterization. Previous observations(1-3) have indicated that its atmosphere has a ratio of methane to carbon monoxide that is 10(5) times smaller than predicted by models for hydrogen-dominated atmospheres at these temperatures(4,5). A recent study proposed that this unusual chemistry could be explained if the planet's atmosphere is significantly enhanced in elements heavier than hydrogen and helium(6). Here we report observations of GJ 436b's atmosphere obtained during transit. The data indicate that the planet's transmission spectrum is featureless, ruling out cloud-free, hydrogen-dominated atmosphere models with an extremely high significance of 48 sigma. The measured spectrum is consistent with either a layer of high cloud located at a pressure level of approximately one millibar or with a relatively hydrogen-poor (three per cent hydrogen and helium mass fraction) atmospheric composition(7-9).	[Knutson, Heather A.; Benneke, Bjoern] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Benneke, Bjoern] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Deming, Drake] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Homeier, Derek] Ctr Rech Astrophys Lyon, F-69364 Lyon, France	California Institute of Technology; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park	Knutson, HA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	hknutson@caltech.edu		Knutson, Heather/0000-0002-5375-4725; Homeier, Derek/0000-0002-8546-9128	European Research Council under the European Community [247060]	European Research Council under the European Community(European Research Council (ERC))	We thank P. McCullough for his assistance in the planning and executing of these observations. We are also grateful to J. Moses, M. Line and N. Nettelmann for conversations on the nature of high-metallicity atmospheres as well as discussions of specific interior and atmosphere models for GJ 436b. D.H. has received support from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 grant agreement number 247060).	Adams ER, 2008, ASTROPHYS J, V673, P1160, DOI 10.1086/524925; Alonso R, 2008, ASTRON ASTROPHYS, V487, pL5, DOI 10.1051/0004-6361:200810007; Ballard S, 2010, ASTROPHYS J, V716, P1047, DOI 10.1088/0004-637X/716/2/1047; Baraffe I, 2008, ASTRON ASTROPHYS, V482, P315, DOI 10.1051/0004-6361:20079321; Bean JL, 2008, ASTRON ASTROPHYS, V486, P1039, DOI 10.1051/0004-6361:200810013; Beaulieu JP, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/16; Benneke B, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/153; Benneke B, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/100; Berta ZK, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/35; Caceres C, 2009, ASTRON ASTROPHYS, V507, P481, DOI 10.1051/0004-6361/200810908; Carter JA, 2009, ASTROPHYS J, V704, P51, DOI 10.1088/0004-637X/704/1/51; Claret A, 2000, ASTRON ASTROPHYS, V363, P1081; Coughlin JL, 2008, ASTROPHYS J LETT, V689, pL149, DOI 10.1086/595822; Deming D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/95; Ehrenreich D, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016356; Ehrenreich D, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016162; Figueira P, 2009, ASTRON ASTROPHYS, V493, P671, DOI 10.1051/0004-6361:20078951; Fortney JJ, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/80; Gillon M, 2009, ASTRON ASTROPHYS, V496, P259, DOI 10.1051/0004-6361:200810929; Gregory P., 2005, BAYESIAN LOGICAL DAT, P167; Heng K, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/60; Knutson HA, 2007, ASTROPHYS J, V655, P564, DOI 10.1086/510111; Knutson HA, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/27; Knutson HA, 2010, ASTROPHYS J, V720, P1569, DOI 10.1088/0004-637X/720/2/1569; Line MR, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/32; Madhusudhan N, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/41; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; McCullough P. M., 2012, 20128 WFC3 SPAC TEL; Miller N, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/2/L29; Morley CV, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/33; Moses JI, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/34; Nettelmann N, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/200911985; Owen JE, 2012, MON NOT R ASTRON SOC, V425, P2931, DOI 10.1111/j.1365-2966.2012.21481.x; Pont F, 2013, MON NOT R ASTRON SOC, V432, P2917, DOI 10.1093/mnras/stt651; Pont F, 2009, MON NOT R ASTRON SOC, V393, pL6, DOI 10.1111/j.1745-3933.2008.00582.x; Rogers LA, 2010, ASTROPHYS J, V712, P974, DOI 10.1088/0004-637X/712/2/974; Sanz-Forcada J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116594; Shporer A, 2009, ASTROPHYS J, V694, P1559, DOI 10.1088/0004-637X/694/2/1559; Sing DK, 2011, MON NOT R ASTRON SOC, V416, P1443, DOI 10.1111/j.1365-2966.2011.19142.x; Stevenson KB, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/9; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; von Braun K, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/171	45	208	210	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					66	+		10.1038/nature12887	http://dx.doi.org/10.1038/nature12887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24380953	Green Accepted, Green Submitted			2022-12-28	WOS:000329163300024
J	Dehnel, T				Dehnel, Tim			A look back at 2013	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2053	2054		10.1016/S0140-6736(13)62683-5	http://dx.doi.org/10.1016/S0140-6736(13)62683-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24367804	Green Published, Bronze			2022-12-28	WOS:000328687800016
J	Yu, C; Zhang, YL; Pan, WW; Li, XM; Wang, ZW; Ge, ZJ; Zhou, JJ; Cang, Y; Tong, C; Sun, QY; Fan, HY				Yu, Chao; Zhang, Yin-Li; Pan, Wei-Wei; Li, Xiao-Meng; Wang, Zhong-Wei; Ge, Zhao-Jia; Zhou, Jian-Jie; Cang, Yong; Tong, Chao; Sun, Qing-Yuan; Fan, Heng-Yu			CRL4 Complex Regulates Mammalian Oocyte Survival and Reprogramming by Activation of TET Proteins	SCIENCE			English	Article							FOLLICULOGENESIS	The duration of a woman's reproductive period is determined by the size and persistence of a dormant oocyte pool. Specific oocyte genes are essential for follicle maintenance and female fertility. The mechanisms that regulate the expression of these genes are poorly understood. We found that a cullin-ring finger ligase-4 (CRL4) complex was crucial in this process. Oocyte-specific deletion of the CRL4 linker protein DDB1 or its substrate adaptor VPRBP (also known as DCAF1) caused rapid oocyte loss, premature ovarian insufficiency, and silencing of fertility maintaining genes. CRL4(VPRBP) activates the TET methylcytosine dioxygenases, which are involved in female germ cell development and zygote genome reprogramming. Hence, CRL4(VPRBP) ubiquitin ligase is a guardian of female reproductive life in germ cells and a maternal reprogramming factor after fertilization.	[Yu, Chao; Zhang, Yin-Li; Pan, Wei-Wei; Li, Xiao-Meng; Zhou, Jian-Jie; Cang, Yong; Tong, Chao; Fan, Heng-Yu] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Yu, Chao; Zhang, Yin-Li; Pan, Wei-Wei; Li, Xiao-Meng; Zhou, Jian-Jie; Cang, Yong; Tong, Chao; Fan, Heng-Yu] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Zhong-Wei; Ge, Zhao-Jia; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Institute of Zoology, CAS	Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	sunqy@ioz.ac.cn; hyfan@zju.edu.cn	Yu, Chao/ADW-9951-2022; LI, Xiao-Meng/G-9761-2018	Yu, Chao/0000-0001-9798-2992; LI, Xiao-Meng/0000-0002-8486-6826; Cang, Yong/0000-0002-1148-7008; Tong, Chao/0000-0001-6521-5465	National Basic Research Program of China [2011CB944504, 2012CB944403, 2012CB966600]; National Natural Science Foundation of China [81172473, 31371449]; Basic Scientific Research Funding of Zhejiang University [2011QN81001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Scientific Research Funding of Zhejiang University	We thank K. Guan and X. Feng for discussions and critical reviews of the manuscript. J.J. Chen and Z. Xia provided VPRBP and TET1, 2, and 3 plasmids, respectively. G. Xu and L. Jia provided TET3 antibody and MLN4924, respectively. Y. Xiong provided Vprbp floxed mice and VPRBP-2RA plasmid. This study was supported by National Basic Research Program of China [2011CB944504 and 2012CB944403 (to H.-Y.F. and Q.-Y.S.) and 2012CB966600 (to C. T.)], National Natural Science Foundation of China (81172473 and 31371449 to H.-Y.F.), and Basic Scientific Research Funding of Zhejiang University (2011QN81001 to H.-Y.F).	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Choi Y, 2008, BIOL REPROD, V79, P1176, DOI 10.1095/biolreprod.108.071217; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Soyal SM, 2000, DEVELOPMENT, V127, P4645	14	87	95	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1518	1521		10.1126/science.1244587	http://dx.doi.org/10.1126/science.1244587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357321				2022-12-28	WOS:000328644300061
J	Stephenson, NL; Das, AJ; Condit, R; Russo, SE; Baker, PJ; Beckman, NG; Coomes, DA; Lines, ER; Morris, WK; Ruger, N; Alvarez, E; Blundo, C; Bunyavejchewin, S; Chuyong, G; Davies, SJ; Duque, A; Ewango, CN; Flores, O; Franklin, JF; Grau, HR; Hao, Z; Harmon, ME; Hubbell, SP; Kenfack, D; Lin, Y; Makana, JR; Malizia, A; Malizia, LR; Pabst, RJ; Pongpattananurak, N; Su, SH; Sun, IF; Tan, S; Thomas, D; van Mantgem, PJ; Wang, X; Wiser, SK; Zavala, MA				Stephenson, N. L.; Das, A. J.; Condit, R.; Russo, S. E.; Baker, P. J.; Beckman, N. G.; Coomes, D. A.; Lines, E. R.; Morris, W. K.; Rueger, N.; Alvarez, E.; Blundo, C.; Bunyavejchewin, S.; Chuyong, G.; Davies, S. J.; Duque, A.; Ewango, C. N.; Flores, O.; Franklin, J. F.; Grau, H. R.; Hao, Z.; Harmon, M. E.; Hubbell, S. P.; Kenfack, D.; Lin, Y.; Makana, J. -R.; Malizia, A.; Malizia, L. R.; Pabst, R. J.; Pongpattananurak, N.; Su, S. -H.; Sun, I-F.; Tan, S.; Thomas, D.; van Mantgem, P. J.; Wang, X.; Wiser, S. K.; Zavala, M. A.			Rate of tree carbon accumulation increases continuously with tree size	NATURE			English	Article							AGE-RELATED DECLINE; GROWTH EFFICIENCY; BIOMASS; STAND; COMPETITION; LIMITATION; ALLOMETRY; CAPACITY; GRADIENT; RULES	Forests are major components of the global carbon cycle, providing substantial feedback to atmospheric greenhouse gas concentrations(1). Our ability to understand and predict changes in the forest carbon cycle-particularly net primary productivity and carbon storage-increasingly relies on models that represent biological processes across several scales of biological organization, from tree leaves to forest stands(2,3). Yet, despite advances in our understanding of productivity at the scales of leaves and stands, no consensus exists about the nature of productivity at the scale of the individual tree(4-7), in part because we lack a broad empirical assessment of whether rates of absolute tree mass growth (and thus carbon accumulation) decrease, remain constant, or increase as trees increase in size and age. Here we present a global analysis of 403 tropical and temperate tree species, showing that for most species mass growth rate increases continuously with tree size. Thus, large, old trees do not act simply as senescent carbon reservoirs but actively fix large amounts of carbon compared to smaller trees; at the extreme, a single big tree can add the same amount of carbon to the forest within a year as is contained in an entire mid-sized tree. The apparent paradoxes of individual tree growth increasing with tree size despite declining leaf-level(8-10) and stand-level(10) productivity can be explained, respectively, by increases in a tree's total leaf area that outpace declines in productivity per unit of leaf area and, among other factors, age-related reductions in population density. Our results resolve conflicting assumptions about the nature of tree growth, inform efforts to under-tand and model forest carbon dynamics, and have additional implications for theories of resource allocation(11) and plant senescence(12).	[Stephenson, N. L.; Das, A. J.] US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA 93271 USA; [Condit, R.; Rueger, N.; Hubbell, S. P.] Smithsonian Trop Res Inst, Balboa, Panama; [Russo, S. E.; Beckman, N. G.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Baker, P. J.] Univ Melbourne, Dept Forest & Ecosyst Sci, Melbourne, Vic 3121, Australia; [Coomes, D. A.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Lines, E. R.] UCL, Dept Geog, London WC1E 6BT, England; [Morris, W. K.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Rueger, N.] Univ Leipzig, spebot, D-04103 Leipzig, Germany; [Alvarez, E.] Jardin Bot Medellin, Medellin, Colombia; [Blundo, C.; Grau, H. R.; Malizia, A.] Univ Nacl Tucuman, Inst Ecol Reg, RA-4107 Yerba Buena, Tucuman, Argentina; [Bunyavejchewin, S.] Dept Natl Pk Wildlife & Plant Conservat, Res Off, Bangkok 10900, Thailand; [Chuyong, G.] Dept Bot & Plant Physiol, Buea, Southwest Provi, Cameroon; [Davies, S. J.; Kenfack, D.] Smithsonian Inst, Ctr Trop Forest Sci, Global Earth Observ, Washington, DC 20013 USA; [Duque, A.] Univ Nacl Colombia, Dept Ciencias Forestales, Medellin, Colombia; [Ewango, C. N.; Makana, J. -R.] Wildlife Conservat Soc, Kinshasa, DEM REP CONGO; [Flores, O.] Univ Reunion, CIRAD, Unite Mixte Rech Peuplements Vegetaux & Bioagrees, F-97410 St Pierre, France; [Franklin, J. F.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Hao, Z.; Wang, X.] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110164, Peoples R China; [Harmon, M. E.; Pabst, R. J.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Hubbell, S. P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Lin, Y.] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Malizia, A.] Univ Nacl Jujuy, Fac Ciencias Agr, RA-4600 San Salvador De Jujuy, Argentina; [Pongpattananurak, N.] Kasetsart Univ, Fac Forestry, Chatuchak Bangkok 10900, Thailand; [Su, S. -H.] Taiwan Forestry Res Inst, Taipei 10066, Taiwan; [Sun, I-F.] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien 97401, Taiwan; [Tan, S.] Sarawak Forestry Dept, Kuching 93660, Sarawak, Malaysia; [Thomas, D.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [van Mantgem, P. J.] US Geol Survey, Western Ecol Res Ctr, Arcata, CA 95521 USA; [Wiser, S. K.] Landcare Res, Lincoln 7640, New Zealand; [Zavala, M. A.] Univ Alcala de Henares, Dept Life Sci, Forest Ecol & Restorat Grp, Madrid 28805, Spain	United States Department of the Interior; United States Geological Survey; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Nebraska System; University of Nebraska Lincoln; University of Melbourne; University of Cambridge; University of London; University College London; University of Melbourne; Leipzig University; Universidad Nacional de Tucuman; Smithsonian Institution; Universidad Nacional de Colombia; CIRAD; University of La Reunion; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Oregon State University; University of California System; University of California Los Angeles; Tunghai University; Kasetsart University; National Dong Hwa University; Jabatan Hutan Sarawak; Oregon State University; United States Department of the Interior; United States Geological Survey; Landcare Research - New Zealand; Universidad de Alcala	Stephenson, NL (corresponding author), US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA 93271 USA.	nstephenson@usgs.gov	Rüger, Nadja/J-6393-2015; Beckman, Noelle G./E-5554-2011; Van Cleave, Keith/AAN-2338-2021; Zavala, Miguel A./H-3603-2015; Wang, Xugao/B-1111-2015; Su, Sheng-Hsin/AAC-3596-2021; Wiser, Susan K./G-1975-2011; Bunyavejchewin, Sarayudh/P-1529-2017; Rüger, Nadja/Q-6418-2019; Alvarez-Davila, Esteban/AAP-4231-2020	Rüger, Nadja/0000-0003-2371-4172; Beckman, Noelle G./0000-0001-5822-0610; Zavala, Miguel A./0000-0003-1456-0132; Wang, Xugao/0000-0003-1207-8852; Su, Sheng-Hsin/0000-0003-1337-3335; Wiser, Susan K./0000-0002-8938-8181; Bunyavejchewin, Sarayudh/0000-0002-1976-5041; Rüger, Nadja/0000-0003-2371-4172; Alvarez-Davila, Esteban/0000-0001-9032-0099; Coomes, David/0000-0002-8261-2582; Baker, Patrick/0000-0002-6560-7124; Kenfack, David/0000-0001-8208-3388; Pongpattananurak, Nantachai/0000-0001-8687-6182; Flores, Olivier/0000-0002-1416-0449; Makana, Jean-Remy/0000-0002-6006-2938; Lines, Emily/0000-0002-5357-8741	United States Geological Survey (USGS) John Wesley Powell Center for Analysis and Synthesis; USGS Ecosystems and Climate and Land Use Change mission areas; Smithsonian Institution Global Earth Observatory-Center for Tropical Forest Science (CTFS); University of Nebraska-Lincoln Program of Excellence in Population Biology Postdoctoral Fellowship; National Natural Science Foundation of China [31370444]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-11]; USGS; CTFS; US National Science Foundation; Andrews LTER [NSF-LTER DEB-0823380]; US National Park Service; US Forest Service (USFS); USFS Forest Inventory and Analysis Program; John D. and Catherine T. MacArthur Foundation; Andrew W. Mellon Foundation; MAGRAMA; Council of Agriculture of Taiwan; National Science Council of Taiwan; National Natural Science Foundation of China; Knowledge Innovation Program of the Chinese Academy of Sciences; Landcare Research; National Vegetation Survey Database (NVS) of New Zealand; French Fund for the Global Environment; Fundacion ProYungas; Direct For Biological Sciences [1354741] Funding Source: National Science Foundation; Division Of Environmental Biology [0823380] Funding Source: National Science Foundation	United States Geological Survey (USGS) John Wesley Powell Center for Analysis and Synthesis; USGS Ecosystems and Climate and Land Use Change mission areas; Smithsonian Institution Global Earth Observatory-Center for Tropical Forest Science (CTFS); University of Nebraska-Lincoln Program of Excellence in Population Biology Postdoctoral Fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Forest and Soil Ecology; USGS(United States Geological Survey); CTFS; US National Science Foundation(National Science Foundation (NSF)); Andrews LTER; US National Park Service; US Forest Service (USFS)(United States Department of Agriculture (USDA)United States Forest Service); USFS Forest Inventory and Analysis Program; John D. and Catherine T. MacArthur Foundation; Andrew W. Mellon Foundation; MAGRAMA; Council of Agriculture of Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Landcare Research; National Vegetation Survey Database (NVS) of New Zealand; French Fund for the Global Environment; Fundacion ProYungas; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the hundreds of people who have established and maintained the forest plots and their associated databases; M. G. Ryan for comments on the manuscript; C. D. Canham and T. Hart for supplying data; C. D. Canham for discussions and feedback; J. S. Baron for hosting our workshops; and Spain's Ministerio de Agricultura, Alimentacion y Medio Ambiente (MAGRAMA) for granting access to the Spanish Forest Inventory Data. Our analyses were supported by the United States Geological Survey (USGS) John Wesley Powell Center for Analysis and Synthesis, the USGS Ecosystems and Climate and Land Use Change mission areas, the Smithsonian Institution Global Earth Observatory-Center for Tropical Forest Science (CTFS), and a University of Nebraska-Lincoln Program of Excellence in Population Biology Postdoctoral Fellowship (to N.G.B.). In addition, X. W. was supported by National Natural Science Foundation of China (31370444) and State Key Laboratory of Forest and Soil Ecology (LFSE2013-11). Data collection was funded by a broad range of organizations including the USGS, the CTFS, the US National Science Foundation, the Andrews LTER (NSF-LTER DEB-0823380), the US National Park Service, the US Forest Service (USFS), the USFS Forest Inventory and Analysis Program, the John D. and Catherine T. MacArthur Foundation, the Andrew W. Mellon Foundation, MAGRAMA, the Council of Agriculture of Taiwan, the National Science Council of Taiwan, the National Natural Science Foundation of China, the Knowledge Innovation Program of the Chinese Academy of Sciences, Landcare Research and the National Vegetation Survey Database (NVS) of New Zealand, the French Fund for the Global Environment and Fundacion ProYungas. This paper is a contribution from the Western Mountain Initiative, a USGS global change research project. Any use of trade names is for descriptive purposes only and does not imply endorsement by the USA government.	BASKERVILLE G L, 1972, Canadian Journal of Forest Research, V2, P49, DOI 10.1139/x72-009; Binkley D, 2004, FOREST ECOL MANAG, V190, P265, DOI 10.1016/j.foreco.2003.10.018; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Carey EV, 2001, GLOBAL CHANGE BIOL, V7, P339, DOI 10.1046/j.1365-2486.2001.00418.x; Caspersen JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028660; Chambers JQ, 2001, FOREST ECOL MANAG, V152, P73, DOI 10.1016/S0378-1127(00)00591-0; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; Das A, 2012, CAN J FOREST RES, V42, P1983, DOI 10.1139/x2012-142; Drake JE, 2010, PLANT CELL ENVIRON, V33, P1756, DOI 10.1111/j.1365-3040.2010.02180.x; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Gilmore DW, 1996, FOREST ECOL MANAG, V84, P209, DOI 10.1016/0378-1127(96)03728-0; Gomez-Aparicio L, 2011, GLOBAL CHANGE BIOL, V17, P2400, DOI 10.1111/j.1365-2486.2011.02421.x; Hilborn Ray, 1997, V28; Jenkins J. C., 2004, NE319 USDA FOR SERV, DOI [10.2737/NE-GTR-319, DOI 10.2737/NE-GTR-319]; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; Kashian DM, 2005, ECOLOGY, V86, P643, DOI 10.1890/03-0828; Kaufmann MR, 1986, TREE PHYSIOL, V2, P47, DOI 10.1093/treephys/2.1-2-3.47; Kutsch WL, 2009, ECOL STUD-ANAL SYNTH, V207, P57, DOI 10.1007/978-3-540-92706-8_4; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Medvigy D, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000812; Meinzer FC, 2011, TREE PHYSIOL SER, V4, P1, DOI 10.1007/978-94-007-1242-3; Mencuccini M, 2005, ECOL LETT, V8, P1183, DOI 10.1111/j.1461-0248.2005.00819.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Munne-Bosch S, 2008, TRENDS PLANT SCI, V13, P216, DOI 10.1016/j.tplants.2008.02.002; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Niklas KJ, 2002, AM J BOT, V89, P812, DOI 10.3732/ajb.89.5.812; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Phillips NG, 2008, J INTEGR PLANT BIOL, V50, P1355, DOI 10.1111/j.1744-7909.2008.00746.x; Piper FI, 2011, ANN BOT-LONDON, V108, P907, DOI 10.1093/aob/mcr195; Pretzsch H, 2005, FOREST SCI, V51, P304; Pretzsch H, 2010, CAN J FOREST RES, V40, P370, DOI 10.1139/X09-195; R Development Core Team, 2009, R LANG ENV STAT COMP; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Ruger N, 2011, OIKOS, V120, P1047, DOI 10.1111/j.1600-0706.2010.19021.x; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Sibly R. M., 2012, METABOLIC ECOLOGY SC; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Steppe K, 2011, TREE PHYSIOL-NETH, V4, P235, DOI 10.1007/978-94-007-1242-3_9; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; Thomas SC, 2011, TREE PHYSIOL-NETH, V4, P33, DOI 10.1007/978-94-007-1242-3_2; Thomas SC, 2010, TREE PHYSIOL, V30, P555, DOI 10.1093/treephys/tpq005; Weiner J, 2001, OIKOS, V94, P374, DOI 10.1034/j.1600-0706.2001.940219.x; Zanne A. E., 2009, DRYAD DIGITAL DATA R; Zianis D., 2005, Silva Fennica Monographs, P1	50	508	532	27	685	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					90	+		10.1038/nature12914	http://dx.doi.org/10.1038/nature12914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24429523				2022-12-28	WOS:000332224400048
J	Roy, S; Huang, H; Liu, SM; Kornberg, TB				Roy, Sougata; Huang, Hai; Liu, Songmei; Kornberg, Thomas B.			Cytoneme-Mediated Contact-Dependent Transport of the Drosophila Decapentaplegic Signaling Protein	SCIENCE			English	Article							WING IMAGINAL DISC; LATERAL INHIBITION; GRADIENT FORMATION; SYNAPSE FORMATION; HUMAN CD4; DPP; RANGE; HEDGEHOG; GENE; FGF	Decapentaplegic (Dpp), a Drosophila morphogen signaling protein, transfers directly at synapses made at sites of contact between cells that produce Dpp and cytonemes that extend from recipient cells. The Dpp that cytonemes receive moves together with activated receptors toward the recipient cell body in motile puncta. Genetic loss-of-function conditions for diaphanous, shibire, neuroglian, and capricious perturbed cytonemes by reducing their number or only the synapses they make with cells they target, and reduced cytoneme-mediated transport of Dpp and Dpp signaling. These experiments provide direct evidence that cells use cytonemes to exchange signaling proteins, that cytoneme-based exchange is essential for signaling and normal development, and that morphogen distribution and signaling can be contact-dependent, requiring cytoneme synapses.	[Roy, Sougata; Huang, Hai; Liu, Songmei; Kornberg, Thomas B.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	tkornberg@ucsf.edu	Huang, Hai/CZY-9855-2022; Roy, Sougaya/I-5341-2019	Huang, Hai/0000-0003-2331-6238; Roy, Sougaya/0000-0002-2236-9277	NIH [K99HL114867, GM030637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL114867, R00HL114867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030637] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: NIH K99HL114867 to S. R. and GM030637 to T.B.K.	Bilioni A, 2013, DEV BIOL, V376, P198, DOI 10.1016/j.ydbio.2012.12.013; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Callejo A, 2011, P NATL ACAD SCI USA, V108, P12591, DOI 10.1073/pnas.1106881108; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Eulenberg KG, 1997, EMBO J, V16, P7156, DOI 10.1093/emboj/16.23.7156; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; GELBART WM, 1989, DEVELOPMENT, V107, P65; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hinshaw JE, 1999, CURR OPIN STRUC BIOL, V9, P260, DOI 10.1016/S0959-440X(99)80036-0; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Klebes A, 2002, GENOME BIOL, V3; Kohsaka H, 2009, DEVELOPMENT, V136, P1127, DOI 10.1242/dev.027920; Koizumi K, 2012, MOL BIOL CELL, V23, P4647, DOI 10.1091/mbc.E12-04-0315; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Massarwa R, 2009, DEV CELL, V16, P877, DOI 10.1016/j.devcel.2009.04.010; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Ninov N, 2010, CURR BIOL, V20, P513, DOI 10.1016/j.cub.2010.01.063; Ohshiro T, 2002, MECH DEVELOP, V114, P3, DOI 10.1016/S0925-4773(02)00042-4; Peng Y, 2012, DEV CELL, V23, P507, DOI 10.1016/j.devcel.2012.07.016; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; Renaud O, 2001, DEV BIOL, V240, P361, DOI 10.1006/dbio.2001.0482; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298; Rousso T, 2013, ELIFE, V2, DOI 10.7554/eLife.00666; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Taniguchi H, 2000, J NEUROBIOL, V42, P104, DOI 10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107	52	143	146	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					852	+		10.1126/science.1244624	http://dx.doi.org/10.1126/science.1244624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24385607	Green Accepted			2022-12-28	WOS:000331552600037
J	Bazari, H; Mahindra, AK; Farkash, EA				Bazari, Hasan; Mahindra, Anuj K.; Farkash, Evan A.			Case 3-2014-A 61-Year-Old Woman with Gastrointestinal Symptoms, Anemia, and Acute Kidney Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; CHRONIC LYMPHOCYTIC-LEUKEMIA; MIXED CRYOGLOBULINEMIA; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; FIBRILLARY GLOMERULONEPHRITIS; IMMUNOLOGICAL FEATURES; MORPHOLOGIC SPECTRUM; VASCULITIS; LYMPHOMA; INFECTION	A 61-year-old woman was admitted to the hospital because of vomiting, diarrhea, anemia, and acute kidney injury. Physical examination was normal. Laboratory testing and a diagnostic procedure were performed. Presentation of CaseDr. Meghan E. Shea (Medicine): A 61-year-old woman was admitted to this hospital because of epigastric pain, vomiting, diarrhea, anemia, and acute kidney injury. The patient had been well until approximately 3 weeks before admission, when vomiting, diarrhea, fevers, arthralgias, and episodes of epigastric pain of increasing frequency and severity developed, which she attributed to a viral gastroenteritis. Two weeks before admission, epigastric and midabdominal pain worsened, with diarrhea and one episode of vomiting. The next day, she came to the emergency department at this hospital. She rated the pain at 4 on a scale of 0 ...	[Bazari, Hasan; Mahindra, Anuj K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Farkash, Evan A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bazari, Hasan; Mahindra, Anuj K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Farkash, Evan A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bazari, H (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; ADEY DB, 1995, J AM SOC NEPHROL, V6, P171; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Alpers CE, 2008, CURR OPIN NEPHROL HY, V17, P243, DOI 10.1097/MNH.0b013e3282f8afe2; Beddhu S, 2002, MEDICINE, V81, P398, DOI 10.1097/00005792-200209000-00005; Bridoux F, 2002, KIDNEY INT, V62, P1764, DOI 10.1046/j.1523-1755.2002.00628.x; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Bryce AH, 2006, AM J HEMATOL, V81, P511, DOI 10.1002/ajh.20643; Chen XL, 2012, WORLD J GASTROENTERO, V18, P1991, DOI 10.3748/wjg.v18.i16.1991; De Vita S, 2012, ARTHRITIS RHEUM-US, V64, P843, DOI 10.1002/art.34331; Enriquez R, 2005, J NEPHROL, V18, P318; Favre G, 2010, AM J KIDNEY DIS, V55, P391, DOI 10.1053/j.ajkd.2009.06.021; Ferri C, 2004, SEMIN ARTHRITIS RHEU, V33, P355, DOI 10.1016/j.semarthrit.2003.10.001; Ferri C, 2002, J CLIN PATHOL, V55, P4, DOI 10.1136/jcp.55.1.4; Ferri C, 2007, AUTOIMMUN REV, V7, P114, DOI 10.1016/j.autrev.2007.02.019; Goodpasture EW, 1919, AM J MED SCI, V158, P863, DOI 10.1097/00000441-191911000-00012; Guillevin L, 1999, ARTHRITIS RHEUM-US, V42, P421, DOI 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6; Herrera GA, 2010, ARCH PATHOL LAB MED, V134, P512, DOI 10.1043/1543-2165-134.4.512; JACQUOT C, 1987, CLIN NEPHROL, V27, P263; Marcucci F, 2011, BLOOD, V117, P1792, DOI 10.1182/blood-2010-06-275818; Markowitz GS, 2004, AM J KIDNEY DIS, V43, P388, DOI 10.1053/j.ajkd.2003.06.005; Matignon M, 2009, MEDICINE, V88, P341, DOI 10.1097/MD.0b013e3181c1750f; Matsui Y, 2011, INT J HEMATOL, V93, P253, DOI 10.1007/s12185-010-0749-8; MELTZER M, 1966, AM J MED, V40, P837, DOI 10.1016/0002-9343(66)90200-2; Monti G, 2005, ARCH INTERN MED, V165, P101, DOI 10.1001/archinte.165.1.101; MOULIN B, 1992, KIDNEY INT, V42, P127, DOI 10.1038/ki.1992.270; PASCUAL M, 1990, J INFECT DIS, V162, P569, DOI 10.1093/infdis/162.2.569; Piehler AP, 2008, CLIN CHEM, V54, P1823, DOI 10.1373/clinchem.2008.106153; POZZATO G, 1994, BLOOD, V84, P3047; Purhonen AK, 2011, NEPHROL DIAL TRANSPL, V26, P1101, DOI 10.1093/ndt/gfq701; Rieu V, 2002, RHEUMATOLOGY, V41, P290, DOI 10.1093/rheumatology/41.3.290; Rutgers A, 2010, RHEUM DIS CLIN N AM, V36, P559, DOI 10.1016/j.rdc.2010.05.002; Saadoun D, 2006, ARCH INTERN MED, V166, P2101, DOI 10.1001/archinte.166.19.2101; Salvarani C, 2010, RHEUMATOLOGY, V49, P1326, DOI 10.1093/rheumatology/keq093; Sethi S, 2012, NEW ENGL J MED, V366, P1119, DOI 10.1056/NEJMra1108178; Sethi S, 2010, CLIN J AM SOC NEPHRO, V5, P770, DOI 10.2215/CJN.06760909; Sheikh SS, 2002, AM J HEMATOL, V71, P306, DOI 10.1002/ajh.10222; Terrier B, 2012, BLOOD, V119, P5996, DOI 10.1182/blood-2011-12-396028; Trejo O, 2001, MEDICINE, V80, P252, DOI 10.1097/00005792-200107000-00004; Tumlin JA, 2007, CLIN J AM SOC NEPHRO, V2, P1054, DOI 10.2215/CJN.04351206; Williams S, 2003, MOL CANCER THER, V2, P835; WOODROFFE AJ, 1977, KIDNEY INT, V12, P268, DOI 10.1038/ki.1977.111	42	6	6	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					362	373		10.1056/NEJMcpc1214220	http://dx.doi.org/10.1056/NEJMcpc1214220			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450895				2022-12-28	WOS:000330036200012
J	Kuppers, M; O'Rourke, L; Bockelee-Morvan, D; Zakharov, V; Lee, S; von Allmen, P; Carry, B; Teyssier, D; Marston, A; Muller, T; Crovisier, J; Barucci, MA; Moreno, R				Kueppers, Michael; O'Rourke, Laurence; Bockelee-Morvan, Dominique; Zakharov, Vladimir; Lee, Seungwon; von Allmen, Paul; Carry, Benoit; Teyssier, David; Marston, Anthony; Mueller, Thomas; Crovisier, Jacques; Barucci, M. Antonietta; Moreno, Raphael			Localized sources of water vapour on the dwarf planet (1) Ceres	NATURE			English	Article							DAWN MISSION; SURFACE; ICE; ORGANICS	The 'snowline' conventionally divides Solar System objects into dry bodies, ranging out to the main asteroid belt, and icy bodies beyond the belt. Models suggest that some of the icy bodies may have migrated into the asteroid belt(1). Recent observations indicate the presence of water ice on the surface of some asteroids(2-4), with sublimation(5) a potential reason for the dust activity observed on others. Hydrated minerals have been found(6-8) on the surface of the largest object in the asteroid belt, the dwarf planet (1) Ceres, which is thought to be differentiated into a silicate core with an icy mantle(9-11). The presence of water vapour around Ceres was suggested by a marginal detection of the photodissociation product of water, hydroxyl (ref. 12), but could not be confirmed by later, more sensitive observations(13). Here we report the detection of water vapour around Ceres, with at least 10(26) molecules being produced per second, originating from localized sources that seem to be linked to mid-latitude regions on the surface(14,15). The water evaporation could be due to comet-like sublimation or to cryo-volcanism, in which volcanoes erupt volatiles such as water instead of molten rocks.	[Kueppers, Michael; O'Rourke, Laurence; Carry, Benoit; Teyssier, David; Marston, Anthony] European Space Agcy, European Space Astron Ctr, Villanueva De La Canada 28691, Spain; [Bockelee-Morvan, Dominique; Zakharov, Vladimir; Crovisier, Jacques; Barucci, M. Antonietta; Moreno, Raphael] Univ Paris Diderot, Univ Paris 06, Observ Paris, CNRS,Lab Etud Spatiales & Instrumentat Astrophys, F-92195 Meudon, France; [Lee, Seungwon; von Allmen, Paul] Jet Prop Lab, La Canada Flintridge, CA 91011 USA; [Carry, Benoit] CNRS, Observ Paris, Inst Mecan Celeste & Calcul Ephemerides, Unite Mixte Rech UMR 8028, F-75014 Paris, France; [Mueller, Thomas] Max Planck Inst Extraterr Phys MPE, D-85748 Garching, Germany	European Space Agency; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Max Planck Society	Kuppers, M (corresponding author), European Space Agcy, European Space Astron Ctr, POB 78, Villanueva De La Canada 28691, Spain.	michael.kueppers@sciops.esa.int		Carry, Benoit/0000-0001-5242-3089; Marston, Anthony/0000-0001-5788-5258	CEA (France); CNES (France); CNRS (France); ASI (Italy); DLR (Germany); ESA; faculty of the European Space Astronomy Centre (ESAC)	CEA (France)(French Atomic Energy Commission); CNES (France)(Centre National D'etudes Spatiales); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ASI (Italy)(Agenzia Spaziale Italiana (ASI)); DLR (Germany)(Helmholtz AssociationGerman Aerospace Centre (DLR)); ESA(European Space Agency); faculty of the European Space Astronomy Centre (ESAC)	Herschel is an ESA space observatory with science instruments provided by European-led principal investigator consortia and with important participation by NASA. The HIFI was designed and built by a consortium of institutes and university departments from across Europe, Canada and the United States under the leadership of SRON, the Netherlands Institute for Space Research, and with major contributions from Germany, France and the USA. This development was supported by national funding agencies: CEA, CNES, CNRS (France); ASI (Italy); and DLR (Germany). Additional funding support for some instrument activities was provided by the ESA. We thank the team at the Herschel Science Centre for their flexibility in scheduling the observations. We thank the Herschel Project Scientist and the Time Allocation Committee for the allocation of Director Discretionary Time. B.C. acknowledges support from the faculty of the European Space Astronomy Centre (ESAC). We thank A. Pollock for proofreading the final text.	AHEARN MF, 1992, ICARUS, V98, P54, DOI 10.1016/0019-1035(92)90206-M; Biver N, 2002, EARTH MOON PLANETS, V90, P5, DOI 10.1023/A:1021599915018; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Carry B, 2008, ASTRON ASTROPHYS, V478, P235, DOI 10.1051/0004-6361:20078166; Carry B, 2012, PLANET SPACE SCI, V73, P98, DOI 10.1016/j.pss.2012.03.009; Carry B, 2012, ICARUS, V217, P20, DOI 10.1016/j.icarus.2011.10.015; Castillo-Rogez JC, 2010, ICARUS, V205, P443, DOI 10.1016/j.icarus.2009.04.008; Crifo JF, 2002, ICARUS, V156, P249, DOI 10.1006/icar.2001.6769; De Graauw T, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014698; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; Gounelle M., 2008, SOLAR SYSTEM NEPTUNE, P525; Howett CJA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003718; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; KING TVV, 1992, SCIENCE, V255, P1551, DOI 10.1126/science.255.5051.1551; LEBOFSKY LA, 1981, ICARUS, V48, P453, DOI 10.1016/0019-1035(81)90055-5; Li JY, 2006, ICARUS, V182, P143, DOI 10.1016/j.icarus.2005.12.012; Licandro J, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015339; McCord TB, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002244; McCord TB, 2011, SPACE SCI REV, V163, P63, DOI 10.1007/s11214-010-9729-9; Milliken RE, 2009, NAT GEOSCI, V2, P258, DOI 10.1038/NGEO478; PEALE SJ, 1979, SCIENCE, V203, P892, DOI 10.1126/science.203.4383.892; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Rousselot P, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/125; Russell CT, 2011, SPACE SCI REV, V163, P3, DOI 10.1007/s11214-011-9836-2; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938; Zakharov V, 2007, ASTRON ASTROPHYS, V473, P303, DOI 10.1051/0004-6361:20066715	28	195	196	5	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					525	+		10.1038/nature12918	http://dx.doi.org/10.1038/nature12918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24451541				2022-12-28	WOS:000329995000034
J	Lerner, BH				Lerner, Barron H.			Searching for Semmelweis	LANCET			English	Editorial Material									[Lerner, Barron H.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Lerner, Barron H.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA	New York University; New York University	Lerner, BH (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	Barron.Lerner@nyumc.org						Carter K. Codell, 1994, CHILDBED FEVER SCI B; Lerner A., 2014, COST DOWNTIME; LOWENTHAL D., 1986, IS FOREIGN COUNTRY; Morton Thompson, 1949, CRY COVENANT; Nuland S B, 2004, DOCTORS PLAGUE GERMS	5	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					210	211		10.1016/S0140-6736(14)60062-3	http://dx.doi.org/10.1016/S0140-6736(14)60062-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24449943	Bronze			2022-12-28	WOS:000330027500015
J	Asahina, K; Watanabe, K; Duistermars, BJ; Hoopfer, E; Gonzalez, CR; Eyjolfsdottir, EA; Perona, P; Anderson, DJ				Asahina, Kenta; Watanabe, Kiichi; Duistermars, Brian J.; Hoopfer, Eric; Gonzalez, Carlos Roberto; Eyjolfsdottir, Eyrun Arna; Perona, Pietro; Anderson, David J.			Tachykinin-Expressing Neurons Control Male-Specific Aggressive Arousal in Drosophila	CELL			English	Article							MALE COURTSHIP BEHAVIOR; OLFACTORY NEURONS; NEURAL CIRCUITRY; RECEPTOR NEURONS; SOCIAL-BEHAVIOR; MELANOGASTER; PHEROMONE; FRUITLESS; MODEL; IDENTIFICATION	Males of most species are more aggressive than females, but the neural mechanisms underlying this dimorphism are not clear. Here, we identify a neuron and a gene that control the higher level of aggression characteristic of Drosophila melanogaster males. Males, but not females, contain a small cluster of FruM(+) neurons that express the neuropeptide tachykinin (Tk). Activation and silencing of these neurons increased and decreased, respectively, intermale aggression without affecting male-female courtship behavior. Mutations in both Tk and a candidate receptor, Takr86C, suppressed the effect of neuronal activation, whereas overexpression of Tk potentiated it. Tk neuron activation overcame reduced aggressiveness caused by eliminating a variety of sensory or contextual cues, suggesting that it promotes aggressive arousal or motivation. Tachykinin/Substance P has been implicated in aggression in mammals, including humans. Thus, the higher aggressiveness of Drosophila males reflects the sexually dimorphic expression of a neuropeptide that controls agonistic behaviors across phylogeny.	[Asahina, Kenta; Watanabe, Kiichi; Duistermars, Brian J.; Hoopfer, Eric; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Asahina, Kenta; Watanabe, Kiichi; Duistermars, Brian J.; Hoopfer, Eric; Anderson, David J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Gonzalez, Carlos Roberto; Eyjolfsdottir, Eyrun Arna; Perona, Pietro] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Hoopfer, Eric] HHMI, Ashburn, VA 20147 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Watanabe, Kiichi/ABA-4854-2020		NRSA postdoctoral fellowship; NIH grant [R01-DA031389]; Moore Foundation grant; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031389] Funding Source: NIH RePORTER	NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moore Foundation grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. J. Dickson, B. Pfeiffer, G. M. Rubin, and D. Nassel for sharing fly strains and antibodies; S. Jeeda and C. Khanbijian for maintenance of fly stocks; G. Mancuso for administrative support; C. Chiu for laboratory management; and B. Pfeiffer, A. M. Wong, and W. Hong for helpful comments on the manuscript. K. A. was a JSPS Postdoctoral Fellow for Research Abroad. K. W. was a Human Frontier Science Program Postdoctoral Fellow. B. J. D. is an Ellison Medical Foundation Fellow of the Life Science Research Foundation. E. H. is supported by an NRSA postdoctoral fellowship. This research was supported in part by NIH grant R01-DA031389 to D. J. A. and a Moore Foundation grant to D. J. A. and P. P. D. J. A. is a Howard Hughes Medical Institute investigator.	Alekseyenko OV, 2013, P NATL ACAD SCI USA, V110, P6151, DOI 10.1073/pnas.1303446110; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Baier A, 2002, J EXP BIOL, V205, P1233; BENTLEY D, 1978, ANNU REV NEUROSCI, V1, P35, DOI 10.1146/annurev.ne.01.030178.000343; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Birse RT, 2006, J NEUROBIOL, V66, P33, DOI 10.1002/neu.20189; Briffa M, 2007, FUNCT ECOL, V21, P627, DOI 10.1111/j.1365-2435.2006.01188.x; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Certel SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013248; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Coccaro EF, 2012, BIOL PSYCHIAT, V72, P238, DOI 10.1016/j.biopsych.2012.02.023; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Halasz J, 2008, BIOL PSYCHIAT, V63, P271, DOI 10.1016/j.biopsych.2007.04.022; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; HOFFMANN AA, 1987, ANIM BEHAV, V35, P1899, DOI 10.1016/S0003-3472(87)80085-4; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Katsouni E, 2009, PEPTIDES, V30, P1586, DOI 10.1016/j.peptides.2009.05.001; Keller M, 2006, BIOL PSYCHIAT, V59, P216, DOI 10.1016/j.biopsych.2005.07.013; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee G, 2000, BEHAV GENET, V30, P263, DOI 10.1023/A:1026541215546; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Lorenz K., 1966, AGGRESSION; Lu BK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002587; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Pan YF, 2012, P NATL ACAD SCI USA, V109, P10065, DOI 10.1073/pnas.1207107109; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Poels J, 2009, PEPTIDES, V30, P545, DOI 10.1016/j.peptides.2008.10.012; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Siegel A, 1997, NEUROSCI BIOBEHAV R, V21, P733, DOI 10.1016/S0149-7634(96)00056-5; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; Steckler T., 2009, CURRENT TOPICS BEHAV, P415; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Tinbergen N, 1951, STUDY INSTINCT; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Winther AME, 2003, J COMP NEUROL, V464, P180, DOI 10.1002/cne.10790; Winther AME, 2001, J EXP BIOL, V204, P1269; Woolf CJ, 1998, NEURON, V20, P1063, DOI 10.1016/S0896-6273(00)80487-0; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zabala F, 2012, CURR BIOL, V22, P1344, DOI 10.1016/j.cub.2012.05.024; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zwarts L, 2012, FLY, V6, P35, DOI 10.4161/fly.19249	75	180	180	2	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					221	235		10.1016/j.cell.2013.11.045	http://dx.doi.org/10.1016/j.cell.2013.11.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439378	Bronze, Green Accepted			2022-12-28	WOS:000329912200023
J	Fields, RD				Fields, R. Douglas			Myelin Formation and Remodeling	CELL			English	Editorial Material							CNS	Myelin is a multilayer wrapping of insulation formed by glial cells around axons that is essential for rapid impulse transmission, but how glial cells accomplish this cellular choreography has long intrigued researchers. In this issue of Cell, Snaidero et al., provide new insights into how myelin forms and is remodeled.	NICHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), NICHD, NIH, Bldg 35,Room 2A211, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD000713-13] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baron W, 1999, J NEUROBIOL, V41, P385, DOI 10.1002/(SICI)1097-4695(19991115)41:3<385::AID-NEU7>3.0.CO;2-E; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Luse S. A., 1959, BIOLOGY MYELIN, P59; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; Sobottka B, 2011, GLIA, V59, P1841, DOI 10.1002/glia.21228; Velumian AA, 2011, NEUROIMAGE, V56, P27, DOI 10.1016/j.neuroimage.2010.11.022; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	10	17	18	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					15	17		10.1016/j.cell.2013.12.038	http://dx.doi.org/10.1016/j.cell.2013.12.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439366	Green Accepted, Bronze			2022-12-28	WOS:000329912200007
J	Makela, KT; Matilainen, M; Pulkkinen, P; Fenstad, AM; Havelin, L; Engesaeter, L; Furnes, O; Pedersen, AB; Overgaard, S; Karrholm, J; Malchau, H; Garellick, G; Ranstam, J; Eskelinen, A				Makela, Keijo T.; Matilainen, Markus; Pulkkinen, Pekka; Fenstad, Anne M.; Havelin, Leif; Engesaeter, Lars; Furnes, Ove; Pedersen, Alma B.; Overgaard, Soren; Karrholm, Johan; Malchau, Henrik; Garellick, Goran; Ranstam, Jonas; Eskelinen, Antti			Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NORWEGIAN ARTHROPLASTY REGISTER; FOLLOW-UP; OSTEOARTHRITIS; ASSOCIATION; REVISIONS	Objective To assess the failure rate of cemented, uncemented, hybrid, and reverse hybrid total hip replacements in patients aged 55 years or older. Design Register study. Setting Nordic Arthroplasty Register Association database (combined data from Sweden, Norway, Denmark, and Finland). Participants 347 899 total hip replacements performed during 1995-2011. Main outcome measures Probability of implant survival (Kaplan-Meier analysis) along with implant survival with revision for any reason as endpoint (Cox multiple regression) adjusted for age, sex, and diagnosis in age groups 55-64, 65-74, and 75 years or older. Results The proportion of total hip replacements using uncemented implants increased rapidly towards the end of the study period. The 10 year survival of cemented implants in patients aged 65 to 74 and 75 or older (93.8%, 95% confidence interval 93.6% to 94.0% and 95.9%, 95.8% to 96.1%, respectively) was higher than that of uncemented (92.9%, 92.3% to 93.4% and 93.0%, 91.8% to 94.0%), hybrid (91.6%, 90.9% to 92.2% and 93.9%, 93.1% to 94.5%), and reverse hybrid (90.7%, 87.3% to 93.2% and 93.2%, 90.7% to 95.1%) implants. The survival of cemented (92.2%, 91.8% to 92.5%) and uncemented (91.8%, 91.3% to 92.2%) implants in patients aged 55 to 64 was similar. During the first six months the risk of revision with cemented implants was lower than with all other types of fixation in all age groups. Conclusion The survival of cemented implants for total hip replacement was higher than that of uncemented implants in patients aged 65 years or older. The increased use of uncemented implants in this age group is not supported by these data. However, because our dataset includes only basic information common to all national registers there is potential for residual confounding.	[Makela, Keijo T.] Turku Univ Hosp, Dept Orthopaed & Traumatol, FI-20100 Turku, Finland; [Matilainen, Markus] Turku Univ, Dept Biostat, Turku, Finland; [Pulkkinen, Pekka] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Fenstad, Anne M.; Havelin, Leif; Engesaeter, Lars; Furnes, Ove] Haukeland Hosp, Dept Orthopaed Surg, N-5021 Bergen, Norway; [Havelin, Leif; Engesaeter, Lars; Furnes, Ove] Univ Bergen, Dept Clin Med, Bergen, Norway; [Pedersen, Alma B.] Aarhus Univ Hosp, Competence Ctr Clin Epidemiol & Biostat, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Overgaard, Soren] Odense Univ Hosp, Traumatol & Clin Inst, Dept Orthopaed Surg, DK-5000 Odense, Denmark; [Overgaard, Soren] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Karrholm, Johan; Malchau, Henrik; Garellick, Goran] Univ Gothenburg, Dept Orthopaed, Inst Surg Sci, Sahlgrenska Univ Hosp, Molndal, Sweden; [Malchau, Henrik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Orthopaed, Boston, MA USA; [Ranstam, Jonas] Skane Univ Hosp, Swedish Natl Competence Ctr Musculoskeletal Disor, Lund, Sweden; [Eskelinen, Antti] Coxa Hosp Joint Replacement, Tampere, Finland	University of Turku; University of Turku; University of Helsinki; University of Bergen; Haukeland University Hospital; University of Bergen; Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University; Sahlgrenska University Hospital; University of Gothenburg; Harvard University; Harvard Medical School; Massachusetts General Hospital; Lund University; Skane University Hospital; Coxa Hospital for Joint Replacement	Makela, KT (corresponding author), Turku Univ Hosp, Dept Orthopaed & Traumatol, Rauhankatu 24 D 32, FI-20100 Turku, Finland.	keijo.makela@fimnet.fi	Ranstam, Jonas/A-4386-2009; Eskelinen, Antti/E-6433-2015; Overgaard, Søren/AAX-9407-2020; Eskelinen, Antti/AAW-9223-2021; Eskelinen, Antti/AAW-9209-2021; Matilainen, Markus/AAH-1899-2021	Ranstam, Jonas/0000-0002-8287-7273; Eskelinen, Antti/0000-0003-0302-0253; Eskelinen, Antti/0000-0003-0302-0253; Matilainen, Markus/0000-0002-5597-2670; pedersen, alma b/0000-0002-3288-9401; Makela, Keijo/0000-0002-4115-1767; Overgaard, Soren/0000-0001-6829-4787	Turku University Hospital; Orion-Farmos Research Foundation	Turku University Hospital; Orion-Farmos Research Foundation	This study was funded by a research grant from Turku University Hospital and a grant from the Orion-Farmos Research Foundation. These are non-profit organisations and with no role in the study. The researchers are totally independent of the funders.	Arthursson AJ, 2005, ACTA ORTHOP, V76, P823, DOI 10.1080/17453670510045435; Australian Orthopaedic Association, AUSTR ORTH ASS ANN R; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Berry DJ, 2002, J BONE JOINT SURG AM, V84A, P171, DOI 10.2106/00004623-200202000-00002; Canadian Joint Replacement Registry, HIP KNEE REPL CAN 20; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Corbett KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013520; Dale H, 2012, ACTA ORTHOP, V83, P449, DOI 10.3109/17453674.2012.733918; Danish Hip Arthroplasty Register (DHAR), 2011, DAN HIP ARTHR REG DH; Della Valle CJ, 2009, J BONE JOINT SURG AM, V91A, P1130, DOI 10.2106/JBJS.H.00168; Espehaug B, 2006, ACTA ORTHOP, V77, P49, DOI 10.1080/17453670610045696; Hallan G, 2010, J BONE JOINT SURG BR, V92B, P196, DOI 10.1302/0301-620X.92B2.22179; Hamilton DF, 2013, SURG-J R COLL SURG E, V11, P117, DOI 10.1016/j.surge.2012.08.002; Havelin LI, 2009, ACTA ORTHOP, V80, P393, DOI 10.3109/17453670903039544; Havelin LI, 2000, ACTA ORTHOP SCAND, V71, P337, DOI 10.1080/000164700317393321; Huo MH, 2011, J BONE JOINT SURG AM, V93A, P1944, DOI 10.2106/JBJS.K.00656; Lie SA, 2004, STAT MED, V23, P3227, DOI 10.1002/sim.1905; Lucht U, 2000, ACTA ORTHOP SCAND, V71, P433, DOI 10.1080/000164700317381081; Makela K, 2008, J BONE JOINT SURG BR, V90B, P1562, DOI 10.1302/0301-620X.90B12.21151; Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; National Joint Registry for England and Wales (NJR England-Wales), 2011, 9 NAT JOINT REG ENGL; Norwegian Arthroplasty Register (NAR), NORW ARTHR REG NAR A; PAAVOLAINEN P, 1991, ACTA ORTHOP SCAND, V62, P27, DOI 10.3109/17453679109155101; Peltola M., 2013, COMMUNICATION; Ranstam J, 2011, ACTA ORTHOP, V82, P258, DOI 10.3109/17453674.2011.588863; Swedish Hip Arthroplasty Register (SHAR), SWED HIP ARTHR REG S; The New Zealand Joint Registry, 13 YEAR REP JAN 1999; Thien T, 2014, J BONE JOIN IN PRESS; Troelsen A, 2013, CLIN ORTHOP RELAT R, V471, P2052, DOI [10.1007/s11999-013-2941-7, 10.1007/s11999-013-3017-4]	30	122	125	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2014	348								f7592	10.1136/bmj.f7592	http://dx.doi.org/10.1136/bmj.f7592			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MK	24418635	Green Published, hybrid			2022-12-28	WOS:000329975600002
J	Watts, G				Watts, Geoff			Anne Lonsdale: champion of academic refuge	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					118	118		10.1016/S0140-6736(14)60011-8	http://dx.doi.org/10.1016/S0140-6736(14)60011-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	287YX	24411958				2022-12-28	WOS:000329579600014
J	Nadarajah, L; Khosravi, M; Dumitriu, S; Klootwijk, E; Kleta, R; Yaqoob, MM; Walsh, SB				Nadarajah, Luxme; Khosravi, Maryam; Dumitriu, Simona; Klootwijk, Enriko; Kleta, Robert; Yaqoob, Muhammad M.; Walsh, Stephen B.			A novel claudin-16 mutation, severe bone disease, and nephrocalcinosis	LANCET			English	Editorial Material									[Nadarajah, Luxme; Yaqoob, Muhammad M.] Royal London Hosp, Renal Unit, Barts Hlth, London E1 1BB, England; [Khosravi, Maryam; Dumitriu, Simona; Klootwijk, Enriko; Kleta, Robert; Walsh, Stephen B.] UCL, UCL Ctr Nephrol, London, England	Barts Health NHS Trust; Royal London Hospital; University of London; University College London	Walsh, SB (corresponding author), Royal Free Hosp, UCL Ctr Nephrol, Pond Lane, Hampstead NW3 1QG, England.	stephen.walsh@ucl.ac.uk	Walsh, Stephen Benedict/AAB-9930-2020	Walsh, Stephen/0000-0002-8693-1353	National Institute for Health Research [ACF-2012-18-015] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Hoorn EJ, 2013, PEDIATR NEPHROL, V28, P1195, DOI 10.1007/s00467-012-2350-2; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; RODRIGUEZSORIANO J, 1994, PEDIATR NEPHROL, V8, P431, DOI 10.1007/BF00856522; WRONG O, 1959, Q J MED, V28, P259; Wrong OM, 2005, OXFORD TEXTBOOK OF C	5	9	9	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					98	98		10.1016/S0140-6736(13)62673-2	http://dx.doi.org/10.1016/S0140-6736(13)62673-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24388313				2022-12-28	WOS:000329341200040
J	Price, CE; Keene, D; Hackett, D				Price, Clare E.; Keene, Daniel; Hackett, David			An intracardiac mass causing shortness of breath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY CARDIAC TUMORS; OF-THE-LITERATURE; TERM-FOLLOW-UP; MYXOMA; METASTASIS		[Price, Clare E.; Keene, Daniel; Hackett, David] Watford Dist Gen Hosp, Watford WD18 OHB, England	Watford General Hospital	Price, CE (corresponding author), Watford Dist Gen Hosp, Watford WD18 OHB, England.	clareprice@gmail.com		Keene, Daniel/0000-0001-7472-7358				Altundag MB, 2005, J NEURO-ONCOL, V75, P181, DOI 10.1007/s11060-005-1859-7; BATEMAN TM, 1983, J THORAC CARDIOV SUR, V86, P601; Braun S, 2005, INT J CARDIOL, V101, P115, DOI 10.1016/j.ijcard.2004.08.047; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Buckley O, 2011, AM J ROENTGENOL, V197, pW837, DOI 10.2214/AJR.10.7260; Burnside N, 2012, INTERACT CARDIOV TH, V15, P1004, DOI 10.1093/icvts/ivs350; Edwards A, 2002, CARDIOVASC SURG, V10, P264, DOI 10.1016/S0967-2109(01)00144-2; Ekinci EI, 2004, INTERN MED J, V34, P243, DOI 10.1111/j.1444-0903.2004.00563.x; ElBardissi AW, 2008, CIRCULATION, V118, pS7, DOI 10.1161/CIRCULATIONAHA.107.783126; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK, V4th ed; Kuroczynski W, 2009, CARDIOL J, V16, P447; Owais TA, 2011, INTERACT CARDIOV TH, V12, P875, DOI 10.1510/icvts.2010.248492; Pucci A, 2000, AM HEART J, V140, P134, DOI 10.1067/mhj.2000.107176; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; Rodrigues D, 2006, BRIT J NEUROSURG, V20, P318, DOI 10.1080/02688690601000394; Selkane C, 2003, ANN THORAC SURG, V76, P1935, DOI 10.1016/S0003-4975(03)01245-1; Vassiliadis N, 1997, MED SCI LAW, V37, P76, DOI 10.1177/002580249703700116	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2014	348								f7594	10.1136/bmj.f7594	http://dx.doi.org/10.1136/bmj.f7594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285QD	24384520				2022-12-28	WOS:000329407800001
J	Greenwald, N; Ando, AW; Butchart, SHM; Tschirhart, J				Greenwald, Noah; Ando, Amy W.; Butchart, Stuart H. M.; Tschirhart, John			The Endangered Species Act at 40	NATURE			English	Editorial Material													Butchart, Stuart HM/Y-2711-2018; Butchart, Stuart/AAJ-1852-2021	Butchart, Stuart/0000-0002-1140-4049; Ando, Amy/0000-0002-3279-8075				Finnoff D, 2008, RESOUR ENERGY ECON, V30, P91, DOI 10.1016/j.reseneeco.2007.08.005; Scott J. M., 2006, ENDANGERED SPECIES A, V1; Suckling K., 2006, MEASURING SUCCESS EN	3	3	3	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					369	370		10.1038/504369a	http://dx.doi.org/10.1038/504369a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24358508	Bronze			2022-12-28	WOS:000328575300029
J	Pietersen, E; Ignatius, E; Streicher, EM; Mastrapa, B; Padanilam, X; Pooran, A; Badri, M; Lesosky, M; van Helden, P; Sirgel, FA; Warren, R; Dheda, K				Pietersen, Elize; Ignatius, Elisa; Streicher, Elizabeth M.; Mastrapa, Barbara; Padanilam, Xavier; Pooran, Anil; Badri, Motasim; Lesosky, Maia; van Helden, Paul; Sirgel, Frederick A.; Warren, Robin; Dheda, Keertan			Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study	LANCET			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EMERGENCE; HIV; EPIDEMIOLOGY; CLOFAZIMINE; MUTATIONS; TMC207	Background Long-term treatment-related outcomes in patients with extensively drug-resistant (XDR) tuberculosis are unknown. We followed up a cohort of patients to address knowledge gaps. Methods Between March, 2008, and August, 2012, we prospectively followed up a cohort of 107 patients from three provinces in South Africa, who had been diagnosed with XDR tuberculosis between August 2002, and February, 2008. Available isolates from 56 patients were genotyped to establish strain type and used for extended susceptibility testing. Findings All patients were treated empirically as inpatients with a median of eight drugs (IQR six to ten). 44 patients (41%) had HIV. 36 (64%) of 56 isolates were resistant to at least eight drugs, and resistance to an increasing number of drugs was associated with the Beijing genotype (p=0.01). After 24 months of follow-up, 17 patients (16%) had a favourable outcome (ie, treatment cure or completion), 49 (46%) had died, seven (7%) had defaulted (interruption of treatment for at least 2 consecutive months), and 25 (23%) had failed treatment. At 60 months, 12 patients (11%) had a favourable outcome, 78 (73%) had died, four (4%) had defaulted, and 11 (10%) had failed treatment. 45 patients were discharged from hospital, of whom 26 (58%) had achieved sputum culture conversion and 19 (42%) had failed treatment. Median survival of patients who had failed treatment from time of discharge was 19.84 months (IQR 4.16-26.04). Clustering of cases and transmission within families containing a patient who had failed treatment and been discharged were shown with genotypic methods. Net sputum culture conversion occurred in 22 patients (21%) and median time to net culture conversion was 8.7 months (IQR 5.6-26.4). Independent predictors of probability of net culture conversion were no history of multidrug-resistant tuberculosis (p=0.0007) and use of clofazamine (p=0.0069). Independent overall predictors of survival were net culture conversion (p<0.0001) and treatment with clofazamine (p=0.021). Antiretroviral therapy was also a predictor of survival in patients with HIV (p=0.003). Interpretation In South Africa, long-term outcomes in patients with XDR tuberculosis are poor, irrespective of HIV status. Because appropriate long-stay or palliative care facilities are scarce, substantial numbers of patients with XDR tuberculosis who have failed treatment and have positive sputum cultures are being discharged from hospital and are likely to transmit disease into the wider community. Testing of new combined regimens is needed urgently and policy makers should implement interventions to minimise disease spread by patients who fail treatment.	[Pietersen, Elize; Pooran, Anil; Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Pietersen, Elize; Pooran, Anil; Dheda, Keertan] Univ Cape Town, Dept Med, Lung Inst, ZA-7925 Cape Town, South Africa; [Ignatius, Elisa] Emory Univ, Sch Med, Dept Internal Med, Atlanta, GA USA; [Streicher, Elizabeth M.; van Helden, Paul; Sirgel, Frederick A.; Warren, Robin] Univ Stellenbosch, Dept Sci & Technol, ZA-7505 Tygerberg, South Africa; [Streicher, Elizabeth M.; van Helden, Paul; Sirgel, Frederick A.; Warren, Robin] Univ Stellenbosch, Natl Res Fdn, Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa; [Streicher, Elizabeth M.; van Helden, Paul; Sirgel, Frederick A.; Warren, Robin] Univ Stellenbosch, MRC, Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Mastrapa, Barbara] Gordonia Prov Hosp, Upington, South Africa; [Padanilam, Xavier] Sizwe Trop Dis Hosp, Johannesburg, South Africa; [Badri, Motasim; Lesosky, Maia] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Badri, Motasim] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Sci & Hlth Profess, Riyadh, Saudi Arabia	University of Cape Town; University of Cape Town; Emory University; Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; University of Cape Town; King Saud Bin Abdulaziz University for Health Sciences	Dheda, K (corresponding author), Groote Schuur Hosp, Div Pulmonol, Dept Med, H47 Old Main Bldg, ZA-7925 Observatory, South Africa.	keertan.dheda@uct.ac.za	Lesosky, Maia/AAM-4174-2020; Ignatius, Elisa/AFU-2351-2022; Ignatius, Elisa/AAW-4025-2020; Streicher, Elizabeth M/I-7780-2018; Streicher, Elizabeth/O-9597-2019; Badri, Motasim/E-1141-2013	Lesosky, Maia/0000-0002-2026-958X; Ignatius, Elisa/0000-0002-4760-0172; Ignatius, Elisa/0000-0002-4760-0172; Streicher, Elizabeth M/0000-0003-3901-1981; Streicher, Elizabeth/0000-0003-3901-1981; Warren, Robin/0000-0001-5741-7358; Badri, Motasim/0000-0002-5268-6492	European and Developing Countries Clinical Trials Partnership; South African National Research Foundation (SARChI); South African Medical Research Council	European and Developing Countries Clinical Trials Partnership; South African National Research Foundation (SARChI)(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding European and Developing Countries Clinical Trials Partnership, South African National Research Foundation (SARChI), and the South African Medical Research Council.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253; Chaisson RE, 1997, AIDS, V11, P311, DOI 10.1097/00002030-199703110-00008; Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Gopal M, 2013, INT J TUBERC LUNG D, V17, P1001, DOI 10.5588/ijtld.12.0144; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Migliori GB, 2007, EUROSURVEILLANCE, V12, P5, DOI DOI 10.2807/ESW.12.20.03194-EN; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; National Health Laboratory Service, 2011, UPD CORP DAT WAR DER; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; O'Donnell MR, 2013, EMERG INFECT DIS, V19, P416, DOI 10.3201/eid1903.120998; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Sharma M, 2011, J CLIN MICROBIOL, V49, P4112, DOI 10.1128/JCM.05195-11; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Sirgel FA, 2012, J ANTIMICROB CHEMOTH, V67, P1088, DOI 10.1093/jac/dks033; Sirgel FA, 2012, MICROB DRUG RESIST, V18, P193, DOI 10.1089/mdr.2011.0063; South African Department of Health, 2011, MAN DRUG RES TUB POL; Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Warren R, 2006, J CLIN MICROBIOL, V44, P254, DOI 10.1128/JCM.44.1.254-256.2006; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2006, WHO GLOB TASK FORC O; WHO, 2008, ANT DRUG RES WORLD W; World Health organization, 2008, POL GUID DRUG SUSC T; World Health Organization, 2011, WHO PROGRESS REPORT	36	176	179	0	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1230	1239		10.1016/S0140-6736(13)62675-6	http://dx.doi.org/10.1016/S0140-6736(13)62675-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LO	24439237				2022-12-28	WOS:000334104600027
J	Larsen, IJ; Almond, PC; Eger, A; Stone, JO; Montgomery, DR; Malcolm, B				Larsen, Isaac J.; Almond, Peter C.; Eger, Andre; Stone, John O.; Montgomery, David R.; Malcolm, Brendon			Rapid Soil Production and Weathering in the Southern Alps, New Zealand	SCIENCE			English	Article							PHYSICAL EROSION; CO2 CONSUMPTION; RATES; CLIMATE; LIMITS	Evaluating conflicting theories about the influence of mountains on carbon dioxide cycling and climate requires understanding weathering fluxes from tectonically uplifting landscapes. The lack of soil production and weathering rate measurements in Earth's most rapidly uplifting mountains has made it difficult to determine whether weathering rates increase or decline in response to rapid erosion. Beryllium-10 concentrations in soils from the western Southern Alps, New Zealand, demonstrate that soil is produced from bedrock more rapidly than previously recognized, at rates up to 2.5 millimeters per year. Weathering intensity data further indicate that soil chemical denudation rates increase proportionally with erosion rates. These high weathering rates support the view that mountains play a key role in global-scale chemical weathering and thus have potentially important implications for the global carbon cycle.	[Larsen, Isaac J.; Stone, John O.; Montgomery, David R.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Larsen, Isaac J.; Stone, John O.; Montgomery, David R.] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Almond, Peter C.; Eger, Andre; Malcolm, Brendon] Lincoln Univ, Dept Soil & Phys Sci, Christchurch 7647, New Zealand	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Lincoln University - New Zealand	Larsen, IJ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	larseni@caltech.edu		Eger, Andre/0000-0001-8442-6815	NSF East Asia and Pacific Summer Institutes program [OISE-1015454]; Royal Society of New Zealand; NASA Earth and Space Science fellowship program; Geological Society of America; University of Washington Department of Earth and Space Sciences	NSF East Asia and Pacific Summer Institutes program; Royal Society of New Zealand(Royal Society of New Zealand); NASA Earth and Space Science fellowship program(National Aeronautics & Space Administration (NASA)); Geological Society of America; University of Washington Department of Earth and Space Sciences(University of Washington)	We thank the NSF East Asia and Pacific Summer Institutes program (OISE-1015454 to I.J.L.), Royal Society of New Zealand, NASA Earth and Space Science fellowship program, Geological Society of America, and University of Washington Department of Earth and Space Sciences for support; A. Heimsath, J. Roering, F. von Blanckenburg, and N. Hovius for stimulating conversations; H. Greenberg for geographic information system support; K. Larsen for assistance collecting sediment samples; R. Sletten for assistance importing samples; A. Heimsath and A. J. West for thorough reviews; and the New Zealand Department of Conservation for granting access to study sites. Data are available in the supplementary materials. I.J.L. and P. C. A. designed and planned the field component of the study; I.J.L., A. E., and B. M. conducted the field sampling; A. E. described soils; and I.J.L. and J.O.S. separated <SUP>10</SUP>Be. I.J.L. wrote the manuscript, with input from all coauthors.	Basher L. R., 1988, Z GEOMORPHOL, V69, P117; Beavan J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044165; Braun J, 2010, EARTH PLANET SC LETT, V300, P197, DOI 10.1016/j.epsl.2010.08.018; Chamberlin T.C., 1899, J GEOL, V7, P545, DOI [10.1086/, 10.1086/608449, DOI 10.1086/608449]; Clarke BA, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF001987; DiBiase RA, 2012, EARTH SURF PROC LAND, V37, P855, DOI 10.1002/esp.3205; Dixon JL, 2012, CR GEOSCI, V344, P597, DOI 10.1016/j.crte.2012.10.012; Dixon JL, 2012, EARTH PLANET SC LETT, V323, P40, DOI 10.1016/j.epsl.2012.01.010; Eger A, 2011, GEODERMA, V163, P185, DOI 10.1016/j.geoderma.2011.04.007; Ferrier KL, 2008, EARTH PLANET SC LETT, V272, P591, DOI 10.1016/j.epsl.2008.05.024; Gabet EJ, 2007, EARTH PLANET SC LETT, V264, P259, DOI 10.1016/j.epsl.2007.09.028; Gabet EJ, 2009, GEOLOGY, V37, P151, DOI 10.1130/G25270A.1; GRIFFITHS GA, 1983, NEW ZEAL J SCI, V26, P197; Heimsath AM, 1997, NATURE, V388, P358, DOI 10.1038/41056; Heimsath AM, 2012, NAT GEOSCI, V5, P210, DOI [10.1038/NGEO1380, 10.1038/ngeo1380]; Hicks D. Murray, 2011, Journal of Hydrology-New Zealand, V50, P81; Hilley GE, 2010, EARTH PLANET SC LETT, V293, P191, DOI 10.1016/j.epsl.2010.01.008; Hilton RG, 2011, EARTH SURF PROC LAND, V36, P1670, DOI 10.1002/esp.2191; Hovius N, 1997, GEOLOGY, V25, P231, DOI 10.1130/0091-7613(1997)025<0231:SFFAMB>2.3.CO;2; Jacobson AD, 2003, GEOLOGY, V31, P865, DOI 10.1130/G19662.1; Larsen IJ, 2012, NAT GEOSCI, V5, P468, DOI 10.1038/ngeo1479; Lyons WB, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2003JF000088; Milliman J. D., 2011, RIVER DISCHARGE TO T; Moore J, 2013, CHEM GEOL, V341, P110, DOI 10.1016/j.chemgeo.2013.01.005; Norris RJ, 2001, J STRUCT GEOL, V23, P507, DOI 10.1016/S0191-8141(00)00122-X; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; TIPPETT JM, 1993, J GEOPHYS RES-SOL EA, V98, P16119, DOI 10.1029/92JB02115; Tsai ZX, 2013, EARTH SURF PROC LAND, V38, P661, DOI 10.1002/esp.3309; West AJ, 2012, GEOLOGY, V40, P811, DOI 10.1130/G33041.1; Whipple KX, 1999, NATURE, V401, P39, DOI 10.1038/43375	31	130	136	2	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					637	640		10.1126/science.1244908	http://dx.doi.org/10.1126/science.1244908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24436184	Green Published			2022-12-28	WOS:000330724000038
J	Sayou, C; Monniaux, M; Nanao, MH; Moyroud, E; Brockington, SF; Thevenon, E; Chahtane, H; Warthmann, N; Melkonian, M; Zhang, Y; Wong, GKS; Weigel, D; Parcy, F; Dumas, R				Sayou, Camille; Monniaux, Marie; Nanao, Max H.; Moyroud, Edwige; Brockington, Samuel F.; Thevenon, Emmanuel; Chahtane, Hicham; Warthmann, Norman; Melkonian, Michael; Zhang, Yong; Wong, Gane Ka-Shu; Weigel, Detlef; Parcy, Francois; Dumas, Renaud			A Promiscuous Intermediate Underlies the Evolution of LEAFY DNA Binding Specificity	SCIENCE			English	Article							REGULATOR; DIVERSITY	Transcription factors (TFs) are key players in evolution. Changes affecting their function can yield novel life forms but may also have deleterious effects. Consequently, gene duplication events that release one gene copy from selective pressure are thought to be the common mechanism by which TFs acquire new activities. Here, we show that LEAFY, a major regulator of flower development and cell division in land plants, underwent changes to its DNA binding specificity, even though plant genomes generally contain a single copy of the LEAFY gene. We examined how these changes occurred at the structural level and identify an intermediate LEAFY form in hornworts that appears to adopt all different specificities. This promiscuous intermediate could have smoothed the evolutionary transitions, thereby allowing LEAFY to evolve new binding specificities while remaining a single-copy gene.	[Sayou, Camille; Monniaux, Marie; Moyroud, Edwige; Thevenon, Emmanuel; Chahtane, Hicham; Parcy, Francois; Dumas, Renaud] CNRS, LPCV, UMR 5168, F-38054 Grenoble, France; [Sayou, Camille; Monniaux, Marie; Moyroud, Edwige; Thevenon, Emmanuel; Chahtane, Hicham; Parcy, Francois; Dumas, Renaud] Univ Grenoble Alpes, LPCV, F-38054 Grenoble, France; [Sayou, Camille; Monniaux, Marie; Moyroud, Edwige; Thevenon, Emmanuel; Chahtane, Hicham; Parcy, Francois; Dumas, Renaud] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Rech Technol & Sci Vivant, LPCV, F-38054 Grenoble, France; [Sayou, Camille; Monniaux, Marie; Moyroud, Edwige; Thevenon, Emmanuel; Chahtane, Hicham; Parcy, Francois; Dumas, Renaud] Inst Natl Rech Agron, LPCV, F-38054 Grenoble, France; [Nanao, Max H.] EMBL, F-38042 Grenoble, France; [Nanao, Max H.] Univ Grenoble Alpes, Unit Virus Host Cell Interact, CNRS, EMBL,UMI 3265, F-38042 Grenoble 9, France; [Brockington, Samuel F.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Warthmann, Norman; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Melkonian, Michael] Univ Cologne, Biozentrum Koln, Inst Bot, Lehrstuhl 1, D-50674 Cologne, Germany; [Zhang, Yong; Wong, Gane Ka-Shu] Beijing Genom Inst BGI Shenzhen, Shenzhen 518083, Peoples R China; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Parcy, Francois] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Cambridge; Max Planck Society; University of Cologne; Beijing Genomics Institute (BGI); University of Alberta; Child & Family Research Institute; University of British Columbia	Nanao, MH (corresponding author), EMBL, 6 Rue Jules Horowitz,BP 181, F-38042 Grenoble, France.	mnanao@embl.fr; francois.parcy@cea.fr	Sayou, Camille/AAX-6377-2020; Nanao, Max/ABA-9292-2021; WONG, Gane Ka-Shu/G-5784-2013; Warthmann, Norman/E-1069-2011; Monniaux, Marie/AAI-8165-2021; Chahtane, Hicham/P-7853-2018; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Moyroud, Edwige/GPX-8552-2022; Dumas, Renaud/E-1835-2011; Brockington, Samuel/K-7819-2013; Sayou, Camille/E-8145-2019; Parcy, François/G-9177-2011; Weigel, Detlef/C-1418-2008	Sayou, Camille/0000-0002-8226-7272; WONG, Gane Ka-Shu/0000-0001-6108-5560; Warthmann, Norman/0000-0002-1178-8409; Monniaux, Marie/0000-0001-6847-3902; Chahtane, Hicham/0000-0002-0976-1186; Weigel, Detlef/0000-0002-2114-7963; Moyroud, Edwige/0000-0001-7908-3205; Brockington, Samuel/0000-0003-1216-219X; Sayou, Camille/0000-0002-8226-7272; Parcy, François/0000-0003-2191-500X; Weigel, Detlef/0000-0002-2114-7963; dumas, renaud/0000-0003-1404-3274; Nanao, Max/0000-0002-6340-1376	Max Planck Society; Agence Nationale de la Recherche [Charmful SVSE2-2011]; Cooperations et Mobilites Internationales Rhone-Alpes; FP7 P-CUBE [227764]; Alberta Ministry of Enterprise and Advanced Education; Alberta Innovates Technology Futures; Innovates Centre of Research Excellence; Musea Ventures; BGI-Shenzhen; Natural Environment Research Council [NE/K009303/1] Funding Source: researchfish; NERC [NE/K009303/1] Funding Source: UKRI	Max Planck Society(Max Planck SocietyFoundation CELLEX); Agence Nationale de la Recherche(French National Research Agency (ANR)); Cooperations et Mobilites Internationales Rhone-Alpes(Region Auvergne-Rhone-Alpes); FP7 P-CUBE; Alberta Ministry of Enterprise and Advanced Education; Alberta Innovates Technology Futures; Innovates Centre of Research Excellence; Musea Ventures; BGI-Shenzhen; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Schmid for help with sequencing; E. Masson, J. Kyozuka, M. Hasebe, C. Scutt, C. Finet, and J. C. Villarreal for sharing materials; A. Maizel and S. Rensing for discussion; and A. Maizel, R. Worsley-Hunt, A. Mathelier, M. Blazquez, O. Nilsson, C. Zubieta, and J. Chen for critical reading of the manuscript. This work was supported by funds from the Max Planck Society (D. W.), the Agence Nationale de la Recherche (grant Charmful SVSE2-2011) and Cooperations et Mobilites Internationales Rhone-Alpes (F. P.), and the FP7 P-CUBE number 227764 (R. D.). The 1000 Plants (1KP) initiative, led by G.K.-S.W., is funded by Alberta Ministry of Enterprise and Advanced Education, Alberta Innovates Technology Futures, Innovates Centre of Research Excellence, Musea Ventures, and BGI-Shenzhen. GenBank accession numbers are as follows: AmboLFY, KF193872; NaLFY, KF269532; KsLFY, KF269535; CsLFY, KF269533; CvLFY, KF269536; and CyLFY: KF269534. The Protein Data bank identification number is 4BHK for the reported crystal structure. We declare no competing financial interests.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Baker CR, 2013, SCIENCE, V342, P104, DOI 10.1126/science.1240810; Baker CR, 2011, P NATL ACAD SCI USA, V108, P7493, DOI 10.1073/pnas.1019177108; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Eick GN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003072; Hames C, 2008, EMBO J, V27, P2628, DOI 10.1038/emboj.2008.184; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Maizel A, 2005, SCIENCE, V308, P260, DOI 10.1126/science.1108229; Moyroud E, 2011, PLANT CELL, V23, P1293, DOI 10.1105/tpc.111.083329; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Tanahashi T, 2005, DEVELOPMENT, V132, P1727, DOI 10.1242/dev.01709; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590	18	91	94	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					645	648		10.1126/science.1248229	http://dx.doi.org/10.1126/science.1248229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24436181				2022-12-28	WOS:000330724000040
J	Van Engelenburg, SB; Shtengel, G; Sengupta, P; Waki, K; Jarnik, M; Ablan, SD; Freed, EO; Hess, HF; Lippincott-Schwartz, J				Van Engelenburg, Schuyler B.; Shtengel, Gleb; Sengupta, Prabuddha; Waki, Kayoko; Jarnik, Michal; Ablan, Sherimay D.; Freed, Eric O.; Hess, Harald F.; Lippincott-Schwartz, Jennifer			Distribution of ESCRT Machinery at HIV Assembly Sites Reveals Virus Scaffolding of ESCRT Subunits	SCIENCE			English	Article							CYTOKINESIS; DYNAMICS; PROTEIN; COMPLEX; ABSCISSION; FILAMENTS; MIDBODY; RELEASE; TSG101; VPS4	The human immunodeficiency virus (HIV) hijacks the endosomal sorting complexes required for transport (ESCRT) to mediate virus release from infected cells. The nanoscale organization of ESCRT machinery necessary for mediating viral abscission is unclear. Here, we applied three-dimensional superresolution microscopy and correlative electron microscopy to delineate the organization of ESCRT components at HIV assembly sites. We observed ESCRT subunits localized within the head of budding virions and released particles, with head-localized levels of CHMP2A decreasing relative to Tsg101 and CHMP4B upon virus abscission. Thus, the driving force for HIV release may derive from initial scaffolding of ESCRT subunits within the viral bud interior followed by plasma membrane association and selective remodeling of ESCRT subunits.	[Van Engelenburg, Schuyler B.; Sengupta, Prabuddha; Jarnik, Michal; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA; [Shtengel, Gleb; Hess, Harald F.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Waki, Kayoko; Ablan, Sherimay D.; Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Ctr Canc Res,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lippincott-Schwartz, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov		Sengupta, Prabuddha/0000-0001-7094-6967	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z99 HD999999] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010775] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Im YJ, 2010, STRUCTURE, V18, P1536, DOI 10.1016/j.str.2010.08.010; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	20	134	134	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					653	656		10.1126/science.1247786	http://dx.doi.org/10.1126/science.1247786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7QC	24436186	Green Accepted			2022-12-28	WOS:000349821400001
J	Lundquist, MR; Storaska, AJ; Liu, TC; Larsen, SD; Evans, T; Neubig, RR; Jaffrey, SR				Lundquist, Mark R.; Storaska, Andrew J.; Liu, Ting-Chun; Larsen, Scott D.; Evans, Todd; Neubig, Richard R.; Jaffrey, Samie R.			Redox Modification of Nuclear Actin by MICAL-2 Regulates SRF Signaling	CELL			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; F-ACTIN; TERNARY COMPLEX; GROWTH-FACTOR; IN-VITRO; MYOCARDIN; COACTIVATOR; GENE; IDENTIFICATION	The serum response factor (SRF) binds to coactivators, such as myocardin-related transcription factorA (MRTF-A), and mediates gene transcription elicited by diverse signaling pathways. SRF/MRTF-A-dependent gene transcription is activated when nuclear MRTF-A levels increase, enabling the formation of transcriptionally active SRF/MRTF-A complexes. The level of nuclear MRTF-A is regulated by nuclear G-actin, which binds to MRTF-A and promotes its nuclear export. However, pathways that regulate nuclear actin levels are poorly understood. Here, we show that MICAL-2, an atypical actin-regulatory protein, mediates SRF/MRTF-A-dependent gene transcription elicited by nerve growth factor and serum. MICAL-2 induces redox-dependent depolymerization of nuclear actin, which decreases nuclear G-actin and increases MRTF-A in the nucleus. Furthermore, we show that MICAL-2 is a target of CCG-1423, a small molecule inhibitor of SRF/MRTF-A-dependent transcription that exhibits efficacy in various preclinical disease models. These data identify redox modification of nuclear actin as a regulatory switch that mediates SRF/MRTF-A-dependent gene transcription.	[Lundquist, Mark R.; Jaffrey, Samie R.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Storaska, Andrew J.; Neubig, Richard R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Liu, Ting-Chun; Evans, Todd] Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Larsen, Scott D.] Univ Michigan, Coll Pharm, Vahlteich Med Chem Core, Ann Arbor, MI 48109 USA; [Neubig, Richard R.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA	Cornell University; University of Michigan System; University of Michigan; Cornell University; University of Michigan System; University of Michigan; Michigan State University	Jaffrey, SR (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu		Jaffrey, Samie/0000-0003-3615-6958; Neubig, Richard/0000-0003-0501-0008	NIH [F32AT4340, HL111400, NS56306]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT004340] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Deglincerti and members of the Jaffrey lab for helpful comments and suggestions. This work was supported by NIH grants F32AT4340 (M. R. L.), HL111400 (T. E.), and NS56306 (S.R.J.).	Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Chong NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040966; CHUN LLY, 1977, J CELL BIOL, V75, P694, DOI 10.1083/jcb.75.3.694; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Davis JL, 2008, INT J DEV BIOL, V52, P389, DOI 10.1387/ijdb.072514jd; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Eppink MHM, 1997, PROTEIN SCI, V6, P2454; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Giridharan SSP, 2012, J CELL SCI, V125, P614, DOI 10.1242/jcs.089367; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Krauss SW, 2003, P NATL ACAD SCI USA, V100, P10752, DOI 10.1073/pnas.1934680100; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Lu PPY, 2011, J NEUROSCI, V31, P16651, DOI 10.1523/JNEUROSCI.3015-11.2011; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mouilleron S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001750; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; SUCK D, 1981, P NATL ACAD SCI-BIOL, V78, P4319, DOI 10.1073/pnas.78.7.4319; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	44	118	128	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					563	576		10.1016/j.cell.2013.12.035	http://dx.doi.org/10.1016/j.cell.2013.12.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24440334	Green Accepted, Bronze			2022-12-28	WOS:000330580800021
J	Magee, LA				Magee, Laura A.			Fluconazole use during the first trimester of pregnancy was not associated with most major birth defects	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Magee, LA (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.			Hviid, Anders/0000-0002-7509-9127				Lopez-Rangel E, 2005, BIRTH DEFECTS RES A, V73, P919, DOI 10.1002/bdra.20189; Marotta F, 2010, EXPERT OPIN DRUG MET, V6, P461, DOI 10.1517/17425251003592111; Tiboni GM, 2006, TOXICOL LETT, V167, P8, DOI 10.1016/j.toxlet.2006.08.004	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC12	10.7326/0003-4819-160-2-201401210-02012	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445710				2022-12-28	WOS:000330275600011
J	Glasziou, P; Altman, DG; Bossuyt, P; Boutron, I; Clarke, M; Julious, S; Michie, S; Moher, D; Wager, E				Glasziou, Paul; Altman, Douglas G.; Bossuyt, Patrick; Boutron, Isabelle; Clarke, Mike; Julious, Steven; Michie, Susan; Moher, David; Wager, Elizabeth			Reducing waste from incomplete or unusable reports of biomedical research	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; DIAGNOSTIC-ACCURACY; SYSTEMATIC REVIEWS; EMPIRICAL-EVIDENCE; CLINICAL-TRIALS; ADVERSE EVENTS; OF-INTEREST; QUALITY; BIAS; INTERVENTIONS	Research publication can both communicate and miscommunicate. Unless research is adequately reported, the time and resources invested in the conduct of research is wasted. Reporting guidelines such as CONSORT, STARD, PRISMA, and ARRIVE aim to improve the quality of research reports, but all are much less adopted and adhered to than they should be. Adequate reports of research should clearly describe which questions were addressed and why, what was done, what was shown, and what the findings mean. However, substantial failures occur in each of these elements. For example, studies of published trial reports showed that the poor description of interventions meant that 40-89% were non-replicable; comparisons of protocols with publications showed that most studies had at least one primary outcome changed, introduced, or omitted; and investigators of new trials rarely set their findings in the context of a systematic review, and cited a very small and biased selection of previous relevant trials. Although best documented in reports of controlled trials, inadequate reporting occurs in all types of studies-animal and other preclinical studies, diagnostic studies, epidemiological studies, clinical prediction research, surveys, and qualitative studies. In this report, and in the Series more generally, we point to a waste at all stages in medical research. Although a more nuanced understanding of the complex systems involved in the conduct, writing, and publication of research is desirable, some immediate action can be taken to improve the reporting of research. Evidence for some recommendations is clear: change the current system of research rewards and regulations to encourage better and more complete reporting, and fund the development and maintenance of infrastructure to support better reporting, linkage, and archiving of all elements of research. However, the high amount of waste also warrants future investment in the monitoring of and research into reporting of research, and active implementation of the findings to ensure that research reports better address the needs of the range of research users.	[Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Robina, Qld 4229, Australia; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Bossuyt, Patrick] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Boutron, Isabelle] INSERM, U738, Paris, France; [Clarke, Mike] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Julious, Steven] Univ Sheffield, Med Stat Grp, Sheffield, S Yorkshire, England; [Michie, Susan] UCL, Dept Psychol, Ctr Outcomes Res & Effectiveness, London, England; [Moher, David] Ottawa Hosp Res Inst, Ottawa Methods Ctr, Ottawa, ON, Canada	Bond University; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); Queens University Belfast; University of Sheffield; University of London; University College London; University of Ottawa; Ottawa Hospital Research Institute	Glasziou, P (corresponding author), Bond Univ, Fac Hlth Sci, Ctr Res Evidence Based Practice, Robina, Qld 4229, Australia.	paul_glasziou@bond.edu.au	Bossuyt, Patrick M./B-4557-2016; Moher, David/I-3408-2019; Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M/AAR-1183-2021; Michie, Susan/A-1745-2010	Bossuyt, Patrick M./0000-0003-4427-0128; Moher, David/0000-0003-2434-4206; Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M/0000-0003-4427-0128; Wager, Elizabeth/0000-0002-4202-7813; Boutron, Isabelle/0000-0002-5263-6241; Michie, Susan/0000-0003-0063-6378	Australia National Health and Medical Research Council [0527500]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J00488X/1, G0901474, G0901530] Funding Source: researchfish; MRC [G0901530, G0901474, MR/J00488X/1] Funding Source: UKRI	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the many reviewers, internal and external, of this paper. PG is supported by Australia National Health and Medical Research Council grant number 0527500.	Allen ES, 1999, NATURE, V402, P722, DOI 10.1038/45370; Altman DG, 2005, PLOS MED, V2, P457, DOI 10.1371/journal.pmed.0020126; Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; [Anonymous], 1965, BMJ-BRIT MED J, V2, P870; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Berwanger O, 2009, J CLIN EPIDEMIOL, V62, P387, DOI 10.1016/j.jclinepi.2008.05.013; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Budd JM, 1999, B MED LIBR ASSOC, V87, P437; Carp J, 2012, NEUROIMAGE, V63, P289, DOI 10.1016/j.neuroimage.2012.07.004; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan A-W, 2014, LANCET; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chowers MY, 2009, J ANTIMICROB CHEMOTH, V64, P239, DOI 10.1093/jac/dkp191; Clark S, 2010, LANCET, V376, P10, DOI 10.1016/S0140-6736(10)61001-X; Clarke M., 2013, Journal of the Bahrain Medical Society, V24, P145; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Cooper RJ, 2002, ANN EMERG MED, V40, P317, DOI 10.1067/mem.2002.127327; Docherty M, 1999, BRIT MED J, V318, P1224; Duff JM, 2010, JNCI-J NATL CANCER I, V102, P702, DOI 10.1093/jnci/djq117; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Forbes TL, 2011, J VASC SURG, V54, p55S, DOI 10.1016/j.jvs.2011.06.019; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glenton C, 2006, J CLIN EPIDEMIOL, V59, P770, DOI 10.1016/j.jclinepi.2005.12.011; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Groenwold RHH, 2008, ANN EPIDEMIOL, V18, P746, DOI 10.1016/j.annepidem.2008.05.007; Habre C, 2013, 7 INT C PEER REV BIO, P29; Hopewell S, 2012, BMJ-BRIT MED J, V344, pe4178; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell S, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-253; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Jefferson T, 1999, BRIT MED J, V319, P580, DOI 10.1136/bmj.319.7209.580; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kiritchenko S, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-56; Kjaergard LL, 2002, J CLIN EPIDEMIOL, V55, P407, DOI 10.1016/S0895-4356(01)00513-3; Lang TA, 2006, REP STAT MED; Lewin Simon, 2009, BMJ, V339, pb3496, DOI 10.1136/bmj.b3496; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Matcham J, 2011, PHARM STAT, V10, P70, DOI 10.1002/pst.417; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moher D, 2009, CAN J ANAESTH, V56, P96, DOI 10.1007/s12630-008-9027-0; Molnar FJ, 1999, CAN MED ASSOC J, V161, P393; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; O'Kelly M, 2011, PHARM STAT, V10, P60, DOI 10.1002/pst.430; Ochodo EA, 2013, RADIOLOGY, V267, P581, DOI 10.1148/radiol.12120527; Picard P, 2000, ANESTH ANALG, V90, P963; Pino C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-63; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Royal Statistical Society, ROYAL STAT SOC STAT; Schilling LM, 2006, AM J EPIDEMIOL, V164, P1141, DOI 10.1093/aje/kwj349; Schriger DL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3803; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Simera I, 2009, ANN INTERN MED, V151, DOI 10.1136/ebm.14.5.132; Smidt N, 2006, NEUROLOGY, V67, P792, DOI 10.1212/01.wnl.0000238386.41398.30; Stewart L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-7; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Vera-Badillo FE, 2013, ANN ONCOL, V24, P1238, DOI 10.1093/annonc/mds636; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wager E, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010031; Wager E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000002.pub3; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	82	716	732	1	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					267	276		10.1016/S0140-6736(13)62228-X	http://dx.doi.org/10.1016/S0140-6736(13)62228-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24411647				2022-12-28	WOS:000330027500036
J	An, DD; Oh, SF; Olszak, T; Neves, JF; Avci, FY; Erturk-Hasdemir, D; Lu, X; Zeissig, S; Blumberg, RS; Kasper, DL				An, Dingding; Oh, Sungwhan F.; Olszak, Torsten; Neves, Joana F.; Avci, Fikri Y.; Erturk-Hasdemir, Deniz; Lu, Xi; Zeissig, Sebastian; Blumberg, Richard S.; Kasper, Dennis L.			Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells	CELL			English	Article							OXAZOLONE COLITIS; RECOGNITION; EXPOSURE; ANTIGENS; HYGIENE; MODEL	Coevolution of beneficial microorganisms with the mammalian intestine fundamentally shapes mammalian physiology. Here, we report that the intestinal microbe Bacteroides fragilis modifies the homeostasis of host invariant natural killer T (iNKT) cells by supplementing the host's endogenous lipid antigen milieu with unique inhibitory sphingolipids. The process occurs early in life and effectively impedes iNKT cell proliferation during neonatal development. Consequently, total colonic iNKT cell numbers are restricted into adulthood, and hosts are protected against experimental iNKT cell-mediated, oxazolone- induced colitis. In studies with neonatal mice lacking access to bacterial sphingolipids, we found that treatment with B. fragilis glycosphingolipids-exemplified by an isolated peak (MW = 717.6) called GSL-Bf717-reduces colonic iNKT cell numbers and confers protection against oxazolone-induced colitis in adulthood. Our results suggest that the distinctive inhibitory capacity of GSL-Bf717 and similar molecules may prove useful in the treatment of autoimmune and allergic disorders in which iNKT cell activation is destructive.	[An, Dingding; Oh, Sungwhan F.; Avci, Fikri Y.; Erturk-Hasdemir, Deniz; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Olszak, Torsten; Neves, Joana F.; Zeissig, Sebastian; Blumberg, Richard S.] Harvard Univ, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Avci, Fikri Y.] Univ Georgia, Ctr Mol Med, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Lu, Xi] Harvard Univ, Sch Med, Div Infect Dis, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University System of Georgia; University of Georgia; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Blumberg, RS (corresponding author), Harvard Univ, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA.	rblumberg@partners.org; dennis_kasper@hms.harvard.edu	Neves, Joana F/J-9406-2014; Zeissig, Sebastian/B-6297-2012; Lu, Xi/AAH-2936-2019	Neves, Joana F/0000-0001-5842-4162; Zeissig, Sebastian/0000-0001-5124-0897; Lu, Xi/0000-0001-7153-6193; Avci, Fikri/0000-0002-1902-7532	NIH [AI090102, DK44319, DK51362, DK53056, DK88199, AI007061]; Crohn's and Colitis Foundation of America Senior Research Award; Crohn's and Colitis Foundation of America Postdoctoral Fellowship Award; Deutsche Forschungsgemeinschaft (DFG) [OL 324/1-1]; DFG [ZE814/4-1]; ERC [336528]; Harvard Digestive Diseases Center [DK034854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090102, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK088199, R01DK051362, R01DK044319, R01DK053056, P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Senior Research Award; Crohn's and Colitis Foundation of America Postdoctoral Fellowship Award; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shakir Edwards for handling of the gnotobiotic mice, Dr. Roderick Bronson for histopathology sample evaluation, Dr. Bella Printseva and Wen Zheng for technical assistance, and Julie B. McCoy for editing. We thank Dr. Yusuf Hannun at Stony Brook University for discussions and help with lipid analysis. Phycoerythrin-tagged PBS-57-loaded and -unloaded mCD1d tetramers were obtained from the NIH Tetramer Core Facility. Dr. Gurdyal Besra at the University of Birmingham, UK, kindly provided PBS-57. Dr. Paul Savage at Brigham Young University kindly provided PBS-44. We thank Tom DiCesare for illustrating the Graphical Abstract. This work was supported by the NIH (grants AI090102 to D. L. K.; DK44319, DK51362, DK53056, and DK88199 to R. S. B.; and AI007061 to S.F.O.), a Crohn's and Colitis Foundation of America Senior Research Award (D. L. K.), a Crohn's and Colitis Foundation of America Postdoctoral Fellowship Award (D. A. and S.Z.), the Deutsche Forschungsgemeinschaft (DFG) OL 324/1-1 (T.O.), DFG ZE814/4-1 (S.Z.), ERC 336528 (S.Z.), and the Harvard Digestive Diseases Center (DK034854).	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; An DD, 2011, P NATL ACAD SCI USA, V108, P4666, DOI 10.1073/pnas.1001501107; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Behar SM, 1999, J IMMUNOL, V162, P161; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Braun NA, 2010, J INNATE IMMUN, V2, P316, DOI 10.1159/000296915; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; KATO M, 1995, ANAEROBE, V1, P135, DOI 10.1006/anae.1995.1009; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Matangkasombut P, 2009, MUCOSAL IMMUNOL, V2, P383, DOI 10.1038/mi.2009.96; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MIYAGAWA E, 1979, J BIOCHEM-TOKYO, V86, P311, DOI 10.1093/oxfordjournals.jbchem.a132528; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Peternel S, 2009, J EUR ACAD DERMATOL, V23, P1123, DOI 10.1111/j.1468-3083.2009.03292.x; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; von Mutius E, 2007, IMMUNOBIOLOGY, V212, P433, DOI 10.1016/j.imbio.2007.03.002; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zitomersky NL, 2011, INFECT IMMUN, V79, P2012, DOI 10.1128/IAI.01348-10	37	352	364	5	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					123	133		10.1016/j.cell.2013.11.042	http://dx.doi.org/10.1016/j.cell.2013.11.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439373	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000329912200015
J	Epshtein, V; Kamarthapu, V; McGary, K; Svetlov, V; Ueberheide, B; Proshkin, S; Mironov, A; Nudler, E				Epshtein, Vitaly; Kamarthapu, Venu; McGary, Katelyn; Svetlov, Vladimir; Ueberheide, Beatrix; Proshkin, Sergey; Mironov, Alexander; Nudler, Evgeny			UvrD facilitates DNA repair by pulling RNA polymerase backwards	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI-UVRD; TRANSCRIPTION ELONGATION; HELICASE-II; GENOME INSTABILITY; GENE-PRODUCT; IN-VITRO; E. COLI; DAMAGE; PROTEIN	UvrD helicase is required for nucleotide excision repair, although its role in this process is not well defined. Here we show that Escherichia coli UvrD binds RNA polymerase during transcription elongation and, using its helicase/translocase activity, forces RNA polymerase to slide backward along DNA. By inducing backtracking, UvrD exposes DNA lesions shielded by blocked RNA polymerase, allowing nucleotide excision repair enzymes to gain access to sites of damage. Our results establish UvrD as a bona fide transcription elongation factor that contributes to genomic integrity by resolving conflicts between transcription and DNA repair complexes. Furthermore, we show that the elongation factor NusA cooperates with UvrD in coupling transcription to DNA repair by promoting backtracking and recruiting nucleotide excision repair enzymes to exposed lesions. Because backtracking is a shared feature of all cellular RNA polymerases, we propose that this mechanism enables RNA polymerases to function as global DNA damage scanners in bacteria and eukaryotes.	[Epshtein, Vitaly; Kamarthapu, Venu; McGary, Katelyn; Svetlov, Vladimir; Ueberheide, Beatrix; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Kamarthapu, Venu; Nudler, Evgeny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Proshkin, Sergey; Mironov, Alexander] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia; [Mironov, Alexander] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia	New York University; Howard Hughes Medical Institute; New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Proshkin, Sergey/G-2733-2017; Mironov, Alexander/G-8531-2013	Proshkin, Sergey/0000-0002-6116-4637; Ueberheide, Beatrix/0000-0003-2512-0204; Nudler, Evgeny/0000-0002-8811-3071; Mironov, Alexander/0000-0003-3914-1380	Russian Foundation for Basic Research; NIH; BGRF; Dynasty foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088118, R01GM058750] Funding Source: NIH RePORTER	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BGRF; Dynasty foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Jeruzalmi for materials. This work was supported by the Russian Foundation for Basic Research (A.M.) and the NIH, BGRF, Dynasty foundation and by the Howard Hughes Medical Institute (E.N.).	Ahn B, 2000, MOL CELLS, V10, P592, DOI 10.1007/s100590000017; ARTHUR HM, 1983, GENE, V25, P309, DOI 10.1016/0378-1119(83)90235-4; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Brueckner F, 2007, FEBS LETT, V581, P2757, DOI 10.1016/j.febslet.2007.05.014; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cohen SE, 2010, P NATL ACAD SCI USA, V107, P15517, DOI 10.1073/pnas.1005203107; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; DOUDNEY CO, 1985, MUTAT RES, V143, P29, DOI 10.1016/0165-7992(85)90100-9; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Gaillard H, 2013, BBA-GENE REGUL MECH, V1829, P141, DOI 10.1016/j.bbagrm.2012.09.008; Ganesan A, 2012, PROG MOL BIOL TRANSL, V110, P25, DOI 10.1016/B978-0-12-387665-2.00002-X; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KUMURA K, 1984, J BIOL CHEM, V259, P1560; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li DQ, 2005, BIOINFORMATICS, V21, P3049, DOI 10.1093/bioinformatics/bti439; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Pakotiprapha D, 2012, NAT STRUCT MOL BIOL, V19, P291, DOI 10.1038/nsmb.2240; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Savery N, 2011, TRANSCR-AUSTIN, V2, P168, DOI 10.4161/trns.2.4.16146; Schalow BJ, 2012, J BACTERIOL, V194, P2637, DOI 10.1128/JB.06725-11; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1990, J BIOL CHEM, V265, P21330; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; VANHOUTEN B, 1994, ANN NY ACAD SCI, V726, P236; Witkin E.M., 1966, RADIATION RES      S, P30; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099	54	152	156	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					372	+		10.1038/nature12928	http://dx.doi.org/10.1038/nature12928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24402227	Green Accepted			2022-12-28	WOS:000329621800036
J	McSwain, MV				McSwain, M. Virginia			ASTROPHYSICS Black hole found orbiting a fast rotator	NATURE			English	Editorial Material							STAR; BINARIES		Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA	Lehigh University	McSwain, MV (corresponding author), Lehigh Univ, Dept Phys, Bldg 16, Bethlehem, PA 18015 USA.	mcswain@lehigh.edu						BRANDT N, 1995, MON NOT R ASTRON SOC, V274, P461, DOI 10.1093/mnras/274.2.461; Casares J, 2014, NATURE, V505, P378, DOI 10.1038/nature12916; Fryer CL, 1999, ASTROPHYS J, V522, P413, DOI 10.1086/307647; Gies DR, 1998, ASTROPHYS J, V493, P440, DOI 10.1086/305113; Hamaguchi K, 2009, ASTROPHYS J LETT, V695, pL4, DOI 10.1088/0004-637X/695/1/L4; Liu QZ, 2006, ASTRON ASTROPHYS, V455, P1165, DOI 10.1051/0004-6361:20064987; McSwain MV, 2008, ASTROPHYS J, V672, P590, DOI 10.1086/523934; Moniez M, 2010, GEN RELAT GRAVIT, V42, P2047, DOI 10.1007/s10714-009-0925-4; Williams SJ, 2010, ASTROPHYS J LETT, V723, pL93, DOI 10.1088/2041-8205/723/1/L93	10	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					296	297		10.1038/505296a	http://dx.doi.org/10.1038/505296a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429624				2022-12-28	WOS:000329621800024
J	Morrison, SJ; Scadden, DT				Morrison, Sean J.; Scadden, David T.			The bone marrow niche for haematopoietic stem cells	NATURE			English	Review							SLAM FAMILY MARKERS; SELF-RENEWAL; N-CADHERIN; MICE LACKING; STEM/PROGENITOR CELLS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; STROMAL CELLS; FACTOR-I; RECEPTOR	Niches are local tissue microenvironments that maintain and regulate stem cells. Haematopoiesis provides a model for understanding mammalian stem cells and their niches, but the haematopoietic stem cell (HSC) niche remains incompletely defined and beset by competing models. Recent progress has been made in elucidating the location and cellular components of the HSC niche in the bone marrow. The niche is perivascular, created partly by mesenchymal stromal cells and endothelial cells and often, but not always, located near trabecular bone. Outstanding questions concern the cellular complexity of the niche, the role of the endosteum and functional heterogeneity among perivascular microenvironments.	[Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA; [Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Harvard Stem Cell Inst, Ctr Regenerat Med, Cambridge, MA 02138 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA.	Sean.Morrison@UTSouthwestern.edu; David_Scadden@Harvard.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	National Heart, Lung and Blood Institute [HL097760]; Howard Hughes Medical Institute; Mary McDermott Cook Chair in Pediatric Genetics; National Institutes of Health [HL044851, HL096372, EB014703]; Gerald and Darlene Jordan Chair in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760, R01HL044851, R03HL096372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mary McDermott Cook Chair in Pediatric Genetics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald and Darlene Jordan Chair in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	S.J.M. was supported by the National Heart, Lung and Blood Institute (HL097760), the Howard Hughes Medical Institute, and the Mary McDermott Cook Chair in Pediatric Genetics. D.T.S. was supported by the National Institutes of Health (HL044851, HL096372, EB014703) and the Gerald and Darlene Jordan Chair in Medicine. We apologize to authors whose work could not be cited because of space limitations.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Barker JE, 1997, EXP HEMATOL, V25, P542; BARKER JE, 1994, EXP HEMATOL, V22, P174; Bromberg O, 2012, BLOOD, V120, P303, DOI 10.1182/blood-2011-09-377853; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dai JC, 2006, BONE, V38, P509, DOI 10.1016/j.bone.2005.10.007; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ellis SL, 2011, BLOOD, V118, P1516, DOI 10.1182/blood-2010-08-303800; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Greenbaum AM, 2012, BLOOD, V120, P295, DOI 10.1182/blood-2011-09-377457; Guerriero A, 1997, BLOOD, V90, P3444, DOI 10.1182/blood.V90.9.3444; Guezguez B, 2013, CELL STEM CELL, V13, P175, DOI 10.1016/j.stem.2013.06.015; Haeckel E., 1992, RIDDLE UNIVERSE; Haeckel E. H., 1866, GENERELLE MORPHOLOGI; Hanoun M, 2013, CELL STEM CELL, V12, P391, DOI 10.1016/j.stem.2013.03.012; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kaushansky K, 1998, BLOOD, V92, P1; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Li PL, 2010, CELL STEM CELL, V6, P199, DOI 10.1016/j.stem.2010.02.007; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Lin C., NATURE IN PRESS; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; LORD BI, 1975, BLOOD, V46, P65; Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800; Mansour A, 2012, J EXP MED, V209, P537, DOI 10.1084/jem.20110994; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Nakamura-Ishizu A, 2012, BLOOD, V119, P5429, DOI 10.1182/blood-2011-11-393645; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Pappenheim A., 1896, VIRCHOWS ARCH PATHOL, V145, P587; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Roberts EW, 2013, J EXP MED, V210, P1137, DOI 10.1084/jem.20122344; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schaniel C, 2011, BLOOD, V118, P2420, DOI 10.1182/blood-2010-09-305664; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Smith-Berdan S, 2012, CELL CYCLE, V11, P675, DOI 10.4161/cc.11.4.19146; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sungaran R, 1997, BLOOD, V89, P101, DOI 10.1182/blood.V89.1.101; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Visnjic D, 2001, J BONE MINER RES, V16, P2222, DOI 10.1359/jbmr.2001.16.12.2222; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; WOLF NS, 1978, CELL TISSUE KINET, V11, P335, DOI 10.1111/j.1365-2184.1978.tb00806.x; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yao LB, 2005, BLOOD, V106, P4093, DOI 10.1182/blood-2005-02-0671; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	125	1436	1480	23	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					327	334		10.1038/nature12984	http://dx.doi.org/10.1038/nature12984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429631	Green Accepted			2022-12-28	WOS:000329621800030
J	Snaidero, N; Mobus, W; Czopka, T; Hekking, LHP; Mathisen, C; Verkleij, D; Goebbels, S; Edgar, J; Merkler, D; Lyons, DA; Nave, KA; Simons, M				Snaidero, Nicolas; Moebus, Wiebke; Czopka, Tim; Hekking, Liesbeth H. P.; Mathisen, Cliff; Verkleij, Dick; Goebbels, Sandra; Edgar, Julia; Merkler, Doron; Lyons, David A.; Nave, Klaus-Armin; Simons, Mikael			Myelin Membrane Wrapping of CNS Axons by PI(3,4,5) P3-Dependent Polarized Growth at the Inner Tongue	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIAL-CELLS; IN-VIVO; OLIGODENDROCYTES; PROTEIN; ENSHEATHMENT; LOCALIZATION; MECHANISMS; TRANSPORT; REVEALS	Central nervous system myelin is a multilayered membrane sheath generated by oligodendrocytes for rapid impulse propagation. However, the underlying mechanisms of myelin wrapping have remained unclear. Using an integrative approach of live imaging, electron microscopy, and genetics, we show that new myelin membranes are incorporated adjacent to the axon at the innermost tongue. Simultaneously, newly formed layers extend laterally, ultimately leading to the formation of a set of closely apposed paranodal loops. An elaborated system of cytoplasmic channels within the growing myelin sheath enables membrane trafficking to the leading edge. Most of these channels close with ongoing development but can be reopened in adults by experimentally raising phosphatidylinositol-(3,4,5)-triphosphate levels, which reinitiates myelin growth. Our model can explain assembly of myelin as a multilayered structure, abnormal myelin outfoldings in neurological disease, and plasticity of myelin biogenesis observed in adult life.	[Snaidero, Nicolas; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Snaidero, Nicolas; Simons, Mikael] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany; [Moebus, Wiebke; Goebbels, Sandra; Edgar, Julia; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Czopka, Tim; Lyons, David A.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland; [Czopka, Tim; Lyons, David A.] Univ Edinburgh, MS Soc Ctr Translat Res, Edinburgh EH16 4SB, Midlothian, Scotland; [Czopka, Tim; Lyons, David A.] Univ Edinburgh, Euan Mac Donald Ctr Motor Neurone Dis Res, Edinburgh EH16 4SB, Midlothian, Scotland; [Czopka, Tim] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Hekking, Liesbeth H. P.; Mathisen, Cliff; Verkleij, Dick] FEI Co, NL-5651 GG Eindhoven, Netherlands; [Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, CH-1211 Geneva, Switzerland; [Merkler, Doron] Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany; [Moebus, Wiebke] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen; Max Planck Society; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Thermo Fisher Scientific; FEI Company; University of Geneva; University of Geneva; University of Gottingen	Simons, M (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	msimons@gwdg.de	Merkler, Doron/N-9157-2016; Czopka, Tim/N-4970-2015; Edgar, Julia M/U-8456-2019	Merkler, Doron/0000-0002-0247-2007; Czopka, Tim/0000-0002-6824-8112; Edgar, Julia M/0000-0002-3869-0962; Simons, Mikael/0000-0001-5329-192X; /0000-0002-2902-7165; Snaidero, Nicolas/0000-0003-1148-6926; Lyons, David/0000-0003-1166-4454	European Research Council (ERC) Starting Grant; German Research Foundation [SI 746/9-1, TRR43]; Lister Institute, an International Reintegration Grant; EMBO Long-Term Fellowship; German Research Foundation Research Center Molecular Physiology of the Brain (CMPB); ERC Advanced Investigator Grant; BBSRC [BB/F023243/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F023243/1] Funding Source: researchfish; Wellcome Trust [102836/Z/13/Z] Funding Source: researchfish	European Research Council (ERC) Starting Grant(European Research Council (ERC)); German Research Foundation(German Research Foundation (DFG)); Lister Institute, an International Reintegration Grant; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); German Research Foundation Research Center Molecular Physiology of the Brain (CMPB); ERC Advanced Investigator Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Torben Ruhwedel for technical assistance. We thank Ueli Suter for providing Plp1-CreERT2 mice. This work was supported by a European Research Council (ERC) Starting Grant (to M.S.), grants from the German Research Foundation (SI 746/9-1; TRR43), E-Rare Research Program, the Tschira-Stiftung, a David Phillips Fellowship from the Biotechnology and Biological Sciences Research Council, a Research Prize from the Lister Institute, an International Reintegration Grant (to D.A.L.), and an EMBO Long-Term Fellowship (to T.C.). D. M. holds stipendiary professorships of the Swiss National Science Foundation (No. PP00P3_128372). K.A.N. is supported by the German Research Foundation Research Center Molecular Physiology of the Brain (CMPB) and an ERC Advanced Investigator Grant (Axoglia).	Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; BENGEREN B, 1954, EXP CELL RES, V7, P558; BLAKEMORE WF, 1969, J ULTRA MOL STRUCT R, V29, P496, DOI 10.1016/S0022-5320(69)90069-0; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; BUNGE RP, 1968, PHYSIOL REV, V48, P197, DOI 10.1152/physrev.1968.48.1.197; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Ioannidou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030775; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; KNOBLER RL, 1976, J ULTRA MOL STRUCT R, V55, P417, DOI 10.1016/S0022-5320(76)80097-4; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Mobius W, 2010, METHOD CELL BIOL, V96, P475, DOI 10.1016/S0091-679X(10)96020-2; Pedraza L, 2009, J NEUROSCI RES, V87, P3480, DOI 10.1002/jnr.22004; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Peters PJ, 2008, METHOD CELL BIOL, V88, P131, DOI [10.1016/S0091-679X(08)00409-1, 10.1016/S0091-679X(08)00408-1]; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sobottka B, 2011, GLIA, V59, P1841, DOI 10.1002/glia.21228; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Velumian AA, 2011, NEUROIMAGE, V56, P27, DOI 10.1016/j.neuroimage.2010.11.022; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	43	236	240	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					277	290		10.1016/j.cell.2013.11.044	http://dx.doi.org/10.1016/j.cell.2013.11.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439382	Green Accepted, Bronze			2022-12-28	WOS:000329912200027
J	Kamerow, D				Kamerow, Douglas			Getting your "T" up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Schwartz LM, 2013, JAMA INTERN MED, V173, P1460, DOI 10.1001/jamainternmed.2013.7579; Singer N., 2013, NY TIMES	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2014	348								g182	10.1136/bmj.g182	http://dx.doi.org/10.1136/bmj.g182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KR	24412845				2022-12-28	WOS:000329611300020
J	Borrero, S; Zite, N; Potter, JE; Trussell, J				Borrero, Sonya; Zite, Nikki; Potter, Joseph E.; Trussell, James			Medicaid Policy on Sterilization - Anachronistic or Still Relevant?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FORM		[Borrero, Sonya] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA 15260 USA; [Borrero, Sonya] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Zite, Nikki] Univ Tennessee, Grad Sch Med, Dept Obstet & Gynecol, Knoxville, TN USA; [Potter, Joseph E.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA; [Trussell, James] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Trussell, James] Hull York Med Sch, Kingston Upon Hull, N Humberside, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Austin; Princeton University; University of Hull; University of York - UK	Borrero, S (corresponding author), Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA 15260 USA.			Potter, Joseph/0000-0002-8960-813X	NICHD NIH HHS [R24 HD042849] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042849] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Borrero S, 2013, CONTRACEPTION, V88, P691, DOI 10.1016/j.contraception.2013.08.004; Thurman AR, 2010, OBSTET GYNECOL, V116, P1071, DOI 10.1097/AOG.0b013e3181f73eaa; Zite NB, 2007, CONTRACEPTION, V75, P256, DOI 10.1016/j.contraception.2006.12.015; Zite NB, 2011, OBSTET GYNECOL, V117, P1160, DOI 10.1097/AOG.0b013e318213cbb1	4	49	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					102	104		10.1056/NEJMp1313325	http://dx.doi.org/10.1056/NEJMp1313325			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TA	24401047	Green Accepted, Green Published			2022-12-28	WOS:000336119800004
J	Cahill, K; Stevens, S; Lancaster, T				Cahill, Kate; Stevens, Sarah; Lancaster, Tim			Pharmacological Treatments for Smoking Cessation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cahill, Kate; Stevens, Sarah; Lancaster, Tim] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Cahill, Kate; Lancaster, Tim] Univ Oxford, Cochrane Tobacco Addict Grp, Oxford OX2 6GG, England	University of Oxford; University of Oxford	Cahill, K (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, New Radcliffe House, Oxford OX2 6GG, England.	kate.cahill@phc.ox.ac.uk		Lancaster, Timothy Ross/0000-0002-0580-1099; Lay-Flurrie, Sarah/0000-0003-1094-8455				Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Cahill K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub6; Centers for Disease Control and Prevention, SMOK TOB US CESS PRO; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; GlaxoSmithKline, ZYB 150 MG PROL REL; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub4	7	120	123	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					193	194		10.1001/jama.2013.283787	http://dx.doi.org/10.1001/jama.2013.283787			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399558				2022-12-28	WOS:000329339400025
J	Gornall, J				Gornall, Jonathan			ALCOHOL AND PUBLIC HEALTH Under the influence: 2. How industry captured the science on minimum unit pricing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION					jgornall@mac.com						Adam Smith Institute, LIST SEN FELL; Alcohol researcher sees red, 1996, TIMES HIGHER ED 0826; [Anonymous], IRON FIST WEBSIT CHR; Bartlett J, 2011, INFLUENCE WHAT WE; Birdwell J, 2012, FEELING THE EFFECTS; Butler E, 2012, FREE SOCIETY; Centre for Economics and Business Research, 2009, MIN ALC PRIC TARG; Centre for Economics and Business Research, 2013, NAT REG EXT OUR SCE; Centre for Economics and Business Research, 2012, MIN UN PRIC IMP CONS; Centre for Economics and Business Research, 2013, SCEN BAS QUANT EC; Doward J., 2013, OBSERVER; Doyle L, 1994, INDEPENDENT; Duffy J, 2012, STAT CRITIQUE, V2; Duffy J, 2013, SIGNIFICANCE, V10, P23; Duffy J. C., 2012, MINIMAL EVIDENCE MIN; DUFFY JC, 1995, INT J EPIDEMIOL, V24, P100, DOI 10.1093/ije/24.1.100; DUFFY JC, 1993, J ROY STAT SOC A STA, V156, P225, DOI 10.2307/2982729; DUFFY JC, 1994, BRIT MED J, V308, P270, DOI 10.1136/bmj.308.6923.270b; Grice Andrew, 2013, INDEPENDENT; Hawkins B, 2012, WATER DRIPPING D; Hogan O, 2012, ALCOHOL CONSUMPTION; McCambridge J, ADDICTION; Owens J, 2013, PR WEEK         1105; Plunkett J., 2012, GUARDIAN; Snowdon C., 2013, IAE BLOG; Snowdon C, 2012, DRINKING SHADOW EC; Snowdon C., 2011, ART SUPPRESSION PLEA; Snowdon C, 2009, SPIKED          0924; Snowdon C, 2012, CONSERVATIVE HO 0220; Whyte J., 2013, QUACK POLICY ABUSING	30	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								f7531	10.1136/bmj.f7531	http://dx.doi.org/10.1136/bmj.f7531			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KI	24403572				2022-12-28	WOS:000329610300003
J	Frenk, J; Gomez-Dantes, O; Moon, S				Frenk, Julio; Gomez-Dantes, Octavio; Moon, Suerie			From sovereignty to solidarity: a renewed concept of global health for an era of complex interdependence	LANCET			English	Editorial Material							PUBLIC-HEALTH; WORLD-HEALTH; GLOBALIZATION; GOVERNANCE; TRANSITION		[Frenk, Julio; Moon, Suerie] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gomez-Dantes, Octavio] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico	Harvard University; Harvard T.H. Chan School of Public Health; Instituto Nacional de Salud Publica	Frenk, J (corresponding author), Harvard Univ, Sch Publ Hlth, Off Dean, Kresge 1005,677 Huntington Ave, Boston, MA 02115 USA.	deansoff@hsph.harvard.edu		Moon, Suerie/0000-0001-8504-1212				[Anonymous], 2012, FINANCING GLOBAL HEA; [Anonymous], 2012, FUTURE WE WANT RESOL; Birn AE, 2005, LANCET, V366, P514, DOI 10.1016/S0140-6736(05)66479-3; Bloom BR, 2005, SCI AM, V293, P92, DOI 10.1038/scientificamerican0905-92; Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831; Chen L, 1996, POCANTICO RETREAT EN, P9; Durkheim E, 1964, THE DIVISON OF LABOR; Fidler D, 2011, GLOBAL HLTH GOVERNAN, V4, P1; Frenk J, 1997, BRIT MED J, V314, P1404; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Fried LP, 2010, LANCET, V375, P535, DOI 10.1016/S0140-6736(10)60203-6; GODUE C, 1992, HUM RES DEV, V95, P113; Gomez-Dantes O, 2001, MANAGING GLOBAL ISSU, P392; Huynen MMTE, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-14; Keohane RO, 1997, THE THEORETICAL EVOL; Kniewald G, 2006, CROAT CHEM ACTA, V79, pXIII; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-5; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; McInnes C, 2012, GLOBAL HEALTH AND IN; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ottersen OP, 2011, LANCET, V378, P1612, DOI 10.1016/S0140-6736(11)61617-6; Rodin J, 2007, PLENARY ADDRESS PRES; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3	24	99	102	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					94	97		10.1016/S0140-6736(13)62561-1	http://dx.doi.org/10.1016/S0140-6736(13)62561-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SP	24388312				2022-12-28	WOS:000329341200039
J	Bloodworth, A				Bloodworth, Andrew			Track flows to manage technology-metal supply	NATURE			English	Editorial Material									British Geol Survey, Nottingham, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Bloodworth, A (corresponding author), British Geol Survey, Nottingham, England.	ajbl@bgs.ac.uk			NERC [bgs05010] Funding Source: UKRI; Natural Environment Research Council [bgs05010] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ALLWOOD J, 2012, SUSTAINABLE MAT; British Geological Survey, 2013, WORLD MIN PROD 2007; Crowson PCF, 2011, MINER ECON, V24, P1, DOI 10.1007/s13563-011-0002-9; Graedel T. E., 2012, MRS BULL, V87, P325; Gunn A. G., 2013, P 12 BIENN SOC GEOL; Hageluken C., 2012, PRECIOUS MAT HDB; Jackson B., 2012, AVAILABILITY INDIUM; Jackson MT, 2007, SCI TOTAL ENVIRON, V385, P117, DOI 10.1016/j.scitotenv.2007.06.004; Ragnarsdottir KV, 2008, NAT GEOSCI, V1, P720, DOI 10.1038/ngeo302; Reck BK, 2012, SCIENCE, V337, P690, DOI 10.1126/science.1217501	10	29	29	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					19	20		10.1038/505019a	http://dx.doi.org/10.1038/505019a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24380940	Bronze, Green Accepted			2022-12-28	WOS:000329163300008
J	Williams, AL; Jacobs, SBR; Moreno-Macias, H; Huerta-Chagoya, A; Churchhouse, C; Marquez-Luna, C; Garcia-Ortiz, H; Gomez-Vazquez, MJ; Burtt, NP; Aguilar-Salinas, CA; Gonzalez-Villalpando, C; Florez, JC; Orozco, L; Haiman, CA; Tusie-Luna, T; Altshuler, D; Williams, AL; Marquez-Luna, C; Huerta-Chagoya, A; Ripke, S; Gomez-Vazquez, MJ; Manning, AK; Moreno-Macias, H; Garcia-Ortiz, H; Neale, B; Burtt, NP; Aguilar-Salinas, CA; Reich, D; Stram, DO; Fernandez-Lopez, JC; Romero-Hidalgo, S; Altshuler, D; Florez, JC; Tusie-Luna, T; Patterson, N; Haiman, CA; Aguilar-Delfin, I; Martinez-Hernandez, A; Centeno-Cruz, F; Mendoza-Caamal, E; Revilla-Monsalve, C; Islas-Andrade, S; Cordova, E; Rodriguez-Arellano, E; Soberon, X; Orozco, L; Florez, JC; Gonzalez-Villalpando, C; Gonzalez-Villalpando, ME; Haiman, CA; Henderson, BE; Monroe, K; Wilkens, L; Kolonel, LN; Le Marchand, L; Riba, L; Ordonez-Sanchez, ML; Rodriguez-Guillen, R; Cruz-Bautista, I; Rodriguez-Torres, M; Munoz-Hernandez, LL; Saenz, T; Gomez, D; Alvirde, U; Burtt, NP; Onofrio, RC; Brodeur, WM; Gage, D; Murphy, J; Franklin, J; Mahan, S; Ardlie, K; Crenshaw, AT; Winckler, W; Prufer, K; Shunkov, MV; Sawyer, S; Stenzel, U; Kelso, J; Lek, M; Sankararaman, S; Williams, AL; Patterson, N; MacArthur, DG; Reich, D; Derevianko, AP; Paabo, S; Jacobs, SBR; Churchhouse, C; Gopal, S; Grammatikos, JA; Smith, IC; Bullock, KH; Deik, AA; Souza, AL; Pierce, KA; Clish, CB; Altshuler, D; Fennell, T; Farjoun, Y; Gabriel, S; Stram, DO; Gross, MD; Pereira, MA; Seielstad, M; Koh, WP; Tai, ES; Flannick, J; Fontanillas, P; Morris, A; Teslovich, TM; Burtt, NP; Atzmon, G; Blangero, J; Bowden, DW; Chambers, J; Cho, YS; Duggirala, R; Glaser, B; Hanis, C; Kooner, J; Laakso, M; Lee, JY; Tai, ES; Teo, YY; Wilson, JG; Haiman, CA; Henderson, BE; Monroe, K; Wilkens, L; Kolonel, LN; Le Marchand, L; Puppala, S; Farook, VS; Thameem, F; Abboud, HE; DeFronzo, RA; Jenkinson, CP; Lehman, DM; Curran, JE; Blangero, J; Duggirala, R; Burtt, NP; Cortes, ML; Altshuler, D; Florez, JC; Haiman, CA; Henderson, BE; Aguilar-Salinas, CA; Gonzalez-Villalpando, C; Orozco, L; Tusie-Luna, T				Williams, Amy L.; Jacobs, Suzanne B. R.; Moreno-Macias, Hortensia; Huerta-Chagoya, Alicia; Churchhouse, Claire; Marquez-Luna, Carla; Garcia-Ortiz, Humberto; Jose Gomez-Vazquez, Maria; Burtt, Noel P.; Aguilar-Salinas, Carlos A.; Gonzalez-Villalpando, Clicerio; Florez, Jose C.; Orozco, Lorena; Haiman, Christopher A.; Tusie-Luna, Teresa; Altshuler, David; Williams, Amy L.; Marquez-Luna, Carla; Huerta-Chagoya, Alicia; Ripke, Stephan; Jose Gomez-Vazquez, Maria; Manning, Alisa K.; Moreno-Macias, Hortensia; Garcia-Ortiz, Humberto; Neale, Benjamin; Burtt, Noel P.; Aguilar-Salinas, Carlos A.; Reich, David; Stram, Daniel O.; Carlos Fernandez-Lopez, Juan; Romero-Hidalgo, Sandra; Altshuler, David; Florez, Jose C.; Tusie-Luna, Teresa; Patterson, Nick; Haiman, Christopher A.; Aguilar-Delfin, Irma; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Revilla-Monsalve, Cristina; Islas-Andrade, Sergio; Cordova, Emilio; Rodriguez-Arellano, Eunice; Soberon, Xavier; Orozco, Lorena; Florez, Jose C.; Gonzalez-Villalpando, Clicerio; Elena Gonzalez-Villalpando, Maria; Haiman, Christopher A.; Henderson, Brian E.; Monroe, Kristine; Wilkens, Lynne; Kolonel, Laurence N.; Le Marchand, Loic; Riba, Laura; Luisa Ordonez-Sanchez, Maria; Rodriguez-Guillen, Rosario; Cruz-Bautista, Ivette; Rodriguez-Torres, Maribel; Liliana Munoz-Hernandez, Linda; Saenz, Tamara; Gomez, Donaji; Alvirde, Ulices; Burtt, Noel P.; Onofrio, Robert C.; Brodeur, Wendy M.; Gage, Diane; Murphy, Jacquelyn; Franklin, Jennifer; Mahan, Scott; Ardlie, Kristin; Crenshaw, Andrew T.; Winckler, Wendy; Prufer, Kay; Shunkov, Michael V.; Sawyer, Susanna; Stenzel, Udo; Kelso, Janet; Lek, Monkol; Sankararaman, Sriram; Williams, Amy L.; Patterson, Nick; MacArthur, Daniel G.; Reich, David; Derevianko, Anatoli P.; Paabo, Svante; Jacobs, Suzanne B. R.; Churchhouse, Claire; Gopal, Shuba; Grammatikos, James A.; Smith, Ian C.; Bullock, Kevin H.; Deik, Amy A.; Souza, Amanda L.; Pierce, Kerry A.; Clish, Clary B.; Altshuler, David; Fennell, Timothy; Farjoun, Yossi; Gabriel, Stacey; Stram, Daniel O.; Gross, Myron D.; Pereira, Mark A.; Seielstad, Mark; Koh, Woon-Puay; Tai, E-Shyong; Flannick, Jason; Fontanillas, Pierre; Morris, Andrew; Teslovich, Tanya M.; Burtt, Noel P.; Atzmon, Gil; Blangero, John; Bowden, Donald W.; Chambers, John; Cho, Yoon Shin; Duggirala, Ravindranath; Glaser, Benjamin; Hanis, Craig; Kooner, Jaspal; Laakso, Markku; Lee, Jong-Young; Tai, E-Shyong; Teo, Yik Ying; Wilson, James G.; Haiman, Christopher A.; Henderson, Brian E.; Monroe, Kristine; Wilkens, Lynne; Kolonel, Laurence N.; Le Marchand, Loic; Puppala, Sobha; Farook, Vidya S.; Thameem, Farook; Abboud, Hanna E.; DeFronzo, Ralph A.; Jenkinson, Christopher P.; Lehman, Donna M.; Curran, Joanne E.; Blangero, John; Duggirala, Ravindranath; Burtt, Noel P.; Cortes, Maria L.; Altshuler, David; Florez, Jose C.; Haiman, Christopher A.; Henderson, Brian E.; Aguilar-Salinas, Carlos A.; Gonzalez-Villalpando, Clicerio; Orozco, Lorena; Tusie-Luna, Teresa		SIGMA Type 2 Diabet Consortium; Broad Genomics Platform; T2D-GENES Consortium	Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico	NATURE			English	Article							INSULIN-RESISTANCE; ASSOCIATION; GENOME; SUSCEPTIBILITY; TRANSPORTER; POPULATIONS; ANCESTRY; MELLITUS; LINKS; KCNQ1	Performing genetic studies in multiple human populations can identify disease risk alleles that are common in one population but rare in others(1), with the potential to illuminate pathophysiology, health disparities, and the population genetic origins of disease alleles. Here we analysed 9.2 million single nucleotide polymorphisms (SNPs) in each of 8,214 Mexicans and other Latin Americans: 3,848 with type 2 diabetes and 4,366 non-diabetic controls. In addition to replicating previous findings(2-4), we identified a novel locus associated with type 2 diabetes at genome-wide significance spanning the solute carriers SLC16A11 and SLC16A13 (P=3.9x10(-13); odds ratio (OR) = 1.29). The association was stronger in younger, leaner people with type 2 diabetes, and replicated in independent samples (P=1.1x10(-4); OR = 1.20). The risk haplotype carries four amino acid substitutions, all in SLC16A11; it is present at similar to 50% frequency in Native American samples and similar to 10% in east Asian, but is rare in European and African samples. Analysis of an archaic genome sequence indicated that the risk haplotype introgressed into modern humans via admixture with Neanderthals. The SLC16A11 messenger RNA is expressed in liver, and V5-tagged SLC16A11 protein localizes to the endoplasmic reticulum. Expression of SLC16A11 in heterologous cells alters lipid metabolism, most notably causing an increase in intracellular triacylglycerol levels. Despite type 2 diabetes having been well studied by genome-wide association studies in other populations, analysis in Mexican and Latin American individuals identified SLC16A11 as a novel candidate gene for type 2 diabetes with a possible role in triacylglycerol metabolism.	[Williams, Amy L.; Jacobs, Suzanne B. R.; Churchhouse, Claire; Florez, Jose C.; Altshuler, David; Ripke, Stephan; Manning, Alisa K.; Neale, Benjamin; Burtt, Noel P.; Murphy, Jacquelyn; Sankararaman, Sriram; Patterson, Nick; MacArthur, Daniel G.; Reich, David; Flannick, Jason; Fontanillas, Pierre] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Reich, David; Altshuler, David; Sankararaman, Sriram] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Moreno-Macias, Hortensia; Moreno-Macias, Hortensia] Univ Autonoma Metropolitana, Mexico City 14387, DF, Mexico; [Jose Gomez-Vazquez, Maria; Tusie-Luna, Teresa; Jose Gomez-Vazquez, Maria; Luisa Ordonez-Sanchez, Maria; Rodriguez-Guillen, Rosario; Cruz-Bautista, Ivette; Rodriguez-Torres, Maribel; Liliana Munoz-Hernandez, Linda; Saenz, Tamara; Gomez, Donaji; Alvirde, Ulices] Inst Nacl Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Riba, Laura; Reich, David] Univ Nacl Autonoma Mexico, Unidad Biol Mol & Med Genom, UNAM INCMNSZ, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Marquez-Luna, Carla; Orozco, Lorena; Marquez-Luna, Carla; Carlos Fernandez-Lopez, Juan; Romero-Hidalgo, Sandra; Aguilar-Delfin, Irma; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Cordova, Emilio; Soberon, Xavier] Inst Nacl Med Genom, Mexico City 14610, DF, Mexico; [Jose Gomez-Vazquez, Maria; Jose Gomez-Vazquez, Maria] Univ Autonoma Nuevo Leon, San Nicolas De Los Garza 66451, Nuevo Leon, Mexico; [Gonzalez-Villalpando, Clicerio; Elena Gonzalez-Villalpando, Maria] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Unidad Invest Diabet & Riesgo Cardiovasc, Ctr Estudios Diabet, Mexico City 01120, DF, Mexico; [Flannick, Jason] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Flannick, Jason] Massachusetts Gen Hosp, Diabet Res Ctr, Diabet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Haiman, Christopher A.; Stram, Daniel O.; Henderson, Brian E.; Monroe, Kristine] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; [Ripke, Stephan; Neale, Benjamin; Lek, Monkol; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Revilla-Monsalve, Cristina; Islas-Andrade, Sergio] Inst Seguro Social SXXI, Unidad Invest Med Enfermedades Metab, Mexico City 06720, DF, Mexico; [Rodriguez-Arellano, Eunice] Inst Seguridad & Serv Sociales Trabajadores Estad, Mexico City 01030, DF, Mexico; [Wilkens, Lynne; Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96813 USA; [Onofrio, Robert C.; Brodeur, Wendy M.; Gage, Diane; Franklin, Jennifer; Mahan, Scott; Ardlie, Kristin; Crenshaw, Andrew T.; Winckler, Wendy; Fennell, Timothy; Farjoun, Yossi; Gabriel, Stacey] Broad Inst Harvard & MIT, Genom Platform, Cambridge, MA 02142 USA; [Prufer, Kay; Sawyer, Susanna; Stenzel, Udo; Kelso, Janet; Paabo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Palaeolith Dept, Novosibirsk 630090, Russia; [Gopal, Shuba; Grammatikos, James A.; Bullock, Kevin H.; Deik, Amy A.; Souza, Amanda L.; Pierce, Kerry A.; Clish, Clary B.] Broad Inst Harvard & MIT, Metabolite Profiling Platform, Cambridge, MA 02142 USA; [Smith, Ian C.] Broad Inst Harvard & MIT, Canc Biol Program, Cambridge, MA 02142 USA; [Gross, Myron D.; Pereira, Mark A.] Univ Minnesota, Minneapolis, MN 55455 USA; [Seielstad, Mark] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Koh, Woon-Puay; Tai, E-Shyong] Duke Natl Univ Singapore, Grad Med Sch, Singapore SINGAPORE16, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117597, Singapore; [Morris, Andrew] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Teslovich, Tanya M.] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, Dept Med, Bronx, NY 10461 USA; [Blangero, John; Duggirala, Ravindranath; Le Marchand, Loic; Puppala, Sobha; Farook, Vidya S.; Curran, Joanne E.] Texas Biomed Res Inst, Dept Med, San Antonio, TX 78227 USA; [Bowden, Donald W.] Wake Forest Sch Med, Dept Internal Med, Dept Biochem, Ctr Genom & Personalized Med Res,Ctr Diabet Res, Winston Salem, NC 27157 USA; [Chambers, John] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London SW7 2AZ, England; [Kooner, Jaspal] Imperial Coll Healthcare NHS Trust, London W2 1NY, England; [Kooner, Jaspal] Ealing Hosp Natl Hlth Serv NHS Trust, Southall UB1 3HW, Middx, England; [Cho, Yoon Shin] Hallym Univ, Dept Biomed Sci, Chunchon 200702, Gangwon Do, South Korea; [Glaser, Benjamin] Hadassah Hebrew Univ, Sch Med, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel; [Glaser, Benjamin] E Wolfson Med Ctr, IDRG, Diabet Unit, IL-58100 Holon, Israel; [Hanis, Craig] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, NHLI, London W12 0HS, England; [Laakso, Markku] Univ Eastern Finland, Dept Med, FI-70211 Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, FI-70211 Kuopio, Finland; [Lee, Jong-Young] Korea Natl Inst Hlth, Ctr Genome Sci, Chungcheongbuk Do 363951, South Korea; [Teo, Yik Ying] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117597, Singapore; Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117456, Singapore; Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117546, Singapore; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Thameem, Farook; Abboud, Hanna E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA; [DeFronzo, Ralph A.; Jenkinson, Christopher P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA; [Lehman, Donna M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Clin Epidemiol, San Antonio, TX 78229 USA; [Cortes, Maria L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Universidad Autonoma Metropolitana - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Autonoma de Nuevo Leon; Instituto Nacional de Salud Publica; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Southern California; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; National University of Singapore; National University of Singapore; University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Texas Biomedical Research Institute; Wake Forest University; Imperial College London; Imperial College London; Hallym University; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Texas System; University of Texas Health Science Center Houston; Imperial College London; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Altshuler, D (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.	mttusie@gmail.com; altshuler@molbio.mgh.harvard.edu	Chen, Peng/E-5546-2015; del Rosario, Rodriguez-Guillen Maria/ADO-2554-2022; Salinas, Carlos A Aguilar/AAL-4491-2020; Clish, Clary/AAB-7124-2019; Blangero, John/ABA-7175-2021; Kelso, Janet/N-1812-2019; Seielstad, Mark/T-7841-2019; Altshuler, David M/A-4476-2009; Clish, Clary B/ABB-9374-2021; Revilla-Monsalve, Cristina/ABG-6663-2021; Ripke, Stephan/AAK-5486-2021; Derevianko, Anatoly P./Q-5975-2016; Fernandez, Juan Carlos/C-4976-2013; Glaser, Benjamin/F-8411-2017; Manning, Alisa Knodle/ABC-7711-2021; /ABI-8453-2020; Lee, Jong-Young/M-6319-2013; Shunkov, Mikhail V./Q-6576-2016; ARELLANO, MARTHA EUNICE RODRIGUEZ/G-3974-2017	Chen, Peng/0000-0002-1422-4641; del Rosario, Rodriguez-Guillen Maria/0000-0002-6587-5786; Kelso, Janet/0000-0002-3618-322X; Altshuler, David M/0000-0002-7250-4107; Clish, Clary B/0000-0001-8259-9245; Derevianko, Anatoly P./0000-0003-1156-8331; Fernandez, Juan Carlos/0000-0003-3680-4193; Glaser, Benjamin/0000-0003-4711-5000; /0000-0002-9402-4219; Lee, Jong-Young/0000-0002-0092-9958; Shunkov, Mikhail V./0000-0003-1388-2308; ARELLANO, MARTHA EUNICE RODRIGUEZ/0000-0002-2135-6175; Munoz-Hernandez, Linda Liliana/0000-0003-2803-4408; Aguilar Delfin, Irma/0000-0002-4869-5302; MacArthur, Daniel/0000-0002-5771-2290; Curran, Joanne/0000-0002-6898-155X	Carlos Slim Health Institute; Consejo Nacional de Ciencia y Tecnologia [138826, 128877, 86867, 2092, M9303, F677-M9407, 251M, 2005-C01-14502, SALUD 2010-2-151165]; CONACyT-SALUD [2009-01-115250]; Direccion General de Asuntos del Personal Academico, UNAM [IT 214711]; Instituto Carlos Slim de la Salud; National Institutes of Health (NIH) [R01HL24799, CA164973, CA054281, CA063464, R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034, U01DK085526]; National Medical Research Council of Singapore; Veterans Administration Epidemiologic grant; National Institutes of Health Ruth L. Kirschstein National Research Service [F32 HG005944];  [R01 DK042273];  [R01 DK047482];  [R01 DK053889];  [R01 DK057295];  [P01 HL045522]; NATIONAL CANCER INSTITUTE [R01CA144034, UM1CA164973, U01CA164973, R01CA054281, R01CA055069, R35CA053890, R01CA080205, R01CA063464, U01CA063464, R37CA054281] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024799, P01HL045522] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399, F32HG005944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057295, U01DK085526, R01DK053889, R01DK042273, R01DK047482] Funding Source: NIH RePORTER	Carlos Slim Health Institute; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-SALUD(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Instituto Carlos Slim de la Salud; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Veterans Administration Epidemiologic grant; National Institutes of Health Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Daly, V. Mootha, E. Lander and K. Estrada for comments on the manuscript, B. Voight, A. Segre, J. Pickrell and the Scientific Advisory Board of the SIGMA Project (especially C. Bustamante) for useful discussions, and A. Subramanian and V. Rusu for assistance with expression analyses. This work was conducted as part of the Slim Initiative for Genomic Medicine, a joint US-Mexico project funded by the Carlos Slim Health Institute. The UNAM/INCMNSZ Diabetes Study was supported by Consejo Nacional de Ciencia y Tecnologia grants 138826, 128877, CONACyT-SALUD 2009-01-115250, and a grant from Direccion General de Asuntos del Personal Academico, UNAM, IT 214711. The Diabetes in Mexico Study was supported by Consejo Nacional de Ciencia y Tecnologia grant 86867 and by Instituto Carlos Slim de la Salud,A.C. The Mexico City Diabetes Study was supported by National Institutes of Health (NIH) grant R01HL24799 and by the Consejo Nacional de Ciencia y Tenologia grants 2092, M9303, F677-M9407, 251M and 2005-C01-14502, SALUD 2010-2-151165. The Multiethnic Cohort was supported by NIH grants CA164973, CA054281 and CA063464. The Singapore Chinese Health Study was funded by the National Medical Research Council of Singapore under its individual research grant scheme and by NIH grants R01 CA55069, R35 CA53890, R01 CA80205 and R01 CA144034. The Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) project was supported by NIH grant U01DK085526. The San Antonio Mexican American Family Studies (SAMAFS) were supported by R01 DK042273, R01 DK047482, R01 DK053889, R01 DK057295, P01 HL045522 and a Veterans Administration Epidemiologic grant to R.A.D. A.L.W. was supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award number F32 HG005944.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Hara K., 2013, HUM MOL GENET; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Max Planck Institute for Evolutionary Anthropology, 2013, HIGH QUAL NEAND GEN; Mednikova MB, 2011, ARCHAEOL ETHNOL ANTH, V39, P129, DOI 10.1016/j.aeae.2011.06.017; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zaitlen N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003032	29	312	326	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					97	+		10.1038/nature12828	http://dx.doi.org/10.1038/nature12828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24390345	Green Accepted			2022-12-28	WOS:000330648100039
J	Lee, J; Urban, A; Li, X; Su, D; Hautier, G; Ceder, G				Lee, Jinhyuk; Urban, Alexander; Li, Xin; Su, Dong; Hautier, Geoffroy; Ceder, Gerbrand			Unlocking the Potential of Cation-Disordered Oxides for Rechargeable Lithium Batteries	SCIENCE			English	Article							CATHODE MATERIALS; ELECTRODE MATERIALS; SOLID-SOLUTION; ION BATTERIES; HIGH-CAPACITY; HIGH-POWER; LIXCOO2; ELECTROCHEMISTRY; EXTRACTION; CHEMISTRY	Nearly all high-energy density cathodes for rechargeable lithium batteries are well-ordered materials in which lithium and other cations occupy distinct sites. Cation-disordered materials are generally disregarded as cathodes because lithium diffusion tends to be limited by their structures. The performance of Li1.211Mo0.467Cr0.3O2 shows that lithium diffusion can be facile in disordered materials. Using ab initio computations, we demonstrate that this unexpected behavior is due to percolation of a certain type of active diffusion channels in disordered Li-excess materials. A unified understanding of high performance in both layered and Li-excess materials may enable the design of disordered-electrode materials with high capacity and high energy density.	[Lee, Jinhyuk; Urban, Alexander; Li, Xin; Hautier, Geoffroy; Ceder, Gerbrand] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Su, Dong] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Brookhaven National Laboratory	Ceder, G (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	gceder@mit.edu	Ceder, Gerbrand/Y-2544-2019; Su, Dong/A-8233-2013; Hautier, Geoffroy/GQP-2814-2022	Su, Dong/0000-0002-1921-6683; /0000-0002-9021-279X	Robert Bosch Corporation; Umicore Specialty Oxides and Chemicals; Samsung Scholarship; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-98CH10886]	Robert Bosch Corporation; Umicore Specialty Oxides and Chemicals; Samsung Scholarship(Samsung); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Supported by the Robert Bosch Corporation, by Umicore Specialty Oxides and Chemicals, and by a Samsung Scholarship (J.L.). Computational resources from the National Energy Research Scientific Computing Center (NERSC) and from the Extreme Science and Engineering Discovery Environment (XSEDE) are gratefully acknowledged. The STEM work carried out at the Center for Functional Nanomaterials, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-98CH10886. We thank N. Twu, S. Kim, and J. Kim for valuable discussions.	Amatucci GG, 1996, J ELECTROCHEM SOC, V143, P1114, DOI 10.1149/1.1836594; Breger J, 2006, CHEM MATER, V18, P4768, DOI 10.1021/cm060886r; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; JACOBSON AJ, 1979, MATER RES BULL, V14, P1437, DOI 10.1016/0025-5408(79)90087-4; JAMES ACWP, 1988, J SOLID STATE CHEM, V76, P87, DOI 10.1016/0022-4596(88)90194-6; Johnson CS, 2004, ELECTROCHEM COMMUN, V6, P1085, DOI 10.1016/j.elecom.2004.08.002; Kang K, 2003, CHEM MATER, V15, P4503, DOI 10.1021/cm034455+; Kang K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094105; Kang KS, 2006, SCIENCE, V311, P977, DOI 10.1126/science.1122152; Lu ZH, 2002, J ELECTROCHEM SOC, V149, pA815, DOI 10.1149/1.1480014; Lu ZH, 2001, ELECTROCHEM SOLID ST, V4, pA200, DOI 10.1149/1.1413182; Obrovac MN, 1998, SOLID STATE IONICS, V112, P9, DOI 10.1016/S0167-2738(98)00225-2; OHZUKU T, 1993, J ELECTROCHEM SOC, V140, P1862, DOI 10.1149/1.2220730; Ozawa K, 2007, J POWER SOURCES, V174, P469, DOI 10.1016/j.jpowsour.2007.06.100; Peres JP, 1996, J PHYS CHEM SOLIDS, V57, P1057, DOI 10.1016/0022-3697(95)00395-9; Pralong V, 2012, CHEM MATER, V24, P12, DOI 10.1021/cm203281q; Rougier A, 1996, J ELECTROCHEM SOC, V143, P1168, DOI 10.1149/1.1836614; Rougier A, 1996, SOLID STATE IONICS, V90, P83, DOI 10.1016/S0167-2738(96)00370-0; Sakurai Y, 1998, SOLID STATE IONICS, V113, P29, DOI 10.1016/S0167-2738(98)00363-4; Sathiya M, 2013, NAT MATER, V12, P827, DOI [10.1038/nmat3699, 10.1038/NMAT3699]; Shaju KM, 2008, DALTON T, P5471, DOI 10.1039/b806662k; THACKERAY MM, 1984, MATER RES BULL, V19, P179, DOI 10.1016/0025-5408(84)90088-6; Van der Ven A, 2000, ELECTROCHEM SOLID ST, V3, P301, DOI 10.1149/1.1391130; Van der Ven A, 1998, PHYS REV B, V58, P2975, DOI 10.1103/PhysRevB.58.2975; Van der Ven A, 1998, J ELECTROCHEM SOC, V145, P2149, DOI 10.1149/1.1838610; Whittingham MS, 2004, CHEM REV, V104, P4271, DOI 10.1021/cr020731c; Yabuuchi N, 2011, J AM CHEM SOC, V133, P4404, DOI 10.1021/ja108588y; Zhang LQ, 2003, J ELECTROCHEM SOC, V150, pA601, DOI 10.1149/1.1566016	29	727	745	58	1069	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					519	522		10.1126/science.1246432	http://dx.doi.org/10.1126/science.1246432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24407480				2022-12-28	WOS:000330343700041
J	Rashad, H				Rashad, Hoda			Health equity in the Arab world: the future we want	LANCET			English	Editorial Material									Amer Univ Cairo, Social Res Ctr, New Cairo 11835, Egypt	Egyptian Knowledge Bank (EKB); American University Cairo	Rashad, H (corresponding author), Amer Univ Cairo, Social Res Ctr, New Cairo 11835, Egypt.	hrashad@aucegypt.edu						Al Riyami Asya, 2012, Oman Med J, V27, P425; [Anonymous], [No title captured]; Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA; GRAHAM WJ, 1992, SOC SCI MED, V35, P967, DOI 10.1016/0277-9536(92)90236-J; Khadr Z, 2012, PUBLIC HEALTH IN THE ARABWORLD, P61; Khawaja M, 2012, PUBLIC HEALTH IN THE ARABWORLD, P75; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Ministry of Economic Development and the United Nations Development Program, 2010, EG PROGR ACH MILL DE; Peter F, 2001, J Appl Philos, V18, P159; Rashad H, 2012, PUBLIC HEALTH IN THE ARABWORLD, P106; UN, 2004, TUN NAT REP MILL DEV; United Nations Development Programme (UNDP), 2013, HUM DEV REP RIS S HU; WHO, 2005, UN AR EM WORLD HLTH	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					286	287		10.1016/S0140-6736(13)62350-8	http://dx.doi.org/10.1016/S0140-6736(13)62350-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452040				2022-12-28	WOS:000330212600008
J	Eleftheriades, GV				Eleftheriades, George V.			ELECTRONICS Protecting the weak from the strong	NATURE			English	Editorial Material									Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada	University of Toronto	Eleftheriades, GV (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.	gelefth@ece.utoronto.ca						Moreau A, 2012, NATURE, V492, P86, DOI 10.1038/nature11615; Rainwater D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013054; Selvanayagam M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041011; Wakatsuchi H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.245501; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	5	33	33	4	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					490	491		10.1038/nature12852	http://dx.doi.org/10.1038/nature12852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24429519				2022-12-28	WOS:000329995000026
J	Casares, J; Negueruela, I; Ribo, M; Ribas, I; Paredes, JM; Herrero, A; Simon-Diaz, S				Casares, J.; Negueruela, I.; Ribo, M.; Ribas, I.; Paredes, J. M.; Herrero, A.; Simon-Diaz, S.			A Be-type star with a black-hole companion	NATURE			English	Article							X-RAY BINARIES; MASSIVE STARS; NEUTRON-STAR; CYGNUS X-1; EVOLUTION; PARAMETERS; SPECTRA; MODELS; MASSES; GALAXY	Stellar-mass black holes have all been discovered through X-ray emission, which arises from the accretion of gas from their binary companions (this gas is either stripped from low-mass stars or supplied as winds from massive ones). Binary evolution models also predict the existence of black holes accreting from the equatorial envelope of rapidly spinning Be-type stars(1-3) (stars of the Be type are hot blue irregular variables showing characteristic spectral emission lines of hydrogen). Of the approximately 80 Be X-ray binaries known in the Galaxy, however, only pulsating neutron stars have been found as companions(2-4). A black hole was formally allowed as a solution for the companion to the Be star MWC656 (ref. 5; also known as HD 215227), although that conclusion was based on a single radial velocity curve of the Be star, a mistaken spectral classification(6) and rough estimates of the inclination angle. Here we report observations of an accretion disk line mirroring the orbit of MWC656. This, together with an improved radial velocity curve of the Be star through fitting sharp Fe II profiles from the equatorial disk, and a refined Be classification (to that of a B1.5-B2 III star), indicates that a black hole of 3.8 to 6.9 solar masses orbits MWC656, the candidate counterpart of the gamma-ray source AGL J2241+4454 (refs 5, 6). The black hole is X-ray quiescent and fed by a radiatively inefficient accretion flow giving a luminosity less than 1.6x10(-7) times the Eddington luminosity. This implies that Be binaries with black-hole companions are difficult to detect in conventional X-ray surveys.	[Casares, J.; Herrero, A.; Simon-Diaz, S.] Inst Astrofis Canarias, E-28205 San Cristobal la Laguna, Santa Cruz De T, Spain; [Casares, J.; Herrero, A.; Simon-Diaz, S.] Univ La Laguna, Dept Astrofis, E-38206 San Cristobal la Laguna, Santa Cruz De T, Spain; [Negueruela, I.] Univ Alicante, Dept Fis Ingn Sistemas & Teoria Senal, E-03080 Alicante, Spain; [Ribo, M.; Paredes, J. M.] Univ Barcelona, Inst Ciencies Cosmos, Dept Astron & Meteorol, IEEC UB, E-08028 Barcelona, Spain; [Ribas, I.] IEEC CSIC, Fac Ciencies, Inst Ciencies Espai, E-08193 Bellaterra, Spain	Instituto de Astrofisica de Canarias; Universidad de la Laguna; Universitat d'Alacant; Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC)	Casares, J (corresponding author), Inst Astrofis Canarias, E-28205 San Cristobal la Laguna, Santa Cruz De T, Spain.	jorge.casares@iac.es	Casares, Jorge/N-4012-2014; Ribas, Ignasi/M-2134-2014; Simón-Díaz, Sergio/AAE-1921-2019; Casares, Jorge/GVT-2693-2022; Herrero, Artemio/H-7312-2015; Negueruela, Ignacio/L-5483-2014; Ribó, Marc/B-3579-2015	Ribas, Ignasi/0000-0002-6689-0312; Simón-Díaz, Sergio/0000-0003-1168-3524; Negueruela, Ignacio/0000-0003-1952-3680; Ribó, Marc/0000-0002-9931-4557; Casares, Jorge/0000-0001-5031-0128; Paredes, Josep M./0000-0002-1566-9044	UK Science and Technology Facilities Council; Spanish MINECO; FEDER [AYA2010-18080, AYA2010-21782-C03-01, AYA2010-21967-C05-04/05, AYA2012-39364-C02-01/02, AYA2012-39612-C03-01, FPA2010-22056-C06-02, SEV2011-0187-01]; Gobierno de Canarias [PID 2010119]; ICREA Academia; Science and Technology Facilities Council [ST/M003035/1, ST/M000095/1] Funding Source: researchfish; STFC [ST/M003035/1, ST/M000095/1, ST/G009465/1] Funding Source: UKRI	UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Spanish MINECO(Spanish Government); FEDER(European Commission); Gobierno de Canarias; ICREA Academia(ICREA); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank T. Maccarone and P. Charles for comments on the paper. This work made use of the molly software package developed by T. R. Marsh. The Liverpool telescope and the Mercator telescope are operated on the island of La Palma by the Liverpool John Moores University and the University of Leuven/Observatory of Geneva, respectively, in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. The Liverpool telescope is funded by the UK Science and Technology Facilities Council. This research was supported by the Spanish MINECO and FEDER under grants AYA2010-18080, AYA2010-21782-C03-01, AYA2010-21967-C05-04/05, AYA2012-39364-C02-01/02, AYA2012-39612-C03-01, FPA2010-22056-C06-02 and SEV2011-0187-01; it was also funded by grant PID 2010119 from the Gobierno de Canarias. J.M.P. acknowledges financial support from ICREA Academia.	Abt HA, 2002, ASTROPHYS J, V573, P359, DOI 10.1086/340590; Albert J, 2007, ASTROPHYS J, V665, pL51, DOI 10.1086/521145; Arias ML, 2006, ASTRON ASTROPHYS, V460, P821, DOI 10.1051/0004-6361:20065160; BALLEREAU D, 1995, ASTRON ASTROPHYS SUP, V111, P423; Belczynski K, 2002, ASTROPHYS J, V572, P407, DOI 10.1086/340304; Belczynski K, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/96; Belczynski K, 2009, ASTROPHYS J, V707, P870, DOI 10.1088/0004-637X/707/2/870; Boersma J., 1961, B ASTRON I NETH, V15, P291; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; Casares J, 2012, MON NOT R ASTRON SOC, V421, P1103, DOI 10.1111/j.1365-2966.2011.20368.x; Coriat M, 2012, MON NOT R ASTRON SOC, V424, P1991, DOI 10.1111/j.1365-2966.2012.21339.x; Esin AA, 1997, ASTROPHYS J, V489, P865, DOI 10.1086/304829; Etzel P. B., 2004, SBOP SPECTROSCOPIC B; Garcia MR, 2001, ASTROPHYS J, V553, pL47, DOI 10.1086/320494; Gray D. F., 1992, OBSERVATIONS ANAL ST, V20; Hanuschik RW, 1996, ASTRON ASTROPHYS, V308, P170; HARMANEC P, 1988, B ASTRON I CZECH, V39, P329; Howarth ID, 2001, MON NOT R ASTRON SOC, V327, P353, DOI 10.1046/j.1365-8711.2001.04658.x; HUBENY I, 1995, ASTROPHYS J, V439, P875, DOI 10.1086/175226; LESH JR, 1968, ASTROPHYS J SUPPL S, V17, P371, DOI 10.1086/190179; Linden T, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/114; LIPUNOV VM, 1994, ASTROPHYS J, V423, pL121, DOI 10.1086/187251; Lucarelli F., 2010, ATEL, V2761, P1; Menou K, 1999, ASTROPHYS J, V513, P811, DOI 10.1086/306878; Merrill PW, 1943, ASTROPHYS J, V98, P153, DOI 10.1086/144557; Mirabel IF, 2012, SCIENCE, V335, P175, DOI 10.1126/science.1215895; NARAYAN R, 1991, ASTROPHYS J, V379, pL17, DOI 10.1086/186143; Negueruela I, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/1/L11; Nicolet B., 1978, Astronomy and Astrophysics Supplement Series, V34, P1; Okazaki AT, 2001, ASTRON ASTROPHYS, V377, P161, DOI 10.1051/0004-6361:20011083; Paredes-Fortuny X, 2012, AIP CONF PROC, V1505, P390, DOI 10.1063/1.4772279; Pavlovski K, 2009, MON NOT R ASTRON SOC, V400, P791, DOI 10.1111/j.1365-2966.2009.15479.x; Peters GJ, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/2; Plotkin RM, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/59; Portegies Zwart S, 1998, ASTRON ASTROPHYS, V332, P173; Puls J, 2005, ASTRON ASTROPHYS, V435, P669, DOI 10.1051/0004-6361:20042365; Raguzova NV, 1999, ASTRON ASTROPHYS, V349, P505; Reig P, 2011, ASTROPHYS SPACE SCI, V332, P1, DOI 10.1007/s10509-010-0575-8; Ryans RSI, 2002, MON NOT R ASTRON SOC, V336, P577, DOI 10.1046/j.1365-8711.2002.05780.x; Sabatini S, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/83; SCHALLER G, 1992, ASTRON ASTROPHYS SUP, V96, P269; SCHNEIDER DP, 1980, ASTROPHYS J, V238, P946, DOI 10.1086/158059; SHAFTER AW, 1986, ASTROPHYS J, V308, P765, DOI 10.1086/164549; Smak J., 1969, Acta Astronomica, V19, P155; Smak J., 1985, Acta Astronomica, V35, P351; STRAIZYS V, 1981, ASTROPHYS SPACE SCI, V80, P353, DOI 10.1007/BF00652936; Thompson G. I., 1978, CATALOGUE STELLAR UL; Torres G, 2010, ASTRON ASTROPHYS REV, V18, P67, DOI 10.1007/s00159-009-0025-1; Walborn NR, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/150; Williams SJ, 2010, ASTROPHYS J LETT, V723, pL93, DOI 10.1088/2041-8205/723/1/L93; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; Zhang F, 2004, ASTROPHYS J, V603, P663, DOI 10.1086/381540; Ziolkowski J, 2011, IAU SYMP P SERIES, P329, DOI 10.1017/S1743921310016340	54	118	119	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					378	+		10.1038/nature12916	http://dx.doi.org/10.1038/nature12916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429635	Green Submitted			2022-12-28	WOS:000329621800037
J	Cho, JY; Sternberg, PW				Cho, Julie Y.; Sternberg, Paul W.			Multilevel Modulation of a Sensory Motor Circuit during C. elegans Sleep and Arousal	CELL			English	Article							OPTICAL INTERROGATION; NEURAL CIRCUITS; NERVOUS-SYSTEM; CONSOLIDATION; QUIESCENCE; NEURONS; MODEL	Sleep is characterized by behavioral quiescence, homeostasis, increased arousal threshold, and rapid reversibility. Understanding how these properties are encoded by a neuronal circuit has been difficult, and no single molecular or neuronal pathway has been shown to be responsible for the regulation of sleep. Taking advantage of the well-mapped neuronal connections of Caenorhabditis elegans and the sleep-like states in this animal, we demonstrate the changed properties of both sensory neurons and downstream interneurons that mediate sleep and arousal. The ASH sensory neuron displays reduced sensitivity to stimuli in the sleep-like state, and the activity of the corresponding interneurons in ASH's motor circuit becomes asynchronous. Restoration of interneuron synchrony is sufficient for arousal. The multilevel circuit depression revealed provides an elegant strategy to promote a robust decrease in arousal while allowing for rapid reversibility of the sleep state.	[Cho, Julie Y.; Sternberg, Paul W.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Cho, Julie Y.; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	pws@caltech.edu		Cho, Julie/0000-0002-9005-5157	National Institutes of Health USPHS training grant [GM07616]; Howard Hughes Medical Institute; NIH grant [DA018341]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER	National Institutes of Health USPHS training grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank William Schafer (University of Cambridge), Alexander Gottschalk (Johann Wolfgang Goethe University), Elissa Hallem (University of California, Los Angeles), and the Caenorhabditis Genetics Center (University of Minnesota) for worm strains and Karl Deisseroth (Stanford University) for channelrhodopsin constructs. We also thank David Anderson, David Prober, Alon Zaslaver, Trevor Fowler, and Lauren Lebon for their input and Meenakshi Doma, Yen-ping Hsueh, Mihoko Kato, Hillel Schwartz, and members of our lab for editorial comments. J.Y.C. was supported by National Institutes of Health USPHS training grant GM07616. This work was supported by the Howard Hughes Medical Institute, with which P.W.S. is an investigator, and by NIH grant DA018341 to P.W.S.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatzigeorgiou M, 2011, NEURON, V70, P299, DOI 10.1016/j.neuron.2011.02.046; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Dabbish NS, 2011, J NEUROSCI, V31, P15932, DOI 10.1523/JNEUROSCI.0742-11.2011; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Lindsay TH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1304; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; Metherate R, 2004, PROG BRAIN RES, V145, P143, DOI 10.1016/S0079-6123(03)45010-3; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Narayan A, 2011, P NATL ACAD SCI USA, V108, P9667, DOI 10.1073/pnas.1106617108; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Schmitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043164; Schwarz J, 2011, CURR BIOL, V21, pR983, DOI 10.1016/j.cub.2011.10.046; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zimmerman JE, 2008, TRENDS NEUROSCI, V31, P371, DOI 10.1016/j.tins.2008.05.001	34	60	61	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					249	260		10.1016/j.cell.2013.11.036	http://dx.doi.org/10.1016/j.cell.2013.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439380	Green Accepted, Bronze			2022-12-28	WOS:000329912200025
J	Wu, H; Zhang, Y				Wu, Hao; Zhang, Yi			Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions	CELL			English	Review							EMBRYONIC STEM-CELLS; DOMAIN-CONTAINING PROTEINS; ACUTE MYELOID-LEUKEMIA; DE-NOVO METHYLATION; CPG BINDING DOMAIN; THYMINE DNA; GENE-EXPRESSION; TET PROTEINS; CXXC DOMAIN; 5-METHYLCYTOSINE OXIDATION	Methylation of cytosines in the mammalian genome represents a key epigenetic modification and is dynamically regulated during development. Compelling evidence now suggests that dynamic regulation of DNA methylation is mainly achieved through a cyclic enzymatic cascade comprised of cytosine methylation, iterative oxidation of methyl group by TET dioxygenases, and restoration of unmodified cytosines by either replication-dependent dilution or DNA glycosylase-initiated base excision repair. In this review, we discuss the mechanism and function of DNA demethylation in mammalian genomes, focusing particularly on how developmental modulation of the cytosine-modifying pathway is coupled to active reversal of DNA methylation in diverse biological processes.	[Wu, Hao; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Wu, Hao; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wu, Hao; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wu, Hao; Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, Y (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, WAB 149G,200 Longwood Ave, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu	Wu, Hao/G-4145-2013; Wu, Hao/H-3899-2017	Wu, Hao/0000-0002-1256-6891; Wu, Hao/0000-0003-1269-7354; Zhang, Yi/0000-0002-2789-0811; Wu, Hao/0000-0003-4395-6929	NIH [GM68804, U01DK089565]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Zhang Lab for their comments on the manuscript. We apologize to colleagues whose work cannot be cited owing to space constrains. This work was supported by NIH grants GM68804 and U01DK089565 (to Y.Z.). H.W. is supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clark TA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-4; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Freudenberg JM, 2012, NUCLEIC ACIDS RES, V40, P3364, DOI 10.1093/nar/gkr1253; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Huang Y, 2012, NAT PROTOC, V7, P1897, DOI 10.1038/nprot.2012.103; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Kemmerich K, 2012, NUCLEIC ACIDS RES, V40, P6016, DOI 10.1093/nar/gks259; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Li WW, 2013, ANGEW CHEM INT EDIT, V52, P4350, DOI 10.1002/anie.201300413; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Lu XY, 2013, J AM CHEM SOC, V135, P9315, DOI 10.1021/ja4044856; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Otani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082961; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Robertson AB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr051; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schiesser S, 2012, ANGEW CHEM INT EDIT, V51, P6516, DOI 10.1002/anie.201202583; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smiley JA, 2005, BBA-GEN SUBJECTS, V1723, P256, DOI 10.1016/j.bbagen.2005.02.001; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Song CX, 2013, TRENDS BIOCHEM SCI, V38, P480, DOI 10.1016/j.tibs.2013.07.003; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2012, NAT BIOTECHNOL, V30, P1107, DOI 10.1038/nbt.2398; Song CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/nmeth.1779]; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Thomson JP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1080; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi S, 2013, NATURE, V504, P460, DOI 10.1038/nature12805; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	214	700	739	22	361	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					45	68		10.1016/j.cell.2013.12.019	http://dx.doi.org/10.1016/j.cell.2013.12.019			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439369	Bronze, Green Accepted			2022-12-28	WOS:000329912200010
J	Dutrieux, P; De Rydt, J; Jenkins, A; Holland, PR; Ha, HK; Lee, SH; Steig, EJ; Ding, QH; Abrahamsen, EP; Schroder, M				Dutrieux, Pierre; De Rydt, Jan; Jenkins, Adrian; Holland, Paul R.; Ha, Ho Kyung; Lee, Sang Hoon; Steig, Eric J.; Ding, Qinghua; Abrahamsen, E. Povl; Schroeder, Michael			Strong Sensitivity of Pine Island Ice-Shelf Melting to Climatic Variability	SCIENCE			English	Article							CIRCUMPOLAR DEEP-WATER; OCEAN CIRCULATION; AMUNDSEN SEA; GLACIER; ANTARCTICA; STABILITY; RETREAT; RATES	Pine Island Glacier has thinned and accelerated over recent decades, significantly contributing to global sea-level rise. Increased oceanic melting of its ice shelf is thought to have triggered those changes. Observations and numerical modeling reveal large fluctuations in the ocean heat available in the adjacent bay and enhanced sensitivity of ice-shelf melting to water temperatures at intermediate depth, as a seabed ridge blocks the deepest and warmest waters from reaching the thickest ice. Oceanic melting decreased by 50% between January 2010 and 2012, with ocean conditions in 2012 partly attributable to atmospheric forcing associated with a strong La Nina event. Both atmospheric variability and local ice shelf and seabed geometry play fundamental roles in determining the response of the Antarctic Ice Sheet to climate.	[Dutrieux, Pierre; De Rydt, Jan; Jenkins, Adrian; Holland, Paul R.; Abrahamsen, E. Povl] British Antarctic Survey, Nat Environm Res Council NERC, Cambridge CB3 0ET, England; [Ha, Ho Kyung; Lee, Sang Hoon] Korea Inst Ocean Sci & Technol KIOST, Korea Polar Res Inst, Inchon, South Korea; [Steig, Eric J.; Ding, Qinghua] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Steig, Eric J.; Ding, Qinghua] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Schroeder, Michael] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Dutrieux, P (corresponding author), British Antarctic Survey, Nat Environm Res Council NERC, Cambridge CB3 0ET, England.	pierre.dutrieux@bas.ac.uk	Holland, Paul R/G-2796-2012; Steig, Eric J/G-9088-2015; Ha, Ho Kyung/HCH-4138-2022; ding, qinghua/G-1186-2011; Dutrieux, Pierre/B-7568-2012; Abrahamsen, Povl/B-2140-2008; De Rydt, Jan/H-5692-2018	Steig, Eric J/0000-0002-8191-5549; Dutrieux, Pierre/0000-0002-8066-934X; Abrahamsen, Povl/0000-0001-5924-5350; De Rydt, Jan/0000-0002-2978-8706; Jenkins, Adrian/0000-0002-9117-0616	Natural Environment Research Council [NE/G001367/1, NE/H02333X/1, NE/J005770/1]; Korea Polar Research Institute [PP12010, PP13020]; NSF [ANT-0424589]; NASA [NNX10AT68G]; NERC [NE/J005770/1, NE/H02333X/1, bas0100028, NE/G001367/1] Funding Source: UKRI; Natural Environment Research Council [bas0100028] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	P.D. and J.D.R. were supported by Natural Environment Research Council grants NE/G001367/1, NE/H02333X/1, and NE/J005770/1. H. K. H. and S. H. L. were supported by Korea Polar Research Institute grants PP12010 and PP13020. The European Centre for Medium-Range Weather Forecasts is acknowledged for serving the ERA-Interim reanalysis data set, and Center for Remote Sensing of Ice Sheets (with support from NSF grant ANT-0424589 and NASA grant NNX10AT68G) is acknowledged for generating and serving radar observations.	Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Dutrieux P, 2013, CRYOSPHERE, V7, P1543, DOI 10.5194/tc-7-1543-2013; Gladstone RM, 2012, EARTH PLANET SC LETT, V333, P191, DOI 10.1016/j.epsl.2012.04.022; Gudmundsson GH, 2012, CRYOSPHERE, V6, P1497, DOI 10.5194/tc-6-1497-2012; Heimbach P, 2012, ANN GLACIOL, V53, P59, DOI 10.3189/2012/AoG60A025; Holland PR, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005219; Jacobs S, 2013, J GEOPHYS RES-OCEANS, V118, P4152, DOI 10.1002/jgrc.20298; Jacobs SS, 1996, GEOPHYS RES LETT, V23, P957, DOI 10.1029/96GL00723; Jacobs S, 2012, OCEANOGRAPHY, V25, P154, DOI 10.5670/oceanog.2012.90; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jamieson SSR, 2012, NAT GEOSCI, V5, P799, DOI [10.1038/ngeo1600, 10.1038/NGEO1600]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Nakayama Y, 2013, DEEP-SEA RES PT I, V77, P50, DOI 10.1016/j.dsr.2013.04.001; Padman L, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007301; Park JW, 2013, GEOPHYS RES LETT, V40, P2137, DOI 10.1002/grl.50379; Petty AA, 2013, J PHYS OCEANOGR, V43, P920, DOI 10.1175/JPO-D-12-0172.1; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033365; Schodlok MP, 2012, ANN GLACIOL, V53, P156, DOI 10.3189/2012AoG60A073; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Shepherd A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042496; St-Laurent P, 2013, J PHYS OCEANOGR, V43, P51, DOI 10.1175/JPO-D-11-0237.1; Stanton TP, 2013, SCIENCE, V341, P1236, DOI 10.1126/science.1239373; Steig EJ, 2012, ANN GLACIOL, V53, P19, DOI 10.3189/2012AoG60A110; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Timmermann R., 2010, EARTH SYST SCI DATA, V2, P261, DOI [10.5194/essd-2-261-2010, DOI 10.5194/ESSD-2-261-2010]; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126	34	262	266	3	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					174	178		10.1126/science.1244341	http://dx.doi.org/10.1126/science.1244341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24385606	Green Submitted, Green Accepted			2022-12-28	WOS:000329440800040
J	Soloveichik, GL				Soloveichik, Grigorii L.			ELECTROCHEMISTRY Metal-free energy storage	NATURE			English	Editorial Material							REDOX FLOW BATTERIES; PROGRESS		[Soloveichik, Grigorii L.] Gen Elect Global Res, Niskayuna, NY 12309 USA; [Soloveichik, Grigorii L.] Gen Elect Global Res, Energy Frontier Res Ctr Electrocatalysis Transpor, Niskayuna, NY 12309 USA	General Electric; General Electric	Soloveichik, GL (corresponding author), Gen Elect Global Res, Niskayuna, NY 12309 USA.	soloveichik@ge.com		Soloveichik, Grigorii/0000-0003-4013-6327				Alt H., 1972, Journal of Applied Electrochemistry, V2, P193, DOI 10.1007/BF02354976; Cho KT, 2012, J ELECTROCHEM SOC, V159, pA1806, DOI 10.1149/2.018211jes; Denholm P., 2010, ROLE ENERGY STORAGE; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; Leung P, 2012, RSC ADV, V2, P10125, DOI 10.1039/c2ra21342g; Soloveichik GL, 2011, ANNU REV CHEM BIOMOL, V2, P503, DOI 10.1146/annurev-chembioeng-061010-114116; Wang W, 2013, ADV FUNCT MATER, V23, P970, DOI 10.1002/adfm.201200694; Weber AZ, 2011, J APPL ELECTROCHEM, V41, P1137, DOI 10.1007/s10800-011-0348-2	8	48	49	2	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					163	165		10.1038/505163a	http://dx.doi.org/10.1038/505163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24402274				2022-12-28	WOS:000329441500024
J	Gornall, J				Gornall, Jonathan			ALCOHOL AND PUBLIC HEALTH Under the influence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						All-Party Parliamentary Beer Group, 2012, BEER TAX FRAUD INQ; [Anonymous], CLIENT LIST; [Anonymous], 2012, E BULLETIN; Australian National Preventive Health Agency, EXPL PUBL INT CAS; Bartlett J, 2011, INFLUENCE WHAT WE KN; Birdwell J, 2012, FEELING THE EFFECTS; Boseley S., 2008, GUARDIAN; Brindle J., 2013, BURTON MAIL; Centre for Economics and Business Research, 2012, MIN UN PRIC IMP CONS; Centre for Policy Studies, 2012, COMMUNICATION; Chapman J., 2012, DAILY MAIL; Department of Health, 2011, PUBL HLTH RESP DEAL; Distilled Spirits Industry Council of Australia, MINIMUM PRICING; Doward J., 2013, OBSERVER; Duffy JC, 2012, MINIMAL EVIDENCE MIM; Harris T, 2013, BROMSGROVE STANDARD; Hawkins B, 2012, WATER DRIPPING STONE; Hawkins B, 2013, CRIT POLICY STUD, V7, P53, DOI 10.1080/19460171.2013.766023; Health of Commons Health Committee, 1 REP SESS 2009 10; Helm Toby, 2013, OBSERVER; HM Government, 2012, ALC STRAT; HM Government, 2010, HLTH LIV HLTH POEPL; HM Government, 2013, BRIEFING NOTES; Hogan O, 2012, ALCOHOL CONSUMPTION; Home Office, 2012, CONSULTATION DELIVER; Jenkins A., 2012, BURTON MAIL; Johnston Philip, 2013, TELEGRAPH; Kirkup J, 2013, TELEGRAPH; Laurance Jeremy, 2010, INDEPENDENT; Mason R., 2013, TELEGRAPH; Meng Y, 2013, MODELLED INCOME GROU; *NICE, 2010, ALC US DIS PREV HARM; NSW Government, REG LOBB; Oxford Economics, 2009, OXFORD ECONOMICS; Public Health, 2011, HLTH COMM 12 REP; Public Health Commission, 2009, WER ALL THIS TOG IMP; Scotch Whisky Association, POL PART PROM; Scotch Whisky Association, 2012, MINIMUM PRICING; Sheffield Alcohol Research Group, 2013, ADD EX IMP BANM; Snowdon C., 2013, IAE BLOG; Snowdon C., 2012, PLAIN PACKAGING COMM; Thomas N., 2013, SUNDAY TELEGRAPH; Triggle N., 2011, BBC NEWS; Van-Horne S, 2013, APP TAK FORM CROWN S; Whyte J., 2013, QUACK POLICY ABUSING; Wine and Spirit Trade Association, GEN FACTS FIG; Wine and Spirit Trade Association, 2013, WHY SHOULD REPS DRIN; Wintour P, 2013, GUARDIAN; Woodard R., 2011, DECANTER	49	40	40	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								f7646	10.1136/bmj.f7646	http://dx.doi.org/10.1136/bmj.f7646			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KI	24401176				2022-12-28	WOS:000329610300006
J	Binagwaho, A; Muhimpundu, MA; Bukhman, G				Binagwaho, Agnes; Muhimpundu, Marie Aimee; Bukhman, Gene		NCD Synergies Grp	80 under 40 by 2020: an equity agenda for NCDs and injuries	LANCET			English	Editorial Material							NONCOMMUNICABLE DISEASES; RWANDA		[Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes; Bukhman, Gene] Harvard Univ, Sch Med, Boston, MA USA; [Binagwaho, Agnes] Geisel Sch Med Dartmouth, Hanover, NH USA; [Muhimpundu, Marie Aimee] Rwanda Biomed Ctr, Kigali, Rwanda; [Bukhman, Gene] Partners Hlth, Boston, MA USA; [Bukhman, Gene] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Dartmouth College; Rwanda Biomedical Center; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Binagwaho, A (corresponding author), Minist Hlth, Kigali, Rwanda.	agnesbinagwaho@yahoo.fr		Mocumbi, Ana/0000-0002-9564-2860; Kwan, Gene/0000-0002-0929-6800				[Anonymous], 2012, THE OAKLAND STATEMEN; [Anonymous], 2013, INAUGURAL NCD SYNERG; [Anonymous], 2011, THE BRAZZAVILLE DECL; [Anonymous], 2013, DRAFT COMPREHENSIVE; [Anonymous], 2011, BOSTON STATEMENT ON; Binagwaho A, 2013, NEW ENGL J MED, V369, P2054, DOI 10.1056/NEJMsr1302176; Binagwaho A, 2011, LANCET, V378, P1916, DOI 10.1016/S0140-6736(11)61837-0; Binagwaho Agnes, 2013, 80 MORTALITY REDUCTI; Brown H, 2007, B WORLD HEALTH ORGAN, V85, P425; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Institute for Health Metrics and Evaluation, GLOBAL BURDEN OF DIS; Mensah GA, 2013, SAMJ S AFR MED J, V103, P77, DOI [10.7196/samj.6347, 10.7196/SAMJ.6347]	13	37	37	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					3	4		10.1016/S0140-6736(13)62423-X	http://dx.doi.org/10.1016/S0140-6736(13)62423-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SP	24388297				2022-12-28	WOS:000329341200006
J	Dysken, MW; Sano, M; Asthana, S; Vertrees, JE; Pallaki, M; Llorente, M; Love, S; Schellenberg, GD; McCarten, JR; Malphurs, J; Prieto, S; Chen, PJ; Loreck, DJ; Trapp, G; Bakshi, RS; Mintzer, JE; Heidebrink, JL; Vidal-Cardona, A; Arroyo, LM; Cruz, AR; Zachariah, S; Kowall, NW; Chopra, MP; Craft, S; Thielke, S; Turvey, CL; Woodman, C; Monnell, KA; Gordon, K; Tomaska, J; Segal, Y; Peduzzi, PN; Guarino, PD				Dysken, Maurice W.; Sano, Mary; Asthana, Sanjay; Vertrees, Julia E.; Pallaki, Muralidhar; Llorente, Maria; Love, Susan; Schellenberg, Gerard D.; McCarten, J. Riley; Malphurs, Julie; Prieto, Susana; Chen, Peijun; Loreck, David J.; Trapp, George; Bakshi, Rajbir S.; Mintzer, Jacobo E.; Heidebrink, Judith L.; Vidal-Cardona, Ana; Arroyo, Lillian M.; Cruz, Angel R.; Zachariah, Sally; Kowall, Neil W.; Chopra, Mohit P.; Craft, Suzanne; Thielke, Stephen; Turvey, Carolyn L.; Woodman, Catherine; Monnell, Kimberly A.; Gordon, Kimberly; Tomaska, Julie; Segal, Yoav; Peduzzi, Peter N.; Guarino, Peter D.			Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; NURSING-HOME PLACEMENT; CLINICAL-TRIALS; CO-MORBIDITY; DOUBLE-BLIND; MODERATE; METAANALYSIS; DEMENTIA; SUPPLEMENTATION; GALANTAMINE	IMPORTANCE Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. OBJECTIVE To determine if vitamin E (alpha tocopherol), memantine, or both slow progression of mild to moderate AD in patients taking an acetylcholinesterase inhibitor. DESIGN, SETTING, AND PARTICIPANTS Double-blind, placebo-controlled, parallel-group, randomized clinical trial involving 613 patients with mild to moderate AD initiated in August 2007 and concluded in September 2012 at 14 Veterans Affairs medical centers. INTERVENTIONS Participants received either 2000 IU/d of alpha tocopherol (n = 152), 20 mg/d of memantine (n = 155), the combination (n = 154), or placebo (n = 152). MAIN OUTCOMES AND MEASURES Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Inventory score (range, 0-78). Secondary outcomes included cognitive, neuropsychiatric, functional, and caregiver measures. RESULTS Over the mean (SD) follow-up of 2.27 (1.22) years, participants receiving alpha tocopherol had slower decline than those receiving placebo as measured by the ADCS-ADL. The change translates into a delay in clinical progression of 19% per year compared with placebo (approximately 6.2 months over the follow-up period). Caregiver time increased least in the alpha tocopherol group. All-cause mortality and safety analyses showed a difference only on the serious adverse event of "infections or infestations" with greater frequencies in the memantine (31 events in 23 participants) and combination groups (44 events in 31 participants) compared with placebo (13 events in 11 participants). [GRAPHICS] . CONCLUSIONS AND RELEVANCE Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden.	[Dysken, Maurice W.; Love, Susan; McCarten, J. Riley; Tomaska, Julie; Segal, Yoav] Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA; [Sano, Mary] James J Peters VA Med Res Ctr, New York, NY USA; [Asthana, Sanjay] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Vertrees, Julia E.] Clin Res Pharm Coordinating Ctr, Cooperat Studies Program, Albuquerque, NM USA; [Pallaki, Muralidhar; Chen, Peijun] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Pallaki, Muralidhar; Chen, Peijun] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Llorente, Maria] Washington DC VA Med Ctr, Washington, DC USA; [Schellenberg, Gerard D.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Malphurs, Julie; Prieto, Susana] Miami VA Healthcare Syst, Miami, FL USA; [Loreck, David J.] VA Maryland Healthcare Syst, Baltimore, MD USA; [Loreck, David J.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Trapp, George; Bakshi, Rajbir S.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Mintzer, Jacobo E.] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Mintzer, Jacobo E.] Med Univ S Carolina, Dept Hlth Studies, Charleston, SC USA; [Mintzer, Jacobo E.] Roper St Francis Healthcare, Charleston, SC USA; [Heidebrink, Judith L.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Vidal-Cardona, Ana; Arroyo, Lillian M.] VA Caribbean Healthcare Syst, San Juan, PR USA; [Cruz, Angel R.; Zachariah, Sally] Bay Pines VA Healthcare Syst, Bay Pines, FL USA; [Kowall, Neil W.; Chopra, Mohit P.] VA Boston Healthcare Syst, Boston, MA USA; [Craft, Suzanne; Thielke, Stephen] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Craft, Suzanne; Thielke, Stephen] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Turvey, Carolyn L.; Woodman, Catherine] Iowa City VA Med Ctr, Iowa City, IA USA; [Turvey, Carolyn L.; Woodman, Catherine] Univ Iowa, Iowa City, IA USA; [Monnell, Kimberly A.; Gordon, Kimberly] WG Bill Hefner VA Med Ctr, Salisbury, NC USA; [Peduzzi, Peter N.; Guarino, Peter D.] VA Connecticut Healthcare Syst, Cooperat Studies Program, Coordinating Ctr, West Haven, CT USA; [Peduzzi, Peter N.; Guarino, Peter D.] Yale Univ, Sch Publ Hlth, New Haven, CT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Dysken, MW (corresponding author), Minneapolis VA Hlth Care Syst, GRECC Program 11G, 1 Vet Dr, Minneapolis, MN 55417 USA.	maurice.dysken@va.gov	Kowall, Neil/M-5378-2019	Kowall, Neil/0000-0002-6624-0213; Turvey, Carolyn/0000-0002-8219-8676; Woodman, Catherine/0000-0003-2792-3561	Veterans Affairs Cooperative Studies Program, Office of Research and Development, Clinical Science RD; Arista Industries; NATIONAL INSTITUTE ON AGING [P30AG013846, P50AG005136, P50AG005138] Funding Source: NIH RePORTER	Veterans Affairs Cooperative Studies Program, Office of Research and Development, Clinical Science RD; Arista Industries; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	VA TEAM-AD was funded by the Veterans Affairs Cooperative Studies Program, Office of Research and Development, Clinical Science R&D. Forest Research Institute, a Division of Forest Laboratories, donated the memantine and matching placebo tablets. DSM Nutritional Products donated the DL-alpha-tocopheryl acetate oil and funding for the purchase of the soybean oil from Arista Industries.	Bakchine S, 2008, J ALZHEIMERS DIS, V13, P97; Brodaty H, 2005, DEMENT GERIATR COGN, V20, P120, DOI 10.1159/000086613; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davis KL, 1997, INT J GERIATR PSYCH, V12, P978, DOI 10.1002/(SICI)1099-1166(199710)12:10<978::AID-GPS659>3.0.CO;2-1; Dysken MW, 2009, AM J GERIAT PSYCHIAT, V17, P621, DOI 10.1097/JGP.0b013e3181a31fcf; Dysken MW, ALZHEIMERS DEMENT, DOI [10.1016/j.jalz.2013.01.014, DOI 10.1016/J.JALZ.2013.01.014]; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Grill JD, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt58; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kalbfleish J., 1980, STAT ANAL FAILURE TI; Knopman DS, 1999, NEUROLOGY, V52, P714, DOI 10.1212/WNL.52.4.714; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller EA, 2011, INT PSYCHOGERIATR, V23, P44, DOI 10.1017/S1041610210000244; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; MOHS RC, 1983, PSYCHOPHARMACOL BULL, V19, P448; ODELL PM, 1992, BIOMETRICS, V48, P951, DOI 10.2307/2532360; Oremus M, 2000, J GERIATR PSYCH NEUR, V13, P197, DOI 10.1177/089198870001300404; Peskind ER, 2006, AM J GERIAT PSYCHIAT, V14, P704, DOI 10.1097/01.JGP.0000224350.82719.83; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Porsteinsson AP, 2008, CURR ALZHEIMER RES, V5, P83, DOI 10.2174/156720508783884576; Potkin SG, 2002, INT PSYCHOGERIATR, V14, P7, DOI 10.1017/S1041610203008640; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rigler SK, 2002, CLIN REHABIL, V16, P420, DOI 10.1191/0269215502cr515oa; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Semla T., UPDATED CRITERIA USE; Smith GE, 2000, J AM GERIATR SOC, V48, P519, DOI 10.1111/j.1532-5415.2000.tb04998.x; STERN Y, 1994, J GERONTOL, V49, pM216, DOI 10.1093/geronj/49.5.M216; Studenski SA, 2004, AGE AGEING, V33, P195, DOI 10.1093/ageing/afh056; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Zhu CW, 2006, NEUROLOGY, V67, P998, DOI 10.1212/01.wnl.0000230160.13272.1b; Zhu CW, 2006, J AM GERIATR SOC, V54, P1596, DOI 10.1111/j.1532-5415.2006.00871.x	39	327	340	3	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					33	44		10.1001/jama.2013.282834	http://dx.doi.org/10.1001/jama.2013.282834			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24381967	Green Accepted, Bronze			2022-12-28	WOS:000329161400016
J	Cassidy, JJ; Jha, AR; Posadas, DM; Giri, R; Venken, KJT; Ji, JR; Jiang, HM; Bellen, HJ; White, KP; Carthew, RW				Cassidy, Justin J.; Jha, Aashish R.; Posadas, Diana M.; Giri, Ritika; Venken, Koen J. T.; Ji, Jingran; Jiang, Hongmei; Bellen, Hugo J.; White, Kevin P.; Carthew, Richard W.			miR-9a Minimizes the Phenotypic Impact of Genomic Diversity by Buffering a Transcription Factor	CELL			English	Article							DROSOPHILA-MELANOGASTER; DNA-BINDING; GENES; MICRORNAS; EVOLUTION; SCUTE; CANALIZATION; SENSELESS; BRISTLES; ACHAETE	Gene expression has to withstand stochastic, environmental, and genomic perturbations. For example, in the latter case, 0.5%-1% of the human genome is typically variable between any two unrelated individuals. Such diversity might create problematic variability in the activity of gene regulatory networks and, ultimately, in cell behaviors. Using multigenerational selection experiments, we find that for the Drosophila proneural network, the effect of genomic diversity is dampened by miR-9a-mediated regulation of senseless expression. Reducing miR-9a regulation of the Senseless transcription factor frees the genomic landscape to exert greater phenotypic influence. Whole-genome sequencing identified genomic loci that potentially exert such effects. A larger set of sequence variants, including variants within proneural network genes, exhibits these characteristics when miR-9a concentration is reduced. These findings reveal that microRNA-target interactions may be a key mechanism by which the impact of genomic diversity on cell behavior is dampened.	[Cassidy, Justin J.; Posadas, Diana M.; Giri, Ritika; Ji, Jingran; Carthew, Richard W.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Jha, Aashish R.; White, Kevin P.] Univ Chicago, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Jha, Aashish R.; White, Kevin P.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Venken, Koen J. T.] Baylor Coll Med, Program Dev Biol, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; [Venken, Koen J. T.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Jiang, Hongmei] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA	Northwestern University; University of Chicago; University of Chicago; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	r-carthew@northwestern.edu	Venken, Koen/B-9909-2013; Jiang, Hongmei/AAU-2911-2021	Venken, Koen/0000-0003-0741-4698; Bellen, Hugo/0000-0001-5992-5989; Jha, Aashish/0000-0003-3227-1086	Chicago Biomedical Consortium; Malkin Foundation; Rappaport Foundation; Pew Latin American Fellows Program; McNair Medical Institute; Howard Hughes Medical Institute; NIH [T32GM008061, T32 HL094282, P50 GM81892, T32 GM007526, GM068743, GM077581]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581, T32GM007526, T32GM008061, P50GM081892, R01GM068743] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Malkin Foundation; Rappaport Foundation; Pew Latin American Fellows Program; McNair Medical Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following for reagents: F. B. Gao, J. Reinitz, the Bloomington Stock Center, the Developmental Hybridoma Studies Bank, and NCI Frederick. Thanks to C. LaBonne for comments on the manuscript. We also thank Bionimbus (http://www.bionimbus.org). We acknowledge support from the Chicago Biomedical Consortium (to J. J. C.), the Malkin and Rappaport Foundations (to J. J. C.), the Pew Latin American Fellows Program (to D. M. P.), the McNair Medical Institute (to K. J. T. V.), the Howard Hughes Medical Institute (to K. J. T. V. and H. J. B.), and the NIH for grants T32GM008061 (to J. J. C.), T32 HL094282 (to A. R. J.), P50 GM81892 (to K. P. W.), T32 GM007526 (to K. J. T. V.), and GM068743 and GM077581 (to R.W.C.).	Acar M, 2006, DEVELOPMENT, V133, P1979, DOI 10.1242/dev.02372; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharya A, 2011, CELL, V147, P881, DOI 10.1016/j.cell.2011.08.055; CAMPUZANO S, 1986, CELL, V44, P303, DOI 10.1016/0092-8674(86)90764-6; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cubadda Y, 1997, GENE DEV, V11, P3083, DOI 10.1101/gad.11.22.3083; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Escudero LM, 2005, DEVELOPMENT, V132, P1211, DOI 10.1242/dev.01691; Falconer DS, 1996, INTRO QUANTITATIVE G; Felix MA, 2012, CURR OPIN GENET DEV, V22, P593, DOI 10.1016/j.gde.2012.08.003; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; Quan XJ, 2005, CELL MOL LIFE SCI, V62, P2036, DOI 10.1007/s00018-005-5124-1; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.1111/j.1558-5646.1959.tb03033.x; RENDEL JM, 1963, GENETICS, V48, P391; SHELDON BL, 1968, AUST J BIOL SCI, V21, P721, DOI 10.1071/BI9680721; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Sokal R.R., 2012, BIOMETRY; Tsai KW, 2011, EPIGENETICS-US, V6, P1189, DOI 10.4161/epi.6.10.16535; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; VANDOREN M, 1991, DEVELOPMENT, V113, P245; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Weir B. S., 1996, GENETIC DATA ANAL	49	66	66	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1556	1567		10.1016/j.cell.2013.10.057	http://dx.doi.org/10.1016/j.cell.2013.10.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360277	Green Accepted, Bronze			2022-12-28	WOS:000328693300012
J	Chavala, SH; Melamud, A; Williamson, JF				Chavala, Sai H.; Melamud, Alexander; Williamson, Jennifer F.			Intraretinal cysticercosis	LANCET			English	Editorial Material									[Chavala, Sai H.; Williamson, Jennifer F.] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC 27599 USA; [Melamud, Alexander] Retina Grp Washington, Washington, DC USA	University of North Carolina; University of North Carolina Chapel Hill	Chavala, SH (corresponding author), Univ N Carolina, Dept Ophthalmol, 5151 Bioinformat Bldg,CB 7040, Chapel Hill, NC 27599 USA.	schavala@med.unc.edu							0	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					799	799		10.1016/S0140-6736(13)61095-8	http://dx.doi.org/10.1016/S0140-6736(13)61095-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	24361240				2022-12-28	WOS:000350051700034
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Gestational Diabetes Mellitus: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							GLUCOSE-TOLERANCE; PREGNANCY; HYPERGLYCEMIA	Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for gestational diabetes mellitus (GDM). Methods: The USPSTF reviewed the evidence on the accuracy of screening tests for GDM, the benefits and harms of screening before and after 24 weeks of gestation, and the benefits and harms of treatment in the mother and infant. Population: This recommendation applies to pregnant women who have not been previously diagnosed with type 1 or 2 diabetes mellitus. Recommendation: The USPSTF recommends screening for GDM in asymptomatic pregnant women after 24 weeks of gestation. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for GDM in asymptomatic pregnant women before 24 weeks of gestation. (I statement)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.							Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; American Academy of Family Physicians, 2013, CLIN PREV SERV DIAB; [Anonymous], 2013, Obstet Gynecol, V122, P406, DOI 10.1097/01.AOG.0000433006.09219.f1; Bevier WC, 1999, AM J PERINAT, V16, P269, DOI 10.1055/s-2007-993871; Blumer I, 2013, J CLIN ENDOCR METAB, V98, P4227, DOI 10.1210/jc.2013-2465; Calonge N, 2008, ANN INTERN MED, V148, P759; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Donovan L, 2013, ANN INTERN MED, V159, P115, DOI 10.7326/0003-4819-159-2-201307160-00657; Gabbe SG, 2004, OBSTET GYNECOL, V103, P1229, DOI 10.1097/01.AOG.0000128045.50439.89; Hamm M, 2012, AHRQ PUBLICATION, V12EHC039EF; Hartling L, 2013, ANN INTERN MED, V159, P123, DOI 10.7326/0003-4819-159-2-201307160-00661; *I MED NAT RES COU, 2009, WEIGHT GAIN PREGN RE; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, 2013, MILD GDM MAN LONG TE; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; Nicholson WK, 2008, AHRQ PUBLICATION; Vandorsten James P, 2013, NIH Consens State Sci Statements, V29, P1	20	166	173	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					414	+		10.7326/M13-2905	http://dx.doi.org/10.7326/M13-2905			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24424622				2022-12-28	WOS:000333521300018
J	Ruiz-Canela, M; Estruch, R; Corella, D; Salas-Salvado, J; Martinez-Gonzalez, MA				Ruiz-Canela, Miguel; Estruch, Ramon; Corella, Dolores; Salas-Salvado, Jordi; Martinez-Gonzalez, Miguel A.			Association of Mediterranean Diet With Peripheral Artery Disease: The PREDIMED Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							NUTRITION		[Ruiz-Canela, Miguel; Martinez-Gonzalez, Miguel A.] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona 31008, Spain; [Estruch, Ramon] Inst Invest Biomed August Pi & Sunyer, Dept Internal Med, Barcelona, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Salas-Salvado, Jordi] St Joan Hosp, Human Nutr Unit, Reus, Spain	University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Valencia	Martinez-Gonzalez, MA (corresponding author), Univ Navarra, Irunlarrea 1, Pamplona 31008, Spain.	mamartinez@unav.es	Salas-Salvado, Jordi/C-7229-2017; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Estruch, Ramon/AAZ-3723-2020; Ruiz-Canela, Miguel/I-7738-2016	Salas-Salvado, Jordi/0000-0003-2700-7459; Ruiz-Canela, Miguel/0000-0002-7684-2787; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808				Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Brostow DP, 2012, NAT REV CARDIOL, V9, P634, DOI 10.1038/nrcardio.2012.117; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Lane JS, 2008, J VASC SURG, V48, P897, DOI 10.1016/j.jvs.2008.05.014; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Naqvi AZ, 2012, ATHEROSCLEROSIS, V222, P545, DOI 10.1016/j.atherosclerosis.2012.03.029	6	116	118	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					415	417		10.1001/jama.2013.280618	http://dx.doi.org/10.1001/jama.2013.280618			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449321	Bronze, Green Published			2022-12-28	WOS:000329939300028
J	Gollihar, J; Levy, M; Ellington, AD				Gollihar, Jimmy; Levy, Matthew; Ellington, Andrew D.			Many Paths to the Origin of Life	SCIENCE			English	Editorial Material							RNA; WATER		[Gollihar, Jimmy; Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Levy, Matthew] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; Yeshiva University; Albert Einstein College of Medicine	Gollihar, J (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	ellingtonlab@gmail.com		Gollihar, Jimmy/0000-0003-3957-2092				Benner S. A., 2013, MINERAL MAG, V77, P686; Benner SA, 2012, ACCOUNTS CHEM RES, V45, P2025, DOI 10.1021/ar200332w; Engelhart AE, 2013, NAT CHEM, V5, P390, DOI 10.1038/nchem.1623; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Ferretti AC, 2013, BIOCHEMISTRY-US, V52, P1227, DOI 10.1021/bi301646n; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; Matsuura T, 2002, P NATL ACAD SCI USA, V99, P7514, DOI 10.1073/pnas.062710399; Meyer AJ, 2012, ACCOUNTS CHEM RES, V45, P2097, DOI 10.1021/ar200325v; Nitschke W, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0258; Powner MW, 2012, J AM CHEM SOC, V134, P13889, DOI 10.1021/ja306176n; Shapiro Robert, 1986, ORIGINS SKEPTICS GUI; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zhu TF, 2012, P NATL ACAD SCI USA, V109, P9828, DOI 10.1073/pnas.1203212109	15	16	17	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					259	260		10.1126/science.1246704	http://dx.doi.org/10.1126/science.1246704			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436411				2022-12-28	WOS:000329718600024
J	Vega-Villa, K				Vega-Villa, Karina			Biodiversity: Ecuador Deters Protection Efforts	SCIENCE			English	Letter												vegavilla1@gmail.com						[Anonymous], 2013, EL UNIVERSO; [Anonymous], 2013, EL COMERCIO	2	0	0	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					248	248		10.1126/science.343.6168.248-b	http://dx.doi.org/10.1126/science.343.6168.248-b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436404				2022-12-28	WOS:000329718600014
J	Iams, JD				Iams, Jay D.			Prevention of Preterm Parturition	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CERVICAL-LENGTH; DOUBLE-BLIND; PREGNANT-WOMEN; BIRTH; PROGESTERONE; RISK; DELIVERY; SUPPLEMENTATION; METRONIDAZOLE; MORTALITY	This article reviews risk factors for preterm delivery, with special attention to previous preterm birth and a short cervix. Strategies for minimizing the risk of preterm birth among high-risk women, including progesterone supplementation and cerclage, are discussed. ForewordThis Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.StageA woman presents for prenatal care in the first trimester of her third pregnancy. Her first child was born at 30 weeks of gestation after preterm labor. Her second pregnancy ended in delivery at 19 weeks of gestation. How would you recommend reducing the risk of preterm birth in this pregnancy? The Clinical Problem In the United States, the annual rate of preterm births (before 37 weeks of gestation) reached a peak of 12.8% in 2006 and was 11.7% in 2011.(1) The rate in the United States remains nearly twice the rate in European nations.(2) Premature birth in the ... Prevention of Preterm Parturition Despite advances in neonatal care, preterm birth remains a leading cause of infant death in the United States, especially among blacks. Systemic changes in reproductive health care to reduce the incidence of multifetal pregnancies and scheduled births before 39 weeks of gestation that lack a medical indication have been temporally associated with decreased preterm birth rates. Strategies to identify and treat medical risk factors in early pregnancy (e.g., genitourinary infection and poor nutrition) have not been effective in reducing preterm birth rates. Previous preterm birth and a short cervix (20 mm, as measured by transvaginal ultrasonography) are major risk factors for preterm birth. The use of progesterone supplementation in women with a previous preterm birth, a short cervix, or both was shown in randomized trials to reduce the frequency of preterm birth and is recommended for women with these risk factors. Cervical cerclage reduces the risk of recurrent preterm birth among women with a short cervix.	Ohio State Univ, Wexner Med Ctr, Div Maternal Fetal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Iams, JD (corresponding author), Ohio State Univ, Wexner Med Ctr, Div Maternal Fetal Med, 395 W 12th Ave, Columbus, OH 43210 USA.	stefanie.palmer@osumc.edu			Sera Prognostics	Sera Prognostics	Dr. Iams reports receiving grant support from Sera Prognostics and honoraria from the American College of Obstetricians and Gynecologists. No other potential conflict of interest relevant to this article was reported.	A. C. of O. and Gynecologists, 2012, OBSTET GYNECOL, V120, P964, DOI DOI 10.1097/AOG.0B013E3182723B1B; [Anonymous], 2013, Obstet Gynecol, V121, P908, DOI 10.1097/01.AOG.0000428648.75548.00; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; [Anonymous], MARCH DIM LESS 39 WE; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman R, 2007, PRETERM BIRTH CAUSES; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Berghella Vincenzo, 2013, AM J OBSTET GYNECOL, V208, P86; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Buhomschi C, 2013, CREASY RESNIKS MATER, P599; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Buppasiri P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007079.pub2; Cahill AG, 2010, AM J OBSTET GYNECOL, V202; Callaghan WM, 2006, PEDIATRICS, V118, P1566, DOI 10.1542/peds.2006-0860; Campbell S, 2011, ULTRASOUND OBST GYN, V38, P1, DOI 10.1002/uog.9073; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Chang J, 2013, AM J OBSTET GYNECOL; Conde-Agudelo A, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.877; CSAPO A, 1956, AM J ANAT, V98, P273, DOI 10.1002/aja.1000980206; Csapo A I, 1977, Ciba Found Symp, P159; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Donovan EF, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.044; Edlow AG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.09.016; Facco FL, 2013, OBSTET GYNECOL, V122, P858, DOI 10.1097/AOG.0b013e3182a2dccd; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Fritz MA, 2009, FERTIL STERIL, V92, P1518, DOI 10.1016/j.fertnstert.2009.08.059; Grobman WA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.09.013; Harper M, 2010, OBSTET GYNECOL, V115, P234, DOI 10.1097/AOG.0b013e3181cbd60e; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Hauth JC, 2010, OBSTET GYNECOL, V116, P653, DOI 10.1097/AOG.0b013e3181ed721d; Healy AJ, 2006, OBSTET GYNECOL, V107, P625, DOI 10.1097/01.AOG.0000201978.83607.96; Hibbard JU, 2000, OBSTET GYNECOL, V96, P972, DOI 10.1016/S0029-7844(00)01074-7; Iams JD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.021; Iams JD, 1998, AM J OBSTET GYNECOL, V178, P1035, DOI 10.1016/S0002-9378(98)70544-7; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; KEIRSE MJNC, 1990, BRIT J OBSTET GYNAEC, V97, P149, DOI 10.1111/j.1471-0528.1990.tb01740.x; Klebanoff MA, 2001, NEW ENGL J MED, V345, P487, DOI 10.1056/NEJMoa003329; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; Mathews T J, 2013, Natl Vital Stat Rep, V61, P1; McManemy J, 2007, AM J OBSTET GYNECOL, V196, P576, DOI 10.1016/j.ajog.2007.01.039; Meis P. J., 2003, NEW ENGL J MED, V349, P1299; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Norwitz ER, 2013, CREASY RESNIKS MATER, P66; O'Brien JM, 2007, ULTRASOUND OBST GYN, V30, P687, DOI 10.1002/uog.5158; Offenbacher S, 2009, OBSTET GYNECOL, V114, P551, DOI 10.1097/AOG.0b013e3181b1341f; Oshiro BT, 2013, OBSTET GYNECOL, V121, P1025, DOI 10.1097/AOG.0b013e31828ca096; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; Parry S, 2012, AM J OBSTET GYNECOL, V207, P101, DOI 10.1016/j.ajog.2012.04.021; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Werner EF, 2011, ULTRASOUND OBST GYN, V38, P32, DOI 10.1002/uog.8911; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Yost NP, 2004, AM J OBSTET GYNECOL, V191, P241, DOI 10.1016/j.ajog.2003.12.029	56	87	94	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					254	261		10.1056/NEJMcp1103640	http://dx.doi.org/10.1056/NEJMcp1103640			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428470				2022-12-28	WOS:000330035600011
J	Frieden, TR				Frieden, Thomas R.			Tobacco Control Progress and Potential	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Centers for Disease Control and Prevention, EARLY RELEASE OF SEL; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; International Tobacco Control Policy Evaluation Project, 2012, ITC URUGUAY NATIONAL; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Mendez D, 2013, TOB CONTROL, V22, P46, DOI 10.1136/tobaccocontrol-2011-050147; US National Library of Medicine, PROFILES IN SCIENCE; World Health Organization, GLOBAL ADULT TOBACCO; World Health Organization, WHO REPORT ON THE GL; World Health Organization, MPOWER	9	15	19	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					133	134		10.1001/jama.2013.284534	http://dx.doi.org/10.1001/jama.2013.284534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SA	24399547				2022-12-28	WOS:000329339400014
J	Chalkidou, K; Marten, R; Cutler, D; Culyer, T; Smith, R; Teerawattananon, Y; Cluzeau, F; Li, R; Sullivan, R; Huang, YZ; Fan, V; Glassman, A; Yu, DZ; Gyansa-Lutterodt, M; McPherson, S; Gadelha, C; Sundararaman, T; Squires, N; Daulaire, N; Sadanandan, R; Shiro, K; Lemgruber, A				Chalkidou, Kalipso; Marten, Robert; Cutler, Derek; Culyer, Tony; Smith, Richard; Teerawattananon, Yot; Cluzeau, Francoise; Li, Ryan; Sullivan, Richard; Huang, Yanzhong; Fan, Victoria; Glassman, Amanda; Yu Dezhi; Gyansa-Lutterodt, Martha; McPherson, Sam; Gadelha, Carlos; Sundararaman, Thiagarajan; Squires, Neil; Daulaire, Nils; Sadanandan, Rajeev; Shiro, Konuma; Lemgruber, Alexandre			Health technology assessment in universal health coverage	LANCET			English	Editorial Material									[Chalkidou, Kalipso; Cutler, Derek; Cluzeau, Francoise; Li, Ryan] NICE, London SW1A 2BU, England; [Marten, Robert] Rockefeller Fdn, New York, NY USA; [Culyer, Tony] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England; [Culyer, Tony] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Smith, Richard] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Teerawattananon, Yot] Minist Publ Hlth, Dept Hlth, Hlth Intervent & Technol Assessment Program, Muang, Nonthaburi, Thailand; [Sullivan, Richard] Kings Coll London, London WC2R 2LS, England; [Huang, Yanzhong] Council Foreign Relat, New York, NY USA; [Fan, Victoria; Glassman, Amanda] Ctr Global Dev, Washington, DC USA; [Yu Dezhi] Minist Hlth, Hefei, Anhui, Peoples R China; [Yu Dezhi] Local Hlth Bur, Hefei, Anhui, Peoples R China; [Gyansa-Lutterodt, Martha] Minist Hlth, Accra, Ghana; [Gadelha, Carlos] Minist Hlth, Brasilia, DF, Brazil; [Sundararaman, Thiagarajan] Natl Rural Hlth Mission, Resource Ctr, New Delhi, India; [Squires, Neil] Dept Int Dev, London, England; [Daulaire, Nils] US Dept HHS, Washington, DC 20201 USA; [Sadanandan, Rajeev] Minist Hlth & Family Welf, Thiruvananthapuram, Kerala, India; [Sadanandan, Rajeev] Minist Foreign Affairs, Tokyo, Japan; [Lemgruber, Alexandre] Amer Hlth Org, Washington, DC USA	National Institute for Health & Care Excellence; University of York - UK; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; Ministry of Public Health - Thailand; University of London; King's College London	Chalkidou, K (corresponding author), NICE, London SW1A 2BU, England.	kalipso.chalkidou@gmail.com	Fan, Victoria/AGG-4359-2022; Li, Ryan/I-4613-2012	Fan, Victoria/0000-0001-7755-9425; GADELHA, CARLOS A. G./0000-0002-9148-8819; Sullivan, Richard/0000-0002-6435-1825; Smith, Richard/0000-0003-3837-6559; Teerawattananon, Yot/0000-0003-2217-2930; Glassman, Amanda/0000-0002-7483-8012; Li, Ryan/0000-0001-9750-9361				Culyer AJ, 2006, HEALTH ECON, V15, P1155, DOI 10.1002/hec.1158; Culyer AJ, 2012, MED DECIS MAKING, V32, P428, DOI 10.1177/0272989X11426484; Glassman A, 2012, PRIORITY SETTING I G; Parkhurst J, 2011, SCIDEVNET       0922; Sassi F, 2001, Health Technol Assess, V5, P1; Smith PC, 2013, HEALTH ECON, V22, P180, DOI 10.1002/hec.2774; UN General Assembly, 2012, AD CONS TEXT GEN ASS; University of York, 2013, PHRC PROJ DISTR COST; WHO Collaborating Center for Knowledge Translation and Health Technology Assessment in Health Equity, ASS HLTH EQ EQ OR TO	9	25	29	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					E48	E49		10.1016/S0140-6736(13)62559-3	http://dx.doi.org/10.1016/S0140-6736(13)62559-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24360390				2022-12-28	WOS:000328687800001
J	Zhang, WW; Oganov, AR; Goncharov, AF; Zhu, Q; Boulfelfel, SE; Lyakhov, AO; Stavrou, E; Somayazulu, M; Prakapenka, VB; Konopkova, Z				Zhang, Weiwei; Oganov, Artem R.; Goncharov, Alexander F.; Zhu, Qiang; Boulfelfel, Salah Eddine; Lyakhov, Andriy O.; Stavrou, Elissaios; Somayazulu, Maddury; Prakapenka, Vitali B.; Konopkova, Zuzana			Unexpected Stable Stoichiometries of Sodium Chlorides	SCIENCE			English	Article							CRYSTAL-STRUCTURE PREDICTION; METALLIZATION; PHASE	Sodium chloride (NaCl), or rocksalt, is well characterized at ambient pressure. As a result of the large electronegativity difference between Na and Cl atoms, it has highly ionic chemical bonding (with 1:1 stoichiometry dictated by charge balance) and B1-type crystal structure. By combining theoretical predictions and diamond anvil cell experiments, we found that new materials with different stoichiometries emerge at high pressures. Compounds such as Na3Cl, Na2Cl, Na3Cl2, NaCl3, and NaCl7 are theoretically stable and have unusual bonding and electronic properties. To test this prediction, we synthesized cubic and orthorhombic NaCl3 and two-dimensional metallic tetragonal Na3Cl. These experiments establish that compounds violating chemical intuition can be thermodynamically stable even in simple systems at nonambient conditions.	[Zhang, Weiwei] China Agr Univ, Dept Appl Phys, Beijing 100080, Peoples R China; [Zhang, Weiwei; Oganov, Artem R.; Zhu, Qiang; Boulfelfel, Salah Eddine; Lyakhov, Andriy O.] SUNY Stony Brook, Dept Geosci, Ctr Mat Design, Stony Brook, NY 11794 USA; [Zhang, Weiwei; Oganov, Artem R.; Zhu, Qiang; Boulfelfel, Salah Eddine; Lyakhov, Andriy O.] SUNY Stony Brook, Inst Adv Computat Sci, Stony Brook, NY 11794 USA; [Oganov, Artem R.] Moscow Inst Phys & Technol, Dolgoprudny City 141700, Moscow Region, Russia; [Oganov, Artem R.] Northwestern Polytech Univ, Sch Mat Sci, Xian 710072, Peoples R China; [Goncharov, Alexander F.; Stavrou, Elissaios; Somayazulu, Maddury] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Goncharov, Alexander F.] Chinese Acad Sci, Ctr Energy Matter Extreme Environm, Hefei 230031, Anhui, Peoples R China; [Goncharov, Alexander F.] Chinese Acad Sci, Key Lab Mat Phys, Inst Solid State Phys, Hefei 230031, Anhui, Peoples R China; [Prakapenka, Vitali B.] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Konopkova, Zuzana] Photon Sci DESY, D-22607 Hamburg, Germany	China Agricultural University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Moscow Institute of Physics & Technology; Northwestern Polytechnical University; Carnegie Institution for Science; Chinese Academy of Sciences; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; University of Chicago; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Zhang, WW (corresponding author), China Agr Univ, Dept Appl Phys, Beijing 100080, Peoples R China.	zwwjennifer@gmail.com; artem.oganov@sunysb.edu	Zhu, Qiang/H-2268-2014; Stavrou, Elissaios/AHA-9657-2022; Oganov, Artem R./O-8234-2019; Goncharov, Alexander F./AAX-9943-2020; Stavrou, Elissaios/AAM-6208-2021; Konopkova, Zuzana/B-2130-2015; Boulfelfel, Salah Eddine/A-7201-2012; Oganov, Artem R/A-1213-2008; Oganov, Artem R./AAA-1478-2021; Stavrou, Elissaios/AAB-7353-2020	Oganov, Artem R./0000-0001-7082-9728; Goncharov, Alexander F./0000-0002-6422-8819; Boulfelfel, Salah Eddine/0000-0003-1412-1826; Oganov, Artem R/0000-0001-7082-9728; Zhu, Qiang/0000-0002-9892-0344	Young Teachers Development Project in China Agricultural University; NSF [EAR-1114313, DMR-1231586, EAR-1128799]; DARPA [W31P4Q1210008, W31P4Q1310005]; Government of the Russian Federation [14.A12.31.0003]; China's Foreign Talents Introduction and Academic Exchange Program [B08040]; NSF; Army Research Office; EFREE, a BES-EFRC center at Carnegie; German Federal Ministry of Education and Research [05K10RFA]; CDAC (NNSA); U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES) [DE-AC02-98CH10086]; DOE [DE-FG02-94ER14466]; DOE-BES [DE-AC02-06CH11357]	Young Teachers Development Project in China Agricultural University; NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Government of the Russian Federation; China's Foreign Talents Introduction and Academic Exchange Program; NSF(National Science Foundation (NSF)); Army Research Office; EFREE, a BES-EFRC center at Carnegie; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); CDAC (NNSA); U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); DOE-BES(United States Department of Energy (DOE))	Supported by the Young Teachers Development Project in China Agricultural University (W.Z.); NSF grants EAR-1114313 and DMR-1231586, DARPA grants W31P4Q1210008 and W31P4Q1310005, Government of the Russian Federation grant 14.A12.31.0003, China's Foreign Talents Introduction and Academic Exchange Program grant B08040 (A.R.O.); NSF, the Army Research Office, and EFREE, a BES-EFRC center at Carnegie (A. F. G.); and German Federal Ministry of Education and Research grant 05K10RFA (Z.K.). M. S. acknowledges support from CDAC (NNSA). Calculations were performed on XSEDE facilities (charge no. TG-DMR110058) and on the cluster of the Center for Functional Nanomaterials, Brookhaven National Laboratory, which is supported by the U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES) under contract DE-AC02-98CH10086. X-ray diffraction experiments were performed at GeoSoilEnviroCARS (Sector 13), Advanced Photon Source (APS), Argonne National Laboratory, and Petra III, DESY, Hamburg, Germany. GeoSoilEnviroCARS is supported by NSF Earth Sciences grant EAR-1128799 and DOE Geosciences grant DE-FG02-94ER14466. Use of the Advanced Photon Source was supported by DOE-BES under contract DE-AC02-06CH11357. Portions of this research were carried out at the light source PETRAIII at DESY, a member of the Helmholtz Association (HGF). USPEX code is available at http://uspex.stonybrook.edu and experimental data are available in the supplementary materials. Author contributions: A.R.O. designed the research. W.Z., A.R.O., Q.Z., and S. E. B. performed the calculations, interpreted data, and wrote the paper. A. L. wrote the latest version of the structure prediction code. A. F. G. and E. S. performed the experiments, interpreted the data and contributed in writing the manuscript. M. S., V. P., and Z.K. performed the experiments and contributed to the experimental methods.	[Anonymous], 2012, VSEPR MODEL MOL GEOM; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; BASSETT WA, 1968, J APPL PHYS, V39, P319, DOI 10.1063/1.1655752; Chen X, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/26005; FROYEN S, 1984, PHYS REV B, V29, P3770, DOI 10.1103/PhysRevB.29.3770; Grabowski SJ, 2012, CHEMPHYSCHEM, V13, P2286, DOI 10.1002/cphc.201200182; Hanfland M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.184109; HEINZ DL, 1984, PHYS REV B, V30, P6045, DOI 10.1103/PhysRevB.30.6045; Hoffmann R., 1988, SOLIDS SURFACES CHEM; Howie RT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064108; Li PF, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4742152; Lyakhov AO, 2013, COMPUT PHYS COMMUN, V184, P1172, DOI 10.1016/j.cpc.2012.12.009; Ma YM, 2009, NATURE, V458, P182, DOI 10.1038/nature07786; Oganov AR, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2210932; Oganov AR, 2011, ACCOUNTS CHEM RES, V44, P227, DOI 10.1021/ar1001318; Oganov AR, 2010, REV MINERAL GEOCHEM, V71, P271, DOI 10.2138/rmg.2010.71.13; Ono S, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012196; ROSS M, 1972, J CHEM PHYS, V56, P4651, DOI 10.1063/1.1677915; Sakai T, 2011, J APPL PHYS, V109, DOI 10.1063/1.3573393; Sata N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104114; Zhu Q, 2013, PHYS CHEM CHEM PHYS, V15, P7696, DOI 10.1039/c3cp50678a; Zurek E, 2009, P NATL ACAD SCI USA, V106, P17640, DOI 10.1073/pnas.0908262106	22	339	350	20	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1502	1505		10.1126/science.1244989	http://dx.doi.org/10.1126/science.1244989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357316	Green Published, Green Submitted			2022-12-28	WOS:000328644300056
J	Feemster, KA; Offit, P				Feemster, Kristen A.; Offit, Paul			"Compassionate Use" for Public Health	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEROGROUP-B; VACCINE		Univ Penn, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Feemster, KA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Room 1202 Abramson Bldg,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	feemster@email.chop.edu						Food and Drug Administration HHS, 2009, Fed Regist, V74, P40900; Food and Drug Administration HHS, 2009, FED REGISTER, V74, P40871; Gorringe AR, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18500; Granoff DM, 2013, PEDIATR INFECT DIS J, V32, P372, DOI 10.1097/INF.0b013e318282942f; Kim E, 2012, 18 INT PATH NEISS C, P270; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033	6	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					421	+		10.7326/M13-2927	http://dx.doi.org/10.7326/M13-2927			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24366602				2022-12-28	WOS:000333521300019
J	Sarkar, U; Bates, DW				Sarkar, Urmimala; Bates, David W.			Care Partners and Online Patient Portals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH RECORDS		[Sarkar, Urmimala] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Sarkar, Urmimala] San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94110 USA; [Sarkar, Urmimala] Ctr Trauma, San Francisco, CA USA; [Bates, David W.] Harvard Univ, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA USA; [Bates, David W.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Partners HealthCare, Boston, MA 02115 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Partners Healthcare System	Sarkar, U (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, 1001 Potrero,Bldg 10,Third Floor,POB 1364, San Francisco, CA 94143 USA.	usarkar@medsfgh.ucsf.edu	Bates, David/AAE-7283-2019					Bourgeois FC, 2008, J AM MED INFORM ASSN, V15, P737, DOI 10.1197/jamia.M2865; Fox S., 2013, FAMILY CAREGIVERS AR; Gillick MR, 2013, JAMA-J AM MED ASSOC, V310, P575, DOI 10.1001/jama.2013.7310; HealthIT.gov, 2013, SUPPORT FAMILY CAREG; Hsiao Chun-Ju, 2012, NCHS Data Brief, P1; Ricciardi L, 2013, HEALTH AFFAIR, V32, P376, DOI 10.1377/hlthaff.2012.1216; Wynia MK, 2011, HEALTH AFFAIR, V30, P266, DOI 10.1377/hlthaff.2010.0342; Zulman DM, 2011, ANN INTERN MED, V155, P805, DOI 10.7326/0003-4819-155-12-201112200-00002	8	72	72	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					357	358		10.1001/jama.2013.285825	http://dx.doi.org/10.1001/jama.2013.285825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	292YT	24394945				2022-12-28	WOS:000329939300017
J	Shivakumar, S; Douketis, J				Shivakumar, Sudeep; Douketis, James			New oral factor Xa inhibitors reduce DVT compared with standard thromboprophylaxis after THR or TKR	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TOTAL HIP		[Shivakumar, Sudeep] Dalhousie Univ, Halifax, NS, Canada; [Douketis, James] McMaster Univ, Hamilton, ON, Canada	Dalhousie University; McMaster University	Shivakumar, S (corresponding author), Dalhousie Univ, Halifax, NS, Canada.		Douketis, James/AAO-5659-2021					Anderson DR, 2013, ANN INTERN MED, V158, P800, DOI 10.7326/0003-4819-158-11-201306040-00004; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Gomez-Outes A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3675	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2							JC3	10.7326/0003-4819-160-2-201401210-02003	http://dx.doi.org/10.7326/0003-4819-160-2-201401210-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24445713				2022-12-28	WOS:000330275600002
J	Goroff, NS				Goroff, Nancy S.			A Clear Path for Polymer Crystallization	SCIENCE			English	Editorial Material									SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goroff, NS (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	nancy.goroff@stonybrook.edu						BAUGHMAN RH, 1974, J POLYM SCI POL PHYS, V12, P1511, DOI 10.1002/pol.1974.180120801; Biradha K, 2013, CHEM SOC REV, V42, P950, DOI 10.1039/c2cs35343a; Bloor D, 1985, POLYDIACETYLENES SYN; Dou LT, 2014, SCIENCE, V343, P272, DOI 10.1126/science.1245875; ENKELMANN V, 1984, ADV POLYM SCI, V63, P91; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896	6	1	1	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					258	259		10.1126/science.1249064	http://dx.doi.org/10.1126/science.1249064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436410				2022-12-28	WOS:000329718600023
J	Hamada-Kawaguchi, N; Nore, BF; Kuwada, Y; Smith, CIE; Yamamoto, D				Hamada-Kawaguchi, Noriko; Nore, Beston F.; Kuwada, Yusuke; Smith, C. I. Edvard; Yamamoto, Daisuke			Btk29A Promotes Wnt4 Signaling in the Niche to Terminate Germ Cell Proliferation in Drosophila	SCIENCE			English	Article							STEM-CELLS; TYROSINE KINASE; PIWI; OVARY; GENE; MAINTENANCE; TRANSPOSONS; MUTATIONS; DIVISION	Btk29A is the Drosophila ortholog of the mammalian Bruton's tyrosine kinase (Btk), mutations of which in humans cause a heritable immunodeficiency disease. Btk29A mutations stabilized the proliferating cystoblast fate, leading to an ovarian tumor. This phenotype was rescued by overexpression of wild-type Btk29A and phenocopied by the interference of Wnt4-beta-catenin signaling or its putative downstream nuclear protein Piwi in somatic escort cells. Btk29A and mammalian Btk directly phosphorylated tyrosine residues of beta-catenin, leading to the up-regulation of its transcriptional activity. Thus, we identify a transcriptional switch involving the kinase Btk29A/Btk and its phosphorylation target, beta-catenin, which functions downstream of Wnt4 in escort cells to terminate Drosophila germ cell proliferation through up-regulation of piwi expression. This signaling mechanism likely represents a versatile developmental switch.	[Hamada-Kawaguchi, Noriko; Kuwada, Yusuke; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan; [Nore, Beston F.; Smith, C. I. Edvard] Karolinska Univ Hosp Huddinge, Dept Lab Med, Karolinska Inst, Clin Res Ctr, SE-14186 Huddinge, Sweden; [Nore, Beston F.] Univ Sulaimani, Dept Biochem, Sch Med, Fac Med Sci, Sulaimani, Kurdistan Regio, Iraq	Tohoku University; Karolinska Institutet; Karolinska University Hospital; University of Sulimanyah	Yamamoto, D (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan.	daichan@m.tohoku.ac.jp	Nore, Beston F./N-9288-2016	Nore, Beston F./0000-0003-3865-2920; SMITH, C. I. Edvard/0000-0003-1907-3392; , Daisuke/0000-0002-4623-0106	Ministry of Education, Culture, Sports, Science, and Technology (Japan) [1802012, 23220007, 24113502]; Swedish Cancer Society; Swedish Research Council; Stockholm County Council (ALF); Grants-in-Aid for Scientific Research [23220007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF)(Stockholm County Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Asaoka, M. Bienz, J. J. Buggy, D. Drummond-Barbosa, P. Lasko, D. McKearin, K. Mochizuki, A. Nagafuchi, Y. Niki, M. Ote, A. Pelisson, K. Sato, H. Siomi, T. Tabata, Y. Tamori, R. Ueda, T. Uemura, H. White-Cooper, Bloomington Stock Center and Drosophila Genetic Resource Center for reagents, M. Suyama for secretarial assistance, and M. O. Gustafsson for technical help. This work was supported by Grant-in-Aids for Scientific Research (nos. 1802012, 23220007, and 24113502) from the Ministry of Education, Culture, Sports, Science, and Technology (Japan) to D. Y. B.F.N., and C. I. E. S. received support from the Swedish Cancer Society, the Swedish Research Council, and the Stockholm County Council (ALF).	Baba K, 1999, MOL CELL BIOL, V19, P4405; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Lin HF, 1997, DEVELOPMENT, V124, P2463; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Navarro C, 2009, P NATL ACAD SCI USA, V106, P9691, DOI 10.1073/pnas.0903837106; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Takada S, 2007, DEVELOPMENT, V134, P1737, DOI 10.1242/dev.02831; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; Wang XX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002426; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	19	39	40	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					294	297		10.1126/science.1244512	http://dx.doi.org/10.1126/science.1244512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436419				2022-12-28	WOS:000329718600035
J	Rahman, N				Rahman, Nazneen			Realizing the promise of cancer predisposition genes	NATURE			English	Review							GENOME-WIDE ASSOCIATION; OF-FUNCTION MUTATIONS; BREAST-CANCER; GERMLINE MUTATIONS; OVARIAN-CANCER; WILMS-TUMOR; SUSCEPTIBILITY; BRCA2; PENETRANCE; RISK	Genes in which germline mutations confer highly or moderately increased risks of cancer are called cancer predisposition genes. More than 100 of these genes have been identified, providing important scientific insights in many areas, particularly the mechanisms of cancer causation. Moreover, clinical utilization of cancer predisposition genes has had a substantial impact on diagnosis, optimized management and prevention of cancer. The recent transformative advances in DNA sequencing hold the promise of many more cancer predisposition gene discoveries, and greater and broader clinical applications. However, there is also considerable potential for incorrect inferences and inappropriate clinical applications. Realizing the promise of cancer predisposition genes for science and medicine will thus require careful navigation.	[Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, London SW2 5NG, England; [Rahman, Nazneen] Royal Marsden Hosp Fdn Trust, Canc Genet Unit, London SM2 5PT, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London SW2 5NG, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440	Cancer Research UK [A9024, A8372] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Bachet JB, 2013, EUR J CANCER, V49, P2531, DOI 10.1016/j.ejca.2013.04.005; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Benusiglio PR, 2013, J MED GENET, V50, P486, DOI 10.1136/jmedgenet-2012-101472; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Boveri T., 1914, ZUR FRAGE DER ENTSTE; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Broca PP, 1866, TRAITE DES TUMEURS; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Burn J, 2013, FAM CANCER, V12, P707, DOI 10.1007/s10689-013-9650-y; Byrski T, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3231; Castro E, 2013, J CLIN ONCOL, V31, P1748, DOI 10.1200/JCO.2012.43.1882; Chang C. Q., 2013, EUR J HUM GENET; Chompret A, 2004, GASTROENTEROLOGY, V126, P318, DOI 10.1053/j.gastro.2003.10.079; Chompret A, 2000, BRIT J CANCER, V82, P1932; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Forbes S. A., 2008, THE CATALOGUE OF SOM; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; Gao LB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-117; Gaudet MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001183; Gayther SA, 2010, CURR OPIN GENET DEV, V20, P231, DOI 10.1016/j.gde.2010.03.001; Goudie DR, 2011, NAT GENET, V43, P365, DOI 10.1038/ng.780; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hafner C, 2013, CELL CYCLE, V12, P43, DOI 10.4161/cc.23108; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; HUFF V, 1991, AM J HUM GENET, V48, P997; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Jafri M, 2012, EUR J ENDOCRINOL, V166, P151, DOI 10.1530/EJE-11-0497; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jozwiak S, 2012, FUTURE ONCOL, V8, P1515, DOI [10.2217/fon.12.146, 10.2217/FON.12.146]; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Logan TF, 2013, CURR ONCOL REP, V15, P83, DOI 10.1007/s11912-013-0299-3; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Moorman PG, 2010, BREAST CANCER RES TR, V124, P441, DOI 10.1007/s10549-010-0842-y; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; Nichols AF, 1996, J BIOL CHEM, V271, P24317, DOI 10.1074/jbc.271.40.24317; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Nishida T, 1998, NAT GENET, V19, P323, DOI 10.1038/1209; Pacini F, 2010, CLIN ONCOL-UK, V22, P475, DOI 10.1016/j.clon.2010.05.002; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rahman N, 2007, HUM MOL GENET, V16, pR60, DOI 10.1093/hmg/ddm026; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reade CJ, 2013, GYNECOL ONCOL, V130, P674, DOI 10.1016/j.ygyno.2013.06.029; Rozen P, 2006, FAM CANCER, V5, P227, DOI 10.1007/s10689-005-5674-2; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Santen GWE, 2012, EPIGENETICS-US, V7, P1219, DOI 10.4161/epi.22299; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Scott RH, 2008, NAT GENET, V40, P1329, DOI 10.1038/ng.243; Scott RH, 2007, NAT CLIN PRACT ONCOL, V4, P130, DOI 10.1038/ncponc0719; Scott RH, 2012, ONCOTARGET, V3, P327; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS153, DOI 10.1007/s10120-011-0116-3; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Smith MJ, 2013, NAT GENET, V45, P295, DOI 10.1038/ng.2552; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Snape K, 2012, BREAST CANCER RES TR, V134, P429, DOI 10.1007/s10549-012-2057-x; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stadler ZK, 2010, ONCOLOGY-NY, V24, P629; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Turnbull C, 2012, HUM MOL GENET, V21, P958, DOI 10.1093/hmg/ddr525; Turner NC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3332; Varghese JS, 2010, CURR OPIN GENET DEV, V20, P201, DOI 10.1016/j.gde.2010.03.012; Vencken PMLH, 2013, ANN ONCOL, V24, P2036, DOI 10.1093/annonc/mdt068; Villanueva A, 2010, BEST PRACT RES CL GA, V24, P725, DOI 10.1016/j.bpg.2010.07.008; Wells SA, 2013, J CLIN ENDOCR METAB, V98, P3149, DOI 10.1210/jc.2013-1204; Wells SA, 2010, J CLIN ONCOL, V28, P767, DOI 10.1200/JCO.2009.23.6604; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wilson J. M. G., 1968, PRINCIPLES AND PRACT; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	112	354	359	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					302	308		10.1038/nature12981	http://dx.doi.org/10.1038/nature12981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429628	Green Accepted			2022-12-28	WOS:000329621800027
J	Ross, RJ; Weiner, MM; Lin, HF				Ross, Robert J.; Weiner, Molly M.; Lin, Haifan			PIWI proteins and PIWI-interacting RNAs in the soma	NATURE			English	Review							PROGRAMMED DNA ELIMINATION; PRIMARY PIRNA BIOGENESIS; CELL SELF-RENEWAL; GERMLINE STEM-CELLS; TUMOR-RELATED DEATH; DROSOPHILA-MELANOGASTER; GENOME REARRANGEMENT; HIWI GENE; MORPHOLOGICAL EVOLUTION; PHENOTYPIC VARIATION	The discovery of millions of PIWI-interacting RNAs revealed a fascinating and unanticipated dimension of biology. The PIWI-piRNA pathway has been commonly perceived as germline-specific, even though the somatic function of PIWI proteins was documented when they were first discovered. Recent studies have begun to re-explore this pathway in somatic cells in diverse organisms, particularly lower eukaryotes. These studies have illustrated the multifaceted somatic functions of the pathway not only in transposon silencing but also in genome rearrangement and epigenetic programming, with biological roles in stem-cell function, whole-body regeneration, memory and possibly cancer.	[Ross, Robert J.; Weiner, Molly M.; Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06509 USA; [Ross, Robert J.; Weiner, Molly M.; Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06509 USA	Yale University; Yale University	Lin, HF (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06509 USA.	haifan.lin@yale.edu			NIH [T32-GM07205, DP1CA174418, R01HD42012]; G. Harold & Leila Mathers Foundation; Ellison Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD042012] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042012] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold & Leila Mathers Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Christensen, C. Juliano and S. Ramesh Mani for their critical reading of the manuscript. R.J.R. and M.M.W. are supported by an NIH Medical Scientist Training Program grant (T32-GM07205). The current work in the Lin lab on PIWIs and piRNA is supported by the NIH (DP1CA174418 and R01HD42012), the G. Harold & Leila Mathers Foundation, and an Ellison Medical Foundation Senior Scholar Award.	Akkouche A, 2013, EMBO REP, V14, P458, DOI 10.1038/embor.2013.38; Alie A, 2011, DEV BIOL, V350, P183, DOI 10.1016/j.ydbio.2010.10.019; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Darricarrere N, 2013, P NATL ACAD SCI USA, V110, P1297, DOI 10.1073/pnas.1213283110; De Mulder K, 2009, DEV BIOL, V334, P198, DOI 10.1016/j.ydbio.2009.07.019; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Funayama N, 2010, EVOL DEV, V12, P275, DOI 10.1111/j.1525-142X.2010.00413.x; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Ge DT, 2013, CURR BIOL, V23, pR318, DOI 10.1016/j.cub.2013.03.033; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Gu TT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003780; Handler D, 2011, EMBO J, V30, P3977, DOI 10.1038/emboj.2011.308; Harris AN, 2001, DEVELOPMENT, V128, P2823; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mani SR, 2013, DEV BIOL; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Nolde MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071950; Ohtani H, 2013, GENE DEV, V27, P1656, DOI 10.1101/gad.221515.113; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Olivieri D, 2012, MOL CELL, V47, P954, DOI 10.1016/j.molcel.2012.07.021; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Pandey RR, 2013, P NATL ACAD SCI USA, V110, P16492, DOI 10.1073/pnas.1316316110; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Perrat PN, 2013, SCIENCE, V340, P91, DOI 10.1126/science.1231965; Qi H, 2011, J BIOL CHEM, V286, P3789, DOI 10.1074/jbc.M110.193888; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Rinkevich Y, 2013, DEV CELL, V24, P76, DOI 10.1016/j.devcel.2012.11.010; Rinkevich Y, 2010, DEV BIOL, V345, P94, DOI 10.1016/j.ydbio.2010.05.500; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schoeberl UE, 2011, J BIOL CHEM, V286, P37045, DOI 10.1074/jbc.R111.276964; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zhao YM, 2012, CANCER-AM CANCER SOC, V118, P2708, DOI 10.1002/cncr.26524; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107	93	279	286	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					353	359		10.1038/nature12987	http://dx.doi.org/10.1038/nature12987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429634	Green Accepted			2022-12-28	WOS:000329621800033
J	Das, RM; Storey, KG				Das, Raman M.; Storey, Kate G.			Apical Abscission Alters Cell Polarity and Dismantles the Primary Cilium During Neurogenesis	SCIENCE			English	Article							MITOTIC SPINDLE ORIENTATION; JUNCTIONS	Withdrawal of differentiating cells from proliferative tissue is critical for embryonic development and adult tissue homeostasis; however, the mechanisms that control this cell behavior are poorly understood. Using high-resolution live-cell imaging in chick neural tube, we uncover a form of cell subdivision that abscises apical cell membrane and mediates neuron detachment from the ventricle. This mechanism operates in chick and mouse, is dependent on actin-myosin contraction, and results in loss of apical cell polarity. Apical abscission also dismantles the primary cilium, known to transduce sonic-hedgehog signals, and is required for expression of cell-cycle-exit gene p27/Kip1. We further show that N-cadherin levels, regulated by neuronal-differentiation factor Neurog2, determine cilium disassembly and final abscission. This cell-biological mechanism may mediate such cell transitions in other epithelia in normal and cancerous conditions.	[Das, Raman M.; Storey, Kate G.] Univ Dundee, Coll Life Sci, Neural Dev Grp, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland	University of Dundee	Storey, KG (corresponding author), Univ Dundee, Coll Life Sci, Neural Dev Grp, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland.	k.g.storey@dundee.ac.uk		Storey, Kate/0000-0003-3506-1287; Das, Raman/0000-0003-3375-619X	Medical Research Council Next Generation Optical Microscopy Award [MR/K015869/1]; Wellcome Trust [083611/Z/07/Z]; MRC [MR/K015869/1] Funding Source: UKRI; Medical Research Council [MR/K015869/1] Funding Source: researchfish	Medical Research Council Next Generation Optical Microscopy Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Weijer, A. Muller, and J. Januschke for comments; J. Swedlow for imaging advice; and S. Swift and C. Thomson in the College of Life Sciences Light Microscopy Facility (LMF) for technical support. Structured-illumination microscopy was carried out with assistance of M. Posch (LMF) and L. Ferrand (GE Healthcare) and supported by the Medical Research Council Next Generation Optical Microscopy Award (MR/K015869/1). R. M. D. and K. G. S. are funded by Wellcome Trust program grant 083611/Z/07/Z.	Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; Ghosh S, 2008, P NATL ACAD SCI USA, V105, P335, DOI 10.1073/pnas.0705713105; Gui HX, 2007, DEV BIOL, V301, P14, DOI 10.1016/j.ydbio.2006.10.035; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kuijpers M, 2011, MOL CELL NEUROSCI, V48, P349, DOI 10.1016/j.mcn.2011.05.004; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Paridaen JTML, 2013, CELL, V155, P333, DOI 10.1016/j.cell.2013.08.060; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Sheen VL, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/480129; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Wong GKW, 2012, J NEUROSCI, V32, P223, DOI 10.1523/JNEUROSCI.2596-11.2012; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663	19	102	103	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					200	204		10.1126/science.1247521	http://dx.doi.org/10.1126/science.1247521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408437	Green Accepted			2022-12-28	WOS:000329440800047
J	Vermeer, JEM; von Wangenheim, D; Barberon, M; Lee, Y; Stelzer, EHK; Maizel, A; Geldner, N				Vermeer, Joop E. M.; von Wangenheim, Daniel; Barberon, Marie; Lee, Yuree; Stelzer, Ernst H. K.; Maizel, Alexis; Geldner, Niko			A Spatial Accommodation by Neighboring Cells Is Required for Organ Initiation in Arabidopsis	SCIENCE			English	Article							AUXIN TRANSPORT; ROOT; GENE	Lateral root formation in plants can be studied as the process of interaction between chemical signals and physical forces during development. Lateral root primordia grow through overlying cell layers that must accommodate this incursion. Here, we analyze responses of the endodermis, the immediate neighbor to an initiating lateral root. Endodermal cells overlying lateral root primordia lose volume, change shape, and relinquish their tight junction-like diffusion barrier to make way for the emerging lateral root primordium. Endodermal feedback is absolutely required for initiation and growth of lateral roots, and we provide evidence that this is mediated by controlled volume loss in the endodermis. We propose that turgidity and rigid cell walls, typical of plants, impose constraints that are specifically modified for a given developmental process.	[Vermeer, Joop E. M.; Barberon, Marie; Lee, Yuree; Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol, Biophore, UNIL Sorge, CH-1015 Lausanne, Switzerland; [von Wangenheim, Daniel; Stelzer, Ernst H. K.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [von Wangenheim, Daniel; Maizel, Alexis] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany	University of Lausanne; Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Vermeer, JEM (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore, UNIL Sorge, CH-1015 Lausanne, Switzerland.	joop.vermeer@unil.ch; niko.geldner@unil.ch	Vermeer, Joop E.M./J-2232-2014; Stelzer, Ernst H K/A-7648-2011; von Wangenheim, Daniel/N-9054-2014; Barberon, Marie/M-3490-2016; Geldner, Niko/Y-2481-2019; Maizel, Alexis/D-3560-2012	Vermeer, Joop E.M./0000-0001-8876-5873; Stelzer, Ernst H K/0000-0003-1545-0736; von Wangenheim, Daniel/0000-0002-6862-1247; Barberon, Marie/0000-0002-8169-8580; Lee, Yuree/0000-0002-4663-6974; Geldner, Niko/0000-0002-2300-9644; Maizel, Alexis/0000-0001-6843-1059	Marie-Curie Intra-European Fellowship; EMBO; Swiss National Science Foundation (SNSF); European Research Council (ERC); land Baden-Wurttemberg; Chica und Heinz Schaller Stiftung; CellNetworks cluster of excellence; Cluster of Excellence at Frankfurt for Macromolecular Complexes (CEF-MC); Deutsche Forschungsgemeinschaft	Marie-Curie Intra-European Fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC)European Commission); land Baden-Wurttemberg; Chica und Heinz Schaller Stiftung; CellNetworks cluster of excellence; Cluster of Excellence at Frankfurt for Macromolecular Complexes (CEF-MC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the Central Imaging Facility (CIF) of the University of Lausanne for technical support, T. Beeckman, M. Bennett, B. De Rybel, Y. Heluriatta and H. Fukaki for sharing published material. We thank T. Beeckman, M. Bennett and T. Goh for helpful comments. We thank B. de Rybel for sharing unpublished results. This work was supported by a Marie-Curie Intra-European Fellowship grant to J.E.M.V., an EMBO long-term fellowship for M. B., and grants of the Swiss National Science Foundation (SNSF) and the European Research Council (ERC) (to N.G.); the land Baden-Wurttemberg, the Chica und Heinz Schaller Stiftung, and the CellNetworks cluster of excellence (to A. M.); and the Cluster of Excellence at Frankfurt for Macromolecular Complexes (CEF-MC) and the Deutsche Forschungsgemeinschaft (to D. v. W., E.H.K.S.).	BELL JK, 1970, PROTOPLASMA, V70, P179, DOI 10.1007/BF01276979; BONNET HT, 1969, J CELL BIOL, V40, P144, DOI 10.1083/jcb.40.1.144; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Cereijido M, 2004, PHYSIOL REV, V84, P1229, DOI 10.1152/physrev.00001.2004; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Geldner N, 2013, ANNU REV PLANT BIOL, V64, P531, DOI 10.1146/annurev-arplant-050312-120050; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Lee Y, 2013, CELL, V153, P402, DOI 10.1016/j.cell.2013.02.045; Lucas M, 2013, P NATL ACAD SCI USA, V110, P5229, DOI 10.1073/pnas.1210807110; Marhavy P, 2013, EMBO J, V32, P149, DOI 10.1038/emboj.2012.303; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; Peret B, 2012, NAT CELL BIOL, V14, P991, DOI 10.1038/ncb2573; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006	21	174	176	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					178	183		10.1126/science.1245871	http://dx.doi.org/10.1126/science.1245871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408432				2022-12-28	WOS:000329440800041
J	Huang, YL; Wu, MT				Huang, Yi-Luan; Wu, Ming-Ting			Emphysematous Aortitis after Endovascular Graft	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huang, Yi-Luan] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan; [Wu, Ming-Ting] Natl Yang Ming Univ, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Huang, YL (corresponding author), Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan.	wu.mingting@gmail.com	Wu, Ming-Ting/C-5428-2009	Wu, Ming-Ting/0000-0002-2850-1400					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					158	158		10.1056/NEJMicm1306161	http://dx.doi.org/10.1056/NEJMicm1306161			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401053				2022-12-28	WOS:000336119800011
J	Venkatesh, B; Lee, AP; Ravi, V; Maurya, AK; Lian, MM; Swann, JB; Ohta, Y; Flajnik, MF; Sutoh, Y; Kasahara, M; Hoon, S; Gangu, V; Roy, SW; Irimia, M; Korzh, V; Kondrychyn, I; Lim, ZW; Tay, BH; Tohari, S; Kong, KW; Ho, SF; Lorente-Galdos, B; Quilez, J; Marques-Bonet, T; Raney, BJ; Ingham, PW; Tay, A; Hillier, LW; Minx, P; Boehm, T; Wilson, RK; Brenner, S; Warren, WC				Venkatesh, Byrappa; Lee, Alison P.; Ravi, Vydianathan; Maurya, Ashish K.; Lian, Michelle M.; Swann, Jeremy B.; Ohta, Yuko; Flajnik, Martin F.; Sutoh, Yoichi; Kasahara, Masanori; Hoon, Shawn; Gangu, Vamshidhar; Roy, Scott W.; Irimia, Manuel; Korzh, Vladimir; Kondrychyn, Igor; Lim, Zhi Wei; Tay, Boon-Hui; Tohari, Sumanty; Kong, Kiat Whye; Ho, Shufen; Lorente-Galdos, Belen; Quilez, Javier; Marques-Bonet, Tomas; Raney, Brian J.; Ingham, Philip W.; Tay, Alice; Hillier, LaDeana W.; Minx, Patrick; Boehm, Thomas; Wilson, Richard K.; Brenner, Sydney; Warren, Wesley C.			Elephant shark genome provides unique insights into gnathostome evolution	NATURE			English	Article							CARTILAGINOUS FISH; METABOLIC-RATE; VERTEBRATES; ORIGIN; REPERTOIRE; PHYLOGENY; RECEPTORS; SEQUENCE; IMMUNITY; LAMPREY	The emergence of jawed vertebrates (gnathostomes) fromjawless vertebrates was accompanied by major morphological and physiological innovations, such as hinged jaws, paired fins and immunoglobulin-based adaptive immunity. Gnathostomes subsequently diverged into two groups, the cartilaginous fishes and the bony vertebrates. Here we report the whole-genome analysis of a cartilaginous fish, the elephant shark (Callorhinchus milii). We find that the C. milii genome is the slowest evolving of all known vertebrates, including the ` living fossil' coelacanth, and features extensive synteny conservation with tetrapod genomes, making it a goodmodel for comparative analyses of gnathostome genomes. Our functional studies suggest that the lack of genes encoding secreted calcium-binding phosphoproteins in cartilaginous fishes explains the absence of bone in their endoskeleton. Furthermore, the adaptive immune system of cartilaginous fishes is unusual: it lacks the canonical CD4 co-receptor and most transcription factors, cytokines and cytokine receptors related to the CD4 lineage, despite the presence of polymorphic major histocompatibility complex class II molecules. It thus presents a new model for understanding the origin of adaptive immunity.	[Venkatesh, Byrappa; Lee, Alison P.; Ravi, Vydianathan; Lian, Michelle M.; Lim, Zhi Wei; Tay, Boon-Hui; Tohari, Sumanty; Tay, Alice; Brenner, Sydney] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Biopolis, Singapore 138673, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore; [Maurya, Ashish K.; Ingham, Philip W.] ASTAR, Inst Mol & Cell Biol, Dev & Biomed Genet Lab, Biopolis, Singapore 138673, Singapore; [Swann, Jeremy B.; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany; [Ohta, Yuko; Flajnik, Martin F.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Sutoh, Yoichi; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; [Hoon, Shawn; Gangu, Vamshidhar; Kong, Kiat Whye; Ho, Shufen] ASTAR, Inst Biomed Sci, Mol Engn Lab, Biopolis, Singapore 138673, Singapore; [Roy, Scott W.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Irimia, Manuel] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Irimia, Manuel] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Korzh, Vladimir; Kondrychyn, Igor] ASTAR, Inst Mol & Cell Biol, Fish Dev Biol Lab, Biopolis, Singapore 138673, Singapore; [Lorente-Galdos, Belen; Quilez, Javier; Marques-Bonet, Tomas] Inst Biol Evolut UPF CSIC, PRBB, Barcelona 08003, Spain; [Lorente-Galdos, Belen; Quilez, Javier; Marques-Bonet, Tomas] ICREA, Barcelona 08010, Catalonia, Spain; [Raney, Brian J.] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Hillier, LaDeana W.; Minx, Patrick; Wilson, Richard K.; Warren, Wesley C.] Washington Univ, Genome Inst, St Louis, MO 63108 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Max Planck Society; University System of Maryland; University of Maryland Baltimore; Hokkaido University; Agency for Science Technology & Research (A*STAR); California State University System; San Francisco State University; University of Toronto; University of Toronto; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; ICREA; University of California System; University of California Santa Cruz; Washington University (WUSTL)	Venkatesh, B (corresponding author), ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Biopolis, Singapore 138673, Singapore.	mcbbv@imcb.a-star.edu.sg; wwarren@genome.wustl.edu	Lim, Zhiwei/Q-7858-2016; Sutoh, Yoichi/AAA-5516-2020; Kondrychyn, Igor/AAC-6237-2022; Ingham, Philip William/AAH-5884-2020; Ingham, Philip W/G-9903-2011; Raney, Brian/ABE-6267-2020; Kondrychyn, Igor/C-2621-2016; Lee, Alison/HCH-1286-2022; Korzh, Vladimir P/H-1596-2011; Kasahara, Masanori/G-7651-2011; Quilez, Javier/J-7107-2015; Wilson, Richard K./AAF-4139-2019; Marques-Bonet, Tomas/I-4618-2014; Ravi, Vydianathan/B-2759-2009; Irimia, Manuel/E-3040-2010; Marques-Bonet, Tomas/ABF-3734-2020; Gangu, Vamshidhar/H-5487-2019; Ingham, Philip/U-4253-2019	Lim, Zhiwei/0000-0003-4620-1986; Sutoh, Yoichi/0000-0002-1607-9759; Kondrychyn, Igor/0000-0002-2268-7291; Ingham, Philip William/0000-0001-8224-9958; Ingham, Philip W/0000-0001-8224-9958; Kondrychyn, Igor/0000-0002-2268-7291; Lee, Alison/0000-0002-3773-1021; Korzh, Vladimir P/0000-0002-6580-7986; Quilez, Javier/0000-0002-0108-2672; Wilson, Richard K./0000-0002-1992-1358; Marques-Bonet, Tomas/0000-0002-5597-3075; Ravi, Vydianathan/0000-0003-0807-7697; Irimia, Manuel/0000-0002-2179-2567; Marques-Bonet, Tomas/0000-0002-5597-3075; Flajnik, Martin Francis/0000-0002-2792-5084; Gangu, Vamshidhar/0000-0002-8012-9394; Lorente-Galdos, Belen/0000-0001-5390-2452; Venkatesh, Byrappa/0000-0003-3620-0277; Sutoh, Yoichi/0000-0002-3470-0465	National Human Genome Research Institute, USA; Biomedical Research Council of A*STAR, Singapore; A*STAR Computational Resource Centre; Max Planck Society; NIH [RR006603, AI27877]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Human Frontiers Science Program Organization; ERC [260372]; MICINN (Spain) [BFU2011-28549]; ICREA Funding Source: Custom; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006603] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U41HG002371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI027877, R01AI027877] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010549] Funding Source: NIH RePORTER	National Human Genome Research Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR Computational Resource Centre(Agency for Science Technology & Research (A*STAR)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontiers Science Program Organization(Human Frontier Science Program); ERC(European Research Council (ERC)European Commission); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Generation of C. milii genome sequence at the Genome Institute at Washington University was supported by grants from the National Human Genome Research Institute, USA. We thank members of the Production Sequencing group at the Genome Institute at Washington University. Sequencing of messenger RNA, small RNA and BAC ends was supported by grants from the Biomedical Research Council of A*STAR, Singapore. This work was supported by the A*STAR Computational Resource Centre through the use of its high-performance computing facilities. We would like to thank J. Danks, J. Bell and J. G. Patil for their help in collecting C. milii samples, and J. K. Joung for CRISPR and Cas9 plasmids. We also thank the following funding agencies: the Max Planck Society (T. B.); NIH grants RR006603 and AI27877 (M. F. F.); the Ministry of Education, Culture, Sports, Science and Technology, Japan (M. K.); the Human Frontiers Science Program Organization (M. I.); ERC Starting Grant (260372) and MICINN (Spain) BFU2011-28549 (T.M.-B.); and the Biomedical Research Council of A*STAR, Singapore (B. V., P. W. I., S. Hoon and V.K.).	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Boehm T, 2012, CURR BIOL, V22, pR722, DOI 10.1016/j.cub.2012.07.003; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Donoghue PCJ, 2006, J EXP ZOOL PART B, V306B, P278, DOI 10.1002/jez.b.21090; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Dooley H, 2005, EUR J IMMUNOL, V35, P936, DOI 10.1002/eji.200425760; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; Ellegren H, 2010, TRENDS ECOL EVOL, V25, P283, DOI 10.1016/j.tree.2009.12.004; Flajnik MF, 2012, IMMUNOGENETICS, V64, P571, DOI 10.1007/s00251-012-0616-2; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Hallstrom BM, 2009, MOL BIOL EVOL, V26, P463, DOI 10.1093/molbev/msn271; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Janvier P., 1996, EARLY VERTEBRATES; Janvier P, 2006, NATURE, V443, P921, DOI 10.1038/443921a; Kawasaki K, 2007, CELLS TISSUES ORGANS, V186, P7, DOI 10.1159/000102678; Kawasaki K, 2009, DEV GENES EVOL, V219, P147, DOI 10.1007/s00427-009-0276-x; Last P. R., 1994, SHARKS RAYS AUSTR, P465; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN AP, 1992, NATURE, V357, P153, DOI 10.1038/357153a0; Martin AP, 1999, MOL BIOL EVOL, V16, P996, DOI 10.1093/oxfordjournals.molbev.a026189; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Rasmussen AS, 1999, P NATL ACAD SCI USA, V96, P2177, DOI 10.1073/pnas.96.5.2177; SCHLOTTERER C, 1991, NATURE, V354, P63, DOI 10.1038/354063a0; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Venkatesh B, 2005, CURR BIOL, V15, pR82, DOI 10.1016/j.cub.2005.01.021; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617	37	475	493	4	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					174	179		10.1038/nature12826	http://dx.doi.org/10.1038/nature12826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24402279	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000329441500030
J	Evins, AE; Cather, C; Pratt, SA; Pachas, GN; Hoeppner, SS; Goff, DC; Achtyes, ED; Ayer, D; Schoenfeld, DA				Evins, A. Eden; Cather, Corinne; Pratt, Sarah A.; Pachas, Gladys N.; Hoeppner, Susanne S.; Goff, Donald C.; Achtyes, Eric D.; Ayer, David; Schoenfeld, David A.			Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; NICOTINE REPLACEMENT THERAPY; DOUBLE-BLIND; SUSTAINED-RELEASE; BUPROPION; SAFETY; DEPRESSION; DEPENDENCE; SMOKERS; ADULTS	IMPORTANCE It is estimated that more than half of those with serious mental illness smoke tobacco regularly. Standard courses of pharmacotherapeutic cessation aids improve short-term abstinence, but most who attain abstinence relapse rapidly after discontinuation of pharmacotherapy. OBJECTIVE To determine whether smokers diagnosed with schizophrenia and bipolar disease have higher rates of prolonged tobacco abstinence with maintenance pharmacotherapy than with standard treatment. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, placebo-controlled, parallel-group, relapse-prevention clinical trial conducted in 10 community mental-health centers. Of 247 smokers with schizophrenia or bipolar disease recruited from March 2008-April 2012, 203 received 12-weeks' open-label varenicline and cognitive behavioral therapy and 87 met abstinence criteria to enter the relapse prevention intervention. INTERVENTIONS Participants who had 2 weeks or more of continuous abstinence at week 12 of open treatment were randomly assigned to receive cognitive behavioral therapy and double-blind varenicline (1 mg, 2 per day) or placebo from weeks 12 to 52. Participants then discontinued study treatment and were followed up to week 76. MAIN OUTCOMES AND MEASURES Seven-day rate of continuous abstinence at study week 52, the end of the relapse-prevention phase, confirmed by exhaled carbon monoxide. Secondary outcomes were continuous abstinence rates for weeks 12 through 64 based on biochemically verified abstinence and weeks 12 through 76, based on self-reported smoking behavior. RESULTS Sixty-one participants completed the relapse-prevention phase; 26 discontinued participation (7 varenicline, 19 placebo) and were considered to have relapsed for the analyses; 18 of these had relapsed prior to dropout. At week 52, point-prevalence abstinence rates were 60% in the varenicline group (24 of 40) vs 19% (9 of 47) in the placebo group (odds ratio [OR], 6.2; 95% CI, 2.2-19.2; P <.001). From weeks 12 through 64, 45%(18 of 40) among those in the varenicline group vs 15%(7 of 47) in the placebo group were continuously abstinent (OR, 4.6; 95% CI, 1.5-15.7; P =.004), and from weeks 12 through 76, 30% (12 of 40) in the varenicline group vs 11% (5 of 47) in the placebo group were continuously abstinent (OR, 3.4; 95% CI, 1.02-13.6; P =.03). There were no significant treatment effects on psychiatric symptom ratings or psychiatric adverse events. CONCLUSIONS AND RELEVANCE Among smokers with serious mental illness who attained initial abstinence with standard treatment, maintenance pharmacotherapy with varenicline and cognitive behavioral therapy improved prolonged tobacco abstinence rates compared with cognitive behavioral therapy alone after 1 year of treatment and at 6 months after treatment discontinuation.	[Evins, A. Eden; Cather, Corinne; Pachas, Gladys N.; Hoeppner, Susanne S.; Schoenfeld, David A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Evins, A. Eden; Cather, Corinne; Pachas, Gladys N.; Hoeppner, Susanne S.; Schoenfeld, David A.] Harvard Univ, Sch Med, Boston, MA USA; [Pratt, Sarah A.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Goff, Donald C.] NYU, Langone Med Ctr, New York, NY USA; [Achtyes, Eric D.] Cherry St Hlth Serv, Grand Rapids, MI USA; [Achtyes, Eric D.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Ayer, David] Centerstone Res Inst, Bloomington, IN USA; [Ayer, David] Indiana Univ, Bloomington, IN 47405 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dartmouth College; New York University; NYU Langone Medical Center; Michigan State University; Michigan State University College of Human Medicine; Indiana University System; Indiana University Bloomington	Evins, AE (corresponding author), 60 Staniford St, Boston, MA 02114 USA.	a_eden_evins@hms.harvard.edu	Hoeppner, Susanne S/C-4631-2015; Achtyes, Eric/AAA-6372-2020; Achtyes, Eric/M-6024-2016	Hoeppner, Susanne S/0000-0003-2060-1666; Achtyes, Eric/0000-0001-8939-1535	National Institute on Drug Abuse [R01 DA021245]; Pfizer; Department of Health and Human Services, Substance Abuse and Mental Health Services Administration [05B1MACMHS]; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA000510, K24DA030443, R01DA021245] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Pfizer(Pfizer); Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by grants R01 DA021245 by National Institute on Drug Abuse with supplemental financial and material support from an investigator-initiated award from Pfizer for study medications and funding, and by 05B1MACMHS to the Massachusetts Department of Mental Health from the Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Treatment Strategies for Smoking Cessation in Patients with Schizophrenia to the North Suffolk Mental Health Association (Dr Evins). Pfizer provided study medication and supplemental support through an investigator-initiated award after the protocol was approved by the institutional review board and the data and safety monitoring board.	ADDINGTON D, 1993, BRIT J PSYCHIAT, V163, P39, DOI 10.1192/S0007125000292581; ANDREASEN NC, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P49; Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Cather C, 2013, J DUAL DIAGN, V9, P87, DOI 10.1080/15504263.2012.749559; Dale Horst W, 2005, Neuropsychiatr Dis Treat, V1, P349; Evins A E, 2001, Nicotine Tob Res, V3, P397, DOI 10.1080/14622200110073920; Evins AE, 2007, J CLIN PSYCHOPHARM, V27, P380, DOI 10.1097/01.jcp.0b013e3180ca86fa; Evins AE, 2013, AM J PSYCHIAT, V170, P1385, DOI 10.1176/appi.ajp.2013.13091257; Evins AE, 2005, J CLIN PSYCHIAT, V66, P1184, DOI 10.4088/JCP.v66n0915; Evins AE, 2005, J CLIN PSYCHOPHARM, V25, P218, DOI 10.1097/01.jcp.0000162802.54076.18; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; George TP, 2008, BIOL PSYCHIAT, V63, P1092, DOI 10.1016/j.biopsych.2007.11.002; George TP, 2002, BIOL PSYCHIAT, V52, P53, DOI 10.1016/S0006-3223(02)01339-2; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Hajek P, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003999.pub3, 10.1002/14651858.CD003999.pub4]; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hong LE, 2011, ARCH GEN PSYCHIAT, V68, P1195, DOI 10.1001/archgenpsychiatry.2011.83; McClave AK, 2010, AM J PUBLIC HEALTH, V100, P2464, DOI 10.2105/AJPH.2009.188136; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pachas GN, 2012, J DUAL DIAGN, V8, P117, DOI 10.1080/15504263.2012.663675; Shim JC, 2012, NEUROPSYCHOPHARMACOL, V37, P660, DOI 10.1038/npp.2011.238; Stapleton JA, 2008, ADDICTION, V103, P146, DOI 10.1111/j.1360-0443.2007.02083.x; Substance Abuse and Mental Health Services Administration, 2012, RESULTS FROM THE 201; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Tsoi DT, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007253.pub3; Weiner E, 2001, AM J PSYCHIAT, V158, P635, DOI 10.1176/appi.ajp.158.4.635; Weiner E, 2011, SCHIZOPHR RES, V129, P94, DOI 10.1016/j.schres.2011.02.003; Welsch SK, 1999, EXP CLIN PSYCHOPHARM, V7, P354, DOI 10.1037/1064-1297.7.4.354; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	32	142	145	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2014	311	2					145	154		10.1001/jama.2013.285113	http://dx.doi.org/10.1001/jama.2013.285113			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SA	24399553	Bronze, Green Accepted			2022-12-28	WOS:000329339400020
J	Gornall, J				Gornall, Jonathan			ALCOHOL AND PUBLIC HEALTH Under the influence: 3. Role of parliamentary groups	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						Advisory Committee on Business Appointments, 2013, APPOINT TAK FORM; [Anonymous], ASDA RESP GOV ALC; Bourne R, 2012, MINIMUM ALCOHOL PROI; Brindle J, 2013, BURTON MAIL     0718; Centre for Policy Studies, 2012, E BULLETIN; Harris T, 2013, BROMSGROVE STANDARD; Home Office, 2012, ALC STRAT CNST; Jenkins A, 2012, BURTON MAIL     0719; Pickles E, 2012, COMMUNICATION   0516; Scotch Whisky Association, POL PARL PROM; Scotch Whisky Association, 2012, MINIMUM PRICING; Van-Horne S, 2013, COMMUNICATION; WHO Regional Office for Europe, 2012, ALC EUR UN CONS HAR; Wilson S., 2013, BRUSSELS; Woodard R., 2011, DECANTER; Zero Waste Scotland, GAV HEW BIOGR	16	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								f7571	10.1136/bmj.f7571	http://dx.doi.org/10.1136/bmj.f7571			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KI	24403573				2022-12-28	WOS:000329610300004
J	Dalziel, M; Crispin, M; Scanlan, CN; Zitzmann, N; Dwek, RA				Dalziel, Martin; Crispin, Max; Scanlan, Christopher N.; Zitzmann, Nicole; Dwek, Raymond A.			Emerging Principles for the Therapeutic Exploitation of Glycosylation	SCIENCE			English	Review							ENZYME-REPLACEMENT THERAPY; IGG GLYCAN HYDROLYSIS; IMMUNODEFICIENCY-VIRUS; STRUCTURAL-ANALYSIS; ANTIBODY GLYCOFORM; CRYSTAL-STRUCTURE; SIALIC-ACID; SERUM IGG; CANCER; CARBOHYDRATE	Glycosylation plays a key role in a wide range of biological processes. Specific modification to a glycan's structure can directly modulate its biological function. Glycans are not only essential to glycoprotein folding, cellular homeostasis, and immune regulation but are involved in multiple disease conditions. An increased molecular and structural understanding of the mechanistic role that glycans play in these pathological processes has driven the development of therapeutics and illuminated novel targets for drug design. This knowledge has enabled the treatment of metabolic disorders and the development of antivirals and shaped cancer and viral vaccine strategies. Furthermore, an understanding of glycosylation has led to the development of specific drug glycoforms, for example, monoclonal antibodies, with enhanced potency.	[Dalziel, Martin; Crispin, Max; Scanlan, Christopher N.; Zitzmann, Nicole; Dwek, Raymond A.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England	University of Oxford	Dwek, RA (corresponding author), Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, S Parks Rd, Oxford OX1 3QU, England.	raymond.dwek@exeter.ox.ac.uk	Crispin, Max/AAG-4098-2020	Crispin, Max/0000-0002-1072-2694; Dalziel, Martin/0000-0002-8967-6378	International AIDS Initiative (IAVI); Scripps Center for HIV/AIDS Vaccine Immunology and Discovery (CHAVI-ID); Medical Research Council; United Therapeutics Corporation, USA; Oxford Glycobiology Institute; MRC [MC_PC_12020] Funding Source: UKRI; Medical Research Council [MC_PC_12020] Funding Source: researchfish	International AIDS Initiative (IAVI); Scripps Center for HIV/AIDS Vaccine Immunology and Discovery (CHAVI-ID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Therapeutics Corporation, USA; Oxford Glycobiology Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Chris Scanlan passed away after a short battle with cancer during the writing of this article. He was a valued and much admired colleague. M.D. and M.C. are supported by the International AIDS Initiative (IAVI), the Scripps Center for HIV/AIDS Vaccine Immunology and Discovery (CHAVI-ID), and the Medical Research Council. M.C. is a Fellow of Oriel College, Oxford. N.Z. is a Research Fellow of Merton College, Oxford, and is also supported by United Therapeutics Corporation, USA, and the Oxford Glycobiology Institute. We thank T. Bowden for helpful discussions and M. Wormald for the video of gp120. M.C. and C.N.S. have made a patent application titled "Combined therapeutic use of antibodies and endoglycosidases" (WO2013110946; international publication date 1 August 2013).	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Andersson IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017881; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Avci FY, 2013, SEMIN IMMUNOL, V25, P146, DOI 10.1016/j.smim.2013.05.005; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Batsalova T, 2010, J IMMUNOL, V185, P2701, DOI 10.4049/jimmunol.1000385; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Bowden TA, 2012, J AM CHEM SOC, V134, P17554, DOI 10.1021/ja306068g; Buskas T, 2009, CHEM COMMUN, P5335, DOI 10.1039/b908664c; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2008, P NATL ACAD SCI USA, V105, P4265, DOI 10.1073/pnas.0711271105; Collin M, 2013, EXP DERMATOL, V22, P511, DOI 10.1111/exd.12171; Crispin M, 2013, P NATL ACAD SCI USA, V110, pE3544, DOI 10.1073/pnas.1310657110; Crispin M, 2013, NAT STRUCT MOL BIOL, V20, P771, DOI 10.1038/nsmb.2627; Crispin M, 2013, P NATL ACAD SCI USA, V110, P10059, DOI 10.1073/pnas.1307776110; Crispin M, 2009, J MOL BIOL, V387, P1061, DOI 10.1016/j.jmb.2009.02.033; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Desnick R. J., 2001, ALFA GALACTOSIDASE D, VIV, P3733; Dunlop DC, 2010, GLYCOBIOLOGY, V20, P812, DOI 10.1093/glycob/cwq020; Durrant LG, 2012, CLIN EXP IMMUNOL, V167, P206, DOI 10.1111/j.1365-2249.2011.04516.x; Eklund Erik A, 2006, NeuroRx, V3, P254; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Freire-De-Lima L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00356; Gaidzik N, 2013, CHEM SOC REV, V42, P4421, DOI 10.1039/c3cs35470a; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Garman E, 2004, CURR DRUG TARGETS, V5, P119, DOI 10.2174/1389450043490604; Gasser B, 2013, FUTURE MICROBIOL, V8, P191, DOI [10.2217/fmb.12.133, 10.2217/FMB.12.133]; Ghaderi D, 2012, BIOTECHNOL GENET ENG, V28, P147, DOI 10.5661/bger-28-147; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Hakamata W, 2012, BIOORG MED CHEM LETT, V22, P62, DOI 10.1016/j.bmcl.2011.11.084; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; Helle F, 2011, VIRUSES-BASEL, V3, P1909, DOI 10.3390/v3101909; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Jez J, 2013, BIOTECHNOL J, V8, P371, DOI 10.1002/biot.201200363; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Lew W, 2000, CURR MED CHEM, V7, P663, DOI 10.2174/0929867003374886; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Lood C, 2012, ARTHRITIS RHEUM-US, V64, P2698, DOI 10.1002/art.34454; Luhn K, 2012, SEMIN IMMUNOPATHOL, V34, P383, DOI 10.1007/s00281-012-0304-1; Mandell RB, 2009, ZOONOSES PUBLIC HLTH, V56, P391, DOI 10.1111/j.1863-2378.2008.01191.x; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Masuda K, 2007, MOL IMMUNOL, V44, P3122, DOI 10.1016/j.molimm.2007.02.005; Matsubara T, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/740982; Means RE, 2000, J VIROL, V74, P11181, DOI 10.1128/JVI.74.23.11181-11190.2000; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Morell CF, 2009, EXPERT OPIN BIOL TH, V9, P631, DOI [10.1517/14712590902902296, 10.1517/14712590902902296 ]; Nandakumar KS, 2013, P NATL ACAD SCI USA, V110, P10252, DOI 10.1073/pnas.1301480110; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Ogorek Christiane, 2012, Methods Mol Biol, V907, P507, DOI 10.1007/978-1-61779-974-7_29; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004; Pollock S, 2008, AIDS, V22, P1961, DOI 10.1097/QAD.0b013e32830efd96; RADEMACHER TW, 1988, GLYCOBIOLOGY ANN REV, V57, P785, DOI DOI 10.1146/ANNUREV.BI.57.070188.004033; Ryan SO, 2010, CANCER RES, V70, P5788, DOI 10.1158/0008-5472.CAN-09-4519; Sazinsky SL, 2008, P NATL ACAD SCI USA, V105, P20167, DOI 10.1073/pnas.0809257105; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schwizer D, 2012, CHEM-EUR J, V18, P1342, DOI 10.1002/chem.201102884; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Thomas Richard J, 2010, Bioeng Bugs, V1, P17, DOI 10.4161/bbug.1.1.10049; Urayama A, 2008, MOL THER, V16, P1261, DOI 10.1038/mt.2008.84; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; Varki A., 2008, ESSENTIALS GLYCOBIOL; Vazquezi AM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00150; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Willison HJ, 2013, TRENDS IMMUNOL, V34, P453, DOI 10.1016/j.it.2013.05.001; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yu XJ, 2013, J MOL BIOL, V425, P1253, DOI 10.1016/j.jmb.2013.02.006; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948	100	320	332	17	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					37	+	1235681	10.1126/science.1235681	http://dx.doi.org/10.1126/science.1235681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7WA	24385630				2022-12-28	WOS:000349838000001
J	Benzer, TI; Nejad, SH; Flood, JG				Benzer, Theodore I.; Nejad, Shamim H.; Flood, James G.			Case 40-2013: A 36-Year-Old Man with Agitation and Paranoia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIQUID-CHROMATOGRAPHY; DRUGS		[Benzer, Theodore I.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Nejad, Shamim H.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Flood, James G.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Benzer, Theodore I.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Nejad, Shamim H.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Flood, James G.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Benzer, TI (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.							Alves E, 2009, NEUROSCIENCE, V158, P514, DOI 10.1016/j.neuroscience.2008.10.041; [Anonymous], 2012, SUBST CATH AKA BATH; Bell L., 1849, AM J INSANITY, V6, P97; Dal Cason T. A., 2007, MICROGRAM J, V5, P3; Fink M, 1999, Bipolar Disord, V1, P54, DOI 10.1034/j.1399-5618.1999.10112.x; Kao L, 2009, ROSENS EMERGENCY MED, P2440; Kelly JP, 2011, DRUG TEST ANAL, V3, P439, DOI 10.1002/dta.313; Menon DV, 2007, J AM COLL CARDIOL, V50, P626, DOI 10.1016/j.jacc.2007.03.060; Nelson LS, 2010, GOLDFRANKS TOXICOLOG, P33; PUOPOLO PR, 1991, CLIN CHEM, V37, P2124; Takahashi M, 2009, TALANTA, V77, P1245, DOI 10.1016/j.talanta.2008.07.062; Young R, 1998, PSYCHOPHARMACOLOGY, V140, P250, DOI 10.1007/s002130050765	12	16	16	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2536	2545		10.1056/NEJMcpc1304051	http://dx.doi.org/10.1056/NEJMcpc1304051			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24369079				2022-12-28	WOS:000328863700012
J	Bachhuber, MA; Cunningham, CO				Bachhuber, Marcus A.; Cunningham, Chinazo O.			Changes in Testing for Human Immunodeficiency Virus, Sexually Transmitted Infections, and Hepatitis C Virus in Opioid Treatment Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bachhuber, Marcus A.; Cunningham, Chinazo O.] Albert Einstein Coll Med, Div Gen Internal Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Cunningham, CO (corresponding author), Albert Einstein Coll Med, 111 E 210th St, Bronx, NY 10467 USA.	ccunning@montefiore.org		Bachhuber, Marcus/0000-0002-5610-8382	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA014551, R01DA032110, R34DA031066, R25DA023021] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], THE DASIS REPORT THE; [Anonymous], THE N SSATS REPORT T; [Anonymous], THE N SSATS REPORT I; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Metsch LR, 2012, AM J PUBLIC HEALTH, V102, P1160, DOI 10.2105/AJPH.2011.300460; Pollack HA, 2010, J SUBST ABUSE TREAT, V38, P307, DOI 10.1016/j.jsat.2009.12.004	6	19	19	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2671	2672		10.1001/jama.2013.278456	http://dx.doi.org/10.1001/jama.2013.278456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24368468	Green Accepted			2022-12-28	WOS:000328818000020
J	Chamala, S; Chanderbali, AS; Der, JP; Lan, TY; Walts, B; Albert, VA; Depamphilis, CW; Leebens-Mack, J; Rounsley, S; Schuster, SC; Wing, RA; Xiao, NQ; Moore, R; Soltis, PS; Soltis, DE; Barbazuk, WB				Chamala, Srikar; Chanderbali, Andre S.; Der, Joshua P.; Lan, Tianying; Walts, Brandon; Albert, Victor A.; Depamphilis, Claude W.; Leebens-Mack, Jim; Rounsley, Steve; Schuster, Stephan C.; Wing, Rod A.; Xiao, Nianqing; Moore, Richard; Soltis, Pamela S.; Soltis, Douglas E.; Barbazuk, W. Brad			Assembly and Validation of the Genome of the Nonmodel Basal Angiosperm Amborella	SCIENCE			English	Article							EVOLUTION; SEQUENCE	Genome sequencing with next-generation sequence (NGS) technologies can now be applied to organisms pivotal to addressing fundamental biological questions, but with genomes previously considered intractable or too expensive to undertake. However, for species with large and complex genomes, extensive genetic and physical map resources have, until now, been required to direct the sequencing effort and sequence assembly. As these resources are unavailable for most species, assembling high-quality genome sequences from NGS data remains challenging. We describe a strategy that uses NGS, fluorescence in situ hybridization, and whole-genome mapping to assemble a high-quality genome sequence for Amborella trichopoda, a nonmodel species crucial to understanding flowering plant evolution. These methods are applicable to many other organisms with limited genomic resources.	[Chamala, Srikar; Chanderbali, Andre S.; Walts, Brandon; Soltis, Douglas E.; Barbazuk, W. Brad] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Chanderbali, Andre S.; Soltis, Pamela S.; Soltis, Douglas E.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Der, Joshua P.; Depamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Der, Joshua P.; Depamphilis, Claude W.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Lan, Tianying; Albert, Victor A.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Leebens-Mack, Jim] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Rounsley, Steve] Dow AgroSci, Indianapolis, IN 46268 USA; [Schuster, Stephan C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Tucson, AZ USA; [Wing, Rod A.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Wing, Rod A.] Univ Arizona, Inst Collaborat Res BIO5, Tucson, AZ 85721 USA; [Xiao, Nianqing; Moore, Richard] OpGen Inc, Gaithersburg, MD 20878 USA; [Soltis, Pamela S.; Soltis, Douglas E.; Barbazuk, W. Brad] Univ Florida, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Georgia; University of Georgia; Dow Chemical Company; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Arizona; University of Arizona; University of Arizona; State University System of Florida; University of Florida	Barbazuk, WB (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	bbarbazuk@ufl.edu	Soltis, Pamela S/GNH-5557-2022; Soltis, Douglas/L-5957-2015; Wing, Rod A/Z-2885-2019; Leebens-Mack, James/AAF-6770-2019; Der, Joshua P/F-9551-2012; Soltis, Pamela S/L-5184-2015; dePamphilis, Claude W/P-6652-2016	Soltis, Pamela S/0000-0001-9310-8659; Wing, Rod A/0000-0001-6633-6226; Leebens-Mack, James/0000-0003-4811-2231; Der, Joshua P/0000-0001-9668-2525; Walts, Brandon/0000-0002-0215-0745; Chanderbali, Andre/0000-0002-8728-6739; Barbazuk, William/0000-0002-0909-4563	NSF-PGRP: National Science Foundation Plant Genome Research Program [0922742]; NCBI [212863]	NSF-PGRP: National Science Foundation Plant Genome Research Program; NCBI	Funded by grant 0922742 from the NSF-PGRP: National Science Foundation Plant Genome Research Program to V. A. A, W. B. B., C. W. D., J.L.M., S. R., D. E. S., and P. S. S. Sequence data are available from the National Center for Biotechnology Information (NCBI) Short Read Archive (SRA) under accession PRJNA212863 and NCBI BioProject ID 212863. Assemblies and additional data are available at http://www.amborella.org; FISH data and probe details are available at http://app.tolkin.org/projects/88. We acknowledge R. Winer (Roche) for technical assistance.	Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Aston C, 1999, TRENDS BIOTECHNOL, V17, P297, DOI 10.1016/S0167-7799(99)01326-8; Chester M, 2010, GENES-BASEL, V1, P166, DOI 10.3390/genes1020166; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Leitch IJ, 2002, BOT J LINN SOC, V140, P175, DOI 10.1046/j.1095-8339.2002.00096.x; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Soltis DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-402; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711; Zuccolo A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r48	16	71	73	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1516	1517		10.1126/science.1241130	http://dx.doi.org/10.1126/science.1241130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357320				2022-12-28	WOS:000328644300060
J	Ojesina, AI; Lichtenstein, L; Freeman, SS; Pedamallu, CS; Imaz-Rosshandler, I; Pugh, TJ; Cherniack, AD; Ambrogio, L; Cibulskis, K; Bertelsen, B; Romero-Cordoba, S; Trevino, V; Vazquez-Santillan, K; Guadarrama, AS; Wright, AA; Rosenberg, MW; Duke, F; Kaplan, B; Wang, R; Nickerson, E; Walline, HM; Lawrence, MS; Stewart, C; Carter, SL; McKenna, A; Rodriguez-Sanchez, IP; Espinosa-Castilla, M; Woie, K; Bjorge, L; Wik, E; Halle, MK; Hoivik, EA; Krakstad, C; Gabino, NB; Gomez-Macias, GS; Valdez-Chapa, LD; Garza-Rodriguez, ML; Maytorena, G; Vazquez, J; Rodea, C; Cravioto, A; Cortes, ML; Greulich, H; Crum, CP; Neuberg, DS; Hidalgo-Miranda, A; Escareno, CR; Akslen, LA; Carey, TE; Vintermyr, OK; Gabriel, SB; Barrera-Saldana, HA; Melendez-Zajgla, J; Getz, G; Salvesen, HB; Meyerson, M				Ojesina, Akinyemi I.; Lichtenstein, Lee; Freeman, Samuel S.; Pedamallu, Chandra Sekhar; Imaz-Rosshandler, Ivan; Pugh, Trevor J.; Cherniack, Andrew D.; Ambrogio, Lauren; Cibulskis, Kristian; Bertelsen, Bjorn; Romero-Cordoba, Sandra; Trevino, Victor; Vazquez-Santillan, Karla; Salido Guadarrama, Alberto; Wright, Alexi A.; Rosenberg, Mara W.; Duke, Fujiko; Kaplan, Bethany; Wang, Rui; Nickerson, Elizabeth; Walline, Heather M.; Lawrence, Michael S.; Stewart, Chip; Carter, Scott L.; McKenna, Aaron; Rodriguez-Sanchez, Iram P.; Espinosa-Castilla, Magali; Woie, Kathrine; Bjorge, Line; Wik, Elisabeth; Halle, Mari K.; Hoivik, Erling A.; Krakstad, Camilla; Belem Gabino, Nayeli; Sofia Gomez-Macias, Gabriela; Valdez-Chapa, Lezmes D.; Lourdes Garza-Rodriguez, Maria; Maytorena, German; Vazquez, Jorge; Rodea, Carlos; Cravioto, Adrian; Cortes, Maria L.; Greulich, Heidi; Crum, Christopher P.; Neuberg, Donna S.; Hidalgo-Miranda, Alfredo; Escareno, Claudia Rangel; Akslen, Lars A.; Carey, Thomas E.; Vintermyr, Olav K.; Gabriel, Stacey B.; Barrera-Saldana, Hugo A.; Melendez-Zajgla, Jorge; Getz, Gad; Salvesen, Helga B.; Meyerson, Matthew			Landscape of genomic alterations in cervical carcinomas	NATURE			English	Article							SOMATIC MUTATIONS; HUMAN-PAPILLOMAVIRUS; SENSITIVE DETECTION; CANCER; DISCOVERY; EXPRESSION; FRAMEWORK; CATALOG; FUSION; DOMAIN	Cervical cancer is responsible for 10-15% of cancer-related deaths in women worldwide(1,2). The aetiological role of infection with high-risk human papilloma viruses (HPVs) in cervical carcinomas is well established(3). Previous studies have also implicated somatic mutations in PIK3CA, PTEN, TP53, STK11 and KRAS(4-7) as well as several copy-number alterations in the pathogenesis of cervical carcinomas(8,9). Here we report whole-exome sequencing analysis of 115 cervical carcinoma-normal paired samples, transcriptome sequencing of 79 cases and whole-genome sequencing of 14 tumour-normal pairs. Previously unknown somatic mutations in 79 primary squamous cell carcinomas include recurrent E322K substitutions in the MAPK1 gene (8%), inactivating mutations in the HLA-B gene (9%), and mutations in EP300 (16%), FBXW7 (15%), NFE2L2 (4%), TP53 (5%) and ERBB2 (6%). We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas. Squamous cell carcinomas have higher frequencies of somatic nucleotide substitutions occurring at cytosines preceded by thymines (Tp*C sites) than adenocarcinomas. Gene expression levels at HPV integration sites were statistically significantly higher in tumours with HPV integration compared with expression of the same genes in tumours without viral integration at the same site. These data demonstrate several recurrent genomic alterations in cervical carcinomas that suggest new strategies to combat this disease.	[Ojesina, Akinyemi I.; Pedamallu, Chandra Sekhar; Pugh, Trevor J.; Wright, Alexi A.; Duke, Fujiko; Kaplan, Bethany; Wang, Rui; Greulich, Heidi; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Ojesina, Akinyemi I.; Lichtenstein, Lee; Freeman, Samuel S.; Pedamallu, Chandra Sekhar; Pugh, Trevor J.; Cherniack, Andrew D.; Ambrogio, Lauren; Cibulskis, Kristian; Rosenberg, Mara W.; Kaplan, Bethany; Nickerson, Elizabeth; Lawrence, Michael S.; Stewart, Chip; Carter, Scott L.; McKenna, Aaron; Cortes, Maria L.; Greulich, Heidi; Gabriel, Stacey B.; Getz, Gad; Meyerson, Matthew] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Imaz-Rosshandler, Ivan; Romero-Cordoba, Sandra; Vazquez-Santillan, Karla; Salido Guadarrama, Alberto; Espinosa-Castilla, Magali; Belem Gabino, Nayeli; Hidalgo-Miranda, Alfredo; Escareno, Claudia Rangel; Melendez-Zajgla, Jorge] Inst Nacl Med Genom, Mexico City 14610, DF, Mexico; [Bertelsen, Bjorn; Akslen, Lars A.; Vintermyr, Olav K.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Trevino, Victor] Tecnol Monterrey, Monterrey 64849, Mexico; [Wright, Alexi A.; Greulich, Heidi] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wang, Rui] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, Shanghai 200032, Peoples R China; [Walline, Heather M.] Univ Michigan, Rackham Grad Sch, Program Biomed Sci, Canc Biol Program, Ann Arbor, MI 48109 USA; [Rodriguez-Sanchez, Iram P.; Sofia Gomez-Macias, Gabriela; Valdez-Chapa, Lezmes D.; Lourdes Garza-Rodriguez, Maria; Barrera-Saldana, Hugo A.] Univ Autonoma Nuevo Leon, Fac Med, Monterrey 64460, Nuevo Leon, Mexico; [Rodriguez-Sanchez, Iram P.; Sofia Gomez-Macias, Gabriela; Valdez-Chapa, Lezmes D.; Lourdes Garza-Rodriguez, Maria; Barrera-Saldana, Hugo A.] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eluterio Gonzalez, Monterrey 64460, Nuevo Leon, Mexico; [Woie, Kathrine; Bjorge, Line; Wik, Elisabeth; Halle, Mari K.; Hoivik, Erling A.; Krakstad, Camilla; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Bjorge, Line; Wik, Elisabeth; Halle, Mari K.; Hoivik, Erling A.; Krakstad, Camilla; Salvesen, Helga B.] Univ Bergen, Ctr Canc Biomarkers, Dept Clin Sci, N-5020 Bergen, Norway; [Maytorena, German; Vazquez, Jorge; Rodea, Carlos; Cravioto, Adrian] Inst Mexicano Seguro Social, Mexico City 06720, DF, Mexico; [Crum, Christopher P.; Meyerson, Matthew] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Neuberg, Donna S.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Escareno, Claudia Rangel] Claremont Grad Univ, Claremont, CA 91711 USA; [Akslen, Lars A.; Vintermyr, Olav K.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers, N-5020 Bergen, Norway; [Carey, Thomas E.] Univ Michigan, Ctr Comprehens Canc, Head & Neck Oncol Program, Ann Arbor, MI 48109 USA; [Carey, Thomas E.] Univ Michigan, Ctr Comprehens Canc, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Instituto Nacional de Medicina Genomica; University of Bergen; Haukeland University Hospital; Tecnologico de Monterrey; Harvard University; Brigham & Women's Hospital; Fudan University; University of Michigan System; University of Michigan; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University of Bergen; Haukeland University Hospital; University of Bergen; Instituto Mexicano del Seguro Social; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Claremont Colleges; Claremont Graduate School; University of Bergen; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	helga.salvesen@uib.no; matthew_meyerson@dfci.harvard.edu	Salido, Ivan/K-8399-2019; Hidalgo-Miranda, Alfredo/B-2123-2010; Bjorge, Line/C-1307-2017; Melendez-Zajgla, Jorge/A-5708-2008; Cherniack, Andrew/AAC-5310-2019; Wik, E./AAA-9105-2020; Pedamallu, Chandra Sekhar/AAV-6723-2020; Lawrence, Michael/AAC-8202-2020; Vazquez, Karla/ABG-7256-2020; Wright, Alexi/T-5793-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Romero-Cordoba, Sandra/AAY-2625-2020; Akslen, Lars A/C-1202-2017; Cibulskis, Kristian/AAC-7380-2019; Krakstad, Camilla/AAB-5138-2020; Bjorge, Line/AAD-6179-2021; Trevino, Victor/C-9219-2009; Romero, Sandra/A-2246-2014; Cherniack, Andrew D./AAY-8132-2020; Pugh, Trevor/Y-2535-2019; salvesen, Helga B/C-1187-2017; Akslen, Lars A./AAG-6097-2021; Halle, Mari K/AAT-4856-2020; salido-guadarrama, ivan/B-4536-2015; Garza-Rodriguez, Maria de Lourdes/K-6128-2013; Rangel-Escareno, Claudia/F-4587-2012	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Bjorge, Line/0000-0002-0240-2770; Vazquez, Karla/0000-0003-1380-2494; Akslen, Lars A/0000-0003-2710-9543; Krakstad, Camilla/0000-0002-0174-8139; Bjorge, Line/0000-0002-0240-2770; Trevino, Victor/0000-0002-7472-9844; Romero, Sandra/0000-0002-5591-696X; Cherniack, Andrew D./0000-0003-0470-0111; Pugh, Trevor/0000-0002-8073-5888; salvesen, Helga B/0000-0002-4438-8831; Akslen, Lars A./0000-0003-2710-9543; Ojesina, Akinyemi/0000-0003-0755-3639; Cibulskis, Kristian/0000-0003-1343-1582; Barrera Saldana, Hugo A./0000-0003-1587-4571; salido-guadarrama, ivan/0000-0001-5166-6222; Halle, Mari K/0000-0002-2660-8271; Carey, Thomas/0000-0002-5202-7518; Freeman, Samuel/0000-0001-8285-0057; Garza-Rodriguez, Maria de Lourdes/0000-0001-7096-2713; Meyerson, Matthew/0000-0002-9133-8108; Rangel-Escareno, Claudia/0000-0003-1303-0834; Rosenberg, Mara/0000-0001-6400-3161; Imaz Rosshandler, Ivan/0000-0001-5975-0138	Carlos Slim Health Institute in Mexico; Rebecca Ridley Kry Fellowship of the Damon Runyon Cancer Research Foundation; MMRF Research Fellow Award; Helse Vest; Research Council of Norway; Norwegian Cancer Society; Harald Andersens legat; CONACyT [SALUD-2008-C01-87625, 161619]; UANL PAICyT [CS1038-1]; Instituto Mexicano del Seguro Social (IMSS); NATIONAL CANCER INSTITUTE [U24CA143867, K07CA166210, T32CA009676] Funding Source: NIH RePORTER	Carlos Slim Health Institute in Mexico; Rebecca Ridley Kry Fellowship of the Damon Runyon Cancer Research Foundation; MMRF Research Fellow Award; Helse Vest; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Harald Andersens legat; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UANL PAICyT; Instituto Mexicano del Seguro Social (IMSS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was conducted as part of the Slim Initiative for Genomic Medicine in the Americas, a project funded by the Carlos Slim Health Institute in Mexico. This work was also partially supported by the Rebecca Ridley Kry Fellowship of the Damon Runyon Cancer Research Foundation (A.I.O.); MMRF Research Fellow Award (A.I.O.); Helse Vest, Research Council of Norway, Norwegian Cancer Society and Harald Andersens legat (H. B. S.); CONACyT grant SALUD-2008-C01-87625 and UANL PAICyT grant CS1038-1 (H.A.B.-S.); and CONACyT grant 161619 (J.M.-Z.). We also thank B. Edvardsen, K. Dahl-Michelsen, A. Mokleiv, K. Madisso, T. Njolstad and E. Valen for technical and programmatic assistance; the staff of the Broad Institute Genomics Platform for their assistance in processing samples and generating the sequencing data used in the analyses; the Instituto Mexicano del Seguro Social (IMSS) for their Support; and L. Gaffney of Broad Institute Communications for figure layout and design.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Arteaga CL, 2012, CLIN CANCER RES, V18, P612, DOI 10.1158/1078-0432.CCR-11-2019; Arvind R, 2005, INT J ONCOL, V27, P1499; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Canadas MP, 2012, J VIROL METHODS, V183, P14, DOI 10.1016/j.jviromet.2012.03.005; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen JH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12224; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P11; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang S, 2007, GYNECOL ONCOL, V105, P662, DOI 10.1016/j.ygyno.2007.01.045; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Narayan G, 2010, FUTURE ONCOL, V6, P1643, DOI 10.2217/FON.10.114; Neve RM, 2002, ONCOGENE, V21, P3934, DOI 10.1038/sj.onc.1205503; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vazquez-Mena O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032667; Walline H. M., 2013, JAMA OTOLARYNGO 1031; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Yang H, 2005, P NATL ACAD SCI USA, V102, P7683, DOI 10.1073/pnas.0406904102; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	55	546	561	4	175	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					371	+		10.1038/nature12881	http://dx.doi.org/10.1038/nature12881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24390348	Green Accepted			2022-12-28	WOS:000331477800042
J	Morden, NE; Colla, CH; Sequist, TD; Rosenthal, MB				Morden, Nancy E.; Colla, Carrie H.; Sequist, Thomas D.; Rosenthal, Meredith B.			Choosing Wisely - The Politics and Economics of Labeling Low-Value Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morden, Nancy E.; Colla, Carrie H.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA; [Morden, Nancy E.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA; [Morden, Nancy E.; Colla, Carrie H.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Sequist, Thomas D.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Sequist, Thomas D.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Sequist, Thomas D.] Partners Healthcare Syst, Boston, MA USA; [Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Morden, NE (corresponding author), Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA.			Rosenthal, Meredith/0000-0003-3410-0184	NIA NIH HHS [K23 AG035030, P01 AG019783] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783, K23AG035030] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguilar I, 2011, ARCH INTERN MED, V171, P1385, DOI 10.1001/archinternmed.2011.231; American College of Emergency Physicians, 2013, 5 THINGS PHYS PAT SH; [Anonymous], 2013, DARTMOUTH ATLAS HLTH; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Stein R, 2009, WASH POST	5	175	176	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					589	592		10.1056/NEJMp1314965	http://dx.doi.org/10.1056/NEJMp1314965			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA6CX	24450859	Green Accepted			2022-12-28	WOS:000331187500003
J	Saleh, SS; Alameddine, MS; Natafgi, NM; Mataria, A; Sabri, B; Nasher, J; Zeiton, M; Ahmad, S; Siddiqi, S				Saleh, Shadi S.; Alameddine, Mohamad S.; Natafgi, Nabil M.; Mataria, Awad; Sabri, Belgacem; Nasher, Jamal; Zeiton, Moez; Ahmad, Shaimaa; Siddiqi, Sameen			The path towards universal health coverage in the Arab uprising countries Tunisia, Egypt, Libya, and Yemen	LANCET			English	Article							WORLD-BANK; PUBLIC-HEALTH; GLOBAL HEALTH; SOUTH-AFRICA; USER FEES; CARE; REFORM; INSURANCE; SERVICES; SYSTEM	The constitutions of many countries in the Arab world clearly highlight the role of governments in guaranteeing provision of health care as a right for all citizens. However, citizens still have inequitable health-care systems. One component of such inequity relates to restricted financial access to health-care services. The recent uprisings in the Arab world, commonly referred to as the Arab spring, created a sociopolitical momentum that should be used to achieve universal health coverage (UHC). At present, many countries of the Arab spring are considering health coverage as a priority in dialogues for new constitutions and national policy agendas. UHC is also the focus of advocacy campaigns of a number of non-governmental organisations and media outlets. As part of the health in the Arab world Series in The Lancet, this report has three overarching objectives. First, we present selected experiences of other countries that had similar social and political changes, and how these events affected their path towards UHC. Second, we present a brief overview of the development of health-care systems in the Arab world with regard to health-care coverage and financing, with a focus on Egypt, Libya, Tunisia, and Yemen. Third, we aim to integrate historical lessons with present contexts in a roadmap for action that addresses the challenges and opportunities for progression towards UHC.	[Saleh, Shadi S.; Alameddine, Mohamad S.; Natafgi, Nabil M.] Amer Univ Beirut, Dept Hlth Management & Policy, Beirut, Lebanon; [Mataria, Awad; Siddiqi, Sameen] WHO Reg Off Eastern Mediterranean, Cairo, Egypt; [Nasher, Jamal] Minist Publ Hlth & Populat, Dept Planning & Dev, Sanaa, Yemen; [Zeiton, Moez] Sadeq Inst, Tripoli, Libya; [Ahmad, Shaimaa] Off Minister Hlth, Cairo, Egypt	American University of Beirut; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt	Saleh, SS (corresponding author), Amer Univ Beirut, Beirut, Lebanon.	ss117@aub.edu.lb	Alameddine, Mohamad/AAN-1624-2020	Alameddine, Mohamad/0000-0002-2299-1242; Natafgi, Nabil/0000-0003-4979-0317	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Achouri H, 2002, TRADE HLTH SERVICES, P207; *AFMC, 2007, STAND TREATM GUID ME; Ahuja R., 2005, 162 IND COUNC RES IN; Akin J.S., 1987, FINANCING HLTH SERVI; Al Azzawi S, 2010, DYNAMICS POVERTY INE; Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38; Albrecht H., 2002, ASIEN AFRIKA LATINAM, V30, P131; Allansson M, 2012, SIPRI YB 2012; [Anonymous], 2008, B WORLD HEALTH ORGAN, V86, P248, DOI 10.2471/BLT.08.030408; [Anonymous], 2011, B WORLD HEALTH ORGAN, V89, P786, DOI 10.2471/BLT.11.041111; [Anonymous], 2002, WORLD DEV REP 2002; [Anonymous], RESEARCH; [Anonymous], 2009, HLTH POLITICS REVOLU; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Balabanova D, 2002, COST SHARING PRIMARY; Baris E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7456; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Ben Romdhane H, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-9; Benjamin M, 1991, Links, V8, P3; Birn AE, 2005, AM J PUBLIC HEALTH, V95, P1091, DOI 10.2105/AJPH.2005.064733; Borrel M, 2004, IND CONFLICT MASS DE; Boutayeb A, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-23; Brown E. Richard, 1979, ROCKEFELLER MED MEN; CAIMED, WELF MED COUNTR GREA; Camau M, 1990, ETAT SANTE BESOIN ME; Capitalism Onoge O., 1975, TOPIAS UTOPIAS HLTH, P219; Carrin G, 2004, HLTH FINANCING POOR; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; Carrin G, 2007, SAMJ S AFR MED J, V97, P130; Chemingui M, 2011, ASSESSING DEV STRATE; Date J, 2005, INT J TUBERC LUNG D, V9, P680; De Ceukelaire W, 2011, TROP MED INT HEALTH, V16, P1185, DOI 10.1111/j.1365-3156.2011.02817.x; De Vos P, 2005, INT J HEALTH SERV, V35, P189, DOI 10.2190/M72R-DBKD-2XWV-HJWB; De Vos P, 2006, TROP MED INT HEALTH, V11, P1604, DOI 10.1111/j.1365-3156.2006.01702.x; Dixon John, 1999, SOCIAL SECURITY GLOB; Doyal L, 1979, POLITICAL EC HLTH; El-Saharty S., 2006, TUNISIA HLTH SECTOR; ELLING RH, 1981, INT J HEALTH SERV, V11, P21, DOI 10.2190/JWM6-D2JC-RLFW-MWDC; ElWarfally MG, 1988, IMAGERY IDEOLOGY US; England S, 2001, PRACTICE POLICIES US; Enke Stephen, 1963, EC DEV; European Neighbourhood and Partnership Instrument, LIB STRAT PAP NAT IN; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Garthoff Raymond, 1994, DETENTE CONFRONTATIO, P556; GU XY, 1995, HEALTH POLICY, V32, P181, DOI 10.1016/0168-8510(95)00735-B; Hassenteufel P, 2001, PUBLIC POLICY ADM, V16, P84; Hjortsberg C, 2003, HEALTH ECON, V12, P755, DOI 10.1002/hec.839; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Holst J, 2012, INT J HEALTH PLAN M, V27, P198, DOI 10.1002/hpm.2107; Hougaard JL, 2011, APPL HEALTH ECON HEA, V9, P1, DOI 10.2165/11531800-000000000-00000; Hughes D, 2007, HEALTH AFFAIR, V26, P999, DOI 10.1377/hlthaff.26.4.999; Hughes D, 2010, SOC SCI MED, V70, P447, DOI 10.1016/j.socscimed.2009.10.031; International Labour Office Social Security Department, 2009, ILORBARER15 SOC SEC; Jabbour S, 2003, BRIT MED J, V326, P1141, DOI 10.1136/bmj.326.7399.1141; Jacobs B, 2004, HEALTH POLICY PLANN, V19, P310, DOI 10.1093/heapol/czh036; Kanbur R., 2013, EC INEQUALITY EC DEV; Kemprecos L, 1993, HLTH CARE FINANCING; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; Koser K, ARAB SPRING NEW AWAK; Krause K, 2005, SECUR DIALOGUE, V36, P447, DOI 10.1177/0967010605060449; Kronfol NM, 2012, PUBLIC HEALTH IN THE ARABWORLD, P400; Laurell AC, 1996, INT J HEALTH SERV, V26, P1, DOI 10.2190/PBX9-N89E-4QFE-046V; Light DW, 2003, AM J PUBLIC HEALTH, V93, P25, DOI 10.2105/AJPH.93.1.25; Loewe M, 2000, SOCIAL SECURITY EGYP; LONG SH, 1994, HEALTH AFFAIR, V13, P211, DOI 10.1377/hlthaff.13.2.211; Longuenesse E, 2012, PUBLIC HEALTH IN THE ARABWORLD, P7; Malik A, 2013, WORLD DEV, V45, P296, DOI 10.1016/j.worlddev.2012.12.015; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Masiye F., 2005, HLTH CARE FINANCING; McIntyre D, 2009, SAMJ S AFR MED J, V99, P725; Medicine Paul J., 1978, CULTURAL CRISIS MODE, P271; Meleigy M, 2010, LANCET, V375, P269, DOI 10.1016/S0140-6736(10)60115-8; Ministry of Public Health, CUB HLTH STAT 2002; Ministry of Public Health & Population, 2008, NAT HLTH ACC REP 200; Missoni E, 2010, UNIVERSAL HLTH CONVE; Nandakumar AK, 2000, WORLD DEV, V28, P187, DOI 10.1016/S0305-750X(99)00118-7; Nandakumar AK, 2000, HEALTH POLICY, V50, P155, DOI 10.1016/S0168-8510(99)00073-1; NIPH, 2005, EQ STUD CARR OUT 200; OCHA, 2011, YEM INCR DISPL CHALL; Ochoa FR, 2007, CIVIL SOC HLTH SYSTE; Ooghe E, 2011, 3518 CESIFO; Ovretveit J, 2006, INT J HEALTH CARE Q, V19, P516, DOI 10.1108/09526860610686999; Paciello MC, 2011, MEDPRO TECHNICAL REP, V4; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pannarunothai S, 2004, HEALTH POLICY, V68, P17, DOI 10.1016/S0168-8510(03)00024-1; PEABODY JW, 1995, HEALTH POLICY, V31, P29, DOI 10.1016/0168-8510(94)00669-6; Pearson Mark, 2004, ISSUES PAPER CASE AB; Perkins K, 2004, HIST MODERN TUNISIA; Pioppi D, 2011, EGYPT NEOAUTHORITARI; Primakov E. M., 2009, RUSSIA ARABS SCENES; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; QFinance, LIB EC; Rau PR, 2002, J BUS, V75, P245, DOI 10.1086/338703; Ravenscroft J, 2012, LANCET, V380, P888, DOI 10.1016/S0140-6736(12)61506-2; Republic of Yemen Health Metrics Network, 2009, HLTH METR NETW HLTH; Roemer M I, 1987, Int J Health Plann Manage, V2, P109, DOI 10.1002/hpm.4740020205; ROSSDALE M, 1965, NEW LEFT REV, P82; Ruger JP, 2005, AM J PUBLIC HEALTH, V95, P60, DOI 10.2105/AJPH.2004.042002; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Russell S, 1997, INT J HEALTH SERV, V27, P359, DOI 10.2190/YHL2-F0EA-JW1M-DHEJ; Saif Ibrahim, 2009, ARAB COUNTRIES STUMB; Saleh SS, INT J HLTH IN PRESS; Saltman R. B., 2004, SOCIAL HLTH INSURANC; Savas B.S., 2002, HLTH CARE SYSTEM TRA; SCHULTZ TW, 1961, AM ECON REV, V51, P1; Schwarz R, 2005, SECUR DIALOGUE, V36, P429, DOI 10.1177/0967010605060447; Shisana O, 2006, SAMJ S AFR MED J, V96, P814; Siddiqi S, 2010, INT J HEALTH PLAN M, V25, P231, DOI 10.1002/hpm.989; Stuckler D, 2010, POLITICAL EC UNIVERS; Tatar M, 2011, HLTH SYST TRANSIT, V13, pXIII; Tatar Mehtap, 2011, Health Syst Transit, V13, P1; The World Bank, 2012, GINI IND 2012; TURSHEN M, 1977, INT J HEALTH SERV, V7, P7, DOI 10.2190/L9G4-KJVK-AW7A-Q9JD; United Nations, 2022, HUMAN DEV REPORTS; USAID, YEMEN COMPL EM FACT; Waitzkin H., 1974, EXPLOITATION ILLNESS; Washington Consensus, 2012, WASHINGTON CONSENSUS, V2012, P15; Waters, 2008, GOOD PRACTICES HLTH, P355; Weinbaum, 1985, MIDDLE E STUDIES, V21, P206, DOI DOI 10.1080/00263208508700624; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, A5820 WHO; WHO, 2008, PHARMAFORUM 0121; WHO World Health Organization, 2006, CONST WHO; WHO-EMRO, 2006, HLTH SYST PROF LIB; WHO-EMRO, 2006, HLTH SYST PROF TUN; WHO-EMRO, 2006, HLTH SYST PROF EG; WHO-EMRO, 2011, DEM SOC HLTH IND COU; WHO-EMRO, 2006, HLTH SYST PROF YEM; WHO-EMRO, 2001, DEM SOC HLTH IND COU; WHO-EMRO, 2012, EMRC59INFDOC5 WHOEMR; WHO-EMRO, 2011, COUNTR COOP STRAT WH; Witter S., 2005, UNNECESSARY EVIL USE; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0; World Bank, 2012, COUNTR DAT PROF; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Bank, 1996, 15158YEM WORLD BANK; World Health Organisation, 2013, TRAD FOR POL DIPL HL; World Health Organization, 2012, REB LIB HLTH SYST PO; World Health Organization, RIGHT HLTH; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0; Zogby James, 2011, HUFFINGTON POST	144	28	28	0	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					368	381		10.1016/S0140-6736(13)62339-9	http://dx.doi.org/10.1016/S0140-6736(13)62339-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24452045				2022-12-28	WOS:000330212600036
J	McIntyre, CW; Burton, JO				McIntyre, Christopher W.; Burton, James O.			ABC of Kidney Disease, 2nd Edition Dialysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMODIALYSIS		[McIntyre, Christopher W.] Derby City Hosp, Dept Renal Med, Derby, England; [Burton, James O.] Univ Leicester, Sch Med & Biol Sci, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of Nottingham; University of Leicester	McIntyre, CW (corresponding author), Derby City Hosp, Dept Renal Med, Derby, England.		Burton, James O/AAQ-7361-2021	Burton, James O/0000-0003-1176-7592				Bender FH, 2006, KIDNEY INT, V70, pS44, DOI 10.1038/sj.ki.5001915; Greneche Sylvie, 2005, Nephrol Ther, V1, P213, DOI 10.1016/j.nephro.2005.01.009; Hayashi R, 2006, NAT CLIN PRACT NEPHR, V2, P504, DOI 10.1038/ncpneph0239; Light P, 2006, CURR HYPERTENS REP, V8, P413, DOI 10.1007/s11906-006-0088-6; RABINDRANATH KS, 2006, COCHRANE DB SYST REV, V18	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2014	348								g2	10.1136/bmj.g2	http://dx.doi.org/10.1136/bmj.g2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BE	24384463				2022-12-28	WOS:000330298100007
J	Dou, LT; Zheng, YH; Shen, XQ; Wu, G; Fields, K; Hsu, WC; Zhou, HP; Yang, Y; Wudl, F				Dou, Letian; Zheng, Yonghao; Shen, Xiaoqin; Wu, Guang; Fields, Kirk; Hsu, Wan-Ching; Zhou, Huanping; Yang, Yang; Wudl, Fred			Single-Crystal Linear Polymers Through Visible Light-Triggered Topochemical Quantitative Polymerization	SCIENCE			English	Article							SOLID-STATE POLYMERIZATION; 4-CENTER TYPE PHOTOPOLYMERIZATION; 2,4-HEXADIYNE-1,6-DIOL; 2,5-DISTYRYLPYRAZINE	One of the challenges in polymer science has been to prepare large-polymer single crystals. We demonstrate a visible light-triggered quantitative topochemical polymerization reaction based on a conjugated dye molecule. Macroscopic-size, high-quality polymer single crystals are obtained. Polymerization is not limited to single crystals, but can also be achieved in highly concentrated solution or semicrystalline thin films. In addition, we show that the polymer decomposes to monomer upon thermolysis, which indicates that the polymerization-depolymerization process is reversible. The physical properties of the polymer crystals enable us to isolate single-polymer strands via mechanical exfoliation, which makes it possible to study individual, long polymer chains.	[Dou, Letian; Zheng, Yonghao; Shen, Xiaoqin; Wudl, Fred] Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA; [Dou, Letian; Hsu, Wan-Ching; Zhou, Huanping; Yang, Yang] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Dou, Letian; Hsu, Wan-Ching; Zhou, Huanping; Yang, Yang] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Zheng, Yonghao; Wudl, Fred] Tohoku Univ, Adv Inst Mat Res, World Premier Int Res Ctr WPI Initiat Program WPI, Santa Barbara, CA 93106 USA; [Zheng, Yonghao; Wudl, Fred] Univ Calif Santa Barbara, Calif NanoSyst Inst, Joint Ctr, Santa Barbara, CA 93106 USA; [Wu, Guang; Wudl, Fred] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Fields, Kirk] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Yang, Y (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.	yangy@ucla.edu; wudl@chem.ucsb.edu	Yang, Yang/A-2944-2011; yang, yang/GWB-9426-2022; yang, yang/HGT-7999-2022; Dou, Letian/L-6031-2019; Lang, Ming/HIK-0758-2022; Zheng, Yonghao/C-2921-2014; Shen, Xiaoqin/I-4685-2013; yang, yang/GVT-5210-2022	Shen, Xiaoqin/0000-0002-7609-0108; Dou, Letian/0000-0001-6411-8591	NSF [DMR-1210893]; Link Foundation Energy Fellowship; Center for Energy Efficient Materials, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001009]; Department of Energy [DE-FG02-08ER46535]	NSF(National Science Foundation (NSF)); Link Foundation Energy Fellowship; Center for Energy Efficient Materials, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE))	L.D. was supported by NSF (grant no. DMR-1210893) and the Link Foundation Energy Fellowship. Y.Z. and X. S. were supported by the Center for Energy Efficient Materials, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award number DE-SC0001009 and Department of Energy (grant no. DE-FG02-08ER46535). We thank M. Cornish and W. Cui at University of California, Santa Barbara, for the help with SEM and nuclear magnetic resonance measurements, respectively. We thank Y. Liu, C.-C. Chen, and C.-J. Hsu at University of California, Los Angeles, for the help with AFM, absorption, and thermogravimetric analysis measurements, respectively. Metrical parameters for the structures of BIT-Ac<INF>2</INF>, BIT-EH<INF>2</INF>, BIT-Hep<INF>2</INF>, BIT-Non<INF>2</INF>, BIT-OH<INF>2</INF>, PBIT-Hep<INF>2</INF>, and PBIT-Non<INF>2</INF> are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-976926, 976927, 976928, 976929, 976930, 976931, and 976932, respectively.	Biradha K, 2013, CHEM SOC REV, V42, P950, DOI 10.1039/c2cs35343a; BLOOR D, 1975, J MATER SCI, V10, P1689, DOI 10.1007/BF00554930; EICHELE H, 1976, CHEM PHYS LETT, V42, P342, DOI 10.1016/0009-2614(76)80379-X; Flory PJ, 1942, J CHEM PHYS, V10, P51, DOI 10.1063/1.1723621; Gabriel S., 1898, BER DTSCH CHEM GES, V31, P1159, DOI [10.1002/cber.189803101213, DOI 10.1002/CBER.189803101213]; GALIOTIS C, 1983, POLYMER, V24, P1023, DOI 10.1016/0032-3861(83)90155-6; Han J, 2007, NEW J CHEM, V31, P543, DOI 10.1039/b613549h; HASEGAWA M, 1969, J POLYM SCI A1, V7, P743, DOI 10.1002/pol.1969.150070227; HASEGAWA M, 1983, CHEM REV, V83, P507, DOI 10.1021/cr00057a001; HASEGAWA M, 1967, J POLYM SCI POL LETT, V5, P813, DOI 10.1002/pol.1967.110050915; Hasegawa M., 1995, ADV PHYS ORG CHEM, V30, P117; Huggins ML, 1941, J CHEM PHYS, V9, P440, DOI 10.1063/1.1750930; Itoh T, 2002, ANGEW CHEM INT EDIT, V41, P4306, DOI 10.1002/1521-3773(20021115)41:22<4306::AID-ANIE4306>3.0.CO;2-W; Johnston P, 2012, CHEM SCI, V3, P2301, DOI 10.1039/c2sc20380d; KHODORKOVSKY V, 1994, TETRAHEDRON LETT, V35, P2955, DOI 10.1016/S0040-4039(00)76670-6; LANDAU EM, 1985, NATURE, V318, P353, DOI 10.1038/318353a0; Lauher JW, 2008, ACCOUNTS CHEM RES, V41, P1215, DOI 10.1021/ar8001427; Liu XG, 2005, SCIENCE, V307, P1763, DOI 10.1126/science.1109487; Lu YF, 2001, NATURE, V410, P913, DOI 10.1038/35073544; MACDIARMID AG, 1975, J CHEM SOC CHEM COMM, P476, DOI 10.1039/c39750000476; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Matsumoto A, 2000, NATURE, V405, P328, DOI 10.1038/35012550; Matsumoto A, 2002, J AM CHEM SOC, V124, P8891, DOI 10.1021/ja0205333; Matsumoto A, 1996, MACROMOLECULES, V29, P423, DOI 10.1021/ma950996b; Morrison R T., 1992, ORGANIC CHEM; Nomura S, 2004, J AM CHEM SOC, V126, P2035, DOI 10.1021/ja0386086; Schmidt, 1962, ANGEW CHEM INT EDIT, V1, P488, DOI [DOI 10.1002/ANIE.196204881, 10.1002/anie.196204881]; Sun AW, 2006, SCIENCE, V312, P1030, DOI 10.1126/science.1124621; SWIATKIEWICZ J, 1984, J POLYM SCI POL PHYS, V22, P1417, DOI 10.1002/pol.1984.180220806; Tanaka K, 2000, J CHEM SOC PERK T 1, P873, DOI 10.1039/a910194m; WEGNER G, 1969, Z NATURFORSCH PT B, VB 24, P824; WEGNER G, 1977, PURE APPL CHEM, V49, P443, DOI 10.1351/pac197749040443; Xu JJ, 2009, NAT MATER, V8, P348, DOI [10.1038/NMAT2405, 10.1038/nmat2405]; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566	34	89	89	19	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					272	277		10.1126/science.1245875	http://dx.doi.org/10.1126/science.1245875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24436414				2022-12-28	WOS:000329718600029
J	Cesari, F; Chou, IH; Eggleston, AK; Gray, N; Nath, D; Shadan, S; Skipper, M				Cesari, Francesca; Chou, I-han; Eggleston, Angela K.; Gray, Noah; Nath, Deepa; Shadan, Sadaf; Skipper, Magdalena			FRONTIERS IN BIOLOGY	NATURE			English	Editorial Material														Gray, Noah/0000-0002-4672-7403; Eggleston, Angela/0000-0001-8682-397X					0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					301	301		10.1038/505301a	http://dx.doi.org/10.1038/505301a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429627	Bronze			2022-12-28	WOS:000329621800026
J	Karamyshev, AL; Patrick, AE; Karamysheva, ZN; Griesemer, DS; Hudson, H; Tjon-Kon-Sang, S; Nilsson, I; Otto, H; Liu, QH; Rospert, S; von Heijne, G; Johnson, AE; Thomas, PJ				Karamyshev, Andrey L.; Patrick, Anna E.; Karamysheva, Zemfira N.; Griesemer, Dustin S.; Hudson, Henry; Tjon-Kon-Sang, Sandra; Nilsson, IngMarie; Otto, Hendrik; Liu, Qinghua; Rospert, Sabine; von Heijne, Gunnar; Johnson, Arthur E.; Thomas, Philip J.			Inefficient SRP Interaction with a Nascent Chain Triggers a mRNA Quality Control Pathway	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; TARGETING PROTEINS; ARGONAUTE PROTEINS; ER MEMBRANE; HUMAN RISC; TRANSLATION; DEGRADATION; RIBOSOME	Misfolded proteins are often cytotoxic, unless cellular systems prevent their accumulation. Data presented here uncover a mechanism by which defects in secretory proteins lead to a dramatic reduction in their mRNAs and protein expression. When mutant signal sequences fail to bind to the signal recognition particle (SRP) at the ribosome exit site, the nascent chain instead contacts Argonaute2 (Ago2), and the mutant mRNAs are specifically degraded. Severity of signal sequence mutations correlated with increased proximity of Ago2 to nascent chain and mRNA degradation. Ago2 knockdown inhibited degradation of the mutant mRNA, while overexpression of Ago2 or knockdown of SRP54 promoted degradation of secretory protein mRNA. The results reveal a previously unappreciated general mechanismof translational quality control, in which specific mRNA degradation preemptively regulates aberrant protein production (RAPP).	[Karamyshev, Andrey L.; Patrick, Anna E.; Karamysheva, Zemfira N.; Griesemer, Dustin S.; Hudson, Henry; Tjon-Kon-Sang, Sandra; Thomas, Philip J.] UT Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Liu, Qinghua] UT Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Nilsson, IngMarie; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden; [Otto, Hendrik; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Otto, Hendrik; Rospert, Sabine] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Johnson, Arthur E.] Texas A&M Univ, Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Stockholm University; Stockholm University; University of Freiburg; University of Freiburg; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Karamyshev, AL (corresponding author), UT Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	andrey.karamyshev@utsouthwestern.edu; philip.thomas@utsouthwestern.edu	Johnson, Arthur E/G-3457-2012; von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; Rospert, Sabine/0000-0002-3089-9614; Patrick, Anna/0000-0003-1625-2598	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [R37DK049835]; CFF grants; National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health [R01GM26494]; Robert A. Welch Foundation [BE-0017, SFB 746, Forschergruppe 967, EXC 294]; Swedish Cancer Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; European Research Council [ERC-2008-AdG 232648]; Knut and Alice Wallenberg Foundation; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Magn. Bergvalls Stiftelse; Carl Trygger Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CFF grants; National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Robert A. Welch Foundation(The Welch Foundation); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Magn. Bergvalls Stiftelse; Carl Trygger Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xuecheng Ye for recombinant human Ago2 purification; Yiwei Miao and Yuanlong Shao for SRP, microsomes, and eANB-Lys-tRNA amb preparation for some experiments; Tara Hessa for introducing some mutations into the PPL gene; Yuh Min Chook for the plasmid containing pyruvate kinase gene. Research reported in this publication was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health R37DK049835 and CFF grants to P.J.T.; by National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under award number R01GM26494 and Robert A. Welch Foundation Chair grant BE-0017 to A.E.J.; grants SFB 746, Forschergruppe 967, and EXC 294 to S.R.; by the Swedish Cancer Foundation, the Swedish Research Council, the Swedish Foundation for Strategic Research, the European Research Council (ERC-2008-AdG 232648) and the Knut and Alice Wallenberg Foundation to G.v.H.; the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Magn. Bergvalls Stiftelse and the Carl Trygger Foundation to I.M.N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; ANDREWS DW, 1989, J CELL BIOL, V108, P797, DOI 10.1083/jcb.108.3.797; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Moshkovich N, 2011, GENE DEV, V25, P1686, DOI 10.1101/gad.16651211; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pinder BD, 2013, EMBO REP, V14, P80, DOI 10.1038/embor.2012.192; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032	49	53	53	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					146	157		10.1016/j.cell.2013.12.017	http://dx.doi.org/10.1016/j.cell.2013.12.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439374	Green Accepted, Bronze			2022-12-28	WOS:000329912200017
J	Kepecs, A; Fishell, G				Kepecs, Adam; Fishell, Gordon			Interneuron cell types are fit to function	NATURE			English	Review							EXPRESSING GABAERGIC NEURONS; CAUDAL GANGLIONIC EMINENCE; FATE MAPPING REVEALS; FAST-SPIKING CELLS; CORTICAL INTERNEURONS; IMMUNOREACTIVE INTERNEURONS; INHIBITORY INTERNEURONS; SHUNTING INHIBITION; PYRAMIDAL CELLS; GENE-FUNCTION	Understanding brain circuits begins with an appreciation of their component parts - the cells. Although GABAergic interneurons are a minority population within the brain, they are crucial for the control of inhibition. Determining the diversity of these interneurons has been a central goal of neurobiologists, but this amazing cell type has so far defied a generalized classification system. Interneuron complexity within the telencephalon could be simplified by viewing them as elaborations of a much more finite group of developmentally specified cardinal classes that become further specialized as they mature. Our perspective emphasizes that the ultimate goal is to dispense with classification criteria and directly define interneuron types by function.	[Kepecs, Adam] Cold Spring Harbor Lab, New York, NY 11724 USA; [Fishell, Gordon] NYU, Langone Med Ctr, New York, NY 10016 USA	Cold Spring Harbor Laboratory; New York University; NYU Langone Medical Center	Fishell, G (corresponding author), NYU, Langone Med Ctr, 1st Ave,Smilow Res Bldg, New York, NY 10016 USA.	kepecs@cshl.edu; gordon.fishell@med.nyu.edu		Kepecs, Adam/0000-0003-0049-8120; Fishell, Gordon/0000-0002-9640-9278	US National Institutes of Health [R01NS075531, MH071679, MH095147, NS074972, NS081297]; McKnight Foundation; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071679, R01MH095147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075531, R01NS081297, P01NS074972] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the authors' laboratories is supported by grants from the US National Institutes of Health (R01NS075531 to A.K. and MH071679, MH095147, NS074972 and NS081297 to G.F.) and generous support from the McKnight (A.K.) and Simons Foundations (G.F.). We are grateful to G. Buzsaki, C. McBain, B. Rudy, M. Long, R. Tsien and members of our laboratories for discussions and comments. We thank J. Demidschstein for creating Fig. 2. and J. Kuhl for Figs 1 and 3.	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Armstrong C, 2012, J PHYSIOL-LONDON, V590, P683, DOI 10.1113/jphysiol.2011.223669; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bassett EA, 2012, TRENDS NEUROSCI, V35, P565, DOI 10.1016/j.tins.2012.05.004; Beier KT, 2011, DEV BIOL, V353, P309, DOI 10.1016/j.ydbio.2011.03.004; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Brody T, 2005, CURR OPIN CELL BIOL, V17, P672, DOI 10.1016/j.ceb.2005.09.013; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Carandini M, 2012, NAT NEUROSCI, V15, P507, DOI 10.1038/nn.3043; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chittajallu R, 2013, NAT NEUROSCI, V16, P1598, DOI 10.1038/nn.3538; Ciceri G, 2013, NAT NEUROSCI, V16, P1199, DOI 10.1038/nn.3485; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Colombo E, 2007, J NEUROSCI, V27, P4786, DOI 10.1523/JNEUROSCI.0417-07.2007; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hajos N, 1996, EUR J NEUROSCI, V8, P1415, DOI 10.1111/j.1460-9568.1996.tb01604.x; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hobert O., 2005, WORMBOOK ONLINE REV; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; LEBER SM, 1990, J NEUROSCI, V10, P2451; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Long J.E., 2009, CEREB CORTEX, V19, pi96, DOI [10.1093/cercor/bhp045, DOI 10.1093/CERCOR/BHP045]; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Lyons MR, 2012, J NEUROSCI, V32, P12780, DOI 10.1523/JNEUROSCI.0534-12.2012; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Nienborg H, 2013, J NEUROSCI, V33, P11145, DOI 10.1523/JNEUROSCI.5320-12.2013; O'Leary DDM, 2006, CEREB CORTEX, V16, pI46, DOI 10.1093/cercor/bhk019; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Sussel L, 1999, DEVELOPMENT, V126, P3359; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tiesinga PHE, 2004, NEURAL COMPUT, V16, P251, DOI 10.1162/089976604322742029; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; van den Berghe V, 2013, NEURON, V77, P70, DOI 10.1016/j.neuron.2012.11.009; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wang B, 2013, J COMP NEUROL, V521, P1561, DOI 10.1002/cne.23242; Wang B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-5; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	125	613	620	7	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					318	326		10.1038/nature12983	http://dx.doi.org/10.1038/nature12983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24429630	Green Accepted			2022-12-28	WOS:000329621800029
J	Yurkiewicz, IR; Korf, BR; Lehmann, LS				Yurkiewicz, Ilana R.; Korf, Bruce R.; Lehmann, Lisa Soleymani			Prenatal Whole-Genome Sequencing - Is the Quest to Know a Fetus's Future Ethical?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Researchers have reported sequencing a fetal genome from cell-free fetal DNA in a pregnant woman's blood, heralding the possibility of performing whole-genome sequencing as early as the first trimester of pregnancy. This innovation raises ethical and policy questions. Researchers recently reported sequencing a fetal genome from cell-free fetal DNA in a pregnant woman's blood,(1) heralding the possibility of performing whole-genome sequencing as early as the first trimester of pregnancy. This possibility adds a new level of complexity to decisions about prenatal testing. Current methods such as chorionic-villus sampling and amniocentesis, which must be performed by physicians, provide information about specific medical conditions. With this advance, expectant parents may eventually obtain genetic information not just about the risk of childhood diseases but also about carrier status for autosomal recessive disorders such as Tay-Sachs disease, the risk of complex adult-onset ...	[Yurkiewicz, Ilana R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Ctr Bioeth, Boston, MA 02115 USA; [Korf, Bruce R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Alabama System; University of Alabama Birmingham	Yurkiewicz, IR (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Korf, Bruce R/H-4882-2012					American College of Medical Genetics, 2005, NEWB SCREEN UN SCREE; [Anonymous], 2008, CHANG MOR FOC NEWB S; Fan HC, 2012, NATURE, V489, P326, DOI 10.1038/nature11423; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]	6	23	23	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					195	197		10.1056/NEJMp1215536	http://dx.doi.org/10.1056/NEJMp1215536			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24428465				2022-12-28	WOS:000330035600004
J	Gatrad, AR; Solanki, GA; Sheikh, A				Gatrad, A. Rashid; Solanki, Guirish A.; Sheikh, Aziz			Baby with an abnormal head	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gatrad, A. Rashid] Manor Hosp, Walsall WS2 9PS, W Midlands, England; [Gatrad, A. Rashid] Univ Kentucky, Lexington, KY 40506 USA; [Solanki, Guirish A.] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England; [Solanki, Guirish A.] Univ Birmingham, Birmingham, W Midlands, England; [Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Div Gen Internal Med & Primary Care, Brigham & Womens Hosp, Sch Med, Boston, MA 02120 USA	University of Kentucky; University of Birmingham; University of Birmingham; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gatrad, AR (corresponding author), Manor Hosp, Walsall WS2 9PS, W Midlands, England.	abdul.gatrad@walsallhealthcare.nhs.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Collett BR, 2013, PEDIATRICS, V131, pE109, DOI 10.1542/peds.2012-1779; Graham JM, 2005, J PEDIATR-US, V146, P258, DOI 10.1016/j.jpeds.2004.10.016; Hutchison BL, 2011, ARCH DIS CHILD, V96, P85, DOI 10.1136/adc.2010.190934; Hutchison BL, 2004, PEDIATRICS, V114, P970, DOI 10.1542/peds.2003-0668-F; KATTWINKEL J, 1992, PEDIATRICS, V89, P1120; Loveday BPT, 2001, J CRANIOFAC SURG, V12, P308, DOI 10.1097/00001665-200107000-00003; Mortenson P, 2012, CHILD NERV SYST, V28, P1407, DOI 10.1007/s00381-012-1755-3; Moss SD, 1997, J NEUROSURG, V87, P667, DOI 10.3171/jns.1997.87.5.0667; Robinson S, 2009, J NEUROSURG, V3, P248; Singh A, 2008, ARCH DIS CHILD, V93, P807, DOI 10.1136/adc.2007.121731; Tunnessen WW, 1999, SIGNS AND SYMPTOMS I	11	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2014	348								f7609	10.1136/bmj.f7609	http://dx.doi.org/10.1136/bmj.f7609			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KR	24415733	Green Published			2022-12-28	WOS:000329611300002
J	Kennel, C; Dressler, A				Kennel, Charles; Dressler, Alan			Coping with Uncertainty in Space Science Planning	SCIENCE			English	Editorial Material									[Kennel, Charles] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Dressler, Alan] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Carnegie Institution for Science	Kennel, C (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	ckennel@ucsd.edu		Kennel, Charles/0000-0001-5997-7201				[No title captured]	1	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					140	141		10.1126/science.1244231	http://dx.doi.org/10.1126/science.1244231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286BZ	24408421				2022-12-28	WOS:000329440800025
J	Ripple, WJ; Estes, JA; Beschta, RL; Wilmers, CC; Ritchie, EG; Hebblewhite, M; Berger, J; Elmhagen, B; Letnic, M; Nelson, MP; Schmitz, OJ; Smith, DW; Wallach, AD; Wirsing, AJ				Ripple, William J.; Estes, James A.; Beschta, Robert L.; Wilmers, Christopher C.; Ritchie, Euan G.; Hebblewhite, Mark; Berger, Joel; Elmhagen, Bodil; Letnic, Mike; Nelson, Michael P.; Schmitz, Oswald J.; Smith, Douglas W.; Wallach, Arian D.; Wirsing, Aaron J.			Status and Ecological Effects of the World's Largest Carnivores	SCIENCE			English	Review							TROPHIC CASCADES; TOP PREDATORS; SEA OTTERS; BIODIVERSITY CONSERVATION; ARID AUSTRALIA; LINKING WOLVES; CLIMATE-CHANGE; CANIS-LUPUS; YELLOWSTONE; PREY	Large carnivores face serious threats and are experiencing massive declines in their populations and geographic ranges around the world. We highlight how these threats have affected the conservation status and ecological functioning of the 31 largest mammalian carnivores on Earth. Consistent with theory, empirical studies increasingly show that large carnivores have substantial effects on the structure and function of diverse ecosystems. Significant cascading trophic interactions, mediated by their prey or sympatric mesopredators, arise when some of these carnivores are extirpated from or repatriated to ecosystems. Unexpected effects of trophic cascades on various taxa and processes include changes to bird, mammal, invertebrate, and herpetofauna abundance or richness; subsidies to scavengers; altered disease dynamics; carbon sequestration; modified stream morphology; and crop damage. Promoting tolerance and coexistence with large carnivores is a crucial societal challenge that will ultimately determine the fate of Earth's largest carnivores and all that depends upon them, including humans.	[Ripple, William J.; Beschta, Robert L.; Nelson, Michael P.] Oregon State Univ, Troph Cascades Program, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Estes, James A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; [Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Ritchie, Euan G.] Deakin Univ, Ctr Integrat Ecol, Burwood, Vic 3125, Australia; [Ritchie, Euan G.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic 3125, Australia; [Hebblewhite, Mark] Univ Montana, Wildlife Biol Program, Dept Ecosyst & Conservat Sci, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Hebblewhite, Mark] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, Res & Innovat Ctr, I-38010 San Michele All Adige, TN, Italy; [Berger, Joel] Univ Montana, Dept Organism Biol & Ecol, Missoula, MT 59812 USA; [Berger, Joel] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Elmhagen, Bodil] Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden; [Letnic, Mike] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Schmitz, Oswald J.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Smith, Douglas W.] Yellowstone Natl Pk, Yellowstone Ctr Resources, Mammoth, WY 82190 USA; [Wallach, Arian D.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Wirsing, Aaron J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Oregon State University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Deakin University; Deakin University; University of Montana System; University of Montana; Fondazione Edmund Mach; University of Montana System; University of Montana; Wildlife Conservation Society; Stockholm University; University of New South Wales Sydney; Yale University; James Cook University; University of Washington; University of Washington Seattle	Ripple, WJ (corresponding author), Oregon State Univ, Troph Cascades Program, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	bill.ripple@oregonstate.edu	hebblewhite, mark/G-6164-2013; Wallach, Arian D./ABC-9215-2020; Nelson, Michael Shawn/GXF-4934-2022; Elmhagen, Bodil/M-4444-2014; Ripple, William/ABE-9353-2020; Hebblewhite, Mark/AAI-8101-2020; Ritchie, Euan/N-1088-2014	Wallach, Arian D./0000-0002-6640-3887; Elmhagen, Bodil/0000-0001-5496-4727; Hebblewhite, Mark/0000-0001-5382-1361; Ritchie, Euan/0000-0003-4410-8868; Letnic, Michael/0000-0003-4191-8427; Wallach, Arian/0000-0001-9689-0092	Division Of Environmental Biology [1245373] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Baril LM, 2011, ECOL APPL, V21, P2283, DOI 10.1890/10-0169.1; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Berger Joel, 2005, P315; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Beschta RL, 2008, ECOHYDROLOGY, V1, P118, DOI 10.1002/eco.12; Beschta RL, 2012, GEOMORPHOLOGY, V157, P88, DOI 10.1016/j.geomorph.2011.04.042; Beschta RL, 2010, FOREST ECOL MANAG, V260, P915, DOI 10.1016/j.foreco.2010.06.012; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Brashares Justin S., 2010, P221; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; Brodie JF, 2013, BIOL CONSERV, V163, P58, DOI 10.1016/j.biocon.2013.01.003; Callan R, 2013, J ECOL, V101, P837, DOI 10.1111/1365-2745.12095; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chambers CM, 2003, ENVIRON RESOUR ECON, V26, P249, DOI 10.1023/A:1026356020521; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Elbroch LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053595; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 2013, AM NAT, V181, pS76, DOI 10.1086/668120; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Estes James A., 2010, P37; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Gormezano LJ, 2013, ECOL EVOL, V3, P3509, DOI 10.1002/ece3.740; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite Mark, 2010, P69; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; Hunter L., 2011, CARNIVORES WORLD; IUCN, IUCN RED LIST SPEC V; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kenyon KW, 1969, N AMER FAUNA, V68, P1, DOI DOI 10.3996/NAFA.68.0001; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; LEOPOLD A, 1947, J WILDLIFE MANAGE, V11, P162, DOI 10.2307/3795561; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Letnic M, 2013, OIKOS, V122, P761, DOI 10.1111/j.1600-0706.2012.20425.x; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2010, AUSTRAL ECOL, V35, P167, DOI 10.1111/j.1442-9993.2009.02022.x; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; Mech L., 2003, WOLF PREY RELATIONS; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Miller BJ, 2012, CAN J ZOOL, V90, P70, DOI 10.1139/Z11-115; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Muhly TB, 2009, ECOL ECON, V68, P2439, DOI 10.1016/j.ecolecon.2009.04.008; Naidoo R, 2011, ENVIRON RESOUR ECON, V48, P321, DOI 10.1007/s10640-010-9412-3; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pasanen-Mortensen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P868, DOI 10.1111/geb.12051; Peterson Rolf O., 2003, Alces, V39, P215; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Ray JC, 2005, 24 WCS; Richardson L, 2009, ECOL ECON, V68, P1535, DOI 10.1016/j.ecolecon.2008.10.016; Ripple WJ, 2008, BIOL CONSERV, V141, P1249, DOI 10.1016/j.biocon.2008.02.028; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ripple WJ, 2014, NAT CLIM CHANGE, V4, P2, DOI 10.1038/nclimate2081; Ripple WJ, 2014, J ANIM ECOL, V83, P223, DOI 10.1111/1365-2656.12123; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ripple WJ, 2012, EUR J WILDLIFE RES, V58, P733, DOI 10.1007/s10344-012-0623-5; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Ripple WJ, 2005, BIOSCIENCE, V55, P613, DOI 10.1641/0006-3568(2005)055[0613:LWAPAL]2.0.CO;2; Ritchie EG, 2012, TRENDS ECOL EVOL, V27, P265, DOI 10.1016/j.tree.2012.01.001; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; SCHMITZ OJ, 1992, THEOR POPUL BIOL, V41, P161, DOI 10.1016/0040-5809(92)90042-R; Schmitz OJ, 2014, ECOSYSTEMS, V17, P344, DOI 10.1007/s10021-013-9715-7; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Smith DW, 2012, NORTHWEST SCI, V86, P276, DOI 10.3955/046.086.0404; Smith P, 2013, GLOBAL CHANGE BIOL, V19, P2285, DOI 10.1111/gcb.12160; Steinfeld H., 2006, Renewable Resources Journal, V24, P15; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh John, 2010, P125; van Bommel L, 2012, WILDLIFE RES, V39, P220, DOI 10.1071/WR11135; Wallach AD, 2010, ECOL LETT, V13, P1008, DOI 10.1111/j.1461-0248.2010.01492.x; White PJ, 2012, AM MIDL NAT, V167, P174, DOI 10.1674/0003-0031-167.1.174; Wikenros C., 2011, THESIS SWEDISH U AGR; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176; Woodroffe R., 2005, CONSERV BIOL; World Bank, 2009, 44010GLB WORLD BANK	100	1862	1941	69	1719	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					151	+	1241484	10.1126/science.1241484	http://dx.doi.org/10.1126/science.1241484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408439	Green Submitted			2022-12-28	WOS:000329440800033
J	Youngs, R				Youngs, Robin			Discharge from the Ear	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Gloucestershire Royal Hosp, Gloucester GL1 3NN, England	Gloucestershire Royal Hospital	Youngs, R (corresponding author), Gloucestershire Royal Hosp, Gloucester GL1 3NN, England.							Gleeson M, SCOTT BROWNS OTOR 19, V3; Phillips JS, 2007, CLIN OTOLARYNGOL, V32, P330, DOI 10.1111/j.1749-4486.2007.01532.x	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2014	348								g150	10.1136/bmj.g150	http://dx.doi.org/10.1136/bmj.g150			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KR	24415630				2022-12-28	WOS:000329611300012
J	Fernandes, RM; Hartling, L				Fernandes, Ricardo M.; Hartling, Lisa			Glucocorticoids for Acute Viral Bronchiolitis in Infants and Young Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fernandes, Ricardo M.] Hosp Santa Maria, Dept Pediat, Lisbon Acad Med Ctr, P-1649035 Lisbon, Portugal; [Fernandes, Ricardo M.] Univ Lisbon, Inst Mol Med, Clin Pharmacol Unit, P-1699 Lisbon, Portugal; [Hartling, Lisa] Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, Edmonton, AB, Canada	Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; University of Alberta	Fernandes, RM (corresponding author), Hosp Santa Maria, Dept Pediat, Lisbon Acad Med Ctr, Ave Prof Egas Moniz, P-1649035 Lisbon, Portugal.	rmfernandes@campus.ul.pt	Fernandes, Ricardo M/C-7501-2015	Fernandes, Ricardo M/0000-0002-7253-6475				Ducharme FM, 2011, PAEDIATR RESPIR REV, V12, P170, DOI 10.1016/j.prrv.2011.02.007; Fernandes RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004878.pub4; Hartling L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1714; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Savenije OEM, 2012, J ALLERGY CLIN IMMUN, V130, P325, DOI 10.1016/j.jaci.2012.05.007; Scottish Intercollegiate Guidelines Network (SIGN), BRONCHIOLITIS IN CHI; Zhang LJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006458.pub3	8	16	20	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					87	88		10.1001/jama.2013.284921	http://dx.doi.org/10.1001/jama.2013.284921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24381968				2022-12-28	WOS:000329161400021
J	Lindgren, J; Sjovall, P; Carney, RM; Uvdal, P; Gren, JA; Dyke, G; Schultz, BP; Shawkey, MD; Barnes, KR; Polcyn, MJ				Lindgren, Johan; Sjovall, Peter; Carney, Ryan M.; Uvdal, Per; Gren, Johan A.; Dyke, Gareth; Schultz, Bo Pagh; Shawkey, Matthew D.; Barnes, Kenneth R.; Polcyn, Michael J.			Skin pigmentation provides evidence of convergent melanism in extinct marine reptiles	NATURE			English	Article							SOFT-TISSUE; COLOR; PRESERVATION; EVOLUTION; LIZARD; BODY	Throughout the animal kingdom, adaptive colouration serves critical functions ranging from inconspicuous camouflage to ostentatious sexual display, and can provide important information about the environment and biology of a particular organism(1,2). The most ubiquitous and abundant pigment, melanin, also has a diverse range of non-visual roles, including thermoregulation in ectotherms(3,4). However, little is known about the functional evolution of this important biochrome through deep time, owing to our limited ability to unambiguously identify traces of it in the fossil record(2). Here we present direct chemical evidence of pigmentation in fossilized skin, from three distantly related marine reptiles: a leatherback turtle(5), a mosasaur(6) and an ichthyosaur(7). We demonstrate that dark traces of soft tissue in these fossils are dominated by molecularly preserved eumelanin, in intimate association with fossilized melanosomes. In addition, we suggest that contrary to the countershading of many pelagic animals(8,9), at least some ichthyosaurs were uniformly dark-coloured in life. Our analyses expand current knowledge of pigmentation in fossil integument beyond that of feathers(2,10), allowing for the reconstruction of colour over much greater ranges of extinct taxa and anatomy. In turn, our results provide evidence of convergent melanism in three disparate lineages of secondarily aquatic tetrapods. Based on extant marine analogues, we propose that the benefits of thermoregulation and/or crypsis are likely to have contributed to this melanisation, with the former having implications for the ability of each group to exploit cold environments.	[Lindgren, Johan; Gren, Johan A.] Lund Univ, Dept Geol, SE-22362 Lund, Sweden; [Sjovall, Peter] SP Tech Res Inst Sweden, SE-50115 Boras, Sweden; [Carney, Ryan M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02906 USA; [Uvdal, Per] Lund Univ, MAX IV Lab, SE-22100 Lund, Sweden; [Uvdal, Per] Lund Univ, Dept Chem, SE-22100 Lund, Sweden; [Dyke, Gareth] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Dyke, Gareth] Univ Southampton, Inst Life Sci, Southampton SO14 3ZH, Hants, England; [Schultz, Bo Pagh] Nat Hist Div, MUSERUM, DK-7800 Skive, Denmark; [Shawkey, Matthew D.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Barnes, Kenneth R.] Mosasaur Ranch Museum, Lajitas, TX 79852 USA; [Polcyn, Michael J.] So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA	Lund University; SP Technical Research Institute of Sweden; Brown University; Lund University; Lund University; University of Southampton; University of Southampton; University System of Ohio; University of Akron; Southern Methodist University	Lindgren, J (corresponding author), Lund Univ, Dept Geol, SE-22362 Lund, Sweden.	johan.lindgren@geol.lu.se	Dyke, Gareth/AAJ-9320-2020; Sjovall, Peter/ABA-7172-2020	Dyke, Gareth/0000-0002-8390-7817; Sjovall, Peter/0000-0002-2696-7215; Shawkey, Matthew/0000-0002-5131-8209	Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences; VINNOVA Swedish Governmental Agency for Innovation Systems; National Geographic Society/Waitt Foundation; National Science Foundation; Human Frontiers Science Program; Air Force Office of Scientific Research; Division Of Earth Sciences [1251895] Funding Source: National Science Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences; VINNOVA Swedish Governmental Agency for Innovation Systems(Vinnova); National Geographic Society/Waitt Foundation(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank I. Gladstone, S. King and the Yorkshire Museum for permission to sample YORYM 1993.338, as well as J. Wyneken, P. Weston and L. Alibardi for providing and sectioning the extant leatherback turtle skin samples, respectively. B. P. Kear took the photograph of PMU R435 (Extended Data Fig. 8). This research was supported by grants from the Swedish Research Council, the Crafoord Foundation, the Royal Swedish Academy of Sciences (J. L.), VINNOVA Swedish Governmental Agency for Innovation Systems (P. S.), the National Geographic Society/Waitt Foundation (R. M. C.), the National Science Foundation, Human Frontiers Science Program, and Air Force Office of Scientific Research (M.D.S.).	Albright LB, 2003, J VERTEBR PALEONTOL, V23, P945, DOI 10.1671/1886-19; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Bostrom BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013925; BUSTARD H R, 1970, Herpetologica, V26, P224; Caro T, 2011, EVOL ECOL, V25, P1231, DOI 10.1007/s10682-011-9479-5; Clusella Trullas S., 2009, ECOLOGY, V90, P2297; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Eckert K., 2012, SYNOPSIS BIOL DATA L; Gottfried M.D., 1989, Historical Biology, V3, P79; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; Kuriyama T, 2006, ZOOL SCI, V23, P793, DOI 10.2108/zsj.23.793; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lindgren J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3423; Lindgren J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1819; Lindgren J, 2009, BIOL LETTERS, V5, P528, DOI 10.1098/rsbl.2009.0097; Martill D.M., 1987, Modern Geology, V11, P265; Martill DM, 1995, PALAEONTOLOGY, V38, P897; Martinez-Levasseur LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02386; McGraw KJ., 2006, BIRD COLORATION, P243; McNamara ME, 2013, PALAEONTOLOGY, V56, P557, DOI 10.1111/pala.12044; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Rich TH, 2002, SCIENCE, V295, P979, DOI 10.1126/science.1068920; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Roulin A, 2013, J HERPETOL, V47, P258, DOI 10.1670/12-028; Thiel V, 2011, ANNU REV EARTH PL SC, V39, P125, DOI 10.1146/annurev-earth-040610-133525; WHITEAR MARY, 1956, ANN AND MAG NAT HIST, V9, P742; Zug George R., 1996, Chelonian Conservation and Biology, V2, P244	30	92	93	4	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					484	+		10.1038/nature12899	http://dx.doi.org/10.1038/nature12899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24402224				2022-12-28	WOS:000332165100037
J	Rajkumar, R; Patel, A; Murphy, K; Colmers, JM; Blum, JD; Conway, PH; Sharfstein, JM				Rajkumar, Rahul; Patel, Ankit; Murphy, Karen; Colmers, John M.; Blum, Jonathan D.; Conway, Patrick H.; Sharfstein, Joshua M.			Maryland's All-Payer Approach to Delivery-System Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Maryland, with its all-payer rate-setting system for hospital services, and the Centers for Medicare and Medicaid Services are launching a new model that will transform the state's delivery system and may guide other federal-state partnerships in improving health care. On January 10, 2014, the Centers for Medicare and Medicaid Services (CMS) and the State of Maryland jointly announced the launch of a statewide model that will transform Maryland's health care delivery system. Although some aspects of the new approach may be unique to Maryland and not applicable elsewhere, both the principles of this model and the process that led to its development may serve as a guide for future federal-state partnership efforts aiming to improve health care and to lower costs through an all-payer approach. Since the late 1970s, Maryland has operated what is now the country's only all-payer ...	[Rajkumar, Rahul; Patel, Ankit; Murphy, Karen; Colmers, John M.; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA; [Colmers, John M.] Maryland Hlth Serv Cost Review Commiss, Baltimore, MD USA; [Colmers, John M.] Johns Hopkins Med, Baltimore, MD USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Rajkumar, Rahul] Brigham & Womens Hosp, Boston, MA 02115 USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Centers for Medicare & Medicaid Services; Johns Hopkins University; Johns Hopkins Medicine; Maryland Department of Health & Mental Hygiene; Harvard University; Brigham & Women's Hospital; Cincinnati Children's Hospital Medical Center	Rajkumar, R (corresponding author), Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA.							Murray R, 2009, HEALTH AFFAIR, V28, P1395, DOI 10.1377/hlthaff.28.5.1395; Porter E, 2013, NY TIMES	2	68	68	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					493	495		10.1056/NEJMp1314868	http://dx.doi.org/10.1056/NEJMp1314868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA4NT	24410022				2022-12-28	WOS:000331073500003
J	Rome, BN; Kramer, DB; Kesselheim, AS				Rome, Benjamin N.; Kramer, Daniel B.; Kesselheim, Aaron S.			FDA Approval of Cardiac Implantable Electronic Devices via Original and Supplement Premarket Approval Pathways, 1979-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVERTER-DEFIBRILLATORS; CARDIOVASCULAR DEVICES; ICD TECHNOLOGY	IMPORTANCE The US Food and Drug Administration (FDA) evaluates high-risk medical devices such as cardiac implantable electronic devices (CIEDs), including pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices, via the premarket approval (PMA) process, during which manufacturers submit clinical data demonstrating safety and effectiveness. Subsequent changes to approved high-risk devices are implemented via "supplements," which may not require additional clinical testing. OBJECTIVE To characterize the prevalence and characteristics of changes to CIEDs made through the PMA supplement process. DESIGN Using the FDA's PMA database, we reviewed all CIEDs approved as original PMAs or supplements from 1979 through 2012. For each supplement, we collected the date approved, type of supplement (panel-track, 180-day, real-time, special, and 30-day notice), and the nature of the changes. We calculated the number of supplements approved per PMA and analyzed trends relating to different supplement regulatory categories over time. For supplements approved via the 180-day regulatory pathway, which often involve significant design changes, from 2010-2012, we identified how often additional clinical data were collected. RESULTS From 1979-2012, the FDA approved 77 original and 5829 supplement PMA applications for CIEDs, with a median of 50 supplements per original PMA (interquartile range [IQR], 23-87). Excluding manufacturing changes that do not alter device design, the number of supplements approved each year was stable around a mean (SD) of 2.6 (0.9) supplements per PMA per year. Premarket approvals remained active via successive supplements over a median period of 15 years (IQR, 8-20), and 79% of the 77 original PMAs approved during our study period were the subject of at least 1 supplement in 2012. Thirty-seven percent of approved supplements involved a change to the device's design. Among 180-day supplements approved from 2010-2012, 23% (15/64) included new clinical data to support safety and effectiveness. CONCLUSIONS AND RELEVANCE Many CIED models currently used by clinicians were approved via the PMA supplement process, not as original PMAs. Most new device models are deemed safe and effective without requiring new clinical data, reinforcing the importance of rigorous postapproval surveillance of these devices.	[Rome, Benjamin N.; Kramer, Daniel B.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Rome, Benjamin N.; Kramer, Daniel B.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, Boston, MA 02120 USA; [Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kramer, Daniel B.] Hebrew SeniorLife Inst Aging Res, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Hebrew SeniorLife	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Rome, Benjamin/0000-0001-5776-3293	Harvard Medical School; Harvard Catalyst Clinical and Translational Research Center; Paul B. Beeson career development award in aging [1K23AG045963]; Robert Wood Johnson Foundation; Greenwall Faculty Scholarship in Bioethics; Agency for Healthcare Research and Quality [K08HS18465-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG045963] Funding Source: NIH RePORTER	Harvard Medical School; Harvard Catalyst Clinical and Translational Research Center; Paul B. Beeson career development award in aging; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Greenwall Faculty Scholarship in Bioethics; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Mr Rome was supported by a Harvard Medical School fellowship. Dr Kramer is the Lois Green Scholar at the Hebrew SeniorLife Institute for Aging Research and is supported by a career development award from the Harvard Catalyst Clinical and Translational Research Center and a Paul B. Beeson career development award in aging (1K23AG045963). Dr Kesselheim is supported by a Robert Wood Johnson Foundation Investigator Award in Health Policy Research, a Greenwall Faculty Scholarship in Bioethics, and a career development award from the Agency for Healthcare Research and Quality (K08HS18465-01).	[Anonymous], PREMARKET APPROVAL P; [Anonymous], PRODUCT CLASSIFICATI; [Anonymous], PMA REVIEW FEES; [Anonymous], MEDICAL DEVICES AND; [Anonymous], 1997, REAL TIME REVIEW PRO; Ardaugh BM, 2013, NEW ENGL J MED, V368, P97, DOI 10.1056/NEJMp1211581; Chen CE, 2012, JAMA-J AM MED ASSOC, V308, P1740, DOI 10.1001/jama.2012.14491; Crosse MG., MEDICAL DEVICES SHOR; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; DiMarco JP, 2003, NEW ENGL J MED, V349, P1836, DOI 10.1056/NEJMra035432; Food and Drug Administration HHS, 2013, FED REGIST, V78, P58785; Hauser RG, 2008, NEW ENGL J MED, V359, P2517, DOI 10.1056/NEJMp0805359; Kay GN, 2012, PACE, V35, P648, DOI 10.1111/j.1540-8159.2012.03398.x; Kramer DB, 2010, AM J THER, V17, P2, DOI 10.1097/MJT.0b013e3181ca8105; Lampert R, 2013, AM HEART J, V165, P1015, DOI 10.1016/j.ahj.2012.12.003; Shein MJ, 2008, NEW ENGL J MED, V359, P2610, DOI 10.1056/NEJMc086467; U.S. Department of Health and Human Services. Food and Drug Administration. Center for Biologics Evaluation and Research (CBER), 2003, GUIDANCE FOR INDUSTR; U.S Food and Drug Administration, GUIDANCE FOR INDUSTR; Zuckerman DM, 2011, ARCH INTERN MED, V171, P1006, DOI 10.1001/archinternmed.2011.30	19	49	49	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2014	311	4					385	391		10.1001/jama.2013.284986	http://dx.doi.org/10.1001/jama.2013.284986			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YT	24449317	Bronze, Green Accepted			2022-12-28	WOS:000329939300024
J	Green, RC; Farahany, NA				Green, Robert C.; Farahany, Nita A.			The FDA is overcautious on consumer genomics	NATURE			English	Editorial Material							RISK		[Green, Robert C.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Green, Robert C.] Harvard Univ, Sch Med, Boston, MA USA; [Green, Robert C.] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Farahany, Nita A.] Duke Univ, Sch Law, Durham, NC 27706 USA; [Farahany, Nita A.] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Duke University; Duke University	Green, RC (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	rcgreen@genetics.med.harvard.edu; farahany@duke.edu	Farahany, Nita/AGH-5500-2022	Farahany, Nita/0000-0003-4808-6256				Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Bloss CS, 2010, GENET MED, V12, P556, DOI 10.1097/GIM.0b013e3181eb51c6; Carver KH, 2008, FOOD DRUG LAW J, V63, P151; Francke U, 2013, PEERJ, V1, DOI 10.7717/peerj.8; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Kalf R. R. J., 2013, GENET MED; Kaufman DJ, 2012, J GENET COUNS, V21, P413, DOI 10.1007/s10897-012-9483-0; Lautenbach DM, 2013, ANNU REV GENOM HUM G, V14, P491, DOI 10.1146/annurev-genom-092010-110722; Swan M, 2010, GENET MED, V12, P279, DOI 10.1097/GIM.0b013e3181d5f73b; Topol EJ, 2012, CREATIVE DESTRUCTION	10	58	59	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					286	287		10.1038/505286a	http://dx.doi.org/10.1038/505286a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	288OR	24436984	Bronze			2022-12-28	WOS:000329621800014
J	Guo, LL; Karpac, J; Tran, SL; Jasper, H				Guo, Linlin; Karpac, Jason; Tran, Susan L.; Jasper, Heinrich			PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and Extend Lifespan	CELL			English	Article							STEM-CELL PROLIFERATION; BACTERIAL-INFECTION; TISSUE HOMEOSTASIS; INNATE IMMUNITY; DUAL OXIDASE; DROSOPHILA; MICROBIOTA; PEPTIDOGLYCAN; RESPONSES; PATHWAY	Interactions between commensals and the host impact the metabolic and immune status of metazoans. Their deregulation is associated with agerelated pathologies like chronic inflammation and cancer, especially in barrier epithelia. Maintaining a healthy commensal population by preserving innate immune homeostasis in such epithelia thus promises to promote health and longevity. Here, we show that, in the aging intestine of Drosophila, chronic activation of the transcription factor Foxo reduces expression of peptidoglycan recognition protein SC2 (PGRP-SC2), a negative regulator of IMD/Relish innate immune signaling, and homolog of the anti-inflammatory molecules PGLYRP1-4. This repression causes deregulation of Rel/NFkB activity, resulting in commensal dysbiosis, stem cell hyperproliferation, and epithelial dysplasia. Restoring PGRP-SC2 expression in enterocytes of the intestinal epithelium, in turn, prevents dysbiosis, promotes tissue homeostasis, and extends lifespan. Our results highlight the importance of commensal control for lifespan of metazoans and identify SC-class PGRPs as longevity-promoting factors.	[Guo, Linlin; Karpac, Jason; Jasper, Heinrich] Buck Inst Res Aging, Novato, CA 94945 USA; [Guo, Linlin] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Tran, Susan L.; Jasper, Heinrich] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Buck Institute for Research on Aging; University of Rochester; University of Rochester	Jasper, H (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	hjasper@buckinstitute.org			National Institute on Aging (NIH) [R01 AG028127]; Ellison Medical Foundation [AG-SS-2224-08]; AFAR/Ellison postdoctoral fellowship; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER	National Institute on Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); AFAR/Ellison postdoctoral fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIH R01 AG028127), the Ellison Medical Foundation (AG-SS-2224-08), and by an AFAR/Ellison postdoctoral fellowship to J.K. We would like to thank Olga Dunaevsky for technical assistance and Drs. B. Ohlstein, N. Perrimon, M. Tatar, D. L. Jones, H. Hayashi, the Vienna Drosophila RNAi Center, and the Bloomington Stock Center for flies.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bonnay F, 2013, P NATL ACAD SCI USA, V110, P2957, DOI 10.1073/pnas.1221910110; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chakrabarti S, 2012, CELL HOST MICROBE, V12, P60, DOI 10.1016/j.chom.2012.06.001; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Kapuria S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003045; Karpac J, 2013, CELL REP, V4, P1250, DOI 10.1016/j.celrep.2013.08.004; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Moskalev A, 2011, AGING-US, V3, P391, DOI 10.18632/aging.100314; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ottaviani E, 2011, BIOGERONTOLOGY, V12, P599, DOI 10.1007/s10522-011-9352-5; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Tanenhaus AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045130; Tominaga K, 2007, FREE RADICAL BIO MED, V43, P1627, DOI 10.1016/j.freeradbiomed.2007.08.029; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weber K, 2005, GENETICS, V169, P1461, DOI 10.1534/genetics.104.027748; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013	71	259	288	5	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 16	2014	156	1-2					109	122		10.1016/j.cell.2013.12.018	http://dx.doi.org/10.1016/j.cell.2013.12.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	292OS	24439372	Green Accepted, Bronze			2022-12-28	WOS:000329912200014
J	Primrose, JN; Perera, R; Gray, A; Rose, P; Fuller, A; Corkhill, A; George, S; Mant, D				Primrose, John N.; Perera, Rafael; Gray, Alastair; Rose, Peter; Fuller, Alice; Corkhill, Andrea; George, Steve; Mant, David		FACS Trial Investigators	Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer The FACS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CURATIVE RESECTION; RADICAL SURGERY; SURVIVAL; SURVEILLANCE; METAANALYSIS; COLONOSCOPY	IMPORTANCE Intensive follow-up after surgery for colorectal cancer is common practice but is based on limited evidence. OBJECTIVE To assess the effect of scheduled blood measurement of carcinoembryonic antigen (CEA) and computed tomography (CT) as follow-up to detect recurrent colorectal cancer treatable with curative intent. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial in 39 National Health Service hospitals in the United Kingdom; 1202 eligible participants were recruited between January 2003 and August 2009 who had undergone curative surgery for primary colorectal cancer, including adjuvant treatment if indicated, with no evidence of residual disease on investigation. INTERVENTIONS Participants were randomly assigned to 1 of 4 groups: CEA only (n = 300), CT only (n = 299), CEA+CT (n = 302), or minimum follow-up (n = 301). Blood CEA was measured every 3 months for 2 years, then every 6 months for 3 years; CT scans of the chest, abdomen, and pelvis were performed every 6 months for 2 years, then annually for 3 years; and the minimum follow-up group received follow-up if symptoms occurred. MAIN OUTCOMES AND MEASURES The primary outcome was surgical treatment of recurrence with curative intent; secondary outcomes were mortality (total and colorectal cancer), time to detection of recurrence, and survival after treatment of recurrence with curative intent. RESULTS After a mean 4.4 (SD, 0.8) years of observation, cancer recurrence was detected in 199 participants (16.6%; 95% CI, 14.5%-18.7%) overall; 71 of 1202 participants (5.9%; 95% CI, 4.6%-7.2%) were treated for recurrence with curative intent, with little difference according to Dukes staging (stage A, 5.1% [13/254]; stage B, 6.1% [34/553]; stage C, 6.2% [22/354]). Surgical treatment of recurrence with curative intent was 2.3% (7/301) in the minimum follow-up group, 6.7%(20/300) in the CEA group, 8%(24/299) in the CT group, and 6.6% (20/302) in the CEA+CT group. Compared with minimum follow-up, the absolute difference in the percentage of patients treated with curative intent in the CEA group was 4.4%(95% CI, 1.0%-7.9%; adjusted odds ratio [OR], 3.00; 95% CI, 1.23-7.33), in the CT groupwas 5.7% (95% CI, 2.2%-9.5%; adjusted OR, 3.63; 95% CI, 1.51-8.69), and in the CEA+CT groupwas 4.3% (95% CI, 1.0%-7.9%; adjusted OR, 3.10; 95% CI, 1.10-8.71). The number of deaths was not significantly different in the combined intensive monitoring groups (CEA, CT, and CEA+CT; 18.2% [164/901]) vs the minimum follow-up group (15.9% [48/301]; difference, 2.3%; 95% CI, -2.6% to 7.1%). CONCLUSIONS AND RELEVANCE Among patients who had undergone curative surgery for primary colorectal cancer, intensive imaging or CEA screening each provided an increased rate of surgical treatment of recurrence with curative intent compared with minimal follow-up; there was no advantage in combining CEA and CT. If there is a survival advantage to any strategy, it is likely to be small.	[Primrose, John N.; Corkhill, Andrea; George, Steve] Univ Southampton, Southampton, Hants, England; [Perera, Rafael; Gray, Alastair; Rose, Peter; Fuller, Alice; Mant, David] Univ Oxford, Oxford, England	University of Southampton; University of Oxford	Primrose, JN (corresponding author), Southampton Gen Hosp, Level SAB C, Mailpoint 816,Tremona Rd, Southampton SO16 6YD, Hants, England.	j.n.primrose@soton.ac.uk	Lund, Jonathan/K-6631-2019	Lund, Jonathan/0000-0001-5195-2181; Primrose, John/0000-0002-2069-7605; Gray, Alastair/0000-0003-0239-7278; Perera, Rafael/0000-0003-2418-2091	UK National Institute for Health Research Health Technology Assessment (NIHR HTA) program [99/10/99]; Cancer Research UK [15956] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10206, 99/10/99, 99/10/09, 11/136/83] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment (NIHR HTA) program; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The project was funded by the UK National Institute for Health Research Health Technology Assessment (NIHR HTA) program (project No. 99/10/99).	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Cancer Research UK, CANCER STATISTICS CO; Colibaseanu DT, 2013, DIS COLON RECTUM, V56, P14, DOI 10.1097/DCR.0b013e3182741929; Drescher CW, 2013, J CLIN ONCOL, V31, P387, DOI 10.1200/JCO.2012.43.6691; GLIMELIUS B, 1992, J CLIN ONCOL, V10, P904, DOI 10.1200/JCO.1992.10.6.904; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Jeffery M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002200.pub2; Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285; Kjeldsen BJ, 1997, BRIT J SURG, V84, P666; MAKELA JT, 1995, ARCH SURG-CHICAGO, V130, P1062; Morris EJA, 2011, GUT, V60, P1087, DOI 10.1136/gut.2010.229575; OHLSSON B, 1995, DIS COLON RECTUM, V38, P619, DOI 10.1007/BF02054122; Pietra N, 1998, DIS COLON RECTUM, V41, P1127, DOI 10.1007/BF02239434; Renehan AG, 2002, BMJ-BRIT MED J, V324, P813, DOI 10.1136/bmj.324.7341.813; Rex DK, 2006, CA-CANCER J CLIN, V56, P160, DOI 10.3322/canjclin.56.3.160; Rodriguez-Moranta F, 2006, J CLIN ONCOL, V24, P386, DOI 10.1200/JCO.2005.02.0826; Schoemaker D, 1998, GASTROENTEROLOGY, V114, P7, DOI 10.1016/S0016-5085(98)70626-2; Secco GB, 2002, EUR J SURG ONCOL, V28, P418, DOI 10.1053/ejso.2001.1250; Tan E, 2009, SURG ONCOL, V18, P15, DOI 10.1016/j.suronc.2008.05.008	19	295	297	2	32	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					263	270		10.1001/jama.2013.285718	http://dx.doi.org/10.1001/jama.2013.285718			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24430319	Bronze			2022-12-28	WOS:000329566400018
J	Kleinman, A				Kleinman, Arthur			How we endure	LANCET			English	Editorial Material									Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	Harvard University	Kleinman, A (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu						Alterra A., 2008, THE CAREGIVER A LIFE; Jackson Michael, 2011, LIFE WITHIN LIMITS W; Kleinman A, 2011, DEEP CHINA: THE MORAL LIFE OF THE PERSON, WHAT ANTHROPOLOGY AND PSYCHIATRY TELL US ABOUT CHINA TODAY, P1; Kleinman A, 1988, THE ILLNESS NARRATIV; Kleinman A, 2011, LANCET, V378, P1621, DOI 10.1016/S0140-6736(11)61688-7; Puett Michael J., 2010, RETHINKING HUMAN, P95	6	11	12	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					119	120		10.1016/S0140-6736(14)60012-X	http://dx.doi.org/10.1016/S0140-6736(14)60012-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	24422215				2022-12-28	WOS:000329579600015
J	Scanlan, D				Scanlan, David			Bacterial Vesicles in the Ocean	SCIENCE			English	Editorial Material							PROCHLOROCOCCUS		Univ Warwick, Sch Life Sci, Coventry CV8 1FN, W Midlands, England	University of Warwick	Scanlan, D (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV8 1FN, W Midlands, England.	d.j.scanlan@warwick.ac.uk	Scanlan, David J/G-4080-2016	Scanlan, David J/0000-0003-3093-4245	NERC [NE/J02273X/1] Funding Source: UKRI; Natural Environment Research Council [NE/J02273X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Falkowski P, 2012, NATURE, V483, pS17, DOI 10.1038/483S17a; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929	12	15	15	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					143	144		10.1126/science.1248566	http://dx.doi.org/10.1126/science.1248566			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24408423				2022-12-28	WOS:000329440800027
J	Guo, YY; Dong, LY; Qiu, XL; Wang, YS; Zhang, BL; Liu, HN; Yu, Y; Zang, Y; Yang, MJ; Huang, ZW				Guo, Yingying; Dong, Liyong; Qiu, Xiaolin; Wang, Yishu; Zhang, Bailing; Liu, Hongnan; Yu, You; Zang, Yi; Yang, Maojun; Huang, Zhiwei			Structural basis for hijacking CBF-beta and CUL5 E3 ligase complex by HIV-1 Vif	NATURE			English	Article							UBIQUITIN LIGASE; SOCS BOX; ENZYME APOBEC3G; PROTEIN; DNA; DEGRADATION; HYPERMUTATION; INFECTION; SOFTWARE; MOTIF	The human immunodeficiency virus (HIV)-1 protein Vif has a central role in the neutralization of host innate defences by hijacking cellular proteasomal degradation pathways to subvert the antiviral activity of host restriction factors(1-6); however, the underlying mechanism by which Vif achieves this remains unclear. Here we report a crystal structure of the Vif-CBF-beta-CUL5-ELOB-ELOC complex. The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-beta, CUL5 and ELOC. The larger domain (alpha/beta domain) of Vif binds to the same side of CBF-beta as RUNX1, indicating that Vif and RUNX1 are exclusive for CBF-beta binding. Interactions of the smaller domain (alpha-domain) of Vif with ELOCand CUL5 are cooperative and mimic those of SOCS2 with the latter two proteins. A unique zinc-finger motif of Vif, which is located between the two Vif domains, makes no contacts with the other proteins but stabilizes the conformation of the alpha-domain, which may be important for Vif-CUL5 interaction. Together, our data reveal the structural basis for Vif hijacking of the CBF-beta and CUL5 E3 ligase complex, laying a foundation for rational design of novel anti-HIV drugs.	[Guo, Yingying; Dong, Liyong; Qiu, Xiaolin; Wang, Yishu; Zhang, Bailing; Liu, Hongnan; Zang, Yi; Huang, Zhiwei] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China; [Yu, You; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China	Harbin Institute of Technology; Tsinghua University	Huang, ZW (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China.	huangzhiwei@hit.edu.cn	Yu, You/B-2239-2019; zhang, bailing/GZA-6966-2022; Huang, Zhiwei/AAF-6846-2019	Yu, You/0000-0002-2311-7477; Yang, Maojun/0000-0002-6798-3094	National Natural Science Foundation of China [31300605, 31030020, 31170679]; Program for New Century Excellent Talents in University [AUGA5710060713]; Ministry of Science and Technology of China [2012CB911101, 2011CB910502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank F. Yu and J. He at Shanghai Synchrotron Radiation Facility (SSRF) for help with data collection. We thank J. Chai for critical reading of the manuscript. This research was funded by the National Natural Science Foundation of China grant 31300605 and the Program for New Century Excellent Talents in University grant AUGA5710060713 to Z.H.; Ministry of Science and Technology of China grants 2012CB911101 and 2011CB910502, and the National Natural Science Foundation of China grants 31030020 and 31170679 to M.Y.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hultquist JF, 2012, AIDS RES HUM RETROV, V28, P1543, DOI [10.1089/aid.2012.0142, 10.1089/AID.2012.0142]; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Kim YK, 2013, ACTA CRYSTALLOGR D, V69, P1587, DOI 10.1107/S0907444913011220; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muniz JRC, 2013, J MOL BIOL, V425, P3166, DOI 10.1016/j.jmb.2013.06.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Warren AJ, 2000, EMBO J, V19, P3004, DOI 10.1093/emboj/19.12.3004; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou XB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1949; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	36	155	159	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					229	+		10.1038/nature12884	http://dx.doi.org/10.1038/nature12884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24402281				2022-12-28	WOS:000329441500041
J	Klootwijk, ED; Reichold, M; Helip-Wooley, A; Tolaymat, A; Broeker, C; Robinette, SL; Reinders, J; Peindl, D; Renner, K; Eberhart, K; Assmann, N; Oefner, PJ; Dettmer, K; Sterner, C; Schroeder, J; Zorger, N; Witzgall, R; Reinhold, SW; Stanescu, HC; Bockenhauer, D; Jaureguiberry, G; Courtneidge, H; Hall, AM; Wijeyesekera, AD; Holmes, E; Nicholson, JK; O'Brien, K; Bernardini, I; Krasnewich, DM; Arcos-Burgos, M; Izumi, Y; Nonoguchi, H; Jia, YZ; Reddy, JK; Ilyas, M; Unwin, RJ; Gahl, WA; Warth, R; Kleta, R				Klootwijk, Enriko D.; Reichold, Markus; Helip-Wooley, Amanda; Tolaymat, Asad; Broeker, Carsten; Robinette, Steven L.; Reinders, Joerg; Peindl, Dominika; Renner, Kathrin; Eberhart, Karin; Assmann, Nadine; Oefner, Peter J.; Dettmer, Katja; Sterner, Christina; Schroeder, Josef; Zorger, Niels; Witzgall, Ralph; Reinhold, Stephan W.; Stanescu, Horia C.; Bockenhauer, Detlef; Jaureguiberry, Graciana; Courtneidge, Holly; Hall, Andrew M.; Wijeyesekera, Anisha D.; Holmes, Elaine; Nicholson, Jeremy K.; O'Brien, Kevin; Bernardini, Isa; Krasnewich, Donna M.; Arcos-Burgos, Mauricio; Izumi, Yuichiro; Nonoguchi, Hiroshi; Jia, Yuzhi; Reddy, Janardan K.; Ilyas, Mohammad; Unwin, Robert J.; Gahl, William A.; Warth, Richard; Kleta, Robert			Mistargeting of Peroxisomal EHHADH and Inherited Renal Fanconi's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-OXIDATION; KIDNEY INJURY; LOWE-SYNDROME; ALPHA; CELLS; MITOCHONDRIA; CYSTINOSIS; ACIDS	Background In renal Fanconi's syndrome, dysfunction in proximal tubular cells leads to renal losses of water, electrolytes, and low-molecular-weight nutrients. For most types of isolated Fanconi's syndrome, the genetic cause and underlying defect remain unknown. Methods We clinically and genetically characterized members of a five-generation black family with isolated autosomal dominant Fanconi's syndrome. We performed genomewide linkage analysis, gene sequencing, biochemical and cell-biologic investigations of renal proximal tubular cells, studies in knockout mice, and functional evaluations of mitochondria. Urine was studied with the use of proton nuclear magnetic resonance (H-1-NMR) spectroscopy. Results We linked the phenotype of this family's Fanconi's syndrome to a single locus on chromosome 3q27, where a heterozygous missense mutation in EHHADH segregated with the disease. The p.E3K mutation created a new mitochondrial targeting motif in the N-terminal portion of EHHADH, an enzyme that is involved in peroxisomal oxidation of fatty acids and is expressed in the proximal tubule. Immuno-cytofluorescence studies showed mistargeting of the mutant EHHADH to mitochondria. Studies of proximal tubular cells revealed impaired mitochondrial oxidative phosphorylation and defects in the transport of fluids and a glucose analogue across the epithelium. H-1-NMR spectroscopy showed elevated levels of mitochondrial metabolites in urine from affected family members. Ehhadh knockout mice showed no abnormalities in renal tubular cells, a finding that indicates a dominant negative nature of the mutation rather than haploinsufficiency. Conclusions Mistargeting of peroxisomal EHHADH disrupts mitochondrial metabolism and leads to renal Fanconi's syndrome; this indicates a central role of mitochondria in proximal tubular function. The dominant negative effect of the mistargeted protein adds to the spectrum of monogenic mechanisms of Fanconi's syndrome. (Funded by the European Commission Seventh Framework Programme and others.)	[Klootwijk, Enriko D.; Stanescu, Horia C.; Bockenhauer, Detlef; Jaureguiberry, Graciana; Courtneidge, Holly; Hall, Andrew M.; Unwin, Robert J.; Kleta, Robert] UCL, Ctr Nephrol, London NW3 2PF, England; [Bockenhauer, Detlef; Kleta, Robert] UCL, Inst Child Hlth, London NW3 2PF, England; [Robinette, Steven L.; Wijeyesekera, Anisha D.; Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, London, England; [Reichold, Markus; Broeker, Carsten; Peindl, Dominika; Sterner, Christina; Warth, Richard] Univ Regensburg, Dept Med Cell Biol, D-93053 Regensburg, Germany; [Renner, Kathrin] Univ Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany; [Reinhold, Stephan W.] Univ Regensburg, Dept Internal Med 2, D-93053 Regensburg, Germany; [Witzgall, Ralph] Univ Regensburg, Dept Mol & Cellular Anat, D-93053 Regensburg, Germany; [Reinders, Joerg; Eberhart, Karin; Assmann, Nadine; Oefner, Peter J.; Dettmer, Katja] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Schroeder, Josef] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Zorger, Niels] Barmherzige Brueder Hosp, Dept Radiol, Regensburg, Germany; [Helip-Wooley, Amanda; Robinette, Steven L.; Stanescu, Horia C.; O'Brien, Kevin; Bernardini, Isa; Krasnewich, Donna M.; Gahl, William A.; Kleta, Robert] NHGRI, NIH, Bethesda, MD 20892 USA; [Izumi, Yuichiro] NHLBI, NIH, Bethesda, MD 20892 USA; [Tolaymat, Asad; Ilyas, Mohammad] Univ Florida, Div Pediat Nephrol, Jacksonville, FL USA; [Arcos-Burgos, Mauricio] Australian Natl Univ, Genome Biol Dept, Canberra, ACT, Australia; [Nonoguchi, Hiroshi] Kitasato Univ, Med Ctr, Saitama, Japan; [Jia, Yuzhi; Reddy, Janardan K.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	University of London; University College London; University of London; University College London; Imperial College London; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University System of Florida; University of Florida; Australian National University; Kitasato University; Northwestern University	Kleta, R (corresponding author), UCL, Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	r.kleta@ucl.ac.uk	Holmes, Elaine/ABE-6606-2020; Vargas Alfonso, Alba Lucia/E-1581-2015; Hall, Andrew/GWV-2838-2022; Holmes, Elaine/A-2189-2015; Reichold, Markus/J-9933-2015; Assmann, Nadine/AAC-5201-2020; Warth, Richard/N-7119-2014; Dettmer, Katja/N-4562-2016; Nicholson, Jeremy K/B-3395-2012; Bockenhauer, Detlef/AAF-6495-2020; Dettmer, Katja/D-6218-2018; Renner, Kathrin/H-3211-2013; Arcos-Burgos, Mauricio/H-1326-2017	Holmes, Elaine/0000-0002-0556-8389; Vargas Alfonso, Alba Lucia/0000-0001-7984-0560; Warth, Richard/0000-0001-6084-0659; Dettmer, Katja/0000-0001-7337-2380; Nicholson, Jeremy K/0000-0002-8123-8349; Bockenhauer, Detlef/0000-0001-5878-941X; Dettmer, Katja/0000-0001-7337-2380; Witzgall, Ralph/0000-0002-5283-4846; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Nonoguchi, Hiroshi/0000-0001-7831-7380; Renner, Kathrin/0000-0002-7116-1368; Reinders, Joerg/0000-0003-1025-7849; Wijeyesekera, Anisha/0000-0001-6151-5065; Hall, Andrew/0000-0002-6328-7892	European Commission [2012-305608]; David and Elaine Potter Foundation; St. Peter's Trust for Kidney, Bladder, and Prostate Research; Kids Kidney Research; Lowe Syndrome Trust; BayGene; Deutsche Forschungsgemeinschaft [SFB699]; Intramural Research Program of the National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-SGCL4-Hall] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); David and Elaine Potter Foundation; St. Peter's Trust for Kidney, Bladder, and Prostate Research; Kids Kidney Research(Kidney Research UK (KRUK)); Lowe Syndrome Trust; BayGene; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	Supported by grants from the European Commission Seventh Framework Programme (2012-305608 [European Consortium for High-Throughput Research in Rare Kidney Diseases], to Drs. Bockenhauer, Unwin, and Kleta), the David and Elaine Potter Foundation (to Dr. Kleta), St. Peter's Trust for Kidney, Bladder, and Prostate Research (to Drs. Bockenhauer and Kleta), Kids Kidney Research (to Drs. Bockenhauer and Kleta), the Lowe Syndrome Trust (to Drs. Bockenhauer, Unwin, and Kleta), BayGene (to Dr. Oefner), and Deutsche Forschungsgemeinschaft (SFB699, to Drs. Reichold, Reinders, and Warth). Also supported in part by the Intramural Research Program of the National Human Genome Research Institute.	BALABAN RS, 1988, AM J PHYSIOL, V254, pF407, DOI 10.1152/ajprenal.1988.254.3.F407; Bockenhauer D, 2008, CLIN J AM SOC NEPHRO, V3, P1430, DOI 10.2215/CJN.00520108; Ciarimboli G, 2011, MOL PHARMACEUT, V8, P270, DOI 10.1021/mp100329u; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Danpure CJ, 2006, BBA-MOL CELL RES, V1763, P1776, DOI 10.1016/j.bbamcr.2006.08.021; Dettmer K, 2011, ANAL BIOANAL CHEM, V399, P1127, DOI 10.1007/s00216-010-4425-x; FOREMAN JW, 1989, NEPHRON, V51, P301, DOI 10.1159/000185313; Hall AM, 2011, J AM SOC NEPHROL, V22, P986, DOI 10.1681/ASN.2011030309; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Izumi Y, 2007, AM J PHYSIOL-RENAL, V292, pF1418, DOI 10.1152/ajprenal.00358.2006; Kaspar H, 2008, J CHROMATOGR B, V870, P222, DOI 10.1016/j.jchromb.2008.06.018; Kleta R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027098.90648.F2; Kleta R, 2004, J PEDIATR-US, V145, P555, DOI 10.1016/j.jpeds.2004.03.056; KLETA R, 1995, PFLUG ARCH EUR J PHY, V429, P370, DOI 10.1007/BF00374152; Kleta R, 2008, CLIN J AM SOC NEPHRO, V3, P1244, DOI 10.2215/CJN.02880608; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Magen D, 2010, NEW ENGL J MED, V362, P1102, DOI 10.1056/NEJMoa0905647; Niaudet P, 1996, PEDIATR NEPHROL, V10, P368; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Stadlmann S, 2006, CELL BIOCHEM BIOPHYS, V44, P179, DOI 10.1385/CBB:44:2:179; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; TOLAYMAT A, 1992, J AM SOC NEPHROL, V2, P1310; Vilasi A, 2007, AM J PHYSIOL-RENAL, V293, pF456, DOI 10.1152/ajprenal.00095.2007; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250	29	64	69	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					129	138		10.1056/NEJMoa1307581	http://dx.doi.org/10.1056/NEJMoa1307581			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401050	Green Accepted			2022-12-28	WOS:000336119800008
J	Strollo, PJ; Soose, RJ; Maurer, JT; de Vries, N; Cornelius, J; Froymovich, O; Hanson, RD; Padhya, TA; Steward, DL; Gillespie, MB; Woodson, BT; Van de Heyning, PH; Goetting, MG; Vanderveken, OM; Feldman, N; Knaack, L; Strohl, KP				Strollo, Patrick J., Jr.; Soose, Ryan J.; Maurer, Joachim T.; de Vries, Nico; Cornelius, Jason; Froymovich, Oleg; Hanson, Ronald D.; Padhya, Tapan A.; Steward, David L.; Gillespie, M. Boyd; Woodson, B. Tucker; Van de Heyning, Paul H.; Goetting, Mark G.; Vanderveken, Oliver M.; Feldman, Neil; Knaack, Lennart; Strohl, Kingman P.		STAR Trial Grp	Upper-Airway Stimulation for Obstructive Sleep Apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOGLOSSAL NERVE-STIMULATION; ELECTRICAL-STIMULATION; PRESSURE THERAPY; ADHERENCE; HYPOPNEA; FAILURE	BACKGROUND Obstructive sleep apnea is associated with considerable health risks. Although continuous positive airway pressure (CPAP) can mitigate these risks, effectiveness can be reduced by inadequate adherence to treatment. We evaluated the clinical safety and effectiveness of upper-airway stimulation at 12 months for the treatment of moderate-to-severe obstructive sleep apnea. METHODS Using a multicenter, prospective, single-group, cohort design, we surgically implanted an upper-airway stimulation device in patients with obstructive sleep apnea who had difficulty either accepting or adhering to CPAP therapy. The primary outcome measures were the apnea-hypopnea index (AHI; the number of apnea or -hypopnea events per hour, with a score of >= 15 indicating moderate-to-severe apnea) and the oxygen desaturation index (ODI; the number of times per hour of sleep that the blood oxygen level drops by >= 4 percentage points from baseline). Secondary outcome measures were the Epworth Sleepiness Scale, the Functional Outcomes of Sleep Questionnaire (FOSQ), and the percentage of sleep time with the oxygen saturation less than 90%. Consecutive participants with a response were included in a randomized, controlled therapy-withdrawal trial. RESULTS The study included 126 participants; 83% were men. The mean age was 54.5 years, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 28.4. The median AHI score at 12 months decreased 68%, from 29.3 events per hour to 9.0 events per hour (P<0.001); the ODI score decreased 70%, from 25.4 events per hour to 7.4 events per hour (P<0.001). Secondary outcome measures showed a reduction in the effects of sleep apnea and improved quality of life. In the randomized phase, the mean AHI score did not differ significantly from the 12-month score in the nonrandomized phase among the 23 participants in the therapy-maintenance group (8.9 and 7.2 events per hour, respectively); the AHI score was significantly higher (indicating more severe apnea) among the 23 participants in the therapy-withdrawal group (25.8 vs. 7.6 events per hour, P<0.001). The ODI results followed a similar pattern. The rate of procedure-related serious adverse events was less than 2%. CONCLUSIONS In this uncontrolled cohort study, upper-airway stimulation led to significant improvements in objective and subjective measurements of the severity of obstructive sleep apnea. (Funded by Inspire Medical Systems; STAR ClinicalTrials.gov number, NCT01161420.)	[Strollo, Patrick J., Jr.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Soose, Ryan J.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Maurer, Joachim T.] Univ Hosp Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Sleep Disorders Ctr, Mannheim, Germany; [Knaack, Lennart] Intersom Koln, Cologne, Germany; [de Vries, Nico] Sint Lucas Hosp, Dept Otolaryngol, Amsterdam, Netherlands; [Cornelius, Jason] North Mem Sleep Hlth Ctr, Maple Grove, MN USA; [Froymovich, Oleg] Paparella Ear Head & Neck Inst, Minneapolis, MN USA; [Hanson, Ronald D.] St Cloud Ear Nose & Throat, St Cloud, MN USA; [Padhya, Tapan A.] Univ S Florida, Coll Med, Dept Otolaryngol Head & Neck Surg, Tampa, FL USA; [Feldman, Neil] St Petersburg Sleep Disorders Ctr, St Petersburg, FL USA; [Steward, David L.] Univ Cincinnati, Dept Otolaryngol Head & Neck Surg, Acad Hlth Ctr, Cincinnati, OH USA; [Gillespie, M. Boyd] Med Coll South Carolina, Dept Otolaryngol, Charleston, SC USA; [Woodson, B. Tucker] Med Coll Wisconsin, Dept Otolaryngol & Human Commun, Milwaukee, WI 53226 USA; [Van de Heyning, Paul H.; Vanderveken, Oliver M.] Univ Antwerp Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Edegem, Belgium; [Van de Heyning, Paul H.; Vanderveken, Oliver M.] Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Goetting, Mark G.] Borgess Med Ctr, Sleep Disorders Ctr, Kalamazoo, MI USA; [Strohl, Kingman P.] Case Western Reserve Univ, Louis Stokes Cleveland Vet Affairs Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Strohl, Kingman P.] Case Western Reserve Univ, Case Med Ctr, Cleveland, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ruprecht Karls University Heidelberg; Sint Lucas Andreas Hospital; State University System of Florida; University of South Florida; University System of Ohio; University of Cincinnati; Medical College of Wisconsin; University of Antwerp; University of Antwerp; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Strollo, PJ (corresponding author), Univ Pittsburgh, Montefiore Med Ctr, Suite S639-11,3459 Fifth Ave, Pittsburgh, PA 15213 USA.	strollopj@upmc.edu	Heyning, Paul H Vande/I-8278-2017; Dieltjens, Marijke/P-7049-2014; Skovlund, Soren/AAK-3058-2020; VANDERVEKEN, Olivier/K-8549-2014; Strollo, Patrick J/L-7062-2016; Woodson, B Tucker/K-2266-2019	Heyning, Paul H Vande/0000-0002-8424-3717; Dieltjens, Marijke/0000-0002-5822-1960; Skovlund, Soren/0000-0003-3464-0885; VANDERVEKEN, Olivier/0000-0002-4088-4213; 	Inspire Medical Systems	Inspire Medical Systems	Supported by Inspire Medical Systems.	American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; Caples SM, 2010, SLEEP, V33, P1396, DOI 10.1093/sleep/33.10.1396; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; Eastwood PR, 2011, SLEEP, V34, P1479, DOI 10.5665/sleep.1380; Elshaug AG, 2007, SLEEP, V30, P461, DOI 10.1093/sleep/30.4.461; Goding GS, 2012, OTOLARYNG HEAD NECK, V146, P1017, DOI 10.1177/0194599812436472; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kohler M, 2011, AM J RESP CRIT CARE, V184, P1192, DOI 10.1164/rccm.201106-0964OC; Lim J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004435.pub3; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Maurer JT, 2012, OPERATIVE TECHNIQUES, V23, P227, DOI [DOI 10.1016/J.0T0T.2012.07.002, 10.1016/j.otot.2012.07.002]; Mwenge GB, 2013, EUR RESPIR J, V41, P360, DOI 10.1183/09031936.00042412; Oliven A, 2003, J APPL PHYSIOL, V95, P2023, DOI 10.1152/japplphysiol.00203.2003; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Ravesloot MJL, 2011, SLEEP, V34, P105, DOI 10.1093/sleep/34.1.105; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; REMMERS JE, 1990, J APPL PHYSIOL, V68, P1286, DOI 10.1152/jappl.1990.68.3.1286; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Schwartz AR, 2012, AM J RESP CRIT CARE, V185, P420, DOI 10.1164/rccm.201109-1614OC; Schwartz AR, 2001, ARCH OTOLARYNGOL, V127, P1216, DOI 10.1001/archotol.127.10.1216; SCHWARTZ AR, 1993, AM REV RESPIR DIS, V147, P1144, DOI 10.1164/ajrccm/147.5.1144; Seicean S, 2008, DIABETES CARE, V31, P1001, DOI 10.2337/dc07-2003; STROHL KP, 1978, NEW ENGL J MED, V299, P969, DOI 10.1056/NEJM197811022991801; Strollo PJ, 1996, NEW ENGL J MED, V334, P99, DOI 10.1056/NEJM199601113340207; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; Van de Heyning PH, 2012, LARYNGOSCOPE, V122, P1626, DOI 10.1002/lary.23301; Vanderveken OM, 2008, AM J RESP CRIT CARE, V178, P197, DOI 10.1164/rccm.200701-114OC; Vanderveken OM, 2013, J CLIN SLEEP MED, V9, P433, DOI 10.5664/jcsm.2658; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711	32	626	643	3	133	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					139	149		10.1056/NEJMoa1308659	http://dx.doi.org/10.1056/NEJMoa1308659			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TA	24401051				2022-12-28	WOS:000336119800009
J	Albert, VA; Barbazuk, WB; dePamphilis, CW; Der, JP; Leebens-Mack, J; Ma, H; Palmer, JD; Rounsley, S; Sankoff, D; Schuster, SC; Soltis, DE; Soltis, PS; Wessler, SR; Wing, RA; Albert, VA; Ammiraju, JSS; Barbazuk, WB; Chamala, S; Chanderbali, AS; DePamphilis, CW; Der, JP; Determann, R; Leebens-Mack, J; Ma, H; Ralph, P; Rounsley, S; Schuster, SC; Soltis, DE; Soltis, PS; Talag, J; Tomsho, L; Walts, B; Wanke, S; Wing, RA; Albert, VA; Barbazuk, WB; Chamala, S; Chanderbali, AS; Chang, TH; Determann, R; Lan, TY; Soltis, DE; Soltis, PS; Arikit, S; Axtell, MJ; Ayyampalayam, S; Barbazuk, WB; Burnette, JM; Chamala, S; De Paoli, E; Depamphilis, CW; Der, JP; Estill, JC; Farrell, NP; Harkess, A; Jiao, YN; Leebens-Mack, J; Liu, K; Mei, WB; Meyers, BC; Shahid, S; Wafula, E; Walts, B; Wessler, SR; Zhai, JX; Zhang, XY; Albert, VA; Carretero-Paulet, L; Depamphilis, CW; Der, JP; Jiao, YN; Leebens-Mack, J; Lyons, E; Sankoff, D; Tang, HB; Wafula, E; Zheng, CF; Albert, VA; Altman, NS; Barbazuk, WB; Carretero-Paulet, L; Depamphilis, CW; Der, JP; Estill, JC; Jiao, YN; Leebens-Mack, J; Liu, K; Mei, WB; Wafula, E; Altman, NS; Arikit, S; Axtell, MJ; Chamala, S; Chanderbali, AS; Chen, F; Chen, JQ; Chiang, V; De Paoli, E; dePamphilis, CW; Der, JP; Determann, R; Fogliani, B; Guo, CC; Harholt, J; Harkess, A; Job, C; Job, D; Kim, S; Kong, HZ; Leebens-Mack, J; Li, GL; Li, L; Liu, J; Ma, H; Meyers, BC; Park, J; Qi, XS; Rajjou, L; Burtet-Sarramegna, V; Sederoff, R; Shahid, S; Soltis, DE; Soltis, PS; Sun, YH; Ulvskov, P; Villegente, M; Xue, JY; Yeh, TF; Yu, XX; Zhai, JX; Acosta, JJ; Albert, VA; Barbazuk, WB; Bruenn, RA; Chamala, S; de Kochko, A; dePamphilis, CW; Der, JP; Herrera-Estrella, LR; Ibarra-Laclette, E; Kirst, M; Leebens-Mack, J; Pissis, SP; Poncet, V; Schuster, SC; Soltis, DE; Soltis, PS; Tomsho, L				Albert, Victor A.; Barbazuk, W. Bradley; dePamphilis, Claude W.; Der, Joshua P.; Leebens-Mack, James; Ma, Hong; Palmer, Jeffrey D.; Rounsley, Steve; Sankoff, David; Schuster, Stephan C.; Soltis, Douglas E.; Soltis, Pamela S.; Wessler, Susan R.; Wing, Rod A.; Albert, Victor A.; Ammiraju, Jetty S. S.; Barbazuk, W. Bradley; Chamala, Srikar; Chanderbali, Andre S.; dePamphilis, Claude W.; Der, Joshua P.; Determann, Ronald; Leebens-Mack, James; Ma, Hong; Ralph, Paula; Rounsley, Steve; Schuster, Stephan C.; Soltis, Douglas E.; Soltis, Pamela S.; Talag, Jason; Tomsho, Lynn; Walts, Brandon; Wanke, Stefan; Wing, Rod A.; Albert, Victor A.; Barbazuk, W. Bradley; Chamala, Srikar; Chanderbali, Andre S.; Chang, Tien-Hao; Determann, Ronald; Lan, Tianying; Soltis, Douglas E.; Soltis, Pamela S.; Arikit, Siwaret; Axtell, Michael J.; Ayyampalayam, Saravanaraj; Barbazuk, W. Bradley; Burnette, James M., III; Chamala, Srikar; De Paoli, Emanuele; dePamphilis, Claude W.; Der, Joshua P.; Estill, James C.; Farrell, Nina P.; Harkess, Alex; Jiao, Yuannian; Leebens-Mack, James; Liu, Kun; Mei, Wenbin; Meyers, Blake C.; Shahid, Saima; Wafula, Eric; Walts, Brandon; Wessler, Susan R.; Zhai, Jixian; Zhang, Xiaoyu; Albert, Victor A.; Carretero-Paulet, Lorenzo; dePamphilis, Claude W.; Der, Joshua P.; Jiao, Yuannian; Leebens-Mack, James; Lyons, Eric; Sankoff, David; Tang, Haibao; Wafula, Eric; Zheng, Chunfang; Albert, Victor A.; Altman, Naomi S.; Barbazuk, W. Bradley; Carretero-Paulet, Lorenzo; dePamphilis, Claude W.; Der, Joshua P.; Estill, James C.; Jiao, Yuannian; Leebens-Mack, James; Liu, Kun; Mei, Wenbin; Wafula, Eric; Altman, Naomi S.; Arikit, Siwaret; Axtell, Michael J.; Chamala, Srikar; Chanderbali, Andre S.; Chen, Feng; Chen, Jian-Qun; Chiang, Vincent; De Paoli, Emanuele; dePamphilis, Claude W.; Der, Joshua P.; Determann, Ronald; Fogliani, Bruno; Guo, Chunce; Harholt, Jesper; Harkess, Alex; Job, Claudette; Job, Dominique; Kim, Sangtae; Kong, Hongzhi; Leebens-Mack, James; Li, Guanglin; Li, Lin; Liu, Jie; Ma, Hong; Meyers, Blake C.; Park, Jongsun; Qi, Xinshuai; Rajjou, Loic; Burtet-Sarramegna, Valerie; Sederoff, Ron; Shahid, Saima; Soltis, Douglas E.; Soltis, Pamela S.; Sun, Ying-Hsuan; Ulvskov, Peter; Villegente, Matthieu; Xue, Jia-Yu; Yeh, Ting-Feng; Yu, Xianxian; Zhai, Jixian; Acosta, Juan J.; Albert, Victor A.; Barbazuk, W. Bradley; Bruenn, Riva A.; Chamala, Srikar; de Kochko, Alexandre; dePamphilis, Claude W.; Der, Joshua P.; Herrera-Estrella, Luis R.; Ibarra-Laclette, Enrique; Kirst, Matias; Leebens-Mack, James; Pissis, Solon P.; Poncet, Valerie; Schuster, Stephan C.; Soltis, Douglas E.; Soltis, Pamela S.; Tomsho, Lynn		Amborella Genome Project	The Amborella Genome and the Evolution of Flowering Plants	SCIENCE			English	Article							BOX GENE FAMILY; WIDE ANALYSIS; PHYLOGENETIC ANALYSIS; EARLY DIVERSIFICATION; 11S GLOBULIN; ARABIDOPSIS; EXPRESSION; ANNOTATION; REGULATORS; SEQUENCE	Amborella trichopoda is strongly supported as the single living species of the sister lineage to all other extant flowering plants, providing a unique reference for inferring the genome content and structure of the most recent common ancestor (MRCA) of living angiosperms. Sequencing the Amborella genome, we identified an ancient genome duplication predating angiosperm diversification, without evidence of subsequent, lineage-specific genome duplications. Comparisons between Amborella and other angiosperms facilitated reconstruction of the ancestral angiosperm gene content and gene order in the MRCA of core eudicots. We identify new gene families, gene duplications, and floral protein-protein interactions that first appeared in the ancestral angiosperm. Transposable elements in Amborella are ancient and highly divergent, with no recent transposon radiations. Population genomic analysis across Amborella's native range in New Caledonia reveals a recent genetic bottleneck and geographic structure with conservation implications.	[Chang, Tien-Hao; Lan, Tianying; Carretero-Paulet, Lorenzo] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Barbazuk, W. Bradley; Soltis, Douglas E.; Chamala, Srikar; Chanderbali, Andre S.; Walts, Brandon; Mei, Wenbin; Qi, Xinshuai] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Barbazuk, W. Bradley; Soltis, Douglas E.; Soltis, Pamela S.; Kirst, Matias] Univ Florida, Genet Inst, Gainesville, FL 32610 USA; [dePamphilis, Claude W.; Der, Joshua P.; Ma, Hong; Ralph, Paula; Axtell, Michael J.; Farrell, Nina P.; Jiao, Yuannian; Wafula, Eric; dePamphilis, Claude W.; Bruenn, Riva A.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [dePamphilis, Claude W.; Ma, Hong; Ralph, Paula; Farrell, Nina P.; Bruenn, Riva A.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Shahid, Saima; dePamphilis, Claude W.] Penn State Univ, Intercoll Plant Biol Grad Program, University Pk, PA 16802 USA; [dePamphilis, Claude W.; Schuster, Stephan C.; dePamphilis, Claude W.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Leebens-Mack, James; Ayyampalayam, Saravanaraj; Estill, James C.; Harkess, Alex; Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Ma, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ma, Hong] Fudan Univ, Inst Genet, Inst Plant Biol, Ctr Evolutionary Biol,Inst Biomed Sci, Shanghai 200433, Peoples R China; [Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Rounsley, Steve; Wing, Rod A.; Ammiraju, Jetty S. S.; Talag, Jason; Lyons, Eric] Univ Arizona, Sch Biol Sci, Tucson, AZ 85721 USA; [Rounsley, Steve; Wing, Rod A.; Ammiraju, Jetty S. S.; Talag, Jason; Lyons, Eric] Univ Arizona, Inst Collaborat Res BIO5, Tucson, AZ 85721 USA; [Rounsley, Steve] Dow AgroSci, Indianapolis, IN 46268 USA; [Sankoff, David; Zheng, Chunfang] Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada; [Schuster, Stephan C.; Tomsho, Lynn] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Schuster, Stephan C.] Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Soltis, Douglas E.; Soltis, Pamela S.; Pissis, Solon P.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Wessler, Susan R.; Burnette, James M., III; Liu, Kun] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Wing, Rod A.; Ammiraju, Jetty S. S.; Talag, Jason] Univ Arizona, Arizona Genom Inst, Tucson, AZ 85721 USA; [Determann, Ronald] Atlanta Bot Garden, Atlanta, GA 30309 USA; [Wanke, Stefan] Tech Univ Dresden, Inst Bot, D-01062 Dresden, Germany; [Lan, Tianying] Chongqing Univ Sci & Technol, Dept Biol, Chongqing 4000042, Peoples R China; [Arikit, Siwaret; Meyers, Blake C.; Zhai, Jixian] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [De Paoli, Emanuele] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Lyons, Eric] Univ Arizona, iPlant Collaborat, Tucson, AZ 85721 USA; [Tang, Haibao] J Craig Venter Inst, Rockville, MD 20850 USA; [Altman, Naomi S.] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Chen, Feng; Li, Guanglin] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; [Chen, Jian-Qun; Xue, Jia-Yu] Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Chiang, Vincent; Liu, Jie; Sederoff, Ron] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Fogliani, Bruno; Burtet-Sarramegna, Valerie; Villegente, Matthieu] Univ New Caledonia, Lab Insulaire Vivant & Environm, Noumea 98851, New Caledonia; [Fogliani, Bruno] Inst Agron Neo Caledonien IAC, Paita 98890, New Caledonia; [Guo, Chunce; Kong, Hongzhi; Li, Lin; Yu, Xianxian] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Harholt, Jesper; Ulvskov, Peter] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark; [Job, Claudette; Job, Dominique] Univ Claude Bernard Lyon, Inst Natl Sci Appl Bayer CropSci Joint Lab UMR524, CNRS, Bayer CropSci, F-69263 Lyon 9, France; [Kim, Sangtae; Park, Jongsun] Sungshin Womens Univ, Sch Biol Sci & Chem, Seoul 142732, South Korea; [Kim, Sangtae; Park, Jongsun] Sungshin Womens Univ, Basic Sci Res Inst, Seoul 142732, South Korea; [Qi, Xinshuai] Zhejiang Univ, Coll Life Sci, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China; [Qi, Xinshuai] Zhejiang Univ, Coll Life Sci, Lab Systemat & Evolutionary Bot & Biodivers, Hangzhou 310058, Zhejiang, Peoples R China; [Rajjou, Loic] INRA AgroParisTech, Jean Pierre Bourgin Inst IJPB, UMR1318, Lab Excellence Saclay Plant Sci LabEx SPS, F-78026 Versailles, France; [Sun, Ying-Hsuan] Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan; [Yeh, Ting-Feng] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10617, Taiwan; [Acosta, Juan J.; Kirst, Matias] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Bruenn, Riva A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [de Kochko, Alexandre; Poncet, Valerie] IRD, UMR Diversite Adaptat & Dev Plantes DIADE, F-34394 Montpellier 5, France; [Herrera-Estrella, Luis R.; Ibarra-Laclette, Enrique] Lab Nacl Genom Biodiversidad, Irapuato 36821, Mexico; [Pissis, Solon P.] Heidelberg Inst Theoret Studies, Sci Comp Grp, D-69118 Heidelberg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia; Fudan University; Fudan University; Indiana University System; Indiana University Bloomington; University of Arizona; University of Arizona; Dow Chemical Company; University of Ottawa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; State University System of Florida; University of Florida; University of California System; University of California Riverside; University of Arizona; Technische Universitat Dresden; Chongqing University of Science & Technology; University of Delaware; University of Udine; University System of Georgia; University of Georgia; University of Arizona; J. Craig Venter Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Nanjing University; University of North Carolina; North Carolina State University; Universite Nouvelle Caledonie; Chinese Academy of Sciences; Institute of Botany, CAS; University of Copenhagen; Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); Sungshin Women's University; Sungshin Women's University; Zhejiang University; Zhejiang University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Chung Hsing University; National Taiwan University; State University System of Florida; University of Florida; University of California System; University of California Berkeley; Institut de Recherche pour le Developpement (IRD); Heidelberg Institute for Theoretical Studies	dePamphilis, CW (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	cwd3@psu.edu; bbarbazuk@ufl.edu; dsoltis@ufl.edu; jleebensmack@plantbio.uga.edu; vaalbert@buffalo.edu; cwd3@psu.edu; jpd18@psu.edu; psoltis@flmnh.ufl.edu	Ma, Hong/W-5251-2018; Der, Joshua P/F-9551-2012; Poncet, Valérie/AGG-5592-2022; Kong, Hongzhi/B-1784-2012; Palmer, Jeffrey/P-6747-2014; de Kochko, Alexandre/C-7512-2009; Soltis, Douglas/L-5957-2015; Tang, Haibao/A-6715-2011; Poncet, Valerie/A-9038-2011; Wing, Rod A/Z-2885-2019; Wanke, Stefan/G-5860-2011; dePamphilis, Claude W/P-6652-2016; Jiao, Yuannian/AAZ-7054-2021; Meyers, Blake/B-6535-2012; shahid, saima/GXV-9647-2022; Zhang, xiaoyu/GXA-3206-2022; Soltis, Pamela S/L-5184-2015; Qi, Xinshuai/E-8538-2017; Leebens-Mack, James/AAF-6770-2019; Harholt, Jesper/F-6865-2014; Herrera-Estrella, Luis/ABC-7431-2020; Ulvskov, Peter/I-1228-2014; Soltis, Pamela S/GNH-5557-2022; Herrera-Estrella, Luis/AAL-2472-2020; Carretero-Paulet, Lorenzo/Z-2744-2019; Zhai, Jixian/HCH-9272-2022	Ma, Hong/0000-0001-8717-4422; Der, Joshua P/0000-0001-9668-2525; Poncet, Valérie/0000-0002-1099-2846; Palmer, Jeffrey/0000-0002-4626-2220; de Kochko, Alexandre/0000-0001-9212-3195; Tang, Haibao/0000-0002-3460-8570; Wing, Rod A/0000-0001-6633-6226; Jiao, Yuannian/0000-0002-8987-2782; Meyers, Blake/0000-0003-3436-6097; Qi, Xinshuai/0000-0003-3883-0387; Leebens-Mack, James/0000-0003-4811-2231; Harholt, Jesper/0000-0002-7984-0066; Ulvskov, Peter/0000-0003-3776-818X; Soltis, Pamela S/0000-0001-9310-8659; Herrera-Estrella, Luis/0000-0001-7936-3856; Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Li, Guanglin/0000-0001-7617-1824; Walts, Brandon/0000-0002-0215-0745; arikit, siwaret/0000-0002-2964-1886; Pissis, Solon/0000-0002-1445-1932; Estill, James/0000-0003-1020-2928; Lyons, Eric/0000-0002-3348-8845; Mei, Wenbin/0000-0002-4838-3034; Yeh, Ting-Feng/0000-0002-4114-6714; Kim, Sangtae/0000-0002-1821-4707	NSF Plant Genome Research Program [0922742]; NSF; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation	NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Sequencing reads, reference genome assembly, and gene annotations of Amborella trichopoda are available from NCBI (BioProject PRJNA212863). The Amborella genome is also available in CoGe (http://genomevolution.org/CoGe/) and at the Amborella Genome Database (http://www.amborella.org), where additional tools for comparative genomic analysis are available. This work was funded by the NSF Plant Genome Research Program (grant 0922742) to C. W. D., H. M., W. B. B., P. S. S., D. E. S., V. A. A., J.L.-M., S. R. W., J.D.P., and S. R., with additional funding from NSF's iPlant Collaborative to P. S. S. and D. E. S. Author contributions are included in the Supplementary Materials.	Adachi M, 2003, P NATL ACAD SCI USA, V100, P7395, DOI 10.1073/pnas.0832158100; Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Barker MS, 2013, PLANT GENOME DIVERSI, V2, P245, DOI [DOI 10.1007/978-3-7091-1160-4_15, DOI 10.1007/978-3-7091-1160-4_]; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Burleigh JG, 2011, SYST BIOL, V60, P117, DOI 10.1093/sysbio/syq072; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chamala S, 2013, SCIENCE, V342, P1516, DOI 10.1126/science.1241130; Chanderbali AS, 2010, P NATL ACAD SCI USA, V107, P22570, DOI 10.1073/pnas.1013395108; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chunfang Zheng, 2011, Algorithms in Bioinformatics. Proceedings of the 11th International Workshop, WABI 2011, P364, DOI 10.1007/978-3-642-23038-7_30; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Darwin C., 1903, LETTER TO HOOKER; De Bodt S, 2003, TRENDS PLANT SCI, V8, P475, DOI 10.1016/j.tplants.2003.09.006; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8; Doyle JA, 2012, ANNU REV EARTH PL SC, V40, P301, DOI 10.1146/annurev-earth-042711-105313; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Estill JC, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-8; Feild TS, 2000, INT J PLANT SCI, V161, P705, DOI 10.1086/314293; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GALIL Z, 1986, COMPUT SURV, V18, P23, DOI 10.1145/6462.6502; Gerats T, 2005, TRENDS PLANT SCI, V10, P251, DOI 10.1016/j.tplants.2005.03.005; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Goremykin VV, 2013, SYST BIOL, V62, P50, DOI 10.1093/sysbio/sys070; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hager KP, 1996, FEBS LETT, V387, P94, DOI 10.1016/0014-5793(96)00477-2; Hernandez-Hernandez T, 2007, MOL BIOL EVOL, V24, P465, DOI 10.1093/molbev/msl182; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Kato A, 2011, METHODS MOL BIOL, V701, P67, DOI 10.1007/978-1-61737-957-4_4; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Leitch IJ, 2002, BOT J LINN SOC, V140, P175, DOI 10.1046/j.1095-8339.2002.00096.x; Leseberg CH, 2006, GENE, V378, P84, DOI 10.1016/j.gene.2006.05.022; Li C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-15; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu CJ, 2010, MOL BIOL EVOL, V27, P1598, DOI 10.1093/molbev/msq044; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2011, INT J PLANT SCI, V172, P541, DOI 10.1086/658923; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Poncet V, 2013, MOL ECOL, V22, P6163, DOI 10.1111/mec.12554; Proost S, 2011, PLANT J, V66, P58, DOI 10.1111/j.1365-313X.2011.04521.x; Qi XS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-143; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; Saidi Y, 2012, TRENDS PLANT SCI, V17, P39, DOI 10.1016/j.tplants.2011.10.002; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Skinner DJ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-29; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Takuno S, 2013, P NATL ACAD SCI USA, V110, P1797, DOI 10.1073/pnas.1215380110; Tandang-Silvas MRG, 2010, BBA-PROTEINS PROTEOM, V1804, P1432, DOI 10.1016/j.bbapap.2010.02.016; Thien LB, 2003, ANN MO BOT GARD, V90, P466, DOI 10.2307/3298537; Timell T. E., 1965, ADV CARBOHYD CHEM, V20, P409, DOI DOI 10.1016/S0096-5332(08)60304-5; Van de Peer Y, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-113; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Weng JK, 2008, P NATL ACAD SCI USA, V105, P7887, DOI 10.1073/pnas.0801696105; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Wuest SE, 2012, P NATL ACAD SCI USA, V109, P13452, DOI 10.1073/pnas.1207075109; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zuccolo A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r48	87	493	502	20	445	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1467	+		10.1126/science.1241089	http://dx.doi.org/10.1126/science.1241089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357323				2022-12-28	WOS:000328644300047
J	Kohl, J; Ostrovsky, AD; Frechter, S; Jefferis, GSXE				Kohl, Johannes; Ostrovsky, Aaron D.; Frechter, Shahar; Jefferis, Gregory S. X. E.			A Bidirectional Circuit Switch Reroutes Pheromone Signals in Male and Female Brains	CELL			English	Article							MALE SEXUAL-BEHAVIOR; MALE COURTSHIP; NEURAL CIRCUITRY; DROSOPHILA; FRUITLESS; RECEPTOR; GENE; IDENTIFICATION; DOUBLESEX; NEURONS	The Drosophila sex pheromone cVA elicits different behaviors in males and females. First- and second-order olfactory neurons show identical pheromone responses, suggesting that sex genes differentially wire circuits deeper in the brain. Using in vivo whole-cell electrophysiology, we now show that two clusters of third-order olfactory neurons have dimorphic pheromone responses. One cluster responds in females; the other responds in males. These clusters are present in both sexes and share a common input pathway, but sex-specific wiring reroutes pheromone information. Regulating dendritic position, the fruitless transcription factor both connects the male-responsive cluster and disconnects the female-responsive cluster from pheromone input. Selective masculinization of third-order neurons transforms their morphology and pheromone responses, demonstrating that circuits can be functionally rewired by the cell-autonomous action of a switch gene. This bidirectional switch, analogous to an electrical changeover switch, provides a simple circuit logic to activate different behaviors in males and females.	[Kohl, Johannes; Ostrovsky, Aaron D.; Frechter, Shahar; Jefferis, Gregory S. X. E.] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Jefferis, GSXE (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 0QH, England.	jefferis@mrc-lmb.cam.ac.uk		Ostrovsky, Aaron/0000-0002-0430-3223; Jefferis, Gregory/0000-0002-0587-9355; Kohl, Johannes/0000-0001-8222-0282	Medical Research Council (MRC) [MC_U105188491]; European Research Council; LMB Graduate Scholarships; EMBO long-term fellowship; MRC [MC_U105188491] Funding Source: UKRI; Medical Research Council [MC_U105188491] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); LMB Graduate Scholarships; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge initial tuition in fly electrophysiology from Glenn Turner in the laboratory of Gilles Laurent, while G.S.X.E.J. was a Wellcome Trust Advanced Training Fellow. We also thank Glenn Turner and Rachel Wilson for subsequent advice. We thank P. Hasel, B. Gyenes, G. Johnson, and J. Roote for assistance with Split Gal4 screening, A. Hodge and the LMB workshops for the odor delivery device, and R. Benton, B. J. Dickson, S. Goodwin, M. Landgraf, the Bloomington Stock Center, and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. We thank R. Benton, J. C. Billeter, D. Logan, L. Luo, L. Newman, A. L. Taylor Tavares, G. Turner, and members of the Jefferis group for comments on the manuscript and R. Wilson, K. Scott, and M. Chatzigeorgiou for discussions. This study made use of the Computational Morphometry Toolkit, supported by the National Institute of Biomedical Imaging and Bioengineering. This work was supported by the Medical Research Council (MRC file reference MC_U105188491) and the European Research Council (to G. S. X. E. J.), by LMB Graduate Scholarships (to J. K. and A.O.), and by an EMBO long-term fellowship (to S.F.).	[Anonymous], 2014, PHEROMONES ANIMAL BE; BAKER BS, 1980, GENETICS, V94, P383; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; BUTLER B, 1986, EMBO J, V5, P3607, DOI 10.1002/j.1460-2075.1986.tb04689.x; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dulac C, 2007, CURR OPIN NEUROBIOL, V17, P675, DOI 10.1016/j.conb.2008.01.009; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Evers JF, 2005, J NEUROPHYSIOL, V93, P2331, DOI 10.1152/jn.00761.2004; Fisek M, 2014, NAT NEUROSCI, V17, P280, DOI 10.1038/nn.3613; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Horowitz P., 2015, ART ELECT; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Ito H, 2012, CELL, V149, P1327, DOI 10.1016/j.cell.2012.04.025; Jang H, 2012, NEURON, V75, P585, DOI 10.1016/j.neuron.2012.06.034; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Masse NY, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00021; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Nojima T, 2010, CURR BIOL, V20, P836, DOI 10.1016/j.cub.2010.02.064; Ostrovsky A. D, 2011, THESIS U CAMBRIDGE C; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; TOMPKINS L, 1983, GENETICS, V103, P179; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	58	128	128	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1610	1623		10.1016/j.cell.2013.11.025	http://dx.doi.org/10.1016/j.cell.2013.11.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24360281	Green Published, hybrid			2022-12-28	WOS:000328693300016
J	Ledford, H				Ledford, Heidi			Software patents await legal fate	NATURE			English	News Item																		2013, NATURE, V498, P281	1	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					410	411		10.1038/507410a	http://dx.doi.org/10.1038/507410a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24436966	Bronze			2022-12-28	WOS:000333402000007
J	Churchyard, GJ; Fielding, KL; Lewis, JJ; Coetzee, L; Corbett, EL; Godfrey-Faussett, P; Hayes, RJ; Chaisson, RE; Grant, AD				Churchyard, Gavin J.; Fielding, Katherine L.; Lewis, James J.; Coetzee, Leonie; Corbett, Elizabeth L.; Godfrey-Faussett, Peter; Hayes, Richard J.; Chaisson, Richard E.; Grant, Alison D.		Thibela TB Study Team	A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALASKAN ESKIMOS; HIV-INFECTION; SOUTH-AFRICA; GOLD MINERS; PROPHYLAXIS; DISEASE; ADULTS; IMPACT	BackgroundTuberculosis is epidemic among workers in South African gold mines. We evaluated an intervention to interrupt tuberculosis transmission by means of mass screening that was linked to treatment for active disease or latent infection. MethodsIn a cluster-randomized study, we designated 15 clusters with 78,744 miners as either intervention clusters (40,981 miners in 8 clusters) or control clusters (37,763 miners in 7 clusters). In the intervention clusters, all miners were offered tuberculosis screening. If active tuberculosis was diagnosed, they were referred for treatment; if not, they were offered 9 months of isoniazid preventive therapy. The primary outcome was the cluster-level incidence of tuberculosis during the 12 months after the intervention ended. Secondary outcomes included tuberculosis prevalence at study completion. ResultsIn the intervention clusters, 27,126 miners (66.2%) underwent screening. Of these miners, 23,659 (87.2%) started taking isoniazid, and isoniazid was dispensed for 6 months or more to 35 to 79% of miners, depending on the cluster. The intervention did not reduce the incidence of tuberculosis, with rates of 3.02 per 100 person-years in the intervention clusters and 2.95 per 100 person-years in the control clusters (rate ratio in the intervention clusters, 1.00; 95% confidence interval [CI], 0.75 to 1.34; P=0.98; adjusted rate ratio, 0.96; 95% CI, 0.76 to 1.21; P=0.71), or the prevalence of tuberculosis (2.35% vs. 2.14%; adjusted prevalence ratio, 0.98; 95% CI, 0.65 to 1.48; P=0.90). Analysis of the direct effect of isoniazid in 10,909 miners showed a reduced incidence of tuberculosis during treatment (1.10 cases per 100 person-years among miners receiving isoniazid vs. 2.91 cases per 100 person-years among controls; adjusted rate ratio, 0.42; 95% CI, 0.20 to 0.88; P=0.03), but there was a subsequent rapid loss of protection. ConclusionsMass screening and treatment for latent tuberculosis had no significant effect on tuberculosis control in South African gold mines, despite the successful use of isoniazid in preventing tuberculosis during treatment.	[Churchyard, Gavin J.; Coetzee, Leonie] Aurum Inst, Johannesburg, South Africa; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin J.; Fielding, Katherine L.; Lewis, James J.; Corbett, Elizabeth L.; Godfrey-Faussett, Peter; Hayes, Richard J.; Grant, Alison D.] London Sch Hyg & Trop Med, London, England; [Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University	Churchyard, GJ (corresponding author), Aurum Inst, Suite 300,Private Bag X30500, ZA-2041 Houghton, South Africa.	gchurchyard@auruminstitute.org	Ukwaja, Kingsley N./A-7794-2013; Lewis, James/F-6333-2013	Ukwaja, Kingsley N./0000-0002-1974-8735; Hayes, Richard/0000-0002-1729-9892; Fielding, Katherine/0000-0002-6524-3754; Lewis, James/0000-0002-8603-2761; Corbett, Elizabeth/0000-0002-3552-3181; Churchyard, Gavin/0000-0002-4269-3699	Thibela TB Current Controlled Trials [ISRCTN63327174]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077486, P30AI094189] Funding Source: NIH RePORTER; Medical Research Council [G0700837, MR/K012126/1, MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish; MRC [MR/K007467/1, G0700837] Funding Source: UKRI	Thibela TB Current Controlled Trials; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Consortium to Respond Effectively to the AIDS TB Epidemic and others; Thibela TB Current Controlled Trials number, ISRCTN63327174)	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Churchyard GJ, 2010, AIDS, V24, pS19, DOI 10.1097/01.aids.0000391018.72542.46; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935; COMSTOCK GW, 1974, AM REV RESPIR DIS, V110, P195; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fielding KL, 2011, CONTEMP CLIN TRIALS, V32, P382, DOI 10.1016/j.cct.2010.12.008; Grant AD, 2005, JAMA-J AM MED ASSOC, V293, P2719, DOI 10.1001/jama.293.22.2719; Grant AD, 2010, AIDS, V24, pS29, DOI 10.1097/01.aids.0000391019.10661.66; Grant AD, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000391020.10661.eb; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Hayes RJ, 2009, INTERD STAT, P3; HORWITZ O, 1966, B WORLD HEALTH ORGAN, V35, P509; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Nyboe J, 1963, REP TUB CHEM PIL PRO; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; van Halsema CL, 2012, INT J TUBERC LUNG D, V16, P967, DOI 10.5588/ijtld.11.0122; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107	30	148	153	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					301	310		10.1056/NEJMoa1214289	http://dx.doi.org/10.1056/NEJMoa1214289			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HP	24450889	Green Accepted			2022-12-28	WOS:000330036200005
